{
  "diabetic-ketoacidosis": {
    "zh": "糖尿病酮酸中毒",
    "en": "Diabetic Ketoacidosis (DKA)",
    "definition": "低血鈣症是指離子化鈣<1.0 mmol/L的電解質異常，主要原因為副甲狀腺功能低下（甲狀腺術後醫源性最常見）、泌乳期低血鈣（eclampsia，哺乳期小型犬）、急性胰臟炎和乙二醇中毒。離子化鈣急劇下降可引起致命性肌肉痙攣和心律不整。關（淋巴瘤、肛囊腺癌）、原發性副甲狀腺功能亢進、腎衰竭和維生素D中毒（Cholecalciferol鼠藥）。慢性高血鈣導致腎小管鈣化和不可逆腎損傷，為需緊急處理的電解質異常。，最常見原因為糖尿病，其他包括應激性高血糖（貓特別常見）、腎上腺皮質功能亢進、肢端肥大症及醫源性（類固醇使用）。持續高血糖造成滲透性利尿和長期器官損傷。是中樞神經系統葡萄糖供應不足的代謝急症。病因多樣，包括胰島素瘤、敗血症、肝衰竭、新生兒低血糖、Addison's disease、醫源性胰島素過量等。腦組織幾乎完全依賴葡萄糖，故低血糖可迅速引起神經症狀。（中大型犬、中老年），約60-70%為惡性（已有轉移），但生物學行為通常較緩慢。診斷依據為低血糖時不適當的高胰島素血症。型（週邊淋巴結腫大），貓多見消化道型和縱膈型。犬淋巴瘤佔所有犬腫瘤的7-24%，中位發病年齡6-9歲。貓淋巴瘤與FeLV感染相關，消化道型常與IBD鑑別困難。免疫表型（B-cell vs T-cell）顯著影響預後。增生並抑制子宮免疫反應，細菌（主要E. coli）經子宮頸上行感染導致膿液蓄積。分開放型（陰道排膿）和閉鎖型（膿液蓄積子宮內，更危險可致破裂和腹膜炎）。壞死為特徵，伴隨全身性發炎反應，嚴重者可進展為多器官衰竭。慢性型以進行性纖維化和腺泡萎縮為主，可能導致外分泌或內分泌功能不全。犬多為急性壞死型，貓常見慢性型且常與IBD和膽管炎共存（三體炎）。",
    "synonyms": [
      "DKA",
      "Diabetic Metabolic Acidosis",
      "Ketoacidosis"
    ],
    "epidemiology": {
      "species": "犬貓皆可，犬較常見",
      "age": "主要影響中老年動物",
      "sex": "無性別傾向",
      "riskFactors": [
        "未控制或新診斷的糖尿病",
        "胰臟炎",
        "感染（尿路感染、皮膚感染）",
        "應激",
        "其他並發症（肝臟或腎臟疾病）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "多尿多渴(PU/PD)",
        "嘔吐",
        "厭食",
        "嗜睡",
        "體重減輕",
        "虛弱"
      ],
      "physicalExam": [
        "脫水（皮膚彈性差、黏膜乾燥）",
        "精神抑鬱",
        "Kussmaul呼吸（深快呼吸）",
        "呼氣時水果香氣味（丙酮）",
        "可能低體溫"
      ]
    },
    "pathophysiology": "細胞外鈣離子濃度降低使細胞膜鈉離子通道閾值電位降低，神經和肌肉細胞興奮性異常增高。臨床表現為面部搔癢抽搐、四肢僵硬到全身性肌肉痙攣和癲癇樣發作。心臟方面低血鈣延長QT間期，嚴重可導致心律不整。PTH分泌不足時，腸道鈣吸收、骨骼鈣動員和腎小管鈣再吸收均減少，形成持續性低血鈣。移直接釋放鈣。高鈣降低神經肌肉興奮性（虛弱、便秘、心搏過緩），在腎小管沉積導致腎源性尿崩症和漸進性腎間質纖維化。產生糖尿和滲透性利尿。細胞能量不足觸發脂肪分解和蛋白質分解代償，長期可導致白內障（犬）、糖尿病性神經病變（貓）和酮酸中毒。持續下降或反調節耗竭，腦細胞因葡萄糖不足而功能障礙，表現為共濟失調、視力喪失、癲癇直至昏迷。慢性反覆低血糖可導致永久性神經損傷。（腎上腺素、升糖素、皮質醇）釋放，產生震顫、虛弱等症狀，嚴重時腦部葡萄糖不足引起癲癇和昏迷。B-cell居多（60-80%），預後較T-cell佳。貓消化道低度惡性小細胞淋巴瘤以T-cell為主。腫瘤浸潤導致器官功能障礙和副腫瘤症候群（高血鈣、貧血）。",
    "diagnosis": {
      "overview": "基於臨床表現、血糖升高（>250 mg/dL）、血液pH <7.35和尿液/血液酮體陽性",
      "differentials": [
        "高血糖高滲性狀態(HHS)",
        "乳酸酸中毒",
        "尿毒症",
        "敗血症"
      ],
      "initialDB": [
        "血糖（升高>250 mg/dL）",
        "血氣分析（pH<7.35, HCO3<15）",
        "電解質（低K、低P、低Mg）",
        "BUN/Crea（腎前性氮血症）",
        "尿液分析（糖尿、酮尿）",
        "陰離子間隙（升高）"
      ],
      "advanced": [
        "血液培養",
        "胰臟特異性脂肪酶(cPL/fPL)",
        "腹部超聲"
      ]
    },
    "treatment": {
      "overview": "急性治療目標：糾正脫水、高血糖、酸中毒、電解質失衡，並識別治療潛在觸發因素",
      "acute": [
        "靜脈輸液：0.9% NaCl 或乳酸林格液，初始10-20 mL/kg/h",
        "胰島素治療：正常胰島素 CRI 0.05-0.1 U/kg/h",
        "鉀補充：20-40 mEq/L 加入輸液",
        "磷補充：若血磷<2.5 mg/dL",
        "監測血糖每1-2小時，目標下降<100 mg/dL/h"
      ],
      "chronic": [
        "調整胰島素劑量",
        "飲食管理",
        "定期血糖曲線監測",
        "治療潛在疾病"
      ]
    },
    "prognosis": "泌乳期低血鈣（eclampsia）經鈣劑靜脈注射後反應迅速，預後極佳但需停止哺乳。甲狀腺術後暫時性副甲狀腺功能低下通常數週內恢復，永久性者需終生口服鈣和維生素D。急性胰臟炎相關低血鈣為預後不良指標。嚴重低血鈣若未及時治療可致心臟驟停。",
    "pearls": [
      "DKA是獸醫內科緊急情況，需要集中護理",
      "監測電解質（尤其是鉀）對避免治療並發症至關重要",
      "避免快速降低血糖（可能導致腦水腫）",
      "某些貓在良好控制後可能進入糖尿病緩解期"
    ],
    "diagnosticAlgorithm": {
      "title": "糖尿病酮酸中毒 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "血糖與酮體",
          "details": "測定血糖、尿酮體和血中β-羥基丁酸",
          "findings": [
            "血糖 >250 mg/dL",
            "酮體陽性"
          ]
        },
        {
          "step": 2,
          "action": "血氣與電解質",
          "details": "靜脈血氣分析、電解質全套",
          "findings": [
            "代謝性酸中毒（pH <7.3, HCO3 <15）",
            "低鉀/低磷需監測"
          ]
        },
        {
          "step": 3,
          "action": "觸發因子評估",
          "details": "尋找感染、胰臟炎等觸發因子",
          "findings": [
            "CBC見應激性白血球升高",
            "cPLI/fPLI排除胰臟炎"
          ]
        },
        {
          "step": 4,
          "action": "穩定+胰島素",
          "details": "輸液穩定後開始胰島素CRI",
          "findings": [
            "血糖逐步下降",
            "酸鹼狀態改善"
          ]
        }
      ]
    },
    "monitoring": [
      "血糖q1-2h（初期）",
      "電解質q2-4h",
      "血氣q4-6h",
      "神經系統檢查",
      "尿量"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "imha": {
    "zh": "免疫介導性溶血性貧血",
    "en": "Immune-Mediated Hemolytic Anemia (IMHA)",
    "definition": "免疫介導性溶血性貧血（IMHA）是犬貓最常見的自體免疫性血液疾病，由自身抗體（IgG、IgM或補體）結合紅血球表面抗原，觸發血管外或血管內溶血，引起急性或慢性貧血。原發性IMHA無可辨識的觸發因子，繼發性可由藥物、感染或腫瘤誘發。犬發病率遠高於貓，中年雌性犬好發。",
    "synonyms": [
      "IMHA",
      "AIHA",
      "Autoimmune Hemolytic Anemia",
      "IHA"
    ],
    "epidemiology": {
      "species": "犬較貓常見",
      "age": "2-8歲犬隻最常見",
      "sex": "母犬發生率較高（約70%）",
      "riskFactors": [
        "品種傾向（Cocker Spaniel、English Springer Spaniel、Old English Sheepdog）",
        "近期疫苗接種",
        "藥物使用",
        "感染",
        "腫瘤"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "急性虛弱",
        "運動不耐",
        "厭食",
        "色素尿（紅/棕色尿）",
        "嘔吐"
      ],
      "physicalExam": [
        "黏膜蒼白或黃疸",
        "心搏過速",
        "脾腫大",
        "肝腫大",
        "發燒",
        "血紅蛋白尿"
      ]
    },
    "pathophysiology": "自身抗體（IgG或IgM）附著於紅血球表面 → 巨噬細胞在脾臟或肝臟吞噬紅血球（血管外溶血）或補體介導的直接溶解（血管內溶血）→ 急性貧血",
    "diagnosis": {
      "overview": "基於貧血、球形紅血球、陽性Coombs試驗和排除其他溶血原因",
      "differentials": [
        "Babesia感染",
        "鋅中毒",
        "洋蔥/大蒜中毒",
        "Heinz body貧血",
        "微血管病性溶血",
        "失血性貧血"
      ],
      "initialDB": [
        "CBC（再生性貧血、球形紅血球）",
        "血液抹片（球形紅血球、聚集）",
        "網織紅血球計數",
        "總膽紅素（升高）",
        "尿液分析（血紅蛋白尿、膽紅素尿）",
        "血型（備輸血用）"
      ],
      "advanced": [
        "Coombs試驗（直接抗球蛋白試驗）",
        "凝血檢查（PT/PTT）",
        "腹部超聲",
        "PCR（Babesia、Mycoplasma）",
        "骨髓檢查"
      ]
    },
    "treatment": {
      "overview": "免疫抑制治療為主，重症需輸血支持",
      "acute": [
        "Prednisolone: 2-3 mg/kg PO q12h（狗）；2-4 mg/kg PO q12-24h（貓）",
        "輸血：若PCV<15%或出現組織缺氧症狀",
        "重症加用：Azathioprine 2 mg/kg PO q24h（狗）或Cyclosporine 5 mg/kg PO q12h",
        "血栓預防：低分子肝素或Aspirin"
      ],
      "chronic": [
        "緩慢減少類固醇劑量（數月）",
        "監測復發",
        "定期CBC追蹤"
      ]
    },
    "prognosis": "整體存活率50-70%。約30%會復發。血栓栓塞是主要死亡原因。早期積極治療可改善預後。",
    "pearls": [
      "約60-70%為原發性（特發性），30-40%為繼發性",
      "血栓栓塞併發症常見且致命",
      "治療反應通常在1-2週內可見",
      "長期免疫抑制治療需監測副作用"
    ],
    "diagnosticAlgorithm": {
      "title": "免疫介導性溶血性貧血 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "詢問病史、用藥史及疫苗史，進行全面理學檢查",
          "findings": [
            "黏膜蒼白或黃疸",
            "心搏過速",
            "脾臟腫大",
            "發燒"
          ]
        },
        {
          "step": 2,
          "action": "血液學檢查",
          "details": "進行CBC含網織紅血球計數及血液抹片檢查",
          "findings": [
            "再生性貧血（網織紅血球增加）",
            "球形紅血球增多",
            "白血球增多",
            "血小板減少"
          ]
        },
        {
          "step": 3,
          "action": "免疫學檢測",
          "details": "進行Coombs試驗（直接抗球蛋白試驗）及自體凝集試驗",
          "findings": [
            "Coombs試驗陽性",
            "鹽水自體凝集試驗陽性",
            "血清膽紅素升高"
          ]
        },
        {
          "step": 4,
          "action": "進階影像與排除",
          "details": "腹部超音波及胸腔X光，排除潛在病因",
          "findings": [
            "肝脾腫大",
            "排除腫瘤性疾病",
            "排除感染性病因（壁蝨傳染病）"
          ]
        }
      ]
    },
    "monitoring": [
      "PCV每日（住院期間）",
      "網織紅血球計數",
      "血小板（排除Evans syndrome）",
      "凝血功能"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "pancreatitis": {
    "zh": "胰臟炎",
    "en": "Pancreatitis",
    "definition": "胰臟炎是胰臟腺泡細胞的發炎性疾病，由胰酶在腺泡內異常提前活化引起自身消化。急性型以胰臟水腫和壞死為特徵，伴隨全身性發炎反應。慢性型以進行性纖維化和腺泡萎縮為主。犬多為急性壞死型，貓常見慢性型且常與IBD和膽管炎共存（三體炎）。",
    "synonyms": [
      "Acute Pancreatitis",
      "Chronic Pancreatitis"
    ],
    "epidemiology": {
      "species": "犬貓皆常見",
      "age": "中老年動物較多",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "高脂飲食",
        "肥胖",
        "高三酸甘油脂血症",
        "藥物（Azathioprine、KBr、L-asparaginase）",
        "內分泌疾病（糖尿病、甲低、Cushing）",
        "腹部創傷"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "厭食",
        "嘔吐",
        "腹瀉",
        "虛弱",
        "腹痛（犬較明顯）"
      ],
      "physicalExam": [
        "腹部疼痛（犬典型「祈禱姿勢」）",
        "脫水",
        "發燒或低體溫",
        "黃疸（嚴重病例）",
        "休克（重症）"
      ]
    },
    "pathophysiology": "正常情況下胰酶在腸道活化；各種原因導致胰酶在胰臟內提前活化 → 胰臟自身消化 → 局部及全身發炎反應 → 可能進展為多器官功能障礙",
    "diagnosis": {
      "overview": "基於臨床症狀、影像學和胰臟特異性酶升高（cPL/fPL）診斷",
      "differentials": [
        "腸阻塞",
        "腸套疊",
        "異物",
        "腹膜炎",
        "膽道疾病",
        "急性腎衰竭"
      ],
      "initialDB": [
        "CBC（白血球升高或降低）",
        "生化（肝指數升高、氮血症、電解質異常）",
        "cPL/fPL（胰臟脂肪酶免疫反應測試）",
        "腹部X光",
        "腹部超聲（最敏感）"
      ],
      "advanced": [
        "CT掃描",
        "腹水分析",
        "組織病理（確診金標準但很少執行）"
      ]
    },
    "treatment": {
      "overview": "支持性治療為主：輸液、止吐、止痛、營養支持",
      "acute": [
        "靜脈輸液：糾正脫水和電解質失衡",
        "止吐藥：Maropitant 1 mg/kg SQ/IV q24h 或 Ondansetron",
        "止痛藥：Buprenorphine、Butorphanol、或CRI fentanyl/ketamine",
        "早期腸內營養（優於NPO）",
        "抗生素：若懷疑感染或穿孔"
      ],
      "chronic": [
        "低脂飲食",
        "胰酶補充（若有EPI）",
        "疼痛管理",
        "控制潛在疾病"
      ]
    },
    "prognosis": "輕度：預後良好。重度壞死性胰臟炎：死亡率可達30-40%。貓的慢性胰臟炎常與IBD和膽管炎同時發生（三體炎）。",
    "pearls": [
      "貓的胰臟炎症狀通常比犬更隱蔽",
      "不再建議長期禁食，早期腸內營養有益",
      "監測並治療併發症（DIC、SIRS、MODS）",
      "貓常見三體炎（胰臟炎+IBD+膽管炎）"
    ],
    "diagnosticAlgorithm": {
      "title": "胰臟炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "詢問飲食史、嘔吐及腹痛症狀，進行腹部觸診",
          "findings": [
            "上腹部疼痛",
            "嘔吐",
            "厭食",
            "脫水"
          ]
        },
        {
          "step": 2,
          "action": "血液生化檢查",
          "details": "進行CBC、血清生化及胰臟特異性脂肪酶檢測",
          "findings": [
            "犬胰臟特異性脂肪酶（cPLI/Spec cPL）升高",
            "白血球增多",
            "肝指數輕度升高",
            "氮血症"
          ]
        },
        {
          "step": 3,
          "action": "腹部超音波",
          "details": "評估胰臟形態及周圍組織變化",
          "findings": [
            "胰臟腫大、低回音",
            "胰臟周圍脂肪高回音",
            "腹腔積液",
            "十二指腸壁增厚"
          ]
        },
        {
          "step": 4,
          "action": "鑑別排除",
          "details": "排除腸阻塞、異物及其他急腹症",
          "findings": [
            "排除腸道異物",
            "排除胃擴張扭轉",
            "排除膽道阻塞"
          ]
        }
      ]
    },
    "monitoring": [
      "臨床症狀",
      "電解質",
      "疼痛評估",
      "營養狀態",
      "cPL/fPL追蹤"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "hypoadrenocorticism": {
    "zh": "腎上腺皮質功能低下症",
    "en": "Hypoadrenocorticism (Addison's Disease)",
    "definition": "腎上腺皮質功能低下症（Addison's disease）是由腎上腺皮質被免疫介導性破壞或萎縮導致糖皮質素和鹽皮質素分泌不足的內分泌疾病。典型型同時缺乏皮質醇和醛固酮，非典型型僅缺乏皮質醇。犬以年輕至中年雌犬好發，Nova Scotia Duck Tolling Retriever和Standard Poodle有遺傳傾向。",
    "synonyms": [
      "Addison's Disease",
      "愛迪生病",
      "Adrenal Insufficiency"
    ],
    "epidemiology": {
      "species": "犬為主，貓罕見",
      "age": "年輕至中年犬（平均4歲）",
      "sex": "母犬較多（約70%）",
      "riskFactors": [
        "品種傾向（Standard Poodle、West Highland White Terrier、Great Dane、Portuguese Water Dog）",
        "免疫介導性疾病",
        "腎上腺出血/梗塞"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "週期性虛弱",
        "嗜睡",
        "厭食",
        "嘔吐",
        "腹瀉",
        "體重減輕",
        "症狀間歇性且應激後加重"
      ],
      "physicalExam": [
        "脫水",
        "低體溫",
        "心搏過緩",
        "虛弱休克（腎上腺危象）",
        "腹痛"
      ]
    },
    "pathophysiology": "自體免疫破壞腎上腺皮質（最常見）→ 糖皮質激素缺乏（代謝、應激反應）+ 鹽皮質激素缺乏（Na/K調節）→ 低鈉、高鉀、低血壓、低血糖、代謝性酸中毒",
    "diagnosis": {
      "overview": "典型電解質異常（低Na、高K、Na:K<27）加ACTH刺激試驗確診",
      "differentials": [
        "急性腎衰竭",
        "腸道疾病",
        "敗血症",
        "其他原因休克"
      ],
      "initialDB": [
        "電解質（低Na、高K、Na:K<27）",
        "BUN/Crea（腎前性升高）",
        "血糖（可能低）",
        "CBC（輕度貧血、無應激白血球圖）",
        "ECG（高K變化）"
      ],
      "advanced": [
        "ACTH刺激試驗（gold standard）",
        "基礎皮質醇",
        "內源性ACTH水平",
        "腹部超聲（小腎上腺）"
      ]
    },
    "treatment": {
      "overview": "急性危象需積極液體復甦和糖皮質激素；長期需終身荷爾蒙替代",
      "acute": [
        "靜脈輸液：0.9% NaCl 快速糾正低血壓和脫水",
        "Dexamethasone: 0.5-2 mg/kg IV（不影響ACTH刺激試驗）",
        "或 Hydrocortisone: 1-2 mg/kg IV q6h",
        "監測並糾正低血糖",
        "ECG監測高血鉀心律不整"
      ],
      "chronic": [
        "Fludrocortisone: 0.01-0.02 mg/kg PO q12-24h",
        "或 DOCP (Percorten-V): 2.2 mg/kg IM/SQ q25-28天",
        "Prednisolone: 0.1-0.2 mg/kg PO q24h（可能需要）"
      ]
    },
    "prognosis": "經適當的鹽皮質素（DOCP或Fludrocortisone）和糖皮質素替代治療後，預後極佳，大多數犬可維持正常壽命和生活品質。需終生每月注射DOCP和每日口服Prednisone，定期監測電解質。Addisonian crisis若未及時治療致死率高，但穩定後長期預後良好。",
    "pearls": [
      "「偉大的模仿者」- 症狀非特異性易被誤診",
      "約30%無典型電解質異常（非典型Addison）",
      "應激（手術、疾病）可誘發危象",
      "終身治療但預後良好"
    ],
    "diagnosticAlgorithm": {
      "title": "腎上腺皮質功能低下症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "詢問慢性嘔吐、虛弱、體重減輕病史",
          "findings": [
            "間歇性嘔吐與腹瀉",
            "虛弱無力",
            "脫水",
            "低體溫"
          ]
        },
        {
          "step": 2,
          "action": "血液生化與電解質",
          "details": "CBC及血清生化學檢查",
          "findings": [
            "高血鉀",
            "低血鈉",
            "鈉鉀比<27",
            "氮血症",
            "低血糖",
            "嗜酸性球增多"
          ]
        },
        {
          "step": 3,
          "action": "ACTH刺激試驗",
          "details": "注射合成ACTH後測量腎上腺皮質醇反應",
          "findings": [
            "基礎皮質醇極低（<1 μg/dL）",
            "刺激後皮質醇無明顯上升",
            "確診腎上腺皮質功能不全"
          ]
        },
        {
          "step": 4,
          "action": "心電圖與影像",
          "details": "評估高血鉀造成的心臟影響及腎上腺大小",
          "findings": [
            "心電圖顯示高鉀變化（T波高尖、QRS增寬）",
            "胸腔X光心臟縮小",
            "超音波腎上腺萎縮"
          ]
        }
      ]
    },
    "monitoring": [
      "電解質每2-4週（調整期）",
      "穩定後每3-6月",
      "臨床症狀"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "hyperadrenocorticism": {
    "zh": "腎上腺皮質功能亢進症",
    "en": "Hyperadrenocorticism (Cushing's Disease)",
    "definition": "腎上腺皮質功能亢進導致皮質醇過度分泌的內分泌疾病，可由腦下垂體腫瘤(PDH)或腎上腺腫瘤(AT)引起。",
    "synonyms": [
      "Cushing's Disease",
      "Cushing's Syndrome",
      "庫欣症",
      "庫興症"
    ],
    "epidemiology": {
      "species": "犬常見，貓罕見",
      "age": "中老年犬（平均10歲）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "品種傾向（Poodle、Dachshund、Beagle、Boston Terrier）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "多尿多渴",
        "多食",
        "腹部膨大",
        "脫毛（對稱性）",
        "運動不耐",
        "喘氣",
        "皮膚變薄"
      ],
      "physicalExam": [
        "壺腹狀腹部",
        "肌肉萎縮",
        "皮膚薄、鈣化",
        "肝腫大",
        "對稱性脫毛",
        "喜樂蒂"
      ]
    },
    "pathophysiology": "PDH(85%)：腦下垂體腫瘤過度分泌ACTH → 雙側腎上腺增生 → 皮質醇過量。AT(15%)：腎上腺腫瘤自主分泌皮質醇。",
    "diagnosis": {
      "overview": "需先確認高皮質醇症再區分PDH vs AT",
      "differentials": [
        "糖尿病",
        "甲狀腺功能低下",
        "肝病"
      ],
      "initialDB": [
        "尿皮質醇/肌酐比(UCCR)",
        "低劑量Dex抑制試驗(LDDS)",
        "ACTH刺激試驗",
        "肝指數（ALP升高）",
        "尿比重（稀釋）"
      ],
      "advanced": [
        "高劑量Dex抑制試驗(HDDS)",
        "內源性ACTH",
        "腹部超聲（腎上腺大小）",
        "腦部MRI/CT"
      ]
    },
    "treatment": {
      "overview": "依據病因選擇藥物或手術治療",
      "acute": [
        "Trilostane: 2-5 mg/kg PO q12h（首選）",
        "Mitotane: 誘導期25-50 mg/kg/day分次給予",
        "監測ACTH刺激試驗指導劑量調整"
      ],
      "chronic": [
        "終身藥物控制",
        "腎上腺切除術（AT）",
        "腦下垂體放射治療（PDH大型腫瘤）"
      ]
    },
    "prognosis": "藥物控制：中位存活約2年。AT手術切除：若良性預後好。腦下垂體大型腫瘤：預後較差。",
    "pearls": [
      "85%為PDH，15%為AT",
      "Trilostane需定期ACTH刺激試驗監測",
      "警惕醫源性Cushing（長期類固醇使用）",
      "糖尿病是常見併發症"
    ],
    "diagnosticAlgorithm": {
      "title": "腎上腺皮質功能亢進症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "詢問多喝多尿、腹部膨大、皮膚變化病史",
          "findings": [
            "多飲多尿",
            "腹部膨大（壺腹狀）",
            "對稱性脫毛",
            "皮膚變薄"
          ]
        },
        {
          "step": 2,
          "action": "血液生化篩檢",
          "details": "CBC、血清生化及尿液分析",
          "findings": [
            "鹼性磷酸酶顯著升高",
            "膽固醇與三酸甘油酯升高",
            "尿比重低",
            "應激性白血球圖譜"
          ]
        },
        {
          "step": 3,
          "action": "內分泌功能試驗",
          "details": "低劑量地塞米松抑制試驗（LDDS）或ACTH刺激試驗",
          "findings": [
            "LDDS 8小時皮質醇未抑制",
            "ACTH刺激後皮質醇過度升高",
            "尿皮質醇/肌酐比值升高"
          ]
        },
        {
          "step": 4,
          "action": "定位診斷",
          "details": "腹部超音波及高劑量地塞米松抑制試驗區分垂體依賴型與腎上腺腫瘤型",
          "findings": [
            "雙側腎上腺腫大（垂體依賴型）",
            "單側腎上腺腫瘤",
            "對側腎上腺萎縮",
            "腦部MRI評估垂體"
          ]
        }
      ]
    },
    "monitoring": [
      "ACTH刺激試驗（治療開始後10-14天，之後定期）",
      "電解質",
      "臨床症狀",
      "肝功能"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "parvovirus": {
    "zh": "犬小病毒腸炎",
    "en": "Canine Parvovirus Enteritis (CPV)",
    "definition": "犬小病毒腸炎（CPV-2）是犬最具傳染性和致死性的病毒性腸炎，由CPV-2a/2b/2c變異株引起。病毒主要攻擊快速分裂細胞（腸道隱窩上皮和骨髓淋巴前驅細胞），導致嚴重出血性腹瀉、白血球減少和免疫抑制。6週至6月齡未完成疫苗接種的幼犬最易感，病毒在環境中可存活數月。",
    "synonyms": [
      "CPV",
      "Parvo",
      "犬小病毒",
      "Canine Parvovirus"
    ],
    "epidemiology": {
      "species": "犬（貓有貓小病毒/貓瘟）",
      "age": "幼犬（6週-6月齡）最易感",
      "sex": "無性別傾向",
      "riskFactors": [
        "未接種疫苗",
        "品種傾向（Rottweiler、Doberman、GSD）",
        "免疫抑制",
        "寄生蟲感染"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "急性嘔吐",
        "血便/水樣腹瀉",
        "厭食",
        "嗜睡",
        "快速脫水"
      ],
      "physicalExam": [
        "脫水",
        "發燒或低體溫",
        "腹痛",
        "虛弱",
        "休克（重症）"
      ]
    },
    "pathophysiology": "病毒經口進入 → 感染快速分裂細胞（腸道隱窩上皮、骨髓、淋巴組織）→ 腸道絨毛壞死 → 嚴重腹瀉和嘔吐 → 細菌移位 → 敗血症/SIRS",
    "diagnosis": {
      "overview": "臨床症狀加糞便ELISA快篩，幼犬急性出血性腹瀉高度懷疑",
      "differentials": [
        "冠狀病毒",
        "腸道寄生蟲",
        "異物",
        "腸套疊",
        "細菌性腸炎",
        "出血性胃腸炎(HGE)"
      ],
      "initialDB": [
        "糞便Parvovirus ELISA",
        "CBC（白血球減少為特徵）",
        "生化（低血糖、電解質失衡）",
        "糞便寄生蟲檢查"
      ],
      "advanced": [
        "糞便PCR",
        "血液培養（懷疑敗血症）"
      ]
    },
    "treatment": {
      "overview": "支持治療為主：積極輸液、止吐、抗生素、營養支持",
      "acute": [
        "靜脈輸液：維持補充（計算脫水量+維持量+持續流失）",
        "止吐藥：Maropitant 1 mg/kg SQ q24h 或 Ondansetron",
        "抗生素：Ampicillin + Enrofloxacin 或 Metronidazole（預防敗血症）",
        "低血糖糾正：Dextrose 補充",
        "營養支持：早期腸內營養（優於NPO）"
      ],
      "chronic": [
        "疫苗接種計劃",
        "環境消毒（漂白水1:30）"
      ]
    },
    "prognosis": "經積極住院治療（IV輸液、抗嘔吐、早期腸道營養、廣效抗生素），存活率可達85-95%。未治療者死亡率>90%。預後不良指標包括嚴重白血球減少（<1000/μL）、低白蛋白血症和併發敗血症。Rottweiler和Doberman品種重症比例較高。恢復後產生長期免疫。",
    "pearls": [
      "白血球減少是重要預後指標",
      "糞便ELISA可能有假陰性（早期或大量病毒脫落後）",
      "早期腸內營養比長期禁食更好",
      "康復後可長期排毒，環境需徹底消毒"
    ],
    "diagnosticAlgorithm": {
      "title": "犬小病毒腸炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "詢問疫苗史、年齡及接觸史，評估脫水程度",
          "findings": [
            "幼犬急性嘔吐與血便",
            "嚴重脫水",
            "發燒或低體溫",
            "腹痛"
          ]
        },
        {
          "step": 2,
          "action": "快速抗原檢測",
          "details": "糞便CPV ELISA快速篩檢",
          "findings": [
            "CPV抗原陽性",
            "注意疫苗後5-12天可能假陽性"
          ]
        },
        {
          "step": 3,
          "action": "血液學檢查",
          "details": "CBC評估白血球數量",
          "findings": [
            "嚴重白血球減少（尤其淋巴球）",
            "嗜中性球減少",
            "血容比降低",
            "低白蛋白血症"
          ]
        },
        {
          "step": 4,
          "action": "支持性監測與排除",
          "details": "持續監測電解質及血糖，排除其他腸炎原因",
          "findings": [
            "低血糖",
            "低血鉀",
            "排除腸套疊",
            "排除異物阻塞"
          ]
        }
      ]
    },
    "monitoring": [
      "電解質",
      "血糖",
      "白血球計數",
      "體溫",
      "糞便性狀"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "pyometra": {
    "zh": "子宮蓄膿",
    "en": "Pyometra",
    "definition": "子宮蓄膿是未絕育母犬貓最常見的生殖系統急症，在黃體期因黃體素促進子宮內膜增生並抑制免疫反應，細菌（主要E. coli）經子宮頸上行感染導致膿液蓄積。分開放型（陰道排膿）和閉鎖型（更危險可致破裂和腹膜炎）。中老年未絕育母犬發病率最高。",
    "synonyms": [
      "Pyometra",
      "子宮積膿",
      "Uterine Infection"
    ],
    "epidemiology": {
      "species": "犬貓（犬更常見）",
      "age": "中老年未絕育母犬/貓（平均7-8歲）",
      "sex": "僅限未絕育母犬/貓",
      "riskFactors": [
        "未絕育",
        "先前假懷孕",
        "外源性荷爾蒙使用",
        "發情後4-8週"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "發情後4-8週出現症狀",
        "陰部分泌物（開放型）",
        "多尿多渴",
        "厭食",
        "嘔吐",
        "腹部膨大"
      ],
      "physicalExam": [
        "發燒",
        "脫水",
        "腹部膨大",
        "陰部分泌物（開放型）",
        "休克（重症/子宮破裂）"
      ]
    },
    "pathophysiology": "黃體期孕酮影響 → 子宮內膜增生 → 細菌感染（主要E. coli）→ 子宮腔積膿 → 內毒素血症 → 全身性炎症反應",
    "diagnosis": {
      "overview": "未絕育母犬發情後出現全身症狀，腹部超聲確診",
      "differentials": [
        "懷孕",
        "子宮積液",
        "腹水",
        "膀胱疾病"
      ],
      "initialDB": [
        "CBC（白血球升高伴左移）",
        "生化（氮血症、肝指數升高）",
        "腹部X光",
        "腹部超聲（子宮擴張、管狀液體）"
      ],
      "advanced": [
        "子宮分泌物培養",
        "凝血功能"
      ]
    },
    "treatment": {
      "overview": "卵巢子宮切除術（OHE）是首選治療",
      "acute": [
        "靜脈輸液：術前穩定",
        "廣譜抗生素",
        "緊急卵巢子宮切除術（OHE）",
        "術後監測敗血症/腹膜炎"
      ],
      "chronic": [
        "保守治療（僅限繁殖犬）：Aglepristone + Prostaglandin",
        "術後長期抗生素"
      ]
    },
    "prognosis": "手術治療預後良好（>90%存活）。保守治療復發率高（50-70%）。子宮破裂/敗血症預後謹慎。",
    "pearls": [
      "閉鎖型比開放型更危險（無法排膿）",
      "術前穩定但不要延遲手術",
      "E. coli是最常見致病菌",
      "預防性絕育可完全預防"
    ],
    "diagnosticAlgorithm": {
      "title": "子宮蓄膿 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "詢問發情週期史、未絕育母犬/貓，評估陰道分泌物",
          "findings": [
            "未絕育中老年母犬",
            "發情後2-8週發病",
            "陰道膿性分泌物（開放型）",
            "腹部膨大"
          ]
        },
        {
          "step": 2,
          "action": "血液學與生化",
          "details": "CBC及血清生化檢查",
          "findings": [
            "白血球顯著增多伴左移",
            "帶狀嗜中性球增加",
            "氮血症",
            "高球蛋白血症"
          ]
        },
        {
          "step": 3,
          "action": "腹部影像",
          "details": "X光及超音波確認子宮狀態",
          "findings": [
            "子宮明顯擴張充滿液體",
            "超音波顯示子宮腔積液",
            "排除子宮腫瘤",
            "評估卵巢"
          ]
        },
        {
          "step": 4,
          "action": "術前評估與治療",
          "details": "評估手術風險並準備卵巢子宮切除術",
          "findings": [
            "評估凝血功能",
            "穩定血液動力學",
            "緊急卵巢子宮摘除術"
          ]
        }
      ]
    },
    "monitoring": [
      "體溫",
      "白血球",
      "腎功能",
      "術後傷口"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "hyperthyroidism": {
    "zh": "甲狀腺功能亢進",
    "en": "Hyperthyroidism",
    "definition": "甲狀腺功能亢進是中老年貓最常見的內分泌疾病（8歲以上發病率約10%），由甲狀腺功能性腺瘤（>95%良性）引起過量T4分泌。過量甲狀腺素加速全身代謝率，影響心血管、消化、神經肌肉等多系統。雙側甲狀腺受累約佔70%。犬甲亢罕見，多為甲狀腺癌。",
    "synonyms": [
      "甲亢",
      "Feline Hyperthyroidism",
      "Thyrotoxicosis"
    ],
    "epidemiology": {
      "species": "貓（犬罕見，通常為甲狀腺癌）",
      "age": "中老年貓（平均12-13歲）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "年齡>8歲",
        "室內貓",
        "罐頭食品餵食"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "體重減輕（食慾正常或增加）",
        "多食",
        "多尿多渴",
        "嘔吐/腹瀉",
        "過動",
        "被毛差"
      ],
      "physicalExam": [
        "消瘦",
        "頸部可觸及甲狀腺結節（70%）",
        "心搏過速",
        "收縮期心雜音",
        "高血壓"
      ]
    },
    "pathophysiology": "甲狀腺腺瘤（>95%良性）→ T4過度分泌 → 代謝率增加 → 心輸出量增加、心肌肥厚、蛋白質分解增加",
    "diagnosis": {
      "overview": "基於臨床症狀加血清T4升高確診",
      "differentials": [
        "糖尿病",
        "慢性腎病",
        "腸道疾病",
        "腫瘤"
      ],
      "initialDB": [
        "血清總T4（通常>4 μg/dL）",
        "CBC（紅血球增多）",
        "生化（肝酵素升高）",
        "血壓",
        "尿比重"
      ],
      "advanced": [
        "游離T4（邊緣病例）",
        "甲狀腺掃描（定位）",
        "T3抑制試驗",
        "心臟超聲"
      ]
    },
    "treatment": {
      "overview": "藥物、手術或放射碘治療",
      "acute": [
        "Methimazole: 2.5 mg PO q12h（起始劑量），調整至維持T4正常",
        "或 Carbimazole: 5 mg PO q12h",
        "控制心搏過速：Atenolol 6.25-12.5 mg PO q12-24h"
      ],
      "chronic": [
        "長期藥物控制",
        "甲狀腺切除術",
        "放射碘治療（I-131）：治癒率95%",
        "限碘飲食（y/d）"
      ]
    },
    "prognosis": "治療後預後良好。平均存活2-4年（取決於併發症）。注意治療後可能揭示潛在CKD。",
    "pearls": [
      "甲亢可「掩蓋」CKD（因增加腎血流），治療後肌酐可能上升",
      "Methimazole試驗可在手術/I-131前評估腎功能",
      "95%以上為良性腺瘤",
      "心臟變化通常在治療後可逆"
    ],
    "diagnosticAlgorithm": {
      "title": "甲狀腺功能亢進 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "觸診甲狀腺、評估體重變化及心率",
          "findings": [
            "甲狀腺腫大可觸及",
            "體重減輕但食慾增加",
            "心搏過速",
            "被毛粗糙"
          ]
        },
        {
          "step": 2,
          "action": "甲狀腺功能檢測",
          "details": "測量血清總T4及游離T4",
          "findings": [
            "血清總T4升高",
            "游離T4升高",
            "若T4邊界值則進行TSH抑制試驗"
          ]
        },
        {
          "step": 3,
          "action": "全面評估併發症",
          "details": "血壓測量、心臟評估及腎功能檢查",
          "findings": [
            "高血壓",
            "心臟肥大",
            "腎指數需評估（治療後可能惡化）",
            "肝指數升高"
          ]
        },
        {
          "step": 4,
          "action": "影像定位",
          "details": "甲狀腺閃爍掃描或超音波",
          "findings": [
            "甲狀腺閃爍掃描定位功能亢進組織",
            "超音波評估甲狀腺結節大小",
            "排除甲狀腺癌"
          ]
        }
      ]
    },
    "monitoring": [
      "T4每2-4週（調整期）",
      "腎功能",
      "血壓",
      "肝功能（Methimazole副作用）"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "hypothyroidism": {
    "zh": "甲狀腺功能低下",
    "en": "Hypothyroidism",
    "definition": "甲狀腺功能低下是犬最常見的內分泌疾病之一，95%以上為原發性，由淋巴球性甲狀腺炎（免疫介導性，50%）或特發性甲狀腺萎縮（50%）導致甲狀腺組織漸進性破壞、T4產量不足。好發於中大型犬（Golden Retriever、Doberman），4-10歲發病。貓原發性甲低罕見。",
    "synonyms": [
      "甲低",
      "Canine Hypothyroidism"
    ],
    "epidemiology": {
      "species": "犬（貓罕見）",
      "age": "中年犬（4-10歲）",
      "sex": "無明顯性別傾向（絕育犬風險略高）",
      "riskFactors": [
        "品種傾向（Golden Retriever、Doberman、Irish Setter、GSD、Dachshund）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "嗜睡",
        "體重增加",
        "不耐冷",
        "皮膚問題",
        "被毛差/脫毛"
      ],
      "physicalExam": [
        "肥胖",
        "對稱性脫毛",
        "皮膚增厚",
        "色素沉著",
        "心搏過緩",
        "悲傷面容"
      ]
    },
    "pathophysiology": "淋巴球性甲狀腺炎（自體免疫）或特發性萎縮 → T4分泌減少 → 代謝率下降 → 皮膚、心血管、神經肌肉、生殖系統影響",
    "diagnosis": {
      "overview": "臨床症狀加T4降低和TSH升高",
      "differentials": [
        "腎上腺皮質功能亢進",
        "其他內分泌疾病",
        "皮膚病"
      ],
      "initialDB": [
        "血清總T4（降低）",
        "TSH（升高）",
        "游離T4",
        "膽固醇（常升高）",
        "輕度貧血"
      ],
      "advanced": [
        "甲狀腺球蛋白抗體（TgAA）",
        "TSH刺激試驗",
        "甲狀腺超聲"
      ]
    },
    "treatment": {
      "overview": "終身甲狀腺激素補充",
      "acute": [
        "Levothyroxine (T4): 0.02 mg/kg PO q12h（起始）",
        "4-6週後評估並調整劑量"
      ],
      "chronic": [
        "終身口服Levothyroxine",
        "定期監測T4水平"
      ]
    },
    "prognosis": "經Levothyroxine替代治療（犬0.02 mg/kg PO q12h）後預後極佳，大多數臨床症狀在4-8週內改善，皮膚和毛髮恢復可能需3-6個月。需終生用藥和定期監測T4/TSH濃度。治療後預期壽命正常。神經性甲低（myxedema coma）罕見但若未及時治療可致命。",
    "pearls": [
      "「低T4綜合症」：其他疾病可假性降低T4",
      "TSH+T4同時測定更準確",
      "治療後精神狀態通常首先改善",
      "心肌病變和神經症狀治療後可改善"
    ],
    "diagnosticAlgorithm": {
      "title": "甲狀腺功能低下 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估皮膚變化、體重增加及精神狀態",
          "findings": [
            "體重增加",
            "對稱性非搔癢性脫毛",
            "皮膚增厚（黏液水腫）",
            "精神遲鈍"
          ]
        },
        {
          "step": 2,
          "action": "甲狀腺功能檢測",
          "details": "測量血清總T4、游離T4及TSH",
          "findings": [
            "血清總T4降低",
            "游離T4降低",
            "TSH升高",
            "抗甲狀腺球蛋白抗體陽性"
          ]
        },
        {
          "step": 3,
          "action": "血液生化輔助",
          "details": "CBC及血清生化檢查尋找支持證據",
          "findings": [
            "輕度非再生性貧血",
            "高膽固醇血症",
            "高三酸甘油酯血症",
            "肌酸激酶輕度升高"
          ]
        },
        {
          "step": 4,
          "action": "鑑別排除",
          "details": "排除非甲狀腺疾病造成的低T4",
          "findings": [
            "排除藥物影響（類固醇、磺胺類）",
            "排除嚴重全身性疾病（病態甲狀腺症候群）",
            "甲狀腺補充試驗性治療反應評估"
          ]
        }
      ]
    },
    "monitoring": [
      "T4（給藥後4-6小時）",
      "TSH",
      "臨床症狀",
      "體重"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "lymphoma": {
    "zh": "淋巴瘤",
    "en": "Lymphoma",
    "definition": "淋巴瘤是犬貓最常見的造血系統惡性腫瘤，起源於T或B淋巴細胞的惡性增殖。犬多見多中心型（週邊淋巴結腫大），貓多見消化道型和縱膈型。免疫表型（B-cell vs T-cell）顯著影響預後和治療反應。",
    "synonyms": [
      "LSA",
      "Lymphosarcoma",
      "淋巴肉瘤"
    ],
    "epidemiology": {
      "species": "犬貓皆常見",
      "age": "中老年（犬6-9歲，貓任何年齡）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "品種傾向（Golden Retriever、Boxer）",
        "FeLV感染（貓）",
        "環境因素"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "淋巴結腫大（犬最常見）",
        "體重減輕",
        "厭食",
        "嘔吐/腹瀉（消化道型）",
        "呼吸困難（縱膈型）"
      ],
      "physicalExam": [
        "無痛性淋巴結腫大",
        "肝脾腫大",
        "胸水（縱膈型）",
        "腸道增厚（消化道型）"
      ]
    },
    "pathophysiology": "淋巴細胞在基因突變驅動下發生克隆性惡性增殖，脫離正常凋亡調控，經血液和淋巴系統擴散全身。犬多中心型以B-cell居多（60-80%），貓消化道型以T-cell為主。腫瘤浸潤導致器官功能障礙和副腫瘤症候群（高血鈣、貧血）。",
    "diagnosis": {
      "overview": "細針抽吸細胞學加影像學分期",
      "differentials": [
        "其他腫瘤",
        "感染性淋巴結炎",
        "反應性淋巴結增生"
      ],
      "initialDB": [
        "淋巴結細針抽吸",
        "CBC",
        "生化",
        "胸腹部X光/超聲",
        "骨髓檢查"
      ],
      "advanced": [
        "組織病理",
        "免疫組化（B/T細胞）",
        "流式細胞術",
        "PARR（克隆性分析）"
      ]
    },
    "treatment": {
      "overview": "化療為主（CHOP類方案）",
      "acute": [
        "CHOP方案（犬）：Cyclophosphamide、Doxorubicin、Vincristine、Prednisolone",
        "貓：COP方案或單藥Chlorambucil",
        "縱膈型緊急：胸水引流、類固醇"
      ],
      "chronic": [
        "維持化療或監測復發",
        "二線化療（復發時）"
      ]
    },
    "prognosis": "犬多中心型化療：中位存活12-14月。貓消化道型：中位存活7-10月。B細胞預後優於T細胞。",
    "pearls": [
      "犬多中心型最常見，貓消化道型最常見",
      "細針抽吸通常足夠診斷",
      "化療可達80-90%緩解率",
      "復發後預後較差"
    ],
    "diagnosticAlgorithm": {
      "title": "淋巴瘤 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "觸診淋巴結、評估全身狀態及分期",
          "findings": [
            "周邊淋巴結無痛性腫大",
            "肝脾腫大",
            "體重減輕",
            "可能無其他症狀（多中心型）"
          ]
        },
        {
          "step": 2,
          "action": "細胞學檢查",
          "details": "淋巴結細針抽吸細胞學",
          "findings": [
            "大量單一型態的淋巴母細胞",
            "有絲分裂像增多",
            "正常淋巴結結構消失",
            "可區分B細胞或T細胞型"
          ]
        },
        {
          "step": 3,
          "action": "分期檢查",
          "details": "CBC、生化、胸腹腔影像及骨髓檢查",
          "findings": [
            "血液異常淋巴球增多",
            "高血鈣（T細胞型）",
            "縱膈腔腫塊（縱膈型）",
            "骨髓浸潤"
          ]
        },
        {
          "step": 4,
          "action": "免疫表型與確診",
          "details": "流式細胞儀或免疫組織化學分型",
          "findings": [
            "B細胞型（CD79a+）預後較佳",
            "T細胞型（CD3+）預後較差",
            "確認分期（WHO I-V期）",
            "指導化療方案選擇"
          ]
        }
      ]
    },
    "monitoring": [
      "淋巴結大小",
      "CBC（化療毒性）",
      "影像學追蹤"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "insulinoma": {
    "zh": "胰島素瘤",
    "en": "Insulinoma",
    "definition": "胰島素瘤是胰臟β細胞的功能性神經內分泌腫瘤，自主性分泌胰島素導致反覆低血糖。犬中大型犬較常見，約60-70%已有轉移但生物學行為較緩慢。",
    "synonyms": [
      "β細胞瘤",
      "Insulin-secreting tumor",
      "胰島細胞瘤"
    ],
    "epidemiology": {
      "species": "犬為主，貓罕見",
      "age": "中老年犬（平均9-10歲）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "大型犬較多（GSD、Irish Setter、Golden Retriever）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "間歇性虛弱",
        "癲癇發作",
        "顫抖",
        "共濟失調",
        "症狀與進食間隔有關"
      ],
      "physicalExam": [
        "可能完全正常",
        "發作期：虛弱、顫抖、定向障礙"
      ]
    },
    "pathophysiology": "β細胞腫瘤失去正常葡萄糖感應負回饋機制，持續自主分泌胰島素，不受血糖調控。過量胰島素促進葡萄糖進入細胞並抑制肝醣分解和糖質新生，導致血糖下降。低血糖觸發反調節激素釋放（腎上腺素、升糖素），產生震顫等症狀，嚴重時腦部缺糖引起癲癇和昏迷。",
    "diagnosis": {
      "overview": "Whipple三聯症：低血糖症狀+血糖<60mg/dL+給糖後症狀緩解",
      "differentials": [
        "肝衰竭",
        "敗血症",
        "腎上腺功能不全",
        "副腫瘤綜合症"
      ],
      "initialDB": [
        "禁食血糖",
        "血糖<60 mg/dL時測胰島素",
        "amended insulin:glucose ratio"
      ],
      "advanced": [
        "腹部超聲",
        "CT掃描",
        "術中探查"
      ]
    },
    "treatment": {
      "overview": "手術切除為首選，藥物控制為輔",
      "acute": [
        "低血糖發作：Dextrose 50% 0.5-1 mL/kg IV稀釋後緩慢給予",
        "小量多餐餵食"
      ],
      "chronic": [
        "手術切除腫瘤（若可能）",
        "Prednisolone 0.5-1 mg/kg q12h",
        "Diazoxide 5-30 mg/kg PO q12h",
        "飲食：少量多餐、複合碳水化合物"
      ]
    },
    "prognosis": "手術切除：中位存活12-14月。單純藥物控制：6-12月。多數為惡性，易轉移。",
    "pearls": [
      "禁食可誘發低血糖，不要長時間禁食",
      "發作時不要給予口服糖（可刺激更多胰島素分泌）",
      "手術中仔細探查，腫瘤可能很小",
      "類固醇可促進糖質新生"
    ],
    "diagnosticAlgorithm": {
      "title": "胰島素瘤 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "詢問癲癇、虛弱、顫抖等低血糖症狀",
          "findings": [
            "間歇性虛弱或崩倒",
            "癲癇發作",
            "進食後症狀暫時緩解",
            "中老年犬"
          ]
        },
        {
          "step": 2,
          "action": "血糖與胰島素配對檢測",
          "details": "同時測量血糖與血清胰島素",
          "findings": [
            "低血糖（<60 mg/dL）",
            "胰島素不適當升高",
            "胰島素/血糖比值升高",
            "修正胰島素/血糖比值>30"
          ]
        },
        {
          "step": 3,
          "action": "腹部影像",
          "details": "腹部超音波及CT掃描定位腫瘤",
          "findings": [
            "胰臟腫塊",
            "肝臟轉移灶",
            "區域淋巴結腫大",
            "超音波可能未見小腫瘤"
          ]
        },
        {
          "step": 4,
          "action": "手術探查與病理",
          "details": "剖腹探查及組織病理學確診",
          "findings": [
            "胰臟結節性腫塊",
            "免疫組織化學染色胰島素陽性",
            "評估轉移程度",
            "術中血糖監測"
          ]
        }
      ]
    },
    "monitoring": [
      "血糖",
      "癲癇頻率",
      "體重",
      "定期超聲追蹤轉移"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "hypoglycemia": {
    "zh": "低血糖症",
    "en": "Hypoglycemia",
    "definition": "低血糖症是指血糖低於正常範圍（犬<60 mg/dL、貓<50 mg/dL），導致中樞神經系統葡萄糖供應不足的代謝急症。病因包括胰島素瘤、敗血症、肝衰竭、新生兒低血糖和醫源性胰島素過量等。",
    "synonyms": [
      "Low blood sugar",
      "低血糖"
    ],
    "epidemiology": {
      "species": "犬貓皆可",
      "age": "幼年動物和老年動物較易發生",
      "sex": "無性別傾向",
      "riskFactors": [
        "幼犬（尤其玩具犬種）",
        "敗血症",
        "胰島素過量",
        "肝病",
        "胰島素瘤"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "虛弱",
        "顫抖",
        "癲癇",
        "行為改變",
        "昏迷"
      ],
      "physicalExam": [
        "虛弱",
        "心搏過速",
        "低體溫（嚴重時）",
        "神經症狀"
      ]
    },
    "pathophysiology": "血糖降至臨界值以下時啟動反調節機制（升糖素促肝醣分解、腎上腺素促糖質新生），產生交感神經樣症狀（震顫、心搏過速）。若反調節耗竭，腦細胞因葡萄糖不足而功能障礙，表現為共濟失調、視力喪失、癲癇直至昏迷。慢性反覆低血糖可致永久性神經損傷。",
    "diagnosis": {
      "overview": "血糖<60 mg/dL即可診斷，重點在於找出病因",
      "differentials": [
        "胰島素瘤",
        "肝衰竭",
        "敗血症",
        "腎上腺功能不全",
        "糖尿病治療過度",
        "幼犬低血糖"
      ],
      "initialDB": [
        "血糖",
        "CBC/生化",
        "電解質",
        "肝功能"
      ],
      "advanced": [
        "胰島素濃度",
        "皮質醇",
        "腹部影像"
      ]
    },
    "treatment": {
      "overview": "緊急補糖 + 找出並治療病因",
      "acute": [
        "Dextrose 50%: 0.5-1 mL/kg IV稀釋至12.5%緩慢給予",
        "持續輸液含2.5-5% Dextrose",
        "重症：Glucagon 0.5-1 mg IM"
      ],
      "chronic": [
        "治療原發病因",
        "飲食管理（少量多餐）"
      ]
    },
    "prognosis": "取決於病因。幼犬低血糖：預後良好。胰島素瘤：預後謹慎。敗血症相關：取決於感染控制。",
    "pearls": [
      "玩具犬幼犬最常見低血糖",
      "不要給予過多糖（可能刺激胰島素分泌）",
      "持續輸液維持血糖穩定",
      "尋找潛在病因很重要"
    ],
    "diagnosticAlgorithm": {
      "title": "低血糖症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估精神狀態、神經學症狀及病史",
          "findings": [
            "虛弱顫抖",
            "癲癇發作",
            "精神遲鈍",
            "幼犬或玩具犬品種"
          ]
        },
        {
          "step": 2,
          "action": "血糖即時測量",
          "details": "床邊血糖儀及靜脈血糖確認",
          "findings": [
            "血糖<60 mg/dL",
            "嚴重低血糖<40 mg/dL",
            "需區分空腹性vs進食後低血糖"
          ]
        },
        {
          "step": 3,
          "action": "病因篩查",
          "details": "CBC、生化、胰島素及肝功能評估",
          "findings": [
            "肝功能異常（肝源性）",
            "胰島素不當升高（胰島素瘤）",
            "腎上腺功能不全",
            "敗血症相關"
          ]
        },
        {
          "step": 4,
          "action": "進階病因確認",
          "details": "影像學及特殊內分泌檢查",
          "findings": [
            "腹部超音波檢查胰臟及肝臟",
            "ACTH刺激試驗排除Addison",
            "排除糖原儲積症",
            "評估腫瘤旁症候群"
          ]
        }
      ]
    },
    "monitoring": [
      "血糖q15-30min（急性期）",
      "神經狀態",
      "原發病監測"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "hyperglycemia": {
    "zh": "高血糖症",
    "en": "Hyperglycemia",
    "definition": "高血糖症是指血糖持續高於正常上限（犬>120 mg/dL空腹），最常見原因為糖尿病，其他包括應激性高血糖（貓常見）、Cushing's和醫源性（類固醇使用）。持續高血糖造成滲透性利尿和器官損傷。",
    "synonyms": [
      "High blood sugar",
      "高血糖"
    ],
    "epidemiology": {
      "species": "犬貓皆可，貓應激性高血糖更常見",
      "age": "中老年較多（糖尿病）",
      "sex": "依病因而異",
      "riskFactors": [
        "糖尿病",
        "應激（貓）",
        "庫欣症",
        "類固醇使用",
        "胰臟炎"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "多尿多渴",
        "多食",
        "體重減輕",
        "無症狀（輕度）"
      ],
      "physicalExam": [
        "可能正常",
        "脫水",
        "白內障（犬）"
      ]
    },
    "pathophysiology": "胰島素不足或組織胰島素阻抗導致葡萄糖轉運蛋白表達降低，骨骼肌和脂肪攝取葡萄糖能力下降。血糖超過腎糖閾產生糖尿和滲透性利尿。細胞能量不足觸發脂肪分解和蛋白質分解代償，長期可導致白內障（犬）和神經病變（貓）。",
    "diagnosis": {
      "overview": "血糖>200 mg/dL，需區分暫時性還是持續性",
      "differentials": [
        "糖尿病",
        "應激性高血糖",
        "庫欣症",
        "藥物誘發",
        "胰臟炎"
      ],
      "initialDB": [
        "血糖",
        "尿液分析",
        "果糖胺",
        "CBC/生化"
      ],
      "advanced": [
        "ACTH刺激試驗",
        "胰臟脂肪酶"
      ]
    },
    "treatment": {
      "overview": "治療取決於病因",
      "acute": [
        "若為DKA：見DKA治療",
        "輸液糾正脫水"
      ],
      "chronic": [
        "糖尿病：胰島素治療",
        "庫欣症：相應治療",
        "停用致病藥物"
      ]
    },
    "prognosis": "應激性：通常自行緩解。糖尿病：需長期管理。庫欣症：取決於控制情況。",
    "pearls": [
      "貓應激血糖可達300-400 mg/dL",
      "果糖胺可區分暫時性和持續性高血糖",
      "持續高血糖>250 mg/dL需要治療",
      "監測併發症（DKA、高滲性）"
    ],
    "diagnosticAlgorithm": {
      "title": "高血糖症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "詢問多喝多尿多食症狀及體重變化",
          "findings": [
            "多飲多尿",
            "體重減輕（糖尿病）",
            "應激相關（貓）",
            "用藥史（類固醇）"
          ]
        },
        {
          "step": 2,
          "action": "血糖與尿液分析",
          "details": "血糖測量及尿液試紙檢查",
          "findings": [
            "血糖持續>200 mg/dL",
            "尿糖陽性",
            "尿酮體陽性（糖尿病酮酸中毒）",
            "尿比重高"
          ]
        },
        {
          "step": 3,
          "action": "糖尿病確認檢查",
          "details": "果糖胺及糖化血色素測量",
          "findings": [
            "果糖胺升高（排除應激性高血糖）",
            "持續性高血糖確認糖尿病",
            "血液氣體分析（代謝性酸中毒）"
          ]
        },
        {
          "step": 4,
          "action": "併發症評估",
          "details": "全面生化及影像評估併發症",
          "findings": [
            "胰臟炎共病",
            "泌尿道感染",
            "白內障（犬）",
            "肝臟脂肪沉積（貓）"
          ]
        }
      ]
    },
    "monitoring": [
      "血糖",
      "尿糖",
      "果糖胺",
      "臨床症狀"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "hypercalcemia": {
    "zh": "高血鈣症",
    "en": "Hypercalcemia",
    "definition": "高血鈣症是指總鈣>12 mg/dL或離子鈣>1.4 mmol/L，犬最常見原因為惡性腫瘤（淋巴瘤、肛囊腺癌）、副甲狀腺亢進和維生素D中毒。慢性高血鈣導致腎小管鈣化和不可逆腎損傷。",
    "synonyms": [
      "High calcium",
      "鈣過高"
    ],
    "epidemiology": {
      "species": "犬較貓常見",
      "age": "中老年（腫瘤相關）",
      "sex": "無明顯傾向",
      "riskFactors": [
        "淋巴瘤",
        "肛門囊腺癌",
        "原發性副甲狀腺功能亢進",
        "維生素D中毒"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "多尿多渴",
        "厭食",
        "嘔吐",
        "便秘",
        "虛弱",
        "嗜睡"
      ],
      "physicalExam": [
        "脫水",
        "心搏過緩",
        "肌肉無力",
        "淋巴結腫大（腫瘤）"
      ]
    },
    "pathophysiology": "高血鈣主要機制：(1)PTHrP（腫瘤分泌）增加骨骼鈣釋放和腎小管鈣再吸收；(2)維生素D過量增加腸道鈣吸收；(3)骨溶解性轉移直接釋放鈣。高鈣降低神經肌肉興奮性（虛弱、便秘），腎小管沉積導致腎源性尿崩症和腎間質纖維化。",
    "diagnosis": {
      "overview": "總鈣>12 mg/dL或離子鈣升高，需找出病因",
      "differentials": [
        "惡性腫瘤高血鈣(最常見)",
        "原發性副甲狀腺功能亢進",
        "腎衰竭",
        "維生素D中毒",
        "Addison病"
      ],
      "initialDB": [
        "總鈣、離子鈣",
        "磷",
        "BUN/Crea",
        "PTH",
        "PTHrP"
      ],
      "advanced": [
        "胸腹部X光/超聲",
        "淋巴結抽吸",
        "骨髓檢查",
        "肛門囊觸診"
      ]
    },
    "treatment": {
      "overview": "積極輸液利尿 + 治療原發病因",
      "acute": [
        "0.9% NaCl 100-125 mL/kg/day",
        "Furosemide 2-4 mg/kg IV q8-12h（充分水合後）",
        "Prednisolone 1-2 mg/kg q12h（淋巴瘤）",
        "Pamidronate 1-2 mg/kg IV over 2h（難治性）"
      ],
      "chronic": [
        "治療原發腫瘤",
        "副甲狀腺切除（原發性亢進）"
      ]
    },
    "prognosis": "取決於病因。腫瘤相關：預後謹慎至差。原發性副甲狀腺亢進手術後：預後良好。",
    "pearls": [
      "「Stones, Bones, Groans, and Moans」記憶症狀",
      "犬高血鈣最常見原因是腫瘤",
      "貓常見特發性高血鈣",
      "輸液是最重要的初始治療"
    ],
    "diagnosticAlgorithm": {
      "title": "高血鈣症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估多飲多尿、食慾及精神狀態",
          "findings": [
            "多飲多尿",
            "食慾減退",
            "虛弱無力",
            "便秘"
          ]
        },
        {
          "step": 2,
          "action": "血鈣確認",
          "details": "測量總鈣、離子鈣及白蛋白校正鈣",
          "findings": [
            "離子鈣升高確認真性高血鈣",
            "排除假性高血鈣（脂血、溶血）",
            "白蛋白校正鈣計算"
          ]
        },
        {
          "step": 3,
          "action": "病因篩查",
          "details": "PTH、PTHrP及腫瘤篩檢",
          "findings": [
            "PTH升高（原發性副甲狀腺功能亢進）",
            "PTHrP升高（惡性腫瘤相關）",
            "淋巴結檢查排除淋巴瘤",
            "肛門腺觸診排除腺癌"
          ]
        },
        {
          "step": 4,
          "action": "影像學定位",
          "details": "頸部超音波、胸腹腔影像",
          "findings": [
            "副甲狀腺結節",
            "縱膈腔腫塊",
            "腎臟礦化",
            "肛門腺腫塊"
          ]
        }
      ]
    },
    "monitoring": [
      "鈣（總鈣和離子鈣）",
      "腎功能",
      "心電圖",
      "原發病追蹤"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "hypocalcemia": {
    "zh": "低血鈣症",
    "en": "Hypocalcemia",
    "definition": "低血鈣症是指離子鈣<1.0 mmol/L，主要原因為副甲狀腺功能低下（甲狀腺術後）、泌乳期低血鈣（eclampsia）、急性胰臟炎和乙二醇中毒。離子鈣急劇下降可引起致命性肌肉痙攣和心律不整。",
    "synonyms": [
      "Low calcium",
      "鈣過低",
      "產後子癇"
    ],
    "epidemiology": {
      "species": "犬貓皆可",
      "age": "哺乳期母犬、副甲狀腺手術後",
      "sex": "母犬（產褥熱）",
      "riskFactors": [
        "哺乳期（小型犬）",
        "副甲狀腺切除術後",
        "慢性腎病",
        "急性胰臟炎",
        "大量輸血"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "肌肉顫抖",
        "僵硬步態",
        "癲癇",
        "行為改變",
        "哺乳期母犬"
      ],
      "physicalExam": [
        "肌肉抽搐",
        "面部肌肉痙攣",
        "發燒",
        "心搏過速"
      ]
    },
    "pathophysiology": "細胞外鈣離子降低使神經肌肉細胞興奮性異常增高，表現為面部搔癢抽搐到四肢僵硬到全身性肌肉痙攣和癲癇。心臟方面低血鈣延長QT間期。PTH不足時腸道鈣吸收、骨骼鈣動員和腎小管鈣再吸收均減少，形成持續性低血鈣。",
    "diagnosis": {
      "overview": "總鈣<7 mg/dL或離子鈣降低伴臨床症狀",
      "differentials": [
        "產褥熱（eclampsia）",
        "副甲狀腺功能低下",
        "慢性腎病",
        "急性胰臟炎",
        "營養性繼發性副甲狀腺亢進"
      ],
      "initialDB": [
        "總鈣、離子鈣",
        "磷",
        "白蛋白",
        "PTH",
        "BUN/Crea"
      ],
      "advanced": [
        "維生素D代謝物",
        "鎂"
      ]
    },
    "treatment": {
      "overview": "急性期緩慢靜脈補鈣，長期口服補充",
      "acute": [
        "10% Calcium gluconate: 0.5-1.5 mL/kg IV緩慢給予（5-10分鐘）",
        "監測心電圖",
        "停止哺乳（產褥熱）"
      ],
      "chronic": [
        "口服鈣補充：50-100 mg/kg/day元素鈣",
        "維生素D（Calcitriol）：若副甲狀腺功能低下"
      ]
    },
    "prognosis": "泌乳期eclampsia經鈣劑靜注後反應迅速預後極佳。甲狀腺術後暫時性副甲狀腺功能低下通常數週恢復，永久性需終生補充。急性胰臟炎相關低血鈣為預後不良指標。嚴重低血鈣未治療可致心臟驟停。",
    "pearls": [
      "產褥熱最常見於小型犬哺乳高峰期（產後2-4週）",
      "鈣補充速度過快可致心律不整",
      "ECG監測補鈣過程",
      "產褥熱幼犬應改為人工餵養"
    ],
    "diagnosticAlgorithm": {
      "title": "低血鈣症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估肌肉顫搐、痙攣及病史",
          "findings": [
            "肌肉顫搐或強直",
            "面部搔癢（貓）",
            "癲癇發作",
            "泌乳期或甲狀腺術後"
          ]
        },
        {
          "step": 2,
          "action": "血鈣與離子鈣測量",
          "details": "確認低血鈣及嚴重程度",
          "findings": [
            "離子鈣降低",
            "總鈣降低",
            "同時檢查白蛋白與磷"
          ]
        },
        {
          "step": 3,
          "action": "病因確認",
          "details": "PTH、維生素D及腎功能檢查",
          "findings": [
            "PTH降低（副甲狀腺功能低下）",
            "腎功能異常（腎性繼發性）",
            "磷升高",
            "鎂離子檢查"
          ]
        },
        {
          "step": 4,
          "action": "心電圖監測",
          "details": "評估低鈣對心臟的影響",
          "findings": [
            "QT間期延長",
            "ST段變化",
            "心律不整風險評估",
            "補鈣治療中監測"
          ]
        }
      ]
    },
    "monitoring": [
      "鈣（急性期q4-6h）",
      "ECG",
      "臨床症狀"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "hypokalemia": {
    "zh": "低血鉀症",
    "en": "Hypokalemia",
    "definition": "低血鉀症是指血清鉀<3.5 mEq/L的電解質異常，最常見於慢性腎病（貓多尿性排鉀增加）、嘔吐腹瀉、利尿劑使用和DKA治療初期（胰島素驅使鉀進入細胞）。鉀是維持細胞膜靜息電位的關鍵離子，低血鉀導致細胞膜超極化，影響骨骼肌、平滑肌和心肌功能。",
    "synonyms": [
      "Low potassium",
      "鉀過低"
    ],
    "epidemiology": {
      "species": "貓較犬常見",
      "age": "中老年（CKD相關）",
      "sex": "無性別傾向",
      "riskFactors": [
        "慢性腎病",
        "嘔吐/腹瀉",
        "利尿劑使用",
        "糖尿病酮酸中毒治療中",
        "Burmese貓（低血鉀性多發性肌病）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "肌肉無力",
        "頸部腹屈（貓特徵）",
        "厭食",
        "嘔吐"
      ],
      "physicalExam": [
        "全身肌肉無力",
        "頸部無法抬起",
        "心律不整"
      ]
    },
    "pathophysiology": "細胞外鉀離子濃度降低使細胞膜靜息電位更負（超極化），增加動作電位產生所需的閾值刺激。臨床表現為骨骼肌無力（典型：貓頸部下垂性肌病、犬廣泛性肌無力），心臟方面延長復極化時間（ECG上T波扁平到U波出現），嚴重時可導致呼吸肌麻痺和橫紋肌溶解。腎臟持續低鉀可引起低鉀性腎病。",
    "diagnosis": {
      "overview": "血清K<3.5 mEq/L",
      "differentials": [
        "攝入不足",
        "腎臟流失（CKD、利尿劑）",
        "GI流失（嘔吐腹瀉）",
        "細胞內轉移（胰島素、重碳酸鹽）"
      ],
      "initialDB": [
        "電解質",
        "BUN/Crea",
        "血氣",
        "ECG"
      ],
      "advanced": [
        "尿鉀排泄",
        "Mg（低鎂可致難治性低鉀）"
      ]
    },
    "treatment": {
      "overview": "口服或靜脈補鉀",
      "acute": [
        "輸液中加KCl：最大0.5 mEq/kg/h",
        "嚴重（K<2.5）：需心電監護"
      ],
      "chronic": [
        "口服Potassium gluconate 2-6 mEq/cat/day",
        "腎臟處方飲食"
      ]
    },
    "prognosis": "輕中度低血鉀經口服或靜脈補鉀後通常迅速改善。靜脈補鉀速率不可超過0.5 mEq/kg/hr。慢性腎病相關低血鉀需長期口服鉀補充（Potassium gluconate）。嚴重低血鉀合併呼吸肌無力或心律不整需緊急處理，延遲治療可危及生命。",
    "pearls": [
      "貓低血鉀頸部腹屈是典型表現",
      "補鉀速度過快可致心律不整",
      "DKA治療中鉀會快速下降",
      "低鎂會使低鉀難以糾正"
    ],
    "diagnosticAlgorithm": {
      "title": "低血鉀症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估肌肉無力、精神狀態",
          "findings": [
            "全身性肌肉無力",
            "頸部腹屈（貓）",
            "精神遲鈍",
            "腸蠕動減少"
          ]
        },
        {
          "step": 2,
          "action": "電解質測量",
          "details": "血清鉀及相關電解質",
          "findings": [
            "血清鉀<3.5 mEq/L",
            "同時評估鈉、氯",
            "血液氣體分析（代謝性鹼中毒）"
          ]
        },
        {
          "step": 3,
          "action": "病因調查",
          "details": "評估丟失原因或攝取不足",
          "findings": [
            "嘔吐腹瀉造成丟失",
            "利尿劑使用",
            "慢性腎病多尿期",
            "食慾不振攝取不足"
          ]
        },
        {
          "step": 4,
          "action": "心電圖與治療監測",
          "details": "評估低鉀心臟影響",
          "findings": [
            "U波出現",
            "T波平坦",
            "ST段壓低",
            "補鉀速率監測"
          ]
        }
      ]
    },
    "monitoring": [
      "電解質q4-8h（補充期）",
      "ECG",
      "肌肉力量"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "hyperkalemia": {
    "zh": "高血鉀症",
    "en": "Hyperkalemia",
    "definition": "高血鉀症是指血清鉀>5.5 mEq/L的電解質緊急狀態，最常見原因為尿道阻塞（公貓）、急性腎衰竭、腎上腺皮質功能低下（Addison's disease）和DKA。鉀是決定心肌電生理活動的關鍵離子，急性高血鉀可在數分鐘內引起致命性心律不整和心跳停止。",
    "synonyms": [
      "High potassium",
      "鉀過高"
    ],
    "epidemiology": {
      "species": "犬貓皆可",
      "age": "任何年齡",
      "sex": "公貓（尿道阻塞）",
      "riskFactors": [
        "尿道阻塞",
        "急性腎衰竭",
        "Addison病",
        "腎後性阻塞",
        "大量組織壞死"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "虛弱",
        "無法排尿",
        "嘔吐",
        "心律不整"
      ],
      "physicalExam": [
        "心搏過緩",
        "肌肉無力",
        "膀胱膨大（阻塞）"
      ]
    },
    "pathophysiology": "細胞外鉀濃度升高使靜息膜電位部分去極化，心肌細胞傳導速度減慢且不均勻。ECG依嚴重度漸進變化：T波高尖(>6.5 mEq/L)到P波消失(>7.0)到QRS增寬(>8.0)到正弦波型到心室顫動或停搏。骨骼肌方面嚴重高血鉀導致弛緩性癱瘓（去極化阻斷）。腎臟是排鉀主要器官，尿量減少是最常見病理機制。",
    "diagnosis": {
      "overview": "血清K>5.5 mEq/L，ECG可見特徵性變化",
      "differentials": [
        "尿道阻塞",
        "急性腎衰竭",
        "Addison病",
        "膀胱破裂",
        "擠壓傷/燒傷"
      ],
      "initialDB": [
        "電解質",
        "BUN/Crea",
        "ECG（T波高尖、QRS寬、P波消失）",
        "血氣"
      ],
      "advanced": [
        "ACTH刺激試驗（Addison）",
        "腹部影像"
      ]
    },
    "treatment": {
      "overview": "緊急心肌保護 + 降低血鉀 + 治療病因",
      "acute": [
        "10% Calcium gluconate 0.5-1 mL/kg IV slow（心肌保護）",
        "Regular insulin 0.25-0.5 U/kg IV + Dextrose",
        "NaHCO3 1-2 mEq/kg IV（嚴重酸中毒）",
        "0.9% NaCl輸液"
      ],
      "chronic": [
        "治療原發病因",
        "解除尿道阻塞",
        "透析（嚴重腎衰竭）"
      ]
    },
    "prognosis": "高血鉀為可逆性急症。處理流程：Calcium gluconate保護心臟（不降鉀），Insulin加Dextrose驅鉀入細胞，解除原因（導尿、輸液恢復尿量）。尿道阻塞解除後預後通常良好。Addison's disease穩定後長期預後佳。急性腎衰竭預後取決於原發病因和腎功能恢復。",
    "pearls": [
      "K>7 mEq/L需緊急處理",
      "鈣不降低血鉀但保護心肌",
      "胰島素促進鉀進入細胞",
      "Addison病的Na:K<27是重要線索"
    ],
    "diagnosticAlgorithm": {
      "title": "高血鉀症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估心率、肌肉無力及排尿狀態",
          "findings": [
            "心搏過緩",
            "肌肉無力",
            "少尿或無尿",
            "嘔吐腹瀉"
          ]
        },
        {
          "step": 2,
          "action": "電解質與腎功能",
          "details": "血清鉀、BUN、肌酐測量",
          "findings": [
            "血清鉀>5.5 mEq/L",
            "氮血症",
            "代謝性酸中毒",
            "鈉鉀比評估"
          ]
        },
        {
          "step": 3,
          "action": "心電圖評估",
          "details": "緊急評估心臟傳導影響",
          "findings": [
            "T波高尖",
            "P波消失",
            "QRS增寬",
            "嚴重時心室停搏風險"
          ]
        },
        {
          "step": 4,
          "action": "病因確認與處理",
          "details": "區分腎臟性、腎上腺性或阻塞性原因",
          "findings": [
            "尿道阻塞（公貓）",
            "急性腎衰竭",
            "Addison病",
            "膀胱破裂"
          ]
        }
      ]
    },
    "monitoring": [
      "ECG連續監測",
      "電解質q1-2h（急性期）",
      "尿量"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "rodenticide-toxicosis": {
    "zh": "滅鼠劑中毒",
    "en": "Rodenticide Toxicosis (Anticoagulant)",
    "definition": "滅鼠劑中毒以抗凝血型（Warfarin、Brodifacoum等）最常見，透過抑制維生素K環氧化物還原酶阻斷凝血因子II、VII、IX、X的活化，導致延遲性出血（攝入後24-72小時）。也包括Bromethalin（神經毒性）和Cholecalciferol（高血鈣）型。",
    "synonyms": [
      "Warfarin poisoning",
      "抗凝血劑中毒",
      "老鼠藥中毒"
    ],
    "epidemiology": {
      "species": "犬較貓常見（犬較不挑食）",
      "age": "任何年齡，幼犬較常見",
      "sex": "無性別傾向",
      "riskFactors": [
        "戶外活動",
        "異食癖",
        "農場環境"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "已知或疑似接觸滅鼠劑",
        "攝入後2-5天出現症狀",
        "虛弱",
        "呼吸困難",
        "出血"
      ],
      "physicalExam": [
        "黏膜蒼白",
        "瘀斑/瘀血",
        "血腫",
        "呼吸困難（胸腔出血）",
        "腹部膨大（腹腔出血）"
      ]
    },
    "pathophysiology": "抗凝血滅鼠劑抑制維生素K環氧化物還原酶 → 維生素K依賴性凝血因子（II、VII、IX、X）無法活化 → 凝血障礙 → 自發性出血",
    "diagnosis": {
      "overview": "凝血時間延長（PT最先延長），接觸史支持診斷",
      "differentials": [
        "DIC",
        "血友病",
        "嚴重肝病",
        "維生素K缺乏"
      ],
      "initialDB": [
        "PT（最敏感）",
        "aPTT",
        "ACT",
        "血小板",
        "PCV/TS"
      ],
      "advanced": [
        "PIVKA測試",
        "凝血因子測定"
      ]
    },
    "treatment": {
      "overview": "維生素K1治療為主，嚴重出血需輸血",
      "acute": [
        "Vitamin K1: 2.5-5 mg/kg PO/SC q12h",
        "嚴重出血：新鮮全血或新鮮冷凍血漿輸注",
        "氧氣支持（胸腔出血）"
      ],
      "chronic": [
        "Vitamin K1持續4-6週（第二代滅鼠劑）",
        "停藥後48-72小時檢查PT"
      ]
    },
    "prognosis": "抗凝血型及時給予維生素K1預後良好（需持續4-6週治療，第二代鼠藥可能需更久）。Bromethalin型預後差（無解毒劑）。Cholecalciferol型需積極處理高血鈣，腎損傷為限制因素。早期去汙是所有類型的關鍵。",
    "pearls": [
      "第二代滅鼠劑（brodifacoum等）作用更強、持續更久",
      "Vitamin K1需口服或皮下，不可靜脈（過敏反應）",
      "治療時間：第一代2週，第二代4-6週",
      "停藥後48-72h複查PT確認療程足夠"
    ],
    "diagnosticAlgorithm": {
      "title": "抗凝血鼠藥中毒 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "暴露史與出血",
          "details": "確認鼠藥接觸史+出血傾向",
          "findings": [
            "攝入抗凝血鼠藥史",
            "瘀青、血尿、呼吸困難"
          ]
        },
        {
          "step": 2,
          "action": "凝血功能",
          "details": "PT/aPTT/ACT檢查",
          "findings": [
            "PT顯著延長（最早24-48小時）",
            "aPTT也延長"
          ]
        },
        {
          "step": 3,
          "action": "PIVKA檢測",
          "details": "維生素K拮抗蛋白檢測",
          "findings": [
            "PIVKA陽性確認抗凝血效應",
            "凝血因子II, VII, IX, X下降"
          ]
        },
        {
          "step": 4,
          "action": "維生素K1治療",
          "details": "Vitamin K1 2.5-5 mg/kg PO分次給予",
          "findings": [
            "PT 48小時後複檢應正常化",
            "需持續治療4-6週"
          ]
        }
      ]
    },
    "monitoring": [
      "PT（停藥後48-72h）",
      "PCV/TS",
      "出血徵象"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "snail-bait-toxicosis": {
    "zh": "蝸牛餌劑中毒",
    "en": "Metaldehyde Toxicosis (Snail Bait)",
    "definition": "蝸牛餌劑中毒由聚乙醛（Metaldehyde）引起，常見於花園使用的蝸牛藥。聚乙醛降低GABA和5-HT濃度，導致嚴重的全身性肌肉震顫、過熱和代謝性酸中毒。犬最常受影響（嗜食蝸牛餌），攝入後1-4小時出現症狀。",
    "synonyms": [
      "Metaldehyde poisoning",
      "Slug bait toxicosis"
    ],
    "epidemiology": {
      "species": "犬為主",
      "age": "任何年齡",
      "sex": "無性別傾向",
      "riskFactors": [
        "花園/庭院有使用蝸牛餌",
        "餌劑通常做成顆粒狀像飼料"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "接觸蝸牛餌劑",
        "快速發作（1-3小時）"
      ],
      "physicalExam": [
        "嚴重肌肉震顫",
        "癲癇",
        "高體溫（可達41-43°C）",
        "過度流涎",
        "腹瀉",
        "意識改變"
      ]
    },
    "pathophysiology": "Metaldehyde降低腦內GABA → 神經興奮失控 → 持續性肌肉震顫 → 高體溫 → 多器官衰竭",
    "diagnosis": {
      "overview": "暴露史加特徵性震顫/癲癇",
      "differentials": [
        "strychnine中毒",
        "tremorgenic mycotoxin",
        "癲癇其他原因"
      ],
      "initialDB": [
        "體溫",
        "血糖",
        "電解質",
        "CK（肌肉損傷）"
      ],
      "advanced": [
        "胃內容物metaldehyde檢測"
      ]
    },
    "treatment": {
      "overview": "控制癲癇/震顫+積極降溫+支持治療",
      "acute": [
        "控制癲癇：Diazepam 0.5-1 mg/kg IV，可能需重複",
        "嚴重：Propofol或Pentobarbital麻醉",
        "積極降溫（目標<40°C）",
        "輸液",
        "催吐/洗胃（若無癲癇）"
      ],
      "chronic": [
        "監測肝腎功能",
        "CK追蹤"
      ]
    },
    "prognosis": "早期積極治療預後良好。嚴重高體溫（>42°C）可致永久性神經損傷或死亡。",
    "pearls": [
      "「Shake and bake」：震顫+高體溫是特徵",
      "高體溫是主要死因",
      "肌肉震顫可持續數天",
      "餌劑常被誤認為飼料"
    ],
    "diagnosticAlgorithm": {
      "title": "蝸牛餌中毒 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "暴露確認",
          "details": "確認聚乙醛(metaldehyde)接觸",
          "findings": [
            "攝入蝸牛餌或污染水源",
            "症狀可在攝入1-4小時出現"
          ]
        },
        {
          "step": 2,
          "action": "臨床辨識",
          "details": "典型肌肉震顫+過熱",
          "findings": [
            "全身性肌肉震顫/強直",
            "體溫>41°C（惡性高熱）"
          ]
        },
        {
          "step": 3,
          "action": "支持診斷",
          "details": "排除其他震顫原因",
          "findings": [
            "血氣：代謝性酸中毒",
            "排除有機磷、strychnine"
          ]
        },
        {
          "step": 4,
          "action": "積極冷卻+肌鬆",
          "details": "控制震顫+降溫+輸液",
          "findings": [
            "Methocarbamol 55-220 mg/kg IV",
            "冷水浴+IV輸液直到穩定"
          ]
        }
      ]
    },
    "monitoring": [
      "體溫q15-30min",
      "癲癇頻率",
      "CK",
      "肝腎功能"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "leptospirosis": {
    "zh": "鉤端螺旋體症",
    "en": "Leptospirosis",
    "definition": "由鉤端螺旋體（Leptospira spp.）引起的人畜共通傳染病，主要影響肝臟和腎臟。",
    "synonyms": [
      "Lepto",
      "Weil's disease",
      "鉤體病"
    ],
    "epidemiology": {
      "species": "犬為主，貓罕見臨床疾病",
      "age": "任何年齡，戶外活動犬風險高",
      "sex": "公犬略多（戶外活動較多）",
      "riskFactors": [
        "接觸受污染水源",
        "接觸野生動物尿液",
        "農村/郊區環境",
        "狩獵犬"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "急性發燒",
        "嘔吐",
        "厭食",
        "肌肉疼痛",
        "黃疸",
        "少尿"
      ],
      "physicalExam": [
        "發燒",
        "黃疸",
        "脫水",
        "腎區疼痛",
        "前葡萄膜炎",
        "出血傾向"
      ]
    },
    "pathophysiology": "經黏膜或傷口進入 → 螺旋體血症 → 定植於腎小管和肝臟 → 急性腎損傷 + 肝炎 → 可發展為慢性帶菌者",
    "diagnosis": {
      "overview": "急性腎肝損傷加MAT抗體效價或PCR確診",
      "differentials": [
        "其他急性肝腎疾病",
        "IMHA",
        "中毒",
        "敗血症"
      ],
      "initialDB": [
        "BUN/Crea（升高）",
        "肝指數（ALT/ALP升高）",
        "膽紅素",
        "尿液分析",
        "血小板"
      ],
      "advanced": [
        "Leptospira MAT（配對血清）",
        "尿液PCR",
        "血液培養"
      ]
    },
    "treatment": {
      "overview": "抗生素治療為主+支持治療",
      "acute": [
        "Ampicillin 22 mg/kg IV q8h（急性期）",
        "或Doxycycline 5 mg/kg PO q12h",
        "積極輸液支持腎臟",
        "止吐、止痛"
      ],
      "chronic": [
        "Doxycycline 5 mg/kg PO q12h共2-3週（清除帶菌）"
      ]
    },
    "prognosis": "及時治療存活率約80%。嚴重腎衰竭或DIC預後差。可能遺留慢性腎病。",
    "pearls": [
      "人畜共通！處理時需防護",
      "配對血清效價（2週間隔）4倍上升有診斷意義",
      "即使恢復也需Doxycycline療程清除帶菌",
      "疫苗可預防但不涵蓋所有血清型"
    ],
    "diagnosticAlgorithm": {
      "title": "鉤端螺旋體症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "詢問環境暴露史、戶外活動及疫苗史",
          "findings": [
            "急性腎衰竭症狀",
            "發燒",
            "嘔吐厭食",
            "黃疸（肝腎型）"
          ]
        },
        {
          "step": 2,
          "action": "血液生化與尿液",
          "details": "CBC、生化及尿液分析",
          "findings": [
            "白血球增多",
            "氮血症",
            "肝指數升高",
            "膽紅素升高",
            "尿中管型"
          ]
        },
        {
          "step": 3,
          "action": "血清學檢測",
          "details": "顯微鏡凝集試驗（MAT）及PCR",
          "findings": [
            "MAT效價>1:800（單次）",
            "配對血清4倍升高",
            "尿液或血液PCR陽性",
            "注意疫苗後可能低效價"
          ]
        },
        {
          "step": 4,
          "action": "影像學評估",
          "details": "腎臟及肝臟超音波",
          "findings": [
            "腎臟腫大高回音",
            "肝臟腫大",
            "腹腔積液",
            "腎盂擴張"
          ]
        }
      ]
    },
    "monitoring": [
      "BUN/Crea",
      "肝指數",
      "尿量",
      "凝血功能"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "ehrlichiosis": {
    "zh": "艾利希體症",
    "en": "Ehrlichiosis",
    "definition": "艾利希體症是由Ehrlichia canis等立克次體經壁蝨（主要為褐犬蝨Rhipicephalus sanguineus）傳播的全身性感染。病原體感染單核球和巨噬細胞，導致急性、亞臨床和慢性三期病程。急性期以發燒和血小板減少為主，慢性期可發展為骨髓抑制和全血球減少。",
    "synonyms": [
      "Canine Monocytic Ehrlichiosis",
      "CME",
      "壁蝨熱"
    ],
    "epidemiology": {
      "species": "犬為主",
      "age": "任何年齡",
      "sex": "無性別傾向",
      "riskFactors": [
        "壁蝨暴露",
        "GSD可能有品種易感性",
        "流浪犬"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "急性期：發燒、嗜睡、厭食",
        "亞臨床期：可能無症狀",
        "慢性期：出血、消瘦、淋巴結腫大"
      ],
      "physicalExam": [
        "發燒",
        "淋巴結腫大",
        "脾腫大",
        "瘀斑/出血",
        "前葡萄膜炎"
      ]
    },
    "pathophysiology": "壁蝨叮咬傳播 → Ehrlichia感染單核球 → 免疫介導性血小板減少、貧血 → 骨髓抑制（慢性期）",
    "diagnosis": {
      "overview": "臨床懷疑加血清學或PCR確診",
      "differentials": [
        "其他壁蝨傳染病",
        "IMTP",
        "淋巴瘤",
        "多發性骨髓瘤"
      ],
      "initialDB": [
        "CBC（血小板減少、貧血、白血球異常）",
        "生化（高球蛋白血症）",
        "SNAP 4Dx"
      ],
      "advanced": [
        "Ehrlichia PCR",
        "血清IFA效價",
        "骨髓檢查"
      ]
    },
    "treatment": {
      "overview": "Doxycycline是首選治療",
      "acute": [
        "Doxycycline 5 mg/kg PO q12h或10 mg/kg PO q24h共28天"
      ],
      "chronic": [
        "慢性期可能需要更長療程",
        "輸血（嚴重貧血）",
        "免疫抑制劑（嚴重免疫介導反應）"
      ]
    },
    "prognosis": "急性和亞臨床期經Doxycycline 5 mg/kg q12h × 28天治療後預後良好，大多數犬完全恢復。慢性期合併骨髓抑制者（全血球減少、骨髓漿細胞增生）預後較差，可能需要長期治療且恢復不完全。持續血小板減少>6個月為預後不良指標。",
    "pearls": [
      "GSD可能發展更嚴重的慢性型",
      "高球蛋白血症是特徵",
      "治療後抗體可持續陽性數月至數年",
      "常與其他壁蝨傳染病共感染"
    ],
    "diagnosticAlgorithm": {
      "title": "艾利希體症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "詢問壁蝨暴露史、旅行史",
          "findings": [
            "發燒",
            "嗜睡厭食",
            "鼻出血或瘀斑",
            "淋巴結腫大"
          ]
        },
        {
          "step": 2,
          "action": "血液學檢查",
          "details": "CBC及血液抹片",
          "findings": [
            "血小板減少",
            "全血球減少（慢性期）",
            "輕度非再生性貧血",
            "單核球中可能見到包涵體"
          ]
        },
        {
          "step": 3,
          "action": "血清學與分子檢測",
          "details": "SNAP 4Dx或IFA及PCR",
          "findings": [
            "Ehrlichia canis抗體陽性",
            "PCR確認活動性感染",
            "區分急性、亞臨床及慢性期"
          ]
        },
        {
          "step": 4,
          "action": "生化與蛋白電泳",
          "details": "評估器官損傷及免疫反應",
          "findings": [
            "高球蛋白血症（多株性）",
            "低白蛋白血症",
            "蛋白電泳多株性升高",
            "肝腎指數變化"
          ]
        }
      ]
    },
    "monitoring": [
      "CBC",
      "球蛋白",
      "治療反應"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "anaplasmosis": {
    "zh": "乏漿體症",
    "en": "Anaplasmosis",
    "definition": "乏漿體症是由Anaplasma phagocytophilum（嗜吞噬球型）或A. platys（血小板型）經壁蝨傳播的立克次體感染。A. phagocytophilum感染嗜中性球引起多系統發炎，A. platys感染血小板引起循環性血小板減少症。分布與壁蝨棲息地重疊。",
    "synonyms": [
      "Canine Granulocytic Anaplasmosis",
      "Anaplasma infection"
    ],
    "epidemiology": {
      "species": "犬為主，貓可感染",
      "age": "任何年齡",
      "sex": "無性別傾向",
      "riskFactors": [
        "壁蝨暴露（Ixodes spp.）",
        "萊姆病流行區"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "急性發燒",
        "嗜睡",
        "厭食",
        "跛行（多發性關節炎）"
      ],
      "physicalExam": [
        "發燒",
        "關節腫脹/疼痛",
        "淋巴結腫大",
        "出血傾向"
      ]
    },
    "pathophysiology": "A. phagocytophilum經壁蝨唾液注入進入血流→選擇性侵入嗜中性球→在嗜中性球胞漿內形成特徵性morulae包涵體→抑制嗜中性球凋亡和殺菌功能→免疫功能受損。同時引起免疫介導性血小板減少和反應性多關節炎。A. platys直接感染血小板引起循環性血小板減少（3-14天週期性升降）。",
    "diagnosis": {
      "overview": "臨床懷疑加血清學或血抹片morulae確診",
      "differentials": [
        "萊姆病",
        "Ehrlichiosis",
        "IMTP",
        "其他發燒原因"
      ],
      "initialDB": [
        "CBC（血小板減少常見）",
        "血抹片（嗜中性球內morulae）",
        "SNAP 4Dx"
      ],
      "advanced": [
        "Anaplasma PCR",
        "關節液分析"
      ]
    },
    "treatment": {
      "overview": "Doxycycline治療",
      "acute": [
        "Doxycycline 5 mg/kg PO q12h共14-28天",
        "嚴重血小板減少：短期Prednisolone"
      ],
      "chronic": [
        "壁蝨預防"
      ]
    },
    "prognosis": "A. phagocytophilum經Doxycycline治療後預後極佳，通常24-48小時內臨床改善。A. platys型較溫和，治療後預後良好。共感染（同時有Ehrlichia或Borrelia）時臨床表現更複雜但治療反應仍佳。持續亞臨床感染可能存在。",
    "pearls": [
      "與萊姆病共用壁蝨媒介，常共感染",
      "血抹片見morulae可快速診斷",
      "比Ehrlichiosis治療反應更快",
      "持續壁蝨預防很重要"
    ],
    "diagnosticAlgorithm": {
      "title": "乏漿體症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "詢問壁蝨暴露史及急性症狀",
          "findings": [
            "發燒",
            "關節疼痛跛行",
            "嗜睡",
            "食慾減退"
          ]
        },
        {
          "step": 2,
          "action": "血液學檢查",
          "details": "CBC及血液抹片",
          "findings": [
            "血小板減少",
            "嗜中性球內可見包涵體（桑椹體）",
            "輕度貧血"
          ]
        },
        {
          "step": 3,
          "action": "血清學與PCR",
          "details": "SNAP 4Dx篩檢及確認性PCR",
          "findings": [
            "Anaplasma phagocytophilum抗體陽性",
            "PCR確認感染",
            "與Ehrlichia共感染評估"
          ]
        },
        {
          "step": 4,
          "action": "關節液分析",
          "details": "疑似多發性關節炎時進行關節穿刺",
          "findings": [
            "非化膿性關節炎",
            "關節液嗜中性球增多",
            "無細菌培養生長"
          ]
        }
      ]
    },
    "monitoring": [
      "臨床症狀",
      "血小板計數"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "babesiosis": {
    "zh": "乏漿體症",
    "en": "Babesiosis",
    "definition": "梨形蟲症是由Babesia屬原蟲經壁蝨傳播的血液寄生蟲病，寄生在紅血球內導致溶血性貧血。犬以B. canis（大型）和B. gibsoni（小型）為主，B. gibsoni常見於美國鬥牛犬且可經咬傷直接傳播。嚴重感染可引起多器官衰竭。",
    "synonyms": [
      "Canine Babesiosis",
      "巴貝斯蟲病",
      "焦蟲病"
    ],
    "epidemiology": {
      "species": "犬為主",
      "age": "任何年齡",
      "sex": "無性別傾向",
      "riskFactors": [
        "壁蝨暴露",
        "鬥犬（直接傳播）",
        "輸血",
        "Greyhound、Pit Bull"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "急性虛弱",
        "厭食",
        "色素尿（紅/棕色尿）"
      ],
      "physicalExam": [
        "黏膜蒼白或黃疸",
        "發燒",
        "脾腫大",
        "心搏過速"
      ]
    },
    "pathophysiology": "Babesia merozoites侵入紅血球→在紅血球內二分裂增殖→紅血球破裂釋出merozoites→感染更多紅血球。直接溶血加上免疫介導性紅血球破壞（表面抗原改變誘發自身抗體），導致嚴重溶血性貧血。大型種（B. canis）引起補體介導的血管內溶血，小型種（B. gibsoni）以血管外溶血為主。嚴重病例可引起DIC和多器官衰竭。",
    "diagnosis": {
      "overview": "血抹片見蟲體或PCR確診",
      "differentials": [
        "IMHA",
        "其他溶血性貧血",
        "Ehrlichiosis"
      ],
      "initialDB": [
        "CBC（再生性貧血）",
        "血抹片（紅血球內蟲體）",
        "網織紅血球",
        "膽紅素"
      ],
      "advanced": [
        "Babesia PCR",
        "Coombs試驗（排除IMHA）"
      ]
    },
    "treatment": {
      "overview": "抗原蟲藥+支持治療",
      "acute": [
        "Imidocarb dipropionate 6.6 mg/kg IM，2週後重複",
        "或Atovaquone + Azithromycin",
        "輸血（嚴重貧血）"
      ],
      "chronic": [
        "可能無法完全清除，成為帶菌者"
      ]
    },
    "prognosis": "B. canis經Imidocarb治療後預後良好，大多數犬可清除感染。B. gibsoni較難完全清除，常需Atovaquone+Azithromycin組合治療，部分犬成為慢性帶原者。複雜型（合併DIC、IMHA或器官衰竭）預後謹慎至差。",
    "pearls": [
      "大型Babesia（B. canis）和小型Babesia（B. gibsoni）治療不同",
      "B. gibsoni常見於Pit Bull，可能無法清除",
      "可能併發真正的IMHA",
      "Imidocarb可能引起膽鹼能副作用"
    ],
    "diagnosticAlgorithm": {
      "title": "乏漿體症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "詢問壁蝨暴露史、評估貧血與黃疸",
          "findings": [
            "發燒",
            "蒼白黏膜",
            "黃疸",
            "脾臟腫大",
            "深色尿"
          ]
        },
        {
          "step": 2,
          "action": "血液抹片檢查",
          "details": "薄血片及厚血片染色鏡檢",
          "findings": [
            "紅血球內見梨形或環形蟲體",
            "Babesia canis（大型）或B. gibsoni（小型）",
            "再生性貧血"
          ]
        },
        {
          "step": 3,
          "action": "PCR確認與分型",
          "details": "分子生物學確認及種別鑑定",
          "findings": [
            "PCR陽性確認感染",
            "區分Babesia種類",
            "低蟲血症時PCR敏感度較高"
          ]
        },
        {
          "step": 4,
          "action": "併發症評估",
          "details": "評估多器官損傷",
          "findings": [
            "溶血性貧血程度",
            "急性腎損傷",
            "DIC篩檢",
            "免疫介導性共病評估"
          ]
        }
      ]
    },
    "monitoring": [
      "PCV",
      "網織紅血球",
      "臨床症狀"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "toxoplasmosis": {
    "zh": "弓形蟲病",
    "en": "Toxoplasmosis",
    "definition": "弓形蟲病由Toxoplasma gondii原蟲引起，貓為唯一確定宿主（排出卵囊），犬為中間宿主。免疫健全的犬貓多為亞臨床感染，免疫抑制時（FIV/FeLV、藥物）可出現多系統臨床症狀，包括肺炎、肝炎、眼內炎和腦炎。",
    "synonyms": [
      "Toxo",
      "弓漿蟲病"
    ],
    "epidemiology": {
      "species": "貓為終宿主，犬為中間宿主",
      "age": "任何年齡",
      "sex": "無性別傾向",
      "riskFactors": [
        "攝入生肉",
        "狩獵",
        "免疫抑制"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "多數無症狀",
        "發燒",
        "厭食",
        "呼吸困難",
        "神經症狀（免疫抑制動物）"
      ],
      "physicalExam": [
        "發燒",
        "淋巴結腫大",
        "眼部病變（葡萄膜炎、視網膜炎）",
        "肺炎",
        "神經症狀"
      ]
    },
    "pathophysiology": "T. gondii經口攝入（卵囊或含組織囊的生肉）→腸道上皮侵入→隨血流擴散至全身→急速分裂體(tachyzoites)在細胞內增殖→組織損傷和發炎。免疫反應控制後形成緩殖子囊(bradyzoites)潛伏於肌肉和腦。免疫抑制時囊壁破裂→急速分裂體重新活化→臨床復發。",
    "diagnosis": {
      "overview": "血清學加臨床症狀",
      "differentials": [
        "FIP",
        "FeLV/FIV相關疾病",
        "腫瘤",
        "其他感染"
      ],
      "initialDB": [
        "Toxoplasma IgG/IgM",
        "CBC/生化",
        "眼底檢查"
      ],
      "advanced": [
        "PCR",
        "腦脊液分析",
        "組織病理"
      ]
    },
    "treatment": {
      "overview": "Clindamycin為首選",
      "acute": [
        "Clindamycin 12.5-25 mg/kg PO q12h共4週",
        "或Trimethoprim-sulfonamide 15 mg/kg PO q12h",
        "支持治療"
      ],
      "chronic": [
        "眼部病變可能需局部或全身類固醇"
      ]
    },
    "prognosis": "免疫健全犬貓多無臨床症狀，預後極佳。臨床感染經Clindamycin治療後大多數反應良好。腦炎型預後較差。FIV/FeLV共感染時治療反應差。貓糞中卵囊排出期僅1-2週（首次感染時），排毒期後不具傳染性。",
    "pearls": [
      "貓通常在初次感染後1-2週排卵囊",
      "大多數感染無臨床症狀",
      "人畜共通但貓糞便排卵囊時間短",
      "孕婦應避免清理貓砂盆"
    ],
    "diagnosticAlgorithm": {
      "title": "弓形蟲病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估神經症狀、眼部病變及免疫狀態",
          "findings": [
            "發燒",
            "呼吸困難",
            "神經症狀",
            "葡萄膜炎",
            "免疫抑制病史"
          ]
        },
        {
          "step": 2,
          "action": "血清學檢測",
          "details": "IgM及IgG抗體測量",
          "findings": [
            "IgM陽性提示近期感染",
            "IgG高效價提示暴露",
            "配對血清效價升高",
            "排除其他原因的抗體升高"
          ]
        },
        {
          "step": 3,
          "action": "血液與生化檢查",
          "details": "CBC及器官功能評估",
          "findings": [
            "嗜中性球減少（急性期）",
            "肝指數升高",
            "肌酸激酶升高",
            "貧血"
          ]
        },
        {
          "step": 4,
          "action": "PCR與組織確診",
          "details": "體液或組織PCR及組織病理",
          "findings": [
            "血液或體液PCR陽性",
            "組織切片見速殖子或囊體",
            "眼部檢查確認弓形蟲性葡萄膜炎"
          ]
        }
      ]
    },
    "monitoring": [
      "臨床症狀",
      "眼睛",
      "抗體效價"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "giardiasis": {
    "zh": "梨形鞭毛蟲症",
    "en": "Giardiasis",
    "definition": "梨形鞭毛蟲症由Giardia duodenalis（亦稱G. lamblia或G. intestinalis）感染小腸引起，是犬貓最常見的腸道寄生蟲之一。囊體經糞口途徑傳播，在環境中可存活數月。幼年動物和群養環境發病率最高。多數感染無症狀，臨床型以慢性間歇性軟便為主。",
    "synonyms": [
      "Giardia infection",
      "賈第蟲病"
    ],
    "epidemiology": {
      "species": "犬貓皆可",
      "age": "幼年動物較常見",
      "sex": "無性別傾向",
      "riskFactors": [
        "受污染水源",
        "多犬/貓環境",
        "免疫抑制"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "慢性間歇性腹瀉",
        "軟便/水便",
        "體重減輕",
        "被毛差"
      ],
      "physicalExam": [
        "可能正常",
        "消瘦",
        "腸道增厚"
      ]
    },
    "pathophysiology": "囊體攝入→胃酸刺激脫囊→活動營養體附著小腸絨毛上皮→機械性損傷微絨毛+T細胞介導的絨毛萎縮→吸收面積減少→脂肪吸收不良和滲透性腹瀉。營養體消耗刷狀緣消化酶導致二糖酶缺乏，加重腹瀉。",
    "diagnosis": {
      "overview": "糞便檢查見囊孢或滋養體，或抗原檢測",
      "differentials": [
        "其他腸道寄生蟲",
        "IBD",
        "食物不耐",
        "細菌性腸炎"
      ],
      "initialDB": [
        "糞便直接抹片（滋養體）",
        "糞便漂浮（囊孢）",
        "Giardia SNAP抗原"
      ],
      "advanced": [
        "糞便PCR"
      ]
    },
    "treatment": {
      "overview": "Fenbendazole或Metronidazole",
      "acute": [
        "Fenbendazole 50 mg/kg PO q24h共5-7天",
        "或Metronidazole 15-25 mg/kg PO q12h共5-7天"
      ],
      "chronic": [
        "環境消毒",
        "治療後洗澡去除囊孢"
      ]
    },
    "prognosis": "經Fenbendazole（50 mg/kg PO × 5天）或Metronidazole治療後預後極佳，大多數犬貓症狀迅速改善。再感染常見（環境囊體持久性）。免疫健全動物可能自行清除。慢性感染偶見體重減輕但罕見嚴重併發症。",
    "pearls": [
      "糞便檢查敏感度低，可能需多次檢查",
      "囊孢在環境中可存活數月",
      "人畜共通，但寵物傳給人類風險低",
      "治療後徹底洗澡很重要"
    ],
    "diagnosticAlgorithm": {
      "title": "梨形鞭毛蟲症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "詢問慢性軟便、脂肪便病史",
          "findings": [
            "慢性間歇性軟便",
            "脂肪便（淡色惡臭）",
            "體重減輕",
            "幼犬幼貓多見"
          ]
        },
        {
          "step": 2,
          "action": "糞便檢查",
          "details": "糞便漂浮法及直接抹片",
          "findings": [
            "梨形鞭毛蟲囊體",
            "活動性營養體（直接抹片）",
            "可能需多次採樣"
          ]
        },
        {
          "step": 3,
          "action": "糞便抗原檢測",
          "details": "ELISA或免疫螢光法",
          "findings": [
            "Giardia抗原陽性",
            "敏感度高於傳統鏡檢",
            "SNAP Giardia快速檢測"
          ]
        },
        {
          "step": 4,
          "action": "治療反應評估",
          "details": "給予抗原蟲藥物評估臨床反應",
          "findings": [
            "Metronidazole或Fenbendazole治療",
            "臨床症狀改善",
            "治療後複檢糞便轉陰"
          ]
        }
      ]
    },
    "monitoring": [
      "糞便性狀",
      "治療後複檢"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "coccidia": {
    "zh": "球蟲症",
    "en": "Coccidiosis",
    "definition": "球蟲症由Isospora（Cystoisospora）屬原蟲感染腸道引起，是幼犬幼貓常見的腸道寄生蟲病。卵囊經糞口途徑傳播，在腸道上皮細胞內完成有性和無性生殖週期。免疫健全的成年動物多為無症狀帶原，幼年和免疫抑制動物可出現水樣或出血性腹瀉。",
    "synonyms": [
      "Coccidiosis",
      "Isospora infection"
    ],
    "epidemiology": {
      "species": "犬貓皆可",
      "age": "幼年動物（<6月齡）",
      "sex": "無性別傾向",
      "riskFactors": [
        "擁擠環境",
        "衛生條件差",
        "應激",
        "免疫抑制"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "水樣腹瀉",
        "可能帶血",
        "脫水",
        "發育遲緩"
      ],
      "physicalExam": [
        "脫水",
        "消瘦",
        "腹部不適"
      ]
    },
    "pathophysiology": "卵囊攝入後在腸道釋出sporozoites→侵入小腸上皮細胞→細胞內經多代裂殖體增殖→破壞大量腸上皮細胞→絨毛脫落和黏膜損傷→吸收不良和分泌性腹瀉。嚴重感染可導致出血性腸炎和脫水。",
    "diagnosis": {
      "overview": "糞便檢查見卵囊",
      "differentials": [
        "Giardia",
        "其他腸道感染",
        "飲食性腹瀉"
      ],
      "initialDB": [
        "糞便漂浮檢查（卵囊）"
      ],
      "advanced": [
        "糞便PCR"
      ]
    },
    "treatment": {
      "overview": "磺胺類藥物為主",
      "acute": [
        "Sulfadimethoxine 55 mg/kg PO首日，後27.5 mg/kg q24h共10-14天",
        "或Ponazuril 50 mg/kg PO q24h共1-3天"
      ],
      "chronic": [
        "環境消毒",
        "隔離感染動物"
      ]
    },
    "prognosis": "經Sulfadimethoxine或Ponazuril治療後預後極佳。大多數幼犬貓在治療後5-7天內症狀改善。嚴重脫水的幼年動物需輸液支持。成年免疫健全動物通常自限性。環境衛生對預防再感染至關重要。",
    "pearls": [
      "健康成年動物常為無症狀帶蟲者",
      "應激可誘發臨床疾病",
      "卵囊需1-2天孢子化才具感染性",
      "環境消毒用10%氨水"
    ],
    "diagnosticAlgorithm": {
      "title": "球蟲症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估腹瀉嚴重度，尤其幼犬幼貓",
          "findings": [
            "水樣或血便",
            "脫水",
            "體重減輕",
            "幼齡動物"
          ]
        },
        {
          "step": 2,
          "action": "糞便漂浮檢查",
          "details": "標準糞便浮游法鏡檢",
          "findings": [
            "卵囊（oocyst）陽性",
            "Isospora（Cystoisospora）種",
            "需區分致病性與非致病性"
          ]
        },
        {
          "step": 3,
          "action": "脫水與營養評估",
          "details": "血液檢查評估全身狀態",
          "findings": [
            "脫水程度評估",
            "低白蛋白",
            "電解質異常",
            "貧血（嚴重感染）"
          ]
        },
        {
          "step": 4,
          "action": "治療與追蹤",
          "details": "抗球蟲治療及環境管理",
          "findings": [
            "Sulfadimethoxine或Ponazuril治療",
            "臨床改善",
            "環境消毒",
            "治療後複檢"
          ]
        }
      ]
    },
    "monitoring": [
      "糞便性狀",
      "體重增長"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "ringworm": {
    "zh": "皮膚真菌症",
    "en": "Dermatophytosis (Ringworm)",
    "definition": "皮膚真菌症（癬）由皮膚癬菌（主要為Microsporum canis，佔犬貓的90%以上）感染毛髮、皮膚和指甲引起。是犬貓和人之間最常見的人畜共通傳染病之一。幼貓和長毛貓品種（Persian）感染率最高。孢子在環境中可存活18個月以上。",
    "synonyms": [
      "Ringworm",
      "皮癬",
      "錢癬"
    ],
    "epidemiology": {
      "species": "犬貓皆可，貓更常見",
      "age": "幼年動物較常見",
      "sex": "無性別傾向",
      "riskFactors": [
        "幼年",
        "免疫抑制",
        "長毛品種（波斯貓）",
        "擁擠環境"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "圓形脫毛",
        "鱗屑",
        "可能搔癢"
      ],
      "physicalExam": [
        "圓形脫毛病灶",
        "鱗屑",
        "斷裂毛髮",
        "結痂"
      ]
    },
    "pathophysiology": "小孢子菌分生孢子接觸皮膚→萌發菌絲侵入角質層和毛髮→角質蛋白酶分解角蛋白作為營養→激發宿主免疫反應→環形擴展的發炎區域（典型癬圈）。感染嚴重度取決於宿主免疫狀態，免疫健全動物通常在1-3個月內自限性清除。",
    "diagnosis": {
      "overview": "Wood's lamp檢查、顯微鏡毛髮檢查、真菌培養",
      "differentials": [
        "細菌性皮膚病",
        "蠕形蟲",
        "過敏",
        "自體免疫皮膚病"
      ],
      "initialDB": [
        "Wood's lamp（M. canis約50%螢光）",
        "毛髮顯微鏡（孢子）",
        "真菌培養（金標準）"
      ],
      "advanced": [
        "PCR",
        "組織病理"
      ]
    },
    "treatment": {
      "overview": "局部+全身抗真菌治療",
      "acute": [
        "局部：Miconazole/Clotrimazole藥膏",
        "石灰硫黃浸泡q1週",
        "全身：Itraconazole 5-10 mg/kg PO q24h",
        "或Terbinafine 30-40 mg/kg PO q24h"
      ],
      "chronic": [
        "環境消毒（漂白水1:10）",
        "治療至培養陰性後2週"
      ]
    },
    "prognosis": "局部感染經外用抗真菌藥（Miconazole/Clotrimazole）治療預後極佳。廣泛感染需全身性治療（Itraconazole或Terbinafine），通常4-8週內治癒。Persian貓和免疫抑制動物可能需更長療程。環境清潔（漂白水消毒）對控制傳播至關重要。",
    "pearls": [
      "人畜共通！處理時需戴手套",
      "培養陰性前持續具傳染性",
      "波斯貓可能為無症狀帶菌者",
      "環境消毒很重要"
    ],
    "diagnosticAlgorithm": {
      "title": "皮膚真菌症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估皮膚病灶分佈及接觸史",
          "findings": [
            "圓形脫毛斑",
            "鱗屑及結痂",
            "可能有輕微搔癢",
            "接觸其他動物史"
          ]
        },
        {
          "step": 2,
          "action": "Wood燈檢查",
          "details": "紫外線燈照射患部",
          "findings": [
            "Microsporum canis約50%會螢光（蘋果綠）",
            "其他菌種不螢光",
            "假陽性：藥物或碎屑"
          ]
        },
        {
          "step": 3,
          "action": "皮膚刮片與毛髮鏡檢",
          "details": "KOH處理後鏡檢",
          "findings": [
            "毛幹內或周圍見關節孢子",
            "斷裂毛髮",
            "真菌菌絲"
          ]
        },
        {
          "step": 4,
          "action": "真菌培養確診",
          "details": "DTM或Sabouraud培養基",
          "findings": [
            "培養基顏色變化",
            "菌落形態鑑定",
            "大分生孢子形態學分類",
            "培養需7-21天"
          ]
        }
      ]
    },
    "monitoring": [
      "病灶改善",
      "真菌培養（每月直至連續陰性）"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "rabies": {
    "zh": "狂犬病",
    "en": "Rabies",
    "definition": "狂犬病由彈狀病毒科Lyssavirus屬的狂犬病病毒（RABV）引起的致命性腦脊髓炎。經被感染動物咬傷後病毒沿周邊神經逆行至中樞神經系統。一旦出現臨床症狀幾乎100%致死。全球每年約5萬人死於狂犬病。是最重要的人畜共通傳染病之一。",
    "synonyms": [
      "Rabies",
      "瘋狗症"
    ],
    "epidemiology": {
      "species": "所有溫血動物",
      "age": "任何年齡",
      "sex": "無性別傾向",
      "riskFactors": [
        "咬傷暴露",
        "未接種疫苗",
        "野生動物接觸"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "被咬傷史",
        "行為改變",
        "攻擊性增加或異常馴服"
      ],
      "physicalExam": [
        "行為改變",
        "流涎（吞嚥困難）",
        "癲癇",
        "癱瘓",
        "昏迷"
      ]
    },
    "pathophysiology": "病毒經咬傷進入傷口→在肌肉細胞中短暫複製→經運動終板進入周邊神經→沿軸突逆行運輸至脊髓和腦→在神經元內大量複製→急性非化膿性腦脊髓炎→再沿唾液腺神經離心傳播至唾液。潛伏期2週至數月（取決於咬傷位置距腦的距離）。",
    "diagnosis": {
      "overview": "只能死後確診（腦組織FA檢測）",
      "differentials": [
        "其他腦炎",
        "中毒",
        "犬瘟熱神經型"
      ],
      "initialDB": [
        "無生前確診方法"
      ],
      "advanced": [
        "死後：腦組織直接螢光抗體（FA）"
      ]
    },
    "treatment": {
      "overview": "無治療方法，確診後安樂死",
      "acute": [
        "疑似暴露：隔離觀察10天",
        "未接種疫苗暴露：安樂死或隔離6月"
      ],
      "chronic": [
        "預防：疫苗"
      ]
    },
    "prognosis": "臨床症狀出現後幾乎100%致死，無有效治療。暴露後預防（PEP）包括傷口清洗+被動免疫+主動免疫，在症狀出現前投予有效。動物狂犬病以安樂死為標準處理。預防接種是犬貓最重要的狂犬病防控手段。",
    "pearls": [
      "法定傳染病，必須通報",
      "人類暴露後需緊急處理",
      "疫苗是唯一預防方法",
      "「麻痺型」比「狂躁型」更常見"
    ],
    "diagnosticAlgorithm": {
      "title": "狂犬病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "詢問咬傷史、疫苗史及神經行為變化",
          "findings": [
            "行為急劇改變",
            "攻擊性增加或異常溫順",
            "流涎過多",
            "吞嚥困難"
          ]
        },
        {
          "step": 2,
          "action": "神經學檢查",
          "details": "全面神經學評估",
          "findings": [
            "進行性神經功能障礙",
            "瞳孔不等大",
            "下頜麻痺",
            "漸進性癱瘓"
          ]
        },
        {
          "step": 3,
          "action": "隔離觀察",
          "details": "法規要求的隔離觀察程序",
          "findings": [
            "10天隔離觀察（已接種犬）",
            "觀察期內監測神經症狀進展",
            "疑似病例通報衛生單位"
          ]
        },
        {
          "step": 4,
          "action": "死後確診",
          "details": "腦組織螢光抗體檢測（FAT）",
          "findings": [
            "直接螢光抗體法（DFA）",
            "Negri體（組織病理）",
            "RT-PCR確認",
            "注意：活體無法確診"
          ]
        }
      ]
    },
    "monitoring": [
      "隔離觀察"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "megaesophagus": {
    "zh": "巨食道症",
    "en": "Megaesophagus",
    "definition": "巨食道症是食道運動功能障礙導致食道擴張和食物滯留的疾病，可為先天性或後天性。後天性原因包括重症肌無力（最常見可逆原因）、Addison's disease、鉛中毒和特發性。吸入性肺炎是最主要的致命併發症。",
    "synonyms": [
      "食道擴張",
      "Esophageal dilatation"
    ],
    "epidemiology": {
      "species": "犬較常見，貓少見",
      "age": "先天性：幼年；後天性：任何年齡",
      "sex": "無明顯傾向",
      "riskFactors": [
        "品種傾向（GSD、Great Dane、Irish Setter、Shar-Pei）",
        "重症肌無力",
        "Addison病"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "反流（非嘔吐）",
        "食後即反流未消化食物",
        "體重減輕",
        "咳嗽（吸入性肺炎）"
      ],
      "physicalExam": [
        "消瘦",
        "肺部異常音（吸入性肺炎）",
        "肌肉無力（若重症肌無力）"
      ]
    },
    "pathophysiology": "食道正常蠕動依賴食道肌層（犬主要為橫紋肌）的協調收縮。神經肌肉傳導障礙（如MG的AChR抗體、迷走神經損傷）或肌肉本身疾病導致蠕動喪失→食道被動擴張→食物和液體滯留→反流→吸入性肺炎風險。先天性可能與食道神經叢發育異常有關。",
    "diagnosis": {
      "overview": "胸部X光見擴張食道，需找出潛在原因",
      "differentials": [
        "食道狹窄",
        "異物",
        "血管環異常"
      ],
      "initialDB": [
        "胸部X光（擴張食道、氣管偏移）",
        "鋇劑造影"
      ],
      "advanced": [
        "AChR抗體（重症肌無力）",
        "ACTH刺激試驗",
        "甲狀腺功能"
      ]
    },
    "treatment": {
      "overview": "高位餵食+治療潛在原因+預防吸入性肺炎",
      "acute": [
        "垂直姿勢餵食（Bailey chair）",
        "小量多餐",
        "食物調成泥狀或肉丸",
        "吸入性肺炎：抗生素"
      ],
      "chronic": [
        "重症肌無力：Pyridostigmine",
        "終身管理"
      ]
    },
    "prognosis": "先天性特發性預後差。後天性有可治療原因者預後較好。吸入性肺炎是主要死因。",
    "pearls": [
      "反流vs嘔吐：反流是被動的，無腹部收縮",
      "Bailey chair改善預後",
      "重症肌無力是最常見可治療原因",
      "定期監測吸入性肺炎"
    ],
    "diagnosticAlgorithm": {
      "title": "巨食道症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "詢問反流（非嘔吐）、進食困難病史",
          "findings": [
            "進食後被動反流（未消化食物）",
            "體重減輕",
            "反覆吸入性肺炎",
            "幼犬或成犬發病"
          ]
        },
        {
          "step": 2,
          "action": "胸腔X光",
          "details": "評估食道擴張及肺部",
          "findings": [
            "食道擴張（含氣或含食物）",
            "吸入性肺炎徵象",
            "前縱膈腔位移",
            "心臟評估"
          ]
        },
        {
          "step": 3,
          "action": "吞鋇造影",
          "details": "動態或靜態鋇劑吞嚥檢查",
          "findings": [
            "食道全段擴張",
            "食道蠕動減弱或消失",
            "排除局部阻塞",
            "評估食道功能"
          ]
        },
        {
          "step": 4,
          "action": "病因篩查",
          "details": "排除繼發性原因",
          "findings": [
            "乙醯膽鹼受體抗體（重症肌無力）",
            "ACTH刺激試驗（Addison病）",
            "甲狀腺功能",
            "鉛中毒篩檢"
          ]
        }
      ]
    },
    "monitoring": [
      "體重",
      "呼吸狀態",
      "反流頻率"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "foreign-body-gi": {
    "zh": "消化道異物",
    "en": "Gastrointestinal Foreign Body",
    "definition": "消化道異物是犬貓常見的外科急症，指攝入的非食物物品滯留在胃或腸道內無法自然排出。犬常吞食玩具、襪子、骨頭等，貓常見線狀異物（毛線、縫線）。線狀異物特別危險，可導致腸道皺褶切割和多處穿孔。",
    "synonyms": [
      "GI foreign body",
      "腸阻塞",
      "異物阻塞"
    ],
    "epidemiology": {
      "species": "犬較貓常見",
      "age": "幼年動物更常見",
      "sex": "無性別傾向",
      "riskFactors": [
        "幼犬",
        "異食癖",
        "玩具",
        "線狀異物（貓）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "嘔吐（可能反覆）",
        "厭食",
        "腹部不適",
        "無法排便"
      ],
      "physicalExam": [
        "腹部疼痛",
        "可觸及異物",
        "脫水",
        "腸套疊"
      ]
    },
    "pathophysiology": "胃異物：阻塞幽門出口→胃擴張和反覆嘔吐→脫水和電解質失衡。腸異物：完全阻塞→近端腸管擴張、遠端塌陷→腸壁血液循環受損→缺血壞死和穿孔→腹膜炎。線狀異物：錨定點（通常在舌下或幽門）固定→腸蠕動使腸管沿線摺疊→線切割腸壁→多處穿孔。",
    "diagnosis": {
      "overview": "影像學確認異物位置",
      "differentials": [
        "腸套疊",
        "腫瘤",
        "狹窄",
        "腸扭轉"
      ],
      "initialDB": [
        "腹部X光（不透光異物、腸擴張）",
        "腹部超聲"
      ],
      "advanced": [
        "鋇劑造影（謹慎，可能穿孔禁忌）"
      ]
    },
    "treatment": {
      "overview": "穩定後手術或內視鏡取出",
      "acute": [
        "輸液穩定",
        "內視鏡取出（胃內異物）",
        "腸切開術或胃切開術",
        "腸切除吻合（若腸壞死）"
      ],
      "chronic": [
        "術後監測吻合口"
      ]
    },
    "prognosis": "胃異物經內視鏡取出預後極佳（成功率>90%）。單純腸阻塞手術切除後預後良好（>85%存活）。線狀異物合併多處穿孔預後較差（65-80%存活）。腸壁壞死範圍和腹膜炎程度是主要預後因子。早期手術顯著改善預後。",
    "pearls": [
      "線狀異物特別危險（可致多處穿孔）",
      "貓舌下檢查線狀異物",
      "單張X光可能遺漏，需多張或超聲",
      "鈕扣電池是緊急情況"
    ],
    "diagnosticAlgorithm": {
      "title": "消化道異物 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "臨床懷疑",
          "details": "急性嘔吐+食慾下降+異物攝入史",
          "findings": [
            "反覆嘔吐（尤其餐後）",
            "年輕犬或有咀嚼異物習慣"
          ]
        },
        {
          "step": 2,
          "action": "腹部X光",
          "details": "腹部正側位X光",
          "findings": [
            "顯影異物直接可見",
            "腸梗阻徵象：腸管擴張+氣液平面"
          ]
        },
        {
          "step": 3,
          "action": "超音波/造影",
          "details": "非顯影異物用超音波或造影劑",
          "findings": [
            "超音波見腸管內高回聲+聲影",
            "造影：充填缺損或線性異物"
          ]
        },
        {
          "step": 4,
          "action": "治療決策",
          "details": "內視鏡取出或手術",
          "findings": [
            "胃內平滑異物→內視鏡嘗試",
            "腸阻塞或穿孔→手術"
          ]
        }
      ]
    },
    "monitoring": [
      "腹部疼痛",
      "嘔吐",
      "排便",
      "術後吻合口滲漏"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "intussusception": {
    "zh": "腸套疊",
    "en": "Intussusception",
    "definition": "腸套疊是一段腸管套入相鄰腸管內的急症，以空迴腸套入結腸（迴腸結腸型）最常見。幼犬最好發，常繼發於腸炎（寄生蟲、病毒）、腫瘤或手術後腸蠕動異常。不治療會導致套入段缺血壞死和腸穿孔。",
    "synonyms": [
      "腸套疊",
      "腸嵌頓"
    ],
    "epidemiology": {
      "species": "犬較貓常見",
      "age": "幼年動物（<1歲）",
      "sex": "無性別傾向",
      "riskFactors": [
        "腸炎",
        "寄生蟲",
        "腸道手術後",
        "腸道腫瘤"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "嘔吐",
        "腹瀉（可能帶血）",
        "厭食",
        "腹痛",
        "嗜睡"
      ],
      "physicalExam": [
        "腹部可觸及香腸樣團塊",
        "腹痛",
        "脫水",
        "發燒"
      ]
    },
    "pathophysiology": "異常腸蠕動（局部刺激引起的持續性蠕動波）→近端腸段被推入遠端腸腔→套入的腸系膜血管被壓迫→靜脈回流受阻（水腫）→動脈供血中斷→缺血壞死→腸管完全阻塞+出血性腸壁損傷。慢性者可形成局部黏連。",
    "diagnosis": {
      "overview": "腹部超聲可見典型「靶環徵」",
      "differentials": [
        "腸阻塞其他原因",
        "腸腫瘤",
        "異物"
      ],
      "initialDB": [
        "腹部超聲（靶環徵/同心環）",
        "腹部X光（擴張腸袢）"
      ],
      "advanced": [
        "鋇劑造影"
      ]
    },
    "treatment": {
      "overview": "手術復位或切除",
      "acute": [
        "輸液穩定",
        "手術探查",
        "嘗試手動復位",
        "若腸壞死或無法復位：腸切除吻合",
        "腸固定術（預防復發）"
      ],
      "chronic": [
        "治療原發病因"
      ]
    },
    "prognosis": "手術整復或切除後預後良好（>85%存活），但復發率約15-25%（若未同時進行腸固定術）。腸壁壞死需切除吻合，預後取決於壞死範圍。術後併發症包括吻合處滲漏和再次套疊。幼犬伴隨腸炎需同時治療原發病。",
    "pearls": [
      "最常見於迴腸-盲腸-結腸交界處",
      "幼年動物腸炎後常見",
      "超聲是首選診斷工具",
      "腸固定術可降低復發率"
    ],
    "diagnosticAlgorithm": {
      "title": "腸套疊 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估急性嘔吐、血便及腹痛",
          "findings": [
            "急性嘔吐",
            "果醬樣血便",
            "腹部疼痛",
            "可觸及腹腔內香腸狀腫塊"
          ]
        },
        {
          "step": 2,
          "action": "腹部影像",
          "details": "X光及超音波檢查",
          "findings": [
            "X光見腸管擴張及軟組織腫塊",
            "超音波「靶心徵」或「同心圓徵」",
            "近端腸管擴張",
            "腹腔積液"
          ]
        },
        {
          "step": 3,
          "action": "血液評估",
          "details": "CBC及生化評估全身狀態",
          "findings": [
            "脫水程度",
            "電解質失衡",
            "白血球變化",
            "低蛋白血症"
          ]
        },
        {
          "step": 4,
          "action": "手術治療",
          "details": "探查腹腔並矯正套疊",
          "findings": [
            "評估腸管存活性",
            "手動復位或腸段切除吻合",
            "檢查是否有前導病灶",
            "術後監測再發"
          ]
        }
      ]
    },
    "monitoring": [
      "排便恢復",
      "吻合口滲漏",
      "復發"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "urolithiasis": {
    "zh": "尿石症",
    "en": "Urolithiasis",
    "definition": "尿石症是泌尿系統中形成結石（尿路結石）的疾病，犬貓最常見為磷酸鎂銨（Struvite）和草酸鈣（Calcium Oxalate）結石。Struvite犬多與UTI相關，貓多為無菌性。結石位置可在腎臟、輸尿管、膀胱或尿道。",
    "synonyms": [
      "尿路結石",
      "Bladder stones",
      "Kidney stones"
    ],
    "epidemiology": {
      "species": "犬貓皆可",
      "age": "中老年較多",
      "sex": "犬：母犬膀胱結石多；公貓：尿道阻塞",
      "riskFactors": [
        "品種傾向（Dalmatian尿酸鹽、Schnauzer草酸鈣）",
        "飲食",
        "尿路感染"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "血尿",
        "頻尿",
        "排尿疼痛",
        "尿道阻塞（公貓/公犬）"
      ],
      "physicalExam": [
        "膀胱內可觸及結石",
        "膀胱疼痛",
        "尿道遠端可能觸及結石"
      ]
    },
    "pathophysiology": "尿液中礦物質過飽和→結晶核形成→逐漸沉積增大為結石。促進因素包括尿液濃縮（飲水不足）、尿液pH異常（鹼性促進Struvite、酸性促進CaOx）、UTI（尿素酶產菌分解尿素升高pH和NH4+促進Struvite）和遺傳因素（Dalmatian的尿酸結石）。",
    "diagnosis": {
      "overview": "影像學發現結石，結石分析確定類型",
      "differentials": [
        "膀胱腫瘤",
        "凝血塊",
        "膀胱息肉"
      ],
      "initialDB": [
        "腹部X光（不透光結石）",
        "腹部超聲（所有結石）",
        "尿液分析（結晶、pH、感染）"
      ],
      "advanced": [
        "結石分析（金標準）"
      ]
    },
    "treatment": {
      "overview": "飲食溶解或手術取出",
      "acute": [
        "鳥糞石：飲食溶解（Hill's s/d、Royal Canin S/O）",
        "草酸鈣、尿酸鹽：手術取出或碎石",
        "尿道阻塞：導尿、沖洗"
      ],
      "chronic": [
        "預防性飲食",
        "增加飲水",
        "治療UTI"
      ]
    },
    "prognosis": "Struvite結石可通過溶石飲食溶解（犬4-6週，貓2-4週），預後極佳。CaOx結石需手術或碎石移除，復發率高（3年內約25-50%需長期飲食預防）。輸尿管結石（貓常見CaOx）可致急性腎後性腎衰竭，需緊急手術或SUB裝置。",
    "pearls": [
      "鳥糞石可溶解，草酸鈣不可",
      "Dalmatian需低嘌呤飲食",
      "結石分析很重要（不同類型處理不同）",
      "UTI常與鳥糞石相關"
    ],
    "diagnosticAlgorithm": {
      "title": "尿石症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "詢問排尿困難、血尿及排尿行為變化",
          "findings": [
            "血尿",
            "頻尿或排尿困難",
            "排尿姿勢異常",
            "可能無症狀"
          ]
        },
        {
          "step": 2,
          "action": "尿液分析與影像",
          "details": "完整尿液分析及結晶鑑定",
          "findings": [
            "尿液結晶（草酸鈣、鳥糞石等）",
            "血尿與蛋白尿",
            "尿液pH評估",
            "細菌培養"
          ]
        },
        {
          "step": 3,
          "action": "影像定位",
          "details": "X光及超音波確認結石位置與數量",
          "findings": [
            "X光顯示不透光結石",
            "超音波偵測透光結石",
            "膀胱、輸尿管及腎臟評估",
            "尿道結石定位"
          ]
        },
        {
          "step": 4,
          "action": "結石分析與治療",
          "details": "結石成分分析指導治療",
          "findings": [
            "紅外線光譜或X光繞射分析",
            "鳥糞石可溶解治療",
            "草酸鈣需手術移除",
            "制定預防飲食方案"
          ]
        }
      ]
    },
    "monitoring": [
      "尿液分析",
      "定期影像追蹤",
      "飲食遵從性"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "glomerulonephritis": {
    "zh": "腎絲球腎炎",
    "en": "Glomerulonephritis",
    "definition": "腎絲球腎炎是腎絲球的免疫介導性發炎疾病，免疫複合物沉積於腎絲球基底膜導致蛋白尿和漸進性腎損傷。犬較貓常見，常繼發於慢性感染（Ehrlichia、Leishmania、心絲蟲）、腫瘤或自體免疫疾病。主要表現為蛋白尿和低白蛋白血症。",
    "synonyms": [
      "GN",
      "腎絲球病變"
    ],
    "epidemiology": {
      "species": "犬較常見",
      "age": "中老年",
      "sex": "無明顯傾向",
      "riskFactors": [
        "慢性感染",
        "腫瘤",
        "免疫介導性疾病"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "可能無症狀",
        "水腫",
        "腹水",
        "PU/PD",
        "體重減輕"
      ],
      "physicalExam": [
        "周邊水腫",
        "腹水",
        "視網膜病變（高血壓）"
      ]
    },
    "pathophysiology": "循環中的免疫複合物（抗原-抗體）沉積於腎絲球基底膜→活化補體系統和招募發炎細胞→基底膜損傷和通透性增加→蛋白質（主要白蛋白）從血漿濾入尿液→低白蛋白血症→水腫/腹水。慢性發炎導致腎絲球硬化和間質纖維化→GFR漸進下降→CKD。",
    "diagnosis": {
      "overview": "持續性高度蛋白尿(UPC>2)排除其他原因",
      "differentials": [
        "腎澱粉樣變性",
        "PLN",
        "腎小管疾病"
      ],
      "initialDB": [
        "尿液分析",
        "UPC（>2高度懷疑）",
        "白蛋白",
        "BUN/Crea",
        "血壓"
      ],
      "advanced": [
        "腎臟切片（確診）",
        "感染性疾病篩檢"
      ]
    },
    "treatment": {
      "overview": "降蛋白尿+治療併發症+找出潛在原因",
      "acute": [
        "ACE抑制劑（Enalapril/Benazepril）",
        "低蛋白飲食",
        "血壓控制",
        "抗血栓（Aspirin/Clopidogrel）"
      ],
      "chronic": [
        "治療潛在原因",
        "免疫抑制劑（某些病例）"
      ]
    },
    "prognosis": "取決於原發病因能否控制和腎功能損傷程度。可逆原因（如感染）治療後蛋白尿可改善。嚴重蛋白尿（UPC>3.5）和氮質血症為預後不良指標。免疫抑制治療（Mycophenolate）+ACE抑制劑（Enalapril/Telmisartan降低腎絲球壓力）+抗血栓治療為標準方案。",
    "pearls": [
      "UPC>0.5（犬）或>0.4（貓）即為蛋白尿",
      "需排除腎前和腎後蛋白尿",
      "血栓栓塞是常見併發症",
      "尋找潛在原因（感染、腫瘤）很重要"
    ],
    "diagnosticAlgorithm": {
      "title": "腎絲球腎炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估水腫、蛋白尿及腎功能",
          "findings": [
            "四肢或腹部水腫",
            "食慾減退",
            "體重變化",
            "可能無明顯症狀"
          ]
        },
        {
          "step": 2,
          "action": "尿液分析",
          "details": "完整尿液分析及UPC測量",
          "findings": [
            "蛋白尿（UPC>2.0）",
            "尿沉渣管型",
            "尿比重變化",
            "尿蛋白/肌酐比值持續升高"
          ]
        },
        {
          "step": 3,
          "action": "血液生化與凝血",
          "details": "評估腎功能及蛋白流失",
          "findings": [
            "低白蛋白血症",
            "高膽固醇血症",
            "氮血症",
            "抗凝血酶III降低"
          ]
        },
        {
          "step": 4,
          "action": "腎臟切片確診",
          "details": "超音波導引腎臟組織切片",
          "findings": [
            "免疫複合體沉積",
            "腎絲球基底膜增厚",
            "系膜增生",
            "排除類澱粉沉積症"
          ]
        }
      ]
    },
    "monitoring": [
      "UPC",
      "BUN/Crea",
      "白蛋白",
      "血壓"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "aortic-thromboembolism": {
    "zh": "主動脈血栓栓塞",
    "en": "Aortic Thromboembolism (ATE)",
    "definition": "主動脈血栓栓塞（ATE）是貓心臟病最具破壞性的併發症，血栓從擴大的左心房脫落，經主動脈隨血流到達分叉處（骶髂分叉最常見），阻斷後肢血液供應。約90%繼發於HCM或其他心肌病。急性發作時疼痛劇烈，為貓最痛苦的急症之一。",
    "synonyms": [
      "ATE",
      "Saddle thrombus",
      "鞍狀血栓",
      "FATE"
    ],
    "epidemiology": {
      "species": "貓為主",
      "age": "中老年貓",
      "sex": "公貓略多",
      "riskFactors": [
        "HCM（最常見）",
        "其他心肌病",
        "甲亢"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "突發後肢癱瘓",
        "劇烈疼痛嚎叫",
        "開口呼吸"
      ],
      "physicalExam": [
        "後肢（單或雙側）：癱瘓、冰冷、無股動脈搏動、蒼白或發紺肉墊（5Ps：Pain, Paralysis, Pulselessness, Pallor, Poikilothermia）"
      ]
    },
    "pathophysiology": "左心房擴大和功能障礙 → 血液淤滯 → 血栓形成 → 栓塞至主動脈三叉（iliac bifurcation）→ 後肢缺血",
    "diagnosis": {
      "overview": "典型臨床表現即可診斷",
      "differentials": [
        "IVDD",
        "創傷",
        "其他血栓原因"
      ],
      "initialDB": [
        "股動脈搏動",
        "後肢溫度/顏色",
        "心臟超聲（左心房血栓、SEC）",
        "血糖（患肢升高）"
      ],
      "advanced": [
        "多普勒血流評估",
        "肌酸激酶"
      ]
    },
    "treatment": {
      "overview": "止痛+抗凝+心臟病管理",
      "acute": [
        "止痛：Buprenorphine、Fentanyl",
        "抗凝：Heparin或低分子肝素",
        "心衰竭管理",
        "輸液（謹慎，可能加重心衰竭）"
      ],
      "chronic": [
        "Clopidogrel 18.75 mg PO q24h（預防復發）",
        "心臟病管理"
      ]
    },
    "prognosis": "急性期死亡率高（40-50%）。存活者中位存活2-6月。72小時內運動功能恢復預後較好。",
    "pearls": [
      "5Ps是診斷特徵",
      "Clopidogrel比Aspirin更有效預防復發",
      "72小時內無改善預後差",
      "嚴重疼痛可能需考慮安樂死"
    ],
    "diagnosticAlgorithm": {
      "title": "主動脈血栓栓塞 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "臨床辨識",
          "details": "貓急性後肢癱瘓+疼痛嚎叫",
          "findings": [
            "後肢冰冷+無脈搏",
            "腳掌發紺+肌肉僵硬"
          ]
        },
        {
          "step": 2,
          "action": "5P評估",
          "details": "Pain, Pulselessness, Pallor, Paralysis, Poikilothermia",
          "findings": [
            "股動脈搏動消失",
            "患肢指甲切開無出血"
          ]
        },
        {
          "step": 3,
          "action": "心臟評估",
          "details": "心臟超音波+NT-proBNP",
          "findings": [
            "大多數有HCM或其他心肌病",
            "左心房自發性顯影（SEC）"
          ]
        },
        {
          "step": 4,
          "action": "治療決策",
          "details": "疼痛控制+抗凝血+心臟治療",
          "findings": [
            "Clopidogrel 18.75 mg/cat/day",
            "預後不良：30天死亡率~50%"
          ]
        }
      ]
    },
    "monitoring": [
      "後肢功能恢復",
      "疼痛管理",
      "心臟狀態",
      "復發"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "arrhythmia": {
    "zh": "心律不整",
    "en": "Cardiac Arrhythmia",
    "definition": "心律不整是指心臟電傳導系統異常導致心跳節律、頻率或傳導路徑偏離正常竇性節律的疾病總稱。包括心搏過速（SVT、VT）、心搏過緩（竇房結病變、房室傳導阻滯）和期前收縮（APCs、VPCs）。犬常見DCM相關室性心律不整，貓以HCM相關心房顫動較多。",
    "synonyms": [
      "心律失常",
      "Dysrhythmia"
    ],
    "epidemiology": {
      "species": "犬貓皆可",
      "age": "任何年齡",
      "sex": "無明顯傾向",
      "riskFactors": [
        "心臟病",
        "電解質失衡",
        "藥物",
        "全身性疾病"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "可能無症狀",
        "虛弱",
        "昏厥",
        "運動不耐",
        "猝死"
      ],
      "physicalExam": [
        "心律不規則",
        "脈搏虧損",
        "心搏過速或過緩"
      ]
    },
    "pathophysiology": "心律不整源於三大電生理機制：(1)自動性異常—非竇房結部位產生異位節律；(2)觸發活動—早期或延遲後去極化引發額外動作電位；(3)折返迴路—傳導路徑中存在單向阻滯和緩慢傳導形成環形激動。結構性心臟病（DCM、HCM）、電解質異常（低血鉀、低血鎂）、缺氧、藥物中毒和自主神經失衡均可誘發。嚴重室性心律不整可導致血流動力學障礙甚至猝死。",
    "diagnosis": {
      "overview": "ECG確診和分類",
      "differentials": [
        "竇性心律不整（正常變異）",
        "病理性心律不整"
      ],
      "initialDB": [
        "ECG",
        "電解質",
        "心臟超聲"
      ],
      "advanced": [
        "24小時Holter監測",
        "電生理檢查"
      ]
    },
    "treatment": {
      "overview": "治療取決於類型和血流動力學影響",
      "acute": [
        "室上性心搏過速：迷走刺激、Diltiazem、β-blocker",
        "心室心搏過速：Lidocaine（急性）、Sotalol/Mexiletine（慢性）",
        "心搏過緩：Atropine試驗、心律調節器"
      ],
      "chronic": [
        "治療原發心臟病",
        "避免誘發因素"
      ]
    },
    "prognosis": "取決於類型和原發病。單純心房顫動預後較好。惡性心室心律不整預後差。",
    "pearls": [
      "犬竇性心律不整常為正常",
      "脈搏虧損提示血流動力學重要性",
      "Holter可發現間歇性心律不整",
      "Boxer和Doberman有遺傳性心律不整傾向"
    ],
    "diagnosticAlgorithm": {
      "title": "心律不整 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "聽診心律、評估脈搏及灌流",
          "findings": [
            "心律不規則",
            "脈搏缺損",
            "虛弱或昏厥",
            "運動不耐"
          ]
        },
        {
          "step": 2,
          "action": "心電圖檢查",
          "details": "12導程ECG或Holter監測",
          "findings": [
            "心房顫動",
            "心室早期收縮",
            "房室傳導阻滯",
            "竇性心搏過緩或過速"
          ]
        },
        {
          "step": 3,
          "action": "心臟超音波",
          "details": "評估心臟結構與功能",
          "findings": [
            "心腔擴大",
            "心肌收縮力評估",
            "瓣膜疾病",
            "腫瘤（心基部或右心房）"
          ]
        },
        {
          "step": 4,
          "action": "進階檢查與病因",
          "details": "電解質、甲狀腺及Holter",
          "findings": [
            "電解質異常（鉀、鈣）",
            "甲狀腺功能",
            "24小時Holter確認心律不整頻率",
            "評估是否需要抗心律不整治療"
          ]
        }
      ]
    },
    "monitoring": [
      "ECG",
      "Holter",
      "臨床症狀",
      "藥物濃度"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "meningitis": {
    "zh": "腦膜炎",
    "en": "Meningitis/Meningoencephalitis",
    "definition": "腦膜炎是腦膜和/或脊膜的發炎性疾病。犬最常見為免疫介導性腦膜炎（SRMA為代表），其次為感染性（細菌、真菌、原蟲）和腫瘤性（淋巴瘤腦膜浸潤）。貓以FIP相關的化膿性或非化膿性腦膜腦炎最常見。",
    "synonyms": [
      "MUO",
      "GME",
      "NME",
      "SRMA"
    ],
    "epidemiology": {
      "species": "犬較常見",
      "age": "年輕至中年",
      "sex": "無明顯傾向",
      "riskFactors": [
        "品種傾向（小型犬：GME、NME；Beagle、Boxer：SRMA）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "發燒",
        "頸部疼痛/僵硬",
        "嗜睡",
        "神經症狀（癲癇、視覺障礙）"
      ],
      "physicalExam": [
        "發燒",
        "頸部僵硬和疼痛",
        "神經缺損（依病變位置）"
      ]
    },
    "pathophysiology": "SRMA（類固醇反應性腦膜動脈炎）：自體免疫攻擊腦膜血管→嗜中性球浸潤→蛛網膜下腔發炎→劇烈頸部疼痛和發燒。感染性：病原體經血行或直接擴散（中耳炎延伸）到達腦膜→化膿性或肉芽腫性發炎→顱內壓升高→神經功能障礙。",
    "diagnosis": {
      "overview": "MRI和CSF分析是關鍵",
      "differentials": [
        "GME（肉芽腫性腦膜腦炎）",
        "NME/NLE（壞死性腦炎）",
        "SRMA（類固醇反應性腦膜炎-動脈炎）",
        "感染性腦炎"
      ],
      "initialDB": [
        "CBC/生化",
        "神經學檢查",
        "MRI"
      ],
      "advanced": [
        "CSF分析（細胞學、蛋白質、培養）",
        "感染性疾病篩檢"
      ]
    },
    "treatment": {
      "overview": "免疫介導性：免疫抑制治療",
      "acute": [
        "Prednisolone 1-2 mg/kg PO q12h",
        "重症加用：Cytarabine或Procarbazine",
        "感染性：抗生素/抗真菌"
      ],
      "chronic": [
        "長期免疫抑制",
        "緩慢減藥"
      ]
    },
    "prognosis": "SRMA：治療後預後良好。GME/NME：預後謹慎，中位存活數月至1年。",
    "pearls": [
      "MUO是描述性診斷，非特定疾病",
      "SRMA好發年輕大型犬，頸痛為主",
      "GME好發小型犬，多灶性神經症狀",
      "長期治療需監測免疫抑制副作用"
    ],
    "diagnosticAlgorithm": {
      "title": "腦膜炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估發燒、頸部疼痛及神經症狀",
          "findings": [
            "頸部僵硬疼痛",
            "發燒",
            "嗜睡",
            "背部弓起"
          ]
        },
        {
          "step": 2,
          "action": "神經學檢查",
          "details": "完整神經學評估",
          "findings": [
            "頸部僵硬",
            "本體感覺異常",
            "腦神經功能評估",
            "意識狀態評估"
          ]
        },
        {
          "step": 3,
          "action": "腦脊髓液分析",
          "details": "CSF採集及分析",
          "findings": [
            "白血球增多（嗜中性球或單核球為主）",
            "蛋白質升高",
            "培養與藥敏試驗",
            "細胞學排除腫瘤"
          ]
        },
        {
          "step": 4,
          "action": "影像學",
          "details": "MRI或CT評估腦膜與腦實質",
          "findings": [
            "腦膜增厚強化",
            "腦實質病灶",
            "排除腫瘤",
            "評估腦水腫程度"
          ]
        }
      ]
    },
    "monitoring": [
      "神經症狀",
      "CSF追蹤",
      "藥物副作用"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "cranial-cruciate-ligament-rupture": {
    "zh": "前十字韌帶斷裂",
    "en": "Cranial Cruciate Ligament Rupture (CCLR)",
    "definition": "前十字韌帶（CCL/ACL）斷裂是犬最常見的後肢跛行原因和骨科手術指適應症。犬CCL損傷多為慢性退化性過程（而非單一創傷事件），與韌帶慢性負荷、免疫介導性退化和脛骨平台角度有關。大型犬（Labrador、Rottweiler）好發，肥胖為重要風險因子。",
    "synonyms": [
      "CCLR",
      "ACL",
      "前十字韌帶損傷"
    ],
    "epidemiology": {
      "species": "犬為主",
      "age": "中大型犬2-10歲",
      "sex": "絕育犬風險較高",
      "riskFactors": [
        "肥胖",
        "品種傾向（Labrador、Rottweiler、Newfoundland）",
        "絕育"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "急性或慢性跛行",
        "後肢不負重或負重減少",
        "可能有受傷史"
      ],
      "physicalExam": [
        "後肢跛行",
        "膝關節腫脹/積液",
        "坐姿異常",
        "肌肉萎縮"
      ]
    },
    "pathophysiology": "犬CCL承受持續的剪力（脛骨推力）→韌帶內膠原纖維漸進性退化→部分撕裂→完全斷裂。CCL喪失後脛骨前移（tibial thrust）→關節不穩定→半月板損傷（內側半月板後角好發）→進行性骨關節炎。約40-60%犬在一側CCL斷裂後1-2年內對側也會斷裂。",
    "diagnosis": {
      "overview": "骨科檢查見關節不穩定+影像學確認",
      "differentials": [
        "髕骨脫位",
        "半月板損傷",
        "關節炎",
        "骨腫瘤"
      ],
      "initialDB": [
        "骨科檢查（前抽屜試驗、脛骨推壓試驗）",
        "膝關節X光"
      ],
      "advanced": [
        "關節鏡",
        "MRI"
      ]
    },
    "treatment": {
      "overview": "手術是大型犬首選",
      "acute": [
        "手術：TPLO、TTA、側線穩定術",
        "術後嚴格限制活動8-12週"
      ],
      "chronic": [
        "保守治療（小型犬<10kg可考慮）：體重管理、活動限制、NSAIDs、物理治療"
      ]
    },
    "prognosis": "手術後預後良好（>90%功能恢復）。約40-60%對側也會斷裂。",
    "pearls": [
      "前抽屜試驗和脛骨推壓試驗確認不穩定",
      "約50%有半月板損傷",
      "對側韌帶也是高風險",
      "TPLO是大型犬首選手術"
    ],
    "diagnosticAlgorithm": {
      "title": "前十字韌帶斷裂 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "跛行評估",
          "details": "後肢跛行+膝關節腫脹",
          "findings": [
            "急性：承重困難",
            "慢性：間歇性跛行+肌肉萎縮"
          ]
        },
        {
          "step": 2,
          "action": "骨科檢查",
          "details": "Drawer test + Tibial thrust",
          "findings": [
            "前抽屜試驗陽性（膝關節前移）",
            "脛骨壓迫試驗陽性"
          ]
        },
        {
          "step": 3,
          "action": "X光",
          "details": "膝關節X光評估",
          "findings": [
            "關節積液（脂肪墊徵象消失）",
            "骨關節炎變化+脛骨前移"
          ]
        },
        {
          "step": 4,
          "action": "手術",
          "details": "TPLO/TTA/lateral suture",
          "findings": [
            "TPLO為目前首選術式",
            "半月板評估（同時損傷常見）"
          ]
        }
      ]
    },
    "monitoring": [
      "術後X光",
      "功能恢復",
      "對側監測",
      "體重管理"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "osteosarcoma": {
    "zh": "骨肉瘤",
    "en": "Osteosarcoma (OSA)",
    "definition": "骨肉瘤是犬最常見的原發性骨腫瘤（佔85%以上），為高度惡性腫瘤，好發於大型和巨型犬的四肢長骨（橈骨遠端、脛骨近端、肱骨近端）。中位發病年齡7-8歲。超過90%在診斷時已有微轉移（主要轉移至肺）。",
    "synonyms": [
      "OSA",
      "骨肉癌"
    ],
    "epidemiology": {
      "species": "犬為主",
      "age": "中老年大型犬（7-9歲）",
      "sex": "公犬略多",
      "riskFactors": [
        "大型/巨型犬（GSD、Great Dane、Irish Wolfhound、Rottweiler）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "漸進性跛行",
        "腫脹",
        "病理性骨折"
      ],
      "physicalExam": [
        "長骨幹骺端腫脹",
        "疼痛",
        "跛行"
      ]
    },
    "pathophysiology": "惡性成骨細胞異常增殖→產生不規則骨基質（骨樣組織）→破壞正常皮質骨結構→溶骨和成骨混合性病變→骨皮質破壞→病理性骨折（嚴重疼痛）。腫瘤細胞經血行播散→肺轉移（最常見）→骨轉移。轉移通常在診斷時已存在（微轉移），故單純截肢中位存活僅4-6個月。",
    "diagnosis": {
      "overview": "X光見溶骨性病變+組織病理確診",
      "differentials": [
        "骨髓炎",
        "真菌性骨炎",
        "軟骨肉瘤"
      ],
      "initialDB": [
        "病變X光",
        "胸部X光（肺轉移分期）",
        "鹼性磷酸酶"
      ],
      "advanced": [
        "骨骼切片",
        "CT（手術規劃）",
        "骨掃描"
      ]
    },
    "treatment": {
      "overview": "截肢+化療是標準治療",
      "acute": [
        "截肢（局部控制）",
        "化療：Carboplatin或Cisplatin+Doxorubicin"
      ],
      "chronic": [
        "姑息：放射治療、止痛",
        "保肢手術（特定病例）"
      ]
    },
    "prognosis": "截肢+化療中位存活約10-12月，1年存活率約50%。單純截肢約4月。",
    "pearls": [
      "「遠離肘關節、靠近膝關節」（好發位置）",
      "轉移時間早，診斷時90%已有微轉移",
      "阿鹼性磷酸酶升高是不良預後因子",
      "三腳犬生活品質可以很好"
    ],
    "diagnosticAlgorithm": {
      "title": "骨肉瘤 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估跛行、腫脹及骨骼疼痛",
          "findings": [
            "漸進性跛行",
            "受影響長骨腫脹",
            "觸診疼痛",
            "大型犬中老年"
          ]
        },
        {
          "step": 2,
          "action": "骨骼X光",
          "details": "受影響區域正交位X光",
          "findings": [
            "骨溶解性及增生性混合病灶",
            "皮質骨破壞",
            "骨膜反應（日光放射狀）",
            "軟組織腫塊"
          ]
        },
        {
          "step": 3,
          "action": "胸腔轉移評估",
          "details": "三視X光或CT評估肺部",
          "findings": [
            "肺部結節性轉移灶",
            "區域淋巴結評估",
            "約90%就診時已有微轉移"
          ]
        },
        {
          "step": 4,
          "action": "組織切片確診",
          "details": "骨骼組織切片病理學",
          "findings": [
            "梭形細胞腫瘤伴骨基質",
            "鹼性磷酸酶組織染色",
            "分級與亞型分類",
            "排除軟骨肉瘤或纖維肉瘤"
          ]
        }
      ]
    },
    "monitoring": [
      "胸部X光每2-3月",
      "疼痛管理",
      "生活品質"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "atopic-dermatitis": {
    "zh": "異位性皮膚炎",
    "en": "Atopic Dermatitis",
    "definition": "異位性皮膚炎是犬貓因遺傳性皮膚屏障功能缺陷和免疫調節異常，對環境過敏原（塵蟎、花粉、黴菌）產生IgE介導的過敏反應所致的慢性瘙癢性皮膚病。為犬第二常見過敏性皮膚病（僅次於跳蚤過敏），通常1-3歲首次發病，具品種易感性。",
    "synonyms": [
      "Atopy",
      "環境過敏",
      "異位性皮炎"
    ],
    "epidemiology": {
      "species": "犬較常見",
      "age": "1-3歲發病",
      "sex": "無明顯傾向",
      "riskFactors": [
        "品種傾向（West Highland White Terrier、Labrador、GSD、Shar-Pei）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "搔癢（臉、腳、腋下、腹股溝）",
        "季節性（可能）",
        "反覆性耳炎"
      ],
      "physicalExam": [
        "皮膚紅斑",
        "脫毛",
        "苔蘚化",
        "繼發感染（細菌/酵母菌）"
      ]
    },
    "pathophysiology": "皮膚屏障蛋白（如filaggrin）表達缺陷→經皮水分散失增加→環境過敏原穿透受損屏障→抗原呈現細胞（Langerhans cells）攝取後活化Th2免疫反應→IL-4/IL-13促進B細胞分泌特異性IgE→IgE結合肥大細胞表面FcεRI受體→再次接觸過敏原後交聯脫顆粒→釋放組織胺、白三烯、前列腺素→血管擴張、瘙癢、紅斑。慢性期轉為Th1主導的苔蘚化病變。",
    "diagnosis": {
      "overview": "排除性診斷+過敏原檢測",
      "differentials": [
        "跳蚤過敏",
        "食物過敏",
        "疥癬",
        "接觸性皮炎"
      ],
      "initialDB": [
        "皮膚搔刮（排除蟎蟲）",
        "皮膚細胞學（感染）",
        "嚴格跳蚤控制"
      ],
      "advanced": [
        "過敏原皮內試驗",
        "血清過敏原檢測"
      ]
    },
    "treatment": {
      "overview": "多模式管理：控制症狀+減少過敏原接觸+免疫治療",
      "acute": [
        "類固醇（短期）",
        "Oclacitinib（Apoquel）",
        "Lokivetmab（Cytopoint）",
        "繼發感染治療"
      ],
      "chronic": [
        "過敏原特異性免疫治療（ASIT）",
        "必需脂肪酸",
        "局部治療（藥浴、外用藥）"
      ]
    },
    "prognosis": "異位性皮膚炎為終身疾病，無法根治但可有效控制。多數犬在多模式治療（過敏原特異性免疫治療ASIT + oclacitinib/lokivetmab + 皮膚屏障修復）下可維持良好生活品質。季節性病例預後較全年性佳。繼發感染和耳炎需同時管理。約60-70%的犬對ASIT有良好反應。",
    "pearls": [
      "需排除跳蚤過敏和食物過敏",
      "約70%有繼發感染需同時治療",
      "ASIT是唯一可能改變病程的治療",
      "Apoquel和Cytopoint比類固醇安全"
    ],
    "diagnosticAlgorithm": {
      "title": "異位性皮膚炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "臨床模式",
          "details": "搔癢+典型分布（面、耳、足、腋窩）",
          "findings": [
            "1-3歲發病",
            "季節性或全年性搔癢"
          ]
        },
        {
          "step": 2,
          "action": "排除其他原因",
          "details": "糞檢+皮膚刮片+飲食試驗",
          "findings": [
            "排除體外寄生蟲（Sarcoptes等）",
            "嚴格食物排除試驗8-12週"
          ]
        },
        {
          "step": 3,
          "action": "過敏原檢測",
          "details": "皮內試驗(IDT)或血清IgE",
          "findings": [
            "IDT為金標準（麻醉下進行）",
            "血清IgE幫助設計免疫療法"
          ]
        },
        {
          "step": 4,
          "action": "多模式治療",
          "details": "避免過敏原+免疫調節+症狀控制",
          "findings": [
            "Oclacitinib/Lokivetmab快速控制",
            "過敏原特異性免疫療法（長期）"
          ]
        }
      ]
    },
    "monitoring": [
      "搔癢程度評分",
      "繼發感染",
      "藥物副作用"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "pyoderma": {
    "zh": "膿皮症",
    "en": "Pyoderma",
    "definition": "膿皮症是犬最常見的細菌性皮膚感染，主要由Staphylococcus pseudintermedius引起。分表淺型（毛囊炎、膿疱疹）和深層型（深層毛囊炎、蜂窩組織炎、癤腫病）。幾乎總是繼發於潛在疾病（過敏、內分泌病、免疫缺陷），單獨治療而不找原發病因易反覆發作。",
    "synonyms": [
      "細菌性皮膚炎",
      "皮膚感染"
    ],
    "epidemiology": {
      "species": "犬較常見",
      "age": "任何年齡",
      "sex": "無明顯傾向",
      "riskFactors": [
        "潛在過敏性皮膚病",
        "免疫抑制",
        "皮膚皺褶"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "搔癢",
        "皮膚病灶",
        "體味"
      ],
      "physicalExam": [
        "表淺：丘疹、膿皰、環狀鱗屑",
        "深層：結節、廔管、出血"
      ]
    },
    "pathophysiology": "皮膚屏障因潛在疾病（過敏、甲狀腺功能低下、Cushing病）受損→正常皮膚菌群S. pseudintermedius伺機增殖→穿透受損表皮→毛囊感染（表淺型）或穿透真皮層（深層型）→嗜中性球浸潤形成膿疱→抓癢自我創傷加速擴散。耐甲氧西林葡萄球菌（MRSP）近年發病率上升，治療更具挑戰性。",
    "diagnosis": {
      "overview": "臨床表現+細胞學確認",
      "differentials": [
        "蠕形蟲",
        "皮膚真菌",
        "自體免疫皮膚病"
      ],
      "initialDB": [
        "皮膚細胞學（細菌、白血球）",
        "皮膚搔刮"
      ],
      "advanced": [
        "細菌培養+藥敏（難治性、深層）"
      ]
    },
    "treatment": {
      "overview": "抗生素+找出並治療潛在原因",
      "acute": [
        "表淺：局部治療（含氯己定藥浴）±全身抗生素",
        "深層：長期全身抗生素（4-6週）",
        "首選：Cephalexin、Amoxicillin-clavulanate"
      ],
      "chronic": [
        "找出並控制潛在原因",
        "維持藥浴"
      ]
    },
    "prognosis": "治療後預後良好，但常復發（若潛在原因未控制）。MRSP感染較難治療。",
    "pearls": [
      "多數膿皮症有潛在原因（過敏最常見）",
      "抗生素需用到病灶癒合後1-2週",
      "MRSP越來越常見",
      "藥浴可減少抗生素需求"
    ],
    "diagnosticAlgorithm": {
      "title": "膿皮症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估皮膚病灶深度、分佈及搔癢程度",
          "findings": [
            "丘疹膿疱",
            "表皮環狀鱗屑（表淺型）",
            "深部竇道及出血性分泌物（深層型）",
            "搔癢程度不一"
          ]
        },
        {
          "step": 2,
          "action": "皮膚細胞學",
          "details": "膿疱或滲出物壓印抹片",
          "findings": [
            "嗜中性球吞噬細菌",
            "球菌（葡萄球菌為主）",
            "桿菌（深層或混合感染）",
            "退化性嗜中性球"
          ]
        },
        {
          "step": 3,
          "action": "細菌培養與藥敏",
          "details": "深層或難治性病例進行培養",
          "findings": [
            "Staphylococcus pseudintermedius",
            "藥敏試驗指導抗生素選擇",
            "耐甲氧西林葡萄球菌（MRSP）篩檢"
          ]
        },
        {
          "step": 4,
          "action": "潛在病因調查",
          "details": "尋找誘發膿皮症的基礎疾病",
          "findings": [
            "甲狀腺功能低下",
            "庫欣氏症",
            "過敏性皮膚病",
            "皮膚刮片排除毛囊蟲"
          ]
        }
      ]
    },
    "monitoring": [
      "病灶癒合",
      "復發",
      "潛在疾病控制"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "otitis-externa": {
    "zh": "外耳炎",
    "en": "Otitis Externa",
    "definition": "外耳炎是犬貓外耳道的急性或慢性炎症，犬發病率約10-20%。主要誘因包括過敏（異位性皮膚炎為最常見潛因）、耳道異物、內分泌病和耳道解剖特徵（垂耳、毛多、狹窄）。繼發細菌（Staphylococcus spp.、Pseudomonas spp.）和酵母菌（Malassezia pachydermatis）感染加重病情。",
    "synonyms": [
      "耳道炎",
      "Ear infection"
    ],
    "epidemiology": {
      "species": "犬較常見",
      "age": "任何年齡",
      "sex": "無明顯傾向",
      "riskFactors": [
        "垂耳品種",
        "過敏性疾病",
        "游泳",
        "多毛耳道"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "搔耳",
        "甩頭",
        "耳朵異味",
        "分泌物"
      ],
      "physicalExam": [
        "耳道紅腫",
        "分泌物（顏色、性質依病因）",
        "疼痛",
        "耳道狹窄"
      ]
    },
    "pathophysiology": "主要誘因（過敏、異物、寄生蟲）破壞耳道上皮→炎症反應導致腺體增生和分泌增加→溫暖潮濕環境利於微生物增殖→繼發感染→進一步炎症和角化異常→耳道壁增厚和狹窄→分泌物積聚加重感染。慢性者耳道骨化和鈣化→不可逆狹窄→可能需要手術（全耳道切除+側鼓泡切開術TECA-LBO）。",
    "diagnosis": {
      "overview": "耳鏡檢查+細胞學確認病原",
      "differentials": [
        "原發：過敏、寄生蟲、異物",
        "繼發：細菌、酵母菌"
      ],
      "initialDB": [
        "耳鏡檢查",
        "耳道細胞學（細菌/酵母菌/白血球）"
      ],
      "advanced": [
        "培養+藥敏（難治性）",
        "CT/MRI（中耳炎）"
      ]
    },
    "treatment": {
      "overview": "清潔+局部治療+找出原發因素",
      "acute": [
        "耳道清潔",
        "局部藥物（依病原選擇）：抗生素、抗真菌、類固醇",
        "疼痛嚴重：短期全身類固醇"
      ],
      "chronic": [
        "治療原發因素（過敏）",
        "手術（嚴重慢性：TECA-LBO）"
      ]
    },
    "prognosis": "急性單純性外耳炎在正確治療和控制潛因後預後良好。慢性反覆性外耳炎預後取決於潛在疾病控制程度和耳道結構改變程度。Pseudomonas相關的耳炎治療較困難。嚴重耳道狹窄者可能需TECA-LBO手術，術後生活品質通常改善顯著。",
    "pearls": [
      "多數外耳炎有潛在原因（過敏最常見）",
      "細胞學區分細菌vs酵母菌很重要",
      "耳道有桿菌考慮培養",
      "單側外耳炎考慮異物或腫瘤"
    ],
    "diagnosticAlgorithm": {
      "title": "外耳炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "耳鏡檢查",
          "details": "評估耳道和鼓膜",
          "findings": [
            "耳道紅腫+分泌物",
            "鼓膜完整性（穿孔需注意用藥）"
          ]
        },
        {
          "step": 2,
          "action": "耳分泌物檢查",
          "details": "細胞學染色",
          "findings": [
            "球菌/桿菌感染",
            "Malassezia酵母菌感染"
          ]
        },
        {
          "step": 3,
          "action": "原因分析",
          "details": "區分原發/促發/維持因子",
          "findings": [
            "原發：過敏（最常見）、異物",
            "維持：中耳炎、耳道增生"
          ]
        },
        {
          "step": 4,
          "action": "治療",
          "details": "清潔+局部+全身+治療原發病",
          "findings": [
            "清潔耳道+局部抗菌/抗黴",
            "慢性：排除過敏並長期管理"
          ]
        }
      ]
    },
    "monitoring": [
      "治療反應",
      "復發",
      "進展為中耳炎"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "glaucoma": {
    "zh": "青光眼",
    "en": "Glaucoma",
    "definition": "青光眼是以眼內壓（IOP）異常升高為特徵的視神經退行性疾病，犬正常IOP為10-25 mmHg。分原發性（房水排出通道先天異常，遺傳性，Cocker Spaniel、Basset Hound好發）和續發性（葡萄膜炎、晶體脫位、眼內腫瘤阻塞房水排出）。急性發作為眼科急症。",
    "synonyms": [
      "綠內障",
      "眼壓過高"
    ],
    "epidemiology": {
      "species": "犬較常見",
      "age": "中老年",
      "sex": "無明顯傾向",
      "riskFactors": [
        "品種傾向（Cocker Spaniel、Basset Hound、Shar-Pei、Beagle）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "急性疼痛",
        "紅眼",
        "視力喪失",
        "眼睛變大（慢性）"
      ],
      "physicalExam": [
        "結膜充血",
        "角膜水腫",
        "瞳孔散大且對光反應遲鈍",
        "眼壓升高（>25 mmHg）"
      ]
    },
    "pathophysiology": "房水由睫狀體分泌→流經後房經瞳孔進入前房→從虹膜角膜角的小樑網和葡萄膜鞏膜途徑排出。排出通道阻塞（開角型：小樑網退化；閉角型：虹膜角膜角關閉；續發性：炎症碎屑或腫瘤阻塞）→房水蓄積→IOP升高→視網膜神經節細胞軸突壓迫性損傷→視神經萎縮→不可逆失明。犬急性青光眼IOP可達60-80 mmHg。",
    "diagnosis": {
      "overview": "眼壓測量+眼科檢查確診",
      "differentials": [
        "葡萄膜炎（眼壓低）",
        "角膜疾病"
      ],
      "initialDB": [
        "眼壓測量（Tonometry）",
        "裂隙燈檢查",
        "眼底檢查"
      ],
      "advanced": [
        "房角鏡檢查",
        "視網膜電圖",
        "眼球超聲"
      ]
    },
    "treatment": {
      "overview": "緊急降眼壓+評估視力挽救可能",
      "acute": [
        "Mannitol 1-2 g/kg IV over 20min",
        "Latanoprost 0.005%局部（禁忌於葡萄膜炎）",
        "Dorzolamide/Timolol"
      ],
      "chronic": [
        "藥物維持",
        "手術（睫狀體冷凍、雷射、引流裝置）",
        "失明且疼痛：眼球摘除或義眼"
      ]
    },
    "prognosis": "原發性：預後謹慎，多數最終失明。早期治療可延緩進展。對側眼預防很重要。",
    "pearls": [
      "急性青光眼是眼科急症",
      "眼壓>30 mmHg 24-48小時可致永久失明",
      "原發性青光眼對側眼50%會發病",
      "與葡萄膜炎區分很重要（治療不同）"
    ],
    "diagnosticAlgorithm": {
      "title": "青光眼 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估眼部疼痛、視力及眼球外觀",
          "findings": [
            "眼紅充血",
            "角膜水腫（藍灰色）",
            "瞳孔擴大固定",
            "眼球腫大（慢性）"
          ]
        },
        {
          "step": 2,
          "action": "眼壓測量",
          "details": "Tonopen或Tonovet眼壓計",
          "findings": [
            "眼壓>25 mmHg（犬）",
            "眼壓>30 mmHg（貓）",
            "雙眼眼壓比較",
            "需緊急處理"
          ]
        },
        {
          "step": 3,
          "action": "眼底與前房角檢查",
          "details": "眼底鏡及隅角鏡檢查",
          "findings": [
            "視神經盤杯盤比增大",
            "視網膜血管變化",
            "隅角開放或關閉",
            "晶體脫位評估"
          ]
        },
        {
          "step": 4,
          "action": "鑑別原發與繼發",
          "details": "區分原發性與繼發性青光眼",
          "findings": [
            "品種好發性（原發性）",
            "葡萄膜炎繼發",
            "晶體脫位繼發",
            "眼內腫瘤繼發"
          ]
        }
      ]
    },
    "monitoring": [
      "眼壓",
      "視力",
      "對側眼"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "cataract": {
    "zh": "白內障",
    "en": "Cataract",
    "definition": "白內障是晶體蛋白（crystallin）變性混濁導致光線無法正常透過的眼科疾病，為犬最常見的致盲原因。依成因分遺傳性（最常見，Poodle、Cocker Spaniel好發）、糖尿病性（75%糖尿病犬在1年內發展白內障）、外傷性和老年性。依成熟度分初期、未成熟、成熟和過熟期。",
    "synonyms": [
      "水晶體混濁"
    ],
    "epidemiology": {
      "species": "犬較常見",
      "age": "先天性/青年型/老年型",
      "sex": "無明顯傾向",
      "riskFactors": [
        "糖尿病（犬）",
        "品種傾向（Cocker Spaniel、Poodle、Boston Terrier）",
        "遺傳"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "視力下降",
        "眼睛變白"
      ],
      "physicalExam": [
        "水晶體混濁",
        "視力障礙",
        "可能併發葡萄膜炎或青光眼"
      ]
    },
    "pathophysiology": "晶體纖維細胞中的水溶性α-crystallin蛋白因氧化損傷、滲透壓改變或遺傳缺陷而凝聚為不溶性蛋白→光散射增加→晶體混濁。糖尿病性白內障：高血糖→晶體內山梨醇累積（醛糖還原酶途徑）→滲透壓升高→水分湧入→晶體纖維腫脹破裂→急速進展。過熟期白內障可誘發晶體源性葡萄膜炎。",
    "diagnosis": {
      "overview": "眼科檢查見水晶體混濁",
      "differentials": [
        "核硬化（老年正常變化）",
        "水晶體脫位"
      ],
      "initialDB": [
        "裂隙燈檢查",
        "眼底檢查（若可透視）",
        "眼壓"
      ],
      "advanced": [
        "眼球超聲（評估視網膜）",
        "視網膜電圖（ERG）"
      ]
    },
    "treatment": {
      "overview": "手術是唯一有效治療",
      "acute": [
        "白內障摘除術（Phacoemulsification）+ 人工水晶體植入"
      ],
      "chronic": [
        "保守：控制併發症（葡萄膜炎）",
        "抗氧化劑（延緩進展？效果有限）"
      ]
    },
    "prognosis": "手術治療（超音波乳化術+人工晶體植入）成功率85-95%，術後視力恢復良好。無手術者最終完全失明但犬適應力佳。糖尿病性白內障術前需良好血糖控制。主要併發症為術後葡萄膜炎和視網膜剝離（2-5%）。",
    "pearls": [
      "犬糖尿病幾乎都會發展白內障",
      "核硬化是老年正常變化，不影響視力",
      "手術前需ERG確認視網膜功能",
      "可能併發葡萄膜炎或青光眼"
    ],
    "diagnosticAlgorithm": {
      "title": "白內障 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估視力下降、瞳孔外觀及年齡",
          "findings": [
            "瞳孔區白色混濁",
            "視力下降或失明",
            "碰撞物體",
            "糖尿病犬快速發展"
          ]
        },
        {
          "step": 2,
          "action": "裂隙燈檢查",
          "details": "細部評估白內障位置與程度",
          "findings": [
            "皮質型、核型或後囊下型",
            "未成熟、成熟或過熟分期",
            "晶體纖維腫脹程度",
            "與核硬化鑑別"
          ]
        },
        {
          "step": 3,
          "action": "眼科全面檢查",
          "details": "評估手術適應症及併發症",
          "findings": [
            "眼壓測量排除青光眼",
            "眼底檢查或超音波（成熟白內障時）",
            "視網膜電圖（ERG）確認視網膜功能",
            "晶體誘發性葡萄膜炎"
          ]
        },
        {
          "step": 4,
          "action": "全身檢查",
          "details": "排除系統性疾病",
          "findings": [
            "血糖檢查排除糖尿病",
            "肝腎功能評估麻醉風險",
            "全面血液檢查",
            "術前心臟評估"
          ]
        }
      ]
    },
    "monitoring": [
      "視力",
      "眼壓",
      "葡萄膜炎"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "brachycephalic-airway-syndrome": {
    "zh": "短頭犬呼吸道症候群",
    "en": "Brachycephalic Airway Syndrome (BAS)",
    "definition": "短頭犬呼吸道症候群是一組因顱顏骨骼短縮導致上呼吸道多處解剖異常的先天性疾病綜合徵。主要病變包括鼻孔狹窄、軟顎過長、喉囊外翻和氣管發育不全。English Bulldog、French Bulldog、Pug最常見。慢性上呼吸道阻力增加可導致繼發性喉塌陷。",
    "synonyms": [
      "BAS",
      "BOAS",
      "短吻犬症候群"
    ],
    "epidemiology": {
      "species": "犬（短頭品種）",
      "age": "幼年發現，隨年齡惡化",
      "sex": "無明顯傾向",
      "riskFactors": [
        "短頭品種（English Bulldog、French Bulldog、Pug、Boston Terrier）",
        "肥胖"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "打鼾",
        "呼吸困難",
        "運動不耐",
        "熱不耐",
        "睡眠呼吸暫停"
      ],
      "physicalExam": [
        "吸氣性喘鳴",
        "鼻孔狹窄",
        "軟顎過長",
        "喉囊外翻",
        "發紺（嚴重）"
      ]
    },
    "pathophysiology": "先天性異常（鼻孔狹窄、軟顎過長）→ 呼吸阻力增加 → 代償性變化（喉囊外翻、氣管發育不全）→ 惡性循環",
    "diagnosis": {
      "overview": "品種+臨床表現+喉鏡檢查",
      "differentials": [
        "氣管塌陷",
        "喉麻痺",
        "異物"
      ],
      "initialDB": [
        "鼻孔視診",
        "喉鏡檢查（麻醉下）"
      ],
      "advanced": [
        "胸部X光（評估氣管）",
        "CT"
      ]
    },
    "treatment": {
      "overview": "手術矯正解剖異常",
      "acute": [
        "急性呼吸窘迫：鎮靜、氧氣、冷卻（若過熱）"
      ],
      "chronic": [
        "手術：鼻孔擴大術、軟顎截短術、喉囊切除術",
        "體重控制",
        "避免過熱"
      ]
    },
    "prognosis": "早期手術矯正（鼻孔擴大術+軟顎切短術，理想在1-2歲）預後良好，約90%的犬臨床症狀顯著改善。延遲手術至繼發性喉塌陷發生後預後變差。術後需嚴格控制體重。極端短頭型（Bulldog）即使術後仍可能有殘餘症狀。中暑為最危險併發症，炎熱環境需特別注意。",
    "pearls": [
      "這些品種麻醉風險較高",
      "熱衰竭風險高",
      "肥胖顯著惡化",
      "早期手術可預防繼發性變化"
    ],
    "diagnosticAlgorithm": {
      "title": "短頭犬呼吸道症候群 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "品種辨識",
          "details": "短頭犬/貓呼吸困難+打鼾",
          "findings": [
            "運動不耐+打鼾+喘鳴音",
            "Pug, Bulldog, Persian等品種"
          ]
        },
        {
          "step": 2,
          "action": "解剖評估",
          "details": "鼻孔+軟顎+喉部檢查",
          "findings": [
            "鼻孔狹窄（外觀即可判斷）",
            "軟顎過長需麻醉下評估"
          ]
        },
        {
          "step": 3,
          "action": "進階評估",
          "details": "CT/內視鏡評估呼吸道",
          "findings": [
            "喉囊外翻（繼發性變化）",
            "氣管發育不全（Bulldog）"
          ]
        },
        {
          "step": 4,
          "action": "手術矯正",
          "details": "多部位矯正手術",
          "findings": [
            "鼻孔擴張+軟顎截短",
            "早期手術(1-2歲)預後較好"
          ]
        }
      ]
    },
    "monitoring": [
      "呼吸狀態",
      "運動耐受性",
      "體重"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "pneumonia": {
    "zh": "肺炎",
    "en": "Pneumonia",
    "definition": "肺炎是肺實質（肺泡和細支氣管）的感染性或非感染性炎症。犬貓最常見為細菌性吸入性肺炎，致病菌包括Pasteurella、Bordetella、E. coli和厭氧菌。吸入性肺炎常繼發於嘔吐、巨食道症、喉麻痺或全身麻醉後。病毒性肺炎（犬流感、犬瘟熱）可繼發細菌感染。",
    "synonyms": [
      "肺臟發炎",
      "Bacterial pneumonia",
      "Aspiration pneumonia"
    ],
    "epidemiology": {
      "species": "犬貓皆可",
      "age": "幼年或老年較易感",
      "sex": "無明顯傾向",
      "riskFactors": [
        "吸入性風險（巨食道症、麻醉、嘔吐）",
        "免疫抑制",
        "病毒感染後"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "咳嗽",
        "呼吸困難",
        "發燒",
        "厭食",
        "嗜睡"
      ],
      "physicalExam": [
        "發燒",
        "肺部囉音",
        "呼吸急促/困難",
        "黏液性或膿性鼻分泌物"
      ]
    },
    "pathophysiology": "病原體（細菌、病毒、真菌）或吸入物（胃酸、食物）進入下呼吸道→肺泡巨噬細胞啟動先天免疫→嗜中性球浸潤→炎症介質釋放→肺泡毛細血管通透性增加→滲出液填充肺泡→氣體交換障礙→低氧血症。吸入性肺炎的胃酸直接損傷肺泡上皮（化學性肺炎），繼發細菌感染。嚴重者進展為ARDS。",
    "diagnosis": {
      "overview": "胸部X光見肺浸潤+臨床症狀",
      "differentials": [
        "肺水腫",
        "肺腫瘤",
        "肺纖維化"
      ],
      "initialDB": [
        "胸部X光",
        "CBC（白血球升高）",
        "脈搏血氧"
      ],
      "advanced": [
        "支氣管肺泡灌洗(BAL)+細胞學/培養",
        "血液培養"
      ]
    },
    "treatment": {
      "overview": "抗生素+支持治療",
      "acute": [
        "廣譜抗生素：Ampicillin-sulbactam + Fluoroquinolone",
        "或Amoxicillin-clavulanate",
        "氧氣支持",
        "輸液",
        "霧化治療"
      ],
      "chronic": [
        "抗生素療程10-14天（或X光正常後1週）",
        "治療原發因素（吸入性風險）"
      ]
    },
    "prognosis": "細菌性肺炎治療後預後良好。吸入性肺炎取決於原發因素。免疫抑制者預後差。",
    "pearls": [
      "吸入性肺炎好發右中葉",
      "培養結果前經驗性廣譜抗生素",
      "巨食道症、喉麻痺犬終身吸入性肺炎風險",
      "貓肺炎較犬少見"
    ],
    "diagnosticAlgorithm": {
      "title": "肺炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估呼吸型態、咳嗽及全身狀態",
          "findings": [
            "咳嗽（濕咳為主）",
            "發燒",
            "呼吸困難",
            "鼻分泌物"
          ]
        },
        {
          "step": 2,
          "action": "胸腔聽診與X光",
          "details": "肺部聽診及正側位胸腔X光",
          "findings": [
            "肺部濕囉音",
            "肺泡型浸潤",
            "支氣管型態",
            "主要影響腹側肺葉（吸入性）"
          ]
        },
        {
          "step": 3,
          "action": "血液與微生物學",
          "details": "CBC及呼吸道樣本分析",
          "findings": [
            "白血球增多伴左移",
            "氣管沖洗液細胞學與培養",
            "藥敏試驗",
            "排除黴菌性肺炎"
          ]
        },
        {
          "step": 4,
          "action": "進階病因評估",
          "details": "評估基礎原因",
          "findings": [
            "排除吸入性原因（巨食道症、麻醉後）",
            "排除免疫抑制",
            "胸腔超音波評估胸水",
            "血液氣體分析"
          ]
        }
      ]
    },
    "monitoring": [
      "呼吸狀態",
      "體溫",
      "X光追蹤"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "chronic-bronchitis": {
    "zh": "慢性支氣管炎",
    "en": "Chronic Bronchitis",
    "definition": "慢性支氣管炎定義為犬連續2個月以上大部分時間有咳嗽症狀，且排除其他已知呼吸道疾病。為中老年小型犬常見的慢性下呼吸道疾病，以氣道黏膜持續性發炎、黏液分泌過多和氣道重塑為特徵。類似人類COPD但犬不與吸菸相關。",
    "synonyms": [
      "COPD",
      "慢性氣管炎"
    ],
    "epidemiology": {
      "species": "犬較常見",
      "age": "中老年（>6歲）",
      "sex": "無明顯傾向",
      "riskFactors": [
        "小型犬",
        "肥胖",
        "環境刺激物"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "慢性咳嗽（>2月）",
        "咳嗽後乾嘔",
        "運動不耐"
      ],
      "physicalExam": [
        "氣管敏感",
        "肺部可能正常或有囉音",
        "咳嗽易誘發"
      ]
    },
    "pathophysiology": "不明原因的慢性氣道炎症→黏膜杯狀細胞增生和黏液腺肥大→黏液分泌過多→纖毛清除功能受損→黏液蓄積→咳嗽反射→氣道平滑肌肥厚和基底膜纖維化（氣道重塑）→管腔狹窄→氣流阻力增加→呼氣時動態氣道塌陷。反覆發炎-修復循環導致不可逆結構改變。常合併氣管塌陷。",
    "diagnosis": {
      "overview": "排除性診斷：排除心臟病、腫瘤、感染後診斷",
      "differentials": [
        "心臟病",
        "氣管塌陷",
        "肺腫瘤",
        "肺炎"
      ],
      "initialDB": [
        "胸部X光（支氣管壁增厚）",
        "心臟評估",
        "糞便寄生蟲"
      ],
      "advanced": [
        "支氣管鏡+BAL"
      ]
    },
    "treatment": {
      "overview": "抗炎+支氣管擴張+環境管理",
      "acute": [
        "Prednisolone 0.5-1 mg/kg PO q12h漸減",
        "支氣管擴張劑（Theophylline、Terbutaline）"
      ],
      "chronic": [
        "吸入類固醇（Fluticasone）",
        "環境控制（減少刺激物）",
        "體重管理"
      ]
    },
    "prognosis": "慢性支氣管炎為不可逆疾病，治療目標為控制症狀和減緩進展。口服糖皮質激素（prednisolone）和吸入型支氣管擴張劑為一線治療。減重可顯著改善症狀。多數犬在適當管理下可維持可接受的生活品質數年。急性惡化期需積極治療。",
    "pearls": [
      "需排除心臟病（尤其小型犬）",
      "吸入類固醇比口服副作用少",
      "肥胖顯著惡化症狀",
      "避免二手菸和空氣污染"
    ],
    "diagnosticAlgorithm": {
      "title": "慢性支氣管炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "臨床定義",
          "details": "咳嗽>2個月+排除其他原因",
          "findings": [
            "每日咳嗽+痰多",
            "中老年小型犬多見"
          ]
        },
        {
          "step": 2,
          "action": "胸部X光",
          "details": "支氣管壁增厚+肺過度充氣",
          "findings": [
            "支氣管壁增厚（甜甜圈/鐵軌徵）",
            "肺過度充氣+支氣管擴張"
          ]
        },
        {
          "step": 3,
          "action": "BAL分析",
          "details": "支氣管肺泡灌洗液細胞學+培養",
          "findings": [
            "嗜中性球或嗜酸性球增多",
            "排除感染（培養+藥敏）"
          ]
        },
        {
          "step": 4,
          "action": "長期管理",
          "details": "抗發炎+支氣管擴張+環境控制",
          "findings": [
            "Prednisolone吸入劑or口服",
            "Theophylline/Terbutaline支氣管擴張"
          ]
        }
      ]
    },
    "monitoring": [
      "咳嗽頻率",
      "運動耐受性",
      "胸部X光"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "dilated-cardiomyopathy": {
    "zh": "擴張型心肌病",
    "en": "Dilated Cardiomyopathy (DCM)",
    "definition": "擴張型心肌病（DCM）是以心室擴張和收縮功能進行性下降為特徵的原發性心肌疾病，為大型犬最常見的心肌病。Doberman Pinscher、Great Dane、Irish Wolfhound有遺傳傾向。Doberman型DCM以室性心律不整和猝死為特徵，可在心臟擴張之前發生。",
    "synonyms": [
      "DCM",
      "擴張性心肌病",
      "充血性心肌病",
      "Congestive Cardiomyopathy"
    ],
    "epidemiology": {
      "species": "主要影響犬，貓罕見（多與牛磺酸缺乏相關）",
      "age": "中大型犬4-10歲，杜賓犬可更早發病",
      "sex": "公犬較母犬更常見（約2-3:1）",
      "riskFactors": [
        "大型及巨型犬種",
        "杜賓犬",
        "拳師犬",
        "大丹犬",
        "愛爾蘭獵狼犬",
        "可卡犬",
        "牛磺酸缺乏（貓）",
        "左旋肉鹼缺乏",
        "某些穀物無關飼料（FDA調查中）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "運動不耐",
        "虛弱",
        "咳嗽",
        "呼吸困難",
        "腹部膨大（腹水）",
        "昏厥",
        "突然死亡（尤其杜賓犬）",
        "食慾下降",
        "體重減輕"
      ],
      "physicalExam": [
        "心搏過速",
        "心律不整（心房顫動、心室早搏）",
        "第三心音（奔馬律）",
        "心雜音（二尖瓣/三尖瓣逆流）",
        "脈搏弱或脈搏缺失",
        "肺部濕囉音",
        "頸靜脈怒張",
        "肝腫大",
        "腹水",
        "黏膜蒼白"
      ]
    },
    "pathophysiology": "心肌細胞功能障礙或喪失 → 心室收縮力下降 → 心室擴張（Frank-Starling代償）→ 心壁變薄 → 二尖瓣/三尖瓣環擴大致瓣膜逆流 → 心房擴張 → 神經內分泌活化（RAAS、交感神經）→ 液體滯留 → 充血性心衰竭",
    "diagnosis": {
      "overview": "心臟超聲是確診金標準，顯示心室擴張和收縮功能下降",
      "differentials": [
        "二尖瓣疾病",
        "心包積液",
        "心律不整誘發的心肌病",
        "缺血性心肌病",
        "牛磺酸缺乏性心肌病"
      ],
      "initialDB": [
        "心臟超聲（LVIDD↑、LVIDS↑、FS↓<20%、EPSS↑）",
        "胸腔X光（心臟擴大、肺水腫）",
        "ECG（心房顫動、心室早搏、寬QRS）",
        "NT-proBNP或cTnI"
      ],
      "advanced": [
        "24小時Holter監測（隱匿性DCM篩檢）",
        "牛磺酸和左旋肉鹼濃度",
        "基因檢測（杜賓犬PDK4突變）"
      ]
    },
    "treatment": {
      "overview": "改善心臟功能、減輕心臟負擔、控制心律不整、改善生活品質",
      "acute": [
        "急性充血性心衰竭：",
        "- 氧氣支持",
        "- Furosemide: 2-4 mg/kg IV q1-4h直到穩定",
        "- Pimobendan: 0.25-0.3 mg/kg PO q12h（正性肌力+血管擴張）",
        "- 硝酸甘油軟膏（降低前負荷）",
        "- 嚴重低心輸出量：Dobutamine 2.5-10 μg/kg/min CRI",
        "心房顫動急性控制：Diltiazem IV或口服"
      ],
      "chronic": [
        "Pimobendan: 0.25-0.3 mg/kg PO q12h（首選正性肌力藥）",
        "ACEI: Enalapril 0.5 mg/kg PO q12-24h 或 Benazepril 0.25-0.5 mg/kg PO q12-24h",
        "Furosemide: 1-4 mg/kg PO q8-12h（依需要調整）",
        "Spironolactone: 1-2 mg/kg PO q12-24h",
        "心房顫動：Diltiazem 0.5-1.5 mg/kg PO q8h 或 Digoxin",
        "心室早搏：Sotalol 1-2 mg/kg PO q12h 或 Mexiletine",
        "牛磺酸補充（若缺乏）：250-500 mg PO q12h",
        "L-carnitine（若缺乏）：50-100 mg/kg PO q8h",
        "Omega-3脂肪酸",
        "限鈉飲食"
      ]
    },
    "prognosis": "預後謹慎至差。杜賓犬DCM預後最差（確診後中位生存期約6-8週至數月）。其他犬種確診CHF後中位生存期約6-24個月。隱匿期DCM可存活較長。",
    "pearls": [
      "杜賓犬DCM有高達30-50%終生罹患率，建議年度Holter和Echo篩檢",
      "心房顫動在DCM犬中很常見，需控制心率",
      "Pimobendan可延長DCM犬的存活時間",
      "隱匿期DCM（無症狀）仍需治療",
      "某些無穀飼料與DCM的關聯仍在研究中",
      "貓DCM多與牛磺酸缺乏相關，補充後可能改善"
    ],
    "diagnosticAlgorithm": {
      "title": "擴張型心肌病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估運動不耐、咳嗽及呼吸困難",
          "findings": [
            "運動不耐",
            "咳嗽（左心衰竭）",
            "腹水（右心衰竭）",
            "昏厥",
            "大型犬品種好發"
          ]
        },
        {
          "step": 2,
          "action": "胸腔X光",
          "details": "評估心臟大小及肺水腫",
          "findings": [
            "全面性心臟擴大",
            "肺靜脈擴張",
            "肺水腫",
            "胸腔積液"
          ]
        },
        {
          "step": 3,
          "action": "心臟超音波",
          "details": "M-mode及2D評估心腔與功能",
          "findings": [
            "左心室擴張",
            "收縮功能下降（FS<25%、EF降低）",
            "左心房擴大",
            "E點中隔距離增加"
          ]
        },
        {
          "step": 4,
          "action": "心電圖與生物標記",
          "details": "ECG及心肌標記物",
          "findings": [
            "心房顫動",
            "心室早期收縮",
            "cTnI升高",
            "NT-proBNP升高",
            "Holter監測VPC頻率"
          ]
        }
      ]
    },
    "monitoring": [
      "呼吸頻率（家中監測RRR<30）",
      "心臟超聲",
      "胸腔X光",
      "ECG/Holter",
      "腎功能和電解質",
      "體重",
      "NT-proBNP"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "hypertrophic-cardiomyopathy": {
    "zh": "肥厚型心肌病",
    "en": "Hypertrophic Cardiomyopathy (HCM)",
    "definition": "原發性心肌肥厚導致心室壁增厚、心室腔縮小、舒張功能障礙的心肌疾病，是貓最常見的心臟病。",
    "synonyms": [
      "HCM",
      "肥厚性心肌病",
      "Hypertrophic Obstructive Cardiomyopathy (HOCM)"
    ],
    "epidemiology": {
      "species": "貓最常見，犬罕見",
      "age": "貓多在5-7歲診斷，但可在任何年齡發生（6個月至16歲）",
      "sex": "公貓較常見（約3:1）",
      "riskFactors": [
        "緬因貓",
        "布偶貓",
        "英國短毛貓",
        "波斯貓",
        "斯芬克斯貓",
        "家族遺傳",
        "甲狀腺機能亢進（繼發性）",
        "系統性高血壓（繼發性）",
        "生長激素過多"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "可能完全無症狀",
        "呼吸困難",
        "呼吸急促",
        "張口呼吸",
        "運動不耐",
        "後肢癱瘓（動脈血栓栓塞）",
        "昏厥",
        "突然死亡",
        "食慾下降"
      ],
      "physicalExam": [
        "心雜音（收縮期，動態性流出道阻塞或SAM）",
        "奔馬律（S4）",
        "心律不整",
        "心搏過速",
        "股動脈脈搏減弱或消失（ATE）",
        "後肢冰冷、疼痛（ATE）",
        "肺部濕囉音（肺水腫）",
        "呼吸音減弱（胸腔積液）"
      ]
    },
    "pathophysiology": "基因突變（肌節蛋白）→ 心肌細胞肥大和排列紊亂 → 左心室壁肥厚 → 舒張功能障礙（順應性下降）→ 左心房擴張 → 肺靜脈壓升高 → 肺水腫/胸腔積液。SAM（二尖瓣收縮期前向運動）→ 動態性流出道阻塞。左心房擴張和血流淤滯 → 血栓形成 → ATE",
    "diagnosis": {
      "overview": "心臟超聲確診，需排除繼發性心肌肥厚原因",
      "differentials": [
        "甲狀腺機能亢進（繼發性肥厚）",
        "系統性高血壓（繼發性肥厚）",
        "主動脈狹窄",
        "脫水假性肥厚",
        "限制型心肌病",
        "未分類心肌病"
      ],
      "initialDB": [
        "心臟超聲（LVW或IVS≥6mm、LA/Ao>1.5、SAM、動態流出道阻塞）",
        "胸腔X光",
        "血壓測量",
        "T4（排除甲亢）",
        "ECG",
        "心肌標記物（cTnI、NT-proBNP）"
      ],
      "advanced": [
        "基因檢測（緬因貓MYBPC3、布偶貓MYBPC3突變）",
        "24小時Holter",
        "進階超聲（組織多普勒、應變成像）"
      ]
    },
    "treatment": {
      "overview": "控制心率、改善舒張功能、預防血栓、治療充血症狀",
      "acute": [
        "急性CHF：",
        "- 氧氣支持（最小化應激）",
        "- Furosemide: 1-2 mg/kg IV/IM q1-4h",
        "- 胸腔穿刺（若有大量胸腔積液）",
        "- 避免過度處置造成應激",
        "動脈血栓栓塞（ATE）：",
        "- 止痛（極重要）：Methadone、Buprenorphine",
        "- 抗凝：Heparin或低分子肝素",
        "- 支持治療"
      ],
      "chronic": [
        "無症狀HCM治療爭議：",
        "- 輕度：可能不需治療或Atenolol",
        "- 中重度心房擴大：建議抗血小板/抗凝",
        "β-blocker: Atenolol 6.25-12.5 mg/貓 PO q12-24h",
        "Diltiazem: 7.5-15 mg/貓 PO q8h（替代β-blocker）",
        "CHF穩定後：Furosemide 1-2 mg/kg PO q12-24h",
        "血栓預防：",
        "- Clopidogrel: 18.75 mg/貓 PO q24h（首選）",
        "- 或 Aspirin: 81 mg/貓 PO q72h",
        "- 高風險：加上Rivaroxaban或低分子肝素",
        "ACEI: Benazepril 0.5-1 mg/kg PO q24h（CHF時）"
      ]
    },
    "prognosis": "高度變異。無症狀貓可存活多年。一旦發展CHF，中位生存期約3-18個月。ATE後預後差，中位生存期約2-6個月，但復發率高。",
    "pearls": [
      "貓HCM是最常見的心臟病，但許多貓終生無症狀",
      "心雜音不代表HCM，約1/3 HCM貓無雜音",
      "NT-proBNP可用於篩檢，但需結合超聲確診",
      "ATE是HCM最嚴重的併發症之一",
      "應激可誘發急性失代償，處置時需溫和",
      "繼發性肥厚（甲亢、高血壓）需排除並治療原因"
    ],
    "diagnosticAlgorithm": {
      "title": "肥厚型心肌病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "聽診心雜音、評估呼吸狀態（貓）",
          "findings": [
            "收縮期心雜音",
            "奔馬律",
            "呼吸困難",
            "後肢癱瘓（血栓）"
          ]
        },
        {
          "step": 2,
          "action": "胸腔X光",
          "details": "評估心臟輪廓及肺部",
          "findings": [
            "左心房擴大（Valentine形狀）",
            "肺水腫",
            "胸腔積液"
          ]
        },
        {
          "step": 3,
          "action": "心臟超音波",
          "details": "2D及M-mode詳細評估",
          "findings": [
            "左心室壁厚度>6mm（貓）",
            "左心室流出道動態阻塞（SAM）",
            "左心房擴大",
            "自發性超音波對比（煙霧狀）"
          ]
        },
        {
          "step": 4,
          "action": "生物標記與監測",
          "details": "NT-proBNP及基因檢測",
          "findings": [
            "NT-proBNP升高",
            "cTnI升高",
            "Maine Coon和Ragdoll基因檢測",
            "評估血栓風險"
          ]
        }
      ]
    },
    "monitoring": [
      "呼吸頻率（家中RRR<30）",
      "心臟超聲（每6-12個月）",
      "T4",
      "血壓",
      "腎功能",
      "NT-proBNP"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "mitral-valve-disease": {
    "zh": "二尖瓣疾病",
    "en": "Mitral Valve Disease (MVD)",
    "definition": "二尖瓣退行性疾病（MMVD/MVD）是犬最常見的心臟病，佔所有犬心臟病的75%以上。因二尖瓣小葉黏液樣退化（myxomatous degeneration）導致瓣膜增厚、脫垂和關閉不全。Cavalier King Charles Spaniel幾乎100%會發展此病。ACVIM分級B1→B2→C→D指導治療。",
    "synonyms": [
      "MVD",
      "MMVD",
      "二尖瓣黏液瘤性退化",
      "Myxomatous Mitral Valve Disease",
      "Endocardiosis",
      "二尖瓣閉鎖不全",
      "Mitral Regurgitation"
    ],
    "epidemiology": {
      "species": "犬最常見，貓罕見",
      "age": "中老年犬（>5歲），年齡增加罹患率增加",
      "sex": "公犬較常見（約1.5:1）",
      "riskFactors": [
        "小型犬種",
        "騎士查理王小獵犬（早發且嚴重）",
        "臘腸犬",
        "貴賓犬",
        "約克夏梗",
        "吉娃娃",
        "博美犬",
        "年齡"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "早期無症狀（僅雜音）",
        "咳嗽（尤其夜間或興奮時）",
        "運動不耐",
        "呼吸困難",
        "昏厥",
        "腹部膨大",
        "食慾下降",
        "體重減輕"
      ],
      "physicalExam": [
        "收縮期心尖區心雜音（左側最響，可輻射至右側）",
        "雜音強度與疾病嚴重度相關",
        "心搏過速",
        "竇性心律不整消失",
        "脈搏品質變化",
        "肺部濕囉音",
        "頸靜脈怒張（若右心衰竭）",
        "腹水",
        "體重減輕/肌肉消耗"
      ]
    },
    "pathophysiology": "瓣膜黏液瘤性退化 → 瓣葉增厚、脫垂 → 腱索延長或斷裂 → 二尖瓣逆流 → 左心房容量超負荷和擴張 → 肺靜脈壓升高 → 肺水腫。慢性容量超負荷 → 離心性左心室重塑 → 最終收縮功能下降 → 低心輸出量",
    "diagnosis": {
      "overview": "聽診發現雜音後以心臟超聲確診和分期",
      "differentials": [
        "擴張型心肌病",
        "先天性二尖瓣發育不良",
        "感染性心內膜炎",
        "心肌梗塞後二尖瓣逆流"
      ],
      "initialDB": [
        "胸腔X光（VHS評估心臟大小、肺水腫）",
        "心臟超聲（LA/Ao、LVIDD、E波速度、逆流評估）",
        "血壓",
        "基本血檢"
      ],
      "advanced": [
        "NT-proBNP",
        "cTnI",
        "ECG/Holter"
      ]
    },
    "treatment": {
      "overview": "依ACVIM分期指引治療。目標：延長壽命、延緩疾病進展、改善生活品質",
      "acute": [
        "急性CHF（肺水腫）：",
        "- 氧氣支持",
        "- Furosemide: 2-4 mg/kg IV q1-2h直到呼吸改善",
        "- Pimobendan: 0.25-0.3 mg/kg PO q12h（立即開始）",
        "- 硝酸甘油（降低前負荷）",
        "- 嚴重時：Nitroprusside CRI",
        "腱索斷裂急性惡化：密切監測，可能需要手術"
      ],
      "chronic": [
        "ACVIM B1期（雜音但無心臟擴大）：監測，無需藥物",
        "ACVIM B2期（心臟擴大但無症狀）：",
        "- Pimobendan: 0.25-0.3 mg/kg PO q12h（EPIC研究證實延長無症狀期）",
        "ACVIM C期（有或曾有CHF症狀）：",
        "- Pimobendan: 0.25-0.3 mg/kg PO q12h",
        "- Furosemide: 1-4 mg/kg PO q8-12h（最低有效劑量）",
        "- ACEI: Enalapril或Benazepril 0.5 mg/kg PO q12h",
        "- Spironolactone: 1-2 mg/kg PO q12-24h",
        "ACVIM D期（難治性CHF）：",
        "- 增加Furosemide劑量或頻率",
        "- 加上Torasemide",
        "- Amlodipine（降低後負荷）",
        "- 飲食調整",
        "- 考慮外科修復（若可行）"
      ]
    },
    "prognosis": "早期MVD進展緩慢，許多犬可存活數年。一旦發展CHF，平均存活約9-12個月（有治療）。EPIC研究顯示Pimobendan在B2期可延長約15個月無症狀期。",
    "pearls": [
      "雜音強度≥3/6且有心臟擴大才建議開始Pimobendan（B2期）",
      "家中呼吸頻率監測是最重要的居家監測指標",
      "咳嗽可能是肺水腫或左主支氣管受壓，需區分",
      "騎士查理王小獵犬常早發且進展快",
      "外科二尖瓣修復在專業中心有良好成果",
      "心房顫動預後較差"
    ],
    "diagnosticAlgorithm": {
      "title": "二尖瓣疾病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "聽診左心尖心雜音及評估症狀",
          "findings": [
            "左心尖收縮期心雜音",
            "咳嗽（尤其夜間或興奮時）",
            "運動不耐",
            "中老年小型犬"
          ]
        },
        {
          "step": 2,
          "action": "胸腔X光",
          "details": "評估心臟大小及肺水腫",
          "findings": [
            "左心房擴大",
            "左心室擴大",
            "肺靜脈擴張",
            "肺水腫（失代償期）"
          ]
        },
        {
          "step": 3,
          "action": "心臟超音波",
          "details": "評估瓣膜形態及血流動力學",
          "findings": [
            "二尖瓣增厚不規則",
            "二尖瓣返流（彩色都卜勒）",
            "左心房/主動脈比值>1.6",
            "左心室擴大（LVIDDN>1.7）"
          ]
        },
        {
          "step": 4,
          "action": "分期與監測",
          "details": "ACVIM B1/B2/C/D分期",
          "findings": [
            "ACVIM分期指導治療",
            "NT-proBNP趨勢追蹤",
            "Holter監測心律不整",
            "呼吸頻率居家監測"
          ]
        }
      ]
    },
    "monitoring": [
      "家中呼吸頻率（RRR<30/min）",
      "胸腔X光",
      "心臟超聲（每6-12個月）",
      "腎功能和電解質",
      "體重",
      "血壓"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; ACVIM Consensus Guidelines 2019"
  },
  "tricuspid-valve-dysplasia": {
    "zh": "三尖瓣發育不良",
    "en": "Tricuspid Valve Dysplasia (TVD)",
    "definition": "三尖瓣發育不良是指三尖瓣裝置（瓣葉、腱索、乳突肌）的先天性畸形，導致三尖瓣關閉不全和右心衰竭。Labrador Retriever和其他大型犬好發，為先天性心臟病中較常見的類型之一。嚴重者可在幼年期出現右側充血性心衰（腹水、頸靜脈擴張）。",
    "synonyms": [
      "TVD",
      "三尖瓣畸形",
      "先天性三尖瓣逆流",
      "Ebstein異常（嚴重形式）"
    ],
    "epidemiology": {
      "species": "犬較常見，貓罕見",
      "age": "先天性，年輕時診斷（通常<1歲）",
      "sex": "公犬略多",
      "riskFactors": [
        "拉布拉多犬",
        "德國牧羊犬",
        "大丹犬",
        "愛爾蘭雪達犬",
        "魏瑪犬",
        "舊英國牧羊犬",
        "遺傳"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "可能無症狀",
        "運動不耐",
        "腹部膨大（腹水）",
        "發育遲緩",
        "昏厥",
        "呼吸困難"
      ],
      "physicalExam": [
        "右側心尖區收縮期雜音",
        "可能有頸靜脈搏動",
        "肝腫大",
        "腹水",
        "頸靜脈怒張",
        "周邊水腫"
      ]
    },
    "pathophysiology": "三尖瓣葉發育異常（增厚、黏連、位置下移）→ 三尖瓣閉鎖不全 → 右心房和右心室容量超負荷 → 右心擴張 → 右心衰竭 → 體靜脈淤血 → 腹水、肝腫大",
    "diagnosis": {
      "overview": "心臟超聲確診，評估瓣膜結構和逆流嚴重程度",
      "differentials": [
        "三尖瓣黏液瘤性退化",
        "心絲蟲相關三尖瓣逆流",
        "肺動脈高血壓繼發三尖瓣逆流",
        "心內膜墊缺損"
      ],
      "initialDB": [
        "心臟超聲（瓣膜結構異常、RA/RV擴張、三尖瓣逆流）",
        "胸腔X光（右心擴大）",
        "ECG（右心房擴大、右束支傳導阻滯、心室早搏）"
      ],
      "advanced": [
        "心血管造影",
        "CT血管造影"
      ]
    },
    "treatment": {
      "overview": "目前無法治癒，治療以控制右心衰竭症狀為主",
      "acute": [
        "急性右心衰竭：",
        "- Furosemide: 2-4 mg/kg IV",
        "- 腹腔穿刺（大量腹水影響呼吸時）",
        "- 氧氣支持（若需要）"
      ],
      "chronic": [
        "輕度無症狀：監測，無需藥物",
        "右心衰竭：",
        "- Furosemide: 1-4 mg/kg PO q8-12h",
        "- Spironolactone: 1-2 mg/kg PO q12-24h",
        "- ACEI: Enalapril 0.5 mg/kg PO q12h",
        "- Pimobendan: 0.25-0.3 mg/kg PO q12h（可能有益）",
        "- 限鈉飲食",
        "- 定期腹腔穿刺（難治性腹水）",
        "心律不整治療（若需要）",
        "外科治療：目前仍在發展中"
      ]
    },
    "prognosis": "高度變異。輕度病例可存活數年。中重度病例預後較差，尤其發展右心衰竭後。Ebstein異常（嚴重形式）預後差。",
    "pearls": [
      "三尖瓣發育不良與二尖瓣發育不良可同時存在",
      "腹水可能是首要臨床表現",
      "ECG可見右心房擴大（P波增高）和右軸偏移",
      "與心絲蟲病鑑別很重要，尤其在流行區",
      "外科修復技術仍在發展中"
    ],
    "diagnosticAlgorithm": {
      "title": "三尖瓣發育不良 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "聽診右心區心雜音、評估腹水",
          "findings": [
            "右心區收縮期心雜音",
            "頸靜脈搏動",
            "腹水",
            "運動不耐"
          ]
        },
        {
          "step": 2,
          "action": "胸腔X光",
          "details": "評估右心擴大",
          "findings": [
            "右心房顯著擴大",
            "右心室擴大",
            "後腔靜脈擴張"
          ]
        },
        {
          "step": 3,
          "action": "心臟超音波",
          "details": "評估三尖瓣形態與功能",
          "findings": [
            "三尖瓣葉發育異常",
            "嚴重三尖瓣返流",
            "右心房心室擴大",
            "可能伴肺動脈高壓"
          ]
        },
        {
          "step": 4,
          "action": "心電圖與進階",
          "details": "ECG及臨床分期",
          "findings": [
            "右心房擴大波形",
            "心律不整（心房顫動）",
            "評估先天性心臟病共存",
            "手術評估"
          ]
        }
      ]
    },
    "monitoring": [
      "腹水量",
      "體重",
      "呼吸頻率",
      "心臟超聲",
      "肝功能",
      "ECG"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "patent-ductus-arteriosus": {
    "zh": "開放性動脈導管",
    "en": "Patent Ductus Arteriosus (PDA)",
    "definition": "出生後動脈導管未能正常關閉，導致主動脈和肺動脈之間持續存在異常通道的先天性心臟缺陷。",
    "synonyms": [
      "PDA",
      "動脈導管未閉",
      "開存性動脈導管"
    ],
    "epidemiology": {
      "species": "犬較貓常見",
      "age": "先天性，通常幼年診斷",
      "sex": "母犬較公犬常見（約3:1）",
      "riskFactors": [
        "貴賓犬",
        "馬爾濟斯犬",
        "博美犬",
        "可卡犬",
        "德國牧羊犬",
        "柯利犬",
        "設得蘭牧羊犬",
        "遺傳"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "可能無症狀",
        "運動不耐",
        "呼吸困難",
        "發育遲緩",
        "後肢無力（若反向PDA）",
        "昏厥"
      ],
      "physicalExam": [
        "連續性機械樣心雜音（左基底部，雜音在S2時最響）",
        "「洗衣機樣雜音」",
        "跳躍脈（水沖脈）",
        "股動脈脈搏強勁",
        "心前區震顫",
        "若左心衰竭：肺部濕囉音",
        "若反向PDA：後肢發紺、差異性發紺"
      ]
    },
    "pathophysiology": "正常：胎兒期動脈導管連接主動脈和肺動脈，出生後數日關閉。PDA：導管未閉 → 血液從高壓主動脈分流至低壓肺動脈（左向右分流）→ 肺過度灌注 → 肺靜脈回流增加 → 左心房和左心室容量超負荷 → 左心衰竭。反向PDA：肺動脈高血壓 → 右向左分流 → 差異性發紺",
    "diagnosis": {
      "overview": "典型連續性雜音高度提示，心臟超聲確診",
      "differentials": [
        "主動脈-肺動脈窗",
        "冠狀動脈瘻管",
        "主動脈竇動脈瘤破裂",
        "動靜脈瘻管"
      ],
      "initialDB": [
        "胸腔X光（左心擴大、肺血管擴張、導管膨大「3」或「D」形）",
        "心臟超聲（導管可視化、左心容量超負荷、多普勒確認分流）",
        "ECG（左心室肥大）"
      ],
      "advanced": [
        "心血管造影",
        "CT血管造影",
        "反向PDA需評估肺動脈壓"
      ]
    },
    "treatment": {
      "overview": "確診後應盡早關閉導管，外科結紮或經導管關閉",
      "acute": [
        "急性CHF穩定：",
        "- Furosemide: 2-4 mg/kg IV",
        "- 氧氣支持",
        "- 穩定後盡快安排手術"
      ],
      "chronic": [
        "導管關閉（首選治療）：",
        "- 經導管關閉（Amplatz Canine Ductal Occluder, ACDO）：微創，成功率高",
        "- 外科結紮：開胸手術",
        "- 建議在2-3月齡時進行",
        "術前CHF管理：",
        "- Furosemide",
        "- ACEI",
        "反向PDA：禁忌關閉導管，僅支持治療",
        "- 避免激動和運動",
        "- 可能使用羥基脲（減少紅血球生成）"
      ]
    },
    "prognosis": "未治療：約64%在1歲內死於CHF。早期導管關閉後：預後極佳，可接近正常壽命。反向PDA：預後差，平均存活約2-3年。",
    "pearls": [
      "連續性機械樣雜音是PDA的經典特徵",
      "早期診斷和治療至關重要",
      "經導管關閉已成為首選治療方式",
      "反向PDA（Eisenmenger綜合症）不可關閉導管",
      "差異性發紺（前肢正常，後肢發紺）提示反向PDA",
      "遺傳性疾病，受影響動物不應繁殖"
    ],
    "diagnosticAlgorithm": {
      "title": "開放性動脈導管 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "聽診連續性（機械性）心雜音",
          "findings": [
            "左心基部連續性心雜音",
            "觸診股動脈彈跳脈",
            "幼犬體檢發現",
            "運動不耐"
          ]
        },
        {
          "step": 2,
          "action": "胸腔X光",
          "details": "評估心臟與肺血管",
          "findings": [
            "左心房及左心室擴大",
            "肺血管過度充盈",
            "主動脈弓及降主動脈擴張",
            "DV像三個突起"
          ]
        },
        {
          "step": 3,
          "action": "心臟超音波與都卜勒",
          "details": "確認PDA及評估血流動力學",
          "findings": [
            "降主動脈至肺動脈的異常通道",
            "連續性湍流（彩色都卜勒）",
            "左心容量過負荷",
            "評估肺動脈壓力"
          ]
        },
        {
          "step": 4,
          "action": "介入或手術治療評估",
          "details": "評估最佳治療方式",
          "findings": [
            "經導管Amplatz裝置閉合",
            "手術結紮",
            "排除反向PDA（Eisenmenger）",
            "術後超音波確認閉合"
          ]
        }
      ]
    },
    "monitoring": [
      "術前：心臟超聲、CHF監測",
      "術後：心臟超聲確認關閉完全、左心大小恢復"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "aortic-stenosis": {
    "zh": "主動脈狹窄",
    "en": "Aortic Stenosis (AS)",
    "definition": "主動脈瓣或其周圍區域狹窄導致左心室流出道阻塞的先天性心臟缺陷，最常見為瓣膜下型。",
    "synonyms": [
      "AS",
      "SAS",
      "Subaortic Stenosis",
      "瓣膜下主動脈狹窄",
      "主動脈口狹窄"
    ],
    "epidemiology": {
      "species": "犬較常見，貓罕見",
      "age": "先天性，通常年輕時診斷",
      "sex": "公犬略多",
      "riskFactors": [
        "紐芬蘭犬",
        "金毛尋回犬",
        "拳師犬",
        "德國牧羊犬",
        "羅威納犬",
        "拉布拉多犬",
        "大丹犬",
        "遺傳"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "可能無症狀",
        "運動不耐",
        "昏厥（尤其運動時）",
        "突然死亡",
        "呼吸困難"
      ],
      "physicalExam": [
        "收縮期遞增遞減型雜音（左基底部，輻射至頸部和胸骨右側）",
        "雜音輻射至頸動脈",
        "股動脈脈搏弱且遲緩上升（pulsus parvus et tardus）",
        "心前區震顫",
        "若CHF：肺部濕囉音"
      ]
    },
    "pathophysiology": "主動脈瓣下纖維環或纖維肌性狹窄 → 左心室流出道阻塞 → 左心室壓力超負荷 → 向心性左心室肥厚 → 舒張功能障礙。高速血流損傷主動脈瓣 → 主動脈瓣逆流。冠狀動脈灌注受損 + 心肌氧需增加 → 心肌缺血 → 心律不整 → 昏厥/猝死",
    "diagnosis": {
      "overview": "心臟超聲結合多普勒確診並評估嚴重程度",
      "differentials": [
        "主動脈瓣狹窄",
        "肺動脈狹窄",
        "心室中隔缺損",
        "動態流出道阻塞"
      ],
      "initialDB": [
        "心臟超聲（瓣膜下狹窄可視化、多普勒流速測量壓力梯度）",
        "胸腔X光（心臟大小可能正常、主動脈後狹窄擴張）",
        "ECG（左心室肥大、心律不整）"
      ],
      "advanced": [
        "24小時Holter監測",
        "心血管造影"
      ]
    },
    "treatment": {
      "overview": "目前無法完全矯正，治療目標為減少症狀和猝死風險",
      "acute": [
        "昏厥急性處理：支持治療",
        "急性CHF：標準CHF治療"
      ],
      "chronic": [
        "輕度（壓力梯度<50 mmHg）：監測，無需藥物",
        "中重度（壓力梯度≥50 mmHg）：",
        "- β-blocker: Atenolol 0.5-1 mg/kg PO q12-24h（減少心肌氧需、預防心律不整）",
        "- 活動限制（避免激烈運動）",
        "- 抗生素預防（牙科或其他手術時，預防心內膜炎）",
        "球囊擴張術：效果不如肺動脈狹窄，改善有限",
        "外科切除：風險高，效果不確定",
        "CHF：標準治療"
      ]
    },
    "prognosis": "取決於嚴重程度。輕度（壓力梯度<50 mmHg）：預後良好，接近正常壽命。重度（壓力梯度>80 mmHg）：高猝死風險，3年存活率約50%。",
    "pearls": [
      "瓣膜下型（SAS）是犬最常見的主動脈狹窄類型",
      "紐芬蘭犬SAS有遺傳基礎，建議篩檢繁殖犬",
      "雜音在成長過程中可能加重（病變進展）",
      "避免激烈運動可減少猝死風險",
      "感染性心內膜炎風險增加",
      "β-blocker可能減少症狀但未證實延長壽命"
    ],
    "diagnosticAlgorithm": {
      "title": "主動脈狹窄 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "聽診左心基部收縮期心雜音",
          "findings": [
            "左心基部漸強-漸弱型心雜音",
            "股動脈脈搏減弱",
            "運動不耐或昏厥",
            "大型犬品種好發"
          ]
        },
        {
          "step": 2,
          "action": "心電圖",
          "details": "評估左心室肥厚",
          "findings": [
            "左心室肥厚（R波增高）",
            "ST段壓低",
            "心室心律不整"
          ]
        },
        {
          "step": 3,
          "action": "心臟超音波",
          "details": "評估狹窄程度及壓力階差",
          "findings": [
            "主動脈瓣下纖維環",
            "主動脈血流速度增加",
            "壓力階差分級（輕度<50、中度50-80、重度>80 mmHg）",
            "左心室同心性肥厚"
          ]
        },
        {
          "step": 4,
          "action": "進階評估與預後",
          "details": "Holter與運動評估",
          "findings": [
            "24小時Holter監測VPC",
            "運動限制建議",
            "基因諮詢（遺傳性）",
            "評估猝死風險"
          ]
        }
      ]
    },
    "monitoring": [
      "心臟超聲（每6-12個月）",
      "Holter監測（評估心律不整）",
      "活動耐受度"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "pulmonic-stenosis": {
    "zh": "肺動脈狹窄",
    "en": "Pulmonic Stenosis (PS)",
    "definition": "肺動脈狹窄是犬第三常見的先天性心臟病，因肺動脈瓣或瓣下區域發育異常導致右心室射血阻力增加。English Bulldog、Boxer、Beagle好發。依狹窄部位分瓣膜型（最常見）、瓣下型和瓣上型。壓力梯度>80 mmHg為重度，需球囊瓣膜成形術介入。",
    "synonyms": [
      "PS",
      "肺動脈瓣狹窄",
      "肺動脈口狹窄",
      "右心室流出道阻塞"
    ],
    "epidemiology": {
      "species": "犬較常見，貓罕見",
      "age": "先天性，通常年輕時診斷",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "英國鬥牛犬",
        "法國鬥牛犬",
        "拳師犬",
        "獒犬",
        "比乙獵犬",
        "可卡犬",
        "西高地白梗",
        "薩摩耶犬",
        "迷你雪納瑞"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "可能無症狀",
        "運動不耐",
        "昏厥",
        "腹部膨大（若右心衰竭）",
        "發紺（若有右向左分流）"
      ],
      "physicalExam": [
        "收縮期遞增遞減型雜音（左基底部，肺動脈區）",
        "心前區震顫",
        "頸靜脈怒張（若右心衰竭）",
        "腹水",
        "肝腫大"
      ]
    },
    "pathophysiology": "肺動脈瓣發育不良或融合 → 右心室流出道阻塞 → 右心室壓力超負荷 → 向心性右心室肥厚 → 最終可能發展右心衰竭。若存在ASD或開放性卵圓孔 → 右向左分流 → 發紺",
    "diagnosis": {
      "overview": "心臟超聲結合多普勒確診並評估嚴重程度",
      "differentials": [
        "主動脈狹窄",
        "心室中隔缺損",
        "法洛四聯症",
        "右心室雙出口"
      ],
      "initialDB": [
        "心臟超聲（瓣膜增厚/融合、右心室肥厚、多普勒壓力梯度）",
        "胸腔X光（右心擴大、主肺動脈後狹窄擴張）",
        "ECG（右心室肥大、右軸偏移）"
      ],
      "advanced": [
        "血管造影",
        "CT血管造影"
      ]
    },
    "treatment": {
      "overview": "球囊瓣膜成形術是首選治療，可顯著降低壓力梯度",
      "acute": [
        "急性右心衰竭：",
        "- Furosemide: 2-4 mg/kg IV",
        "- 腹腔穿刺（大量腹水時）",
        "- 氧氣支持"
      ],
      "chronic": [
        "輕度（壓力梯度<50 mmHg）：監測，無需干預",
        "中重度（壓力梯度≥50-80 mmHg）：",
        "- 球囊瓣膜成形術（首選）：成功率高，可降低50%以上壓力梯度",
        "- β-blocker: Atenolol 0.5-1 mg/kg PO q12-24h（若不適合手術）",
        "Type B發育不良（瓣膜下肥厚型）：球囊效果較差，可能需外科",
        "右心衰竭：",
        "- Furosemide",
        "- ACEI",
        "- 低鈉飲食"
      ]
    },
    "prognosis": "球囊瓣膜成形術後預後良好。輕度PS通常預後極佳。重度未治療PS：預後較差，可能發展右心衰竭或猝死。Type A（瓣膜融合型）治療反應比Type B（發育不良型）好。",
    "pearls": [
      "Type A（瓣膜融合型）球囊擴張效果最好",
      "Type B（發育不良型，常見於英國鬥牛犬）球囊效果較差",
      "壓力梯度>80 mmHg為重度，建議介入",
      "球囊瓣膜成形術是微創且效果良好的選擇",
      "短頭犬種PS常合併冠狀動脈異常（R2A）",
      "遺傳性疾病，受影響動物不應繁殖"
    ],
    "diagnosticAlgorithm": {
      "title": "肺動脈狹窄 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "聽診左心基部收縮期心雜音",
          "findings": [
            "左心基部收縮期心雜音",
            "幼犬體檢發現",
            "運動不耐",
            "昏厥"
          ]
        },
        {
          "step": 2,
          "action": "心電圖",
          "details": "評估右心室肥厚",
          "findings": [
            "右心室肥厚波形",
            "右軸偏移",
            "偶見心律不整"
          ]
        },
        {
          "step": 3,
          "action": "心臟超音波",
          "details": "評估肺動脈瓣狹窄程度",
          "findings": [
            "瓣膜型或瓣膜下型狹窄",
            "肺動脈瓣血流速度增加",
            "壓力階差評估",
            "右心室同心性肥厚"
          ]
        },
        {
          "step": 4,
          "action": "介入治療評估",
          "details": "球囊擴張術評估",
          "findings": [
            "壓力階差>80 mmHg建議介入",
            "經導管球囊瓣膜擴張術",
            "評估冠狀動脈異常（英國鬥牛犬）",
            "術後追蹤壓力階差"
          ]
        }
      ]
    },
    "monitoring": [
      "心臟超聲（術後追蹤壓力梯度）",
      "ECG",
      "右心衰竭徵象"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "ventricular-septal-defect": {
    "zh": "心室中隔缺損",
    "en": "Ventricular Septal Defect (VSD)",
    "definition": "心室中隔缺損（VSD）是犬貓常見的先天性心臟病，為左右心室之間存在異常通道。小型限制性VSD因高壓差產生特徵性右側心基底部粗糙收縮期雜音，血流動力學影響輕微。大型非限制性VSD導致左向右分流增加、肺血流量增加和左心容量超負荷，最終可能發展Eisenmenger症候群。",
    "synonyms": [
      "VSD",
      "心室間隔缺損",
      "室間隔缺損"
    ],
    "epidemiology": {
      "species": "犬貓皆可發生",
      "age": "先天性",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "英國鬥牛犬",
        "西高地白梗",
        "拉布拉多犬",
        "英國史賓格犬",
        "遺傳"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "小型限制性VSD可能無症狀",
        "運動不耐",
        "呼吸困難",
        "發育遲緩",
        "發紺（若反向分流）"
      ],
      "physicalExam": [
        "收縮期心雜音（右側胸骨旁最響）",
        "心前區震顫",
        "若大型VSD左心衰竭：肺部濕囉音",
        "若反向VSD：發紺"
      ]
    },
    "pathophysiology": "心室中隔發育不完全 → 左右心室間異常通道。小型限制性VSD：高速左向右分流，血流動力學影響小。大型非限制性VSD：大量左向右分流 → 肺過度灌注 → 左心容量超負荷 → 左心衰竭。慢性肺過度灌注 → 肺動脈高血壓 → 反向分流（Eisenmenger綜合症）",
    "diagnosis": {
      "overview": "心臟超聲可直接觀察缺損並評估分流方向和量",
      "differentials": [
        "心內膜墊缺損",
        "主動脈瓣逆流",
        "二尖瓣逆流",
        "三尖瓣逆流"
      ],
      "initialDB": [
        "心臟超聲（缺損可視化、彩色多普勒分流、Qp:Qs比值）",
        "胸腔X光（心臟擴大程度、肺血管）",
        "ECG"
      ],
      "advanced": [
        "心導管檢查",
        "CT血管造影"
      ]
    },
    "treatment": {
      "overview": "依缺損大小和血流動力學影響決定治療策略",
      "acute": [
        "急性CHF：標準CHF治療"
      ],
      "chronic": [
        "小型限制性VSD（無心臟擴大）：",
        "- 通常不需治療",
        "- 定期監測",
        "- 抗生素預防（手術時）",
        "中大型VSD有血流動力學影響：",
        "- CHF藥物治療（Furosemide、ACEI、Pimobendan）",
        "- 經導管關閉或外科修復（技術上可行時）",
        "Eisenmenger綜合症（反向VSD）：",
        "- 禁忌關閉缺損",
        "- 支持治療",
        "- 肺動脈高血壓治療（Sildenafil）"
      ]
    },
    "prognosis": "小型限制性VSD：預後極佳，可正常壽命。大型VSD：取決於是否能成功關閉。Eisenmenger綜合症：預後差。",
    "pearls": [
      "VSD位置多在膜周部（perimembranous）",
      "雜音強度不一定反映缺損大小（小缺損高速血流可產生響亮雜音）",
      "Qp:Qs>2:1提示顯著分流",
      "小型VSD可能自發性縮小或關閉",
      "大型VSD應考慮早期關閉以防止Eisenmenger綜合症",
      "感染性心內膜炎風險增加"
    ],
    "diagnosticAlgorithm": {
      "title": "心室中隔缺損 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "聽診右胸壁收縮期心雜音",
          "findings": [
            "右胸壁高音調收縮期心雜音",
            "幼犬體檢發現",
            "小缺損可能無症狀"
          ]
        },
        {
          "step": 2,
          "action": "胸腔X光",
          "details": "評估心臟大小及肺血管",
          "findings": [
            "小缺損X光正常",
            "大缺損心臟擴大",
            "肺血管充盈增加"
          ]
        },
        {
          "step": 3,
          "action": "心臟超音波",
          "details": "確認缺損位置與大小",
          "findings": [
            "心室中隔連續性中斷",
            "彩色都卜勒顯示左至右分流",
            "缺損大小測量",
            "評估血流動力學影響"
          ]
        },
        {
          "step": 4,
          "action": "預後與監測",
          "details": "臨床分級與追蹤",
          "findings": [
            "小限制性缺損預後良好",
            "大缺損可能導致充血性心衰",
            "Eisenmenger症候群風險",
            "定期超音波追蹤"
          ]
        }
      ]
    },
    "monitoring": [
      "心臟超聲定期追蹤",
      "心臟大小變化",
      "肺動脈壓估計"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "atrial-septal-defect": {
    "zh": "心房中隔缺損",
    "en": "Atrial Septal Defect (ASD)",
    "definition": "心房中隔缺損（ASD）是左右心房之間存在異常通道的先天性心臟病。犬較少見，但在某些品種（Boxer、Samoyed）有遺傳傾向。左向右分流導致右心容量超負荷和肺血流增加。小型ASD可能終身無症狀，大型ASD可導致右心衰竭和心房顫動。",
    "synonyms": [
      "ASD",
      "心房間隔缺損",
      "房間隔缺損"
    ],
    "epidemiology": {
      "species": "犬貓皆可發生，犬較常見",
      "age": "先天性",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "薩摩耶犬",
        "拳師犬",
        "杜賓犬",
        "遺傳",
        "常與其他先天性心臟病合併"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "多數無症狀",
        "運動不耐（大型缺損）",
        "呼吸困難",
        "發紺（若反向分流）"
      ],
      "physicalExam": [
        "可能無雜音或有輕微收縮期雜音（肺動脈區相對狹窄）",
        "第二心音固定分裂",
        "若大型ASD合併三尖瓣逆流：右側收縮期雜音"
      ]
    },
    "pathophysiology": "心房中隔缺損 → 左向右分流（因左心房壓力略高於右心房）→ 右心容量超負荷 → 右心擴張 → 可能發展肺動脈高血壓 → 反向分流（Eisenmenger，罕見）",
    "diagnosis": {
      "overview": "心臟超聲可直接觀察缺損，但可能被誤診或漏診",
      "differentials": [
        "開放性卵圓孔（PFO）",
        "肺靜脈異常回流",
        "三尖瓣疾病"
      ],
      "initialDB": [
        "心臟超聲（缺損可視化、右心擴張、彩色多普勒分流）",
        "胸腔X光（右心擴大、肺血管擴張）",
        "ECG（右心擴大、不完全右束支傳導阻滯）"
      ],
      "advanced": [
        "氣泡對比超聲",
        "經食道超聲",
        "心導管檢查"
      ]
    },
    "treatment": {
      "overview": "多數ASD血流動力學影響小，不需治療",
      "acute": [
        "若有急性右心衰竭：標準治療"
      ],
      "chronic": [
        "小型ASD：不需治療，定期監測",
        "大型ASD有顯著右心擴張：",
        "- 經導管關閉（若技術可行）",
        "- 外科修復",
        "右心衰竭：利尿劑、ACEI",
        "反向ASD：禁忌關閉，支持治療"
      ]
    },
    "prognosis": "多數ASD預後良好，尤其小型缺損。大型ASD若能成功關閉預後也好。Eisenmenger綜合症罕見但預後差。",
    "pearls": [
      "單純ASD較VSD和PDA少見",
      "ASD常與其他先天性心臟病合併",
      "開放性卵圓孔（PFO）與真正ASD不同",
      "ASD可能終生無症狀",
      "經導管關閉技術在獸醫領域發展中"
    ],
    "diagnosticAlgorithm": {
      "title": "心房中隔缺損 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "聽診肺動脈區收縮期心雜音",
          "findings": [
            "肺動脈區柔和收縮期心雜音",
            "可能無明顯症狀",
            "右心容量過負荷",
            "運動不耐"
          ]
        },
        {
          "step": 2,
          "action": "胸腔X光",
          "details": "評估右心與肺血管",
          "findings": [
            "右心擴大",
            "肺血管充盈增加",
            "主肺動脈段突出"
          ]
        },
        {
          "step": 3,
          "action": "心臟超音波",
          "details": "確認ASD並評估分流",
          "findings": [
            "心房中隔連續性中斷",
            "彩色都卜勒左至右分流",
            "右心房心室擴大",
            "對比超音波（氣泡研究）"
          ]
        },
        {
          "step": 4,
          "action": "進階評估",
          "details": "評估手術或介入需求",
          "findings": [
            "分流量評估（Qp:Qs）",
            "右心導管檢查",
            "評估是否需要封堵術",
            "合併其他先天性心臟病篩檢"
          ]
        }
      ]
    },
    "monitoring": [
      "心臟超聲定期追蹤",
      "右心大小",
      "肺動脈壓"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "heartworm-disease": {
    "zh": "心絲蟲病",
    "en": "Heartworm Disease",
    "definition": "由犬心絲蟲(Dirofilaria immitis)感染引起的嚴重心肺疾病，成蟲寄生於肺動脈和右心。",
    "synonyms": [
      "Dirofilariasis",
      "犬心絲蟲感染",
      "Canine Heartworm Disease"
    ],
    "epidemiology": {
      "species": "犬為主要宿主，貓為非典型宿主（感染較輕但症狀可能更嚴重）",
      "age": "任何年齡，感染需數月至數年才出現症狀",
      "sex": "無性別傾向",
      "riskFactors": [
        "生活在流行區",
        "未使用預防藥物",
        "戶外活動",
        "蚊蟲暴露"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "早期可能無症狀",
        "咳嗽（慢性、輕度）",
        "運動不耐",
        "呼吸困難",
        "昏厥",
        "腹部膨大（腹水）",
        "體重減輕",
        "咳血"
      ],
      "physicalExam": [
        "心雜音（三尖瓣逆流）",
        "肺部異常音",
        "肝腫大",
        "腹水",
        "頸靜脈搏動",
        "休克徵象（腔靜脈症候群）",
        "貓：呼吸困難、嘔吐、神經症狀"
      ]
    },
    "pathophysiology": "蚊蟲傳播L3幼蟲 → 皮下移行發育 → 進入血管 → 到達肺動脈成熟（約6個月）→ 成蟲引起血管內皮損傷 → 肺動脈炎和栓塞 → 肺動脈高血壓 → 右心衰竭。腔靜脈症候群：大量蟲體阻塞三尖瓣和腔靜脈 → 急性右心衰竭和溶血",
    "diagnosis": {
      "overview": "抗原檢測是主要篩檢方法，結合微絲蚴檢查",
      "differentials": [
        "原發性肺動脈高血壓",
        "肺血栓栓塞",
        "慢性呼吸道疾病",
        "右心衰竭其他原因"
      ],
      "initialDB": [
        "心絲蟲抗原檢測（檢測成蟲，感染後6-7個月才陽性）",
        "微絲蚴檢查（改良Knott法或濃縮法）",
        "胸腔X光（肺動脈擴張、扭曲、肺實質病變）",
        "心臟超聲（蟲體可視化、右心擴張、三尖瓣逆流）"
      ],
      "advanced": [
        "CBC（嗜酸性球增多、貧血）",
        "生化（肝腎功能）",
        "尿液分析",
        "貓：抗體檢測"
      ]
    },
    "treatment": {
      "overview": "殺蟲治療前需評估風險和分期，嚴重病例需先穩定",
      "acute": [
        "腔靜脈症候群：",
        "- 緊急外科取蟲（經頸靜脈）",
        "- 輸液支持",
        "- 氧氣",
        "急性肺血栓栓塞：",
        "- 籠內休息",
        "- 氧氣",
        "- 抗炎劑量類固醇",
        "- 支持治療"
      ],
      "chronic": [
        "美國心絲蟲學會（AHS）治療指南：",
        "治療前準備：",
        "- 開始口服預防藥（殺死微絲蚴和幼蟲）",
        "- Doxycycline 10 mg/kg PO q12h x 4週（殺死Wolbachia共生菌）",
        "- 限制運動",
        "殺成蟲治療（Melarsomine）：",
        "- 第1天：2.5 mg/kg IM深層腰部肌肉",
        "- 等待30天",
        "- 第31天：2.5 mg/kg IM",
        "- 第32天：2.5 mg/kg IM（對側）",
        "術後管理：",
        "- 嚴格限制運動6-8週",
        "- Prednisone漸減",
        "- 監測血栓栓塞併發症",
        "抗原測試追蹤（治療後6-9個月）"
      ]
    },
    "prognosis": "輕度感染：治療後預後良好。中重度感染：預後謹慎，取決於肺動脈和心臟損傷程度。腔靜脈症候群：急性死亡率高。貓：預後更難預測。",
    "pearls": [
      "預防勝於治療 - 每月預防藥是最佳策略",
      "抗原檢測可能有假陰性（低蟲量、全公蟲、免疫複合物阻斷）",
      "殺蟲後血栓栓塞是主要併發症，嚴格限制運動很重要",
      "Doxycycline可減少殺蟲後的肺部反應",
      "貓心絲蟲病診斷和治療更具挑戰性",
      "年度篩檢建議所有狗，即使使用預防藥"
    ],
    "diagnosticAlgorithm": {
      "title": "心絲蟲病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "詢問預防用藥史及居住地區",
          "findings": [
            "咳嗽",
            "運動不耐",
            "腹水",
            "昏厥"
          ]
        },
        {
          "step": 2,
          "action": "抗原與微絲蟲檢測",
          "details": "成蟲抗原及微絲蟲篩檢",
          "findings": [
            "心絲蟲抗原ELISA陽性",
            "微絲蟲集中法檢查",
            "抗原可能假陰性（低蟲量或單性感染）"
          ]
        },
        {
          "step": 3,
          "action": "胸腔影像",
          "details": "X光評估心肺變化",
          "findings": [
            "右心擴大",
            "肺動脈擴張迂曲",
            "肺實質浸潤",
            "後腔靜脈擴張"
          ]
        },
        {
          "step": 4,
          "action": "超音波與分級",
          "details": "心臟超音波及嚴重度分級",
          "findings": [
            "肺動脈或右心室內可見蟲體",
            "右心擴大",
            "肺動脈高壓",
            "治療前穩定評估"
          ]
        }
      ]
    },
    "monitoring": [
      "治療期間臨床症狀",
      "胸腔X光",
      "抗原測試（治療後6-9個月確認清除）"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; American Heartworm Society Guidelines"
  },
  "pericardial-effusion": {
    "zh": "心包積液",
    "en": "Pericardial Effusion",
    "definition": "心包積液是指心包腔內液體異常蓄積，導致心臟舒張受限（心包填塞）。犬最常見原因為血管肉瘤（右心房/右心耳）、心基底部腫瘤（chemodectoma）和特發性心包炎。Golden Retriever和German Shepherd好發腫瘤性心包積液。急性心包填塞為心臟急症，需緊急心包穿刺引流。",
    "synonyms": [
      "心包滲出液",
      "心包積水",
      "Pericardial Fluid Accumulation"
    ],
    "epidemiology": {
      "species": "犬較常見，貓罕見",
      "age": "中老年犬（腫瘤相關），任何年齡（特發性或感染性）",
      "sex": "公犬較常見（血管肉瘤）",
      "riskFactors": [
        "大型犬",
        "金毛尋回犬（血管肉瘤）",
        "德國牧羊犬（血管肉瘤）",
        "短頭犬種（心臟基底腫瘤）",
        "心臟腫瘤",
        "凝血障礙"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "虛弱",
        "運動不耐",
        "腹部膨大（腹水）",
        "昏厥",
        "突然倒下",
        "呼吸困難",
        "食慾下降"
      ],
      "physicalExam": [
        "Beck三徵：低血壓、頸靜脈怒張、心音低沉",
        "心搏過速",
        "脈搏弱",
        "奇脈",
        "腹水",
        "肝腫大",
        "黏膜蒼白",
        "CRT延長"
      ]
    },
    "pathophysiology": "心包積液積聚 → 心包腔壓力升高 → 心室舒張充盈受限（心臟壓塞）→ 心輸出量下降 → 代償性心搏過速和全身血管收縮 → 組織灌注不足。病因：腫瘤（血管肉瘤、心臟基底腫瘤、間皮瘤）、特發性、感染、凝血障礙、尿毒症、心臟破裂",
    "diagnosis": {
      "overview": "心臟超聲快速確診，需同時評估病因",
      "differentials": [
        "腹腔積液其他原因",
        "充血性心衰竭",
        "休克其他原因"
      ],
      "initialDB": [
        "心臟超聲（心包積液、心臟壓塞徵象、腫瘤評估）",
        "胸腔X光（球形心影）",
        "ECG（低電壓、電交替）",
        "心包液分析"
      ],
      "advanced": [
        "CT（尋找腫瘤）",
        "心包液細胞學",
        "心臟標記物（cTnI）"
      ]
    },
    "treatment": {
      "overview": "心包穿刺是急性處理的關鍵，長期管理取決於病因",
      "acute": [
        "心包穿刺術：",
        "- 右側臥位，4-6肋間心尖區",
        "- 超聲引導下更安全",
        "- 使用大口徑導管（14-16G）",
        "- 引流直到負壓或臨床改善",
        "- 保存液體送檢",
        "輸液支持",
        "ECG監測（穿刺中可能心律不整）"
      ],
      "chronic": [
        "特發性心包積液：",
        "- 可能需反覆穿刺",
        "- 心包切除術（經常復發者）",
        "- 預後較好",
        "腫瘤相關：",
        "- 血管肉瘤：預後差，化療（Doxorubicin）可能延長數月",
        "- 心臟基底腫瘤：進展慢，心包切除術後可能存活1-2年",
        "- 間皮瘤：化療或胸腔內藥物",
        "感染性：抗生素治療",
        "心包切除術：",
        "- 經常復發的特發性",
        "- 結紮性心包炎",
        "- 緩解腫瘤相關心包積液"
      ]
    },
    "prognosis": "特發性：心包切除術後預後良好，5年存活率可達50%以上。血管肉瘤：預後差，中位生存期約1-4個月。心臟基底腫瘤：進展慢，中位生存期可達1-2年。",
    "pearls": [
      "積液量和速度決定症狀嚴重度 - 慢性積聚可耐受更大量",
      "血性心包積液不一定是腫瘤（特發性也可能血性）",
      "心包液pH<7.0或葡萄糖低提示感染",
      "心包液細胞學對腫瘤診斷敏感度低（約50%）",
      "穿刺後立即改善具有診斷價值（確認壓塞）",
      "金毛尋回犬心包積液高度懷疑血管肉瘤"
    ],
    "diagnosticAlgorithm": {
      "title": "心包積液 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估運動不耐、腹水及心音減弱",
          "findings": [
            "心音減弱（遙遠心音）",
            "頸靜脈擴張",
            "腹水",
            "運動不耐或虛脫"
          ]
        },
        {
          "step": 2,
          "action": "胸腔X光與心電圖",
          "details": "評估心臟輪廓及電氣變化",
          "findings": [
            "球形心臟輪廓",
            "低電壓QRS波群",
            "電交替現象",
            "肺野通常清晰"
          ]
        },
        {
          "step": 3,
          "action": "心臟超音波",
          "details": "確認積液及評估病因",
          "findings": [
            "無回音區包圍心臟",
            "右心房心室舒張期塌陷（心包填塞）",
            "心基部或右心房腫塊",
            "纖維素沉積"
          ]
        },
        {
          "step": 4,
          "action": "心包穿刺與分析",
          "details": "治療性與診斷性心包穿刺",
          "findings": [
            "出血性積液（最常見）",
            "細胞學分析排除腫瘤",
            "穩定血流動力學",
            "評估是否需要心包切除術"
          ]
        }
      ]
    },
    "monitoring": [
      "臨床症狀",
      "超聲追蹤積液再積聚",
      "腫瘤篩查"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "infective-endocarditis": {
    "zh": "感染性心內膜炎",
    "en": "Infective Endocarditis (IE)",
    "definition": "感染性心內膜炎是微生物（主要為細菌）感染心臟瓣膜或心內膜形成贅生物（vegetation）的嚴重疾病。犬以主動脈瓣和二尖瓣最常受累，常見致病菌包括Staphylococcus、Streptococcus、E. coli和Bartonella。中大型犬好發，常見感染源為泌尿道、口腔、皮膚和椎間盤感染。",
    "synonyms": [
      "IE",
      "細菌性心內膜炎",
      "Bacterial Endocarditis",
      "心內膜炎"
    ],
    "epidemiology": {
      "species": "犬較常見，貓罕見",
      "age": "中大型犬，中老年",
      "sex": "公犬較常見",
      "riskFactors": [
        "大型犬",
        "主動脈瓣疾病",
        "先天性心臟病",
        "免疫抑制",
        "長期導管留置",
        "口腔疾病",
        "椎間盤炎",
        "前列腺炎",
        "先前心臟手術"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "發燒（可能間歇性）",
        "嗜睡",
        "食慾下降",
        "體重減輕",
        "跛行（栓塞性關節炎）",
        "呼吸困難",
        "昏厥",
        "急性神經症狀（腦栓塞）"
      ],
      "physicalExam": [
        "發燒",
        "新出現的心雜音或雜音變化",
        "心律不整",
        "跛行/關節腫脹",
        "脾腫大",
        "瘀點",
        "眼部病變",
        "神經缺損"
      ]
    },
    "pathophysiology": "菌血症 + 心內膜損傷 → 細菌定植 → 形成感染性疣狀贅生物（細菌、纖維蛋白、血小板）→ 瓣膜破壞 → 瓣膜逆流 → 充血性心衰竭。贅生物碎片脫落 → 敗血性栓塞 → 多器官感染/梗塞（腎、脾、腦、關節）",
    "diagnosis": {
      "overview": "基於臨床表現、血液培養陽性、心臟超聲發現疣狀贅生物（改良Duke標準）",
      "differentials": [
        "非感染性瓣膜疾病",
        "其他發燒原因",
        "免疫介導性疾病",
        "腫瘤"
      ],
      "initialDB": [
        "血液培養（多次、抗生素使用前、動脈和靜脈）",
        "心臟超聲（疣狀贅生物、瓣膜逆流、心臟擴大）",
        "CBC（白血球增多、貧血、血小板減少）",
        "生化（腎功能、肝功能）",
        "尿液分析（蛋白尿、血尿）"
      ],
      "advanced": [
        "尿液培養",
        "關節液分析",
        "C-反應蛋白",
        "ECG（傳導阻滯提示膿腫）"
      ]
    },
    "treatment": {
      "overview": "長期靜脈抗生素治療，支持性心臟藥物",
      "acute": [
        "經驗性抗生素（血液培養結果前）：",
        "- Ampicillin 22 mg/kg IV q8h + Enrofloxacin 5-10 mg/kg IV q24h",
        "- 或 Ampicillin + Gentamicin（監測腎功能）",
        "急性CHF：標準CHF治療"
      ],
      "chronic": [
        "根據血液培養和藥敏調整抗生素",
        "抗生素療程：至少6-8週",
        "- 前2-4週IV",
        "- 之後可轉口服（若臨床改善）",
        "常見致病菌：",
        "- Staphylococcus（最常見）",
        "- Streptococcus",
        "- E. coli",
        "- Bartonella（需特殊培養）",
        "心臟藥物（若有CHF或瓣膜逆流）：",
        "- Furosemide",
        "- ACEI",
        "- Pimobendan",
        "外科瓣膜置換：在獸醫很少進行"
      ]
    },
    "prognosis": "預後謹慎至差。主動脈瓣受累預後較二尖瓣差。早期診斷和積極治療可改善預後。死亡率約50-70%。",
    "pearls": [
      "主動脈瓣是犬最常受累的瓣膜",
      "「發燒+新雜音」高度懷疑IE",
      "血液培養陰性不能排除（可能已使用抗生素或Bartonella等難培養菌）",
      "Bartonella是重要病因，尤其在流行區",
      "椎間盤炎和IE可能同時存在",
      "口腔健康維護可能預防IE"
    ],
    "diagnosticAlgorithm": {
      "title": "感染性心內膜炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估發燒、新發心雜音及多系統徵象",
          "findings": [
            "不明原因發燒",
            "新出現或加重的心雜音",
            "跛行（栓塞性關節炎）",
            "脾腫大"
          ]
        },
        {
          "step": 2,
          "action": "血液培養",
          "details": "多次血液培養（使用前停抗生素）",
          "findings": [
            "至少3套血液培養",
            "分離細菌（Staphylococcus, Streptococcus, Bartonella, E. coli）",
            "藥敏試驗指導治療"
          ]
        },
        {
          "step": 3,
          "action": "心臟超音波",
          "details": "評估瓣膜贅生物",
          "findings": [
            "瓣膜上振盪性贅生物",
            "主動脈瓣或二尖瓣最常受影響",
            "瓣膜返流加重",
            "心腔擴大"
          ]
        },
        {
          "step": 4,
          "action": "全身栓塞篩檢",
          "details": "評估栓塞併發症",
          "findings": [
            "關節液分析（化膿性關節炎）",
            "尿液分析（腎梗塞）",
            "脾臟超音波（脾梗塞）",
            "神經學評估"
          ]
        }
      ]
    },
    "monitoring": [
      "體溫",
      "心臟超聲（疣狀物大小變化）",
      "血液培養複查",
      "腎功能",
      "心律"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "arterial-thromboembolism": {
    "zh": "動脈血栓栓塞",
    "en": "Arterial Thromboembolism (ATE)",
    "definition": "動脈血栓栓塞（ATE）是血栓從心臟脫落隨動脈血流栓塞遠端動脈的急症，貓最常見於腹主動脈分叉處（鞍狀血栓）。約90%與心肌病（主要HCM）相關。表現為急性後肢癱瘓、後肢疼痛、股動脈脈搏消失和肢端發紺。為貓心臟病最嚴重的併發症之一。",
    "synonyms": [
      "ATE",
      "貓主動脈血栓栓塞",
      "Feline Aortic Thromboembolism",
      "FATE",
      "騎跨式栓塞",
      "Saddle Thrombus"
    ],
    "epidemiology": {
      "species": "貓最常見（與HCM相關），犬罕見",
      "age": "中老年貓（平均8-12歲）",
      "sex": "公貓略多",
      "riskFactors": [
        "肥厚型心肌病（HCM）",
        "其他心肌病",
        "左心房擴張",
        "自發性回聲對比",
        "先前ATE病史",
        "心房顫動"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "突然發作後肢癱瘓",
        "劇烈疼痛/嚎叫",
        "無法行走",
        "拖行後肢",
        "可能有已知心臟病史"
      ],
      "physicalExam": [
        "後肢癱瘓（最常見）",
        "股動脈脈搏消失",
        "後肢冰冷",
        "肉墊發紺或蒼白",
        "後肢肌肉僵硬（晚期）",
        "劇烈疼痛",
        "過度換氣",
        "低體溫",
        "心雜音或奔馬律",
        "呼吸急促/困難"
      ]
    },
    "pathophysiology": "心臟病（HCM等）→ 左心房擴張和血流淤滯 → 血栓形成（通常在左心耳）→ 血栓脫落 → 主動脈遠端分叉處栓塞（最常見）→ 後肢急性缺血 → 缺血性神經肌肉損傷。血管收縮物質釋放 → 側枝循環受損 → 加重缺血",
    "diagnosis": {
      "overview": "典型臨床表現（5P's）結合股動脈脈搏消失即可臨床診斷",
      "differentials": [
        "椎間盤疾病",
        "脊髓栓塞",
        "下運動神經元疾病",
        "創傷"
      ],
      "initialDB": [
        "體檢（5P's：Pain疼痛、Pulselessness無脈、Paralysis癱瘓、Pallor蒼白、Poikilothermia溫差）",
        "心臟超聲（心臟病評估、左心房血栓）",
        "多普勒超聲（確認血流阻斷）",
        "血糖（患肢血糖通常低於前肢）"
      ],
      "advanced": [
        "肌酸激酶（CK，顯著升高）",
        "電解質（高血鉀）",
        "凝血功能",
        "乳酸"
      ]
    },
    "treatment": {
      "overview": "止痛是首要任務，抗凝治療，支持性心臟治療",
      "acute": [
        "止痛（極重要）：",
        "- Methadone 0.1-0.3 mg/kg IV/IM q4-6h",
        "- 或 Buprenorphine 0.01-0.02 mg/kg IV/IM q6-8h",
        "- 或 Fentanyl CRI",
        "抗凝治療：",
        "- Heparin: 250-300 IU/kg IV，然後150-250 IU/kg SC q8h",
        "- 或 低分子肝素（Enoxaparin）: 1 mg/kg SC q12h",
        "溶栓治療（效果和風險爭議）：",
        "- tPA或Streptokinase（出血風險高）",
        "心臟病治療：",
        "- CHF：Furosemide",
        "- 氧氣支持",
        "支持治療：",
        "- 維持水合",
        "- 監測高血鉀",
        "- 體溫管理"
      ],
      "chronic": [
        "長期抗血小板/抗凝治療：",
        "- Clopidogrel 18.75 mg/貓 PO q24h（首選）",
        "- 或 Aspirin 81 mg/貓 PO q72h",
        "- 高風險：加上Rivaroxaban 1.25-2.5 mg/貓 PO q24h",
        "心臟病管理：",
        "- β-blocker或Diltiazem",
        "- ACEI（若CHF）",
        "物理治療（恢復期）"
      ]
    },
    "prognosis": "整體預後謹慎。短期存活率約30-40%。有些貓可在數週內恢復功能。預後不良因素：低體溫、多肢受累、嚴重心臟病、高血鉀、休克。復發率高（約25-50%在1年內）。",
    "pearls": [
      "ATE是獸醫急診最痛苦的病症之一，止痛是第一優先",
      "約90%的貓ATE有潛在心臟病（主要是HCM）",
      "股動脈脈搏消失是診斷關鍵",
      "患肢血糖低於前肢有診斷價值",
      "恢復功能可能需要數週，主人教育很重要",
      "即使恢復，復發風險高",
      "Clopidogrel比Aspirin預防效果更好（FAT CAT研究）"
    ],
    "diagnosticAlgorithm": {
      "title": "動脈血栓栓塞 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "急性後肢癱瘓評估（貓）",
          "findings": [
            "急性後肢癱瘓與疼痛",
            "後肢觸診冰冷",
            "股動脈脈搏消失",
            "腳墊蒼白或發紺"
          ]
        },
        {
          "step": 2,
          "action": "心臟評估",
          "details": "確認基礎心臟病",
          "findings": [
            "心臟超音波確認HCM或其他心肌病",
            "左心房自發性對比",
            "左心房血栓",
            "NT-proBNP升高"
          ]
        },
        {
          "step": 3,
          "action": "血液與代謝",
          "details": "評估缺血再灌注影響",
          "findings": [
            "血清鉀升高（壞死肌肉釋放）",
            "肌酸激酶顯著升高",
            "代謝性酸中毒",
            "氮血症"
          ]
        },
        {
          "step": 4,
          "action": "預後評估",
          "details": "評估治療反應與預後因素",
          "findings": [
            "受影響肢體功能恢復評估",
            "體溫變化",
            "多肢受影響預後差",
            "再發風險評估與抗血栓治療"
          ]
        }
      ]
    },
    "monitoring": [
      "疼痛控制",
      "心臟功能",
      "電解質（尤其鉀）",
      "肢體循環恢復",
      "復發徵象"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "systemic-hypertension": {
    "zh": "系統性高血壓",
    "en": "Systemic Hypertension",
    "definition": "系統性高血壓是犬貓收縮壓持續>160 mmHg的疾病。犬貓多為繼發性，貓最常見原因為慢性腎臟病（CKD）和甲狀腺功能亢進，犬常見於CKD、Cushing病和腎上腺腫瘤。高血壓可導致靶器官損傷（TOD）：眼（視網膜剝離）、腎、腦和心臟。",
    "synonyms": [
      "高血壓",
      "Arterial Hypertension",
      "全身性高血壓"
    ],
    "epidemiology": {
      "species": "犬貓皆可發生，貓較常見",
      "age": "中老年動物",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "慢性腎病（最常見原因）",
        "甲狀腺機能亢進（貓）",
        "腎上腺皮質機能亢進",
        "嗜鉻細胞瘤",
        "醛固酮過多症",
        "糖尿病",
        "肥胖"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "可能無症狀",
        "突然失明",
        "眼睛異常",
        "神經症狀（癲癇、步態異常）",
        "多飲多尿",
        "體重變化"
      ],
      "physicalExam": [
        "眼部：視網膜出血、水腫、剝離、眼前房出血、失明",
        "心臟：心雜音、奔馬律、左心室肥厚",
        "神經：精神改變、癲癇、共濟失調、頭部傾斜",
        "腎臟：可能觸及腎臟異常"
      ]
    },
    "pathophysiology": "血壓持續升高 → 血管壁應力增加 → 內皮損傷和動脈硬化。靶器官損傷：眼（小血管出血/剝離）、腎（腎小球硬化）、心（壓力超負荷致左心室肥厚）、腦（出血/缺血）",
    "diagnosis": {
      "overview": "多次測量確認持續高血壓，並評估靶器官損傷和潛在病因",
      "differentials": [
        "白袍高血壓（焦慮性）",
        "測量誤差"
      ],
      "initialDB": [
        "血壓測量（Doppler或oscillometric，多次測量）",
        "眼科檢查（眼底檢查）",
        "CBC、生化（腎功能、電解質）",
        "尿液分析和UPC",
        "T4（貓）"
      ],
      "advanced": [
        "心臟超聲",
        "腹部超聲",
        "低劑量地塞米松抑制試驗（懷疑庫欣）",
        "醛固酮/腎素比",
        "腹部CT（腎上腺腫瘤）"
      ]
    },
    "treatment": {
      "overview": "降壓藥物控制血壓，治療潛在病因，防止靶器官損傷",
      "acute": [
        "高血壓急症（嚴重眼或神經症狀）：",
        "- Amlodipine（首選）: 犬 0.1-0.25 mg/kg PO q24h；貓 0.625-1.25 mg/貓 PO q24h",
        "- 嚴重時：Hydralazine或Nitroprusside CRI",
        "- 避免血壓下降過快（維持腦灌注）"
      ],
      "chronic": [
        "貓首選：Amlodipine 0.625-1.25 mg/貓 PO q24h",
        "- 若效果不足可增至2.5 mg/貓",
        "- 可加上Telmisartan 2 mg/kg PO q24h",
        "犬：",
        "- Amlodipine 0.1-0.5 mg/kg PO q24h",
        "- ACEI: Enalapril或Benazepril 0.5 mg/kg PO q12-24h",
        "- β-blocker: Atenolol（若心搏過速）",
        "治療潛在病因：",
        "- 甲亢：抗甲狀腺藥物",
        "- 腎病：腎病管理",
        "- 庫欣：相應治療",
        "目標血壓：",
        "- 收縮壓 <140-160 mmHg（無靶器官損傷）",
        "- 收縮壓 <140 mmHg（有靶器官損傷）"
      ]
    },
    "prognosis": "取決於潛在病因和靶器官損傷程度。早期發現和控制可預防或延緩靶器官損傷。視網膜剝離若及時降壓可能恢復部分視力。",
    "pearls": [
      "貓高血壓常與CKD和甲亢相關",
      "突然失明可能是高血壓的首要表現",
      "眼底檢查是評估靶器官損傷的重要方法",
      "測量血壓需要正確技術和動物放鬆",
      "Amlodipine是貓高血壓的首選藥物",
      "血壓分級：正常<140，低風險140-159，中風險160-179，高風險≥180 mmHg",
      "治療高血壓可能揭露潛在的CKD進展"
    ],
    "diagnosticAlgorithm": {
      "title": "系統性高血壓 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "測量血壓並評估靶器官損傷",
          "findings": [
            "收縮壓>160 mmHg",
            "視網膜病變（出血、剝離）",
            "左心室肥厚",
            "蛋白尿"
          ]
        },
        {
          "step": 2,
          "action": "血壓確認",
          "details": "多次都卜勒或示波法測量",
          "findings": [
            "安靜環境測量5-7次取平均",
            "排除白袍效應",
            "分級：輕度140-159、中度160-179、重度≥180"
          ]
        },
        {
          "step": 3,
          "action": "靶器官評估",
          "details": "眼底、心臟、腎臟及腦部",
          "findings": [
            "眼底鏡檢查視網膜",
            "心臟超音波左心室壁厚度",
            "UPC評估蛋白尿",
            "神經學評估"
          ]
        },
        {
          "step": 4,
          "action": "病因篩查",
          "details": "尋找繼發性原因",
          "findings": [
            "慢性腎臟病",
            "甲狀腺功能亢進（貓）",
            "腎上腺皮質功能亢進",
            "嗜鉻細胞瘤",
            "高醛固酮症"
          ]
        }
      ]
    },
    "monitoring": [
      "血壓（每1-2週直到穩定，之後每3-6個月）",
      "眼底檢查",
      "腎功能",
      "心臟超聲（若有左心室肥厚）"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; ACVIM Consensus on Hypertension"
  },
  "pulmonary-hypertension": {
    "zh": "肺動脈高血壓",
    "en": "Pulmonary Hypertension (PH)",
    "definition": "肺動脈高血壓（PH）是指肺動脈壓力異常升高的疾病，犬經超音波估算三尖瓣反流壓力梯度>50 mmHg為中度以上。依病因分為肺動脈性（原發性、先天左向右分流）、左心疾病相關、呼吸疾病相關（慢性支氣管炎）、血栓栓塞性和心絲蟲相關。Cavalier和West Highland好發。",
    "synonyms": [
      "PH",
      "肺高壓",
      "Pulmonary Arterial Hypertension",
      "PAH"
    ],
    "epidemiology": {
      "species": "犬較常見，貓罕見",
      "age": "中老年犬",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "心絲蟲病",
        "慢性呼吸道疾病",
        "左心疾病（二尖瓣病變）",
        "先天性心臟病",
        "肺血栓栓塞",
        "高海拔"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "運動不耐",
        "呼吸困難",
        "咳嗽",
        "昏厥",
        "腹部膨大（腹水）",
        "發紺"
      ],
      "physicalExam": [
        "心雜音（三尖瓣逆流或肺動脈瓣逆流）",
        "第二心音分裂或增強",
        "頸靜脈怒張",
        "肝腫大",
        "腹水",
        "發紺",
        "心搏過速"
      ]
    },
    "pathophysiology": "各種原因導致肺血管阻力增加 → 肺動脈壓升高 → 右心室壓力超負荷 → 右心室肥厚 → 右心衰竭。分類（基於人類WHO分組）：第1組：肺動脈高血壓（原發性）；第2組：左心疾病相關；第3組：肺疾病/低氧相關；第4組：血栓栓塞相關；第5組：多因素",
    "diagnosis": {
      "overview": "心臟超聲估計肺動脈壓是主要診斷方法，同時需尋找病因",
      "differentials": [
        "右心衰竭其他原因",
        "三尖瓣疾病"
      ],
      "initialDB": [
        "心臟超聲（三尖瓣逆流速度估計PAP、右心擴張/肥厚、中隔平坦化）",
        "胸腔X光（肺動脈擴張、右心擴大、肺部病變）",
        "心絲蟲抗原測試",
        "動脈血氣（低氧血症）"
      ],
      "advanced": [
        "心導管（確診金標準，獸醫少用）",
        "CT血管造影（肺栓塞）",
        "凝血功能",
        "D-dimer",
        "6分鐘步行試驗"
      ]
    },
    "treatment": {
      "overview": "治療潛在病因，使用肺血管擴張劑，支持性右心衰竭治療",
      "acute": [
        "急性右心衰竭：",
        "- 氧氣支持",
        "- Furosemide: 2-4 mg/kg IV",
        "- 減少應激",
        "嚴重低氧：氧氣，可能需機械通氣"
      ],
      "chronic": [
        "肺血管擴張劑：",
        "- Sildenafil（首選）: 1-2 mg/kg PO q8-12h",
        "- Tadalafil: 1 mg/kg PO q24h",
        "- Pimobendan: 0.25-0.3 mg/kg PO q12h（正性肌力+血管擴張）",
        "右心衰竭治療：",
        "- Furosemide: 1-4 mg/kg PO q8-12h",
        "- Spironolactone: 1-2 mg/kg PO q12-24h",
        "治療潛在病因：",
        "- 心絲蟲：殺蟲治療",
        "- 左心病：心臟藥物",
        "- 呼吸道疾病：支氣管擴張劑、類固醇",
        "- 血栓栓塞：抗凝治療",
        "氧氣治療（若慢性低氧）",
        "限制運動"
      ]
    },
    "prognosis": "取決於病因和嚴重程度。繼發於可治療病因（心絲蟲）預後較好。原發性或嚴重繼發性PH預後較差。中位存活期可能為數月至1-2年。",
    "pearls": [
      "三尖瓣逆流速度>3 m/s提示肺動脈高血壓",
      "心臟超聲估計的肺動脈壓可能低估實際壓力",
      "Sildenafil是目前獸醫最常用的肺血管擴張劑",
      "心絲蟲是犬PH的重要且可預防的原因",
      "昏厥在PH犬中常見且預後較差",
      "需要尋找和治療潛在病因"
    ],
    "diagnosticAlgorithm": {
      "title": "肺動脈高血壓 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估呼吸困難、運動不耐及昏厥",
          "findings": [
            "運動不耐",
            "呼吸困難",
            "昏厥",
            "發紺"
          ]
        },
        {
          "step": 2,
          "action": "胸腔X光",
          "details": "評估心肺結構",
          "findings": [
            "右心擴大",
            "主肺動脈段突出",
            "肺動脈分支擴張",
            "肺實質評估"
          ]
        },
        {
          "step": 3,
          "action": "心臟超音波",
          "details": "評估肺動脈壓力與右心功能",
          "findings": [
            "三尖瓣返流速度增加（>2.8 m/s）",
            "估算肺動脈壓力",
            "右心室擴大與功能下降",
            "心室中隔扁平化"
          ]
        },
        {
          "step": 4,
          "action": "病因調查",
          "details": "尋找導致肺高壓的原因",
          "findings": [
            "心絲蟲抗原檢測",
            "左心疾病評估",
            "慢性呼吸道疾病",
            "血栓栓塞篩檢"
          ]
        }
      ]
    },
    "monitoring": [
      "臨床症狀",
      "心臟超聲（三尖瓣逆流速度、右心大小）",
      "運動耐受度",
      "血氧"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; ACVIM Consensus on PH"
  },
  "intervertebral-disc-disease": {
    "zh": "椎間盤疾病",
    "en": "Intervertebral Disc Disease (IVDD)",
    "definition": "椎間盤退化導致髓核突出或纖維環膨出壓迫脊髓或神經根，引起疼痛和神經功能障礙的常見脊髓疾病。",
    "synonyms": [
      "IVDD",
      "椎間盤突出",
      "Herniated Disc",
      "Slipped Disc",
      "椎間盤脫出",
      "Disc Extrusion",
      "Disc Protrusion"
    ],
    "epidemiology": {
      "species": "犬最常見，貓罕見",
      "age": "Hansen Type I: 3-7歲；Hansen Type II: 8歲以上",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "軟骨發育不良品種（Dachshund、Beagle、Shih Tzu、Pekingese、Cocker Spaniel、French Bulldog）",
        "肥胖",
        "高衝擊活動（跳躍、爬樓梯）",
        "遺傳因素"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "急性或漸進性後肢無力/癱瘓",
        "頸部或背部疼痛",
        "不願行走或跳躍",
        "哭叫（尤其移動時）",
        "步態異常",
        "大小便失禁（嚴重）"
      ],
      "physicalExam": [
        "脊椎疼痛（觸診或活動時）",
        "本體感覺缺失",
        "運動失調",
        "輕癱或癱瘓",
        "反射異常（依病變位置）",
        "肌肉萎縮（慢性）",
        "深部痛覺缺失（嚴重）"
      ]
    },
    "pathophysiology": "Hansen Type I（突出型）：髓核急性突出穿過纖維環 → 脊髓急性壓迫和挫傷。Hansen Type II（膨出型）：纖維環慢性退化變厚 → 慢性脊髓壓迫。壓迫導致：缺血、水腫、神經細胞損傷、軸突退化。頸椎好發C2-C3、C3-C4；胸腰椎好發T11-L2（T12-T13最常見）。",
    "diagnosis": {
      "overview": "神經學檢查定位病變，影像學確認",
      "differentials": [
        "纖維軟骨栓塞(FCE)",
        "脊髓腫瘤",
        "脊髓炎",
        "椎體骨折/脫位",
        "退化性脊髓病",
        "椎間盤脊椎炎",
        "先天性脊髓異常"
      ],
      "initialDB": [
        "完整神經學檢查",
        "脊椎X光（椎間隙變窄、礦化椎間盤）",
        "血液檢查（排除系統性疾病）"
      ],
      "advanced": [
        "MRI（首選：可見軟組織、脊髓變化）",
        "CT（骨骼細節、礦化椎間盤）",
        "脊髓造影（若無MRI）",
        "腦脊液分析"
      ]
    },
    "treatment": {
      "overview": "依嚴重程度分級治療：保守治療或手術減壓",
      "acute": [
        "神經功能分級：",
        "  Grade I: 僅疼痛 → 保守治療",
        "  Grade II: 輕度運動失調，可行走 → 保守或手術",
        "  Grade III: 嚴重運動失調，輕癱 → 手術建議",
        "  Grade IV: 癱瘓，保留深部痛覺 → 手術",
        "  Grade V: 癱瘓，無深部痛覺 → 緊急手術（48小時內）",
        "保守治療（Grade I-II）：",
        "  - 嚴格籠休4-6週",
        "  - 止痛：Gabapentin 5-10 mg/kg PO q8-12h",
        "  - 肌肉鬆弛：Methocarbamol 15-20 mg/kg PO q8h",
        "  - NSAIDs（無類固醇使用時）：Carprofen 2.2 mg/kg PO q12h",
        "  - 避免類固醇（爭議且副作用多）",
        "手術治療：",
        "  - 半椎板切除術(Hemilaminectomy)：胸腰椎",
        "  - 腹側開窗術(Ventral Slot)：頸椎",
        "  - 目的：減壓、移除突出物質"
      ],
      "chronic": [
        "物理治療和復健",
        "水療（水中跑步機）",
        "輪椅輔助（永久癱瘓）",
        "膀胱管理（神經性膀胱）",
        "體重管理",
        "環境調整（防滑地板、斜坡）"
      ]
    },
    "prognosis": "Grade I-II: 保守治療成功率85-95%。Grade III-IV: 手術成功率80-95%。Grade V: 手術成功率50-60%（深部痛覺喪失<48小時較佳）。深部痛覺喪失>48小時預後差。復發率約15-20%。",
    "pearls": [
      "深部痛覺是最重要的預後指標",
      "Dachshund的IVDD風險是其他品種的10-12倍",
      "進行性脊髓軟化(PMM)是致命併發症，約10% Grade V病例",
      "「籠休」必須嚴格，僅允許出籠大小便",
      "類固醇與NSAIDs不可併用",
      "MRI可發現X光看不到的軟組織壓迫"
    ],
    "diagnosticAlgorithm": {
      "title": "椎間盤疾病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估疼痛部位、神經功能缺失程度",
          "findings": [
            "背部或頸部疼痛",
            "後肢無力或癱瘓",
            "本體感覺異常",
            "深部痛覺評估"
          ]
        },
        {
          "step": 2,
          "action": "神經學檢查",
          "details": "定位病灶節段",
          "findings": [
            "步態評估",
            "脊髓反射測試",
            "本體感覺測試",
            "疼痛感覺評估（深部痛覺）"
          ]
        },
        {
          "step": 3,
          "action": "脊椎影像",
          "details": "X光初步評估",
          "findings": [
            "椎間盤空間狹窄",
            "椎間盤鈣化",
            "脊椎X光可能正常",
            "排除骨折或腫瘤"
          ]
        },
        {
          "step": 4,
          "action": "進階影像確診",
          "details": "MRI或CT脊髓造影",
          "findings": [
            "MRI確認突出位置與嚴重度",
            "脊髓壓迫程度",
            "區分Hansen Type I與II",
            "指導手術減壓位置"
          ]
        }
      ]
    },
    "monitoring": [
      "神經功能評估（每日→每週）",
      "疼痛評估",
      "膀胱功能",
      "復健進展",
      "體重"
    ],
    "reference": "Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; Brisson BA: Intervertebral disc disease in dogs. Vet Clin North Am Small Anim Pract 40:829-858, 2010"
  },
  "fibrocartilaginous-embolism": {
    "zh": "纖維軟骨栓塞",
    "en": "Fibrocartilaginous Embolism (FCE)",
    "definition": "椎間盤纖維軟骨物質栓塞脊髓血管導致缺血性脊髓病變，引起急性、非進行性、通常非疼痛性的神經功能障礙。",
    "synonyms": [
      "FCE",
      "脊髓梗塞",
      "Spinal Cord Infarction",
      "Ischemic Myelopathy",
      "纖維軟骨栓塞性脊髓病"
    ],
    "epidemiology": {
      "species": "犬為主，貓罕見",
      "age": "年輕至中年成犬（平均3-6歲）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "大型和巨型犬種（German Shepherd、Labrador、Great Dane）",
        "小型犬中Miniature Schnauzer和Shetland Sheepdog較常見",
        "運動或輕微創傷後發作"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "急性發作（通常與運動或輕微創傷相關）",
        "發作時可能尖叫",
        "初期疼痛後迅速消退",
        "非進行性（24小時內穩定）",
        "不對稱性神經缺損常見"
      ],
      "physicalExam": [
        "不對稱性輕癱或癱瘓",
        "發作後24小時內無疼痛",
        "下運動神經元或上運動神經元徵象（依病變位置）",
        "一側肢體可能比另一側嚴重",
        "脊椎觸診不痛"
      ]
    },
    "pathophysiology": "椎間盤纖維軟骨物質（髓核來源）→ 進入脊髓血管系統（動脈或靜脈）→ 栓塞脊髓節段血管 → 缺血 → 脊髓壞死。確切進入機制不明，可能與椎間盤退化和新生血管有關。病變範圍取決於栓塞血管分布。",
    "diagnosis": {
      "overview": "臨床特徵高度提示，MRI確認，排除其他疾病",
      "differentials": [
        "IVDD（Hansen Type I）",
        "脊髓創傷",
        "脊髓腫瘤",
        "脊髓炎",
        "出血",
        "動靜脈畸形"
      ],
      "initialDB": [
        "完整神經學檢查",
        "脊椎X光（通常正常）",
        "血液檢查"
      ],
      "advanced": [
        "MRI（首選）：急性期可見T2高信號脊髓內病變",
        "腦脊液分析（輕度蛋白升高或正常）",
        "排除壓迫性病變"
      ]
    },
    "treatment": {
      "overview": "支持治療和物理復健為主，無特異性治療",
      "acute": [
        "無手術指征（非壓迫性病變）",
        "支持治療：",
        "  - 舒適的墊褥（預防褥瘡）",
        "  - 輔助翻身（癱瘓動物每4小時）",
        "  - 膀胱管理（手動擠壓或導尿）",
        "  - 營養支持",
        "止痛（若有殘餘疼痛）：Gabapentin 5-10 mg/kg PO q8-12h",
        "類固醇無明確療效，不建議使用"
      ],
      "chronic": [
        "物理治療是關鍵：",
        "  - 被動關節活動",
        "  - 站立訓練",
        "  - 水療",
        "  - 神經肌肉電刺激",
        "輪椅輔助（部分病例）",
        "持續膀胱管理（若需要）"
      ]
    },
    "prognosis": "整體預後較好。約75-85%犬隻在數週至數月內恢復行走能力。預後因素：深部痛覺保留者預後好；病變範圍小者預後好；一週內有改善者預後好。完全恢復可能，但部分可能有殘餘缺損。",
    "pearls": [
      "「急性、非進行性、非疼痛性、不對稱性」是FCE的典型特徵",
      "與IVDD鑑別：IVDD通常疼痛且對稱",
      "MRI的急性脊髓內T2高信號支持診斷",
      "確診需排除壓迫性病變",
      "物理治療對恢復至關重要",
      "貓的FCE極為罕見"
    ],
    "diagnosticAlgorithm": {
      "title": "纖維軟骨栓塞 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "急性非疼痛性單側神經缺失",
          "findings": [
            "超急性發作（運動中）",
            "單側或不對稱神經缺失",
            "初期疼痛後迅速消失",
            "大型犬年輕至中年"
          ]
        },
        {
          "step": 2,
          "action": "神經學定位",
          "details": "詳細神經學檢查",
          "findings": [
            "上運動或下運動神經元徵象",
            "病灶單側性",
            "脊髓節段定位",
            "排除多灶性病變"
          ]
        },
        {
          "step": 3,
          "action": "MRI確診",
          "details": "脊髓磁振造影",
          "findings": [
            "T2加權脊髓內高信號",
            "病灶對應臨床定位",
            "無明顯壓迫性病灶",
            "排除椎間盤突出"
          ]
        },
        {
          "step": 4,
          "action": "排除診斷",
          "details": "與其他急性脊髓病鑑別",
          "findings": [
            "排除椎間盤突出（MRI）",
            "排除脊髓腫瘤",
            "排除創傷",
            "CSF分析排除感染"
          ]
        }
      ]
    },
    "monitoring": [
      "每日神經功能評估（前1-2週）",
      "膀胱功能",
      "皮膚完整性",
      "肌肉量",
      "復健進展"
    ],
    "reference": "Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; De Risio L et al: Fibrocartilaginous embolic myelopathy in small animals. Vet Clin North Am Small Anim Pract 40:859-869, 2010"
  },
  "degenerative-myelopathy": {
    "zh": "退化性脊髓病",
    "en": "Degenerative Myelopathy (DM)",
    "definition": "成年犬的進行性、非疼痛性脊髓退化疾病，特徵為後肢進行性運動失調和輕癱，最終導致四肢癱瘓。與SOD1基因突變相關。",
    "synonyms": [
      "DM",
      "German Shepherd Degenerative Myelopathy",
      "慢性退化性脊髓病",
      "Canine Degenerative Myelopathy"
    ],
    "epidemiology": {
      "species": "犬，貓極罕見",
      "age": "中老年犬（通常8歲以上）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "品種：German Shepherd（最常見）、Pembroke Welsh Corgi、Boxer、Rhodesian Ridgeback、Chesapeake Bay Retriever",
        "SOD1基因突變純合子"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "隱匿性起病，進行性惡化",
        "後肢無力和運動失調",
        "指甲磨損",
        "腳背著地",
        "非疼痛性",
        "大小便功能初期正常",
        "病程6-12個月後可能發展為四肢無力"
      ],
      "physicalExam": [
        "後肢上運動神經元性輕癱",
        "本體感覺缺失",
        "跨步反應延遲或缺失",
        "後肢肌肉萎縮",
        "脊椎觸診無疼痛",
        "晚期可能出現前肢異常",
        "晚期可能有下運動神經元徵象"
      ]
    },
    "pathophysiology": "SOD1(Superoxide dismutase 1)基因突變 → 蛋白質異常聚集 → 軸突和髓鞘退化 → 脊髓白質變性。病變主要在胸腰脊髓，後期擴展至頸髓和腦幹。類似人類肌萎縮側索硬化症(ALS)的動物模型。",
    "diagnosis": {
      "overview": "排除性診斷；確診需要病理學檢查",
      "differentials": [
        "IVDD（Hansen Type II）",
        "腰薦椎狹窄",
        "脊髓腫瘤",
        "髖關節疾病",
        "多發性神經根病",
        "退化性關節炎"
      ],
      "initialDB": [
        "完整神經學檢查",
        "脊椎X光（排除骨病變）",
        "SOD1基因檢測（風險評估，非確診）",
        "血液檢查"
      ],
      "advanced": [
        "MRI（排除壓迫性病變；DM時脊髓可能萎縮）",
        "腦脊液分析（通常正常）",
        "電生理檢查",
        "肌肉/神經活檢",
        "確診：死後脊髓病理"
      ]
    },
    "treatment": {
      "overview": "無治癒方法，以支持治療和延緩進展為主",
      "acute": [
        "無急性治療需求（進行性疾病）",
        "向主人解釋疾病本質和預後"
      ],
      "chronic": [
        "物理治療：",
        "  - 持續運動（維持肌肉量）",
        "  - 水療（減重運動）",
        "  - 被動關節活動",
        "  - 站立訓練",
        "營養補充（理論效益，證據有限）：",
        "  - 維生素E",
        "  - Omega-3脂肪酸",
        "  - N-乙醯半胱氨酸",
        "輔助設備：",
        "  - 後肢支撐帶",
        "  - 輪椅",
        "  - 防滑靴套",
        "環境調整：防滑地板",
        "安樂死時機討論（生活品質考量）"
      ]
    },
    "prognosis": "預後差，疾病不可逆且持續進行。從後肢癱瘓到需要安樂死通常6-12個月。維持運動可能減緩進展。最終因呼吸肌麻痺或生活品質考量而安樂死。",
    "pearls": [
      "DM是排除性診斷，確診需要病理",
      "SOD1基因檢測：純合子突變=高風險，但非所有都會發病",
      "與IVDD Type II鑑別：DM非疼痛性，兩側對稱",
      "保持運動是目前最佳「治療」",
      "類似人類ALS，是重要的研究模型",
      "早期MRI可能正常或僅見脊髓輕度萎縮"
    ],
    "diagnosticAlgorithm": {
      "title": "退化性脊髓病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估漸進性後肢無力（大型犬）",
          "findings": [
            "漸進性後肢共濟失調",
            "本體感覺缺失",
            "無疼痛表現",
            "中老年大型犬（德國牧羊犬）"
          ]
        },
        {
          "step": 2,
          "action": "神經學檢查",
          "details": "詳細神經學定位",
          "findings": [
            "上運動神經元後肢徵象",
            "本體感覺明顯缺失",
            "脊髓反射正常或亢進",
            "排除下運動神經元疾病"
          ]
        },
        {
          "step": 3,
          "action": "影像排除",
          "details": "MRI排除其他脊髓壓迫",
          "findings": [
            "MRI無明顯壓迫性病灶",
            "排除椎間盤疾病",
            "排除脊髓腫瘤",
            "可能見脊髓萎縮"
          ]
        },
        {
          "step": 4,
          "action": "基因檢測與臨床診斷",
          "details": "SOD1基因突變檢測",
          "findings": [
            "SOD1基因突變（純合子）",
            "臨床排除診斷",
            "確診需死後病理",
            "與物理復健計畫"
          ]
        }
      ]
    },
    "monitoring": [
      "定期神經功能評估",
      "肌肉量",
      "生活品質評估",
      "膀胱功能（晚期）"
    ],
    "reference": "Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; Coates JR, Wininger FA: Canine degenerative myelopathy. Vet Clin North Am Small Anim Pract 40:929-950, 2010"
  },
  "idiopathic-epilepsy": {
    "zh": "特發性癲癇",
    "en": "Idiopathic Epilepsy",
    "definition": "排除結構性和代謝性原因後，反覆發生的癲癇發作。被認為有遺傳基礎，是犬最常見的癲癇病因。",
    "synonyms": [
      "原發性癲癇",
      "Primary Epilepsy",
      "Genetic Epilepsy",
      "遺傳性癲癇",
      "IE"
    ],
    "epidemiology": {
      "species": "犬最常見，貓較少見",
      "age": "首次發作通常6個月至6歲（多數1-5歲）",
      "sex": "公犬略多（某些品種）",
      "riskFactors": [
        "品種傾向：Labrador Retriever、Golden Retriever、German Shepherd、Beagle、Belgian Shepherd（Tervuren）、Border Collie、Australian Shepherd、Vizsla",
        "家族史"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "反覆發生的癲癇發作",
        "發作間期完全正常",
        "可能有前兆期（焦慮、躲藏、尋求主人）",
        "發作類型：全身性強直-陣攣最常見",
        "發作後期：混亂、失明、飢餓"
      ],
      "physicalExam": [
        "發作間期：神經學檢查完全正常",
        "發作時：意識喪失、強直-陣攣、流涎、排尿排便",
        "發作後：短暫意識模糊、失明、運動失調"
      ]
    },
    "pathophysiology": "遺傳因素導致神經元興奮性和抑制性平衡失調 → 神經元異常同步放電 → 癲癇發作。某些品種已確認特定基因突變（如LGI2 in Lagotto Romagnolo）。大多數為多基因遺傳。",
    "diagnosis": {
      "overview": "排除性診斷：排除結構性、代謝性和中毒原因",
      "differentials": [
        "結構性癲癇（腦腫瘤、腦炎、腦積水）",
        "代謝性癲癇（低血糖、肝腦病、電解質異常）",
        "反應性癲癇（中毒）",
        "運動障礙",
        "暈厥",
        "發作性睡病"
      ],
      "initialDB": [
        "完整神經學檢查（應正常）",
        "CBC、生化全套、電解質",
        "血糖（發作時和空腹）",
        "甲狀腺功能",
        "膽汁酸或血氨（排除肝腦病）",
        "尿液分析"
      ],
      "advanced": [
        "腦部MRI（>6歲首發或神經學異常者必要）",
        "腦脊液分析",
        "腦電圖（EEG）（可用性有限）",
        "基因檢測（特定品種）"
      ]
    },
    "treatment": {
      "overview": "抗癲癇藥物(AED)控制發作頻率和嚴重度",
      "acute": [
        "叢集發作或癲癇持續狀態（見急診章節）：",
        "  - Diazepam: 0.5-1 mg/kg IV/rectal",
        "  - Midazolam: 0.2-0.5 mg/kg IM/IN",
        "  - 若無效：Levetiracetam 60 mg/kg IV",
        "居家發作處理教育"
      ],
      "chronic": [
        "開始長期AED治療的指征：",
        "  - 發作頻率>1次/月",
        "  - 叢集發作史",
        "  - 癲癇持續狀態史",
        "  - 發作後期嚴重或延長",
        "一線藥物選擇（犬）：",
        "  - Phenobarbital: 2.5-3 mg/kg PO q12h（目標血藥濃度25-35 ug/mL）",
        "  - Levetiracetam (Keppra): 20-30 mg/kg PO q8h（安全性高）",
        "  - Zonisamide: 5-10 mg/kg PO q12h",
        "  - Potassium bromide: 30-40 mg/kg PO q24h（負荷量可更快）",
        "貓：",
        "  - Phenobarbital: 1-2 mg/kg PO q12h",
        "  - Levetiracetam: 20 mg/kg PO q8h（首選）",
        "難治性癲癇：聯合用藥或加用Imepitoin"
      ]
    },
    "prognosis": "約70-80%犬隻可用藥物達到良好控制（發作減少>50%）。約20-30%為難治性（藥物反應差）。預後因素：發作頻率高、叢集發作、早發型預後較差。大多數需終身治療。",
    "pearls": [
      "「排除性診斷」- 必須排除其他原因",
      "首發年齡>6歲應高度懷疑結構性病變",
      "Phenobarbital需定期監測血藥濃度和肝功能",
      "不可突然停藥（誘發反彈發作）",
      "叢集發作是急診",
      "建議主人記錄發作日誌"
    ],
    "diagnosticAlgorithm": {
      "title": "特發性癲癇 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "詳細癲癇發作史及發作間期評估",
          "findings": [
            "全身性強直陣攣發作",
            "發作間期神經學正常",
            "1-5歲首次發作",
            "品種好發（邊境牧羊犬等）"
          ]
        },
        {
          "step": 2,
          "action": "血液生化篩檢",
          "details": "排除代謝性癲癇原因",
          "findings": [
            "血糖正常",
            "肝功能正常（排除PSS）",
            "電解質正常",
            "膽汁酸正常"
          ]
        },
        {
          "step": 3,
          "action": "進階腦部影像",
          "details": "MRI排除結構性腦病",
          "findings": [
            "MRI腦部正常",
            "排除腫瘤",
            "排除腦炎",
            "排除水腦症"
          ]
        },
        {
          "step": 4,
          "action": "CSF分析與確診",
          "details": "腦脊髓液排除感染性/炎性原因",
          "findings": [
            "CSF正常",
            "排除腦膜腦炎",
            "排除感染（犬瘟熱等）",
            "臨床排除診斷確認特發性癲癇"
          ]
        }
      ]
    },
    "monitoring": [
      "發作日誌（頻率、持續時間、類型）",
      "血藥濃度（Phenobarbital、Bromide）",
      "肝功能（Phenobarbital）",
      "腎功能（Bromide）",
      "CBC",
      "生活品質"
    ],
    "reference": "Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; Podell M et al: 2015 ACVIM small animal consensus statement on seizure management in dogs. J Vet Intern Med 30:477-490, 2016"
  },
  "granulomatous-meningoencephalitis": {
    "zh": "肉芽腫性腦膜腦炎",
    "en": "Granulomatous Meningoencephalitis (GME)",
    "definition": "犬的非感染性、免疫介導的中樞神經系統炎症性疾病，特徵為單核細胞和組織細胞在腦和脊髓形成肉芽腫性病變。",
    "synonyms": [
      "GME",
      "Inflammatory Reticulosis",
      "網狀細胞增生症",
      "Meningoencephalitis of Unknown Etiology (MUE)"
    ],
    "epidemiology": {
      "species": "犬，貓極罕見",
      "age": "年輕至中年（平均5歲，但1-12歲皆可）",
      "sex": "母犬可能略多",
      "riskFactors": [
        "小型犬品種：Maltese、Yorkshire Terrier、Poodle、Chihuahua、Pug",
        "中型犬亦可發生"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "急性或亞急性起病",
        "進行性神經功能障礙",
        "依病變位置表現：前腦徵象（癲癇、行為改變、盲目）、腦幹徵象（運動失調、頭歪斜、顏面麻痺）、脊髓徵象（輕癱）",
        "頸部疼痛常見"
      ],
      "physicalExam": [
        "多灶性神經學缺損（最常見）",
        "或單灶性病變（占位型GME）",
        "或僅眼部病變（眼部GME）",
        "發燒（部分病例）",
        "頸部僵硬或疼痛"
      ]
    },
    "pathophysiology": "確切病因不明，被認為是免疫介導的炎症反應。病理特徵：血管周圍淋巴細胞、單核細胞、組織細胞浸潤，形成肉芽腫。三種形式：播散型（多灶性，最常見且最具侵襲性）、局灶型（占位效應）、眼部型（視神經和眼部）。",
    "diagnosis": {
      "overview": "MRI和腦脊液支持診斷，確診需組織病理",
      "differentials": [
        "壞死性腦膜腦炎(NME)",
        "壞死性白質腦炎(NLE)",
        "感染性腦炎（犬瘟熱、隱球菌、弓漿蟲）",
        "腦腫瘤",
        "腦梗塞"
      ],
      "initialDB": [
        "完整神經學檢查",
        "眼底檢查（視神經乳頭水腫、視網膜炎）",
        "CBC、生化（通常正常）",
        "傳染病篩檢"
      ],
      "advanced": [
        "腦部MRI：T2高信號病變、可能有強化和占位效應",
        "腦脊液分析：單核細胞增多、蛋白升高",
        "確診：腦組織活檢或死後病理（臨床上常依MRI+CSF推定診斷）"
      ]
    },
    "treatment": {
      "overview": "免疫抑制治療",
      "acute": [
        "高劑量類固醇起始：",
        "  - Prednisone/Prednisolone: 1-2 mg/kg PO q12h x 2-4週",
        "  - 或 Dexamethasone: 0.25-0.5 mg/kg IV q12-24h（急性嚴重）",
        "癲癇控制：抗癲癇藥物",
        "腦水腫管理（若有）：Mannitol"
      ],
      "chronic": [
        "類固醇逐漸減量至最低有效劑量",
        "添加類固醇節約藥物（steroid-sparing）：",
        "  - Cytosine arabinoside (Ara-C): 50 mg/m2 SQ q12h x 2天，每3-4週",
        "  - 或 Cyclosporine: 5-10 mg/kg PO q12h",
        "  - 或 Mycophenolate mofetil: 10-20 mg/kg PO q12h",
        "  - 或 Leflunomide: 2-4 mg/kg PO q24h",
        "  - 或 Procarbazine: 25-50 mg/m2 PO q24h",
        "維持治療通常需要終身"
      ]
    },
    "prognosis": "預後謹慎至差。播散型預後最差，中位生存期數月。局灶型和眼部型預後較好，部分可存活1-2年以上。治療反應良好者預後較佳。復發常見。",
    "pearls": [
      "GME屬於「不明原因腦膜腦炎(MUE)」大類",
      "與NME和NLE統稱為「犬特發性非感染性腦炎」",
      "Ara-C是小動物腫瘤科常用藥物，在GME有良好效果",
      "MRI雖高度提示但無法與NME/NLE或腫瘤完全區分",
      "早期積極治療可能改善預後",
      "類固醇副作用在長期治療中是顯著問題"
    ],
    "diagnosticAlgorithm": {
      "title": "肉芽腫性腦膜腦炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估急性多灶性神經症狀",
          "findings": [
            "急性進行性神經缺失",
            "多灶性腦部徵象",
            "頸部疼痛",
            "小型犬好發"
          ]
        },
        {
          "step": 2,
          "action": "血液與基本檢查",
          "details": "排除感染性原因",
          "findings": [
            "CBC與生化篩檢",
            "壁蝨傳染病篩檢",
            "隱球菌抗原",
            "弓形蟲抗體"
          ]
        },
        {
          "step": 3,
          "action": "MRI腦部",
          "details": "評估病灶特徵與分佈",
          "findings": [
            "多灶性或單灶性強化病灶",
            "腦膜強化",
            "腦幹或小腦病灶常見",
            "需與腦腫瘤鑑別"
          ]
        },
        {
          "step": 4,
          "action": "CSF分析",
          "details": "腦脊髓液細胞學與蛋白",
          "findings": [
            "單核球性白血球增多",
            "蛋白質升高",
            "PCR排除感染",
            "免疫抑制治療前確認"
          ]
        }
      ]
    },
    "monitoring": [
      "神經功能評估",
      "類固醇副作用（PU/PD、食慾、皮膚、肌肉）",
      "追蹤MRI（評估療效）",
      "腦脊液複查（部分病例）"
    ],
    "reference": "Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; Granger N et al: Canine meningoencephalomyelitis of unknown origin. Vet Clin North Am Small Anim Pract 40:881-900, 2010"
  },
  "necrotizing-meningoencephalitis": {
    "zh": "壞死性腦膜腦炎",
    "en": "Necrotizing Meningoencephalitis (NME)",
    "definition": "犬的非感染性、免疫介導的腦部炎症性疾病，特徵為腦實質壞死病變，主要影響灰質和白質交界處，高度品種相關。",
    "synonyms": [
      "NME",
      "Pug Dog Encephalitis",
      "巴哥腦炎",
      "Necrotizing Encephalitis"
    ],
    "epidemiology": {
      "species": "犬（特定品種），貓極罕見",
      "age": "年輕成犬（多數1-7歲，平均2-4歲）",
      "sex": "母犬可能略多",
      "riskFactors": [
        "高度品種相關：Pug（最典型）、Yorkshire Terrier、Maltese、Chihuahua、French Bulldog、Shih Tzu",
        "可能有遺傳傾向"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "急性或亞急性起病",
        "快速進行性",
        "癲癇發作（最常見，常難以控制）",
        "視力障礙/失明",
        "行為改變",
        "意識改變（昏迷）"
      ],
      "physicalExam": [
        "前腦徵象為主：癲癇、失明、盤旋、頭壓牆、行為改變",
        "可能有運動失調",
        "頸部疼痛或僵硬",
        "進行性惡化"
      ]
    },
    "pathophysiology": "病因不明，認為是免疫介導。病理特徵：灰質和白質廣泛壞死，炎症細胞浸潤，主要影響大腦皮質。與GME不同，NME以壞死為主，血管周圍炎症較輕。Pug犬中可能與DLA II類基因型相關。",
    "diagnosis": {
      "overview": "MRI高度提示，確診需病理學",
      "differentials": [
        "GME",
        "壞死性白質腦炎(NLE)",
        "感染性腦炎",
        "腦腫瘤",
        "腦梗塞",
        "代謝性腦病"
      ],
      "initialDB": [
        "神經學檢查",
        "眼底檢查",
        "CBC、生化（通常正常）",
        "傳染病篩檢"
      ],
      "advanced": [
        "腦部MRI：多灶性T2高信號，主要在灰白質交界，不對稱性，可能有腦萎縮",
        "腦脊液：單核細胞增多、蛋白升高",
        "確診：病理學"
      ]
    },
    "treatment": {
      "overview": "與GME相似的免疫抑制治療，但療效較差",
      "acute": [
        "高劑量類固醇：",
        "  - Prednisone: 1-2 mg/kg PO q12h",
        "積極癲癇控制（常難治）：",
        "  - Levetiracetam: 20-30 mg/kg PO q8h",
        "  - 加用Phenobarbital或Zonisamide",
        "腦水腫處理：Mannitol 0.5-1 g/kg IV"
      ],
      "chronic": [
        "免疫抑制藥物（同GME）：",
        "  - Cytosine arabinoside",
        "  - Cyclosporine",
        "  - Mycophenolate",
        "持續癲癇管理",
        "支持治療"
      ]
    },
    "prognosis": "預後差，通常比GME更具侵襲性。中位生存期通常僅數週至數月。癲癇控制困難是主要問題。少數病例可較長期存活。早期積極治療可能改善預後。",
    "pearls": [
      "NME在Pug犬中特別典型（Pug Dog Encephalitis）",
      "癲癇常是首發症狀且難以控制",
      "與NLE區分：NLE主要影響白質",
      "MRI上壞死病變和萎縮是特徵",
      "比GME進展更快且預後更差",
      "需要與主人充分溝通預後"
    ],
    "diagnosticAlgorithm": {
      "title": "壞死性腦膜腦炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估急性神經症狀（小型犬）",
          "findings": [
            "急性癲癇發作",
            "視力喪失",
            "行為改變",
            "巴哥犬、約克夏等好發"
          ]
        },
        {
          "step": 2,
          "action": "神經學檢查",
          "details": "腦部定位評估",
          "findings": [
            "前腦徵象（癲癇、盤旋）",
            "視覺缺失",
            "意識改變",
            "多灶性或對稱性"
          ]
        },
        {
          "step": 3,
          "action": "MRI腦部",
          "details": "特徵性壞死灶評估",
          "findings": [
            "大腦皮質多灶性壞死灶",
            "T2高信號病灶",
            "灰白質交界處受影響",
            "腦膜強化"
          ]
        },
        {
          "step": 4,
          "action": "CSF與排除",
          "details": "腦脊髓液分析與鑑別",
          "findings": [
            "單核球性白血球增多",
            "蛋白質升高",
            "排除感染性腦炎",
            "組織病理（死後確診）"
          ]
        }
      ]
    },
    "monitoring": [
      "癲癇頻率和嚴重度",
      "神經功能",
      "生活品質",
      "藥物副作用"
    ],
    "reference": "Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; Levine JM et al: Necrotizing meningoencephalitis in Pug Dogs. J Vet Intern Med 22:1128-1134, 2008"
  },
  "vestibular-disease": {
    "zh": "前庭疾病",
    "en": "Vestibular Disease",
    "definition": "影響前庭系統（維持平衡和空間定向）的疾病總稱，分為周邊型（內耳和前庭神經）和中樞型（腦幹前庭核）。",
    "synonyms": [
      "Vestibular Syndrome",
      "前庭症候群",
      "Old Dog Vestibular Disease",
      "老犬前庭疾病",
      "Geriatric Vestibular Syndrome"
    ],
    "epidemiology": {
      "species": "犬貓皆常見",
      "age": "周邊型：犬老年（特發性）、貓任何年齡；中樞型：任何年齡",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "老年（特發性）",
        "中耳/內耳感染",
        "甲狀腺功能低下（犬）",
        "耳毒性藥物",
        "顱內病變（中樞型）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "急性發作的傾斜/倒向一側",
        "眼球震顫",
        "嘔吐",
        "食慾下降",
        "頭傾斜",
        "轉圈"
      ],
      "physicalExam": [
        "周邊型徵象：",
        "  - 頭傾斜向病變側",
        "  - 水平或旋轉眼球震顫（快相向對側）",
        "  - 跌倒或滾向病變側",
        "  - 無本體感覺缺失",
        "  - 可能有顏面麻痺或霍納氏症候群（同側）",
        "中樞型徵象：",
        "  - 垂直或方向改變的眼球震顫",
        "  - 本體感覺缺失",
        "  - 意識改變",
        "  - 其他顱神經缺損",
        "  - 運動失調超過傾斜程度"
      ]
    },
    "pathophysiology": "周邊型：內耳前庭器官或前庭神經(CN VIII)病變 → 兩側前庭輸入不平衡 → 傾斜和眼球震顫。中樞型：腦幹前庭核或其聯繫病變 → 類似但常伴其他神經缺損。犬特發性前庭疾病原因不明，可能與血管問題相關。",
    "diagnosis": {
      "overview": "區分周邊型和中樞型是關鍵，指導進一步檢查",
      "differentials": [
        "周邊型：特發性（老犬最常見）、中耳/內耳炎、耳毒性藥物、甲狀腺功能低下、多發性神經病、耳腫瘤",
        "中樞型：腦腫瘤、腦幹腦炎、腦梗塞、腦外傷、硫胺缺乏"
      ],
      "initialDB": [
        "完整神經學檢查（區分周邊/中樞）",
        "耳鏡檢查",
        "耳道和鼓室X光或CT",
        "血液檢查（含甲狀腺功能）"
      ],
      "advanced": [
        "腦部MRI（中樞型或對治療無反應者）",
        "耳道和鼓室CT",
        "腦脊液分析",
        "BAER（腦幹聽覺誘發反應）"
      ]
    },
    "treatment": {
      "overview": "治療原發病因；特發性以支持治療為主",
      "acute": [
        "特發性前庭疾病：",
        "  - 支持治療",
        "  - 防跌倒和受傷",
        "  - 輸液（若嘔吐導致脫水）",
        "止吐/抗暈：",
        "  - Maropitant (Cerenia): 1 mg/kg SQ/PO q24h",
        "  - 或 Meclizine: 犬 25 mg PO q8-24h",
        "  - 或 Diphenhydramine: 2-4 mg/kg PO/IM q8h",
        "中耳炎：抗生素（全身和/或局部）",
        "中樞型：治療原發病因"
      ],
      "chronic": [
        "物理治療（恢復期）",
        "環境調整（防滑墊）",
        "中耳炎：可能需要手術（鼓室切開、全耳道切除）",
        "甲狀腺功能低下：補充甲狀腺素"
      ]
    },
    "prognosis": "特發性前庭疾病：預後良好，多數2-4週明顯改善，部分殘餘頭傾斜。中耳炎：治療原發感染後預後良好。中樞型：依病因而異。腫瘤相關者預後差。",
    "pearls": [
      "犬特發性前庭病是老犬「中風樣」發作最常見原因",
      "周邊型和中樞型的區分至關重要",
      "本體感覺缺失提示中樞型",
      "垂直眼球震顫幾乎確定是中樞型",
      "特發性無需影像學（除非懷疑中樞）",
      "恢復期頭傾斜可能永久存在"
    ],
    "diagnosticAlgorithm": {
      "title": "前庭疾病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估頭部歪斜、眼球震顫方向",
          "findings": [
            "頭部歪斜",
            "自發性眼球震顫",
            "共濟失調（向患側偏倒）",
            "嘔吐噁心"
          ]
        },
        {
          "step": 2,
          "action": "神經學定位",
          "details": "區分周邊與中樞前庭",
          "findings": [
            "水平或旋轉眼震（周邊）",
            "垂直或方向改變眼震（中樞）",
            "對側本體感覺缺失（中樞）",
            "面癱或Horner（周邊）"
          ]
        },
        {
          "step": 3,
          "action": "耳鏡與影像",
          "details": "耳道檢查及影像學",
          "findings": [
            "耳鏡檢查排除中耳炎",
            "CT/MRI鼓室泡評估",
            "MRI腦幹與小腦（疑似中樞型）",
            "排除腦腫瘤"
          ]
        },
        {
          "step": 4,
          "action": "進階病因確認",
          "details": "特定病因檢查",
          "findings": [
            "甲狀腺功能（老犬）",
            "CSF分析（中樞型）",
            "壁蝨傳染病篩檢",
            "老犬特發性前庭疾病（排除診斷）"
          ]
        }
      ]
    },
    "monitoring": [
      "神經功能進展",
      "食慾和水分攝取",
      "嘔吐情況",
      "行走能力"
    ],
    "reference": "Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; Rossmeisl JH: Vestibular disease in dogs and cats. Vet Clin North Am Small Anim Pract 40:81-100, 2010"
  },
  "hydrocephalus": {
    "zh": "水腦症",
    "en": "Hydrocephalus",
    "definition": "腦室內腦脊液(CSF)異常積聚導致腦室擴張和顱內壓升高的疾病，分為先天性和後天性。",
    "synonyms": [
      "腦積水",
      "水頭症",
      "Ventriculomegaly"
    ],
    "epidemiology": {
      "species": "犬較常見，貓罕見",
      "age": "先天性：幼犬/幼貓；後天性：任何年齡",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "先天性：玩具犬和短頭品種（Chihuahua、Yorkshire Terrier、Pomeranian、Maltese、Pug、Boston Terrier、English Bulldog）",
        "後天性：腦腫瘤、腦炎、出血、創傷"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "先天性：幼年時發現、發育遲緩、學習困難",
        "後天性：進行性神經功能惡化",
        "癲癇",
        "失明",
        "行為異常"
      ],
      "physicalExam": [
        "先天性：圓頂狀頭顱、開放囟門、雙眼外斜（落日徵）、發育不良",
        "前腦徵象：行為改變、盤旋、失明、癲癇",
        "可能有運動失調",
        "嚴重者昏迷"
      ]
    },
    "pathophysiology": "CSF生成（脈絡叢）、循環或吸收（蛛網膜顆粒）障礙 → CSF積聚 → 腦室擴張 → 腦實質壓迫 → 神經功能障礙。先天性常因腦中導水管狹窄（阻塞性）。後天性可因腫瘤、感染、出血阻塞CSF流動。",
    "diagnosis": {
      "overview": "影像學確認腦室擴張",
      "differentials": [
        "腦萎縮（腦室擴大但因腦實質減少）",
        "腦囊腫",
        "其他先天性腦畸形"
      ],
      "initialDB": [
        "神經學檢查",
        "頭顱觸診（開放囟門）",
        "眼底檢查（視神經乳頭水腫）"
      ],
      "advanced": [
        "腦部MRI（首選）或CT",
        "超音波（經開放囟門）",
        "腦脊液分析（謹慎，顱內壓高時風險）"
      ]
    },
    "treatment": {
      "overview": "藥物減少CSF產生或手術引流",
      "acute": [
        "急性神經惡化/顱內壓升高：",
        "  - Mannitol: 0.5-1 g/kg IV over 15-20min",
        "  - 頭部抬高15-30度",
        "  - 避免頸部壓迫"
      ],
      "chronic": [
        "藥物治療：",
        "  - Omeprazole: 0.5-1 mg/kg PO q12-24h（減少CSF產生）",
        "  - Furosemide: 0.5-1 mg/kg PO q12h（輔助）",
        "  - Prednisone: 0.25-0.5 mg/kg PO q12-24h（減少水腫）",
        "癲癇控制：抗癲癇藥物",
        "手術治療：",
        "  - 腦室-腹膜分流術(Ventriculoperitoneal shunt)",
        "  - 適用於藥物無效或嚴重病例",
        "  - 併發症：感染、阻塞、過度引流"
      ]
    },
    "prognosis": "先天性輕度：可能無症狀或穩定，預後可良好。有症狀者：藥物控制可能有效，嚴重者需手術。手術成功率約80%，但分流相關併發症常見。後天性：依原發病因而異。",
    "pearls": [
      "「腦室擴大」不等於「水腦症」- 需有臨床症狀或進行性",
      "許多短頭犬種有無症狀的腦室擴大",
      "開放囟門本身非診斷標準",
      "Omeprazole減少CSF產生的機制未完全明瞭",
      "分流手術需長期追蹤監測",
      "後天性需尋找和治療原發病因"
    ],
    "diagnosticAlgorithm": {
      "title": "水腦症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估頭部形態及神經症狀",
          "findings": [
            "圓頂狀頭顱",
            "囟門開放",
            "癲癇發作",
            "行為異常"
          ]
        },
        {
          "step": 2,
          "action": "神經學檢查",
          "details": "前腦功能評估",
          "findings": [
            "視力缺失",
            "盤旋行為",
            "意識狀態改變",
            "肢體本體感覺異常"
          ]
        },
        {
          "step": 3,
          "action": "腦部影像",
          "details": "超音波（幼犬囟門開放時）或MRI",
          "findings": [
            "腦室系統擴張",
            "腦實質變薄",
            "MRI確認程度與類型",
            "超音波經囟門檢查"
          ]
        },
        {
          "step": 4,
          "action": "鑑別與治療評估",
          "details": "區分先天與後天性",
          "findings": [
            "排除腫瘤阻塞性水腦",
            "排除感染性腦膜炎",
            "評估VP分流需求",
            "藥物治療反應"
          ]
        }
      ]
    },
    "monitoring": [
      "神經功能",
      "頭圍（幼年）",
      "囟門大小",
      "追蹤MRI",
      "分流功能（若手術）"
    ],
    "reference": "Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; Thomas WB: Hydrocephalus in dogs and cats. Vet Clin North Am Small Anim Pract 40:143-159, 2010"
  },
  "syringomyelia": {
    "zh": "脊髓空洞症",
    "en": "Syringomyelia (SM)",
    "definition": "脊髓內形成液體腔洞（脊髓空洞）的疾病，常繼發於Chiari樣畸形(CM)，導致脊髓損傷和神經性疼痛。",
    "synonyms": [
      "SM",
      "脊髓空洞",
      "Chiari-like Malformation and Syringomyelia (CMSM)",
      "Chiari樣畸形伴脊髓空洞症"
    ],
    "epidemiology": {
      "species": "犬為主，貓罕見",
      "age": "症狀通常1-7歲出現（6月齡至>10歲皆可）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "高度品種相關：Cavalier King Charles Spaniel（>95%有CM，約35-70%有SM）",
        "King Charles Spaniel、Brussels Griffon、Affenpinscher、Chihuahua、Yorkshire Terrier、Maltese等"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "神經性疼痛（最典型）：抓搔頸肩部（尤其牽繩行走時）",
        "幻搔(Phantom scratching)：腳不接觸皮膚的搔抓動作",
        "頸部疼痛",
        "對頭頸觸摸敏感",
        "夜間嗚咽",
        "行走異常"
      ],
      "physicalExam": [
        "頸部疼痛或過敏",
        "脊柱側彎（部分病例）",
        "輕度運動失調",
        "前肢無力",
        "肌肉萎縮（嚴重）",
        "頭傾斜（部分）"
      ]
    },
    "pathophysiology": "Chiari樣畸形：枕骨發育不全 → 後顱窩過小 → 小腦扁桃體疝入枕骨大孔 → 阻礙CSF正常流動 → CSF脈動壓力異常 → CSF進入脊髓中央管 → 形成脊髓空洞 → 壓迫脊髓背角（感覺神經元）→ 神經性疼痛和感覺異常。",
    "diagnosis": {
      "overview": "MRI是診斷金標準",
      "differentials": [
        "頸椎間盤疾病",
        "脊髓腫瘤",
        "脊髓炎",
        "過敏性皮膚病（搔癢行為）",
        "肩關節問題"
      ],
      "initialDB": [
        "神經學檢查",
        "皮膚科評估（排除搔癢其他原因）"
      ],
      "advanced": [
        "頸胸椎MRI（必要）：可見小腦扁桃體疝出、枕骨大孔擁擠、脊髓空洞（T2高信號管狀結構）",
        "全脊髓MRI（空洞範圍評估）"
      ]
    },
    "treatment": {
      "overview": "藥物控制疼痛；手術減壓適用於嚴重或進行性病例",
      "acute": [
        "疼痛控制：",
        "  - Gabapentin: 10-20 mg/kg PO q8h（首選）",
        "  - 或 Pregabalin: 2-4 mg/kg PO q8-12h",
        "  - 可加用NSAIDs：Carprofen 2.2 mg/kg PO q12h",
        "減少CSF壓力：",
        "  - Omeprazole: 0.5-1 mg/kg PO q12-24h",
        "  - 或 Cimetidine: 5-10 mg/kg PO q6-12h",
        "類固醇（短期）：Prednisone 0.5-1 mg/kg PO q24h"
      ],
      "chronic": [
        "長期藥物管理（同上）",
        "手術治療：",
        "  - 枕骨大孔減壓術(Foramen Magnum Decompression)",
        "  - 適應症：藥物無效、症狀嚴重或進行性",
        "  - 成功率約80%症狀改善，但約25-50%可能復發",
        "避免頸部牽引（使用胸背帶）",
        "避免極端頸部位置"
      ]
    },
    "prognosis": "進行性疾病，症狀可能逐漸惡化。藥物可控制多數輕中度病例。手術可改善症狀但不能治癒。早期空洞預後較好。嚴重神經缺損預後較差。生活品質管理是重點。",
    "pearls": [
      "Cavalier King Charles Spaniel是「代表品種」",
      "幻搔是高度特異性徵象",
      "MRI是唯一可靠診斷方法",
      "「有SM」不等於「有症狀」- 許多為亞臨床",
      "胸背帶取代項圈非常重要",
      "遺傳篩檢和負責任繁殖可減少發病率"
    ],
    "diagnosticAlgorithm": {
      "title": "脊髓空洞症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估頸部搔抓及疼痛行為",
          "findings": [
            "幻影搔抓（不碰觸皮膚的搔抓動作）",
            "頸部或肩部疼痛",
            "夜間啼叫",
            "騎士查理士王小獵犬好發"
          ]
        },
        {
          "step": 2,
          "action": "神經學檢查",
          "details": "評估感覺異常分佈",
          "findings": [
            "頸部過敏",
            "觸覺異常",
            "漸進性步態異常",
            "脊髓反射評估"
          ]
        },
        {
          "step": 3,
          "action": "MRI脊髓",
          "details": "確認脊髓空洞與Chiari畸形",
          "findings": [
            "脊髓內空洞（T2高信號）",
            "小腦扁桃體疝出（Chiari樣畸形）",
            "後顱窩擁擠",
            "空洞範圍評估"
          ]
        },
        {
          "step": 4,
          "action": "治療方案評估",
          "details": "藥物或手術治療計畫",
          "findings": [
            "藥物疼痛管理（Gabapentin）",
            "減少CSF生成（Omeprazole）",
            "後顱窩減壓手術評估",
            "長期追蹤MRI"
          ]
        }
      ]
    },
    "monitoring": [
      "疼痛評估量表",
      "神經功能",
      "藥物副作用",
      "生活品質",
      "追蹤MRI（手術後或進行性惡化）"
    ],
    "reference": "Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; Rusbridge C et al: Syringomyelia in Cavalier King Charles Spaniels. J Am Vet Med Assoc 232:1870-1876, 2008"
  },
  "myasthenia-gravis": {
    "zh": "重症肌無力",
    "en": "Myasthenia Gravis (MG)",
    "definition": "神經肌肉接合處乙醯膽鹼受體(AChR)功能障礙導致的骨骼肌無力疾病，分為先天性（受體缺乏）和後天性（自體免疫抗體介導）。",
    "synonyms": [
      "MG",
      "肌無力症",
      "重症肌無力症"
    ],
    "epidemiology": {
      "species": "犬較常見，貓亦可發生",
      "age": "先天性：幼年發病；後天性：雙峰（1-4歲和9-13歲）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "品種傾向（後天性）：Akita、German Shepherd、Golden Retriever、Labrador、Dachshund",
        "先天性：Jack Russell Terrier、Smooth Fox Terrier、Springer Spaniel",
        "胸腺瘤相關"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "運動不耐（運動後惡化，休息後改善）",
        "虛弱",
        "吞嚥困難",
        "反覆吸入性肺炎",
        "巨食道症狀（逆流、嘔吐）",
        "聲音改變"
      ],
      "physicalExam": [
        "局部型：僅影響特定肌群",
        "  - 食道型：巨食道（最常見局部型）",
        "  - 咽喉型：吞嚥困難、發聲異常",
        "  - 眼型：眼瞼下垂（罕見）",
        "全身型：",
        "  - 進行性全身肌肉無力",
        "  - 運動後明顯惡化",
        "  - 脊椎反射正常",
        "  - 可能有巨食道"
      ]
    },
    "pathophysiology": "後天性：自體抗體攻擊神經肌肉接合處的AChR → 受體減少和功能障礙 → 乙醯膽鹼訊號傳導失敗 → 肌肉無力。先天性：AChR或其他接合處蛋白的遺傳缺陷。與胸腺瘤相關病例中，胸腺異常可能觸發自體免疫。",
    "diagnosis": {
      "overview": "臨床表現、血清抗體檢測和藥物試驗",
      "differentials": [
        "多發性肌炎",
        "其他原因的巨食道",
        "代謝性肌病",
        "急性多發性神經根炎",
        "蜱麻痺",
        "肉毒桿菌中毒"
      ],
      "initialDB": [
        "神經學檢查",
        "Tensilon試驗(Edrophonium): 0.1-0.2 mg/kg IV（短暫改善支持診斷）",
        "AChR抗體滴度（確診後天性）",
        "胸腔X光（巨食道、胸腺瘤）"
      ],
      "advanced": [
        "胸腔CT（胸腺瘤評估）",
        "肌電圖(EMG)：遞減反應",
        "肌肉活檢（先天性）"
      ]
    },
    "treatment": {
      "overview": "抗膽鹼酯酶藥物、免疫抑制（後天性）、處理併發症",
      "acute": [
        "Pyridostigmine (Mestinon): 0.5-3 mg/kg PO q8-12h",
        "若無法口服：Neostigmine 0.04 mg/kg IM q6h",
        "吸入性肺炎治療：廣譜抗生素",
        "肌無力危象：",
        "  - 呼吸支持（氧氣、可能需機械通氣）",
        "  - 謹慎使用抗膽鹼酯酶（避免膽鹼能危象）"
      ],
      "chronic": [
        "抗膽鹼酯酶藥物維持",
        "免疫抑制（後天性，尤其抗體高滴度）：",
        "  - Prednisone: 1-2 mg/kg PO q12-24h（緩慢增量以避免惡化）",
        "  - Azathioprine: 2 mg/kg PO q24h",
        "  - Mycophenolate: 10-20 mg/kg PO q12h",
        "胸腺切除術（胸腺瘤相關）",
        "巨食道管理：",
        "  - 高位餵食（Bailey椅）",
        "  - 少量多餐",
        "  - 餵食後維持直立15-30分鐘",
        "  - 飲食調整（稠度）"
      ]
    },
    "prognosis": "後天性：部分可自發緩解（約30-50%在6-18個月內）。治療反應良好者預後較佳。與胸腺瘤相關者需手術，預後較謹慎。吸入性肺炎是主要死亡原因。先天性：預後依嚴重程度和品種而異。",
    "pearls": [
      "巨食道可以是MG的唯一表現",
      "Tensilon試驗陰性不能排除MG",
      "抗體滴度與嚴重度不完全相關",
      "類固醇初期可能暫時惡化症狀",
      "吸入性肺炎預防是護理重點",
      "部分病例可自發緩解"
    ],
    "diagnosticAlgorithm": {
      "title": "重症肌無力 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估運動後加重的肌肉無力",
          "findings": [
            "運動後肌肉無力加重",
            "休息後改善",
            "巨食道症",
            "面部肌肉無力"
          ]
        },
        {
          "step": 2,
          "action": "Edrophonium試驗",
          "details": "短效抗膽鹼酯酶藥物試驗",
          "findings": [
            "注射後肌力暫時改善",
            "試驗陽性支持診斷",
            "需準備Atropine備用",
            "可能假陰性"
          ]
        },
        {
          "step": 3,
          "action": "乙醯膽鹼受體抗體",
          "details": "血清AChR抗體效價測量",
          "findings": [
            "AChR抗體效價升高確診",
            "區分全身型與局部型",
            "抗體陰性不排除診斷（血清陰性型）"
          ]
        },
        {
          "step": 4,
          "action": "併發症與共病篩檢",
          "details": "胸腔影像及甲狀腺檢查",
          "findings": [
            "胸腔X光排除胸腺瘤",
            "吸入性肺炎評估",
            "甲狀腺功能（自體免疫共病）",
            "巨食道症管理"
          ]
        }
      ]
    },
    "monitoring": [
      "肌肉力量評估",
      "體重",
      "胸腔X光（巨食道、肺炎）",
      "AChR抗體滴度追蹤",
      "藥物副作用"
    ],
    "reference": "Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; Shelton GD: Myasthenia gravis and disorders of neuromuscular transmission. Vet Clin North Am Small Anim Pract 32:189-206, 2002"
  },
  "polymyositis": {
    "zh": "多發性肌炎",
    "en": "Polymyositis",
    "definition": "多發性肌炎是免疫介導的骨骼肌炎症性疾病，以進行性肌肉無力、肌萎縮和肌酶升高（CK/AST）為特徵。犬可為特發性或副腫瘤性（胸腺瘤相關），大型犬好發。肌肉活檢可見淋巴球和巨噬細胞浸潤。需與重症肌無力、感染性肌炎和多發性神經肌病鑑別。",
    "synonyms": [
      "免疫介導性肌炎",
      "Immune-mediated Myositis",
      "Inflammatory Myopathy",
      "炎症性肌病"
    ],
    "epidemiology": {
      "species": "犬較常見，貓罕見",
      "age": "任何年齡，成犬最常見",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "品種傾向：German Shepherd、Boxer、Newfoundland、Hungarian Vizsla",
        "可能與感染、腫瘤或其他自體免疫疾病相關"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "進行性肌肉無力",
        "僵硬步態",
        "運動不耐",
        "吞嚥困難（咽部肌肉受累）",
        "發聲改變",
        "肌肉萎縮",
        "肌肉疼痛"
      ],
      "physicalExam": [
        "全身肌肉無力",
        "肌肉萎縮",
        "肌肉觸診疼痛",
        "顳肌和咀嚼肌萎縮（特定類型）",
        "發燒（部分病例）",
        "脊椎反射正常或降低"
      ]
    },
    "pathophysiology": "免疫介導機制（可能T細胞介導）→ 淋巴細胞和巨噬細胞浸潤肌肉 → 肌纖維損傷和壞死 → 肌肉再生嘗試 → 進行性肌肉萎縮和纖維化。某些型式有特定自體抗體（如抗2M型肌纖維抗體）。",
    "diagnosis": {
      "overview": "肌肉酵素升高、EMG異常、肌肉活檢確診",
      "differentials": [
        "重症肌無力",
        "感染性肌炎（弓漿蟲、Neospora）",
        "代謝性肌病",
        "內分泌性肌病（甲狀腺功能低下、庫欣症）",
        "皮肌炎",
        "咀嚼肌肌炎"
      ],
      "initialDB": [
        "肌肉酵素：CK（通常明顯升高）、AST、LDH",
        "CBC、生化全套",
        "甲狀腺功能",
        "傳染病篩檢（弓漿蟲、Neospora抗體）"
      ],
      "advanced": [
        "肌電圖(EMG)：自發活動、纖顫電位",
        "肌肉活檢（確診）：炎症細胞浸潤、肌纖維壞死和再生",
        "2M抗體檢測（特定型式）",
        "ANA（排除SLE）"
      ]
    },
    "treatment": {
      "overview": "免疫抑制治療",
      "acute": [
        "類固醇：",
        "  - Prednisone: 2-4 mg/kg/day PO 分次給予",
        "  - 急性嚴重：Dexamethasone 0.2-0.5 mg/kg IV",
        "支持治療：",
        "  - 輸液",
        "  - 營養支持（吞嚥困難者）",
        "  - 褥瘡預防（臥床者）"
      ],
      "chronic": [
        "類固醇漸減至最低有效劑量",
        "類固醇節約藥物：",
        "  - Azathioprine: 2 mg/kg PO q24h",
        "  - 或 Mycophenolate: 10-20 mg/kg PO q12h",
        "  - 或 Cyclosporine: 5-10 mg/kg PO q12h",
        "物理治療（恢復期）",
        "長期監測復發"
      ]
    },
    "prognosis": "預後變異大。多數對免疫抑制治療反應良好，但可能需要長期治療。復發常見。吞嚥困難和呼吸肌受累預後較差。慢性肌肉萎縮可能不完全恢復。",
    "pearls": [
      "CK明顯升高是重要線索，但不特異",
      "必須排除感染性原因（弓漿蟲、Neospora）",
      "肌肉活檢是確診金標準",
      "咀嚼肌肌炎是特殊的局部型式",
      "治療反應通常需2-4週才明顯",
      "完全停藥後復發率高"
    ],
    "diagnosticAlgorithm": {
      "title": "多發性肌炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估肌肉疼痛、僵硬及步態",
          "findings": [
            "全身肌肉疼痛",
            "僵硬步態",
            "吞嚥困難",
            "肌肉萎縮"
          ]
        },
        {
          "step": 2,
          "action": "血液生化",
          "details": "肌肉酵素評估",
          "findings": [
            "肌酸激酶（CK）顯著升高",
            "AST升高",
            "血清肌紅蛋白升高",
            "CBC排除感染"
          ]
        },
        {
          "step": 3,
          "action": "肌電圖",
          "details": "神經肌肉功能評估",
          "findings": [
            "自發性異常電位",
            "纖顫電位",
            "正尖波",
            "複合反覆放電"
          ]
        },
        {
          "step": 4,
          "action": "肌肉切片確診",
          "details": "肌肉組織病理學",
          "findings": [
            "淋巴球性肌纖維浸潤",
            "肌纖維壞死與再生",
            "排除感染性肌炎",
            "免疫組織化學分型"
          ]
        }
      ]
    },
    "monitoring": [
      "CK（治療反應指標）",
      "肌肉力量和萎縮",
      "體重",
      "類固醇副作用",
      "複查EMG（部分病例）"
    ],
    "reference": "Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; Evans J et al: Canine inflammatory myopathies: A clinicopathological review of 200 cases. J Vet Intern Med 18:679-691, 2004"
  },
  "cognitive-dysfunction-syndrome": {
    "zh": "認知功能障礙症候群",
    "en": "Cognitive Dysfunction Syndrome (CDS)",
    "definition": "老年犬貓的進行性神經退化性疾病，特徵為行為改變、認知能力下降，類似人類阿茲海默症。",
    "synonyms": [
      "CDS",
      "認知障礙",
      "Canine/Feline Dementia",
      "犬貓痴呆",
      "老年痴呆",
      "認知功能退化"
    ],
    "epidemiology": {
      "species": "犬貓皆常見",
      "age": "老年（犬>8歲，貓>11歲；患病率隨年齡增加）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "高齡是主要因素",
        "某些品種可能更易患病",
        "缺乏心智刺激"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "DISHA徵象：",
        "  - D: Disorientation（定向障礙）- 迷路、盯著牆壁",
        "  - I: Interaction changes（互動改變）- 對主人反應減少",
        "  - S: Sleep-wake cycle disturbances（睡眠週期紊亂）- 夜間嚎叫、日夜顛倒",
        "  - H: House soiling（居家排泄異常）- 忘記訓練",
        "  - A: Activity changes（活動改變）- 減少或重複行為",
        "可能有焦慮增加"
      ],
      "physicalExam": [
        "神經學檢查通常正常（除年齡相關變化）",
        "可能有反應遲鈍",
        "可能有聽力或視力下降",
        "需排除其他醫學問題"
      ]
    },
    "pathophysiology": "類似人類阿茲海默症的病理改變：β-澱粉樣蛋白在腦內沉積 → 老年斑形成 → 神經元損傷和死亡 → 腦萎縮 → 認知功能下降。氧化壓力、血管病變和神經傳導物質（如多巴胺）減少也參與病程。",
    "diagnosis": {
      "overview": "排除性診斷；需排除其他導致類似行為改變的疾病",
      "differentials": [
        "腦腫瘤",
        "腦炎",
        "代謝性腦病（肝腦病、尿毒症）",
        "甲狀腺功能異常",
        "高血壓性腦病",
        "疼痛",
        "聽力/視力喪失",
        "其他行為問題"
      ],
      "initialDB": [
        "完整神經學檢查",
        "CBC、生化全套",
        "甲狀腺功能",
        "血壓測量",
        "尿液分析"
      ],
      "advanced": [
        "腦部MRI（排除結構性病變，可能見腦萎縮）",
        "認知功能評估量表"
      ]
    },
    "treatment": {
      "overview": "多模式治療：環境管理、飲食調整、藥物和營養補充",
      "acute": [
        "無急性治療（慢性退化性疾病）",
        "處理任何共病問題"
      ],
      "chronic": [
        "環境富化：",
        "  - 維持規律的日常作息",
        "  - 心智刺激（益智玩具、訓練）",
        "  - 適度運動",
        "  - 維持社交互動",
        "飲食：",
        "  - 抗氧化飲食（Hill's b/d等）",
        "  - Medium-chain triglycerides (MCT)",
        "藥物治療：",
        "  - Selegiline (Anipryl): 0.5-1 mg/kg PO q24h AM（MAO-B抑制劑）",
        "  - 效果通常在4-8週後評估",
        "營養補充：",
        "  - SAMe (S-adenosyl-L-methionine): 18-20 mg/kg PO q24h",
        "  - Omega-3脂肪酸（DHA/EPA）",
        "  - 維生素E和C",
        "  - Apoaequorin (Neutricks)",
        "焦慮管理：",
        "  - Trazodone（夜間嚎叫）",
        "  - 費洛蒙產品"
      ]
    },
    "prognosis": "進行性疾病，無法治癒。治療目標是減緩進展和維持生活品質。部分狗貓對治療有良好反應。平均存活期診斷後1-2年。",
    "pearls": [
      "CDS常被低估 - 主人可能認為「只是老了」",
      "需徹底排除其他醫學原因",
      "早期介入可能更有效",
      "夜間嚎叫是常見且困擾主人的症狀",
      "多模式治療優於單一方法",
      "「用進廢退」- 心智刺激很重要"
    ],
    "diagnosticAlgorithm": {
      "title": "認知功能障礙症候群 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "DISHA評估問卷（迷失、互動、睡眠、如廁、活動）",
          "findings": [
            "夜間不安嚎叫",
            "迷失在熟悉環境",
            "如廁習慣改變",
            "與主人互動減少"
          ]
        },
        {
          "step": 2,
          "action": "全身疾病排除",
          "details": "完整血液檢查排除代謝原因",
          "findings": [
            "甲狀腺功能檢查",
            "肝腎功能評估",
            "血壓測量",
            "血糖檢查"
          ]
        },
        {
          "step": 3,
          "action": "神經學與感官評估",
          "details": "排除其他神經疾病",
          "findings": [
            "基本神經學檢查",
            "視力與聽力評估",
            "排除腦腫瘤（MRI）",
            "排除前庭疾病"
          ]
        },
        {
          "step": 4,
          "action": "臨床評分與治療",
          "details": "認知功能評分及治療計畫",
          "findings": [
            "DISHA量表評分",
            "行為修正建議",
            "營養補充（抗氧化劑、MCT）",
            "藥物治療（Selegiline）"
          ]
        }
      ]
    },
    "monitoring": [
      "行為日誌",
      "認知功能評估量表",
      "生活品質評估",
      "定期複診"
    ],
    "reference": "Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; Landsberg GM et al: Cognitive dysfunction in cats: A syndrome we used to dismiss as old age. J Feline Med Surg 12:837-848, 2010"
  },
  "horners-syndrome": {
    "zh": "霍納氏症候群",
    "en": "Horner's Syndrome",
    "definition": "眼部交感神經支配中斷導致的典型徵象群，包括瞳孔縮小、眼瞼下垂、眼球內陷和第三眼瞼突出。",
    "synonyms": [
      "Horner氏症候群",
      "Oculosympathetic Paresis",
      "眼交感神經麻痺"
    ],
    "epidemiology": {
      "species": "犬貓皆可發生",
      "age": "任何年齡，依病因而異",
      "sex": "無明顯性別傾向，Golden Retriever在特發性病例中較多",
      "riskFactors": [
        "中耳/內耳疾病",
        "頸部創傷或手術",
        "胸腔腫瘤",
        "臂神經叢病變",
        "品種：Golden Retriever、Cocker Spaniel（特發性）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "眼睛「外觀異常」",
        "可能有耳部疾病、頸部創傷或手術史",
        "可能無其他症狀"
      ],
      "physicalExam": [
        "霍納氏症候群四徵：",
        "  - Miosis（瞳孔縮小）- 患側瞳孔較小",
        "  - Ptosis（上眼瞼下垂）",
        "  - Enophthalmos（眼球內陷）",
        "  - Third eyelid protrusion（第三眼瞼突出）",
        "可能伴隨：",
        "  - 同側結膜充血",
        "  - 若為周邊病變，可能有前庭徵象、顏面麻痺"
      ]
    },
    "pathophysiology": "交感神經傳導路徑三級：一級（下視丘→胸椎T1-T3脊髓）→ 二級（脊髓→頸前神經節）→ 三級（神經節→眼部）。任一級中斷都會導致霍納氏症候群。犬貓最常見：三級（中耳、鼓室泡）>特發性>二級（胸腔）>一級（頸椎/腦幹）。",
    "diagnosis": {
      "overview": "臨床徵象確診；藥理試驗定位病變層級；影像學找病因",
      "differentials": [
        "前葡萄膜炎（瞳孔縮小的其他原因）",
        "眼眶疾病"
      ],
      "initialDB": [
        "完整眼科檢查",
        "神經學檢查",
        "耳鏡檢查",
        "藥理定位試驗：",
        "  - Phenylephrine 10%滴眼：三級病變<20分鐘瞳孔散大；二級或一級>40分鐘"
      ],
      "advanced": [
        "胸腔X光（胸腔腫瘤）",
        "頸椎X光/MRI",
        "耳道和鼓室CT/MRI",
        "臂神經叢評估"
      ]
    },
    "treatment": {
      "overview": "治療潛在病因；特發性多數自行恢復",
      "acute": [
        "無緊急處理需求（霍納本身不損害視力）",
        "針對原發病因治療：",
        "  - 中耳炎：抗生素、可能手術",
        "  - 腫瘤：依類型和位置",
        "  - 創傷：支持治療"
      ],
      "chronic": [
        "特發性：觀察，多數8-16週內自行恢復",
        "若有美觀考量：Phenylephrine 10% q12h（暫時性改善）",
        "長期未恢復者可能為永久性"
      ]
    },
    "prognosis": "取決於病因。特發性（最常見）：預後良好，多數自行恢復。中耳炎相關：治療感染後恢復。腫瘤相關：依腫瘤類型和位置。部分病例可能永久存在但不影響視力。",
    "pearls": [
      "霍納氏症候群本身不影響視力",
      "藥理試驗幫助定位但不總是準確",
      "中耳疾病是犬貓最常見病因",
      "Golden Retriever的特發性病例常見",
      "若有其他神經徵象，需更積極尋找病因",
      "特發性通常自行恢復，需耐心等待"
    ],
    "diagnosticAlgorithm": {
      "title": "霍納氏症候群 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估眼部三聯征",
          "findings": [
            "瞳孔縮小（miosis）",
            "眼瞼下垂（ptosis）",
            "眼球內陷（enophthalmos）",
            "第三眼瞼突出"
          ]
        },
        {
          "step": 2,
          "action": "藥理學定位",
          "details": "局部去甲腎上腺素或苯福林試驗",
          "findings": [
            "1% Phenylephrine 20分鐘內散瞳（節後型）",
            "20-40分鐘散瞳（節前型）",
            "超過40分鐘（中樞型）"
          ]
        },
        {
          "step": 3,
          "action": "耳部與頸部檢查",
          "details": "評估中耳與頸部結構",
          "findings": [
            "耳鏡檢查排除中耳炎",
            "頸部觸診腫塊",
            "甲狀腺區域評估"
          ]
        },
        {
          "step": 4,
          "action": "進階影像",
          "details": "CT/MRI定位病灶",
          "findings": [
            "鼓室泡CT評估",
            "頸部與胸腔影像",
            "腦幹MRI（中樞型）",
            "排除腫瘤性病因"
          ]
        }
      ]
    },
    "monitoring": [
      "霍納徵象變化",
      "原發疾病治療反應",
      "神經功能"
    ],
    "reference": "Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; Kern TJ et al: Horner's syndrome in dogs and cats: 100 cases. J Am Vet Med Assoc 195:369-373, 1989"
  },
  "facial-nerve-paralysis": {
    "zh": "顏面神經麻痺",
    "en": "Facial Nerve Paralysis",
    "definition": "第七對顱神經（顏面神經）功能障礙導致的面部表情肌麻痺，表現為眼瞼閉合障礙、耳朵下垂和嘴唇下垂。",
    "synonyms": [
      "顏面神經癱瘓",
      "Facial Palsy",
      "Bell's Palsy（特發性）",
      "CN VII Paralysis"
    ],
    "epidemiology": {
      "species": "犬較常見，貓亦可發生",
      "age": "任何年齡，中老年較多",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "中耳/內耳疾病",
        "甲狀腺功能低下",
        "外傷",
        "腫瘤（顏面神經相關）",
        "品種：Cocker Spaniel、Cavalier King Charles Spaniel、Pembroke Welsh Corgi較常見特發性"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "眼睛無法閉合",
        "嘴唇一側下垂",
        "流涎（從患側流出）",
        "進食困難（食物卡在患側）",
        "可能有耳部疾病史"
      ],
      "physicalExam": [
        "患側徵象：",
        "  - 眼瞼無法閉合（眨眼反射缺失）",
        "  - 上下嘴唇下垂",
        "  - 耳朵位置下垂",
        "  - 鼻孔不對稱",
        "  - 角膜反射傳入正常但傳出缺失",
        "雙側麻痺（罕見）：表情呆滯",
        "可能伴隨：霍納氏症候群、前庭徵象（若中耳疾病）"
      ]
    },
    "pathophysiology": "顏面神經經內耳道、面神經管和鼓室走行 → 控制面部表情肌、淚腺和唾液腺。病變可在顱內段、岩骨段或周邊段。中耳病變常影響面神經（解剖位置接近）。犬貓最常見原因：特發性>中耳炎>甲狀腺功能低下>創傷>腫瘤。",
    "diagnosis": {
      "overview": "臨床診斷明確；尋找潛在病因",
      "differentials": [
        "腦幹病變（顱內）",
        "神經肌肉疾病（若雙側或伴全身症狀）"
      ],
      "initialDB": [
        "完整神經學檢查",
        "眼科檢查（Schirmer淚液試驗、角膜狀況）",
        "耳鏡檢查",
        "甲狀腺功能檢測",
        "血液檢查"
      ],
      "advanced": [
        "耳道和鼓室CT/MRI",
        "腦部MRI（若懷疑顱內病變）",
        "肌電圖",
        "淚液分泌功能評估"
      ]
    },
    "treatment": {
      "overview": "保護角膜、治療潛在病因",
      "acute": [
        "角膜保護（最重要）：",
        "  - 人工淚液：q4-6h（頻繁使用）",
        "  - 潤滑眼膏：夜間",
        "  - 若Schirmer淚液試驗降低：",
        "    Cyclosporine 0.2%眼藥 q12h或",
        "    Tacrolimus 0.03%眼藥 q12h",
        "治療原發病因：",
        "  - 中耳炎：抗生素",
        "  - 甲狀腺功能低下：Levothyroxine補充"
      ],
      "chronic": [
        "持續眼部護理",
        "特發性：觀察，部分可自行恢復",
        "若中耳炎：可能需要手術（全耳道切除術）",
        "物理治療（部分建議）"
      ]
    },
    "prognosis": "特發性：約50%在數週至數月內恢復。中耳炎相關：治療感染後約50%恢復。甲狀腺功能低下相關：補充治療後可能改善。創傷/腫瘤：依嚴重程度。部分永久性麻痺但可管理併發症。",
    "pearls": [
      "角膜保護是最重要的治療目標",
      "眼瞼閉合障礙導致暴露性角膜炎",
      "特發性是排除性診斷",
      "顏面麻痺伴前庭徵象強烈提示中耳疾病",
      "甲狀腺功能低下可導致多發性顱神經病變",
      "恢復後可能有殘餘不對稱"
    ],
    "diagnosticAlgorithm": {
      "title": "顏面神經麻痺 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估面部不對稱及功能缺失",
          "findings": [
            "唇部下垂",
            "食物從患側掉落",
            "無法閉眼",
            "耳朵下垂"
          ]
        },
        {
          "step": 2,
          "action": "神經學檢查",
          "details": "腦神經功能全面評估",
          "findings": [
            "角膜反射減弱（患側）",
            "瞼反射缺失",
            "評估其他腦神經",
            "區分上下運動神經元型"
          ]
        },
        {
          "step": 3,
          "action": "耳部與影像",
          "details": "排除中耳疾病",
          "findings": [
            "耳鏡檢查",
            "鼓室泡X光或CT",
            "排除中耳炎/腫瘤",
            "腦部MRI（中樞型）"
          ]
        },
        {
          "step": 4,
          "action": "病因確認",
          "details": "鑑別特發性與繼發性",
          "findings": [
            "甲狀腺功能檢查",
            "壁蝨傳染病篩檢",
            "排除手術/創傷後",
            "特發性（排除診斷）"
          ]
        }
      ]
    },
    "monitoring": [
      "角膜健康（染色檢查）",
      "Schirmer淚液試驗",
      "神經功能恢復",
      "原發疾病治療反應"
    ],
    "reference": "Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; Garosi LS et al: Results of diagnostic investigations and long-term outcome of 33 dogs with brain infarction. J Vet Intern Med 19:725-731, 2005"
  },
  "trigeminal-neuritis": {
    "zh": "三叉神經炎",
    "en": "Trigeminal Neuritis",
    "definition": "三叉神經（第五對顱神經）的特發性炎症性疾病，主要影響運動支，導致急性雙側下顎麻痺，無法閉合口部。",
    "synonyms": [
      "特發性三叉神經炎",
      "Idiopathic Trigeminal Neuropathy",
      "Mandibular Paralysis",
      "Dropped Jaw",
      "下顎麻痺",
      "張口症"
    ],
    "epidemiology": {
      "species": "犬為主，貓罕見",
      "age": "任何年齡，成犬最常見",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "無特定品種傾向（任何品種可發生）",
        "病因不明"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "急性發作（24-48小時內）",
        "無法閉合嘴巴",
        "進食和飲水困難",
        "流涎",
        "無法撿起玩具/物品"
      ],
      "physicalExam": [
        "典型徵象：",
        "  - 下顎下垂、無法閉合",
        "  - 雙側咀嚼肌張力喪失",
        "  - 舌頭功能正常",
        "  - 吞嚥功能正常（可以吞嚥，但無法抓取食物）",
        "感覺功能：",
        "  - 純運動型：面部感覺正常",
        "  - 混合型（少數）：面部感覺減退",
        "霍納氏症候群可能伴隨（部分病例）"
      ]
    },
    "pathophysiology": "確切病因不明。病理特徵：三叉神經雙側非化膿性炎症和脫髓鞘，主要影響運動支（支配咀嚼肌）。被認為可能是免疫介導或病毒相關。感覺支通常保留，但部分病例可能受累。自限性疾病。",
    "diagnosis": {
      "overview": "臨床診斷為主；需排除其他原因",
      "differentials": [
        "狂犬病（重要排除！）",
        "肉毒桿菌中毒",
        "多發性肌炎（咀嚼肌肌炎）",
        "三叉神經腫瘤",
        "下顎骨折/脫臼",
        "顳顎關節疾病",
        "破傷風"
      ],
      "initialDB": [
        "完整神經學檢查",
        "口腔檢查（排除骨折/脫臼）",
        "咀嚼肌觸診",
        "面部感覺測試",
        "狂犬病風險評估"
      ],
      "advanced": [
        "肌電圖：咀嚼肌去神經支配",
        "MRI：可見三叉神經增粗和強化",
        "肌肉活檢（排除肌炎）",
        "腦脊液分析"
      ]
    },
    "treatment": {
      "overview": "支持治療為主；通常自行恢復",
      "acute": [
        "營養支持（最重要）：",
        "  - 輔助進食：將食物放入口腔後方",
        "  - 高位餵食（抬高碗）",
        "  - 軟食或流質飲食（成球狀放入口腔）",
        "  - 用注射器給水（小心吸入）",
        "  - 嚴重者：食道餵管或胃管",
        "保護口腔：",
        "  - 軟繃帶/吊帶支撐下顎（部分建議，需小心）",
        "  - 保持口腔清潔"
      ],
      "chronic": [
        "持續營養支持直到恢復",
        "物理治療：被動開合下顎（維持關節活動）",
        "類固醇效果不確定：",
        "  - 部分建議Prednisone 1 mg/kg PO q24h",
        "  - 但多數病例自行恢復，類固醇效果不明",
        "等待自然恢復"
      ]
    },
    "prognosis": "預後良好。約90%病例在2-4週內開始恢復，多數在4-8週內完全恢復。少數可能需要更長時間或有殘餘肌肉萎縮。復發罕見。主要風險是恢復前的營養不良和吸入性肺炎。",
    "pearls": [
      "「下顎下垂但吞嚥功能正常」是典型特徵",
      "必須排除狂犬病（尤其在疫區）",
      "營養支持是治療關鍵",
      "通常2-4週開始改善",
      "咀嚼肌萎縮可能在恢復後仍存在",
      "與咀嚼肌肌炎鑑別：肌炎會痛且不能張口"
    ],
    "diagnosticAlgorithm": {
      "title": "三叉神經炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估下頜下垂無法閉合",
          "findings": [
            "下頜下垂（bilateral最常見）",
            "無法拾取食物",
            "流涎",
            "角膜感覺可能保留"
          ]
        },
        {
          "step": 2,
          "action": "神經學檢查",
          "details": "三叉神經功能評估",
          "findings": [
            "下頜張力喪失",
            "咬肌萎縮",
            "角膜反射（感覺支評估）",
            "排除其他腦神經異常"
          ]
        },
        {
          "step": 3,
          "action": "影像排除",
          "details": "MRI排除結構性病變",
          "findings": [
            "三叉神經根增粗強化",
            "排除腦幹病灶",
            "排除腫瘤",
            "排除中耳疾病"
          ]
        },
        {
          "step": 4,
          "action": "臨床管理",
          "details": "支持性照護與預後評估",
          "findings": [
            "輔助餵食技術指導",
            "2-4週觀察自然恢復",
            "排除潛在免疫介導病因",
            "大多數4-6週恢復"
          ]
        }
      ]
    },
    "monitoring": [
      "體重",
      "進食能力",
      "下顎功能恢復",
      "咀嚼肌萎縮程度",
      "吸入性肺炎徵象"
    ],
    "reference": "Cote E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; Mayhew PD et al: Trigeminal neuropathy in dogs: A retrospective study of 29 cases. J Am Anim Hosp Assoc 38:262-270, 2002"
  },
  "gastric-dilatation-volvulus": {
    "zh": "胃擴張扭轉",
    "en": "Gastric Dilatation-Volvulus (GDV)",
    "definition": "胃部急性擴張並沿其腸系膜軸旋轉的危及生命緊急狀況，導致胃流出道阻塞、血管壓迫和組織缺血。",
    "synonyms": [
      "GDV",
      "胃扭轉",
      "Bloat",
      "Gastric Torsion",
      "胃脹氣扭轉"
    ],
    "epidemiology": {
      "species": "犬（貓極罕見）",
      "age": "中老年犬較常見（平均7歲），但任何年齡可發生",
      "sex": "公犬略多",
      "riskFactors": [
        "大型深胸犬種（Great Dane、German Shepherd、Standard Poodle、Weimaraner、Irish Setter、Saint Bernard）",
        "體重>20 kg",
        "胸深/胸寬比高",
        "一級親屬有GDV史",
        "快速進食",
        "每日一餐大量餵食",
        "進食後劇烈運動",
        "膨脹性乾糧",
        "焦慮性情",
        "年齡增長"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "急性發作（通常數小時內）",
        "非生產性乾嘔（典型）",
        "流涎",
        "腹部膨大",
        "煩躁不安",
        "虛弱或倒地",
        "呼吸困難",
        "進食後發生"
      ],
      "physicalExam": [
        "腹部明顯膨脹（左側明顯）",
        "叩診呈鼓音",
        "非生產性乾嘔",
        "流涎",
        "心搏過速",
        "脈搏弱或無法觸及",
        "CRT延長",
        "黏膜蒼白或發紺",
        "低血壓",
        "休克徵象",
        "觸診脾臟可能異位"
      ]
    },
    "pathophysiology": "胃擴張（氣體、液體、食物）→ 胃沿腸系膜軸順時針旋轉（從尾側看）90-360度 → 幽門和賁門阻塞 → 胃進一步擴張 → 壓迫後腔靜脈和門脈 → 靜脈回流減少 → 心輸出量下降 → 休克。同時：脾臟隨胃旋轉可能扭轉 → 脾臟充血壞死；胃壁缺血 → 胃壁壞死（尤其大彎側）；再灌注損傷 → SIRS、心律不整、DIC",
    "diagnosis": {
      "overview": "臨床表現高度提示，腹部X光確認",
      "differentials": [
        "單純胃擴張（無扭轉）",
        "脾臟扭轉",
        "腸阻塞",
        "腹腔腫瘤"
      ],
      "initialDB": [
        "腹部X光（右側臥位最佳）：「雙氣泡」征、「Popeye手臂」征、「C」字型胃、幽門移位至背側",
        "PCV/TS",
        "乳酸（>6 mmol/L預後差）",
        "電解質",
        "血氣",
        "ECG"
      ],
      "advanced": [
        "凝血功能",
        "血液培養（若懷疑敗血症）"
      ]
    },
    "treatment": {
      "overview": "緊急穩定 + 胃減壓 + 外科手術。這是外科急症！",
      "acute": [
        "休克復甦（同時進行）：",
        "  - 兩條大口徑靜脈導管",
        "  - 等張晶體液 60-90 mL/kg/h（第一小時）",
        "  - 膠體液 10-20 mL/kg bolus",
        "胃減壓：",
        "  - 口胃管（首選，若可通過賁門）",
        "  - 經皮穿刺減壓（若口胃管失敗）：右側腹最鼓音處",
        "止痛：Opioids（Fentanyl 2-5 μg/kg IV）",
        "抗心律不整（若有室性心律不整）：",
        "  - Lidocaine: 2 mg/kg IV bolus, then 50-80 μg/kg/min CRI",
        "廣譜抗生素：Ampicillin-Sulbactam 或 Cefazolin + Metronidazole",
        "緊急手術（穩定後立即）：",
        "  - 復位胃和脾臟",
        "  - 評估胃壁和脾臟活性",
        "  - 胃壁壞死：部分胃切除",
        "  - 脾臟扭轉/壞死：脾臟切除",
        "  - 胃固定術（Gastropexy）預防復發"
      ],
      "chronic": [
        "術後護理：",
        "  - 持續ECG監測（心律不整高峰在術後12-72小時）",
        "  - 電解質監測和補充",
        "  - 營養支持（術後12-24小時開始小量餵食）",
        "預防復發：",
        "  - 預防性胃固定術（高風險犬）",
        "  - 少量多餐",
        "  - 避免進食後運動",
        "  - 使用慢食碗"
      ]
    },
    "prognosis": "整體存活率約80-90%（及時手術）。預後不良因素：乳酸>6 mmol/L、胃壁壞死、脾臟切除、術前心律不整、低血壓時間長。無胃固定術復發率高達80%，有胃固定術復發率<5%。",
    "pearls": [
      "「時間就是胃壁」- 延遲手術增加壞死風險",
      "Great Dane終生GDV風險約40%",
      "預防性胃固定術可考慮於高風險犬（如絕育時同時進行）",
      "術後心律不整（室性早搏、室速）常見，峰值在12-72小時",
      "乳酸是良好的預後指標",
      "右側臥X光最能顯示「雙氣泡」征"
    ],
    "diagnosticAlgorithm": {
      "title": "胃擴張扭轉 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "緊急評估腹部膨脹與休克徵象",
          "findings": [
            "急性腹部膨脹",
            "非生產性乾嘔",
            "腹部觸診鼓音",
            "休克徵象（心搏過速、蒼白黏膜）"
          ]
        },
        {
          "step": 2,
          "action": "影像確認",
          "details": "腹部X光右側臥位",
          "findings": [
            "胃擴張含氣",
            "雙泡徵（double bubble sign）",
            "脾臟位移",
            "排除單純胃擴張"
          ]
        },
        {
          "step": 3,
          "action": "穩定與減壓",
          "details": "緊急液體復甦與胃減壓",
          "findings": [
            "大口徑靜脈導管輸液",
            "胃管或穿刺減壓",
            "心電圖監測（心室心律不整）",
            "電解質與乳酸監測"
          ]
        },
        {
          "step": 4,
          "action": "手術治療",
          "details": "剖腹探查與固定術",
          "findings": [
            "胃復位與評估存活性",
            "脾臟評估（可能需切除）",
            "胃固定術預防復發",
            "術後48小時心律監測"
          ]
        }
      ]
    },
    "monitoring": [
      "ECG（持續監測48-72小時）",
      "乳酸",
      "電解質（尤其鉀）",
      "血壓",
      "尿量",
      "傷口/腹部"
    ],
    "reference": "Cote E: Clinical Veterinary Advisor, 3rd Ed. Elsevier, 2015; Brockman DJ et al: Canine gastric dilatation/volvulus syndrome in a veterinary critical care unit. JAVMA 207:460-464, 1995"
  },
  "gastric-ulcer": {
    "zh": "胃潰瘍",
    "en": "Gastric Ulcer",
    "definition": "胃潰瘍是胃黏膜屏障遭破壞導致黏膜下層甚至肌層組織缺損的疾病。犬最常見原因為NSAID使用（抑制PGE2合成）、肥大細胞瘤（組織胺過度分泌）、肝臟疾病和腎衰竭（尿毒素刺激）。嘔血和黑便為特徵性表現。胃穿孔為致命性併發症需緊急手術。",
    "synonyms": [
      "Gastric Ulceration",
      "胃糜爛",
      "Gastroduodenal Ulcer",
      "Peptic Ulcer"
    ],
    "epidemiology": {
      "species": "犬貓皆可發生",
      "age": "任何年齡，中老年較常見",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "NSAIDs使用（最常見原因）",
        "皮質類固醇",
        "肝臟疾病",
        "腎臟疾病",
        "肥大細胞瘤",
        "胃泌素瘤",
        "應激（重症、手術、創傷）",
        "脊髓疾病",
        "休克",
        "Helicobacter感染（角色不明確）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "嘔吐（可能有咖啡渣樣物或鮮血）",
        "黑便（melena）",
        "食慾下降",
        "體重減輕",
        "腹痛",
        "虛弱",
        "NSAID或類固醇用藥史"
      ],
      "physicalExam": [
        "腹部觸診疼痛（上腹部）",
        "黏膜蒼白（若出血）",
        "心搏過速",
        "黑便（直腸檢查）",
        "可能觸及腹部腫塊（若有腫瘤）",
        "脫水"
      ]
    },
    "pathophysiology": "正常胃黏膜保護機制受損（黏液-碳酸氫鹽屏障、前列腺素、黏膜血流）→ 胃酸和胃蛋白酶對黏膜的損傷 → 糜爛（淺表）→ 潰瘍（深達黏膜下層）。NSAIDs抑制COX-1 → 前列腺素減少 → 黏膜保護減弱。肥大細胞瘤釋放組織胺 → 胃酸分泌增加。",
    "diagnosis": {
      "overview": "臨床懷疑結合內視鏡確診",
      "differentials": [
        "胃炎",
        "胃腫瘤",
        "胃異物",
        "胰臟炎",
        "肝膽疾病",
        "腎衰竭",
        "Addison病"
      ],
      "initialDB": [
        "CBC（貧血、血小板）",
        "生化（BUN升高可因消化道出血）",
        "糞便潛血",
        "腹部X光",
        "腹部超聲"
      ],
      "advanced": [
        "上消化道內視鏡（金標準）+活檢",
        "凝血功能",
        "胃泌素濃度（若懷疑胃泌素瘤）",
        "肥大細胞瘤排查"
      ]
    },
    "treatment": {
      "overview": "停用致病藥物、抑制胃酸、保護黏膜、治療原發病因",
      "acute": [
        "停用NSAIDs和皮質類固醇",
        "輸液支持（若脫水或出血）",
        "輸血（若嚴重貧血 PCV<20%）",
        "胃酸抑制：",
        "  - PPI（首選）：Omeprazole 1-2 mg/kg PO q12-24h",
        "  - 或 Pantoprazole 1 mg/kg IV q12-24h（重症）",
        "  - H2阻斷劑：Famotidine 0.5-1 mg/kg PO/IV q12-24h",
        "黏膜保護：",
        "  - Sucralfate: 0.5-1 g PO q8h（空腹，與其他藥物間隔2小時）",
        "  - Misoprostol: 2-5 μg/kg PO q8h（前列腺素類似物）",
        "止吐：Maropitant 1 mg/kg SC/IV q24h",
        "穿孔或無法控制的出血：緊急手術"
      ],
      "chronic": [
        "長期胃酸抑制（4-8週或更長）",
        "治療原發病因（腫瘤、肝腎病等）",
        "避免使用胃毒性藥物",
        "若必須使用NSAIDs：選擇COX-2選擇性，併用胃保護劑",
        "飲食：少量多餐、易消化飲食"
      ]
    },
    "prognosis": "取決於病因。藥物性潰瘍停藥後預後良好。腫瘤相關預後取決於腫瘤類型。穿孔預後謹慎。",
    "pearls": [
      "NSAIDs + 皮質類固醇併用風險顯著增加",
      "BUN升高但Creatinine正常提示消化道出血",
      "肥大細胞瘤應列入鑑別診斷",
      "PPI比H2阻斷劑更有效抑制胃酸",
      "Sucralfate需空腹給予，會影響其他藥物吸收",
      "貓的胃潰瘍較少見但可發生"
    ],
    "diagnosticAlgorithm": {
      "title": "胃潰瘍 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估嘔血、黑便及腹痛",
          "findings": [
            "嘔吐（可能含咖啡渣樣物）",
            "黑便（melena）",
            "上腹部疼痛",
            "用藥史（NSAIDs）"
          ]
        },
        {
          "step": 2,
          "action": "血液學與生化",
          "details": "評估貧血與潛在出血",
          "findings": [
            "再生性貧血",
            "低蛋白血症",
            "BUN升高（消化道出血）",
            "凝血功能評估"
          ]
        },
        {
          "step": 3,
          "action": "影像學",
          "details": "腹部超音波及X光",
          "findings": [
            "胃壁增厚",
            "腹腔積液",
            "排除胃腫瘤",
            "肝臟與腎臟評估"
          ]
        },
        {
          "step": 4,
          "action": "內視鏡確診",
          "details": "胃鏡直視及切片",
          "findings": [
            "直視潰瘍病灶",
            "切片排除腫瘤",
            "Helicobacter篩檢",
            "評估潰瘍深度與活動性"
          ]
        }
      ]
    },
    "monitoring": [
      "PCV/TS",
      "糞便顏色",
      "食慾和嘔吐",
      "腹部疼痛",
      "內視鏡追蹤（嚴重病例）"
    ],
    "reference": "Cote E: Clinical Veterinary Advisor, 3rd Ed. Elsevier, 2015"
  },
  "inflammatory-bowel-disease": {
    "zh": "發炎性腸病",
    "en": "Inflammatory Bowel Disease (IBD)",
    "definition": "一組以胃腸道黏膜慢性炎症細胞浸潤為特徵的疾病，導致持續或反覆的消化道症狀。需要組織病理學確診並排除其他原因。",
    "synonyms": [
      "IBD",
      "慢性腸病",
      "Chronic Enteropathy",
      "淋巴細胞-漿細胞性腸炎",
      "嗜酸性腸炎"
    ],
    "epidemiology": {
      "species": "犬貓皆常見",
      "age": "中老年較常見，但任何年齡可發生",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "品種傾向（犬：German Shepherd、Basenji、Soft-Coated Wheaten Terrier、Shar-Pei、Boxer）",
        "品種傾向（貓：Siamese）",
        "遺傳因素",
        "腸道菌群失調"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "慢性（>3週）間歇性或持續性嘔吐和/或腹瀉",
        "體重減輕",
        "食慾改變（增加或減少）",
        "腸鳴音增加",
        "排氣增加",
        "小腸型腹瀉（量大、次數少）vs 大腸型（量少、次數多、裡急後重）"
      ],
      "physicalExam": [
        "體態評分下降",
        "腹部觸診：腸壁增厚、腸系膜淋巴結腫大",
        "被毛品質差",
        "可能有腹水（低蛋白血症）",
        "口腔潰瘍（貓嚴重病例）"
      ]
    },
    "pathophysiology": "遺傳易感性 + 環境觸發因素（飲食抗原、腸道菌群）→ 腸道免疫反應失調 → 黏膜屏障功能受損 → 抗原持續刺激 → 慢性炎症。炎症細胞類型決定分類：淋巴細胞-漿細胞性（最常見）、嗜酸性、肉芽腫性等。",
    "diagnosis": {
      "overview": "IBD是排除性診斷，需要組織病理學確認",
      "differentials": [
        "食物反應性腸病",
        "抗生素反應性腸病",
        "腸道淋巴瘤",
        "腸道感染（Giardia、寄生蟲、細菌）",
        "胰外分泌功能不全",
        "甲狀腺功能亢進（貓）",
        "腸道異物"
      ],
      "initialDB": [
        "CBC（嗜酸性球？貧血？）",
        "生化（蛋白、肝腎功能）",
        "TLI（排除EPI）",
        "糞便檢查（寄生蟲、Giardia抗原）",
        "cobalamin/folate",
        "腹部超聲",
        "fPLI/cPLI（排除胰臟炎）"
      ],
      "advanced": [
        "上/下消化道內視鏡+活檢（金標準）",
        "或剖腹探查+全層活檢",
        "組織病理學（WSAVA標準化評分）",
        "FISH（細菌黏附）",
        "免疫組化（排除淋巴瘤）"
      ]
    },
    "treatment": {
      "overview": "階梯式治療：飲食試驗 → 抗菌治療 → 免疫抑制",
      "acute": [
        "排除感染（驅蟲、Giardia治療）",
        "飲食試驗（最少2-4週）：",
        "  - 新蛋白質飲食（Novel protein）",
        "  - 或水解蛋白飲食（Hydrolyzed protein）",
        "  - 嚴格限制，無零食",
        "若飲食無反應，考慮抗菌治療：",
        "  - Metronidazole: 10-15 mg/kg PO q12h x 2-4週",
        "  - 或 Tylosin: 10-20 mg/kg PO q12h"
      ],
      "chronic": [
        "免疫抑制治療（飲食和抗菌無效時）：",
        "犬：",
        "  - Prednisone: 1-2 mg/kg PO q12h，逐漸減量",
        "  - Budesonide: 3 mg/m² PO q24h（局部作用，全身副作用較少）",
        "  - 難治性：加用 Azathioprine 2 mg/kg PO q24h（初始）→ q48h",
        "  - 或 Chlorambucil 4-6 mg/m² PO q48h",
        "貓：",
        "  - Prednisolone: 1-2 mg/kg PO q12h，逐漸減量",
        "  - Budesonide: 1 mg/cat PO q24h",
        "  - Chlorambucil: 2 mg/cat PO q48-72h（比Azathioprine安全）",
        "Cobalamin補充（若缺乏）：",
        "  - 犬：250-1500 μg SC q7d x 6週，然後q30d",
        "  - 貓：250 μg SC q7d x 6週",
        "益生菌可能有輔助效果",
        "嚴重低蛋白血症：見PLE治療"
      ]
    },
    "prognosis": "多數可良好控制但需長期管理。預後因素：疾病嚴重度、對治療反應、低白蛋白血症（預後差）、組織學類型。嗜酸性腸炎通常對類固醇反應好。需要鑑別淋巴瘤（預後差）。",
    "pearls": [
      "IBD和腸道淋巴瘤（尤其貓小細胞淋巴瘤）可能難以區分",
      "Cobalamin缺乏會影響治療反應，需要補充",
      "German Shepherd的IBD常較嚴重且難治",
      "Basenji的免疫增生性腸病預後較差",
      "飲食試驗需要嚴格執行才有診斷價值",
      "全層活檢比內視鏡活檢更能評估深層病變"
    ],
    "diagnosticAlgorithm": {
      "title": "發炎性腸病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "詢問慢性嘔吐腹瀉、體重減輕病史",
          "findings": [
            "慢性嘔吐（>3週）",
            "慢性小腸或大腸型腹瀉",
            "漸進性體重減輕",
            "食慾改變"
          ]
        },
        {
          "step": 2,
          "action": "血液生化與排除",
          "details": "基本篩檢排除其他原因",
          "findings": [
            "低白蛋白血症",
            "葉酸/B12測量",
            "排除寄生蟲",
            "排除胰外分泌功能不全"
          ]
        },
        {
          "step": 3,
          "action": "腹部超音波",
          "details": "腸壁厚度與淋巴結評估",
          "findings": [
            "腸壁增厚",
            "腸壁層次結構改變",
            "腸系膜淋巴結腫大",
            "排除腫瘤性病變"
          ]
        },
        {
          "step": 4,
          "action": "內視鏡與組織切片",
          "details": "胃腸道內視鏡及多部位切片",
          "findings": [
            "胃十二指腸鏡+結腸鏡",
            "多點切片（每部位6-8處）",
            "病理分型（淋巴球漿細胞型等）",
            "排除腸道淋巴瘤"
          ]
        }
      ]
    },
    "monitoring": [
      "體重",
      "CCECAI或FCEAI臨床評分",
      "白蛋白",
      "Cobalamin",
      "臨床症狀"
    ],
    "reference": "Cote E: Clinical Veterinary Advisor, 3rd Ed. Elsevier, 2015; Washabau RJ et al: Endoscopic, biopsy, and histopathologic guidelines for the evaluation of gastrointestinal inflammation in companion animals. JVIM 24:10-26, 2010"
  },
  "protein-losing-enteropathy": {
    "zh": "蛋白質流失性腸病",
    "en": "Protein-Losing Enteropathy (PLE)",
    "definition": "蛋白質流失性腸病（PLE）是一組因腸道過度流失蛋白質導致低白蛋白血症的疾病綜合徵。常見病因包括淋巴管擴張症（Yorkshire Terrier好發）、炎症性腸病（IBD）和腸道淋巴瘤。白蛋白<2.0 g/dL時易出現胸腹水和水腫。血栓栓塞是重要併發症。",
    "synonyms": [
      "PLE",
      "腸道蛋白流失症",
      "Intestinal Protein Loss"
    ],
    "epidemiology": {
      "species": "犬較常見，貓少見",
      "age": "中年犬較常見",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "品種傾向（Yorkshire Terrier、Soft-Coated Wheaten Terrier、Rottweiler、Basenji、Norwegian Lundehund）",
        "IBD",
        "腸道淋巴瘤",
        "淋巴管擴張",
        "消化道寄生蟲"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "慢性腹瀉（小腸型）",
        "體重減輕",
        "嘔吐",
        "腹部膨大（腹水）",
        "肢體水腫",
        "呼吸困難（胸水）",
        "食慾可能正常或下降"
      ],
      "physicalExam": [
        "消瘦",
        "腹水",
        "周邊水腫",
        "胸水（呼吸困難）",
        "腸壁增厚",
        "腸系膜淋巴結腫大",
        "被毛品質差"
      ]
    },
    "pathophysiology": "多種機制導致腸道蛋白流失：1）黏膜損傷（IBD、感染）→ 蛋白滲漏；2）淋巴管擴張或阻塞 → 富含蛋白的淋巴液漏入腸腔；3）腫瘤浸潤。低白蛋白血症 → 膠體滲透壓下降 → 水腫、腹水、胸水。同時可能流失免疫球蛋白、抗凝血因子、脂溶性維生素。",
    "diagnosis": {
      "overview": "確認低蛋白血症，排除其他原因，找出腸道病因",
      "differentials": [
        "蛋白流失性腎病",
        "肝功能衰竭",
        "失血",
        "皮膚大面積傷口",
        "長期飢餓"
      ],
      "initialDB": [
        "血清蛋白（白蛋白<2.0 g/dL，球蛋白也常低）",
        "尿蛋白/肌酐比（排除腎流失）",
        "肝功能（排除肝病）",
        "膽固醇（常低）",
        "鈣（常低，低白蛋白校正後）",
        "糞便檢查",
        "cobalamin/folate",
        "腹部超聲（腸壁、淋巴結、淋巴管）"
      ],
      "advanced": [
        "上下消化道內視鏡+活檢",
        "組織病理學",
        "淋巴管造影（少用）"
      ]
    },
    "treatment": {
      "overview": "治療原發腸道疾病 + 支持低白蛋白血症",
      "acute": [
        "嚴重低白蛋白血症（<1.5 g/dL）伴腔體積液：",
        "  - 新鮮冷凍血漿 10-20 mL/kg（補充白蛋白短暫）",
        "  - 人工膠體（Hetastarch）5-10 mL/kg bolus",
        "  - 25% Human albumin（有過敏風險）",
        "腹水/胸水：治療性穿刺（若影響呼吸）",
        "輸液支持（注意膠體滲透壓）"
      ],
      "chronic": [
        "飲食管理：",
        "  - 超低脂飲食（淋巴管擴張：脂肪<15%乾物質基準）",
        "  - 中鏈三酸甘油酯(MCT)補充（不經淋巴吸收）",
        "  - 高品質蛋白質",
        "  - 可能需水解蛋白或新蛋白飲食",
        "免疫抑制（若為IBD）：",
        "  - Prednisone/Prednisolone: 2 mg/kg PO q12h",
        "  - 常需加用第二線藥物：",
        "    Azathioprine（犬）: 2 mg/kg PO q24h",
        "    Chlorambucil（貓或犬）: 4-6 mg/m² PO q48h",
        "    Cyclosporine: 5 mg/kg PO q12-24h",
        "Cobalamin補充",
        "抗血栓（低白蛋白血症增加血栓風險）：",
        "  - Clopidogrel: 1-2 mg/kg PO q24h",
        "  - 或低劑量Aspirin: 0.5-1 mg/kg PO q24h",
        "營養補充：",
        "  - 脂溶性維生素（若嚴重吸收不良）",
        "  - 鈣和維生素D（若低鈣）"
      ]
    },
    "prognosis": "預後謹慎至差，取決於病因。Yorkshire Terrier淋巴管擴張經飲食控制可良好。嚴重IBD或腫瘤預後較差。白蛋白<1.5 g/dL預後不良。血栓栓塞是重要併發症和死因。",
    "pearls": [
      "白蛋白和球蛋白同時低提示腸道流失（肝病多見白蛋白低球蛋白正常或高）",
      "總鈣低但離子鈣可能正常（白蛋白結合鈣減少）",
      "血栓風險高：流失抗凝血因子，應考慮預防性抗血栓",
      "Yorkshire Terrier的淋巴管擴張對超低脂飲食反應可能很好",
      "Norwegian Lundehund有特殊的PLE/淋巴管擴張傾向",
      "治療反應可能需要4-6週才見效"
    ],
    "diagnosticAlgorithm": {
      "title": "蛋白質流失性腸病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估腹水、水腫及慢性腸道症狀",
          "findings": [
            "低白蛋白血症引起腹水",
            "四肢水腫",
            "慢性腹瀉",
            "體重減輕"
          ]
        },
        {
          "step": 2,
          "action": "血液生化",
          "details": "確認蛋白質流失",
          "findings": [
            "白蛋白<2.0 g/dL",
            "球蛋白降低",
            "低膽固醇血症",
            "低鈣血症（離子鈣降低）"
          ]
        },
        {
          "step": 3,
          "action": "腹部影像",
          "details": "超音波評估腸道與腹腔",
          "findings": [
            "腸壁增厚",
            "腸壁條紋（乳糜管擴張）",
            "腹腔積液",
            "腸系膜淋巴結腫大"
          ]
        },
        {
          "step": 4,
          "action": "內視鏡與切片確診",
          "details": "全段腸道內視鏡與深層切片",
          "findings": [
            "淋巴管擴張",
            "發炎性浸潤",
            "排除淋巴瘤",
            "多部位切片比較"
          ]
        }
      ]
    },
    "monitoring": [
      "白蛋白（每1-2週）",
      "體重",
      "腹圍",
      "臨床症狀",
      "血栓警示症狀"
    ],
    "reference": "Cote E: Clinical Veterinary Advisor, 3rd Ed. Elsevier, 2015; Dossin O, Lavoue R: Protein-losing enteropathies in dogs. Vet Clin North Am Small Anim Pract 41:399-418, 2011"
  },
  "hemorrhagic-gastroenteritis": {
    "zh": "出血性胃腸炎",
    "en": "Hemorrhagic Gastroenteritis (HGE)",
    "definition": "急性、嚴重的出血性腹瀉綜合症，特徵為血性腹瀉、嘔吐和快速血液濃縮。現也稱為急性出血性腹瀉綜合症(AHDS)。",
    "synonyms": [
      "HGE",
      "AHDS",
      "Acute Hemorrhagic Diarrhea Syndrome",
      "出血性腸炎"
    ],
    "epidemiology": {
      "species": "犬（貓罕見）",
      "age": "青年至中年（2-4歲最常見）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "小型犬種（Miniature Schnauzer、Yorkshire Terrier、Miniature Poodle、Maltese）",
        "焦慮性情",
        "都市環境",
        "先前HGE病史（可復發）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "突發性血性腹瀉（「覆盆子果醬」樣）",
        "嘔吐",
        "嗜睡",
        "食慾廢絕",
        "數小時內快速惡化",
        "通常無發燒史"
      ],
      "physicalExam": [
        "血性腹瀉",
        "脫水",
        "心搏過速",
        "CRT延長",
        "腹部觸診可能疼痛",
        "體溫通常正常或略低",
        "休克徵象（嚴重病例）"
      ]
    },
    "pathophysiology": "病因不完全明確。可能與Clostridium perfringens腸毒素或其他細菌毒素有關。腸道黏膜急性壞死 → 大量蛋白質、液體和血液流入腸腔 → 血液濃縮（PCV可>60%）→ 低血容量性休克。不是典型的細菌性腸炎。",
    "diagnosis": {
      "overview": "臨床表現結合顯著血液濃縮，排除其他出血性腹瀉原因",
      "differentials": [
        "犬小病毒腸炎",
        "腸套疊",
        "胃腸道異物/穿孔",
        "凝血障礙",
        "Addison病",
        "急性胰臟炎",
        "細菌性腸炎（Salmonella、Campylobacter）",
        "寄生蟲（鉤蟲大量感染）",
        "腸道腫瘤出血"
      ],
      "initialDB": [
        "PCV/TS（PCV顯著升高>55-60%，TS正常或低）",
        "血糖",
        "電解質",
        "糞便檢查（寄生蟲、Parvovirus快篩）",
        "血塗片"
      ],
      "advanced": [
        "凝血功能",
        "腹部X光/超聲",
        "糞便培養（若懷疑細菌感染）",
        "Cortisol基礎值或ACTH刺激試驗（排除Addison）"
      ]
    },
    "treatment": {
      "overview": "積極輸液復甦是治療關鍵",
      "acute": [
        "靜脈輸液（最重要）：",
        "  - 等張晶體液：休克劑量 60-90 mL/kg/h（第一小時）",
        "  - 之後根據脫水程度和持續流失調整",
        "  - 補鉀（低鉀常見）",
        "膠體液（嚴重病例）：",
        "  - Hetastarch 5-10 mL/kg bolus",
        "止吐：",
        "  - Maropitant 1 mg/kg SC/IV q24h",
        "  - Ondansetron 0.1-0.2 mg/kg IV q8-12h",
        "抗生素（爭議，但嚴重病例常用）：",
        "  - Ampicillin 22 mg/kg IV q8h",
        "  - 或 Metronidazole 10-15 mg/kg IV q12h",
        "胃腸保護：",
        "  - Omeprazole 1 mg/kg PO/IV q12-24h",
        "禁食12-24小時後逐漸恢復餵食"
      ],
      "chronic": [
        "恢復期餵食：高消化性低脂飲食",
        "益生菌可能有益",
        "監測復發（可能再發）"
      ]
    },
    "prognosis": "及時治療預後良好，多數犬24-72小時內顯著改善。死亡率<10%（及時治療）。可能復發。",
    "pearls": [
      "PCV升高但TS正常或低是HGE特徵（與脫水不同）",
      "與Parvovirus鑑別：HGE通常無發燒、白血球正常、Parvo快篩陰性",
      "抗生素使用有爭議，但嚴重病例仍常使用預防繼發感染",
      "輸液反應通常很快，12-24小時內改善",
      "不要低估輸液需求，可能需要大量",
      "恢復後可正常餵食，無需長期飲食限制"
    ],
    "diagnosticAlgorithm": {
      "title": "出血性胃腸炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估急性血便與脫水程度",
          "findings": [
            "急性嚴重血便（果醬樣）",
            "嘔吐",
            "快速脫水",
            "腹部疼痛"
          ]
        },
        {
          "step": 2,
          "action": "血液學",
          "details": "CBC及PCV/TP",
          "findings": [
            "PCV顯著升高（>60%）",
            "總蛋白正常或低",
            "血液濃縮",
            "白血球變化"
          ]
        },
        {
          "step": 3,
          "action": "排除性診斷",
          "details": "排除其他急性出血性腸炎原因",
          "findings": [
            "CPV抗原檢測陰性",
            "腹部X光排除異物",
            "凝血功能正常",
            "排除Addison病"
          ]
        },
        {
          "step": 4,
          "action": "監測與治療反應",
          "details": "液體復甦及臨床監測",
          "findings": [
            "積極靜脈輸液後PCV下降",
            "電解質校正",
            "24-72小時臨床改善",
            "糞便培養（疑似Clostridium）"
          ]
        }
      ]
    },
    "monitoring": [
      "PCV/TS（每4-6小時直到穩定）",
      "電解質",
      "血糖",
      "尿量",
      "糞便性狀"
    ],
    "reference": "Cote E: Clinical Veterinary Advisor, 3rd Ed. Elsevier, 2015"
  },
  "colitis": {
    "zh": "結腸炎",
    "en": "Colitis",
    "definition": "結腸黏膜的炎症，導致大腸型腹瀉（頻繁、量少、可能帶黏液或鮮血、裡急後重）。可為急性或慢性。",
    "synonyms": [
      "Large Bowel Diarrhea",
      "大腸炎",
      "大腸型腹瀉"
    ],
    "epidemiology": {
      "species": "犬貓皆可發生",
      "age": "任何年齡",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "飲食不當",
        "寄生蟲",
        "細菌感染",
        "應激",
        "品種傾向（犬：German Shepherd、Boxer - 組織細胞性潰瘍性結腸炎）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "大腸型腹瀉特徵：",
        "  - 排便頻繁（>3-4次/日）",
        "  - 每次量少",
        "  - 裡急後重（tenesmus）",
        "  - 排便急迫感",
        "  - 黏液便",
        "  - 鮮血（hematochezia）",
        "體重通常維持（除非嚴重或慢性）",
        "嘔吐較少見"
      ],
      "physicalExam": [
        "腹部觸診通常無異常",
        "直腸檢查可能疼痛",
        "可能觸及增厚的結腸",
        "肛門區可能有糞便沾染"
      ]
    },
    "pathophysiology": "急性：感染、飲食、應激導致結腸黏膜炎症 → 分泌增加、吸收減少 → 腹瀉。慢性：可能與IBD、食物不耐受、菌群失調有關。組織細胞性潰瘍性結腸炎（Boxer、French Bulldog）：與黏膜相關大腸桿菌感染有關。",
    "diagnosis": {
      "overview": "區分急性vs慢性，排除感染和其他原因",
      "differentials": [
        "感染性（Giardia、Tritrichomonas、Campylobacter、Salmonella、Clostridium、寄生蟲）",
        "飲食反應性",
        "IBD（結腸型）",
        "應激性結腸炎",
        "結腸腫瘤",
        "直腸息肉"
      ],
      "initialDB": [
        "糞便檢查（寄生蟲、Giardia抗原）",
        "糞便培養（Salmonella、Campylobacter）",
        "糞便Clostridium毒素",
        "直腸檢查",
        "糞便細胞學（炎症細胞、原蟲）"
      ],
      "advanced": [
        "結腸鏡+活檢",
        "腹部超聲",
        "FISH（E. coli，組織細胞性結腸炎）"
      ]
    },
    "treatment": {
      "overview": "急性多可自限或飲食調整；慢性需針對病因",
      "acute": [
        "急性結腸炎：",
        "  - 飲食：高纖維或低殘渣飲食試驗",
        "  - 驅蟲（經驗性）：Fenbendazole 50 mg/kg PO q24h x 5天",
        "  - Metronidazole: 10-15 mg/kg PO q12h x 5-7天",
        "  - Probiotics",
        "感染性（確診後）：",
        "  - Giardia：Fenbendazole或Metronidazole",
        "  - Tritrichomonas（貓）：Ronidazole 30 mg/kg PO q24h x 14天",
        "  - Clostridium：Metronidazole或Tylosin"
      ],
      "chronic": [
        "飲食試驗（4-6週）：",
        "  - 高纖維飲食（添加車前子）",
        "  - 或新蛋白/水解蛋白飲食",
        "慢性特發性結腸炎：",
        "  - Sulfasalazine（犬）: 10-30 mg/kg PO q8-12h",
        "  - 或 Mesalamine（5-ASA）",
        "  - 難治性：Prednisone 1-2 mg/kg PO q12h",
        "組織細胞性潰瘍性結腸炎：",
        "  - Enrofloxacin 5-10 mg/kg PO q24h x 6-8週",
        "  - 預後可良好"
      ]
    },
    "prognosis": "急性結腸炎預後良好。慢性結腸炎需要長期管理。組織細胞性潰瘍性結腸炎抗生素治療後預後良好。結腸腫瘤預後取決於類型和分期。",
    "pearls": [
      "大腸型vs小腸型腹瀉區分很重要（見臨床表現）",
      "鮮血便提示結腸或直腸問題",
      "Tritrichomonas是貓慢性大腸型腹瀉的常見原因",
      "高纖維飲食對許多慢性結腸炎有效",
      "Boxer的組織細胞性結腸炎需長期Enrofloxacin治療",
      "直腸檢查是評估結腸疾病的重要步驟"
    ],
    "diagnosticAlgorithm": {
      "title": "結腸炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估大腸型腹瀉症狀",
          "findings": [
            "頻繁少量排便",
            "黏液血便",
            "裏急後重",
            "排便急迫"
          ]
        },
        {
          "step": 2,
          "action": "糞便檢查",
          "details": "完整糞便分析",
          "findings": [
            "糞便浮游法排除寄生蟲",
            "糞便培養（Salmonella, Campylobacter）",
            "Giardia抗原",
            "Clostridium毒素"
          ]
        },
        {
          "step": 3,
          "action": "血液與腹部影像",
          "details": "基本篩檢",
          "findings": [
            "CBC排除感染",
            "生化排除代謝原因",
            "腹部超音波結腸壁增厚",
            "排除腹腔腫塊"
          ]
        },
        {
          "step": 4,
          "action": "結腸鏡與切片",
          "details": "內視鏡確認病因與分型",
          "findings": [
            "結腸黏膜充血水腫",
            "多點切片",
            "病理分型（淋巴球漿細胞型、嗜酸球型）",
            "排除腫瘤"
          ]
        }
      ]
    },
    "monitoring": [
      "糞便性狀和頻率",
      "體重",
      "直腸檢查追蹤"
    ],
    "reference": "Cote E: Clinical Veterinary Advisor, 3rd Ed. Elsevier, 2015"
  },
  "constipation-megacolon": {
    "zh": "便秘/巨結腸",
    "en": "Constipation/Megacolon",
    "definition": "便秘為排便困難或減少；巨結腸為結腸持續性擴張伴運動功能障礙，導致頑固性便秘。貓最常見。",
    "synonyms": [
      "Obstipation",
      "頑固性便秘",
      "Feline Megacolon",
      "貓巨結腸"
    ],
    "epidemiology": {
      "species": "貓最常見，犬少見",
      "age": "中老年貓（平均5-8歲）",
      "sex": "公貓略多（約70%）",
      "riskFactors": [
        "肥胖",
        "脫水",
        "低纖維飲食",
        "缺乏運動",
        "疼痛性排便（骨盆骨折、肛門腺疾病）",
        "神經疾病",
        "骨盆狹窄（骨折後）",
        "特發性（最常見）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "排便減少或無排便",
        "排便困難（tenesmus）",
        "排便時哭叫",
        "糞便乾硬",
        "可能有嘔吐",
        "食慾下降",
        "嗜睡",
        "可能有少量液狀糞便（繞過糞石）"
      ],
      "physicalExam": [
        "腹部觸診：堅硬擴張的結腸（充滿糞便）",
        "脫水",
        "體態評估",
        "直腸檢查：糞便嵌塞、骨盆狹窄評估",
        "神經學檢查（排除神經原因）",
        "肛門區檢查"
      ]
    },
    "pathophysiology": "特發性巨結腸：結腸平滑肌功能障礙 → 運動力下降 → 糞便滯留 → 水分過度吸收 → 糞便乾硬 → 進一步擴張 → 惡性循環。繼發性：骨盆狹窄、神經病變、代謝問題（低鉀、高鈣、甲狀腺功能低下）可導致。長期擴張 → 不可逆結腸肌肉損傷。",
    "diagnosis": {
      "overview": "臨床表現結合影像學確認，排除可治療原因",
      "differentials": [
        "特發性巨結腸",
        "骨盆骨折/狹窄",
        "神經病變",
        "代謝性（低鉀、高鈣、甲狀腺功能低下）",
        "藥物性（Opioids、抗膽鹼藥）",
        "腫瘤",
        "直腸狹窄/異物"
      ],
      "initialDB": [
        "腹部X光（結腸擴張程度、糞便量、骨盆結構）",
        "生化（鉀、鈣、腎功能）",
        "T4（貓）",
        "直腸檢查",
        "神經學檢查"
      ],
      "advanced": [
        "骨盆X光（骨盆狹窄評估）",
        "腹部超聲",
        "結腸鏡（排除腫瘤/狹窄）"
      ]
    },
    "treatment": {
      "overview": "解除糞便嵌塞 + 長期管理預防復發 + 嚴重病例手術",
      "acute": [
        "糾正脫水和電解質失衡",
        "糞便嵌塞清除（可能需鎮靜/麻醉）：",
        "  - 溫鹽水灌腸（5-10 mL/kg）",
        "  - 手動碎解糞石（溫和）",
        "  - 避免使用磷酸鹽灌腸（對貓有毒）",
        "灌腸溶液選擇：",
        "  - 溫水或溫鹽水",
        "  - Docusate sodium（軟便劑）",
        "  - Lactulose溶液",
        "多次短療程比一次長時間更安全"
      ],
      "chronic": [
        "飲食管理：",
        "  - 高纖維飲食（輕度病例）",
        "  - 或低殘渣飲食（減少糞便量）",
        "  - 增加水分攝入（濕食、飲水噴泉）",
        "緩瀉劑：",
        "  - Lactulose: 0.5 mL/kg PO q8-12h（調整至軟便）",
        "  - Polyethylene glycol(MiraLax): 1/8-1/4 tsp/cat PO q12-24h",
        "促動力藥：",
        "  - Cisapride: 2.5-5 mg/cat PO q8-12h",
        "  - Ranitidine: 1-2 mg/kg PO q12h（輕微促動力）",
        "軟便劑：",
        "  - Docusate sodium: 50 mg/cat PO q12-24h",
        "環境：充足乾淨的貓砂盆、減少應激",
        "手術（內科無效）：",
        "  - 結腸次全切除術（Subtotal colectomy）",
        "  - 術後最初可能腹瀉，多數長期預後良好"
      ]
    },
    "prognosis": "輕度便秘：內科管理預後良好。巨結腸：內科可控制一段時間但多數最終需要手術。結腸次全切除術預後良好（>90%改善）。",
    "pearls": [
      "貓巨結腸多為特發性（約60%）",
      "磷酸鹽灌腸（Fleet enema）對貓有致命危險（高磷、低鈣）",
      "不要過度灌腸，可能造成結腸損傷",
      "Cisapride是最有效的結腸促動力藥，但可能需要複方藥局配製",
      "結腸切除術後的腹瀉通常在數週至數月內改善",
      "骨盆狹窄嚴重時可能需要骨盆骨切開術"
    ],
    "diagnosticAlgorithm": {
      "title": "便秘/巨結腸 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估排便頻率與困難程度",
          "findings": [
            "排便減少或無排便",
            "排便疼痛用力",
            "觸診結腸內硬結糞便",
            "腹部膨脹"
          ]
        },
        {
          "step": 2,
          "action": "腹部影像",
          "details": "X光評估糞便蓄積程度",
          "findings": [
            "結腸大量糞便蓄積",
            "結腸擴張程度",
            "排除骨盆骨折狹窄",
            "排除腫瘤阻塞"
          ]
        },
        {
          "step": 3,
          "action": "血液生化",
          "details": "評估脫水與代謝原因",
          "findings": [
            "脫水程度",
            "低血鉀",
            "甲狀腺功能（貓）",
            "高血鈣"
          ]
        },
        {
          "step": 4,
          "action": "治療評估",
          "details": "灌腸與長期管理",
          "findings": [
            "灌腸清除糞便",
            "飲食調整（纖維補充）",
            "促腸蠕動藥物",
            "嚴重巨結腸可能需結腸切除術"
          ]
        }
      ]
    },
    "monitoring": [
      "排便頻率和性狀",
      "腹部觸診",
      "體重",
      "X光追蹤（若需要）"
    ],
    "reference": "Cote E: Clinical Veterinary Advisor, 3rd Ed. Elsevier, 2015; Washabau RJ: Feline constipation and idiopathic megacolon. In: Bonagura JD, Twedt DC: Kirk's Current Veterinary Therapy XV. Elsevier, 2014"
  },
  "esophageal-foreign-body": {
    "zh": "食道異物",
    "en": "Esophageal Foreign Body",
    "definition": "食道異物是指骨頭、玩具、肉乾或其他物體卡在食道中無法通過的急症。最常見卡住位置為胸腔入口、心基底部和橫膈裂孔。小型犬和梗犬好發。異物壓迫超過24-48小時可導致食道壞死和穿孔，後續縱膈炎和膿胸為致命性併發症。內視鏡取出為首選治療。",
    "synonyms": [
      "食道卡異物",
      "Esophageal Obstruction",
      "食道阻塞"
    ],
    "epidemiology": {
      "species": "犬最常見，貓較少",
      "age": "年輕犬最常見（好奇亂吃）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "小型犬（相對食道直徑較小）",
        "年輕好動犬隻",
        "搶食行為",
        "常見異物：骨頭（最常見）、魚鉤、針、玩具、食物塊"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "進食後急性不適",
        "流涎",
        "吞嚥困難",
        "乾嘔",
        "反流（非嘔吐）",
        "頸部不適",
        "拒食",
        "煩躁不安",
        "咳嗽（若壓迫氣管）"
      ],
      "physicalExam": [
        "流涎",
        "吞嚥痛",
        "頸部觸診可能有疼痛",
        "可能觸及頸部異物（頸段食道）",
        "脫水",
        "發燒（若有穿孔或感染）",
        "皮下氣腫（若有穿孔）"
      ]
    },
    "pathophysiology": "異物滯留常見部位：胸腔入口、心基部、食道裂孔（生理性狹窄處）。異物壓迫食道黏膜 → 缺血 → 壞死 → 可能穿孔 → 縱隔炎、胸膜炎、膿胸（嚴重併發症）。尖銳異物直接穿刺食道壁。時間越長損傷越嚴重。",
    "diagnosis": {
      "overview": "病史高度提示，影像學確認位置和併發症",
      "differentials": [
        "食道狹窄",
        "食道腫瘤",
        "食道裂孔疝",
        "血管環異常",
        "食道運動障礙",
        "口咽異物"
      ],
      "initialDB": [
        "頸胸部X光（正側位）：顯影異物、食道擴張、氣體積聚",
        "注意縱隔、胸腔積液/氣腫",
        "避免使用鋇劑（若懷疑穿孔）"
      ],
      "advanced": [
        "內視鏡（診斷+治療金標準）",
        "CT（評估穿孔和併發症）",
        "碘對比劑造影（若懷疑穿孔）"
      ]
    },
    "treatment": {
      "overview": "這是急症！盡快取出異物，評估和處理併發症",
      "acute": [
        "穩定：輸液、止痛、禁食",
        "異物取出（首選內視鏡）：",
        "  - 全身麻醉",
        "  - 內視鏡引導下取出",
        "  - 若無法經口取出，可嘗試推入胃內（鈍性異物）",
        "  - 骨頭可能需碎解後取出",
        "內視鏡失敗或穿孔時：手術取出",
        "  - 頸段：頸側切開",
        "  - 胸段：開胸術",
        "取出後內視鏡評估食道損傷程度"
      ],
      "chronic": [
        "術後管理：",
        "  - 輕度損傷：禁食24小時後開始流質餵食",
        "  - 中重度損傷：",
        "    - 胃管餵食7-14天",
        "    - 或經皮胃造廔管(PEG tube)",
        "  - 廣譜抗生素（若懷疑穿孔或嚴重損傷）",
        "  - 胃酸抑制劑（減少反流）",
        "  - Sucralfate懸液",
        "食道狹窄預防/治療：",
        "  - Prednisone: 0.5-1 mg/kg PO q12h x 2-3週",
        "  - 球囊擴張（若形成狹窄）"
      ]
    },
    "prognosis": "早期取出（<24小時）且無穿孔預後良好。滯留時間長、穿孔、嚴重壞死預後謹慎至差。食道狹窄是常見併發症（約30-50%嚴重損傷病例）。",
    "pearls": [
      "時間是關鍵 - 越早取出，併發症越少",
      "骨頭是最常見的食道異物",
      "不要嘗試讓動物自行嘔出，可能加重損傷",
      "皮下氣腫提示穿孔",
      "內視鏡是首選取出方法",
      "食道狹窄可能在取出後1-3週形成"
    ],
    "diagnosticAlgorithm": {
      "title": "食道異物 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "急性吞嚥困難與流涎",
          "findings": [
            "急性劇烈流涎",
            "吞嚥困難",
            "反流",
            "頸部或胸部疼痛"
          ]
        },
        {
          "step": 2,
          "action": "影像確認",
          "details": "頸胸部X光",
          "findings": [
            "不透光異物直接可見",
            "食道擴張含氣",
            "排除食道穿孔（氣縱膈、胸腔積液）",
            "骨頭卡在心基部食道"
          ]
        },
        {
          "step": 3,
          "action": "內視鏡取出",
          "details": "食道內視鏡評估與取出",
          "findings": [
            "直視異物",
            "評估食道黏膜損傷",
            "內視鏡抓取或推入胃",
            "嚴重損傷時需手術"
          ]
        },
        {
          "step": 4,
          "action": "術後評估",
          "details": "食道損傷程度與併發症監測",
          "findings": [
            "食道穿孔風險評估",
            "術後禁食期管理",
            "食道狹窄風險監測",
            "抗生素與黏膜保護劑"
          ]
        }
      ]
    },
    "monitoring": [
      "食慾和吞嚥功能",
      "發燒",
      "胸腔X光（若有穿孔風險）",
      "反流症狀",
      "食道狹窄徵象"
    ],
    "reference": "Cote E: Clinical Veterinary Advisor, 3rd Ed. Elsevier, 2015"
  },
  "exocrine-pancreatic-insufficiency": {
    "zh": "胰外分泌功能不全",
    "en": "Exocrine Pancreatic Insufficiency (EPI)",
    "definition": "胰外分泌功能不全（EPI）是因胰臟腺泡萎縮導致消化酶（脂肪酶、澱粉酶、蛋白酶）分泌嚴重不足的疾病。犬以免疫介導性胰腺腺泡萎縮為主要病因（German Shepherd好發），貓多繼發於慢性胰臟炎。特徵性表現為多食伴體重下降和大量脂肪便。cTLI<2.5 μg/L確診。",
    "synonyms": [
      "EPI",
      "胰臟功能不全",
      "Pancreatic Insufficiency",
      "消化酶缺乏"
    ],
    "epidemiology": {
      "species": "犬較常見，貓少見",
      "age": "犬：年輕至中年（German Shepherd 1-5歲）；貓：中老年",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "犬：品種傾向（German Shepherd、Rough Collie - 胰腺萎縮）",
        "貓：慢性胰臟炎後",
        "胰臟切除術後"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "慢性小腸型腹瀉（量大、油脂性）",
        "體重減輕（儘管食慾旺盛或增加）",
        "多食（polyphagia）",
        "脂肪便（steatorrhea）- 灰白色油膩便",
        "可能有食糞症",
        "被毛品質差",
        "腸鳴音增加"
      ],
      "physicalExam": [
        "消瘦/體態評分低",
        "被毛乾燥粗糙",
        "可能有皮屑",
        "腹部觸診通常無異常",
        "肛門區可能有油脂性糞便沾染"
      ]
    },
    "pathophysiology": "犬：胰腺腺泡萎縮（PAA，遺傳性，最常見於German Shepherd）或慢性胰臟炎 → 外分泌組織喪失>90% → 消化酶（脂肪酶、蛋白酶、澱粉酶）缺乏 → 脂肪、蛋白質、碳水化合物消化不良 → 吸收不良 → 腹瀉、消瘦。繼發：腸道菌群過度生長、Cobalamin缺乏常見。",
    "diagnosis": {
      "overview": "TLI是診斷金標準",
      "differentials": [
        "IBD",
        "腸道淋巴瘤",
        "寄生蟲",
        "SIBO",
        "其他吸收不良疾病"
      ],
      "initialDB": [
        "血清TLI（Trypsin-Like Immunoreactivity）：",
        "  - 犬：<2.5 μg/L（正常5.7-45.2）= EPI",
        "  - 貓：<8 μg/L（正常12-82）= EPI",
        "  - 需空腹12小時採血",
        "Cobalamin（常低）",
        "Folate（可能高，提示SIBO）"
      ],
      "advanced": [
        "糞便彈性蛋白酶（Fecal elastase）",
        "糞便脂肪定量（較少用）",
        "腹部超聲（胰臟萎縮）"
      ]
    },
    "treatment": {
      "overview": "終身消化酶補充 + Cobalamin補充 + 飲食管理",
      "acute": [
        "消化酶補充（終身）：",
        "  - 粉狀胰酶製劑（Pancreatin/Pancrelipase）",
        "  - 劑量：初始 1-2 茶匙/餐（犬），1/2-1 茶匙/餐（貓）",
        "  - 與食物混合餵食",
        "  - 根據反應調整劑量",
        "生豬/牛胰臟（替代品，若成本考量）：",
        "  - 30-90 g/餐（需冷凍保存）"
      ],
      "chronic": [
        "Cobalamin補充（若缺乏，常見）：",
        "  - 犬：250-1500 μg SC q7d x 6週，然後q30d",
        "  - 貓：250 μg SC q7d x 6週",
        "  - 或口服Cobalamin（較高劑量）",
        "飲食：",
        "  - 高消化性、低纖維",
        "  - 適度脂肪（低脂飲食不一定更好）",
        "  - 少量多餐",
        "抗生素（若有SIBO）：",
        "  - Tylosin 10-20 mg/kg PO q12h",
        "  - 或Metronidazole 10-15 mg/kg PO q12h",
        "維生素補充（若嚴重吸收不良）：",
        "  - 脂溶性維生素（A、D、E、K）"
      ]
    },
    "prognosis": "經適當治療預後良好，多數犬貓可維持良好生活品質。需要終身酶補充。部分病例可能難以完全控制體重。",
    "pearls": [
      "German Shepherd的PAA有遺傳性，不建議繁殖",
      "TLI是種屬特異性的，犬貓需要分別檢測",
      "Cobalamin缺乏會影響治療反應，必須補充",
      "初始治療可能需要2-4週才見明顯改善",
      "酶預先與食物混合不會增加效果",
      "貓EPI通常繼發於慢性胰臟炎，可能同時有糖尿病"
    ],
    "diagnosticAlgorithm": {
      "title": "胰外分泌功能不全 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估體重減輕與大量脂肪便",
          "findings": [
            "體重進行性減輕",
            "食慾正常或增加",
            "大量泡沫狀脂肪便",
            "被毛粗糙"
          ]
        },
        {
          "step": 2,
          "action": "胰臟功能檢測",
          "details": "血清TLI（胰臟免疫反應性脂肪酶）",
          "findings": [
            "犬TLI<2.5 μg/L確診",
            "貓TLI<8 μg/L確診",
            "空腹12小時後採血"
          ]
        },
        {
          "step": 3,
          "action": "營養評估",
          "details": "評估吸收不良的影響",
          "findings": [
            "血清葉酸降低",
            "血清B12降低",
            "低膽固醇",
            "脂溶性維生素缺乏"
          ]
        },
        {
          "step": 4,
          "action": "治療反應確認",
          "details": "胰臟酵素補充試驗",
          "findings": [
            "補充胰臟酵素後症狀改善",
            "B12補充注射",
            "體重恢復",
            "糞便性狀改善"
          ]
        }
      ]
    },
    "monitoring": [
      "體重",
      "糞便性狀",
      "Cobalamin（治療初期每月）",
      "食慾和精神狀態"
    ],
    "reference": "Cote E: Clinical Veterinary Advisor, 3rd Ed. Elsevier, 2015; Westermarck E, Wiberg M: Exocrine pancreatic insufficiency in dogs. Vet Clin North Am Small Anim Pract 33:1165-1179, 2003"
  },
  "hepatic-lipidosis": {
    "zh": "肝臟脂肪沉積症",
    "en": "Hepatic Lipidosis",
    "definition": "肝臟脂肪過度堆積導致肝功能障礙的疾病，最常見於厭食後的過重貓。是貓最常見的肝臟疾病。",
    "synonyms": [
      "Feline Hepatic Lipidosis",
      "貓脂肪肝",
      "Fatty Liver Disease",
      "FHL"
    ],
    "epidemiology": {
      "species": "貓（犬罕見且通常繼發於其他疾病）",
      "age": "中年貓（平均7歲）",
      "sex": "無明顯性別傾向，但過重貓多見",
      "riskFactors": [
        "過重/肥胖（最重要）",
        "厭食超過2-7天",
        "應激事件（搬家、新寵物、環境變化）",
        "潛在疾病（糖尿病、胰臟炎、IBD、膽管炎、腫瘤）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "食慾下降或完全厭食（2天至數週）",
        "體重減輕",
        "嘔吐",
        "嗜睡",
        "近期應激或環境變化",
        "可能有潛在疾病症狀"
      ],
      "physicalExam": [
        "黃疸（常見，80-90%）",
        "肝臟腫大",
        "消瘦（但可能仍過重）",
        "脫水",
        "虛弱",
        "肌肉萎縮",
        "嗜睡",
        "流涎（噁心）",
        "腹水（嚴重低白蛋白病例）",
        "肝腦病徵象（嚴重病例）"
      ]
    },
    "pathophysiology": "厭食 → 外周脂肪動員增加 → 游離脂肪酸湧入肝臟 → 肝臟代謝能力不足（貓缺乏足夠的脂蛋白合成和分泌能力）→ 三酸甘油酯堆積於肝細胞 → 肝細胞腫脹和功能障礙 → 膽汁淤積和黃疸。過重貓脂肪動員更多，風險更高。厭食本身又加重病情（惡性循環）。",
    "diagnosis": {
      "overview": "臨床懷疑結合實驗室和影像學，肝臟細胞學或活檢確診",
      "differentials": [
        "膽管炎/膽管肝炎",
        "肝腫瘤",
        "淋巴瘤",
        "胰臟炎",
        "三體炎（胰臟炎+膽管炎+IBD）",
        "糖尿病"
      ],
      "initialDB": [
        "CBC（可能有Heinz小體）",
        "生化：ALT↑、ALP↑↑（可達10倍以上）、膽紅素↑、低鉀常見",
        "凝血功能（可能延長）",
        "腹部超聲（肝臟高回聲、腫大）",
        "尿液分析"
      ],
      "advanced": [
        "肝臟細針抽吸細胞學（可確診，但有出血風險）",
        "肝臟活檢",
        "Cobalamin/Folate",
        "fPLI（排除胰臟炎）",
        "尋找潛在疾病"
      ]
    },
    "treatment": {
      "overview": "關鍵是早期積極營養支持（餵食管）+ 支持治療",
      "acute": [
        "輸液糾正脫水和電解質（尤其低鉀）：",
        "  - 補鉀：20-40 mEq/L",
        "  - 補磷（若低）",
        "營養支持（最關鍵）：",
        "  - 食道餵食管或胃造廔管（PEG）：首選",
        "  - 不要強迫口服餵食（應激+嗆咳風險）",
        "  - 不要使用食慾刺激劑替代餵食管",
        "餵食計畫：",
        "  - 高蛋白飲食（30-40%蛋白質）",
        "  - 起始：1/3計算熱量需求，3-5天增至全量",
        "  - RER = 70 × (體重kg)^0.75",
        "  - 每日分6-8餐餵食",
        "止吐：Maropitant 1 mg/kg SC/IV q24h",
        "維生素補充：",
        "  - Vitamin K1: 0.5-1.5 mg/kg SC q12h x 3劑（若凝血異常）",
        "  - Vitamin B complex",
        "  - Vitamin E: 10 IU/kg/day"
      ],
      "chronic": [
        "持續管餵餵食4-6週或更長",
        "肝臟支持：",
        "  - SAMe (S-adenosylmethionine): 20 mg/kg PO q24h 空腹",
        "  - Ursodiol: 10-15 mg/kg PO q24h（若膽汁淤積明顯）",
        "L-Carnitine: 250-500 mg/cat PO q24h（可能有助脂肪代謝）",
        "治療潛在疾病",
        "逐漸過渡到自主進食後移除餵食管"
      ]
    },
    "prognosis": "積極營養支持存活率約60-80%。預後不良因素：嚴重低鉀、嚴重低磷、肝腦病、嚴重凝血障礙、潛在疾病（如淋巴瘤）。恢復後預防復發很重要。",
    "pearls": [
      "「不要讓過重貓厭食超過2天」是重要的主人教育",
      "餵食管是救命措施，不是最後手段",
      "強迫口服餵食會增加肝腦病和嗆咳風險",
      "ALP升高通常比ALT更顯著（貓特點）",
      "約50%有潛在疾病誘發厭食",
      "恢復需要4-6週，主人需要耐心和配合"
    ],
    "diagnosticAlgorithm": {
      "title": "肝臟脂肪沉積症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估厭食史及黃疸（貓）",
          "findings": [
            "肥胖貓突然厭食>3天",
            "漸進性黃疸",
            "嗜睡",
            "體重快速減輕"
          ]
        },
        {
          "step": 2,
          "action": "血液生化",
          "details": "肝臟指數與膽紅素",
          "findings": [
            "ALP與GGT顯著升高",
            "膽紅素升高",
            "ALT中度升高",
            "低血鉀"
          ]
        },
        {
          "step": 3,
          "action": "腹部超音波",
          "details": "肝臟回音評估",
          "findings": [
            "肝臟瀰漫性高回音",
            "肝臟腫大",
            "排除膽道阻塞",
            "排除其他肝臟疾病"
          ]
        },
        {
          "step": 4,
          "action": "肝臟細針抽吸或切片",
          "details": "細胞學或組織學確認",
          "findings": [
            "肝細胞內大量脂肪空泡",
            "排除淋巴瘤",
            "排除膽管肝炎",
            "評估共病原因"
          ]
        }
      ]
    },
    "monitoring": [
      "體重",
      "肝指數（每週）",
      "電解質（尤其鉀）",
      "進食量和嘔吐",
      "黃疸程度",
      "神經狀態"
    ],
    "reference": "Cote E: Clinical Veterinary Advisor, 3rd Ed. Elsevier, 2015; Center SA: Feline hepatic lipidosis. Vet Clin North Am Small Anim Pract 35:225-269, 2005"
  },
  "portosystemic-shunt": {
    "zh": "肝門脈分流",
    "en": "Portosystemic Shunt (PSS)",
    "definition": "門脈血液繞過肝臟直接進入體循環的異常血管通道，導致肝臟功能降低和全身性毒素（如氨）累積。",
    "synonyms": [
      "PSS",
      "Portosystemic Vascular Anomaly",
      "PSVA",
      "肝分流",
      "Liver Shunt",
      "門體分流"
    ],
    "epidemiology": {
      "species": "犬貓皆可發生",
      "age": "先天性：年輕（多在1歲前診斷）；後天性：任何年齡",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "先天性肝外分流：小型犬（Yorkshire Terrier、Maltese、Shih Tzu、Miniature Schnauzer、Pug）",
        "先天性肝內分流：大型犬（Irish Wolfhound、Golden Retriever、Labrador、Australian Cattle Dog）",
        "貓較少見（波斯貓、喜馬拉雅貓略多）",
        "後天性：門脈高壓（肝硬化等）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "生長遲緩",
        "體型小於同窩",
        "間歇性神經症狀（餐後或蛋白攝入後惡化）",
        "行為異常（呆滯、盯視、轉圈）",
        "癲癇",
        "失明",
        "下泌尿道症狀（尿結石，尿酸銨）",
        "多尿多渴",
        "嘔吐、腹瀉",
        "流涎（貓）"
      ],
      "physicalExam": [
        "體型小",
        "肌肉發育不良",
        "可能有神經症狀",
        "麻醉恢復延遲史",
        "可能有銅色虹膜（貓）",
        "肝臟小（先天性）或正常/大（後天性）"
      ]
    },
    "pathophysiology": "門脈血液繞過肝臟 → 1）毒素（氨、芳香族氨基酸、假性神經傳導物質）直接進入體循環 → 肝腦病；2）肝臟營養因子減少 → 肝臟發育不良或萎縮；3）尿酸代謝異常 → 尿酸銨結石。先天性：胚胎期血管未正常閉合；後天性：門脈高壓導致側枝循環開放。",
    "diagnosis": {
      "overview": "臨床懷疑結合肝功能檢測和影像學確認分流",
      "differentials": [
        "其他肝臟疾病",
        "腎衰竭（尿素氮升高）",
        "特發性癲癇",
        "中毒",
        "代謝性腦病"
      ],
      "initialDB": [
        "CBC（可能有輕度非再生性貧血、紅血球小）",
        "生化：BUN低、白蛋白低、肝指數輕度升高或正常、膽固醇低、血糖低",
        "尿液分析（尿酸銨結晶、尿比重低）",
        "空腹和餐後膽汁酸（顯著升高）",
        "空腹血氨（升高）"
      ],
      "advanced": [
        "腹部超聲（尋找分流血管、小肝、腎結石）",
        "CT血管造影（金標準定位分流）",
        "門脈造影（手術中）",
        "肝臟活檢"
      ]
    },
    "treatment": {
      "overview": "手術結紮/閉塞分流血管是根本治療；內科管理肝腦病",
      "acute": [
        "肝腦病急性發作：",
        "  - 停止蛋白攝入",
        "  - 輸液（避免乳酸林格，用0.9% NaCl或含葡萄糖液）",
        "  - Lactulose: 0.5 mL/kg PO q8h 或灌腸",
        "  - 抗生素減少產氨菌：",
        "    Metronidazole 7.5 mg/kg PO q12h",
        "    或 Neomycin 20 mg/kg PO q8h",
        "  - 癲癇控制（避免使用肝代謝藥物）：",
        "    Levetiracetam 20-60 mg/kg IV",
        "  - 低血糖處理"
      ],
      "chronic": [
        "內科管理（術前或不適合手術）：",
        "  - 蛋白限制飲食（乳蛋白和植物蛋白較好）",
        "  - Lactulose: 0.5 mL/kg PO q8-12h（調整至每日2-3次軟便）",
        "  - 抗生素：Metronidazole或Amoxicillin",
        "  - SAMe補充",
        "手術治療：",
        "  - Ameroid constrictor：漸進性閉塞",
        "  - Cellophane banding：漸進性閉塞",
        "  - 部分或完全結紮",
        "  - 介入性栓塞（肝內分流）",
        "術後監測門脈高壓徵象",
        "術後膽汁酸可能持續異常（肝臟發育不完全）"
      ]
    },
    "prognosis": "手術治療預後良好（80-90%臨床改善）。單一肝外分流手術預後最好。多發性後天分流預後較差。肝內分流手術較複雜。單純內科治療可維持部分病例但長期預後較差。",
    "pearls": [
      "餐後膽汁酸是良好的篩檢工具",
      "血氨升高但膽汁酸正常需考慮尿素循環酶缺陷",
      "貓PSS較犬少見但臨床表現類似（常見流涎）",
      "術前穩定很重要，嚴重肝腦病需先內科控制",
      "術後「分流性腦病」可能發生（快速閉塞導致門脈高壓）",
      "年輕時手術預後比年長好（肝臟仍可發育）"
    ],
    "diagnosticAlgorithm": {
      "title": "肝門脈分流 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估神經症狀、生長遲緩及泌尿症狀",
          "findings": [
            "生長遲緩（先天型）",
            "餐後神經症狀（肝腦病）",
            "尿酸銨結石",
            "幼犬或年輕犬"
          ]
        },
        {
          "step": 2,
          "action": "血液生化與膽汁酸",
          "details": "篩檢肝功能",
          "findings": [
            "餐前餐後膽汁酸明顯升高",
            "低白蛋白",
            "低BUN",
            "低血糖",
            "小紅血球症"
          ]
        },
        {
          "step": 3,
          "action": "腹部超音波",
          "details": "尋找異常分流血管",
          "findings": [
            "門脈分流血管直接可見",
            "肝臟縮小",
            "腎臟腫大",
            "門靜脈血流異常"
          ]
        },
        {
          "step": 4,
          "action": "CT血管造影確診",
          "details": "確認分流血管解剖及手術計畫",
          "findings": [
            "CT angiography定位分流血管",
            "區分肝內與肝外分流",
            "門靜脈壓力評估",
            "手術（Ameroid收縮環）或內科管理"
          ]
        }
      ]
    },
    "monitoring": [
      "神經狀態",
      "膽汁酸（術後3個月）",
      "血氨",
      "肝指數",
      "腹部超聲"
    ],
    "reference": "Cote E: Clinical Veterinary Advisor, 3rd Ed. Elsevier, 2015; Berent AC, Tobias KM: Portosystemic vascular anomalies. Vet Clin North Am Small Anim Pract 39:513-541, 2009"
  },
  "cholangiohepatitis": {
    "zh": "膽管肝炎",
    "en": "Cholangiohepatitis",
    "definition": "膽道系統和肝臟的炎症性疾病，貓最常見的肝膽疾病之一。可分為中性球性（急性/化膿性）和淋巴細胞性（慢性）兩大類。",
    "synonyms": [
      "Cholangitis",
      "膽管炎",
      "Feline Cholangitis Complex",
      "貓膽管炎複合症"
    ],
    "epidemiology": {
      "species": "貓最常見，犬較少（犬多見慢性肝炎）",
      "age": "中性球性：年輕至中年；淋巴細胞性：中老年",
      "sex": "公貓略多（中性球性）",
      "riskFactors": [
        "腸道疾病（IBD）",
        "胰臟炎",
        "膽道結構異常",
        "細菌上行感染",
        "可能與免疫機制有關（淋巴細胞性）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "食慾下降或厭食",
        "嘔吐",
        "嗜睡",
        "體重減輕",
        "黃疸",
        "中性球性：急性起病、發燒；淋巴細胞性：慢性病程、間歇性症狀"
      ],
      "physicalExam": [
        "黃疸",
        "肝臟腫大或萎縮",
        "腹部觸診疼痛（中性球性）",
        "發燒（中性球性常見）",
        "脫水",
        "可能有腹水"
      ]
    },
    "pathophysiology": "中性球性：細菌從腸道經膽管上行感染（常見大腸桿菌、腸球菌）→ 急性化膿性炎症 → 膽汁淤積和肝細胞損傷。淋巴細胞性：可能為免疫介導，也可能是中性球性的慢性演變 → 門脈區淋巴細胞和漿細胞浸潤 → 進展至肝硬化。「三體炎」：膽管炎 + 胰臟炎 + IBD 常同時存在。",
    "diagnosis": {
      "overview": "需要肝臟活檢確定類型，但臨床可初步區分",
      "differentials": [
        "肝脂肪沉積症",
        "肝臟腫瘤/淋巴瘤",
        "FIP",
        "肝臟毒素",
        "其他膽道疾病"
      ],
      "initialDB": [
        "CBC：中性球性可見白血球增多、左移；淋巴細胞性白血球正常",
        "生化：ALT↑、ALP↑、GGT↑、膽紅素↑",
        "腹部超聲：膽管擴張、膽囊壁增厚、肝臟回聲改變",
        "凝血功能",
        "尿液分析"
      ],
      "advanced": [
        "肝臟細針抽吸細胞學",
        "肝臟活檢（金標準，區分類型）",
        "膽汁培養和敏感試驗",
        "fPLI（排除胰臟炎）",
        "Cobalamin/Folate（評估腸道）"
      ]
    },
    "treatment": {
      "overview": "中性球性需抗生素；淋巴細胞性需免疫抑制",
      "acute": [
        "中性球性膽管炎：",
        "  - 抗生素（長療程4-6週）：",
        "    - Amoxicillin-Clavulanate: 12.5-25 mg/kg PO q12h",
        "    - + Metronidazole: 7.5-10 mg/kg PO q12h",
        "    - 或 Enrofloxacin + Metronidazole",
        "  - 輸液支持",
        "  - 止吐：Maropitant",
        "  - 營養支持（可能需餵食管，因常合併肝脂肪沉積）",
        "淋巴細胞性膽管炎（及慢性期）：",
        "  - Prednisolone: 1-2 mg/kg PO q12h，逐漸減量",
        "  - 難治性可加用Chlorambucil",
        "共同治療：",
        "  - Ursodiol: 10-15 mg/kg PO q24h（利膽、肝保護）",
        "  - SAMe: 90 mg/cat PO q24h 空腹",
        "  - Vitamin K1（若凝血異常）",
        "  - 治療合併的胰臟炎/IBD"
      ],
      "chronic": [
        "長期肝臟支持：",
        "  - Ursodiol持續使用",
        "  - SAMe或Silybin",
        "飲食：高品質蛋白質、適度脂肪",
        "監測和治療「三體炎」的各組成部分"
      ]
    },
    "prognosis": "中性球性：及時抗生素治療預後良好，但需長療程避免復發。淋巴細胞性：預後較謹慎，可能進展至肝硬化，但許多貓可長期管理。「三體炎」需要同時處理三個器官系統。",
    "pearls": [
      "貓的膽管和胰管共同開口，易發生「三體炎」",
      "中性球性較急性，淋巴細胞性較慢性",
      "膽汁培養陽性率不高，經驗性抗生素常需要",
      "淋巴細胞性膽管炎和低度淋巴瘤可能難以區分",
      "肝脂肪沉積常與膽管炎同時存在",
      "Ursodiol對貓膽管疾病有良好證據支持"
    ],
    "diagnosticAlgorithm": {
      "title": "膽管肝炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估黃疸、嘔吐及食慾不振（貓）",
          "findings": [
            "黃疸",
            "嘔吐",
            "食慾不振",
            "發燒（化膿型）"
          ]
        },
        {
          "step": 2,
          "action": "血液生化",
          "details": "肝膽指數評估",
          "findings": [
            "ALP與GGT升高",
            "ALT/AST升高",
            "膽紅素升高",
            "白血球增多（化膿型）"
          ]
        },
        {
          "step": 3,
          "action": "腹部超音波",
          "details": "肝膽系統評估",
          "findings": [
            "肝內或肝外膽管擴張",
            "膽囊壁增厚",
            "膽泥或膽石",
            "排除胰臟炎共病"
          ]
        },
        {
          "step": 4,
          "action": "肝臟切片與培養",
          "details": "超音波導引肝臟切片",
          "findings": [
            "組織病理區分化膿型vs淋巴球型",
            "細菌培養與藥敏（化膿型）",
            "排除淋巴瘤",
            "「三炎症」共病評估（膽管炎+IBD+胰臟炎）"
          ]
        }
      ]
    },
    "monitoring": [
      "肝指數",
      "膽紅素",
      "超聲追蹤",
      "體重和食慾",
      "Cobalamin"
    ],
    "reference": "Cote E: Clinical Veterinary Advisor, 3rd Ed. Elsevier, 2015; Rothuizen J et al: WSAVA Standards for Clinical and Histological Diagnosis of Canine and Feline Liver Diseases. Saunders, 2006"
  },
  "copper-storage-hepatopathy": {
    "zh": "銅儲積性肝病",
    "en": "Copper Storage Hepatopathy",
    "definition": "肝臟銅異常蓄積導致肝細胞損傷和進行性肝病的疾病。可為原發性（遺傳性）或繼發於膽汁淤積。",
    "synonyms": [
      "Copper-Associated Hepatitis",
      "銅中毒性肝病",
      "Copper Toxicosis",
      "銅蓄積症"
    ],
    "epidemiology": {
      "species": "犬（貓罕見）",
      "age": "中年（通常3-7歲出現症狀）",
      "sex": "母犬可能略多（某些品種）",
      "riskFactors": [
        "品種傾向：Bedlington Terrier（COMMD1基因突變）、West Highland White Terrier、Skye Terrier、Doberman Pinscher、Labrador Retriever、Dalmatian",
        "高銅飲食（長期）",
        "膽汁淤積性疾病（繼發性）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "可能長期無症狀",
        "慢性進行性症狀：",
        "  - 食慾下降",
        "  - 體重減輕",
        "  - 嘔吐",
        "  - 多尿多渴",
        "  - 黃疸",
        "急性危機（溶血、肝衰竭）可能是首發表現"
      ],
      "physicalExam": [
        "黃疸",
        "肝臟腫大或（晚期）萎縮",
        "腹水",
        "消瘦",
        "急性期可能有溶血性貧血表現（蒼白、黃疸）"
      ]
    },
    "pathophysiology": "原發性：遺傳性銅代謝缺陷（如Bedlington Terrier的COMMD1基因突變）→ 膽汁銅排泄減少 → 肝細胞銅蓄積。繼發性：膽汁淤積 → 膽汁銅排泄障礙 → 銅蓄積。銅蓄積 → 氧化損傷 → 肝細胞壞死 → 慢性肝炎 → 肝硬化 → 肝衰竭。急性大量銅釋放可導致溶血性危機。",
    "diagnosis": {
      "overview": "肝臟活檢銅定量是金標準",
      "differentials": [
        "其他慢性肝炎",
        "藥物性肝病",
        "感染性肝炎",
        "膽管炎",
        "肝腫瘤"
      ],
      "initialDB": [
        "CBC（可能有再生性貧血、Heinz小體）",
        "生化：ALT↑、ALP↑、膽紅素↑（晚期）、白蛋白↓（晚期）",
        "凝血功能",
        "腹部超聲"
      ],
      "advanced": [
        "肝臟活檢+組織病理學（銅染色：Rhodanine、Rubeanic acid）",
        "肝臟銅定量（金標準）：",
        "  - 正常：<400 μg/g乾重",
        "  - 升高：400-1000 μg/g",
        "  - 顯著升高：>1000-2000 μg/g（Bedlington可>10000）",
        "遺傳檢測（Bedlington Terrier）"
      ]
    },
    "treatment": {
      "overview": "減少銅攝入 + 銅螯合治療 + 肝臟支持",
      "acute": [
        "急性肝衰竭/溶血危機：",
        "  - 輸液支持",
        "  - 輸血（若嚴重溶血）",
        "  - 止吐、肝臟支持",
        "  - 治療肝腦病（若有）"
      ],
      "chronic": [
        "銅螯合劑（主要治療）：",
        "  - D-Penicillamine: 10-15 mg/kg PO q12h 空腹",
        "    （副作用：嘔吐、食慾下降，需與食物間隔）",
        "  - Trientine: 10-15 mg/kg PO q12h（副作用較少）",
        "鋅補充（阻止銅吸收）：",
        "  - Zinc gluconate/acetate: 50-100 mg元素鋅 PO q12h",
        "  - 不可與銅螯合劑同時給予（間隔2小時）",
        "  - 可用於維持期或無法耐受螯合劑時",
        "飲食：",
        "  - 低銅飲食（避免肝臟、貝類、堅果）",
        "  - 處方肝臟飲食",
        "肝臟支持：",
        "  - SAMe: 20 mg/kg PO q24h",
        "  - Ursodiol: 10-15 mg/kg PO q24h",
        "  - Vitamin E: 10 IU/kg PO q24h（抗氧化）"
      ]
    },
    "prognosis": "早期診斷和治療預後可良好。已有肝硬化預後較差。Bedlington Terrier若未治療可能致命。定期監測和終身治療是必要的。",
    "pearls": [
      "Bedlington Terrier的COMMD1檢測可用於篩檢和繁殖決策",
      "肝臟銅定量需要足夠組織量，需向實驗室確認",
      "D-Penicillamine空腹給予效果最好但胃腸副作用多",
      "鋅治療需要數月才能降低肝臟銅含量",
      "繼發性銅蓄積治療原發病更重要",
      "飲食中銅含量往往被低估（自來水管、飼料添加）"
    ],
    "diagnosticAlgorithm": {
      "title": "銅儲積性肝病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估肝臟疾病症狀及品種背景",
          "findings": [
            "漸進性食慾減退",
            "黃疸",
            "腹水",
            "好發品種（Bedlington梗、拉布拉多等）"
          ]
        },
        {
          "step": 2,
          "action": "血液生化",
          "details": "肝臟功能評估",
          "findings": [
            "ALT/AST升高",
            "膽紅素升高（晚期）",
            "白蛋白降低",
            "凝血時間延長"
          ]
        },
        {
          "step": 3,
          "action": "肝臟切片",
          "details": "超音波導引肝臟組織切片",
          "findings": [
            "組織病理見肝細胞內銅顆粒",
            "Rhodanine或Rubeanic acid特殊染色",
            "定量銅含量（>2000 ppm dry weight）",
            "纖維化與壞死程度"
          ]
        },
        {
          "step": 4,
          "action": "治療監測",
          "details": "螯合治療與飲食管理",
          "findings": [
            "D-penicillamine或Trientine治療",
            "低銅飲食",
            "鋅補充（競爭吸收）",
            "定期肝指數與切片追蹤"
          ]
        }
      ]
    },
    "monitoring": [
      "肝指數（每1-2個月）",
      "肝臟活檢銅定量（每6-12個月，評估治療效果）",
      "鋅治療時監測血清鋅"
    ],
    "reference": "Cote E: Clinical Veterinary Advisor, 3rd Ed. Elsevier, 2015; Fieten H et al: Canine models of copper toxicosis for understanding mammalian copper metabolism. Mamm Genome 23:62-75, 2012"
  },
  "anal-sac-disease": {
    "zh": "肛門腺疾病",
    "en": "Anal Sac Disease",
    "definition": "肛門腺（肛門囊）的疾病，包括嵌塞、感染（肛門腺炎）和膿腫形成。是小動物常見的問題。",
    "synonyms": [
      "肛門囊疾病",
      "Anal Gland Disease",
      "Anal Sac Impaction",
      "肛門腺嵌塞",
      "Anal Sac Abscess"
    ],
    "epidemiology": {
      "species": "犬最常見，貓較少見",
      "age": "任何年齡",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "小型犬種",
        "肥胖",
        "軟便或腹瀉（無法自然排空）",
        "過敏性皮膚病",
        "解剖異常（腺管狹窄）",
        "低纖維飲食"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "摩擦屁股（scooting）",
        "過度舔肛門區",
        "排便困難或疼痛",
        "尾根或肛門區腫脹",
        "坐立不安",
        "追咬尾巴",
        "膿腫破裂後可見肛門旁傷口"
      ],
      "physicalExam": [
        "肛門腺腫大、堅硬（嵌塞）",
        "觸診疼痛（感染/膿腫）",
        "肛門旁紅腫（膿腫）",
        "可能有膿性或血性分泌物",
        "發燒（感染嚴重時）",
        "肛門旁皮膚破潰（膿腫破裂）"
      ]
    },
    "pathophysiology": "正常肛門腺在排便時被擠壓排空。嵌塞：腺體分泌物濃稠或排出口阻塞 → 腺體腫脹 → 不適。感染：細菌入侵（常為糞便菌群）→ 肛門腺炎 → 可能形成膿腫 → 可能穿破皮膚形成廔管。",
    "diagnosis": {
      "overview": "直腸檢查和肛門腺擠壓即可診斷",
      "differentials": [
        "肛門周圍廔管",
        "肛門腫瘤（尤其肛門囊腺癌）",
        "會陰疝",
        "直腸脫出",
        "肛門周圍皮膚感染"
      ],
      "initialDB": [
        "直腸檢查和肛門腺觸診",
        "肛門腺內容物檢查（正常為棕色糊狀，感染為膿性或血性）"
      ],
      "advanced": [
        "分泌物細胞學和培養（反覆感染時）",
        "腹部/會陰超聲（排除腫瘤）",
        "直腸鏡（排除直腸疾病）"
      ]
    },
    "treatment": {
      "overview": "擠壓排空 + 沖洗（感染時）+ 抗生素（膿腫）+ 必要時手術",
      "acute": [
        "肛門腺嵌塞：",
        "  - 手動擠壓排空（外部或直腸內）",
        "  - 嚴重嵌塞可能需鎮靜",
        "肛門腺炎/膿腫：",
        "  - 擠壓排空（可能需鎮靜/止痛）",
        "  - 生理鹽水或稀釋Chlorhexidine沖洗",
        "  - 抗生素注入（如Panalog）",
        "  - 全身抗生素（膿腫）：",
        "    Amoxicillin-Clavulanate 12.5-25 mg/kg PO q12h x 7-14天",
        "  - 熱敷促進引流",
        "  - 膿腫破裂：清創、引流、抗生素"
      ],
      "chronic": [
        "反覆嵌塞的預防：",
        "  - 定期擠壓（每4-8週）",
        "  - 增加飲食纖維",
        "  - 體重管理",
        "反覆感染或嚴重病例：",
        "  - 肛門腺切除術（Anal sacculectomy）",
        "  - 併發症：暫時性或永久性大便失禁（<5%）"
      ]
    },
    "prognosis": "單純嵌塞預後良好。反覆感染可考慮手術切除。肛門腺切除術成功率高但有大便失禁風險。",
    "pearls": [
      "定期美容院擠壓可能不必要且可能造成創傷",
      "過敏性皮膚病常與反覆肛門腺問題相關",
      "老年犬肛門腺腫塊需排除腺癌",
      "貓肛門腺問題較少但可發生",
      "肛門腺分泌物有強烈臭味是正常的",
      "雙側同時切除比單側有較高大便失禁風險"
    ],
    "diagnosticAlgorithm": {
      "title": "肛門腺疾病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "觀察舔咬肛門區域及磨蹭行為",
          "findings": [
            "磨蹭屁股（scooting）",
            "舔咬肛門區域",
            "排便困難",
            "肛門周圍腫脹"
          ]
        },
        {
          "step": 2,
          "action": "肛門腺觸診",
          "details": "直腸指診評估肛門腺",
          "findings": [
            "肛門腺腫脹充滿",
            "分泌物性狀（正常vs膿性）",
            "肛門腺膿瘍（波動感）",
            "硬結或腫塊"
          ]
        },
        {
          "step": 3,
          "action": "分泌物評估",
          "details": "擠壓肛門腺內容物檢查",
          "findings": [
            "正常：淺棕色液體",
            "嵌塞：濃稠深色",
            "感染：膿性或血性",
            "細胞學排除腫瘤"
          ]
        },
        {
          "step": 4,
          "action": "進階檢查",
          "details": "疑似腫瘤時",
          "findings": [
            "細針抽吸細胞學",
            "直腸超音波",
            "區域淋巴結評估",
            "高血鈣篩檢（肛門腺腺癌）"
          ]
        }
      ]
    },
    "monitoring": [
      "症狀復發",
      "肛門區檢查",
      "定期擠壓（若有嵌塞傾向）"
    ],
    "reference": "Cote E: Clinical Veterinary Advisor, 3rd Ed. Elsevier, 2015"
  },
  "rectal-prolapse": {
    "zh": "直腸脫出",
    "en": "Rectal Prolapse",
    "definition": "直腸脫出是直腸黏膜或全層經肛門向外翻出的急症，幼犬幼貓較常見。常見誘因包括嚴重腹瀉（寄生蟲、腸炎）、裡急後重（結腸炎、泌尿道阻塞）、會陰疝和直腸腫瘤。需與小腸套疊脫出（探針可沿壁插入為套疊）鑑別。輕度可保守復位，反覆者需結腸固定術。",
    "synonyms": [
      "直腸脫垂",
      "Rectal Prolapse",
      "脫肛"
    ],
    "epidemiology": {
      "species": "犬貓皆可發生",
      "age": "幼年動物較常見（腸道寄生蟲相關）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "腸道寄生蟲（幼年動物最常見原因）",
        "嚴重腹瀉",
        "便秘和裡急後重",
        "難產",
        "下泌尿道疾病（裡急後重）",
        "直腸/結腸腫瘤",
        "會陰疝"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "肛門突出紅色腫塊",
        "排便困難或裡急後重",
        "腹瀉或便秘史",
        "可能有血便或黏液便",
        "舔肛門區"
      ],
      "physicalExam": [
        "圓柱形紅色組織從肛門突出",
        "部分脫出：僅黏膜",
        "完全脫出：全層直腸壁",
        "組織可能水腫、乾燥或壞死",
        "可能有外傷或潰瘍",
        "區分脫出vs腸套疊（探針測試）"
      ]
    },
    "pathophysiology": "裡急後重（tenesmus）→ 腹壓持續增加 → 直腸黏膜或全層脫出 → 暴露在外的組織水腫、乾燥 → 可能外傷或壞死。若不處理，水腫加重使復位更困難。",
    "diagnosis": {
      "overview": "臨床診斷明確，需區分脫出類型和尋找原因",
      "differentials": [
        "腸套疊脫出（雙層，探針可插入肛門旁）",
        "直腸腫瘤",
        "直腸息肉"
      ],
      "initialDB": [
        "身體檢查確認脫出",
        "探針測試：直腸脫出探針無法插入組織與肛門之間；腸套疊脫出可以",
        "糞便檢查（寄生蟲）",
        "直腸檢查（評估腫塊、狹窄）"
      ],
      "advanced": [
        "腹部X光或超聲（評估腸套疊、腫塊）",
        "結腸鏡（排除腫瘤/息肉）",
        "CBC和生化"
      ]
    },
    "treatment": {
      "overview": "復位脫出組織 + 防止復發 + 治療根本原因",
      "acute": [
        "評估組織活性",
        "減輕水腫：",
        "  - 50%葡萄糖溶液或高滲鹽水濕敷15-20分鐘",
        "  - 冷敷",
        "手動復位（可能需鎮靜/麻醉）：",
        "  - 潤滑組織",
        "  - 輕柔推回",
        "復位後防止復發：",
        "  - 荷包縫合（Purse-string suture）：留置3-5天",
        "  - 確保可排便",
        "組織壞死時：直腸切除術（Rectal resection）",
        "治療根本原因：",
        "  - 驅蟲",
        "  - 治療腹瀉/便秘",
        "  - 治療下泌尿道疾病"
      ],
      "chronic": [
        "反覆脫出：",
        "  - Colopexy（結腸固定術）",
        "確保治療根本原因",
        "飲食調整（纖維、水分）"
      ]
    },
    "prognosis": "早期復位且組織健康預後良好。需要找出並治療根本原因以防復發。壞死組織需要手術切除，預後仍可良好但更複雜。",
    "pearls": [
      "幼年動物直腸脫出首先考慮寄生蟲",
      "探針測試可區分直腸脫出和腸套疊脫出",
      "高滲溶液可有效減輕組織水腫",
      "荷包縫合不要太緊，需能排便",
      "反覆脫出需考慮手術固定",
      "組織顏色從紅轉暗紫/黑色提示壞死"
    ],
    "diagnosticAlgorithm": {
      "title": "直腸脫出 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "直視評估脫出組織",
          "findings": [
            "肛門外圓柱狀粉紅色組織",
            "區分直腸黏膜脫出vs全層脫出",
            "組織水腫或壞死",
            "幼犬或慢性腹瀉病史"
          ]
        },
        {
          "step": 2,
          "action": "脫出類型鑑別",
          "details": "探針測試鑑別完全vs不完全",
          "findings": [
            "探針沿脫出組織與肛門間通過（完全脫出）",
            "不完全脫出僅黏膜",
            "評估組織存活性"
          ]
        },
        {
          "step": 3,
          "action": "病因調查",
          "details": "尋找導致裏急後重的原因",
          "findings": [
            "糞便檢查（寄生蟲）",
            "直腸指診排除腫塊",
            "泌尿生殖系統評估",
            "腹部超音波"
          ]
        },
        {
          "step": 4,
          "action": "治療評估",
          "details": "復位或手術方案",
          "findings": [
            "手動復位並荷包縫合",
            "嚴重壞死需切除",
            "治療基礎病因",
            "預防復發"
          ]
        }
      ]
    },
    "monitoring": [
      "組織活性",
      "復發",
      "排便功能",
      "根本原因控制"
    ],
    "reference": "Cote E: Clinical Veterinary Advisor, 3rd Ed. Elsevier, 2015"
  },
  "acute-kidney-injury": {
    "zh": "急性腎損傷",
    "en": "Acute Kidney Injury (AKI)",
    "definition": "腎臟功能在數小時至數天內急劇下降，導致氮質血症、電解質失衡和尿量異常的緊急狀態。",
    "synonyms": [
      "AKI",
      "急性腎衰竭",
      "Acute Renal Failure",
      "ARF",
      "急性腎功能不全"
    ],
    "epidemiology": {
      "species": "犬貓皆可發生",
      "age": "任何年齡，但老年動物風險較高",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "腎毒性藥物（NSAIDs、氨基糖苷類）",
        "百合中毒（貓）",
        "葡萄/葡萄乾中毒（犬）",
        "乙二醇中毒",
        "脫水",
        "低血壓",
        "敗血症",
        "尿道阻塞",
        "腎前性因素"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "突發嘔吐",
        "厭食",
        "嗜睡",
        "尿量改變（少尿或無尿）",
        "可能有毒物暴露史",
        "近期手術或麻醉"
      ],
      "physicalExam": [
        "脫水",
        "口腔潰瘍（尿毒症）",
        "口臭（氨味）",
        "腹部疼痛（腎臟腫大）",
        "黏膜蒼白",
        "體溫可低或高",
        "心律不整（高血鉀）"
      ]
    },
    "pathophysiology": "腎前性：腎臟灌注不足 → GFR下降。腎性：直接腎小管損傷 → 細胞壞死 → 腎功能喪失。腎後性：尿路阻塞 → 背壓升高 → 腎損傷。共同結果：氮質血症、電解質失衡（高血鉀）、代謝性酸中毒、液體失衡",
    "diagnosis": {
      "overview": "基於急性氮質血症病史和臨床表現，需區分腎前性、腎性和腎後性",
      "differentials": [
        "腎前性氮質血症",
        "腎後性阻塞",
        "慢性腎臟病急性惡化",
        "腎盂腎炎"
      ],
      "initialDB": [
        "BUN/Creatinine",
        "電解質（K+尤其重要）",
        "尿液分析（比重、沉渣）",
        "血氣分析",
        "腹部超聲（腎臟大小、腎盂積水）"
      ],
      "advanced": [
        "SDMA",
        "尿液蛋白/肌酐比",
        "腎臟活檢（特定情況）",
        "尿液培養",
        "乙二醇/鈣草酸鹽晶體"
      ]
    },
    "treatment": {
      "overview": "恢復腎灌注、糾正電解質和酸鹼失衡、治療原發病因、支持治療",
      "acute": [
        "靜脈輸液復甦：晶體液糾正脫水（計算脫水量 + 維持需求 + 持續損失）",
        "高血鉀處理（K+ >6.5 mEq/L）：",
        "- 10% Calcium gluconate: 0.5-1 mL/kg IV slow（心臟保護）",
        "- Regular insulin: 0.25-0.5 U/kg IV + Dextrose 2 g/U insulin",
        "- Sodium bicarbonate: 1-2 mEq/kg IV slow",
        "利尿劑（恢復水合後若仍少尿）：",
        "- Furosemide: 2-6 mg/kg IV（可持續輸注2-5 mg/kg/h）",
        "- Mannitol: 0.5-1 g/kg IV over 20min（需排除梗阻）",
        "代謝性酸中毒：Sodium bicarbonate（若pH<7.1或HCO3<12）",
        "止吐：Maropitant 1 mg/kg IV/SQ q24h",
        "胃保護：Omeprazole 1 mg/kg PO q12-24h",
        "腎臟替代治療（血液透析）：嚴重或無反應病例"
      ],
      "chronic": [
        "逐漸過渡至腎臟處方飲食",
        "監測腎功能恢復",
        "避免腎毒性藥物"
      ]
    },
    "prognosis": "取決於病因、嚴重程度和治療反應。腎前性若及時糾正預後良好。腎性損傷可能需要數週恢復，部分可能進展為CKD。存活率約40-60%。少尿/無尿和嚴重高血鉀預後較差。",
    "pearls": [
      "尿比重<1.030（犬）或<1.035（貓）伴隨氮質血症提示腎性問題",
      "腎臟大小正常或腫大提示AKI；萎縮提示CKD",
      "貓百合中毒24-72小時後出現腎衰竭",
      "乙二醇中毒治療黃金時間：犬<8-12小時，貓<3小時",
      "尿量目標：>1-2 mL/kg/h"
    ],
    "diagnosticAlgorithm": {
      "title": "急性腎損傷 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估尿量、嘔吐及脫水程度",
          "findings": [
            "突發厭食嘔吐",
            "少尿或無尿",
            "口腔潰瘍與氨味",
            "脫水"
          ]
        },
        {
          "step": 2,
          "action": "血液生化與電解質",
          "details": "腎功能及電解質評估",
          "findings": [
            "BUN與肌酐急性升高",
            "SDMA升高",
            "高血鉀",
            "代謝性酸中毒"
          ]
        },
        {
          "step": 3,
          "action": "尿液分析",
          "details": "尿液性狀與沉渣",
          "findings": [
            "尿比重低（等張尿）",
            "尿中管型",
            "蛋白尿",
            "葡萄糖尿（腎小管損傷）"
          ]
        },
        {
          "step": 4,
          "action": "影像與病因確認",
          "details": "腎臟超音波與毒物/感染篩查",
          "findings": [
            "腎臟腫大高回音",
            "排除腎後性阻塞",
            "毒物暴露史（乙二醇、百合、NSAIDs）",
            "鉤端螺旋體篩檢"
          ]
        }
      ]
    },
    "monitoring": [
      "尿量（導尿管+收集）",
      "體重（q8-12h）",
      "BUN/Creatinine（q12-24h）",
      "電解質（q8-12h）",
      "血壓",
      "CVP（若有）"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; IRIS AKI Guidelines"
  },
  "chronic-kidney-disease": {
    "zh": "慢性腎臟病",
    "en": "Chronic Kidney Disease (CKD)",
    "definition": "慢性腎臟病（CKD）是腎臟結構和功能的進行性不可逆損傷，持續超過3個月。IRIS分期依血清肌酐和SDMA分為1-4期，結合蛋白尿亞分期和血壓亞分期指導治療。為老年貓最常見疾病之一（15歲以上貓>30%），犬亦常見。早期無症狀，晚期出現多飲多尿、食慾下降和嘔吐。",
    "synonyms": [
      "CKD",
      "慢性腎衰竭",
      "Chronic Renal Failure",
      "CRF",
      "腎功能不全"
    ],
    "epidemiology": {
      "species": "貓較犬更常見",
      "age": "老年動物好發（貓>10歲，犬>7歲）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "老年",
        "先前AKI",
        "腎毒性藥物暴露",
        "腎盂腎炎史",
        "多囊腎病（波斯貓）",
        "腎發育不良",
        "澱粉樣變性"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "多飲多尿（PU/PD）",
        "食慾下降",
        "體重減輕",
        "嘔吐",
        "口臭",
        "被毛品質變差",
        "嗜睡",
        "便秘"
      ],
      "physicalExam": [
        "脫水",
        "消瘦",
        "口腔潰瘍",
        "被毛粗糙",
        "腎臟可能縮小（觸診）",
        "黏膜蒼白（貧血）",
        "高血壓（視網膜病變）"
      ]
    },
    "pathophysiology": "功能性腎元持續喪失 → 殘餘腎元代償性肥大 → 高濾過 → 腎絲球硬化 → 進一步腎元喪失（惡性循環）。後果：氮質血症、濃縮能力喪失、電解質失衡、代謝性酸中毒、腎性貧血、腎性繼發性副甲狀腺亢進",
    "diagnosis": {
      "overview": "基於持續性氮質血症、等張尿、影像學腎臟變化。IRIS分期指導治療",
      "differentials": [
        "急性腎損傷",
        "腎前性氮質血症",
        "腎後性阻塞",
        "甲狀腺亢進（貓）"
      ],
      "initialDB": [
        "BUN/Creatinine",
        "SDMA",
        "尿液分析（比重、蛋白）",
        "UPC（尿蛋白/肌酐比）",
        "電解質（K+、磷）",
        "CBC（貧血）",
        "腹部超聲"
      ],
      "advanced": [
        "血壓測量",
        "甲狀腺功能（貓）",
        "PTH和離子鈣",
        "眼底檢查",
        "腎臟活檢（特定情況）"
      ]
    },
    "irisStaging": {
      "stage1": "Creatinine <1.4 mg/dL（犬）或 <1.6 mg/dL（貓）；SDMA <18 μg/dL",
      "stage2": "Creatinine 1.4-2.8 mg/dL（犬）或 1.6-2.8 mg/dL（貓）；SDMA 18-35 μg/dL",
      "stage3": "Creatinine 2.9-5.0 mg/dL；SDMA 36-54 μg/dL",
      "stage4": "Creatinine >5.0 mg/dL；SDMA >54 μg/dL",
      "subStaging": "依據蛋白尿（非蛋白尿、臨界蛋白尿、蛋白尿）和血壓（正常、前期高血壓、高血壓、嚴重高血壓）"
    },
    "treatment": {
      "overview": "減緩疾病進展、控制併發症、維持生活品質",
      "acute": [
        "尿毒症危象處理：",
        "- 靜脈輸液糾正脫水",
        "- 止吐：Maropitant 1 mg/kg SQ q24h",
        "- 胃保護：Omeprazole 1 mg/kg PO q12-24h",
        "- 食慾刺激：Mirtazapine 1.88 mg/貓 q48h 或犬 0.5-1 mg/kg q24h"
      ],
      "chronic": [
        "飲食管理（腎臟處方飲食）：限制磷、適度蛋白、增加omega-3",
        "磷結合劑（若高磷血症）：Aluminum hydroxide、Calcium carbonate、Lanthanum、Sucroferric oxyhydroxide",
        "蛋白尿控制：",
        "- ACE抑制劑：Benazepril 0.5-1 mg/kg PO q12-24h 或 Enalapril 0.5 mg/kg PO q12-24h",
        "- ARB：Telmisartan 1 mg/kg PO q24h（貓首選）",
        "高血壓控制：Amlodipine 0.1-0.25 mg/kg PO q24h（貓首選）",
        "貧血管理：Darbepoetin 1 μg/kg SQ q1-2週（需補充鐵）",
        "噁心/嘔吐：Maropitant、Ondansetron",
        "代謝性酸中毒：Potassium citrate 或 Sodium bicarbonate",
        "低血鉀：Potassium gluconate 補充",
        "皮下輸液：維持水合（家庭照護）"
      ]
    },
    "prognosis": "取決於IRIS分期和併發症控制。Stage 1-2：數年。Stage 3：數月至1-2年。Stage 4：數週至數月。蛋白尿和高血壓加速進展。",
    "pearls": [
      "SDMA比Creatinine更早偵測腎功能下降（約40% vs 75%功能喪失）",
      "貓CKD常合併甲狀腺亢進，治療甲亢後腎功能可能惡化",
      "腎臟處方飲食可延長2-3倍存活時間",
      "高磷血症加速CKD進展",
      "血壓>160 mmHg需要治療以保護靶器官"
    ],
    "diagnosticAlgorithm": {
      "title": "慢性腎臟病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估多飲多尿、體重減輕病史",
          "findings": [
            "多飲多尿",
            "體重減輕與肌肉流失",
            "口腔潰瘍",
            "被毛粗糙"
          ]
        },
        {
          "step": 2,
          "action": "血液生化與IRIS分期",
          "details": "腎功能指標及分期",
          "findings": [
            "肌酐與SDMA升高",
            "IRIS分期（1-4期）",
            "電解質異常",
            "非再生性貧血"
          ]
        },
        {
          "step": 3,
          "action": "尿液分析與UPC",
          "details": "尿液評估與蛋白定量",
          "findings": [
            "尿比重持續偏低",
            "蛋白尿（UPC>0.4犬/>0.2貓）",
            "亞分期（蛋白尿與高血壓）"
          ]
        },
        {
          "step": 4,
          "action": "影像與並發症",
          "details": "腎臟形態與血壓",
          "findings": [
            "腎臟縮小表面不規則（晚期）",
            "超音波腎臟回音增強",
            "血壓測量",
            "甲狀腺功能（貓）"
          ]
        }
      ]
    },
    "monitoring": [
      "BUN/Crea/SDMA q2-4週（初期）then q2-4月",
      "UPC",
      "血壓q1-3月",
      "電解質",
      "PCV",
      "體重",
      "生活品質評估"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; IRIS Guidelines 2023"
  },
  "feline-lower-urinary-tract-disease": {
    "zh": "貓下泌尿道疾病",
    "en": "Feline Lower Urinary Tract Disease (FLUTD)",
    "definition": "貓下泌尿道疾病（FLUTD）是影響貓膀胱和尿道的一組臨床症候群總稱，以血尿、頻尿、排尿困難和不適當排尿為特徵。最常見原因為特發性膀胱炎（FIC，佔55-69%），其次為尿路結石（15-21%）、感染（1-8%）和尿道栓子。公貓尿道阻塞為急症。",
    "synonyms": [
      "FLUTD",
      "貓泌尿症候群",
      "FUS",
      "Feline Urologic Syndrome",
      "貓特發性膀胱炎",
      "FIC"
    ],
    "epidemiology": {
      "species": "貓特有",
      "age": "1-10歲，好發於中年（2-6歲）",
      "sex": "公貓和母貓皆可發生，公貓更易阻塞",
      "riskFactors": [
        "室內生活",
        "多貓家庭",
        "緊迫/壓力",
        "肥胖",
        "缺乏運動",
        "乾糧為主",
        "飲水量少"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "頻尿",
        "排尿困難",
        "血尿",
        "亂尿（不在貓砂盆排尿）",
        "舔舐生殖器",
        "叫聲痛苦",
        "反覆發作"
      ],
      "physicalExam": [
        "膀胱可能敏感",
        "膀胱大小（阻塞時膨大且硬）",
        "尿道可能觸診到結石",
        "會陰區可能紅腫"
      ]
    },
    "etiology": {
      "overview": "FLUTD是症候群，非單一診斷",
      "causes": [
        "特發性膀胱炎（FIC）：最常見（55-65%）",
        "尿路結石：10-25%（草酸鈣、鳥糞石）",
        "尿道栓子：10-20%",
        "泌尿道感染：<5%（年輕貓罕見）",
        "解剖異常：尿道狹窄、腫瘤",
        "行為問題"
      ]
    },
    "pathophysiology": "FIC：緊迫 → HPA軸失調 → 膀胱GAG層損傷 → 神經性炎症 → 疼痛和臨床症狀。結石：礦物質過飽和 → 結晶形成 → 結石生長 → 阻塞或刺激。栓子：晶體+黏液+細胞碎片 → 尿道阻塞",
    "diagnosis": {
      "overview": "排除可治療病因（結石、感染），FIC為排除性診斷",
      "differentials": [
        "特發性膀胱炎",
        "尿路結石",
        "泌尿道感染",
        "尿道阻塞",
        "腫瘤",
        "解剖異常"
      ],
      "initialDB": [
        "尿液分析（包含沉渣）",
        "尿液培養",
        "腹部X光",
        "腹部超聲"
      ],
      "advanced": [
        "尿道造影",
        "膀胱鏡",
        "尿石分析"
      ]
    },
    "treatment": {
      "overview": "依據病因治療：FIC以環境管理和鎮痛為主；結石依類型處理",
      "acute": [
        "疼痛控制：Buprenorphine 0.01-0.02 mg/kg SL q6-8h",
        "解痙：Prazosin 0.25-0.5 mg/貓 PO q8-12h（公貓尿道痙攣）",
        "抗焦慮：短期可考慮Gabapentin 5-10 mg/kg PO",
        "若阻塞：見「尿道阻塞」處理"
      ],
      "chronic": [
        "環境豐富化（MEMO）：",
        "- 多個貓砂盆（n+1原則）",
        "- 增加飲水量（流動飲水器、濕食）",
        "- 減少緊迫（貓費洛蒙、安全空間）",
        "- 互動和遊戲",
        "飲食管理：增加水分攝取、泌尿道處方飲食",
        "鳥糞石結石：溶解飲食（若適用）",
        "草酸鈣結石：手術移除（無法溶解）",
        "Amitriptyline：10 mg/貓 PO q24h（頑固性FIC，需監測）",
        "Polysulfated glycosaminoglycan：可考慮（證據有限）"
      ]
    },
    "prognosis": "FIC：多數自限性（數天內緩解），但復發率高。結石：移除後預後良好，需預防復發。公貓阻塞若未及時處理可致命。",
    "pearls": [
      "年輕貓（<10歲）UTI罕見，不要常規使用抗生素",
      "FIC是排除性診斷，但最常見",
      "環境管理比藥物更重要",
      "公貓反覆阻塞可考慮會陰尿道造口術",
      "草酸鈣結石無法溶解，鳥糞石可溶解"
    ],
    "diagnosticAlgorithm": {
      "title": "貓下泌尿道疾病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估排尿異常及阻塞風險",
          "findings": [
            "頻尿血尿",
            "排尿困難",
            "不在貓砂盆排尿",
            "公貓可能完全阻塞"
          ]
        },
        {
          "step": 2,
          "action": "尿液分析",
          "details": "完整尿液分析",
          "findings": [
            "血尿",
            "結晶（鳥糞石或草酸鈣）",
            "尿pH",
            "細菌培養（年長貓）"
          ]
        },
        {
          "step": 3,
          "action": "腹部影像",
          "details": "X光與超音波評估泌尿道",
          "findings": [
            "膀胱壁增厚",
            "結石評估",
            "排除腫瘤",
            "膀胱充盈度（阻塞評估）"
          ]
        },
        {
          "step": 4,
          "action": "病因分類與管理",
          "details": "區分各型FLUTD",
          "findings": [
            "特發性膀胱炎（最常見60-70%）",
            "結石相關",
            "細菌感染（較少見年輕貓）",
            "壓力因素評估與環境管理"
          ]
        }
      ]
    },
    "monitoring": [
      "症狀緩解情況",
      "尿液分析（追蹤）",
      "影像學追蹤結石",
      "體重管理"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; AAFP/ISFM Guidelines on FLUTD"
  },
  "urinary-tract-infection": {
    "zh": "泌尿道感染",
    "en": "Urinary Tract Infection (UTI)",
    "definition": "泌尿道感染（UTI）是細菌（最常見E. coli，佔40-50%）侵犯泌尿系統的感染性疾病。犬雌性好發（尿道短），貓UTI較少見（<10歲貓罕見，老年貓和CKD/DM貓增加）。分簡單性UTI（無潛在疾病）和複雜性UTI（伴結構異常或免疫抑制）。尿液培養為診斷金標準。",
    "synonyms": [
      "UTI",
      "膀胱炎",
      "Bacterial Cystitis",
      "尿路感染"
    ],
    "epidemiology": {
      "species": "犬較貓常見",
      "age": "母犬任何年齡，公犬和貓多為老年",
      "sex": "母犬較公犬常見（尿道較短）",
      "riskFactors": [
        "母犬（解剖因素）",
        "老年",
        "糖尿病",
        "腎上腺皮質功能亢進",
        "免疫抑制",
        "尿液滯留",
        "尿路結石",
        "留置導尿管",
        "先天性異常"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "頻尿",
        "排尿困難",
        "血尿",
        "尿液混濁或惡臭",
        "亂尿",
        "舔舐泌尿生殖區"
      ],
      "physicalExam": [
        "膀胱可能敏感",
        "發燒（若腎盂腎炎）",
        "會陰區可能發紅",
        "外陰分泌物（母犬）"
      ]
    },
    "pathophysiology": "細菌（多為腸道菌）上行感染 → 黏附於膀胱上皮 → 繁殖 → 炎症反應 → 黏膜損傷 → 臨床症狀。宿主防禦機制受損加重感染：正常尿流、黏膜屏障、免疫功能",
    "commonPathogens": [
      "Escherichia coli（最常見）",
      "Staphylococcus spp.",
      "Proteus spp.",
      "Enterococcus spp.",
      "Klebsiella spp.",
      "Pseudomonas（複雜性UTI）"
    ],
    "diagnosis": {
      "overview": "尿液培養和藥敏試驗是金標準",
      "differentials": [
        "特發性膀胱炎（貓）",
        "尿路結石",
        "腫瘤",
        "前列腺疾病（公犬）"
      ],
      "initialDB": [
        "尿液分析（膀胱穿刺取樣最佳）",
        "尿液培養和藥敏",
        "尿沉渣（細菌、WBC）"
      ],
      "advanced": [
        "腹部超聲",
        "X光（排除結石）",
        "血糖（排除糖尿病）",
        "腎上腺功能檢查"
      ]
    },
    "utiClassification": {
      "simple": "首次或偶發性UTI，無潛在疾病或解剖異常",
      "complicated": "反覆感染、有潛在疾病、解剖異常、或感染擴展（腎盂腎炎、前列腺炎）",
      "subclinical": "尿液培養陽性但無臨床症狀（通常不治療，除非特殊情況）"
    },
    "treatment": {
      "overview": "基於尿液培養和藥敏結果選擇抗生素",
      "acute": [
        "單純性UTI（經驗性治療，等待培養結果）：",
        "- Amoxicillin: 11-15 mg/kg PO q8h × 7-14天",
        "- Amoxicillin-clavulanate: 12.5-25 mg/kg PO q12h",
        "- Trimethoprim-sulfa: 15-30 mg/kg PO q12h",
        "複雜性UTI：依據培養結果，療程較長（4-6週）",
        "腎盂腎炎：見相關條目",
        "鎮痛（若需要）：NSAIDs短期使用（注意腎功能）"
      ],
      "chronic": [
        "復發性UTI管理：",
        "- 尋找並治療潛在病因",
        "- 長期低劑量抗生素（夜間給藥）",
        "- 或間歇性自我治療（主人觀察症狀時給藥）",
        "增加水分攝取",
        "定期監測尿液培養"
      ]
    },
    "prognosis": "單純性UTI：預後良好。複雜性/復發性：取決於潛在病因控制。",
    "pearls": [
      "膀胱穿刺取樣避免污染，是培養金標準",
      "年輕健康貓UTI罕見，需考慮其他病因",
      "無症狀菌尿通常不需治療（除非免疫抑制、即將手術等）",
      "反覆UTI應尋找潛在病因（糖尿病、腎上腺皮質功能亢進）",
      "氟喹諾酮類應保留給多重抗藥性感染"
    ],
    "diagnosticAlgorithm": {
      "title": "泌尿道感染 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估排尿症狀及全身狀態",
          "findings": [
            "頻尿",
            "血尿",
            "排尿困難",
            "尿液混濁或惡臭"
          ]
        },
        {
          "step": 2,
          "action": "尿液分析",
          "details": "膀胱穿刺採樣分析",
          "findings": [
            "膀胱穿刺尿液",
            "白血球增多",
            "細菌（桿菌或球菌）",
            "血尿與蛋白尿"
          ]
        },
        {
          "step": 3,
          "action": "尿液培養與藥敏",
          "details": "細菌鑑定與抗生素選擇",
          "findings": [
            "常見E. coli, Staphylococcus, Proteus",
            "藥敏試驗指導抗生素",
            "區分單純vs複雜UTI"
          ]
        },
        {
          "step": 4,
          "action": "潛在原因篩查",
          "details": "評估易感因素",
          "findings": [
            "腹部影像排除結石",
            "庫欣氏症篩檢",
            "糖尿病篩檢",
            "尿道解剖異常評估"
          ]
        }
      ]
    },
    "monitoring": [
      "治療結束後5-7天尿液培養確認清除",
      "反覆感染需定期培養"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; ISCAID Guidelines on UTI"
  },
  "pyelonephritis": {
    "zh": "腎盂腎炎",
    "en": "Pyelonephritis",
    "definition": "腎盂腎炎是細菌感染引起的腎盂和腎實質炎症，為泌尿道感染上行擴展至腎臟的嚴重併發症。最常見致病菌為E. coli。危險因子包括尿路結石、尿道導管留置、糖尿病和免疫抑制。急性型以發燒、腎區疼痛和腎腫大為特徵，慢性型可導致腎臟纖維化和CKD。",
    "synonyms": [
      "腎臟感染",
      "Upper UTI",
      "Kidney Infection"
    ],
    "epidemiology": {
      "species": "犬較貓常見",
      "age": "任何年齡，中老年較多",
      "sex": "母犬略多",
      "riskFactors": [
        "下泌尿道感染上行",
        "尿路結石",
        "先天性異常（異位輸尿管、VUR）",
        "免疫抑制",
        "糖尿病",
        "腎上腺皮質功能亢進",
        "留置導尿管"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "發燒",
        "嗜睡",
        "食慾下降",
        "嘔吐",
        "腰背痛",
        "多飲多尿",
        "可能有下泌尿道症狀"
      ],
      "physicalExam": [
        "發燒",
        "腎臟區疼痛（腰部觸診）",
        "腎臟可能腫大",
        "脫水",
        "黏膜充血或蒼白"
      ]
    },
    "pathophysiology": "細菌從膀胱上行至腎臟 → 腎盂黏膜感染 → 擴展至腎實質 → 化膿性炎症 → 腎間質纖維化（慢性）→ 腎功能喪失。血源性感染較少見但可發生。",
    "diagnosis": {
      "overview": "臨床表現結合尿液培養陽性和影像學發現",
      "differentials": [
        "下泌尿道感染",
        "腎結石",
        "急性腎損傷",
        "腎膿腫"
      ],
      "initialDB": [
        "尿液分析和培養",
        "CBC（嗜中性球增多、左移）",
        "生化（可能氮質血症）",
        "腹部超聲（腎盂擴張、腎臟腫大、皮質回音改變）"
      ],
      "advanced": [
        "腹部CT",
        "靜脈腎盂造影",
        "腎臟穿刺培養"
      ]
    },
    "treatment": {
      "overview": "長期抗生素治療基於培養結果，支持治療",
      "acute": [
        "住院治療（嚴重病例）：",
        "- 靜脈輸液糾正脫水",
        "- IV抗生素（初期）：",
        "  * Ampicillin: 20-40 mg/kg IV q6-8h + Enrofloxacin: 5-10 mg/kg IV q24h",
        "  * 或 Ampicillin-sulbactam: 20-30 mg/kg IV q8h",
        "- 止痛：Buprenorphine或其他鴉片類",
        "- 止吐：Maropitant 1 mg/kg IV q24h"
      ],
      "chronic": [
        "口服抗生素（依培養結果）：4-6週療程",
        "常用選擇：",
        "- Amoxicillin-clavulanate: 12.5-25 mg/kg PO q12h",
        "- 氟喹諾酮類：Enrofloxacin 5-10 mg/kg PO q24h",
        "- Trimethoprim-sulfa: 15-30 mg/kg PO q12h",
        "治療潛在病因（結石移除、異常矯正）",
        "慢性腎盂腎炎可能需要更長療程"
      ]
    },
    "prognosis": "急性若及時治療預後良好。慢性或反覆發作可導致永久性腎損傷和CKD。雙側嚴重感染預後謹慎。",
    "pearls": [
      "急性腎盂腎炎是全身性疾病，不只是UTI",
      "超聲可見腎盂擴張但不一定有積水",
      "氮質血症可能是暫時性（腎臟腫脹）或永久性（腎損傷）",
      "抗生素療程需要4-6週以根除腎臟感染",
      "治療後需追蹤尿液培養確認清除"
    ],
    "diagnosticAlgorithm": {
      "title": "腎盂腎炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估發燒、腎區疼痛及泌尿症狀",
          "findings": [
            "發燒",
            "腎區疼痛",
            "嘔吐",
            "多飲多尿"
          ]
        },
        {
          "step": 2,
          "action": "血液與尿液",
          "details": "CBC、生化及尿液分析",
          "findings": [
            "白血球增多",
            "氮血症",
            "尿中白血球管型",
            "菌尿"
          ]
        },
        {
          "step": 3,
          "action": "尿液培養",
          "details": "膀胱穿刺培養",
          "findings": [
            "細菌培養陽性",
            "藥敏試驗",
            "高菌量（>10^5 CFU/mL）"
          ]
        },
        {
          "step": 4,
          "action": "腎臟超音波",
          "details": "評估腎臟結構變化",
          "findings": [
            "腎盂擴張",
            "腎實質回音改變",
            "腎臟腫大",
            "排除尿路阻塞"
          ]
        }
      ]
    },
    "monitoring": [
      "體溫",
      "腎功能（BUN/Crea）",
      "尿液培養（治療中和治療後）",
      "超聲追蹤"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "polycystic-kidney-disease": {
    "zh": "多囊性腎病",
    "en": "Polycystic Kidney Disease (PKD)",
    "definition": "多囊性腎病（PKD）是以雙側腎臟多發性囊腫進行性增大為特徵的遺傳性腎臟疾病。波斯貓和相關品種為常染色體顯性遺傳（PKD1基因突變），發病率約36-49%。犬罕見。囊腫隨年齡增大壓迫正常腎組織→腎功能進行性喪失→最終CKD。超音波可在10-16週齡偵測到囊腫。",
    "synonyms": [
      "PKD",
      "多囊腎",
      "Polycystic Kidneys"
    ],
    "epidemiology": {
      "species": "貓較常見（波斯貓及相關品種），犬少見",
      "age": "先天性，但臨床症狀多在中老年出現",
      "sex": "無性別傾向",
      "breedPredisposition": [
        "波斯貓（約36-50%發生率）",
        "喜馬拉雅貓",
        "英國短毛貓",
        "異國短毛貓",
        "蘇格蘭摺耳貓"
      ],
      "riskFactors": [
        "遺傳（常染色體顯性遺傳，PKD1基因突變）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "多飲多尿（PU/PD）",
        "體重減輕",
        "食慾下降",
        "嘔吐",
        "嗜睡"
      ],
      "physicalExam": [
        "腎臟不規則腫大（雙側觸診）",
        "腹部觸診可感覺到凹凸不平的腎臟",
        "脫水",
        "CKD相關症狀"
      ]
    },
    "pathophysiology": "PKD1基因突變 → polycystin-1蛋白異常 → 腎小管上皮細胞增殖和分泌異常 → 囊腫形成和擴大 → 壓迫正常腎實質 → 腎功能進行性喪失。囊腫數量和大小隨年齡增加。",
    "diagnosis": {
      "overview": "超聲診斷為主，基因檢測可早期確診",
      "differentials": [
        "腎臟腫瘤",
        "腎臟淋巴瘤",
        "腎周假性囊腫",
        "水腎"
      ],
      "initialDB": [
        "腹部超聲（多個囊腫，雙側腎臟）",
        "BUN/Creatinine/SDMA",
        "尿液分析",
        "血壓"
      ],
      "advanced": [
        "PKD1基因檢測（可在幼年進行）",
        "CT或MRI"
      ]
    },
    "geneticTesting": {
      "indication": "繁殖前篩檢、早期診斷",
      "method": "PCR檢測PKD1基因突變",
      "timing": "可在任何年齡進行，推薦繁殖前"
    },
    "treatment": {
      "overview": "無法治癒，治療目標為延緩CKD進展和控制併發症",
      "acute": [
        "尿毒症危象：同CKD處理",
        "囊腫感染：長期抗生素（需穿透囊腫壁）",
        "- Fluoroquinolones較佳穿透性",
        "- 療程4-6週"
      ],
      "chronic": [
        "CKD管理（參見CKD條目）：",
        "- 腎臟處方飲食",
        "- 磷結合劑",
        "- 血壓控制",
        "- 蛋白尿控制",
        "- 皮下輸液維持水合",
        "Tolvaptan：在人類PKD有效，獸醫尚無標準用法",
        "囊腫引流：僅用於巨大囊腫引起不適（效果暫時）"
      ]
    },
    "prognosis": "進展速度因個體差異大。多數貓在3-10歲出現CKD。平均診斷腎衰竭年齡約7歲。基因檢測陽性不等於一定會發展為腎衰竭。",
    "pearls": [
      "超聲10週齡即可檢測到囊腫，但早期可能漏診",
      "基因檢測是唯一100%準確的早期診斷方法",
      "繁殖控制是降低發病率的關鍵",
      "囊腫感染難以治療，抗生素需能穿透囊壁",
      "肝臟也可能有囊腫（較少引起臨床症狀）"
    ],
    "diagnosticAlgorithm": {
      "title": "多囊性腎病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "觸診腎臟腫大及品種評估",
          "findings": [
            "波斯貓及相關品種好發",
            "腎臟觸診腫大不規則",
            "可能無症狀（早期）",
            "晚期CKD症狀"
          ]
        },
        {
          "step": 2,
          "action": "腹部超音波",
          "details": "腎臟超音波確認囊腫",
          "findings": [
            "雙側腎臟多發性無回音囊腫",
            "囊腫大小不一",
            "肝臟囊腫可能共存",
            "腎臟結構異常"
          ]
        },
        {
          "step": 3,
          "action": "腎功能評估",
          "details": "血液生化監測進展",
          "findings": [
            "SDMA與肌酐評估",
            "尿比重",
            "蛋白尿評估",
            "IRIS分期"
          ]
        },
        {
          "step": 4,
          "action": "基因檢測與管理",
          "details": "PKD1基因篩檢",
          "findings": [
            "PKD1基因突變（波斯貓）",
            "繁殖建議",
            "定期超音波追蹤囊腫大小",
            "CKD管理方案"
          ]
        }
      ]
    },
    "monitoring": [
      "定期超聲（q6-12月）",
      "腎功能（BUN/Crea/SDMA）",
      "血壓",
      "體重"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "protein-losing-nephropathy": {
    "zh": "蛋白質流失性腎病",
    "en": "Protein-Losing Nephropathy (PLN)",
    "definition": "蛋白質流失性腎病（PLN）是因腎絲球基底膜損傷導致大量蛋白質經尿液流失的疾病，尿蛋白/肌酐比值UPC>2.0。犬常見原因包括免疫複合物性腎絲球腎炎、腎澱粉樣變性和遺傳性腎病（Soft-Coated Wheaten Terrier、Bernese Mountain Dog）。低白蛋白血症可導致水腫、胸腹水和血栓形成。",
    "synonyms": [
      "PLN",
      "腎絲球疾病",
      "Glomerulonephritis",
      "腎絲球腎炎",
      "蛋白尿性腎病"
    ],
    "epidemiology": {
      "species": "犬較貓常見",
      "age": "中老年犬好發",
      "sex": "無明顯性別傾向",
      "breedPredisposition": [
        "Soft-coated Wheaten Terrier",
        "Bernese Mountain Dog",
        "English Cocker Spaniel",
        "Bull Terrier",
        "Dalmatian",
        "Samoyed"
      ],
      "riskFactors": [
        "感染性疾病（萊姆病、心絲蟲）",
        "免疫介導疾病",
        "腫瘤",
        "遺傳因素"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "初期可能無症狀",
        "體重減輕",
        "嗜睡",
        "水腫",
        "腹水",
        "呼吸困難（胸水）",
        "CKD症狀"
      ],
      "physicalExam": [
        "四肢水腫",
        "腹水",
        "體腔積液",
        "消瘦",
        "高血壓相關徵象"
      ]
    },
    "pathophysiology": "腎絲球屏障損傷（免疫複合物沉積、遺傳缺陷等）→ 通透性增加 → 白蛋白和其他蛋白質流失 → 低白蛋白血症 → 水腫、腹水。同時：高脂血症、凝血亢進（抗凝血酶III流失）→ 血栓栓塞風險增加",
    "diagnosis": {
      "overview": "基於持續性蛋白尿（UPC > 0.5犬，> 0.4貓）和排除其他蛋白尿原因",
      "differentials": [
        "下泌尿道感染/炎症引起的蛋白尿",
        "管性蛋白尿",
        "其他低白蛋白血症原因"
      ],
      "initialDB": [
        "UPC（尿蛋白/肌酐比）",
        "尿液分析和培養",
        "BUN/Crea/SDMA",
        "血漿白蛋白",
        "血脂",
        "CBC"
      ],
      "advanced": [
        "抗凝血酶III",
        "膽固醇",
        "感染疾病篩檢（萊姆病、心絲蟲等）",
        "ANA",
        "腎臟超聲",
        "腎臟活檢（金標準診斷腎絲球疾病類型）"
      ]
    },
    "treatment": {
      "overview": "治療原發病因、減少蛋白尿、管理併發症",
      "acute": [
        "嚴重低白蛋白血症（<1.5 g/dL）：",
        "- 新鮮冷凍血漿",
        "- 人工膠體（慎用）",
        "血栓栓塞預防：",
        "- Clopidogrel: 1-2 mg/kg PO q24h",
        "- 或/加 低劑量Aspirin: 0.5-1 mg/kg PO q24h"
      ],
      "chronic": [
        "減少蛋白尿（腎保護）：",
        "- ACE抑制劑：Enalapril/Benazepril 0.5-1 mg/kg PO q12-24h",
        "- ARB：Telmisartan 1 mg/kg PO q24h",
        "- 可合併使用",
        "高血壓控制：Amlodipine 0.1-0.25 mg/kg PO q24h",
        "腎臟處方飲食（限制蛋白、補充omega-3）",
        "免疫抑制治療（免疫介導性腎絲球腎炎）：",
        "- Mycophenolate: 10-20 mg/kg PO q12h",
        "- 避免長期類固醇（可能加重蛋白尿和促進血栓）",
        "治療原發感染（萊姆病：Doxycycline）",
        "抗凝治療持續進行"
      ]
    },
    "prognosis": "取決於原發病因和治療反應。UPC > 3.5和低白蛋白血症預後較差。血栓栓塞是常見致死併發症。",
    "pearls": [
      "UPC > 2.0 高度提示腎絲球疾病",
      "必須排除尿路感染和炎症再評估蛋白尿",
      "血栓栓塞風險與蛋白尿嚴重程度相關",
      "腎臟活檢可區分不同類型腎絲球疾病",
      "類固醇在多數情況下不是首選免疫抑制劑"
    ],
    "diagnosticAlgorithm": {
      "title": "蛋白質流失性腎病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估水腫、腹水及蛋白尿",
          "findings": [
            "四肢或腹部水腫",
            "腹水",
            "體重變化",
            "可能無其他明顯症狀"
          ]
        },
        {
          "step": 2,
          "action": "尿液蛋白定量",
          "details": "UPC持續測量",
          "findings": [
            "UPC>2.0（顯著蛋白尿）",
            "排除泌尿道感染影響",
            "連續採樣確認持續性"
          ]
        },
        {
          "step": 3,
          "action": "血液生化",
          "details": "評估蛋白流失嚴重度",
          "findings": [
            "低白蛋白血症",
            "高膽固醇血症",
            "抗凝血酶III降低（血栓風險）",
            "氮血症（晚期）"
          ]
        },
        {
          "step": 4,
          "action": "腎臟切片",
          "details": "超音波導引腎切片確診",
          "findings": [
            "腎絲球病變分型",
            "免疫複合體沉積",
            "類澱粉沉積",
            "膜性腎病"
          ]
        }
      ]
    },
    "monitoring": [
      "UPC（q2-4週初期，然後q2-4月）",
      "血壓",
      "白蛋白",
      "腎功能",
      "血栓症狀"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; ACVIM Consensus Statement on PLN"
  },
  "renal-dysplasia": {
    "zh": "腎發育不良",
    "en": "Renal Dysplasia",
    "definition": "腎發育不良是指腎臟在發育過程中分化異常導致的先天性腎臟疾病。病理特徵為腎臟含有不成熟的腎元（胎兒型腎小球和腎小管）、軟骨化生和纖維化。Lhasa Apso、Shih Tzu、Standard Poodle有遺傳傾向。幼犬和年輕犬出現多飲多尿和發育不良時應懷疑。",
    "synonyms": [
      "腎發育異常",
      "Juvenile Nephropathy",
      "幼年型腎病",
      "Familial Nephropathy"
    ],
    "epidemiology": {
      "species": "犬較常見",
      "age": "幼年至青年（通常<2歲出現症狀）",
      "sex": "無明顯性別傾向",
      "breedPredisposition": [
        "Shih Tzu",
        "Lhasa Apso",
        "Soft-coated Wheaten Terrier",
        "Standard Poodle",
        "Alaskan Malamute",
        "Chow Chow",
        "Golden Retriever",
        "Cocker Spaniel"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "多飲多尿",
        "生長遲緩",
        "食慾不振",
        "體重不增或減輕",
        "嘔吐",
        "嗜睡",
        "被毛品質差"
      ],
      "physicalExam": [
        "體型較同齡小",
        "消瘦",
        "脫水",
        "腎臟小或觸診不到",
        "可能有口腔潰瘍",
        "橡皮頜（腎性骨營養不良）"
      ]
    },
    "pathophysiology": "胎兒期腎臟發育異常 → 不成熟或發育不全的腎小管和腎絲球 → 功能性腎元減少 → 代償性肥大不足以彌補 → 進行性腎功能喪失。病理特徵：原始腎小管、不成熟腎絲球、間質纖維化",
    "diagnosis": {
      "overview": "幼年動物出現CKD表現應懷疑，腎臟活檢確診",
      "differentials": [
        "腎盂腎炎",
        "腎毒性",
        "先天性尿路梗阻",
        "多囊腎病"
      ],
      "initialDB": [
        "BUN/Creatinine",
        "尿液分析（等張尿）",
        "電解質",
        "腹部超聲（小腎臟、皮髓質分界不清）",
        "X光（可能有骨骼變化）"
      ],
      "advanced": [
        "腎臟活檢（確診）",
        "離子鈣/PTH（繼發性甲狀旁腺亢進）"
      ]
    },
    "treatment": {
      "overview": "無法治癒，治療同CKD，預後較差",
      "acute": [
        "尿毒症危象：",
        "- 靜脈輸液",
        "- 止吐",
        "- 胃保護"
      ],
      "chronic": [
        "CKD支持治療：",
        "- 腎臟處方飲食",
        "- 磷結合劑",
        "- 皮下輸液維持水合",
        "- 促紅血球生成素（若貧血）",
        "腎性骨營養不良管理：",
        "- 磷控制",
        "- 活性維生素D（Calcitriol）慎用"
      ]
    },
    "prognosis": "預後差，多數在2歲前進展至終末期腎衰竭。存活時間取決於診斷時腎功能和治療反應。",
    "pearls": [
      "幼年犬CKD應高度懷疑腎發育不良",
      "超聲可見小而不規則的腎臟",
      "腎臟活檢是唯一確診方法",
      "繁殖計畫應排除受影響品系",
      "「橡皮頜」是腎性骨營養不良的特徵性表現"
    ],
    "diagnosticAlgorithm": {
      "title": "腎發育不良 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "幼犬生長遲緩與多飲多尿",
          "findings": [
            "幼犬生長遲緩",
            "多飲多尿",
            "體重減輕",
            "好發品種"
          ]
        },
        {
          "step": 2,
          "action": "血液生化",
          "details": "腎功能評估",
          "findings": [
            "氮血症",
            "磷升高",
            "非再生性貧血",
            "代謝性酸中毒"
          ]
        },
        {
          "step": 3,
          "action": "腹部超音波",
          "details": "腎臟形態評估",
          "findings": [
            "腎臟小且不規則",
            "皮髓質分界不清",
            "腎臟回音增強",
            "可能不對稱"
          ]
        },
        {
          "step": 4,
          "action": "腎臟切片確診",
          "details": "組織病理學",
          "findings": [
            "未成熟腎元（胚胎型腎絲球）",
            "腎小管發育異常",
            "間質纖維化",
            "確診與預後評估"
          ]
        }
      ]
    },
    "monitoring": [
      "腎功能定期評估",
      "生長曲線",
      "鈣磷代謝",
      "血壓"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "ectopic-ureter": {
    "zh": "異位輸尿管",
    "en": "Ectopic Ureter",
    "definition": "輸尿管開口於膀胱三角區以外的位置（如尿道、陰道、子宮）的先天性異常，導致尿失禁。",
    "synonyms": [
      "EU",
      "Ureteral Ectopia",
      "輸尿管異位"
    ],
    "epidemiology": {
      "species": "犬較貓常見",
      "age": "先天性，通常幼年診斷",
      "sex": "母犬較公犬更常被診斷（公犬可能症狀較輕）",
      "breedPredisposition": [
        "Siberian Husky",
        "Labrador Retriever",
        "Golden Retriever",
        "Newfoundland",
        "English Bulldog",
        "West Highland White Terrier",
        "Fox Terrier"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "出生即有尿失禁（持續滴尿）",
        "從未完全控制排尿",
        "會陰區皮膚炎",
        "反覆泌尿道感染"
      ],
      "physicalExam": [
        "會陰區濕潤或尿灼傷",
        "可能有外陰發育不全",
        "膀胱大小可能正常或較小",
        "可能觸診到擴張的輸尿管"
      ]
    },
    "pathophysiology": "胚胎發育期輸尿管芽位置異常 → 輸尿管開口於正常膀胱三角區外 → 尿液繞過尿道括約肌 → 持續性尿失禁。分類：壁內型（沿膀胱壁內延伸開口於遠端）vs 壁外型（完全繞過膀胱）",
    "diagnosis": {
      "overview": "影像學確診異位開口位置",
      "differentials": [
        "括約肌功能不全",
        "先天性尿道異常",
        "下泌尿道感染",
        "前庭陰道異常"
      ],
      "initialDB": [
        "尿液分析和培養",
        "腹部超聲（輸尿管擴張、開口位置）",
        "排泄性靜脈腎盂造影"
      ],
      "advanced": [
        "CT泌尿道造影（首選）",
        "膀胱鏡和尿道鏡（可同時診斷和治療）",
        "逆行性尿道造影"
      ]
    },
    "treatment": {
      "overview": "手術矯正為主，術後可能仍需藥物控制",
      "acute": [
        "泌尿道感染治療：抗生素基於培養結果",
        "皮膚護理：保持會陰區清潔乾燥"
      ],
      "chronic": [
        "手術選項：",
        "- 膀胱鏡引導雷射消融（壁內型首選）",
        "- 新輸尿管膀胱吻合術（開放手術）",
        "- 腎臟/輸尿管切除（單側，若腎功能差）",
        "術後尿失禁管理（30-50%仍有殘餘尿失禁）：",
        "- Phenylpropanolamine (PPA): 1.5-2 mg/kg PO q8-12h",
        "- 雌激素（絕育母犬）：DES 0.1-1 mg PO q24-72h",
        "術後UTI預防和監測"
      ]
    },
    "prognosis": "手術成功率約50-90%。壁內型雷射消融成功率較高。術後仍有尿失禁可能，藥物可改善。",
    "pearls": [
      "幼年母犬尿失禁首先考慮異位輸尿管",
      "單側或雙側皆可發生，雙側約50%",
      "CT泌尿道造影是目前最佳診斷方法",
      "膀胱鏡雷射消融創傷小、恢復快",
      "術後殘餘尿失禁常見，可能需要長期藥物控制"
    ],
    "diagnosticAlgorithm": {
      "title": "異位輸尿管 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "幼犬持續尿失禁病史",
          "findings": [
            "出生即有持續滴尿",
            "母犬好發",
            "正常排尿但同時滴尿",
            "會陰部皮膚刺激"
          ]
        },
        {
          "step": 2,
          "action": "尿液分析與培養",
          "details": "排除感染並評估腎功能",
          "findings": [
            "泌尿道感染常併發",
            "腎功能基本評估"
          ]
        },
        {
          "step": 3,
          "action": "影像診斷",
          "details": "超音波與CT泌尿道造影",
          "findings": [
            "超音波輸尿管走向追蹤",
            "CT urography確認輸尿管開口位置",
            "輸尿管開口於膀胱頸或尿道",
            "對側腎臟與輸尿管評估"
          ]
        },
        {
          "step": 4,
          "action": "手術矯正",
          "details": "內視鏡或手術治療",
          "findings": [
            "膀胱鏡確認開口位置",
            "雷射消融術（intramural型）",
            "手術輸尿管移植（extramural型）",
            "術後尿失禁追蹤"
          ]
        }
      ]
    },
    "monitoring": [
      "術後尿失禁程度",
      "尿液培養",
      "腎功能",
      "超聲追蹤"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "urethral-obstruction": {
    "zh": "尿道阻塞",
    "en": "Urethral Obstruction",
    "definition": "尿道阻塞是指尿道被結石、結晶栓子、黏液蛋白栓子或腫瘤完全或部分堵塞導致無法排尿的泌尿急症。公貓因尿道遠端（陰莖段）極為狹窄而最常受累，為貓急診中最常見的急症之一。完全阻塞24-48小時可因高血鉀致心律不整和急性腎後性腎衰竭而致命。",
    "synonyms": [
      "UO",
      "尿道梗阻",
      "Blocked Cat",
      "Urinary Obstruction",
      "FUO (Feline Urethral Obstruction)"
    ],
    "epidemiology": {
      "species": "公貓最常見，公犬也可發生",
      "age": "貓：1-10歲；犬：任何年齡（結石相關）",
      "sex": "公性動物為主（尿道較長較窄）",
      "riskFactors": [
        "公貓（最高風險）",
        "肥胖",
        "室內生活",
        "缺乏運動",
        "乾糧飲食",
        "飲水少",
        "FLUTD病史"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "頻繁進出貓砂盆",
        "排尿姿勢但無尿或少尿",
        "叫聲痛苦",
        "嘔吐",
        "嗜睡",
        "食慾下降",
        "最後可能虛脫"
      ],
      "physicalExam": [
        "膀胱極度膨脹且硬（「像網球」）",
        "腹部疼痛",
        "心搏過緩（高血鉀）",
        "低體溫",
        "脫水",
        "黏膜蒼白",
        "陰莖可能外露或有分泌物"
      ]
    },
    "pathophysiology": "尿道阻塞 → 膀胱過度膨脹 → 尿液滯留 → 氮質血症 → 高血鉀（危及生命的心律不整）→ 代謝性酸中毒 → 若不治療24-48小時內死亡。膀胱可能破裂（少見）",
    "diagnosis": {
      "overview": "觸診膨脹膀胱即可診斷，需評估代謝狀態",
      "differentials": [
        "膀胱無張力（神經性）",
        "尿道痙攣",
        "尿道腫瘤"
      ],
      "initialDB": [
        "身體觸診（膀胱）",
        "電解質（K+首要）",
        "BUN/Creatinine",
        "血氣分析",
        "ECG（心律）",
        "腹部X光（結石位置）"
      ],
      "advanced": [
        "腹部超聲",
        "尿道造影"
      ]
    },
    "treatment": {
      "overview": "緊急穩定 → 解除阻塞 → 術後監測和預防復發",
      "acute": [
        "代謝穩定（在導尿前）：",
        "- 靜脈通路和輸液：0.9% NaCl 優先（不含K+）",
        "- 嚴重高血鉀處理（K+ >7-8 mEq/L）：",
        "  * 10% Calcium gluconate: 0.5-1 mL/kg IV slow（心臟保護）",
        "  * Regular insulin: 0.25-0.5 U/kg IV + Dextrose",
        "- ECG監測",
        "- 嚴重心搏過緩：Atropine 0.02-0.04 mg/kg IV",
        "解除阻塞：",
        "- 鎮靜/麻醉：Butorphanol + Dexmedetomidine（低劑量若不穩定）",
        "- 逆行沖洗尿道：無菌生理鹽水",
        "- 放置留置導尿管（3.5-5 Fr）",
        "- 若無法導尿：膀胱穿刺暫時減壓",
        "術後輸液：糾正脫水、促進利尿"
      ],
      "chronic": [
        "移除導尿管後監測排尿",
        "Prazosin（尿道鬆弛）：0.25-0.5 mg/貓 PO q8-12h × 3-5天",
        "止痛：Buprenorphine 0.01-0.02 mg/kg SL q6-8h",
        "FLUTD長期管理（見相關條目）",
        "反覆阻塞：會陰尿道造口術（PU手術）"
      ]
    },
    "prognosis": "及時治療預後良好（>90%存活）。延遲治療可致死。約30-40%會復發。PU手術後阻塞罕見但仍可能UTI。",
    "pearls": [
      "公貓尿道阻塞是急診，不能等待",
      "先穩定高血鉀再嘗試導尿",
      "Calcium gluconate保護心臟但不降低血鉀",
      "導尿後24-48小時可能出現「阻塞後利尿」",
      "PU手術改變尿道解剖，不治療潛在病因"
    ],
    "diagnosticAlgorithm": {
      "title": "尿道阻塞 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "緊急評估排尿狀態與全身狀態",
          "findings": [
            "多次嘗試排尿但無尿",
            "膀胱觸診極度膨大且疼痛",
            "嘔吐與嗜睡",
            "公貓最常見"
          ]
        },
        {
          "step": 2,
          "action": "血液急診檢查",
          "details": "電解質與腎功能",
          "findings": [
            "高血鉀（致命風險）",
            "代謝性酸中毒",
            "氮血症",
            "心電圖監測"
          ]
        },
        {
          "step": 3,
          "action": "導尿解除阻塞",
          "details": "尿道導管置放",
          "findings": [
            "鎮靜後尿道導管置放",
            "沖洗尿道塞子",
            "留置導管24-72小時",
            "收集尿液分析"
          ]
        },
        {
          "step": 4,
          "action": "病因分析與預防",
          "details": "結石分析與復發預防",
          "findings": [
            "尿液結晶分析",
            "結石成分分析",
            "飲食調整（處方飼料）",
            "嚴重復發考慮會陰尿道造口術"
          ]
        }
      ]
    },
    "monitoring": [
      "ECG（術中和術後）",
      "尿量（目標>2 mL/kg/h）",
      "電解質（q4-8h初期）",
      "BUN/Creatinine",
      "移除導尿管後排尿情況"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "bladder-tumor": {
    "zh": "膀胱腫瘤",
    "en": "Bladder Tumor",
    "definition": "膀胱腫瘤以移行上皮細胞癌（TCC/尿路上皮癌）為犬最常見的膀胱惡性腫瘤（>95%），Scottish Terrier風險為其他品種的18倍。好發於三角區（trigone），常侵犯輸尿管開口和尿道造成排尿困難。肥胖和除草劑暴露為環境風險因子。COX抑制劑piroxicam有抗腫瘤活性。",
    "synonyms": [
      "膀胱癌",
      "Bladder Cancer",
      "移行細胞癌",
      "TCC",
      "Urothelial Carcinoma"
    ],
    "epidemiology": {
      "species": "犬遠較貓常見",
      "age": "老年犬（平均9-11歲）",
      "sex": "母犬略多於公犬",
      "breedPredisposition": [
        "Scottish Terrier（風險最高，18-20倍）",
        "West Highland White Terrier",
        "Beagle",
        "Shetland Sheepdog",
        "Wire Hair Fox Terrier"
      ],
      "riskFactors": [
        "殺蟲劑/除草劑暴露",
        "環蟲酮暴露（舊式跳蚤藥）",
        "肥胖",
        "雌性"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "血尿（最常見）",
        "頻尿",
        "排尿困難",
        "反覆「UTI」對抗生素反應差",
        "排尿不完全",
        "後期可能有跛行（骨轉移）"
      ],
      "physicalExam": [
        "直腸觸診可能摸到膀胱三角區或尿道腫塊",
        "膀胱壁增厚",
        "前列腺受侵犯（公犬）",
        "副腫瘤骨病變"
      ]
    },
    "pathophysiology": "TCC起源於膀胱移行上皮 → 好發於膀胱三角區 → 局部侵犯 → 可能累及尿道和前列腺 → 淋巴結轉移 → 肺轉移。病理特徵：乳頭狀或浸潤性生長",
    "diagnosis": {
      "overview": "影像學發現病灶，細胞學或組織學確診",
      "differentials": [
        "慢性膀胱炎",
        "多發性息肉",
        "其他膀胱腫瘤（少見）"
      ],
      "initialDB": [
        "尿液分析",
        "腹部超聲（膀胱壁腫塊）",
        "胸腔X光（轉移篩檢）",
        "腹部X光（淋巴結腫大）"
      ],
      "advanced": [
        "BRAF突變檢測（尿液PCR，敏感性85%）",
        "創傷性導尿細胞學",
        "膀胱鏡活檢",
        "CT（分期）"
      ]
    },
    "staging": {
      "T": "T1: 乳頭狀，限於黏膜; T2: 侵犯肌層; T3: 侵犯鄰近器官",
      "N": "N0: 無淋巴結轉移; N1: 淋巴結轉移",
      "M": "M0: 無遠端轉移; M1: 遠端轉移"
    },
    "treatment": {
      "overview": "手術切除困難（位置），化療和NSAIDs為主要治療",
      "acute": [
        "尿道阻塞處理：",
        "- 支架置放",
        "- 導尿管",
        "- 膀胱造口術（暫時）"
      ],
      "chronic": [
        "醫學治療（主要）：",
        "- Piroxicam: 0.3 mg/kg PO q24h（COX抑制劑，抗腫瘤作用）",
        "- 或 Meloxicam: 0.1-0.2 mg/kg PO q24h",
        "化療：",
        "- Mitoxantrone: 5-6 mg/m² IV q3週",
        "- 或 Carboplatin: 300 mg/m² IV q3-4週",
        "- 或 Vinblastine: 2-3 mg/m² IV q1-2週",
        "- 合併NSAID效果更好",
        "手術（選擇性病例）：",
        "- 部分膀胱切除術（非三角區腫瘤）",
        "- 全膀胱切除+尿路改道（少見）",
        "姑息性治療：尿道支架、膀胱造口術"
      ]
    },
    "prognosis": "預後謹慎至差。中位生存期：單獨NSAID約6個月，NSAID+化療約10-12個月。尿道阻塞是常見死亡原因。",
    "pearls": [
      "TCC好發膀胱三角區，手術切除困難",
      "BRAF V595E突變存在於約85%犬TCC",
      "不建議經腹膀胱穿刺活檢（可能種植轉移）",
      "Piroxicam有直接抗腫瘤作用，不只是止痛",
      "反覆「UTI」治療無效應懷疑膀胱腫瘤"
    ],
    "diagnosticAlgorithm": {
      "title": "膀胱腫瘤 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估慢性血尿與排尿困難",
          "findings": [
            "慢性反覆血尿",
            "排尿困難",
            "抗生素治療無效的「UTI」",
            "中老年犬"
          ]
        },
        {
          "step": 2,
          "action": "尿液分析與細胞學",
          "details": "尿液評估",
          "findings": [
            "血尿",
            "尿液細胞學（敏感度有限）",
            "BRAF突變檢測（尿液）",
            "排除感染"
          ]
        },
        {
          "step": 3,
          "action": "腹部超音波",
          "details": "膀胱腫塊評估",
          "findings": [
            "膀胱壁不規則增厚腫塊",
            "三角區好發",
            "評估輸尿管阻塞",
            "區域淋巴結評估"
          ]
        },
        {
          "step": 4,
          "action": "切片與分期",
          "details": "經導管或手術切片",
          "findings": [
            "組織病理確診（多為移行上皮癌/TCC）",
            "胸腔X光分期",
            "腹腔淋巴結CT評估",
            "COX-2抑制劑（Piroxicam）治療評估"
          ]
        }
      ]
    },
    "monitoring": [
      "定期超聲（腫瘤大小）",
      "尿液分析",
      "胸腔X光（轉移）",
      "生活品質評估"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "urinary-incontinence": {
    "zh": "尿失禁",
    "en": "Urinary Incontinence",
    "definition": "尿失禁是無意識的尿液滲漏，最常見為絕育母犬的尿道括約肌功能不全（USMI/激素反應性尿失禁），佔犬尿失禁的50-80%。大型犬和肥胖犬好發。其他原因包括先天異常（異位輸尿管）、神經性膀胱功能障礙和前列腺疾病。phenylpropanolamine (PPA)為一線治療，反應率約85%。",
    "synonyms": [
      "UI",
      "小便失禁",
      "Involuntary Urination"
    ],
    "epidemiology": {
      "species": "犬較貓常見",
      "age": "依病因而異（括約肌功能不全多在絕育後數月至數年出現）",
      "sex": "絕育母犬最常見（括約肌功能不全）",
      "breedPredisposition": [
        "大型犬",
        "Boxer",
        "Doberman",
        "Old English Sheepdog",
        "German Shepherd",
        "Rottweiler",
        "Irish Setter"
      ],
      "riskFactors": [
        "絕育（母犬）",
        "肥胖",
        "尾巴對接",
        "先天性異常"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "休息時滴尿",
        "床墊濕掉",
        "會陰區濕潤",
        "動物本身不自覺",
        "行為正常"
      ],
      "physicalExam": [
        "會陰區濕潤或尿灼傷",
        "膀胱大小可能正常",
        "神經學檢查（若懷疑神經性）",
        "陰道/外陰檢查"
      ]
    },
    "pathophysiology": "正常排尿控制依賴膀胱逼尿肌放鬆（儲尿期）和尿道括約肌收縮之間的協調。尿道括約肌功能不全（USMI）是絕育母犬最常見的機轉，絕育後雌激素下降導致尿道平滑肌張力降低及黏膜萎縮，使尿道閉合壓不足。神經性尿失禁可因上運動神經元（UMN）或下運動神經元（LMN）損傷所致：UMN 病變造成逼尿肌反射亢進（急迫性尿失禁），LMN 病變則導致逼尿肌無張力（滿溢性尿失禁）。解剖異常如異位輸尿管則繞過正常括約肌機制，尿液持續漏出。",
    "etiology": {
      "usmr": "尿道括約肌功能不全(USMI)：絕育母犬最常見",
      "neurogenic": "神經性：脊髓疾病、馬尾症候群、椎間盤疾病",
      "anatomic": "解剖異常：異位輸尿管、前庭陰道異常",
      "overflow": "滿溢性：尿道阻塞、膀胱無張力",
      "urgency": "急迫性：膀胱炎、膀胱腫瘤"
    },
    "diagnosis": {
      "overview": "詳細病史區分真性尿失禁和其他排尿異常，確定病因",
      "differentials": [
        "行為性排尿問題",
        "多尿",
        "下泌尿道感染",
        "異位輸尿管"
      ],
      "initialDB": [
        "尿液分析和培養",
        "神經學檢查",
        "腹部超聲",
        "腹部X光"
      ],
      "advanced": [
        "尿動力學檢查",
        "CT泌尿道造影",
        "膀胱鏡",
        "MRI（脊髓評估）"
      ]
    },
    "treatment": {
      "overview": "依據病因治療，USMI以藥物為主",
      "acute": [
        "感染相關：抗生素治療",
        "阻塞相關：解除阻塞"
      ],
      "chronic": [
        "USMI藥物治療：",
        "- Phenylpropanolamine (PPA): 1.5-2 mg/kg PO q8-12h（α促效劑）",
        "- 雌激素（絕育母犬）：",
        "  * Diethylstilbestrol (DES): 0.1-1 mg PO q24h × 5-7天，然後q週",
        "  * 或 Estriol: 2 mg/犬 PO q24h",
        "- 合併PPA和雌激素效果更好",
        "手術選項（藥物無效）：",
        "- 膀胱頸注射填充劑",
        "- 人工尿道括約肌",
        "- 膠原蛋白注射",
        "異位輸尿管：手術矯正",
        "神經性：治療原發病因、間歇性導尿"
      ]
    },
    "prognosis": "USMI：藥物控制率約90%。異位輸尿管術後約50-70%改善。神經性：取決於原發病因。",
    "pearls": [
      "絕育母犬尿失禁首先考慮USMI",
      "幼年動物尿失禁考慮異位輸尿管",
      "PPA對USMI效果好但有心血管副作用",
      "雌激素需監測骨髓抑制（少見）",
      "真性尿失禁動物不自知，與行為問題不同"
    ],
    "diagnosticAlgorithm": {
      "title": "尿失禁 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "詢問尿失禁型態與發生時機",
          "findings": [
            "休息或睡覺時漏尿",
            "絕育後母犬好發",
            "會陰部潮濕",
            "皮膚炎"
          ]
        },
        {
          "step": 2,
          "action": "尿液分析與培養",
          "details": "排除感染",
          "findings": [
            "尿液分析排除UTI",
            "培養排除慢性感染",
            "尿比重評估"
          ]
        },
        {
          "step": 3,
          "action": "神經學評估",
          "details": "排除神經源性原因",
          "findings": [
            "會陰反射",
            "肛門張力",
            "後肢神經學",
            "排除脊髓病變"
          ]
        },
        {
          "step": 4,
          "action": "影像與功能評估",
          "details": "膀胱與尿道評估",
          "findings": [
            "腹部超音波膀胱結構",
            "排除異位輸尿管",
            "膀胱頸評估",
            "藥物試驗（Phenylpropanolamine反應）"
          ]
        }
      ]
    },
    "monitoring": [
      "症狀控制程度",
      "藥物副作用",
      "定期尿液培養（繼發感染）"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "prostatic-disease": {
    "zh": "前列腺疾病",
    "en": "Prostatic Disease",
    "definition": "前列腺疾病是未絕育公犬的常見泌尿生殖系統疾病。良性前列腺增生（BPH）在6歲以上未絕育公犬中>95%，為雄激素依賴性。其他前列腺疾病包括前列腺炎（急性/慢性）、前列腺囊腫（滯留囊腫和旁前列腺囊腫）、前列腺膿瘍和前列腺腺癌（不論絕育與否）。去勢為BPH的根治性治療。",
    "synonyms": [
      "前列腺疾病",
      "攝護腺疾病",
      "Prostate Disease"
    ],
    "epidemiology": {
      "species": "犬（公犬）",
      "age": "依疾病類型而異",
      "sex": "公犬專有",
      "riskFactors": [
        "未絕育",
        "年齡（BPH、腫瘤）"
      ]
    },
    "pathophysiology": "前列腺受雄激素（睪固酮經 5α 還原酶轉化為二氫睪固酮 DHT）持續刺激，是 BPH 的主要機轉；DHT 促進前列腺上皮和基質細胞增殖，腺體逐漸增大。前列腺炎多由尿道上行感染（E. coli 最常見）或血行性播散引起，感染組織液化可形成膿瘍。前列腺癌（多為腺癌或移行上皮癌）具高度惡性，早期即可經淋巴或血行轉移至腰下淋巴結、肺和腰椎。值得注意的是，絕育並不降低前列腺癌風險，部分研究甚至顯示絕育犬發生率更高。",
    "diseaseTypes": {
      "bph": {
        "name": "良性前列腺增生(BPH)",
        "age": "中老年未絕育公犬",
        "description": "雄激素依賴性前列腺增大",
        "symptoms": "可能無症狀、排便困難、血尿、前列腺液滴出"
      },
      "prostatitis": {
        "name": "前列腺炎",
        "age": "任何年齡",
        "description": "細菌感染，急性或慢性",
        "symptoms": "發燒、疼痛、排尿困難、全身症狀"
      },
      "abscess": {
        "name": "前列腺膿瘍",
        "age": "中老年",
        "description": "前列腺炎併發症",
        "symptoms": "嚴重全身症狀、發燒、腹痛"
      },
      "cyst": {
        "name": "前列腺囊腫",
        "age": "中老年",
        "description": "前列腺內或前列腺旁囊腫",
        "symptoms": "大小依賴，可能壓迫周圍結構"
      },
      "carcinoma": {
        "name": "前列腺癌",
        "age": "老年（絕育和未絕育皆可）",
        "description": "惡性腫瘤，常見轉移",
        "symptoms": "排尿困難、排便困難、後肢跛行（骨轉移）"
      }
    },
    "clinicalPresentation": {
      "history": [
        "排便困難（糞便扁平）",
        "排尿困難",
        "血尿/尿道分泌物",
        "後肢僵硬",
        "發燒（感染）",
        "嗜睡"
      ],
      "physicalExam": [
        "直腸觸診前列腺：腫大、不對稱、疼痛、硬度改變",
        "可能觸及腹部腫塊",
        "睪丸異常（Sertoli cell tumor）",
        "神經學異常（腫瘤轉移）"
      ]
    },
    "diagnosis": {
      "overview": "直腸觸診初步評估，影像學和細胞學確診",
      "differentials": [
        "BPH",
        "前列腺炎/膿瘍",
        "囊腫",
        "腫瘤",
        "前列腺旁囊腫"
      ],
      "initialDB": [
        "直腸觸診",
        "腹部X光",
        "腹部超聲",
        "尿液分析和培養",
        "前列腺液培養"
      ],
      "advanced": [
        "超聲引導穿刺活檢",
        "CT（分期）",
        "前列腺特異性抗原（犬：非特異性）"
      ]
    },
    "treatment": {
      "overview": "依據病因治療",
      "bph": [
        "絕育：最有效治療（4-6週內顯著縮小）",
        "藥物（若不願絕育）：",
        "- Finasteride: 0.1-0.5 mg/kg PO q24h（5α還原酶抑制劑）",
        "- Osaterone acetate（抗雄激素）"
      ],
      "prostatitis": [
        "長期抗生素（4-6週以上）：",
        "- Trimethoprim-sulfa: 15-30 mg/kg PO q12h",
        "- 或 Fluoroquinolones: Enrofloxacin 5-10 mg/kg PO q24h",
        "- Chloramphenicol（穿透性佳）",
        "絕育（促進恢復）",
        "止痛"
      ],
      "abscess": [
        "手術引流（開放或超聲引導）",
        "部分前列腺切除或去勢",
        "長期抗生素",
        "靜脈輸液支持"
      ],
      "carcinoma": [
        "手術切除困難且效果差",
        "化療：Carboplatin、Mitoxantrone",
        "NSAIDs：Piroxicam 0.3 mg/kg PO q24h",
        "放射治療（緩解症狀）",
        "尿道支架（阻塞）",
        "姑息性止痛"
      ]
    },
    "prognosis": "BPH：絕育後預後極佳。前列腺炎：治療後預後良好。膿瘍：預後謹慎。前列腺癌：預後差，中位生存期約2-4個月。",
    "pearls": [
      "直腸觸診是評估前列腺的基本方法",
      "BPH是未絕育公犬最常見前列腺問題",
      "絕育不預防前列腺癌（可能甚至增加風險）",
      "前列腺液或精液培養比尿液培養更準確",
      "抗生素需能穿透前列腺屏障"
    ],
    "diagnosticAlgorithm": {
      "title": "前列腺疾病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估排便排尿困難及血尿（未絕育公犬）",
          "findings": [
            "排便困難",
            "血尿或尿道分泌物",
            "後肢僵硬",
            "發燒（膿瘍）"
          ]
        },
        {
          "step": 2,
          "action": "直腸觸診",
          "details": "前列腺大小與對稱性",
          "findings": [
            "前列腺腫大",
            "對稱增生（BPH）vs不對稱（腫瘤/膿瘍）",
            "疼痛（攝護腺炎/膿瘍）",
            "固定不動（腫瘤）"
          ]
        },
        {
          "step": 3,
          "action": "影像學",
          "details": "腹部X光與超音波",
          "findings": [
            "前列腺腫大",
            "囊腫或膿瘍（無回音區）",
            "礦化（腫瘤高度懷疑）",
            "區域淋巴結評估"
          ]
        },
        {
          "step": 4,
          "action": "細胞學與培養",
          "details": "前列腺液或細針抽吸",
          "findings": [
            "前列腺液細胞學",
            "細菌培養與藥敏",
            "細針抽吸排除腫瘤",
            "絕育後追蹤BPH縮小"
          ]
        }
      ]
    },
    "monitoring": [
      "前列腺大小（超聲）",
      "尿液培養",
      "臨床症狀",
      "若腫瘤：定期影像學分期"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "hydronephrosis": {
    "zh": "腎水腫",
    "en": "Hydronephrosis",
    "definition": "腎水腫是因輸尿管或腎盂出口阻塞導致尿液蓄積造成腎盂和腎盞持續擴張、腎實質萎縮的疾病。常見原因包括輸尿管結石（貓最常見）、輸尿管狹窄、腫瘤壓迫和先天性異常。單側者可長期代償無症狀，雙側者導致腎後性氮血症。超音波可見腎盂擴張和腎實質變薄。",
    "synonyms": [
      "腎積水",
      "水腎",
      "Renal Pelvis Dilation"
    ],
    "epidemiology": {
      "species": "犬貓皆可發生",
      "age": "任何年齡",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "輸尿管結石",
        "輸尿管腫瘤",
        "輸尿管狹窄",
        "異位輸尿管",
        "腹腔腫瘤壓迫",
        "意外輸尿管結紮"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "單側可能無症狀",
        "雙側表現為急性或慢性腎衰竭",
        "腹部腫脹",
        "食慾下降",
        "嘔吐",
        "若感染可能發燒"
      ],
      "physicalExam": [
        "腹部觸診可能摸到腫大腎臟",
        "腎區疼痛（急性）",
        "脫水（若雙側或單腎動物）"
      ]
    },
    "pathophysiology": "尿路梗阻 → 尿液回流 → 腎盂壓力升高 → 腎實質缺血 → 腎小管萎縮 → 皮質變薄 → 腎功能喪失。完全梗阻數天內可造成不可逆損傷。部分梗阻可能數週至數月進展。",
    "diagnosis": {
      "overview": "超聲是診斷首選，需確定梗阻原因和位置",
      "differentials": [
        "腎盂腎炎",
        "腎周假性囊腫",
        "多囊腎病",
        "腎盂擴張（非梗阻性）"
      ],
      "initialDB": [
        "腹部超聲（腎盂擴張、皮質厚度、輸尿管擴張）",
        "BUN/Creatinine",
        "尿液分析和培養",
        "腹部X光（結石？）"
      ],
      "advanced": [
        "CT泌尿道造影",
        "靜脈腎盂造影",
        "順行性腎盂造影"
      ]
    },
    "treatment": {
      "overview": "解除梗阻、保存腎功能、治療感染",
      "acute": [
        "緊急減壓（若雙側或單腎）：",
        "- 腎盂穿刺引流",
        "- 輸尿管支架或腎造口術",
        "感染控制：抗生素",
        "輸液支持"
      ],
      "chronic": [
        "解除梗阻的手術：",
        "- 輸尿管切開取石",
        "- 輸尿管新植入術",
        "- SUB系統（皮下輸尿管旁路）",
        "- 輸尿管支架",
        "腎切除術（嚴重萎縮無功能且對側腎正常）",
        "感染：長期抗生素"
      ]
    },
    "prognosis": "取決於梗阻持續時間、腎皮質厚度和對側腎功能。早期解除梗阻（<1-2週）預後較好。嚴重萎縮（皮質<2-3 mm）功能恢復有限。",
    "pearls": [
      "單側腎水腫常因無症狀而延遲診斷",
      "腎皮質厚度是評估腎功能恢復潛力的指標",
      "貓輸尿管結石導致腎水腫越來越常見",
      "SUB系統是貓輸尿管梗阻的有效解決方案",
      "解除梗阻後可能出現阻塞後利尿"
    ],
    "diagnosticAlgorithm": {
      "title": "腎水腫 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估腎區疼痛與排尿狀態",
          "findings": [
            "單側腎區疼痛或腫大",
            "可能無症狀",
            "雙側阻塞時少尿",
            "嘔吐"
          ]
        },
        {
          "step": 2,
          "action": "腹部超音波",
          "details": "腎盂擴張程度評估",
          "findings": [
            "腎盂擴張（無回音區擴大）",
            "腎實質變薄",
            "輸尿管擴張（追蹤阻塞點）",
            "對側腎臟代償評估"
          ]
        },
        {
          "step": 3,
          "action": "血液生化",
          "details": "腎功能評估",
          "findings": [
            "雙側阻塞時氮血症",
            "單側可能腎功能正常",
            "電解質異常"
          ]
        },
        {
          "step": 4,
          "action": "阻塞原因確認",
          "details": "定位阻塞點與治療",
          "findings": [
            "輸尿管結石",
            "腫瘤壓迫",
            "後腹腔纖維化",
            "介入解除或手術（SUB裝置）"
          ]
        }
      ]
    },
    "monitoring": [
      "腎功能（若雙側）",
      "超聲追蹤腎盂大小",
      "尿液培養",
      "對側腎評估"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011"
  },
  "nephrotoxicity": {
    "zh": "腎毒性",
    "en": "Nephrotoxicity",
    "definition": "腎毒性是指藥物、毒素或其他外源性物質對腎臟造成的直接損傷，主要影響腎小管上皮細胞。犬貓常見腎毒性物質包括NSAID、胺基糖苷類抗生素（gentamicin）、百合花（貓）、乙二醇（防凍液）和葡萄/葡萄乾。早期表現為多尿，進展為少尿/無尿型急性腎損傷。及早辨認和停止暴露是關鍵。",
    "synonyms": [
      "腎臟中毒",
      "藥物性腎損傷",
      "Toxic Nephropathy",
      "Drug-induced Nephrotoxicity"
    ],
    "epidemiology": {
      "species": "犬貓皆可發生",
      "age": "任何年齡",
      "sex": "無性別傾向",
      "riskFactors": [
        "老年",
        "已有腎臟疾病",
        "脫水",
        "低血壓",
        "同時使用多種腎毒性藥物"
      ]
    },
    "commonNephrotoxins": {
      "drugs": [
        "氨基糖苷類抗生素（Gentamicin, Amikacin）",
        "NSAIDs（Carprofen, Meloxicam, Ibuprofen）",
        "ACE抑制劑（過量或脫水時）",
        "Amphotericin B",
        "Cisplatin",
        "Cyclosporine",
        "造影劑"
      ],
      "toxins": [
        "乙二醇（防凍劑）",
        "百合植物（貓）",
        "葡萄/葡萄乾（犬）",
        "重金屬（鉛、汞）",
        "蛇毒",
        "蜜蜂/黃蜂毒"
      ],
      "endogenous": [
        "肌紅蛋白（橫紋肌溶解）",
        "血紅蛋白（溶血）",
        "高鈣血症",
        "尿酸（腫瘤溶解症候群）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "毒物暴露或可疑藥物使用史",
        "突然嘔吐",
        "厭食",
        "嗜睡",
        "尿量改變"
      ],
      "physicalExam": [
        "脫水",
        "腎臟可能腫大且疼痛",
        "口腔潰瘍（尿毒症）",
        "可能有特定中毒徵象"
      ]
    },
    "pathophysiology": {
      "mechanisms": [
        "直接腎小管毒性（氨基糖苷類、重金屬）",
        "腎血流改變（NSAIDs、ACE抑制劑）",
        "結晶沉積（乙二醇→草酸鈣）",
        "急性腎小管壞死",
        "間質性腎炎"
      ],
      "etg": "乙二醇 → 乙醇脫氫酶代謝 → 乙醛酸、草酸 → 草酸鈣結晶沉積於腎小管 → 阻塞和毒性 → 急性腎衰竭"
    },
    "diagnosis": {
      "overview": "病史（暴露史）結合AKI表現",
      "differentials": [
        "其他AKI原因",
        "腎前性氮質血症",
        "尿路梗阻"
      ],
      "initialDB": [
        "BUN/Creatinine",
        "電解質",
        "尿液分析（結晶、管型）",
        "血氣",
        "乙二醇檢測（若懷疑）"
      ],
      "advanced": [
        "藥物血中濃度（氨基糖苷類）",
        "腎臟活檢",
        "特定毒物篩檢"
      ]
    },
    "treatment": {
      "overview": "停止暴露、支持治療、特定解毒劑（若有）",
      "acute": [
        "一般措施：",
        "- 停用可疑藥物",
        "- 積極靜脈輸液（促進腎臟灌注和毒物排泄）",
        "- 糾正電解質異常",
        "特定解毒劑：",
        "乙二醇中毒：",
        "- Fomepizole: 犬-首劑20 mg/kg IV，然後15 mg/kg × 3次 q12h；貓-125 mg/kg IV，然後31 mg/kg × 3次 q12h",
        "- 或 Ethanol: 20% 溶液 5-6 mL/kg IV q4-6h（競爭性抑制）",
        "- 黃金治療時間：犬<8-12h，貓<3h",
        "百合中毒（貓）：",
        "- 48-72小時積極輸液利尿",
        "- 無特定解毒劑",
        "葡萄/葡萄乾中毒（犬）：",
        "- 催吐（若剛攝入）",
        "- 活性碳",
        "- 積極輸液48-72小時",
        "支持治療：",
        "- 止吐：Maropitant",
        "- 胃保護：Omeprazole",
        "- 血液透析（嚴重病例）"
      ],
      "chronic": [
        "監測腎功能恢復",
        "避免再次暴露",
        "若進展為CKD則長期管理"
      ]
    },
    "prognosis": "取決於毒物類型、暴露劑量和治療時機。乙二醇：若在黃金時間內治療預後可好；延遲則預後極差。百合：及時輸液約50-90%存活。氨基糖苷類：停藥後多數可恢復。",
    "pearls": [
      "百合對貓極度腎毒性，包括花粉",
      "乙二醇中毒貓的治療窗口極短（<3小時）",
      "NSAIDs在脫水或低血壓動物中腎毒性風險大增",
      "尿液中草酸鈣結晶提示乙二醇中毒",
      "預防勝於治療：避免高風險情況"
    ],
    "diagnosticAlgorithm": {
      "title": "腎毒性 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "詢問藥物與毒物暴露史",
          "findings": [
            "近期使用NSAIDs、氨基糖苷類或順鉑",
            "百合攝入（貓）",
            "乙二醇（防凍液）攝入",
            "葡萄/葡萄乾攝入"
          ]
        },
        {
          "step": 2,
          "action": "腎功能急性變化",
          "details": "連續監測腎指數",
          "findings": [
            "BUN與肌酐急性升高",
            "SDMA早期升高",
            "尿量減少",
            "電解質失衡"
          ]
        },
        {
          "step": 3,
          "action": "尿液分析",
          "details": "腎小管損傷指標",
          "findings": [
            "管型（顆粒管型）",
            "等張尿",
            "葡萄糖尿（近端小管損傷）",
            "草酸鈣結晶（乙二醇）"
          ]
        },
        {
          "step": 4,
          "action": "解毒與支持治療",
          "details": "針對特定毒物治療",
          "findings": [
            "乙二醇：Fomepizole或乙醇治療",
            "百合：積極輸液利尿",
            "停用腎毒性藥物",
            "透析評估（嚴重案例）"
          ]
        }
      ]
    },
    "monitoring": [
      "尿量",
      "BUN/Creatinine q12-24h",
      "電解質",
      "尿液分析"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 2nd Ed. Mosby, 2011; ASPCA Animal Poison Control"
  },
  "diabetes-mellitus": {
    "zh": "糖尿病",
    "en": "Diabetes Mellitus",
    "definition": "因胰島素絕對或相對缺乏導致的碳水化合物、脂肪和蛋白質代謝異常，特徵為持續性高血糖和相關臨床症狀。",
    "synonyms": [
      "DM",
      "Sugar Diabetes",
      "糖尿病",
      "Insulin Deficiency Diabetes"
    ],
    "epidemiology": {
      "species": "犬貓皆常見",
      "age": "犬：中老年（7-9歲高峰）；貓：中老年（平均10-13歲）",
      "sex": "犬：未絕育母犬風險較高；貓：公貓較多（尤其已絕育肥胖公貓）",
      "riskFactors": [
        "肥胖（尤其貓）",
        "品種傾向（犬：Samoyed、Australian Terrier、Miniature Schnauzer、Miniature/Toy Poodle；貓：Burmese）",
        "胰臟炎",
        "庫欣症",
        "使用類固醇或黃體素",
        "懷孕/動情期（母犬）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "多飲多尿（PU/PD）",
        "多食（polyphagia）",
        "體重減輕（儘管食慾增加）",
        "嗜睡",
        "肌肉萎縮",
        "貓：後肢無力/跖行姿勢（糖尿病神經病變）"
      ],
      "physicalExam": [
        "消瘦或體態過低",
        "肌肉量減少",
        "脫水",
        "白內障（犬常見，貓罕見）",
        "肝腫大",
        "貓：跖行姿勢、被毛不良",
        "酮酸中毒時：嘔吐、虛弱、Kussmaul呼吸"
      ]
    },
    "pathophysiology": "犬：主要為胰島β細胞破壞（類似人類1型DM），與免疫介導、胰臟炎、品種遺傳相關。貓：主要為胰島素阻抗+β細胞功能衰退（類似人類2型DM），胰澱粉樣沉積常見。結果：高血糖 → 腎臟葡萄糖閾值超過 → 滲透性利尿 → PU/PD → 細胞無法利用葡萄糖 → 脂肪分解 → 酮體產生",
    "diagnosis": {
      "overview": "持續性空腹高血糖結合糖尿確診。排除應激性高血糖（尤其貓）",
      "differentials": [
        "應激性高血糖（貓）",
        "庫欣症",
        "肢端肥大症（貓）",
        "胰臟炎",
        "腎臟疾病",
        "甲狀腺功能亢進（貓）"
      ],
      "initialDB": [
        "血糖（空腹>200 mg/dL 犬；>250 mg/dL 貓）",
        "尿液分析（糖尿、可能酮尿）",
        "果糖胺（Fructosamine）：反映2-3週平均血糖",
        "CBC、生化全套",
        "尿液培養（UTI常見併發症）"
      ],
      "advanced": [
        "胰臟特異性脂肪酶(Spec cPL/fPL)",
        "腹部超音波",
        "糖化血紅蛋白(HbA1c)",
        "胰島素濃度（懷疑胰島素阻抗時）"
      ]
    },
    "treatment": {
      "overview": "胰島素治療為主，配合飲食管理。貓部分病例可能緩解",
      "acute": [
        "糖尿病酮酸中毒(DKA)：",
        "  - 積極輸液復甦（0.9% NaCl）",
        "  - 短效胰島素(Regular Insulin)：0.1-0.2 U/kg/h IV CRI 或 IM q1-2h",
        "  - 電解質補充（尤其鉀、磷）",
        "  - 監測並糾正酸中毒",
        "  - 當血糖<250 mg/dL時轉為皮下胰島素+輸液加葡萄糖"
      ],
      "chronic": [
        "胰島素治療：",
        "犬：",
        "  - Vetsulin (Lente porcine): 0.25-0.5 U/kg SC q12h",
        "  - NPH insulin: 0.25-0.5 U/kg SC q12h",
        "  - Glargine: 若NPH控制不佳",
        "貓：",
        "  - Glargine (Lantus) 或 Detemir (Levemir): 1-2 U/貓 SC q12h（首選）",
        "  - ProZinc (PZI): 1-2 U/貓 SC q12h",
        "飲食管理：",
        "  - 犬：高纖維、複合碳水化合物飲食",
        "  - 貓：高蛋白、低碳水化合物飲食（關鍵！）",
        "  - 定時定量餵食",
        "體重管理（肥胖者減重）",
        "母犬：建議絕育"
      ]
    },
    "prognosis": "犬：需終身胰島素治療，適當管理下預後良好，中位生存期約3年。貓：約20-30%可達到糖尿病緩解（尤其早期積極治療+飲食控制），緩解後需監測復發。併發症影響預後。",
    "pearls": [
      "貓的應激性高血糖可達300-400 mg/dL，果糖胺有助於區分",
      "犬糖尿病幾乎都需終身胰島素；貓有緩解可能",
      "貓的低碳水化合物飲食非常重要，可提高緩解率",
      "白內障在犬糖尿病極為常見（>80%），貓罕見",
      "Somogyi效應：過量胰島素導致反彈性高血糖",
      "居家血糖監測可改善控制效果"
    ],
    "diagnosticAlgorithm": {
      "title": "糖尿病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估多飲多尿多食與體重減輕",
          "findings": [
            "多飲多尿",
            "多食但體重減輕",
            "白內障（犬）",
            "後肢跛行（貓：糖尿病神經病變）"
          ]
        },
        {
          "step": 2,
          "action": "血糖與尿液",
          "details": "確認持續性高血糖",
          "findings": [
            "空腹血糖>200 mg/dL",
            "尿糖陽性",
            "尿酮體評估",
            "果糖胺升高（排除應激性高血糖）"
          ]
        },
        {
          "step": 3,
          "action": "併發症篩檢",
          "details": "DKA與共病評估",
          "findings": [
            "血液氣體分析（酮酸中毒）",
            "胰臟炎共病",
            "UTI篩檢",
            "肝臟脂肪沉積（貓）"
          ]
        },
        {
          "step": 4,
          "action": "治療監測",
          "details": "胰島素治療與血糖曲線",
          "findings": [
            "胰島素選擇與起始劑量",
            "血糖曲線監測",
            "果糖胺追蹤",
            "居家尿糖或血糖監測指導"
          ]
        }
      ]
    },
    "monitoring": [
      "血糖曲線（每2-4週直到穩定）",
      "果糖胺（每4-6週）",
      "體重",
      "水攝取量",
      "臨床症狀",
      "尿液分析（每3-6個月）"
    ],
    "reference": "Cote E: Clinical Veterinary Advisor: Dogs and Cats, 2nd Ed. Mosby, 2011"
  },
  "hyperthyroidism-cat": {
    "zh": "甲狀腺功能亢進（貓）",
    "en": "Hyperthyroidism (Feline)",
    "definition": "因甲狀腺激素（T3、T4）過度分泌導致的高代謝狀態，是老年貓最常見的內分泌疾病。",
    "synonyms": [
      "Feline Hyperthyroidism",
      "貓甲亢",
      "Thyrotoxicosis",
      "甲狀腺毒症"
    ],
    "epidemiology": {
      "species": "貓（犬罕見且通常與甲狀腺腫瘤相關）",
      "age": "中老年貓（平均12-13歲，>95%超過10歲）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "年齡",
        "室內飼養",
        "罐頭飲食（某些研究）",
        "使用貓砂（某些研究）",
        "環境因素（某些研究提示多溴二苯醚等）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "體重減輕（儘管食慾增加或正常）",
        "多食",
        "多飲多尿",
        "嘔吐",
        "腹瀉/軟便",
        "過度活躍/不安/易怒",
        "被毛不良",
        "虛弱"
      ],
      "physicalExam": [
        "消瘦、肌肉萎縮",
        "甲狀腺結節可觸及（>80%病例）",
        "心搏過速",
        "心雜音或奔馬律",
        "高血壓",
        "過度活躍",
        "被毛粗糙或脫毛"
      ]
    },
    "pathophysiology": "95%以上為良性甲狀腺腺瘤或腺瘤樣增生（雙側70%，單側30%），<5%為甲狀腺癌。甲狀腺激素增加 → 基礎代謝率增加 → 蛋白質分解、脂肪動員 → 體重減輕。同時影響心臟（肥厚性心肌病變）、腎臟（GFR增加可能掩蓋潛在CKD）。",
    "diagnosis": {
      "overview": "血清總T4升高結合典型臨床表現。正常T4不能排除（早期或隱匿性甲亢）",
      "differentials": [
        "慢性腎病",
        "糖尿病",
        "腸道疾病（IBD、淋巴瘤）",
        "肝病",
        "心臟病"
      ],
      "initialDB": [
        "血清總T4（Total T4）：升高確診；正常時需進一步檢查",
        "CBC、生化全套（評估併發症）",
        "尿液分析",
        "血壓測量",
        "胸腔X光"
      ],
      "advanced": [
        "游離T4（Free T4）：總T4正常但高度懷疑時",
        "TSH濃度：甲亢時應降低",
        "甲狀腺閃爍掃描(99mTc)：評估異位甲狀腺組織、癌症",
        "心臟超聲（評估甲亢性心臟病）",
        "T3抑制試驗（少用）"
      ]
    },
    "treatment": {
      "overview": "四種治療選項：藥物、放射碘、手術、飲食。選擇取決於患者狀況和主人因素",
      "acute": [
        "嚴重甲亢或甲狀腺風暴（罕見）：",
        "  - Beta-blocker (Atenolol): 6.25-12.5 mg/貓 PO q12-24h",
        "  - 支持治療（輸液、降溫）",
        "  - Methimazole 立即開始"
      ],
      "chronic": [
        "1. 藥物治療（最常用初始治療）：",
        "  - Methimazole: 2.5 mg PO q12h 起始，依T4調整",
        "  - Carbimazole: 5 mg PO q8h 或 10-15 mg PO q24h",
        "  - 經皮Methimazole（耳廓內側）：不耐口服時",
        "  - 需終身用藥，監測副作用",
        "",
        "2. 放射碘治療(I-131)（金標準/治癒性）：",
        "  - 單次注射，治癒率>95%",
        "  - 無需麻醉",
        "  - 需專門設施和隔離期",
        "",
        "3. 手術切除（治癒性）：",
        "  - 雙側或單側甲狀腺切除",
        "  - 術前需用藥物穩定",
        "  - 風險：低血鈣、喉返神經損傷",
        "",
        "4. 飲食治療：",
        "  - Hill's y/d（極低碘飲食）",
        "  - 必須是唯一飲食來源",
        "  - 適合無法給藥或不適合其他治療者"
      ]
    },
    "prognosis": "治療後預後良好。放射碘治療治癒率>95%。藥物控制需終身。主要影響預後的因素：併發CKD、心臟病、高血壓。治療後需評估潛在腎功能。",
    "pearls": [
      "治療前務必評估腎功能 - 甲亢可掩蓋潛在CKD",
      "治療後1個月內重測腎功能",
      "Methimazole副作用：嘔吐、厭食、面部搔抓、骨髓抑制、肝毒性",
      "甲狀腺閃爍掃描是評估是否適合手術的最佳方法",
      "部分「隱匿性甲亢」T4正常但有臨床症狀",
      "放射碘是最佳長期治療選擇（若可行）"
    ],
    "diagnosticAlgorithm": {
      "title": "甲狀腺功能亢進（貓） 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "觸診甲狀腺、評估體重及心率（貓）",
          "findings": [
            "甲狀腺腫大可觸及",
            "體重減輕但食慾增加",
            "心搏過速或心雜音",
            "行為過度活躍"
          ]
        },
        {
          "step": 2,
          "action": "甲狀腺功能",
          "details": "血清T4檢測",
          "findings": [
            "血清總T4升高",
            "邊界值時測游離T4",
            "反覆檢測確認"
          ]
        },
        {
          "step": 3,
          "action": "全面併發症評估",
          "details": "評估心腎功能",
          "findings": [
            "高血壓",
            "甲狀腺心肌病（HCM樣變化）",
            "腎功能基線（治療後可能惡化）",
            "肝指數升高"
          ]
        },
        {
          "step": 4,
          "action": "治療選擇評估",
          "details": "四種治療方式比較",
          "findings": [
            "放射碘（I-131）治療",
            "抗甲狀腺藥物（Methimazole）",
            "處方飲食（碘限制）",
            "甲狀腺切除術"
          ]
        }
      ]
    },
    "monitoring": [
      "藥物治療：T4、腎功能、CBC（前3個月每2-4週，穩定後每3-6個月）",
      "血壓",
      "體重",
      "心臟狀況",
      "藥物副作用"
    ],
    "reference": "Cote E: Clinical Veterinary Advisor: Dogs and Cats, 2nd Ed. Mosby, 2011"
  },
  "hypothyroidism-dog": {
    "zh": "甲狀腺功能低下（犬）",
    "en": "Hypothyroidism (Canine)",
    "definition": "因甲狀腺激素（T3、T4）產生不足導致的低代謝狀態，是犬最常見的內分泌疾病之一。",
    "synonyms": [
      "Canine Hypothyroidism",
      "犬甲低",
      "甲狀腺功能減退"
    ],
    "epidemiology": {
      "species": "犬常見，貓罕見（通常為醫源性或放射碘後）",
      "age": "中年犬（4-10歲，平均7歲）",
      "sex": "無明顯性別傾向，絕育動物可能風險略高",
      "riskFactors": [
        "品種傾向（Golden Retriever、Doberman Pinscher、Irish Setter、Miniature Schnauzer、Dachshund、Cocker Spaniel、Airedale Terrier）",
        "中大型犬較常見",
        "絕育"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "嗜睡、活動力下降",
        "體重增加（儘管食慾正常或下降）",
        "畏寒",
        "皮膚問題（脫毛、皮膚感染）",
        "繁殖障礙"
      ],
      "physicalExam": [
        "肥胖",
        "雙側對稱性脫毛（軀幹、尾巴「鼠尾」）",
        "皮膚增厚、色素沉著",
        "皮脂溢出",
        "反覆皮膚感染",
        "心搏過緩",
        "「悲傷面容」（黏液水腫）",
        "神經肌肉症狀（罕見：虛弱、跛行、面部麻痺）"
      ]
    },
    "pathophysiology": "95%為原發性（甲狀腺本身問題）：50%淋巴細胞性甲狀腺炎（免疫介導），50%特發性甲狀腺萎縮。繼發性（腦下垂體TSH不足）和三發性（下視丘TRH不足）罕見。甲狀腺激素減少 → 代謝率下降 → 體重增加、嗜睡、毛髮生長週期異常。",
    "diagnosis": {
      "overview": "結合臨床症狀、低T4和TSH升高診斷。單獨T4低不能確診（非甲狀腺病態綜合症）",
      "differentials": [
        "非甲狀腺病態綜合症(NTIS/Euthyroid Sick Syndrome)",
        "庫欣症",
        "藥物影響（類固醇、磺胺藥、Phenobarbital）",
        "其他代謝疾病"
      ],
      "initialDB": [
        "總T4（Total T4）：低；但正常不能排除、低不能確診",
        "游離T4（Free T4 by ED）：更準確",
        "TSH（犬TSH）：原發性甲低時升高",
        "CBC、生化全套（可能見高膽固醇、輕度貧血）"
      ],
      "advanced": [
        "甲狀腺球蛋白自身抗體(TgAA)：陽性提示淋巴細胞性甲狀腺炎",
        "T3抑制試驗",
        "TSH刺激試驗（黃金標準但TSH難取得）",
        "甲狀腺閃爍掃描"
      ]
    },
    "treatment": {
      "overview": "終身甲狀腺激素補充治療",
      "acute": [
        "黏液水腫昏迷（罕見急症）：",
        "  - Levothyroxine IV（若可取得）或高劑量口服",
        "  - 支持治療（保溫、輸液、通氣支持）",
        "  - 類固醇（若懷疑腎上腺功能不全）"
      ],
      "chronic": [
        "Levothyroxine (L-T4)：",
        "  - 起始劑量：0.02 mg/kg 或 0.5 mg/m² PO q12h",
        "  - 最大單次劑量：0.8 mg",
        "  - 與食物間隔給藥（空腹吸收較好）",
        "  - 品牌藥物較佳（生物利用度穩定）",
        "",
        "劑量調整：",
        "  - 4-6週後根據T4濃度和臨床反應調整",
        "  - 目標：給藥後4-6小時T4在正常上限或略高"
      ]
    },
    "prognosis": "適當補充甲狀腺激素預後極佳。臨床症狀改善時程：活動力1-2週，皮膚3-6個月。需終身治療。",
    "pearls": [
      "不要僅憑低T4診斷 - NTIS在病犬很常見",
      "結合fT4和TSH可提高診斷準確性",
      "高膽固醇血症是甲低的常見發現",
      "某些藥物（Phenobarbital、類固醇、磺胺藥）可降低T4",
      "治療反應是最佳確診方式之一",
      "每6-12個月監測一次足夠（穩定後）"
    ],
    "diagnosticAlgorithm": {
      "title": "甲狀腺功能低下（犬） 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估體重增加與皮膚變化（犬）",
          "findings": [
            "體重增加嗜睡",
            "對稱性脫毛",
            "皮膚增厚（黏液水腫）",
            "尾巴脫毛（鼠尾）"
          ]
        },
        {
          "step": 2,
          "action": "甲狀腺功能",
          "details": "T4、fT4與TSH",
          "findings": [
            "總T4降低",
            "游離T4降低",
            "TSH升高",
            "排除病態甲狀腺症候群"
          ]
        },
        {
          "step": 3,
          "action": "輔助檢查",
          "details": "支持診斷的額外發現",
          "findings": [
            "高膽固醇血症",
            "輕度非再生性貧血",
            "肌酸激酶輕度升高"
          ]
        },
        {
          "step": 4,
          "action": "治療反應",
          "details": "Levothyroxine補充",
          "findings": [
            "起始劑量0.02 mg/kg BID",
            "4-6週後複檢T4",
            "精神活力改善",
            "被毛再生（可能需數月）"
          ]
        }
      ]
    },
    "monitoring": [
      "治療後4-6週測T4（給藥後4-6小時）",
      "穩定後每6-12個月監測",
      "臨床症狀改善",
      "體重",
      "皮膚狀況"
    ],
    "reference": "Cote E: Clinical Veterinary Advisor: Dogs and Cats, 2nd Ed. Mosby, 2011"
  },
  "pheochromocytoma": {
    "zh": "嗜鉻細胞瘤",
    "en": "Pheochromocytoma",
    "definition": "起源於腎上腺髓質嗜鉻細胞的腫瘤，可分泌兒茶酚胺（腎上腺素、去甲腎上腺素）導致陣發性或持續性高血壓及相關症狀。",
    "synonyms": [
      "Pheo",
      "嗜鉻細胞瘤",
      "Adrenal Medullary Tumor",
      "Chromaffin Cell Tumor"
    ],
    "epidemiology": {
      "species": "犬為主，貓罕見",
      "age": "老年犬（平均10-11歲）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "無已知品種傾向",
        "約50%為惡性",
        "可能與功能性腎上腺皮質腫瘤並存"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "陣發性虛弱或倒地",
        "不安、焦躁",
        "喘氣",
        "嘔吐",
        "心悸感",
        "運動不耐",
        "體重減輕",
        "症狀可間歇性發作"
      ],
      "physicalExam": [
        "高血壓（可能陣發性）",
        "心搏過速或心律不整",
        "眼底病變（視網膜出血、脫離）",
        "腹部可觸及腫塊（若腫瘤夠大）",
        "後肢水腫（若侵犯後腔靜脈）",
        "出血傾向"
      ]
    },
    "pathophysiology": "腫瘤自主分泌兒茶酚胺 → 陣發性或持續性血管收縮 → 高血壓 → 靶器官損傷（心臟、眼、腎、腦）。腫瘤可局部侵犯後腔靜脈、腎靜脈。約50%有遠處轉移（肝、肺、淋巴結）。",
    "diagnosis": {
      "overview": "需高度懷疑。影像學發現腎上腺腫塊結合高血壓提示診斷",
      "differentials": [
        "腎上腺皮質腫瘤",
        "腎上腺轉移瘤",
        "其他原因高血壓",
        "心臟疾病"
      ],
      "initialDB": [
        "血壓測量（重複測量，可能陣發性升高）",
        "眼底檢查",
        "腹部超音波（腎上腺腫塊）",
        "CBC、生化（可能高血糖、低血鉀）"
      ],
      "advanced": [
        "尿液兒茶酚胺或代謝產物（metanephrines）：敏感度有限",
        "腹部CT/MRI：評估腫瘤範圍和血管侵犯",
        "超音波評估後腔靜脈侵犯",
        "胸腔X光/CT：轉移評估"
      ]
    },
    "treatment": {
      "overview": "手術切除是首選治療。需術前穩定血壓",
      "acute": [
        "高血壓危象：",
        "  - Phentolamine: 0.02-0.1 mg/kg IV bolus",
        "  - Nitroprusside: 1-5 μg/kg/min CRI",
        "心律不整：",
        "  - Beta-blocker（必須在Alpha-blocker之後使用）"
      ],
      "chronic": [
        "手術前準備（10-14天）：",
        "  - Phenoxybenzamine (Alpha-blocker): 0.25-1.5 mg/kg PO q12h",
        "  - 目標：血壓正常化、減少手術風險",
        "  - 輸液擴張血容量",
        "",
        "手術切除：",
        "  - 腎上腺切除術（有經驗的外科醫師）",
        "  - 術中準備處理血壓波動",
        "  - 可能需要後腔靜脈腫瘤栓子取出",
        "",
        "無法手術時：",
        "  - Phenoxybenzamine長期控制",
        "  - 化療效果有限"
      ]
    },
    "prognosis": "完全切除且無轉移預後可良好（中位生存期>3年）。有血管侵犯或轉移預後較差（中位生存期約1年）。術中死亡風險存在。",
    "pearls": [
      "陣發性症狀是重要線索",
      "術前Alpha-blocker準備極為重要",
      "Beta-blocker必須在Alpha-blocker之後使用（避免無對抗的Alpha效應）",
      "術中血壓可能劇烈波動",
      "約50%為惡性，但惡性度的影像學預測困難",
      "可與功能性皮質腫瘤並存"
    ],
    "diagnosticAlgorithm": {
      "title": "嗜鉻細胞瘤 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估陣發性症狀",
          "findings": [
            "陣發性虛脫",
            "心搏過速",
            "高血壓",
            "焦躁不安"
          ]
        },
        {
          "step": 2,
          "action": "血壓與心電圖",
          "details": "血流動力學評估",
          "findings": [
            "持續或陣發性高血壓",
            "竇性心搏過速",
            "心律不整",
            "血壓波動大"
          ]
        },
        {
          "step": 3,
          "action": "腹部影像",
          "details": "腎上腺腫塊定位",
          "findings": [
            "腹部超音波腎上腺腫塊",
            "CT確認腫塊大小與侵犯範圍",
            "血管侵犯評估",
            "對側腎上腺評估"
          ]
        },
        {
          "step": 4,
          "action": "內分泌確認",
          "details": "兒茶酚胺代謝物",
          "findings": [
            "尿液兒茶酚胺代謝物",
            "血漿Metanephrine與Normetanephrine",
            "術前α-adrenergic阻斷",
            "手術切除計畫"
          ]
        }
      ]
    },
    "monitoring": [
      "術後血壓",
      "影像學追蹤（復發/轉移）",
      "臨床症狀"
    ],
    "reference": "Cote E: Clinical Veterinary Advisor: Dogs and Cats, 2nd Ed. Mosby, 2011"
  },
  "hyperparathyroidism": {
    "zh": "副甲狀腺功能亢進",
    "en": "Hyperparathyroidism",
    "definition": "副甲狀腺激素(PTH)過度分泌導致高鈣血症的疾病。分為原發性（副甲狀腺本身問題）和繼發性（對低鈣或高磷的反應）。",
    "synonyms": [
      "HPT",
      "副甲狀腺功能亢進症",
      "Primary Hyperparathyroidism",
      "PHPTH"
    ],
    "epidemiology": {
      "species": "犬較常見，貓少見",
      "age": "老年犬（平均10-11歲）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "品種傾向（Keeshond有遺傳傾向）",
        "原發性：副甲狀腺腺瘤最常見",
        "繼發性：CKD、營養性（鈣不足）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "多飲多尿（高鈣血症導致）",
        "虛弱、嗜睡",
        "食慾下降",
        "便秘",
        "嘔吐",
        "可能無症狀（偶然發現高鈣）"
      ],
      "physicalExam": [
        "常無特異性發現",
        "肌肉無力",
        "脫水",
        "可能觸及頸部腫塊（若腺瘤夠大）",
        "心律不整（嚴重高鈣）"
      ]
    },
    "pathophysiology": "原發性：副甲狀腺腺瘤（單發最常見）或增生自主分泌PTH → PTH促進骨�ite吸收、腎臟鈣重吸收、腸道鈣吸收 → 高鈣血症。繼發性：CKD → 磷滯留 → 低鈣 → PTH代償性升高。高鈣血症影響腎臟、神經肌肉、心臟功能。",
    "diagnosis": {
      "overview": "高鈣血症 + PTH不適當升高或正常高值 = 原發性HPT",
      "differentials": [
        "惡性腫瘤相關高鈣血症(HHM)",
        "維生素D中毒",
        "肉芽腫性疾病",
        "腎衰竭（繼發性HPT）",
        "Addison's disease"
      ],
      "initialDB": [
        "離子鈣（首選）或總鈣",
        "磷：原發性HPT通常正常低值或低",
        "PTH（同時測鈣）：原發性升高或不適當正常",
        "PTHrP：腫瘤相關高鈣時升高",
        "腎功能（BUN、Creatinine）",
        "尿液分析"
      ],
      "advanced": [
        "頸部超音波：副甲狀腺腫塊",
        "99mTc-sestamibi閃爍掃描：定位病灶",
        "腹部超音波：腎結石、腎鈣化"
      ]
    },
    "treatment": {
      "overview": "原發性HPT首選手術切除病變腺體",
      "acute": [
        "嚴重高鈣血症（>16 mg/dL或有症狀）：",
        "  - 0.9% NaCl積極輸液：促進鈣排泄",
        "  - Furosemide: 2-4 mg/kg IV q8-12h（輸液充足後）",
        "  - Calcitonin: 4-8 IU/kg SC q8-12h（快速但短效）",
        "  - Bisphosphonates: Pamidronate 1-2 mg/kg IV over 2-4h",
        "  - Glucocorticoids: 對淋巴瘤等有效，對原發性HPT無效"
      ],
      "chronic": [
        "手術切除：",
        "  - 術前影像定位病灶",
        "  - 副甲狀腺腺瘤切除",
        "  - 術後監測低鈣血症",
        "",
        "超音波引導經皮熱消融/乙醇注射：",
        "  - 非手術替代選項",
        "  - 較少侵入性",
        "",
        "術後管理：",
        "  - 監測血鈣（術後24-72小時最低點）",
        "  - 低鈣血症補充：",
        "    * 輕度：口服鈣補充",
        "    * 嚴重：Calcium gluconate 10%: 0.5-1.5 mL/kg IV slow",
        "  - Calcitriol: 20-30 ng/kg/day（促進鈣吸收）"
      ]
    },
    "prognosis": "手術成功切除預後極佳。約2-4%可能復發或為癌。術後低鈣血症通常是暫時性的。",
    "pearls": [
      "高鈣血症鑑別：腫瘤最常見，原發性HPT次之",
      "PTH正常但高鈣 = 不適當正常 = 支持原發性HPT",
      "惡性腫瘤高鈣通常PTH低、PTHrP高",
      "術後低鈣血症（「飢餓骨症候群」）需密切監測",
      "Keeshond有遺傳性原發性HPT"
    ],
    "diagnosticAlgorithm": {
      "title": "副甲狀腺功能亢進 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估高血鈣相關症狀",
          "findings": [
            "多飲多尿",
            "食慾減退",
            "虛弱",
            "泌尿道結石"
          ]
        },
        {
          "step": 2,
          "action": "血鈣與PTH",
          "details": "鈣與副甲狀腺激素配對",
          "findings": [
            "離子鈣升高",
            "PTH不適當升高（正常或高值）",
            "磷正常或偏低"
          ]
        },
        {
          "step": 3,
          "action": "影像定位",
          "details": "頸部超音波定位結節",
          "findings": [
            "副甲狀腺結節",
            "超音波導引下可見低回音結節",
            "排除甲狀腺腫瘤"
          ]
        },
        {
          "step": 4,
          "action": "手術或微創治療",
          "details": "治療方式選擇",
          "findings": [
            "手術切除增生腺體",
            "超音波導引乙醇消融",
            "術後低血鈣監測",
            "補鈣管理"
          ]
        }
      ]
    },
    "monitoring": [
      "術後血鈣（每6-12小時共48-72小時）",
      "穩定後每週至每月",
      "長期每6-12個月追蹤"
    ],
    "reference": "Cote E: Clinical Veterinary Advisor: Dogs and Cats, 2nd Ed. Mosby, 2011"
  },
  "hypoparathyroidism": {
    "zh": "副甲狀腺功能低下",
    "en": "Hypoparathyroidism",
    "definition": "副甲狀腺激素(PTH)分泌不足或作用缺陷導致低鈣血症的疾病。可為原發性（免疫介導、醫源性）或罕見的先天性。",
    "synonyms": [
      "Hypopara",
      "副甲狀腺功能減退",
      "PTH Deficiency"
    ],
    "epidemiology": {
      "species": "犬為主，貓少見",
      "age": "中年犬（平均4-8歲）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "甲狀腺/副甲狀腺手術後（醫源性，最常見）",
        "品種傾向（原發性免疫介導型：Toy Poodle、Miniature Schnauzer、Labrador、German Shepherd）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "肌肉顫抖、抽搐",
        "面部搔抓",
        "步態僵硬",
        "焦躁不安",
        "喘氣",
        "癲癇發作",
        "嗜睡",
        "症狀可間歇性發作"
      ],
      "physicalExam": [
        "肌肉強直或顫抖",
        "肌肉痙攣（尤其面部）",
        "發燒（肌肉活動）",
        "心搏過緩",
        "第三眼瞼突出",
        "白內障（慢性低鈣）"
      ]
    },
    "pathophysiology": "原發性：免疫介導的副甲狀腺破壞。醫源性：甲狀腺手術時意外損傷或切除。PTH缺乏 → 骨鈣釋放減少、腎臟鈣重吸收減少、腸道鈣吸收減少 → 低鈣血症 → 神經肌肉興奮性增加 → 強直、癲癇。",
    "diagnosis": {
      "overview": "低鈣血症 + PTH低或不適當正常 = 副甲狀腺功能低下",
      "differentials": [
        "腎衰竭（低鈣合併高磷）",
        "低白蛋白血症（假性低鈣）",
        "膿毒症",
        "胰臟炎",
        "乙二醇中毒",
        "產後低鈣（哺乳）",
        "EDTA抗凝血管假性低鈣"
      ],
      "initialDB": [
        "離子鈣（首選）：降低",
        "總鈣和白蛋白：校正後總鈣低",
        "磷：升高（腎功能正常時）",
        "PTH（與鈣同時測）：低或不適當正常",
        "腎功能（BUN、Creatinine）：正常排除腎性原因",
        "ECG：QT延長"
      ],
      "advanced": [
        "頸部超音波：評估副甲狀腺",
        "鎂濃度：低鎂可加重低鈣症狀",
        "維生素D代謝物"
      ]
    },
    "treatment": {
      "overview": "急性低鈣血症緊急處理，慢性需終身鈣和維生素D補充",
      "acute": [
        "低鈣血症急症（癲癇、強直）：",
        "  - 10% Calcium gluconate: 0.5-1.5 mL/kg IV slow (over 10-20min)",
        "  - 持續ECG監測（心搏過緩立即停止）",
        "  - 避免皮下注射（組織壞死）",
        "  - 可重複給予或CRI: 2.5-3.75 mg/kg/h elemental Ca",
        "控制癲癇：",
        "  - Diazepam（若仍在發作）",
        "  - 鈣補充通常可控制"
      ],
      "chronic": [
        "口服鈣補充：",
        "  - Calcium carbonate: 25-50 mg/kg/day elemental Ca 分次給予",
        "  - 或 Calcium gluconate/lactate",
        "",
        "維生素D補充（必需）：",
        "  - Calcitriol（首選）: 20-30 ng/kg/day 起始",
        "    * 作用快、半衰期短，調整方便",
        "  - 或 Dihydrotachysterol: 0.02-0.03 mg/kg/day",
        "  - 或 Ergocalciferol（作用慢，不推薦起始）",
        "",
        "劑量調整：",
        "  - 目標鈣：正常低限（8-9.5 mg/dL）",
        "  - 避免過度補充導致高鈣血症和腎鈣化"
      ]
    },
    "prognosis": "適當補充終身預後良好。需終身治療和監測。初期劑量調整期風險較高。",
    "pearls": [
      "醫源性是最常見原因 - 甲狀腺手術後需密切監測",
      "離子鈣比總鈣更準確",
      "Calcitriol因半衰期短是首選維生素D",
      "過度補充導致的高鈣血症和腎鈣化需警惕",
      "目標維持鈣在正常低限，不需要正常化",
      "急性時避免碳酸鈣（吸收不夠快）"
    ],
    "diagnosticAlgorithm": {
      "title": "副甲狀腺功能低下 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估低血鈣神經肌肉症狀",
          "findings": [
            "肌肉顫搐痙攣",
            "面部搔癢（貓）",
            "癲癇發作",
            "甲狀腺手術後"
          ]
        },
        {
          "step": 2,
          "action": "血鈣與PTH",
          "details": "確認低鈣低PTH",
          "findings": [
            "離子鈣降低",
            "PTH不適當偏低",
            "磷升高",
            "鎂離子正常"
          ]
        },
        {
          "step": 3,
          "action": "心電圖",
          "details": "低鈣心臟影響",
          "findings": [
            "QT間期延長",
            "心律不整風險",
            "連續監測"
          ]
        },
        {
          "step": 4,
          "action": "治療與維持",
          "details": "鈣與維生素D補充",
          "findings": [
            "急性期靜脈鈣劑",
            "維持期口服鈣與活性維生素D",
            "定期離子鈣監測",
            "劑量調整"
          ]
        }
      ]
    },
    "monitoring": [
      "初期：血鈣每週測量直到穩定",
      "穩定後：每2-4個月",
      "腎功能和尿比重（腎鈣化風險）"
    ],
    "reference": "Cote E: Clinical Veterinary Advisor: Dogs and Cats, 2nd Ed. Mosby, 2011"
  },
  "hypersomatotropism": {
    "zh": "生長激素過多症",
    "en": "Hypersomatotropism (Acromegaly)",
    "definition": "因生長激素(GH)過度分泌導致的代謝和形態學改變。貓主要由腦下垂體腫瘤引起，犬主要由黃體素相關引起。",
    "synonyms": [
      "Acromegaly",
      "肢端肥大症",
      "GH Excess",
      "巨人症（生長板關閉前）"
    ],
    "epidemiology": {
      "species": "貓較常見（腦下垂體腫瘤），犬少見（黃體素相關）",
      "age": "貓：老年（平均10-11歲）；犬：中年母犬（動情期相關）",
      "sex": "貓：公貓較多；犬：未絕育母犬",
      "riskFactors": [
        "貓：無已知品種傾向",
        "犬：未絕育母犬、外源性黃體素使用"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "難以控制的糖尿病（胰島素阻抗明顯）",
        "體型/體重增加（儘管可能多食）",
        "下頜骨突出、面部變寬",
        "呼吸困難或打鼾（軟組織增生）",
        "多飲多尿"
      ],
      "physicalExam": [
        "下頜骨突出（prognathia inferior）",
        "頭部和面部寬大",
        "爪子增大（貓）",
        "體重增加",
        "器官腫大（心臟、肝臟、腎臟）",
        "口腔軟組織增生",
        "心雜音（心肌病變）"
      ]
    },
    "pathophysiology": "貓：腦下垂體GH分泌腫瘤（通常為腺瘤）。犬：黃體素刺激乳腺產生GH。GH過量 → IGF-1升高 → 軟骨、骨骼、軟組織增生 + 胰島素阻抗 → 糖尿病。心臟也受影響導致肥厚性心肌病。",
    "diagnosis": {
      "overview": "難控制的糖尿病貓應考慮此診斷。IGF-1升高結合臨床特徵",
      "differentials": [
        "單純糖尿病",
        "甲狀腺功能亢進",
        "心臟病其他原因",
        "腎病"
      ],
      "initialDB": [
        "IGF-1（血清）：升高強烈支持診斷（>1000 ng/mL高度提示）",
        "血糖和果糖胺：糖尿病證據",
        "CBC、生化全套",
        "心臟超聲：評估心肌病變"
      ],
      "advanced": [
        "頭部CT/MRI：腦下垂體腫瘤",
        "GH濃度（不常用，波動大）",
        "腹部超音波：器官腫大"
      ]
    },
    "treatment": {
      "overview": "貓：放射治療或藥物控制；犬：絕育或停止黃體素",
      "acute": [
        "糖尿病控制：",
        "  - 高劑量胰島素（可能需>15 U/貓 q12h）",
        "  - 頻繁監測血糖"
      ],
      "chronic": [
        "貓：",
        "  - 放射治療：可控制腫瘤、改善胰島素敏感性",
        "  - 腦下垂體切除術：少數中心",
        "  - Pasireotide（生長抑素類似物）：部分病例有效",
        "  - 保守治療：高劑量胰島素控制糖尿病",
        "",
        "犬：",
        "  - 絕育（首選）：移除黃體素來源",
        "  - 停止外源性黃體素",
        "  - GH和IGF-1應在數週內正常化"
      ]
    },
    "prognosis": "犬：絕育後通常可治癒。貓：放射治療後中位生存期約2年；保守治療約1年。心臟病和糖尿病控制影響預後。",
    "pearls": [
      "難以控制的糖尿病貓應檢測IGF-1",
      "胰島素需求>1.5-2 U/kg q12h 提示胰島素阻抗",
      "面部和身體變化可能subtle，比較舊照片有幫助",
      "約25%肢端肥大症貓IGF-1可正常（需CT/MRI）",
      "犬肢端肥大症絕育可治癒",
      "治療後糖尿病可能緩解"
    ],
    "diagnosticAlgorithm": {
      "title": "生長激素過多症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估胰島素抗性與體型變化（貓）",
          "findings": [
            "胰島素需求量異常高",
            "體重增加/體型增大",
            "下頜突出",
            "器官腫大"
          ]
        },
        {
          "step": 2,
          "action": "血液生化",
          "details": "糖尿病與器官功能",
          "findings": [
            "持續性高血糖",
            "胰島素抗性（需>6 IU/次）",
            "肝腎指數",
            "心臟評估"
          ]
        },
        {
          "step": 3,
          "action": "IGF-1測量",
          "details": "生長激素間接評估",
          "findings": [
            "IGF-1顯著升高",
            "IGF-1>1000 ng/mL高度懷疑"
          ]
        },
        {
          "step": 4,
          "action": "腦部影像",
          "details": "垂體腫瘤評估",
          "findings": [
            "MRI垂體腫塊",
            "CT垂體區域",
            "腫瘤大小與延伸",
            "放射治療評估"
          ]
        }
      ]
    },
    "monitoring": [
      "血糖和糖尿病控制",
      "IGF-1（治療後）",
      "心臟超聲",
      "MRI追蹤腫瘤大小（放療後）"
    ],
    "reference": "Cote E: Clinical Veterinary Advisor: Dogs and Cats, 2nd Ed. Mosby, 2011"
  },
  "growth-hormone-deficiency": {
    "zh": "生長激素缺乏",
    "en": "Growth Hormone Deficiency",
    "definition": "生長激素(GH)分泌不足導致的發育遲緩或成年動物的皮膚和代謝異常。可為先天性或後天性。",
    "synonyms": [
      "GH Deficiency",
      "Pituitary Dwarfism",
      "腦下垂體侏儒症",
      "生長激素不足"
    ],
    "epidemiology": {
      "species": "犬為主（先天性），貓罕見",
      "age": "先天性：幼犬（2-3月齡開始明顯）；後天性：成年",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "品種傾向（先天性）：German Shepherd（常見）、Karelian Bear Dog、Saarloos Wolfdog、Czechoslovakian Wolfdog",
        "遺傳性（常染色體隱性）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "幼年：生長遲緩、同窩最小",
        "保留幼年被毛、不換毛",
        "智力和行為正常",
        "成年：雙側對稱性脫毛",
        "嗜睡"
      ],
      "physicalExam": [
        "身材矮小（幼年發病）",
        "保留幼年被毛（柔軟、綿毛狀）",
        "雙側對稱性脫毛（軀幹）",
        "皮膚色素沉著過度",
        "睪丸發育不全（公犬）",
        "可能保留乳齒"
      ]
    },
    "pathophysiology": "先天性：腦下垂體發育異常（囊腫、發育不全）→ GH和其他腦下垂體激素缺乏。German Shepherd多為腦下垂體囊腫。GH缺乏 → IGF-1減少 → 骨骼發育不全、毛囊週期異常、皮膚變薄。常合併甲狀腺功能低下（繼發性）。",
    "diagnosis": {
      "overview": "幼年型侏儒症臨床特徵明顯；成年型需功能性檢測",
      "differentials": [
        "先天性甲狀腺功能低下",
        "先天性腎上腺皮質功能低下",
        "肝門脈分流",
        "營養不良",
        "寄生蟲感染",
        "其他侏儒原因"
      ],
      "initialDB": [
        "IGF-1：降低（篩檢）",
        "CBC、生化全套",
        "甲狀腺功能：常繼發性低下",
        "ACTH刺激試驗：評估腎上腺功能"
      ],
      "advanced": [
        "GH刺激試驗（確診）：",
        "  - Clonidine、GHRH或Xylazine刺激",
        "  - GH反應低下確診",
        "頭部MRI/CT：腦下垂體囊腫或發育不全",
        "遺傳檢測（某些品種）"
      ]
    },
    "treatment": {
      "overview": "GH補充治療效果有限且取得困難；支持治療為主",
      "acute": [
        "無急性治療需求"
      ],
      "chronic": [
        "生長激素補充（若可取得）：",
        "  - Porcine GH: 0.1 IU/kg SC 3次/週，共4-6週",
        "  - 效果不一，可能導致糖尿病",
        "  - 來源困難",
        "",
        "替代療法：",
        "  - Progestins（刺激乳腺GH）：",
        "    * Medroxyprogesterone: 2.5-5 mg/kg SC q3週",
        "    * 風險：糖尿病、子宮蓄膿、乳腺腫瘤",
        "",
        "甲狀腺激素補充（若繼發性甲低）：",
        "  - Levothyroxine: 標準劑量",
        "",
        "皮膚護理：保濕、預防感染"
      ]
    },
    "prognosis": "壽命通常縮短（先天性，約3-5歲）。繼發感染和代謝問題常見死因。治療可改善皮膚症狀但難以改變預後。",
    "pearls": [
      "German Shepherd腦下垂體侏儒症有遺傳檢測可用",
      "保留幼年毛是特徵性表現",
      "常合併其他腦下垂體激素缺乏",
      "GH補充風險大於益處（糖尿病風險）",
      "繁殖計畫中應排除帶因者"
    ],
    "diagnosticAlgorithm": {
      "title": "生長激素缺乏 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估生長遲緩與皮膚變化",
          "findings": [
            "比例性侏儒症",
            "幼犬生長遲緩",
            "被毛保留幼年毛",
            "皮膚變薄"
          ]
        },
        {
          "step": 2,
          "action": "血液篩檢",
          "details": "排除其他生長遲緩原因",
          "findings": [
            "甲狀腺功能正常",
            "肝腎功能評估",
            "骨齡評估（X光）"
          ]
        },
        {
          "step": 3,
          "action": "GH刺激試驗",
          "details": "Clonidine或GHRH刺激後測量GH",
          "findings": [
            "GH刺激後反應不足",
            "基礎IGF-1降低",
            "排除先天性甲低"
          ]
        },
        {
          "step": 4,
          "action": "基因與品種",
          "details": "遺傳性評估",
          "findings": [
            "德國牧羊犬垂體性侏儒症",
            "GH基因缺陷",
            "繁殖建議",
            "GH補充治療評估"
          ]
        }
      ]
    },
    "monitoring": [
      "皮膚狀況",
      "甲狀腺功能",
      "血糖（若使用progestins或GH）",
      "整體生長和發育"
    ],
    "reference": "Cote E: Clinical Veterinary Advisor: Dogs and Cats, 2nd Ed. Mosby, 2011"
  },
  "diabetes-insipidus": {
    "zh": "尿崩症",
    "en": "Diabetes Insipidus",
    "definition": "因抗利尿激素(ADH/AVP)缺乏（中樞性）或腎臟對ADH反應不足（腎源性）導致的大量稀釋尿液和繼發性多飲。",
    "synonyms": [
      "DI",
      "水尿症",
      "Central DI",
      "Nephrogenic DI",
      "CDI",
      "NDI"
    ],
    "epidemiology": {
      "species": "犬貓皆可發生，但罕見",
      "age": "任何年齡",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "頭部創傷",
        "腦下垂體腫瘤",
        "腦下垂體手術後",
        "先天性（罕見）",
        "腎臟疾病（腎源性）",
        "藥物（鋰、某些利尿劑）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "極度多飲（可>100 mL/kg/day）",
        "極度多尿",
        "尿稀如水",
        "尿失禁（膀胱容量不足）",
        "可能有神經症狀（若有腦部病變）"
      ],
      "physicalExam": [
        "通常無特異性發現",
        "脫水（若無法自由飲水）",
        "神經學異常（腦部病變時）"
      ]
    },
    "pathophysiology": "中樞性(CDI)：下視丘-腦下垂體後葉損傷 → ADH分泌不足 → 腎臟集合管水重吸收減少 → 大量稀釋尿液。腎源性(NDI)：ADH正常但腎臟V2受體或aquaporin-2異常 → 對ADH反應不足。原發性多飲：行為性過度飲水導致的繼發性尿液稀釋。",
    "diagnosis": {
      "overview": "排除其他PU/PD原因後，水剝奪試驗和DDAVP反應試驗鑑別",
      "differentials": [
        "糖尿病",
        "庫欣症",
        "腎衰竭",
        "肝衰竭",
        "高鈣血症",
        "子宮蓄膿",
        "甲狀腺功能亢進（貓）",
        "低鈉血症",
        "原發性多飲"
      ],
      "initialDB": [
        "尿比重：極低（<1.005-1.008）",
        "血清滲透壓：正常或略高",
        "尿液滲透壓：低（<血清滲透壓）",
        "CBC、生化全套、尿液分析：排除其他原因",
        "甲狀腺功能（貓）、腎上腺功能（若懷疑）"
      ],
      "advanced": [
        "改良式水剝奪試驗：",
        "  - 在監測下限水直到體重減少3-5%或血清滲透壓>320 mOsm/kg",
        "  - 測尿比重和滲透壓",
        "  - 給予DDAVP後再測（區分CDI vs NDI）",
        "",
        "DDAVP試驗反應：",
        "  - CDI：尿液濃縮改善",
        "  - NDI：無反應",
        "  - 原發性多飲：漸進式改善",
        "",
        "頭部MRI：評估下視丘-腦下垂體區"
      ]
    },
    "treatment": {
      "overview": "CDI對DDAVP反應良好；NDI治療較困難",
      "acute": [
        "嚴重脫水時：",
        "  - 輸液補充（注意不要過快糾正鈉）",
        "  - 自由飲水（若可行）"
      ],
      "chronic": [
        "中樞性尿崩症(CDI)：",
        "  - Desmopressin (DDAVP)：",
        "    * 滴眼劑入結膜囊：1-4滴 q12-24h",
        "    * 或口服：0.05-0.2 mg q8-12h",
        "    * 劑量依反應調整",
        "",
        "腎源性尿崩症(NDI)：",
        "  - 治療困難",
        "  - Thiazide利尿劑 + 低鈉飲食：可減少20-50%尿量",
        "  - 確保自由飲水",
        "",
        "原發性多飲：",
        "  - 行為修正",
        "  - 漸進式限水"
      ]
    },
    "prognosis": "CDI用DDAVP控制良好，預後佳。腦部腫瘤相關預後取決於腫瘤性質。NDI控制較差但可存活。需終身治療。",
    "pearls": [
      "完全性CDI尿比重<1.005；部分性可能略高",
      "水剝奪試驗有風險，需在醫院密切監測",
      "DDAVP滴眼劑比口服便宜且有效",
      "過量DDAVP可能導致水中毒（低鈉血症）",
      "創傷後CDI可能是暫時性的",
      "腎髓質沖刷可延長尿液濃縮恢復時間"
    ],
    "diagnosticAlgorithm": {
      "title": "尿崩症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估嚴重多飲多尿",
          "findings": [
            "極度多飲多尿",
            "尿量極大（>100 mL/kg/day）",
            "尿液極稀",
            "渴飲行為"
          ]
        },
        {
          "step": 2,
          "action": "尿液分析",
          "details": "尿比重評估",
          "findings": [
            "尿比重極低（<1.005）",
            "排除糖尿病（無尿糖）",
            "排除腎臟病"
          ]
        },
        {
          "step": 3,
          "action": "水剝奪試驗",
          "details": "禁水後測量尿比重與體重",
          "findings": [
            "禁水後尿比重仍低（中樞型）",
            "給予DDAVP後尿比重上升（中樞型）",
            "給予DDAVP無反應（腎源型）"
          ]
        },
        {
          "step": 4,
          "action": "腦部影像",
          "details": "MRI垂體評估",
          "findings": [
            "垂體腫塊（中樞型）",
            "後葉亮點消失",
            "排除創傷後",
            "原發性vs繼發性"
          ]
        }
      ]
    },
    "monitoring": [
      "飲水量和尿量",
      "尿比重",
      "電解質（尤其鈉）",
      "體重"
    ],
    "reference": "Cote E: Clinical Veterinary Advisor: Dogs and Cats, 2nd Ed. Mosby, 2011"
  },
  "hyperaldosteronism": {
    "zh": "高醛固酮症",
    "en": "Hyperaldosteronism (Conn's Syndrome)",
    "definition": "腎上腺醛固酮過度分泌導致高血壓、低血鉀和代謝性鹼中毒的疾病。分為原發性（腎上腺腫瘤或增生）和繼發性（腎素-血管緊張素系統活化）。",
    "synonyms": [
      "Conn's Syndrome",
      "Primary Hyperaldosteronism",
      "原發性高醛固酮症",
      "PHA"
    ],
    "epidemiology": {
      "species": "貓較常見（原發性），犬少見",
      "age": "貓：老年（平均13歲）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "年齡",
        "原發性：腎上腺腫瘤（單側腺瘤或癌）或雙側增生",
        "繼發性：心衰竭、肝硬化、腎病"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "肌肉無力（低血鉀）",
        "頸部腹側屈曲（貓特徵性）",
        "嗜睡",
        "多飲多尿",
        "失明（高血壓視網膜病變）"
      ],
      "physicalExam": [
        "全身肌肉無力",
        "頸部腹側屈曲（無法抬頭）",
        "高血壓",
        "眼底病變（視網膜出血、脫離、水腫）",
        "心雜音或奔馬律"
      ]
    },
    "pathophysiology": "原發性：腎上腺腫瘤或增生自主分泌醛固酮。繼發性：低血容量或腎灌流減少 → RAAS活化。醛固酮過量 → 腎臟鈉重吸收和鉀排泄增加 → 高血壓 + 低血鉀 → 肌肉無力、心律不整。",
    "diagnosis": {
      "overview": "低血鉀 + 高血壓 + 腎上腺腫塊高度提示原發性高醛固酮症",
      "differentials": [
        "慢性腎病（貓常見低血鉀原因）",
        "甲狀腺功能亢進（貓）",
        "其他腎上腺腫瘤",
        "藥物性低血鉀",
        "原發性高血壓"
      ],
      "initialDB": [
        "電解質：低血鉀（通常<3.0 mEq/L）、可能高鈉",
        "血壓：升高",
        "CBC、生化全套",
        "甲狀腺功能（排除甲亢）",
        "腎功能"
      ],
      "advanced": [
        "醛固酮濃度：升高",
        "醛固酮/腎素比值(ARR)：升高（原發性）",
        "腹部超音波：腎上腺腫塊或增生",
        "腹部CT：更精確評估腎上腺",
        "眼底檢查"
      ]
    },
    "treatment": {
      "overview": "手術切除腎上腺腫瘤或藥物控制",
      "acute": [
        "低血鉀處理：",
        "  - 口服或靜脈鉀補充（KCl）",
        "  - 嚴重時緩慢IV: 0.5 mEq/kg/h",
        "",
        "高血壓處理：",
        "  - Amlodipine: 0.625-1.25 mg/貓 PO q24h"
      ],
      "chronic": [
        "手術治療（首選，若單側腫瘤）：",
        "  - 腎上腺切除術",
        "  - 術前鉀和血壓控制",
        "  - 可能需要術後類固醇補充",
        "",
        "藥物治療（無法手術或雙側病變）：",
        "  - Spironolactone（醛固酮拮抗劑）: 2 mg/kg PO q12h",
        "  - 或 Eplerenone: 較少副作用",
        "  - 鉀補充（若需要）",
        "  - 高血壓藥物（Amlodipine）"
      ]
    },
    "prognosis": "手術成功切除良性腫瘤預後良好。惡性腫瘤或雙側增生預後較差。藥物可控制症狀但不治癒。眼睛病變可能不可逆。",
    "pearls": [
      "貓的頸部腹側屈曲是低血鉀肌病的特徵",
      "不是所有貓低血鉀都是高醛固酮症 - CKD更常見",
      "腎上腺癌vs腺瘤影像學難以區分",
      "術後對側腎上腺可能萎縮，需監測",
      "Spironolactone可能引起貓的面部皮炎",
      "高血壓視網膜病變可能導致永久失明"
    ],
    "diagnosticAlgorithm": {
      "title": "高醛固酮症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估低血鉀相關症狀（貓）",
          "findings": [
            "肌肉無力",
            "頸部腹屈",
            "低血鉀",
            "高血壓"
          ]
        },
        {
          "step": 2,
          "action": "電解質與血壓",
          "details": "鉀與血壓測量",
          "findings": [
            "持續性低血鉀",
            "高血壓",
            "代謝性鹼中毒",
            "血鈉正常或偏高"
          ]
        },
        {
          "step": 3,
          "action": "醛固酮測量",
          "details": "血清醛固酮",
          "findings": [
            "醛固酮升高",
            "醛固酮/腎素比值升高",
            "排除其他低鉀原因"
          ]
        },
        {
          "step": 4,
          "action": "腎上腺影像",
          "details": "超音波與CT",
          "findings": [
            "腎上腺腫塊",
            "單側或雙側腎上腺腫大",
            "CT確認腫塊大小",
            "手術或藥物（Spironolactone）"
          ]
        }
      ]
    },
    "monitoring": [
      "血鉀（每週直到穩定）",
      "血壓",
      "臨床症狀",
      "影像追蹤（腫瘤大小）"
    ],
    "reference": "Cote E: Clinical Veterinary Advisor: Dogs and Cats, 2nd Ed. Mosby, 2011"
  },
  "thyroid-carcinoma": {
    "zh": "甲狀腺癌",
    "en": "Thyroid Carcinoma",
    "definition": "起源於甲狀腺上皮細胞的惡性腫瘤。犬甲狀腺腫瘤多為惡性但通常無功能；貓甲狀腺腫瘤多為良性但有功能。",
    "synonyms": [
      "Thyroid Cancer",
      "甲狀腺惡性腫瘤",
      "Thyroid Neoplasia"
    ],
    "epidemiology": {
      "species": "犬為主（惡性多），貓較少（通常良性功能性）",
      "age": "犬：老年（平均9-10歲）；貓甲狀腺癌：老年",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "犬：無已知品種傾向，中大型犬可能較多",
        "貓：長期未治療的甲狀腺功能亢進"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "頸部腫塊（漸進性增大）",
        "呼吸困難或喘息",
        "吞嚥困難",
        "聲音改變",
        "體重減輕",
        "功能性腫瘤：甲亢症狀"
      ],
      "physicalExam": [
        "頸部可觸及腫塊（常單側）",
        "腫塊可移動或固定",
        "頸部淋巴結腫大",
        "功能性腫瘤：心搏過速、消瘦"
      ]
    },
    "pathophysiology": "犬：90%以上甲狀腺腫瘤為惡性（腺癌、濾泡性癌、髓質癌）。約10-20%有功能（分泌甲狀腺激素）。侵襲性強，常侵犯周圍組織和血管，轉移至肺和區域淋巴結常見。貓：甲狀腺腫瘤<5%為惡性，但惡性者侵襲性強。",
    "diagnosis": {
      "overview": "頸部腫塊 + 影像評估 + 細胞學/組織學確診",
      "differentials": [
        "良性甲狀腺腺瘤（貓）",
        "甲狀腺增生",
        "頸部淋巴結腫大",
        "涎腺腫瘤",
        "頸部其他腫瘤"
      ],
      "initialDB": [
        "甲狀腺功能（T4、TSH）：評估功能狀態",
        "頸部超音波：腫塊大小、侵犯程度、淋巴結",
        "胸腔X光（三視圖）：肺轉移評估",
        "細針抽吸細胞學（若可行）"
      ],
      "advanced": [
        "99mTc甲狀腺閃爍掃描：評估功能和異位組織",
        "CT/MRI：術前分期、侵犯評估",
        "組織病理學（切除或活檢）",
        "免疫組織化學（甲狀腺球蛋白、降鈣素）"
      ]
    },
    "treatment": {
      "overview": "可移動腫瘤首選手術；固定或轉移者考慮其他治療",
      "acute": [
        "功能性腫瘤引起甲亢：術前藥物控制"
      ],
      "chronic": [
        "手術切除（首選，若腫瘤可移動）：",
        "  - 甲狀腺切除術",
        "  - 可能需要雙側切除",
        "  - 保留副甲狀腺（若可行）",
        "",
        "放射治療：",
        "  - 無法切除或切除不完全",
        "  - 外部放射治療",
        "",
        "放射碘(I-131)：",
        "  - 功能性腫瘤",
        "  - 轉移性分化型甲狀腺癌",
        "  - 高劑量，需專門設施",
        "",
        "化療：",
        "  - Doxorubicin為主",
        "  - 效果有限",
        "",
        "酪氨酸激酶抑制劑：",
        "  - Toceranib: 某些病例可能有效",
        "",
        "術後：",
        "  - 監測甲狀腺功能",
        "  - 低鈣血症管理（若副甲狀腺損傷）",
        "  - 甲狀腺激素補充（若雙側切除）"
      ]
    },
    "prognosis": "可完全切除的可移動腫瘤預後較好（中位生存期>2年）。侵犯周圍組織或轉移預後差（中位生存期約3-6個月）。貓甲狀腺癌預後通常較差。",
    "pearls": [
      "犬頸部腫塊應考慮甲狀腺癌",
      "腫塊可移動vs固定是重要預後因素",
      "大部分犬甲狀腺腫瘤無功能（T4正常）",
      "術前閃爍掃描有助於評估手術可行性",
      "貓甲狀腺功能亢進惡性比例<5%",
      "轉移常見部位：肺和區域淋巴結"
    ],
    "diagnosticAlgorithm": {
      "title": "甲狀腺癌 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估頸部腫塊及是否固定",
          "findings": [
            "頸部可觸及腫塊",
            "腫塊固定或可移動",
            "可能有吞嚥困難",
            "可能伴甲狀腺功能亢進或正常"
          ]
        },
        {
          "step": 2,
          "action": "甲狀腺功能",
          "details": "T4與相關指標",
          "findings": [
            "T4可能正常或升高",
            "游離T4",
            "促甲狀腺素"
          ]
        },
        {
          "step": 3,
          "action": "影像分期",
          "details": "頸部與胸腔影像",
          "findings": [
            "頸部超音波腫塊特徵",
            "胸腔X光排除肺轉移",
            "CT評估侵犯範圍",
            "區域淋巴結"
          ]
        },
        {
          "step": 4,
          "action": "細胞學或切片",
          "details": "細針抽吸或手術切片",
          "findings": [
            "細針抽吸細胞學",
            "組織病理確診",
            "免疫組化分型",
            "甲狀腺閃爍掃描評估I-131治療"
          ]
        }
      ]
    },
    "monitoring": [
      "術後：甲狀腺功能、血鈣",
      "影像追蹤（胸腔X光、超音波）",
      "頸部觸診（局部復發）"
    ],
    "reference": "Cote E: Clinical Veterinary Advisor: Dogs and Cats, 2nd Ed. Mosby, 2011"
  },
  "adrenal-tumor": {
    "zh": "腎上腺腫瘤",
    "en": "Adrenal Tumor",
    "definition": "起源於腎上腺皮質或髓質的腫瘤。皮質腫瘤可為功能性（分泌皮質醇或醛固酮）或無功能性；髓質腫瘤主要為嗜鉻細胞瘤。",
    "synonyms": [
      "Adrenal Neoplasia",
      "Adrenocortical Tumor",
      "腎上腺腫塊"
    ],
    "epidemiology": {
      "species": "犬貓皆可發生",
      "age": "老年（犬平均9-11歲；貓平均11-12歲）",
      "sex": "功能性皮質腫瘤母犬略多；嗜鉻細胞瘤無性別傾向",
      "riskFactors": [
        "年齡",
        "大型犬腎上腺依賴性庫欣症(ADH)較多"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "功能性皮質腫瘤（皮質醇）：庫欣症症狀",
        "功能性皮質腫瘤（醛固酮）：高醛固酮症症狀",
        "嗜鉻細胞瘤：陣發性症狀",
        "無功能性腫瘤：可能無症狀（偶然發現）或腹痛、腹脹"
      ],
      "physicalExam": [
        "依功能狀態而異",
        "大型腫瘤可能觸及腹部腫塊",
        "腫瘤出血：急性腹痛、休克",
        "後腔靜脈侵犯：後肢水腫"
      ]
    },
    "pathophysiology": "皮質腫瘤：腺瘤（良性）或癌（惡性），約50%各佔一半。功能性者自主分泌皮質激素。髓質腫瘤（嗜鉻細胞瘤）：分泌兒茶酚胺。惡性腫瘤可局部侵犯（後腔靜脈常見）或遠處轉移（肝、肺）。",
    "diagnosis": {
      "overview": "影像學發現腎上腺腫塊後，評估功能狀態和侵犯範圍",
      "differentials": [
        "腦下垂體依賴性庫欣症（雙側腎上腺增生）",
        "轉移性腫瘤",
        "腎上腺增生",
        "腎上腺囊腫",
        "其他腹膜後腫塊"
      ],
      "initialDB": [
        "腹部超音波：腎上腺大小、對稱性、腫塊特徵",
        "評估後腔靜脈侵犯",
        "皮質醇功能檢測：LDDS、UCCR",
        "內源性ACTH：ADH時低",
        "電解質（高醛固酮症時低血鉀）"
      ],
      "advanced": [
        "腹部CT/MRI：精確分期、血管侵犯評估",
        "尿液兒茶酚胺/metanephrines（嗜鉻細胞瘤）",
        "胸腔影像：轉移評估",
        "血壓測量",
        "凝血功能（術前）"
      ]
    },
    "treatment": {
      "overview": "可切除腫瘤首選手術；無法手術者藥物或保守治療",
      "acute": [
        "腫瘤出血/破裂：",
        "  - 輸液復甦",
        "  - 輸血（若需要）",
        "  - 緊急手術（穩定後）",
        "",
        "嗜鉻細胞瘤高血壓危象：見嗜鉻細胞瘤治療"
      ],
      "chronic": [
        "手術切除（首選）：",
        "  - 腎上腺切除術",
        "  - 術前穩定（功能性腫瘤：控制皮質醇或血壓）",
        "  - 後腔靜脈腫瘤栓子處理",
        "  - 術後皮質醇補充（對側腎上腺萎縮）",
        "",
        "無法手術的功能性皮質腫瘤：",
        "  - Trilostane或Mitotane控制",
        "  - 劑量可能需較高",
        "",
        "無功能性腫瘤：",
        "  - 小型：監測觀察",
        "  - 大型或進展：考慮手術",
        "",
        "轉移性疾病：",
        "  - 化療（效果有限）",
        "  - 姑息治療"
      ]
    },
    "prognosis": "良性腺瘤完全切除預後佳。惡性癌視侵犯和轉移程度而定。有血管侵犯者手術風險和預後較差。中位生存期差異大（數月至數年）。",
    "pearls": [
      "腎上腺「偶發瘤」(incidentaloma)：偶然發現，需評估功能和惡性度",
      "腫瘤>2cm惡性可能性增加",
      "後腔靜脈侵犯不一定是手術禁忌，但風險增加",
      "功能性ADH對側腎上腺可能萎縮 - 術後需皮質醇補充",
      "CT對血管侵犯評估優於超音波"
    ],
    "diagnosticAlgorithm": {
      "title": "腎上腺腫瘤 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估內分泌或腫塊效應症狀",
          "findings": [
            "庫欣症狀（功能性腫瘤）",
            "腹部腫塊",
            "高血壓",
            "體重變化"
          ]
        },
        {
          "step": 2,
          "action": "內分泌功能",
          "details": "LDDS及ACTH刺激試驗",
          "findings": [
            "LDDS不被抑制",
            "ACTH刺激過度或無反應",
            "電解質（醛固酮瘤）",
            "兒茶酚胺（嗜鉻細胞瘤）"
          ]
        },
        {
          "step": 3,
          "action": "影像定位",
          "details": "超音波與CT",
          "findings": [
            "腎上腺腫塊大小",
            "血管侵犯（後腔靜脈血栓）",
            "對側腎上腺萎縮（功能性腺瘤）",
            "轉移評估"
          ]
        },
        {
          "step": 4,
          "action": "手術計畫",
          "details": "術前準備與評估",
          "findings": [
            "腫瘤可切除性",
            "術前穩定（嗜鉻細胞瘤需α阻斷）",
            "凝血功能",
            "術後腎上腺功能不全風險"
          ]
        }
      ]
    },
    "monitoring": [
      "術後：皮質醇（腎上腺功能恢復）",
      "影像追蹤（復發/轉移）",
      "藥物治療時：ACTH刺激試驗、電解質"
    ],
    "reference": "Cote E: Clinical Veterinary Advisor: Dogs and Cats, 2nd Ed. Mosby, 2011"
  },
  "otitis-interna": {
    "zh": "內耳炎",
    "en": "Otitis Interna",
    "definition": "內耳（迷路）的炎症性疾病，通常由中耳炎向內蔓延引起，影響前庭器官和耳蝸結構，導致平衡障礙和聽力損失。是周邊前庭症候群的重要鑑別診斷之一。",
    "synonyms": [
      "內耳感染",
      "迷路炎",
      "Labyrinthitis",
      "Inner Ear Infection"
    ],
    "epidemiology": {
      "species": "犬貓均可發生，犬較常見（因外耳炎→中耳炎→內耳炎的進展路徑）",
      "age": "任何年齡，慢性外耳炎患犬風險增加",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "慢性外耳炎病史",
        "長耳品種（Cocker Spaniel、Basset Hound）",
        "鼓膜穿孔",
        "中耳炎未治療",
        "鼻咽息肉（貓）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "頭部傾斜（患側）",
        "行走不穩/轉圈",
        "嘔吐（前庭刺激）",
        "聽力下降",
        "耳部疼痛或搔抓",
        "食慾下降"
      ],
      "physicalExam": [
        "頭部傾斜向患側",
        "水平或旋轉性眼球震顫（快相朝向健側）",
        "共濟失調（前庭性）",
        "霍納氏症候群（交感神經損傷）",
        "面神經麻痺（同側）",
        "耳道分泌物或異味",
        "觸診鼓室泡疼痛"
      ]
    },
    "pathophysiology": "感染（細菌最常見，以Pseudomonas、Staphylococcus為主）經由穿孔鼓膜從中耳蔓延至內耳迷路。炎症直接破壞前庭感覺上皮（半規管、橢圓囊和球囊）導致平衡障礙，並損傷耳蝸毛細胞導致感音神經性聽力損失。膿性滲出物壓迫顏面神經（CN VII）和交感神經幹，分別引起面神經麻痺和霍納氏症候群。嚴重時感染可穿破岩骨蔓延至腦幹引起腦膜腦炎。",
    "diagnosis": {
      "overview": "基於前庭症狀+耳部疾病證據。CT/MRI是評估鼓室泡和內耳結構的金標準",
      "differentials": [
        "中耳炎（無前庭症狀）",
        "特發性前庭症候群",
        "中樞性前庭疾病（腦幹病變）",
        "鼻咽息肉（貓）",
        "耳毒性藥物"
      ],
      "initialDB": [
        "耳鏡檢查（鼓膜完整性、外耳道分泌物）",
        "神經學檢查（區分周邊vs中樞前庭）",
        "鼓室泡X光（鼓室泡硬化或溶解）",
        "耳道分泌物細菌培養及藥敏試驗"
      ],
      "advanced": [
        "CT（鼓室泡骨變化的最佳評估）",
        "MRI（內耳軟組織和腦幹評估）",
        "肌電圖（面神經功能）",
        "BAER（聽力評估）"
      ]
    },
    "treatment": {
      "overview": "長期全身性抗生素（4-6週以上）為基石，嚴重病例需手術引流鼓室泡",
      "acute": [
        "全身性抗生素：依據培養藥敏選擇（經驗性首選Fluoroquinolone或Cephalosporin）",
        "療程至少4-6週（骨和內耳穿透性考量）",
        "Pseudomonas感染：Enrofloxacin 5-20 mg/kg PO q24h或Marbofloxacin",
        "抗發炎：Prednisolone 0.5-1 mg/kg PO q24h漸減",
        "止吐：Maropitant 1 mg/kg SC/PO q24h（前庭症狀嚴重時）",
        "耳道沖洗（鼓膜穿孔時需使用生理鹽水）"
      ],
      "chronic": [
        "嚴重/難治病例：鼓室泡截骨術（Ventral Bulla Osteotomy, VBO）引流",
        "全耳道切除+鼓室泡截骨術（TECA-LBO，終末期耳病）",
        "持續耳道維護和清潔",
        "治療潛在原因（過敏、外耳炎）"
      ]
    },
    "prognosis": "82%的犬中耳/內耳炎可用藥物和耳道沖洗成功控制。前庭症狀通常在2-4週內明顯改善，但可能遺留永久性頭部傾斜或輕度平衡障礙。聽力損失可能為永久性。面神經麻痺多數可恢復但需數週至數月。併發腦膜腦炎者預後較差。",
    "pearls": [
      "內耳炎的眼球震顫為水平或旋轉性，快相朝向健側——與中樞前庭疾病的方向多變性不同",
      "霍納氏症候群（瞳孔縮小、眼瞼下垂、第三眼瞼脫出）常伴隨內耳炎/中耳炎",
      "CT比X光更敏感於偵測鼓室泡病變",
      "貓的中耳炎/內耳炎應排除鼻咽息肉",
      "耳毒性藥物（Gentamicin耳滴劑）在鼓膜穿孔時禁用——可加重內耳損傷"
    ],
    "diagnosticAlgorithm": {
      "title": "內耳炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "前庭症狀評估",
          "details": "神經學檢查區分周邊vs中樞前庭疾病",
          "findings": [
            "頭部傾斜方向",
            "眼球震顫類型和方向",
            "姿態反應（周邊正常/中樞異常）",
            "意識狀態（周邊正常/中樞可能異常）"
          ]
        },
        {
          "step": 2,
          "action": "耳部檢查",
          "details": "耳鏡檢查+鼓膜評估+培養",
          "findings": [
            "鼓膜完整性",
            "外耳道分泌物性質",
            "細菌培養及藥敏",
            "面神經功能和霍納氏症候群"
          ]
        },
        {
          "step": 3,
          "action": "影像學評估",
          "details": "CT/MRI評估鼓室泡和內耳",
          "findings": [
            "CT：鼓室泡骨溶解或硬化",
            "鼓室泡內軟組織密度增加",
            "MRI：內耳訊號改變",
            "排除中樞前庭病變"
          ]
        },
        {
          "step": 4,
          "action": "治療計畫",
          "details": "依嚴重程度選擇藥物或手術",
          "findings": [
            "培養導向抗生素4-6週",
            "抗發炎+止吐",
            "嚴重→手術（VBO或TECA-LBO）",
            "追蹤前庭症狀和聽力"
          ]
        }
      ]
    },
    "monitoring": [
      "前庭症狀改善程度",
      "面神經功能恢復",
      "聽力評估（BAER）",
      "耳道分泌物培養追蹤",
      "影像學追蹤（鼓室泡癒合）"
    ],
    "reference": "MSD Veterinary Manual: Otitis Media and Interna 2023; MSPCA-Angell: Otitis Media/Interna and Neurologic Deficits"
  },
  "nasopharyngeal-polyp": {
    "zh": "鼻咽息肉",
    "en": "Nasopharyngeal Polyp",
    "definition": "源自中耳或耳咽管黏膜的良性炎性組織腫塊，可向鼻咽部或外耳道延伸生長，造成上呼吸道阻塞和/或中耳疾病。主要發生於幼貓，為貓上呼吸道阻塞的重要鑑別診斷。",
    "synonyms": [
      "鼻咽部息肉",
      "耳咽息肉",
      "Inflammatory Polyp",
      "Aural Polyp"
    ],
    "epidemiology": {
      "species": "幾乎僅見於貓（犬極罕見）",
      "age": "幼貓和青年貓最常見（多數<2歲）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "幼齡（<1歲最常見）",
        "上呼吸道感染史（可能為觸發因素）",
        "中耳慢性炎症",
        "先天性因素（耳咽管上皮異常）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "漸進性呼吸雜音（打鼾聲/鼻鼾）",
        "慢性鼻分泌物（單側或雙側）",
        "吞嚥困難",
        "耳部搔抓或頭部搖晃",
        "聽力下降",
        "打噴嚏"
      ],
      "physicalExam": [
        "吸氣性鼻鼾（stertor）",
        "口咽部可見粉紅色腫塊（軟腭後方）",
        "外耳道可見腫塊（耳道型）",
        "鼓膜膨出",
        "頭部傾斜（中耳受累時）",
        "霍納氏症候群（罕見）"
      ]
    },
    "pathophysiology": "息肉起源於中耳黏膜或耳咽管上皮的慢性炎症反應，確切病因不明，可能與上呼吸道病毒感染（如FHV-1、FCV）後的慢性炎症有關。組織學為高度血管化的纖維結締組織被覆上皮。息肉可沿耳咽管向鼻咽部延伸（鼻咽型），或經鼓膜向外耳道延伸（耳道型），或同時雙向生長。鼻咽型造成鼻咽部機械性阻塞。",
    "diagnosis": {
      "overview": "口腔檢查+耳鏡+影像學。軟腭後方或外耳道可視化腫塊高度提示，CT/MRI評估範圍，組織病理確診",
      "differentials": [
        "鼻咽腫瘤",
        "鼻咽狹窄",
        "異物",
        "慢性鼻炎",
        "鼻咽部膿腫"
      ],
      "initialDB": [
        "口腔檢查（輕翻軟腭觀察鼻咽部）",
        "耳鏡檢查（外耳道型息肉）",
        "鼓室泡X光",
        "鎮靜下鼻咽鏡檢查"
      ],
      "advanced": [
        "CT（金標準：評估鼓室泡受累和息肉範圍）",
        "MRI（軟組織詳細評估）",
        "組織病理學確診",
        "細菌培養（二次感染）"
      ]
    },
    "treatment": {
      "overview": "手術切除為標準治療。牽拉法簡單但復發率較高，鼓室泡截骨術復發率最低",
      "acute": [
        "牽拉法切除（Traction-avulsion）：鎮靜下經口或經耳道牽拉息肉至基底部斷裂",
        "術後Prednisolone 1-2 mg/kg PO q24h漸減2-3週（降低復發率）",
        "鼓室泡截骨術（Ventral Bulla Osteotomy, VBO）：適用於鼓室泡受累病例",
        "術後抗生素：Amoxicillin-clavulanate 12.5-25 mg/kg PO q12h × 2-4週"
      ],
      "chronic": [
        "追蹤監測復發（牽拉法復發率15-50%）",
        "復發病例考慮VBO",
        "治療併發中耳炎",
        "長期呼吸功能監測"
      ]
    },
    "prognosis": "牽拉法切除後復發率15-50%，加用類固醇可降低復發率。鼓室泡截骨術復發率最低（<5%）。大多數貓經適當手術治療後可完全治癒。術後可能出現暫時性霍納氏症候群或面神經麻痺（通常數週恢復）。早期診斷和治療預後更佳。",
    "pearls": [
      "鼻咽息肉幾乎是貓的專屬疾病——幼貓慢性鼻鼾聲首先考慮",
      "牽拉法+術後類固醇是侵入性最小的治療，但復發率15-50%",
      "VBO復發率最低但手術較大",
      "組織病理學是確診和排除腫瘤的關鍵",
      "術後暫時性霍納氏症候群常見且通常會恢復"
    ],
    "diagnosticAlgorithm": {
      "title": "鼻咽息肉 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "臨床懷疑",
          "details": "幼貓+慢性上呼吸道阻塞+吸氣性鼻鼾",
          "findings": [
            "年齡<2歲",
            "吸氣性鼻鼾（stertor）",
            "慢性鼻分泌物",
            "耳部症狀（搔抓、頭搖）"
          ]
        },
        {
          "step": 2,
          "action": "直接觀察",
          "details": "鎮靜下口腔和耳道檢查",
          "findings": [
            "軟腭後方可見粉紅色腫塊",
            "外耳道可見腫塊",
            "鼓膜異常（膨出/穿孔）",
            "觸診鼓室泡"
          ]
        },
        {
          "step": 3,
          "action": "影像學評估",
          "details": "CT評估鼓室泡和息肉範圍",
          "findings": [
            "鼓室泡充填軟組織密度",
            "息肉延伸方向和範圍",
            "雙側vs單側",
            "排除腫瘤性病變"
          ]
        },
        {
          "step": 4,
          "action": "手術切除與確診",
          "details": "牽拉法或VBO切除+組織病理",
          "findings": [
            "組織病理：炎性纖維結締組織",
            "排除腫瘤",
            "術後類固醇預防復發",
            "追蹤監測復發"
          ]
        }
      ]
    },
    "monitoring": [
      "術後呼吸功能",
      "復發監測（尤其牽拉法後3-6個月）",
      "耳道和中耳狀態",
      "面神經功能",
      "霍納氏症候群恢復"
    ],
    "reference": "Cornell Feline Health Center: Nasopharyngeal Polyps; ACVS: Nasopharyngeal Polyps; Vet Surg 2016"
  },
  "chronic-rhinitis": {
    "zh": "慢性鼻炎",
    "en": "Chronic Rhinitis (Lymphoplasmacytic Rhinitis)",
    "definition": "鼻腔黏膜的慢性炎症，以淋巴漿細胞浸潤為主要組織學特徵。犬的慢性特發性淋巴漿細胞性鼻炎（LPR）是排除腫瘤和真菌後最常見的慢性鼻病。病因通常不明（特發性），可能涉及免疫介導或過敏機制。",
    "synonyms": [
      "淋巴漿細胞性鼻炎",
      "特發性慢性鼻炎",
      "LPR",
      "Idiopathic Rhinitis"
    ],
    "epidemiology": {
      "species": "犬較常見，貓亦可發生但較少見",
      "age": "中年至老年犬為主",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "長頭品種（Dolichocephalic breeds）",
        "過敏體質",
        "環境空氣過敏原暴露",
        "慢性牙齒疾病（口鼻瘻管）",
        "先前鼻腔疾病史"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "慢性鼻分泌物（黏液性到黏液膿性）",
        "持續打噴嚏",
        "反向打噴嚏（reverse sneezing）",
        "鼻出血（偶見）",
        "鼻塞導致張口呼吸",
        "病程數月至數年，對抗生素反應差"
      ],
      "physicalExam": [
        "鼻分泌物（單側或雙側）",
        "鼻腔氣流減少",
        "打噴嚏",
        "鼻孔周圍色素脫失或潰瘍（嚴重分泌物刺激）",
        "面部無變形（與腫瘤鑑別）",
        "淋巴結通常不腫大"
      ]
    },
    "pathophysiology": "確切病因不明。組織學以淋巴細胞和漿細胞浸潤鼻黏膜為特徵，伴有黏膜上皮增生、杯狀細胞增多和黏膜下腺體增生。可能涉及的機制包括：(1)環境過敏原引發的持續免疫反應，(2)先前感染後的免疫失調，(3)黏膜免疫球蛋白（尤其IgA）表達降低導致黏膜屏障功能不全。慢性炎症導致鼻甲骨破壞和鼻腔結構改變，進一步損害黏膜纖毛清除功能，形成惡性循環。",
    "diagnosis": {
      "overview": "排除性診斷：必須先排除腫瘤、真菌感染和異物。組織病理學確認淋巴漿細胞浸潤",
      "differentials": [
        "鼻腔腫瘤（腺癌、淋巴瘤）",
        "真菌性鼻炎（Aspergillosis）",
        "鼻腔異物",
        "口鼻瘻管",
        "牙齒疾病"
      ],
      "initialDB": [
        "鼻腔X光",
        "鼻分泌物細胞學和培養",
        "牙科檢查（排除口鼻瘻管）",
        "血清Aspergillus抗體"
      ],
      "advanced": [
        "CT（鼻腔結構詳細評估，排除腫瘤和真菌斑塊）",
        "鼻腔鏡檢查+活檢（金標準）",
        "組織病理學（確認LPR，排除腫瘤）",
        "鼻腔沖洗細胞學"
      ]
    },
    "treatment": {
      "overview": "治療困難且反應不一。抗發炎藥物為主，但療效有限，多數需長期管理而非治癒",
      "acute": [
        "口服類固醇：Prednisolone 1-2 mg/kg PO q12h × 2-4週，然後漸減至最低有效劑量",
        "Piroxicam 0.3 mg/kg PO q24h（非類固醇選擇）",
        "吸入性類固醇：Fluticasone MDI via spacer（減少全身副作用）",
        "抗生素：二次細菌感染時使用（Amoxicillin-clavulanate或Doxycycline）",
        "鼻腔沖洗（生理鹽水，緩解症狀）"
      ],
      "chronic": [
        "長期低劑量類固醇維持（隔日給藥）",
        "環境過敏原管理（空氣清淨器、減少灰塵）",
        "定期鼻腔沖洗",
        "抗組織胺（Cetirizine 1 mg/kg PO q12-24h，療效有限）"
      ]
    },
    "prognosis": "特發性LPR是慢性進行性疾病，通常無法治癒但可管理症狀。對抗生素反應差，對類固醇反應中等但常需長期使用。生活品質通常可接受但症狀反覆發作。鼻出血反覆發作者需定期排除腫瘤發展。不影響壽命但影響生活品質。",
    "pearls": [
      "慢性鼻炎是排除性診斷——必須先排除腫瘤和真菌！",
      "CT+鼻腔鏡+活檢是鑑別診斷三聯檢查",
      "對抗生素反應差是LPR的特徵之一",
      "面部變形強烈提示腫瘤而非LPR",
      "吸入性類固醇可減少全身副作用，但犬的配合度是挑戰"
    ],
    "diagnosticAlgorithm": {
      "title": "慢性鼻炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "臨床評估",
          "details": "慢性鼻分泌物病史和特徵",
          "findings": [
            "分泌物性質（黏液/膿/血）",
            "單側vs雙側",
            "面部是否變形",
            "牙齒和口腔檢查"
          ]
        },
        {
          "step": 2,
          "action": "排除常見病因",
          "details": "影像學和血清學排除腫瘤和真菌",
          "findings": [
            "CT：鼻甲骨變化模式",
            "Aspergillus血清學",
            "牙科X光（口鼻瘻管）",
            "面部變形→高度懷疑腫瘤"
          ]
        },
        {
          "step": 3,
          "action": "鼻腔鏡+活檢",
          "details": "直接觀察+組織取樣",
          "findings": [
            "黏膜增生和充血",
            "排除腫塊病變",
            "多點活檢",
            "沖洗細胞學"
          ]
        },
        {
          "step": 4,
          "action": "組織病理確認",
          "details": "確認LPR並排除其他病因",
          "findings": [
            "淋巴漿細胞浸潤為主",
            "排除腫瘤和真菌",
            "制定長期管理計畫",
            "定期追蹤（排除腫瘤發展）"
          ]
        }
      ]
    },
    "monitoring": [
      "症狀嚴重程度評分",
      "鼻分泌物性質變化",
      "定期影像追蹤（排除腫瘤發展）",
      "類固醇副作用監測",
      "生活品質評估"
    ],
    "reference": "Plickert HD, et al. Canine chronic inflammatory rhinitis. Vet Clin North Am Small Anim Pract 2006;36(4):799-820; Irish Vet J 2018"
  },
  "ear-mites": {
    "zh": "耳疥蟲感染",
    "en": "Ear Mites (Otodectes cynotis)",
    "definition": "由耳疥蟲（Otodectes cynotis）寄生於外耳道引起的高度傳染性外寄生蟲病。是貓外耳炎最常見的原因（佔50-85%），犬亦常見。蟲體生活在耳道表面，以組織液和碎屑為食，引發強烈搔癢和炎症。",
    "synonyms": [
      "耳蟎",
      "耳蟲",
      "Otodectic Mange",
      "Otoacariasis"
    ],
    "epidemiology": {
      "species": "貓比犬更常見；亦可感染雪貂",
      "age": "幼年動物最常見（幼貓幼犬），但任何年齡均可感染",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "幼齡動物",
        "多貓/多犬家庭（高度傳染性）",
        "收容所或繁殖場",
        "流浪/半戶外貓",
        "與感染動物直接接觸"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "劇烈耳部搔癢",
        "頻繁搖頭",
        "耳部搔抓",
        "深色耳道分泌物",
        "耳部異味",
        "同居動物有類似症狀"
      ],
      "physicalExam": [
        "外耳道深褐色至黑色蠟狀或咖啡渣樣分泌物",
        "耳道紅腫",
        "搔癢反射（搓揉耳根時後腿蹬踢）",
        "耳殼內側抓傷或結痂",
        "耳血腫（繼發性）",
        "耳鏡下可見白色移動蟲體"
      ]
    },
    "pathophysiology": "O. cynotis為非穿入性表面蟲，生活週期約3週（卵→幼蟲→前若蟲→若蟲→成蟲），全部在宿主耳道完成。蟲體以表皮碎屑和組織液為食，其分泌物和排泄物引發宿主的過敏性和炎症反應。嚴重搔癢導致自我創傷。蟲體偶可轉移至皮膚其他部位引起異位性皮膚炎。繼發細菌和/或酵母菌感染常見。長期感染可導致慢性外耳道增生和中耳炎。",
    "diagnosis": {
      "overview": "耳鏡直接觀察蟲體或耳道分泌物顯微鏡檢查可確診。深褐色咖啡渣樣分泌物+劇烈搔癢高度提示",
      "differentials": [
        "細菌性外耳炎",
        "酵母菌性外耳炎（Malassezia）",
        "過敏性外耳炎",
        "耳道異物"
      ],
      "initialDB": [
        "耳鏡檢查（直接觀察白色蟲體移動）",
        "耳道分泌物顯微鏡檢查（礦物油塗片，觀察蟲體和蟲卵）",
        "耳道分泌物細胞學（排除繼發感染）"
      ],
      "advanced": [
        "皮膚搔刮檢查（異位性感染時）",
        "細菌培養（繼發感染時）",
        "鼓膜完整性評估（排除中耳炎）"
      ]
    },
    "treatment": {
      "overview": "殺蟲治療+耳道清潔+治療繼發感染。所有同居動物必須同時治療",
      "acute": [
        "Selamectin（Revolution）6-12 mg/kg局部spot-on，每月一次×2-3個月",
        "Fluralaner（Bravecto）局部或口服（單次即可有效）",
        "Sarolaner（Simparica）或Afoxolaner（NexGard）口服月劑",
        "Ivermectin 0.2-0.4 mg/kg SC/PO（注意：Collie品種禁用）",
        "耳道清潔：先用耳道清潔液軟化移除分泌物",
        "局部耳滴劑含殺蟲成分（如含Thiabendazole/Pyrethrins）"
      ],
      "chronic": [
        "所有同居犬貓雪貂必須同時治療（高度傳染性）",
        "環境清潔（蟲體可在環境存活數天）",
        "治療繼發細菌/酵母菌感染",
        "3週後複查確認清除（完整生活週期）"
      ]
    },
    "prognosis": "使用現代殺蟲藥物預後極佳。系統性isoxazoline類藥物（Fluralaner、Sarolaner）單次即可有效清除。關鍵是所有同居動物同時治療以防止再感染。未治療可導致慢性外耳道增生和繼發性中耳炎。",
    "pearls": [
      "深褐色咖啡渣樣耳道分泌物+劇烈搔癢=首先考慮耳疥蟲",
      "所有同居動物必須同時治療——這是治療失敗最常見原因",
      "現代isoxazoline類藥物（Bravecto等）單次即有效，已取代傳統多次治療",
      "Ivermectin對Collie和相關品種可能有致命毒性（MDR1基因突變）",
      "耳血腫常是未治療耳疥蟲搔癢的繼發結果"
    ],
    "diagnosticAlgorithm": {
      "title": "耳疥蟲感染 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "臨床懷疑",
          "details": "耳部搔癢+深色耳道分泌物+同居動物症狀",
          "findings": [
            "劇烈耳部搔癢",
            "深褐色咖啡渣樣分泌物",
            "同居動物類似症狀",
            "搔癢反射陽性"
          ]
        },
        {
          "step": 2,
          "action": "耳鏡檢查",
          "details": "直接觀察耳道中白色移動蟲體",
          "findings": [
            "白色蟲體在分泌物中移動",
            "耳道紅腫",
            "分泌物量多",
            "鼓膜完整性評估"
          ]
        },
        {
          "step": 3,
          "action": "顯微鏡確認",
          "details": "耳道分泌物礦物油塗片檢查",
          "findings": [
            "成蟲（8隻腳）",
            "若蟲",
            "蟲卵",
            "排除其他蟎蟲"
          ]
        },
        {
          "step": 4,
          "action": "治療與追蹤",
          "details": "殺蟲治療+同居動物同治",
          "findings": [
            "選擇系統性殺蟲藥",
            "耳道清潔",
            "所有同居動物治療",
            "3週後複查"
          ]
        }
      ]
    },
    "monitoring": [
      "治療後3週複查耳道（完整生活週期後）",
      "耳道分泌物追蹤",
      "搔癢症狀改善",
      "同居動物症狀",
      "繼發感染控制"
    ],
    "reference": "CAPC: Otodectic Mite Guidelines; Today's Veterinary Practice: Ear Mites 2023; VCA Animal Hospitals"
  },
  "aural-hematoma": {
    "zh": "耳血腫",
    "en": "Aural Hematoma (Auricular Hematoma)",
    "definition": "耳翼（耳殼）軟骨與皮膚之間的血液積聚，形成柔軟波動感腫脹。通常因劇烈搖頭或搔耳導致耳翼血管破裂。不是獨立診斷，而是潛在耳部疾病（外耳炎、耳疥蟲等）引起搔癢的繼發結果。",
    "synonyms": [
      "耳翼血腫",
      "耳瓣血腫",
      "Ear Flap Hematoma"
    ],
    "epidemiology": {
      "species": "犬遠較貓常見，垂耳犬種風險最高",
      "age": "任何年齡，但中老年犬較常見（慢性外耳炎病史）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "垂耳品種（Cocker Spaniel、Basset Hound、Labrador）",
        "外耳炎（最常見潛在原因）",
        "耳疥蟲感染",
        "過敏性皮膚病",
        "凝血功能障礙（罕見）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "耳翼突然腫脹",
        "搖頭或搔耳",
        "耳部搔癢或不適",
        "外耳炎病史",
        "一側或雙側"
      ],
      "physicalExam": [
        "耳翼內側柔軟波動感腫脹（如水球）",
        "耳翼溫熱、觸痛",
        "耳翼增厚",
        "同側外耳道可能有發炎或分泌物",
        "嚴重時耳翼變形"
      ]
    },
    "pathophysiology": "劇烈搖頭或搔耳造成耳翼軟骨板與皮膚之間的小血管斷裂，血液積聚於軟骨和耳翼凹面皮膚之間的潛在空間。機制可能包括：(1)直接創傷（搖頭撞擊硬物），(2)搔抓導致血管撕裂，(3)可能涉及免疫介導機制（部分病例無明確創傷史）。未治療的血腫會機化形成纖維組織，導致永久性耳翼皺縮變形（「菜花耳」）。貓的耳翼較薄，癒合後變形更明顯。",
    "diagnosis": {
      "overview": "臨床診斷直接明確（耳翼波動感腫脹）。重點在找出潛在原因（外耳炎、寄生蟲、過敏）",
      "differentials": [
        "耳翼腫瘤",
        "耳翼蜂窩性組織炎",
        "膿腫",
        "血清腫"
      ],
      "initialDB": [
        "視診和觸診（波動感腫脹）",
        "耳鏡檢查（查找潛在外耳炎）",
        "耳道分泌物檢查（細胞學、蟎蟲）"
      ],
      "advanced": [
        "穿刺液分析（血液→血腫，膿液→膿腫）",
        "凝血功能（反覆或無創傷史時）",
        "皮膚過敏原檢測（反覆發作時）"
      ]
    },
    "treatment": {
      "overview": "血腫引流+防止復發+治療潛在原因。方法從保守到手術多種選擇",
      "acute": [
        "穿刺抽吸+類固醇注入：針穿抽除血液後注入Triamcinolone 1-2 mg/耳",
        "手術引流+縫合固定：切開耳翼凹面引流，放置多處穿透性褥式縫合（防止再積血）",
        "引流管放置：Penrose drain或Teat cannula留置7-14天",
        "Prednisolone 1 mg/kg PO q24h × 7-14天（部分方案）",
        "耳翼繃帶固定（減少搖頭創傷）"
      ],
      "chronic": [
        "治療潛在原因（外耳炎、耳疥蟲、過敏）——最重要！",
        "耳道清潔和維護",
        "過敏管理（若為潛在因素）",
        "監測對側耳（風險增加）"
      ]
    },
    "prognosis": "治療後功能性預後良好。美觀性預後取決於治療方法和時機：早期手術縫合固定美觀效果最佳，保守治療或延遲治療可能導致永久性耳翼皺縮。關鍵在治療潛在原因以防復發。未治療血腫不會危及生命但必然導致耳翼變形。",
    "pearls": [
      "耳血腫不是診斷——是搔癢/搖頭的後果，必須找出並治療潛在原因",
      "治療潛在外耳炎比處理血腫本身更重要",
      "穿刺抽吸後不做任何處理→幾乎100%復發",
      "未治療的血腫會機化→永久性「菜花耳」",
      "貓的耳翼薄而癒合變形更嚴重"
    ],
    "diagnosticAlgorithm": {
      "title": "耳血腫 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "確認血腫",
          "details": "耳翼波動感腫脹的臨床診斷",
          "findings": [
            "耳翼凹面柔軟波動感腫脹",
            "溫熱、觸痛",
            "穿刺抽出血液（確認非膿腫）"
          ]
        },
        {
          "step": 2,
          "action": "查找潛在原因",
          "details": "耳鏡+耳道分泌物檢查",
          "findings": [
            "外耳炎（最常見原因）",
            "耳疥蟲",
            "過敏性皮膚病",
            "耳道異物"
          ]
        },
        {
          "step": 3,
          "action": "選擇治療方案",
          "details": "依據血腫大小和飼主期望",
          "findings": [
            "小型/早期→穿刺+類固醇注入",
            "大型/反覆→手術縫合固定",
            "引流管放置7-14天",
            "耳翼繃帶保護"
          ]
        },
        {
          "step": 4,
          "action": "治療潛在病因",
          "details": "預防復發的關鍵",
          "findings": [
            "外耳炎治療",
            "殺蟲治療（耳疥蟲）",
            "過敏管理",
            "定期耳道維護"
          ]
        }
      ]
    },
    "monitoring": [
      "術後傷口癒合",
      "血腫復發監測",
      "潛在外耳炎控制",
      "耳翼外觀變化",
      "對側耳狀態"
    ],
    "reference": "ACVS: Aural Hematoma; Cornell Feline Health Center; Merck Veterinary Manual: Auricular Hematomas 2023"
  },
  "congenital-deafness": {
    "zh": "先天性耳聾",
    "en": "Congenital Deafness",
    "definition": "出生時即存在或出生後數週內發生的永久性聽力喪失，多數為遺傳性感音神經性耳聾，與色素基因（piebald、merle、白色基因）相關。影響超過100個犬品種。BAER（腦幹聽覺誘發反應）檢測是確診金標準。",
    "synonyms": [
      "遺傳性耳聾",
      "色素相關耳聾",
      "Hereditary Sensorineural Deafness"
    ],
    "epidemiology": {
      "species": "犬超過100個品種受影響；白色貓（尤其藍眼）亦常見",
      "age": "出生即有或出生後3-4週發展（耳蝸血供退化時期）",
      "sex": "部分品種有性別傾向（如Dalmatian公犬略高）",
      "riskFactors": [
        "Piebald基因品種（Dalmatian最高約30%、Bull Terrier、English Setter、Australian Cattle Dog）",
        "Merle基因品種（Collie、Shetland Sheepdog、Dachshund）",
        "白色貓（尤其藍眼白貓，聾率可達65-85%）",
        "雙merle配種後代",
        "藍眼（與耳聾風險相關）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "對聲音無反應（飼主報告）",
        "難以喚醒",
        "服從訓練困難",
        "容易受驚（被意外觸碰時）",
        "與同窩幼犬比較反應遲鈍",
        "單側聾可能不被察覺"
      ],
      "physicalExam": [
        "手拍測試無反應（但需排除視覺或氣流察覺）",
        "瞳孔對強光聲音無間接反應",
        "白色被毛或斑塊",
        "藍色虹膜（一側或雙側）",
        "其他方面健康正常",
        "神經學檢查正常（非腦部病變）"
      ]
    },
    "pathophysiology": "遺傳性感音神經性耳聾與黑色素細胞發育缺陷有關。正常情況下，耳蝸血管紋（stria vascularis）需要黑色素細胞維持內淋巴液的離子平衡（高鉀環境）。piebald或merle等白色基因抑制黑色素細胞遷移至內耳。出生後3-4週，缺乏黑色素細胞的血管紋退化→內淋巴鉀離子濃度無法維持→耳蝸毛細胞死亡→永久性感音神經性耳聾。可為單側或雙側。與中枢神經系統無關。",
    "diagnosis": {
      "overview": "BAER（腦幹聽覺誘發反應）檢測是唯一客觀確診方法，可區分單側vs雙側聾",
      "differentials": [
        "獲得性耳聾（老年性、耳毒性藥物）",
        "傳導性聽力損失（中耳炎、耵聹栓塞）",
        "中樞性聽覺處理障礙"
      ],
      "initialDB": [
        "BAER檢測（5-6週齡即可執行）",
        "耳鏡檢查（排除外耳道和鼓膜異常）",
        "一般理學檢查",
        "家族史調查"
      ],
      "advanced": [
        "遺傳基因檢測（部分品種可用：Rottweiler-LOXHD1、Doberman-PTPRQ）",
        "CT（排除中耳結構異常）",
        "完整眼科檢查（藍眼與耳聾相關性）"
      ]
    },
    "treatment": {
      "overview": "先天性感音神經性耳聾目前無法治療或逆轉。管理重點在行為適應和安全措施",
      "acute": [
        "確認診斷後與飼主充分溝通（單側聾vs雙側聾的影響差異）",
        "建議BAER檢測所有繁殖候選犬",
        "聾犬不建議用於繁殖"
      ],
      "chronic": [
        "視覺手勢訓練取代聲音指令",
        "振動項圈輔助溝通（非電擊項圈）",
        "安全環境管理（避免交通危險、從視線內接近）",
        "聾貓建議室內飼養"
      ]
    },
    "prognosis": "先天性感音神經性耳聾為永久性，目前無治療方法。單側聾動物通常適應良好，生活品質接近正常。雙側聾動物需要特殊照護但可以有良好的生活品質。不影響壽命。通過選擇性繁殖（BAER篩選）可降低品種內發生率。",
    "pearls": [
      "BAER是唯一能客觀區分單側vs雙側聾的方法——單側聾飼主常不察覺",
      "犬最早5-6週齡即可做BAER檢測",
      "白色被毛+藍眼=耳聾風險顯著增加",
      "雙merle（homozygous merle）後代聾率極高——應避免此配種",
      "聾犬可以用視覺手勢和振動訓練得很好——不需要安樂死"
    ],
    "diagnosticAlgorithm": {
      "title": "先天性耳聾 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "臨床懷疑",
          "details": "高風險品種+對聲音反應異常",
          "findings": [
            "品種風險評估（Dalmatian、白色貓等）",
            "飼主報告對聲音無反應",
            "服從訓練困難",
            "與同窩比較反應遲鈍"
          ]
        },
        {
          "step": 2,
          "action": "排除其他聽力障礙",
          "details": "耳鏡+理學檢查排除傳導性問題",
          "findings": [
            "耳道通暢",
            "鼓膜完整",
            "無中耳炎證據",
            "神經學檢查正常"
          ]
        },
        {
          "step": 3,
          "action": "BAER確診",
          "details": "腦幹聽覺誘發反應檢測",
          "findings": [
            "雙側聾：雙耳無波形",
            "單側聾：一耳無波形",
            "正常聽力：I-V波正常",
            "5-6週齡即可檢測"
          ]
        },
        {
          "step": 4,
          "action": "管理計畫",
          "details": "繁殖建議+飼主教育",
          "findings": [
            "聾犬不繁殖",
            "視覺訓練方案",
            "安全環境管理",
            "品種繁殖者BAER篩選建議"
          ]
        }
      ]
    },
    "monitoring": [
      "定期行為評估",
      "安全環境維護",
      "繁殖群BAER篩選計畫",
      "基因檢測（可用品種）"
    ],
    "reference": "Strain GM. Deafness in Dogs and Cats. CABI 2011; Merck Veterinary Manual: Deafness in Animals 2023; LSU Deafness in Dogs & Cats"
  },
  "laryngeal-paralysis": {
    "zh": "喉麻痺",
    "en": "Laryngeal Paralysis (GOLPP)",
    "definition": "控制喉部杓狀軟骨開閉的喉返神經功能障礙，導致吸氣時杓狀軟骨無法正常外展張開，造成上呼吸道阻塞。多數為後天性，近年研究發現老年犬的喉麻痺通常是全身性多發性神經病變的一部分（GOLPP：老年性喉麻痺多發性神經病變）。",
    "synonyms": [
      "喉部麻痺",
      "GOLPP",
      "Geriatric Onset Laryngeal Paralysis Polyneuropathy",
      "Lar Par"
    ],
    "epidemiology": {
      "species": "犬遠較貓常見",
      "age": "後天性：中老年大型犬（平均10歲以上），先天性：<1歲",
      "sex": "公犬略多於母犬",
      "riskFactors": [
        "大型和巨型品種（Labrador Retriever最常見、Golden Retriever、St. Bernard、Irish Setter）",
        "老年（>9歲）",
        "甲狀腺功能低下（有爭議的關聯性）",
        "先天性：Bouvier des Flandres、Dalmatian幼犬"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "漸進性吸氣性喘鳴（stridor）",
        "叫聲改變（沙啞或消失）",
        "運動不耐加重",
        "炎熱天氣或興奮時呼吸困難加劇",
        "後肢無力（GOLPP的早期神經徵象）",
        "進食時偶爾咳嗽或嗆咳"
      ],
      "physicalExam": [
        "吸氣性喘鳴（高音調stridor）",
        "吸氣努力增加",
        "黏膜可能發紺（嚴重時）",
        "後肢本體感覺輕微異常（GOLPP）",
        "肌肉萎縮（晚期）",
        "聲音沙啞",
        "高溫或興奮時症狀明顯惡化"
      ]
    },
    "pathophysiology": "GOLPP理論：大多數老年犬喉麻痺為全身性神經退行性疾病的表現，最長的神經最先受影響。喉返神經（全身最長的迷走神經分支，尤其左側繞主動脈弓）最早退化→杓狀軟骨外展肌（背側環杓肌）失去神經支配→吸氣時杓狀軟骨被動內收阻塞聲門→上呼吸道阻塞。隨病程進展，其他長神經也受影響→食道功能障礙（吞嚥困難、巨食道症）和後肢運動神經病變（後肢無力）。上呼吸道阻塞→吸氣負壓增加→喉部水腫和發炎→惡性循環。",
    "diagnosis": {
      "overview": "鎮靜下直接喉部觀察是確診方法——觀察杓狀軟骨在吸氣時是否正常外展",
      "differentials": [
        "氣管塌陷",
        "短頭犬呼吸道症候群",
        "喉部腫塊/腫瘤",
        "會厭逆翻",
        "氣管異物"
      ],
      "initialDB": [
        "頸胸X光（排除腫塊、巨食道、肺炎）",
        "鎮靜下喉部檢查（金標準：觀察杓狀軟骨運動）",
        "神經學檢查（GOLPP相關：後肢本體感覺）"
      ],
      "advanced": [
        "胸腔X光（排除吸入性肺炎和巨食道症）",
        "甲狀腺功能檢測（排除甲低）",
        "肌電圖/神經傳導（GOLPP確認）",
        "食道造影或內視鏡（吞嚥功能評估）"
      ]
    },
    "treatment": {
      "overview": "輕症保守管理，中重度手術（單側杓狀軟骨側向固定術tie-back）。手術改善呼吸但增加吸入性肺炎風險",
      "acute": [
        "急性呼吸危象：鎮靜（Acepromazine 0.02-0.05 mg/kg IM）+氧氣+降溫",
        "Dexamethasone 0.1-0.2 mg/kg IV（減輕喉部水腫）",
        "氣管插管（嚴重阻塞時緊急處理）",
        "手術：單側杓狀軟骨側向固定術（Unilateral Arytenoid Lateralization, Tie-back）",
        "術後：抬高食碗、軟食、限制活動2-4週"
      ],
      "chronic": [
        "輕症保守管理：避免高溫、限制劇烈運動、使用胸背帶（非頸圈）",
        "體重管理（減輕呼吸負荷）",
        "術後長期：注意吸入性肺炎風險（約25%術後發生）",
        "GOLPP進展監測（後肢功能、吞嚥功能）"
      ]
    },
    "prognosis": "Tie-back手術後呼吸功能顯著改善，90%以上飼主滿意。主要風險為術後吸入性肺炎（約25%在術後某個時間點發生）。GOLPP為進行性疾病，後肢功能和食道功能可能隨時間惡化。手術後中位存活約2年（多數因GOLPP進展而非喉麻痺本身）。保守管理適用於輕症但不能逆轉病程。",
    "pearls": [
      "GOLPP：大多數老年犬的喉麻痺是全身性神經退行性疾病的冰山一角",
      "鎮靜深度影響喉部檢查結果——過深的鎮靜會抑制正常杓狀軟骨運動→假陽性",
      "Tie-back手術後吸入性肺炎風險終身約25%——術前必須與飼主充分溝通",
      "急性喉部危象時Acepromazine鎮靜常比插管更有效",
      "後肢無力可能比喉部症狀更早出現（GOLPP）——需同時評估神經功能"
    ],
    "diagnosticAlgorithm": {
      "title": "喉麻痺 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "臨床懷疑",
          "details": "老年大型犬+漸進性吸氣喘鳴+叫聲改變",
          "findings": [
            "吸氣性stridor",
            "叫聲沙啞",
            "運動不耐",
            "高溫/興奮時惡化"
          ]
        },
        {
          "step": 2,
          "action": "排除其他上呼吸道阻塞",
          "details": "頸胸X光+神經學檢查",
          "findings": [
            "X光排除腫塊和巨食道",
            "神經學：後肢本體感覺評估",
            "排除氣管塌陷",
            "甲狀腺功能檢測"
          ]
        },
        {
          "step": 3,
          "action": "喉部檢查確診",
          "details": "適度鎮靜下直接觀察杓狀軟骨運動",
          "findings": [
            "杓狀軟骨吸氣時不外展=確診",
            "注意鎮靜深度不要過深",
            "評估雙側vs單側",
            "排除喉部腫塊"
          ]
        },
        {
          "step": 4,
          "action": "治療決策",
          "details": "依嚴重程度選擇保守vs手術",
          "findings": [
            "輕症→保守管理+環境控制",
            "中重度→Tie-back手術",
            "術前胸腔X光排除肺炎",
            "術後吸入性肺炎風險教育"
          ]
        }
      ]
    },
    "monitoring": [
      "呼吸功能評估",
      "術後吸入性肺炎監測（長期）",
      "後肢功能（GOLPP進展）",
      "吞嚥功能",
      "體重管理"
    ],
    "reference": "Stanley BJ, et al. GOLPP. J Vet Intern Med 2020; ACVS: Laryngeal Paralysis; VCA Animal Hospitals"
  },
  "inguinal-hernia": {
    "zh": "腹股溝疝氣",
    "en": "Inguinal Hernia",
    "definition": "腹股溝疝氣是腹腔臟器（如腸道、膀胱、子宮或網膜）經由擴大的腹股溝環突出至腹股溝區域的先天性或後天性疾病。先天性型態因腹股溝管發育異常所致，後天性型態常與荷爾蒙、肥胖或妊娠有關。",
    "synonyms": [
      "鼠蹊疝氣",
      "腹股溝裂孔疝"
    ],
    "epidemiology": {
      "species": "犬貓皆可，犬較常見",
      "age": "先天性：幼年；後天性：中老年母犬",
      "sex": "母犬較好發（腹股溝管較短寬、雌激素影響結締組織）",
      "riskFactors": [
        "玩具犬種（吉娃娃、馬爾濟斯、貴賓）",
        "未絕育母犬",
        "肥胖",
        "妊娠",
        "先天腹股溝環過大"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "腹股溝區域可觸及腫塊",
        "腫塊可能時大時小",
        "嵌頓時出現疼痛、嘔吐、食慾下降",
        "母犬懷孕後期加重"
      ],
      "physicalExam": [
        "腹股溝區域可觸診軟性腫塊",
        "可復位性疝氣可將內容物推回腹腔",
        "嵌頓性疝氣觸診疼痛且無法復位",
        "絞扼性疝氣伴局部發熱腫脹",
        "雙側腹股溝應同時檢查"
      ]
    },
    "pathophysiology": "腹股溝管由內腹斜肌外側界定、直肌和內腹斜肌內側界定。當腹股溝環先天性過大或後天因荷爾蒙（雌激素）影響使結締組織鬆弛時，腹壓增加可推動腹腔臟器通過腹股溝管突出。嵌頓（incarceration）發生時臟器被卡住無法復位，若血供受阻則進展為絞扼（strangulation），導致組織缺血壞死，為外科急症。",
    "diagnosis": {
      "overview": "多數可藉觸診確診，影像學用於評估嵌頓內容物",
      "differentials": [
        "腹股溝淋巴結腫大",
        "脂肪瘤",
        "乳腺腫瘤延伸",
        "膿瘍"
      ],
      "initialDB": [
        "腹股溝區觸診（可復位性 vs 嵌頓性）",
        "腹部X光",
        "腹部超音波（評估疝氣內容物）"
      ],
      "advanced": [
        "對比X光（疑似膀胱疝出時）",
        "CT掃描（複雜疝氣評估）"
      ]
    },
    "treatment": {
      "overview": "手術修復為首選治療，嵌頓或絞扼時為急診手術",
      "acute": [
        "絞扼性疝氣：緊急開腹探查+壞死組織切除",
        "靜脈輸液支持+止痛",
        "抗生素預防性投予"
      ],
      "chronic": [
        "擇期疝氣修補術（herniorrhaphy）",
        "同時進行卵巢子宮切除術（未絕育母犬）",
        "雙側腹股溝環均應評估並修補"
      ]
    },
    "prognosis": "擇期手術修補預後極佳，復發率低。絞扼性疝氣若及時手術，預後仍佳；延誤治療導致腸壞死時預後下降。建議術後限制活動2-4週。",
    "pearls": [
      "母犬腹股溝疝氣常見於未絕育中老年犬，修補時應同時絕育",
      "雙側腹股溝均應檢查，單側疝氣對側亦可能有潛在缺損",
      "嵌頓性疝氣不應嘗試強力復位，應直接手術"
    ],
    "diagnosticAlgorithm": {
      "title": "腹股溝疝氣 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "理學檢查",
          "details": "觸診腹股溝區域腫塊，評估可復位性",
          "findings": [
            "軟性可復位腫塊",
            "硬性不可復位腫塊（嵌頓）",
            "疼痛伴發熱（絞扼）"
          ]
        },
        {
          "step": 2,
          "action": "影像學檢查",
          "details": "X光及超音波評估疝氣內容物",
          "findings": [
            "腸管疝出",
            "膀胱疝出",
            "子宮/網膜疝出"
          ]
        },
        {
          "step": 3,
          "action": "實驗室檢查",
          "details": "嵌頓或絞扼時評估全身狀態",
          "findings": [
            "CBC（感染指標）",
            "生化指標（腎功能若膀胱嵌頓）"
          ]
        },
        {
          "step": 4,
          "action": "手術計畫",
          "details": "根據疝氣類型決定擇期或急診手術",
          "findings": [
            "可復位→擇期修補",
            "嵌頓/絞扼→急診手術"
          ]
        }
      ]
    },
    "monitoring": [
      "術後傷口癒合狀況",
      "術後2-4週限制活動",
      "觀察復發跡象",
      "體重管理"
    ],
    "reference": "VCA Animal Hospitals — Inguinal Hernias; MSD Veterinary Manual — Hernias in Animals; dvm360 — Hernia Repair Proceedings"
  },
  "diaphragmatic-hernia-congenital": {
    "zh": "先天性橫膈疝氣",
    "en": "Congenital Diaphragmatic Hernia",
    "definition": "先天性橫膈疝氣是因胚胎發育期間橫膈膜形成不完全，導致腹腔臟器（肝臟、胃、腸道、脾臟等）經由橫膈缺損進入胸腔的先天性疾病。包括腹膜心包橫膈疝氣（PPDH）和胸膜腹膜裂孔疝氣等亞型。",
    "synonyms": [
      "先天性膈疝",
      "PPDH（腹膜心包橫膈疝氣）"
    ],
    "epidemiology": {
      "species": "犬貓皆可，貓較犬常見先天性型",
      "age": "先天性：任何年齡可診斷，常於幼年或偶然發現",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "遺傳缺陷",
        "胚胎期致畸因子暴露",
        "Weimaraner犬種（PPDH好發）",
        "波斯貓和喜馬拉雅貓"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "呼吸困難（輕度至嚴重）",
        "運動不耐",
        "偶發嘔吐或食慾下降",
        "部分病例無症狀（偶然影像學發現）"
      ],
      "physicalExam": [
        "胸腔聽診肺音減弱或消失",
        "胸腔內可聽到腸蠕動音",
        "心音可能移位",
        "腹部觸診臟器減少（因位移至胸腔）",
        "嚴重者呈端坐呼吸"
      ]
    },
    "pathophysiology": "胚胎發育期間，橫膈膜由隔膜橫板（septum transversum）、胸膜腹膜膜、食道背系膜和體壁肌肉組織融合形成。任何部分發育障礙均可導致橫膈缺損。腹腔臟器經缺損移入胸腔，壓迫肺葉導致肺不張和通氣不足。PPDH型態中腹腔臟器進入心包囊，可能影響心臟舒張功能。長期代償後急性失代償可能因臟器嵌頓或胃擴張觸發。",
    "diagnosis": {
      "overview": "胸腔X光為主要診斷工具，超音波和CT可進一步確認",
      "differentials": [
        "外傷性橫膈疝氣",
        "胸腔積液",
        "肺葉扭轉",
        "胸腔腫瘤"
      ],
      "initialDB": [
        "胸腔X光（腹側背側+側位）",
        "腹腔超音波（評估腹腔臟器位置）",
        "胸腔超音波"
      ],
      "advanced": [
        "對比消化道攝影（確認胃腸疝出）",
        "CT掃描（術前計畫）",
        "心臟超音波（PPDH評估心包內容物）"
      ]
    },
    "treatment": {
      "overview": "手術修補為根治性治療，術前需穩定呼吸循環狀態",
      "acute": [
        "氧氣支持",
        "胸腔穿刺引流（大量氣胸或積液時）",
        "靜脈輸液穩定循環"
      ],
      "chronic": [
        "腹正中開腹橫膈修補術",
        "疝出臟器復位回腹腔",
        "橫膈缺損直接縫合或網片修補"
      ]
    },
    "prognosis": "PPDH手術死亡率低，長期預後極佳。非PPDH型先天性橫膈疝氣預後取決於疝出臟器種類和併發症。術後需注意再膨脹性肺水腫（re-expansion pulmonary edema），特別是慢性病例。",
    "pearls": [
      "PPDH常為偶然影像學發現，無症狀者仍建議手術以防未來嵌頓",
      "術後緩慢復位肺葉以減少再膨脹性肺水腫風險",
      "先天性橫膈疝氣在貓比犬更常見"
    ],
    "diagnosticAlgorithm": {
      "title": "先天性橫膈疝氣 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "理學檢查+聽診",
          "details": "評估呼吸型態和胸腔聽診異常",
          "findings": [
            "肺音減弱/消失",
            "胸腔腸蠕動音",
            "心音移位"
          ]
        },
        {
          "step": 2,
          "action": "胸腹X光",
          "details": "正側位X光評估橫膈完整性",
          "findings": [
            "橫膈輪廓消失",
            "胸腔內可見腹腔臟器影像",
            "心影增大（PPDH）"
          ]
        },
        {
          "step": 3,
          "action": "超音波+對比攝影",
          "details": "進一步確認疝出內容物",
          "findings": [
            "肝臟/腸道位於胸腔",
            "心包內可見臟器（PPDH）"
          ]
        },
        {
          "step": 4,
          "action": "CT術前評估",
          "details": "複雜病例的手術計畫",
          "findings": [
            "精確定位缺損大小和位置",
            "評估併發臟器損傷"
          ]
        }
      ]
    },
    "monitoring": [
      "術後呼吸監測（再膨脹性肺水腫）",
      "術後胸腔X光追蹤",
      "活動限制2-4週",
      "長期預後評估"
    ],
    "reference": "ACVS — Diaphragmatic Hernia; Merck Veterinary Manual — Diaphragmatic Hernia in Animals; VCA Animal Hospitals"
  },
  "pectus-excavatum": {
    "zh": "漏斗胸",
    "en": "Pectus Excavatum",
    "definition": "漏斗胸是一種先天性胸骨畸形，表現為胸骨向內凹陷（特別是後段胸骨），導致胸腔容積減少。嚴重病例可壓迫心肺，影響呼吸和心臟功能。主要見於幼犬和幼貓，貓較犬常見。",
    "synonyms": [
      "凹胸",
      "沉胸",
      "Funnel Chest"
    ],
    "epidemiology": {
      "species": "犬貓皆可，貓較常見",
      "age": "出生即存在，通常於幼年（< 4月齡）發現",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "遺傳因素（可能為遺傳性缺陷）",
        "鬥牛犬和臘腸犬好發",
        "緬甸貓好發",
        "早產或低體重幼畜"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "胸部明顯凹陷",
        "呼吸費力或呼吸急促",
        "運動不耐",
        "發育遲緩",
        "輕度病例可能無症狀"
      ],
      "physicalExam": [
        "胸骨後段明顯向背側凹陷",
        "觸診可感受胸骨凹陷程度",
        "心音可能異常（心臟位移）",
        "肺音可能減弱",
        "嚴重者可見發紺"
      ]
    },
    "pathophysiology": "漏斗胸的確切病因不明，推測與胸骨和肋軟骨的先天性發育異常有關，可能涉及軟骨基質代謝缺陷。胸骨向背側凹陷壓迫胸腔內容物，減少功能性肺容積，限制肺擴張能力。嚴重凹陷可使心臟位移或受壓，影響心輸出量。部分病例可隨成長自行改善，但嚴重病例需早期手術干預。",
    "diagnosis": {
      "overview": "視診和觸診即可初步診斷，影像學評估嚴重程度",
      "differentials": [
        "扁胸（pectus carinatum）",
        "肋骨骨折",
        "胸壁腫瘤",
        "先天性心臟病"
      ],
      "initialDB": [
        "胸部X光（側位+腹背位）",
        "觸診評估凹陷程度",
        "胸骨指數測量（Vertebral Index）"
      ],
      "advanced": [
        "CT掃描（精確測量凹陷程度和心肺壓迫）",
        "心臟超音波（評估心功能）",
        "動脈血氣分析"
      ]
    },
    "treatment": {
      "overview": "輕度病例可觀察，嚴重病例需於2-4月齡內手術矯正",
      "acute": [
        "氧氣支持（呼吸窘迫時）",
        "胸腔穿刺（併發氣胸時）"
      ],
      "chronic": [
        "外固定夾板矯正術（最常見方法）",
        "夾板縫合於胸骨，外部施加矯正力約6週",
        "成年後手術矯正效果差，胸壁順應性已降低"
      ]
    },
    "prognosis": "輕度病例部分可隨成長改善，預後良好。嚴重病例未經治療預後差。2-4月齡內手術矯正成功率較高，延遲手術因胸壁硬化效果下降。術後需密切監測夾板位置和傷口。",
    "pearls": [
      "手術矯正應在2-4月齡進行，越早越好",
      "部分輕度病例可隨成長自行改善",
      "嚴重漏斗胸需排除併發先天性心臟病"
    ],
    "diagnosticAlgorithm": {
      "title": "漏斗胸 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "視診+觸診",
          "details": "評估胸骨凹陷程度和呼吸狀態",
          "findings": [
            "胸骨明顯凹陷",
            "呼吸費力",
            "發育遲緩"
          ]
        },
        {
          "step": 2,
          "action": "胸部X光",
          "details": "側位和腹背位X光評估",
          "findings": [
            "胸骨指數異常",
            "心臟位移",
            "肺壓迫"
          ]
        },
        {
          "step": 3,
          "action": "CT掃描",
          "details": "精確測量凹陷程度和評估併發症",
          "findings": [
            "Haller指數計算",
            "心肺受壓程度"
          ]
        },
        {
          "step": 4,
          "action": "心臟超音波",
          "details": "排除先天性心臟病",
          "findings": [
            "心功能評估",
            "排除結構性異常"
          ]
        }
      ]
    },
    "monitoring": [
      "術後夾板固定位置",
      "呼吸功能改善追蹤",
      "成長發育監測",
      "術後6週移除夾板"
    ],
    "reference": "MSPCA-Angell — Pectus Excavatum; PMC — Surgical correction of pectus excavatum in cats; PetMD — Chest Bone Deformity"
  },
  "persistent-right-aortic-arch": {
    "zh": "持續性右主動脈弓",
    "en": "Persistent Right Aortic Arch",
    "definition": "持續性右主動脈弓（PRAA）是最常見的血管環異常，正常發育時右側第四主動脈弓應退化，但在PRAA中右側弓持續存在並形成主動脈，與動脈導管韌帶共同環繞並壓迫食道，導致食道梗阻和巨食道。約佔血管環異常病例的95%。",
    "synonyms": [
      "PRAA",
      "血管環異常"
    ],
    "epidemiology": {
      "species": "犬較常見，貓偶見",
      "age": "斷奶開始固體食物時發病（3-6月齡）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "德國牧羊犬",
        "愛爾蘭雪達犬",
        "波士頓梗犬",
        "英國鬥牛犬",
        "拉布拉多犬",
        "遺傳因素"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "斷奶後開始嘔吐/反流固體食物",
        "液體食物可正常通過",
        "發育遲緩",
        "體重減輕",
        "偶有咳嗽（吸入性肺炎）"
      ],
      "physicalExam": [
        "體重過輕、營養不良",
        "前胸部食道擴張（頸部觸診）",
        "肺部聽診異常（吸入性肺炎時）",
        "反流未消化食物（非嘔吐物）"
      ]
    },
    "pathophysiology": "胚胎發育時左右各有第四主動脈弓。正常情況下左弓發育為主動脈，右弓退化。PRAA中右弓持續存在成為主動脈，位於食道右背側。動脈導管韌帶（ligamentum arteriosum）從左肺動脈連接至右側主動脈，跨越食道左側。食道因此被氣管（腹側）、主動脈（右背側）、肺動脈（左側）和動脈導管韌帶（左背側）形成的血管環包圍壓迫，導致環前方食道擴張（巨食道），固體食物無法通過。",
    "diagnosis": {
      "overview": "胸部X光可見前縱隔食道擴張，對比攝影確認，CT精確定位",
      "differentials": [
        "先天性巨食道",
        "食道異物",
        "食道狹窄",
        "其他血管環異常"
      ],
      "initialDB": [
        "胸部X光（可見心基部前食道擴張）",
        "對比食道攝影（鋇劑吞嚥）",
        "CBC和生化（評估營養狀態）"
      ],
      "advanced": [
        "CT血管造影（精確定位異常血管走向）",
        "心臟超音波（排除併發先天性心臟病）",
        "內視鏡（評估食道黏膜）"
      ]
    },
    "treatment": {
      "overview": "手術切斷動脈導管韌帶以解除血管環壓迫為唯一根治方法",
      "acute": [
        "吸入性肺炎治療：抗生素+氧氣支持",
        "營養支持：高熱量流質餵食",
        "垂直姿勢餵食減少反流"
      ],
      "chronic": [
        "左側第四肋間開胸術切斷動脈導管韌帶",
        "術後繼續垂直姿勢餵食3-6個月",
        "逐漸轉換為固體食物",
        "早期手術（2-6月齡）預後最佳"
      ]
    },
    "prognosis": "87%的犬術後長期預後良好至極佳。早期手術（6月齡內）效果最好。術前已有嚴重巨食道者，食道功能可能無法完全恢復，需長期管理餵食方式。吸入性肺炎是主要死亡原因。",
    "pearls": [
      "PRAA佔所有血管環異常的95%",
      "關鍵鑑別：反流固體食物但液體正常通過",
      "手術越早進行效果越好，延遲會導致永久性食道損傷",
      "術後需持續垂直餵食數月至食道功能恢復"
    ],
    "diagnosticAlgorithm": {
      "title": "持續性右主動脈弓 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "病史+理學檢查",
          "details": "斷奶後反流固體食物為主要線索",
          "findings": [
            "固體食物反流、液體正常",
            "發育遲緩",
            "營養不良"
          ]
        },
        {
          "step": 2,
          "action": "胸部X光",
          "details": "評估食道擴張和肺部狀態",
          "findings": [
            "心基部前食道擴張",
            "可能的吸入性肺炎"
          ]
        },
        {
          "step": 3,
          "action": "對比食道攝影",
          "details": "鋇劑吞嚥確認食道梗阻位置",
          "findings": [
            "心基部食道狹窄",
            "狹窄前食道明顯擴張"
          ]
        },
        {
          "step": 4,
          "action": "CT血管造影",
          "details": "術前精確定位異常血管",
          "findings": [
            "右側主動脈弓",
            "動脈導管韌帶走向確認"
          ]
        }
      ]
    },
    "monitoring": [
      "術後反流改善程度",
      "體重增長追蹤",
      "吸入性肺炎監測",
      "逐漸恢復正常飲食"
    ],
    "reference": "Merck Veterinary Manual — Vascular Malformations; ACVS; UC Davis School of Veterinary Medicine"
  },
  "portosystemic-shunt-congenital": {
    "zh": "先天性門體分流",
    "en": "Congenital Portosystemic Shunt",
    "definition": "先天性門體分流（CPSS）是一種先天性血管異常，門脈血液經由異常血管通道繞過肝臟直接進入體循環。導致肝臟發育不全、解毒功能障礙，毒素（特別是氨）累積於血液中引起肝性腦病等全身性症狀。分為肝外型（小型犬和貓多見）和肝內型（大型犬多見）。",
    "synonyms": [
      "先天性肝門脈分流",
      "CPSS",
      "Liver Shunt"
    ],
    "epidemiology": {
      "species": "犬貓皆可",
      "age": "多於1歲前出現症狀",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "約克夏梗（肝外型最常見犬種）",
        "馬爾濟斯、西乎犬",
        "愛爾蘭獵狼犬、金毛犬（肝內型）",
        "波斯貓和喜馬拉雅貓",
        "遺傳傾向"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "神經症狀（迷失方向、踱步、凝視牆壁、癲癇）",
        "餐後症狀加重",
        "發育遲緩、體型小於同窩仔",
        "多飲多尿",
        "間歇性嘔吐或腹瀉",
        "異食癖"
      ],
      "physicalExam": [
        "體型偏小",
        "肝臟觸診縮小",
        "銅色虹膜（貓）",
        "尿酸銨結石（膀胱觸診）",
        "神經學檢查異常（共濟失調、頭部震顫）"
      ]
    },
    "pathophysiology": "正常情況下，門脈血液攜帶來自胃腸道的營養物質和毒素進入肝臟進行代謝和解毒。先天性門體分流中，異常血管使門脈血液繞過肝竇直接進入後腔靜脈或奇靜脈。肝臟因缺乏門脈血流中的肝營養因子（hepatotropic factors）而發育不全（microhepatica）。腸道產生的氨、硫醇、假性神經傳導物質等毒素未經肝臟代謝直接進入體循環，累積後引起肝性腦病（hepatic encephalopathy）。尿酸因肝臟無法將其轉化為尿囊素而在尿液中累積，形成尿酸銨結石。",
    "diagnosis": {
      "overview": "血清膽汁酸檢測為篩檢首選，CT血管造影為確診金標準",
      "differentials": [
        "後天性門體分流（繼發於肝硬化）",
        "肝微血管發育不全",
        "其他原因的肝性腦病",
        "先天性腎功能異常"
      ],
      "initialDB": [
        "空腹及餐後血清膽汁酸",
        "CBC（常見微小紅血球症）",
        "生化（BUN低、白蛋白低、膽固醇低）",
        "尿液分析（尿酸銨結晶）"
      ],
      "advanced": [
        "CT血管造影（確診金標準，精確定位分流血管）",
        "腹部超音波+都卜勒（篩檢分流血管）",
        "門脈壓力測量（術中）",
        "核醫學門脈造影"
      ]
    },
    "treatment": {
      "overview": "手術漸進式結紮或介入性栓塞為首選，內科治療用於術前穩定或無法手術者",
      "acute": [
        "肝性腦病急性發作：乳果糖灌腸+IV輸液",
        "抗癲癇藥物（levetiracetam）",
        "低蛋白飲食+抗生素（減少腸道氨產生）"
      ],
      "chronic": [
        "ameroid constrictor或cellophane banding漸進式結紮",
        "經皮經靜脈彈簧圈栓塞（肝內型）",
        "內科管理：乳果糖+甲硝唑/安比西林+處方低蛋白飲食"
      ]
    },
    "prognosis": "犬手術治療後預後通常良好。肝外單一分流手術成功率>85%。貓的預後略遜於犬。純內科治療的長期預後較差。術後需監測門脈高壓症狀（多發性後天分流形成）。",
    "pearls": [
      "約克夏梗和小型犬多為肝外型，大型犬多為肝內型",
      "餐後神經症狀加重是重要的診斷線索",
      "血清膽汁酸正常不能完全排除分流（敏感度85-90%）",
      "術前內科穩定至少2-4週再進行手術"
    ],
    "diagnosticAlgorithm": {
      "title": "先天性門體分流 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "臨床懷疑",
          "details": "幼年小型犬餐後神經症狀",
          "findings": [
            "發育遲緩",
            "餐後行為異常",
            "多飲多尿"
          ]
        },
        {
          "step": 2,
          "action": "血液篩檢",
          "details": "膽汁酸+CBC+生化",
          "findings": [
            "空腹/餐後膽汁酸升高",
            "微小紅血球症",
            "BUN/白蛋白/膽固醇偏低"
          ]
        },
        {
          "step": 3,
          "action": "影像篩檢",
          "details": "腹部超音波+都卜勒評估",
          "findings": [
            "肝臟縮小",
            "異常血管通道",
            "門脈血流異常"
          ]
        },
        {
          "step": 4,
          "action": "確診影像",
          "details": "CT血管造影精確定位",
          "findings": [
            "分流血管起止點",
            "肝內型vs肝外型分類",
            "術前計畫"
          ]
        }
      ]
    },
    "monitoring": [
      "術後膽汁酸追蹤（1個月、3個月、6個月）",
      "肝臟大小追蹤（超音波）",
      "神經症狀改善",
      "體重增長",
      "尿液分析（結石風險）"
    ],
    "reference": "PMC — Congenital PSS Classification and Diagnosis (Vet Sci 2023); ACVS — Portosystemic Shunts; dvm360"
  },
  "systemic-lupus-erythematosus": {
    "zh": "全身性紅斑狼瘡",
    "en": "Systemic Lupus Erythematosus",
    "definition": "全身性紅斑狼瘡（SLE）是一種多系統自體免疫疾病，免疫系統產生針對自身細胞核成分（包括雙股DNA、RNA和蛋白質抗原）的自體抗體，形成免疫複合物沉積於多個器官，導致廣泛性組織損傷。可影響皮膚、關節、腎臟、血液系統等多個器官系統。",
    "synonyms": [
      "SLE",
      "紅斑性狼瘡",
      "系統性紅斑狼瘡"
    ],
    "epidemiology": {
      "species": "犬較常見，貓罕見",
      "age": "中年犬（平均5歲），範圍廣",
      "sex": "母犬略好發",
      "riskFactors": [
        "德國牧羊犬",
        "喜樂蒂牧羊犬",
        "貴賓犬",
        "米格魯犬",
        "阿富汗獵犬",
        "遺傳傾向",
        "紫外線暴露可能觸發"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "間歇性跛行（多發性關節炎）",
        "皮膚病變（面部、耳朵）",
        "發燒反覆不退",
        "食慾下降體重減輕",
        "多飲多尿（腎臟受損時）"
      ],
      "physicalExam": [
        "多關節腫脹疼痛（非侵蝕性）",
        "皮膚潰瘍或紅斑（鼻部、耳廓、四肢）",
        "發燒",
        "淋巴結腫大",
        "黏膜蒼白（溶血性貧血時）",
        "脾臟腫大"
      ]
    },
    "pathophysiology": "SLE的病理機制涉及免疫耐受性喪失，B細胞和T細胞對自身抗原產生反應。抗核抗體（ANA）與細胞核成分結合形成免疫複合物，沉積於腎絲球基底膜、關節滑膜、血管壁和皮膚真皮-表皮交界處，活化補體系統引起第III型過敏反應。腎臟免疫複合物沉積導致膜增殖性腎絲球腎炎，是最嚴重的併發症。免疫複合物也可直接攻擊紅血球和血小板，導致免疫媒介性溶血性貧血（IMHA）和血小板減少症（ITP）。",
    "diagnosis": {
      "overview": "需符合多項診斷標準，ANA檢測為核心篩檢工具",
      "differentials": [
        "圓盤狀紅斑狼瘡（DLE）",
        "免疫媒介性多發性關節炎",
        "類風濕性關節炎",
        "感染性多發性關節炎",
        "藥物反應"
      ],
      "initialDB": [
        "ANA檢測（敏感度97-100%）",
        "CBC（貧血、血小板減少）",
        "生化（BUN/Cr升高、白蛋白下降）",
        "尿液分析（蛋白尿）"
      ],
      "advanced": [
        "Coombs試驗（IMHA確認）",
        "關節液分析",
        "腎臟活檢（腎絲球腎炎分型）",
        "皮膚活檢（免疫螢光染色）",
        "抗dsDNA抗體"
      ]
    },
    "treatment": {
      "overview": "免疫抑制治療為主，需長期管理",
      "acute": [
        "Prednisolone 2-4 mg/kg/day（誘導劑量）",
        "嚴重溶血或血小板減少：輸血支持",
        "腎衰竭：IV輸液+支持治療"
      ],
      "chronic": [
        "逐漸減量Prednisolone至最低有效劑量",
        "Azathioprine 2 mg/kg/day（犬）或Cyclosporine 5 mg/kg q12h",
        "Mycophenolate mofetil（難治病例）",
        "避免紫外線暴露",
        "腎臟保護（ACE抑制劑、低蛋白飲食）"
      ]
    },
    "prognosis": "長期預後謹慎至不良。多數犬在診斷後1年內因器官損傷或治療併發症死亡。腎臟受累是最主要的預後不良因素。早期診斷和積極免疫抑制可改善預後。需終身治療和監測。",
    "pearls": [
      "ANA陰性幾乎可排除SLE（陰性預測值>99%）",
      "SLE必須累及兩個以上器官系統才能確診",
      "腎絲球腎炎是最嚴重的併發症和主要死因",
      "與DLE不同，SLE累及全身多系統"
    ],
    "diagnosticAlgorithm": {
      "title": "全身性紅斑狼瘡 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "臨床懷疑",
          "details": "多系統症狀（關節+皮膚+血液+腎臟）",
          "findings": [
            "多關節炎",
            "皮膚病變",
            "發燒",
            "蛋白尿"
          ]
        },
        {
          "step": 2,
          "action": "ANA篩檢",
          "details": "抗核抗體檢測",
          "findings": [
            "ANA陽性（高敏感度）",
            "ANA陰性→幾乎排除SLE"
          ]
        },
        {
          "step": 3,
          "action": "器官評估",
          "details": "評估各器官受累程度",
          "findings": [
            "CBC（血液系統）",
            "尿液分析（腎臟）",
            "關節液（關節）",
            "皮膚活檢"
          ]
        },
        {
          "step": 4,
          "action": "確診標準",
          "details": "需符合≥2個器官系統受累+ANA陽性",
          "findings": [
            "多系統受累確認",
            "排除其他自體免疫疾病"
          ]
        }
      ]
    },
    "monitoring": [
      "CBC和血小板計數（每2-4週）",
      "腎功能和尿蛋白定量",
      "免疫抑制劑藥物副作用",
      "ANA效價追蹤"
    ],
    "reference": "VCA Animal Hospitals — SLE in Dogs; Veterinary Partner — VIN; PubMed — 75 cases study; PMC — ACVIM consensus"
  },
  "discoid-lupus-erythematosus": {
    "zh": "圓盤狀紅斑狼瘡",
    "en": "Discoid Lupus Erythematosus",
    "definition": "圓盤狀紅斑狼瘡（DLE）是一種僅限於皮膚的自體免疫疾病，主要影響鼻鏡（nasal planum），造成鼻部色素脫失、結痂、潰瘍。與全身性紅斑狼瘡不同，DLE不累及內臟器官，預後顯著較好。為犬最常見的自體免疫性皮膚病之一。",
    "synonyms": [
      "DLE",
      "鼻部狼瘡",
      "皮膚型紅斑狼瘡"
    ],
    "epidemiology": {
      "species": "幾乎僅見於犬，貓極罕見",
      "age": "中年犬",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "德國牧羊犬",
        "哈士奇",
        "阿拉斯加雪橇犬",
        "喜樂蒂牧羊犬",
        "英國鬥牛犬",
        "紫外線暴露加重"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "鼻部顏色變淡或脫色",
        "鼻部結痂或出血",
        "陽光暴露後症狀加重",
        "夏季惡化冬季改善"
      ],
      "physicalExam": [
        "鼻鏡色素脫失（黑→藍灰→粉紅）",
        "鼻鏡正常鵝卵石紋路消失",
        "鼻鏡結痂、糜爛或潰瘍",
        "可能延伸至鼻樑、耳朵",
        "無全身症狀"
      ]
    },
    "pathophysiology": "DLE的發病機制與SLE類似但僅限於皮膚。自體抗體和免疫複合物沉積於表皮-真皮交界處（基底膜帶），活化補體導致基底層角質細胞損傷和液化性變性。免疫螢光染色可見基底膜帶免疫球蛋白和補體沉積（lupus band test陽性）。紫外線暴露可促進角質細胞凋亡並暴露核抗原，加重自體免疫反應。鼻鏡因缺乏被毛保護且UV暴露量大，故為最常受累部位。",
    "diagnosis": {
      "overview": "皮膚活檢為確診方法，需排除SLE和其他鼻部疾病",
      "differentials": [
        "黏膜皮膚膿皮症",
        "天疱瘡（尋常型或落葉型）",
        "皮膚淋巴瘤",
        "鼻部鱗狀細胞癌",
        "自發性色素脫失（雪鼻）"
      ],
      "initialDB": [
        "鼻部皮膚活檢（組織病理學）",
        "CBC和生化（排除全身性疾病）",
        "ANA檢測（排除SLE）"
      ],
      "advanced": [
        "免疫螢光染色（lupus band test）",
        "尿液分析（排除腎臟受累）",
        "真菌培養（排除皮黴菌）"
      ]
    },
    "treatment": {
      "overview": "局部治療為首選，避免紫外線暴露，嚴重者需全身免疫抑制",
      "acute": [
        "Tacrolimus 0.1%軟膏外用BID",
        "或強效外用類固醇（betamethasone）"
      ],
      "chronic": [
        "持續外用Tacrolimus維持治療",
        "避免陽光暴露（特別是上午10點到下午4點）",
        "嚴重者：Doxycycline + Niacinamide口服",
        "頑固病例：低劑量Prednisolone或Hydroxychloroquine"
      ]
    },
    "prognosis": "DLE預後良好，多數犬對治療反應佳。需持續治療和避免UV暴露。本病不會轉變為全身性紅斑狼瘡。鼻部潰瘍長期未控制有極低風險轉變為鱗狀細胞癌。",
    "pearls": [
      "DLE與SLE的關鍵區別：DLE僅累及皮膚，無全身症狀",
      "鼻鏡色素脫失+鵝卵石紋路消失是早期徵象",
      "需先做1個月抗生素療程排除黏膜皮膚膿皮症",
      "紫外線防護是治療成功的關鍵"
    ],
    "diagnosticAlgorithm": {
      "title": "圓盤狀紅斑狼瘡 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "臨床觀察",
          "details": "鼻鏡病變評估",
          "findings": [
            "色素脫失",
            "結痂或潰瘍",
            "夏季加重"
          ]
        },
        {
          "step": 2,
          "action": "排除感染",
          "details": "先做抗生素試驗排除膿皮症",
          "findings": [
            "1個月抗生素無反應→非膿皮症",
            "有反應→黏膜皮膚膿皮症"
          ]
        },
        {
          "step": 3,
          "action": "皮膚活檢",
          "details": "組織病理學確認",
          "findings": [
            "基底膜帶淋巴細胞浸潤",
            "基底層液化變性",
            "色素失禁"
          ]
        },
        {
          "step": 4,
          "action": "排除SLE",
          "details": "ANA+全身檢查",
          "findings": [
            "ANA陰性",
            "無關節/腎臟/血液受累→確認DLE"
          ]
        }
      ]
    },
    "monitoring": [
      "鼻部病變改善程度",
      "紫外線防護依從性",
      "外用藥物副作用",
      "季節性變化追蹤"
    ],
    "reference": "Veterinary Partner — VIN — DLE; Veterinary Practice — Cutaneous LE; Mar Vista Animal Medical Center"
  },
  "evan-syndrome": {
    "zh": "乙凡氏症候群",
    "en": "Evans Syndrome",
    "definition": "乙凡氏症候群是免疫媒介性溶血性貧血（IMHA）和免疫媒介性血小板減少症（ITP）同時或序貫發生的自體免疫疾病。約60%的IMHA犬會同時出現ITP。同時攻擊紅血球和血小板使病情更加嚴重，治療更具挑戰性。",
    "synonyms": [
      "Evans Syndrome",
      "IMHA合併ITP"
    ],
    "epidemiology": {
      "species": "犬為主，貓偶見",
      "age": "中年犬（2-8歲）",
      "sex": "母犬（特別是已絕育母犬）好發",
      "riskFactors": [
        "可卡犬",
        "英國跳獵犬",
        "迷你雪納瑞",
        "古代牧羊犬",
        "貴賓犬",
        "近期疫苗接種或感染可能觸發"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "突然虛弱無力",
        "運動不耐",
        "食慾下降",
        "尿液變深色",
        "鼻出血或牙齦出血",
        "皮下瘀斑"
      ],
      "physicalExam": [
        "黏膜蒼白且可能黃疸",
        "心搏過速",
        "脾臟腫大",
        "皮膚瘀斑或紫斑",
        "發燒",
        "呼吸急促"
      ]
    },
    "pathophysiology": "乙凡氏症候群中，免疫系統同時產生抗紅血球和抗血小板的自體抗體。IMHA部分：抗體結合紅血球表面抗原，抗體包覆的紅血球被脾臟和肝臟巨噬細胞吞噬（血管外溶血），產生球形紅血球和脾腫大。嚴重時補體媒介的血管內溶血在循環中直接破壞紅血球，導致血紅素血症、血紅素尿和可能的急性腎損傷。ITP部分：抗血小板抗體導致血小板被加速破壞，骨髓代償性增加巨核細胞但無法追上破壞速度。兩者合併使患者同時面臨嚴重貧血和出血風險。",
    "diagnosis": {
      "overview": "CBC顯示同時貧血和血小板減少，Coombs試驗確認免疫性溶血",
      "differentials": [
        "單獨IMHA",
        "單獨ITP",
        "DIC（瀰漫性血管內凝血）",
        "骨髓疾病",
        "藥物引起的血球減少"
      ],
      "initialDB": [
        "CBC（貧血+血小板減少+網狀紅血球增加）",
        "血液抹片（球形紅血球、自凝集）",
        "生化（膽紅素升高）",
        "尿液分析（血紅素尿、膽紅素尿）"
      ],
      "advanced": [
        "直接Coombs試驗",
        "生理食鹽水凝集試驗",
        "凝血功能檢查（PT/aPTT排除DIC）",
        "骨髓檢查（排除骨髓疾病）",
        "腹部超音波（脾臟評估）"
      ]
    },
    "treatment": {
      "overview": "高劑量免疫抑制+支持性輸血，雙重免疫攻擊需更積極治療",
      "acute": [
        "Prednisolone 2-4 mg/kg/day",
        "危及生命的貧血：輸注紅血球濃厚液",
        "嚴重血小板減少伴出血：人類靜脈免疫球蛋白（hIVIG）",
        "靜脈輸液+氧氣支持"
      ],
      "chronic": [
        "第二線免疫抑制劑：Cyclosporine或Mycophenolate mofetil",
        "Azathioprine 2 mg/kg/day（犬）",
        "逐漸減量類固醇（數月過程）",
        "抗血栓預防：低劑量Aspirin或Clopidogrel"
      ]
    },
    "prognosis": "乙凡氏症候群預後較單獨IMHA或ITP更差。死亡率約40-60%。血栓栓塞是主要死亡原因之一。對初始免疫抑制治療有反應者預後較佳。復發率高，需長期免疫抑制治療。",
    "pearls": [
      "約60%的IMHA犬同時有ITP→應常規監測血小板計數",
      "自凝集試驗陽性可省略Coombs試驗",
      "血栓栓塞預防至關重要（肺栓塞是主要死因）",
      "比單獨IMHA需要更積極的免疫抑制治療"
    ],
    "diagnosticAlgorithm": {
      "title": "乙凡氏症候群 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "急性評估",
          "details": "評估貧血和出血嚴重度",
          "findings": [
            "蒼白+黃疸",
            "皮膚瘀斑",
            "心搏過速"
          ]
        },
        {
          "step": 2,
          "action": "CBC+血液抹片",
          "details": "確認同時貧血和血小板減少",
          "findings": [
            "PCV下降+網狀紅血球增加",
            "血小板計數<50,000/μL",
            "球形紅血球"
          ]
        },
        {
          "step": 3,
          "action": "免疫媒介確認",
          "details": "凝集試驗和Coombs試驗",
          "findings": [
            "自凝集陽性或Coombs陽性",
            "排除DIC（PT/aPTT正常）"
          ]
        },
        {
          "step": 4,
          "action": "病因調查",
          "details": "排除繼發性原因",
          "findings": [
            "感染篩檢（心絲蟲、壁蝨媒介）",
            "腹部影像（腫瘤排除）",
            "藥物史評估"
          ]
        }
      ]
    },
    "monitoring": [
      "每日PCV/TS和血小板估計（住院期）",
      "每週CBC（穩定後）",
      "凝血功能監測",
      "免疫抑制劑副作用",
      "血栓徵象監測"
    ],
    "reference": "VCA Animal Hospitals — Evans Syndrome; PMC — IMHA with thrombocytopenia; Today's Veterinary Practice — IMHA"
  },
  "cold-agglutinin-disease": {
    "zh": "冷凝集素病",
    "en": "Cold Agglutinin Disease",
    "definition": "冷凝集素病是一種罕見的自體免疫性溶血性貧血，由低溫活化型自體抗體（通常為IgM型）引起。這些冷反應性抗體在低於體溫的環境中與紅血球表面抗原結合，導致紅血球凝集和補體媒介溶血。末梢循環因溫度較低而最先受影響。",
    "synonyms": [
      "CAD",
      "冷型自體免疫性溶血性貧血"
    ],
    "epidemiology": {
      "species": "犬貓皆極罕見",
      "age": "無特定年齡好發",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "淋巴瘤或其他腫瘤",
        "慢性感染（如Mycoplasma）",
        "免疫系統疾病"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "寒冷環境暴露後症狀加重",
        "末梢（耳尖、尾尖、趾端）發紺或壞死",
        "虛弱無力",
        "尿液變色"
      ],
      "physicalExam": [
        "黏膜蒼白",
        "耳尖、尾尖或趾端發紺/壞死",
        "黃疸（溶血時）",
        "脾臟腫大",
        "末梢組織冰冷"
      ]
    },
    "pathophysiology": "冷凝集素為IgM型自體抗體，在低溫（<37°C，通常<30°C）下與紅血球表面多醣抗原（通常為I/i抗原）結合，造成紅血球凝集。IgM五聚體高效活化補體經典途徑，C3b沉積於紅血球表面。當血液回流至溫暖的中心循環時，IgM抗體解離，但C3b仍留在紅血球表面，被肝臟庫佛氏細胞辨識並吞噬（血管外溶血）。嚴重時完整補體級聯被活化至C5-C9膜攻擊複合物，導致血管內溶血。末梢循環溫度最低，故耳尖、鼻端、尾尖和趾端最先出現紅血球凝集和缺血壞死。",
    "diagnosis": {
      "overview": "室溫血液自凝集+加溫至37°C後凝集消失為特徵性診斷",
      "differentials": [
        "暖型IMHA",
        "DIC",
        "冷球蛋白血症",
        "末梢血管疾病"
      ],
      "initialDB": [
        "CBC（貧血+可能自凝集干擾自動計數）",
        "血液抹片（紅血球凝集）",
        "室溫凝集試驗+37°C加溫試驗",
        "生化（膽紅素升高）"
      ],
      "advanced": [
        "冷凝集素效價測定（4°C）",
        "直接Coombs試驗（特異性）",
        "流式細胞儀（補體C3沉積）",
        "腫瘤篩檢（排除繼發性）"
      ]
    },
    "treatment": {
      "overview": "保持溫暖環境為首要措施，免疫抑制治療控制抗體產生",
      "acute": [
        "將動物置於溫暖環境",
        "溫熱IV輸液",
        "嚴重貧血：輸注加溫紅血球",
        "氧氣支持"
      ],
      "chronic": [
        "免疫抑制劑：Prednisolone+Chlorambucil",
        "持續避免寒冷暴露",
        "繼發性病例：治療原發病（腫瘤、感染）",
        "Mycophenolate mofetil（難治病例）"
      ]
    },
    "prognosis": "原發性冷凝集素病在適當管理（保暖+免疫抑制）下可長期控制。繼發於腫瘤的病例預後取決於原發腫瘤治療效果。末梢組織壞死為不可逆損傷。避免寒冷環境暴露對預防復發至關重要。",
    "pearls": [
      "室溫凝集+加溫消失是冷凝集素病的特徵性診斷",
      "保暖是最基本也最重要的治療措施",
      "末梢壞死（耳尖、尾尖）提示冷型IMHA",
      "應排除淋巴瘤等繼發性原因"
    ],
    "diagnosticAlgorithm": {
      "title": "冷凝集素病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "臨床懷疑",
          "details": "貧血+末梢壞死+寒冷加重",
          "findings": [
            "末梢發紺/壞死",
            "黏膜蒼白",
            "寒冷暴露後惡化"
          ]
        },
        {
          "step": 2,
          "action": "凝集試驗",
          "details": "室溫vs 37°C對照",
          "findings": [
            "室溫血液凝集",
            "加溫至37°C凝集消失",
            "確認冷反應性抗體"
          ]
        },
        {
          "step": 3,
          "action": "溶血評估",
          "details": "評估溶血嚴重度",
          "findings": [
            "PCV下降",
            "膽紅素升高",
            "血紅素尿"
          ]
        },
        {
          "step": 4,
          "action": "病因調查",
          "details": "排除繼發性原因",
          "findings": [
            "淋巴瘤篩檢",
            "Mycoplasma PCR",
            "腹部超音波"
          ]
        }
      ]
    },
    "monitoring": [
      "環境溫度管理",
      "PCV追蹤",
      "末梢組織狀態",
      "冷凝集素效價"
    ],
    "reference": "PubMed — Cold hemagglutinin disease in a dog; PetMD — Cold Agglutinin Disease in Cats; PMC — ACVIM consensus IMHA"
  },
  "distributive-shock": {
    "zh": "分配性休克",
    "en": "Distributive Shock",
    "definition": "因全身性血管擴張和血管通透性增加導致有效循環血量嚴重分佈不均的休克類型。包括敗血性休克、過敏性休克和神經性休克。血管內容量正常但血管張力喪失導致組織灌流不足。",
    "synonyms": [
      "血管擴張性休克",
      "Vasodilatory Shock"
    ],
    "epidemiology": {
      "species": "犬貓均可發生；敗血性休克為最常見亞型",
      "age": "任何年齡，免疫力低下者風險增加",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "敗血症（腹膜炎、肺炎、腎盂腎炎）",
        "過敏原暴露（疫苗、蜂螫、藥物）",
        "脊髓損傷（神經性休克）",
        "嚴重創傷或燒傷",
        "免疫抑制狀態"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "敗血性：感染病灶或手術後發熱",
        "過敏性：疫苗注射或蟲螫後數分鐘內急性發作",
        "神經性：脊髓創傷史",
        "突發虛弱或倒地",
        "嘔吐或腹瀉",
        "面部腫脹（過敏性）"
      ],
      "physicalExam": [
        "黏膜充血（高動力期）或蒼白（失代償期）",
        "CRT<1秒（高動力期）或>2秒（失代償期）",
        "心搏過速",
        "脈搏洪大跳躍（高動力期）或微弱（失代償期）",
        "低血壓（對輸液反應差）",
        "體溫升高（敗血性）或正常/偏低（過敏性）",
        "蕁麻疹/血管性水腫（過敏性）"
      ]
    },
    "pathophysiology": "敗血性：細菌內毒素和促炎細胞因子（TNF-α、IL-1、IL-6）觸發全身性血管擴張，一氧化氮（NO）大量釋放導致持續性低血壓。血管通透性增加導致血漿外滲。過敏性：IgE介導的肥大細胞脫顆粒，大量組織胺釋放導致血管擴張和通透性增加。犬的過敏性休克主要靶器官為肝臟（門脈系統血管阻力可增加220%），貓則以肺部為主。神經性：脊髓損傷導致交感神經失控→血管張力喪失。",
    "diagnosis": {
      "overview": "臨床休克表現+特徵性血液動力學模式（高動力期vs失代償期）+病因線索",
      "differentials": [
        "低血容積性休克",
        "心因性休克",
        "阻塞性休克",
        "藥物過量"
      ],
      "initialDB": [
        "血壓測量（低血壓為核心特徵）",
        "乳酸測定（>4 mmol/L提示組織灌流不足）",
        "CBC/生化（白血球計數、感染標記）",
        "血液培養（敗血性休克）",
        "血氣分析"
      ],
      "advanced": [
        "PCT降鈣素原（敗血症標記）",
        "心臟超音波（排除心因性）",
        "TFAST/AFAST",
        "影像學（定位感染灶）"
      ]
    },
    "treatment": {
      "overview": "針對病因治療+容積復甦+升壓藥維持灌流壓",
      "acute": [
        "過敏性休克首選：Epinephrine 0.01-0.02 mg/kg IM/IV（每5-15分鐘可重複）",
        "晶體液快速輸注：犬20 mL/kg、貓10 mL/kg bolus over 15 min（可重複）",
        "膠體液：Hetastarch 5 mL/kg bolus（血管通透性增加時）",
        "升壓藥（輸液反應不足時）：Norepinephrine 0.1-2 μg/kg/min或Vasopressin 0.5-5 mU/kg/min",
        "Dopamine 5-20 μg/kg/min CRI（次選升壓藥）",
        "敗血性：廣效抗生素（在第一小時內給予）"
      ],
      "chronic": [
        "敗血性：source control（感染灶清除/引流/手術）",
        "過敏性：抗組織胺（Diphenhydramine 2 mg/kg IM）+H2 blocker+類固醇",
        "持續升壓藥支持和逐步減量",
        "營養支持與免疫功能恢復"
      ]
    },
    "prognosis": "過敏性休克若即時給予Epinephrine預後良好。敗血性休克死亡率40-70%，取決於感染來源是否可控制和器官功能損害程度。神經性休克視脊髓損傷程度而定。所有亞型的預後均與介入速度密切相關。",
    "pearls": [
      "分配性休克的血液動力學特徵：高心搏出量+低血管阻力（與心因性休克相反）",
      "犬的過敏性休克靶器官是肝臟（門脈充血），貓是肺部",
      "Epinephrine是過敏性休克唯一的第一線藥物，抗組織胺和類固醇僅為輔助",
      "敗血性休克的黃金一小時：在第一小時內給予抗生素和輸液復甦",
      "如果輸液無法維持血壓→早期開始升壓藥（Norepinephrine首選）"
    ],
    "diagnosticAlgorithm": {
      "title": "分配性休克 診斷與處置流程",
      "steps": [
        {
          "step": 1,
          "action": "休克類型鑑別",
          "details": "評估血液動力學模式和病因線索",
          "findings": [
            "高動力期：黏膜充血、脈搏洪大、CRT<1秒",
            "失代償期：黏膜蒼白、脈搏微弱",
            "病因線索：感染?過敏暴露?脊髓損傷?",
            "低血壓+輸液反應差=分配性休克"
          ]
        },
        {
          "step": 2,
          "action": "快速病因評估",
          "details": "區分敗血性/過敏性/神經性",
          "findings": [
            "發熱+感染灶→敗血性",
            "過敏原暴露+蕁麻疹→過敏性",
            "脊髓創傷+心搏過緩→神經性",
            "血液培養送檢（敗血性）"
          ]
        },
        {
          "step": 3,
          "action": "病因導向治療",
          "details": "針對亞型給予第一線治療",
          "findings": [
            "過敏性→Epinephrine IM/IV",
            "敗血性→廣效抗生素+輸液",
            "神經性→輸液+升壓藥",
            "所有亞型：MAP目標≥65 mmHg"
          ]
        },
        {
          "step": 4,
          "action": "升壓藥與器官支持",
          "details": "輸液反應不足時啟動升壓藥",
          "findings": [
            "Norepinephrine首選升壓藥",
            "Vasopressin作為附加",
            "乳酸清除率作為復甦指標",
            "source control（敗血性）"
          ]
        }
      ]
    },
    "monitoring": [
      "血壓（連續監測，MAP目標≥65 mmHg）",
      "乳酸（復甦指標，q2-4h）",
      "CVP（容量狀態）",
      "尿量（>1-2 mL/kg/hr）",
      "體溫",
      "血液培養追蹤（敗血性）",
      "心電圖"
    ],
    "reference": "Silverstein DC. Small Animal Critical Care Medicine, 2nd Ed. Saunders, 2014; Pachtinger G. Distributive Shock. Clinician's Brief 2019"
  },
  "cardiogenic-shock": {
    "zh": "心因性休克",
    "en": "Cardiogenic Shock",
    "definition": "因心臟幫浦功能嚴重障礙（收縮或舒張功能異常）導致心搏出量不足、組織灌流不全的危急狀態。與低血容積性休克不同，血管內容量正常或增加，但心臟無法有效輸出。",
    "synonyms": [
      "心源性休克",
      "Pump Failure Shock"
    ],
    "epidemiology": {
      "species": "犬貓均可發生；犬以DCM和瓣膜疾病為主因，貓以HCM為主因",
      "age": "中老年動物較常見，與心臟疾病好發年齡一致",
      "sex": "犬DCM好發於大型公犬；貓HCM好發於公貓",
      "riskFactors": [
        "擴張性心肌病（DCM，大型犬）",
        "肥厚性心肌病（HCM，貓）",
        "嚴重瓣膜疾病",
        "心包填塞",
        "嚴重心律不整",
        "心肌炎"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "呼吸急促/困難進行性加重",
        "運動不耐或突然虛弱",
        "已知心臟病史",
        "咳嗽（犬為主）",
        "食慾下降",
        "開口呼吸（貓）"
      ],
      "physicalExam": [
        "心搏過速或心律不整",
        "脈搏微弱",
        "肺部囉音（肺水腫）",
        "心雜音或奔馬律",
        "頸靜脈怒張",
        "肝腫大",
        "黏膜蒼白或發紺",
        "口鼻血泡沫（嚴重肺水腫）"
      ]
    },
    "pathophysiology": "心肌收縮力下降或舒張功能障礙→每搏輸出量減少→心搏出量不足。Frank-Starling機制代償導致前負荷增加（容積過載），但病變心臟無法有效利用。RAAS活化導致鈉水滯留加重充血。肺靜脈壓升高→肺水腫。後負荷增加進一步加重心臟負擔。最終形成惡性循環：低心搏出量→組織缺氧→代謝性酸中毒→心肌進一步抑制。",
    "diagnosis": {
      "overview": "臨床休克表現+心臟功能障礙證據。關鍵鑑別：液體復甦禁忌，與低血容積性休克治療方向相反",
      "differentials": [
        "低血容積性休克（需仔細區別）",
        "阻塞性休克（心包填塞、肺栓塞）",
        "嚴重肺部疾病",
        "張力性氣胸"
      ],
      "initialDB": [
        "胸腔X光（心臟擴大、肺水腫）",
        "心臟超音波（FS%降低、室壁運動異常）",
        "心電圖（心律不整、傳導異常）",
        "血壓測量（收縮壓<90 mmHg）",
        "NT-proBNP或cardiac troponin"
      ],
      "advanced": [
        "進階心臟超音波（E/A比值、組織都普勒）",
        "中心靜脈壓（CVP升高）",
        "連續血壓監測",
        "乳酸/血氣分析"
      ]
    },
    "treatment": {
      "overview": "與低血容積性休克相反——限制輸液、降低前後負荷、改善心肌收縮力。需依據病因選擇策略",
      "acute": [
        "氧氣治療（優先穩定呼吸）",
        "利尿劑：Furosemide 2-4 mg/kg IV（犬），1-2 mg/kg IV（貓）PRN",
        "正性肌力藥：Dobutamine 5-15 μg/kg/min CRI（改善收縮力）",
        "血管擴張劑：Nitroglycerin外用或Nitroprusside 1-5 μg/kg/min（降低後負荷）",
        "抗心律不整：依據心律類型選擇（Lidocaine、Diltiazem等）",
        "禁忌：大量快速輸液（會加重肺水腫）"
      ],
      "chronic": [
        "口服心衰藥物（Pimobendan 0.25 mg/kg PO q12h、ACE inhibitor）",
        "口服利尿劑維持（Furosemide、Spironolactone）",
        "飲食管理（限鈉）",
        "活動限制與環境壓力控制"
      ]
    },
    "prognosis": "急性心因性休克預後嚴峻，住院死亡率高。犬DCM穩定後中位存活3-6個月。貓HCM合併CHF中位存活約18個月。瓣膜疾病經藥物控制後存活相對較長。心包填塞引起者若能排液預後較佳。",
    "pearls": [
      "心因性休克禁忌大量快速輸液——這是與低血容積性休克的最關鍵區別",
      "犬有肺囉音+心雜音+頸靜脈怒張=高度懷疑心因性休克",
      "Dobutamine是急性心因性休克首選正性肌力藥",
      "貓的心因性休克常以呼吸窘迫為首發表現，需避免過度stress",
      "測量NT-proBNP有助於區分心源性vs非心源性呼吸困難"
    ],
    "diagnosticAlgorithm": {
      "title": "心因性休克 診斷與處置流程",
      "steps": [
        {
          "step": 1,
          "action": "休克鑑別",
          "details": "評估休克類型——是否有容量過載（充血）證據",
          "findings": [
            "頸靜脈怒張",
            "肺部囉音/呼吸困難",
            "心雜音或奔馬律",
            "肝腫大"
          ]
        },
        {
          "step": 2,
          "action": "心臟功能評估",
          "details": "胸腔X光+心臟超音波+ECG",
          "findings": [
            "心臟擴大（X光VHS增加）",
            "FS%<25%或E/A異常",
            "肺水腫（X光肺紋增粗）",
            "心律不整（ECG）"
          ]
        },
        {
          "step": 3,
          "action": "穩定呼吸功能",
          "details": "氧氣+利尿劑，禁止大量輸液",
          "findings": [
            "Furosemide IV→30-60分鐘內尿量增加",
            "氧氣治療→SpO2改善",
            "限制輸液速率",
            "呼吸頻率下降"
          ]
        },
        {
          "step": 4,
          "action": "心肌支持與病因治療",
          "details": "正性肌力藥+血管擴張劑+抗心律不整",
          "findings": [
            "Dobutamine CRI→血壓改善",
            "Pimobendan口服（穩定後）",
            "針對性抗心律不整",
            "長期心衰管理計畫"
          ]
        }
      ]
    },
    "monitoring": [
      "血壓（連續監測）",
      "呼吸頻率與型態",
      "心電圖連續監測",
      "SpO2",
      "尿量（利尿反應評估）",
      "胸腔X光（肺水腫變化）",
      "心臟超音波追蹤"
    ],
    "reference": "Silverstein DC. Small Animal Critical Care Medicine, 2nd Ed. Saunders, 2014; Ware WA. Cardiovascular Disease in Small Animal Medicine. Manson, 2011"
  },
  "hemorrhagic-shock": {
    "zh": "出血性休克",
    "en": "Hemorrhagic Shock",
    "definition": "因急性大量失血導致有效循環血量嚴重不足，組織灌流不足引發細胞缺氧和器官功能障礙的危急狀態。屬於低血容積性休克的亞型，犬失血達總血量30-40%即可致命。",
    "synonyms": [
      "失血性休克",
      "Hemorrhagic Hypovolemic Shock"
    ],
    "epidemiology": {
      "species": "犬貓均可發生，犬因創傷和脾臟腫瘤破裂較常見",
      "age": "任何年齡，老年犬因脾臟血管腫瘤（血管肉瘤）風險增加",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "外傷（車禍、咬傷、刀傷）",
        "脾臟腫瘤破裂（血管肉瘤）",
        "凝血功能障礙（滅鼠藥中毒、DIC）",
        "手術併發症",
        "消化道潰瘍出血"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "已知創傷史",
        "突發虛弱或倒地",
        "腹部膨脹（腹腔內出血）",
        "已知抗凝血劑暴露",
        "吐血或黑便",
        "術後出血"
      ],
      "physicalExam": [
        "心搏過速（犬>140 bpm，貓>220 bpm）",
        "脈搏微弱或消失",
        "黏膜蒼白",
        "CRT延長>2秒",
        "低血壓（收縮壓<90 mmHg）",
        "四肢冰冷",
        "意識混沌或嗜睡"
      ]
    },
    "pathophysiology": "急性失血導致靜脈回流減少→心搏出量降低→組織灌流不足。早期代償反應包括：壓力感受器啟動交感神經→心率加快、血管收縮、腎素-血管張力素-醛固酮系統活化以保留水鈉。當失血超過代償能力（犬約30%總血量），進入失代償期：乳酸堆積→代謝性酸中毒→心肌抑制→惡性循環。持續缺氧導致細胞死亡、內皮損傷和全身性發炎反應，最終引發MODS和DIC。",
    "diagnosis": {
      "overview": "臨床診斷結合血液動力學指標：休克指數（HR/SBP）升高、乳酸升高、PCV/TP進行性下降",
      "differentials": [
        "其他類型休克（心因性、分配性、阻塞性）",
        "嚴重脫水",
        "心包積液",
        "張力性氣胸"
      ],
      "initialDB": [
        "PCV/TP/血液抹片（急診快速評估）",
        "血壓測量（Doppler或oscillometric）",
        "乳酸測定",
        "TFAST/AFAST超音波（腹腔/胸腔積液）",
        "CBC/生化"
      ],
      "advanced": [
        "凝血功能（PT/aPTT/D-dimer）",
        "血型（輸血前準備）",
        "交叉配血試驗",
        "影像學（定位出血來源）"
      ]
    },
    "treatment": {
      "overview": "控制出血來源+容積復甦+維持組織氧合。現代概念強調「低容積復甦」和「損害控制手術」",
      "acute": [
        "止血：壓迫外傷傷口、腹帶加壓（腹腔出血）、緊急手術",
        "晶體液：初始快速輸注10-20 mL/kg（犬）或5-10 mL/kg（貓）over 15-30 min，評估反應後重複",
        "膠體液：Hetastarch 5 mL/kg（犬）或2-5 mL/kg（貓）bolus",
        "輸血指標：PCV<20%或急性失血>20%血量→pRBC 10-20 mL/kg",
        "新鮮冷凍血漿：15-20 mL/kg（凝血因子補充+膠體壓維持）",
        "低容積復甦策略：MAP目標60-65 mmHg即可（避免稀釋性凝血障礙）"
      ],
      "chronic": [
        "持續監測血液動力學穩定性",
        "尋找並處理出血根源（腫瘤切除、器官修復）",
        "鐵劑補充（慢性失血後）",
        "營養支持與恢復"
      ]
    },
    "prognosis": "取決於失血量、出血速率和介入時間。失血<20%總血量且及時止血預後良好。失血>40%或合併DIC者死亡率顯著增加。脾臟血管肉瘤破裂即使手術存活，中位存活僅1-3個月。",
    "pearls": [
      "犬總血量約80-90 mL/kg，貓約60-70 mL/kg",
      "PCV在急性出血後數小時才開始下降——初始PCV正常不能排除嚴重出血",
      "AFAST可在數分鐘內偵測腹腔積液，比X光更快速",
      "低容積復甦策略（permissive hypotension）可減少稀釋性凝血障礙",
      "貓的輸液復甦劑量約為犬的一半，過量易導致肺水腫"
    ],
    "diagnosticAlgorithm": {
      "title": "出血性休克 診斷與處置流程",
      "steps": [
        {
          "step": 1,
          "action": "快速休克評估",
          "details": "ABCD approach + 休克指數計算",
          "findings": [
            "心搏過速+脈搏微弱",
            "黏膜蒼白+CRT延長",
            "低血壓（MAP<65 mmHg）",
            "意識改變"
          ]
        },
        {
          "step": 2,
          "action": "出血來源定位",
          "details": "TFAST/AFAST超音波+PCV/TP/乳酸",
          "findings": [
            "AFAST陽性（腹腔積液）",
            "PCV進行性下降",
            "乳酸>4 mmol/L",
            "外在出血來源"
          ]
        },
        {
          "step": 3,
          "action": "容積復甦啟動",
          "details": "分段式輸液復甦+輸血準備",
          "findings": [
            "晶體液bolus後評估反應",
            "PCV<20%→啟動輸血",
            "凝血異常→FFP",
            "維持MAP 60-65 mmHg"
          ]
        },
        {
          "step": 4,
          "action": "決定性止血",
          "details": "手術或介入處理出血來源",
          "findings": [
            "手術適應症評估",
            "脾臟切除（腫瘤破裂）",
            "創傷修復",
            "持續監測48小時"
          ]
        }
      ]
    },
    "monitoring": [
      "血壓（連續或每15分鐘）",
      "PCV/TP（每1-2小時急性期）",
      "乳酸（復甦指標）",
      "尿量（灌流充足指標 >1-2 mL/kg/hr）",
      "凝血功能",
      "心電圖"
    ],
    "reference": "Hopper K. Volume resuscitation in the acutely hemorrhaging patient. Front Vet Sci 2021;8:638104; Silverstein DC. Small Animal Critical Care Medicine, 2nd Ed. Saunders, 2014"
  },
  "smoke-inhalation": {
    "zh": "煙霧吸入傷害",
    "en": "Smoke Inhalation Injury",
    "definition": "因火災或燃燒環境中吸入煙霧導致的複合性呼吸道損傷，包括：(1)熱損傷（上呼吸道灼傷），(2)化學損傷（有毒氣體腐蝕下呼吸道），(3)全身性中毒（一氧化碳和氰化物導致組織缺氧）。可伴隨皮膚燒傷。",
    "synonyms": [
      "煙害吸入",
      "火災吸入傷害",
      "Smoke Inhalation",
      "Inhalation Injury"
    ],
    "epidemiology": {
      "species": "犬貓均可發生；貓因躲藏習性在火災中更難救出",
      "age": "任何年齡",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "住宅火災",
        "車庫或密閉空間燃燒",
        "短頭犬種（呼吸道更脆弱）",
        "既有呼吸道疾病",
        "幼年或老年動物（逃生能力差）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "火災現場救出",
        "密閉空間煙霧暴露",
        "咳嗽和呼吸困難",
        "口鼻周圍燒焦或煤灰",
        "面部或體表燒傷",
        "意識改變"
      ],
      "physicalExam": [
        "呼吸困難/呼吸窘迫",
        "口鼻黏膜充血或燒傷",
        "鼻腔和口腔煤灰沉積",
        "肺部囉音或哮鳴音",
        "黏膜櫻桃紅（CO中毒）或發紺",
        "角膜水腫（熱/化學損傷）",
        "體表燒傷"
      ]
    },
    "pathophysiology": "煙霧傷害分三個機制：(1)熱損傷：主要影響上呼吸道（聲門以上），因為空氣散熱效率高保護了下呼吸道，但蒸氣可達下呼吸道。引起黏膜水腫和氣道阻塞。(2)化學損傷：燃燒產物（醛類、酸類、氨）直接腐蝕呼吸道上皮，破壞黏膜纖毛清除機制，引發化學性肺炎和ARDS。(3)全身性中毒：一氧化碳（CO）與血紅蛋白結合力為O₂的200倍，形成碳氧血紅蛋白（COHb）→組織缺氧。氰化物（HCN）抑制線粒體細胞色素c氧化酶→有氧代謝停止。",
    "diagnosis": {
      "overview": "基於煙霧暴露史+呼吸道症狀。CO-oximetry是確診CO中毒的關鍵。呼吸道損傷程度可能在24-72小時後才完全顯現",
      "differentials": [
        "其他原因呼吸窘迫",
        "過敏性支氣管炎",
        "吸入性肺炎",
        "ARDS（其他病因）"
      ],
      "initialDB": [
        "SpO2/血氣分析（注意：傳統脈搏血氧儀無法區分COHb）",
        "CO-oximetry（碳氧血紅蛋白濃度）",
        "胸腔X光（初期可能正常，24-48小時後出現浸潤）",
        "CBC/生化",
        "乳酸測定（升高提示氰化物中毒或灌流不足）"
      ],
      "advanced": [
        "支氣管鏡檢查（評估氣道損傷程度）",
        "連續胸腔X光（48-72小時監測）",
        "氰化物濃度（若可用）",
        "心電圖（心肌缺氧/CO中毒）"
      ]
    },
    "treatment": {
      "overview": "100%氧氣為基石治療（加速CO排除+改善組織氧合）。氣道管理和支持療法。懷疑氰化物中毒立即給予解毒劑",
      "acute": [
        "100%氧氣治療（CO半衰期在室內空氣中250分鐘→100%O₂下30-40分鐘）",
        "氣道管理：插管（嚴重上呼吸道水腫時需緊急氣切）",
        "支氣管擴張劑：Albuterol霧化或Aminophylline 5-10 mg/kg IV",
        "氰化物解毒劑：Hydroxocobalamin 70 mg/kg IV（首選）或Sodium thiosulfate",
        "輸液治療：審慎給予，避免加重肺水腫",
        "Nebulization：生理鹽水霧化+叩擊排痰"
      ],
      "chronic": [
        "住院監測48-72小時（呼吸道損傷延遲表現）",
        "廣效抗生素（若有證據顯示二次感染）",
        "燒傷傷口照護",
        "肺部物理治療（叩擊、姿位引流、鼓勵咳嗽）"
      ]
    },
    "prognosis": "輕度煙霧吸入經氧氣治療預後良好。中重度呼吸道損傷預後取決於ARDS發展程度和併發症。伴隨嚴重皮膚燒傷（>50%體表面積）者預後不良。呼吸道損傷的完整嚴重程度可能在48-72小時後才顯現。",
    "pearls": [
      "傳統脈搏血氧儀SpO2會被CO中毒「騙」——讀數可能正常但實際嚴重缺氧",
      "CO半衰期：室內空氣250分鐘→100% O₂ 30-40分鐘→高壓氧15-20分鐘",
      "呼吸道損傷程度在初始評估時可能被低估——需48-72小時持續監測",
      "乳酸不明原因升高+煙霧暴露→高度懷疑氰化物中毒→不需等確認就給Hydroxocobalamin",
      "黏膜櫻桃紅色是CO中毒特徵但並非總是出現"
    ],
    "diagnosticAlgorithm": {
      "title": "煙霧吸入傷害 診斷與處置流程",
      "steps": [
        {
          "step": 1,
          "action": "緊急評估與氧氣治療",
          "details": "確認煙霧暴露史，立即給予100%氧氣",
          "findings": [
            "口鼻煤灰沉積",
            "呼吸困難程度評估",
            "黏膜顏色（櫻桃紅=CO中毒）",
            "體表燒傷評估"
          ]
        },
        {
          "step": 2,
          "action": "CO/氰化物評估",
          "details": "CO-oximetry+乳酸測定",
          "findings": [
            "COHb>10%確認CO中毒",
            "乳酸不明原因升高→懷疑氰化物",
            "SpO2不可靠（假正常）",
            "立即Hydroxocobalamin（懷疑HCN）"
          ]
        },
        {
          "step": 3,
          "action": "呼吸道評估",
          "details": "胸腔X光+肺部聽診+氣道評估",
          "findings": [
            "初期X光可能正常",
            "上呼吸道水腫→需準備氣切",
            "下呼吸道：哮鳴音/囉音",
            "支氣管鏡（可行時）"
          ]
        },
        {
          "step": 4,
          "action": "延遲性損傷監測",
          "details": "住院48-72小時密集監測",
          "findings": [
            "連續胸腔X光（q12-24h）",
            "ARDS發展監測",
            "呼吸功能趨勢",
            "二次感染徵象"
          ]
        }
      ]
    },
    "monitoring": [
      "SpO2（注意CO中毒時不可靠）+CO-oximetry",
      "呼吸頻率與型態",
      "胸腔X光（q12-24h前72小時）",
      "血氣分析",
      "乳酸",
      "體溫",
      "燒傷傷口狀態"
    ],
    "reference": "Merck Veterinary Manual: Smoke Inhalation Injury 2023; Lee JA. Smoke Inhalation in Veterinary Patients. Vet Clin N Am 2024"
  },
  "electrocution": {
    "zh": "觸電傷害",
    "en": "Electrocution (Electrical Injury)",
    "definition": "因接觸電源（最常見為咬電線）導致的組織損傷和全身性效應。主要併發症包括非心因性肺水腫（神經源性）、心律不整、口腔燒傷和心肺驟停。幼年動物因好奇咬嚼電線為最常見情境。",
    "synonyms": [
      "電擊傷",
      "電傷害",
      "Electrical Injury",
      "Electric Shock"
    ],
    "epidemiology": {
      "species": "犬貓均可發生，幼犬幼貓因咬電線最常見",
      "age": "幼年動物為最高風險群（好奇心驅使咬嚼電線）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "幼年動物（<1歲）好奇咬電線",
        "室內電線暴露",
        "假期裝飾燈串",
        "咬嚼行為（出牙期）",
        "戶外電線或閃電擊中（罕見）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "被發現咬電線或靠近電源",
        "突然尖叫或驚嚇",
        "口腔發現燒傷痕跡",
        "呼吸困難",
        "倒地或短暫失去意識",
        "口腔流涎或拒食"
      ],
      "physicalExam": [
        "口腔燒傷（嘴唇、舌頭、腭部灰白色或焦黑壞死斑）",
        "呼吸困難（肺水腫）",
        "肺部囉音或濕囉音",
        "心律不整",
        "黏膜蒼白或發紺",
        "口鼻粉紅色泡沫（肺水腫）",
        "肌肉僵硬或震顫"
      ]
    },
    "pathophysiology": "電流通過組織時產生熱效應導致局部燒傷。低壓交流電（家用110-220V）主要危害為：(1)神經源性肺水腫：電流刺激引發大量兒茶酚胺釋放→肺微血管壓力急劇升高→肺泡-毛細血管膜損傷→非心因性肺水腫（可延遲12-36小時出現）。(2)心律不整：電流直接影響心臟傳導系統，可引發心室顫動或心搏停止。(3)口腔組織壞死：電流入口處（通常為嘴唇-腭部接觸電線處）產生局部凝固性壞死。",
    "diagnosis": {
      "overview": "基於電線咬嚼或電源接觸史+口腔燒傷+呼吸窘迫。需持續監測12-36小時以偵測延遲性肺水腫",
      "differentials": [
        "其他原因口腔潰瘍（化學灼傷、自體免疫）",
        "心因性肺水腫",
        "過敏性反應",
        "中毒"
      ],
      "initialDB": [
        "胸腔X光（肺水腫——初期可能正常）",
        "心電圖（心律不整）",
        "SpO2/血氣分析",
        "CBC/生化（器官損傷評估）"
      ],
      "advanced": [
        "連續胸腔X光（延遲性肺水腫可在12-36小時出現）",
        "心臟超音波（排除心因性肺水腫）",
        "肝腎功能追蹤",
        "心電圖連續監測24小時"
      ]
    },
    "treatment": {
      "overview": "支持療法為主：氧氣治療+肺水腫處理+心律不整控制+口腔傷口照護",
      "acute": [
        "氧氣治療（鼻導管或氧氣籠）",
        "肺水腫處理：Furosemide 2-4 mg/kg IV（犬），1-2 mg/kg IV（貓）",
        "嚴重呼吸窘迫：氣管插管+正壓通氣",
        "心律不整：Lidocaine 2 mg/kg IV bolus（犬VPC/VT），持續25-80 μg/kg/min CRI",
        "疼痛管理：Buprenorphine 0.01-0.02 mg/kg IV/IM",
        "口腔燒傷沖洗：0.12% Chlorhexidine口腔沖洗"
      ],
      "chronic": [
        "住院監測12-36小時（延遲性肺水腫）",
        "口腔傷口長期照護（軟食、抗生素覆蓋感染）",
        "口腔壞死組織可能在1-2週後脫落需清創",
        "嚴重口腔缺損可能需重建手術"
      ]
    },
    "prognosis": "輕度觸電（口腔燒傷為主）預後良好，口腔傷口通常2-3週癒合。中度（併發肺水腫）經適當氧氣和利尿劑治療後多能恢復，神經源性肺水腫通常12-24小時開始消退。嚴重（心肺驟停或大面積燒傷）預後較差。貓及時就醫者預後通常良好。",
    "pearls": [
      "非心因性肺水腫可延遲12-36小時出現——即使初期X光正常也需住院監測",
      "口腔燒傷是觸電的「指紋」——灰白色凝固壞死斑見於嘴唇或腭部",
      "神經源性肺水腫機制：兒茶酚胺風暴→肺微血管壓力驟升",
      "壞死組織脫落可能在1-2週後發生，可能導致口鼻瘻管",
      "假期期間（聖誕燈串）是幼犬幼貓觸電高峰期"
    ],
    "diagnosticAlgorithm": {
      "title": "觸電傷害 診斷與處置流程",
      "steps": [
        {
          "step": 1,
          "action": "初始評估與穩定",
          "details": "ABCD approach + 確認電源暴露史",
          "findings": [
            "口腔燒傷檢查",
            "呼吸型態評估",
            "心律評估",
            "意識狀態"
          ]
        },
        {
          "step": 2,
          "action": "心肺功能評估",
          "details": "胸腔X光+ECG+SpO2",
          "findings": [
            "X光：肺水腫（可能初期正常）",
            "ECG：心律不整類型",
            "SpO2下降",
            "心臟超音波排除心因性"
          ]
        },
        {
          "step": 3,
          "action": "急性治療",
          "details": "氧氣+利尿劑+抗心律不整",
          "findings": [
            "Furosemide→肺水腫改善",
            "Lidocaine→VPC控制",
            "氧氣治療→SpO2改善",
            "疼痛管理（口腔燒傷）"
          ]
        },
        {
          "step": 4,
          "action": "延遲性併發症監測",
          "details": "住院12-36小時監測延遲性肺水腫",
          "findings": [
            "連續X光q12h",
            "肺水腫通常12-24h消退",
            "口腔壞死組織追蹤（1-2週）",
            "心律監測24小時"
          ]
        }
      ]
    },
    "monitoring": [
      "胸腔X光（q12h前36小時）",
      "心電圖連續監測24小時",
      "SpO2",
      "呼吸頻率",
      "口腔傷口狀態",
      "食慾與進食能力"
    ],
    "reference": "MSPCA-Angell: Electrical Cord Injury 2023; BMC Vet Res: Pulmonary edema secondary to electrocution 2024; Merck Veterinary Manual 2023"
  },
  "crush-injury": {
    "zh": "壓砸傷",
    "en": "Crush Injury / Crush Syndrome",
    "definition": "因長時間壓迫導致肌肉組織缺血壞死，壓力解除後釋放大量肌紅蛋白、鉀離子及其他細胞內容物入血，引發橫紋肌溶解症和全身性「再灌流傷害」。主要併發症為急性腎損傷（肌紅蛋白腎毒性）和致命性高鉀血症。",
    "synonyms": [
      "壓碾傷",
      "擠壓症候群",
      "Crush Syndrome",
      "Traumatic Rhabdomyolysis"
    ],
    "epidemiology": {
      "species": "犬較貓常見（犬更常暴露於車禍和大型物體壓迫）",
      "age": "任何年齡，戶外活動頻繁者風險較高",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "車禍（最常見原因）",
        "建築物倒塌",
        "重物墜落壓迫",
        "地震等自然災害",
        "大型動物踩踏"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "已知壓迫/創傷事件",
        "被困於重物下",
        "車禍後肢體腫脹",
        "解除壓迫後急性惡化（paradoxical）",
        "深色（可樂色）尿液",
        "患肢極度疼痛"
      ],
      "physicalExam": [
        "受壓肢體嚴重腫脹、硬實",
        "肌肉觸診極度疼痛",
        "皮下瘀傷",
        "深色尿液（肌紅蛋白尿）",
        "心搏過速或心律不整（高鉀血症）",
        "休克徵象（蒼白、CRT延長、低血壓）",
        "受壓區域遠端脈搏減弱"
      ]
    },
    "pathophysiology": "壓迫期：持續壓迫→肌肉缺血→ATP耗竭→細胞膜Na⁺/K⁺-ATPase失能→細胞內鉀、磷、肌紅蛋白累積。解壓（再灌流）期：壓力解除後缺血組織再灌流→大量鉀離子、肌紅蛋白、磷酸鹽、尿酸和乳酸釋入循環。肌紅蛋白在酸性尿液中沉積於腎小管→急性腎小管壞死（AKI發生率達人醫報告的50%）。高鉀血症→致命性心律不整。自由基和炎性介質造成全身性再灌流傷害。",
    "diagnosis": {
      "overview": "基於壓迫創傷史+肌紅蛋白尿+CK顯著升高。需緊急評估鉀離子和腎功能",
      "differentials": [
        "運動性橫紋肌溶解（無壓迫史）",
        "藥物性肌病",
        "熱衰竭伴橫紋肌溶解",
        "蛇咬傷引起的肌壞死"
      ],
      "initialDB": [
        "CK（肌酸激酶，常>10,000 U/L，可達數十萬）",
        "電解質（緊急鉀離子——高鉀可致命）",
        "BUN/Crea（AKI評估）",
        "尿液分析（肌紅蛋白尿→深色尿、潛血陽性但無RBC）",
        "心電圖（高鉀血症心律變化）"
      ],
      "advanced": [
        "血氣分析（代謝性酸中毒）",
        "磷酸鹽/鈣離子",
        "凝血功能（DIC風險）",
        "影像學（評估骨折和軟組織損傷）"
      ]
    },
    "treatment": {
      "overview": "關鍵：壓力解除前即開始輸液！積極輸液稀釋肌紅蛋白+鹼化尿液+控制高鉀血症",
      "acute": [
        "積極靜脈輸液：0.9% NaCl 4-6 mL/kg/hr（解壓前開始，維持尿量>2 mL/kg/hr）",
        "尿液鹼化：NaHCO₃ 1-2 mEq/kg IV慢速（目標尿pH>6.5，防止肌紅蛋白沉積）",
        "高鉀血症處理：Regular Insulin 0.25-0.5 U/kg IV + Dextrose 50% 1-2 g/U insulin",
        "Calcium gluconate 10% 0.5-1.5 mL/kg IV緩慢（心肌保護，ECG監測）",
        "Mannitol 0.5-1 g/kg IV over 20 min（利尿+自由基清除）",
        "止痛：Methadone 0.1-0.3 mg/kg IV或Fentanyl CRI 2-5 μg/kg/hr"
      ],
      "chronic": [
        "持續輸液維持尿量目標>2 mL/kg/hr",
        "腎功能支持（必要時血液透析）",
        "壞死組織清創或截肢（嚴重肢體壓砸）",
        "營養支持與復健"
      ]
    },
    "prognosis": "輕度壓砸傷（小面積、短時間壓迫）經積極輸液預後良好。廣泛肌肉壞死合併AKI者預後較差。高鉀血症是最急性致命風險。文獻報告犬經間歇性血液透析治療橫紋肌溶解合併AKI可完全恢復。早期積極輸液是改善預後的關鍵。",
    "pearls": [
      "壓力解除是最危險的時刻——再灌流傷害可致急性高鉀血症和心停止",
      "理想的做法是在解壓前就開始輸液（pre-rescue fluid resuscitation）",
      "CK>10,000 U/L高度提示橫紋肌溶解，>100,000 U/L預示嚴重AKI風險",
      "尿液潛血試紙陽性但鏡檢無紅血球→肌紅蛋白尿（非血尿）",
      "尿液鹼化（pH>6.5）可減少肌紅蛋白在腎小管沉積"
    ],
    "diagnosticAlgorithm": {
      "title": "壓砸傷/壓砸症候群 診斷與處置流程",
      "steps": [
        {
          "step": 1,
          "action": "現場評估與輸液",
          "details": "確認壓迫創傷史，解壓前開始輸液",
          "findings": [
            "受壓時間和範圍評估",
            "立即建立靜脈通路",
            "0.9% NaCl 4-6 mL/kg/hr開始",
            "解壓後密切監測血壓和心律"
          ]
        },
        {
          "step": 2,
          "action": "高鉀血症緊急評估",
          "details": "ECG+急查電解質+CK",
          "findings": [
            "ECG：高尖T波→帳篷狀T波→QRS增寬",
            "K⁺>6.0 mEq/L需緊急處理",
            "CK顯著升高（>10,000 U/L）",
            "肌紅蛋白尿（深色尿）"
          ]
        },
        {
          "step": 3,
          "action": "腎保護策略",
          "details": "積極輸液+尿液鹼化+利尿",
          "findings": [
            "尿量目標>2 mL/kg/hr",
            "NaHCO₃鹼化尿液（pH>6.5）",
            "Mannitol利尿",
            "BUN/Crea基線值"
          ]
        },
        {
          "step": 4,
          "action": "持續監測與後續處理",
          "details": "腎功能追蹤+傷口處理+併發症監測",
          "findings": [
            "Crea q12-24h追蹤AKI",
            "電解質q6-12h",
            "CK趨勢（下降=肌肉損傷穩定）",
            "壞死組織清創評估"
          ]
        }
      ]
    },
    "monitoring": [
      "電解質（K⁺ q4-6h急性期）",
      "CK（橫紋肌溶解趨勢）",
      "BUN/Crea（AKI監測）",
      "尿量（目標>2 mL/kg/hr）",
      "尿液顏色和pH",
      "心電圖連續監測",
      "血壓"
    ],
    "reference": "Chen Y, Aroch I. Acute kidney injury secondary to traumatic rhabdomyolysis in a dog. JVECC 2018;28(5):469-475; K9 Clinical Practice Guideline: Blast, Burn and Crush Injuries"
  },
  "dystocia": {
    "zh": "難產",
    "en": "Dystocia",
    "definition": "難產是指分娩過程中因母體或胎兒因素導致的異常分娩，無法自然娩出胎兒。母體因素包括子宮收縮無力（子宮遲緩）和產道狹窄；胎兒因素包括胎位不正、胎兒過大或畸形。子宮遲緩（uterine inertia）是最常見的母體性難產原因。",
    "synonyms": [
      "難產",
      "分娩困難",
      "Obstructed Labor"
    ],
    "epidemiology": {
      "species": "犬貓皆可，犬較常見",
      "age": "繁殖年齡母犬貓",
      "sex": "僅母犬貓",
      "riskFactors": [
        "短頭種犬（鬥牛犬、波士頓梗）",
        "小型犬種",
        "初產或高齡母犬",
        "單胎妊娠（胎兒過大）",
        "多胎妊娠（子宮過度擴張致遲緩）",
        "肥胖",
        "骨盆骨折史"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "強烈陣痛超過30分鐘無胎兒產出",
        "綠色分泌物超過2小時無胎兒",
        "胎兒間隔超過2-4小時",
        "妊娠超過70-72天",
        "虛弱、嘔吐、精神沉鬱"
      ],
      "physicalExam": [
        "腹部觸診可感受胎兒",
        "陰道檢查可能觸及胎兒",
        "體溫先降後升",
        "脫水徵象",
        "腹部緊繃或疼痛"
      ]
    },
    "pathophysiology": "難產分為母體性和胎兒性。母體性難產中，原發性子宮遲緩（primary uterine inertia）為子宮肌層無法產生足夠有效收縮，可能因低血鈣、子宮過度擴張、年齡或品種因素。繼發性子宮遲緩因長時間阻塞性難產導致子宮肌疲勞。產道阻塞型難產可因骨盆狹窄、陰道狹窄、軟組織腫塊或先前骨折所致。胎兒性難產因胎位異常（橫位、頭部偏斜、後肢屈曲）或胎兒絕對過大（單胎妊娠）、胎兒畸形（水腦症）所致。胎兒窘迫時心率降至<160 bpm提示需緊急介入。",
    "diagnosis": {
      "overview": "病史和理學檢查為主，影像學評估胎兒大小、數量和位置",
      "differentials": [
        "正常分娩延遲",
        "假性懷孕",
        "子宮扭轉",
        "子宮破裂"
      ],
      "initialDB": [
        "陰道指診（評估產道和胎兒位置）",
        "腹部X光（胎兒數量、大小、位置）",
        "腹部超音波（胎兒心率評估）"
      ],
      "advanced": [
        "血液生化（Ca²⁺、血糖、電解質）",
        "陰道細胞學（確認預產期）",
        "超音波胎兒心率持續監測"
      ]
    },
    "treatment": {
      "overview": "醫療管理適用於非阻塞性難產；手術（剖腹產）適用於醫療失敗或阻塞性難產",
      "acute": [
        "醫療催產：Oxytocin 0.5-2 IU IM/IV（非阻塞型）",
        "10% Calcium gluconate 1 mL/kg IV緩慢給予",
        "葡萄糖補充（低血糖時）",
        "剖腹產（C-section）：阻塞性難產或醫療失敗時"
      ],
      "chronic": [
        "術後抗生素",
        "哺乳支持",
        "新生兒照護"
      ]
    },
    "prognosis": "醫療管理催產成功率僅20-40%。及時剖腹產母犬存活率高，胎兒存活率取決於手術時機。延誤處理可導致子宮破裂、敗血症或母犬死亡。短頭種犬（如鬥牛犬）通常需計畫性剖腹產。",
    "pearls": [
      "子宮遲緩是最常見的難產原因，不是胎位不正",
      "胎兒心率<160 bpm提示窘迫，需緊急介入",
      "阻塞性難產禁用Oxytocin（可致子宮破裂）",
      "綠色陰道分泌物代表胎盤分離，限時娩出"
    ],
    "diagnosticAlgorithm": {
      "title": "難產 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "病史和理學檢查",
          "details": "評估分娩進程和母體狀態",
          "findings": [
            "陣痛持續時間",
            "胎兒間隔",
            "陰道分泌物性質"
          ]
        },
        {
          "step": 2,
          "action": "陰道指診",
          "details": "評估產道和胎兒位置",
          "findings": [
            "子宮頸開放度",
            "胎兒呈示部",
            "產道阻塞"
          ]
        },
        {
          "step": 3,
          "action": "影像學檢查",
          "details": "X光和超音波評估",
          "findings": [
            "胎兒數量和大小",
            "胎兒心率",
            "骨盆產道比例"
          ]
        },
        {
          "step": 4,
          "action": "治療決策",
          "details": "醫療催產 vs 剖腹產",
          "findings": [
            "非阻塞→嘗試醫療催產",
            "阻塞或胎兒窘迫→剖腹產"
          ]
        }
      ]
    },
    "monitoring": [
      "分娩進程",
      "胎兒心率",
      "母體生命徵象",
      "術後恢復和泌乳"
    ],
    "reference": "Merck Veterinary Manual — Dystocia in Small Animals; Cornell CVM; dvm360 — Managing Dystocia; Clinician's Brief"
  },
  "eclampsia": {
    "zh": "產褥癇",
    "en": "Eclampsia",
    "definition": "產褥癇（又稱產後低血鈣症或泌乳搐搦）是哺乳期母犬貓因血鈣急性降低（<7 mg/dL）導致的危及生命的代謝急症。通常發生在產後1-4週泌乳高峰期，小型犬最常見。表現為肌肉震顫、僵硬、抽搐，可進展為高熱和死亡。",
    "synonyms": [
      "產後低血鈣症",
      "泌乳搐搦",
      "Puerperal Tetany",
      "Milk Fever"
    ],
    "epidemiology": {
      "species": "犬較常見，貓少見",
      "age": "繁殖年齡哺乳中母犬",
      "sex": "僅哺乳期母犬貓",
      "riskFactors": [
        "小型犬種（吉娃娃、博美、玩具貴賓、迷你品犬）",
        "初產母犬",
        "窩仔數多",
        "營養不良",
        "妊娠期不當鈣補充",
        "產後1-4週"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "正在哺乳中的母犬",
        "初期：躁動不安、氣喘",
        "進行性肌肉震顫和僵硬",
        "步態不穩",
        "抽搐發作"
      ],
      "physicalExam": [
        "肌肉震顫和抽搐",
        "全身肌肉僵硬（角弓反張）",
        "體溫升高（>40.5°C，因肌肉活動）",
        "心搏過速",
        "瞳孔散大",
        "黏膜蒼白"
      ]
    },
    "pathophysiology": "產褥癇的根本原因為泌乳期鈣質大量流入乳汁，超過腸道吸收和骨骼動員的代償能力。小型犬體內鈣儲備相對較少，大窩仔泌乳需求更高。妊娠期過度補鈣反而抑制副甲狀腺激素（PTH）分泌和維生素D活化，降低泌乳期的鈣動員能力。當血清鈣<7 mg/dL時，神經肌肉興奮性異常增加：細胞外鈣降低使鈉通道閾值降低，神經和肌肉細胞更容易去極化，導致自發性肌肉收縮（搐搦）和震顫。持續性肌肉活動產生大量熱能，導致危及生命的高熱（>41°C）。",
    "diagnosis": {
      "overview": "臨床症狀+哺乳史即可高度懷疑，血清鈣確認",
      "differentials": [
        "癲癇",
        "中毒（甲基黃嘌呤、有機磷）",
        "低血糖",
        "腦炎"
      ],
      "initialDB": [
        "血清總鈣和離子鈣（<7 mg/dL確診）",
        "血糖（排除低血糖）",
        "體溫監測"
      ],
      "advanced": [
        "電解質全套",
        "心電圖（低鈣相關心律不整）",
        "甲狀旁腺激素"
      ]
    },
    "treatment": {
      "overview": "靜脈緩慢注射鈣劑為急救核心，同時降溫和止痙",
      "acute": [
        "10% Calcium gluconate 0.5-1.5 mL/kg IV緩慢給予（10-20分鐘）",
        "心電圖監測（鈣給予期間）",
        "體溫>40°C：積極降溫",
        "Diazepam 0.5 mg/kg IV（抽搐控制）"
      ],
      "chronic": [
        "幼仔立即離乳或補充人工奶",
        "口服鈣補充：Calcium carbonate 25-50 mg/kg/day",
        "維生素D補充促進鈣吸收",
        "24-72小時內可逐漸恢復部分哺乳（監測下）"
      ]
    },
    "prognosis": "及時靜脈補鈣後15-20分鐘內即可見明顯改善。預後極佳如果及早治療。延遲治療可因高熱（>41.5°C）導致腦損傷或死亡。復發率高，需持續口服鈣補充至離乳。妊娠期避免過量補鈣可降低風險。",
    "pearls": [
      "產後1-4週哺乳小型犬出現震顫→高度懷疑產褥癇",
      "妊娠期過度補鈣反而增加產褥癇風險",
      "IV鈣劑必須緩慢給予並監測心電圖",
      "嚴重者需立即離乳，後續可逐漸恢復部分哺乳"
    ],
    "diagnosticAlgorithm": {
      "title": "產褥癇 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "臨床識別",
          "details": "哺乳母犬出現震顫/抽搐",
          "findings": [
            "哺乳期1-4週",
            "小型犬",
            "肌肉震顫→抽搐"
          ]
        },
        {
          "step": 2,
          "action": "急診血液檢查",
          "details": "確認低血鈣",
          "findings": [
            "總鈣<7 mg/dL",
            "離子鈣降低",
            "血糖正常或低"
          ]
        },
        {
          "step": 3,
          "action": "緊急治療",
          "details": "IV鈣劑+心電圖監測",
          "findings": [
            "治療性診斷：IV鈣後快速改善",
            "體溫監測"
          ]
        },
        {
          "step": 4,
          "action": "後續管理",
          "details": "離乳+口服鈣補充",
          "findings": [
            "幼仔管理",
            "口服鈣劑量調整",
            "復發預防"
          ]
        }
      ]
    },
    "monitoring": [
      "血清鈣濃度追蹤",
      "體溫監測",
      "幼仔營養狀況",
      "母犬神經肌肉狀態"
    ],
    "reference": "Merck Veterinary Manual — Eclampsia; VCA Animal Hospitals; Veterinary Partner — VIN; CriticalCareDVM"
  },
  "metritis": {
    "zh": "子宮炎",
    "en": "Metritis",
    "definition": "子宮炎是子宮內膜和肌層的急性細菌感染，通常發生在分娩後1-7天內。常見誘因包括難產、助產操作污染、胎兒或胎盤滯留。主要致病菌為E. coli。如不及時治療可進展為敗血症和毒血症，危及生命。",
    "synonyms": [
      "產後子宮炎",
      "Postpartum Metritis"
    ],
    "epidemiology": {
      "species": "犬貓皆可",
      "age": "繁殖年齡產後母犬貓",
      "sex": "僅產後母犬貓",
      "riskFactors": [
        "難產或助產操作",
        "胎兒或胎盤滯留",
        "剖腹產",
        "陰道撕裂傷",
        "免疫力低下"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "產後1-7天出現症狀",
        "惡臭陰道分泌物",
        "發燒",
        "食慾下降",
        "母性行為減弱",
        "泌乳量減少"
      ],
      "physicalExam": [
        "惡臭的血膿性或出血性陰道分泌物",
        "發燒（>39.5°C）",
        "脫水",
        "腹部觸診子宮增大和疼痛",
        "黏膜充血或蒼白",
        "心搏過速"
      ]
    },
    "pathophysiology": "產後子宮頸開放，加上分娩創傷和殘留的惡露提供細菌生長基質。E. coli是最常見致病菌，其他包括鏈球菌、葡萄球菌和厭氧菌。細菌在子宮壁和腔內繁殖，釋放內毒素（LPS）導致全身性發炎反應。子宮內膜和肌層的感染導致局部化膿和壞死，同時細菌和毒素經由開放的子宮血管和淋巴管進入全身循環，引起毒血症和敗血症。嗜中性球趨化至子宮造成大量膿性分泌物。如合併胎兒或胎盤滯留，壞死組織提供更豐富的細菌培養基。",
    "diagnosis": {
      "overview": "臨床症狀+產後病史+陰道分泌物特徵即可初步診斷",
      "differentials": [
        "正常產後惡露",
        "子宮蓄膿",
        "陰道炎",
        "子宮破裂"
      ],
      "initialDB": [
        "陰道分泌物細胞學和培養",
        "CBC（嗜中性球增多伴左移）",
        "生化（脫水和器官功能）",
        "腹部超音波（子宮增大、液體積聚）"
      ],
      "advanced": [
        "腹部X光（排除滯留胎兒）",
        "凝血功能（排除DIC）",
        "血液培養（懷疑敗血症時）"
      ]
    },
    "treatment": {
      "overview": "廣效抗生素+子宮排空為治療核心，嚴重者需OHE",
      "acute": [
        "廣效抗生素（Amoxicillin-clavulanate或頭孢菌素類）",
        "靜脈輸液抗休克",
        "PGF2α 0.25 mg/kg SC SID×5天（促進子宮排空）",
        "嚴重者或不留種者：緊急OHE"
      ],
      "chronic": [
        "根據培養藥敏調整抗生素",
        "營養支持",
        "幼仔管理（分泌物有毒性時可能需離乳）"
      ]
    },
    "prognosis": "及時抗生素和支持治療下多數母犬貓反應良好。延誤治療可進展為敗血症，預後下降。OHE是最確定的治療方法（不留種者）。保守治療成功者，未來繁殖能力可能受損。",
    "pearls": [
      "產後1-7天的惡臭陰道分泌物=高度懷疑子宮炎",
      "區分正常惡露（紅棕色、量少、無臭）和子宮炎分泌物（膿性、惡臭）",
      "必須排除滯留胎兒或胎盤（X光或超音波）",
      "PGF2α可促進子宮排空但有副作用（嘔吐、腹瀉、流涎）"
    ],
    "diagnosticAlgorithm": {
      "title": "子宮炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "病史評估",
          "details": "產後時間和分娩過程",
          "findings": [
            "產後1-7天",
            "難產或助產史",
            "惡臭陰道分泌物"
          ]
        },
        {
          "step": 2,
          "action": "理學+實驗室",
          "details": "全身評估和感染指標",
          "findings": [
            "發燒",
            "嗜中性球增多",
            "子宮觸診腫大疼痛"
          ]
        },
        {
          "step": 3,
          "action": "影像學",
          "details": "超音波和X光",
          "findings": [
            "子宮液體積聚",
            "排除滯留胎兒",
            "子宮壁增厚"
          ]
        },
        {
          "step": 4,
          "action": "培養+治療",
          "details": "分泌物培養+經驗性抗生素",
          "findings": [
            "E. coli最常見",
            "培養藥敏指導用藥"
          ]
        }
      ]
    },
    "monitoring": [
      "體溫追蹤",
      "陰道分泌物量和性質",
      "CBC追蹤（感染控制）",
      "幼仔健康和營養"
    ],
    "reference": "Merck Veterinary Manual — Metritis in Small Animals; VetsCraft; wagwalking.com"
  },
  "vaginitis": {
    "zh": "陰道炎",
    "en": "Vaginitis",
    "definition": "陰道炎是陰道或前庭的炎症反應，分為幼年型（前青春期）和成犬型。幼年型陰道炎多於第一次發情後自行緩解，為良性過程。成犬型陰道炎通常有潛在誘因如解剖異常、尿失禁、異物或腫瘤。犬較常見，貓少見。",
    "synonyms": [
      "Vaginitis",
      "陰道前庭炎"
    ],
    "epidemiology": {
      "species": "犬為主，貓少見",
      "age": "幼年型：<1歲未發情前；成犬型：任何年齡",
      "sex": "僅母犬貓",
      "riskFactors": [
        "未絕育幼犬（幼年型）",
        "已絕育母犬（成犬型較常見）",
        "陰門內陷（recessed vulva）",
        "尿失禁",
        "陰道狹窄或中隔",
        "異物"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "陰道分泌物（黏液性至黏液膿性）",
        "頻繁舔舐外陰部",
        "頻尿或排尿困難",
        "幼年型通常症狀輕微"
      ],
      "physicalExam": [
        "陰門周圍黏液性或膿性分泌物",
        "陰門或前庭黏膜充血",
        "陰門內陷（肥胖犬常見）",
        "無全身症狀（一般無發燒）"
      ]
    },
    "pathophysiology": "幼年型陰道炎發生於低雌激素環境中（未發情前），陰道上皮薄且缺乏角化保護，局部免疫防禦不足，正常陰道菌叢失衡導致輕度炎症。第一次發情時雌激素使陰道上皮增厚和角化，恢復局部防禦機制，多數可自行緩解。成犬型陰道炎通常有結構或功能異常作為誘因：陰門內陷導致尿液和糞便污染陰道；陰道狹窄或中隔阻礙分泌物排出；尿失禁持續刺激陰道黏膜；腫瘤或異物引起局部炎症。細菌培養常見混合菌叢，為繼發性而非原因。",
    "diagnosis": {
      "overview": "理學檢查+分泌物細胞學為基礎，需排除潛在解剖異常",
      "differentials": [
        "子宮蓄膿（未絕育犬）",
        "子宮炎",
        "泌尿道感染",
        "陰道腫瘤",
        "發情期正常分泌物"
      ],
      "initialDB": [
        "陰道分泌物細胞學",
        "尿液分析和培養",
        "陰道指診（排除狹窄、腫塊、異物）"
      ],
      "advanced": [
        "陰道鏡檢查",
        "陰道培養和藥敏",
        "腹部超音波（排除子宮疾病）",
        "陰道對比攝影（排除解剖異常）"
      ]
    },
    "treatment": {
      "overview": "幼年型多自行緩解；成犬型需治療潛在病因",
      "acute": [
        "局部清潔（溫水沖洗）",
        "有症狀的細菌性陰道炎：Amoxicillin-clavulanate口服2-3週"
      ],
      "chronic": [
        "幼年型：等待第一次發情後評估（多數自行緩解）",
        "陰門內陷：外陰成形術（episioplasty）",
        "陰道狹窄：手術矯正",
        "尿失禁：藥物治療（phenylpropanolamine）"
      ]
    },
    "prognosis": "幼年型陰道炎預後極佳，多數在第一次發情後自行緩解。成犬型陰道炎預後取決於潛在病因的可治療性。抗生素治療2-3週通常可緩解症狀。需注意幼年犬不宜在陰道炎未緩解前絕育。",
    "pearls": [
      "幼年型陰道炎不需治療，等待第一次發情",
      "術前檢查發現陰道炎→推遲絕育至緩解或發情後",
      "陰門內陷是成犬型陰道炎的常見潛在原因",
      "Amoxicillin-clavulanate對91-100%常見致病菌有效"
    ],
    "diagnosticAlgorithm": {
      "title": "陰道炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "年齡和病史分型",
          "details": "區分幼年型和成犬型",
          "findings": [
            "<1歲未發情→幼年型",
            ">1歲或已絕育→成犬型"
          ]
        },
        {
          "step": 2,
          "action": "分泌物評估",
          "details": "細胞學和培養",
          "findings": [
            "嗜中性球浸潤",
            "混合菌叢",
            "排除腫瘤細胞"
          ]
        },
        {
          "step": 3,
          "action": "解剖學評估",
          "details": "指診+陰道鏡",
          "findings": [
            "陰門內陷",
            "陰道狹窄",
            "異物或腫塊"
          ]
        },
        {
          "step": 4,
          "action": "排除其他疾病",
          "details": "尿液分析+超音波",
          "findings": [
            "排除UTI",
            "排除子宮蓄膿",
            "排除腫瘤"
          ]
        }
      ]
    },
    "monitoring": [
      "分泌物量和性質",
      "發情週期（幼年型）",
      "潛在病因治療反應",
      "尿液分析追蹤"
    ],
    "reference": "VCA Animal Hospitals — Vaginitis in Dogs; Merck Veterinary Manual; dvm360; PetMD"
  },
  "paraphimosis": {
    "zh": "包皮嵌頓",
    "en": "Paraphimosis",
    "definition": "包皮嵌頓是陰莖無法縮回包皮鞘內的緊急狀態。暴露的陰莖黏膜迅速乾燥、腫脹，進一步壓迫阻礙靜脈回流和淋巴引流，形成惡性循環。若30-60分鐘內未復位，可導致組織缺血壞死，嚴重者需陰莖截除。",
    "synonyms": [
      "陰莖嵌頓",
      "Penile Entrapment"
    ],
    "epidemiology": {
      "species": "犬為主，貓極罕見",
      "age": "任何年齡公犬",
      "sex": "僅公犬",
      "riskFactors": [
        "交配後",
        "包皮開口過小",
        "包皮周圍毛髮纏繞",
        "陰莖腫瘤或異物",
        "神經系統疾病影響陰莖回縮",
        "外傷"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "陰莖持續外露無法縮回",
        "交配後或興奮後發生",
        "頻繁舔舐陰莖",
        "排尿困難"
      ],
      "physicalExam": [
        "陰莖外露腫脹充血",
        "陰莖黏膜乾燥或發紺",
        "觸診疼痛",
        "包皮環緊縮",
        "嚴重者陰莖組織壞死變色"
      ]
    },
    "pathophysiology": "正常射精或興奮後陰莖海綿體充血，使陰莖從包皮中突出。正常情況下海綿體血液排空後陰莖縮回包皮鞘。包皮嵌頓時，包皮開口（或環繞的毛髮、狹窄環）作為縮窄帶阻止陰莖回縮。暴露的陰莖黏膜迅速失去濕潤（正常由包皮液保護），組織腫脹增加。靜脈和淋巴回流受阻使腫脹進一步加劇，動脈血流雖可進入但無法回流，形成組織充血水腫的惡性循環。持續>2小時可導致組織缺血，>24小時可發生不可逆壞死。尿道腫脹可阻塞排尿。",
    "diagnosis": {
      "overview": "視診即可確診，需評估組織活力和尋找誘因",
      "differentials": [
        "陰莖異常勃起（priapism）",
        "陰莖骨折",
        "陰莖腫瘤",
        "包皮炎"
      ],
      "initialDB": [
        "陰莖和包皮視診",
        "評估組織顏色和活力",
        "檢查環繞毛髮或異物"
      ],
      "advanced": [
        "超音波（排除陰莖腫瘤）",
        "尿道造影（排除尿道阻塞）"
      ]
    },
    "treatment": {
      "overview": "緊急復位為首要目標，嚴重組織壞死需截除",
      "acute": [
        "清潔和潤滑暴露的陰莖",
        "冷敷減少腫脹",
        "先推包皮近端再引導陰莖回縮",
        "Acepromazine 0.005-0.03 mg/kg（鎮靜+輕度降壓助於復位）",
        "嚴重腫脹：高張糖液紗布包裹消腫"
      ],
      "chronic": [
        "復發者：包皮開口擴大術",
        "環繞毛髮：定期修剪包皮周圍毛髮",
        "壞死組織：部分或全部陰莖截除",
        "腫瘤誘發：腫瘤切除"
      ]
    },
    "prognosis": "快速復位（<30-60分鐘）預後極佳。組織損傷輕微者完全恢復。嚴重壞死需陰莖截除但犬仍可正常排尿（保留尿道造口術）。復發性包皮嵌頓需手術矯正潛在原因。",
    "pearls": [
      ">30-60分鐘未復位即為急診",
      "Acepromazine是首選鎮靜劑（α-阻斷降壓有利復位）",
      "復位前先潤滑和消腫，不要強行推回",
      "復發者需檢查包皮開口是否過小"
    ],
    "diagnosticAlgorithm": {
      "title": "包皮嵌頓 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "視診確認",
          "details": "陰莖外露無法縮回",
          "findings": [
            "陰莖腫脹充血",
            "黏膜乾燥",
            "包皮環緊縮"
          ]
        },
        {
          "step": 2,
          "action": "組織活力評估",
          "details": "評估缺血程度",
          "findings": [
            "粉紅色→活力佳",
            "發紺→缺血",
            "黑色→壞死"
          ]
        },
        {
          "step": 3,
          "action": "誘因搜尋",
          "details": "檢查毛髮纏繞、異物、腫塊",
          "findings": [
            "環繞毛髮",
            "包皮狹窄",
            "腫瘤"
          ]
        },
        {
          "step": 4,
          "action": "緊急復位",
          "details": "潤滑+消腫+復位",
          "findings": [
            "成功復位",
            "需手術介入"
          ]
        }
      ]
    },
    "monitoring": [
      "復位後陰莖組織恢復",
      "排尿功能",
      "復發監測",
      "包皮周圍衛生"
    ],
    "reference": "Merck Veterinary Manual — Paraphimosis; PetMD; MSPCA-Angell; Veterinary Partner — VIN"
  },
  "orchitis-epididymitis": {
    "zh": "睪丸副睪炎",
    "en": "Orchitis-Epididymitis",
    "definition": "睪丸炎（orchitis）和副睪炎（epididymitis）為睪丸和副睪的炎症，常同時發生。多為細菌感染所致，也可由布氏桿菌（Brucella canis）、真菌、病毒或免疫媒介機制引起。急性型表現為局部疼痛腫脹和全身症狀；慢性型可導致不可逆的生殖功能喪失。",
    "synonyms": [
      "睪丸炎",
      "副睪炎",
      "Epididymo-orchitis"
    ],
    "epidemiology": {
      "species": "犬為主，貓罕見",
      "age": "成年未絕育公犬",
      "sex": "僅公犬",
      "riskFactors": [
        "未絕育",
        "接觸受感染的母犬（布氏桿菌）",
        "泌尿道感染",
        "攝護腺炎",
        "外傷（咬傷、穿刺傷）",
        "免疫低下"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "陰囊腫脹疼痛",
        "跛行或行走不願（疼痛）",
        "發燒",
        "食慾下降",
        "舔舐陰囊",
        "不孕"
      ],
      "physicalExam": [
        "單側或雙側陰囊腫脹",
        "觸診疼痛明顯",
        "陰囊皮膚紅腫發熱",
        "發燒",
        "慢性型：睪丸萎縮硬化",
        "可能有陰囊皮膚潰瘍或廔管"
      ]
    },
    "pathophysiology": "感染性睪丸副睪炎中，細菌可經由血行、尿道逆行或直接穿透（外傷）到達睪丸和副睪。E. coli、Brucella canis、葡萄球菌和鏈球菌為常見致病菌。感染引起急性炎症反應，睪丸間質水腫、嗜中性球浸潤、曲細精管損傷。睪丸溫度因炎症升高（正常應低於體溫2-3°C），熱損傷（thermal insult）破壞生精上皮。受損的精原細胞可暴露血睪屏障（blood-testis barrier）內的抗原，觸發免疫媒介性睪丸炎，即使感染控制後仍持續自體免疫攻擊。慢性期纖維化和曲細精管退化導致不可逆不孕。",
    "diagnosis": {
      "overview": "觸診和超音波評估，布氏桿菌篩檢為必須",
      "differentials": [
        "陰囊疝氣",
        "睪丸腫瘤",
        "睪丸扭轉",
        "陰囊水腫"
      ],
      "initialDB": [
        "陰囊和睪丸觸診",
        "陰囊超音波",
        "布氏桿菌血清學（RSAT或ME-RSAT）",
        "CBC（感染指標）"
      ],
      "advanced": [
        "細針穿刺細胞學",
        "精液分析和培養",
        "組織活檢（排除腫瘤）",
        "布氏桿菌PCR或血液培養"
      ]
    },
    "treatment": {
      "overview": "不留種者以去勢為首選；留種者抗生素治療但生殖功能恢復預後謹慎",
      "acute": [
        "廣效抗生素（根據培養調整）",
        "NSAIDs止痛消炎",
        "冷敷減腫",
        "布氏桿菌陽性：Doxycycline+Enrofloxacin長期療程"
      ],
      "chronic": [
        "去勢術（castration）— 首選治療",
        "布氏桿菌陽性犬：視為終身感染者，繁殖犬應退役",
        "抗生素療程完成後追蹤培養"
      ]
    },
    "prognosis": "去勢術後預後良好。保守治療的生殖功能恢復預後謹慎，即使感染控制後熱損傷和免疫媒介性損傷可導致永久不孕。布氏桿菌性睪丸炎預後較差，為人畜共通傳染病需通報。慢性型睪丸萎縮為不可逆。",
    "pearls": [
      "所有睪丸副睪炎犬必須做布氏桿菌篩檢",
      "布氏桿菌為人畜共通傳染病，陽性犬需隔離",
      "即使感染治癒，免疫媒介性持續損傷仍可導致不孕",
      "不留種者直接去勢是最佳治療"
    ],
    "diagnosticAlgorithm": {
      "title": "睪丸副睪炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "理學檢查",
          "details": "陰囊觸診和全身評估",
          "findings": [
            "陰囊腫脹疼痛",
            "發燒",
            "單側或雙側"
          ]
        },
        {
          "step": 2,
          "action": "影像和實驗室",
          "details": "超音波+CBC+布氏桿菌",
          "findings": [
            "超音波：睪丸/副睪腫脹",
            "WBC升高",
            "布氏桿菌血清學"
          ]
        },
        {
          "step": 3,
          "action": "病原學確認",
          "details": "培養和藥敏",
          "findings": [
            "精液或穿刺液培養",
            "布氏桿菌PCR"
          ]
        },
        {
          "step": 4,
          "action": "治療決策",
          "details": "去勢 vs 保守治療",
          "findings": [
            "不留種→去勢",
            "留種→抗生素+追蹤"
          ]
        }
      ]
    },
    "monitoring": [
      "布氏桿菌追蹤血清學",
      "精液品質評估（留種者）",
      "對側睪丸狀態",
      "疼痛和腫脹消退"
    ],
    "reference": "Merck Veterinary Manual — Orchitis and Epididymitis; PMC — Brucella canis; wagwalking.com"
  },
  "tooth-fracture": {
    "zh": "牙齒骨折",
    "en": "Tooth Fracture",
    "definition": "牙齒因外力創傷或咀嚼硬物導致的牙冠或牙根結構斷裂，依據美國獸醫牙科學院（AVDC）分類分為琺瑯質裂隙、琺瑯質骨折、非複雜性牙冠骨折、複雜性牙冠骨折（露髓）及牙根骨折五類，是小動物最常見的口腔創傷之一。",
    "synonyms": [
      "斷齒",
      "碎齒",
      "Fractured Tooth",
      "Dental Fracture"
    ],
    "epidemiology": {
      "species": "犬貓皆可，犬較常見",
      "age": "任何年齡，青壯年犬因活動量大較常見",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "咀嚼硬物（骨頭、鹿角、蹄）",
        "外傷（車禍、摔落、打鬥）",
        "大型犬種（上顎犬齒及第四前臼齒最常骨折）",
        "貓以上下顎犬齒最常見"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "咀嚼時疼痛或不願咀嚼",
        "單側咀嚼",
        "口腔出血",
        "飼主發現齒冠缺損"
      ],
      "physicalExam": [
        "齒冠可見斷裂面",
        "露髓點呈粉紅色或暗色",
        "齒齦紅腫或瘻管",
        "叩診疼痛",
        "相關淋巴結腫大"
      ]
    },
    "pathophysiology": "外力超過牙齒結構強度時造成琺瑯質、齒質或齒髓腔的斷裂。非複雜性骨折未暴露齒髓，但齒質小管暴露可導致細菌入侵引起繼發性牙髓炎。複雜性骨折直接暴露齒髓，細菌經髓腔進入導致牙髓壞死、根尖周炎，繼而形成根尖膿瘍或瘻管。未治療的骨折可導致慢性疼痛、骨溶解及鄰近組織感染。",
    "diagnosis": {
      "overview": "口腔檢查結合牙科放射線學確認骨折類型及根尖狀態",
      "differentials": [
        "牙齒磨耗",
        "牙齒吸收（貓）",
        "琺瑯質發育不全",
        "齲齒"
      ],
      "initialDB": [
        "全口腔檢查（需全身麻醉）",
        "牙科探針檢查齒髓暴露",
        "牙科放射線攝影",
        "齒齦探診評估牙周狀態"
      ],
      "advanced": [
        "根尖周圍放射線評估",
        "活齒檢測（electric/thermal pulp test）",
        "CBCT（錐狀束電腦斷層）"
      ]
    },
    "treatment": {
      "overview": "依骨折類型選擇保守治療、活髓治療、根管治療或拔牙",
      "acute": [
        "止痛（NSAIDs 如 meloxicam 0.1mg/kg PO q24h）",
        "複雜性骨折急性期（<48h）可考慮活髓治療（vital pulp therapy）",
        "嚴重感染時抗生素治療（amoxicillin-clavulanate 12.5-25mg/kg PO q12h）"
      ],
      "chronic": [
        "非複雜性骨折：密封劑修復或定期監測",
        "複雜性骨折：根管治療（成功率約95%）或拔牙",
        "根尖膿瘍：拔牙為首選"
      ]
    },
    "prognosis": "非複雜性骨折經適當密封修復預後良好。複雜性骨折若及時進行活髓治療（暴露<48小時）成功率高；根管治療失敗率僅約5%。未治療的複雜性骨折將導致牙髓壞死和慢性疼痛，最終需要拔牙。",
    "pearls": [
      "犬最常骨折的牙齒為上顎犬齒和上顎第四前臼齒（裂齒）",
      "齒髓暴露點隨時間由粉紅變暗棕，暗色不代表無感染需放射線確認",
      "任何牙齒變色（粉紅、紫色、灰色）都應進行牙科放射線檢查評估齒髓活力"
    ],
    "diagnosticAlgorithm": {
      "title": "牙齒骨折 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "口腔檢查",
          "details": "全身麻醉下進行全口檢查，確認骨折位置與類型",
          "findings": [
            "齒冠可見斷裂",
            "齒髓暴露或未暴露",
            "牙齒變色"
          ]
        },
        {
          "step": 2,
          "action": "牙科放射線",
          "details": "每顆骨折齒至少拍攝一張根尖片",
          "findings": [
            "根尖透明區（膿瘍）",
            "牙根骨折",
            "牙周韌帶增寬"
          ]
        },
        {
          "step": 3,
          "action": "分類與評估",
          "details": "依AVDC分類確認骨折嚴重度與治療方案",
          "findings": [
            "非複雜性vs複雜性",
            "急性vs慢性",
            "根尖健康vs病變"
          ]
        },
        {
          "step": 4,
          "action": "制定治療計畫",
          "details": "根據骨折類型、暴露時間及根尖狀態選擇治療方式",
          "findings": [
            "監測",
            "修復",
            "根管治療",
            "拔牙"
          ]
        }
      ]
    },
    "monitoring": [
      "術後2週回診確認傷口癒合",
      "根管治療後6-12個月放射線追蹤",
      "活髓治療後6個月確認齒髓活力",
      "定期口腔檢查預防再發"
    ],
    "reference": "AVDC Nomenclature 2024; Niemiec BA. Veterinary Periodontology. Wiley 2013; Reiter AM, Gracis M. BSAVA Manual of Canine and Feline Dentistry 4th ed."
  },
  "retained-deciduous-teeth": {
    "zh": "乳齒滯留",
    "en": "Retained Deciduous Teeth",
    "definition": "乳齒在永久齒萌出後未正常脫落而滯留於口腔中的狀態。正常犬有28顆乳齒（42顆永久齒），貓有26顆乳齒（30顆永久齒），乳齒應在永久齒萌出時因齒根吸收而自然脫落，滯留乳齒可導致齒列不正、牙周病及咬合異常。",
    "synonyms": [
      "殘存乳齒",
      "持續性乳齒",
      "Persistent Deciduous Teeth",
      "Retained Baby Teeth"
    ],
    "epidemiology": {
      "species": "犬較常見，貓偶見",
      "age": "4-7月齡（換牙期）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "玩具犬及小型犬種（約克夏、馬爾濟斯、博美、吉娃娃）",
        "遺傳傾向",
        "短頭種",
        "口腔創傷影響換牙"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "口臭",
        "飼主注意到雙排牙齒",
        "咀嚼困難",
        "口腔不適"
      ],
      "physicalExam": [
        "乳齒與永久齒並排（雙排齒）",
        "永久齒偏位萌出",
        "齒間食物殘渣堆積",
        "齒齦紅腫",
        "犬齒最常滯留，其次為切齒和前臼齒"
      ]
    },
    "pathophysiology": "正常換牙過程中，永久齒齒胚發育產生的壓力刺激乳齒齒根吸收（破齒細胞活化），使乳齒鬆動脫落。滯留發生於乳齒齒根吸收機制異常，可能因永久齒萌出路徑偏離、遺傳因素或局部損傷導致。滯留乳齒佔據永久齒正常位置，迫使永久齒偏位萌出，造成異常咬合。兩齒間狹窄空間極易堆積牙菌斑，加速牙周病發展。",
    "diagnosis": {
      "overview": "口腔檢查確認乳齒滯留，放射線評估乳齒齒根狀態及永久齒位置",
      "differentials": [
        "多生齒（supernumerary teeth）",
        "永久齒缺失（乳齒正常保留）",
        "齒列擁擠"
      ],
      "initialDB": [
        "口腔視診確認雙排齒",
        "牙科放射線攝影確認永久齒存在",
        "咬合評估"
      ],
      "advanced": [
        "全口牙科放射線（評估所有乳齒狀態）",
        "頭部CT（複雜病例）"
      ]
    },
    "treatment": {
      "overview": "確認永久齒已萌出後應儘早拔除滯留乳齒",
      "acute": [
        "手術拔除滯留乳齒（需完整拔出齒根）",
        "可與絕育手術同時進行",
        "術後止痛（meloxicam 0.1mg/kg PO q24h共3天）"
      ],
      "chronic": [
        "咬合矯正（永久齒已偏位時）",
        "定期牙科清潔預防牙周病",
        "複雜病例轉診獸醫牙科專科"
      ]
    },
    "prognosis": "及早拔除（永久齒剛萌出時）預後極佳，永久齒多能自行移動至正常位置。延遲處理可導致永久性咬合異常，需要矯正治療。拔除時需注意完整移除乳齒齒根，避免損傷鄰近永久齒齒胚。",
    "pearls": [
      "規則：永久齒一旦萌出且乳齒未脫落，即應拔除乳齒",
      "拔除乳齒時必須確認齒根完整拔出，殘留齒根可導致持續問題",
      "犬齒滯留最常見，且最容易導致咬合異常"
    ],
    "diagnosticAlgorithm": {
      "title": "乳齒滯留 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "口腔視診",
          "details": "檢查是否有乳齒與永久齒並存",
          "findings": [
            "雙排犬齒",
            "雙排切齒",
            "永久齒偏位"
          ]
        },
        {
          "step": 2,
          "action": "牙科放射線",
          "details": "確認永久齒齒胚存在且乳齒齒根未吸收",
          "findings": [
            "永久齒已萌出",
            "乳齒齒根完整未吸收",
            "永久齒缺失（需保留乳齒）"
          ]
        },
        {
          "step": 3,
          "action": "咬合評估",
          "details": "評估咬合關係及永久齒偏位程度",
          "findings": [
            "正常咬合",
            "輕度偏位",
            "嚴重咬合異常"
          ]
        },
        {
          "step": 4,
          "action": "治療決策",
          "details": "根據永久齒存在與否及咬合狀態決定拔除時機",
          "findings": [
            "立即拔除",
            "擇期拔除",
            "保留乳齒（無永久齒時）"
          ]
        }
      ]
    },
    "monitoring": [
      "拔除後1-2週回診確認傷口癒合",
      "追蹤永久齒是否移動至正常位置",
      "4-6週後評估咬合改善情形",
      "定期口腔檢查預防牙周病"
    ],
    "reference": "Niemiec BA. Small Animal Dental, Oral and Maxillofacial Disease. CRC Press 2022; Gorrel C. Veterinary Dentistry for the General Practitioner 2nd ed. Saunders 2013."
  },
  "oronasal-fistula": {
    "zh": "口鼻瘻管",
    "en": "Oronasal Fistula",
    "definition": "口腔與鼻腔之間形成異常通道的病理狀態，最常因嚴重牙周病導致上顎犬齒區域齒槽骨破壞而形成，也可因拔牙併發症、外傷、腫瘤或先天性腭裂引起。食物和液體可經瘻管進入鼻腔，導致慢性鼻炎和鼻竇感染。",
    "synonyms": [
      "口鼻廔管",
      "Oroantral Fistula",
      "Palatal Fistula"
    ],
    "epidemiology": {
      "species": "犬較常見，貓偶見",
      "age": "中老年犬（牙周病繼發），任何年齡（外傷性）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "嚴重牙周病",
        "上顎犬齒拔除併發症",
        "小型犬及短頭種（齒列擁擠）",
        "口腔腫瘤",
        "顏面外傷"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "慢性單側鼻分泌物（黏液膿性）",
        "進食或飲水時打噴嚏",
        "鼻腔反覆感染",
        "口臭"
      ],
      "physicalExam": [
        "上顎齒齦或硬腭可見瘻管開口",
        "探針可從口腔通過至鼻腔",
        "牙周探診深度異常",
        "鼻分泌物（單側為主）",
        "相關牙齒鬆動或缺失"
      ]
    },
    "pathophysiology": "牙周病進展過程中，牙菌斑細菌引起牙周韌帶和齒槽骨的慢性發炎與破壞。上顎犬齒的齒根與鼻腔底部僅有薄層骨板分隔，當牙周破壞延伸至此區域，骨板被溶解後形成口腔至鼻腔的異常通道。拔牙後若齒槽窩癒合不良或術中穿孔鼻腔底部亦可形成瘻管。口腔內的食物、細菌和液體經瘻管進入鼻腔，引起持續性鼻炎和繼發性細菌感染。",
    "diagnosis": {
      "overview": "全身麻醉下口腔檢查結合牙科放射線確認瘻管位置和大小",
      "differentials": [
        "原發性鼻炎",
        "鼻腔腫瘤",
        "鼻腔異物",
        "先天性腭裂",
        "黴菌性鼻炎"
      ],
      "initialDB": [
        "全身麻醉下口腔探診",
        "牙周探針探查瘻管",
        "牙科放射線攝影",
        "鼻腔分泌物細胞學"
      ],
      "advanced": [
        "頭部CT評估瘻管範圍及鼻竇狀態",
        "鼻鏡檢查",
        "細菌培養及藥敏試驗"
      ]
    },
    "treatment": {
      "overview": "手術修復為唯一有效治療，使用齒齦黏膜瓣重建口鼻分隔",
      "acute": [
        "拔除相關病齒",
        "清創瘻管周圍壞死組織",
        "齒齦黏膜瓣覆蓋修復（需無張力縫合）",
        "術後抗生素（amoxicillin-clavulanate 12.5-25mg/kg PO q12h共10-14天）"
      ],
      "chronic": [
        "術後軟食2-3週",
        "避免咀嚼硬物至少4週",
        "複發性瘻管可能需要雙層黏膜瓣修復",
        "嚴重病例需轉診口腔外科"
      ]
    },
    "prognosis": "初次手術修復成功率約70-80%。失敗的主要原因為黏膜瓣張力過大或血供不良。複發病例可進行二次修復，大多數最終可成功關閉。早期發現和治療可避免慢性鼻竇感染等併發症。",
    "pearls": [
      "上顎犬齒區域是口鼻瘻管最常見的發生位置",
      "修復的關鍵是無張力的黏膜瓣閉合和良好的血液供應",
      "術前處理鼻腔感染可提高手術成功率"
    ],
    "diagnosticAlgorithm": {
      "title": "口鼻瘻管 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "臨床評估",
          "details": "評估鼻分泌物、打噴嚏史及口臭",
          "findings": [
            "慢性單側鼻分泌物",
            "進食時打噴嚏",
            "口臭"
          ]
        },
        {
          "step": 2,
          "action": "麻醉下口腔檢查",
          "details": "牙周探針探查上顎齒齦區域",
          "findings": [
            "瘻管開口可見",
            "探針可通過至鼻腔",
            "牙齒鬆動"
          ]
        },
        {
          "step": 3,
          "action": "影像學檢查",
          "details": "牙科放射線及/或CT評估",
          "findings": [
            "齒槽骨缺損",
            "鼻腔內液體",
            "鼻竇受累"
          ]
        },
        {
          "step": 4,
          "action": "手術修復",
          "details": "清創後以黏膜瓣無張力修復",
          "findings": [
            "瘻管成功關閉",
            "需二次手術",
            "需轉診"
          ]
        }
      ]
    },
    "monitoring": [
      "術後48-72小時評估黏膜瓣存活",
      "2週後拆線並評估癒合",
      "1個月後確認瘻管完全關閉",
      "持續監測鼻分泌物是否改善"
    ],
    "reference": "Reiter AM, Gracis M. BSAVA Manual of Canine and Feline Dentistry 4th ed. 2018; Smith MM. Oronasal fistula repair. Clin Tech Small Anim Pract. 2000;15(2):86-90."
  },
  "masticatory-myositis": {
    "zh": "咀嚼肌炎",
    "en": "Masticatory Muscle Myositis",
    "definition": "犬的咀嚼肌群（顳肌、咬肌、翼肌）發生免疫介導性發炎的自體免疫疾病，因免疫系統攻擊咀嚼肌特有的2M型肌纖維而引起。急性期表現為咀嚼肌腫脹疼痛，慢性期因肌肉纖維化導致嚴重萎縮和開口困難。",
    "synonyms": [
      "咬肌炎",
      "MMM",
      "Masticatory Myositis",
      "Eosinophilic Myositis"
    ],
    "epidemiology": {
      "species": "犬（貓極罕見）",
      "age": "任何年齡，中大型犬較常見",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "大型犬種",
        "德國牧羊犬、騎士查理王獵犬、拉布拉多",
        "中年犬",
        "遺傳易感性"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "無法張口或不願張口",
        "進食困難或拒食",
        "口腔疼痛",
        "頭部腫脹（急性期）或萎縮（慢性期）"
      ],
      "physicalExam": [
        "急性期：咀嚼肌雙側對稱性腫脹、觸診疼痛",
        "慢性期：嚴重雙側顳肌和咬肌萎縮",
        "開口受限（牙關緊閉）",
        "眼球凹陷（顳肌萎縮）",
        "體溫正常或輕度升高"
      ]
    },
    "pathophysiology": "咀嚼肌含有獨特的2M型肌纖維，此纖維蛋白僅存在於咀嚼肌群中，不存在於四肢或其他骨骼肌。免疫系統對2M纖維產生自體抗體和CD8+ T細胞介導的攻擊，導致肌纖維壞死和發炎細胞浸潤。急性期以淋巴球和漿細胞浸潤為主，若未治療則進入慢性期，肌纖維被纖維結締組織取代，導致不可逆的肌肉萎縮和纖維化，嚴重限制開口運動。",
    "diagnosis": {
      "overview": "血清2M抗體檢測為首選確診方法，敏感度80-90%、特異度100%",
      "differentials": [
        "多發性肌炎",
        "三叉神經炎",
        "顳顎關節疾病",
        "牙周膿瘍",
        "破傷風",
        "異物"
      ],
      "initialDB": [
        "血清2M抗體免疫螢光檢測",
        "CBC（可見嗜酸性球增多）",
        "CK（肌酸激酶，急性期升高）",
        "開口角度測量"
      ],
      "advanced": [
        "咀嚼肌活體組織檢查（免疫組織化學染色）",
        "MRI評估肌肉狀態",
        "肌電圖（EMG）"
      ]
    },
    "treatment": {
      "overview": "免疫抑制劑量的糖皮質素為首選治療，需長期維持治療",
      "acute": [
        "Prednisone 1-2mg/kg PO q12h共3-4週",
        "急性疼痛劇烈時可先靜脈注射dexamethasone",
        "軟食或灌食支持"
      ],
      "chronic": [
        "Prednisone逐步減量至最低有效劑量（0.5mg/kg q48h）",
        "總療程通常6-12個月",
        "復發時增加劑量重新控制",
        "Azathioprine可作為steroid-sparing agent（1-2mg/kg PO q24-48h）"
      ]
    },
    "prognosis": "早期診斷和治療預後良好，約73%的犬恢復正常咀嚼功能。約27%可能復發但通常對再次治療有反應。慢性纖維化期開始治療預後較差，肌肉萎縮和開口限制可能為永久性。未治療將進展為嚴重肌肉纖維化和永久性牙關緊閉。",
    "pearls": [
      "2M抗體檢測特異度100%，陽性即可確診",
      "開始免疫抑制治療前應先採血檢測，類固醇可能造成假陰性",
      "治療目標是抑制免疫反應並在纖維化發生前恢復肌肉功能"
    ],
    "diagnosticAlgorithm": {
      "title": "咀嚼肌炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "臨床評估",
          "details": "評估開口程度、咀嚼肌體積和對稱性",
          "findings": [
            "開口受限",
            "肌肉腫脹或萎縮",
            "觸診疼痛"
          ]
        },
        {
          "step": 2,
          "action": "2M抗體檢測",
          "details": "血清送檢2M纖維抗體免疫螢光試驗",
          "findings": [
            "陽性（確診）",
            "陰性（考慮其他鑑別診斷或已用類固醇）"
          ]
        },
        {
          "step": 3,
          "action": "輔助檢查",
          "details": "CBC、CK、必要時肌肉活檢",
          "findings": [
            "CK升高",
            "嗜酸性球增多",
            "活檢見肌纖維壞死和炎症浸潤"
          ]
        },
        {
          "step": 4,
          "action": "免疫抑制治療",
          "details": "開始免疫抑制劑量prednisone並追蹤反應",
          "findings": [
            "4週內改善",
            "無改善需重新評估診斷"
          ]
        }
      ]
    },
    "monitoring": [
      "每2-4週評估開口角度改善",
      "定期CK監測（反映肌肉損傷程度）",
      "類固醇副作用監測（PU/PD、肝指數）",
      "減藥期間密切觀察復發徵象"
    ],
    "reference": "Melmed C et al. MMM: Pathogenesis, diagnosis, and treatment. Compend Contin Educ Vet. 2004;26(8):590; Pitcher GDC, Hahn CN. J Vet Intern Med. 2007;21(4):776."
  },
  "territorial-aggression": {
    "zh": "領域性攻擊行為",
    "en": "Territorial Aggression",
    "definition": "犬貓針對入侵其感知領域的陌生人或動物展現的攻擊行為，常見於犬保護家園、庭院或特定空間。行為動機多基於恐懼或學習強化，在護衛犬種中尤為明顯。需與其他類型攻擊（資源保護、恐懼性、疼痛性）區別診斷。",
    "synonyms": [
      "地盤攻擊",
      "領地攻擊行為",
      "Territorial Defense Aggression"
    ],
    "epidemiology": {
      "species": "犬為主，貓亦可見",
      "age": "社會成熟期後（犬1-3歲）逐漸明顯",
      "sex": "未絕育公犬較常見",
      "riskFactors": [
        "護衛犬種（德國牧羊犬、羅威納、杜賓）",
        "缺乏社會化",
        "過去成功驅趕入侵者的學習經驗",
        "未絕育"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "對進入家中或庭院的陌生人吠叫/撲咬",
        "在自家領域外不表現攻擊",
        "郵差/送貨員為常見目標",
        "隨年齡加劇"
      ],
      "physicalExam": [
        "體格檢查通常正常",
        "可能見到焦慮相關行為（尾巴低垂、耳朵後貼）",
        "激動狀態下瞳孔放大、豎毛",
        "需排除疼痛相關攻擊"
      ]
    },
    "pathophysiology": "領域性攻擊的神經行為基礎涉及杏仁核和下視丘的恐懼-攻擊迴路。犬感知陌生者進入其領域時，觸發戰鬥或逃跑反應。在家園環境中逃跑不是優先選項，攻擊行為被啟動。當入侵者離開（如郵差完成遞送），犬感知為攻擊成功驅趕了威脅，形成操作制約學習，強化攻擊行為。護衛犬種經過選育具有較低的攻擊閾值和較強的領域防衛本能。未絕育公犬受睪固酮影響，攻擊閾值進一步降低。",
    "diagnosis": {
      "overview": "行為評估為主，排除醫學原因後根據攻擊情境和模式確診",
      "differentials": [
        "恐懼性攻擊",
        "資源保護性攻擊",
        "疼痛相關攻擊",
        "甲狀腺功能低下相關行為改變",
        "腦部疾病"
      ],
      "initialDB": [
        "詳細行為史問卷",
        "完整體格檢查",
        "CBC和生化（排除代謝疾病）",
        "甲狀腺功能檢查"
      ],
      "advanced": [
        "行為專科醫師評估",
        "影像學檢查（排除腦部病變）",
        "尿液皮質醇/肌酐比值"
      ]
    },
    "treatment": {
      "overview": "環境管理、行為修正和必要時藥物治療的多模式方案",
      "acute": [
        "環境管理（訪客來時安全隔離犬隻）",
        "阻止視覺刺激（遮蔽窗戶和圍欄）",
        "口罩訓練（緊急管理）"
      ],
      "chronic": [
        "減敏感和反制約訓練",
        "Fluoxetine 1-2mg/kg PO q24h",
        "Clomipramine 1-3mg/kg PO q12h",
        "定期行為諮詢和進度追蹤"
      ]
    },
    "prognosis": "在護衛犬種中無法完全消除領域性攻擊本能，但透過長期行為修正和環境管理可顯著降低攻擊頻率和強度。預後與飼主配合度高度相關。早期社會化和訓練介入效果較好。嚴重病例可能需要永久性環境管理。",
    "pearls": [
      "領域性攻擊在中性場所不會表現，此特徵是鑑別診斷的關鍵",
      "絕育可降低但無法消除領域性攻擊",
      "行為修正前必須排除甲狀腺功能低下等醫學原因"
    ],
    "diagnosticAlgorithm": {
      "title": "領域性攻擊行為 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "行為史評估",
          "details": "確認攻擊僅發生在自家領域且目標為陌生者",
          "findings": [
            "領域限定攻擊",
            "陌生者為目標",
            "中性場所不攻擊"
          ]
        },
        {
          "step": 2,
          "action": "醫學排除",
          "details": "血液學、甲狀腺功能排除醫學原因",
          "findings": [
            "醫學檢查正常",
            "甲狀腺低下",
            "疼痛來源"
          ]
        },
        {
          "step": 3,
          "action": "攻擊類型分類",
          "details": "區別領域性、恐懼性、資源保護性攻擊",
          "findings": [
            "純領域性",
            "混合型",
            "需重新分類"
          ]
        },
        {
          "step": 4,
          "action": "治療計畫",
          "details": "制定環境管理+行為修正+藥物方案",
          "findings": [
            "輕度（環境管理即可）",
            "中度（加藥物）",
            "嚴重（轉診行為專科）"
          ]
        }
      ]
    },
    "monitoring": [
      "每月行為進度評估",
      "攻擊事件頻率記錄",
      "藥物療效和副作用追蹤",
      "飼主遵從度評估"
    ],
    "reference": "Overall KL. Manual of Clinical Behavioral Medicine for Dogs and Cats. Elsevier 2013; AAHA Canine and Feline Behavior Management Guidelines 2015."
  },
  "fear-based-aggression": {
    "zh": "恐懼性攻擊行為",
    "en": "Fear-Based Aggression",
    "definition": "犬貓因恐懼、焦慮或感受威脅而表現的防禦性攻擊行為，是最常見的攻擊類型。動物感知無法逃脫時以攻擊作為自我保護手段，常見於社會化不足、曾有創傷經歷或遺傳性焦慮體質的個體。與領域性攻擊不同，可在任何環境中發生。",
    "synonyms": [
      "恐懼攻擊",
      "防禦性攻擊",
      "Fear Aggression",
      "Defensive Aggression"
    ],
    "epidemiology": {
      "species": "犬貓皆常見",
      "age": "社會化敏感期後可開始表現（犬3-6月齡後）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "社會化不足",
        "曾遭受虐待或創傷",
        "遺傳性焦慮體質",
        "早期與母犬分離",
        "收容所動物"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "面對陌生人或動物時退縮/躲藏後攻擊",
        "獸醫就診時攻擊行為",
        "被逼入角落時咬人",
        "攻擊後快速退縮"
      ],
      "physicalExam": [
        "恐懼體姿（身體壓低、尾巴夾緊、耳朵後貼）",
        "瞳孔放大",
        "喘氣、流涎",
        "觸診時可能有攻擊反應",
        "體格檢查通常正常"
      ]
    },
    "pathophysiology": "恐懼性攻擊是「戰鬥或逃跑」反應中的戰鬥成分。當動物感知威脅且逃跑路線被阻斷時，杏仁核激活交感神經系統，腎上腺釋放兒茶酚胺引起全身性壓力反應。前額葉皮質對恐懼反應的調節不足（社會化不足或遺傳因素）導致恐懼閾值降低。反覆的恐懼經歷可導致杏仁核致敏化，使動物對越來越輕微的刺激產生恐懼攻擊反應。如果攻擊成功使威脅退縮，負增強進一步鞏固攻擊行為。",
    "diagnosis": {
      "overview": "行為評估為主，特別注意攻擊前的恐懼訊號和身體語言",
      "differentials": [
        "領域性攻擊",
        "疼痛相關攻擊",
        "資源保護性攻擊",
        "重導向攻擊",
        "醫學原因（甲狀腺功能低下、神經系統疾病）"
      ],
      "initialDB": [
        "詳細行為史和攻擊觸發因子分析",
        "完整體格檢查（排除疼痛）",
        "CBC/生化",
        "甲狀腺功能"
      ],
      "advanced": [
        "行為專科醫師評估",
        "行為影片分析",
        "焦慮量表評估",
        "必要時影像學（排除神經疾病）"
      ]
    },
    "treatment": {
      "overview": "多模式治療：環境管理+減敏感/反制約+抗焦慮藥物",
      "acute": [
        "避免觸發情境",
        "安全管理（口罩、牽繩、隔離）",
        "Fear Free獸醫就診策略",
        "短效抗焦慮藥（trazodone 3-5mg/kg PO事前給予）"
      ],
      "chronic": [
        "系統性減敏感和反制約訓練",
        "Fluoxetine 1-2mg/kg PO q24h",
        "Gabapentin 5-10mg/kg PO q8-12h（貓）",
        "環境豐富化和正向強化訓練"
      ]
    },
    "prognosis": "透過長期行為修正和藥物治療，多數病例可顯著改善。完全消除恐懼性攻擊在嚴重病例中不太可能，但可降低至可管理水平。預後與飼主教育程度和配合度、攻擊嚴重度、觸發因子的可控性密切相關。幼年開始介入效果優於成年。",
    "pearls": [
      "恐懼性攻擊是最常見的犬攻擊類型，而非「支配性」攻擊",
      "攻擊前的恐懼訊號（舔唇、轉頭、鯨魚眼）是早期辨識的關鍵",
      "懲罰會加劇恐懼性攻擊，絕不應使用厭惡訓練方法"
    ],
    "diagnosticAlgorithm": {
      "title": "恐懼性攻擊行為 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "行為評估",
          "details": "分析攻擊情境、前驅訊號和身體語言",
          "findings": [
            "恐懼體姿先於攻擊",
            "逃脫受阻時攻擊",
            "攻擊後退縮"
          ]
        },
        {
          "step": 2,
          "action": "醫學排除",
          "details": "排除疼痛、內分泌和神經系統疾病",
          "findings": [
            "醫學正常",
            "疼痛來源",
            "甲狀腺異常"
          ]
        },
        {
          "step": 3,
          "action": "觸發因子分析",
          "details": "詳細記錄所有觸發情境和閾值",
          "findings": [
            "特定觸發因子",
            "廣泛性恐懼",
            "情境限定"
          ]
        },
        {
          "step": 4,
          "action": "多模式治療",
          "details": "制定管理+行為修正+藥物的個別化方案",
          "findings": [
            "行為修正為主",
            "需加藥物",
            "轉診專科"
          ]
        }
      ]
    },
    "monitoring": [
      "每2-4週行為進度追蹤",
      "攻擊事件記錄（頻率、強度、觸發因子）",
      "藥物副作用監測",
      "飼主安全教育持續評估"
    ],
    "reference": "Overall KL. Manual of Clinical Behavioral Medicine. Elsevier 2013; Horwitz DF, Mills DS. BSAVA Manual of Canine and Feline Behavioural Medicine 2nd ed. 2009."
  },
  "pica-coprophagia": {
    "zh": "異食癖/食糞症",
    "en": "Pica and Coprophagia",
    "definition": "異食癖（Pica）為攝食非食物物質的行為異常，食糞症（Coprophagia）為攝食糞便的行為。可為行為性（無聊、焦慮、學習行為）或醫學性（營養不良、消化吸收障礙、內分泌疾病）。母犬食用幼犬糞便屬正常哺育行為，非病理性。",
    "synonyms": [
      "異嗜症",
      "食糞行為",
      "Allotriophagia"
    ],
    "epidemiology": {
      "species": "犬較常見（食糞），貓偶見（異食毛線/塑膠）",
      "age": "幼犬較常見食糞，任何年齡可發生異食癖",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "環境刺激不足和無聊",
        "分離焦慮",
        "消化吸收不良（EPI）",
        "藥物誘發多食（類固醇、苯巴比妥）",
        "甲狀腺功能低下或糖尿病"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "食用石頭、襪子、塑膠等非食物",
        "食用自己或其他動物糞便",
        "反覆異物阻塞史",
        "可能合併嘔吐或腹瀉"
      ],
      "physicalExam": [
        "體格檢查可能正常",
        "營養不良徵象（消瘦、毛髮粗糙）",
        "腹部觸診（異物）",
        "口腔異物碎片"
      ]
    },
    "pathophysiology": "行為性異食癖可能源於環境刺激不足（無聊）、焦慮相關的自我安撫行為、或幼年期學習經驗。食糞症在母犬哺育期為正常行為（維持巢穴衛生），幼犬可能模仿學習。醫學性異食癖可因消化吸收不良（EPI、IBD）導致營養不足而驅動攝食行為，或因內分泌疾病（甲狀腺功能低下、糖尿病、庫欣氏症）引起多食。藥物（糖皮質素、苯巴比妥、苯二氮平類）可誘發多食和異食行為。腸道寄生蟲導致的營養競爭也可能是原因之一。",
    "diagnosis": {
      "overview": "排除醫學原因後進行行為診斷",
      "differentials": [
        "胰臟外分泌功能不足（EPI）",
        "炎症性腸病",
        "腸道寄生蟲",
        "甲狀腺功能低下",
        "庫欣氏症",
        "糖尿病",
        "強迫行為障礙"
      ],
      "initialDB": [
        "詳細飲食和行為史",
        "CBC/生化/甲狀腺功能",
        "糞便浮游法（寄生蟲）",
        "TLI（胰臟功能）"
      ],
      "advanced": [
        "腹部影像學（排除異物阻塞）",
        "食物排除試驗",
        "皮質醇測試（排除庫欣氏症）",
        "行為專科評估"
      ]
    },
    "treatment": {
      "overview": "治療基礎疾病+環境管理+行為修正",
      "acute": [
        "異物阻塞時緊急手術",
        "驅蟲治療（如糞檢陽性）",
        "環境管理（移除可食用非食物物質）"
      ],
      "chronic": [
        "治療基礎疾病（EPI補充酵素、內分泌疾病控制）",
        "增加環境豐富化和運動量",
        "Leave it指令訓練",
        "食糞：食物添加劑（減少糞便吸引力）或直接清理糞便"
      ]
    },
    "prognosis": "醫學原因導致的異食癖在治療基礎疾病後通常可改善。行為性食糞症在幼犬多為自限性，成犬期自然減少。行為性異食癖預後視飼主管理能力和環境因素而定，完全消除可能困難但可透過環境管理有效控制。反覆異物攝食者有腸阻塞和手術風險。",
    "pearls": [
      "異食癖必須先排除醫學原因（EPI、內分泌疾病、寄生蟲）再做行為診斷",
      "母犬食用幼犬糞便是正常哺育行為，無需治療",
      "貓的毛線/線狀異物攝食極為危險，可導致線狀異物腸阻塞"
    ],
    "diagnosticAlgorithm": {
      "title": "異食癖/食糞症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "病史評估",
          "details": "確認攝食物質類型、頻率和環境因素",
          "findings": [
            "食糞",
            "非食物物質",
            "特定物質偏好"
          ]
        },
        {
          "step": 2,
          "action": "醫學排除",
          "details": "血液學、糞檢、TLI排除醫學原因",
          "findings": [
            "EPI",
            "寄生蟲",
            "內分泌疾病",
            "醫學正常"
          ]
        },
        {
          "step": 3,
          "action": "行為評估",
          "details": "評估環境豐富度、焦慮程度和學習史",
          "findings": [
            "無聊相關",
            "焦慮相關",
            "學習行為"
          ]
        },
        {
          "step": 4,
          "action": "綜合治療",
          "details": "治療基礎疾病+環境管理+行為修正",
          "findings": [
            "醫學治療有效",
            "需行為修正",
            "需環境改善"
          ]
        }
      ]
    },
    "monitoring": [
      "治療後追蹤異食行為頻率",
      "基礎疾病控制指標",
      "腹部影像（異物攝食者）",
      "體重和營養狀態評估"
    ],
    "reference": "Horwitz DF, Mills DS. BSAVA Manual of Canine and Feline Behavioural Medicine 2nd ed. 2009; VCA: Dog Behavior Problems - Coprophagia."
  },
  "psychogenic-alopecia": {
    "zh": "心因性脫毛症",
    "en": "Psychogenic Alopecia",
    "definition": "貓因心理壓力或焦慮導致的過度理毛行為，造成毛髮脫落或稀薄的行為異常。為排除性診斷，研究顯示送診為心因性脫毛的貓中僅約10%為純粹行為性，76%有潛在醫學原因（食物過敏、特應性皮炎、跳蚤過敏等），因此必須先徹底排除所有皮膚科和全身性疾病。",
    "synonyms": [
      "過度理毛症",
      "壓力性脫毛",
      "Feline Psychogenic Overgrooming",
      "Barbering"
    ],
    "epidemiology": {
      "species": "貓（犬極罕見）",
      "age": "任何年齡",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "多貓家庭衝突",
        "環境變化（搬家、新成員）",
        "室內飼養且環境豐富度不足",
        "暹羅和東方短毛等品種可能較多",
        "分離焦慮"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "腹部或大腿內側毛髮稀疏",
        "飼主可能目睹或未目睹過度理毛",
        "毛髮易拔除",
        "家庭環境壓力因子"
      ],
      "physicalExam": [
        "對稱性脫毛（腹部、大腿內側、前肢）",
        "斷裂毛髮（非完全脫落）",
        "皮膚通常無發炎",
        "拔毛試驗（trichogram）見斷裂毛尖",
        "可能有隱蔽性理毛（飼主不在時）"
      ]
    },
    "pathophysiology": "過度理毛被認為是壓力相關的轉位行為（displacement behavior），正常理毛行為在焦慮刺激下被過度執行。貓每天花約50%清醒時間理毛，壓力可增加理毛頻率和強度。神經化學層面涉及血清素系統失調，慢性壓力導致下視丘-垂體-腎上腺軸（HPA axis）持續激活。然而，最新研究顯示大多數過度理毛貓存在隱蔽性搔癢症（occult pruritus），食物過敏是最常見的醫學原因，其次為特應性皮炎、跳蚤過敏和蠕形蟎感染。純粹行為性的心因性脫毛在徹底排除後僅佔約10%。",
    "diagnosis": {
      "overview": "排除性診斷——必須先系統性排除所有引起搔癢和脫毛的醫學原因",
      "differentials": [
        "食物不良反應（最常見醫學原因）",
        "特應性皮炎",
        "跳蚤過敏性皮炎",
        "蠕形蟎感染",
        "皮黴菌感染",
        "甲狀腺功能亢進"
      ],
      "initialDB": [
        "皮膚刮片和毛髮顯微鏡",
        "黴菌培養",
        "嚴格跳蚤控制試驗（8週）",
        "CBC/生化/甲狀腺功能"
      ],
      "advanced": [
        "食物排除試驗（新蛋白質飲食8-12週）",
        "皮膚活檢",
        "過敏原特異性IgE檢測",
        "行為專科轉診"
      ]
    },
    "treatment": {
      "overview": "治療潛在醫學原因+環境壓力管理+必要時行為藥物",
      "acute": [
        "治療已確認的皮膚疾病",
        "嚴格跳蚤控制",
        "伊莉莎白圈（嚴重自傷時暫時使用）"
      ],
      "chronic": [
        "環境豐富化（垂直空間、隱蔽處、互動玩具）",
        "費洛蒙擴散器（Feliway®）",
        "Fluoxetine 0.5-1mg/kg PO q24h",
        "Clomipramine 0.5mg/kg PO q24h",
        "減少多貓衝突和環境壓力"
      ]
    },
    "prognosis": "有醫學原因者治療後預後良好（76%可確認醫學原因）。純粹行為性的心因性脫毛透過環境修正和藥物治療可改善但可能反覆。能識別並去除壓力源的病例預後最佳。長期環境豐富化和壓力管理是維持緩解的關鍵。",
    "pearls": [
      "76%被懷疑為心因性脫毛的貓實際上有醫學原因——必須徹底排除",
      "食物過敏是最常見的隱蔽性搔癢原因，排除試驗需至少8週",
      "貓可能只在飼主不在時過度理毛（隱蔽性理毛），監視攝影機可協助診斷"
    ],
    "diagnosticAlgorithm": {
      "title": "心因性脫毛症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "皮膚學檢查",
          "details": "皮膚刮片、毛髮鏡檢、黴菌培養",
          "findings": [
            "蟎蟲",
            "黴菌感染",
            "正常"
          ]
        },
        {
          "step": 2,
          "action": "跳蚤和食物排除",
          "details": "8週嚴格跳蚤控制+8-12週食物排除試驗",
          "findings": [
            "跳蚤過敏確認",
            "食物過敏確認",
            "無改善"
          ]
        },
        {
          "step": 3,
          "action": "全身性排除",
          "details": "甲狀腺功能、皮膚活檢、過敏檢測",
          "findings": [
            "甲狀腺亢進",
            "特應性皮炎",
            "無醫學原因"
          ]
        },
        {
          "step": 4,
          "action": "行為性診斷",
          "details": "確認壓力源並開始環境修正和藥物治療",
          "findings": [
            "環境壓力確認",
            "需行為藥物",
            "多因子"
          ]
        }
      ]
    },
    "monitoring": [
      "脫毛範圍和毛髮再生追蹤",
      "食物排除試驗遵從度確認",
      "行為藥物副作用監測",
      "家庭環境壓力源持續評估"
    ],
    "reference": "Waisglass SE et al. Underlying medical conditions in cats with presumptive psychogenic alopecia. JAVMA. 2006;228(11):1705-1709; Horwitz DF. BSAVA Manual of Canine and Feline Behavioural Medicine 2nd ed."
  },
  "nasal-tumor": {
    "zh": "鼻腔腫瘤",
    "en": "Nasal Tumor",
    "definition": "發生於鼻腔和副鼻竇的原發性腫瘤，佔犬所有腫瘤約2%。犬以上皮性腫瘤（腺癌、鱗狀細胞癌）最常見，貓以淋巴瘤最常見。鼻腔腫瘤具有局部侵犯性強的特點，可破壞鼻甲骨、篩板和鄰近結構，但遠端轉移率相對較低。",
    "synonyms": [
      "鼻腫瘤",
      "鼻腔癌",
      "Nasal Neoplasia",
      "Sinonasal Tumor"
    ],
    "epidemiology": {
      "species": "犬貓皆可",
      "age": "中老年（犬平均10歲，貓平均9-10歲）",
      "sex": "公犬略多",
      "riskFactors": [
        "長鼻犬種（柯利犬、牧羊犬、大丹犬）",
        "都市環境（空氣污染）",
        "二手煙暴露",
        "老年動物"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "慢性單側鼻分泌物（後期變雙側）",
        "鼻出血",
        "打噴嚏增加",
        "顏面變形",
        "呼吸困難"
      ],
      "physicalExam": [
        "單側或雙側鼻分泌物（黏液膿性至血性）",
        "顏面不對稱或腫脹",
        "眼球突出（腫瘤延伸至眼眶）",
        "氣流不對稱",
        "局部淋巴結腫大"
      ]
    },
    "pathophysiology": "鼻腔腫瘤起源於鼻腔和副鼻竇內的各種組織。犬最常見的是腺癌（起源於鼻腔腺體上皮），其次為鱗狀細胞癌和軟組織肉瘤。貓最常見的是淋巴瘤。腫瘤在鼻腔內生長破壞鼻甲骨結構，堵塞氣道並侵蝕周圍組織。進展期可穿過篩板進入顱腔（腦部侵犯）或破壞硬腭進入口腔。長鼻犬種可能因鼻腔表面積大、空氣過濾面積廣而增加致癌物質暴露。確診時通常腫瘤已有顯著局部侵犯。",
    "diagnosis": {
      "overview": "CT為首選影像學，鼻鏡引導活檢確認組織學類型",
      "differentials": [
        "慢性鼻炎（原發性或繼發性）",
        "黴菌性鼻炎（麴菌病）",
        "鼻腔異物",
        "牙科疾病",
        "凝血障礙"
      ],
      "initialDB": [
        "頭部放射線（初步評估，靈敏度有限）",
        "胸腔放射線（排除肺轉移）",
        "基本血液學和凝血功能",
        "鼻腔分泌物細胞學"
      ],
      "advanced": [
        "頭部CT/MRI（評估腫瘤範圍和骨骼破壞）",
        "鼻鏡檢查和活檢",
        "局部淋巴結FNA",
        "腹部超音波（分期）"
      ]
    },
    "treatment": {
      "overview": "放射治療為主要治療方式，可合併手術和/或化療",
      "acute": [
        "止鼻血（局部血管收縮劑、紗條填塞）",
        "抗生素治療繼發性細菌感染",
        "止痛（NSAIDs + gabapentin）"
      ],
      "chronic": [
        "放射治療（每日分次照射，3-4週療程）",
        "姑息性放射治療（較少次數，緩解症狀）",
        "化療（carboplatin、mitoxantrone）",
        "貓鼻腔淋巴瘤：化療反應良好（CHOP方案）"
      ]
    },
    "prognosis": "犬鼻腔腫瘤未治療中位生存期約3-5個月。放射治療後中位生存期延長至6-18個月。手術+放療+化療的多模式治療可進一步改善。貓鼻腔淋巴瘤對化療和放療反應較好，中位生存期可達12-24個月。早期診斷和治療可顯著改善預後。",
    "pearls": [
      "慢性單側鼻分泌物在老年長鼻犬種應高度懷疑鼻腔腫瘤",
      "CT比傳統放射線能更準確評估腫瘤範圍和篩板完整性",
      "貓鼻腔淋巴瘤對化療反應良好，預後比犬鼻腔癌症好"
    ],
    "diagnosticAlgorithm": {
      "title": "鼻腔腫瘤 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "臨床評估",
          "details": "評估鼻分泌物特性、持續時間和顏面對稱性",
          "findings": [
            "單側鼻分泌物",
            "鼻出血",
            "顏面變形"
          ]
        },
        {
          "step": 2,
          "action": "影像學檢查",
          "details": "CT評估腫瘤範圍、骨骼破壞和顱內延伸",
          "findings": [
            "鼻甲骨破壞",
            "篩板侵犯",
            "眼眶延伸"
          ]
        },
        {
          "step": 3,
          "action": "組織診斷",
          "details": "鼻鏡引導活檢取得病理診斷",
          "findings": [
            "腺癌",
            "SCC",
            "淋巴瘤（貓）"
          ]
        },
        {
          "step": 4,
          "action": "分期和治療",
          "details": "胸部X光分期後選擇放療/化療方案",
          "findings": [
            "局部腫瘤",
            "區域轉移",
            "遠端轉移"
          ]
        }
      ]
    },
    "monitoring": [
      "治療後每2-3個月CT追蹤",
      "鼻分泌物和呼吸狀態監測",
      "胸腔X光定期檢查轉移",
      "放療副作用管理（皮膚炎、角膜炎）"
    ],
    "reference": "Merck Veterinary Manual: Neoplasia of the Respiratory System; Withrow SJ, Vail DM. Small Animal Clinical Oncology 6th ed. Elsevier 2020."
  },
  "brain-tumor": {
    "zh": "腦腫瘤",
    "en": "Brain Tumor",
    "definition": "發生於顱內的原發性或轉移性腫瘤。犬約90%的原發性腦腫瘤為腦膜瘤（50%）、膠質瘤（35%）和脈絡叢腫瘤（7%）。貓以腦膜瘤最常見。臨床表現取決於腫瘤位置，癲癇發作是最常見的首發症狀。MRI為確診首選影像工具。",
    "synonyms": [
      "顱內腫瘤",
      "腦癌",
      "Intracranial Neoplasia",
      "Brain Cancer"
    ],
    "epidemiology": {
      "species": "犬貓皆可",
      "age": "中老年（犬平均9歲，貓平均11歲）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "老年動物",
        "短頭種犬較易發膠質瘤（拳師、波士頓梗、法國鬥牛犬）",
        "長頭種犬較易發腦膜瘤（金毛、德牧）",
        "貓以腦膜瘤為主"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "新發癲癇發作（最常見首發症狀）",
        "行為改變（遲鈍、迷失方向）",
        "步態不穩",
        "視力改變",
        "頭部歪斜或繞圈"
      ],
      "physicalExam": [
        "神經學缺損（依腫瘤位置而異）",
        "前腦腫瘤：意識改變、繞圈、視力缺損",
        "後腦腫瘤：共濟失調、頭部歪斜、眼球震顫",
        "腦幹腫瘤：顱神經缺損、意識障礙",
        "視乳頭水腫"
      ]
    },
    "pathophysiology": "原發性腦腫瘤起源於顱內各種組織。腦膜瘤起源於蛛網膜帽細胞，多為良性但占位效應明顯，壓迫周圍腦實質。膠質瘤（星狀細胞瘤、寡突膠質細胞瘤）起源於神經膠質細胞，浸潤性生長，難以手術完整切除。脈絡叢腫瘤起源於腦室脈絡叢上皮，可阻礙腦脊液循環導致腦水腫。腫瘤的佔位效應、周圍水腫和腦脊液循環障礙共同增加顱內壓，導致神經功能障礙。癲癇發作是前腦腫瘤最常見的臨床表現，因腫瘤周圍皮質神經元興奮性異常增加。",
    "diagnosis": {
      "overview": "MRI為確診首選，組織學確認需手術取樣或立體定位活檢",
      "differentials": [
        "腦炎（感染性或免疫介導性）",
        "腦血管意外（中風）",
        "特發性癲癇",
        "代謝性腦病",
        "頭部外傷"
      ],
      "initialDB": [
        "完整神經學檢查",
        "CBC/生化/電解質",
        "胸腔X光（排除轉移性腫瘤原發灶）",
        "眼底檢查（視乳頭水腫）"
      ],
      "advanced": [
        "腦部MRI（含增強掃描）",
        "腦脊液分析（MRI正常時）",
        "CT（替代方案，MRI不可用時）",
        "腦部活檢（手術或立體定位）"
      ]
    },
    "treatment": {
      "overview": "手術、放射治療和姑息治療為主要選擇，依腫瘤類型和位置而定",
      "acute": [
        "抗癲癇治療（levetiracetam 20mg/kg PO/IV q8h）",
        "降低顱內壓（mannitol 0.5-1g/kg IV over 20min）",
        "類固醇減輕腫瘤周圍水腫（dexamethasone 0.25-0.5mg/kg IV q12h）"
      ],
      "chronic": [
        "腦膜瘤：手術切除（貓預後較犬好）",
        "放射治療（手術+放療中位生存11-28個月）",
        "化療（lomustine、hydroxyurea用於膠質瘤）",
        "姑息治療（類固醇+抗癲癇藥控制症狀）"
      ]
    },
    "prognosis": "預後依腫瘤類型和治療方式差異大。犬腦膜瘤手術+放療中位生存期11-28個月；單純放療11.5-19個月。貓腦膜瘤因多為表淺型可完整切除，術後生存期可超過3年。膠質瘤因浸潤性生長難以完整切除，預後較差。姑息治療（僅類固醇+抗癲癇）中位生存期約2-4個月。未治療將因顱內壓升高和神經功能惡化而死亡。",
    "pearls": [
      "老年犬新發癲癇的首要鑑別診斷是腦腫瘤",
      "貓腦膜瘤通常為表淺型，手術完整切除預後明顯優於犬",
      "短頭種犬（拳師、波士頓梗）是膠質瘤的高風險品種"
    ],
    "diagnosticAlgorithm": {
      "title": "腦腫瘤 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "神經學評估",
          "details": "完整神經學檢查定位病灶",
          "findings": [
            "前腦徵象",
            "後腦徵象",
            "腦幹徵象",
            "多灶性"
          ]
        },
        {
          "step": 2,
          "action": "基礎檢查",
          "details": "血液學排除代謝性原因和系統性疾病",
          "findings": [
            "代謝正常",
            "電解質異常",
            "原發腫瘤證據"
          ]
        },
        {
          "step": 3,
          "action": "腦部MRI",
          "details": "增強MRI確認腫瘤存在、位置和特徵",
          "findings": [
            "腦膜瘤（均勻增強）",
            "膠質瘤（環狀增強）",
            "轉移性腫瘤（多灶性）"
          ]
        },
        {
          "step": 4,
          "action": "治療決策",
          "details": "根據腫瘤類型、位置和患者狀態選擇治療方案",
          "findings": [
            "手術候選",
            "放療候選",
            "姑息治療"
          ]
        }
      ]
    },
    "monitoring": [
      "抗癲癇藥物血清濃度",
      "每3-6個月MRI追蹤",
      "神經功能評分定期評估",
      "類固醇副作用監測"
    ],
    "reference": "Snyder JM et al. Canine intracranial primary neoplasia. Front Oncol. 2019;9:1151; VSSO: Brain Tumors - Canine; VSSO: Brain Tumors - Feline."
  },
  "perianal-adenoma": {
    "zh": "肛周腺瘤",
    "en": "Perianal Adenoma",
    "definition": "犬肛周皮脂腺（肝樣腺）的良性腫瘤，是犬第三常見的皮膚腫瘤。具有明確的雄性激素（睪固酮）依賴性，幾乎僅見於未絕育公犬。腫瘤通常發生在肛門周圍，但肝樣腺分布的任何位置（尾根、包皮、後肢內側）皆可發生。",
    "synonyms": [
      "肛門周圍腺瘤",
      "肝樣腺瘤",
      "Hepatoid Gland Adenoma",
      "Circumanal Gland Tumor"
    ],
    "epidemiology": {
      "species": "犬",
      "age": "中老年犬（平均10歲）",
      "sex": "95%為未絕育公犬",
      "riskFactors": [
        "未絕育公犬（雄性激素依賴）",
        "中老年",
        "西伯利亞哈士奇、可卡犬、英國鬥牛犬可能較多"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "肛門周圍腫塊",
        "排便時可能出血",
        "過度舔舐肛門區域",
        "通常無全身症狀"
      ],
      "physicalExam": [
        "肛門周圍1個或多個圓形、堅硬、皮下腫塊",
        "表面可能潰瘍和出血",
        "多為無痛性",
        "腫瘤生長緩慢",
        "可能在尾根、包皮、後肢內側發現"
      ]
    },
    "pathophysiology": "肛周腺（又稱肝樣腺，因細胞形態類似肝細胞而得名）分布於肛門周圍皮膚，受雄性激素促進生長和雌性激素抑制生長。未絕育公犬的睪固酮持續刺激肝樣腺細胞增殖，導致良性腺瘤形成。這解釋了為何95%發生於未絕育公犬，絕育後因雄性激素急劇降低，腫瘤可明顯縮小甚至消退。約10%的肛周腺腫瘤為惡性（肛周腺癌），不具雄性激素依賴性，可發生於任何性別且預後較差。鑑別良惡性需要組織病理學。",
    "diagnosis": {
      "overview": "臨床特徵高度提示，FNA和組織學確認良惡性",
      "differentials": [
        "肛周腺癌（惡性）",
        "肛囊腺癌",
        "肥大細胞瘤",
        "皮脂腺瘤",
        "黑色素瘤"
      ],
      "initialDB": [
        "體格檢查和直腸指診",
        "FNA細胞學",
        "完整血液學和生化"
      ],
      "advanced": [
        "切除式組織活檢和病理組織學",
        "腹部超音波（惡性轉移排除）",
        "腰下淋巴結評估",
        "睪丸超音波（排除睪丸腫瘤）"
      ]
    },
    "treatment": {
      "overview": "絕育是良性肛周腺瘤的首選和最有效治療",
      "acute": [
        "絕育手術（可使腫瘤縮小50-95%）",
        "大型或潰瘍性腫瘤同時手術切除",
        "術後止痛和傷口照護"
      ],
      "chronic": [
        "單純絕育後追蹤腫瘤縮小情形",
        "殘留腫瘤可考慮冷凍手術或放射治療",
        "惡性肛周腺癌：廣泛切除+化療",
        "定期肛門區域觸診追蹤"
      ]
    },
    "prognosis": "良性肛周腺瘤絕育後預後極佳，大多數在數週至數月內顯著縮小。術後復發率低。惡性肛周腺癌預後較差，局部復發率高且可轉移至腰下淋巴結和內臟器官。組織學確認良惡性是決定預後的關鍵。",
    "pearls": [
      "95%發生於未絕育公犬——絕育是最有效的治療和預防方式",
      "絕育後良性腫瘤通常在數週內開始縮小",
      "母犬或已絕育公犬出現的肛周腫塊應高度懷疑惡性腺癌"
    ],
    "diagnosticAlgorithm": {
      "title": "肛周腺瘤 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "臨床評估",
          "details": "確認腫塊位置、大小和患犬絕育狀態",
          "findings": [
            "未絕育公犬（典型）",
            "已絕育犬（懷疑惡性）",
            "母犬（懷疑惡性）"
          ]
        },
        {
          "step": 2,
          "action": "細胞學評估",
          "details": "FNA區分腺瘤和其他腫瘤",
          "findings": [
            "肝樣腺細胞（良性特徵）",
            "異型性增加（懷疑惡性）",
            "其他腫瘤類型"
          ]
        },
        {
          "step": 3,
          "action": "分期檢查",
          "details": "懷疑惡性時進行分期",
          "findings": [
            "局部腫瘤",
            "淋巴結轉移",
            "遠端轉移"
          ]
        },
        {
          "step": 4,
          "action": "治療決策",
          "details": "良性→絕育；惡性→廣泛切除",
          "findings": [
            "絕育+觀察",
            "手術切除",
            "多模式治療"
          ]
        }
      ]
    },
    "monitoring": [
      "絕育後每月評估腫瘤大小變化",
      "3-6個月後確認腫瘤完全消退",
      "定期肛門區域觸診追蹤復發",
      "惡性病例每3個月影像學追蹤"
    ],
    "reference": "Withrow SJ, Vail DM. Small Animal Clinical Oncology 6th ed. Elsevier 2020; Turek MM, Withrow SJ. Perianal tumors. In: Withrow & MacEwen's."
  },
  "injection-site-sarcoma": {
    "zh": "注射部位肉瘤",
    "en": "Injection-Site Sarcoma",
    "definition": "貓在注射部位（主要為疫苗）發生的高度局部侵犯性間葉組織惡性腫瘤，以纖維肉瘤最常見。發生率約每1000-10000次注射1例，發生時間可在注射後4週至10年。肌肉筋膜下層深處生長，局部復發率高，約25%可發生遠端轉移。",
    "synonyms": [
      "疫苗相關肉瘤",
      "貓注射部位纖維肉瘤",
      "FISS",
      "Vaccine-Associated Sarcoma",
      "Feline Injection-Site Sarcoma"
    ],
    "epidemiology": {
      "species": "貓（犬極罕見）",
      "age": "任何年齡，中位數8-10歲",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "FeLV和狂犬病疫苗（含佐劑疫苗風險較高）",
        "長效注射藥物（抗生素、糖皮質素）",
        "微晶片植入",
        "非吸收性縫線",
        "同一部位反覆注射"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "注射部位進行性增大的腫塊",
        "腫塊可能快速生長",
        "初期無痛，後期可能出現不適",
        "注射後數月至數年出現"
      ],
      "physicalExam": [
        "皮下堅硬腫塊",
        "與底層組織附著固定",
        "觸診邊界常不清楚",
        "直徑常>2cm",
        "腫塊表面可能潰瘍",
        "區域淋巴結通常不腫大"
      ]
    },
    "pathophysiology": "注射部位肉瘤被認為起源於注射引起的慢性局部發炎反應。含佐劑疫苗和其他刺激性注射物質在局部引起持續的肉芽腫性發炎，巨噬細胞和成纖維細胞長期增殖和細胞因子（特別是PDGF和TGF-β）釋放，累積的基因突變（包括p53抑癌基因失活）最終導致惡性轉化。腫瘤在肌肉筋膜面生長，沿筋膜平面廣泛延伸，因此外觀所見範圍遠小於實際浸潤範圍。腫瘤細胞學顯示高度多形性的梭形細胞，核分裂指數高，反映其侵犯性。約25%的病例可經血行轉移至肺。",
    "diagnosis": {
      "overview": "注射部位持續>1月或>2cm的腫塊應高度懷疑並進行活檢",
      "differentials": [
        "注射部位肉芽腫（良性反應）",
        "其他皮下肉瘤",
        "脂肪瘤",
        "纖維瘤",
        "淋巴瘤"
      ],
      "initialDB": [
        "FNA細胞學（可區分肉芽腫和肉瘤，但敏感度有限）",
        "三視胸腔X光（排除肺轉移）",
        "CBC/生化",
        "注射史調查"
      ],
      "advanced": [
        "切開式組織活檢（確診必須）",
        "CT/MRI評估腫瘤深度和範圍",
        "腹部超音波（完整分期）"
      ]
    },
    "treatment": {
      "overview": "激進首次手術是最重要的治療環節，建議合併放療和/或化療",
      "acute": [
        "激進手術切除（3-5cm邊界+至少一層完整筋膜面深度）",
        "術前CT/MRI規劃切除範圍",
        "四肢腫瘤可能需要截肢"
      ],
      "chronic": [
        "術後放射治療（降低局部復發）",
        "化療（doxorubicin或carboplatin）",
        "復發腫瘤再次激進手術",
        "手術+化療+放療三模式治療延長無病期至18-24個月"
      ]
    },
    "prognosis": "首次手術的激進程度是最重要的預後因子。激進首次手術的局部復發率約14-28%，而保守手術復發率高達42-69%。單純手術中位生存期12-16個月，三模式治療（手術+化療+放療）延長至18-24個月。約25%發生肺轉移。首次手術由外科專科醫師執行可顯著改善預後。",
    "pearls": [
      "3-2-1法則：注射後3個月仍存在、直徑>2cm、或1個月內在增大的腫塊應立即活檢",
      "首次手術必須激進（3-5cm邊界），保守手術後復發的再手術更困難",
      "疫苗應注射在四肢遠端（而非肩胛間），以便必要時可截肢治療"
    ],
    "diagnosticAlgorithm": {
      "title": "注射部位肉瘤 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "腫塊監測",
          "details": "套用3-2-1法則評估注射部位腫塊",
          "findings": [
            ">3個月仍存在",
            ">2cm",
            "1個月內增大"
          ]
        },
        {
          "step": 2,
          "action": "組織診斷",
          "details": "FNA初篩+切開式活檢確診",
          "findings": [
            "肉芽腫（觀察）",
            "肉瘤確診",
            "不確定（需活檢）"
          ]
        },
        {
          "step": 3,
          "action": "分期檢查",
          "details": "CT/MRI評估腫瘤範圍+胸部X光排除轉移",
          "findings": [
            "局部腫瘤",
            "深層延伸",
            "肺轉移"
          ]
        },
        {
          "step": 4,
          "action": "治療計畫",
          "details": "轉診外科專科進行激進手術+輔助治療",
          "findings": [
            "激進手術可行",
            "需截肢",
            "多模式治療"
          ]
        }
      ]
    },
    "monitoring": [
      "術後每月觸診手術部位3個月",
      "之後每3個月檢查共2年",
      "每3-6個月胸腔X光（肺轉移監測）",
      "復發早期發現可提高再手術成功率"
    ],
    "reference": "Hartmann K et al. ABCD guidelines on FISS prevention and management. JFMS. 2024;26(6); Today's Vet Practice: FISS Risk Factors, Diagnosis and Treatment."
  },
  "zinc-toxicosis": {
    "zh": "鋅中毒",
    "en": "Zinc Toxicosis",
    "definition": "犬貓因攝食含鋅物質（1982年後的美國硬幣含97.5%鋅、鋅螺帽螺栓、氧化鋅藥膏等）導致的金屬中毒，主要引起血管內溶血性貧血、胃腸道損傷和多器官衰竭。攝入1-2枚硬幣即可導致中毒，每枚硬幣含約2440mg元素鋅。",
    "synonyms": [
      "鋅毒性",
      "硬幣中毒",
      "Zinc Poisoning",
      "Penny Toxicosis"
    ],
    "epidemiology": {
      "species": "犬較常見（幼犬尤其）",
      "age": "幼犬最常見（異食傾向）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "幼犬異食行為",
        "家中可接觸到硬幣",
        "鋅含量高的螺帽螺栓",
        "氧化鋅藥膏攝入"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "嘔吐（可能為首發症狀）",
        "腹瀉",
        "嗜睡和食慾下降",
        "尿液顏色變深（血紅素尿）",
        "可能有攝食硬幣或金屬物的目擊史"
      ],
      "physicalExam": [
        "黃疸",
        "黏膜蒼白",
        "心搏過速",
        "血紅素尿（深紅色尿液）",
        "腹部觸診可能觸及異物",
        "可聽到心臟雜音（貧血相關）"
      ]
    },
    "pathophysiology": "攝入的鋅在胃酸環境中溶解釋放鋅離子。鋅離子直接損傷胃腸道黏膜引起嘔吐和腹瀉（第一階段）。吸收進入血液後，鋅離子與紅血球膜結合，導致氧化損傷、Heinz body形成和球狀紅血球產生，引發血管內溶血（第二階段，可在攝入後數小時至數天發生）。大量溶血釋放的血紅蛋白導致血紅素尿，並可損傷腎小管引起急性腎衰竭。鋅還直接損傷肝臟和胰臟組織。嚴重病例可進展為DIC和多器官衰竭。",
    "diagnosis": {
      "overview": "腹部放射線發現金屬異物+溶血性貧血為高度提示",
      "differentials": [
        "免疫介導性溶血性貧血",
        "洋蔥中毒",
        "銅中毒",
        "磷化鋅中毒",
        "Heinz body貧血"
      ],
      "initialDB": [
        "腹部放射線（金屬異物）",
        "CBC（再生性貧血、球狀紅血球、Heinz bodies）",
        "生化（肝指數、腎指數、膽紅素升高）",
        "尿液分析（血紅素尿）"
      ],
      "advanced": [
        "血清鋅濃度",
        "凝血功能（DIC篩檢）",
        "腹部超音波",
        "網織紅血球計數"
      ]
    },
    "treatment": {
      "overview": "立即移除鋅來源+支持性治療+輸血（嚴重貧血）",
      "acute": [
        "內視鏡或手術移除金屬異物（最優先）",
        "靜脈輸液（LRS 90ml/kg/day）糾正脫水和酸血症",
        "PCV<10%或嚴重臨床症狀時輸血",
        "胃腸道保護劑（sucralfate 0.5-1g PO q8h）"
      ],
      "chronic": [
        "持續監測PCV和網織紅血球計數",
        "移除異物後鋅濃度通常迅速下降",
        "螯合治療爭議大，通常不推薦",
        "腎臟和肝臟功能支持"
      ]
    },
    "prognosis": "及時移除鋅來源並給予支持治療後預後良好。延遲診斷或治療可導致嚴重溶血性貧血、急性腎衰竭和DIC，預後變差。攝入量大或就診延遲超過48小時者死亡率顯著增加。移除異物後，血鋅濃度通常在24-48小時內明顯下降。",
    "pearls": [
      "1982年後美國硬幣含97.5%鋅，幼犬吞食硬幣是最常見的鋅中毒原因",
      "腹部X光見到金屬異物+溶血性貧血=高度懷疑鋅中毒",
      "移除鋅來源是最重要的治療，螯合劑在鋅中毒中效果有限"
    ],
    "diagnosticAlgorithm": {
      "title": "鋅中毒 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "急診評估",
          "details": "評估黏膜顏色、PCV和異物攝入史",
          "findings": [
            "蒼白黏膜",
            "黃疸",
            "血紅素尿"
          ]
        },
        {
          "step": 2,
          "action": "影像學檢查",
          "details": "腹部X光確認金屬異物",
          "findings": [
            "金屬異物可見",
            "胃內硬幣",
            "腸道異物"
          ]
        },
        {
          "step": 3,
          "action": "血液學確認",
          "details": "CBC、生化、凝血功能評估溶血和器官損傷",
          "findings": [
            "溶血性貧血",
            "肝腎指數升高",
            "DIC徵象"
          ]
        },
        {
          "step": 4,
          "action": "緊急治療",
          "details": "移除異物+輸血+支持治療",
          "findings": [
            "內視鏡移除",
            "手術移除",
            "需輸血"
          ]
        }
      ]
    },
    "monitoring": [
      "PCV每4-6小時監測直到穩定",
      "網織紅血球計數追蹤再生反應",
      "腎功能和尿液輸出量監測",
      "異物移除後確認血鋅濃度下降"
    ],
    "reference": "Merck Veterinary Manual: Zinc Toxicosis in Animals; Breitschwerdt EB et al. JAVMA. 1986;188(12):1426-1430; VCA: Zinc Poisoning in Pets."
  },
  "lead-toxicosis": {
    "zh": "鉛中毒",
    "en": "Lead Toxicosis",
    "definition": "犬貓因攝食含鉛物質（老舊油漆碎片、鉛管焊料、釣魚鉛墜、彈藥等）導致的重金屬中毒，主要影響消化系統和中樞神經系統。幼犬和幼貓最易受影響，低劑量慢性暴露可引起長期神經行為異常，急性暴露可導致嚴重癲癇和死亡。",
    "synonyms": [
      "鉛毒性",
      "鉛金屬中毒",
      "Lead Poisoning",
      "Plumbism"
    ],
    "epidemiology": {
      "species": "犬較常見，貓亦可見",
      "age": "幼犬最常見（6月齡-2歲，探索和啃咬行為）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "居住於老舊房屋（鉛漆）",
        "房屋翻修期間",
        "接觸鉛管或焊料",
        "釣魚鉛墜或彈藥攝入",
        "都市環境"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "嘔吐",
        "腹瀉或便秘",
        "食慾下降",
        "癲癇發作（急性）",
        "行為改變（慢性）"
      ],
      "physicalExam": [
        "消化道症狀（嘔吐、腹痛）",
        "神經症狀（癲癇、震顫、失明、行為異常）",
        "血液塗片見有核紅血球和嗜鹼性點彩紅血球",
        "幼犬多表現神經症狀",
        "貓以食慾不振、嘔吐和癲癇為主"
      ]
    },
    "pathophysiology": "鉛經消化道吸收後分布全身，主要影響三個系統：(1)血液系統——鉛抑制δ-aminolevulinic acid dehydratase (ALAD)和ferrochelatase等血紅素合成酶，導致不成熟紅血球提前釋放（有核紅血球和嗜鹼性點彩紅血球出現於週邊血液）；(2)消化系統——直接刺激胃腸道黏膜引起嘔吐、腹痛和腸蠕動異常；(3)神經系統——鉛穿過血腦屏障（幼年動物屏障不成熟更易穿過），引起腦水腫、神經元脫髓鞘和壞死。幼犬因腸道吸收率高和血腦屏障不成熟，比成犬更易表現嚴重神經症狀。",
    "diagnosis": {
      "overview": "血鉛濃度>2.9μmol/L結合臨床症狀為確診標準",
      "differentials": [
        "癲癇（特發性或其他原因）",
        "腦炎",
        "其他金屬中毒",
        "有機磷中毒",
        "犬瘟熱"
      ],
      "initialDB": [
        "血液塗片（有核紅血球、嗜鹼性點彩紅血球）",
        "全血鉛濃度",
        "腹部放射線（金屬異物）",
        "CBC/生化"
      ],
      "advanced": [
        "尿液δ-aminolevulinic acid",
        "骨骼放射線（慢性鉛線）",
        "腦脊液分析（排除腦炎）"
      ]
    },
    "treatment": {
      "overview": "移除鉛來源+螯合治療+控制癲癇",
      "acute": [
        "癲癇控制（diazepam 0.5-1mg/kg IV）",
        "移除消化道內鉛異物（內視鏡/手術/灌腸）",
        "腦水腫管理（mannitol 0.5-1g/kg IV）"
      ],
      "chronic": [
        "Succimer (DMSA) 10mg/kg PO q8h共10天（首選螯合劑）",
        "Ca-EDTA 25mg/kg SC q6h共5天（替代螯合劑）",
        "Thiamine 2mg/kg IM q24h（配合Ca-EDTA使用）",
        "移除環境中所有鉛來源"
      ]
    },
    "prognosis": "及時診斷和螯合治療後預後良好，通常24-48小時內可見改善。嚴重神經症狀（持續癲癇）預後較差，可能有永久性神經損傷。慢性低劑量暴露可導致持久的行為和認知異常。環境中鉛來源未移除會導致再暴露和復發。",
    "pearls": [
      "血液塗片見有核紅血球和嗜鹼性點彩紅血球是鉛中毒的重要線索",
      "必須在開始螯合治療前先移除消化道內的鉛異物（Ca-EDTA會增加腸道鉛吸收）",
      "Succimer (DMSA)是目前推薦的首選螯合劑，副作用比Ca-EDTA少"
    ],
    "diagnosticAlgorithm": {
      "title": "鉛中毒 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "臨床懷疑",
          "details": "GI症狀+神經症狀+環境暴露史",
          "findings": [
            "嘔吐+癲癇",
            "老屋翻修",
            "金屬異物攝入"
          ]
        },
        {
          "step": 2,
          "action": "血液學初篩",
          "details": "血液塗片和腹部X光",
          "findings": [
            "有核紅血球",
            "嗜鹼性點彩",
            "金屬異物"
          ]
        },
        {
          "step": 3,
          "action": "確認檢查",
          "details": "全血鉛濃度測定",
          "findings": [
            "血鉛>2.9μmol/L確診",
            "血鉛臨界值需追蹤"
          ]
        },
        {
          "step": 4,
          "action": "治療",
          "details": "移除鉛源+螯合治療+控制症狀",
          "findings": [
            "螯合治療反應良好",
            "癲癇需控制",
            "環境源需移除"
          ]
        }
      ]
    },
    "monitoring": [
      "螯合治療後7天追蹤血鉛濃度",
      "可能需要第二療程螯合治療",
      "CBC監測貧血改善",
      "神經功能持續評估"
    ],
    "reference": "Merck Veterinary Manual: Lead Poisoning in Animals; Gwaltney-Brant SM. Lead. In: Small Animal Toxicology 3rd ed. Elsevier 2013."
  },
  "metaldehyde-toxicosis": {
    "zh": "滅蝸靈中毒",
    "en": "Metaldehyde Toxicosis",
    "definition": "犬因攝食含滅蝸靈的蝸牛蛞蝓誘餌導致的急性中毒，滅蝸靈在體內代謝為乙醛，引起嚴重的中樞神經興奮、肌肉震顫和癲癇。臨床表現被稱為「搖擺與烘烤」(shake and bake)——劇烈震顫/癲癇伴隨危險性高體溫，致死量犬為100-300mg/kg。",
    "synonyms": [
      "蝸牛餌中毒",
      "蛞蝓餌中毒",
      "Snail Bait Poisoning",
      "Slug Bait Toxicosis"
    ],
    "epidemiology": {
      "species": "犬為主（貓偶見）",
      "age": "任何年齡",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "庭院使用蝸牛蛞蝓誘餌",
        "誘餌存放不當被犬接觸",
        "戶外散步接觸",
        "誘餌外觀和氣味對犬有吸引力"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "已知或懷疑接觸蝸牛蛞蝓誘餌",
        "急性發作震顫或癲癇",
        "症狀在攝入後數分鐘至3小時內出現",
        "嘔吐"
      ],
      "physicalExam": [
        "劇烈肌肉震顫",
        "癲癇發作",
        "危險性高體溫（>41°C）",
        "過度流涎",
        "心搏過速",
        "瞳孔散大",
        "角弓反張",
        "意識狀態異常"
      ]
    },
    "pathophysiology": "滅蝸靈攝入後在胃中被代謝為乙醛（acetaldehyde），此代謝物具有直接神經毒性。乙醛降低中樞神經系統中γ-氨基丁酸（GABA）的濃度——GABA是主要的抑制性神經遞質，其減少導致神經元過度興奮。同時降低血清素和去甲腎上腺素濃度，進一步降低癲癇閾值。失去抑制性神經控制導致持續的肌肉震顫和癲癇發作，大量的肌肉活動產生過多熱能，引起危及生命的高體溫。代謝性酸中毒繼發於持續的肌肉活動和乳酸堆積。嚴重的高體溫可導致肝壞死和DIC。",
    "diagnosis": {
      "overview": "根據暴露史和典型「搖擺與烘烤」臨床表現做臨床診斷",
      "differentials": [
        "有機磷或氨基甲酸酯中毒",
        "氟乙酸鈉（1080）中毒",
        "番木鱉鹼中毒",
        "特發性癲癇",
        "巧克力中毒",
        "腦炎"
      ],
      "initialDB": [
        "暴露史調查",
        "體溫監測",
        "血液學和生化（代謝性酸中毒、乳酸升高）",
        "尿液/嘔吐物毒物分析"
      ],
      "advanced": [
        "胃內容物或嘔吐物滅蝸靈定量",
        "血氣分析",
        "肝功能監測（24-48h後）"
      ]
    },
    "treatment": {
      "overview": "控制癲癇+降低體溫+支持治療",
      "acute": [
        "Diazepam 0.5-2mg/kg IV控制癲癇",
        "Methocarbamol 55-220mg/kg IV（肌肉鬆弛）",
        "靜脈輸液含乳酸鈉或碳酸氫鈉矯正酸中毒",
        "主動降溫（冷水浴、風扇、冷靜脈輸液）"
      ],
      "chronic": [
        "難治性癲癇：propofol或pentobarbital CRI",
        "肝臟保護（IV葡萄糖、S-adenosylmethionine）",
        "監測48-72小時（遲發性肝損傷）",
        "嘔吐引起者若尚在攝入1小時內可洗胃"
      ]
    },
    "prognosis": "及早治療者預後良好，多數犬在24-48小時內恢復。未治療者可因持續癲癇、高體溫和代謝性酸中毒死亡，死亡可在攝入後數小時內發生。預後取決於攝入量和治療開始時間。遲發性肝衰竭可在72小時後出現。高體溫控制不佳者預後差。",
    "pearls": [
      "「搖擺與烘烤」(shake and bake)——肌肉震顫/癲癇+高體溫是滅蝸靈中毒的典型特徵",
      "沒有特異性解毒劑，治療以支持療法為主",
      "Methocarbamol是控制肌肉震顫的重要藥物"
    ],
    "diagnosticAlgorithm": {
      "title": "滅蝸靈中毒 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "急診評估",
          "details": "評估暴露史、神經症狀和體溫",
          "findings": [
            "震顫/癲癇",
            "高體溫",
            "蝸牛餌接觸史"
          ]
        },
        {
          "step": 2,
          "action": "穩定患者",
          "details": "立即控制癲癇和降溫",
          "findings": [
            "diazepam有效",
            "需methocarbamol",
            "需propofol"
          ]
        },
        {
          "step": 3,
          "action": "實驗室評估",
          "details": "血氣、乳酸、肝腎功能",
          "findings": [
            "代謝性酸中毒",
            "乳酸升高",
            "肝指數升高"
          ]
        },
        {
          "step": 4,
          "action": "持續監測",
          "details": "48-72小時ICU監護",
          "findings": [
            "神經症狀改善",
            "遲發性肝損傷",
            "完全恢復"
          ]
        }
      ]
    },
    "monitoring": [
      "體溫每30分鐘監測直到正常",
      "神經狀態持續評估",
      "肝功能48-72小時後追蹤",
      "酸鹼平衡和乳酸監測"
    ],
    "reference": "Merck Veterinary Manual: Metaldehyde Poisoning in Animals; VCA: Metaldehyde Toxicity (Slug Bait Poisoning); Puschner B. Metaldehyde. In: Small Animal Toxicology 3rd ed."
  },
  "blue-green-algae-toxicosis": {
    "zh": "藍綠藻中毒",
    "en": "Blue-Green Algae Toxicosis",
    "definition": "犬因飲用或游泳於受藍綠藻（藍菌門）污染的水體而導致的急性中毒。藍菌產生的毒素分為肝毒素（microcystin）和神經毒素（anatoxin），分別導致急性肝衰竭或急性神經肌肉麻痺。此中毒無特異性解毒劑，嚴重暴露死亡率極高。",
    "synonyms": [
      "藍菌中毒",
      "藻類中毒",
      "Cyanobacteria Toxicosis",
      "Cyanotoxin Poisoning"
    ],
    "epidemiology": {
      "species": "犬為主（戶外活動和飲水行為）",
      "age": "任何年齡",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "在湖泊、池塘或河流中游泳或飲水",
        "溫暖季節（夏末秋初藻華盛期）",
        "靜水體和富營養化水域",
        "犬的舔毛行為（游泳後舔除毛上的藻類）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "近期在池塘/湖泊游泳或飲水",
        "急性發病",
        "嘔吐、腹瀉",
        "突然虛弱或倒下"
      ],
      "physicalExam": [
        "神經毒素型：肌肉僵硬、癲癇、震顫、麻痺、過度流涎",
        "肝毒素型：嘔吐（可能帶血）、黑便、黃疸、低血糖",
        "呼吸困難",
        "虛脫和休克",
        "皮膚接觸部位刺激性紅疹"
      ]
    },
    "pathophysiology": "藍菌（藍綠藻）在適宜條件下（溫暖、富營養化水體）大量繁殖形成藻華，產生兩類主要毒素：(1)神經毒素（anatoxin-a/s）——結合在神經肌肉接合處的乙醯膽鹼受體或抑制乙醯膽鹼酯酶，導致持續的神經肌肉刺激，引起肌肉僵硬、震顫、癲癇和呼吸肌麻痺，發病在暴露後60分鐘內，進展極快；(2)肝毒素（microcystin/nodularin）——被肝細胞主動攝取後抑制蛋白磷酸酶1和2A，導致細胞骨架崩潰和肝細胞大量壞死，引起急性肝衰竭、凝血障礙和內出血，發病在暴露後4小時內。",
    "diagnosis": {
      "overview": "臨床診斷為主——暴露史+急性多器官衰竭，水樣檢測可確認",
      "differentials": [
        "有機磷中毒（神經毒素型）",
        "黃曲毒素中毒（肝毒素型）",
        "毒蘑菇中毒",
        "Sago palm中毒",
        "鉤端螺旋體病"
      ],
      "initialDB": [
        "暴露史（近期水域接觸）",
        "CBC/生化/凝血功能",
        "血糖和白蛋白（肝毒素型降低）",
        "尿液分析"
      ],
      "advanced": [
        "水樣藍菌毒素檢測",
        "胃內容物毒素分析",
        "肝臟超音波",
        "ELISA法microcystin檢測"
      ]
    },
    "treatment": {
      "overview": "無特異性解毒劑，治療為積極的支持療法",
      "acute": [
        "神經毒素型：diazepam控制癲癇+atropine（若anticholinesterase型）+機械通氣（呼吸衰竭）",
        "肝毒素型：靜脈輸液+肝臟保護+新鮮冷凍血漿（凝血障礙）",
        "活性碳（攝入1小時內）",
        "洗胃（早期且未癲癇時）"
      ],
      "chronic": [
        "肝臟保護劑（SAMe、milk thistle）",
        "Vitamin K1（凝血障礙）",
        "ICU密集監護至少48-72小時",
        "皮膚暴露者徹底沖洗"
      ]
    },
    "prognosis": "高劑量暴露預後極差，死亡率極高，死亡可在數小時內發生。神經毒素型進展最快，呼吸衰竭是主要死因。肝毒素型若度過急性期可能存活但可能有永久性肝損傷。低劑量暴露或僅皮膚接觸者經支持治療可能恢復。預防是最重要的策略——避免犬隻接觸有藻華的水體。",
    "pearls": [
      "無特異性解毒劑，高劑量暴露死亡率極高，預防勝於治療",
      "游泳後犬的舔毛行為可額外攝入大量毒素，暴露後應立即沖洗",
      "夏末秋初溫暖水體的綠色/藍綠色薄膜是藻華的警示信號"
    ],
    "diagnosticAlgorithm": {
      "title": "藍綠藻中毒 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "暴露評估",
          "details": "確認近期水域接觸史和水體狀況",
          "findings": [
            "水域游泳/飲水史",
            "水體有可見藻華",
            "多隻動物同時發病"
          ]
        },
        {
          "step": 2,
          "action": "症狀分類",
          "details": "區分神經毒素型和肝毒素型",
          "findings": [
            "急性神經症狀（<1h）",
            "肝臟症狀（2-4h）",
            "混合型"
          ]
        },
        {
          "step": 3,
          "action": "實驗室評估",
          "details": "血液學和肝功能評估損傷程度",
          "findings": [
            "肝酶劇升",
            "凝血障礙",
            "低血糖低白蛋白"
          ]
        },
        {
          "step": 4,
          "action": "積極支持治療",
          "details": "ICU監護+對症處理+水樣送檢",
          "findings": [
            "穩定可能存活",
            "多器官衰竭",
            "需機械通氣"
          ]
        }
      ]
    },
    "monitoring": [
      "神經功能持續評估",
      "肝功能和凝血功能每6-12小時監測",
      "尿量和腎功能監測",
      "48-72小時後評估肝臟恢復"
    ],
    "reference": "Merck Veterinary Manual: Algal Poisoning of Animals; Cornell CVM: Blue-green Algae Poisoning; VCA: Cyanobacteria Poisoning."
  },
  "disseminated-intravascular-coagulation": {
    "zh": "瀰漫性血管內凝血",
    "en": "Disseminated Intravascular Coagulation",
    "definition": "瀰漫性血管內凝血（DIC）是一種危及生命的凝血功能異常，其特徵為凝血系統被過度活化，在微血管中形成廣泛微血栓，同時消耗凝血因子和血小板，最終導致同時出現微血管血栓和出血傾向。DIC永遠是繼發於其他嚴重原發疾病。",
    "synonyms": [
      "DIC",
      "消耗性凝血病變"
    ],
    "epidemiology": {
      "species": "犬較常見，貓少見",
      "age": "任何年齡（取決於原發疾病）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "嚴重敗血症/SIRS",
        "胃擴張扭轉（GDV）",
        "熱衰竭",
        "IMHA",
        "惡性腫瘤（血管肉瘤）",
        "蛇咬傷",
        "急性胰臟炎",
        "嚴重外傷"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "已存在嚴重疾病",
        "突然出現異常出血",
        "皮下瘀斑",
        "黏膜出血",
        "尿液或糞便帶血"
      ],
      "physicalExam": [
        "多部位自發性出血（牙齦、鼻腔、注射部位）",
        "皮膚瘀斑或紫斑",
        "黏膜蒼白",
        "心搏過速",
        "低血壓",
        "穿刺部位持續滲血"
      ]
    },
    "pathophysiology": "DIC的核心機制為過量凝血酶（thrombin）生成。原發疾病釋放組織因子（tissue factor）或活化內皮細胞，啟動凝血級聯反應，產生大量凝血酶。過量凝血酶使纖維蛋白原轉化為纖維蛋白，在微血管中形成廣泛微血栓，導致器官微循環障礙和缺血損傷（腎、肺、肝最常受累）。隨著凝血因子和血小板被大量消耗（消耗性凝血病變），凝血功能反而降低，出現矛盾性出血。同時纖溶系統被活化產生纖維蛋白降解產物（FDPs/D-dimer），這些降解產物本身也抑制凝血和血小板功能，進一步加重出血。",
    "diagnosis": {
      "overview": "血小板減少+PT/aPTT延長+D-dimer升高為典型三聯徵",
      "differentials": [
        "嚴重肝病凝血障礙",
        "維生素K缺乏",
        "抗凝血劑中毒",
        "骨髓衰竭",
        "免疫媒介性血小板減少"
      ],
      "initialDB": [
        "CBC（血小板減少、碎裂紅血球）",
        "凝血功能：PT和aPTT（延長）",
        "纖維蛋白原（早期升高、晚期降低）",
        "D-dimer（升高）"
      ],
      "advanced": [
        "抗凝血酶III活性（降低）",
        "FDPs（升高）",
        "血栓彈力圖（TEG/ROTEM）",
        "器官損傷評估（腎功能、肝功能）"
      ]
    },
    "treatment": {
      "overview": "治療原發疾病為根本，同時補充凝血因子和控制凝血活化",
      "acute": [
        "積極治療原發疾病",
        "新鮮冷凍血漿（補充凝血因子+抗凝血酶）",
        "血小板輸注（嚴重血小板減少伴活動性出血）",
        "Heparin（低劑量75-150 IU/kg SC q8h，仍有爭議）"
      ],
      "chronic": [
        "持續治療和監測原發疾病",
        "維持組織灌注（IV輸液、血管活性藥物）",
        "紅血球輸注（嚴重貧血時）",
        "營養支持"
      ]
    },
    "prognosis": "DIC預後嚴重至極差。出血型DIC犬存活率約40%。預後主要取決於原發疾病能否有效控制。DIC的出現代表原發疾病已嚴重進展。早期辨識和積極治療原發疾病是改善預後的唯一途徑。",
    "pearls": [
      "DIC永遠是繼發性的，必須找出並治療原發疾病",
      "血小板計數是最靈敏的DIC早期指標",
      "出血不一定代表DIC已進入消耗期，早期DIC以高凝狀態為主",
      "新鮮冷凍血漿是補充凝血因子的首選"
    ],
    "diagnosticAlgorithm": {
      "title": "瀰漫性血管內凝血 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "臨床警覺",
          "details": "嚴重疾病患者出現異常出血",
          "findings": [
            "原有嚴重疾病",
            "自發性出血",
            "穿刺部位持續滲血"
          ]
        },
        {
          "step": 2,
          "action": "凝血篩檢",
          "details": "CBC+凝血功能+D-dimer",
          "findings": [
            "血小板下降",
            "PT/aPTT延長",
            "D-dimer升高"
          ]
        },
        {
          "step": 3,
          "action": "嚴重度評估",
          "details": "評估器官損傷和出血程度",
          "findings": [
            "纖維蛋白原水平",
            "抗凝血酶III活性",
            "碎裂紅血球（微血管病）"
          ]
        },
        {
          "step": 4,
          "action": "原發病因調查",
          "details": "找出觸發DIC的原發疾病",
          "findings": [
            "敗血症來源",
            "腫瘤篩檢",
            "組織壞死評估"
          ]
        }
      ]
    },
    "monitoring": [
      "連續血小板計數（每4-8小時）",
      "凝血功能追蹤",
      "出血量和部位",
      "原發疾病控制情況",
      "器官功能監測"
    ],
    "reference": "eClinpath — DIC; Veterinary Partner — VIN; dvm360 — DIC Diagnosis and Treatment; PubMed — Update on DIC"
  },
  "pure-red-cell-aplasia": {
    "zh": "純紅血球再生不良",
    "en": "Pure Red Cell Aplasia",
    "definition": "純紅血球再生不良（PRCA）是一種罕見的骨髓疾病，特徵為骨髓中紅血球前驅細胞選擇性缺失或極度減少，而顆粒球和巨核細胞生成正常。導致嚴重的非再生性貧血，網狀紅血球計數極低。多數為免疫媒介性，少數與感染或腫瘤相關。",
    "synonyms": [
      "PRCA",
      "紅血球生成不良"
    ],
    "epidemiology": {
      "species": "犬貓皆可",
      "age": "犬中位年齡6.5歲；貓8月齡-3歲",
      "sex": "犬：已絕育母犬顯著好發",
      "riskFactors": [
        "拉布拉多犬",
        "貓白血病病毒（FeLV）感染（貓）",
        "免疫系統失調",
        "近期藥物暴露或感染"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "進行性虛弱無力",
        "運動不耐",
        "食慾下降",
        "嗜睡",
        "黏膜逐漸蒼白"
      ],
      "physicalExam": [
        "黏膜極度蒼白",
        "心搏過速",
        "心臟收縮期雜音（貧血性）",
        "無黃疸（非溶血性）",
        "無脾臟腫大（通常）",
        "無出血傾向（血小板正常）"
      ]
    },
    "pathophysiology": "PRCA的主要機制為免疫系統選擇性攻擊骨髓中的紅血球前驅細胞（特別是紅血球母細胞和前紅血球母細胞）。可能的免疫機制包括：(1)抗紅血球前驅細胞抗體直接破壞前驅細胞；(2)細胞激素異常抑制紅血球生成；(3)抗紅血球生成素（EPO）抗體中和EPO活性；(4)感染引起的交叉反應抗體攻擊紅血球前驅細胞。骨髓中紅血球系列（E系列）嚴重缺乏，而髓系（M系列）和巨核細胞正常，M:E比值顯著升高。周邊血液表現為嚴重非再生性正球性正色性貧血，網狀紅血球計數極低。",
    "diagnosis": {
      "overview": "骨髓檢查確認紅血球前驅細胞缺失是確診關鍵",
      "differentials": [
        "慢性腎病引起的非再生性貧血",
        "骨髓發育不良症候群",
        "再生不良性貧血",
        "鐵缺乏性貧血",
        "慢性疾病貧血"
      ],
      "initialDB": [
        "CBC（嚴重貧血、網狀紅血球極低、WBC和血小板正常）",
        "網狀紅血球計數（<1%或絕對值極低）",
        "生化+尿液分析（排除腎病）",
        "FeLV/FIV檢測（貓）"
      ],
      "advanced": [
        "骨髓穿刺+活檢（紅血球系列缺失，M:E比值升高）",
        "直接Coombs試驗",
        "EPO濃度測量",
        "感染篩檢（細小病毒、Ehrlichia）"
      ]
    },
    "treatment": {
      "overview": "免疫抑制治療為主，嚴重貧血需輸血支持",
      "acute": [
        "嚴重貧血（PCV<10-12%）：紅血球輸注",
        "Prednisolone 2-4 mg/kg/day起始",
        "氧氣支持"
      ],
      "chronic": [
        "Prednisolone逐漸減量至維持劑量",
        "反應不佳者加用：Cyclosporine 5 mg/kg q12h",
        "Cyclophosphamide（難治病例）",
        "人類重組紅血球生成素（rHuEPO，部分病例有效）",
        "長期監測和劑量調整"
      ]
    },
    "prognosis": "犬對免疫抑制治療反應：完全緩解55%、部分緩解18%、反應不佳27%。貓需長期積極免疫抑制治療。FeLV相關PRCA預後較差。及時診斷和治療可顯著改善預後。部分病例需終身低劑量免疫抑制維持。",
    "pearls": [
      "PRCA的關鍵特徵：嚴重貧血但WBC和血小板正常",
      "無黃疸（非溶血性機制）可與IMHA區分",
      "骨髓檢查是確診必須",
      "犬以已絕育母犬和拉布拉多好發"
    ],
    "diagnosticAlgorithm": {
      "title": "純紅血球再生不良 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "識別非再生性貧血",
          "details": "嚴重貧血但網狀紅血球極低",
          "findings": [
            "PCV極低（中位11%）",
            "網狀紅血球<1%",
            "WBC和血小板正常"
          ]
        },
        {
          "step": 2,
          "action": "排除常見原因",
          "details": "腎病、鐵缺乏、慢性疾病",
          "findings": [
            "腎功能正常",
            "鐵代謝正常",
            "FeLV/FIV陰性（或陽性→注意）"
          ]
        },
        {
          "step": 3,
          "action": "骨髓檢查",
          "details": "穿刺+活檢確認紅血球前驅缺失",
          "findings": [
            "紅血球系列缺失",
            "M:E比值顯著升高",
            "髓系和巨核細胞正常"
          ]
        },
        {
          "step": 4,
          "action": "免疫媒介確認",
          "details": "Coombs試驗和治療反應",
          "findings": [
            "Coombs陽性（57%犬）",
            "免疫抑制治療反應"
          ]
        }
      ]
    },
    "monitoring": [
      "PCV和網狀紅血球計數（每1-2週）",
      "骨髓追蹤（治療反應評估）",
      "免疫抑制劑副作用",
      "FeLV狀態（貓）"
    ],
    "reference": "PubMed — PRCA in dogs 43 cases; PubMed — Primary PRCA 13 cases; PubMed — PRCA in cats 9 cases; PMC 2021"
  },
  "nasopharyngeal-stenosis": {
    "zh": "鼻咽狹窄",
    "en": "Nasopharyngeal Stenosis",
    "definition": "鼻咽部（後鼻孔至軟腭後方區域）的病理性狹窄，可為先天性（鼻咽閉鎖）或後天性（炎症後疤痕形成），導致嚴重鼻塞和上呼吸道阻塞。後天性多因慢性上呼吸道炎症、手術或嘔吐引起的黏膜損傷後疤痕攣縮。",
    "synonyms": [
      "鼻咽部狹窄",
      "後鼻孔狹窄",
      "Choanal Stenosis",
      "Imperforate Nasopharynx"
    ],
    "epidemiology": {
      "species": "犬貓均可發生，貓的報告較多",
      "age": "先天性：幼齡動物；後天性：任何年齡",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "慢性上呼吸道感染（貓尤其FHV-1）",
        "先前鼻咽部手術",
        "慢性嘔吐",
        "鼻咽息肉切除後",
        "先天性鼻咽閉鎖"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "慢性嚴重鼻塞",
        "吸氣性鼻鼾聲（stertor）",
        "張口呼吸",
        "運動不耐",
        "進食困難（嚴重阻塞時）",
        "慢性鼻分泌物"
      ],
      "physicalExam": [
        "明顯吸氣性鼻鼾",
        "鼻腔氣流顯著減少",
        "張口呼吸",
        "鼻分泌物",
        "口腔檢查軟腭後方無法直接觀察（需鏡檢）"
      ]
    },
    "pathophysiology": "後天性NPS：鼻咽黏膜損傷（感染、嘔吐酸、手術創傷）→黏膜潰瘍→纖維母細胞增生和膠原沉積→疤痕組織形成→環狀或膜狀狹窄。狹窄處形成緻密纖維組織帶（web），可幾乎完全阻塞鼻咽通道。先天性NPS（鼻咽閉鎖）：胚胎發育期間鼻咽管腔化不完全，殘留骨性或膜性阻塞。兩種型態均導致嚴重鼻腔氣流限制和呼吸困難。",
    "diagnosis": {
      "overview": "CT和鼻咽鏡檢查是診斷金標準。CT評估狹窄範圍和骨性結構，鏡檢直接觀察狹窄程度",
      "differentials": [
        "鼻咽息肉",
        "鼻咽腫瘤",
        "鼻腔異物",
        "軟腭過長",
        "嚴重慢性鼻炎"
      ],
      "initialDB": [
        "口腔檢查（軟腭後方）",
        "X光側位片（鼻咽氣柱中斷）",
        "鎮靜下鼻咽鏡檢查"
      ],
      "advanced": [
        "CT（金標準：評估狹窄位置、範圍和骨性結構）",
        "MRI（軟組織評估）",
        "螢光透視（吞嚥和氣流評估）",
        "組織活檢（排除腫瘤）"
      ]
    },
    "treatment": {
      "overview": "介入性治療為主：球囊擴張、支架植入或手術切除。單純球囊擴張復發率高，支架植入效果較持久",
      "acute": [
        "球囊擴張術（Balloon Dilation）：經鼻或經口導入球囊導管擴張狹窄處",
        "膜狀切除術+球囊擴張（組合技術）",
        "球囊擴張後局部Mitomycin C塗抹（抑制疤痕再形成）",
        "金屬支架植入（最持久效果）：balloon-expandable metallic stent",
        "手術切除疤痕組織+黏膜瓣修復（嚴重病例）"
      ],
      "chronic": [
        "球囊擴張可能需要多次重複（復發率高）",
        "支架植入後監測：組織增生、感染、支架斷裂",
        "長期呼吸功能評估",
        "抗發炎藥物（減少再狹窄）"
      ]
    },
    "prognosis": "整體成功率約78%（46例研究，中位追蹤24個月）。球囊擴張單獨使用失敗率較高，支架植入效果最持久但有組織增生、慢性感染和支架斷裂等併發症。Mitomycin C輔助球囊擴張可降低復發率。先天性鼻咽閉鎖的治療通常較後天性狹窄效果好。",
    "pearls": [
      "後天性NPS最常見原因是慢性上呼吸道炎症後的疤痕形成",
      "球囊擴張簡單但復發率高——常需多次重複",
      "支架植入提供最持久效果但有長期併發症",
      "Mitomycin C（抑制纖維母細胞增生）是減少再狹窄的新輔助策略",
      "CT是評估狹窄範圍的金標準——比X光敏感得多"
    ],
    "diagnosticAlgorithm": {
      "title": "鼻咽狹窄 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "臨床懷疑",
          "details": "慢性嚴重鼻塞+吸氣性鼻鼾不對抗生素治療反應",
          "findings": [
            "嚴重吸氣性鼻鼾",
            "鼻腔氣流極度減少",
            "張口呼吸",
            "慢性上呼吸道炎症或手術史"
          ]
        },
        {
          "step": 2,
          "action": "影像學評估",
          "details": "CT評估狹窄位置和範圍",
          "findings": [
            "CT：鼻咽部軟組織密度增加",
            "狹窄位置和長度",
            "骨性vs膜性狹窄",
            "排除腫瘤性病變"
          ]
        },
        {
          "step": 3,
          "action": "鼻咽鏡確認",
          "details": "鎮靜下直接觀察狹窄程度",
          "findings": [
            "環狀或膜狀狹窄",
            "狹窄程度（>70%=嚴重）",
            "組織活檢排除腫瘤",
            "評估介入治療可行性"
          ]
        },
        {
          "step": 4,
          "action": "介入性治療",
          "details": "球囊擴張±支架±Mitomycin C",
          "findings": [
            "球囊擴張+Mitomycin C",
            "嚴重/反覆→支架植入",
            "術後呼吸改善評估",
            "定期追蹤再狹窄"
          ]
        }
      ]
    },
    "monitoring": [
      "呼吸功能（鼻腔氣流改善）",
      "鼻鼾聲減輕程度",
      "定期鼻咽鏡追蹤（再狹窄）",
      "支架併發症監測（組織增生、感染、斷裂）"
    ],
    "reference": "Berent AC, et al. Interventional treatment of benign NPS in dogs and cats: 46 cases. JAVMA 2018;253(10):1300-1311"
  },
  "tracheal-hypoplasia": {
    "zh": "氣管發育不全",
    "en": "Tracheal Hypoplasia",
    "definition": "氣管發育不全是一種先天性疾病，因氣管軟骨環異常融合或重疊導致氣管管徑先天性狹窄。常見於短頭種犬，為短頭種氣道症候群（BOAS）的組成之一。英國鬥牛犬發生率最高（約55%）。",
    "synonyms": [
      "先天性氣管狹窄",
      "Hypoplastic Trachea"
    ],
    "epidemiology": {
      "species": "犬為主（幾乎僅見於短頭種）",
      "age": "先天性，可於任何年齡診斷",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "英國鬥牛犬（55%發生率）",
        "巴哥犬",
        "波士頓梗犬",
        "法國鬥牛犬",
        "其他短頭種犬"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "呼吸困難或呼吸音增大",
        "運動不耐",
        "打鼾",
        "咳嗽",
        "部分犬無明顯症狀"
      ],
      "physicalExam": [
        "吸氣性喘鳴音",
        "呼吸音增強",
        "短頭種特徵性臉部構造",
        "可能伴有BOAS其他表現（鼻孔狹窄、軟顎過長）",
        "嚴重者可見發紺"
      ]
    },
    "pathophysiology": "正常氣管由C型軟骨環支撐，背側由氣管肌膜（dorsal tracheal membrane）覆蓋。氣管發育不全中，軟骨環異常融合或重疊，環狀結構過度閉合，導致氣管內徑先天性狹窄。氣流通過狹窄氣管時阻力增加，增加呼吸功。此外，狹窄的氣管降低黏液纖毛清除效率，增加呼吸道感染風險。氣管發育不全常與BOAS的其他組成（鼻孔狹窄、軟顎過長、喉囊翻轉）同時存在，多重狹窄加乘呼吸阻力。部分幼犬的氣管發育不全可隨成長部分或完全改善。",
    "diagnosis": {
      "overview": "胸頸部X光測量氣管直徑與胸廓入口比值即可診斷",
      "differentials": [
        "氣管塌陷",
        "氣管異物",
        "氣管腫瘤",
        "氣管外壓迫"
      ],
      "initialDB": [
        "頸胸部X光（側位）",
        "氣管直徑/胸廓入口比值（TD/TI ratio）",
        "氣管直徑/第三肋骨比值"
      ],
      "advanced": [
        "CT掃描（精確測量氣管各段直徑）",
        "氣管內視鏡",
        "動態呼吸攝影（排除氣管塌陷）"
      ]
    },
    "treatment": {
      "overview": "無手術矯正方法，以保守治療和管理BOAS為主",
      "acute": [
        "呼吸窘迫：氧氣支持+鎮靜",
        "急性感染：抗生素",
        "短效類固醇減輕氣道腫脹"
      ],
      "chronic": [
        "體重管理（避免肥胖增加呼吸負擔）",
        "支氣管擴張劑（必要時）",
        "避免高溫和劇烈運動",
        "同時矯正BOAS其他組成（鼻孔擴大術、軟顎縮短術）"
      ]
    },
    "prognosis": "無併發心臟病或嚴重BOAS的犬，氣管發育不全可能不產生臨床症狀。部分幼犬隨成長氣管可部分改善。合併嚴重BOAS者需同時處理所有氣道狹窄組成。英國鬥牛犬的氣管發育不全最為嚴重但部分可隨成熟改善。",
    "pearls": [
      "英國鬥牛犬超過半數有氣管發育不全",
      "TD/TI ratio < 0.20 高度提示氣管發育不全",
      "部分幼犬可隨成長改善，不需急於介入",
      "氣管發育不全無法手術矯正，重點在管理BOAS"
    ],
    "diagnosticAlgorithm": {
      "title": "氣管發育不全 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "品種和症狀評估",
          "details": "短頭種犬合併呼吸困難",
          "findings": [
            "短頭種（特別是英國鬥牛犬）",
            "呼吸音增大",
            "運動不耐"
          ]
        },
        {
          "step": 2,
          "action": "頸胸X光",
          "details": "側位X光測量氣管直徑",
          "findings": [
            "氣管管徑狹窄",
            "TD/TI ratio降低",
            "排除氣管塌陷"
          ]
        },
        {
          "step": 3,
          "action": "CT掃描",
          "details": "精確評估氣管各段直徑",
          "findings": [
            "全段或局部氣管狹窄",
            "軟骨環融合/重疊"
          ]
        },
        {
          "step": 4,
          "action": "BOAS綜合評估",
          "details": "評估所有短頭種氣道組成",
          "findings": [
            "鼻孔狹窄程度",
            "軟顎長度",
            "喉囊狀態"
          ]
        }
      ]
    },
    "monitoring": [
      "定期X光追蹤氣管直徑（幼犬）",
      "體重管理",
      "呼吸功能評估",
      "BOAS症狀監測"
    ],
    "reference": "PMC — Radiographic tracheal dimensions in brachycephalic breeds; UPEI — Hypoplastic Trachea; Cornell CVM — BOAS"
  },
  "uterine-torsion": {
    "zh": "子宮扭轉",
    "en": "Uterine Torsion",
    "definition": "子宮扭轉是子宮沿其長軸旋轉的罕見但嚴重的生殖急症。多發生於妊娠晚期或合併子宮蓄膿時。扭轉阻斷子宮血供，導致組織缺血壞死，可迅速進展為休克和敗血症。犬貓均罕見，但一旦發生需緊急手術。",
    "synonyms": [
      "子宮旋轉",
      "Uterine Rotation"
    ],
    "epidemiology": {
      "species": "犬貓皆罕見",
      "age": "妊娠中後期或中老年（合併子宮病變時）",
      "sex": "僅母犬貓",
      "riskFactors": [
        "妊娠（特別是晚期）",
        "子宮蓄膿",
        "子宮積液",
        "子宮腫瘤",
        "腹腔空間大（大型犬）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "急性腹痛",
        "嘔吐",
        "不安和躁動",
        "食慾廢絕",
        "陰道出血或異常分泌物",
        "妊娠犬突然停止分娩進程"
      ],
      "physicalExam": [
        "腹部觸診疼痛",
        "腹部膨脹",
        "脫水",
        "心搏過速",
        "黏膜蒼白或充血",
        "體溫升高或降低（休克）"
      ]
    },
    "pathophysiology": "子宮扭轉發生時子宮體或子宮角沿長軸旋轉，扭轉程度從90度到360度以上不等。扭轉首先阻斷靜脈回流（因靜脈壁薄、壓力低），導致子宮充血腫脹。隨扭轉程度加重，動脈供應亦被阻斷，子宮組織缺血壞死。妊娠子宮因重量和活動度增加，較易發生扭轉。子宮蓄膿的膨大子宮同樣增加扭轉風險。壞死的子宮壁通透性增加，細菌和毒素進入腹腔引起腹膜炎，進入血循環引起敗血症和休克。",
    "diagnosis": {
      "overview": "臨床症狀提示急腹症，確診通常需手術探查",
      "differentials": [
        "難產",
        "子宮破裂",
        "卵巢扭轉",
        "胃擴張扭轉",
        "腸梗阻"
      ],
      "initialDB": [
        "腹部超音波（子宮異常腫大、血流異常）",
        "腹部X光",
        "CBC和生化（炎症和器官功能）"
      ],
      "advanced": [
        "都卜勒超音波（評估子宮血流）",
        "腹腔穿刺（排除腹膜炎）",
        "凝血功能（排除DIC）"
      ]
    },
    "treatment": {
      "overview": "緊急手術為唯一治療方法",
      "acute": [
        "休克矯正：大量IV輸液",
        "止痛",
        "緊急開腹探查",
        "妊娠犬：剖腹產+OHE",
        "非妊娠犬：OHE"
      ],
      "chronic": [
        "術後抗生素",
        "術後止痛和營養支持",
        "腹膜炎者需腹腔灌洗"
      ]
    },
    "prognosis": "及時手術糾正休克後預後良好。延誤手術導致子宮壞死、腹膜炎和DIC時預後差。妊娠犬的胎兒存活率取決於缺血時間。術後多建議OHE以防復發。",
    "pearls": [
      "子宮扭轉是罕見但致命的急症",
      "妊娠晚期急性腹痛+分娩停滯→考慮子宮扭轉",
      "確診通常需手術探查",
      "及時手術是改善預後的關鍵"
    ],
    "diagnosticAlgorithm": {
      "title": "子宮扭轉 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "急性腹痛評估",
          "details": "理學檢查和病史",
          "findings": [
            "急性腹痛",
            "妊娠或子宮病變史",
            "休克徵象"
          ]
        },
        {
          "step": 2,
          "action": "影像學",
          "details": "超音波和X光",
          "findings": [
            "子宮異常腫大",
            "子宮血流異常",
            "腹腔液體"
          ]
        },
        {
          "step": 3,
          "action": "穩定和準備手術",
          "details": "休克矯正+手術準備",
          "findings": [
            "IV輸液抗休克",
            "血液檢查",
            "凝血功能"
          ]
        },
        {
          "step": 4,
          "action": "手術探查",
          "details": "開腹確診+治療",
          "findings": [
            "子宮扭轉確認",
            "組織活力評估",
            "OHE±剖腹產"
          ]
        }
      ]
    },
    "monitoring": [
      "術後生命徵象",
      "腹膜炎徵象",
      "傷口癒合",
      "DIC監測"
    ],
    "reference": "Cornell CVM; Merck Veterinary Manual — Dystocia; Frontiers in Vet Science — Uterine Torsion"
  },
  "transmissible-venereal-tumor": {
    "zh": "傳染性性病腫瘤",
    "en": "Transmissible Venereal Tumor",
    "definition": "犬的獨特傳染性腫瘤，透過交配或直接接觸（舔舐、嗅聞）傳播活腫瘤細胞。TVT的腫瘤細胞本身即為傳染原，具有異常的染色體核型（59條而非正常犬78條），是已知最古老的無性繁殖細胞系之一，估計已存在超過6000年。主要影響生殖器官但可轉移至皮膚和黏膜。",
    "synonyms": [
      "TVT",
      "Sticker腫瘤",
      "Sticker Sarcoma",
      "Venereal Granuloma"
    ],
    "epidemiology": {
      "species": "犬",
      "age": "性活躍年齡（1-8歲）",
      "sex": "公母犬皆可",
      "riskFactors": [
        "未絕育且自由漫遊的犬",
        "流浪犬群體",
        "熱帶和亞熱帶地區",
        "多犬共處環境"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "生殖器腫塊",
        "血性陰道分泌物（母犬）或包皮分泌物（公犬）",
        "過度舔舐生殖器",
        "腫塊可能在鼻腔或口腔（經舔舐傳播）"
      ],
      "physicalExam": [
        "陰莖、陰道或外陰表面的分葉狀菜花樣腫塊",
        "腫塊表面易出血",
        "質地脆、紅色至灰紅色",
        "偶見鼻腔、口腔或皮膚轉移",
        "局部淋巴結可能腫大"
      ]
    },
    "pathophysiology": "TVT是一種自然傳播的同種異體移植物，腫瘤細胞本身即為傳染性實體。傳播機制為交配或黏膜接觸時，活的腫瘤細胞經由破損的上皮植入受體犬的黏膜。TVT細胞的MHC-I表達被下調，使其能逃避宿主免疫監視。在免疫健全的犬中，TVT通常經過生長期（P期）→穩定期（S期）→消退期（R期）的自然病程，但免疫功能不全者可能持續生長和轉移。TVT對vincristine化療有極佳的反應率（>90%完全緩解），使其成為少數可靠化療治癒的腫瘤之一。",
    "diagnosis": {
      "overview": "臨床表現高度提示，FNA或活檢確診",
      "differentials": [
        "其他生殖道腫瘤（平滑肌瘤、肥大細胞瘤）",
        "生殖器肉芽腫",
        "尿道脫出",
        "陰道增生"
      ],
      "initialDB": [
        "體格檢查（生殖器視診）",
        "FNA細胞學（見特徵性圓形細胞含清晰細胞質空泡）",
        "CBC/生化"
      ],
      "advanced": [
        "組織活檢和免疫組織化學",
        "影像學（排除遠端轉移）",
        "胸腔X光"
      ]
    },
    "treatment": {
      "overview": "Vincristine化療是首選治療，反應率極高",
      "acute": [
        "Vincristine 0.5-0.7mg/m² IV每週1次",
        "通常需要4-6次治療",
        "首次治療後即可見腫瘤縮小"
      ],
      "chronic": [
        "治療至腫瘤完全消失後再多給1-2次",
        "殘留腫瘤：手術切除+繼續vincristine",
        "多重抗藥病例：doxorubicin替代",
        "絕育預防再暴露"
      ]
    },
    "prognosis": "Vincristine治療預後極佳，完全緩解率>90%。復發率極低。少數多重抗藥病例可用doxorubicin替代。遠端轉移罕見（<5%），多見於免疫功能不全的犬。未治療者在免疫健全犬中可能自行消退，但通常需要數月，期間持續傳播。",
    "pearls": [
      "TVT對vincristine的反應率>90%，是少數可靠化療治癒的腫瘤",
      "TVT的腫瘤細胞有59條染色體（正常犬78條），是存在超過6000年的異體移植物",
      "未絕育的流浪犬群體是TVT最重要的傳播庫"
    ],
    "diagnosticAlgorithm": {
      "title": "傳染性性病腫瘤 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "臨床評估",
          "details": "檢查生殖器腫塊的形態和分泌物",
          "findings": [
            "菜花樣腫塊",
            "易出血",
            "血性分泌物"
          ]
        },
        {
          "step": 2,
          "action": "細胞學確診",
          "details": "FNA見特徵性圓形細胞",
          "findings": [
            "TVT特徵細胞（確診）",
            "其他腫瘤類型",
            "需活檢確認"
          ]
        },
        {
          "step": 3,
          "action": "分期檢查",
          "details": "排除遠端轉移",
          "findings": [
            "局部腫瘤",
            "鼻腔/口腔轉移",
            "遠端轉移"
          ]
        },
        {
          "step": 4,
          "action": "Vincristine治療",
          "details": "每週一次化療直到完全緩解",
          "findings": [
            "完全緩解",
            "部分緩解需繼續",
            "抗藥需換藥"
          ]
        }
      ]
    },
    "monitoring": [
      "每週化療前評估腫瘤大小",
      "每週CBC（vincristine骨髓抑制）",
      "治療結束後1個月確認無復發",
      "建議絕育預防再暴露"
    ],
    "reference": "Strakova A, Murchison EP. The cancer which survived: insights from the genome of an 11000-year-old cancer. Curr Opin Genet Dev. 2015;30:49-55; Withrow SJ. Small Animal Clinical Oncology 6th ed."
  },
  "jaw-fracture": {
    "zh": "頜骨骨折",
    "en": "Jaw Fracture",
    "definition": "下頜骨或上頜骨因外傷、嚴重牙周病或腫瘤侵蝕導致的骨骼斷裂，犬發生率約3%、貓約15%。下頜骨骨折較上頜骨常見，車禍是最主要的病因，小型犬因嚴重牙周病導致的病理性骨折亦不少見。",
    "synonyms": [
      "顎骨骨折",
      "Mandibular Fracture",
      "Maxillary Fracture"
    ],
    "epidemiology": {
      "species": "犬貓皆可，貓發生率更高（15% vs 3%）",
      "age": "任何年齡；外傷性多見於年輕動物，病理性多見於老年小型犬",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "車禍或高處墜落",
        "嚴重牙周病（小型犬、老年犬）",
        "口腔腫瘤骨質侵蝕",
        "醫源性（拔牙併發症）",
        "貓的高樓症候群"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "外傷史",
        "無法進食或飲水",
        "口腔出血",
        "流涎",
        "頜部變形"
      ],
      "physicalExam": [
        "下頜或面部腫脹不對稱",
        "咬合不正",
        "觸診骨折線有異常活動度和捻髮音",
        "口腔黏膜撕裂",
        "牙齒鬆動或移位",
        "顏面神經損傷徵象"
      ]
    },
    "pathophysiology": "外傷性骨折因超過骨骼承受力的外力直接或間接作用於頜骨而發生。車禍是最常見原因，高處墜落和動物打鬥次之。病理性骨折發生於骨質已被牙周病、腫瘤或代謝性骨病削弱的情況下，正常咀嚼力或輕微外力即可造成骨折。小型犬下頜骨相對薄弱，嚴重牙周病導致齒槽骨大量流失後，下頜體區域極易發生病理性骨折。骨折導致疼痛、咬合異常和進食障礙。",
    "diagnosis": {
      "overview": "體格檢查結合放射線學或CT確認骨折位置、類型和移位程度",
      "differentials": [
        "顳顎關節脫臼",
        "顳顎關節炎",
        "軟組織損傷",
        "牙齒骨折"
      ],
      "initialDB": [
        "口腔和顏面觸診",
        "口腔內放射線攝影",
        "標準頭部放射線（DV和lateral）",
        "全身狀態評估（外傷患者）"
      ],
      "advanced": [
        "CT掃描（評估複雜骨折和骨折碎片）",
        "牙科放射線（評估齒根與骨折線關係）",
        "術前血液學檢查"
      ]
    },
    "treatment": {
      "overview": "依骨折類型選擇保守或手術治療，目標為恢復正常咬合",
      "acute": [
        "穩定患者（外傷急救優先）",
        "止痛（buprenorphine 0.01-0.02mg/kg IV/IM q6-8h）",
        "口套或繃帶暫時固定",
        "軟食或管灌餵食"
      ],
      "chronic": [
        "齒間固定術（wire/acrylic splint）",
        "外固定器",
        "骨板和骨釘固定",
        "上顎骨折通常較穩定可保守治療",
        "病理性骨折需同時處理原發病因"
      ]
    },
    "prognosis": "上顎骨折預後通常良好至極佳。下頜骨骨折預後視骨折類型、位置和病因而定：外傷性簡單骨折手術修復後預後良好；老年小型犬牙周病導致的病理性骨折預後較差（骨癒合能力差）。最常見的併發症為咬合不正和骨髓炎。",
    "pearls": [
      "貓頜骨骨折發生率（15%）遠高於犬（3%），多與高處墜落相關",
      "下頜聯合（mandibular symphysis）分離在貓極為常見，用鋼絲固定效果良好",
      "小型犬牙周病相關骨折的骨癒合較差，可能需要長期軟食"
    ],
    "diagnosticAlgorithm": {
      "title": "頜骨骨折 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "外傷患者先穩定生命徵象，評估多重創傷",
          "findings": [
            "生命徵象穩定",
            "多重創傷",
            "呼吸道阻塞"
          ]
        },
        {
          "step": 2,
          "action": "口腔觸診",
          "details": "評估咬合、骨折活動度和軟組織損傷",
          "findings": [
            "咬合不正",
            "異常活動度",
            "捻髮音"
          ]
        },
        {
          "step": 3,
          "action": "影像學檢查",
          "details": "放射線或CT確認骨折位置和類型",
          "findings": [
            "骨折位置和移位",
            "骨折線與齒根關係",
            "多發骨折"
          ]
        },
        {
          "step": 4,
          "action": "治療計畫",
          "details": "根據骨折穩定度和咬合評估選擇固定方式",
          "findings": [
            "保守治療",
            "齒間固定",
            "手術固定"
          ]
        }
      ]
    },
    "monitoring": [
      "術後2週評估咬合和固定穩定度",
      "4-6週放射線追蹤骨癒合",
      "8-12週移除固定裝置",
      "定期口腔檢查監測咬合和牙周狀態"
    ],
    "reference": "ACVS Surgical Summary: Mandibular Fractures 2024; Verstraete FJM, Lommer MJ. Oral and Maxillofacial Surgery in Dogs and Cats 2nd ed. Elsevier 2020."
  },
  "tongue-tumor": {
    "zh": "舌腫瘤",
    "en": "Tongue Tumor",
    "definition": "發生於舌部的腫瘤性病變，犬最常見的為鱗狀細胞癌（SCC）和惡性黑色素瘤，貓則以鱗狀細胞癌為主（最常發生於舌根腹側）。口腔腫瘤是犬第四常見的腫瘤類型，具有局部侵犯性強的特點，常呈冰山效應（深層浸潤範圍遠大於表面所見）。",
    "synonyms": [
      "舌部腫瘤",
      "口腔舌腫瘤",
      "Lingual Neoplasia",
      "Oral Tongue Mass"
    ],
    "epidemiology": {
      "species": "犬貓皆可",
      "age": "中老年（犬平均10歲，貓平均12歲）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "老年動物",
        "口腔色素沉著犬種（黑色素瘤）",
        "貓慢性口炎可能增加SCC風險",
        "環境致癌物質暴露（二手煙）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "進食困難",
        "流涎增加（可能帶血）",
        "口臭",
        "體重減輕",
        "舌部腫塊"
      ],
      "physicalExam": [
        "舌部可見腫塊（可為潰瘍型或增生型）",
        "腫塊易出血",
        "下頜淋巴結腫大",
        "舌運動受限",
        "惡臭口腔分泌物"
      ]
    },
    "pathophysiology": "口腔鱗狀細胞癌起源於口腔黏膜上皮細胞的惡性轉化，通常具有強烈的局部侵犯性，可侵蝕深層肌肉和骨骼組織。貓的口腔SCC特別好發於舌根腹側，可能與舔毛行為導致環境致癌物質（如二手煙殘留物）在該區域濃縮有關。惡性黑色素瘤起源於黑色素細胞，是犬最常見的口腔惡性腫瘤，轉移率高（肺和局部淋巴結）。腫瘤外觀常呈冰山效應，深層組織浸潤範圍遠大於表面可見範圍。",
    "diagnosis": {
      "overview": "組織活檢和病理組織學為確診依據，影像學評估腫瘤範圍和轉移",
      "differentials": [
        "嗜酸性肉芽腫",
        "口腔乳突狀瘤",
        "纖維瘤",
        "口腔炎性息肉",
        "異物肉芽腫"
      ],
      "initialDB": [
        "口腔檢查（需全身麻醉）",
        "細針抽吸細胞學",
        "頭頸部放射線",
        "胸腔放射線（3 views評估肺轉移）"
      ],
      "advanced": [
        "切開或切除式組織活檢",
        "頭部CT/MRI評估腫瘤範圍",
        "淋巴結細針抽吸",
        "腹部超音波（分期）"
      ]
    },
    "treatment": {
      "overview": "手術切除為首選，視腫瘤類型可合併放療或化療",
      "acute": [
        "手術廣泛切除（需2cm安全邊界）",
        "部分舌切除術（glossectomy）",
        "術後止痛和營養支持（食道餵食管）"
      ],
      "chronic": [
        "惡性黑色素瘤：黑色素瘤疫苗（Oncept®）",
        "SCC：放射治療（非手術候選者）",
        "化療（carboplatin、piroxicam等）",
        "貓SCC治療選擇有限，預後差"
      ]
    },
    "prognosis": "犬下頜前端SCC手術切除後中位生存期19-43個月，預後相對較好。舌根或扁桃體SCC預後較差，轉移率高。犬口腔黑色素瘤轉移率高，手術+疫苗中位生存期約12-18個月。貓口腔SCC預後極差，確診後中位生存期僅2-4個月，一年存活率不到10%。",
    "pearls": [
      "貓口腔SCC最常發生在舌根腹側，早期不易發現",
      "口腔腫瘤具冰山效應，深層浸潤範圍通常遠大於表面所見",
      "任何口腔腫塊持續超過2週應進行活檢"
    ],
    "diagnosticAlgorithm": {
      "title": "舌腫瘤 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "臨床評估",
          "details": "全身麻醉下詳細口腔檢查和腫塊評估",
          "findings": [
            "腫塊大小和位置",
            "潰瘍或出血",
            "淋巴結狀態"
          ]
        },
        {
          "step": 2,
          "action": "細胞學/組織學",
          "details": "FNA或切開式活檢取得病理診斷",
          "findings": [
            "SCC",
            "惡性黑色素瘤",
            "良性腫瘤"
          ]
        },
        {
          "step": 3,
          "action": "分期檢查",
          "details": "胸腔X光、淋巴結FNA、CT評估腫瘤範圍",
          "findings": [
            "局部腫瘤",
            "淋巴結轉移",
            "遠端轉移"
          ]
        },
        {
          "step": 4,
          "action": "制定治療計畫",
          "details": "根據腫瘤類型和分期選擇手術、放療或化療",
          "findings": [
            "手術可切除",
            "需多模式治療",
            "姑息治療"
          ]
        }
      ]
    },
    "monitoring": [
      "術後2週評估傷口癒合",
      "每2-3個月胸腔X光檢查轉移",
      "每月口腔和淋巴結觸診",
      "體重和食慾持續追蹤"
    ],
    "reference": "Liptak JM, Withrow SJ. Oral Tumors. In: Withrow & MacEwen's Small Animal Clinical Oncology 6th ed. Elsevier 2020; Merck Veterinary Manual: Oral Tumors in Small Animals."
  },
  "hyperactivity-disorder": {
    "zh": "過動症",
    "en": "Hyperactivity Disorder",
    "definition": "犬貓表現持續性過度活動、注意力不集中和衝動控制障礙的行為異常，類似人類的注意力不足過動症（ADHD）。真正的神經化學性過動症在犬中罕見，多數被認為過動的犬實際上是因缺乏運動和訓練導致的正常高能量行為，需鑑別真性過動與環境管理不足。",
    "synonyms": [
      "注意力不足過動症",
      "犬ADHD",
      "Hyperkinesis",
      "Canine ADHD"
    ],
    "epidemiology": {
      "species": "犬為主（貓極罕見）",
      "age": "幼犬至青年犬（6月齡-3歲）最常被提出",
      "sex": "公犬略多",
      "riskFactors": [
        "高能量工作犬種（邊境牧羊犬、傑克羅素梗）",
        "運動量嚴重不足",
        "缺乏訓練和結構化活動",
        "早期與母犬分離"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "無法安靜坐下",
        "持續性躁動不安",
        "注意力極短",
        "破壞行為",
        "即使大量運動後仍無法平靜"
      ],
      "physicalExam": [
        "心率可能輕度升高",
        "檢查時持續躁動",
        "無法配合基本指令",
        "體格檢查通常正常",
        "真性過動：methylphenidate試驗後心率下降和行為鎮靜（矛盾反應）"
      ]
    },
    "pathophysiology": "真性過動症（hyperkinesis）是多巴胺和去甲腎上腺素系統失調的神經化學性疾病，大腦前額葉皮質功能不足導致衝動控制和注意力調節障礙。診斷性特徵是對中樞興奮劑（methylphenidate）產生矛盾性鎮靜反應——正常犬會更興奮，真性過動犬反而安靜下來（因為補充了不足的多巴胺/去甲腎上腺素信號）。然而，絕大多數被飼主認為「過動」的犬實際上只是高能量品種在缺乏足夠運動和心智刺激環境下的正常行為表現，並非真正的神經化學異常。",
    "diagnosis": {
      "overview": "排除環境因素後，methylphenidate試驗是鑑別真性過動與正常高活動量的關鍵",
      "differentials": [
        "正常高能量品種行為",
        "運動量不足",
        "分離焦慮",
        "強迫行為障礙",
        "甲狀腺功能亢進",
        "疼痛或不適"
      ],
      "initialDB": [
        "詳細行為史（運動量、環境、訓練）",
        "完整體格檢查",
        "CBC/生化/甲狀腺功能",
        "靜息心率和呼吸頻率基線"
      ],
      "advanced": [
        "Methylphenidate試驗（0.2-1mg/kg PO，監測心率反應）",
        "行為專科評估",
        "尿液兒茶酚胺代謝物",
        "腦部MRI（排除結構異常）"
      ]
    },
    "treatment": {
      "overview": "環境管理和運動增加為首要，真性過動可考慮藥物治療",
      "acute": [
        "大幅增加每日運動量和心智刺激",
        "結構化日常作息",
        "正向強化訓練基本服從",
        "短效鎮靜（trazodone）用於特定情境"
      ],
      "chronic": [
        "真性過動：Methylphenidate 0.2-1mg/kg PO q12h",
        "環境豐富化和互動玩具",
        "每日至少2次中高強度運動",
        "持續訓練和心智挑戰（嗅聞遊戲、食物益智玩具）"
      ]
    },
    "prognosis": "多數「過動犬」並非真性過動，增加運動和訓練後可顯著改善，預後良好。真性過動症（methylphenidate矛盾反應陽性）較罕見，需長期藥物管理但多數可獲得良好控制。飼主教育和期望管理是治療成功的關鍵。",
    "pearls": [
      "絕大多數「過動犬」只是運動量不足的高能量品種，不是真性過動",
      "Methylphenidate矛盾反應（興奮劑反而使犬安靜）是診斷真性過動的金標準",
      "增加運動和心智刺激是最重要的治療策略，無論是否為真性過動"
    ],
    "diagnosticAlgorithm": {
      "title": "過動症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "環境評估",
          "details": "確認每日運動量、環境豐富度和訓練程度",
          "findings": [
            "運動不足",
            "環境貧乏",
            "已充足仍過動"
          ]
        },
        {
          "step": 2,
          "action": "醫學排除",
          "details": "血液學和甲狀腺功能排除代謝疾病",
          "findings": [
            "醫學正常",
            "甲狀腺異常",
            "疼痛來源"
          ]
        },
        {
          "step": 3,
          "action": "Methylphenidate試驗",
          "details": "單次給予methylphenidate監測心率和行為反應",
          "findings": [
            "矛盾反應（真性過動）",
            "正常反應（環境性過動）"
          ]
        },
        {
          "step": 4,
          "action": "治療方案",
          "details": "環境管理為基礎，真性過動加藥物治療",
          "findings": [
            "環境管理改善",
            "需持續藥物治療"
          ]
        }
      ]
    },
    "monitoring": [
      "增加運動後2-4週行為評估",
      "Methylphenidate劑量調整和副作用監測",
      "每月行為進度追蹤",
      "飼主配合度和生活品質評估"
    ],
    "reference": "Overall KL. Manual of Clinical Behavioral Medicine. Elsevier 2013; Luescher AU. Hyperkinesis in dogs: Six case reports. Can Vet J. 1993;34(6):368."
  },
  "inter-cat-aggression": {
    "zh": "貓間攻擊行為",
    "en": "Inter-Cat Aggression",
    "definition": "同住貓隻之間發生的攻擊或衝突行為，是多貓家庭最常見的行為問題。可表現為明顯的打鬥、追逐，或較隱蔽的資源控制、阻擋通道和社交壓力。常因資源競爭、社會階層不穩定、新成員加入或領域重疊引起。",
    "synonyms": [
      "貓與貓攻擊",
      "多貓衝突",
      "Intercat Aggression",
      "Feline Social Conflict"
    ],
    "epidemiology": {
      "species": "貓",
      "age": "社會成熟期（2-4歲）後常加劇",
      "sex": "未絕育公貓較常見明顯攻擊",
      "riskFactors": [
        "多貓家庭",
        "資源不足（食碗、水碗、貓砂盆、休息點）",
        "新貓引入不當",
        "室內空間有限",
        "社會成熟期社會結構改變"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "追逐和打鬥",
        "一隻貓持續躲藏",
        "隨地排泄（壓力相關）",
        "食慾改變",
        "新貓加入後衝突"
      ],
      "physicalExam": [
        "可能見到咬傷或抓傷",
        "壓力貓可能消瘦",
        "壓力相關疾病（膀胱炎、過度理毛）",
        "攻擊貓通常體格正常",
        "需排除疼痛原因"
      ]
    },
    "pathophysiology": "貓是獨居性掠食者，其社會結構與犬不同。在野外，貓形成鬆散的母系群體，群體接受或排斥成員。多貓家庭中的衝突通常源於：(1)資源競爭——貓砂盆、食碗、休息點和飼主注意力不足以供應所有貓；(2)社會成熟後階層變動——2-4歲社會成熟後，原本和平相處的貓可能開始爭奪社會地位；(3)新成員引入——未經適當介紹的新貓被視為入侵者；(4)領域重疊——室內空間有限迫使貓共享不願共享的區域。慢性社交壓力可導致壓力相關疾病（特發性膀胱炎、過度理毛、食慾改變）。",
    "diagnosis": {
      "overview": "行為評估為主，分析衝突模式、資源分布和社會互動",
      "differentials": [
        "遊戲行為（幼貓）",
        "疼痛相關攻擊",
        "重導向攻擊",
        "醫學原因（甲狀腺亢進、神經疾病）",
        "領域性攻擊（對室外貓）"
      ],
      "initialDB": [
        "多貓家庭環境評估",
        "資源清點（N+1法則）",
        "各貓基本健康檢查",
        "甲狀腺功能（老年貓）"
      ],
      "advanced": [
        "行為專科評估",
        "居家影片觀察",
        "壓力指標評估（尿液皮質醇）",
        "受害貓壓力相關疾病排除"
      ]
    },
    "treatment": {
      "overview": "增加資源、空間管理和漸進式重新介紹",
      "acute": [
        "暫時完全分離衝突貓隻",
        "各自獨立的資源組（食碗、貓砂盆、水碗）",
        "Feliway® MultiCat費洛蒙擴散器",
        "受傷貓的傷口處理"
      ],
      "chronic": [
        "漸進式重新介紹（氣味交換→視覺接觸→直接接觸）",
        "資源N+1法則（N隻貓需N+1組資源）",
        "增加垂直空間和隱蔽處",
        "必要時Fluoxetine 0.5-1mg/kg PO q24h（攻擊貓）"
      ]
    },
    "prognosis": "預後視衝突嚴重度和時間長度而定。輕度衝突透過資源增加和空間管理多可改善。嚴重或長期衝突（>數月）的完全和解較困難，可能需要永久性部分隔離和資源分區管理。部分病例可能需考慮重新安置其中一隻貓。",
    "pearls": [
      "貓砂盆數量應為貓數+1，且分散放置在不同位置",
      "社會成熟期（2-4歲）是多貓衝突的高峰期",
      "隱蔽性衝突（阻擋通道、盯視、資源獨佔）比打鬥更常見但更易被忽略"
    ],
    "diagnosticAlgorithm": {
      "title": "貓間攻擊行為 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "衝突評估",
          "details": "分析攻擊模式、頻率、觸發因子和受害貓",
          "findings": [
            "明顯打鬥",
            "隱蔽性壓力",
            "資源相關"
          ]
        },
        {
          "step": 2,
          "action": "環境評估",
          "details": "清點資源數量和空間分布",
          "findings": [
            "資源不足",
            "空間有限",
            "逃跑路線不足"
          ]
        },
        {
          "step": 3,
          "action": "醫學排除",
          "details": "各貓健康檢查排除疼痛和疾病",
          "findings": [
            "疼痛來源",
            "甲狀腺亢進",
            "醫學正常"
          ]
        },
        {
          "step": 4,
          "action": "管理計畫",
          "details": "分離+資源增加+漸進式重新介紹",
          "findings": [
            "資源增加即改善",
            "需漸進式重新介紹",
            "可能需永久隔離"
          ]
        }
      ]
    },
    "monitoring": [
      "衝突頻率和強度追蹤",
      "受害貓壓力相關疾病監測",
      "重新介紹進度評估",
      "費洛蒙療效追蹤"
    ],
    "reference": "Crowell-Davis SL et al. Social organization in the cat. JAVMA. 2004;224(9):1451-1458; AAFP Feline Environmental Needs Guidelines 2013."
  },
  "redirected-aggression": {
    "zh": "重導向攻擊行為",
    "en": "Redirected Aggression",
    "definition": "犬貓在無法接近引起激動的實際目標時，將攻擊轉向身邊無關的人或動物的行為。是犬貓攻擊飼主的常見原因之一，通常發生突然且飼主不理解觸發因子。貓的重導向攻擊尤為常見，經典場景為看到窗外的陌生貓後攻擊同住貓或飼主。",
    "synonyms": [
      "轉移性攻擊",
      "移轉攻擊",
      "Displaced Aggression"
    ],
    "epidemiology": {
      "species": "犬貓皆見，貓尤為常見",
      "age": "任何年齡",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "窗外可見陌生動物",
        "高激動性個體",
        "多動物家庭",
        "無法接近激動源的環境",
        "以往攻擊史"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "看似無預警地突然攻擊飼主或同住動物",
        "攻擊前可能注視窗外或門外",
        "攻擊力度常很強",
        "攻擊後可能持續激動數小時至數天"
      ],
      "physicalExam": [
        "激動狀態：瞳孔放大、豎毛、低吼",
        "體格檢查通常正常",
        "受害者可能有嚴重咬傷（特別是貓的攻擊）",
        "需排除疼痛和神經疾病"
      ]
    },
    "pathophysiology": "重導向攻擊涉及激動狀態的溢出效應。當動物看到或聽到激動源（如窗外的陌生貓、門外的陌生犬、門鈴響）但無法直接接觸時，交感神經系統高度激活，腎上腺素和去甲腎上腺素大量釋放。此時若有人或動物接觸激動中的動物（如飼主觸碰正在窗邊嘶吼的貓），積累的攻擊能量被「重導向」至最近的可及目標。貓的重導向攻擊特別危險，因為貓可維持高度激動狀態長達數小時甚至數天，在此期間對任何接近的個體都可能攻擊。",
    "diagnosis": {
      "overview": "根據攻擊情境分析確認重導向機制",
      "differentials": [
        "特發性攻擊",
        "恐懼性攻擊",
        "疼痛相關攻擊",
        "癲癇後期攻擊",
        "腦部疾病"
      ],
      "initialDB": [
        "詳細攻擊事件重建（時間、地點、前驅事件）",
        "環境因素分析（窗外視野、外部動物）",
        "完整體格和神經學檢查",
        "基本血液學"
      ],
      "advanced": [
        "居家監視攝影",
        "行為專科評估",
        "腦部MRI（排除神經疾病）",
        "腦電圖（排除癲癇）"
      ]
    },
    "treatment": {
      "overview": "識別和消除激動源+急性期管理+環境修正",
      "acute": [
        "不要觸碰激動中的動物",
        "安全隔離激動動物至暗室靜置",
        "激動後至少等待數小時再接觸",
        "受害者傷口處理"
      ],
      "chronic": [
        "阻斷視覺刺激（窗戶貼膜、遮蔽）",
        "室外陌生貓驅離（動態噴水器）",
        "Feliway®費洛蒙（貓）",
        "必要時短期抗焦慮藥物"
      ]
    },
    "prognosis": "若能成功識別和消除激動源，預後良好。無法去除激動源（如無法控制的室外流浪貓）時可透過視覺阻斷管理。貓的重導向攻擊可能導致同住貓之間長期敵對關係，需要漸進式重新介紹。飼主教育（避免觸碰激動中的貓）是預防的關鍵。",
    "pearls": [
      "永遠不要觸碰或試圖安撫正在高度激動狀態的貓，等待其自行冷靜",
      "窗外的陌生貓是貓重導向攻擊最常見的觸發因子",
      "一次嚴重的重導向攻擊可能導致同住貓之間永久性的敵對關係"
    ],
    "diagnosticAlgorithm": {
      "title": "重導向攻擊行為 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "事件重建",
          "details": "詳細還原攻擊前後的時間線和環境",
          "findings": [
            "可識別激動源",
            "激動後攻擊無關目標",
            "無明確觸發"
          ]
        },
        {
          "step": 2,
          "action": "醫學排除",
          "details": "體格、神經學檢查和基本血液學",
          "findings": [
            "醫學正常",
            "疼痛來源",
            "神經異常"
          ]
        },
        {
          "step": 3,
          "action": "環境評估",
          "details": "檢查窗外視野和外部動物活動",
          "findings": [
            "外部動物確認",
            "門鈴/噪音觸發",
            "未知觸發"
          ]
        },
        {
          "step": 4,
          "action": "管理方案",
          "details": "阻斷激動源+飼主教育+必要時藥物",
          "findings": [
            "環境修正有效",
            "需藥物輔助",
            "同住動物需重新介紹"
          ]
        }
      ]
    },
    "monitoring": [
      "攻擊事件頻率追蹤",
      "環境修正效果評估",
      "同住動物關係恢復進度",
      "飼主安全行為遵從度"
    ],
    "reference": "Overall KL. Manual of Clinical Behavioral Medicine. Elsevier 2013; Chapman BL, Voith VL. Cat aggression redirected to people. JAVMA. 1990;196(6):947."
  },
  "plasmacytoma": {
    "zh": "漿細胞瘤",
    "en": "Plasmacytoma",
    "definition": "犬的骨髓外漿細胞（extramedullary plasmacytoma）良性腫瘤，是犬皮膚最常見的圓形細胞腫瘤之一。與惡性多發性骨髓瘤不同，骨髓外漿細胞瘤通常為單一良性病灶，好發於皮膚、口腔黏膜和消化道。皮膚型幾乎全部為良性，手術切除即可治癒。",
    "synonyms": [
      "骨髓外漿細胞瘤",
      "皮膚漿細胞瘤",
      "Extramedullary Plasmacytoma",
      "Cutaneous Plasmacytoma"
    ],
    "epidemiology": {
      "species": "犬（貓罕見）",
      "age": "中老年犬（平均9-10歲）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "老年犬",
        "可卡犬可能較多",
        "無明確環境風險因子"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "皮膚或黏膜腫塊",
        "通常單一病灶",
        "緩慢生長",
        "通常無全身症狀"
      ],
      "physicalExam": [
        "隆起的圓形皮膚結節",
        "多為無毛、紅色至粉紅色",
        "質地堅韌",
        "好發部位：四肢、軀幹、耳朵、口腔",
        "通常<2cm",
        "表面可能潰瘍"
      ]
    },
    "pathophysiology": "骨髓外漿細胞瘤起源於B淋巴球終末分化的漿細胞在骨髓以外的組織異常增殖。與多發性骨髓瘤（骨髓內漿細胞惡性增殖）不同，骨髓外漿細胞瘤通常為單一克隆性良性增殖，不伴隨全身性免疫球蛋白異常或骨髓浸潤。皮膚型漿細胞瘤幾乎全部為良性。口腔和消化道型的局部侵犯性和復發率略高。免疫組織化學顯示腫瘤細胞表達CD79a和MUM-1，但不表達CD3。極少數可能轉化為全身性漿細胞疾病。",
    "diagnosis": {
      "overview": "FNA或活檢確診，需排除多發性骨髓瘤",
      "differentials": [
        "肥大細胞瘤",
        "組織球瘤",
        "淋巴瘤",
        "黑色素瘤",
        "多發性骨髓瘤"
      ],
      "initialDB": [
        "FNA細胞學（見成熟漿細胞）",
        "CBC/生化（排除高球蛋白血症）",
        "尿液分析（排除Bence-Jones蛋白尿）"
      ],
      "advanced": [
        "組織活檢和免疫組織化學",
        "血清蛋白電泳",
        "骨髓穿刺（排除多發性骨髓瘤）",
        "全身放射線（排除骨溶解病灶）"
      ]
    },
    "treatment": {
      "overview": "手術完整切除為皮膚型的首選和治癒性治療",
      "acute": [
        "手術切除（1cm邊界即可）",
        "口腔型可能需要更廣泛切除"
      ],
      "chronic": [
        "不完全切除：追加手術或放射治療",
        "多發或復發型：考慮低劑量化療（melphalan+prednisolone）",
        "消化道型：手術+化療"
      ]
    },
    "prognosis": "皮膚型漿細胞瘤手術切除後預後極佳，治癒率接近100%。口腔型局部復發率較高（約20%）但通常可再次切除控制。消化道型預後較差。極少數（<2%）進展為全身性漿細胞疾病。皮膚型是犬最常見且預後最好的皮膚圓形細胞腫瘤之一。",
    "pearls": [
      "皮膚漿細胞瘤幾乎全部為良性，手術切除即可治癒",
      "需與多發性骨髓瘤鑑別——檢查血清蛋白電泳和尿液Bence-Jones蛋白",
      "FNA見典型的漿細胞（偏心核、核周透明區）即可初步診斷"
    ],
    "diagnosticAlgorithm": {
      "title": "漿細胞瘤 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "細胞學評估",
          "details": "FNA確認漿細胞腫瘤",
          "findings": [
            "典型漿細胞",
            "不典型細胞（需活檢）",
            "其他腫瘤類型"
          ]
        },
        {
          "step": 2,
          "action": "排除骨髓瘤",
          "details": "血清蛋白電泳、尿液和CBC",
          "findings": [
            "無全身性異常",
            "高球蛋白血症",
            "Bence-Jones蛋白陽性"
          ]
        },
        {
          "step": 3,
          "action": "手術切除",
          "details": "完整切除並送組織病理學",
          "findings": [
            "完整切除",
            "邊界不乾淨",
            "惡性特徵"
          ]
        },
        {
          "step": 4,
          "action": "術後評估",
          "details": "確認切除完整並計畫追蹤",
          "findings": [
            "治癒",
            "需追加治療",
            "需全身分期"
          ]
        }
      ]
    },
    "monitoring": [
      "術後2週評估傷口癒合",
      "3個月和6個月後局部觸診追蹤",
      "年度血清蛋白電泳（排除全身進展）",
      "口腔型每3個月口腔檢查"
    ],
    "reference": "Rakich PM et al. Mucocutaneous plasmacytomas in dogs. JAVMA. 1989;194(6):803-806; Withrow SJ. Small Animal Clinical Oncology 6th ed."
  },
  "hepatocutaneous-syndrome": {
    "zh": "肝皮膚症候群",
    "en": "Hepatocutaneous Syndrome",
    "definition": "犬的罕見代謝性皮膚病，正式名稱為表淺壞死性皮膚炎（superficial necrolytic dermatitis），與特徵性肝病變相關。超音波下肝臟呈「瑞士起司」樣外觀。臨床表現為足墊和黏膜皮膚交界處的嚴重結痂、潰瘍和紅斑，因全身性胺基酸缺乏導致表皮壞死。",
    "synonyms": [
      "表淺壞死性皮膚炎",
      "壞死性遊走性紅斑",
      "Superficial Necrolytic Dermatitis",
      "Necrolytic Migratory Erythema",
      "SND"
    ],
    "epidemiology": {
      "species": "犬（貓極罕見）",
      "age": "中老年犬（平均10歲以上）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "慢性肝病",
        "升糖素瘤（罕見）",
        "長期苯巴比妥治療",
        "糖尿病"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "足墊腫脹疼痛和皸裂",
        "面部和生殖器區域結痂和潰瘍",
        "跛行（足墊疼痛）",
        "嗜睡和食慾下降"
      ],
      "physicalExam": [
        "足墊嚴重角化過度、皸裂和潰瘍",
        "眼周、口周、鼻周和生殖器周圍結痂紅斑",
        "壓力點皮膚病變",
        "皮膚組織學見「紅白藍」三層特徵",
        "可能合併糖尿病症狀"
      ]
    },
    "pathophysiology": "肝皮膚症候群的核心機制為嚴重的全身性胺基酸缺乏，導致表皮角質形成細胞營養不足而壞死。肝臟嚴重受損後（原因可為特發性肝空泡化病變、苯巴比妥毒性、升糖素瘤等），肝臟正常的胺基酸代謝功能喪失，加上可能的升糖素異常升高（升糖素分解代謝胺基酸），導致血漿胺基酸濃度嚴重降低。表皮角質形成細胞因胺基酸不足無法正常合成蛋白質，發生細胞內水腫和壞死。組織學上表現為病理性「紅白藍」三層模式：過度角化（紅）、表層角質形成細胞空泡變性（白）和基底層增生（藍）。超音波下肝臟呈特徵性的「瑞士起司」樣多發低回聲結節。",
    "diagnosis": {
      "overview": "皮膚活檢見「紅白藍」模式+腹部超音波見「瑞士起司」肝為高度診斷性",
      "differentials": [
        "鋅缺乏性皮膚炎",
        "皮肌炎",
        "落葉型天疱瘡",
        "全身性紅斑性狼瘡",
        "藥物反應"
      ],
      "initialDB": [
        "皮膚活檢（見特徵性三層模式）",
        "腹部超音波（肝臟瑞士起司樣）",
        "CBC/生化（低白蛋白、低胺基酸、高肝酶）",
        "血糖（常合併糖尿病）"
      ],
      "advanced": [
        "血漿胺基酸濃度分析",
        "血清升糖素濃度",
        "肝臟活檢（確認肝病類型）",
        "胰臟影像學（排除升糖素瘤）"
      ]
    },
    "treatment": {
      "overview": "補充胺基酸為核心治療，合併皮膚護理和基礎疾病管理",
      "acute": [
        "靜脈胺基酸輸注（經頸靜脈中心導管）",
        "高蛋白飲食和口服胺基酸補充",
        "足墊護理（柔軟劑、防水繃帶）",
        "繼發感染抗生素治療"
      ],
      "chronic": [
        "定期靜脈胺基酸輸注（每1-2週）",
        "口服SAMe、精胺酸、穀胱甘肽等補充",
        "自製高蛋白均衡飲食",
        "管理合併的糖尿病",
        "升糖素瘤：手術切除（罕見可治癒病因）"
      ]
    },
    "prognosis": "傳統上被認為預後極差（中位生存期約6個月），但近年研究顯示積極的胺基酸補充和營養管理可顯著延長生存期，部分犬可維持良好生活品質超過1年。升糖素瘤引起者若能手術切除為唯一可能的治癒途徑。苯巴比妥相關者停藥後可能改善。",
    "pearls": [
      "腹部超音波見「瑞士起司」樣肝+足墊病變=高度懷疑肝皮膚症候群",
      "皮膚活檢的「紅白藍」三層模式是病理學確診的關鍵",
      "靜脈胺基酸輸注是最有效的治療，可在數天內改善皮膚病變"
    ],
    "diagnosticAlgorithm": {
      "title": "肝皮膚症候群 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "臨床評估",
          "details": "足墊病變+黏膜皮膚交界處結痂+全身症狀",
          "findings": [
            "足墊角化潰瘍",
            "面部結痂",
            "跛行"
          ]
        },
        {
          "step": 2,
          "action": "皮膚活檢",
          "details": "確認「紅白藍」組織學模式",
          "findings": [
            "典型SND模式",
            "非典型需鑑別",
            "排除其他皮膚病"
          ]
        },
        {
          "step": 3,
          "action": "腹部超音波",
          "details": "評估肝臟形態和胰臟",
          "findings": [
            "瑞士起司樣肝",
            "升糖素瘤",
            "正常（非典型）"
          ]
        },
        {
          "step": 4,
          "action": "營養支持治療",
          "details": "開始胺基酸輸注和營養管理",
          "findings": [
            "皮膚改善",
            "需持續輸注",
            "合併糖尿病管理"
          ]
        }
      ]
    },
    "monitoring": [
      "皮膚病變嚴重度追蹤（足墊和面部）",
      "血漿白蛋白和胺基酸濃度",
      "血糖監測（糖尿病管理）",
      "肝功能定期追蹤"
    ],
    "reference": "Merck Veterinary Manual: Hepatocutaneous Syndrome in Small Animals; Loftus JP et al. Treatment and outcomes of dogs with HCS. JVIM. 2022;36(1):106-115."
  },
  "calcinosis-cutis": {
    "zh": "皮膚鈣質沉著症",
    "en": "Calcinosis Cutis",
    "definition": "犬皮膚和皮下組織中發生不可溶性鈣鹽（磷酸鈣和碳酸鈣）異常沉積的疾病。最常見的原因為內源性或外源性糖皮質素過量（庫欣氏症或醫源性），其次為腎衰竭相關的高磷血症。沉積的鈣鹽引起嚴重的皮膚發炎反應和繼發感染。",
    "synonyms": [
      "鈣質沉著",
      "皮膚鈣化症",
      "Cutaneous Calcinosis",
      "Metastatic Calcification"
    ],
    "epidemiology": {
      "species": "犬（貓極罕見）",
      "age": "中老年犬（與庫欣氏症年齡分布一致）",
      "sex": "無明顯性別傾向（與基礎疾病相關）",
      "riskFactors": [
        "庫欣氏症（自發性或醫源性）",
        "長期糖皮質素治療",
        "慢性腎病（高磷血症）",
        "維生素D中毒"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "皮膚堅硬的白色丘疹或斑塊",
        "皮膚搔癢和發炎",
        "長期使用類固醇病史或庫欣氏症症狀",
        "皮膚脆弱易碎"
      ],
      "physicalExam": [
        "皮膚堅硬的白色/黃白色丘疹、結節或斑塊",
        "好發部位：背側頸部、腹股溝、腋下",
        "皮膚觸感粗糙似砂紙",
        "繼發性皮膚感染",
        "可能有庫欣氏症其他症狀（PU/PD、腹部膨脹、對稱性脫毛）"
      ]
    },
    "pathophysiology": "皮膚鈣質沉著症依機制分為：(1)轉移性鈣化——血鈣或血磷升高導致鈣磷乘積超過閾值（>70 mg²/dL²），鈣鹽在組織中沉積。常見於腎衰竭（高磷血症）、維生素D中毒和原發性副甲狀腺功能亢進。(2)營養不良性鈣化——局部組織損傷後鈣鹽沉積於壞死或變性組織。(3)醫源性/庫欣氏症相關——糖皮質素過量透過多種機制促進皮膚鈣化：增加鈣磷乘積、損傷膠原纖維彈性纖維結構、改變皮膚基質成分使其更易沉積鈣鹽。沉積的鈣鹽結晶引起異物反應性肉芽腫性發炎，並破壞周圍組織。",
    "diagnosis": {
      "overview": "皮膚活檢確認鈣質沉積+尋找基礎病因（庫欣氏症最常見）",
      "differentials": [
        "毛囊炎",
        "皮膚黴菌感染",
        "皮膚異物反應",
        "皮膚腫瘤"
      ],
      "initialDB": [
        "皮膚活檢（von Kossa染色確認鈣沉積）",
        "CBC/生化（鈣、磷）",
        "ACTH刺激試驗或LDDS試驗（排除庫欣氏症）",
        "尿液分析"
      ],
      "advanced": [
        "腹部超音波（腎上腺評估）",
        "離子鈣",
        "PTH和維生素D代謝物",
        "高劑量地塞米松抑制試驗"
      ]
    },
    "treatment": {
      "overview": "治療基礎病因為根本，鈣化病灶可能在控制病因後逐漸消退",
      "acute": [
        "皮膚繼發感染的抗生素治療",
        "局部護理（軟化劑、預防外傷）",
        "如為外源性類固醇所致，逐步減量停藥"
      ],
      "chronic": [
        "庫欣氏症治療（mitotane或trilostane）",
        "慢性腎病管理（控制高磷血症）",
        "DMSO局部塗抹（可能促進鈣沉積消退）",
        "大型或有症狀的病灶手術切除"
      ]
    },
    "prognosis": "預後與基礎疾病的控制密切相關。外源性糖皮質素停藥後鈣化病灶通常在數週至數月內逐漸消退。庫欣氏症有效控制後亦可見改善。研究顯示伴有非典型性激素型庫欣氏症和鈣質沉著的犬對mitotane反應優於trilostane。慢性腎病相關者預後取決於腎病管理。",
    "pearls": [
      "庫欣氏症犬出現皮膚白色硬結即應懷疑鈣質沉著症",
      "控制基礎病因（停藥/治療庫欣氏症）是最重要的治療",
      "鈣質沉著可為庫欣氏症的首發或唯一皮膚表現"
    ],
    "diagnosticAlgorithm": {
      "title": "皮膚鈣質沉著症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "臨床評估",
          "details": "皮膚病灶形態和基礎疾病病史",
          "findings": [
            "白色硬結斑塊",
            "庫欣氏症症狀",
            "類固醇使用史"
          ]
        },
        {
          "step": 2,
          "action": "皮膚活檢",
          "details": "確認鈣質沉積和發炎反應",
          "findings": [
            "von Kossa陽性",
            "肉芽腫性發炎",
            "排除其他病因"
          ]
        },
        {
          "step": 3,
          "action": "基礎病因調查",
          "details": "ACTH刺激試驗、鈣磷和腎功能",
          "findings": [
            "庫欣氏症",
            "醫源性",
            "腎病",
            "維生素D中毒"
          ]
        },
        {
          "step": 4,
          "action": "治療基礎病因",
          "details": "控制庫欣氏症或停藥+局部護理",
          "findings": [
            "病因控制後消退",
            "需手術切除大病灶",
            "持續管理"
          ]
        }
      ]
    },
    "monitoring": [
      "基礎疾病控制指標（ACTH刺激試驗、鈣磷）",
      "皮膚病灶大小和數量追蹤",
      "繼發感染監測",
      "鈣質沉著消退進度評估"
    ],
    "reference": "VCA: Calcinosis Circumscripta and Cutis; Miller WH et al. Muller & Kirk's Small Animal Dermatology 7th ed. Saunders 2013."
  },
  "otitis-externa-chronic": {
    "zh": "慢性外耳炎",
    "en": "Chronic Otitis Externa",
    "definition": "外耳道的長期反覆發作性炎症，伴隨進行性耳道結構改變（上皮增生、腺體增生、纖維化和鈣化）。是犬最常見的皮膚病之一，通常有潛在主要原因（過敏最常見）驅動反覆感染。終末期可導致不可逆耳道狹窄需全耳道切除。",
    "synonyms": [
      "慢性反覆性外耳炎",
      "End-stage Ear Disease",
      "Recurrent Otitis Externa"
    ],
    "epidemiology": {
      "species": "犬遠較貓常見，佔犬皮膚科門診的10-20%",
      "age": "任何年齡，但隨年齡增加而更常見",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "異位性皮膚炎（犬慢性外耳炎最常見主因43%）",
        "食物過敏",
        "垂耳品種（Cocker Spaniel、Basset Hound）",
        "多毛耳道品種（Poodle）",
        "耳道結構狹窄（Shar-Pei）",
        "游泳頻繁（耳道潮濕）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "反覆發作的耳部搔癢",
        "耳道分泌物反覆出現",
        "頻繁搖頭",
        "對多次抗生素治療僅短暫改善",
        "病程數月至數年",
        "進行性惡化"
      ],
      "physicalExam": [
        "耳道紅腫和增厚",
        "耳道分泌物（黃褐色蠟狀→膿性）",
        "耳道狹窄（增生性改變）",
        "耳道觸診疼痛",
        "鼓膜可能穿孔",
        "耳殼內側苔癬化（慢性搔抓）",
        "耳道鈣化（觸診堅硬）"
      ]
    },
    "pathophysiology": "慢性外耳炎的PSPP模型：Primary(主因)+Secondary(繼發)+Predisposing(易感)+Perpetuating(持續)因子。主因（過敏、內分泌病）改變耳道微環境→繼發細菌（Staphylococcus、Pseudomonas）和/或酵母菌（Malassezia）過度增生→炎症循環加劇。持續因子使治療失敗：中耳炎作為持續感染庫、耳道不可逆結構改變（上皮增生→腺體增生→纖維化→鈣化）。Pseudomonas生物膜形成使抗生素治療更加困難。終末期耳道完全鈣化阻塞，藥物治療無效。",
    "diagnosis": {
      "overview": "臨床診斷直接，重點在找出主要原因（尤其過敏）和評估耳道結構改變程度以決定治療方向",
      "differentials": [
        "急性外耳炎（首次發作）",
        "中耳炎",
        "耳道腫瘤",
        "耳道異物",
        "耳疥蟲"
      ],
      "initialDB": [
        "耳鏡檢查（耳道狀態、鼓膜、分泌物性質）",
        "耳道分泌物細胞學（細菌球菌vs桿菌、酵母菌、中性球）",
        "細菌培養+藥敏（尤其Pseudomonas疑慮時）",
        "皮膚病評估（過敏徵象）"
      ],
      "advanced": [
        "CT（評估中耳和耳道鈣化程度）",
        "皮膚過敏原檢測（intradermal或血清IgE）",
        "食物排除試驗（排除食物過敏）",
        "組織病理學（排除腫瘤）"
      ]
    },
    "treatment": {
      "overview": "三管齊下：(1)治療主因（過敏），(2)控制繼發感染，(3)評估是否需手術。終末期耳道需TECA-LBO",
      "acute": [
        "耳道清潔：鎮靜下深度沖洗（生理鹽水或專用清潔液）",
        "局部抗菌：依細胞學選擇（球菌→Fusidic acid; 桿菌→Gentamicin/Polymyxin; 酵母→Clotrimazole）",
        "全身性抗生素：Pseudomonas→Fluoroquinolone（Enrofloxacin 5-20 mg/kg PO q24h）",
        "局部類固醇（Dexamethasone或Betamethasone耳滴劑）",
        "全身性類固醇（短期衝擊：Prednisolone 1 mg/kg PO q24h × 7-14天）"
      ],
      "chronic": [
        "治療潛在過敏（Oclacitinib、Lokivetmab、飲食管理）",
        "長期耳道維護清潔（飼主居家執行，頻率從每日→每週遞減）",
        "終末期耳道：全耳道切除+鼓室泡截骨術（TECA-LBO）",
        "Ablative CO2雷射（替代手術選擇）"
      ]
    },
    "prognosis": "取決於耳道結構改變程度和主因控制。早期介入+過敏控制預後良好。耳道鈣化/終末期需TECA-LBO，手術預後通常良好（解決疼痛和感染）但犧牲聽力。Pseudomonas生物膜感染治療困難。關鍵在識別和管理主因（過敏），否則即使手術也可能對側耳繼續發作。",
    "pearls": [
      "慢性外耳炎=有主因驅動——找不到主因就無法控制",
      "過敏是犬慢性外耳炎最常見主因（>40%）——耳炎可能是唯一的過敏表現",
      "細胞學比培養更重要——培養陽性不代表感染，細胞學看到吞噬細菌才是",
      "Pseudomonas+桿菌+耳道潰瘍=最具挑戰的組合",
      "耳道鈣化+觸診堅硬=終末期→藥物無效，需TECA-LBO"
    ],
    "diagnosticAlgorithm": {
      "title": "慢性外耳炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "耳道評估",
          "details": "耳鏡+細胞學+培養",
          "findings": [
            "耳道增生/狹窄程度",
            "分泌物細胞學（球菌/桿菌/酵母菌）",
            "鼓膜完整性",
            "耳道觸感（軟→硬鈣化）"
          ]
        },
        {
          "step": 2,
          "action": "主因調查",
          "details": "尋找驅動因素（過敏為首）",
          "findings": [
            "過敏史（季節性?全年?）",
            "皮膚其他病灶",
            "食物排除試驗",
            "內分泌評估（甲低）"
          ]
        },
        {
          "step": 3,
          "action": "結構評估",
          "details": "CT評估中耳和耳道變化",
          "findings": [
            "耳道鈣化程度",
            "中耳受累?",
            "耳道殘餘管腔",
            "決定藥物vs手術"
          ]
        },
        {
          "step": 4,
          "action": "治療策略",
          "details": "感染控制+主因管理+手術評估",
          "findings": [
            "急性感染控制（局部+全身）",
            "主因管理（過敏治療）",
            "終末期→TECA-LBO",
            "維護清潔計畫"
          ]
        }
      ]
    },
    "monitoring": [
      "耳道細胞學追蹤（治療反應）",
      "培養追蹤（Pseudomonas）",
      "過敏控制效果",
      "耳道結構變化",
      "飼主居家清潔頻率調整",
      "對側耳監測"
    ],
    "reference": "Today's Veterinary Practice: Chronic Otitis in Dogs 2023; MSD Veterinary Manual: Otitis Externa 2023; JAVMA 2023"
  },
  "middle-ear-effusion": {
    "zh": "中耳積液",
    "en": "Middle Ear Effusion (PSOM)",
    "definition": "中耳腔（鼓室泡）內異常液體（黏液或漿液）積聚，導致鼓膜膨出和聽力障礙。包括原發性分泌性中耳炎（PSOM，幾乎專見於Cavalier King Charles Spaniel）和繼發於感染或外耳炎的中耳積液。PSOM的黏液極為黏稠（「膠耳」）。",
    "synonyms": [
      "中耳積液",
      "膠耳",
      "原發性分泌性中耳炎",
      "PSOM",
      "Glue Ear",
      "Secretory Otitis Media"
    ],
    "epidemiology": {
      "species": "犬為主，PSOM幾乎僅見於Cavalier King Charles Spaniel",
      "age": "PSOM：任何年齡的Cavalier；繼發性：與外耳炎年齡分佈相同",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "Cavalier King Charles Spaniel（PSOM最高風險，可達50%）",
        "慢性外耳炎（繼發性中耳積液）",
        "短頭品種（耳咽管功能不良）",
        "上呼吸道感染",
        "其他偶報品種：Boxer、Dachshund、Shih Tzu"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "頭頸部疼痛/觸摸頸部敏感",
        "耳部搔抓",
        "搖頭",
        "聽力下降",
        "叫聲改變",
        "面部搔癢"
      ],
      "physicalExam": [
        "鼓膜膨出（耳鏡下可見）",
        "頸部觸診疼痛",
        "頭部傾斜（嚴重時）",
        "面神經麻痺（罕見）",
        "霍納氏症候群（罕見）",
        "外耳道可能看似正常（PSOM特徵——無外耳炎）"
      ]
    },
    "pathophysiology": "PSOM：鼓室泡內黏膜分泌細胞過度增生和活化，產生高度黏稠的黏液（「膠」），填充中耳腔。確切病因不明，可能與耳咽管功能不良（短頭構造影響引流）和品種遺傳易感性有關。黏液積聚→鼓膜膨出→鼓膜壓力→頭頸疼痛。黏液壓迫聽小骨→傳導性聽力損失。可壓迫顏面神經或交感神經→面神經麻痺或霍納氏症候群。繼發性中耳積液：外耳炎或上呼吸道感染經鼓膜穿孔或耳咽管逆行蔓延。",
    "diagnosis": {
      "overview": "耳鏡下鼓膜膨出+CT/MRI確認鼓室泡內容物。PSOM的鼓膜膨出但外耳道無炎症是特徵性表現",
      "differentials": [
        "化膿性中耳炎（感染性）",
        "膽脂瘤",
        "中耳腫瘤",
        "鼓室泡骨折"
      ],
      "initialDB": [
        "耳鏡檢查（鼓膜膨出、外觀完整）",
        "鼓室泡X光",
        "神經學檢查（面神經、霍納氏）"
      ],
      "advanced": [
        "MRI（最可靠的診斷方式：鼓室泡內訊號改變）",
        "CT（鼓室泡骨變化）",
        "鼓膜穿刺抽吸（診斷+治療）",
        "抽吸液細胞學和培養"
      ]
    },
    "treatment": {
      "overview": "鼓膜切開引流（myringotomy）+鼓室泡沖洗為主要治療。PSOM常需重複處理",
      "acute": [
        "鼓膜切開術（Myringotomy）：經鼓膜尾腹側象限切開引流",
        "鼓室泡沖洗：生理鹽水反覆沖洗移除黏稠黏液",
        "視訊耳鏡輔助（更精確的手術和沖洗）",
        "局部Betamethasone（85%病例使用）",
        "全身性Prednisolone 0.5-1 mg/kg PO q24h漸減"
      ],
      "chronic": [
        "全身性抗生素（92%病例使用，依培養選擇）",
        "黏液溶解劑（N-acetylcysteine，57%病例使用）",
        "PSOM常需多次重複myringotomy",
        "定期耳鏡追蹤鼓膜狀態"
      ]
    },
    "prognosis": "PSOM為慢性反覆性疾病，多數需定期重複治療。單次引流後復發率高。長期管理以維護類固醇和定期監測為主。生活品質通常可維持但需持續獸醫照護。繼發性中耳積液如能控制原發外耳炎預後較好。面神經麻痺和霍納氏症候群治療後多數可恢復。",
    "pearls": [
      "Cavalier King Charles Spaniel有頭頸疼痛或抓耳→務必考慮PSOM",
      "PSOM特徵：鼓膜膨出但外耳道看似正常——不像一般中耳炎有外耳炎",
      "MRI是偵測PSOM最可靠的影像學方法",
      "PSOM的黏液極為黏稠——需要反覆沖洗才能清除",
      "頭頸疼痛可能被誤診為頸椎病——CKCS務必排除PSOM"
    ],
    "diagnosticAlgorithm": {
      "title": "中耳積液/PSOM 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "臨床懷疑",
          "details": "品種+頭頸疼痛+耳部症狀",
          "findings": [
            "Cavalier品種",
            "頸部觸診疼痛",
            "耳部搔抓/搖頭",
            "聽力下降"
          ]
        },
        {
          "step": 2,
          "action": "耳鏡檢查",
          "details": "評估鼓膜和外耳道",
          "findings": [
            "鼓膜膨出（光滑完整但凸出）",
            "外耳道可能無炎症（PSOM特徵）",
            "鼓膜顏色改變",
            "神經學異常?"
          ]
        },
        {
          "step": 3,
          "action": "影像確認",
          "details": "MRI或CT評估鼓室泡",
          "findings": [
            "MRI：鼓室泡高訊號",
            "CT：鼓室泡軟組織密度",
            "雙側vs單側",
            "排除腫瘤和膽脂瘤"
          ]
        },
        {
          "step": 4,
          "action": "治療性引流",
          "details": "Myringotomy+沖洗+培養",
          "findings": [
            "鼓膜穿刺引流",
            "黏稠黏液（PSOM特徵）",
            "生理鹽水反覆沖洗",
            "培養+類固醇+抗生素"
          ]
        }
      ]
    },
    "monitoring": [
      "頭頸疼痛改善",
      "鼓膜狀態（定期耳鏡追蹤）",
      "聽力評估",
      "神經功能（面神經、霍納氏）",
      "PSOM復發監測"
    ],
    "reference": "Stern-Bertholtz W, et al. Primary secretory otitis media in CKCS. JVIM 2003; MSPCA-Angell: PSOM; Vet Dermatol 2012"
  },
  "facial-fold-dermatitis": {
    "zh": "面部皺褶皮膚炎",
    "en": "Facial Fold Dermatitis",
    "definition": "犬面部皮膚皺褶（特別是短頭種犬的鼻面部皺褶和部分品種的唇部皺褶）因持續摩擦、潮濕和通氣不良導致的細菌和/或酵母菌繼發感染。屬於皮膚皺褶膿皮症（skin fold pyoderma）的面部型。嚴重的皺褶可導致慢性刺激性角膜炎。",
    "synonyms": [
      "皺褶性皮膚炎",
      "面部皮膚摺皮膚炎",
      "Skin Fold Dermatitis",
      "Facial Fold Pyoderma"
    ],
    "epidemiology": {
      "species": "犬",
      "age": "任何年齡",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "短頭種犬（巴哥、英國鬥牛犬、法國鬥牛犬、波士頓梗）",
        "沙皮犬",
        "可卡犬（唇褶）",
        "過度肥胖加劇皺褶深度"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "面部搔癢和摩擦",
        "面部異味",
        "面部分泌物或結痂",
        "眼睛不適（皺褶刺激角膜時）"
      ],
      "physicalExam": [
        "面部皺褶內紅腫、濕潤",
        "皺褶深處可見黃色至綠色分泌物",
        "惡臭",
        "皮膚糜爛或潰瘍",
        "周圍毛髮染色（淚漬）",
        "可能合併刺激性角膜炎"
      ]
    },
    "pathophysiology": "面部皺褶的解剖結構創造了一個潮濕、溫暖和缺乏通氣的微環境，非常適合細菌（主要為Staphylococcus pseudintermedius）和酵母菌（Malassezia pachydermatis）的過度生長。皺褶內兩側皮膚持續摩擦導致慢性機械性刺激和上皮損傷，破壞皮膚屏障功能。淚液或唾液的持續浸潤進一步增加濕度。感染和發炎互相加劇，形成惡性循環。短頭種犬的鼻面部皺褶是構造性問題，由品種繁殖選擇導致的顏面骨骼短縮使面部皮膚相對過多而形成深褶。嚴重的鼻部皺褶可向下壓迫角膜，造成慢性刺激性角膜病變。",
    "diagnosis": {
      "overview": "臨床診斷為主，細胞學確認感染類型",
      "differentials": [
        "蠕形蟎感染",
        "皮膚黴菌感染",
        "特應性皮炎",
        "天疱瘡",
        "盤狀紅斑性狼瘡"
      ],
      "initialDB": [
        "皺褶處壓片細胞學（確認細菌和/或酵母菌）",
        "完整皮膚檢查",
        "眼科檢查（排除角膜病變）"
      ],
      "advanced": [
        "細菌培養和藥敏試驗（反覆感染時）",
        "皮膚刮片（排除蠕形蟎）",
        "皮膚活檢（排除自體免疫疾病）"
      ]
    },
    "treatment": {
      "overview": "局部清潔+抗菌治療為急性管理，手術矯正為根治方法",
      "acute": [
        "每日皺褶清潔（chlorhexidine溶液或清潔濕紙巾）",
        "局部抗菌藥膏（mupirocin或miconazole）",
        "保持皺褶乾燥",
        "口服抗生素（嚴重感染時：cephalexin 22mg/kg PO q12h）"
      ],
      "chronic": [
        "面部皺褶切除術（cheiloplasty或面部整形）——根治方法",
        "長期每日清潔維護（不手術時）",
        "控制體重減少皺褶深度",
        "角膜病變處理（潤滑劑或手術）"
      ]
    },
    "prognosis": "保守治療（清潔+抗菌）可控制症狀但需終身維護，停止護理後必然復發。手術切除皺褶（面部整形術）為根治方法，術後預後極佳。合併角膜病變者手術矯正更為重要。飼主教育和長期護理配合是非手術管理成功的關鍵。",
    "pearls": [
      "皮膚皺褶切除術是唯一的根治方法，保守治療需要終身維護",
      "面部皺褶可造成刺激性角膜炎，嚴重者需同時進行眼科評估",
      "每日用含chlorhexidine的濕紙巾清潔皺褶是簡單有效的日常護理"
    ],
    "diagnosticAlgorithm": {
      "title": "面部皺褶皮膚炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "臨床評估",
          "details": "評估皺褶深度、感染程度和角膜狀態",
          "findings": [
            "輕度紅腫",
            "感染性分泌物",
            "角膜刺激"
          ]
        },
        {
          "step": 2,
          "action": "細胞學確認",
          "details": "壓片檢查確認感染微生物",
          "findings": [
            "細菌（球菌）",
            "酵母菌",
            "混合感染"
          ]
        },
        {
          "step": 3,
          "action": "排除其他病因",
          "details": "皮膚刮片排除蠕形蟎，必要時活檢",
          "findings": [
            "單純皺褶感染",
            "合併蟎蟲",
            "自體免疫疾病"
          ]
        },
        {
          "step": 4,
          "action": "治療決策",
          "details": "保守管理或手術矯正",
          "findings": [
            "保守管理足夠",
            "建議手術矯正",
            "角膜需同時處理"
          ]
        }
      ]
    },
    "monitoring": [
      "保守治療每2-4週追蹤感染控制",
      "術後2週評估傷口癒合",
      "角膜狀態定期追蹤",
      "飼主護理技巧教育和遵從度評估"
    ],
    "reference": "Miller WH et al. Muller & Kirk's Small Animal Dermatology 7th ed. Saunders 2013; Fossum TW. Small Animal Surgery 5th ed. Elsevier 2019."
  },
  "congenital-megaesophagus": {
    "zh": "先天性巨食道症",
    "en": "Congenital Megaesophagus",
    "definition": "先天性巨食道症是食道因先天性神經肌肉功能異常導致的瀰漫性擴張和蠕動喪失。食道無法有效將食物推送至胃部，導致食物滯留、反流和吸入性肺炎風險。為犬最常見的食道運動障礙，貓較少見。",
    "synonyms": [
      "先天性食道擴張",
      "先天性食道無蠕動症"
    ],
    "epidemiology": {
      "species": "犬為主，貓罕見（除自主神經失調症外）",
      "age": "斷奶開始固體食物時發病（3-12週齡）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "鋼毛獵狐梗（遺傳性，常染色體隱性）",
        "迷你雪納瑞（遺傳性）",
        "大丹犬",
        "德國牧羊犬",
        "拉布拉多犬",
        "紐芬蘭犬",
        "沙皮犬",
        "愛爾蘭雪達犬"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "斷奶後開始反流未消化食物",
        "反流為被動過程（與嘔吐不同，無腹部用力）",
        "體重減輕、發育遲緩",
        "咳嗽（吸入性肺炎）",
        "食慾正常但營養不良"
      ],
      "physicalExam": [
        "體重不足、消瘦",
        "頸部食道擴張可觸及",
        "肺部聽診可能有囉音（吸入性肺炎）",
        "被毛粗糙",
        "口臭"
      ]
    },
    "pathophysiology": "先天性巨食道症的確切病因尚不完全明瞭，推測為食道神經肌肉接合的發育缺陷。可能涉及迷走神經傳入神經異常或食道肌層（犬的食道全段為橫紋肌）功能缺陷。食道失去正常蠕動功能後呈現瀰漫性擴張（megaesophagus），食物依賴重力通過食道。滯留的食物可發酵產氣進一步擴張食道，也可在反流時被誤吸入氣管引起吸入性肺炎，這是最主要的死亡原因。",
    "diagnosis": {
      "overview": "胸部X光可見食道擴張，鋇劑造影確認運動功能喪失",
      "differentials": [
        "持續性右主動脈弓（PRAA）",
        "食道異物",
        "食道狹窄",
        "後天性巨食道症（重症肌無力等）"
      ],
      "initialDB": [
        "胸部X光（側位可見食道擴張、氣管背側位移）",
        "鋇劑食道造影（確認食道運動功能喪失）",
        "CBC和生化"
      ],
      "advanced": [
        "乙醯膽鹼受體抗體檢測（排除重症肌無力）",
        "甲狀腺功能（排除甲狀腺機能低下）",
        "食道內視鏡",
        "食道壓力測定"
      ]
    },
    "treatment": {
      "overview": "以營養管理為主，無有效的手術治療方法",
      "acute": [
        "吸入性肺炎治療：廣效抗生素+氧氣支持",
        "營養支持：高熱量流質飲食",
        "脫水矯正"
      ],
      "chronic": [
        "垂直姿勢餵食（Bailey chair或高架餵食台）",
        "餐後維持直立10-30分鐘利用重力排空食道",
        "少量多餐（每日3-6次）",
        "高熱量泥狀食物（部分犬反而用固體食物球更好）",
        "Cisapride促進食道蠕動（效果因個體而異）"
      ]
    },
    "prognosis": "先天性巨食道症預後優於後天性，部分幼犬可在成長過程中恢復食道功能（恢復率20-46%）。嚴重者需終身管理餵食方式。吸入性肺炎是主要死亡原因。配合diligent餵食管理，許多犬仍可達到正常壽命。",
    "pearls": [
      "反流（被動、管狀未消化食物）vs嘔吐（主動、腹部用力、含膽汁）是關鍵鑑別",
      "Bailey chair垂直餵食是最重要的管理措施",
      "先天性型部分可隨成長恢復，但後天性型恢復率極低",
      "每隻犬對食物質地的反應不同，需個別試驗最佳餵食方式"
    ],
    "diagnosticAlgorithm": {
      "title": "先天性巨食道症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "病史評估",
          "details": "區分反流與嘔吐，確認發病年齡",
          "findings": [
            "被動反流未消化食物",
            "斷奶後發病",
            "液體較固體易通過"
          ]
        },
        {
          "step": 2,
          "action": "胸部X光",
          "details": "評估食道擴張和併發症",
          "findings": [
            "食道瀰漫性擴張",
            "氣管背側位移",
            "吸入性肺炎徵象"
          ]
        },
        {
          "step": 3,
          "action": "對比食道攝影",
          "details": "鋇劑吞嚥確認食道蠕動喪失",
          "findings": [
            "鋇劑滯留於食道",
            "無有效蠕動波",
            "排除局部梗阻"
          ]
        },
        {
          "step": 4,
          "action": "排除繼發原因",
          "details": "排除後天性巨食道症的已知病因",
          "findings": [
            "AChR抗體陰性（排除MG）",
            "甲狀腺功能正常",
            "PRAA排除"
          ]
        }
      ]
    },
    "monitoring": [
      "體重和體態追蹤",
      "肺部X光監測吸入性肺炎",
      "餵食方式調整",
      "食道功能恢復評估（幼犬定期追蹤）"
    ],
    "reference": "VCA Animal Hospitals — Megaesophagus; Merck Veterinary Manual; Veterinary Partner — VIN; Clinician's Brief"
  },
  "tetralogy-of-fallot": {
    "zh": "法洛氏四合症",
    "en": "Tetralogy of Fallot",
    "definition": "法洛氏四合症（TOF）是一種複雜的先天性心臟缺陷，包含四個病理組成：肺動脈狹窄、心室中隔缺損（VSD）、主動脈騎跨（overriding aorta）和右心室肥厚。因右至左分流導致未氧合血進入體循環，產生發紺。約佔犬先天性心臟病的1/4000。",
    "synonyms": [
      "TOF",
      "法洛四聯症"
    ],
    "epidemiology": {
      "species": "犬較常見，貓偶見",
      "age": "出生即存在，通常6月齡內出現症狀",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "基斯犬（Keeshond）— 遺傳性",
        "英國鬥牛犬",
        "可能的遺傳傾向"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "運動不耐",
        "發紺（嘴唇、舌頭、牙齦呈紫藍色）",
        "運動後暈厥或虛脫",
        "發育遲緩",
        "癲癇發作（嚴重缺氧時）"
      ],
      "physicalExam": [
        "黏膜發紺",
        "心臟聽診：收縮期雜音（肺動脈狹窄）",
        "發育遲緩體型偏小",
        "血容比升高（代償性紅血球增多症）",
        "運動後發紺加重"
      ]
    },
    "pathophysiology": "TOF源於胚胎期心臟圓錐幹（conotruncal）發育異常。肺動脈狹窄增加右心室壓力，當右心室壓力超過左心室壓力時，血液通過VSD形成右至左分流（right-to-left shunt），未氧合血直接進入主動脈和體循環。主動脈騎跨使主動脈根部跨坐於VSD上方，同時接收左右心室的血液。右心室因後負荷增加而代償性肥厚。分流量取決於肺動脈狹窄的嚴重程度和VSD大小。代償性紅血球增多症（polycythemia）是對慢性低氧的適應反應，但過度增加使血液黏稠度上升，增加血栓風險。",
    "diagnosis": {
      "overview": "心臟超音波為確診方法，可同時評估四個病理組成和分流方向",
      "differentials": [
        "艾森曼格症候群",
        "肺動脈狹窄（單純型）",
        "心室中隔缺損（單純型）",
        "其他發紺性先天性心臟病"
      ],
      "initialDB": [
        "心臟聽診",
        "胸部X光（右心室增大、肺血管紋路減少）",
        "CBC（紅血球增多症、PCV升高）",
        "動脈血氧飽和度"
      ],
      "advanced": [
        "心臟超音波（確診：四個組成同時可見）",
        "心臟CT/MRI",
        "心導管檢查（壓力測量）"
      ]
    },
    "treatment": {
      "overview": "以姑息性管理為主，根治性手術（體外循環下修復）在獸醫極少執行",
      "acute": [
        "發紺危象：氧氣支持+鎮靜",
        "嚴重紅血球增多症（PCV>65-70%）：治療性放血+等量晶體液補充"
      ],
      "chronic": [
        "β-阻斷劑（atenolol或propranolol）減少右心室流出道動態性梗阻",
        "避免劇烈運動",
        "姑息性手術：改良Blalock-Taussig分流術（少數中心可執行）",
        "定期監測PCV，必要時治療性放血"
      ]
    },
    "prognosis": "未治療的TOF多數犬在1歲內死亡。β-阻斷劑和限制運動可延長生存期。接受改良Blalock-Taussig分流手術的犬平均存活約7年。貓的TOF極少見，文獻報告有限。",
    "pearls": [
      "TOF是獸醫最常見的發紺性先天性心臟病",
      "PCV>65%時應考慮治療性放血以降低血液黏稠度",
      "運動和激動可加重發紺（因增加右至左分流）",
      "基斯犬為已知遺傳性好發品種"
    ],
    "diagnosticAlgorithm": {
      "title": "法洛氏四合症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "理學檢查",
          "details": "評估發紺和心臟雜音",
          "findings": [
            "黏膜發紺",
            "收縮期雜音",
            "運動不耐"
          ]
        },
        {
          "step": 2,
          "action": "基礎檢查",
          "details": "X光+CBC評估",
          "findings": [
            "右心室增大",
            "肺血管紋路減少",
            "PCV升高（紅血球增多症）"
          ]
        },
        {
          "step": 3,
          "action": "心臟超音波",
          "details": "確診四個病理組成",
          "findings": [
            "肺動脈狹窄",
            "VSD",
            "主動脈騎跨",
            "右心室肥厚"
          ]
        },
        {
          "step": 4,
          "action": "分流評估",
          "details": "評估分流方向和嚴重度",
          "findings": [
            "右至左分流確認",
            "肺動脈狹窄梯度",
            "預後評估"
          ]
        }
      ]
    },
    "monitoring": [
      "定期PCV監測（每1-3個月）",
      "心臟超音波追蹤",
      "運動限制依從性",
      "發紺程度變化"
    ],
    "reference": "Merck Veterinary Manual — Tetralogy of Fallot in Animals; UC Davis CVM; JAVMA 2016 — 31 cases study"
  },
  "primary-ciliary-dyskinesia": {
    "zh": "原發性纖毛運動障礙",
    "en": "Primary Ciliary Dyskinesia",
    "definition": "原發性纖毛運動障礙（PCD）是一組遺傳性纖毛結構和功能異常疾病，導致呼吸道黏膜纖毛清除功能喪失。約50%病例伴有內臟轉位（situs inversus），稱為Kartagener症候群。呈常染色體隱性遺傳。",
    "synonyms": [
      "PCD",
      "不動纖毛症候群",
      "Kartagener症候群（伴內臟轉位時）"
    ],
    "epidemiology": {
      "species": "犬為主，貓極罕見",
      "age": "幼年發病（通常<1歲出現慢性呼吸道症狀）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "古代牧羊犬（Old English Sheepdog）— 已知基因突變",
        "英國可卡犬",
        "比格犬",
        "邊境牧羊犬",
        "長毛臘腸犬",
        "近親繁殖"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "慢性鼻分泌物（從幼年開始）",
        "反覆呼吸道感染（鼻竇炎、支氣管炎、肺炎）",
        "慢性咳嗽（濕咳）",
        "公犬不孕（精子運動異常）"
      ],
      "physicalExam": [
        "雙側黏液膿性鼻分泌物",
        "肺部聽診囉音和喘鳴音",
        "支氣管擴張徵象",
        "心音右側較強（右位心，50%病例）",
        "體態可能正常或偏瘦"
      ]
    },
    "pathophysiology": "呼吸道上皮纖毛頂端和杯狀細胞分泌的黏液是黏液纖毛清除系統的重要組成。正常時，吸入的病原體和異物黏附於黏液層，由纖毛的協調擺動（escalator action）向口腔方向推送排出。PCD中，纖毛的動力臂蛋白（dynein arm）或微管結構異常導致纖毛不動或運動不協調，黏液清除功能喪失。黏液滯留於呼吸道導致細菌繁殖和慢性感染，反覆感染引起支氣管擴張。同一基因缺陷也影響精子鞭毛運動（導致雄性不孕）和胚胎期節點纖毛（導致內臟左右不對稱，即situs inversus）。",
    "diagnosis": {
      "overview": "無金標準診斷法，需綜合臨床表現、影像學和組織學",
      "differentials": [
        "慢性鼻竇炎（其他原因）",
        "支氣管擴張（後天性）",
        "慢性支氣管炎",
        "氣道異物"
      ],
      "initialDB": [
        "胸部X光（支氣管擴張型態）",
        "鼻腔和胸腔X光",
        "CBC（慢性感染指標）",
        "鼻分泌物細菌培養"
      ],
      "advanced": [
        "呼吸道黏膜刷取活檢+電子顯微鏡（觀察纖毛超微結構）",
        "CT掃描（評估支氣管擴張和鼻竇病變）",
        "基因檢測（古代牧羊犬可做）",
        "精子運動分析（公犬）"
      ]
    },
    "treatment": {
      "overview": "無根治方法，以控制感染和促進分泌物排出為主",
      "acute": [
        "急性肺炎：廣效抗生素（基於培養藥敏結果）",
        "霧化治療（生理食鹽水）促進分泌物排出",
        "拍痰/物理治療"
      ],
      "chronic": [
        "長期間歇性抗生素治療（根據培養結果）",
        "定期霧化治療+物理治療",
        "避免環境刺激物（煙塵、灰塵）",
        "運動適度促進分泌物排出"
      ]
    },
    "prognosis": "PCD無法治癒，為終身管理疾病。積極控制感染和促進分泌物排出可維持良好生活品質。支氣管擴張為不可逆病變，隨時間可能進展。多數犬在適當管理下可維持數年良好生活品質。建議攜帶基因者不做繁殖。",
    "pearls": [
      "右位心（X光心影在右側）+慢性鼻分泌物+反覆肺炎 = 高度懷疑PCD",
      "約50%PCD伴有situs inversus（Kartagener症候群）",
      "古代牧羊犬已有基因檢測可用",
      "公犬不孕可為唯一主訴"
    ],
    "diagnosticAlgorithm": {
      "title": "原發性纖毛運動障礙 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "臨床懷疑",
          "details": "幼年起慢性呼吸道感染+右位心",
          "findings": [
            "慢性鼻分泌物",
            "反覆肺炎",
            "右位心（50%）"
          ]
        },
        {
          "step": 2,
          "action": "影像學檢查",
          "details": "X光和CT評估",
          "findings": [
            "支氣管擴張",
            "慢性鼻竇炎",
            "右位心或內臟轉位"
          ]
        },
        {
          "step": 3,
          "action": "組織學確認",
          "details": "呼吸道黏膜活檢+電子顯微鏡",
          "findings": [
            "dynein臂缺失",
            "微管異常",
            "纖毛方向紊亂"
          ]
        },
        {
          "step": 4,
          "action": "基因檢測",
          "details": "特定品種可做基因檢測",
          "findings": [
            "古代牧羊犬CCDC39基因突變",
            "常染色體隱性遺傳確認"
          ]
        }
      ]
    },
    "monitoring": [
      "定期胸部X光追蹤支氣管擴張",
      "呼吸道培養藥敏監測",
      "體重和生活品質評估",
      "繁殖建議（攜帶者不繁殖）"
    ],
    "reference": "PMC — Siewert-Kartagener's syndrome in a dog; PMC — PCD prevalence in OES; Morrison 1987 — PCD in the Dog (JVIM)"
  },
  "hypoplastic-trachea": {
    "zh": "氣管發育不良",
    "en": "Hypoplastic Trachea",
    "definition": "氣管發育不良是先天性氣管軟骨環發育異常導致的氣管管徑狹窄，與氣管發育不全（tracheal hypoplasia）為同義詞。主要見於短頭種犬，英國鬥牛犬發生率最高。氣管管徑狹窄增加氣道阻力，影響呼吸功能和黏液清除。",
    "synonyms": [
      "氣管發育不全",
      "Tracheal Hypoplasia"
    ],
    "epidemiology": {
      "species": "犬為主（短頭種）",
      "age": "先天性，任何年齡可發現",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "英國鬥牛犬",
        "巴哥犬",
        "波士頓梗犬",
        "法國鬥牛犬"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "呼吸困難",
        "運動不耐",
        "打鼾或呼吸音過大",
        "反覆呼吸道感染",
        "部分犬無症狀"
      ],
      "physicalExam": [
        "吸氣性喘鳴音",
        "短頭種臉部特徵",
        "BOAS相關表現",
        "嚴重者可見發紺"
      ]
    },
    "pathophysiology": "氣管軟骨環在胚胎發育過程中形成異常，環狀結構過度融合或重疊，導致氣管內徑比正常小。氣管直徑減小使氣道阻力按反比第四次方增加（泊肅葉定律），即使輕度狹窄也顯著增加呼吸功。黏液纖毛清除功能因狹窄氣管而降低，增加呼吸道感染易感性。通常與BOAS的其他組成並存，多重氣道狹窄產生加乘效應。",
    "diagnosis": {
      "overview": "X光測量氣管管徑比值為主要診斷方法",
      "differentials": [
        "氣管塌陷",
        "氣管內異物",
        "氣管腫瘤",
        "氣管外壓迫性病灶"
      ],
      "initialDB": [
        "頸胸X光側位",
        "氣管直徑/胸廓入口比值測量",
        "CBC（感染指標）"
      ],
      "advanced": [
        "CT掃描",
        "氣管內視鏡",
        "動態螢光透視"
      ]
    },
    "treatment": {
      "overview": "無手術矯正方法，保守治療和BOAS管理為主",
      "acute": [
        "呼吸窘迫時氧氣支持",
        "短效類固醇減輕氣道水腫",
        "急性感染抗生素治療"
      ],
      "chronic": [
        "體重控制",
        "避免過度運動和高溫環境",
        "支氣管擴張劑（必要時）",
        "BOAS手術矯正（鼻孔、軟顎等）"
      ]
    },
    "prognosis": "輕度者可能終身無症狀，部分幼犬隨成長改善。合併嚴重BOAS者預後取決於綜合氣道管理。體重控制和避免環境誘因是長期管理關鍵。",
    "pearls": [
      "本病與tracheal-hypoplasia為同義詞，強調不同面向",
      "體重管理是最重要的保守治療措施",
      "繁殖選擇應避免嚴重氣管發育不良個體"
    ],
    "diagnosticAlgorithm": {
      "title": "氣管發育不良 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "品種風險評估",
          "details": "短頭種犬呼吸症狀",
          "findings": [
            "短頭種犬",
            "呼吸音增大",
            "運動不耐"
          ]
        },
        {
          "step": 2,
          "action": "X光測量",
          "details": "頸胸側位X光氣管直徑",
          "findings": [
            "TD/TI ratio < 0.20",
            "氣管全段狹窄"
          ]
        },
        {
          "step": 3,
          "action": "進階影像",
          "details": "CT或內視鏡精確評估",
          "findings": [
            "軟骨環異常",
            "氣管各段直徑"
          ]
        },
        {
          "step": 4,
          "action": "綜合評估",
          "details": "評估BOAS所有組成",
          "findings": [
            "鼻孔狹窄",
            "軟顎過長",
            "喉囊翻轉"
          ]
        }
      ]
    },
    "monitoring": [
      "氣管直徑追蹤（幼犬成長期）",
      "體重管理",
      "呼吸症狀監測",
      "BOAS綜合管理"
    ],
    "reference": "UPEI — Hypoplastic Trachea; PMC — Radiographic tracheal dimensions; wagwalking.com — Hypoplastic Trachea in Dogs"
  },
  "mammary-gland-hyperplasia": {
    "zh": "乳腺增生",
    "en": "Mammary Gland Hyperplasia",
    "definition": "乳腺纖維腺瘤樣增生（FAH）是一種非腫瘤性、黃體素誘發的乳腺快速增殖性疾病，以乳腺間質和管上皮的異常增生為特徵。主要見於年輕未絕育母貓（第一次發情週期後）或接受外源性黃體素的貓。佔貓乳腺腫塊的13-20%。",
    "synonyms": [
      "貓乳腺纖維腺瘤樣增生",
      "FAH",
      "Feline Fibroadenomatous Change"
    ],
    "epidemiology": {
      "species": "貓為主，犬極罕見",
      "age": "年輕貓（第一次發情週期後）",
      "sex": "母貓為主；使用外源性黃體素的公貓或絕育貓亦可發生",
      "riskFactors": [
        "未絕育年輕母貓",
        "第一次發情週期",
        "假懷孕",
        "妊娠",
        "外源性黃體素治療（megestrol acetate）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "一個或多個乳腺快速腫大",
        "最近的發情或妊娠",
        "使用黃體素類藥物史",
        "皮膚可能潰瘍"
      ],
      "physicalExam": [
        "一個或多個乳腺顯著腫大（可達數公分）",
        "質地堅實但非硬性",
        "可能對稱性多腺體受累",
        "覆蓋皮膚緊繃、可能潰瘍",
        "無疼痛（通常）",
        "無全身症狀"
      ]
    },
    "pathophysiology": "FAH是乳腺對內源性或外源性黃體素的過度反應。正常黃體期黃體素刺激乳腺發育，但FAH中此反應被異常放大。組織學上表現為乳腺小葉內管上皮增殖和小葉間間質大量增生，形成纖維腺瘤樣腫塊。FAH組織同時表達黃體素受體和雌激素受體，提示兩種激素均參與發病。年輕母貓第一次黃體期黃體素急劇上升為常見觸發因素。假懷孕和妊娠同樣提供持續高黃體素環境。外源性黃體素（如megestrol acetate用於行為控制或皮膚病）也可誘發FAH。重要的是FAH為非腫瘤性增生，需與乳腺癌鑑別。",
    "diagnosis": {
      "overview": "組織病理學確認非腫瘤性質，需與乳腺癌鑑別",
      "differentials": [
        "乳腺腫瘤（腺癌）",
        "乳腺炎",
        "乳腺囊腫",
        "淋巴結腫大"
      ],
      "initialDB": [
        "理學檢查（多腺體對稱性腫大提示FAH）",
        "細針穿刺細胞學",
        "胸部X光（排除乳腺癌轉移）"
      ],
      "advanced": [
        "組織切片活檢（確診：纖維上皮增生，無異型性）",
        "黃體素受體免疫組織化學染色"
      ]
    },
    "treatment": {
      "overview": "抗黃體素藥物（aglepristone）為首選，或OHE移除激素來源",
      "acute": [
        "Aglepristone（抗黃體素）10 mg/kg SC Day 1, 2, 7",
        "首次注射後6天即可見腫塊縮小",
        "完全緩解通常4週內"
      ],
      "chronic": [
        "OHE（未絕育者）移除內源性黃體素來源",
        "停用外源性黃體素",
        "嚴重皮膚潰瘍：傷口護理",
        "乳腺切除術（僅在壞死或aglepristone無效時）"
      ]
    },
    "prognosis": "FAH預後極佳。Aglepristone治療後多數在4週內完全緩解。OHE可根治性預防復發。停用外源性黃體素後亦可自行消退。重要的是須與乳腺癌鑑別，後者預後截然不同。",
    "pearls": [
      "年輕母貓多腺體快速對稱腫大→高度懷疑FAH而非腫瘤",
      "Aglepristone是特異性治療，6天內即見效",
      "必須做組織學排除乳腺癌",
      "外源性黃體素（megestrol acetate）可在公貓引起FAH"
    ],
    "diagnosticAlgorithm": {
      "title": "乳腺增生 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "臨床評估",
          "details": "年齡、性別、激素暴露史",
          "findings": [
            "年輕未絕育母貓",
            "多腺體快速腫大",
            "近期發情或黃體素用藥"
          ]
        },
        {
          "step": 2,
          "action": "細胞學篩檢",
          "details": "細針穿刺",
          "findings": [
            "纖維上皮增生",
            "無異型細胞",
            "排除腫瘤"
          ]
        },
        {
          "step": 3,
          "action": "影像排除轉移",
          "details": "胸部X光",
          "findings": [
            "無肺轉移→支持良性診斷",
            "有轉移→重新考慮惡性腫瘤"
          ]
        },
        {
          "step": 4,
          "action": "組織學確診",
          "details": "切片活檢",
          "findings": [
            "纖維腺瘤樣增生確認",
            "無惡性特徵"
          ]
        }
      ]
    },
    "monitoring": [
      "腫塊大小追蹤（治療後）",
      "皮膚完整性",
      "復發監測",
      "黃體素暴露避免"
    ],
    "reference": "UC Davis — Feline Mammary Hyperplasia; PMC — Aglepristone treatment; Texas A&M TVMDL; JVIM"
  },
  "galactostasis": {
    "zh": "乳汁鬱積",
    "en": "Galactostasis",
    "definition": "乳汁鬱積是乳汁在乳腺內滯留導致的非感染性乳腺炎。常見於假懷孕動物或突然斷奶時。乳腺因殘留乳汁充脹而腫脹、疼痛，但無細菌感染。若不處理可能繼發為感染性乳腺炎。",
    "synonyms": [
      "乳汁滯留",
      "非感染性乳腺炎",
      "Milk Stasis"
    ],
    "epidemiology": {
      "species": "犬較常見，貓偶見",
      "age": "繁殖年齡或假懷孕母犬",
      "sex": "僅母犬貓",
      "riskFactors": [
        "假懷孕",
        "突然斷奶（非漸進式）",
        "乳腺排空不足",
        "窩仔數少（部分乳腺未被吸吮）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "乳腺腫脹硬實",
        "近期斷奶或假懷孕",
        "不適或疼痛表現",
        "舔舐乳腺"
      ],
      "physicalExam": [
        "一個或多個乳腺腫脹充盈",
        "觸診溫暖但無明顯發熱",
        "輕度至中度疼痛",
        "乳汁可被擠出（正常外觀）",
        "無全身症狀（不發燒）"
      ]
    },
    "pathophysiology": "乳汁鬱積發生在乳汁持續產生但未被有效排出的情況下。假懷孕時泌乳素升高刺激泌乳，但無幼仔吸吮。突然斷奶時乳汁仍在產生但排出停止。滯留的乳汁使乳腺腺泡和乳管膨脹，壓力增加導致局部組織水腫和輕度炎症反應（非感染性炎症）。乳汁中的脂肪和蛋白質分解可進一步刺激炎症。若乳頭有微小創傷或細菌逆行感染，非感染性乳汁鬱積可進展為感染性（化膿性）乳腺炎，此時需要抗生素治療。",
    "diagnosis": {
      "overview": "臨床病史和理學檢查即可診斷，需排除感染性乳腺炎",
      "differentials": [
        "感染性乳腺炎",
        "乳腺腫瘤",
        "乳腺增生（FAH）",
        "乳腺膿瘍"
      ],
      "initialDB": [
        "乳腺觸診和乳汁外觀評估",
        "乳汁細胞學（排除感染：無大量嗜中性球）",
        "體溫監測"
      ],
      "advanced": [
        "乳汁培養（排除細菌感染）",
        "乳腺超音波（排除膿瘍或腫塊）"
      ]
    },
    "treatment": {
      "overview": "減少泌乳刺激+物理療法為主，無需抗生素",
      "acute": [
        "冷敷或溫敷乳腺（減輕不適）",
        "適度擠出滯留乳汁（不要完全排空以免刺激再泌乳）",
        "止痛：NSAID（如meloxicam）"
      ],
      "chronic": [
        "漸進式斷奶（減少餵食次數和量）",
        "減少母犬食物和水的攝取量（降低泌乳）",
        "假懷孕者：Cabergoline 5 μg/kg/day口服（抑制泌乳素）",
        "伊麗莎白圈（防止自我吸吮刺激泌乳）"
      ]
    },
    "prognosis": "乳汁鬱積預後極佳。多數在減少泌乳刺激後數天至1-2週緩解。預防重點在漸進式斷奶。假懷孕引起者可用Cabergoline有效控制。需監測是否繼發感染。",
    "pearls": [
      "乳汁鬱積 vs 感染性乳腺炎：前者不發燒、乳汁正常外觀、無全身症狀",
      "不要完全排空乳腺（會反射性增加泌乳）",
      "漸進式斷奶是最佳預防方法",
      "假懷孕是未絕育母犬乳汁鬱積的常見原因"
    ],
    "diagnosticAlgorithm": {
      "title": "乳汁鬱積 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "病史確認",
          "details": "斷奶時間或假懷孕狀態",
          "findings": [
            "近期斷奶",
            "假懷孕",
            "未哺乳但泌乳"
          ]
        },
        {
          "step": 2,
          "action": "理學檢查",
          "details": "乳腺評估和全身狀態",
          "findings": [
            "乳腺充脹",
            "無發燒",
            "乳汁外觀正常"
          ]
        },
        {
          "step": 3,
          "action": "排除感染",
          "details": "乳汁細胞學和培養",
          "findings": [
            "無大量嗜中性球→非感染性",
            "有嗜中性球/細菌→感染性乳腺炎"
          ]
        },
        {
          "step": 4,
          "action": "治療和監測",
          "details": "物理療法+泌乳控制",
          "findings": [
            "冷/溫敷",
            "減少飲食量",
            "Cabergoline（假懷孕）"
          ]
        }
      ]
    },
    "monitoring": [
      "乳腺腫脹程度",
      "體溫（排除繼發感染）",
      "乳汁性狀",
      "食慾和精神狀態"
    ],
    "reference": "Merck Veterinary Manual — Mastitis in Small Animals; MSD Veterinary Manual — Periparturient Problems; VetsCraft"
  },
  "feline-orofacial-pain-syndrome": {
    "zh": "貓口面疼痛症候群",
    "en": "Feline Orofacial Pain Syndrome",
    "definition": "貓的神經性疼痛疾病，以發作性口腔不適、過度舔舐咀嚼動作及自我傷害行為（舌頭和唇部自咬）為特徵。被認為是三叉神經痛的貓科對應疾病，緬甸貓有遺傳易感性，暗示涉及中樞或三叉神經節的感覺訊號處理異常。",
    "synonyms": [
      "FOPS",
      "貓顏面疼痛症候群",
      "Feline Trigeminal Neuropathy"
    ],
    "epidemiology": {
      "species": "貓（犬極罕見）",
      "age": "任何年齡，中位數約5歲，幼貓換牙期可首發",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "緬甸貓（品種遺傳傾向）",
        "牙科疾病（牙周病、齒吸收）",
        "環境壓力（多貓家庭衝突）",
        "換牙期"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "發作性過度舔舐或咀嚼動作",
        "爪抓臉部或嘴巴",
        "進食時突然後退",
        "自咬舌頭或嘴唇",
        "壓力環境下症狀加劇"
      ],
      "physicalExam": [
        "舌頭或口唇自傷性潰瘍（通常單側）",
        "過度流涎",
        "發作間期檢查可能正常",
        "可能合併牙科疾病",
        "觸碰口周可誘發疼痛反應"
      ]
    },
    "pathophysiology": "FOPS被認為是三叉神經系統的神經性疼痛疾病，類似人類的三叉神經痛。三叉神經末梢受損或致敏（如牙科疾病、換牙過程）後，中樞或三叉神經節對痛覺訊號的處理發生異常，產生自發性疼痛和異常疼痛（allodynia）。研究顯示63%的病例合併口腔病變（牙周病、口腔潰瘍、永久齒萌出等），提示周邊神經損傷是重要的觸發因子。緬甸貓的品種傾向暗示遺傳性的神經處理缺陷。壓力因素（如多貓環境衝突）可加劇症狀發作。",
    "diagnosis": {
      "overview": "排除性診斷，需排除口腔疾病後根據典型行為模式確診",
      "differentials": [
        "牙周病",
        "齒吸收（FORL）",
        "口腔腫瘤",
        "口腔異物",
        "強迫行為障礙",
        "狂犬病"
      ],
      "initialDB": [
        "全身麻醉下完整口腔檢查",
        "全口牙科放射線",
        "基礎血液學和生化",
        "神經學檢查"
      ],
      "advanced": [
        "頭部MRI（排除腦部病變）",
        "病灶組織活檢（排除腫瘤）",
        "試驗性止痛治療反應評估"
      ]
    },
    "treatment": {
      "overview": "多模式治療：處理口腔觸發因子、神經性疼痛藥物、環境管理",
      "acute": [
        "伊莉莎白圈防止自傷",
        "軟爪套（Soft Claws®）減少抓傷",
        "處理任何牙科疾病（拔除病齒）",
        "止痛（buprenorphine 0.01-0.03mg/kg 口腔黏膜 q6-8h）"
      ],
      "chronic": [
        "Gabapentin 5-10mg/kg PO q8-12h（一線神經痛藥物）",
        "Phenobarbital 1-2mg/kg PO q12h（替代選擇）",
        "環境壓力管理（減少多貓衝突）",
        "長期可能需要持續藥物控制"
      ]
    },
    "prognosis": "預後視觸發因子和治療反應而異。能識別並處理口腔觸發因子（如拔除病齒）的病例預後較好，部分可完全緩解。需要長期神經性疼痛藥物管理的病例可維持良好生活品質但難以完全治癒。未治療將持續自傷導致嚴重口腔損傷。",
    "pearls": [
      "FOPS是排除性診斷，必須先徹底排除所有口腔疾病",
      "即使只有輕微齒齦炎也應積極治療，因為是重要的神經致敏因子",
      "環境壓力（特別是多貓家庭衝突）是常被忽略的重要觸發因子"
    ],
    "diagnosticAlgorithm": {
      "title": "貓口面疼痛症候群 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "行為評估",
          "details": "詳細問診發作模式、自傷行為和環境壓力",
          "findings": [
            "發作性口腔不適",
            "單側自傷",
            "壓力相關加劇"
          ]
        },
        {
          "step": 2,
          "action": "口腔檢查",
          "details": "全身麻醉下完整口腔和牙科放射線檢查",
          "findings": [
            "牙科疾病（可為觸發因子）",
            "自傷性潰瘍",
            "口腔正常"
          ]
        },
        {
          "step": 3,
          "action": "排除其他疾病",
          "details": "血液學、神經學檢查排除系統性疾病",
          "findings": [
            "血液學正常",
            "神經學正常",
            "需MRI進一步排除"
          ]
        },
        {
          "step": 4,
          "action": "試驗性治療",
          "details": "處理觸發因子並開始gabapentin試驗",
          "findings": [
            "症狀改善（支持診斷）",
            "無改善（重新評估）"
          ]
        }
      ]
    },
    "monitoring": [
      "用藥後2-4週評估症狀頻率和嚴重度",
      "定期口腔檢查監測自傷程度",
      "gabapentin劑量調整依臨床反應",
      "環境管理效果持續評估"
    ],
    "reference": "Rusbridge C et al. Feline orofacial pain syndrome (FOPS): a retrospective study of 113 cases. JFMS. 2010;12(6):498-508; Ertelt J et al. Successful treatment of FOPS. Vet Rec Case Rep. 2024."
  },
  "eosinophilic-stomatitis": {
    "zh": "嗜酸性口炎",
    "en": "Eosinophilic Stomatitis",
    "definition": "貓的口腔嗜酸性肉芽腫複合症的口腔表現，以嗜酸性球為主的發炎細胞浸潤口腔黏膜導致潰瘍和肉芽腫性病變。被認為是過敏性或免疫異常反應的一部分，可影響舌、硬腭、軟腭及唇部，屬於貓嗜酸性肉芽腫複合症（EGC）的口腔形式。",
    "synonyms": [
      "貓嗜酸性口腔病",
      "Feline Eosinophilic Oral Disease",
      "Oral Eosinophilic Granuloma"
    ],
    "epidemiology": {
      "species": "貓（犬罕見）",
      "age": "任何年齡，年輕至中年貓較常見",
      "sex": "無明顯性別傾向（部分文獻報告母貓略多）",
      "riskFactors": [
        "過敏體質",
        "環境或食物過敏",
        "跳蚤過敏",
        "遺傳易感性",
        "免疫功能異常"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "進食困難或食慾下降",
        "流涎",
        "口臭",
        "體重減輕",
        "口腔不適表現（爪抓嘴巴）"
      ],
      "physicalExam": [
        "舌部和硬腭凸起的粉色/黃色肉芽腫性病變",
        "口腔潰瘍",
        "上唇無痛性潰瘍（rodent ulcer）",
        "下唇腫脹",
        "齒齦紅腫",
        "約2/3病例有多處病灶"
      ]
    },
    "pathophysiology": "嗜酸性肉芽腫複合症被認為是過敏性或免疫介導性反應的結果，但確切觸發因子通常難以確認。嗜酸性球在過敏反應中釋放多種化學介質（主要堿性蛋白、嗜酸性球陽離子蛋白等），導致組織腫脹、潰瘍和肉芽腫形成。口腔形式可能與吸入性過敏原、食物過敏、跳蚤叮咬過敏或特發性免疫異常有關。約半數病例顯示口腔不適和進食困難，潰瘍性病變常見且可多處同時受影響。",
    "diagnosis": {
      "overview": "組織學活檢確診，需同時排除感染性和腫瘤性病因",
      "differentials": [
        "口腔鱗狀細胞癌",
        "貓慢性齒齦口炎",
        "口腔異物反應",
        "黴菌感染",
        "貓口面疼痛症候群"
      ],
      "initialDB": [
        "細針抽吸細胞學（可見嗜酸性球浸潤）",
        "CBC（常見嗜酸性球增多）",
        "基本生化",
        "FeLV/FIV檢測"
      ],
      "advanced": [
        "切開式組織活檢和病理組織學",
        "食物過敏排除試驗（8-12週）",
        "皮膚科過敏檢測",
        "細菌培養及藥敏試驗"
      ]
    },
    "treatment": {
      "overview": "控制過敏觸發因子為基礎，免疫抑制治療控制發炎反應",
      "acute": [
        "Prednisolone 1-2mg/kg PO q24h共2-4週後逐步減量",
        "積極跳蚤控制（全環境）",
        "合併細菌感染時加用抗生素（amoxicillin-clavulanate 12.5mg/kg PO q12h）"
      ],
      "chronic": [
        "Cyclosporine（Atopica®）7mg/kg PO q24h（類固醇替代選擇）",
        "食物過敏排除飲食",
        "Triamcinolone acetonide 局部注射（頑固病灶）",
        "長期維持最低有效劑量免疫抑制"
      ]
    },
    "prognosis": "預後視觸發因子可否識別而定。能識別並去除過敏原（如跳蚤控制、食物排除）的病例預後良好，可能完全緩解。特發性病例可能需要長期免疫抑制治療維持，但大多數可達到臨床控制。早期多模式治療（抗菌+免疫抑制+過敏原控制）效果最佳。",
    "pearls": [
      "EGC口腔形式的非典型表現可能被誤診為腫瘤，活檢是關鍵",
      "積極跳蚤控制應作為所有病例的第一線治療嘗試",
      "食物排除試驗需要至少8週才能看到效果"
    ],
    "diagnosticAlgorithm": {
      "title": "嗜酸性口炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "臨床評估",
          "details": "口腔檢查評估病灶形態、分布和數量",
          "findings": [
            "典型肉芽腫/潰瘍病灶",
            "多處受影響",
            "嘴唇病變"
          ]
        },
        {
          "step": 2,
          "action": "細胞學和血液學",
          "details": "FNA和CBC確認嗜酸性球浸潤",
          "findings": [
            "嗜酸性球增多",
            "FeLV/FIV陰性",
            "嗜酸性球浸潤"
          ]
        },
        {
          "step": 3,
          "action": "組織活檢",
          "details": "切開式活檢排除腫瘤並確認EGC",
          "findings": [
            "嗜酸性肉芽腫",
            "排除SCC",
            "排除感染"
          ]
        },
        {
          "step": 4,
          "action": "尋找觸發因子",
          "details": "跳蚤控制試驗、食物排除飲食",
          "findings": [
            "跳蚤過敏確認",
            "食物過敏確認",
            "特發性"
          ]
        }
      ]
    },
    "monitoring": [
      "治療後2-4週評估病灶大小和數量",
      "CBC追蹤嗜酸性球變化",
      "類固醇或cyclosporine副作用監測",
      "長期追蹤復發情形"
    ],
    "reference": "Buckley L, Nuttall T. Feline eosinophilic granuloma complex. JFMS. 2012;14(7):471-481; Cornell Feline Health Center: Eosinophilic Granuloma Complex."
  },
  "hypovolemic-shock": {
    "zh": "低血容積性休克",
    "en": "Hypovolemic Shock",
    "definition": "因血管內容量嚴重不足導致心搏出量降低、組織灌流不全的休克類型。可因失血（出血性）或非出血性體液喪失（嚴重嘔吐、腹瀉、第三間隙積液、燒傷）引起。是小動物急診中最常見的休克類型。",
    "synonyms": [
      "容積不足性休克",
      "Volume Depletion Shock"
    ],
    "epidemiology": {
      "species": "犬貓均常見，是最常見的休克類型",
      "age": "幼年和老年動物代償能力差，風險較高",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "創傷",
        "嚴重嘔吐腹瀉（腸胃炎、腸阻塞）",
        "第三間隙體液喪失（腹膜炎、胰臟炎）",
        "嚴重燒傷",
        "大量出血（手術、腫瘤破裂）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "已知體液喪失病因（嘔吐、腹瀉、創傷、出血）",
        "進行性虛弱",
        "食慾廢絕",
        "尿量減少",
        "意識改變"
      ],
      "physicalExam": [
        "心搏過速",
        "脈搏微弱細速",
        "黏膜蒼白或灰白",
        "CRT延長>2秒",
        "皮膚彈性降低（脫水）",
        "低血壓（收縮壓<90 mmHg）",
        "四肢冰冷",
        "嗜睡或昏迷"
      ]
    },
    "pathophysiology": "血管內容量減少→靜脈回流降低→前負荷下降→每搏輸出量降低→心搏出量不足。代償反應：壓力感受器活化→交感神經興奮→心率增加+血管收縮+腎素-血管張力素-醛固酮系統活化。ADH釋放促進水分滯留。代償失敗後→組織灌流不足→無氧代謝→乳酸堆積→代謝性酸中毒→心肌抑制→不可逆休克。",
    "diagnosis": {
      "overview": "臨床休克表現+明確體液喪失病史。PCV/TP、乳酸、血壓為核心評估指標",
      "differentials": [
        "心因性休克（容積過載而非不足）",
        "分配性休克（血管擴張性）",
        "阻塞性休克（心包填塞、GDV）",
        "嚴重脫水（尚未達休克）"
      ],
      "initialDB": [
        "PCV/TP（快速評估）",
        "血壓測量",
        "乳酸測定",
        "電解質+血糖",
        "BUN/Crea（腎灌流評估）"
      ],
      "advanced": [
        "血氣分析（酸鹼平衡）",
        "TFAST/AFAST超音波（腔體積液）",
        "凝血功能",
        "CVP測量（指導輸液）"
      ]
    },
    "treatment": {
      "overview": "快速容積復甦+治療潛在病因。輸液速率和種類依據脫水/出血嚴重程度調整",
      "acute": [
        "等張晶體液：犬shock dose 60-90 mL/kg（分1/4劑量bolus，每次評估反應），貓40-60 mL/kg",
        "快速輸液bolus：犬20-25 mL/kg over 15-30 min，貓10-20 mL/kg over 15-30 min",
        "膠體液：Hetastarch 5 mL/kg bolus（低蛋白或持續低血壓時）",
        "高張鹽水：7.5% NaCl 3-5 mL/kg over 5-10 min（快速擴容，出血性低容積）",
        "輸血：PCV<20%（急性出血）→pRBC 10-20 mL/kg",
        "電解質矯正：低鉀血症、低鈣血症等"
      ],
      "chronic": [
        "治療潛在病因（止血、止瀉、手術）",
        "維持輸液（維持需求量+持續喪失量+脫水矯正量）",
        "營養支持（早期腸道營養）",
        "逐步減少輸液速率"
      ]
    },
    "prognosis": "輕中度低血容積性休克經適當輸液復甦預後良好。重度休克（失代償期）且合併多器官功能障礙者死亡率顯著增高。預後取決於病因可逆性、介入時間及器官損傷程度。乳酸清除率是重要預後指標。",
    "pearls": [
      "低血容積性休克是小動物急診最常見休克類型，輸液是基石治療",
      "犬的shock dose晶體液90 mL/kg、貓44-60 mL/kg——但不要一次全給，分1/4劑量逐步評估",
      "高張鹽水可快速擴容但效果短暫（30-60分鐘），必須後續接等張晶體液",
      "貓的輸液復甦要更保守——過量易導致肺水腫",
      "乳酸清除率（每2小時下降>50%）比單一數值更能預測預後"
    ],
    "diagnosticAlgorithm": {
      "title": "低血容積性休克 診斷與處置流程",
      "steps": [
        {
          "step": 1,
          "action": "休克辨識與分級",
          "details": "評估灌流指標：HR、脈搏品質、CRT、黏膜、血壓、意識",
          "findings": [
            "代償期：心搏過速+黏膜正常+CRT正常",
            "早期失代償：心搏過速+黏膜蒼白+CRT延長",
            "晚期失代償：心搏過緩+黏膜灰白+低血壓",
            "乳酸>4 mmol/L提示組織灌流不足"
          ]
        },
        {
          "step": 2,
          "action": "病因評估",
          "details": "判斷出血性vs非出血性體液喪失",
          "findings": [
            "PCV/TP同步下降→出血性",
            "PCV正常+TP下降→蛋白喪失",
            "病史：嘔吐/腹瀉→非出血性",
            "AFAST→腹腔/胸腔積液"
          ]
        },
        {
          "step": 3,
          "action": "容積復甦",
          "details": "分段式bolus輸液+評估反應",
          "findings": [
            "晶體液1/4 shock dose→15 min後評估",
            "HR下降+BP改善=正向反應",
            "無反應→重複bolus或加膠體",
            "PCV<20%→輸血準備"
          ]
        },
        {
          "step": 4,
          "action": "持續治療與監測",
          "details": "維持灌流+治療病因+監測併發症",
          "findings": [
            "乳酸q2h追蹤清除率",
            "尿量>1-2 mL/kg/hr",
            "MAP≥65 mmHg",
            "治療潛在病因"
          ]
        }
      ]
    },
    "monitoring": [
      "血壓（每15-30分鐘或連續）",
      "乳酸（q2-4h，追蹤清除率）",
      "PCV/TP（q2-4h急性期）",
      "尿量（>1-2 mL/kg/hr）",
      "心率與脈搏品質",
      "電解質與血糖",
      "體重（輸液過量指標）"
    ],
    "reference": "Silverstein DC. Small Animal Critical Care Medicine, 2nd Ed. Saunders, 2014; Merck Veterinary Manual: Fluid Resuscitation Plan 2023"
  },
  "near-drowning": {
    "zh": "溺水救治",
    "en": "Near-Drowning (Submersion Injury)",
    "definition": "因浸沒或沈入液體中導致呼吸功能損害的急症。水分吸入造成肺表面活性物質稀釋和失活、支氣管痙攣、肺泡-毛細血管膜通透性增加及非心因性肺水腫。「二次溺水」可在初始事件後數小時至數天出現。",
    "synonyms": [
      "溺水",
      "浸沒傷害",
      "Submersion Injury",
      "Drowning"
    ],
    "epidemiology": {
      "species": "犬較貓常見（犬更頻繁接觸水域），貓溺水預後更差",
      "age": "幼年動物和老年動物風險較高",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "無人看管的泳池接觸",
        "自然水域暴露（河流、湖泊、海洋）",
        "癲癇病史（水中發作）",
        "冬季冰面墜入",
        "短頭犬種（泳技差）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "水中浸沒事件",
        "發現時在水中或水邊",
        "咳嗽或嘔吐水",
        "呼吸困難",
        "可能有短暫無意識",
        "事件後短期看似正常（二次溺水前兆）"
      ],
      "physicalExam": [
        "呼吸困難/呼吸窘迫",
        "肺部囉音/濕囉音",
        "低體溫（常見併發症）",
        "心搏過速或心搏過緩（重度低溫）",
        "黏膜發紺",
        "意識改變（嗜睡至昏迷）",
        "口鼻泡沫樣分泌物"
      ]
    },
    "pathophysiology": "水分吸入→肺表面活性物質（surfactant）稀釋和功能失活→肺泡塌陷（肺不張）。肺泡-毛細血管膜損傷→通透性增加→非心因性肺水腫。支氣管痙攣加重通氣障礙。淡水吸入→肺泡液體快速吸收入血→血液稀釋→電解質紊亂。海水吸入→高滲液吸引組織液入肺→更嚴重肺水腫。低氧血症→多器官損傷。低體溫為常見併發症但亦有神經保護效果。",
    "diagnosis": {
      "overview": "基於浸沒事件史+呼吸窘迫+影像學表現。需高度警覺「二次溺水」延遲性肺水腫",
      "differentials": [
        "其他原因肺水腫（心因性）",
        "吸入性肺炎",
        "異物吸入",
        "ARDS"
      ],
      "initialDB": [
        "SpO2/血氣分析（低氧血症程度）",
        "胸腔X光（肺水腫、肺不張）",
        "肺部超音波（B-lines表示肺水腫）",
        "直腸溫度（低體溫評估）",
        "CBC/生化/電解質"
      ],
      "advanced": [
        "連續胸腔X光（監測二次溺水）",
        "心電圖（心律不整、低溫相關）",
        "凝血功能",
        "血液培養（吸入污水後感染風險）"
      ]
    },
    "treatment": {
      "overview": "氧氣治療為基石+回溫+支持療法。必須監測至少24-48小時以偵測延遲性肺水腫",
      "acute": [
        "確保氣道通暢（清除口腔異物和水分）",
        "100%氧氣治療（鼻導管、氧氣籠或插管機械通氣）",
        "嚴重低氧：氣管插管+正壓通氣（PEEP 5-10 cmH2O）",
        "低體溫回溫（參見低體溫症處置）",
        "輸液治療：審慎給予（避免加重肺水腫），等張晶體液維持",
        "支氣管擴張劑：Terbutaline 0.01 mg/kg SC（支氣管痙攣時）"
      ],
      "chronic": [
        "住院監測至少24-48小時（二次溺水可延遲出現）",
        "連續SpO2/血氣監測",
        "抗生素（若吸入污水：Amoxicillin-clavulanate或Fluoroquinolone）",
        "肺部物理治療（叩擊、姿位引流）"
      ]
    },
    "prognosis": "犬的存活率約72%（文獻報告18/25），貓的預後較差（0/3存活的報告）。淡水溺水較海水溺水預後略佳。低體溫可能具神經保護效果。延遲性（二次）溺水是重要死因，需住院監測至少48小時。",
    "pearls": [
      "「二次溺水」可在初始事件後數小時至數天出現——必須住院監測≥48小時",
      "肺部超音波B-lines比X光更即時且可重複監測肺水腫程度",
      "淡水vs海水對治療策略影響不大，兩者都會破壞surfactant",
      "不要嘗試倒掛動物「倒水」——無效且浪費時間",
      "低體溫本身可能提供神經保護效果，回溫不宜過急"
    ],
    "diagnosticAlgorithm": {
      "title": "溺水救治 診斷與處置流程",
      "steps": [
        {
          "step": 1,
          "action": "緊急評估與氣道確保",
          "details": "ABCD approach，清除口腔異物和水分",
          "findings": [
            "呼吸型態評估",
            "SpO2測量（<94%需氧氣）",
            "體溫測量（低體溫常見）",
            "意識狀態評估"
          ]
        },
        {
          "step": 2,
          "action": "氧合與呼吸支持",
          "details": "氧氣治療，嚴重者機械通氣",
          "findings": [
            "鼻導管O2→SpO2目標>94%",
            "嚴重低氧→插管+PEEP",
            "肺部聽診（濕囉音程度）",
            "支氣管痙攣→擴張劑"
          ]
        },
        {
          "step": 3,
          "action": "影像與實驗室評估",
          "details": "胸腔X光/肺超音波+血液檢查",
          "findings": [
            "肺水腫範圍（X光）",
            "B-lines數量（肺超音波）",
            "血氣：低氧血症程度",
            "電解質紊亂"
          ]
        },
        {
          "step": 4,
          "action": "延遲性併發症監測",
          "details": "住院48小時監測二次溺水",
          "findings": [
            "連續SpO2監測",
            "每6-12小時胸腔X光或肺超音波",
            "體溫穩定化",
            "感染徵象監測"
          ]
        }
      ]
    },
    "monitoring": [
      "SpO2/血氣分析（連續或q2-4h）",
      "呼吸頻率與型態",
      "胸腔X光/肺超音波（q6-12h前48小時）",
      "體溫（回溫監測）",
      "電解質",
      "神經狀態"
    ],
    "reference": "Nemi C, et al. Noncardiogenic pulmonary edema in dogs and cats. JVECC 2023;33(3); Today's Veterinary Practice: Environmental Lung Injuries 2020"
  },
  "heatstroke": {
    "zh": "熱衰竭/中暑",
    "en": "Heatstroke",
    "definition": "非發熱性體溫過高（核心體溫>41°C/106°F），因散熱機制失敗導致全身性發炎反應、熱休克蛋白表達異常及多器官功能障礙的危急症候群。若未及時治療可迅速進展為DIC、急性腎損傷及死亡。",
    "synonyms": [
      "熱射病",
      "熱中風",
      "Heat Stroke",
      "Hyperthermia"
    ],
    "epidemiology": {
      "species": "犬遠較貓常見，短頭犬種為最高風險群",
      "age": "任何年齡均可發生，老年犬因心肺代償能力下降風險增加",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "短頭品種（Bulldog、Pug、Boston Terrier、Pekingese）",
        "肥胖或過重",
        "厚毛或深色毛髮",
        "心肺疾病或上呼吸道疾病史",
        "高溫高濕環境暴露（車內密閉、戶外運動）",
        "缺乏飲水或遮蔭"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "高溫環境暴露或劇烈運動後",
        "突發虛弱或倒地",
        "持續喘息不停",
        "嘔吐或腹瀉",
        "意識改變（躁動→嗜睡→昏迷）",
        "車內密閉空間暴露史"
      ],
      "physicalExam": [
        "直腸溫度>41°C（常達42-43°C）",
        "黏膜充血磚紅色或蒼白泥灰色",
        "心搏過速",
        "喘息或呼吸困難",
        "CRT延長",
        "點狀出血或瘀斑（DIC徵象）",
        "肌肉震顫或癲癇發作"
      ]
    },
    "pathophysiology": "體溫超過散熱代償能力時，高溫直接導致蛋白質變性和細胞膜損傷。熱休克蛋白（HSP）表達異常，觸發全身性發炎反應（SIRS）。腸道黏膜屏障破壞導致細菌易位和內毒素血症。凝血瀑布過度活化引發DIC，加上橫紋肌溶解釋放肌紅蛋白造成急性腎小管壞死。最終導致多器官功能衰竭（MODS）。",
    "diagnosis": {
      "overview": "臨床診斷為主：高溫暴露史+核心體溫>41°C+多系統異常。需快速評估多器官受損程度",
      "differentials": [
        "感染性發熱（敗血症）",
        "癲癇重積狀態",
        "惡性高熱",
        "運動性高熱",
        "甲狀腺風暴"
      ],
      "initialDB": [
        "直腸溫度測量",
        "CBC（血小板減少、破碎紅血球提示DIC）",
        "血清生化（BUN/Crea升高、肝酶ALT/AST升高、電解質）",
        "凝血功能（PT/aPTT/D-dimer/纖維蛋白原）",
        "血氣分析（代謝性酸中毒）"
      ],
      "advanced": [
        "尿液分析（肌紅素尿、管型）",
        "乳酸測定（組織灌流指標）",
        "心電圖（心律不整監測）",
        "TFAST/腹部超音波（排除其他病因）"
      ]
    },
    "treatment": {
      "overview": "時間是最關鍵預後因素：緊急降溫+積極輸液+多器官功能支持",
      "acute": [
        "立即降溫：室溫水噴灑+風扇對流蒸發散熱（禁用冰水，避免周邊血管收縮阻礙散熱）",
        "降溫目標：直腸溫達39.4°C時停止積極降溫，避免反彈性低體溫",
        "靜脈輸液：室溫等張晶體液（犬60-90 mL/kg/hr shock dose，貓40-60 mL/kg/hr）",
        "氧氣治療：鼻導管或氧氣籠",
        "抗癲癇：Diazepam 0.5-1 mg/kg IV PRN",
        "止吐：Maropitant 1 mg/kg SC/IV q24h",
        "廣效抗生素：考慮腸道細菌易位風險（Ampicillin-sulbactam 或 Cephalosporin）"
      ],
      "chronic": [
        "住院監測24-72小時（延遲性AKI和DIC常見）",
        "DIC處理：新鮮冷凍血漿15-20 mL/kg",
        "腎功能支持：持續輸液維持尿量>1-2 mL/kg/hr",
        "康復期避免高溫環境和劇烈運動",
        "長期預後評估（腎功能、神經後遺症）"
      ]
    },
    "prognosis": "死亡率約50%，與最高體溫值和高溫持續時間正相關。體溫>42°C且持續>30分鐘者死亡率達50-70%。即時降溫可將死亡率降至<30%。存活者需注意延遲性AKI（24-72小時後）和神經後遺症。",
    "pearls": [
      "死亡率與最高體溫及持續時間正相關，早期介入是關鍵",
      "禁用冰水降溫——周邊血管收縮反而阻礙核心散熱",
      "39.4°C時停止積極降溫，避免低體溫反彈",
      "DIC和AKI可能在降溫後24-72小時才顯現，需持續監測",
      "短頭犬種即使輕度體溫升高也可能快速惡化"
    ],
    "diagnosticAlgorithm": {
      "title": "熱衰竭/中暑 診斷與處置流程",
      "steps": [
        {
          "step": 1,
          "action": "緊急評估與降溫",
          "details": "ABCD評估+直腸溫度測量，確認高溫暴露史",
          "findings": [
            "直腸溫度>41°C",
            "黏膜磚紅色或泥灰色",
            "意識改變（躁動→昏迷）",
            "心搏過速+CRT延長"
          ]
        },
        {
          "step": 2,
          "action": "多器官功能篩檢",
          "details": "急查CBC/生化/凝血/血氣，評估器官損傷程度",
          "findings": [
            "血小板<100×10⁹/L（DIC風險）",
            "ALT/AST顯著升高（肝損傷）",
            "BUN/Crea升高（AKI）",
            "代謝性酸中毒+乳酸升高"
          ]
        },
        {
          "step": 3,
          "action": "凝血功能詳細評估",
          "details": "PT/aPTT/D-dimer/纖維蛋白原/血液抹片",
          "findings": [
            "PT/aPTT延長",
            "D-dimer升高",
            "纖維蛋白原降低",
            "血液抹片見裂片紅血球（DIC確認）"
          ]
        },
        {
          "step": 4,
          "action": "穩定化與持續監測",
          "details": "積極輸液+器官支持，72小時密集監測",
          "findings": [
            "體溫穩定在38-39°C",
            "尿量>1-2 mL/kg/hr",
            "凝血指標趨勢改善",
            "神經狀態評估（延遲性腦損傷）"
          ]
        }
      ]
    },
    "monitoring": [
      "體溫（每15-30分鐘直到穩定）",
      "尿量（導尿管監測，目標>1-2 mL/kg/hr）",
      "凝血功能（PT/aPTT/血小板 q12-24h前72小時）",
      "腎功能（BUN/Crea/電解質 q12-24h）",
      "肝功能（ALT/AST/膽紅素）",
      "神經狀態評估",
      "心電圖監測"
    ],
    "reference": "Bruchim Y, et al. Heat stroke in dogs: A retrospective study. JVECC 2017;27(2):116-127; MSD Veterinary Manual 2023"
  },
  "hypothermia": {
    "zh": "低體溫症",
    "en": "Hypothermia",
    "definition": "核心體溫低於正常範圍（犬<37.5°C/貓<37.8°C）的病理狀態。依嚴重程度分為輕度（36-37.5°C）、中度（34-36°C）和重度（<34°C）。可為原發性（環境暴露）或繼發性（疾病、麻醉、休克）。",
    "synonyms": [
      "低溫症",
      "體溫過低",
      "Accidental Hypothermia"
    ],
    "epidemiology": {
      "species": "犬貓均可發生，小型犬和幼貓風險較高",
      "age": "新生幼畜和老年動物最易受影響（體溫調節能力差）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "新生幼畜（體溫調節中樞未成熟）",
        "小型或超小型品種（體表面積/體重比大）",
        "老年動物（代謝率低）",
        "全身麻醉或鎮靜",
        "休克或嚴重創傷",
        "寒冷環境暴露或落水"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "寒冷環境暴露",
        "落水或長時間戶外",
        "術後恢復期",
        "新生幼畜分離母體",
        "創傷或休克後",
        "長時間未進食（低代謝狀態）"
      ],
      "physicalExam": [
        "直腸溫度低於正常",
        "輕度：顫抖、嗜睡",
        "中度：停止顫抖、心搏過緩、瞳孔散大",
        "重度：僵硬、反射消失、表觀死亡",
        "黏膜蒼白或發紺",
        "呼吸淺慢",
        "心搏過緩"
      ]
    },
    "pathophysiology": "核心體溫下降時，初期交感神經代償引起血管收縮和顫抖產熱。溫度降至<34°C後，體溫調節失敗——停止顫抖，血管從收縮轉為擴張，加速核心熱量散失。代謝率每降1°C約下降6%，心肌傳導減慢引發心搏過緩和心律不整。嚴重時出現Osborn波（J波）。<28°C時心室顫動風險極高。凝血功能障礙、血小板功能異常和免疫抑制亦隨溫度降低而惡化。",
    "diagnosis": {
      "overview": "臨床診斷直接明確：低核心體溫+對應臨床徵象。重點在評估潛在病因和併發症",
      "differentials": [
        "原發性低體溫（環境暴露）",
        "繼發性低體溫（休克、敗血症、甲狀腺低下）",
        "麻醉後低體溫",
        "新生兒低體溫"
      ],
      "initialDB": [
        "直腸溫度（需使用可測低溫的溫度計）",
        "CBC/生化（評估器官功能）",
        "血氣分析（代謝性酸中毒）",
        "血糖（低血糖常見伴發症）",
        "心電圖（心搏過緩、Osborn波、心律不整）"
      ],
      "advanced": [
        "凝血功能（PT/aPTT延長常見）",
        "乳酸（灌流不足指標）",
        "甲狀腺功能（排除甲低作為病因）",
        "影像學（排除創傷）"
      ]
    },
    "treatment": {
      "overview": "根據嚴重程度選擇回溫策略：輕度被動回溫，中重度主動核心回溫，目標每小時升溫1-2°C",
      "acute": [
        "輕度：被動外部回溫（毛毯包裹、溫暖環境）",
        "中度：主動外部回溫（溫水袋、強制暖氣、Bair Hugger加溫毯）",
        "重度：主動核心回溫（溫熱靜脈輸液40-42°C、溫水腹腔灌洗、溫水灌腸）",
        "靜脈輸液：預溫至40°C的等張晶體液",
        "血糖矯正：50% Dextrose 0.5-1 mL/kg IV（低血糖時）",
        "心律不整處理：需先回溫至>30°C再考慮抗心律不整藥物"
      ],
      "chronic": [
        "持續監測直到體溫穩定>37.5°C至少24小時",
        "治療潛在病因（甲狀腺低下、敗血症、休克）",
        "營養支持（恢復代謝功能）",
        "注意「回溫後降低」現象（afterdrop）——周邊冷血回流核心"
      ]
    },
    "prognosis": "輕中度低體溫經適當回溫預後良好。重度低體溫（<30°C）即使出現心肺停止，適當治療後仍有完全康復的潛力（\"沒有人是死的，直到溫暖且死亡\"原則）。預後取決於潛在病因、低溫持續時間及併發症嚴重程度。",
    "pearls": [
      "體溫<34°C時動物停止顫抖——這是惡化徵兆而非改善",
      "Osborn波（J波）是ECG特徵表現，見於30-34°C",
      "重度低體溫不要急於心肺復甦——先回溫至>30°C",
      "回溫過程中注意afterdrop現象（周邊冷血回流導致核心溫度再降）",
      "貓的回溫需特別注意輸液速率，避免肺水腫"
    ],
    "diagnosticAlgorithm": {
      "title": "低體溫症 診斷與處置流程",
      "steps": [
        {
          "step": 1,
          "action": "體溫評估與分級",
          "details": "使用可測低溫的直腸溫度計，確定嚴重程度",
          "findings": [
            "輕度36-37.5°C：顫抖、嗜睡",
            "中度34-36°C：停止顫抖、心搏過緩",
            "重度<34°C：僵硬、無反射",
            "需使用專用低溫溫度計"
          ]
        },
        {
          "step": 2,
          "action": "病因篩查",
          "details": "區分原發性（環境暴露）與繼發性（疾病相關）",
          "findings": [
            "環境暴露史",
            "麻醉/手術史",
            "創傷/休克徵象",
            "甲狀腺功能低下體徵"
          ]
        },
        {
          "step": 3,
          "action": "併發症評估",
          "details": "ECG、血氣、血糖、凝血功能",
          "findings": [
            "ECG：Osborn波、心搏過緩",
            "代謝性酸中毒",
            "低血糖",
            "凝血功能異常"
          ]
        },
        {
          "step": 4,
          "action": "分級回溫治療",
          "details": "依嚴重程度選擇回溫策略，目標1-2°C/hr",
          "findings": [
            "輕度→被動回溫",
            "中度→主動外部回溫",
            "重度→核心回溫（溫熱輸液/腹腔灌洗）",
            "監測afterdrop現象"
          ]
        }
      ]
    },
    "monitoring": [
      "核心體溫（每15-30分鐘）",
      "心電圖連續監測（心律不整）",
      "血壓",
      "血氣與電解質",
      "血糖（q2-4h）",
      "尿量",
      "凝血功能"
    ],
    "reference": "Brodeur A, et al. Hypothermia and targeted temperature management in cats and dogs. JVECC 2017;27(2):151-163; MSD Veterinary Manual 2023"
  },
  "lens-luxation": {
    "zh": "水晶體脫位",
    "en": "Lens Luxation",
    "definition": "眼球水晶體因懸韌帶（zonules）斷裂而從正常位置移位的眼科急症。依移位方向分為前脫位（進入前房）和後脫位（落入玻璃體腔）。前脫位為眼科急症，可在數小時內引發急性青光眼而導致不可逆失明。",
    "synonyms": [
      "水晶體脫位",
      "晶狀體脫位",
      "Lens Displacement",
      "Ectopia Lentis"
    ],
    "epidemiology": {
      "species": "犬貓皆可",
      "age": "犬原發性：3-8歲（品種相關）；貓繼發性：任何年齡",
      "sex": "無性別傾向",
      "riskFactors": [
        "犬原發性：梗犬類（Jack Russell、Fox Terrier、Shar-Pei）——ADAMTS17基因突變",
        "貓：慢性前葡萄膜炎（最常見原因）",
        "慢性青光眼（眼球腫大拉伸懸韌帶）",
        "外傷",
        "老年性懸韌帶退化"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "急性疼痛和畏光（前脫位）",
        "突發眼睛外觀改變",
        "流淚增加",
        "眨眼頻繁或閉眼",
        "可能雙眼先後發病"
      ],
      "physicalExam": [
        "前脫位：前房內可見水晶體、瞳孔不規則、角膜水腫",
        "後脫位：前房加深、虹膜震顫（iridodonesis）",
        "眼壓升高（前脫位常>40 mmHg）",
        "眼睛充血和疼痛",
        "視力喪失"
      ]
    },
    "pathophysiology": "水晶體由環形懸韌帶（zonular fibers）懸掛在睫狀體上。原發性水晶體脫位（犬）因ADAMTS17基因突變導致懸韌帶結構性缺陷和進行性降解，通常先出現半脫位再完全脫位。繼發性脫位（貓最常見）因慢性前葡萄膜炎的發炎介質破壞懸韌帶。前脫位時水晶體進入前房，阻塞虹膜-角膜角的房水排出通路，導致急性眼壓飆升（青光眼）。高眼壓壓迫視網膜和視神經血管，數小時內即可造成不可逆的視網膜和視神經損傷。後脫位通常較溫和，但仍有玻璃體脫出和繼發青光眼的風險。",
    "diagnosis": {
      "overview": "裂隙燈檢查和眼壓測量為基本診斷工具",
      "differentials": [
        "青光眼（原發性）",
        "前葡萄膜炎",
        "角膜水腫其他原因",
        "眼內腫瘤"
      ],
      "initialDB": [
        "裂隙燈檢查（直接可視化水晶體位置）",
        "眼壓測量（Tonometry，前脫位常升高）",
        "直接和間接眼底鏡檢查",
        "瞳孔對光反射評估"
      ],
      "advanced": [
        "眼部超音波（確認水晶體位置和玻璃體狀態）",
        "前房角鏡檢查（gonioscopy）",
        "ADAMTS17基因檢測（品種犬）",
        "全身檢查排除葡萄膜炎病因"
      ]
    },
    "treatment": {
      "overview": "前脫位為急症需緊急處理；後脫位可保守管理或擇期手術",
      "acute": [
        "前脫位急救：降眼壓——Mannitol 1-2 g/kg IV + Dorzolamide/Timolol眼藥水",
        "縮瞳劑（後脫位）：Demecarium bromide 0.25% q12h防止前移",
        "止痛：全身性NSAIDs或Opioids"
      ],
      "chronic": [
        "前脫位手術：水晶體摘除術（Intracapsular Lens Extraction, ICLE）",
        "無法保眼時：眼球摘除或義眼置入",
        "後脫位保守：縮瞳劑+定期監測眼壓",
        "梗犬品種：預防性監測對側眼"
      ]
    },
    "prognosis": "前脫位若在24-48小時內手術，保留視力的機率約40-50%；延遲處理預後差。後脫位保守管理預後較好但需長期監測。合併青光眼且視力已喪失者預後不良，多需眼球摘除。原發性雙眼脫位犬對側眼日後脫位機率極高。",
    "pearls": [
      "前脫位是眼科急症——每延遲1小時，視力保留機率下降；目標24小時內手術",
      "梗犬品種（JRT、Fox Terrier）有ADAMTS17基因突變，一眼脫位後對側眼需密切監測",
      "貓的水晶體脫位多為慢性葡萄膜炎繼發——治療脫位的同時要找潛在病因（FIP、淋巴瘤、弓蟲症）"
    ],
    "diagnosticAlgorithm": {
      "title": "水晶體脫位 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "裂隙燈檢查",
          "details": "確認水晶體位置（前脫位/後脫位/半脫位）",
          "findings": [
            "前房內水晶體（前脫位）",
            "前房加深+虹膜震顫（後脫位）"
          ]
        },
        {
          "step": 2,
          "action": "眼壓測量",
          "details": "立即測量雙眼眼壓",
          "findings": [
            "前脫位常>40 mmHg",
            "後脫位眼壓可能正常"
          ]
        },
        {
          "step": 3,
          "action": "視力評估",
          "details": "評估威脅反射、瞳孔對光反射和障礙物迴避",
          "findings": [
            "視力狀態決定治療急迫性",
            "PLR消失提示預後不良"
          ]
        },
        {
          "step": 4,
          "action": "病因鑑別+處理",
          "details": "犬評估品種遺傳史；貓排查葡萄膜炎病因",
          "findings": [
            "犬：ADAMTS17基因相關",
            "貓：慢性葡萄膜炎（FIP、淋巴瘤等）"
          ]
        }
      ]
    },
    "monitoring": [
      "眼壓（術後daily×1週，之後weekly×1月，之後monthly）",
      "對側眼定期裂隙燈檢查（原發性者q3-6月）",
      "視力評估（威脅反射、障礙物迴避）",
      "眼底檢查（監測視網膜剝離和視神經損傷）"
    ],
    "reference": "Merck Vet Manual - Dislocation of the Lens; Cornell Canine Health Center - Primary Lens Luxation; VCA Hospitals - Lens Luxation in Dogs"
  },
  "nuclear-sclerosis": {
    "zh": "水晶體核硬化症",
    "en": "Nuclear Sclerosis (Lenticular Sclerosis)",
    "definition": "犬貓的正常老化性水晶體變化，因水晶體纖維終生持續增生壓迫核心導致核部緻密硬化，外觀呈藍灰色霧狀。不影響視力（除極嚴重者影響近距深度知覺），無需治療。常被飼主誤認為白內障。",
    "synonyms": [
      "核硬化",
      "水晶體硬化",
      "Lenticular Sclerosis",
      "Lens Nuclear Sclerosis"
    ],
    "epidemiology": {
      "species": "犬貓皆有",
      "age": "犬>7歲、貓>8-10歲開始出現，隨年齡逐漸加重",
      "sex": "無性別傾向",
      "riskFactors": [
        "年齡（不可避免的老化變化）",
        "日曬暴露可能加速硬化"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "飼主注意到眼睛變「混濁」或「灰白色」",
        "視力通常無明顯影響",
        "雙眼對稱出現",
        "漸進性變化"
      ],
      "physicalExam": [
        "雙眼對稱性藍灰色核部混濁",
        "散瞳後可見混濁僅限核部，皮質和周邊仍透明",
        "眼底反射（tapetal reflection）正常可見",
        "視力正常（威脅反射陽性、障礙物迴避正常）",
        "眼壓正常"
      ]
    },
    "pathophysiology": "水晶體纖維由水晶體赤道部的上皮細胞終生持續產生，新纖維在外層累加，將舊纖維向核心壓迫。隨年齡增長，核部纖維因持續壓縮而失去水分、蛋白質密度增加並氧化交聯，導致折射率改變而呈現特徵性的藍灰色外觀。與白內障不同的是，核硬化僅改變水晶體的光學密度和硬度，但不會造成蛋白質沉澱或不透明化，因此光線仍可正常通過。這是完全正常的生理性老化過程，所有老年犬貓都會發生，只是程度不同。",
    "diagnosis": {
      "overview": "裂隙燈檢查即可區分核硬化與白內障",
      "differentials": [
        "白內障（最重要的鑑別）",
        "水晶體前囊混濁",
        "玻璃體混濁"
      ],
      "initialDB": [
        "裂隙燈檢查（光學切面可見核部密度增加但皮質清澈）",
        "直接眼底鏡——核硬化時眼底反射正常可見（白內障則不行）",
        "威脅反射和障礙物迴避測試"
      ],
      "advanced": [
        "散瞳後詳細水晶體檢查（排除早期皮質白內障）",
        "眼部超音波（排除後段病變）"
      ]
    },
    "treatment": {
      "overview": "核硬化為正常老化變化，無需治療",
      "acute": [
        "不需要任何急性治療"
      ],
      "chronic": [
        "無需藥物或手術治療",
        "定期眼科追蹤（排除併發白內障）",
        "向飼主解釋此為正常老化非疾病"
      ]
    },
    "prognosis": "核硬化為良性老化變化，終身預後極好。不會導致失明，不會進展為白內障。唯一需注意的是部分老年犬可能同時發展真正的白內障，需定期鑑別。",
    "pearls": [
      "核硬化 vs 白內障最快速的鑑別法：用直接眼底鏡——核硬化可看到眼底反射（tapetal reflection），白內障看不到",
      "所有>7歲的犬和>10歲的貓都有不同程度的核硬化——向飼主解釋這是正常老化，不是白內障",
      "散瞳後在裂隙燈下可清楚看到核硬化僅限核部，皮質仍完全透明"
    ],
    "diagnosticAlgorithm": {
      "title": "水晶體核硬化症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "飼主主訴評估",
          "details": "飼主注意到老年犬貓眼睛變灰白色",
          "findings": [
            "雙眼對稱性藍灰色改變",
            "視力行為無明顯變化"
          ]
        },
        {
          "step": 2,
          "action": "眼底反射測試",
          "details": "用直接眼底鏡觀察眼底反射",
          "findings": [
            "核硬化：眼底反射正常可見",
            "白內障：眼底反射減弱或消失"
          ]
        },
        {
          "step": 3,
          "action": "裂隙燈檢查",
          "details": "散瞳後裂隙燈檢查水晶體各層",
          "findings": [
            "核部密度增加呈藍灰色",
            "皮質清澈透明"
          ]
        },
        {
          "step": 4,
          "action": "確認診斷+衛教",
          "details": "排除白內障後向飼主說明正常老化",
          "findings": [
            "確認為核硬化非白內障",
            "不需治療，定期追蹤"
          ]
        }
      ]
    },
    "monitoring": [
      "年度眼科檢查（排除併發白內障）",
      "視力行為觀察（飼主居家評估）",
      "眼壓測量（老年犬貓常規篩檢）",
      "眼底檢查（排除其他老年性眼病）"
    ],
    "reference": "ACVO - Cataracts vs Nuclear Sclerosis; Merck Vet Manual - The Lens in Animals; dvm360 - Cataracts: How to Uncover the Imposter"
  },
  "keratitis": {
    "zh": "角膜炎",
    "en": "Keratitis",
    "definition": "角膜的發炎性疾病，依是否有上皮缺損分為潰瘍性角膜炎和非潰瘍性角膜炎。犬最常見的原因為乾眼症（KCS）和外傷；貓則以皰疹病毒感染為首要原因。未及時治療可導致角膜穿孔和永久性視力喪失。",
    "synonyms": [
      "角膜炎",
      "角膜發炎",
      "Corneal Inflammation",
      "Corneal Keratitis"
    ],
    "epidemiology": {
      "species": "犬貓皆常見",
      "age": "任何年齡",
      "sex": "無性別傾向",
      "riskFactors": [
        "犬：乾眼症（KCS）、短頭犬種（眼球突出、瞬目不完全）、外傷",
        "貓：皰疹病毒第一型（FHV-1，超過90%貓攜帶）",
        "眼瞼異常（內翻、外翻、睫毛異位）",
        "角膜暴露（面神經麻痺、眼球突出）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "眨眼頻繁或閉眼（疼痛）",
        "流淚或黏液膿性分泌物",
        "眼睛發紅",
        "角膜外觀混濁或有白斑",
        "光敏感"
      ],
      "physicalExam": [
        "角膜混濁（水腫或瘢痕）",
        "角膜新生血管（表淺或深層）",
        "螢光素染色陽性（潰瘍性）或陰性（非潰瘍性）",
        "結膜充血",
        "眼分泌物（漿液性至膿性）",
        "Schirmer淚液試驗可能偏低（KCS相關）"
      ]
    },
    "pathophysiology": "角膜炎的發病機制因病因而異。潰瘍性角膜炎：角膜上皮和基質的物理性或感染性破壞，暴露的基質膠原吸引嗜中性球和基質金屬蛋白酶，可導致溶解性角膜潰瘍（melting ulcer）快速穿孔。非潰瘍性角膜炎：多為免疫介導機制——免疫細胞浸潤角膜基質引起慢性發炎、色素沉著和新生血管。犬KCS相關角膜炎因淚液不足使角膜失去營養、潤滑和免疫防禦。貓FHV-1感染直接破壞角膜上皮細胞並誘發免疫性基質角膜炎。",
    "diagnosis": {
      "overview": "螢光素染色區分潰瘍性與非潰瘍性，Schirmer試驗評估淚液量",
      "differentials": [
        "乾眼症（KCS）",
        "角膜潰瘍（外傷、感染）",
        "角膜異物",
        "青光眼",
        "前葡萄膜炎",
        "免疫性角膜炎（色素性、結節性）"
      ],
      "initialDB": [
        "螢光素染色（Fluorescein staining）",
        "Schirmer淚液試驗（STT，正常犬 >15 mm/min）",
        "裂隙燈檢查（評估角膜各層）",
        "眼壓測量（排除青光眼）"
      ],
      "advanced": [
        "角膜細胞學刮片（感染性角膜炎）",
        "細菌/真菌培養和藥敏試驗",
        "FHV-1 PCR（貓）",
        "角膜共聚焦顯微鏡"
      ]
    },
    "treatment": {
      "overview": "治療取決於類型：潰瘍性以抗菌和促癒合為主，非潰瘍性以免疫調節為主",
      "acute": [
        "潰瘍性：廣譜抗生素眼藥水（Tobramycin或Ofloxacin q4-6h）",
        "止痛：Atropine 1% 眼藥水（睫狀體鬆弛、止痛）",
        "溶解性潰瘍：自體血清眼藥水（抑制MMP）+ 緊急角膜移植",
        "貓FHV-1：Famciclovir 40-90 mg/kg PO q8-12h"
      ],
      "chronic": [
        "KCS：Cyclosporine 0.2% 或 Tacrolimus 0.02% 眼藥水q12h（終身）",
        "免疫性角膜炎：Cyclosporine + 短期類固醇（確認無潰瘍後）",
        "人工淚液補充（KCS）",
        "矯正眼瞼異常（手術）"
      ]
    },
    "prognosis": "表淺性潰瘍在適當治療下通常5-7天癒合，預後良好。深層或溶解性潰瘍需積極治療，可能導致角膜穿孔和眼球喪失。KCS需終身管理但控制良好時視力可維持。貓FHV-1角膜炎容易復發（壓力誘發），但多數發作可控制。免疫性角膜炎需長期治療但預後合理。",
    "pearls": [
      "角膜有螢光素著色=潰瘍——禁用類固醇眼藥水（會抑制癒合並促進感染和穿孔）",
      "貓的角膜炎——假設是疱疹病毒（FHV-1）直到證明不是，因為>90%的貓攜帶此病毒",
      "Schirmer試驗<15 mm/min（犬）= KCS——這是犬角膜炎最常見的潛在原因"
    ],
    "diagnosticAlgorithm": {
      "title": "角膜炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "螢光素染色",
          "details": "評估角膜上皮完整性，區分潰瘍性vs非潰瘍性",
          "findings": [
            "染色陽性=潰瘍性",
            "染色陰性=非潰瘍性"
          ]
        },
        {
          "step": 2,
          "action": "淚液試驗",
          "details": "Schirmer試驗測量淚液產量",
          "findings": [
            "<15 mm/min=KCS",
            "正常>15 mm/min"
          ]
        },
        {
          "step": 3,
          "action": "裂隙燈+眼壓",
          "details": "評估角膜深度、新生血管類型，測量眼壓",
          "findings": [
            "新生血管型態提示急性vs慢性",
            "眼壓排除青光眼"
          ]
        },
        {
          "step": 4,
          "action": "病因鑑別",
          "details": "根據種別、染色結果和STT確定治療方案",
          "findings": [
            "犬KCS→免疫調節治療",
            "貓FHV-1→抗病毒治療"
          ]
        }
      ]
    },
    "monitoring": [
      "螢光素複染（潰瘍：q3-5天直至癒合）",
      "Schirmer試驗（KCS：q1-3月評估治療反應）",
      "裂隙燈追蹤（角膜透明度和新生血管變化）",
      "眼壓定期測量（特別是前葡萄膜炎繼發者）"
    ],
    "reference": "Merck Vet Manual - The Cornea in Animals; Today's Vet Nurse - Nonulcerative Keratitis; dvm360 - Canine Keratitis"
  },
  "dry-socket-alveolar-osteitis": {
    "zh": "乾性齒槽炎",
    "en": "Dry Socket (Alveolar Osteitis)",
    "definition": "拔牙術後齒槽窩內血塊溶解或未形成導致的併發症，暴露的齒槽骨因缺乏血塊保護而發炎壞死，引起劇烈疼痛和癒合延遲。在獸醫臨床中較人醫少見但確有記載，與拔牙技術、術後護理和局部因素有關。",
    "synonyms": [
      "齒槽骨炎",
      "拔牙後乾窩症",
      "Alveolar Osteitis",
      "Fibrinolytic Alveolitis"
    ],
    "epidemiology": {
      "species": "犬貓皆可",
      "age": "任何年齡，與拔牙術相關",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "困難拔牙（手術時間長）",
        "術中過度創傷",
        "術後過早咀嚼硬物",
        "嚴重牙周病拔牙",
        "免疫抑制狀態"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "拔牙數天後口腔疼痛加劇",
        "止痛藥無效",
        "食慾下降",
        "口臭"
      ],
      "physicalExam": [
        "拔牙窩內無血塊或肉芽組織",
        "齒槽窩內惡臭液體",
        "齒槽骨暴露可見",
        "周圍軟組織紅腫",
        "觸診拔牙區域劇痛"
      ]
    },
    "pathophysiology": "正常拔牙後齒槽窩內應形成血塊，作為癒合的支架和骨面的保護層。乾性齒槽炎發生於血塊因局部纖溶酶原活化增加而溶解（纖溶性齒槽炎），或因手術創傷、感染等原因未能正常形成。血塊喪失後齒槽骨表面直接暴露於口腔環境，細菌侵入導致骨表面發炎和壞死，產生劇烈疼痛。在獸醫中較人醫罕見，可能因為動物拔牙技術較少使用局部血管收縮劑。",
    "diagnosis": {
      "overview": "根據拔牙病史和典型臨床表現即可診斷",
      "differentials": [
        "正常拔牙後疼痛",
        "拔牙窩感染",
        "殘留齒根",
        "齒槽骨骨折",
        "口鼻瘻管"
      ],
      "initialDB": [
        "口腔視診（拔牙窩空洞、無血塊）",
        "牙科放射線（排除殘留齒根和骨折）",
        "觸診評估疼痛"
      ],
      "advanced": [
        "細菌培養（頑固感染）",
        "CT（懷疑擴散性骨髓炎）"
      ]
    },
    "treatment": {
      "overview": "清創、沖洗和局部藥物填塞促進二次癒合",
      "acute": [
        "輕柔刮除齒槽窩壞死組織",
        "生理食鹽水或chlorhexidine溶液沖洗",
        "齒槽窩填塞含碘仿紗條或gelatin sponge",
        "全身性止痛（NSAIDs + tramadol）"
      ],
      "chronic": [
        "抗生素治療（cefalexin 22mg/kg PO q12h共7-10天）",
        "每日或隔日換藥直到肉芽組織生長",
        "軟食2-3週",
        "嚴重病例可能需要黏膜瓣覆蓋"
      ]
    },
    "prognosis": "經適當清創和局部治療後，大多數病例在1-2週內形成健康肉芽組織，預後良好。齒槽窩癒合時間較正常拔牙延長2-3週。極少數可進展為擴散性骨髓炎，需要更積極的治療。",
    "pearls": [
      "獸醫臨床中乾性齒槽炎比人醫少見，但拔牙後持續疼痛加劇應高度懷疑",
      "預防重於治療：微創拔牙技術和良好的術後止血是關鍵",
      "拔牙後建議軟食至少1週以保護血塊"
    ],
    "diagnosticAlgorithm": {
      "title": "乾性齒槽炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "病史評估",
          "details": "確認拔牙時間和術後疼痛加劇模式",
          "findings": [
            "拔牙後2-5天疼痛加劇",
            "止痛藥效果差",
            "口臭"
          ]
        },
        {
          "step": 2,
          "action": "口腔檢查",
          "details": "視診拔牙窩血塊狀態",
          "findings": [
            "血塊缺失",
            "齒槽骨暴露",
            "惡臭液體"
          ]
        },
        {
          "step": 3,
          "action": "放射線檢查",
          "details": "排除殘留齒根和骨折",
          "findings": [
            "無殘留齒根",
            "齒槽骨完整",
            "骨折或碎片"
          ]
        },
        {
          "step": 4,
          "action": "治療性清創",
          "details": "刮除壞死組織、沖洗、填塞",
          "findings": [
            "健康出血面",
            "肉芽組織開始生長"
          ]
        }
      ]
    },
    "monitoring": [
      "每1-2天換藥評估肉芽組織生長",
      "1週後評估疼痛改善程度",
      "2-3週後確認齒槽窩癒合進展",
      "注意骨髓炎徵象（持續腫脹、瘻管）"
    ],
    "reference": "Wyels SVC. Alveolar osteitis (dry socket) in a dog: a case report. J Vet Dent. 1998;15(2):97-98; VCA: Feline Alveolar Osteitis."
  },
  "gingival-hyperplasia": {
    "zh": "齒齦增生",
    "en": "Gingival Hyperplasia",
    "definition": "齒齦組織因細胞增殖導致的異常增生肥大，是犬常見的口腔良性病變。可為特發性（品種相關）或藥物誘發性（cyclosporine、phenytoin等）。增生的齒齦組織形成假性牙周囊袋，容易堆積食物殘渣和細菌，增加牙周病風險。",
    "synonyms": [
      "牙齦增生",
      "齒齦肥大",
      "Gingival Overgrowth",
      "Gingival Enlargement"
    ],
    "epidemiology": {
      "species": "犬為主（貓罕見）",
      "age": "中年至老年犬",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "品種傾向（拳師犬、鬥牛犬、可卡犬、大丹犬、柯利犬）",
        "Cyclosporine使用（42%發生率）",
        "Amlodipine使用",
        "慢性齒齦炎"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "齒齦腫大被飼主發現",
        "口臭",
        "進食時出血",
        "通常無明顯疼痛"
      ],
      "physicalExam": [
        "齒齦組織瀰漫性增生",
        "增生組織覆蓋部分齒冠",
        "假性牙周囊袋形成",
        "齒齦表面光滑或呈結節狀",
        "觸診質地堅韌",
        "可能合併牙周病"
      ]
    },
    "pathophysiology": "特發性齒齦增生是齒齦結締組織中成纖維細胞增殖和膠原蛋白過度沉積的結果，具有明確的品種遺傳傾向。藥物誘發性齒齦增生（特別是cyclosporine）的機制涉及藥物抑制鈣離子通道，影響齒齦成纖維細胞的代謝，促進細胞增殖和細胞外基質（主要為膠原蛋白）的過度產生。對照研究顯示42%使用免疫抑制劑量cyclosporine的犬在20-24週內出現齒齦增生，發生率和嚴重度與血藥濃度正相關。增生組織形成的假性囊袋成為細菌堆積的溫床，加速繼發性牙周病。",
    "diagnosis": {
      "overview": "臨床診斷為主，活檢用於排除腫瘤性病變",
      "differentials": [
        "齒齦瘤（epulis）",
        "口腔纖維瘤",
        "口腔鱗狀細胞癌",
        "齒齦炎",
        "漿細胞瘤"
      ],
      "initialDB": [
        "口腔檢查評估增生範圍",
        "用藥史調查（cyclosporine、amlodipine等）",
        "牙科放射線（評估齒槽骨狀態）"
      ],
      "advanced": [
        "組織活檢和病理組織學（排除腫瘤）",
        "全口牙科放射線",
        "血藥濃度監測（藥物誘發病例）"
      ]
    },
    "treatment": {
      "overview": "手術切除增生組織並處理誘發因子",
      "acute": [
        "齒齦成形術（gingivoplasty）全身麻醉下進行",
        "同時進行牙科清潔和牙周治療",
        "術後止痛（meloxicam 0.1mg/kg PO q24h共3-5天）"
      ],
      "chronic": [
        "藥物誘發：考慮替換藥物或減量",
        "Cyclosporine誘發：azithromycin 6.6-10.8mg/kg PO q24h共4-14週（可使增生消退）",
        "定期牙科清潔預防復發",
        "日常口腔護理（刷牙、潔牙骨）"
      ]
    },
    "prognosis": "特發性齒齦增生經手術切除後常復發，需要定期維護。藥物誘發性齒齦增生若能停藥或替換藥物，增生通常可消退或明顯改善。Azithromycin治療cyclosporine誘發的齒齦增生效果良好，大多數病例增生完全消退且繼續使用cyclosporine也不復發。定期口腔護理和牙科清潔可減緩復發速度。",
    "pearls": [
      "任何局灶性、不對稱、結節狀或潰瘍性的齒齦增生都應活檢排除腫瘤",
      "Azithromycin是cyclosporine誘發齒齦增生的有效非手術治療選擇",
      "拳師犬是最好發的品種，常需反覆手術治療"
    ],
    "diagnosticAlgorithm": {
      "title": "齒齦增生 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "臨床評估",
          "details": "評估增生分布（瀰漫性vs局灶性）和用藥史",
          "findings": [
            "瀰漫性增生",
            "局灶性腫塊",
            "用藥相關"
          ]
        },
        {
          "step": 2,
          "action": "鑑別腫瘤",
          "details": "活檢排除惡性腫瘤（特別是局灶性或非典型病灶）",
          "findings": [
            "良性增生",
            "epulis",
            "惡性腫瘤"
          ]
        },
        {
          "step": 3,
          "action": "牙科評估",
          "details": "放射線檢查齒槽骨和繼發性牙周病",
          "findings": [
            "假性囊袋",
            "繼發牙周病",
            "齒槽骨正常"
          ]
        },
        {
          "step": 4,
          "action": "治療決策",
          "details": "根據病因選擇手術或藥物治療",
          "findings": [
            "手術齒齦成形",
            "azithromycin藥物治療",
            "停藥/換藥"
          ]
        }
      ]
    },
    "monitoring": [
      "術後2週評估傷口癒合",
      "每3-6個月口腔檢查評估復發",
      "藥物誘發病例監測血藥濃度",
      "定期牙科清潔維護口腔衛生"
    ],
    "reference": "Nishikawa S et al. Cyclosporine-induced gingival overgrowth in dogs. J Vet Dent. 2010; VCA: Gingival Hyperplasia; Niemiec BA. Veterinary Periodontology. Wiley 2013."
  },
  "idiopathic-cystitis": {
    "zh": "貓自發性膀胱炎",
    "en": "Feline Idiopathic Cystitis (FIC)",
    "definition": "貓最常見的下泌尿道疾病，佔貓下泌尿道症狀（FLUTD）病例的55-69%。特徵為無菌性膀胱壁發炎，病因不明但與神經內分泌系統失調和環境壓力密切相關。屬排除性診斷，需先排除感染、結石和腫瘤等已知病因。",
    "synonyms": [
      "貓自發性膀胱炎",
      "FIC",
      "貓間質性膀胱炎",
      "Feline Interstitial Cystitis",
      "Pandora Syndrome"
    ],
    "epidemiology": {
      "species": "貓（極少見於犬）",
      "age": "1-10歲，好發2-6歲中年貓",
      "sex": "公貓母貓發生率相當，但公貓因尿道較窄更易出現尿道阻塞",
      "riskFactors": [
        "室內飼養且缺乏環境豐富化",
        "肥胖/體重過重",
        "多貓家庭或環境壓力",
        "乾飼料為主食（飲水量不足）",
        "緊張型性格",
        "缺乏運動"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "頻尿（頻繁進出貓砂盆）",
        "血尿（尿液帶粉紅色至紅色）",
        "排尿困難或排尿姿勢異常",
        "不在貓砂盆外排尿",
        "過度舔舐生殖區域",
        "症狀反覆發作，常與壓力事件相關"
      ],
      "physicalExam": [
        "膀胱觸診敏感或增厚",
        "公貓可能出現尿道阻塞（膀胱脹大、堅硬）",
        "會陰部可見尿液汙染",
        "體態評分常偏高",
        "其餘理學檢查多無特異性發現"
      ]
    },
    "pathophysiology": "FIC的病理生理涉及膀胱黏膜防禦機制缺損、神經內分泌系統失調和環境壓力三者的複雜交互作用。膀胱上皮的糖胺多醣（GAG）保護層缺損使尿液中刺激性物質滲透至黏膜下層，激活C纖維感覺神經釋放P物質，引發神經源性發炎。同時，患貓的下視丘-垂體-腎上腺軸（HPA axis）反應異常，交感神經系統持續亢進，導致兒茶酚胺濃度升高。這些變化形成膀胱局部發炎和全身性壓力反應的惡性循環。",
    "diagnosis": {
      "overview": "FIC為排除性診斷，需系統性排除其他FLUTD病因後方可確診",
      "differentials": [
        "泌尿道感染（UTI）",
        "膀胱結石/尿道結石",
        "膀胱腫瘤（移行上皮細胞癌）",
        "尿道栓子",
        "行為性排尿異常"
      ],
      "initialDB": [
        "完整尿液分析（無菌採集）",
        "尿液培養與藥敏試驗",
        "腹部X光（排除結石）",
        "CBC/血液生化（評估全身狀態）"
      ],
      "advanced": [
        "腹部超音波（評估膀胱壁厚度、排除腫瘤）",
        "膀胱鏡檢（見黏膜下出血點—肎皮球體）",
        "尿液GAG濃度測定",
        "對比攝影排除解剖異常"
      ]
    },
    "treatment": {
      "overview": "治療以多模式環境修正（MEMO）為核心，輔以飲食管理和壓力緩解",
      "acute": [
        "阻塞型：緊急導尿解除阻塞+靜脈輸液矯正電解質",
        "疼痛管理：Buprenorphine 0.01-0.03 mg/kg SL q6-8h",
        "短期抗痙攣藥：Prazosin 0.25-0.5 mg/cat PO q12h（公貓）"
      ],
      "chronic": [
        "環境豐富化：增加貓砂盆數量（N+1原則）、垂直空間、藏匿處",
        "飲食轉換為濕食為主（增加飲水量）",
        "費洛蒙擴散器（Feliway®）減壓",
        "嚴重復發型：Amitriptyline 2.5-12.5 mg/cat PO q24h"
      ]
    },
    "prognosis": "多數急性發作在5-7天內自行緩解，但約50%的貓在6-12個月內復發。透過完善的環境修正（MEMO），復發率可降低70-80%。少數貓發展為慢性持續型，需長期管理。公貓尿道阻塞未及時處理可致命。",
    "pearls": [
      "FIC是排除診斷——年輕貓（<10歲）的FLUTD先排除結石和阻塞，老年貓要先排除UTI和腫瘤",
      "環境修正（MEMO）的效果遠優於任何藥物治療，是最重要的長期管理策略",
      "公貓尿道阻塞是急診，48小時未處理可因高血鉀導致心律不整死亡"
    ],
    "diagnosticAlgorithm": {
      "title": "貓自發性膀胱炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "病史與臨床評估",
          "details": "確認FLUTD症狀（頻尿、血尿、排尿困難），評估環境壓力因子",
          "findings": [
            "頻尿/血尿/排尿困難",
            "室內飼養+環境壓力"
          ]
        },
        {
          "step": 2,
          "action": "尿液分析與培養",
          "details": "無菌採集尿液進行完整分析和細菌培養",
          "findings": [
            "血尿但培養陰性",
            "結晶可能存在但非主因"
          ]
        },
        {
          "step": 3,
          "action": "影像學檢查",
          "details": "X光和/或超音波排除結石和腫瘤",
          "findings": [
            "無結石或腫塊",
            "膀胱壁可能增厚"
          ]
        },
        {
          "step": 4,
          "action": "排除性確診",
          "details": "排除感染、結石、腫瘤和解剖異常後確診FIC",
          "findings": [
            "所有已知病因被排除",
            "確診FIC並制定MEMO計畫"
          ]
        }
      ]
    },
    "monitoring": [
      "症狀日記（排尿頻率、血尿程度、壓力事件記錄）",
      "體重管理（維持理想體態BCS 4-5/9）",
      "飲水量監測（目標增加至少50%）",
      "定期尿液分析（q3-6個月，監測復發）"
    ],
    "reference": "Buffington CAT (2011) Idiopathic Cystitis in Domestic Cats. Vet Clin North Am Small Anim Pract; PMC Review (2022) Frontiers Vet Sci 9:900847; VCA Hospitals - Feline Idiopathic Cystitis"
  },
  "uroabdomen": {
    "zh": "尿液腹",
    "en": "Uroabdomen",
    "definition": "因泌尿道任何部位（腎臟至骨盆尿道）完整性喪失，導致尿液滲漏至腹腔或後腹膜腔的急症。最常見原因為鈍性外傷（車禍），犬以膀胱破裂為主（>50%），貓以輸尿管損傷較常見。未及時處理將導致嚴重電解質失衡和氮質血症。",
    "synonyms": [
      "尿液腹",
      "泌尿道破裂",
      "Uroperitoneum",
      "Urinary Tract Rupture"
    ],
    "epidemiology": {
      "species": "犬貓皆可",
      "age": "任何年齡，幼年動物腹壁較薄更易受傷",
      "sex": "公犬風險較高（尿道長而窄，膀胱內壓急升時更易破裂）",
      "riskFactors": [
        "車禍或鈍性腹部外傷",
        "尿道阻塞後膀胱過度膨脹",
        "粗暴徒手排尿或導尿操作",
        "腹部手術後（術後滲漏）",
        "泌尿道腫瘤"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "近期外傷史或泌尿道手術",
        "尿量減少或無尿",
        "漸進性精神萎靡和厭食",
        "腹部膨脹",
        "嘔吐"
      ],
      "physicalExam": [
        "腹部膨脹和波動感",
        "觸診腹部疼痛",
        "膀胱可能無法觸及或異常小",
        "黏膜蒼白或充血",
        "心搏過緩（高血鉀所致）",
        "脫水"
      ]
    },
    "pathophysiology": "泌尿道破裂後尿液滲漏至腹腔，尿素氮和肌酸酐經腹膜吸收導致嚴重的腎後性氮質血症。尿液中的鉀離子被重吸收導致危及生命的高血鉀症（可致心搏過緩和心律不整）。同時鈉和氯經腹膜稀釋效應而降低。腹腔內尿液引起化學性腹膜炎，腹膜血管擴張導致體液第三空間分佈和低血容量性休克。慢性滲漏還可能導致後腹膜纖維化和輸尿管狹窄。",
    "diagnosis": {
      "overview": "結合腹水分析（肌酸酐比值）和影像學確認滲漏部位",
      "differentials": [
        "其他原因腹水（心衰、肝病、腹膜炎）",
        "腎後性阻塞（結石/腫瘤）",
        "急性腎損傷",
        "腹腔內出血"
      ],
      "initialDB": [
        "CBC/血液生化（BUN、肌酸酐、電解質）",
        "腹部超音波（確認腹水）",
        "腹水分析：腹水/血清肌酸酐比 ≥2:1確診",
        "腹水/血清鉀比 >1.4:1 支持診斷"
      ],
      "advanced": [
        "陽性對比膀胱尿道攝影（定位下泌尿道破裂）",
        "排泄性尿路攝影（定位腎臟/輸尿管損傷）",
        "CT尿路攝影（高敏感度定位）"
      ]
    },
    "treatment": {
      "overview": "先穩定再手術——糾正電解質失衡後再進行手術修補",
      "acute": [
        "積極靜脈輸液（0.9% NaCl，糾正脫水和稀釋鉀離子）",
        "高血鉀處理：Regular Insulin 0.25-0.5 U/kg IV + Dextrose + Calcium gluconate 10% 0.5-1.5 ml/kg IV",
        "腹腔引流管放置（持續引流尿液減少毒素吸收）",
        "留置導尿管引流"
      ],
      "chronic": [
        "手術修補泌尿道破裂部位",
        "術後持續監測尿量和腎功能",
        "抗生素預防感染（Ampicillin-Sulbactam或Enrofloxacin）",
        "長期追蹤腎功能和輸尿管通暢性"
      ]
    },
    "prognosis": "犬的死亡率約21%，貓約41%。早期診斷和積極穩定治療可顯著改善預後。膀胱破裂的手術修補成功率高，但腎臟或輸尿管損傷的預後較差。合併嚴重腹膜炎或多器官損傷者預後不良。",
    "pearls": [
      "腹水肌酸酐/血清肌酸酐比 ≥2:1 是確診的金標準——急診中簡單快速且準確",
      "Uroabdomen是內科急症而非外科急症——先穩定電解質再開刀",
      "高血鉀是最致命的併發症，心電圖監測（尋找帳篷狀T波和心搏過緩）至關重要"
    ],
    "diagnosticAlgorithm": {
      "title": "尿液腹 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "臨床懷疑",
          "details": "外傷後或術後出現少尿、腹脹、氮質血症",
          "findings": [
            "腹部膨脹+波動感",
            "高BUN/肌酸酐+高血鉀"
          ]
        },
        {
          "step": 2,
          "action": "腹水採樣分析",
          "details": "腹腔穿刺取腹水，比較腹水與血清肌酸酐",
          "findings": [
            "腹水/血清肌酸酐比 ≥2:1",
            "腹水/血清鉀比 >1.4:1"
          ]
        },
        {
          "step": 3,
          "action": "穩定患者",
          "details": "靜脈輸液、處理高血鉀、放置引流管",
          "findings": [
            "電解質逐步改善",
            "血流動力學穩定"
          ]
        },
        {
          "step": 4,
          "action": "影像定位+手術",
          "details": "對比攝影定位破裂部位，穩定後手術修補",
          "findings": [
            "確認破裂部位",
            "手術修補+術後監測"
          ]
        }
      ]
    },
    "monitoring": [
      "每2-4小時監測電解質（特別是鉀離子）",
      "精確尿量測量（目標 >1-2 ml/kg/hr）",
      "腹水量監測（引流管產出量）",
      "術後追蹤腎功能（BUN/Cr q24-48h）"
    ],
    "reference": "Stafford & Bartges (2013) JVECC 23:28-43; Today's Vet Practice - Uroabdomen Approach & Management; Merck Vet Manual - Uroabdomen"
  },
  "hypophosphatemia": {
    "zh": "低磷血症",
    "en": "Hypophosphatemia",
    "definition": "血清磷濃度低於正常範圍（犬 <2.5 mg/dL，貓 <3.0 mg/dL）的代謝異常。嚴重低磷血症（<1.5 mg/dL）可導致溶血性貧血、神經症狀和心肌病變等危及生命的併發症。最常見於糖尿病酮酸中毒治療後、再餵食症候群和副甲狀腺功能亢進。",
    "synonyms": [
      "低磷血症",
      "磷缺乏症",
      "Phosphorus Deficiency"
    ],
    "epidemiology": {
      "species": "犬貓皆可",
      "age": "任何年齡，重症住院患者更常見",
      "sex": "無性別傾向",
      "riskFactors": [
        "糖尿病酮酸中毒（DKA）胰島素治療後",
        "長期厭食後再餵食（再餵食症候群）",
        "原發性或繼發性副甲狀腺功能亢進",
        "庫欣氏症（腎臟磷排泄增加）",
        "貓肝脂肪沉積症",
        "長期制酸劑使用"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "正在治療DKA或長期厭食後開始進食",
        "漸進性虛弱和嗜睡",
        "食慾下降",
        "呼吸急促"
      ],
      "physicalExam": [
        "全身性肌肉無力",
        "黏膜蒼白（溶血性貧血）",
        "心音減弱或心律不整",
        "神經症狀：運動失調、癲癇、昏迷",
        "呼吸淺快"
      ]
    },
    "pathophysiology": "磷是ATP合成、2,3-DPG生成和細胞膜完整性的必需元素。低磷血症的機制包括：(1)跨細胞轉移——胰島素和葡萄糖促使磷進入細胞內（DKA治療後最常見）；(2)腎臟排泄增加——副甲狀腺素抑制近端腎小管磷重吸收；(3)腸道吸收減少——厭食、嘔吐或制酸劑結合磷。嚴重缺磷導致紅血球內ATP和2,3-DPG耗竭，紅血球變形能力下降而溶血；骨骼肌和膈肌無力；心肌收縮力下降；以及中樞神經系統能量代謝障礙。",
    "diagnosis": {
      "overview": "血清磷濃度測定結合臨床背景判斷嚴重程度和病因",
      "differentials": [
        "糖尿病酮酸中毒治療併發症",
        "再餵食症候群",
        "副甲狀腺功能亢進",
        "庫欣氏症",
        "腎小管疾病（Fanconi症候群）"
      ],
      "initialDB": [
        "血液生化全套（磷、鈣、鎂、鉀、血糖）",
        "CBC（評估溶血——網織紅血球、紅血球型態）",
        "離子鈣測定",
        "尿液分析（評估腎臟磷排泄）"
      ],
      "advanced": [
        "副甲狀腺素（iPTH）測定",
        "維生素D代謝物測定",
        "分段式磷排泄率（FEP）計算",
        "血氣分析（評估酸鹼狀態）"
      ]
    },
    "treatment": {
      "overview": "根據嚴重程度選擇口服或靜脈補充磷，同時治療原發病因",
      "acute": [
        "嚴重低磷（<1.5 mg/dL）：Potassium phosphate 0.01-0.06 mmol/kg/hr IV CRI",
        "靜脈補充期間每6小時監測血磷、鈣和鉀",
        "伴隨溶血者需輸血支持"
      ],
      "chronic": [
        "輕至中度：口服磷酸鈉或磷酸鉀補充",
        "DKA患者：在胰島素治療開始時即預防性監測和補充",
        "矯正原發病因（如副甲狀腺手術、停用制酸劑）"
      ]
    },
    "prognosis": "輕至中度低磷血症經適當補充預後良好。嚴重低磷血症（<1.0 mg/dL）伴溶血性貧血和神經症狀者死亡率較高，需積極ICU管理。DKA相關低磷血症在適當監測下通常可預防和及時矯正。",
    "pearls": [
      "DKA治療開始胰島素後4-24小時是低磷血症的高風險窗口——必須預防性監測",
      "嚴重低磷血症的三大紅旗：溶血性貧血+肌肉無力+神經症狀",
      "靜脈補磷時需同時監測鈣（磷鈣沉積風險）和鉀（使用磷酸鉀時）"
    ],
    "diagnosticAlgorithm": {
      "title": "低磷血症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "確認低磷",
          "details": "血清磷測定，犬 <2.5、貓 <3.0 mg/dL",
          "findings": [
            "血磷偏低",
            "評估臨床嚴重程度"
          ]
        },
        {
          "step": 2,
          "action": "評估臨床背景",
          "details": "確認是否有DKA治療、長期厭食、副甲狀腺異常等背景",
          "findings": [
            "DKA胰島素治療後",
            "再餵食症候群風險"
          ]
        },
        {
          "step": 3,
          "action": "併發症評估",
          "details": "CBC評估溶血、心電圖、神經學檢查",
          "findings": [
            "溶血性貧血（嚴重時）",
            "肌肉無力/神經症狀"
          ]
        },
        {
          "step": 4,
          "action": "補充與監測",
          "details": "根據嚴重程度口服或靜脈補磷，定期監測",
          "findings": [
            "磷濃度逐步回升",
            "併發症改善"
          ]
        }
      ]
    },
    "monitoring": [
      "血清磷濃度（急性補充期間q4-6h，穩定後q12-24h）",
      "CBC和網織紅血球計數（監測溶血）",
      "血清鈣和鉀（防止補磷併發症）",
      "臨床神經學狀態評估"
    ],
    "reference": "Merck Vet Manual - Hypophosphatemia in Animals; eClinpath - Phosphate; DVM (1989) JVIM 3:160-171"
  },
  "hyperosmolar-syndrome": {
    "zh": "高滲透壓高血糖症候群",
    "en": "Hyperosmolar Hyperglycemic State (HHS)",
    "definition": "糖尿病的嚴重急性併發症，特徵為極度高血糖（>600 mg/dL）、血清滲透壓顯著升高（犬>325 mOsm/kg，貓>350 mOsm/kg）、嚴重脫水和中樞神經系統抑制，但無或僅有輕微酮症和代謝性酸中毒。死亡率高於糖尿病酮酸中毒（DKA）。",
    "synonyms": [
      "高滲透壓症候群",
      "HHS",
      "高血糖高滲透壓狀態",
      "Diabetic Hyperosmolar Syndrome",
      "Nonketotic Hyperosmolar Syndrome"
    ],
    "epidemiology": {
      "species": "犬貓皆可",
      "age": "中老年（多為已知或新診斷糖尿病患者）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "未控制或新診斷的糖尿病",
        "併發感染或其他疾病（觸發因子）",
        "飲水受限或慢性脫水",
        "使用糖皮質素或利尿劑",
        "腎功能不全"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "多飲多尿病史（數週至數月）",
        "漸進性精神沉鬱至昏迷",
        "食慾廢絕",
        "體重減輕",
        "嘔吐"
      ],
      "physicalExam": [
        "嚴重脫水（皮膚帳篷延遲、黏膜乾燥、CRT延長）",
        "精神極度沉鬱或昏迷",
        "心搏過速",
        "低血壓",
        "Kussmaul呼吸不明顯（與DKA不同）",
        "可能有瞳孔異常或神經缺損"
      ]
    },
    "pathophysiology": "HHS發生在殘存的胰島素分泌足以抑制脂肪分解和酮體生成，但不足以控制血糖的情況。持續高血糖超過腎臟葡萄糖閾值導致滲透性利尿，造成大量水分和電解質丟失。嚴重脫水使腎絲球濾過率下降，進一步減少葡萄糖排泄，形成高血糖-脫水-高血糖的惡性循環。血漿滲透壓升高導致腦細胞脫水和中樞神經系統功能障礙。與DKA不同的是，HHS患者有足夠的胰島素抑制酮體生成，因此缺乏酮酸中毒的典型表現。",
    "diagnosis": {
      "overview": "依據血糖>600 mg/dL + 血清滲透壓升高 + 無明顯酮症確診",
      "differentials": [
        "糖尿病酮酸中毒（DKA）",
        "急性腎損傷",
        "中樞神經系統疾病",
        "中毒（乙二醇等）"
      ],
      "initialDB": [
        "血糖測定（>600 mg/dL / >33 mmol/L）",
        "血清電解質（Na+常升高、K+可能正常或偏低）",
        "血清滲透壓測定或計算（2×Na + Glucose/18 + BUN/2.8）",
        "靜脈血氣分析（pH通常>7.3）",
        "尿酮體測試（陰性或微量）"
      ],
      "advanced": [
        "全血液生化（評估腎功能和肝功能）",
        "CBC（白血球升高提示感染觸發因子）",
        "胸腹部影像學（尋找感染源）",
        "尿液培養"
      ]
    },
    "treatment": {
      "overview": "積極補液為首要治療，延遲使用胰島素（4-6小時後），緩慢矯正血糖和滲透壓避免腦水腫",
      "acute": [
        "靜脈輸液：0.9% NaCl初始bolus犬10-20 ml/kg、貓5-10 ml/kg",
        "電解質補充：重點補鉀（KCl依血鉀濃度調整）",
        "延遲胰島素：待補液4-6小時後開始Regular Insulin 0.05-0.1 U/kg/hr CRI",
        "血糖下降速度控制在每小時不超過50-75 mg/dL"
      ],
      "chronic": [
        "血糖穩定後轉為皮下長效胰島素",
        "尋找並治療觸發因子（感染最常見）",
        "飲食管理和體重控制",
        "定期血糖曲線和果糖胺監測"
      ]
    },
    "prognosis": "HHS死亡率明顯高於DKA，犬貓報告的死亡率可達30-50%以上。預後取決於就診時的脫水程度、神經症狀嚴重度和併發疾病。早期積極補液和緩慢矯正滲透壓是改善預後的關鍵。存活的動物在穩定後需終身胰島素治療和糖尿病管理。",
    "pearls": [
      "HHS vs DKA的關鍵鑑別：HHS血糖更高（>600 vs >250）、無明顯酮症、滲透壓更高、神經症狀更突出",
      "治療的首要步驟是補液而非胰島素——過早給胰島素會造成滲透壓急劇下降引發腦水腫",
      "血糖和鈉濃度必須緩慢矯正——每小時血糖下降不超過50-75 mg/dL"
    ],
    "diagnosticAlgorithm": {
      "title": "高滲透壓高血糖症候群 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "血糖與酮體",
          "details": "測定血糖和尿酮體",
          "findings": [
            "血糖 >600 mg/dL",
            "酮體陰性或微量陽性"
          ]
        },
        {
          "step": 2,
          "action": "滲透壓評估",
          "details": "測定或計算血清滲透壓",
          "findings": [
            "犬>325或貓>350 mOsm/kg",
            "嚴重脫水"
          ]
        },
        {
          "step": 3,
          "action": "電解質和酸鹼",
          "details": "血氣分析和全面電解質評估",
          "findings": [
            "pH >7.3（無明顯酸中毒）",
            "Na+常偏高、K+需密切監測"
          ]
        },
        {
          "step": 4,
          "action": "補液穩定+尋找觸發因子",
          "details": "積極補液，同時尋找併發感染等觸發因子",
          "findings": [
            "感染是最常見的觸發因子",
            "穩定後開始胰島素治療"
          ]
        }
      ]
    },
    "monitoring": [
      "血糖（q1-2h直至穩定）",
      "血清電解質（q2-4h，特別是鈉和鉀）",
      "血清滲透壓（q4-6h，確保緩慢下降）",
      "神經學狀態評估（q2-4h，警惕腦水腫）"
    ],
    "reference": "VETEMCRIT - HHS Protocol; Today's Vet Nurse - Hyperglycemic Hyperosmolar Syndrome; PubMed (2023) 33:e12859"
  },
  "insulinoma-cat": {
    "zh": "貓胰島素瘤",
    "en": "Feline Insulinoma",
    "definition": "貓胰臟β細胞的功能性腫瘤，自主性分泌過量胰島素導致反覆性低血糖。在貓中極為罕見（遠較犬少見），但臨床表現可能嚴重且危及生命。多數為惡性，確診時約50%已有轉移。",
    "synonyms": [
      "胰島素瘤（貓）",
      "β細胞腫瘤",
      "Insulin-Secreting Tumor",
      "Islet Cell Tumor"
    ],
    "epidemiology": {
      "species": "貓（極罕見，犬較常見）",
      "age": "中老年（平均12-15歲）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "老年貓",
        "無已知品種傾向"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "間歇性虛弱或癱瘓",
        "發作性癲癇或肌肉抽搐",
        "精神沉鬱和嗜睡",
        "後肢無力",
        "進食後或運動後症狀改善",
        "症狀呈發作性、反覆出現"
      ],
      "physicalExam": [
        "神經學檢查可能正常（發作間期）",
        "發作時：運動失調、震顫、癲癇",
        "可能觸及腹部腫塊（少見）",
        "一般體態良好或偏胖"
      ]
    },
    "pathophysiology": "胰島素瘤源自胰臟蘭氏小島β細胞的腫瘤性增生，不受正常血糖反饋機制調控地持續分泌胰島素。過量胰島素促使葡萄糖進入細胞並抑制肝醣分解和糖質新生，導致血糖降至危險水平（<60 mg/dL）。低血糖觸發兒茶酚胺釋放（代償性升糖反應），引起震顫和心搏過速。持續性低血糖超過腦部代償能力時，導致神經糖缺乏而出現癲癇、昏迷甚至死亡。貓的胰島素瘤約60-70%為惡性，常見轉移至區域淋巴結和肝臟。",
    "diagnosis": {
      "overview": "低血糖伴隨不適當升高的血清胰島素濃度為診斷基礎",
      "differentials": [
        "肝衰竭相關低血糖",
        "敗血症",
        "副腫瘤症候群（其他腫瘤分泌類胰島素因子）",
        "腎上腺功能不全",
        "糖原貯積症"
      ],
      "initialDB": [
        "血糖測定（低血糖時採血）",
        "血清胰島素濃度（低血糖時同步測定——不適當正常或升高即為異常）",
        "CBC/血液生化全套",
        "果糖胺（評估慢性低血糖程度）"
      ],
      "advanced": [
        "腹部超音波（胰臟腫塊、肝臟轉移）",
        "腹部CT（提高小腫瘤偵測率）",
        "對比增強超音波",
        "術中探查和組織病理確診"
      ]
    },
    "treatment": {
      "overview": "手術切除為首選，醫療管理用於無法手術或術後復發的病例",
      "acute": [
        "低血糖急救：50% Dextrose 0.5-1 ml/kg IV稀釋後緩慢推注",
        "持續靜脈輸液含2.5-5% Dextrose",
        "禁忌大量推注高濃度葡萄糖（會刺激更多胰島素分泌）"
      ],
      "chronic": [
        "手術切除腫瘤（部分胰臟切除）",
        "醫療管理：Diazoxide 5-30 mg/kg PO q12h（抑制胰島素釋放）",
        "頻繁少量餵食（高蛋白低碳水化合物飲食）",
        "Prednisolone 1-2 mg/kg PO q12h（促進糖質新生）"
      ]
    },
    "prognosis": "貓胰島素瘤經手術治療的1年存活率約75%，2年約51%，3年約10%。未手術僅用醫療管理的中位存活時間較短。轉移性疾病預後較差但部分貓即使有轉移仍可透過Diazoxide和飲食管理維持數月良好生活品質。",
    "pearls": [
      "低血糖時的胰島素濃度測定是關鍵——即使在正常範圍內，低血糖時胰島素不應該正常，因此'不適當正常'等於異常",
      "禁忌快速推注高濃度葡萄糖（50%）——會刺激腫瘤釋放更多胰島素造成反彈性低血糖",
      "貓胰島素瘤極罕見，但不能因為'貓不常見'就忽略——老年貓反覆低血糖應列入鑑別"
    ],
    "diagnosticAlgorithm": {
      "title": "貓胰島素瘤 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "確認低血糖",
          "details": "測定血糖<60 mg/dL且排除人為因素",
          "findings": [
            "反覆性低血糖",
            "進食後暫時改善"
          ]
        },
        {
          "step": 2,
          "action": "同步胰島素測定",
          "details": "低血糖發作時同步測定血清胰島素",
          "findings": [
            "胰島素不適當正常或升高",
            "胰島素/血糖比值異常"
          ]
        },
        {
          "step": 3,
          "action": "影像學定位",
          "details": "腹部超音波和/或CT掃描胰臟和肝臟",
          "findings": [
            "胰臟腫塊",
            "肝臟或淋巴結轉移灶"
          ]
        },
        {
          "step": 4,
          "action": "手術探查+病理",
          "details": "手術探查、腫瘤切除和組織病理確診",
          "findings": [
            "β細胞腫瘤確認",
            "分期和轉移評估"
          ]
        }
      ]
    },
    "monitoring": [
      "血糖（居家監測q12h或出現症狀時）",
      "血清果糖胺（q1-3月評估血糖控制）",
      "腹部超音波（q3-6月監測復發或轉移）",
      "臨床症狀記錄（虛弱、癲癇發作頻率和嚴重度）"
    ],
    "reference": "Veytsman et al (2023) Vet Surg 52:442-450; ACVS - Insulinoma; Merck Vet Manual - Islet Cell Tumors"
  },
  "aldosteronoma": {
    "zh": "醛固酮瘤（原發性高醛固酮症）",
    "en": "Primary Hyperaldosteronism (Aldosteronoma)",
    "definition": "腎上腺皮質腫瘤自主性分泌過量醛固酮，導致低血鉀和全身性高血壓的內分泌疾病。是貓最常見的腎上腺皮質疾病，多為單側腎上腺腺瘤或腺癌。因初始症狀不特異，常被延遲診斷。",
    "synonyms": [
      "原發性高醛固酮症",
      "Conn氏症候群",
      "Primary Hyperaldosteronism",
      "Conn Syndrome"
    ],
    "epidemiology": {
      "species": "貓為主（犬罕見）",
      "age": "中老年貓（平均13歲）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "老年貓",
        "腎上腺腫瘤家族史不明"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "漸進性後肢無力或不願跳躍",
        "頸部腹屈（cervical ventroflexion）",
        "突發失明",
        "精神沉鬱和嗜睡",
        "多飲多尿"
      ],
      "physicalExam": [
        "低鉀性肌病：後肢無力、蹠行姿勢、頸部腹屈",
        "全身性高血壓（收縮壓 >160 mmHg）",
        "視網膜剝離或眼底出血（高血壓性視網膜病變）",
        "腹部觸診偶可觸及腎上腺腫塊"
      ]
    },
    "pathophysiology": "腎上腺皮質球狀帶腫瘤（腺瘤或腺癌）不受腎素-血管張力素系統調控地自主分泌醛固酮。過量醛固酮作用於遠端腎小管和集合管，促進鈉重吸收和鉀排泄，導致低血鉀症和代謝性鹼中毒。鈉滯留引起血管容積擴張和全身性高血壓。嚴重低血鉀（<3.0 mEq/L）導致骨骼肌細胞膜過度極化而無法正常興奮，表現為瀰漫性肌肉無力。持續性高血壓損傷靶器官，特別是眼底（視網膜剝離）和腎臟（腎硬化）。",
    "diagnosis": {
      "overview": "低血鉀+高血壓+腎上腺腫塊的三聯徵高度提示本病",
      "differentials": [
        "腎臟疾病相關低鉀",
        "甲狀腺功能亢進",
        "嗜鉻細胞瘤",
        "庫欣氏症",
        "其他低血鉀原因（飲食、嘔吐、利尿劑）"
      ],
      "initialDB": [
        "血液生化（血鉀 <3.5 mEq/L、可能伴肌酸酐升高）",
        "血壓測量（收縮壓 >160 mmHg）",
        "眼底檢查（視網膜病變）",
        "電解質全套"
      ],
      "advanced": [
        "血清醛固酮濃度（顯著升高）",
        "血漿腎素活性（受抑制，醛固酮/腎素比升高）",
        "腹部超音波或CT（腎上腺腫塊，多為單側）",
        "腎上腺CT三期增強掃描"
      ]
    },
    "treatment": {
      "overview": "手術切除受影響的腎上腺為治療首選，醫療管理用於手術前穩定或無法手術的病例",
      "acute": [
        "補鉀：KCl添加至靜脈輸液中（不超過0.5 mEq/kg/hr）",
        "降壓：Amlodipine 0.125-0.25 mg/kg PO q24h",
        "醛固酮拮抗劑：Spironolactone 1-2 mg/kg PO q12h"
      ],
      "chronic": [
        "單側腎上腺切除術（adrenalectomy）",
        "術後大多數貓不需長期用藥",
        "內科管理：Spironolactone + Amlodipine + 口服補鉀",
        "定期監測血壓和電解質"
      ]
    },
    "prognosis": "手術切除腺瘤的預後良好，多數貓術後低血鉀和高血壓可完全緩解且不需長期用藥。腺癌的預後較差但術後仍可能獲得數月至數年的良好生活品質。未治療的持續性高血壓將導致不可逆的靶器官損傷（失明、腎衰竭）。內科管理可有效控制但需終身用藥。",
    "pearls": [
      "老年貓出現低血鉀+高血壓+肌肉無力的三聯徵——首先考慮原發性高醛固酮症",
      "突發失明（視網膜剝離）可能是本病的首發症狀，不要忽略測血壓",
      "本病在貓中被嚴重低估——任何不明原因低血鉀的老年貓都應測醛固酮濃度"
    ],
    "diagnosticAlgorithm": {
      "title": "原發性高醛固酮症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "臨床懷疑",
          "details": "老年貓出現低血鉀、高血壓或肌肉無力",
          "findings": [
            "血鉀 <3.5 mEq/L",
            "收縮壓 >160 mmHg"
          ]
        },
        {
          "step": 2,
          "action": "醛固酮測定",
          "details": "測定血清醛固酮濃度和腎素活性",
          "findings": [
            "醛固酮顯著升高",
            "腎素活性受抑制"
          ]
        },
        {
          "step": 3,
          "action": "影像定位",
          "details": "腹部超音波或CT掃描腎上腺",
          "findings": [
            "單側腎上腺腫塊",
            "評估對側腎上腺和轉移"
          ]
        },
        {
          "step": 4,
          "action": "術前穩定+手術",
          "details": "補鉀降壓穩定後行腎上腺切除術",
          "findings": [
            "術後低血鉀和高血壓緩解",
            "病理確認腺瘤或腺癌"
          ]
        }
      ]
    },
    "monitoring": [
      "血清鉀濃度（術前q24-48h，術後q1-3月）",
      "血壓測量（q1-3月）",
      "眼底檢查（q3-6月監測視網膜病變）",
      "腹部超音波（q6月監測復發，腺癌患者）"
    ],
    "reference": "AAHA (2023) Selected Endocrinopathies Guidelines - Feline Hyperaldosteronism; Merck Vet Manual; Javadi et al (2005) JVIM 19:834-839"
  },
  "acromegaly": {
    "zh": "肢端肥大症",
    "en": "Acromegaly (Hypersomatotropism)",
    "definition": "因垂體腺瘤過度分泌生長激素（GH）所致的慢性內分泌疾病，主要影響貓。過量GH導致胰島素阻抗性糖尿病、軟組織和骨骼過度生長、心肌肥大和腎臟肥大。是貓難以控制的糖尿病的重要鑑別診斷。",
    "synonyms": [
      "肢端肥大症",
      "高生長激素症",
      "Hypersomatotropism",
      "GH-Secreting Pituitary Adenoma"
    ],
    "epidemiology": {
      "species": "貓為主（犬極罕見，犬的肢端肥大症多與孕酮相關）",
      "age": "中老年貓（平均10-11歲）",
      "sex": "公貓略多",
      "riskFactors": [
        "公貓",
        "已知糖尿病且對胰島素反應差",
        "垂體腺瘤"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "糖尿病症狀：多飲多尿、多食",
        "胰島素需求持續增加（>6-8 U/次仍控制不佳）",
        "體重增加（非肥胖，為軟組織增生）",
        "頭部或四肢變大",
        "呼吸困難或打鼾加重"
      ],
      "physicalExam": [
        "體型壯碩、體重增加",
        "下顎前突（prognathia inferior）",
        "頭部寬大、爪子增厚",
        "心雜音或心音增強（心肌肥大）",
        "腎臟觸診增大",
        "關節僵硬"
      ]
    },
    "pathophysiology": "垂體前葉的GH分泌型腺瘤不受下視丘抑制因子調控地持續分泌過量生長激素。GH直接作用和通過刺激肝臟產生類胰島素生長因子-1（IGF-1）間接作用，導致多系統病變。GH的抗胰島素效應引起嚴重的胰島素阻抗性——高劑量胰島素仍無法有效降低血糖。持續的GH和IGF-1刺激導致軟組織增生（下顎、爪墊、內臟增大）、骨骼改變和心肌向心性肥大。腎臟增大和腎絲球高濾過最終可發展為慢性腎病。垂體腫瘤本身可壓迫視交叉和下視丘。",
    "diagnosis": {
      "overview": "糖尿病貓胰島素需求異常高時應懷疑本病，IGF-1和垂體影像為確診依據",
      "differentials": [
        "單純糖尿病",
        "腎上腺功能亢進（庫欣氏症）",
        "甲狀腺功能亢進",
        "胰島素抗體形成"
      ],
      "initialDB": [
        "血清IGF-1濃度（>1000 ng/mL高度提示）",
        "血液生化（高血糖、可能有氮質血症）",
        "果糖胺（持續升高）",
        "尿液分析（糖尿）"
      ],
      "advanced": [
        "垂體MRI或CT（確認腺瘤大小和位置）",
        "心臟超音波（評估心肌肥大程度）",
        "腎臟超音波（評估腎臟大小）",
        "GH濃度測定（需專門實驗室）"
      ]
    },
    "treatment": {
      "overview": "治療目標為控制GH過量分泌和管理糖尿病及其他併發症",
      "acute": [
        "高劑量胰島素控制血糖（可能需10-20 U/次）",
        "補液和電解質矯正（如有DKA）"
      ],
      "chronic": [
        "放射治療：垂體腫瘤照射（最常用，成功率高但效果緩慢需>3年）",
        "蝶鞍經路垂體切除術（Transsphenoidal hypophysectomy，可達完全緩解但需專業神經外科）",
        "藥物治療：Pasireotide（體抑素類似物，費用高）",
        "持續高劑量胰島素管理糖尿病"
      ]
    },
    "prognosis": "長期預後不佳，多數貓最終死於充血性心衰竭、慢性腎衰竭或垂體腫瘤擴大。但透過積極治療（特別是放射治療或手術），許多貓可維持1-3年的良好生活品質。部分貓在治療後GH降低足以使糖尿病緩解。早期診斷和治療可顯著改善預後。",
    "pearls": [
      "糖尿病貓每次胰島素需求>6 U/次仍控制不佳——必須排除肢端肥大症",
      "體重增加但非肥胖的糖尿病貓是典型線索——GH促進瘦體重增加",
      "IGF-1 >1000 ng/mL加上垂體CT/MRI可見腺瘤即可確診"
    ],
    "diagnosticAlgorithm": {
      "title": "肢端肥大症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "臨床懷疑",
          "details": "糖尿病貓胰島素需求持續升高，體態壯碩",
          "findings": [
            "胰島素需求 >6 U/次",
            "體重增加、下顎增大"
          ]
        },
        {
          "step": 2,
          "action": "IGF-1篩檢",
          "details": "測定血清IGF-1濃度",
          "findings": [
            "IGF-1 >1000 ng/mL高度提示",
            "排除其他胰島素阻抗原因"
          ]
        },
        {
          "step": 3,
          "action": "垂體影像",
          "details": "CT或MRI掃描垂體區域",
          "findings": [
            "垂體腺瘤",
            "評估腫瘤大小和周圍結構"
          ]
        },
        {
          "step": 4,
          "action": "併發症評估+治療",
          "details": "心臟和腎臟功能評估，選擇治療方案",
          "findings": [
            "心肌肥大程度",
            "腎臟大小和功能"
          ]
        }
      ]
    },
    "monitoring": [
      "血糖和果糖胺（q2-4週調整胰島素）",
      "血清IGF-1（q3-6月評估治療反應）",
      "心臟超音波（q6-12月監測心肌肥大）",
      "腎功能（BUN/Cr q3-6月）"
    ],
    "reference": "Merck Vet Manual - Acromegaly in Cats; PMC (2024) Animals 14:310; MSPCA-Angell - Feline Hypersomatotropism"
  },
  "thymic-lymphoma": {
    "zh": "胸腺淋巴瘤",
    "en": "Thymic (Mediastinal) Lymphoma",
    "definition": "起源於胸腺或前縱膈淋巴組織的惡性腫瘤，是貓最常見的縱膈腫塊。貓以T細胞型為主，常見於年輕FeLV陽性貓。犬則較少見。臨床表現以呼吸困難和胸腔積液為主要特徵，化學治療為主要治療方式。",
    "synonyms": [
      "縱膈淋巴瘤",
      "前縱膈淋巴瘤",
      "Mediastinal Lymphoma",
      "Anterior Mediastinal Lymphoma"
    ],
    "epidemiology": {
      "species": "貓為主（佔貓淋巴瘤10-20%），犬較少見",
      "age": "貓：年輕（2-3歲，FeLV相關）或老年（>10歲）雙峰分佈；犬：中老年",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "貓白血病病毒（FeLV）感染",
        "年輕貓",
        "暹羅貓和東方短毛品種",
        "犬：金毛獵犬、拳師犬"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "漸進性呼吸困難",
        "運動不耐受",
        "食慾下降和體重減輕",
        "吞嚥困難或反流",
        "咳嗽"
      ],
      "physicalExam": [
        "呼吸急促和呼吸困難",
        "胸部聽診心音和肺音減弱（胸腔積液）",
        "頸部前方胸廓可觸及腫塊",
        "胸廓前部叩診呈濁音",
        "可能有頭頸部水腫（前腔靜脈症候群）"
      ]
    },
    "pathophysiology": "胸腺淋巴瘤起源於胸腺內T淋巴球（貓）或B淋巴球（犬部分）的惡性轉化。在FeLV感染的貓中，病毒整合入宿主基因組激活原癌基因（特別是c-myc），導致T細胞不受控制增殖。腫瘤在前縱膈快速擴張，壓迫氣管和食道導致呼吸困難和吞嚥障礙。腫瘤刺激胸膜產生大量滲出液（胸腔積液），進一步壓迫肺葉。壓迫前腔靜脈可導致頭頸部靜脈回流受阻（前腔靜脈症候群）。腫瘤細胞可能產生異位副腫瘤激素導致高鈣血症（犬較常見）。",
    "diagnosis": {
      "overview": "胸腔影像學結合細針穿刺細胞學或胸水分析確診",
      "differentials": [
        "胸腺上皮腫瘤（thymoma）",
        "異位甲狀腺腫瘤",
        "心基底腫瘤",
        "胸腔膿瘍",
        "縱膈肉芽腫"
      ],
      "initialDB": [
        "胸部X光（前縱膈腫塊+胸腔積液）",
        "FeLV/FIV檢測（貓）",
        "CBC/血液生化（可能見高鈣血症）",
        "胸水分析和細胞學"
      ],
      "advanced": [
        "超音波引導細針穿刺（FNA）細胞學",
        "流式細胞術（免疫表型分析T/B細胞）",
        "胸部CT（評估腫瘤範圍和血管侵犯）",
        "骨髓穿刺（分期）"
      ]
    },
    "treatment": {
      "overview": "化學治療為主要治療方式，手術僅適用於胸腺上皮腫瘤",
      "acute": [
        "胸腔積液引流（改善呼吸）",
        "氧氣支持",
        "高鈣血症處理：生理食鹽水利尿+Furosemide"
      ],
      "chronic": [
        "CHOP方案化療（Cyclophosphamide + Doxorubicin + Vincristine + Prednisolone）",
        "貓單藥化療：Chlorambucil + Prednisolone（年老或狀態差者）",
        "放射治療（輔助或化療抵抗型）",
        "定期追蹤胸部X光和血液檢查"
      ]
    },
    "prognosis": "化療反應率高（70-80%），達完全緩解的貓中位存活時間約12-32個月。FeLV陽性貓預後較FeLV陰性者差。犬的縱膈淋巴瘤預後中等，與T/B細胞分型相關。未治療者存活時間僅數週。",
    "pearls": [
      "年輕貓+前縱膈腫塊+胸腔積液=首先排除FeLV相關淋巴瘤",
      "胸腺淋巴瘤（化療治療）vs 胸腺上皮腫瘤（手術治療）的鑑別至關重要——細胞學或流式細胞術可區分",
      "化療反應通常非常迅速——呼吸困難可在開始Prednisolone後24-48小時內改善"
    ],
    "diagnosticAlgorithm": {
      "title": "胸腺淋巴瘤 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "胸部影像",
          "details": "胸部X光確認前縱膈腫塊和胸腔積液",
          "findings": [
            "前縱膈腫塊",
            "胸腔積液"
          ]
        },
        {
          "step": 2,
          "action": "穿刺細胞學",
          "details": "超音波引導FNA或胸水細胞學",
          "findings": [
            "大量淋巴母細胞",
            "流式細胞術確認T/B分型"
          ]
        },
        {
          "step": 3,
          "action": "FeLV/FIV+分期",
          "details": "FeLV/FIV檢測、血液生化、骨髓穿刺",
          "findings": [
            "FeLV狀態",
            "高鈣血症（犬較常見）"
          ]
        },
        {
          "step": 4,
          "action": "開始化療",
          "details": "穩定患者後開始CHOP或改良方案化療",
          "findings": [
            "化療反應評估",
            "胸部X光追蹤"
          ]
        }
      ]
    },
    "monitoring": [
      "胸部X光（化療期間q2-4週評估腫瘤縮小和積液）",
      "CBC（化療前每次確認白血球足夠）",
      "血清鈣濃度（犬，監測副腫瘤高鈣血症）",
      "FeLV病毒載量（貓，評估預後）"
    ],
    "reference": "Frontiers Vet Sci (2020) 7:444; Royal Canin Academy - Feline Mediastinal Lymphoma; VSSO - Thoracic Tumors"
  },
  "splenic-torsion": {
    "zh": "脾臟扭轉",
    "en": "Splenic Torsion",
    "definition": "脾臟沿其血管蒂軸旋轉導致血流受阻的急性腹部急症。可為原發性（單獨發生）或繼發於胃擴張-扭轉（GDV）。大型深胸犬最易發生，症狀包括急性腹痛、脾臟腫大和可能的血液動力學不穩定。脾臟切除為治療首選。",
    "synonyms": [
      "脾扭轉",
      "脾臟扭轉症",
      "Splenic Torsion",
      "Torsion of the Spleen"
    ],
    "epidemiology": {
      "species": "犬（貓極罕見）",
      "age": "中年至老年大型犬",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "大型深胸犬（大丹犬、德國牧羊犬、聖伯納犬）",
        "胃擴張-扭轉（GDV）病史",
        "脾臟腫大（脾臟腫瘤、脾臟血腫）",
        "既往脾臟切除後對側扭轉（罕見）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "急性腹部疼痛和不安",
        "食慾廢絕和嘔吐",
        "精神沉鬱",
        "腹部膨脹",
        "慢性型可表現為間歇性厭食和嗜睡"
      ],
      "physicalExam": [
        "腹部觸診疼痛",
        "脾臟明顯腫大（可觸及）",
        "黏膜蒼白（貧血或休克）",
        "心搏過速",
        "腹部膨脹",
        "可能有腹水"
      ]
    },
    "pathophysiology": "脾臟沿其血管蒂（脾動脈和脾靜脈）旋轉，首先壓迫低壓的靜脈回流，導致脾臟鬱血性腫脹。持續扭轉後動脈供血也受阻，引起脾臟缺血和壞死。大量血液滯留在腫脹的脾臟中（可達體循環血量的30%），導致有效循環血量下降和低血容量性休克。脾臟壞死釋放的血栓素和發炎介質可引發瀰漫性血管內凝血（DIC）。慢性部分扭轉可導致脾臟被動鬱血和血腫形成。脾臟切除後脾韌帶鬆弛可增加日後胃扭轉的風險。",
    "diagnosis": {
      "overview": "腹部超音波和X光結合臨床表現進行診斷",
      "differentials": [
        "脾臟腫瘤（血管肉瘤）",
        "脾臟血腫",
        "胃擴張-扭轉（GDV）",
        "腸繫膜扭轉",
        "腹腔內出血其他原因"
      ],
      "initialDB": [
        "腹部X光（脾臟腫大、異位）",
        "腹部超音波（脾臟腫大、回聲改變、脾門血流異常）",
        "CBC（貧血、血小板減少）",
        "血液生化和凝血功能"
      ],
      "advanced": [
        "超音波都卜勒（脾臟血管血流評估——減少或消失）",
        "腹部CT（精確評估扭轉程度和血管狀態）",
        "腹腔穿刺（排除腹腔內出血）"
      ]
    },
    "treatment": {
      "overview": "脾臟切除為確定性治療，術前需穩定患者",
      "acute": [
        "積極靜脈輸液穩定血流動力學",
        "輸血（PCV <20% 或進行性貧血）",
        "止痛：Opioids（Methadone 0.1-0.3 mg/kg IV）",
        "糾正凝血異常"
      ],
      "chronic": [
        "緊急脾臟切除術（splenectomy）——不要嘗試復位",
        "術中評估胃的位置和韌帶鬆弛度",
        "考慮同時進行預防性胃固定術（gastropexy）",
        "脾臟送病理檢查（排除潛在腫瘤）"
      ]
    },
    "prognosis": "單純脾臟扭轉經手術切除後預後良好，多數犬可完全恢復。合併GDV者預後較差（GDV整體死亡率約20%）。術後需監測脾臟切除後可能的日後GDV風險。若脾臟扭轉為脾臟腫瘤（特別是血管肉瘤）繼發，則預後取決於腫瘤性質。",
    "pearls": [
      "脾臟扭轉後日後GDV風險增加——手術時應考慮同時做預防性胃固定術",
      "超音波都卜勒見脾臟血管血流消失是確診的關鍵發現",
      "扭轉的脾臟不要嘗試復位——直接切除，因為再灌注損傷和壞死組織釋放毒素可能致命"
    ],
    "diagnosticAlgorithm": {
      "title": "脾臟扭轉 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "臨床懷疑",
          "details": "大型犬急性腹痛、脾臟腫大",
          "findings": [
            "腹部觸診疼痛+脾腫大",
            "心搏過速+黏膜蒼白"
          ]
        },
        {
          "step": 2,
          "action": "影像學",
          "details": "腹部超音波評估脾臟位置和血流",
          "findings": [
            "脾臟異位+回聲改變",
            "都卜勒：脾門血流減少或消失"
          ]
        },
        {
          "step": 3,
          "action": "穩定患者",
          "details": "輸液、輸血、止痛",
          "findings": [
            "血流動力學穩定",
            "凝血功能評估"
          ]
        },
        {
          "step": 4,
          "action": "緊急脾臟切除",
          "details": "手術切除脾臟，考慮同時胃固定術",
          "findings": [
            "切除脾臟送病理",
            "評估是否需要胃固定術"
          ]
        }
      ]
    },
    "monitoring": [
      "術後PCV/TP q4-6h×24h",
      "心電圖監測（脾臟切除後48h內心律不整風險）",
      "凝血功能（DIC風險）",
      "長期追蹤GDV風險（大型犬）"
    ],
    "reference": "Vet Med Illinois - Splenic Torsion; dvm360 - Primary Splenic Torsion in Dogs; Today's Vet Practice - Canine Abdominal Organ Torsions"
  },
  "ovarian-remnant-syndrome": {
    "zh": "卵巢殘留症候群",
    "en": "Ovarian Remnant Syndrome",
    "definition": "卵巢殘留症候群（ORS）是已進行卵巢子宮切除術（OHE）的母犬貓因殘留功能性卵巢組織而重新出現發情行為的疾病。原因包括手術未完全摘除卵巢、異位卵巢組織或卵巢組織自體移植。殘留組織持續分泌生殖激素，引起發情症狀和潛在的蓄膿風險。",
    "synonyms": [
      "ORS",
      "卵巢殘餘症候群",
      "絕育後發情"
    ],
    "epidemiology": {
      "species": "犬貓皆可，貓可能更常見（解剖因素）",
      "age": "任何已絕育母犬貓",
      "sex": "僅已絕育母犬貓",
      "riskFactors": [
        "OHE手術不完全",
        "肥胖（手術視野受限）",
        "貓的卵巢韌帶較難分離",
        "異位卵巢組織（罕見）",
        "卵巢組織術中脫落自體移植"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "絕育後重新出現發情行為",
        "外陰腫脹和分泌物",
        "吸引公犬/公貓",
        "行為改變（躁動、親人、提臀姿勢）",
        "週期性出現"
      ],
      "physicalExam": [
        "外陰腫脹充血",
        "陰道分泌物",
        "乳腺發育",
        "行為表現符合發情",
        "無子宮可觸及（已切除）"
      ]
    },
    "pathophysiology": "ORS的根本原因為體內殘留具有功能的卵巢組織。最常見原因為OHE手術時未完全切除卵巢（特別是左側卵巢，因解剖位置較深）。貓的卵巢韌帶（proper ligament）較厚實，外科醫師有時無法完全將卵巢外翻暴露和分離。少數情況下存在異位卵巢組織（accessory ovarian tissue），或手術中卵巢碎片脫落後在腹腔內自體移植並恢復功能。殘留卵巢組織形成功能性卵泡，分泌雌激素引起發情表現。若排卵後形成黃體則分泌黃體素。長期雌激素暴露增加子宮殘端蓄膿（stump pyometra）和乳腺腫瘤風險。",
    "diagnosis": {
      "overview": "發情期陰道細胞學+血清黃體素或AMH確認功能性卵巢組織",
      "differentials": [
        "外源性雌激素暴露",
        "腎上腺疾病",
        "正常的絕育後行為問題",
        "從未實際絕育"
      ],
      "initialDB": [
        "陰道細胞學（發情期角化細胞>90%確認雌激素影響）",
        "血清黃體素（排卵後升高）",
        "抗穆勒管激素（AMH）— 陽性=有卵巢組織"
      ],
      "advanced": [
        "腹部超音波（搜尋殘留卵巢組織）",
        "LH濃度（絕育犬正常升高，有卵巢者較低）",
        "GnRH刺激試驗"
      ]
    },
    "treatment": {
      "overview": "手術探查和切除殘留卵巢組織為唯一根治方法",
      "acute": [
        "排卵誘導後3-6週手術探查（黃體使殘留組織較易辨識）"
      ],
      "chronic": [
        "開腹或腹腔鏡探查雙側卵巢蒂",
        "切除所有殘留卵巢組織",
        "組織送病理確認",
        "術後追蹤AMH或LH確認完全切除"
      ]
    },
    "prognosis": "手術切除殘留卵巢組織後預後極佳，發情症狀完全消失。排卵誘導後3-6週手術可提高殘留組織辨識率。未治療的ORS長期有子宮殘端蓄膿和乳腺腫瘤風險。",
    "pearls": [
      "AMH是診斷ORS最可靠的單一檢測",
      "排卵誘導後3-6週手術探查效果最佳（黃體可見）",
      "左側卵巢蒂為最常見殘留部位",
      "未治療ORS有蓄膿和乳腺腫瘤風險"
    ],
    "diagnosticAlgorithm": {
      "title": "卵巢殘留症候群 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "臨床懷疑",
          "details": "絕育母犬貓重現發情",
          "findings": [
            "外陰腫脹",
            "發情行為",
            "吸引公犬"
          ]
        },
        {
          "step": 2,
          "action": "激素確認",
          "details": "AMH和/或黃體素檢測",
          "findings": [
            "AMH陽性=有卵巢組織",
            "黃體素升高=有黃體",
            "陰道細胞學=雌激素效應"
          ]
        },
        {
          "step": 3,
          "action": "影像定位",
          "details": "超音波搜尋殘留組織",
          "findings": [
            "卵巢蒂區域腫塊",
            "卵泡或黃體結構"
          ]
        },
        {
          "step": 4,
          "action": "手術切除",
          "details": "排卵後3-6週探查",
          "findings": [
            "殘留卵巢組織切除",
            "病理確認",
            "術後AMH追蹤"
          ]
        }
      ]
    },
    "monitoring": [
      "術後AMH（應轉為陰性）",
      "發情行為消失確認",
      "乳腺檢查",
      "子宮殘端評估"
    ],
    "reference": "Merck Veterinary Manual — ORS; Cornell CVM; PubMed — 21 cases study; UC Davis CVM"
  },
  "benign-prostatic-hyperplasia": {
    "zh": "良性前列腺增生",
    "en": "Benign Prostatic Hyperplasia (BPH)",
    "definition": "未結紮公犬最常見的前列腺疾病，因雄性激素（特別是雙氫睪固酮DHT）長期刺激導致前列腺組織非腫瘤性增生和腫大。發生率隨年齡增長急遽上升，6歲以上未結紮公犬80%以上有BPH，多數無臨床症狀。結紮為最有效治療。",
    "synonyms": [
      "前列腺肥大",
      "BPH",
      "良性前列腺肥大",
      "Prostatic Hyperplasia"
    ],
    "epidemiology": {
      "species": "犬（僅未結紮公犬），貓極罕見",
      "age": ">6歲發生率80%，>9歲95%",
      "sex": "僅未結紮公犬",
      "riskFactors": [
        "未結紮（最關鍵因素）",
        "年齡增長",
        "雄性激素/雌激素比例改變"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "多數無臨床症狀（偶然發現）",
        "包皮滴血或血性分泌物",
        "血精",
        "排便困難（扁平狀糞便）",
        "偶有排尿困難"
      ],
      "physicalExam": [
        "直腸觸診：前列腺對稱性腫大、無痛、表面光滑",
        "包皮口可見血性或漿液性分泌物",
        "大便可能呈扁帶狀（前列腺壓迫直腸）",
        "排尿通常正常"
      ]
    },
    "pathophysiology": "未結紮公犬的睪丸持續分泌睪固酮，進入前列腺上皮細胞後被5-α還原酶轉化為生物活性更強的雙氫睪固酮（DHT）。DHT與細胞核內雄性激素受體結合，促進前列腺上皮細胞和基質細胞增殖。隨年齡增長，睪固酮和雌激素的比例改變（睪固酮相對下降、雌激素相對上升），雌激素增加前列腺對DHT的敏感性，進一步促進增生。前列腺呈對稱性、離心性增大，向背側壓迫直腸（排便困難）而非壓迫尿道（與人類不同）。增生的腺體可出現囊性變化和自發性出血。",
    "diagnosis": {
      "overview": "直腸觸診+影像學+排除其他前列腺疾病",
      "differentials": [
        "前列腺炎（急性/慢性）",
        "前列腺腺癌",
        "前列腺囊腫",
        "前列腺膿瘍"
      ],
      "initialDB": [
        "直腸觸診（對稱性腫大、無痛）",
        "腹部X光（前列腺陰影增大）",
        "腹部超音波（對稱性增大、均勻回聲或散在囊性變化）",
        "尿液分析和培養（排除感染）"
      ],
      "advanced": [
        "前列腺超音波引導FNA或切片（排除腫瘤）",
        "精液分析（血精評估）",
        "前列腺沖洗液細胞學和培養",
        "CPSE（犬前列腺特異性酯酶）血清標記物"
      ]
    },
    "treatment": {
      "overview": "結紮是最有效的治療，非結紮犬可用藥物管理",
      "acute": [
        "併發前列腺炎時：抗生素（選擇能穿透前列腺的藥物如Enrofloxacin或TMP-SMX）"
      ],
      "chronic": [
        "結紮術（castration）——前列腺在結紮後數週內明顯縮小（50-70%）",
        "種公犬藥物管理：Finasteride 0.1-0.5 mg/kg PO q24h（5-α還原酶抑制劑）",
        "Osaterone acetate 0.25-0.5 mg/kg PO q24h × 7天（歐洲核准）",
        "Deslorelin implant（GnRH激動劑，化學去勢效果）"
      ]
    },
    "prognosis": "結紮後BPH幾乎100%可緩解，前列腺在2-3個月內縮回正常大小。藥物治療有效但停藥後復發。BPH本身為良性，不會轉化為前列腺癌。未治療的嚴重BPH可能併發前列腺炎或前列腺囊腫。",
    "pearls": [
      "未結紮老年公犬+對稱性無痛前列腺腫大=BPH——不要急著做切片，先結紮觀察3個月",
      "犬BPH壓迫的是直腸（排便困難）而非尿道（排尿困難）——這與人類BPH不同",
      "已結紮犬出現前列腺腫大=不是BPH，要高度懷疑前列腺癌"
    ],
    "diagnosticAlgorithm": {
      "title": "良性前列腺增生 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "直腸觸診",
          "details": "確認前列腺大小、對稱性和疼痛度",
          "findings": [
            "對稱性腫大",
            "無痛、表面光滑"
          ]
        },
        {
          "step": 2,
          "action": "影像學",
          "details": "X光和超音波評估前列腺",
          "findings": [
            "均勻性增大",
            "可能散在囊性變化"
          ]
        },
        {
          "step": 3,
          "action": "排除感染和腫瘤",
          "details": "尿液培養、可能需要FNA",
          "findings": [
            "尿液培養陰性",
            "細胞學：增生上皮無異型"
          ]
        },
        {
          "step": 4,
          "action": "治療",
          "details": "結紮或藥物管理",
          "findings": [
            "結紮後前列腺縮小50-70%",
            "定期觸診追蹤"
          ]
        }
      ]
    },
    "monitoring": [
      "結紮後直腸觸診（1個月和3個月確認縮小）",
      "藥物治療者q3-6月前列腺超音波",
      "尿液分析（監測繼發感染）",
      "精液分析（種公犬評估精液品質）"
    ],
    "reference": "Merck Vet Manual - Benign Prostatic Hyperplasia in Dogs; PMC (2025) New Approaches to BPH; VCA Hospitals - Prostatic Disease in Dogs"
  },
  "testicular-tumor": {
    "zh": "睪丸腫瘤",
    "en": "Testicular Tumor",
    "definition": "犬第二常見的腫瘤類型，包括三種主要類型：間質細胞瘤（Leydig cell tumor，最常見~50%）、精上皮瘤（Seminoma，~42%）和支持細胞瘤（Sertoli cell tumor，~8%）。多為良性或低度惡性，結紮（雙側睪丸切除）通常可治癒。隱睪犬罹患精上皮瘤和支持細胞瘤的風險顯著增加。",
    "synonyms": [
      "睾丸腫瘤",
      "精巢腫瘤",
      "Testicular Neoplasia",
      "Testicular Cancer"
    ],
    "epidemiology": {
      "species": "犬（貓極罕見）",
      "age": "中老年未結紮公犬（平均10歲）",
      "sex": "僅未結紮公犬",
      "riskFactors": [
        "未結紮",
        "隱睪症（精上皮瘤和支持細胞瘤風險增加10-14倍）",
        "品種：拳師犬、德國牧羊犬、阿富汗獵犬、威瑪犬、喜樂蒂牧羊犬"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "單側睪丸腫大（或觸不到隱睪側睪丸）",
        "對側睪丸萎縮",
        "支持細胞瘤雌性化症狀：對稱性脫毛、乳腺腫大、包皮下垂",
        "多數間質細胞瘤無臨床症狀（偶然發現）"
      ],
      "physicalExam": [
        "單側睪丸腫大或結節",
        "對側睪丸萎縮（雌激素抑制效應）",
        "雌性化徵兆（支持細胞瘤）：對稱性非搔癢性脫毛、色素沉著",
        "乳腺增生",
        "隱睪犬腹腔內可觸及腫塊"
      ]
    },
    "pathophysiology": "三種腫瘤的發病機制各異：(1)間質細胞瘤（Leydig cell）：睪丸間質內產生睪固酮的細胞良性增殖，多數功能性但臨床影響小，幾乎不轉移；(2)精上皮瘤（Seminoma）：精原細胞的腫瘤性增殖，類似人類精上皮瘤，隱睪是重要風險因子，轉移率<15%；(3)支持細胞瘤（Sertoli cell）：支持精子發育的支持細胞增殖，約20-30%為功能性（分泌雌激素），高雌激素可導致骨髓抑制（再生不良性貧血，為最嚴重併發症）。隱睪使睪丸長期處於較高的腹腔溫度環境，增加腫瘤性轉化風險。",
    "diagnosis": {
      "overview": "觸診+超音波+必要時活檢確診，分期評估轉移",
      "differentials": [
        "睪丸炎/副睪炎",
        "睪丸扭轉",
        "精索腫瘤",
        "腹股溝疝氣（隱睪犬）"
      ],
      "initialDB": [
        "雙側睪丸觸診和比較",
        "睪丸超音波（腫塊特徵、血流）",
        "CBC（支持細胞瘤可見貧血、白血球減少、血小板減少）",
        "血液生化"
      ],
      "advanced": [
        "胸部X光（肺轉移篩檢）",
        "腹部超音波（淋巴結轉移、隱睪定位）",
        "雌激素濃度測定（支持細胞瘤）",
        "術後組織病理確定腫瘤類型"
      ]
    },
    "treatment": {
      "overview": "雙側睪丸切除（結紮）為標準治療，對多數病例具治癒性",
      "acute": [
        "嚴重骨髓抑制（支持細胞瘤雌激素中毒）：輸血+支持性治療",
        "隱睪犬腹腔內腫瘤扭轉：緊急手術"
      ],
      "chronic": [
        "雙側睪丸切除術（orchidectomy/castration）",
        "腹腔內隱睪需剖腹探查取出",
        "轉移性腫瘤：化學治療（Cisplatin或Carboplatin）",
        "術後監測雌性化症狀改善和骨髓恢復"
      ]
    },
    "prognosis": "間質細胞瘤和無轉移的精上皮瘤、支持細胞瘤在結紮後預後極佳（治癒率>95%）。已轉移者（<15%）預後較差但仍可嘗試化療。支持細胞瘤合併嚴重骨髓抑制（再生不良性貧血）預後不良，即使手術去除腫瘤，骨髓恢復仍需數週至數月，部分犬不可逆。",
    "pearls": [
      "隱睪犬的睪丸腫瘤風險增加10-14倍——隱睪犬即使無症狀也建議結紮",
      "支持細胞瘤的'雌性化'三徵：對稱性脫毛+乳腺增生+對側睪丸萎縮——高度提示此診斷",
      "支持細胞瘤最危險的併發症不是轉移，而是雌激素導致的骨髓抑制——CBC是必做檢查"
    ],
    "diagnosticAlgorithm": {
      "title": "睪丸腫瘤 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "觸診+超音波",
          "details": "雙側睪丸觸診比較，超音波評估腫塊",
          "findings": [
            "單側腫大+對側萎縮",
            "超音波見實質性或囊性腫塊"
          ]
        },
        {
          "step": 2,
          "action": "CBC+雌激素",
          "details": "血液檢查評估骨髓功能和雌激素影響",
          "findings": [
            "骨髓抑制（支持細胞瘤）",
            "雌性化徵兆"
          ]
        },
        {
          "step": 3,
          "action": "分期檢查",
          "details": "胸部X光和腹部超音波評估轉移",
          "findings": [
            "淋巴結轉移",
            "肺轉移（罕見）"
          ]
        },
        {
          "step": 4,
          "action": "手術+病理",
          "details": "雙側睪丸切除，術後病理確定腫瘤類型",
          "findings": [
            "組織病理分型",
            "切緣評估"
          ]
        }
      ]
    },
    "monitoring": [
      "CBC（術後q2-4週監測骨髓恢復，支持細胞瘤）",
      "雌性化症狀追蹤（脫毛應在術後2-4個月改善）",
      "腹部和胸部影像（q3-6月×1年，監測轉移）",
      "體格檢查（包皮下垂和乳腺增生消退）"
    ],
    "reference": "VCA Hospitals - Testicular Tumors; VSSO - Testicular Tumors; BluePearl - Testicular Tumors in Dogs"
  },
  "anal-furunculosis": {
    "zh": "肛周瘻管",
    "en": "Perianal Fistula (Anal Furunculosis)",
    "definition": "肛門周圍組織形成慢性、深層、引流性瘻管和潰瘍的免疫介導性疾病。以德國牧羊犬最為好發（佔病例80%以上），被認為與腸道免疫失調（類似人類克隆氏病）有關。環孢素為一線治療藥物，手術為難治性病例的備選方案。",
    "synonyms": [
      "肛門瘻管",
      "肛瘻",
      "Perianal Fistula",
      "Perianal Sinus"
    ],
    "epidemiology": {
      "species": "犬（貓極罕見）",
      "age": "中年至老年（平均5-8歲）",
      "sex": "公犬略多於母犬",
      "riskFactors": [
        "德國牧羊犬（>80%病例）",
        "愛爾蘭雪達犬",
        "低尾位品種（尾根位置低使肛周通風不良）",
        "免疫系統異常"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "排便困難或排便時哭叫",
        "肛門周圍惡臭膿性分泌物",
        "頻繁舔舐肛門區域",
        "血便或黏液便",
        "體重減輕",
        "坐下困難"
      ],
      "physicalExam": [
        "肛門周圍多發性引流性瘻管和潰瘍",
        "肛周皮膚紅腫、糜爛和結痂",
        "嚴重時瘻管可環繞整個肛門",
        "觸診極度疼痛（可能需鎮靜檢查）",
        "可能伴有肛門括約肌張力下降"
      ]
    },
    "pathophysiology": "肛周瘻管被認為是免疫介導性疾病，與犬炎症性腸病（IBD）有共同的免疫病理機制。遺傳易感性（特別是德國牧羊犬的MHC II類基因型）使免疫系統對肛門腺和周圍組織的正常菌群產生異常免疫反應。T細胞和巨噬細胞浸潤肛周組織，釋放促炎細胞因子（TNF-α、IL-1β）導致組織破壞和瘻管形成。低尾位品種肛周區域通風不良和濕熱環境促進細菌繁殖，加重發炎。瘻管深入肛周組織甚至侵犯肛門括約肌，持續引流膿性分泌物。約50%以上的患犬同時有結腸炎或IBD的組織學證據。",
    "diagnosis": {
      "overview": "典型病變的視覺識別即可初步診斷，但需排除腫瘤",
      "differentials": [
        "肛門囊腺癌",
        "肛門囊膿瘍",
        "肛周腫瘤",
        "肛門囊炎",
        "直腸瘻管"
      ],
      "initialDB": [
        "鎮靜下完整肛周視覺檢查和觸診",
        "直腸指檢（評估括約肌張力和直腸黏膜）",
        "CBC/血液生化（基線評估）",
        "糞便檢查"
      ],
      "advanced": [
        "病變活檢（排除腫瘤，特別是不典型病例）",
        "結腸鏡+活檢（評估併發IBD）",
        "肛門超音波或MRI（評估瘻管深度和範圍）",
        "免疫學檢查"
      ]
    },
    "treatment": {
      "overview": "環孢素免疫調節為一線治療，手術保留給難治性病例",
      "acute": [
        "止痛：Tramadol 2-5 mg/kg PO q8-12h 或 Gabapentin",
        "局部清潔和溫水浸泡"
      ],
      "chronic": [
        "Cyclosporine 5-10 mg/kg PO q12-24h（治療8-12週至病變癒合）",
        "可合併Ketoconazole 2.5-10 mg/kg PO q24h（抑制CsA代謝，降低用藥成本）",
        "病變癒合後緩慢減量（每4-6週減25%）至最低有效劑量",
        "難治性：Tacrolimus 0.1% 局部外用q12h",
        "手術（最後手段）：病灶切除、冷凍手術或肛門囊切除"
      ]
    },
    "prognosis": "環孢素治療的完全緩解率約85%。但停藥後復發率高，約50-75%的犬需長期低劑量維持治療。早期治療反應較好，嚴重環形瘻管預後較差。手術可改善難治性病例但併發症包括肛門失禁。合併IBD者需同時管理腸道疾病。",
    "pearls": [
      "德國牧羊犬+肛周潰瘍和瘻管=肛周瘻管是首要診斷——但必須活檢排除肛門囊腺癌",
      "環孢素治療初期可合併Ketoconazole降低成本（Ketoconazole抑制CsA代謝使血藥濃度升高）",
      "約50%以上的肛周瘻管犬同時有IBD——考慮結腸鏡檢查和飲食管理"
    ],
    "diagnosticAlgorithm": {
      "title": "肛周瘻管 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "視覺檢查",
          "details": "鎮靜下仔細檢查肛門周圍",
          "findings": [
            "多發性引流性瘻管",
            "肛周組織紅腫潰瘍"
          ]
        },
        {
          "step": 2,
          "action": "活檢排除腫瘤",
          "details": "不典型病變或單發性病變需活檢",
          "findings": [
            "確認為發炎性瘻管",
            "排除肛門囊腺癌"
          ]
        },
        {
          "step": 3,
          "action": "評估合併症",
          "details": "直腸指檢+考慮結腸鏡評估IBD",
          "findings": [
            "括約肌張力評估",
            "結腸炎組織學證據"
          ]
        },
        {
          "step": 4,
          "action": "開始免疫調節治療",
          "details": "環孢素+/- Ketoconazole，定期追蹤",
          "findings": [
            "4-8週評估治療反應",
            "完全緩解後開始減量"
          ]
        }
      ]
    },
    "monitoring": [
      "肛周病變視覺評估（q2-4週×治療期間）",
      "環孢素血藥濃度（合併Ketoconazole時）",
      "腎功能和肝功能（環孢素長期使用）",
      "體重和糞便品質（IBD共病管理）"
    ],
    "reference": "Merck Vet Manual - Perianal Fistula in Dogs; Today's Vet Practice - Perianal Fistulas; JAVMA (1997) 211:1249-1253"
  },
  "immune-mediated-polyarthritis-non-erosive": {
    "zh": "非侵蝕性免疫媒介性多發關節炎",
    "en": "Non-erosive Immune-Mediated Polyarthritis",
    "definition": "非侵蝕性免疫媒介性多發關節炎（IMPA）是犬最常見的免疫媒介性關節疾病，特徵為兩個或以上關節滑膜的無菌性炎症反應。與侵蝕性類風濕關節炎不同，非侵蝕性IMPA不造成關節軟骨和骨骼的永久性破壞。分為原發性（特發性）和繼發性兩型。",
    "synonyms": [
      "IMPA",
      "免疫媒介性多關節炎",
      "特發性多關節炎"
    ],
    "epidemiology": {
      "species": "犬為主，貓少見",
      "age": "中年犬（平均4-6歲）",
      "sex": "大型犬種好發，無明顯性別傾向",
      "riskFactors": [
        "大型犬種",
        "德國牧羊犬",
        "杜賓犬",
        "拳師犬",
        "潛在感染灶（牙周病、UTI）",
        "腫瘤",
        "炎性腸病",
        "近期疫苗接種"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "間歇性跛行或僵硬步態",
        "不願走動或上下樓梯",
        "多關節受累（可能輪替）",
        "發燒",
        "食慾下降"
      ],
      "physicalExam": [
        "多關節腫脹和疼痛（特別是腕關節和跗關節）",
        "僵硬步態（如同踩蛋殼般行走）",
        "發燒（38.9-40.5°C）",
        "關節觸診疼痛反應",
        "可能的淋巴結腫大"
      ]
    },
    "pathophysiology": "非侵蝕性IMPA的病理機制主要為免疫複合物沉積於關節滑膜。原發性IMPA中，確切的抗原觸發不明，可能與分子模擬或免疫調節異常有關。繼發性IMPA中，遠端感染灶、腫瘤或藥物產生的免疫複合物經血行沉積於關節滑膜，活化補體和嗜中性球趨化。滑膜液中大量嗜中性球浸潤（無菌性化膿性關節炎），釋放蛋白酶和活性氧物種導致滑膜炎。但因無直接針對軟骨或骨骼的自體免疫攻擊，故X光通常不見侵蝕性病變。",
    "diagnosis": {
      "overview": "關節液分析顯示無菌性嗜中性球增多為診斷基礎",
      "differentials": [
        "感染性多關節炎（細菌、真菌、Lyme disease）",
        "侵蝕性IMPA（類風濕關節炎）",
        "全身性紅斑狼瘡",
        "退化性關節病",
        "多發性骨髓瘤"
      ],
      "initialDB": [
        "多關節關節液穿刺+分析（嗜中性球>5-12%、培養陰性）",
        "CBC和生化",
        "尿液培養（排除UTI）",
        "胸腹X光（排除腫瘤）"
      ],
      "advanced": [
        "關節液培養（排除感染）",
        "關節X光（排除侵蝕性病變）",
        "ANA檢測（排除SLE）",
        "Lyme disease和Ehrlichia血清學",
        "腹部超音波"
      ]
    },
    "treatment": {
      "overview": "免疫抑制治療為主，繼發性IMPA需同時治療原發疾病",
      "acute": [
        "Prednisolone 1-2 mg/kg/day",
        "疼痛管理：Gabapentin",
        "關節補充劑",
        "必要時靜脈輸液"
      ],
      "chronic": [
        "Prednisolone逐漸減量（6-8個月療程）",
        "反應不佳或復發：加用Leflunomide或Cyclosporine",
        "Mycophenolate mofetil（替代選擇）",
        "繼發性：控制原發疾病（牙科治療、抗生素等）",
        "物理治療促進關節功能"
      ]
    },
    "prognosis": "原發性IMPA對免疫抑制治療反應通常良好。繼發性IMPA在原發疾病控制後預後佳。復發率不低，需密切監測。部分病例在停藥後復發。多數犬在適當治療下可維持良好生活品質。",
    "pearls": [
      "關節液分析是診斷IMPA的金標準（嗜中性球增多+培養陰性）",
      "至少採集4個關節的關節液",
      "繼發性IMPA佔30-50%，務必尋找潛在病因",
      "僵硬步態如同踩蛋殼般行走是典型表現"
    ],
    "diagnosticAlgorithm": {
      "title": "非侵蝕性免疫媒介性多發關節炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "臨床懷疑",
          "details": "多關節腫脹疼痛+發燒",
          "findings": [
            "僵硬步態",
            "多關節疼痛",
            "發燒"
          ]
        },
        {
          "step": 2,
          "action": "關節液分析",
          "details": "至少4關節穿刺",
          "findings": [
            "嗜中性球增多（>5-12%）",
            "細菌培養陰性",
            "非侵蝕性"
          ]
        },
        {
          "step": 3,
          "action": "排除感染和SLE",
          "details": "血清學+ANA+影像",
          "findings": [
            "壁蝨媒介感染陰性",
            "ANA陰性",
            "關節X光無侵蝕"
          ]
        },
        {
          "step": 4,
          "action": "繼發病因搜尋",
          "details": "尋找遠端感染灶或腫瘤",
          "findings": [
            "口腔檢查（牙周病）",
            "尿液培養",
            "胸腹影像（腫瘤篩檢）"
          ]
        }
      ]
    },
    "monitoring": [
      "關節腫脹和疼痛評估",
      "發燒監測",
      "免疫抑制劑副作用",
      "定期CBC和生化",
      "復發徵象"
    ],
    "reference": "Today's Veterinary Practice — Canine IMPA; PMC — 84 UK cases review; dvm360; Veterinary Partner — VIN"
  },
  "steroid-responsive-meningitis-arteritis": {
    "zh": "類固醇反應性腦膜炎動脈炎",
    "en": "Steroid-Responsive Meningitis-Arteritis (SRMA)",
    "definition": "犬最常見的非感染性腦膜炎，為免疫介導性疾病，主要侵犯軟腦膜和相關動脈壁。好發於6-18月齡的年輕犬，以嚴重頸部疼痛和發燒為特徵。對高劑量糖皮質素治療反應極佳，80-100%的犬可達臨床緩解。",
    "synonyms": [
      "SRMA",
      "無菌性腦膜炎",
      "免疫介導性腦膜炎",
      "犬疼痛症候群",
      "Beagle Pain Syndrome"
    ],
    "epidemiology": {
      "species": "犬（貓極罕見）",
      "age": "6-18月齡最常見（範圍12週至6歲以上）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "品種：拳師犬、米格魯、伯恩山犬、威瑪犬、新斯科舍鴨誘獵犬",
        "年輕犬",
        "疫苗接種後偶有報告（時間相關但未證實因果）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "急性嚴重頸部疼痛（不願低頭、轉頭或上下樓梯）",
        "發燒（>39.5°C）",
        "精神沉鬱和食慾下降",
        "步態僵硬",
        "被觸摸時哭叫"
      ],
      "physicalExam": [
        "頸部僵硬和觸診劇痛",
        "被動屈曲頸部引發疼痛反射",
        "發燒（39.5-41°C）",
        "脊椎其他區域也可能疼痛",
        "神經學檢查通常正常（急性期）",
        "慢性型可出現共濟失調"
      ]
    },
    "pathophysiology": "SRMA的確切觸發因子不明，被認為是遺傳易感個體在環境因子（可能為感染或疫苗抗原）刺激下發生的免疫介導性疾病。異常的Th2型免疫反應導致IgA過度生產（血清和腦脊液中IgA顯著升高為特徵性發現）。IgA免疫複合物沉積在軟腦膜血管壁引起壞死性動脈炎，嗜中性球大量浸潤腦膜（腦脊液呈嗜中性球性炎症）。動脈壁損傷導致腦膜血管通透性增加、蛋白質滲出和發炎介質釋放，引起嚴重疼痛。急性期主要為嗜中性球浸潤，慢性型或治療不足的病例可轉為淋巴球-漿細胞性浸潤伴肉芽腫形成。",
    "diagnosis": {
      "overview": "腦脊液分析（嗜中性球增多+IgA升高）結合臨床特徵確診",
      "differentials": [
        "細菌性腦膜炎",
        "肉芽腫性腦膜腦炎（GME）",
        "椎間盤疾病",
        "免疫介導性多發性關節炎",
        "脊椎骨髓炎"
      ],
      "initialDB": [
        "CBC（白血球升高，以嗜中性球為主）",
        "CRP（C反應蛋白顯著升高——良好的監測指標）",
        "血清IgA測定",
        "基本血液生化"
      ],
      "advanced": [
        "腦脊液分析（嗜中性球顯著增多、蛋白質升高、培養陰性）",
        "腦脊液IgA測定（顯著升高）",
        "MRI（排除其他結構性原因，SRMA可見腦膜增強）",
        "血液培養（排除菌血症）"
      ]
    },
    "treatment": {
      "overview": "高劑量糖皮質素為治療基石，緩慢減量持續6-12個月",
      "acute": [
        "Prednisolone 2-4 mg/kg/day PO（起始劑量，分1-2次）",
        "通常24-48小時內疼痛和發燒顯著改善",
        "嚴重疼痛輔助：Opioids（短期）"
      ],
      "chronic": [
        "Prednisolone維持2週後開始緩慢減量",
        "每4-6週減量25%，總療程6-12個月",
        "以CRP監測指導減量速度",
        "復發時：回到上一個有效劑量",
        "類固醇抵抗型：加用Azathioprine 2 mg/kg PO q24h或Mycophenolate"
      ]
    },
    "prognosis": "整體預後良好至極佳。80-100%的犬對初始類固醇治療反應良好。但約1/3的犬在治療過程中或停藥後復發。復發通常在停藥後8-28天發生，多數對重新開始治療仍有反應。慢性型或反覆復發型預後稍差，可能需要長期低劑量維持治療或加用免疫抑制劑。",
    "pearls": [
      "年輕犬（<2歲）+嚴重頸痛+發燒+白血球升高=SRMA是首要鑑別——腦脊液嗜中性球增多但培養陰性即可確診",
      "CRP是監測治療反應和預測復發的最佳指標——每次減量前測CRP",
      "減量太快是復發的最常見原因——必須緩慢減量，總療程至少6個月"
    ],
    "diagnosticAlgorithm": {
      "title": "類固醇反應性腦膜炎動脈炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "臨床懷疑",
          "details": "年輕犬急性頸痛+發燒+白血球升高",
          "findings": [
            "頸部僵硬劇痛",
            "發燒 >39.5°C"
          ]
        },
        {
          "step": 2,
          "action": "CRP和IgA",
          "details": "測定CRP（顯著升高）和血清IgA",
          "findings": [
            "CRP顯著升高",
            "IgA可能升高"
          ]
        },
        {
          "step": 3,
          "action": "腦脊液分析",
          "details": "全身麻醉下腦脊液穿刺",
          "findings": [
            "嗜中性球顯著增多",
            "蛋白質升高、培養陰性"
          ]
        },
        {
          "step": 4,
          "action": "開始類固醇治療",
          "details": "高劑量Prednisolone，24-48小時評估反應",
          "findings": [
            "快速臨床改善",
            "CRP下降"
          ]
        }
      ]
    },
    "monitoring": [
      "CRP（每次減量前和減量後2週測定）",
      "CBC（白血球計數追蹤）",
      "臨床疼痛評估（每次回診）",
      "類固醇副作用監測（多飲多尿、體重、肝酵素）"
    ],
    "reference": "MSPCA-Angell - SRMA; Fitzpatrick Referrals - SRMA; PMC (2023) Narrative Review"
  },
  "discospondylitis": {
    "zh": "椎間盤脊椎炎",
    "en": "Discospondylitis",
    "definition": "椎間盤和相鄰椎體端板的細菌或真菌感染性疾病，主要影響犬。感染途徑以血行性播散最常見（泌尿道、心內膜炎、皮膚感染等來源），最常見的致病菌為金黃色葡萄球菌。臨床表現為脊柱疼痛，嚴重時可導致脊髓壓迫和神經功能缺損。",
    "synonyms": [
      "椎間盤炎",
      "脊椎骨髓炎",
      "Diskospondylitis",
      "Vertebral Osteomyelitis",
      "Spondylodiscitis"
    ],
    "epidemiology": {
      "species": "犬為主（貓罕見）",
      "age": "中年至老年大型犬（平均3-9歲）",
      "sex": "公犬多於母犬（2:1）",
      "riskFactors": [
        "大型犬品種（德國牧羊犬、大丹犬）",
        "免疫抑制",
        "慢性泌尿道感染",
        "感染性心內膜炎",
        "植入物或手術史",
        "Brucella canis感染"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "脊柱疼痛（不願運動、上下樓梯困難）",
        "發燒",
        "食慾下降和體重減輕",
        "步態僵硬",
        "嚴重時後肢無力或癱瘓"
      ],
      "physicalExam": [
        "脊柱觸診定點壓痛（最常見L7-S1和胸腰椎交界處）",
        "脊柱活動受限",
        "發燒",
        "肌肉萎縮（慢性）",
        "神經學缺損（嚴重時：後肢無力、本體感覺缺損）"
      ]
    },
    "pathophysiology": "致病微生物（最常見金黃色葡萄球菌Staphylococcus pseudintermedius）經血行途徑到達椎體端板的血管豐富區域，在此定植和增殖。感染從椎體端板擴散至椎間盤（缺乏血供的無血管組織），導致椎間盤壞死和椎體端板溶骨性破壞。發炎反應產生肉芽組織和膿瘍，可向椎管方向擴展壓迫脊髓或馬尾神經根。反應性新骨形成（骨贅）是慢性病變的特徵。真菌性椎間盤脊椎炎（Aspergillus spp.）預後較差，常見於免疫抑制犬或德國牧羊犬。Brucella canis感染需特殊關注因為有人畜共通傳染的風險。",
    "diagnosis": {
      "overview": "脊椎X光典型改變結合培養確認致病菌",
      "differentials": [
        "椎間盤突出",
        "脊椎腫瘤",
        "脊椎骨折",
        "椎間盤脊椎病（退化性）",
        "多發性骨髓瘤"
      ],
      "initialDB": [
        "脊椎X光（椎體端板溶解、椎間隙狹窄或塌陷、反應性新骨形成）",
        "CBC/血液生化（白血球升高、CRP升高）",
        "尿液分析和培養（尋找感染來源）",
        "血液培養"
      ],
      "advanced": [
        "Brucella canis血清學（公犬必做）",
        "CT或MRI（早期偵測、評估椎管壓迫）",
        "椎間盤FNA培養（影像引導下）",
        "骨核掃描（多發性病灶偵測）"
      ]
    },
    "treatment": {
      "overview": "長期抗生素治療（6-12個月）為基石，嚴重神經壓迫需手術減壓",
      "acute": [
        "經驗性抗生素：Cephalexin 22-30 mg/kg PO q8h 或 Amoxicillin-Clavulanate",
        "止痛：NSAIDs（Meloxicam 0.1 mg/kg q24h）+/- Gabapentin",
        "嚴格籠內休息（限制活動減少脊柱負荷）"
      ],
      "chronic": [
        "依據培養結果調整抗生素，療程最少6-8週（通常需6-12個月）",
        "真菌性：Itraconazole或Fluconazole長期治療",
        "Brucella：多藥聯合（Doxycycline + Aminoglycoside），建議結紮",
        "手術指徵：進行性神經惡化、椎管膿瘍壓迫、椎體不穩定"
      ]
    },
    "prognosis": "細菌性椎間盤脊椎炎在適當抗生素治療下預後良好，但療程長（6-12個月），過早停藥復發率高。真菌性預後保守至中等，可能需終身治療。Brucella感染需人畜共通傳染預防。伴隨嚴重脊髓壓迫和神經功能缺損者預後較差。",
    "pearls": [
      "脊椎X光改變在發病後3-6週才出現——早期病例X光可能正常，需用MRI或骨掃描",
      "公犬必須做Brucella canis血清學——這是人畜共通傳染病",
      "抗生素療程至少6個月——過早停藥是復發的最常見原因"
    ],
    "diagnosticAlgorithm": {
      "title": "椎間盤脊椎炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "臨床評估",
          "details": "脊柱定點壓痛+發燒+血液發炎指標升高",
          "findings": [
            "脊柱壓痛",
            "WBC和CRP升高"
          ]
        },
        {
          "step": 2,
          "action": "脊椎影像",
          "details": "X光（端板溶解）或MRI（早期偵測）",
          "findings": [
            "椎體端板破壞",
            "椎間隙改變"
          ]
        },
        {
          "step": 3,
          "action": "病原學確認",
          "details": "血液培養+尿液培養+Brucella血清學",
          "findings": [
            "致病菌鑑定",
            "Brucella排除"
          ]
        },
        {
          "step": 4,
          "action": "長期抗生素+追蹤",
          "details": "依培養結果選藥，6-12個月療程",
          "findings": [
            "影像學改善",
            "臨床疼痛緩解"
          ]
        }
      ]
    },
    "monitoring": [
      "脊椎X光（q4-8週評估骨骼癒合）",
      "CRP（q2-4週評估發炎改善）",
      "神經學檢查（q2-4週評估功能恢復）",
      "血液和尿液培養（停藥前確認感染清除）"
    ],
    "reference": "VCA Hospitals - Discospondylitis; Today's Vet Nurse - Discospondylitis; PMC (2023) JAVMA Multi-institutional Study"
  },
  "atlantoaxial-instability": {
    "zh": "寰樞椎不穩定",
    "en": "Atlantoaxial Instability",
    "definition": "第一頸椎（寰椎C1）和第二頸椎（樞椎C2）之間異常活動度增加的先天性神經外科疾病。主要因樞椎齒突（dens）發育不全或缺失和橫韌帶缺陷所致。好發於玩具犬品種幼犬，異常活動導致脊髓壓迫，輕則頸痛，重則四肢癱瘓甚至呼吸衰竭死亡。",
    "synonyms": [
      "寰樞關節脫位",
      "寰樞椎半脫位",
      "AA不穩定",
      "Atlantoaxial Subluxation",
      "AA Luxation"
    ],
    "epidemiology": {
      "species": "犬（貓極罕見）",
      "age": "幼年至年輕（多在2歲前診斷）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "玩具犬品種：約克夏犬、吉娃娃、貴賓犬（玩具型）、博美犬",
        "先天性齒突發育不全或缺失",
        "橫韌帶發育不良",
        "外傷（加重先天缺陷）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "頸部疼痛（哭叫、不願被抱起）",
        "步態異常或運動失調",
        "突發四肢無力或癱瘓",
        "頭部保持僵直位置",
        "輕微外傷後症狀突然惡化"
      ],
      "physicalExam": [
        "頸部觸診疼痛和抗拒被動屈曲",
        "四肢共濟失調（UMN四肢本體感覺缺損）",
        "四肢輕癱至四肢癱瘓",
        "頸部活動受限",
        "嚴重時呼吸異常（膈神經受損）"
      ]
    },
    "pathophysiology": "正常情況下，寰椎與樞椎之間的穩定性由齒突（dens/odontoid process）及其周圍韌帶（橫韌帶、翼韌帶和頂韌帶）維持。先天性寰樞椎不穩定的病因包括：(1)齒突發育不全（hypoplasia）、缺失（aplasia）或未融合（non-union）；(2)橫韌帶先天性缺陷或鬆弛。這些結構異常允許C1相對於C2的異常背側移位，導致樞椎椎體向脊髓腹側壓迫。頸部屈曲時壓迫加重。脊髓壓迫可從輕微（僅頸痛）到嚴重（四肢癱瘓、呼吸衰竭）。急性外傷或不當頸部操作可導致突然惡化甚至死亡。",
    "diagnosis": {
      "overview": "頸部X光顯示C1-C2異常間隙，MRI評估脊髓壓迫程度",
      "differentials": [
        "椎間盤突出（頸椎）",
        "其他先天性脊椎畸形",
        "脊髓空洞症（Chiari-like malformation）",
        "骨折/脫位",
        "腫瘤"
      ],
      "initialDB": [
        "頸部側位X光（C1-C2間隙增寬——正常<2mm，不穩定者常>4mm）",
        "避免屈曲位拍攝（風險極高，可加重壓迫）",
        "神經學定位（C1-C5 UMN四肢病變）"
      ],
      "advanced": [
        "MRI（評估脊髓壓迫程度、水腫和脊髓空洞症）",
        "CT（骨骼結構3D重建，術前計畫）",
        "透視動態檢查（在全身麻醉和呼吸支持下進行）"
      ]
    },
    "treatment": {
      "overview": "手術固定成功率約90%，保守治療成功率約50%",
      "acute": [
        "頸部制動（頸圈或夾板）",
        "糖皮質素：Dexamethasone 0.1-0.2 mg/kg IV（脊髓水腫）",
        "嚴格限制活動",
        "止痛"
      ],
      "chronic": [
        "手術固定（首選——成功率~90%）：腹側或背側穩定術",
        "腹側技術：螺絲/鋼釘固定C1-C2",
        "背側技術：鋼絲環扎或AATB（Kishigami）技術",
        "保守治療（較輕微病例）：頸圈/頸部夾板+限制活動6-8週——成功率~50%"
      ]
    },
    "prognosis": "手術治療的成功率約90%，年輕犬（<2歲）和症狀持續<10個月者預後最好。保守治療成功率約50%，復發率高。嚴重四肢癱瘓和呼吸困難者預後較差。術後併發症包括植入物鬆脫和失敗。體重輕的玩具犬手術技術要求高。",
    "pearls": [
      "玩具犬幼犬+頸痛+四肢共濟失調=必須排除寰樞椎不穩定——禁止在未排除前做頸部屈曲操作",
      "頸部X光拍攝時絕對不要屈曲頸部——可能加重脊髓壓迫導致呼吸停止",
      "手術成功率（90%）遠高於保守治療（50%）——對於有神經症狀的病例應積極建議手術"
    ],
    "diagnosticAlgorithm": {
      "title": "寰樞椎不穩定 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "臨床懷疑",
          "details": "玩具犬幼犬頸痛和四肢共濟失調",
          "findings": [
            "C1-C5 UMN病變定位",
            "品種和年齡符合"
          ]
        },
        {
          "step": 2,
          "action": "頸部X光",
          "details": "中立位頸部側位X光（禁止屈曲位）",
          "findings": [
            "C1-C2間隙增寬",
            "齒突異常"
          ]
        },
        {
          "step": 3,
          "action": "MRI/CT",
          "details": "評估脊髓壓迫程度和骨骼結構",
          "findings": [
            "脊髓壓迫和水腫",
            "齒突形態和韌帶狀態"
          ]
        },
        {
          "step": 4,
          "action": "治療決策",
          "details": "依症狀嚴重度選擇手術或保守治療",
          "findings": [
            "手術固定（神經症狀者）",
            "保守管理（僅頸痛者）"
          ]
        }
      ]
    },
    "monitoring": [
      "神經學評估（術後q1-2週×1月，之後q1-3月）",
      "頸部X光（術後1、3、6月評估固定穩定性）",
      "活動限制（術後8-12週嚴格限制）",
      "長期神經功能追蹤"
    ],
    "reference": "ACVS - Atlantoaxial Instability; Cornell - Craniocervical Junction; PubMed (2018) Vet Radiol Ultrasound"
  },
  "lumbosacral-disease": {
    "zh": "腰薦椎疾病",
    "en": "Lumbosacral Disease (Degenerative Lumbosacral Stenosis)",
    "definition": "L7-S1（第七腰椎至第一薦椎）交界處的退化性狹窄導致馬尾神經根壓迫的疾病，是犬最常見的腰薦椎神經疾病。以大型犬（特別是德國牧羊犬和工作犬）最為好發，臨床表現為腰部疼痛、後肢跛行和尾部功能異常。類似人類的馬尾症候群。",
    "synonyms": [
      "退化性腰薦椎狹窄",
      "馬尾症候群",
      "Cauda Equina Syndrome",
      "Degenerative Lumbosacral Stenosis",
      "DLSS"
    ],
    "epidemiology": {
      "species": "犬（貓罕見）",
      "age": "中老年大型犬（5-10歲）",
      "sex": "公犬略多",
      "riskFactors": [
        "大型犬品種（德國牧羊犬最好發）",
        "工作犬和運動犬",
        "肥胖",
        "高強度活動",
        "先天性腰薦椎畸形"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "後肢活動力下降",
        "起立困難",
        "不願跳躍或上下樓梯",
        "尾巴下垂或不搖尾",
        "排尿或排便困難（嚴重時）",
        "後肢拖行"
      ],
      "physicalExam": [
        "腰薦椎交界處觸診壓痛",
        "後肢伸展時（lordosis test）疼痛加劇",
        "後肢肌肉萎縮",
        "尾巴張力下降",
        "後肢本體感覺可能缺損",
        "肛門反射可能減弱",
        "坐骨神經痛（後肢跛行）"
      ]
    },
    "pathophysiology": "腰薦椎疾病的病理生理涉及多因素性椎管狹窄。L7-S1椎間盤退化（脫水、突出）是核心病因，導致椎間隙狹窄和椎間盤物質突入椎管壓迫馬尾神經根。伴隨的椎間關節骨關節炎造成骨贅增生，黃韌帶肥厚和椎板增厚進一步縮窄椎管。腰薦椎的活動度大和承重使退化變化加速。馬尾包含L7、S1-S3和尾椎的脊神經根，壓迫導致坐骨神經痛（後肢疼痛和跛行）、陰部神經功能障礙（排尿排便異常）和尾神經功能喪失（尾巴下垂）。脊柱過伸（lordosis）加重椎管狹窄，解釋了為何活動後症狀加劇。",
    "diagnosis": {
      "overview": "臨床症狀+進階影像學（CT/MRI）確認壓迫部位和程度",
      "differentials": [
        "髖關節發育不良",
        "十字韌帶斷裂",
        "椎間盤脊椎炎（L7-S1）",
        "脊椎腫瘤",
        "退化性脊髓病"
      ],
      "initialDB": [
        "神經學檢查（LMN後肢病變定位、lordosis test）",
        "腰薦椎X光（椎間隙狹窄、骨贅、終板硬化）",
        "骨盆X光（同時排除髖關節問題）"
      ],
      "advanced": [
        "MRI（首選——軟組織對比最佳，可見椎間盤突出和神經根壓迫）",
        "CT（骨骼結構詳細評估）",
        "CT脊髓攝影（CT + 對比劑注射）",
        "肌電圖（EMG，確認去神經支配）"
      ]
    },
    "treatment": {
      "overview": "保守治療為初始選擇，手術適用於保守治療失敗或進行性神經惡化的病例",
      "acute": [
        "止痛：NSAIDs（Meloxicam 0.1 mg/kg q24h）+ Gabapentin 5-10 mg/kg q8-12h",
        "嚴格限制活動（4-6週）",
        "體重管理"
      ],
      "chronic": [
        "保守治療：物理治療（水療、核心肌群強化）+ 體重控制 + 活動調整",
        "手術減壓：背側椎板切除術（dorsal laminectomy）——移除壓迫結構",
        "手術固定融合：L7-S1椎間融合術（嚴重不穩定時）",
        "術後物理復健"
      ]
    },
    "prognosis": "保守治療可使50-60%的犬臨床改善。手術減壓的成功率約70-80%，工作犬恢復工作能力的比例約60%。預後取決於術前神經功能缺損程度——輕微疼痛者預後最好，排尿排便失禁者預後較差。肥胖和持續高強度活動是復發的危險因子。",
    "pearls": [
      "Lordosis test（腰薦椎過伸壓迫試驗）是最重要的理學檢查——過伸加壓L7-S1時引發疼痛高度提示本病",
      "德國牧羊犬腰薦椎疾病和髖關節發育不良常同時存在——兩者都要評估",
      "X光可能低估病變——腰薦椎X光正常不能排除本病，MRI是確診的金標準"
    ],
    "diagnosticAlgorithm": {
      "title": "腰薦椎疾病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "臨床定位",
          "details": "後肢跛行+腰薦壓痛+lordosis test陽性",
          "findings": [
            "腰薦椎定點壓痛",
            "lordosis test引發疼痛"
          ]
        },
        {
          "step": 2,
          "action": "基礎影像",
          "details": "腰薦椎和骨盆X光",
          "findings": [
            "椎間隙狹窄和骨贅",
            "同時評估髖關節"
          ]
        },
        {
          "step": 3,
          "action": "進階影像",
          "details": "MRI或CT確認壓迫部位和程度",
          "findings": [
            "椎間盤突出",
            "馬尾神經根壓迫"
          ]
        },
        {
          "step": 4,
          "action": "治療選擇",
          "details": "依症狀嚴重度選擇保守或手術",
          "findings": [
            "輕度：保守+物理治療",
            "重度/進行性：手術減壓"
          ]
        }
      ]
    },
    "monitoring": [
      "臨床疼痛評估和步態分析（q2-4週×治療初期）",
      "體重管理（肥胖加重症狀）",
      "神經學功能評估（排尿排便功能、後肢力量）",
      "活動量調整（避免高衝擊活動如跳躍）"
    ],
    "reference": "PMC (2019) Vet Sci 6:99; dvm360 - Degenerative Lumbosacral Stenosis; AAHA (2021) Lumbosacral Conditions"
  },
  "myelodysplastic-syndrome": {
    "zh": "骨髓發育不良症候群",
    "en": "Myelodysplastic Syndrome",
    "definition": "骨髓發育不良症候群（MDS）是一組骨髓造血幹細胞的克隆性腫瘤疾病，特徵為骨髓造血功能異常（dysplasia）和周邊血液一系或多系血球減少。MDS可視為白血病的前期狀態，有一定比例會進展為急性骨髓性白血病。貓的MDS多與貓白血病病毒（FeLV）感染相關。",
    "synonyms": [
      "MDS",
      "骨髓增生異常症候群",
      "前白血病狀態"
    ],
    "epidemiology": {
      "species": "貓較犬常見（與FeLV相關）",
      "age": "貓：年輕至中年（FeLV相關）；犬：中老年",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "貓白血病病毒（FeLV）感染（貓的主要原因）",
        "化學治療藥物暴露",
        "游離輻射暴露",
        "環境毒素",
        "苯接觸"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "慢性進行性虛弱",
        "食慾下降",
        "反覆感染",
        "異常出血",
        "嗜睡"
      ],
      "physicalExam": [
        "黏膜蒼白（貧血）",
        "發燒（感染）",
        "皮膚瘀斑或紫斑（血小板減少）",
        "脾臟腫大",
        "淋巴結腫大",
        "牙齦出血"
      ]
    },
    "pathophysiology": "MDS起源於造血幹細胞的克隆性異常增殖。異常幹細胞在骨髓中分化為形態異常的血球前驅細胞（dysplasia），表現為巨母紅血球、多核或分葉異常的嗜中性球、微小巨核細胞等。這些異常細胞的成熟和功能受損，大量在骨髓內凋亡（無效造血，ineffective hematopoiesis），導致骨髓富含細胞但周邊血液卻出現血球減少（矛盾現象）。在貓中，FeLV插入宿主基因組可導致原癌基因活化和抑癌基因失活，直接引起造血幹細胞的克隆性異常。MDS有一定比例（犬約20-30%、貓更高）進展為急性骨髓性白血病（AML），預後更差。",
    "diagnosis": {
      "overview": "骨髓檢查為確診必須，需評估異常形態學特徵",
      "differentials": [
        "營養性缺乏（B12、葉酸、鐵）",
        "慢性腎病",
        "再生不良性貧血",
        "急性白血病",
        "骨髓纖維化"
      ],
      "initialDB": [
        "CBC（一系或多系血球減少）",
        "血液抹片（血球形態異常：巨大紅血球、低分葉嗜中性球）",
        "網狀紅血球計數（通常低）",
        "FeLV/FIV檢測（貓）"
      ],
      "advanced": [
        "骨髓穿刺+活檢（確診：異常形態+芽細胞百分比）",
        "骨髓芽細胞計數（<20% = MDS, ≥20% = AML）",
        "細胞化學染色",
        "流式細胞儀免疫表型分析"
      ]
    },
    "treatment": {
      "overview": "無根治方法（除骨髓移植外），以支持治療為主",
      "acute": [
        "嚴重貧血：紅血球輸注",
        "嚴重感染：廣效抗生素",
        "出血：血小板輸注（效果短暫）"
      ],
      "chronic": [
        "人類重組紅血球生成素（rHuEPO）改善貧血",
        "低劑量Prednisolone",
        "FeLV陽性貓：抗病毒治療（干擾素）",
        "營養支持",
        "骨髓移植（實驗階段）"
      ]
    },
    "prognosis": "MDS整體預後不良。FeLV相關MDS貓平均存活2-3年。犬的存活時間依進展速度而異。進展為AML後預後極差。多數動物最終因敗血症、出血或嚴重貧血死亡或安樂死。及時支持治療可改善生活品質但難以延長生存期。",
    "pearls": [
      "骨髓富含細胞但周邊血球減少是MDS的矛盾特徵",
      "貓的MDS幾乎都與FeLV相關",
      "芽細胞<20%為MDS，≥20%為AML",
      "MDS是白血病前期，需定期骨髓監測進展"
    ],
    "diagnosticAlgorithm": {
      "title": "骨髓發育不良症候群 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "識別血球減少",
          "details": "不明原因的一系或多系血球減少",
          "findings": [
            "非再生性貧血",
            "嗜中性球減少",
            "血小板減少"
          ]
        },
        {
          "step": 2,
          "action": "血液抹片形態學",
          "details": "評估血球形態異常",
          "findings": [
            "巨大紅血球",
            "低分葉嗜中性球",
            "巨大血小板"
          ]
        },
        {
          "step": 3,
          "action": "骨髓檢查",
          "details": "穿刺+活檢確認異常造血",
          "findings": [
            "骨髓富含細胞",
            "多系異常形態（dysplasia）",
            "芽細胞百分比"
          ]
        },
        {
          "step": 4,
          "action": "分類和分期",
          "details": "WHO/FAB分類",
          "findings": [
            "芽細胞<20%→MDS",
            "芽細胞≥20%→AML",
            "FeLV狀態（貓）"
          ]
        }
      ]
    },
    "monitoring": [
      "定期CBC追蹤血球變化",
      "骨髓芽細胞比例監測（是否進展為AML）",
      "感染防治",
      "FeLV病毒量（貓）"
    ],
    "reference": "Veteriankey — Myelodysplastic Syndromes; Merck Veterinary Manual; PubMed — MDS in cats with FeLV; National Canine Cancer Foundation"
  },
  "canine-atopic-dermatitis": {
    "zh": "犬異位性皮膚炎",
    "en": "Canine Atopic Dermatitis",
    "definition": "犬隻因遺傳易感性對環境過敏原（如塵蟎、花粉、黴菌）產生IgE介導的過敏反應，導致慢性復發性搔癢性皮膚病。",
    "synonyms": [
      "犬異位症",
      "Canine Atopy",
      "CAD"
    ],
    "epidemiology": {
      "species": "犬，貓極少使用此診斷",
      "age": "通常1-3歲首次發病",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "品種遺傳（西高地白梗、拉布拉多、法鬥、金毛）",
        "都市環境",
        "家族過敏史"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "季節性或全年性搔癢",
        "反覆耳道感染",
        "搔癢先於皮膚病變出現",
        "症狀逐年惡化",
        "對類固醇治療反應良好"
      ],
      "physicalExam": [
        "面部搔癢（眼周、口周）",
        "趾間紅腫及舔舐",
        "腋下及腹股溝紅斑",
        "耳廓內側紅腫",
        "慢性皮膚苔蘚化及色素沉著",
        "繼發性細菌或酵母菌感染"
      ]
    },
    "pathophysiology": "皮膚屏障功能缺陷（如filaggrin基因異常）導致環境過敏原穿透皮膚，樹突細胞捕獲過敏原後呈現給Th2淋巴細胞，促使B細胞產生過敏原特異性IgE。IgE結合肥大細胞表面受體，再次接觸過敏原時引發脫顆粒反應，釋放組織胺和發炎介質，導致搔癢和發炎。",
    "diagnosis": {
      "overview": "臨床診斷為主，需排除其他搔癢性疾病。Favrot標準可輔助臨床診斷。",
      "differentials": [
        "跳蚤過敏性皮膚炎",
        "食物過敏",
        "疥癬",
        "毛囊蟲症",
        "接觸性皮膚炎",
        "細菌性膿皮症"
      ],
      "initialDB": [
        "皮膚刮片排除外寄生蟲",
        "皮膚細胞學（排除感染）",
        "嚴格跳蚤防治試驗",
        "食物排除試驗（8-12週）"
      ],
      "advanced": [
        "皮內過敏原測試（IDAT）",
        "血清過敏原特異性IgE檢測",
        "皮膚切片（非特異性但可排除其他疾病）"
      ]
    },
    "treatment": {
      "overview": "多模式治療：避免過敏原、修復皮膚屏障、控制發炎和搔癢、管理繼發感染。",
      "acute": [
        "Oclacitinib（Apoquel）快速止癢",
        "短期類固醇（潑尼松龍0.5-1mg/kg）",
        "治療繼發性細菌或酵母菌感染",
        "外用類固醇噴劑"
      ],
      "chronic": [
        "過敏原特異性免疫治療（ASIT/減敏療法）",
        "Lokivetmab（Cytopoint）每4-8週注射",
        "Oclacitinib長期口服",
        "環孢素（Atopica）",
        "必需脂肪酸補充",
        "定期藥浴和皮膚保濕"
      ]
    },
    "prognosis": "無法治癒但可良好控制。多數病例需終身管理。過敏原特異性免疫治療約60-70%病例有效改善。早期診斷和多模式治療可顯著提升生活品質。",
    "pearls": [
      "Favrot標準：符合5/8項則敏感性85%、特異性79%",
      "搔癢出現在皮膚病變之前是異位性皮膚炎的特徵",
      "必須排除跳蚤過敏和食物過敏後才能確診",
      "繼發性感染是急性發作的常見原因"
    ],
    "diagnosticAlgorithm": {
      "title": "犬異位性皮膚炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估搔癢分布（面部、耳朵、足部、腋下、腹股溝），發病年齡（1-3歲好發）",
          "findings": [
            "面部及耳部搔癢",
            "足部舔咬",
            "腋下及腹股溝紅腫",
            "季節性或全年性症狀"
          ]
        },
        {
          "step": 2,
          "action": "排除其他搔癢病因",
          "details": "皮膚搔刮排除蟎蟲、跳蚤防治排除跳蚤過敏、食物排除試驗排除食物過敏",
          "findings": [
            "皮膚搔刮排除疥癬",
            "跳蚤預防及治療（排除FAD）",
            "黴菌培養排除皮黴菌",
            "8-12週嚴格食物排除試驗"
          ]
        },
        {
          "step": 3,
          "action": "Favrot臨床標準評估",
          "details": "應用Favrot 2010臨床標準（8項中符合≥5項）輔助臨床診斷",
          "findings": [
            "3歲前發病",
            "主要室內生活",
            "類固醇反應性搔癢",
            "足部受累"
          ]
        },
        {
          "step": 4,
          "action": "過敏原檢測與確診",
          "details": "皮內試驗或血清IgE檢測鑑定過敏原（用於免疫治療規劃，非診斷）",
          "findings": [
            "環境過敏原鑑定（塵蟎、花粉、黴菌）",
            "用於免疫治療配方設計",
            "異位性皮膚炎為臨床排除診斷",
            "長期管理方案制定"
          ]
        }
      ]
    },
    "monitoring": [
      "搔癢評分（PVAS）",
      "皮膚感染復發頻率",
      "藥物副作用（肝腎功能）",
      "免疫治療反應評估"
    ],
    "reference": "Hensel P et al. BMC Vet Res 2015; Olivry T et al. ICADA guidelines. Vet Dermatol 2015"
  },
  "flea-allergy-dermatitis": {
    "zh": "跳蚤過敏性皮膚炎",
    "en": "Flea Allergy Dermatitis",
    "definition": "對跳蚤唾液中的過敏原產生過敏反應，導致嚴重搔癢性皮膚炎。是犬貓最常見的過敏性皮膚病。",
    "synonyms": [
      "FAD",
      "跳蚤咬傷過敏",
      "Flea Bite Hypersensitivity"
    ],
    "epidemiology": {
      "species": "犬貓皆常見",
      "age": "任何年齡，但通常1歲以上首次發病",
      "sex": "無性別傾向",
      "riskFactors": [
        "溫暖潮濕環境",
        "戶外活動",
        "跳蚤預防不足",
        "異位性體質"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "劇烈搔癢（尤其腰薦部）",
        "季節性或全年性（視氣候）",
        "跳蚤預防不規律",
        "同居動物可能無症狀"
      ],
      "physicalExam": [
        "犬：腰薦部、尾根部、大腿內側丘疹性皮膚炎",
        "貓：粟粒性皮膚炎、嗜酸球性肉芽腫複合體",
        "脫毛（對稱性或局部）",
        "繼發性細菌感染",
        "跳蚤或跳蚤糞便可見（但敏感動物可能極少）"
      ]
    },
    "pathophysiology": "跳蚤唾液含有多種半抗原和過敏原蛋白，可引發第I型（即發型）和第IV型（遲發型）過敏反應。敏感動物僅需少數跳蚤叮咬即可引發嚴重全身性搔癢。",
    "diagnosis": {
      "overview": "主要基於臨床表現、病變分布和對跳蚤控制的反應。",
      "differentials": [
        "異位性皮膚炎",
        "食物過敏",
        "疥癬",
        "皮膚真菌感染",
        "毛囊蟲症"
      ],
      "initialDB": [
        "仔細梳毛尋找跳蚤或跳蚤糞便",
        "跳蚤糞便濕紙巾測試（紅棕色暈染）",
        "皮膚刮片排除其他寄生蟲"
      ],
      "advanced": [
        "皮內過敏原測試（跳蚤抗原）",
        "嚴格跳蚤防治試驗（6-8週）作為診斷性治療",
        "皮膚切片（表淺血管周圍炎伴嗜酸球浸潤）"
      ]
    },
    "treatment": {
      "overview": "核心為嚴格跳蚤預防和環境控制，輔以止癢和感染控制。",
      "acute": [
        "速效殺蚤劑（如Spinosad、Nitenpyram）",
        "短期類固醇止癢",
        "治療繼發性感染",
        "環境除蚤處理"
      ],
      "chronic": [
        "全年持續性跳蚤預防（所有同居動物）",
        "Isoxazoline類藥物（如Fluralaner、Afoxolaner）",
        "環境控制（定期清洗寢具、吸塵）",
        "必需脂肪酸輔助"
      ]
    },
    "prognosis": "嚴格跳蚤控制下預後極佳。關鍵在於所有同居動物都必須持續預防，且需配合環境除蚤。",
    "pearls": [
      "敏感動物上可能找不到跳蚤（因過度理毛移除）",
      "必須同時治療所有同居動物",
      "環境中95%的跳蚤族群是蟲卵和幼蟲",
      "貓的粟粒性皮膚炎是FAD的經典表現"
    ],
    "diagnosticAlgorithm": {
      "title": "跳蚤過敏性皮膚炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估搔癢分布（尾根部、後腿內側、腹部），觀察跳蚤或跳蚤糞便",
          "findings": [
            "尾根部嚴重搔癢",
            "後背及後腿內側脫毛",
            "皮膚紅腫丘疹",
            "跳蚤糞便（黑色小粒）"
          ]
        },
        {
          "step": 2,
          "action": "跳蚤檢查",
          "details": "仔細梳檢跳蚤或跳蚤糞便（濕紙巾測試呈紅褐色溶解為跳蚤糞）",
          "findings": [
            "發現跳蚤或跳蚤糞便",
            "濕紙巾測試陽性",
            "可能未見跳蚤（過敏動物過度理毛移除）",
            "環境中可能有跳蚤"
          ]
        },
        {
          "step": 3,
          "action": "治療性診斷",
          "details": "給予嚴格跳蚤防治（動物及環境）8-12週，觀察症狀改善",
          "findings": [
            "嚴格跳蚤防治後搔癢改善",
            "皮膚病變消退",
            "所有同住動物需同時治療",
            "環境清潔及處理"
          ]
        },
        {
          "step": 4,
          "action": "確診",
          "details": "跳蚤防治後症狀改善即可確診，皮內試驗可輔助但非必要",
          "findings": [
            "跳蚤控制後完全緩解",
            "跳蚤過敏性皮膚炎確診",
            "需終生跳蚤防治",
            "排除合併異位性皮膚炎"
          ]
        }
      ]
    },
    "monitoring": [
      "搔癢程度改善",
      "皮膚病變消退",
      "跳蚤預防依從性",
      "繼發感染控制"
    ],
    "reference": "Dryden MW. Vet Dermatol 2009; Rust MK. Vet Dermatol 2005"
  },
  "cranial-cruciate-ligament-disease": {
    "zh": "前十字韌帶疾病",
    "en": "Cranial Cruciate Ligament Disease",
    "definition": "膝關節前十字韌帶（CCL）的退行性斷裂，導致關節不穩定、疼痛和進行性骨關節炎。是犬後肢跛行最常見的骨科原因。",
    "synonyms": [
      "前十字韌帶斷裂",
      "CCL斷裂",
      "ACL斷裂",
      "CCLD"
    ],
    "epidemiology": {
      "species": "犬極常見，貓偶見",
      "age": "大型犬1-5歲，小型犬中老年",
      "sex": "絕育犬風險較高",
      "riskFactors": [
        "肥胖",
        "品種傾向（拉布拉多、羅威那、紐芬蘭）",
        "絕育",
        "脛骨平台角度過大",
        "對側CCL斷裂（40-60%在1-2年內）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "急性後肢跛行（部分或完全斷裂）",
        "運動後跛行加重",
        "逐漸性後肢跛行",
        "坐下時患肢外伸",
        "雙側時起立困難"
      ],
      "physicalExam": [
        "脛骨前推試驗陽性",
        "脛骨壓迫試驗陽性",
        "膝關節積液",
        "內側支持帶增厚（medial buttress）",
        "肌肉萎縮",
        "半月板彈響（meniscal click）"
      ]
    },
    "pathophysiology": "犬CCL疾病主要為退行性過程而非急性創傷。韌帶隨時間退化、纖維斷裂逐漸增加，最終完全斷裂。關節不穩定導致半月板損傷和進行性骨關節炎。",
    "diagnosis": {
      "overview": "基於臨床檢查（脛骨前推和壓迫試驗）和影像學。",
      "differentials": [
        "髕骨脫位",
        "半月板損傷",
        "膝關節骨關節炎",
        "膝關節感染",
        "腫瘤"
      ],
      "initialDB": [
        "骨科檢查（可能需鎮靜）",
        "膝關節X光（積液、骨贅）",
        "觸診脛骨前推/壓迫試驗"
      ],
      "advanced": [
        "關節鏡檢查",
        "CT/MRI（評估半月板）",
        "關節液分析"
      ]
    },
    "treatment": {
      "overview": "大型犬強烈建議手術穩定。小型犬可嘗試保守治療。",
      "acute": [
        "止痛（NSAIDs）",
        "限制活動",
        "冷敷消腫"
      ],
      "chronic": [
        "手術治療（TPLO為首選）",
        "TTA（脛骨粗隆前移術）",
        "側向縫線穩定術（小型犬）",
        "術後復健（8-12週）",
        "體重管理",
        "關節保健品（葡萄糖胺、軟骨素）"
      ]
    },
    "prognosis": "TPLO手術成功率約90-95%，大多數犬可恢復良好功能。未手術大型犬預後較差，進行性骨關節炎不可避免。小型犬保守治療約可接受但功能恢復較慢。",
    "pearls": [
      "40-60%的犬會在對側膝蓋發生CCL斷裂",
      "半月板損傷的彈響聲是手術探查的重要指標",
      "肥胖是最重要的可控風險因素",
      "急性非負重性跛行常伴隨半月板損傷"
    ],
    "diagnosticAlgorithm": {
      "title": "前十字韌帶疾病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估後肢跛行模式（急性或慢性進行性），詢問外傷史或活動情況",
          "findings": [
            "後肢跛行（承重減少）",
            "坐下時患肢外展",
            "活動後跛行加重",
            "肌肉萎縮（慢性）"
          ]
        },
        {
          "step": 2,
          "action": "骨科檢查",
          "details": "前抽屜試驗及脛骨前移試驗（鎮靜下更準確），評估關節積液",
          "findings": [
            "前抽屜試驗陽性",
            "脛骨壓迫試驗陽性",
            "關節積液（內側關節囊膨出）",
            "關節活動範圍受限"
          ]
        },
        {
          "step": 3,
          "action": "影像學檢查",
          "details": "膝關節X光評估關節退化程度、排除其他病變、測量脛骨平台角度",
          "findings": [
            "關節積液影像",
            "骨贅形成（退化性關節病）",
            "脛骨平台角度（TPLO規劃用）",
            "排除骨腫瘤"
          ]
        },
        {
          "step": 4,
          "action": "確診與手術規劃",
          "details": "根據臨床檢查及影像確診，評估手術方式（TPLO、TTA、關節外穩定術）",
          "findings": [
            "前十字韌帶部分或完全撕裂",
            "內側半月板損傷評估",
            "對側膝關節評估（60%雙側發生）",
            "手術方式選擇"
          ]
        }
      ]
    },
    "monitoring": [
      "術後X光追蹤",
      "對側膝關節評估",
      "體重管理",
      "骨關節炎進展",
      "活動功能評估"
    ],
    "reference": "Kowaleski MP et al. Vet Surg 2012; Bergh MS et al. JAVMA 2014"
  },
  "hip-dysplasia": {
    "zh": "髖關節發育不良",
    "en": "Hip Dysplasia",
    "definition": "髖關節先天性發育異常，髖臼與股骨頭不匹配導致關節鬆弛、半脫位和進行性退行性關節病變。",
    "synonyms": [
      "CHD",
      "Canine Hip Dysplasia",
      "髖關節形成不良"
    ],
    "epidemiology": {
      "species": "犬較常見，貓偶見",
      "age": "幼犬5-12月齡出現症狀，或中老年因骨關節炎就診",
      "sex": "無明顯性別差異",
      "riskFactors": [
        "品種遺傳（德國牧羊犬、拉布拉多、黃金獵犬、聖伯納）",
        "快速生長",
        "過度營養",
        "過早激烈運動"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "後肢跛行或僵硬",
        "起立困難",
        "運動不耐",
        "上下樓梯困難",
        "兔跳步態",
        "幼犬或老年犬兩個發病高峰期"
      ],
      "physicalExam": [
        "Ortolani試驗陽性（幼犬）",
        "後肢肌肉萎縮",
        "髖關節伸展疼痛",
        "活動範圍減少",
        "骨關節炎的捻髮音"
      ]
    },
    "pathophysiology": "遺傳性多基因疾病，髖關節在發育過程中韌帶鬆弛導致關節不穩定，股骨頭與髖臼間的異常磨損引發軟骨退化和骨關節炎。環境因素（過度生長、肥胖）加速病程。",
    "diagnosis": {
      "overview": "結合臨床檢查和影像學確診。",
      "differentials": [
        "腰薦椎疾病",
        "前十字韌帶疾病",
        "多發性關節炎",
        "股骨頭無菌性壞死（Legg-Perthes病）"
      ],
      "initialDB": [
        "骨科理學檢查",
        "Ortolani試驗（鎮靜下）",
        "骨盆腔X光（標準伸展位）"
      ],
      "advanced": [
        "PennHIP壓力X光",
        "CT掃描",
        "關節液分析"
      ]
    },
    "treatment": {
      "overview": "依年齡和嚴重程度選擇保守或手術治療。",
      "acute": [
        "止痛（NSAIDs）",
        "限制活動",
        "體重管理"
      ],
      "chronic": [
        "保守治療（體重控制、適度運動、NSAIDs、關節保健品）",
        "幼犬預防性手術（JPS恥骨聯合固定術<16週）",
        "DPO/TPO（三聯骨盆截骨術）",
        "全髖關節置換術（THR）",
        "股骨頭頸切除術（FHNE，小型犬）",
        "物理治療和水療"
      ]
    },
    "prognosis": "輕度發育不良經保守治療可維持良好生活品質。嚴重病例全髖關節置換術後95%以上可恢復正常功能。FHNE在小型犬效果良好。",
    "pearls": [
      "PennHIP是評估髖關節鬆弛度最客觀的方法",
      "過度補鈣反而加重發育不良",
      "控制幼犬生長速度比限制運動更重要",
      "雙側X光常見不對稱表現"
    ],
    "diagnosticAlgorithm": {
      "title": "髖關節發育不良 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估後肢跛行、起立困難、兔跳步態，注意好發品種（德牧、拉布拉多、黃金獵犬）",
          "findings": [
            "後肢跛行或僵硬",
            "起立困難",
            "兔跳步態（雙後肢同時推進）",
            "運動後症狀加重"
          ]
        },
        {
          "step": 2,
          "action": "骨科檢查",
          "details": "Ortolani試驗評估髖關節鬆弛度，後肢伸展疼痛評估",
          "findings": [
            "Ortolani試驗陽性（年輕犬）",
            "髖關節伸展疼痛",
            "後肢肌肉萎縮",
            "關節活動範圍受限"
          ]
        },
        {
          "step": 3,
          "action": "影像學確診",
          "details": "標準骨盆伸展X光評估關節吻合度，Norberg角測量",
          "findings": [
            "髖臼淺化",
            "股骨頭覆蓋率不足",
            "Norberg角<105度",
            "退化性關節病變"
          ]
        },
        {
          "step": 4,
          "action": "分級與治療規劃",
          "details": "髖關節發育不良分級（OFA或PennHIP），根據年齡及嚴重度選擇治療",
          "findings": [
            "OFA分級（正常到嚴重）",
            "年輕犬可考慮JPS或TPO",
            "成犬考慮THR或FHO",
            "保守管理（體重控制、NSAID、物理治療）"
          ]
        }
      ]
    },
    "monitoring": [
      "體重控制",
      "活動功能評估",
      "X光追蹤骨關節炎進展",
      "疼痛評估"
    ],
    "reference": "Smith GK et al. JAVMA 2001; Vezzoni A et al. Vet Comp Orthop Traumatol 2008"
  },
  "patellar-luxation": {
    "zh": "髕骨脫位",
    "en": "Patellar Luxation",
    "definition": "髕骨脫位是指髕骨從股骨滑車溝脫出的骨科疾病，為小型犬最常見的後肢跛行原因之一。分內側脫位（最常見，小型犬佔75-80%）和外側脫位（大型犬較多）。依嚴重度分Grade I-IV：Grade I可手動脫位但自行復位，Grade IV永久脫位無法復位。Grade III-IV建議手術矯正。",
    "synonyms": [
      "膝蓋骨脫位",
      "髕骨脫臼",
      "Trick Knee"
    ],
    "epidemiology": {
      "species": "犬較常見（小型犬內側脫位），貓偶見",
      "age": "先天性可早期發現，臨床症狀常在成年後出現",
      "sex": "母犬略多（1.5:1）",
      "riskFactors": [
        "小型犬種（貴賓、吉娃娃、約克夏、博美）",
        "大型犬外側脫位",
        "先天性骨骼畸形"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "間歇性跳躍式跛行（skipping gait）",
        "突然抬腿數步後恢復正常",
        "運動後僵硬",
        "嚴重者持續跛行"
      ],
      "physicalExam": [
        "髕骨可手動推移（分級I-IV）",
        "Grade I：可推出但自行復位",
        "Grade II：可推出或自行脫位，可手動復位",
        "Grade III：持續脫位，可手動復位但立即脫出",
        "Grade IV：持續脫位，無法手動復位",
        "股骨內旋（內側脫位）"
      ]
    },
    "pathophysiology": "先天性股骨滑車溝淺化、脛骨粗隆內側（或外側）偏移、股四頭肌力線偏移等骨骼排列異常，導致髕骨無法穩定在滑車溝中。長期脫位可導致軟骨磨損和前十字韌帶損傷。",
    "diagnosis": {
      "overview": "理學檢查即可診斷和分級。影像學評估骨骼畸形程度。",
      "differentials": [
        "前十字韌帶疾病",
        "髖關節疾病",
        "股骨頭壞死（Legg-Perthes）",
        "骨折"
      ],
      "initialDB": [
        "觸診分級",
        "步態分析",
        "膝關節X光"
      ],
      "advanced": [
        "CT評估骨骼畸形",
        "同時評估前十字韌帶完整性"
      ]
    },
    "treatment": {
      "overview": "Grade I通常不需手術。Grade II以上或有臨床症狀建議手術矯正。",
      "acute": [
        "止痛（NSAIDs）",
        "限制活動"
      ],
      "chronic": [
        "手術矯正（滑車溝加深術）",
        "脛骨粗隆轉位術",
        "外側關節囊縮縫術",
        "嚴重畸形需矯正截骨術",
        "術後限制活動6-8週",
        "體重管理"
      ]
    },
    "prognosis": "Grade I-II手術矯正成功率高（>90%）。Grade III-IV預後較謹慎，可能需更複雜的矯正手術。術後10-15%復發率。早期手術可預防骨關節炎和CCL損傷。",
    "pearls": [
      "15-20%的髕骨脫位犬會合併CCL斷裂",
      "內側脫位佔小型犬的90%以上",
      "Grade II以上建議預防性手術以避免關節退化",
      "雙側脫位佔50%病例"
    ],
    "diagnosticAlgorithm": {
      "title": "髕骨脫位 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "觀察間歇性跛行（跳步後恢復正常）、注意小型犬好發（內側脫位）",
          "findings": [
            "間歇性後肢抬舉（跳步）",
            "跛行自行恢復",
            "小型犬好發（內側脫位）",
            "大型犬可能外側脫位"
          ]
        },
        {
          "step": 2,
          "action": "骨科觸診",
          "details": "觸診髕骨位置及可推動性，評估脫位分級（I-IV級）",
          "findings": [
            "Grade I：可手動脫位但自動復位",
            "Grade II：可手動脫位需手動復位",
            "Grade III：持續脫位可手動復位但立即再脫",
            "Grade IV：持續脫位無法手動復位"
          ]
        },
        {
          "step": 3,
          "action": "影像學評估",
          "details": "膝關節X光評估骨骼排列異常程度、股骨溝深度、脛骨嵴偏移",
          "findings": [
            "髕骨位置異常",
            "股骨滑車溝淺化",
            "脛骨嵴內偏或外偏",
            "退化性關節病變"
          ]
        },
        {
          "step": 4,
          "action": "手術適應症評估",
          "details": "Grade II以上或有持續跛行者建議手術矯正",
          "findings": [
            "滑車溝加深術",
            "脛骨嵴移植術",
            "關節囊收緊術",
            "股骨矯正截骨（嚴重時）"
          ]
        }
      ]
    },
    "monitoring": [
      "術後X光",
      "跛行程度",
      "對側膝關節",
      "骨關節炎發展"
    ],
    "reference": "Roush JK. Vet Clin North Am Small Anim Pract 2005; Arthurs GI et al. Vet Comp Orthop Traumatol 2006"
  },
  "osteoarthritis": {
    "zh": "骨關節炎",
    "en": "Osteoarthritis",
    "definition": "關節軟骨進行性退化伴隨滑膜發炎和骨贅增生的慢性退行性關節疾病，導致疼痛和功能障礙。",
    "synonyms": [
      "退行性關節病",
      "DJD",
      "Degenerative Joint Disease"
    ],
    "epidemiology": {
      "species": "犬貓皆常見（貓常被低估）",
      "age": "中老年多見，但可繼發於幼年關節疾病",
      "sex": "無明顯性別差異",
      "riskFactors": [
        "肥胖",
        "先前關節損傷或手術",
        "關節發育不良",
        "品種傾向",
        "高強度工作犬"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "漸進性僵硬和跛行",
        "晨起僵硬（暖身後改善）",
        "天冷時症狀加重",
        "活動量減少",
        "貓：跳躍減少、理毛減少、脾氣改變"
      ],
      "physicalExam": [
        "關節腫脹",
        "活動範圍減少",
        "捻髮音",
        "關節周圍肌肉萎縮",
        "關節屈伸時疼痛",
        "貓：常缺乏明顯跛行但活動力下降"
      ]
    },
    "pathophysiology": "關節軟骨因機械壓力和發炎介質損傷逐漸退化。軟骨細胞代償性增殖不足以修復損傷，軟骨下骨暴露，滑膜發炎釋放更多發炎介質（IL-1、TNF-α、PGE2），形成惡性循環。邊緣骨贅增生為代償性反應。",
    "diagnosis": {
      "overview": "結合臨床檢查和影像學。貓需仔細觀察行為變化。",
      "differentials": [
        "免疫媒介性關節炎",
        "感染性關節炎",
        "關節腫瘤",
        "韌帶損傷"
      ],
      "initialDB": [
        "完整骨科檢查",
        "X光（骨贅、關節腔狹窄、軟骨下硬化）",
        "步態分析"
      ],
      "advanced": [
        "關節液分析",
        "CT/MRI",
        "壓力板步態分析",
        "血液檢查排除全身性疾病"
      ]
    },
    "treatment": {
      "overview": "多模式鎮痛、體重管理和維持關節功能為核心。無法治癒但可良好管理。",
      "acute": [
        "NSAIDs（Meloxicam、Carprofen）",
        "鴉片類止痛（嚴重疼痛）",
        "冷敷或熱敷",
        "限制活動"
      ],
      "chronic": [
        "體重管理（最重要的單一措施）",
        "長期NSAIDs",
        "Librela（犬抗NGF單抗）/ Solensia（貓抗NGF單抗）",
        "關節保健品（葡萄糖胺、Omega-3脂肪酸）",
        "物理治療和水療",
        "環境改善（防滑墊、斜坡、矮食碗）",
        "適度規律運動"
      ]
    },
    "prognosis": "進行性疾病，無法治癒但通過多模式管理可長期維持良好生活品質。早期介入效果較好。貓OA嚴重低診率，提高認知很重要。",
    "pearls": [
      "貓的OA發生率可能高達90%（>12歲），但極少表現典型跛行",
      "體重減輕6-8%即可顯著改善症狀",
      "抗NGF單抗（Librela/Solensia）是近年突破性治療",
      "X光嚴重程度與臨床症狀不一定相關"
    ],
    "diagnosticAlgorithm": {
      "title": "骨關節炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估慢性進行性跛行、僵硬（尤其休息後）、活動量下降，詢問品種及年齡",
          "findings": [
            "慢性進行性跛行",
            "休息後僵硬（起立困難）",
            "活動量及遊戲意願下降",
            "行為改變（攻擊性增加、不願被觸碰）"
          ]
        },
        {
          "step": 2,
          "action": "骨科檢查",
          "details": "系統性評估所有關節的活動範圍、疼痛、腫脹、捻發音",
          "findings": [
            "關節活動範圍受限",
            "關節操作時疼痛",
            "關節腫脹及骨贅增生",
            "捻發音（關節磨擦感）"
          ]
        },
        {
          "step": 3,
          "action": "影像學確診",
          "details": "受累關節X光確認退化性變化",
          "findings": [
            "骨贅形成",
            "關節間隙狹窄",
            "軟骨下骨硬化",
            "關節積液"
          ]
        },
        {
          "step": 4,
          "action": "排除繼發原因",
          "details": "評估是否有原發性關節疾病導致繼發性OA，關節液分析排除其他關節炎",
          "findings": [
            "前十字韌帶疾病繼發",
            "髖關節發育不良繼發",
            "髕骨脫位繼發",
            "原發性退化性關節炎"
          ]
        }
      ]
    },
    "monitoring": [
      "疼痛評分（如CBPI犬簡短疼痛量表）",
      "活動功能",
      "體重",
      "NSAIDs長期使用的腎肝功能監測"
    ],
    "reference": "Innes JF. Vet Surg 2022; Gruen ME et al. JAVMA 2022"
  },
  "mast-cell-tumor": {
    "zh": "肥大細胞瘤",
    "en": "Mast Cell Tumor",
    "definition": "起源於肥大細胞的腫瘤，是犬最常見的皮膚惡性腫瘤。生物學行為差異極大，從良性到高度惡性。",
    "synonyms": [
      "MCT",
      "肥大細胞肉瘤",
      "Mastocytoma"
    ],
    "epidemiology": {
      "species": "犬最常見（佔皮膚腫瘤16-21%），貓皮膚型多為良性",
      "age": "中老年犬（平均8-9歲）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "品種傾向（拳師犬、波士頓梗、拉布拉多、金毛、巴哥）",
        "短頭犬種",
        "先前MCT病史"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "皮膚或皮下腫塊",
        "腫塊大小可能波動（脫顆粒反應）",
        "反覆腫脹和消退",
        "病程數週至數月"
      ],
      "physicalExam": [
        "皮膚腫塊外觀多變（偽裝大師）",
        "Darier徵象（觸摸後紅腫）",
        "局部紅腫水腫",
        "區域淋巴結腫大",
        "內臟型可見脾肝腫大"
      ]
    },
    "pathophysiology": "肥大細胞惡性增生，含有大量組織胺、肝素和蛋白酶等生物活性物質的顆粒。脫顆粒可導致局部水腫、潰瘍、全身性組織胺釋放效應（胃潰瘍、低血壓、凝血障礙）。c-KIT基因突變在部分MCT中扮演重要角色。",
    "diagnosis": {
      "overview": "細針抽吸細胞學即可快速診斷。組織病理分級對預後至關重要。",
      "differentials": [
        "其他皮膚腫瘤（脂肪瘤、組織球瘤）",
        "蟲咬反應",
        "肉芽腫",
        "皮膚感染"
      ],
      "initialDB": [
        "細針抽吸細胞學（特徵性紫色顆粒）",
        "區域淋巴結抽吸",
        "腹部超音波（肝脾）"
      ],
      "advanced": [
        "切除組織病理分級（Patnaik或Kiupel系統）",
        "c-KIT突變分析",
        "Ki67增殖指數",
        "AgNOR",
        "胸部X光",
        "骨髓抽吸（高級別）"
      ]
    },
    "treatment": {
      "overview": "手術切除是低-中級別MCT的首選治療。高級別需輔助化療或放療。",
      "acute": [
        "術前抗組織胺（H1和H2阻斷劑）",
        "胃黏膜保護劑",
        "廣泛手術切除（2-3cm邊界）"
      ],
      "chronic": [
        "高級別：Vinblastine + Prednisolone化療",
        "c-KIT突變陽性：Toceranib（Palladia）或Masitinib（Masivet）",
        "放射治療（邊界不完整）",
        "低級別完整切除可能不需輔助治療"
      ]
    },
    "prognosis": "低級別完整切除預後優良（中位存活>4年）。高級別中位存活約6個月。c-KIT突變陽性對酪氨酸激酶抑制劑反應良好。Kiupel二級分類系統（低/高）臨床使用較為簡便。",
    "pearls": [
      "MCT是犬腫瘤的偽裝大師，任何皮膚腫塊都應抽吸",
      "術前使用H1+H2抗組織胺可減少脫顆粒併發症",
      "不要擠壓MCT以避免大量脫顆粒",
      "拳師犬的MCT通常級別較低，預後較好"
    ],
    "diagnosticAlgorithm": {
      "title": "肥大細胞瘤 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "觸診皮膚或皮下腫塊，注意Darier sign（觸摸後腫塊周圍紅腫），注意好發品種",
          "findings": [
            "皮膚單一或多發腫塊",
            "觸摸後腫塊紅腫（Darier sign）",
            "大小變化不定",
            "好發品種（拳師犬、拉布拉多、金毛）"
          ]
        },
        {
          "step": 2,
          "action": "細針抽吸細胞學",
          "details": "FNA細胞學檢查確認肥大細胞特徵（紫色顆粒）",
          "findings": [
            "圓形細胞含紫色嗜鉻性顆粒",
            "細胞學可快速確認MCT",
            "顆粒多寡評估分化程度",
            "嗜酸性球可能伴隨"
          ]
        },
        {
          "step": 3,
          "action": "分期檢查",
          "details": "局部淋巴結FNA、腹部超音波（肝脾）、血液學檢查",
          "findings": [
            "局部淋巴結轉移評估",
            "肝脾超音波及FNA",
            "外周血嗜酸性球增多",
            "buffy coat肥大細胞評估"
          ]
        },
        {
          "step": 4,
          "action": "手術切除與分級",
          "details": "廣泛切除（2-3cm邊界）送病理分級（Patnaik或Kiupel系統）",
          "findings": [
            "Kiupel分級（低級或高級）",
            "切除邊界評估（乾淨或不乾淨）",
            "c-KIT突變檢測",
            "Ki-67增殖指數"
          ]
        }
      ]
    },
    "monitoring": [
      "切除部位復發",
      "區域淋巴結",
      "腹部超音波（肝脾）",
      "新發皮膚腫塊"
    ],
    "reference": "London CA et al. Vet Clin North Am 2014; Kiupel M et al. Vet Pathol 2011"
  },
  "hemangiosarcoma": {
    "zh": "血管肉瘤",
    "en": "Hemangiosarcoma",
    "definition": "血管肉瘤（HSA）是起源於血管內皮細胞的高度惡性腫瘤，犬為最常受影響的物種。脾臟、右心房和皮下是三個最常見原發部位。German Shepherd和Golden Retriever好發。脾臟HSA常因腫瘤破裂引起急性腹腔出血和休克就診。全身轉移率極高（>90%），中位生存期僅3-6個月。",
    "synonyms": [
      "HSA",
      "血管內皮肉瘤",
      "Angiosarcoma"
    ],
    "epidemiology": {
      "species": "犬較常見，貓罕見",
      "age": "中老年犬（8-13歲）",
      "sex": "公犬略多",
      "riskFactors": [
        "品種傾向（德國牧羊犬、黃金獵犬、拉布拉多）",
        "大型犬",
        "皮膚型與日曬暴露相關（毛髮稀疏犬）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "急性虛脫或昏厥（脾臟腫瘤破裂出血）",
        "間歇性虛弱（反覆少量出血自行吸收）",
        "食慾下降",
        "腹部膨大",
        "運動不耐"
      ],
      "physicalExam": [
        "黏膜蒼白",
        "心率加快",
        "腹部觸診可及腫塊",
        "腹腔積液（血腹）",
        "心包積液（心臟型）",
        "脾臟腫大",
        "皮膚型：暗紅色皮下腫塊"
      ]
    },
    "pathophysiology": "血管內皮細胞惡性增生形成異常血管通道，腫瘤血管壁脆弱極易破裂。脾臟型最常見（約50%），其次為右心房、肝臟和皮下。血行轉移迅速，最常轉移至肝臟和肺臟。常合併DIC和微血管病性溶血性貧血。",
    "diagnosis": {
      "overview": "影像學發現脾臟腫塊為起點，但確診需組織病理。急診常因脾臟破裂出血而診斷。",
      "differentials": [
        "脾臟血腫",
        "其他脾臟腫瘤（淋巴瘤、結節性增生）",
        "心包積液其他原因",
        "腹腔內出血其他原因"
      ],
      "initialDB": [
        "全血球計數（貧血、紅血球碎片）",
        "凝血功能（DIC篩查）",
        "腹部超音波",
        "胸部X光",
        "心臟超音波"
      ],
      "advanced": [
        "腹腔穿刺液分析（PCV比對）",
        "脾臟切除後組織病理確診",
        "CT分期",
        "凝血功能全套"
      ]
    },
    "treatment": {
      "overview": "脾臟切除是初始治療，但單獨手術預後很差，需輔助化療。",
      "acute": [
        "急診穩定（靜脈輸液、輸血）",
        "緊急脾臟切除止血",
        "心包穿刺引流（心包積液型）"
      ],
      "chronic": [
        "Doxorubicin為基礎的化療方案",
        "Doxorubicin + Cyclophosphamide",
        "Metronomic化療",
        "皮膚型：廣泛切除可能治癒",
        "I'm-Yunity（雲芝多醣體）輔助"
      ]
    },
    "prognosis": "內臟型預後極差。單獨脾臟切除中位存活1-3個月。脾切除加化療中位存活4-6個月。皮膚真皮型預後最好。心臟型預後最差。約2/3的脾臟腫塊在犬為惡性。",
    "pearls": [
      "德國牧羊犬和黃金獵犬的脾臟腫塊應高度懷疑HSA",
      "急性腹腔內出血的老年大型犬首先考慮脾臟HSA破裂",
      "血液抹片上的紅血球碎片（裂紅血球）是重要線索",
      "心包積液鑑別最常見的兩個原因是HSA和心基部腫瘤"
    ],
    "diagnosticAlgorithm": {
      "title": "血管肉瘤 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估急性虛弱崩潰（脾臟破裂出血），注意好發品種（德牧、黃金獵犬）",
          "findings": [
            "急性虛弱或崩潰",
            "黏膜蒼白（內出血）",
            "腹部膨脹",
            "皮膚結節（皮膚型）"
          ]
        },
        {
          "step": 2,
          "action": "急診評估",
          "details": "FAST超音波確認腹腔積液，PCV/TP評估貧血",
          "findings": [
            "腹腔積液（血性）",
            "PCV下降",
            "脾臟腫塊",
            "心包積液（心臟型）"
          ]
        },
        {
          "step": 3,
          "action": "影像與實驗室",
          "details": "胸腹部X光及超音波評估轉移，凝血功能評估",
          "findings": [
            "脾臟腫塊（超音波）",
            "肝臟轉移結節",
            "肺部轉移（X光）",
            "DIC跡象"
          ]
        },
        {
          "step": 4,
          "action": "手術與病理確診",
          "details": "緊急脾臟切除（穩定化後），病理確診腫瘤類型",
          "findings": [
            "血管肉瘤病理確認",
            "分期（I-III）",
            "肝臟及右心房評估",
            "化療方案規劃（doxorubicin-based）"
          ]
        }
      ]
    },
    "monitoring": [
      "腹部超音波追蹤",
      "胸部X光",
      "全血球計數",
      "凝血功能",
      "心臟超音波（心臟型）"
    ],
    "reference": "Clifford CA et al. JAVMA 2000; Thamm DH. Withrow & MacEwen's Small Animal Clinical Oncology, 6th Ed. 2020"
  },
  "mammary-tumor": {
    "zh": "乳腺腫瘤",
    "en": "Mammary Tumor",
    "definition": "起源於乳腺組織的腫瘤，犬約50%為惡性，貓約85-90%為惡性。是未絕育母犬最常見的腫瘤。",
    "synonyms": [
      "乳腺癌",
      "乳房腫瘤",
      "Mammary Gland Tumor"
    ],
    "epidemiology": {
      "species": "犬貓皆常見（未絕育母犬/貓）",
      "age": "中老年（犬平均10-11歲，貓平均10-12歲）",
      "sex": "母犬/貓為主，公犬/貓極少且多為惡性",
      "riskFactors": [
        "未絕育或晚期絕育",
        "外源性黃體素使用",
        "肥胖（幼年期）",
        "犬：初情前絕育風險<0.5%，第一次發情後絕育8%，第二次後26%"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "乳腺區域腫塊",
        "逐漸增大",
        "可能有乳頭分泌物",
        "炎性乳腺癌：急性紅腫疼痛"
      ],
      "physicalExam": [
        "乳腺鏈上單發或多發腫塊",
        "犬後兩對乳腺最常見",
        "腫塊固著於皮膚或深層",
        "區域淋巴結腫大",
        "炎性乳腺癌：瀰漫性紅腫水腫"
      ]
    },
    "pathophysiology": "荷爾蒙（雌激素和黃體素）刺激乳腺上皮細胞增生，長期刺激增加突變累積和惡性轉化風險。惡性腫瘤可局部侵犯和經淋巴及血行轉移至肺、肝、骨和腦。貓乳腺腫瘤大多為侵襲性腺癌。",
    "diagnosis": {
      "overview": "組織病理學是確診和分類的金標準。術前分期很重要。",
      "differentials": [
        "乳腺增生",
        "乳腺炎",
        "脂肪瘤",
        "其他皮膚腫瘤"
      ],
      "initialDB": [
        "完整乳腺鏈觸診",
        "胸部X光（三視圖肺轉移篩查）",
        "腹部超音波",
        "區域淋巴結抽吸"
      ],
      "advanced": [
        "切除組織病理分類和分級",
        "免疫組織化學（ER/PR）",
        "CT分期",
        "荷爾蒙受體分析"
      ]
    },
    "treatment": {
      "overview": "手術切除為主要治療，貓建議積極手術。同時絕育可能降低復發風險。",
      "acute": [
        "手術切除",
        "犬：腫塊切除至單側乳腺鏈切除",
        "貓：建議雙側乳腺鏈切除",
        "同時施行卵巢子宮切除術"
      ],
      "chronic": [
        "惡性高級別：Doxorubicin或Carboplatin化療",
        "Carboplatin對犬乳腺癌效果",
        "抗荷爾蒙治療研究中",
        "炎性乳腺癌：NSAIDs輔助"
      ]
    },
    "prognosis": "犬良性腫瘤手術治癒。犬惡性腫瘤<3cm且未轉移預後良好。貓乳腺腫瘤預後較差，<2cm中位存活>3年，>3cm中位存活約4-12個月。炎性乳腺癌預後極差。腫瘤大小是最重要的預後因素。",
    "pearls": [
      "早期絕育是最有效的預防措施",
      "貓乳腺腫瘤應視為惡性直到證明為良性",
      "腫瘤大小是犬貓最重要的預後因素",
      "炎性乳腺癌常被誤診為乳腺炎"
    ],
    "diagnosticAlgorithm": {
      "title": "乳腺腫瘤 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "觸診所有乳腺鏈（犬5對、貓4對），記錄腫塊位置、大小、數量",
          "findings": [
            "乳腺腫塊（單一或多發）",
            "後段乳腺好發（犬）",
            "腫塊固定或可移動",
            "可能有潰瘍或分泌物"
          ]
        },
        {
          "step": 2,
          "action": "理學檢查與FNA",
          "details": "區域淋巴結觸診，FNA細胞學初步判斷良惡性",
          "findings": [
            "腹股溝或腋下淋巴結腫大",
            "FNA見上皮細胞特徵",
            "良性vs惡性初步判斷",
            "犬50%良性/貓85%惡性"
          ]
        },
        {
          "step": 3,
          "action": "分期檢查",
          "details": "三段式胸部X光排除肺轉移、腹部超音波評估區域淋巴結",
          "findings": [
            "胸部X光排除肺轉移",
            "腹部超音波淋巴結評估",
            "基礎血液檢查",
            "評估是否適合手術"
          ]
        },
        {
          "step": 4,
          "action": "手術切除與病理分級",
          "details": "手術切除（腫瘤切除至乳腺鏈切除不等），病理分型及分級",
          "findings": [
            "腫瘤組織學類型確認",
            "惡性程度分級",
            "淋巴管侵犯評估",
            "切除邊界評估"
          ]
        }
      ]
    },
    "monitoring": [
      "術後胸部X光（每3個月，持續2年）",
      "手術部位觸診",
      "對側乳腺鏈",
      "區域淋巴結"
    ],
    "reference": "Sorenmo KU et al. Vet Pathol 2011; Zappulli V et al. Vet Pathol 2015"
  },
  "feline-infectious-peritonitis": {
    "zh": "貓傳染性腹膜炎",
    "en": "Feline Infectious Peritonitis",
    "definition": "由貓冠狀病毒突變株引起的致死性免疫介導性全身性疾病，分為滲出型（濕型）和非滲出型（乾型）。",
    "synonyms": [
      "FIP",
      "貓傳腹"
    ],
    "epidemiology": {
      "species": "貓",
      "age": "幼貓（3月-2歲）和老年貓（>10歲）風險最高",
      "sex": "公貓略多",
      "riskFactors": [
        "多貓環境（收容所、繁殖場）",
        "幼貓",
        "純種貓",
        "免疫抑制",
        "應激"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "漸進性食慾下降和消瘦",
        "反覆發燒（對抗生素無反應）",
        "腹部膨大（濕型）",
        "慢性病程",
        "可能有上呼吸道感染史"
      ],
      "physicalExam": [
        "濕型：腹水和/或胸水、黃疸",
        "乾型：肉芽腫性器官病變、葡萄膜炎、神經症狀",
        "發燒",
        "黃疸",
        "腎臟不規則增大",
        "腸系膜淋巴結腫大"
      ]
    },
    "pathophysiology": "腸道貓冠狀病毒（FECV）在個體內突變為能在巨噬細胞內複製的FIPV。感染的巨噬細胞引發免疫介導性血管炎和肉芽腫。Th1反應佔優勢→乾型；抗體介導反應→免疫複合物沉積→血管炎→滲出型。",
    "diagnosis": {
      "overview": "確診困難，需綜合臨床、實驗室和病理學證據。近年GS-441524治療的出現使早期診斷更加重要。",
      "differentials": [
        "淋巴瘤",
        "細菌性腹膜炎",
        "心臟病（胸水）",
        "肝病（腹水）",
        "弓蟲症"
      ],
      "initialDB": [
        "腹水/胸水分析（蛋白質>35g/L、Rivalta試驗陽性）",
        "全血球計數（淋巴球減少）",
        "生化（高球蛋白血症、A/G比<0.4）",
        "冠狀病毒抗體力價"
      ],
      "advanced": [
        "積液RT-PCR",
        "積液免疫細胞化學",
        "組織切片免疫組織化學（確診）",
        "AGP（α1酸性糖蛋白升高）"
      ]
    },
    "treatment": {
      "overview": "GS-441524和Molnupiravir等抗病毒藥物已革命性地改變FIP治療。過去被認為幾乎100%致命的疾病現在有高治癒率。",
      "acute": [
        "GS-441524注射（初期）",
        "支持療法（輸液、營養支持）",
        "腹水/胸水引流（呼吸窘迫時）",
        "發燒和疼痛管理"
      ],
      "chronic": [
        "GS-441524口服或注射（84天療程）",
        "Molnupiravir（替代選擇）",
        "神經型和眼型可能需更高劑量和更長療程",
        "營養支持和症狀管理",
        "定期監測確認治癒"
      ]
    },
    "prognosis": "使用GS-441524治療，濕型治癒率約80-90%，乾型約70-80%，神經型約60-70%。未治療幾乎100%致命。復發率約10-15%，多在停藥後3個月內。",
    "pearls": [
      "冠狀病毒抗體力價高不等於FIP，大多數陽性貓不會發病",
      "Rivalta試驗是簡便有效的積液初步篩查",
      "A/G比<0.4高度提示FIP",
      "GS-441524的出現徹底改變了FIP的預後"
    ],
    "diagnosticAlgorithm": {
      "title": "貓傳染性腹膜炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估年輕貓的持續性發熱、體重下降，區分濕型（積液）和乾型（肉芽腫）",
          "findings": [
            "持續性不退燒",
            "體重下降、食慾不振",
            "腹部膨脹（濕型）",
            "眼部或神經症狀（乾型）"
          ]
        },
        {
          "step": 2,
          "action": "實驗室檢查",
          "details": "CBC、生化（白球蛋白比）、急性期蛋白、冠狀病毒抗體效價",
          "findings": [
            "高球蛋白血症",
            "白球蛋白比<0.6",
            "淋巴球減少",
            "非再生性貧血"
          ]
        },
        {
          "step": 3,
          "action": "積液分析（濕型）",
          "details": "腹腔或胸腔積液分析，特徵為高蛋白低細胞數滲出液",
          "findings": [
            "蛋白>3.5g/dL",
            "黃色黏稠液體",
            "Rivalta試驗陽性",
            "細胞數偏低（以巨噬細胞為主）"
          ]
        },
        {
          "step": 4,
          "action": "確診檢查",
          "details": "積液或組織的冠狀病毒RT-PCR、免疫組織化學染色",
          "findings": [
            "積液FCoV RT-PCR陽性",
            "組織免疫組織化學確認冠狀病毒抗原",
            "肉芽腫性血管炎（病理特徵）",
            "綜合臨床證據確診"
          ]
        }
      ]
    },
    "monitoring": [
      "治療期間：臨床症狀、體重、血液檢查（球蛋白、A/G比、AGP）",
      "停藥後3個月密切追蹤",
      "復發監測"
    ],
    "reference": "Pedersen NC et al. J Feline Med Surg 2019; Tasker S. J Feline Med Surg 2023"
  },
  "feline-leukemia-virus": {
    "zh": "貓白血病病毒感染",
    "en": "Feline Leukemia Virus Infection",
    "definition": "貓白血病病毒（FeLV）為反轉錄病毒，可導致免疫抑制、貧血、淋巴瘤和其他腫瘤。是貓最重要的致死性傳染病之一。",
    "synonyms": [
      "FeLV感染",
      "貓白血病"
    ],
    "epidemiology": {
      "species": "貓",
      "age": "幼貓最易感（<4月齡），隨年齡增長抵抗力增強",
      "sex": "公貓感染風險較高（戶外打鬥）",
      "riskFactors": [
        "戶外接觸其他貓",
        "多貓環境",
        "幼齡",
        "與感染貓密切接觸（互舔、共用食碗）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "慢性反覆感染",
        "消瘦",
        "食慾下降",
        "慢性口腔炎",
        "反覆發燒"
      ],
      "physicalExam": [
        "蒼白黏膜（貧血）",
        "淋巴結腫大",
        "脾腫大",
        "口腔炎/齒齦炎",
        "腫瘤腫塊",
        "黃疸",
        "體況差"
      ]
    },
    "pathophysiology": "FeLV經口鼻感染，在口咽淋巴組織複製，經血行擴散至骨髓。可整合入宿主基因組。感染結局包括：進行性感染（持續病毒血症）、退行性感染（潛伏）、短暫性感染（清除）或不完全感染。進行性感染導致免疫抑制、骨髓異常、腫瘤形成。",
    "diagnosis": {
      "overview": "SNAP檢測為初步篩查，需確認試驗和結果解讀。",
      "differentials": [
        "FIV感染",
        "其他免疫抑制原因",
        "原發性淋巴瘤",
        "原發性貧血"
      ],
      "initialDB": [
        "SNAP ELISA快速檢測（p27抗原）",
        "全血球計數",
        "血液抹片",
        "血清生化"
      ],
      "advanced": [
        "IFA確認試驗（骨髓感染確認）",
        "PCR（偵測前病毒DNA）",
        "骨髓抽吸（貧血或血球異常時）",
        "分期檢查（X光、超音波）"
      ]
    },
    "treatment": {
      "overview": "無特效抗病毒治療。以支持療法、管理併發症和維持生活品質為主。",
      "acute": [
        "治療繼發感染（積極抗生素）",
        "輸血（嚴重貧血）",
        "支持療法"
      ],
      "chronic": [
        "室內隔離飼養",
        "定期健康檢查（每6個月）",
        "及時治療繼發感染",
        "淋巴瘤化療",
        "干擾素輔助（效果有限）",
        "營養支持"
      ]
    },
    "prognosis": "進行性感染（持續抗原陽性）中位存活約2.5-3年。約70%在3年內死於相關疾病。退行性感染可長期存活。FeLV相關淋巴瘤對化療有一定反應但預後較FeLV陰性差。",
    "pearls": [
      "初次SNAP陽性應在30天後重新檢測確認",
      "IFA陽性代表骨髓感染，較難逆轉",
      "疫苗可有效預防但無法治療已感染貓",
      "FeLV陽性貓應隔離飼養以保護其他貓"
    ],
    "diagnosticAlgorithm": {
      "title": "貓白血病病毒感染 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估反覆感染、體重下降、貧血、淋巴瘤等FeLV相關疾病",
          "findings": [
            "反覆感染或慢性口炎",
            "體重下降",
            "貧血（黏膜蒼白）",
            "淋巴結腫大"
          ]
        },
        {
          "step": 2,
          "action": "篩檢測試",
          "details": "ELISA快速篩檢（偵測p27抗原），適用於臨床篩檢",
          "findings": [
            "ELISA p27陽性（血液中病毒抗原）",
            "ELISA陰性（需考慮時機及再測）",
            "所有新貓應篩檢",
            "陽性結果需確認"
          ]
        },
        {
          "step": 3,
          "action": "確認試驗",
          "details": "IFA或PCR確認ELISA陽性結果，區分暫時性和持續性感染",
          "findings": [
            "IFA陽性（骨髓感染，持續性病毒血症）",
            "PCR確認前病毒DNA整合",
            "ELISA陽性+IFA陽性=持續性感染",
            "ELISA陽性+IFA陰性=可能暫時性（30天後複查）"
          ]
        },
        {
          "step": 4,
          "action": "感染分期與管理",
          "details": "確認感染狀態後評估相關疾病及預後",
          "findings": [
            "持續性病毒血症（預後較差）",
            "回歸性感染（潛伏）",
            "相關疾病篩檢（淋巴瘤、貧血）",
            "隔離管理防止傳播"
          ]
        }
      ]
    },
    "monitoring": [
      "每6個月全血球計數和生化",
      "FeLV抗原追蹤",
      "體重和臨床症狀",
      "腫塊發展"
    ],
    "reference": "Hartmann K. J Feline Med Surg 2012; Levy JK et al. J Vet Intern Med 2008"
  },
  "feline-immunodeficiency-virus": {
    "zh": "貓免疫缺陷病毒感染",
    "en": "Feline Immunodeficiency Virus Infection",
    "definition": "由貓免疫缺陷病毒（慢病毒屬反轉錄病毒）引起的慢性免疫抑制疾病，與人類HIV相似但不傳染人。",
    "synonyms": [
      "FIV感染",
      "貓愛滋"
    ],
    "epidemiology": {
      "species": "貓",
      "age": "中年成年貓最常診斷（因潛伏期長）",
      "sex": "公貓顯著多於母貓（3:1，因打鬥傳播）",
      "riskFactors": [
        "未絕育公貓",
        "戶外活動",
        "打鬥行為",
        "多貓環境"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "慢性口腔炎",
        "反覆上呼吸道感染",
        "慢性腹瀉",
        "消瘦",
        "打鬥傷口史"
      ],
      "physicalExam": [
        "慢性齒齦口腔炎",
        "淋巴結腫大",
        "體況差",
        "慢性鼻炎",
        "皮膚感染",
        "神經症狀（晚期）"
      ]
    },
    "pathophysiology": "FIV主要經咬傷傳播。感染CD4+ T淋巴細胞並逐漸耗竭。分為急性期（短暫病毒血症、淋巴結腫大）、無症狀攜帶期（可長達數年）和終末期（AIDS-like，嚴重免疫抑制）。CD4/CD8比值倒轉是特徵。",
    "diagnosis": {
      "overview": "SNAP抗體檢測為初步篩查。母源抗體可造成幼貓假陽性。",
      "differentials": [
        "FeLV感染",
        "其他免疫抑制原因",
        "慢性口腔炎其他原因",
        "淋巴瘤"
      ],
      "initialDB": [
        "SNAP ELISA抗體快速檢測",
        "全血球計數（淋巴球減少）",
        "血清生化"
      ],
      "advanced": [
        "Western Blot確認",
        "PCR（前病毒DNA）",
        "CD4/CD8比值",
        "病毒載量"
      ]
    },
    "treatment": {
      "overview": "無特效抗病毒治療。重點為管理併發症、預防繼發感染和維持生活品質。",
      "acute": [
        "積極治療繼發感染",
        "口腔炎治療（全口拔牙常有效）",
        "支持療法"
      ],
      "chronic": [
        "室內飼養（保護自身和其他貓）",
        "定期健康檢查",
        "及時治療感染",
        "營養支持",
        "口腔疾病管理",
        "避免免疫抑制藥物"
      ]
    },
    "prognosis": "無症狀攜帶期可長達數年甚至終身。許多FIV陽性貓可維持良好生活品質多年。一旦進入終末期免疫抑制，預後較差。中位存活自診斷起約5年。",
    "pearls": [
      "FIV陽性貓不等於立即安樂死，多數可正常生活多年",
      "幼貓<6月齡陽性應在6月齡後重新檢測（排除母源抗體）",
      "口腔炎是FIV最常見的臨床問題",
      "FIV疫苗會導致抗體檢測陽性，目前已不建議使用"
    ],
    "diagnosticAlgorithm": {
      "title": "貓免疫缺陷病毒感染 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估慢性感染、口腔疾病、體重下降，注意高風險群（未絕育公貓、流浪貓）",
          "findings": [
            "慢性口炎/齒齦炎",
            "反覆上呼吸道感染",
            "慢性腹瀉",
            "體重下降"
          ]
        },
        {
          "step": 2,
          "action": "篩檢測試",
          "details": "ELISA/快速免疫層析法偵測抗FIV抗體",
          "findings": [
            "抗FIV抗體陽性",
            "注意疫苗接種史（疫苗可致假陽性）",
            "幼貓<6月齡可能有母體抗體",
            "高風險群建議篩檢"
          ]
        },
        {
          "step": 3,
          "action": "確認試驗",
          "details": "Western blot或PCR確認篩檢陽性結果",
          "findings": [
            "Western blot確認抗體",
            "PCR偵測前病毒DNA",
            "區分疫苗抗體vs感染抗體",
            "幼貓>6月齡後複查"
          ]
        },
        {
          "step": 4,
          "action": "感染分期與監測",
          "details": "評估免疫功能（CD4:CD8比值）、相關疾病篩檢",
          "findings": [
            "CD4+ T細胞計數",
            "基礎疾病評估",
            "口腔疾病管理",
            "室內飼養防止傳播"
          ]
        }
      ]
    },
    "monitoring": [
      "每6個月健康檢查",
      "全血球計數（CD4淋巴球）",
      "體重",
      "口腔健康",
      "繼發感染徵兆"
    ],
    "reference": "Hartmann K. Vet Clin North Am 2012; Levy JK et al. JFMS 2008"
  },
  "canine-distemper": {
    "zh": "犬瘟熱",
    "en": "Canine Distemper",
    "definition": "由犬瘟熱病毒（副黏液病毒科Morbillivirus屬）引起的高度傳染性多系統疾病，影響呼吸、消化、皮膚和中樞神經系統。",
    "synonyms": [
      "犬瘟",
      "Canine Distemper Virus Infection",
      "CDV"
    ],
    "epidemiology": {
      "species": "犬及其他犬科動物",
      "age": "3-6月齡幼犬最易感（母源抗體消退後）",
      "sex": "無性別傾向",
      "riskFactors": [
        "未接種疫苗或疫苗不完整",
        "收容所環境",
        "幼犬",
        "免疫抑制"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "發燒（雙峰熱）",
        "眼鼻分泌物",
        "咳嗽",
        "嘔吐腹瀉",
        "抽搐",
        "收容所或未疫苗史"
      ],
      "physicalExam": [
        "黏液膿性眼鼻分泌物",
        "肺部囉音",
        "脫水",
        "鼻鏡和腳墊過度角化（硬墊症）",
        "肌陣攣（myoclonus）",
        "癲癇發作",
        "共濟失調",
        "視力障礙"
      ]
    },
    "pathophysiology": "經氣溶膠或接觸感染，首先在呼吸道淋巴組織複製，隨後病毒血症擴散至全身淋巴組織、上皮細胞和中樞神經系統。導致淋巴球壞死（免疫抑制）、上皮細胞損傷和脫髓鞘性腦炎。神經症狀可在呼吸/消化症狀後數週出現。",
    "diagnosis": {
      "overview": "結合臨床表現、疫苗史和實驗室檢查。確診需病毒學檢測。",
      "differentials": [
        "犬傳染性肝炎",
        "犬小病毒腸炎",
        "犬傳染性氣管支氣管炎",
        "弓蟲症",
        "肉芽腫性腦膜腦炎"
      ],
      "initialDB": [
        "全血球計數（早期淋巴球減少）",
        "結膜或鼻腔拭子RT-PCR",
        "犬瘟熱快速抗原檢測",
        "胸部X光（間質性肺炎）"
      ],
      "advanced": [
        "血清學（IgM抗體）",
        "腦脊液分析和PCR（神經型）",
        "MRI（腦部病變）",
        "組織病理（包涵體）"
      ]
    },
    "treatment": {
      "overview": "無特效抗病毒治療。支持療法為主，治療繼發感染並控制神經症狀。",
      "acute": [
        "靜脈輸液糾正脫水",
        "廣效抗生素（繼發感染）",
        "止吐止瀉",
        "營養支持",
        "隔離防疫"
      ],
      "chronic": [
        "抗癲癇藥物（神經症狀）",
        "物理治療",
        "肌陣攣可能為永久性",
        "硬墊症的護理"
      ]
    },
    "prognosis": "死亡率50-90%（視毒株和免疫狀態）。出現神經症狀者預後極差。康復犬可能留有永久性神經後遺症（肌陣攣、癲癇、硬墊症）。存活幼犬可能有牙釉質發育不全。",
    "pearls": [
      "肌陣攣（rhythmic myoclonus）是犬瘟熱幾乎病理性的特徵",
      "硬墊症是犬瘟熱的經典但非必要的表現",
      "疫苗是最有效的預防手段",
      "老犬腦炎可能是犬瘟熱的晚期表現"
    ],
    "diagnosticAlgorithm": {
      "title": "犬瘟熱 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估多系統症狀（呼吸道、消化道、神經），詢問疫苗史及接觸史",
          "findings": [
            "雙相性發熱",
            "眼鼻膿性分泌物",
            "咳嗽及肺炎",
            "嘔吐及腹瀉"
          ]
        },
        {
          "step": 2,
          "action": "神經學評估",
          "details": "評估神經症狀（可與呼吸道/消化道症狀同時或延遲出現）",
          "findings": [
            "肌陣攣（咀嚼肌或四肢抽搐）",
            "癲癇發作",
            "共濟失調",
            "足墊增厚（硬墊症）"
          ]
        },
        {
          "step": 3,
          "action": "實驗室診斷",
          "details": "CDV RT-PCR（結膜拭子、血液、尿液）、包涵體尋找",
          "findings": [
            "RT-PCR陽性（確診）",
            "結膜或呼吸道上皮細胞包涵體",
            "淋巴球減少",
            "CSF分析（神經型）"
          ]
        },
        {
          "step": 4,
          "action": "確診與預後",
          "details": "結合臨床表現及實驗室結果確診，評估預後",
          "findings": [
            "CDV確診",
            "神經症狀者預後差",
            "肌陣攣通常為永久性",
            "與疫苗相關腦炎鑑別"
          ]
        }
      ]
    },
    "monitoring": [
      "神經症狀進展",
      "繼發感染",
      "營養狀態",
      "隔離措施",
      "同居犬疫苗狀態"
    ],
    "reference": "Greene CE. Infectious Diseases of the Dog and Cat, 4th Ed. 2012; Martella V et al. Vet Microbiol 2008"
  },
  "keratoconjunctivitis-sicca": {
    "zh": "乾性角結膜炎",
    "en": "Keratoconjunctivitis Sicca",
    "definition": "乾性角結膜炎（KCS/乾眼症）是因淚液水層分泌不足導致角膜和結膜慢性發炎的眼科疾病。犬Schirmer淚液試驗（STT）<15 mm/min為可疑，<10 mm/min確診。最常見原因為免疫介導性淚腺炎，West Highland White Terrier、Cavalier King Charles Spaniel、Cocker Spaniel和Pug好發。黏液性分泌物和角膜色素沉著為特徵。",
    "synonyms": [
      "KCS",
      "乾眼症",
      "Dry Eye"
    ],
    "epidemiology": {
      "species": "犬較常見，貓少見",
      "age": "中老年犬，但免疫介導性可在任何年齡發生",
      "sex": "母犬略多",
      "riskFactors": [
        "品種傾向（西施犬、鬥牛犬、可卡犬、巴哥、約克夏）",
        "短頭犬種",
        "Sulfonamide藥物使用",
        "全身麻醉後暫時性",
        "甲狀腺低下"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "慢性眼睛分泌物（黏液膿性）",
        "反覆結膜炎",
        "眼睛紅腫",
        "頻繁眨眼或搔眼"
      ],
      "physicalExam": [
        "角膜表面無光澤乾燥",
        "黏液膿性分泌物",
        "結膜充血",
        "角膜血管新生",
        "角膜色素沉著",
        "角膜潰瘍（繼發）",
        "角膜混濁"
      ]
    },
    "pathophysiology": "約75%犬KCS為免疫介導性淚腺炎，淚腺腺泡受T淋巴細胞浸潤破壞。其他原因包括藥物毒性（Sulfonamide、Etodolac）、神經源性（顏面神經麻痺）、先天性淚腺發育不全。淚液不足導致角膜上皮乾燥、發炎、感染和進行性纖維化。",
    "diagnosis": {
      "overview": "Schirmer淚液試驗（STT）是診斷金標準。",
      "differentials": [
        "過敏性結膜炎",
        "細菌性結膜炎",
        "角膜潰瘍",
        "眼瞼內翻"
      ],
      "initialDB": [
        "Schirmer淚液試驗I（正常犬>15mm/min，<10mm確診KCS）",
        "螢光素染色（排除角膜潰瘍）",
        "眼壓測量"
      ],
      "advanced": [
        "淚膜破裂時間（BUT）",
        "Bengal Rose染色",
        "淚腺組織切片（少用）",
        "甲狀腺功能檢查"
      ]
    },
    "treatment": {
      "overview": "免疫介導性以環孢素或他克莫司（Tacrolimus）為主要治療。需終身用藥。",
      "acute": [
        "人工淚液頻繁使用",
        "治療繼發感染（局部抗生素）",
        "角膜潰瘍處理"
      ],
      "chronic": [
        "環孢素眼用製劑（Optimmune 0.2%）每日兩次",
        "Tacrolimus 0.03%眼藥（環孢素無效時）",
        "人工淚液輔助",
        "定期清潔眼部分泌物",
        "手術（腮腺管轉位術，藥物無效時）"
      ]
    },
    "prognosis": "免疫介導性KCS對環孢素或Tacrolimus治療反應良好（約75-85%改善）。需終身治療，停藥會復發。早期治療效果較好，長期角膜損傷可能不可逆。",
    "pearls": [
      "STT應在任何眼科檢查操作之前進行",
      "Tacrolimus效力約為環孢素的4倍",
      "藥物反應通常需2-6週才完全顯現",
      "Sulfonamide引起的KCS可能為不可逆"
    ],
    "diagnosticAlgorithm": {
      "title": "乾性角結膜炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "觀察眼部黏稠分泌物、角膜混濁、眼睛不適，注意好發品種（西施犬、鬥牛犬、可卡犬）",
          "findings": [
            "黏稠黃綠色眼分泌物",
            "角膜混濁或新生血管",
            "眨眼頻繁",
            "結膜充血"
          ]
        },
        {
          "step": 2,
          "action": "淚液測試（STT）",
          "details": "Schirmer淚液測試為確診金標準，正常值犬>15mm/min",
          "findings": [
            "STT<10mm/min（KCS確診）",
            "STT 10-15mm/min（可疑）",
            "STT>15mm/min（正常）",
            "雙眼比較"
          ]
        },
        {
          "step": 3,
          "action": "眼科全面評估",
          "details": "螢光素染色評估角膜損傷、裂隙燈評估角膜狀態、眼壓測量",
          "findings": [
            "角膜潰瘍（螢光素陽性）",
            "角膜色素沉著",
            "角膜新生血管",
            "角膜脂質沉積"
          ]
        },
        {
          "step": 4,
          "action": "病因評估",
          "details": "區分免疫媒介性（最常見）、藥物性、神經性、先天性原因",
          "findings": [
            "免疫媒介性（最常見，淚腺淋巴細胞浸潤）",
            "藥物性（磺胺類藥物）",
            "神經性（面神經或三叉神經異常）",
            "先天性（淚腺發育不全）"
          ]
        }
      ]
    },
    "monitoring": [
      "STT每月追蹤至穩定，後每3-6個月",
      "角膜健康評估",
      "藥物依從性",
      "繼發感染"
    ],
    "reference": "Hartley C. In Practice 2010; Maggs DJ. Slatter's Fundamentals of Veterinary Ophthalmology, 6th Ed. 2018"
  },
  "corneal-ulcer": {
    "zh": "角膜潰瘍",
    "en": "Corneal Ulcer",
    "definition": "角膜上皮及可能深層基質的缺損，常因外傷、感染或角膜營養障礙引起，是小動物眼科最常見的急診之一。",
    "synonyms": [
      "角膜糜爛",
      "角膜缺損",
      "Corneal Erosion",
      "Ulcerative Keratitis"
    ],
    "epidemiology": {
      "species": "犬貓皆常見",
      "age": "任何年齡",
      "sex": "無性別傾向",
      "riskFactors": [
        "短頭犬種（眼球突出、瞬目不全）",
        "KCS（乾眼症）",
        "外傷",
        "眼瞼異常（內翻、睫毛異位）",
        "貓皰疹病毒感染"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "突然眼睛疼痛",
        "流淚",
        "頻繁眨眼或閉眼",
        "眼睛分泌物",
        "畏光"
      ],
      "physicalExam": [
        "螢光素染色陽性（上皮缺損）",
        "結膜充血",
        "眼瞼痙攣",
        "角膜水腫",
        "前房蓄膿（感染性深層潰瘍）",
        "角膜融解（melting ulcer：嚴重感染）",
        "Descemet膜膨出（即將穿孔）"
      ]
    },
    "pathophysiology": "角膜上皮損傷後暴露基質層，基質膠原蛋白易受細菌蛋白酶和內源性MMPs分解。表層潰瘍可在3-7天內上皮化癒合。感染或基質融解時，基質蛋白酶快速降解膠原蛋白導致角膜穿孔風險。犬的自發性慢性角膜上皮缺損（SCCEDs/拳師犬潰瘍）因上皮與基質間附著異常而不癒合。",
    "diagnosis": {
      "overview": "螢光素染色是診斷角膜潰瘍的基本工具。需評估深度和有無感染。",
      "differentials": [
        "角膜異物",
        "KCS",
        "青光眼",
        "前葡萄膜炎",
        "角膜基質膿腫"
      ],
      "initialDB": [
        "螢光素染色",
        "裂隙燈檢查（深度評估）",
        "STT（排除KCS）",
        "眼壓測量（排除青光眼）"
      ],
      "advanced": [
        "角膜細胞學和培養（感染性潰瘍）",
        "角膜刮片",
        "眼部超音波（穿孔疑慮）",
        "貓：FHV-1 PCR"
      ]
    },
    "treatment": {
      "overview": "依深度分級治療。表層潰瘍局部抗生素即可，深層潰瘍或融解性潰瘍為眼科急診。",
      "acute": [
        "局部廣效抗生素（每4-6小時）",
        "局部散瞳止痛劑（Atropine）",
        "Elizabethan collar防止搔抓",
        "融解性潰瘍：加用血清eye drops和局部MMP抑制劑",
        "深層/即將穿孔：結膜瓣手術或角膜移植"
      ],
      "chronic": [
        "SCCEDs：角膜清創術+格柵角膜切開術",
        "治療潛在原因（矯正眼瞼異常、KCS治療）",
        "FHV-1相關：抗病毒眼藥（Famciclovir全身性）"
      ]
    },
    "prognosis": "單純表層潰瘍3-7天癒合，預後極佳。深層潰瘍和融解性潰瘍需積極治療，可能需手術。角膜穿孔為眼科急診。SCCEDs清創後癒合率約80-90%。",
    "pearls": [
      "絕對禁止在角膜潰瘍使用局部類固醇",
      "融解性潰瘍（melting ulcer）是急診，角膜可能在24小時內穿孔",
      "自體血清eye drops含有抗蛋白酶可抑制角膜融解",
      "持續不癒合的潰瘍應排除異物、睫毛異常和KCS"
    ],
    "diagnosticAlgorithm": {
      "title": "角膜潰瘍 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估眼部急性疼痛（瞇眼、流淚、畏光），詢問外傷或異物暴露史",
          "findings": [
            "急性瞇眼及流淚",
            "畏光",
            "結膜充血",
            "角膜混濁"
          ]
        },
        {
          "step": 2,
          "action": "螢光素染色（確診）",
          "details": "螢光素染色評估潰瘍範圍、深度及特徵",
          "findings": [
            "螢光素染色陽性（上皮缺損）",
            "評估潰瘍深度（淺層/深層/角膜穿孔）",
            "邊緣特徵（游離上皮＝SCCED）",
            "樹突狀潰瘍（貓FHV-1）"
          ]
        },
        {
          "step": 3,
          "action": "進階評估",
          "details": "裂隙燈評估基質溶解程度，STT排除乾眼症，細胞學/培養（複雜潰瘍）",
          "findings": [
            "基質溶解（膠原酶活性）",
            "前房反應（前葡萄膜炎）",
            "角膜穿孔（前房塌陷）",
            "感染性評估（膿性分泌物）"
          ]
        },
        {
          "step": 4,
          "action": "潰瘍分型與治療決策",
          "details": "根據深度、原因及特徵分型，決定藥物或手術治療",
          "findings": [
            "淺層單純潰瘍（藥物治療）",
            "SCCED/拳師犬潰瘍（清創+格子切開）",
            "深層溶解性潰瘍（結膜瓣或角膜移植）",
            "穿孔性潰瘍（緊急手術）"
          ]
        }
      ]
    },
    "monitoring": [
      "每24-48小時螢光素重新評估（深層潰瘍）",
      "感染控制",
      "癒合進度",
      "併發症（前葡萄膜炎、穿孔）"
    ],
    "reference": "Maggs DJ. Slatter's Fundamentals of Veterinary Ophthalmology, 6th Ed. 2018; Gelatt KN. Vet Ophthalmol 2021"
  },
  "brachycephalic-obstructive-airway-syndrome": {
    "zh": "短頭顱阻塞性呼吸道症候群",
    "en": "Brachycephalic Obstructive Airway Syndrome",
    "definition": "短頭犬種因頭顱結構異常導致上呼吸道多處阻塞的綜合症候群，包括鼻孔狹窄、軟顎過長、喉囊外翻和喉部塌陷。",
    "synonyms": [
      "BOAS",
      "短頭症候群",
      "Brachycephalic Syndrome"
    ],
    "epidemiology": {
      "species": "犬較常見（法鬥、英鬥、巴哥、波士頓梗、北京犬），貓偶見（波斯貓、異短）",
      "age": "先天性，症狀可從幼年出現並隨年齡惡化",
      "sex": "無明顯性別差異",
      "riskFactors": [
        "短頭犬種",
        "肥胖（加重症狀）",
        "高溫高濕環境",
        "激動或運動"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "打鼾",
        "運動不耐",
        "呼吸困難",
        "熱天症狀加重",
        "進食困難或反流",
        "睡眠呼吸暫停",
        "暈厥"
      ],
      "physicalExam": [
        "吸氣性喘鳴音（stertor/stridor）",
        "鼻孔狹窄",
        "張口呼吸",
        "發紺（嚴重時）",
        "軟顎過長",
        "過度喘息",
        "體溫升高"
      ]
    },
    "pathophysiology": "先天性頭顱骨短縮但軟組織未按比例縮減，導致：(1)鼻孔狹窄增加吸氣阻力，(2)軟顎過長阻塞喉頭入口，(3)增加的負壓導致繼發性喉囊外翻和喉部塌陷。長期上呼吸道阻塞導致呼吸道繼發性變化加重（惡性循環）。同時常伴有消化道問題（食道裂孔疝、胃食道反流）。",
    "diagnosis": {
      "overview": "臨床表現和品種即可高度懷疑。確切評估需全身麻醉下喉鏡檢查。",
      "differentials": [
        "喉麻痺",
        "氣管塌陷",
        "喉部腫瘤",
        "異物"
      ],
      "initialDB": [
        "臨床評估（呼吸音、鼻孔評估）",
        "頸胸部X光",
        "BOAS功能分級"
      ],
      "advanced": [
        "麻醉下喉鏡和氣管內視鏡",
        "CT掃描（詳細解剖評估）",
        "消化道內視鏡（評估併發GI問題）",
        "睡眠監測"
      ]
    },
    "treatment": {
      "overview": "手術矯正為主要治療。早期手術效果較好，可預防繼發性變化。",
      "acute": [
        "氧氣補充",
        "降溫（過熱時）",
        "鎮靜（減少焦慮和呼吸努力）",
        "短期類固醇減輕喉部水腫",
        "嚴重者氣管插管或緊急氣管切開"
      ],
      "chronic": [
        "鼻孔擴張術（Alar fold resection）",
        "軟顎切短術（Staphylectomy）",
        "喉囊切除",
        "體重管理",
        "避免過熱和劇烈運動",
        "抗酸劑（併發GI問題時）"
      ]
    },
    "prognosis": "早期手術矯正預後良好，約90%犬顯著改善。喉部塌陷（Grade III）預後較差。術後需長期體重和環境管理。法鬥和英鬥的手術和麻醉風險較其他品種高。",
    "pearls": [
      "短頭犬種麻醉和手術風險較高，拔管需特別謹慎",
      "肥胖管理是非手術最重要的措施",
      "GI症狀（反流、嘔吐）與BOAS高度相關",
      "年輕時手術可預防繼發性喉部塌陷"
    ],
    "diagnosticAlgorithm": {
      "title": "短頭顱阻塞性呼吸道症候群 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "觀察呼吸型態、聽診上呼吸道雜音，評估品種風險（英國鬥牛犬、法國鬥牛犬、巴哥犬、波斯貓等短頭犬貓）",
          "findings": [
            "吸氣性喘鳴音",
            "鼻孔狹窄",
            "運動不耐受",
            "睡眠時打鼾或呼吸暫停"
          ]
        },
        {
          "step": 2,
          "action": "口腔與咽喉檢查",
          "details": "在鎮靜或麻醉下直接觀察軟顎長度、喉部結構與扁桃體大小",
          "findings": [
            "軟顎過長覆蓋會厭",
            "喉囊外翻",
            "扁桃體腫大",
            "喉門狹窄"
          ]
        },
        {
          "step": 3,
          "action": "影像學檢查",
          "details": "頸部側位 X 光評估氣管直徑，必要時進行 CT 掃描評估鼻道與鼻甲骨",
          "findings": [
            "氣管發育不全（氣管直徑/胸腔入口比值降低）",
            "鼻甲骨增生阻塞鼻道",
            "咽部軟組織增厚"
          ]
        },
        {
          "step": 4,
          "action": "功能評估與分級",
          "details": "根據症狀嚴重程度進行臨床分級，評估是否需要手術矯正",
          "findings": [
            "第一級：輕度打鼾，運動正常",
            "第二級：中度呼吸困難，運動受限",
            "第三級：重度呼吸窘迫，發紺"
          ]
        }
      ]
    },
    "monitoring": [
      "術後呼吸評估",
      "體重管理",
      "運動耐受度",
      "GI症狀"
    ],
    "reference": "Meola SD. Vet Clin North Am 2013; Liu NC et al. PLoS ONE 2017"
  },
  "tracheal-collapse": {
    "zh": "氣管塌陷",
    "en": "Tracheal Collapse",
    "definition": "氣管軟骨環退化導致氣管管腔動態性塌陷，引起慢性咳嗽和呼吸困難。主要影響中老年小型犬。",
    "synonyms": [
      "氣管軟化症",
      "Tracheomalacia"
    ],
    "epidemiology": {
      "species": "犬（小型犬），貓極罕見",
      "age": "中老年犬（6-7歲以上），但可更早出現",
      "sex": "無明顯性別差異",
      "riskFactors": [
        "小型犬種（約克夏、博美、吉娃娃、貴賓、馬爾濟斯）",
        "肥胖",
        "牽繩拉扯頸部",
        "呼吸道感染",
        "二手煙"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "慢性鵝叫聲咳嗽（goose-honk cough）",
        "激動或運動後咳嗽加重",
        "拉牽繩時咳嗽",
        "進行性呼吸困難",
        "暈厥"
      ],
      "physicalExam": [
        "觸壓氣管誘發咳嗽",
        "吸氣性（頸段塌陷）或呼氣性（胸段塌陷）呼吸困難",
        "可能併發心臟雜音",
        "肥胖",
        "發紺（嚴重發作時）"
      ]
    },
    "pathophysiology": "氣管軟骨環中糖胺聚糖和硫酸軟骨素含量減少，導致軟骨失去結構支撐力。背側氣管膜鬆弛下垂。頸段氣管在吸氣時塌陷（負壓），胸段和主支氣管在呼氣時塌陷（正壓）。咳嗽和發炎進一步加重氣管損傷形成惡性循環。",
    "diagnosis": {
      "overview": "結合臨床症狀、影像學和氣管鏡檢查。動態評估很重要。",
      "differentials": [
        "慢性支氣管炎",
        "心臟病（咳嗽）",
        "BOAS",
        "喉麻痺",
        "肺腫瘤"
      ],
      "initialDB": [
        "頸胸部X光（吸氣和呼氣相）",
        "觸診氣管",
        "心臟評估（排除心臟病）"
      ],
      "advanced": [
        "透視檢查（動態氣管評估，金標準分級）",
        "氣管支氣管鏡（直視分級和取樣）",
        "CT掃描",
        "心臟超音波"
      ]
    },
    "treatment": {
      "overview": "輕中度以內科治療為主。嚴重或內科難治性考慮氣管支架或手術。",
      "acute": [
        "鎮靜（Butorphanol）",
        "氧氣補充",
        "短期類固醇（減輕氣管發炎）",
        "支氣管擴張劑"
      ],
      "chronic": [
        "體重管理（極重要）",
        "止咳藥（Hydrocodone、Butorphanol）",
        "支氣管擴張劑（Theophylline）",
        "改用胸背帶取代項圈",
        "避免刺激物和過熱",
        "氣管內支架（嚴重病例）",
        "氣管外環固定術（頸段）"
      ]
    },
    "prognosis": "內科治療多數可控制症狀多年。進行性疾病，可能逐漸惡化。氣管支架可顯著改善嚴重病例但可能有併發症（支架移位、肉芽組織增生）。合併肺高壓或支氣管塌陷者預後較差。",
    "pearls": [
      "鵝叫聲咳嗽是氣管塌陷的典型特徵",
      "70%以上的氣管塌陷犬同時有支氣管塌陷",
      "項圈壓力可加重氣管塌陷，應改用胸背帶",
      "常與二尖瓣疾病並存，需同時評估心臟"
    ],
    "diagnosticAlgorithm": {
      "title": "氣管塌陷 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "詢問病史（典型鵝鳴樣咳嗽），確認品種傾向（約克夏、博美、吉娃娃等小型犬），進行氣管觸診誘咳試驗",
          "findings": [
            "典型鵝鳴樣陣發性咳嗽",
            "興奮或牽繩時咳嗽加劇",
            "氣管觸診陽性反應",
            "肥胖"
          ]
        },
        {
          "step": 2,
          "action": "胸腔X光檢查",
          "details": "拍攝吸氣相和呼氣相頸部與胸部 X 光，觀察氣管直徑變化",
          "findings": [
            "吸氣相頸部氣管塌陷",
            "呼氣相胸腔內氣管塌陷",
            "氣管直徑減少超過50%",
            "心臟肥大（伴隨疾病）"
          ]
        },
        {
          "step": 3,
          "action": "透視或內視鏡檢查",
          "details": "X光透視動態觀察呼吸週期氣管變化，或支氣管鏡直接觀察塌陷部位與程度",
          "findings": [
            "動態塌陷確認",
            "塌陷分級（I-IV級）",
            "支氣管壁紅腫",
            "黏液分泌增加"
          ]
        },
        {
          "step": 4,
          "action": "鑑別診斷排除",
          "details": "排除其他慢性咳嗽原因，包括心臟病、慢性支氣管炎、喉麻痺",
          "findings": [
            "心臟超音波排除心臟病",
            "支氣管灌洗液細胞學",
            "甲狀腺功能檢測排除甲低"
          ]
        }
      ]
    },
    "monitoring": [
      "咳嗽頻率和嚴重度",
      "呼吸功能",
      "體重",
      "心臟功能",
      "支架病例需定期追蹤"
    ],
    "reference": "Johnson LR. Vet Clin North Am 2016; Tappin SW. J Small Anim Pract 2016"
  },
  "feline-asthma": {
    "zh": "貓哮喘",
    "en": "Feline Asthma",
    "definition": "貓下呼吸道的慢性嗜酸球性發炎伴隨支氣管高反應性和可逆性氣道阻塞。是貓最常見的下呼吸道疾病。",
    "synonyms": [
      "貓支氣管哮喘",
      "貓過敏性支氣管炎",
      "Feline Allergic Bronchitis"
    ],
    "epidemiology": {
      "species": "貓",
      "age": "2-8歲常見，任何年齡可發生",
      "sex": "無明顯性別傾向，暹羅貓可能較易感",
      "riskFactors": [
        "室內環境過敏原（塵蟎、貓砂粉塵、香氛）",
        "二手煙",
        "暹羅貓",
        "肥胖"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "間歇性咳嗽",
        "呼吸急促",
        "張口呼吸（急性發作）",
        "哮喘發作",
        "運動不耐",
        "症狀可能為季節性"
      ],
      "physicalExam": [
        "呼氣性呼吸努力（腹部用力）",
        "肺部哮鳴音（wheezes）",
        "延長呼氣相",
        "急性發作時發紺",
        "桶狀胸（慢性空氣滯留）"
      ]
    },
    "pathophysiology": "吸入性過敏原引發氣道Th2型免疫反應，嗜酸球浸潤氣道壁，肥大細胞脫顆粒釋放組織胺和白三烯。導致支氣管平滑肌痙攣、黏液過度分泌和氣道壁增厚。慢性病例可發生氣道重塑（平滑肌增生、纖維化）。",
    "diagnosis": {
      "overview": "結合臨床表現、X光和排除其他原因。確診需氣管沖洗細胞學。",
      "differentials": [
        "心絲蟲相關呼吸道疾病",
        "肺蟲感染",
        "肺腫瘤",
        "胸腔積液",
        "心臟病"
      ],
      "initialDB": [
        "胸部X光（支氣管壁增厚、肺過度充氣）",
        "全血球計數（嗜酸球增多，約20%病例）",
        "心絲蟲抗體/抗原檢測",
        "糞便浮游法（排除肺蟲）"
      ],
      "advanced": [
        "支氣管肺泡灌洗（BAL）細胞學（嗜酸球>17%）",
        "氣管鏡",
        "胸部CT",
        "過敏原檢測"
      ]
    },
    "treatment": {
      "overview": "類固醇抗炎和支氣管擴張劑為治療核心。吸入療法可減少全身性副作用。",
      "acute": [
        "氧氣補充（氧氣籠）",
        "注射Terbutaline（支氣管擴張，0.01mg/kg SC/IM）",
        "短效注射類固醇（Dexamethasone IV）",
        "最小化壓力和操作"
      ],
      "chronic": [
        "吸入類固醇（Fluticasone MDI + AeroKat spacer）",
        "口服Prednisolone（逐漸減至最低有效劑量）",
        "吸入支氣管擴張劑（Albuterol急救用）",
        "環境過敏原控制",
        "無塵貓砂",
        "減敏治療（已知過敏原時）"
      ]
    },
    "prognosis": "多數貓對治療反應良好，可長期控制。慢性氣道重塑可能導致不可逆性氣道阻塞。急性嚴重發作可能致命。吸入療法是長期管理的最佳選擇。",
    "pearls": [
      "貓的咳嗽幾乎總是呼吸道疾病（不像犬常為心臟病）",
      "急性發作時避免過度壓力和操作，貓可能因應激加重呼吸衰竭",
      "AeroKat spacer讓貓吸入類固醇治療成為可能",
      "心絲蟲相關呼吸道疾病臨床表現與哮喘幾乎相同"
    ],
    "diagnosticAlgorithm": {
      "title": "貓哮喘 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "觀察呼吸型態，確認是否有陣發性呼吸困難、喘息或咳嗽，詢問環境過敏原暴露史",
          "findings": [
            "呼氣性呼吸困難",
            "聽診可聞呼氣喘鳴音",
            "陣發性咳嗽",
            "腹式呼吸"
          ]
        },
        {
          "step": 2,
          "action": "胸腔X光檢查",
          "details": "拍攝胸腔正側位 X 光，評估肺野型態與支氣管壁變化",
          "findings": [
            "支氣管壁增厚（甜甜圈徵、鐵軌徵）",
            "肺過度充氣",
            "橫膈膜平坦化",
            "肺葉塌陷（嚴重時）"
          ]
        },
        {
          "step": 3,
          "action": "實驗室與進階檢查",
          "details": "血液檢查評估嗜酸性球比例，支氣管肺泡灌洗液細胞學分析",
          "findings": [
            "周邊血液嗜酸性球增多",
            "BAL液嗜酸性球>17%",
            "糞便寄生蟲檢查陰性（排除肺蟲）",
            "心絲蟲抗體/抗原檢測陰性"
          ]
        },
        {
          "step": 4,
          "action": "治療性診斷",
          "details": "給予支氣管擴張劑與糖皮質激素試驗治療，觀察臨床反應",
          "findings": [
            "支氣管擴張劑反應良好",
            "吸入型類固醇改善症狀",
            "排除心臟病（心臟超音波正常）"
          ]
        }
      ]
    },
    "monitoring": [
      "呼吸頻率和努力程度",
      "咳嗽頻率",
      "X光追蹤",
      "類固醇副作用（糖尿病風險）"
    ],
    "reference": "Reinero CR. J Feline Med Surg 2011; Trzil JE. Vet Clin North Am 2020"
  },
  "periodontal-disease": {
    "zh": "牙周病",
    "en": "Periodontal Disease",
    "definition": "影響牙齒周圍支持結構（牙齦、牙周韌帶、齒槽骨和牙骨質）的發炎性和破壞性疾病。是犬貓最常見的疾病。",
    "synonyms": [
      "牙周炎",
      "齒齦炎",
      "Periodontitis"
    ],
    "epidemiology": {
      "species": "犬貓皆極常見",
      "age": "隨年齡增加，3歲以上犬貓>80%有某種程度的牙周病",
      "sex": "無性別傾向",
      "riskFactors": [
        "小型犬種（牙齒擁擠）",
        "缺乏口腔護理",
        "乾糧不能有效預防",
        "免疫抑制",
        "牙齒排列不正"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "口臭",
        "進食困難或偏好軟食",
        "流涎",
        "面部腫脹",
        "鼻分泌物（口鼻瘺管）",
        "齒齦出血"
      ],
      "physicalExam": [
        "牙結石堆積",
        "齒齦紅腫（齒齦炎）",
        "齒齦退縮",
        "牙齒鬆動",
        "牙周囊袋",
        "口鼻瘺管",
        "下頷骨骨折（嚴重小型犬）"
      ]
    },
    "pathophysiology": "牙菌斑（細菌生物膜）附著牙齒表面，引發齒齦發炎。未治療時細菌向齦下發展，發炎反應破壞牙周韌帶和齒槽骨。厭氧菌（如Porphyromonas、Fusobacterium）在深層囊袋中增殖。最終牙齒失去支持結構。全身性影響包括菌血症和可能的心臟、腎臟、肝臟損傷。",
    "diagnosis": {
      "overview": "完整評估需全身麻醉下牙科檢查和X光。清醒檢查僅能初步評估。",
      "differentials": [
        "口腔腫瘤",
        "貓牙吸收病變（FORL）",
        "口腔炎",
        "自體免疫性口腔疾病"
      ],
      "initialDB": [
        "清醒口腔檢查",
        "全身麻醉下牙周探針檢查",
        "牙科X光（齒槽骨流失評估）"
      ],
      "advanced": [
        "全口牙科X光系列",
        "細菌培養（難治性病例）",
        "組織切片（排除腫瘤）"
      ]
    },
    "treatment": {
      "overview": "專業牙科清潔是核心治療。嚴重牙周病的牙齒需拔除。家庭口腔護理是預防復發的關鍵。",
      "acute": [
        "全身麻醉下專業牙科清潔（洗牙）",
        "齦下刮治和根面整平",
        "不可救治牙齒的拔除",
        "局部和/或全身性抗生素",
        "止痛"
      ],
      "chronic": [
        "每日刷牙（最有效的家庭護理）",
        "牙科專用食糧",
        "口腔沖洗液",
        "VOHC認證口腔護理產品",
        "定期專業牙科檢查和清潔"
      ]
    },
    "prognosis": "齒齦炎（早期）完全可逆。牙周炎造成的骨質流失不可逆但可阻止進展。拔除嚴重病牙後犬貓生活品質顯著改善。預防性護理可大幅延緩疾病進展。",
    "pearls": [
      "非麻醉洗牙（NAD）無法進行齦下治療，不建議作為牙周治療",
      "每日刷牙是最有效的牙菌斑控制方法",
      "小型犬的下頷骨可因嚴重牙周病而病理性骨折",
      "牙科疾病被認為與心臟、腎臟疾病有關聯"
    ],
    "diagnosticAlgorithm": {
      "title": "牙周病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "觀察口臭程度、進食習慣變化，清醒狀態下初步口腔檢查",
          "findings": [
            "口臭",
            "牙齦紅腫出血",
            "可見牙結石堆積",
            "流涎或進食困難"
          ]
        },
        {
          "step": 2,
          "action": "麻醉下完整口腔檢查",
          "details": "全身麻醉下進行詳細牙齒探測，使用牙周探針測量牙周囊袋深度",
          "findings": [
            "牙周囊袋深度增加（犬>3mm，貓>1mm）",
            "牙齦退縮",
            "齒根暴露",
            "牙齒動搖度增加"
          ]
        },
        {
          "step": 3,
          "action": "口腔X光檢查",
          "details": "全口齒科X光拍攝，評估齒槽骨流失程度",
          "findings": [
            "水平性或垂直性齒槽骨吸收",
            "齒根尖周圍透射影",
            "齒根吸收",
            "骨質密度降低"
          ]
        },
        {
          "step": 4,
          "action": "分期與治療計劃",
          "details": "根據檢查結果進行牙周病分期（第1-4期），制定治療計劃",
          "findings": [
            "第1期：僅牙齦炎",
            "第2期：早期牙周炎（<25%骨喪失）",
            "第3期：中度牙周炎（25-50%骨喪失）",
            "第4期：重度牙周炎（>50%骨喪失）"
          ]
        }
      ]
    },
    "monitoring": [
      "口腔檢查頻率依嚴重度",
      "家庭護理依從性",
      "全身健康影響"
    ],
    "reference": "Niemiec BA. Vet Clin North Am 2013; Bellows J et al. JAVMA 2019"
  },
  "chocolate-toxicosis": {
    "zh": "巧克力中毒",
    "en": "Chocolate Toxicosis",
    "definition": "犬貓攝入巧克力中的甲基黃嘌呤類物質（可可鹼和咖啡因）導致的中毒，主要影響心血管、中樞神經和泌尿系統。",
    "synonyms": [
      "可可鹼中毒",
      "Theobromine Toxicosis"
    ],
    "epidemiology": {
      "species": "犬最常見（不挑食習性），貓偶見",
      "age": "幼犬最常見（好奇亂吃）",
      "sex": "無性別傾向",
      "riskFactors": [
        "節日期間（巧克力禮盒易取得）",
        "烘焙巧克力和可可粉毒性最高",
        "小型犬（每公斤攝入量更大）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "攝入巧克力的明確病史",
        "1-12小時內出現症狀",
        "嘔吐",
        "躁動不安",
        "飲水量增加"
      ],
      "physicalExam": [
        "嘔吐（可能含巧克力）",
        "腹瀉",
        "多尿",
        "心搏過速",
        "心律不整",
        "高度興奮",
        "肌肉震顫",
        "癲癇發作（嚴重）",
        "高體溫"
      ]
    },
    "pathophysiology": "可可鹼和咖啡因為甲基黃嘌呤類，競爭性抑制腺苷受體（CNS興奮）、抑制磷酸二酯酶（增加cAMP，心肌興奮）、增加細胞內鈣離子（平滑肌效應）。犬代謝可可鹼的半衰期約17.5小時，遠長於人類。致死劑量約100-200mg/kg可可鹼。烘焙巧克力含量最高（390-450mg/oz）。",
    "diagnosis": {
      "overview": "主要基於攝入病史和臨床表現。需估算可可鹼攝入量。",
      "differentials": [
        "咖啡因中毒",
        "其他興奮劑中毒",
        "殺蟲劑中毒",
        "原發性心律不整"
      ],
      "initialDB": [
        "詳細病史（巧克力種類、量、攝入時間）",
        "心電圖",
        "全血球計數和生化"
      ],
      "advanced": [
        "血清可可鹼和咖啡因濃度",
        "尿液分析",
        "持續心電監護"
      ]
    },
    "treatment": {
      "overview": "早期去汙染和支持療法。攝入2小時內催吐最有效。",
      "acute": [
        "催吐（攝入<2小時，Apomorphine犬/Hydrogen peroxide）",
        "活性炭吸附（重複給予因腸肝循環）",
        "靜脈輸液促進排泄",
        "心律不整治療（Lidocaine）",
        "抗癲癇（Diazepam）",
        "導尿管（減少可可鹼膀胱再吸收）"
      ],
      "chronic": [
        "持續監護至症狀消退",
        "靜脈輸液",
        "反覆活性炭（每4-6小時）"
      ]
    },
    "prognosis": "輕中度中毒（<40mg/kg可可鹼）預後良好。早期去汙染顯著改善預後。嚴重心律不整或癲癇者預後較謹慎。死亡率在適當治療下<5%。",
    "pearls": [
      "烘焙巧克力毒性約為牛奶巧克力的10倍",
      "白巧克力幾乎不含可可鹼，毒性極低",
      "可可鹼的腸肝循環使反覆活性炭有效",
      "導尿管防止膀胱中可可鹼再吸收是獨特的治療考量"
    ],
    "diagnosticAlgorithm": {
      "title": "巧克力中毒 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "病史確認與暴露量評估",
          "details": "確認攝入巧克力種類、數量及攝入時間，計算甲基黃嘌呤攝入劑量",
          "findings": [
            "確認巧克力類型（烘焙用>黑巧克力>牛奶巧克力>白巧克力）",
            "計算可可鹼劑量（mg/kg）",
            "攝入時間距就診時間",
            "體重紀錄"
          ]
        },
        {
          "step": 2,
          "action": "臨床症狀評估",
          "details": "根據攝入劑量與時間評估臨床表現，進行完整理學檢查",
          "findings": [
            "嘔吐與腹瀉",
            "心動過速或心律不整",
            "過度興奮或躁動",
            "多尿多飲"
          ]
        },
        {
          "step": 3,
          "action": "心電圖與實驗室檢查",
          "details": "連續心電圖監測，血液學與生化檢查評估臟器影響",
          "findings": [
            "竇性心動過速",
            "心室早期收縮",
            "血清肌酐或BUN升高",
            "高血糖或低血鉀"
          ]
        },
        {
          "step": 4,
          "action": "監測與併發症評估",
          "details": "持續監測生命徵象與神經狀態，評估是否有嚴重併發症",
          "findings": [
            "癲癇發作（高劑量）",
            "體溫升高",
            "肌肉震顫",
            "橫紋肌溶解（極重度）"
          ]
        }
      ]
    },
    "monitoring": [
      "心電監護（12-24小時）",
      "神經狀態",
      "體溫",
      "尿量"
    ],
    "reference": "Gwaltney-Brant SM. Vet Med 2001; Brutlag A. Vet Clin North Am 2012"
  },
  "anticoagulant-rodenticide-toxicosis": {
    "zh": "抗凝血殺鼠劑中毒",
    "en": "Anticoagulant Rodenticide Toxicosis",
    "definition": "攝入抗凝血殺鼠劑（如Brodifacoum、Bromadiolone等）導致維生素K依賴性凝血因子耗竭，引起致命性出血。",
    "synonyms": [
      "老鼠藥中毒",
      "華法林中毒",
      "Warfarin Toxicosis"
    ],
    "epidemiology": {
      "species": "犬最常見（嗜口性高），貓較少",
      "age": "任何年齡，幼犬較常誤食",
      "sex": "無性別傾向",
      "riskFactors": [
        "環境中放置老鼠藥",
        "接觸中毒鼠隻（二次中毒）",
        "戶外自由活動犬"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "攝入殺鼠劑的可能病史（常不確定）",
        "攝入後2-5天出現出血症狀",
        "虛弱",
        "呼吸困難",
        "運動不耐"
      ],
      "physicalExam": [
        "黏膜蒼白",
        "瘀斑和瘀點",
        "鼻出血",
        "血尿",
        "血便/黑便",
        "呼吸困難（胸腔出血或肺出血）",
        "腹部膨大（腹腔出血）",
        "關節腫脹（關節內出血）"
      ]
    },
    "pathophysiology": "抗凝血殺鼠劑抑制維生素K環氧化物還原酶（VKORC），阻斷維生素K再生循環。維生素K依賴性凝血因子（II、VII、IX、X）和蛋白C/S無法羧化活化。第二代長效殺鼠劑（Brodifacoum等）半衰期可達數週至數月，需長期維生素K1治療。",
    "diagnosis": {
      "overview": "凝血時間延長結合病史或治療反應確診。出血症狀通常延遲2-5天出現。",
      "differentials": [
        "DIC",
        "嚴重肝病",
        "血友病",
        "血小板減少症",
        "其他中毒"
      ],
      "initialDB": [
        "PT（最敏感，因Factor VII半衰期最短6小時）",
        "aPTT",
        "全血球計數（貧血程度）",
        "血小板計數"
      ],
      "advanced": [
        "PIVKA試驗",
        "凝血因子活性",
        "毒物分析（血液或胃內容物）",
        "腹部/胸部超音波（出血定位）"
      ]
    },
    "treatment": {
      "overview": "維生素K1是特效解毒劑。嚴重出血需緊急穩定。",
      "acute": [
        "攝入<2小時：催吐+活性炭",
        "嚴重出血：新鮮冷凍血漿或全血輸血",
        "靜脈輸液支持",
        "維生素K1 SC注射（2.5-5mg/kg，分多點注射）",
        "勿IV給予維生素K1（過敏反應風險）"
      ],
      "chronic": [
        "維生素K1口服（2.5-5mg/kg/day，分2次，與脂肪食物同服）",
        "第二代殺鼠劑需治療4-6週",
        "第一代（Warfarin）治療1-2週",
        "停藥48-72小時後複查PT"
      ]
    },
    "prognosis": "早期診斷和正確治療預後極佳。嚴重出血（腦、心包）可能致命。治療期間維生素K1不可中斷。停藥後PT複查確認凝血功能恢復正常。",
    "pearls": [
      "PT是最早延長的凝血指標（Factor VII半衰期僅6小時）",
      "維生素K1必須與脂肪食物同服以促進吸收",
      "停藥後48-72小時必須複查PT確認安全",
      "維生素K3（Menadione）無效，必須使用K1（Phytonadione）"
    ],
    "diagnosticAlgorithm": {
      "title": "抗凝血殺鼠劑中毒 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "病史與暴露評估",
          "details": "確認接觸殺鼠劑的可能性、產品種類（第一代vs第二代）、攝入量與時間",
          "findings": [
            "已知或疑似接觸殺鼠劑產品",
            "暴露後2-5天出現出血徵象",
            "活動力下降與虛弱",
            "呼吸困難"
          ]
        },
        {
          "step": 2,
          "action": "凝血功能檢查",
          "details": "進行凝血檢測，重點關注外源性凝血途徑（維生素K依賴因子）",
          "findings": [
            "PT（凝血酶原時間）明顯延長",
            "aPTT延長",
            "ACT延長",
            "PIVKA升高"
          ]
        },
        {
          "step": 3,
          "action": "血液學與影像學檢查",
          "details": "全血球計數評估貧血程度，胸腹部X光或超音波評估出血部位",
          "findings": [
            "再生性貧血（PCV下降）",
            "血小板正常",
            "胸腔積液（血胸）",
            "腹腔積液或後腹腔出血"
          ]
        },
        {
          "step": 4,
          "action": "確診與治療反應評估",
          "details": "給予維生素K1治療後追蹤凝血功能，可送毒物學檢測確認",
          "findings": [
            "維生素K1治療後24-48小時PT恢復正常",
            "停藥後48-72小時複檢PT",
            "血液或肝臟毒物學檢測陽性"
          ]
        }
      ]
    },
    "monitoring": [
      "PT（治療前、治療中、停藥後48-72小時）",
      "PCV/TS",
      "出血徵兆",
      "維生素K1依從性"
    ],
    "reference": "Waddell LS et al. JVECC 2013; DeClementi C. Vet Clin North Am 2012"
  },
  "congestive-heart-failure": {
    "zh": "充血性心力衰竭",
    "en": "Congestive Heart Failure",
    "definition": "心臟無法維持足夠的心輸出量以滿足身體代謝需求，導致靜脈壓升高和組織液體滯留。是各種心臟病的終末表現。",
    "synonyms": [
      "CHF",
      "心衰竭",
      "鬱血性心衰竭"
    ],
    "epidemiology": {
      "species": "犬貓皆常見",
      "age": "犬：中老年（二尖瓣疾病）、幼年（先天性）；貓：任何年齡（HCM）",
      "sex": "犬二尖瓣疾病公犬較多，貓HCM公貓較多",
      "riskFactors": [
        "犬：二尖瓣黏液樣變性（小型犬）、擴張型心肌病（大型犬）",
        "貓：肥厚型心肌病",
        "先天性心臟病",
        "心絲蟲病"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "運動不耐",
        "咳嗽（犬左心衰竭）",
        "呼吸急促/困難",
        "夜間不安",
        "食慾下降",
        "昏厥",
        "腹部膨大（右心衰竭）"
      ],
      "physicalExam": [
        "心雜音",
        "肺部囉音（肺水腫）",
        "心率加快",
        "呼吸急促",
        "腹水（右心衰竭）",
        "頸靜脈怒張",
        "黏膜蒼白或發紺",
        "肝脾腫大",
        "貓：張口呼吸、呼吸困難"
      ]
    },
    "pathophysiology": "心臟泵血功能不全→心輸出量下降→神經體液代償啟動（RAAS系統、交感神經、ADH）→鈉水滯留、血管收縮→靜脈壓升高→左心衰竭導致肺水腫，右心衰竭導致腹水和體腔積液。代償機制長期反而加速心臟惡化（惡性循環）。",
    "diagnosis": {
      "overview": "結合臨床表現、影像學和生物標記物。需鑑別心因性和非心因性呼吸困難。",
      "differentials": [
        "原發性呼吸道疾病",
        "肺炎",
        "肺腫瘤",
        "胸腔積液（非心因性）",
        "貧血"
      ],
      "initialDB": [
        "胸部X光（心臟大小、肺水腫、胸水）",
        "心臟超音波（LA/Ao比值、收縮功能）",
        "心電圖",
        "NT-proBNP或proBNP"
      ],
      "advanced": [
        "完整心臟超音波（M-mode、2D、Doppler）",
        "血壓測量",
        "全血球計數和生化（腎功能）",
        "心絲蟲檢測",
        "Holter監測"
      ]
    },
    "treatment": {
      "overview": "急性穩定以利尿和氧氣為主。慢性管理需多藥物組合治療。",
      "acute": [
        "Furosemide IV/IM（2-4mg/kg，可每1-2小時重複）",
        "氧氣補充",
        "鎮靜（Butorphanol）減輕焦慮",
        "Pimobendan口服（立即開始）",
        "嚴重肺水腫：Nitroprusside CRI",
        "胸腔積液引流（貓）"
      ],
      "chronic": [
        "Furosemide口服（調至最低有效劑量）",
        "Pimobendan（犬0.25mg/kg BID）",
        "ACE抑制劑（Enalapril/Benazepril）",
        "Spironolactone",
        "低鈉飲食",
        "限制劇烈運動",
        "犬DCM：加用Pimobendan可能延緩病程"
      ]
    },
    "prognosis": "犬二尖瓣疾病CHF中位存活約8-12個月（治療下）。犬DCM中位存活3-6個月。貓HCM/CHF變異大，數月至數年。急性肺水腫死亡率約10-20%。Pimobendan顯著延長犬CHF存活。",
    "pearls": [
      "犬的咳嗽可能是心臟病但也常是氣管塌陷或支氣管炎",
      "貓心臟病常無前兆，首發表現可能就是呼吸困難或血栓",
      "NT-proBNP可幫助區分心因性和呼吸性呼吸困難",
      "睡眠呼吸頻率（SRR）>30次/分是CHF早期監測指標"
    ],
    "diagnosticAlgorithm": {
      "title": "充血性心力衰竭 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估呼吸型態、心音聽診、頸靜脈充盈度，詢問運動耐受力變化",
          "findings": [
            "呼吸急促或端坐呼吸",
            "心臟雜音",
            "肺部囉音（左心衰竭）",
            "腹部膨大或頸靜脈怒張（右心衰竭）"
          ]
        },
        {
          "step": 2,
          "action": "胸腔X光檢查",
          "details": "評估心臟大小、肺血管型態與肺野浸潤，判斷肺水腫程度",
          "findings": [
            "心臟輪廓增大",
            "肺靜脈擴張",
            "肺間質或肺泡浸潤（肺水腫）",
            "胸腔積液"
          ]
        },
        {
          "step": 3,
          "action": "心臟超音波檢查",
          "details": "評估心臟結構與功能，確認心衰竭病因",
          "findings": [
            "左心房擴大（LA/Ao比值增加）",
            "瓣膜異常或反流",
            "收縮功能下降（FS/EF降低）",
            "心室壁運動異常"
          ]
        },
        {
          "step": 4,
          "action": "生物標記與分期",
          "details": "測定心臟生物標記，進行ACVIM心衰竭分期（A-D期）",
          "findings": [
            "NT-proBNP或cTnI升高",
            "ACVIM分期（B1/B2/C/D）",
            "電解質異常（低鈉低氯）",
            "腎功能指標變化（心腎症候群）"
          ]
        }
      ]
    },
    "monitoring": [
      "睡眠呼吸頻率（主人在家監測）",
      "胸部X光",
      "心臟超音波（每3-6個月）",
      "腎功能和電解質",
      "體重"
    ],
    "reference": "Keene BW et al. ACVIM Consensus Statement. J Vet Intern Med 2019; Luis Fuentes V et al. J Vet Intern Med 2020"
  },
  "pleural-effusion": {
    "zh": "胸腔積液",
    "en": "Pleural Effusion",
    "definition": "胸腔（胸膜腔）內異常液體蓄積，導致肺臟擴張受限和呼吸困難。是臨床重要的急診表現。",
    "synonyms": [
      "胸水",
      "胸膜積液",
      "Hydrothorax"
    ],
    "epidemiology": {
      "species": "犬貓皆常見",
      "age": "任何年齡，視潛在病因而異",
      "sex": "視病因而異",
      "riskFactors": [
        "心臟病（尤其貓）",
        "腫瘤",
        "感染（膿胸）",
        "乳糜胸",
        "FIP（貓）",
        "低白蛋白血症"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "呼吸困難",
        "運動不耐",
        "食慾下降",
        "咳嗽（犬較常見）",
        "急性或慢性病程"
      ],
      "physicalExam": [
        "呼吸急促和努力",
        "限制性呼吸模式",
        "腹部呼吸",
        "腹側肺音減弱",
        "背側肺音正常（液氣交界）",
        "心音減弱",
        "發紺",
        "貓：張口呼吸"
      ]
    },
    "pathophysiology": "正常胸膜腔僅含少量液體（潤滑用）。胸腔積液因以下機制蓄積：靜脈壓升高（心衰竭→漏出液）、血管通透性增加（感染/腫瘤→滲出液）、淋巴管阻塞（腫瘤→乳糜液）、低膠體滲透壓（低白蛋白→漏出液）、隔膜破裂（尿液、膽汁）。積液壓迫肺臟導致通氣不足和呼吸窘迫。",
    "diagnosis": {
      "overview": "確認積液存在、分類液體性質和尋找潛在病因。胸腔穿刺既是診斷也是治療。",
      "differentials": [
        "心臟病",
        "腫瘤（淋巴瘤、胸腺瘤）",
        "膿胸",
        "FIP",
        "乳糜胸",
        "肺葉扭轉",
        "橫膈疝",
        "低白蛋白血症"
      ],
      "initialDB": [
        "胸部X光（排液前後）",
        "胸腔穿刺和液體分析（比重、蛋白質、有核細胞計數、細胞學）",
        "全血球計數和生化"
      ],
      "advanced": [
        "液體培養（疑似膿胸）",
        "液體三酸甘油酯和膽固醇（乳糜液鑑別）",
        "心臟超音波",
        "胸部超音波引導穿刺",
        "CT掃描",
        "FIP相關檢查（貓）"
      ]
    },
    "treatment": {
      "overview": "緊急胸腔穿刺引流緩解呼吸窘迫，同時治療潛在病因。",
      "acute": [
        "治療性胸腔穿刺（緊急緩解呼吸）",
        "氧氣補充",
        "穩定循環（輸液、需要時謹慎以免加重）"
      ],
      "chronic": [
        "針對潛在病因治療",
        "心臟病：利尿劑和心臟藥物",
        "膿胸：胸管引流+長期抗生素",
        "腫瘤：化療或手術",
        "乳糜胸：低脂飲食、Rutin、胸管結紮手術",
        "FIP：GS-441524抗病毒治療",
        "反覆積液：胸管或胸膜固定術"
      ]
    },
    "prognosis": "取決於潛在病因。感染性（膿胸）積極治療預後良好。腫瘤相關預後較差。心因性胸水可通過心臟病治療控制。FIP過去預後極差但現有抗病毒治療大幅改善。乳糜胸手術治療成功率約50-80%。",
    "pearls": [
      "貓的胸腔積液最常見原因是心臟病和腫瘤",
      "呼吸窘迫的貓應先穩定再進行X光檢查",
      "乳糜液三酸甘油酯>100mg/dL且高於血清值",
      "膿胸需早期積極引流，單靠抗生素效果不佳"
    ],
    "diagnosticAlgorithm": {
      "title": "胸腔積液 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估呼吸型態，胸部聽診注意呼吸音減弱或消失的區域，叩診濁音界",
          "findings": [
            "限制性呼吸型態",
            "腹側呼吸音減弱",
            "叩診腹側濁音",
            "心音模糊或遙遠"
          ]
        },
        {
          "step": 2,
          "action": "影像學檢查",
          "details": "胸腔X光確認積液存在與量，胸部超音波引導穿刺定位",
          "findings": [
            "胸腔X光見肺葉後縮與液氣界面",
            "心臟輪廓模糊",
            "超音波確認積液位置與量",
            "肺葉塌陷程度"
          ]
        },
        {
          "step": 3,
          "action": "胸腔穿刺與液體分析",
          "details": "治療性/診斷性胸腔穿刺，進行積液細胞學、生化與培養",
          "findings": [
            "漏出液（蛋白低、細胞少）→心衰竭/低白蛋白",
            "改良型漏出液→腫瘤/心臟病",
            "滲出液（蛋白高、細胞多）→感染/FIP",
            "乳糜液（三酸甘油酯高）→乳糜胸"
          ]
        },
        {
          "step": 4,
          "action": "病因學檢查",
          "details": "根據積液性質進行病因調查，包括心臟超音波、FIP檢測、腫瘤篩查",
          "findings": [
            "心臟超音波評估心臟病",
            "FIP抗體/PCR檢測",
            "積液細胞學或組織學查腫瘤細胞",
            "細菌培養與藥敏（膿胸）"
          ]
        }
      ]
    },
    "monitoring": [
      "呼吸頻率和努力",
      "X光追蹤液體量",
      "潛在病因治療反應",
      "反覆穿刺需求"
    ],
    "reference": "Beatty J et al. J Feline Med Surg 2010; Fossum TW. Small Animal Surgery, 5th Ed. 2019"
  },
  "anaphylaxis": {
    "zh": "過敏性休克",
    "en": "Anaphylaxis",
    "definition": "急性嚴重的全身性第I型過敏反應，可導致心血管塌陷、呼吸衰竭和死亡。犬的休克器官為肝臟和腸道，貓為肺臟。",
    "synonyms": [
      "全身性過敏反應",
      "過敏性反應",
      "Anaphylactic Shock"
    ],
    "epidemiology": {
      "species": "犬貓皆可發生",
      "age": "任何年齡",
      "sex": "無性別傾向",
      "riskFactors": [
        "先前致敏暴露",
        "疫苗接種",
        "蜂螫蟲咬",
        "藥物過敏（抗生素、NSAIDs）",
        "血液製品輸注",
        "食物過敏原"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "暴露過敏原後數分鐘至數小時發生",
        "急性虛脫",
        "嘔吐腹瀉（犬）",
        "呼吸困難（貓）"
      ],
      "physicalExam": [
        "犬：急性嘔吐、血便、低血壓、休克",
        "貓：急性呼吸窘迫、支氣管痙攣、喉頭水腫",
        "面部/眼瞼水腫（血管性水腫）",
        "蕁麻疹",
        "心搏過速",
        "黏膜蒼白或發紺",
        "體溫下降"
      ]
    },
    "pathophysiology": "先前致敏後產生的IgE結合肥大細胞和嗜鹼球表面。再次暴露同一過敏原時，IgE交聯引發大規模脫顆粒，釋放組織胺、白三烯、前列腺素等。犬的休克器官為肝靜脈和腸道（肝靜脈充血、腸道出血性壞死）。貓為肺臟（支氣管痙攣、肺水腫）。全身性血管擴張和通透性增加導致循環衰竭。",
    "diagnosis": {
      "overview": "主要為臨床診斷，基於過敏原暴露史和急性全身性反應。",
      "differentials": [
        "其他原因的休克（敗血性、低容積性、心因性）",
        "急性胃腸道疾病",
        "急性呼吸衰竭",
        "中毒"
      ],
      "initialDB": [
        "臨床表現和暴露史",
        "血壓測量",
        "全血球計數（嗜酸球減少）",
        "血液氣體分析"
      ],
      "advanced": [
        "血清tryptase濃度（升高支持診斷）",
        "過敏原特異性IgE（事後確認）"
      ]
    },
    "treatment": {
      "overview": "Epinephrine是首選急救藥物。同時進行積極的支持療法。",
      "acute": [
        "Epinephrine IM（0.01-0.02mg/kg，1:1000）- 首選且最重要",
        "靜脈輸液快速擴容（Shock dose crystalloids）",
        "氧氣補充",
        "Diphenhydramine（H1阻斷劑）",
        "Ranitidine/Famotidine（H2阻斷劑）",
        "Dexamethasone IV（預防二相反應）",
        "支氣管擴張劑（支氣管痙攣時）",
        "必要時氣管插管"
      ],
      "chronic": [
        "觀察4-24小時（二相反應風險）",
        "口服抗組織胺2-3天",
        "短期類固醇",
        "避免再次暴露已知過敏原",
        "高風險動物備用Epinephrine"
      ]
    },
    "prognosis": "及時給予Epinephrine和支持療法，多數病例可完全恢復。延遲治療可能致命。約20%可能出現二相反應（4-8小時後再發）。",
    "pearls": [
      "Epinephrine是唯一的第一線急救藥物，不要延遲給予",
      "犬的過敏性休克主要表現為嘔吐/腹瀉/肝充血而非支氣管痙攣",
      "貓的過敏性休克以呼吸道症狀為主",
      "疫苗後建議觀察15-30分鐘"
    ],
    "diagnosticAlgorithm": {
      "title": "過敏性休克 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "緊急評估與穩定",
          "details": "快速評估ABC（氣道、呼吸、循環），確認過敏暴露史（疫苗、藥物、蜜蜂螫傷等）",
          "findings": [
            "急性發作（數分鐘至數小時內）",
            "低血壓或休克",
            "面部/喉頭水腫",
            "蕁麻疹或血管性水腫"
          ]
        },
        {
          "step": 2,
          "action": "臨床症狀辨識",
          "details": "確認涉及兩個以上器官系統的急性過敏反應",
          "findings": [
            "皮膚：紅斑、蕁麻疹、搔癢",
            "消化道：嘔吐、腹瀉（犬常見）",
            "呼吸道：喘鳴、呼吸困難",
            "心血管：心動過速、脈搏微弱、低血壓"
          ]
        },
        {
          "step": 3,
          "action": "實驗室與監測",
          "details": "建立靜脈通路，連續生命徵象監測，基礎血液檢查",
          "findings": [
            "血容比變化（犬脾臟收縮致升高）",
            "低血壓持續",
            "乳酸升高",
            "凝血功能異常（DIC風險）"
          ]
        },
        {
          "step": 4,
          "action": "治療反應確認",
          "details": "腎上腺素給予後觀察臨床反應，確認診斷",
          "findings": [
            "腎上腺素反應良好",
            "血壓回升",
            "水腫消退",
            "注意雙相反應（4-8小時後復發）"
          ]
        }
      ]
    },
    "monitoring": [
      "持續心電監護",
      "血壓",
      "呼吸功能",
      "4-24小時觀察二相反應",
      "過敏原記錄"
    ],
    "reference": "Shmuel DL et al. JVECC 2013; Dowling PM. Can Vet J 2011"
  },
  "food-allergy": {
    "zh": "食物過敏",
    "en": "Food Allergy",
    "definition": "對食物中特定蛋白質成分產生的免疫介導性不良反應，導致皮膚和/或消化道症狀。是犬貓第三常見的過敏性皮膚病。",
    "synonyms": [
      "食物不良反應",
      "Adverse Food Reaction",
      "Cutaneous Adverse Food Reaction",
      "CAFR"
    ],
    "epidemiology": {
      "species": "犬貓皆常見",
      "age": "任何年齡（<1歲或>6歲發病應高度懷疑）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "品種傾向（拉布拉多、德國牧羊犬、西高地白梗、暹羅貓）",
        "異位性體質",
        "慢性腸道發炎"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "全年性（非季節性）搔癢",
        "慢性嘔吐/腹瀉",
        "搔癢對類固醇反應不完全",
        "可能有耳道感染",
        "排便頻率增加"
      ],
      "physicalExam": [
        "犬：面部、耳朵、足部、腋下、腹股溝搔癢（與異位性皮膚炎相似）",
        "貓：頭頸部搔癢、粟粒性皮膚炎、嗜酸球性肉芽腫",
        "慢性耳道炎",
        "肛周搔癢",
        "繼發性感染"
      ]
    },
    "pathophysiology": "食物蛋白質穿過腸道黏膜屏障後被免疫系統識別為外來抗原，引發IgE介導和/或T細胞介導的免疫反應。最常見的過敏原蛋白質為牛肉、乳製品、雞肉、小麥、大豆（犬）和牛肉、魚、雞肉、乳製品（貓）。過敏原通常為分子量>10kDa的糖蛋白。",
    "diagnosis": {
      "overview": "食物排除試驗是唯一可靠的診斷方法。血清食物過敏原IgE檢測不可靠。",
      "differentials": [
        "異位性皮膚炎",
        "跳蚤過敏性皮膚炎",
        "疥癬",
        "接觸性皮膚炎",
        "炎症性腸病"
      ],
      "initialDB": [
        "排除跳蚤過敏（嚴格跳蚤預防）",
        "排除外寄生蟲（皮膚刮片）",
        "食物排除試驗（8-12週）"
      ],
      "advanced": [
        "新型蛋白質飲食試驗（兔、鹿、袋鼠等動物未曾接觸的蛋白）",
        "水解蛋白飲食試驗",
        "食物激發試驗（確認診斷）",
        "皮膚切片（排除其他疾病）"
      ]
    },
    "treatment": {
      "overview": "確認過敏食物後終身避免。食物排除試驗本身即為治療性診斷。",
      "acute": [
        "開始食物排除試驗",
        "治療繼發性感染",
        "短期止癢（Oclacitinib或短期類固醇）"
      ],
      "chronic": [
        "長期避免已確認的過敏食物",
        "選用適當的商業限定成分飲食",
        "水解蛋白飲食作為替代",
        "逐步食物激發試驗確認具體過敏原",
        "治療併發的異位性皮膚炎"
      ]
    },
    "prognosis": "一旦確認過敏食物並嚴格避免，預後極佳。多數犬貓在食物排除後2-6週皮膚症狀改善，消化道症狀可能更早改善。約30%的食物過敏動物同時有環境過敏（異位性皮膚炎）。",
    "pearls": [
      "食物排除試驗必須嚴格（無零食、調味劑、咬膠），8-12週才有結論",
      "血清食物過敏原IgE檢測假陽性率高，不建議作為診斷依據",
      "約30%的食物過敏犬同時有異位性皮膚炎",
      "食物過敏可在任何年齡首次出現，即使長期食用同一食物"
    ],
    "diagnosticAlgorithm": {
      "title": "食物過敏 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估與病史收集",
          "details": "詳細詢問飲食史、症狀發作年齡、季節性、抗生素/類固醇反應",
          "findings": [
            "非季節性搔癢",
            "發病年齡多<1歲",
            "面部/耳部/肛周搔癢",
            "同時伴有消化道症狀（嘔吐/腹瀉）"
          ]
        },
        {
          "step": 2,
          "action": "排除其他搔癢原因",
          "details": "進行皮膚刮搔、耳鏡、皮膚細胞學，排除寄生蟲與感染",
          "findings": [
            "皮膚刮搔陰性（排除蟎蟲）",
            "跳蚤梳檢查陰性",
            "繼發性馬拉色菌或細菌感染",
            "類固醇反應不完全"
          ]
        },
        {
          "step": 3,
          "action": "排除飲食試驗",
          "details": "嚴格進行8-12週排除飲食試驗（新型蛋白或水解蛋白飲食）",
          "findings": [
            "試驗期間症狀改善>50%",
            "需嚴格禁止零食與其他食物",
            "症狀改善通常在4-6週開始",
            "記錄每週搔癢評分"
          ]
        },
        {
          "step": 4,
          "action": "食物激發試驗確診",
          "details": "排除飲食改善後，逐一重新引入原食物成分，觀察症狀復發",
          "findings": [
            "重新引入原食物後症狀復發（數小時至14天內）",
            "確認過敏原成分",
            "常見過敏原：牛肉、雞肉、乳製品、小麥",
            "建立長期飲食管理計劃"
          ]
        }
      ]
    },
    "monitoring": [
      "排除試驗期間症狀變化",
      "食物激發反應",
      "繼發感染控制",
      "營養均衡評估"
    ],
    "reference": "Mueller RS et al. BMC Vet Res 2016; Olivry T et al. Vet Dermatol 2015"
  },
  "demodicosis": {
    "zh": "蠕形蟎病",
    "en": "Demodicosis",
    "definition": "由蠕形蟎（Demodex spp.）過度增殖引起的皮膚病。犬主要為 Demodex canis，貓為 Demodex cati 和 Demodex gatoi。分為局部型和全身型，全身型常與免疫抑制相關。",
    "synonyms": [
      "Demodectic Mange",
      "Red Mange",
      "Follicular Mange"
    ],
    "epidemiology": {
      "species": "犬較常見，貓少見",
      "age": "犬：幼年型（3-18月齡）；成年型（>4歲，常有潛在免疫抑制）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "免疫抑制（腫瘤、庫欣氏症、化療）",
        "遺傳易感性（純種犬如沙皮犬、鬥牛犬、德國牧羊犬）",
        "營養不良",
        "內寄生蟲感染",
        "壓力"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "局部型：面部或前肢出現1-5處脫毛斑",
        "全身型：廣泛脫毛、皮膚發紅",
        "可能伴有繼發細菌感染導致膿皮症",
        "搔癢程度不一，無繼發感染時通常不癢"
      ],
      "physicalExam": [
        "局部型：眼周、口周、前肢局部脫毛斑",
        "全身型：廣泛性脫毛、紅斑、鱗屑",
        "毛囊角栓（follicular casts）",
        "繼發膿皮症時可見丘疹、膿皰、痂皮",
        "嚴重時可見蜂窩織炎及淋巴結腫大",
        "足蠕形蟎症（pododermatitis）：足部腫脹、疼痛"
      ]
    },
    "pathophysiology": "蠕形蟎為正常皮膚共生蟲，棲息於毛囊和皮脂腺中。當宿主細胞免疫功能缺陷（特別是T細胞功能）時，蟎蟲過度增殖，導致毛囊炎和毛囊周圍炎。幼年型與遺傳性T細胞功能缺陷有關；成年型常反映潛在的免疫抑制疾病。繼發細菌感染（主要為葡萄球菌）可加重病情。",
    "diagnosis": {
      "overview": "深層皮膚刮搔檢查（deep skin scraping）為主要診斷方法，需刮至出血點以獲取毛囊內蟎蟲。",
      "differentials": [
        "皮黴菌病",
        "細菌性膿皮症",
        "過敏性皮膚炎",
        "疥蟎病",
        "落葉型天疱瘡"
      ],
      "initialDB": [
        "深層皮膚刮搔檢查（擠壓後刮搔至輕微出血）",
        "拔毛檢查（trichography）",
        "皮膚壓片細胞學（評估繼發感染）",
        "成年發病型應進行CBC、生化、尿液分析"
      ],
      "advanced": [
        "皮膚活檢（刮搔陰性但臨床高度懷疑時）",
        "成年型：腎上腺功能檢測、腫瘤篩檢",
        "貓：FeLV/FIV檢測"
      ]
    },
    "treatment": {
      "overview": "局部型多數可自行痊癒。全身型需要殺蟎治療及處理繼發感染，成年型需找出並治療潛在疾病。",
      "acute": [
        "Isoxazoline 類藥物（首選）：fluralaner（Bravecto）或 afoxolaner（NexGard）",
        "Ivermectin 0.3-0.6 mg/kg PO q24h（漸進增量，注意MDR1基因突變品種）",
        "繼發膿皮症：全身性抗生素治療4-6週",
        "含 benzoyl peroxide 洗毛精輔助清潔毛囊"
      ],
      "chronic": [
        "持續殺蟎治療直至連續兩次月檢刮搔陰性",
        "避免使用免疫抑制藥物",
        "成年型：治療潛在免疫抑制疾病",
        "不建議全身型患犬用於繁殖"
      ]
    },
    "prognosis": "局部型：90%可自行緩解，預後良好。全身型幼年型：經適當治療多數可痊癒，但療程可能需3-6個月。成年型：預後取決於潛在疾病的控制。",
    "pearls": [
      "Isoxazoline 類藥物已成為治療首選，療效優異且安全性高",
      "成年發病的全身型蠕形蟎病務必尋找潛在免疫抑制原因",
      "MDR1基因突變品種（柯利犬等）禁用高劑量ivermectin",
      "治療需持續至皮膚刮搔連續兩次陰性後再延長一個月",
      "貓蠕形蟎病罕見，發生時需排除FeLV/FIV及其他免疫抑制疾病"
    ],
    "diagnosticAlgorithm": {
      "title": "蠕形蟎病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估皮膚病變分布與型態，詢問年齡、品種傾向與免疫狀態",
          "findings": [
            "局部或全身性脫毛",
            "面部/四肢脫毛（幼犬局部型）",
            "毛囊丘疹或膿皰",
            "皮膚紅腫或鱗屑"
          ]
        },
        {
          "step": 2,
          "action": "皮膚刮搔檢查",
          "details": "深層皮膚刮搔（擠壓皮膚後刮取至見血），鏡檢觀察蟎蟲",
          "findings": [
            "發現成蟲/幼蟲/蟲卵",
            "確認蟎蟲種類（犬蠕形蟎/貓蠕形蟎/Demodex injai）",
            "評估蟲體數量與生活史各期比例",
            "足部可用毛髮拔取法（拔毛鏡檢）"
          ]
        },
        {
          "step": 3,
          "action": "繼發感染評估",
          "details": "皮膚細胞學檢查評估繼發細菌感染，必要時進行細菌培養",
          "findings": [
            "繼發性葡萄球菌深層膿皮症",
            "毛囊炎/蜂窩組織炎",
            "局部淋巴結腫大",
            "體溫升高（嚴重感染時）"
          ]
        },
        {
          "step": 4,
          "action": "潛在病因調查",
          "details": "成犬發病型需調查免疫抑制原因",
          "findings": [
            "甲狀腺功能低下檢測",
            "腎上腺皮質功能亢進檢測",
            "腫瘤篩查",
            "免疫抑制藥物使用史"
          ]
        }
      ]
    },
    "monitoring": [
      "每4週進行皮膚刮搔檢查評估蟎蟲數量",
      "監測繼發感染的改善情況",
      "成年型監測潛在疾病的控制狀態",
      "使用ivermectin時監測神經毒性症狀"
    ],
    "reference": "Miller WH, Griffin CE, Campbell KL: Muller and Kirk's Small Animal Dermatology, 7th Ed. Elsevier, 2013"
  },
  "sarcoptic-mange": {
    "zh": "疥蟎病",
    "en": "Sarcoptic Mange",
    "definition": "由疥蟎（Sarcoptes scabiei var. canis）感染引起的高度搔癢性皮膚病，具有高度傳染性，可短暫感染人類（人畜共通）。",
    "synonyms": [
      "Scabies",
      "Canine Scabies",
      "疥瘡"
    ],
    "epidemiology": {
      "species": "犬較常見，貓極少見（貓有Notoedres cati）",
      "age": "任何年齡均可感染",
      "sex": "無性別傾向",
      "riskFactors": [
        "與感染動物直接接觸",
        "收容所或犬舍環境",
        "流浪犬",
        "免疫抑制動物",
        "野生動物接觸（狐狸等）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "劇烈搔癢，對類固醇反應差",
        "耳緣、肘部、腹部、跗關節最先受影響",
        "搔癢程度與皮損嚴重度不成比例",
        "同住動物或飼主可能出現皮膚症狀"
      ],
      "physicalExam": [
        "耳廓邊緣痂皮和脫毛（pinnal-pedal reflex 陽性率約75-90%）",
        "丘疹、紅斑、黃色痂皮",
        "嚴重抓傷導致的表皮脫落和苔蘚化",
        "好發部位：耳緣、肘部、跗關節、腹部",
        "慢性病例可見全身性皮膚增厚和色素沉著"
      ]
    },
    "pathophysiology": "疥蟎鑽入表皮角質層挖掘隧道，在其中產卵和排泄。蟎蟲的排泄物和分泌物引起強烈的第I型（IgE介導）和第IV型（遲發型）超敏反應。這種免疫反應是劇烈搔癢的主因，且解釋了為何蟎蟲數量少時仍可引起嚴重症狀。",
    "diagnosis": {
      "overview": "臨床表現高度提示但皮膚刮搔敏感度低（僅20-50%陽性），常需試驗性治療確認。",
      "differentials": [
        "異位性皮膚炎",
        "食物過敏",
        "跳蚤過敏性皮膚炎",
        "蠕形蟎病",
        "皮黴菌病",
        "落葉型天疱瘡"
      ],
      "initialDB": [
        "多處淺層皮膚刮搔（耳緣、肘部等好發部位）",
        "Pinnal-pedal reflex 測試",
        "皮膚壓片細胞學",
        "Sarcoptes IgG 血清學檢測"
      ],
      "advanced": [
        "皮膚活檢（通常非特異性，可見嗜酸性球浸潤）",
        "試驗性殺蟎治療（治療反應性診斷）"
      ]
    },
    "treatment": {
      "overview": "殺蟎治療為主，所有同住動物需同時治療，環境需徹底清潔。",
      "acute": [
        "Isoxazoline 類藥物（首選）：fluralaner 或 sarolaner 單次口服",
        "Selamectin（Revolution）6-12 mg/kg 外用，每2週一次共3-4次",
        "Ivermectin 0.2-0.4 mg/kg SC 或 PO，每1-2週一次共4-6次",
        "搔癢嚴重時短期使用 prednisolone 0.5-1 mg/kg/day 共3-5天",
        "所有接觸動物同時治療"
      ],
      "chronic": [
        "環境清潔（蟎蟲離開宿主可存活數天）",
        "清洗所有床墊和毯子",
        "持續治療直至症狀完全消退",
        "嚴重苔蘚化病例可能需數週至數月恢復"
      ]
    },
    "prognosis": "經適當治療預後極佳，多數病例在治療後4週內顯著改善。搔癢通常在治療開始後1-2週減輕。",
    "pearls": [
      "Pinnal-pedal reflex 是最有用的臨床診斷線索",
      "皮膚刮搔陰性不能排除疥蟎病，敏感度僅20-50%",
      "搔癢對類固醇反應差是重要鑑別點",
      "Isoxazoline 類藥物已大幅簡化治療",
      "人畜共通：飼主的紅疹在動物治療後會自行消退",
      "任何劇烈搔癢的犬都應考慮疥蟎病"
    ],
    "diagnosticAlgorithm": {
      "title": "疥蟎病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估搔癢程度與分布，確認接觸史與人畜共患可能",
          "findings": [
            "劇烈搔癢（類固醇反應差）",
            "耳廓邊緣/肘部/腹側優先受累",
            "耳-足反射陽性（Pinnal-pedal reflex）",
            "家中其他動物或人有搔癢症狀"
          ]
        },
        {
          "step": 2,
          "action": "皮膚刮搔檢查",
          "details": "多處淺層皮膚刮搔，選擇耳緣、肘部等好發部位",
          "findings": [
            "發現疥蟎成蟲/幼蟲/蟲卵（敏感度僅20-50%）",
            "大量鱗屑與痂皮",
            "表皮增生",
            "注意：陰性結果不能排除診斷"
          ]
        },
        {
          "step": 3,
          "action": "血清學與輔助檢查",
          "details": "疥蟎IgG抗體檢測（ELISA），糞便浮游法檢查蟎蟲卵",
          "findings": [
            "疥蟎ELISA抗體陽性（感染3-5週後）",
            "糞便中可能發現蟎蟲卵",
            "周邊血液嗜酸性球增多"
          ]
        },
        {
          "step": 4,
          "action": "治療性診斷",
          "details": "高度懷疑時給予殺蟎劑治療性診斷（isoxazoline類藥物）",
          "findings": [
            "治療後2-4週搔癢明顯改善",
            "皮膚病變逐漸消退",
            "確認診斷",
            "所有接觸動物需同時治療"
          ]
        }
      ]
    },
    "monitoring": [
      "治療後2-4週評估搔癢改善程度",
      "4-6週後重複皮膚刮搔",
      "監測同住動物是否出現症狀",
      "確認飼主皮膚症狀是否消退"
    ],
    "reference": "Miller WH, Griffin CE, Campbell KL: Muller and Kirk's Small Animal Dermatology, 7th Ed. Elsevier, 2013"
  },
  "hot-spot": {
    "zh": "急性濕性皮膚炎",
    "en": "Acute Moist Dermatitis (Hot Spot)",
    "definition": "急性、局部性、表淺性的化膿性皮膚炎，由自我創傷（舔、抓、咬）引起，常在數小時內快速發展。",
    "synonyms": [
      "Pyotraumatic Dermatitis",
      "Moist Eczema",
      "Summer Sores"
    ],
    "epidemiology": {
      "species": "犬較常見，貓少見",
      "age": "任何年齡，好發於成年犬",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "厚密被毛品種（黃金獵犬、拉布拉多、聖伯納、德國牧羊犬）",
        "高溫潮濕環境",
        "游泳後未完全乾燥",
        "過敏性皮膚炎",
        "跳蚤感染",
        "耳炎",
        "肛囊疾病",
        "被毛糾結"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "數小時內急性出現的局部脫毛和潮濕皮損",
        "患犬持續舔咬特定部位",
        "可能有近期游泳、洗澡或淋雨史",
        "常有潛在搔癢原因（跳蚤、過敏等）"
      ],
      "physicalExam": [
        "界限分明的紅斑、潮濕、滲出性病灶",
        "表面被毛脫落或黏附膿性分泌物",
        "病灶周圍皮膚通常正常",
        "好發部位：頰部、頸部、臀部、大腿外側",
        "觸診疼痛",
        "病灶可能被周圍被毛覆蓋而外觀比實際小"
      ]
    },
    "pathophysiology": "由潛在搔癢原因（過敏、外寄生蟲、耳炎等）引起的自我創傷，破壞皮膚屏障後繼發表淺細菌感染（主要為葡萄球菌）。潮濕環境促進細菌增殖，搔癢-抓搔循環加速病灶擴大。厚毛品種因被毛保持濕度，更易發生。",
    "diagnosis": {
      "overview": "主要根據典型臨床外觀診斷，需區分表淺型和深層型（pyotraumatic folliculitis）。",
      "differentials": [
        "深層膿皮症",
        "皮黴菌病",
        "蠕形蟎病",
        "腫瘤性病變",
        "熱傷"
      ],
      "initialDB": [
        "臨床外觀評估",
        "剃毛後完整評估病灶範圍",
        "皮膚壓片細胞學（評估細菌和是否有桿菌）",
        "尋找潛在原因（跳蚤檢查、耳鏡檢查）"
      ],
      "advanced": [
        "細菌培養和藥敏試驗（反覆發作或治療無效時）",
        "皮膚活檢（非典型病灶）",
        "過敏原檢測（反覆發作時）"
      ]
    },
    "treatment": {
      "overview": "剃毛、清潔、控制感染和搔癢、找出並治療潛在原因。",
      "acute": [
        "病灶周圍剃毛並以 chlorhexidine 2-4% 溶液清潔",
        "外用抗菌藥膏（mupirocin 或 fusidic acid）BID",
        "短期口服 prednisolone 0.5-1 mg/kg/day 共5-7天控制搔癢",
        "疼痛明顯時短期鎮痛（如 tramadol）",
        "伊莉莎白頸圈防止持續自我創傷",
        "深層型或大面積：全身性抗生素（cephalexin 22 mg/kg BID）3-4週"
      ],
      "chronic": [
        "找出並治療潛在原因（跳蚤預防、過敏管理、耳炎治療）",
        "定期梳毛和保持皮膚乾燥",
        "游泳或洗澡後徹底吹乾",
        "反覆發作者考慮過敏檢測"
      ]
    },
    "prognosis": "個別病灶治療反應迅速，通常7-14天痊癒。但若未處理潛在原因，復發率高。",
    "pearls": [
      "剃毛後的實際病灶通常比外觀大很多",
      "必須區分表淺型和深層型（衛星狀丘疹提示深層型）",
      "深層型需全身性抗生素而非僅外用",
      "反覆發作務必尋找潛在原因（過敏、跳蚤、耳炎）",
      "黃金獵犬的臀部hot spot常與跳蚤過敏或肛囊疾病相關"
    ],
    "diagnosticAlgorithm": {
      "title": "急性濕性皮膚炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "觀察病變特徵與分布，詢問發病速度與可能誘因",
          "findings": [
            "急性發作的紅腫濕潤病變",
            "界限分明的脫毛區",
            "表面滲出液與痂皮",
            "動物持續舔咬病變部位"
          ]
        },
        {
          "step": 2,
          "action": "病變檢查與取樣",
          "details": "剃毛清潔病變周圍，評估病變深度，進行皮膚細胞學",
          "findings": [
            "表淺性膿皮症（限於表皮）",
            "細胞學見大量嗜中性球與球菌",
            "病變周圍衛星狀丘疹（深層感染）",
            "評估是否合併深層毛囊炎"
          ]
        },
        {
          "step": 3,
          "action": "潛在誘因調查",
          "details": "尋找引發自我創傷的根本原因",
          "findings": [
            "跳蚤過敏性皮膚炎",
            "耳道感染（面頰部熱斑）",
            "肛門囊疾病（尾根部熱斑）",
            "過敏性皮膚炎或接觸性刺激"
          ]
        }
      ]
    },
    "monitoring": [
      "3-5天回診評估治療反應",
      "確認搔癢程度改善",
      "監測潛在原因的控制情況",
      "評估是否需要長期過敏管理"
    ],
    "reference": "Miller WH, Griffin CE, Campbell KL: Muller and Kirk's Small Animal Dermatology, 7th Ed. Elsevier, 2013"
  },
  "elbow-dysplasia": {
    "zh": "肘關節發育不良",
    "en": "Elbow Dysplasia",
    "definition": "犬肘關節發育異常的統稱，包括內側冠狀突分裂（FCP）、肘突不癒合（UAP）、肱骨內側踝骨軟骨炎（OCD）及關節不協調（incongruity）。為犬前肢跛行最常見的發育性原因之一。",
    "synonyms": [
      "Elbow Incongruity",
      "Fragmented Coronoid Process",
      "Ununited Anconeal Process"
    ],
    "epidemiology": {
      "species": "犬（大型及巨型犬種）",
      "age": "通常4-10月齡開始出現症狀",
      "sex": "公犬略多於母犬",
      "riskFactors": [
        "大型及巨型品種（拉布拉多、黃金獵犬、德國牧羊犬、羅威納、伯恩山犬）",
        "遺傳因素",
        "生長速度過快",
        "過度鈣質補充",
        "高熱量飲食導致過速生長",
        "常為雙側性（25-80%）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "前肢跛行，運動後加重",
        "通常4-10月齡開始出現",
        "休息後僵硬（起步跛）",
        "可能為雙側性（雙側時跛行可能不明顯）",
        "活動量逐漸下降"
      ],
      "physicalExam": [
        "肘關節活動範圍減小（特別是屈曲和伸展）",
        "肘關節屈曲和旋前時疼痛",
        "內側冠狀突區域按壓痛",
        "肘關節積液（波動感）",
        "慢性病例可見肌肉萎縮和關節腫大",
        "步態分析：負重時頭部抬起"
      ]
    },
    "pathophysiology": "肘關節發育不良源於橈骨和尺骨生長不協調，導致關節面不吻合（incongruity），進而引起關節軟骨和骨骼的異常應力。FCP是最常見的病理，內側冠狀突承受異常壓力導致軟骨下骨微裂和碎裂。UAP為肘突骨化中心未能與尺骨融合。OCD為肱骨滑車內側的軟骨碎片。這些病變均導致進行性骨關節炎。",
    "diagnosis": {
      "overview": "結合臨床檢查和影像學診斷。X光可見繼發性關節炎變化，但CT為評估FCP的金標準。",
      "differentials": [
        "全骨炎（panosteitis）",
        "肱骨骨軟骨炎",
        "肘關節脫臼",
        "肘關節骨折",
        "關節感染",
        "免疫介導性多發關節炎"
      ],
      "initialDB": [
        "肘關節正面和側面X光（雙側比較）",
        "骨科理學檢查",
        "關節液分析（排除感染或免疫性關節炎）"
      ],
      "advanced": [
        "CT掃描（FCP的金標準診斷）",
        "關節鏡檢查（診斷與治療）",
        "MRI",
        "對側肘關節影像評估"
      ]
    },
    "treatment": {
      "overview": "輕度病例可保守治療，中度至重度或年輕病例多建議手術。長期需管理繼發性骨關節炎。",
      "acute": [
        "手術治療：關節鏡下碎片移除（FCP）、固定或移除（UAP）、OCD碎片移除",
        "近端尺骨截骨術（proximal ulnar osteotomy）矯正不協調",
        "PAUL 手術（proximal abducting ulnar osteotomy）",
        "術後限制活動4-6週"
      ],
      "chronic": [
        "體重管理（維持理想體態）",
        "NSAIDs 長期止痛（meloxicam、carprofen）",
        "關節保健品（glucosamine/chondroitin、omega-3脂肪酸）",
        "適度規律運動維持肌肉量",
        "物理治療和復健",
        "嚴重退行性關節病可考慮全肘關節置換"
      ]
    },
    "prognosis": "取決於診斷時關節炎嚴重程度。早期手術治療預後較佳，但多數患犬終將發展出一定程度的骨關節炎。多數犬經適當管理可維持良好的生活品質。",
    "pearls": [
      "雙側發病率高，即使僅單側跛行也應評估對側",
      "CT比X光更敏感地檢測FCP",
      "FCP是最常見的肘關節發育不良形式",
      "早期體重控制和適度運動對預後至關重要",
      "發育期避免過度鈣質補充和高熱量飲食"
    ],
    "diagnosticAlgorithm": {
      "title": "肘關節發育不良 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估步態（前肢跛行），確認品種傾向（拉布拉多、金毛、德牧等大型犬），關節觸診",
          "findings": [
            "前肢跛行（單側或雙側）",
            "運動後跛行加劇",
            "肘關節腫脹或活動範圍減少",
            "肘關節屈曲/伸展時疼痛"
          ]
        },
        {
          "step": 2,
          "action": "X光檢查",
          "details": "拍攝肘關節多角度X光（屈曲側位、前後位、斜位），雙側比較",
          "findings": [
            "關節不協調（尺橈骨階梯）",
            "內側冠狀突碎裂",
            "關節退行性變化",
            "鈎突未癒合"
          ]
        },
        {
          "step": 3,
          "action": "進階影像學",
          "details": "CT掃描提供三維重建，精確評估骨骼病變",
          "findings": [
            "CT確認冠狀突碎裂程度",
            "鈎突癒合狀態",
            "剝脫性骨軟骨炎病灶",
            "關節面不整"
          ]
        },
        {
          "step": 4,
          "action": "關節鏡或手術探查",
          "details": "關節鏡直接觀察關節內病變，同時可進行治療",
          "findings": [
            "軟骨損傷程度分級",
            "游離體確認與移除",
            "關節面磨損評估",
            "制定手術或保守治療計劃"
          ]
        }
      ]
    },
    "monitoring": [
      "術後6-8週回診評估恢復",
      "定期X光追蹤骨關節炎進展",
      "體重監測",
      "評估止痛藥效果和副作用（特別是腎肝功能）",
      "對側肘關節定期評估"
    ],
    "reference": "Tobias KM, Johnston SA: Veterinary Surgery: Small Animal, 2nd Ed. Elsevier, 2018"
  },
  "melanoma": {
    "zh": "黑色素瘤",
    "en": "Melanoma",
    "definition": "源自黑色素細胞的腫瘤。在犬中，口腔黑色素瘤為最常見的口腔惡性腫瘤，具有高度侵襲性和轉移傾向；皮膚黑色素瘤多為良性。貓的黑色素瘤較少見但多為惡性。",
    "synonyms": [
      "Malignant Melanoma",
      "Melanocytic Neoplasm"
    ],
    "epidemiology": {
      "species": "犬較常見，貓少見",
      "age": "中老年犬（平均10-12歲）",
      "sex": "公犬略多",
      "riskFactors": [
        "深色素品種（蘇格蘭梗、迷你雪納瑞、黃金獵犬、愛爾蘭雪達犬）",
        "口腔黏膜色素沉著",
        "甲床和腳趾部位預後差",
        "犬口腔黑色素瘤惡性率極高"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "口腔型：口臭、流涎、進食困難、口腔出血",
        "皮膚型：皮膚上逐漸增大的色素性或非色素性腫塊",
        "甲床型：趾頭腫脹、跛行、指甲脫落",
        "體重減輕（晚期）"
      ],
      "physicalExam": [
        "口腔型：牙齦或口腔黏膜上黑色或非色素性（amelanotic）腫塊",
        "皮膚型：孤立性色素性結節，可為黑色、棕色或肉色",
        "甲床型：趾頭腫脹和變形",
        "區域淋巴結腫大",
        "評估是否有遠端轉移徵兆"
      ]
    },
    "pathophysiology": "黑色素瘤源自神經嵴衍生的黑色素細胞。口腔和甲床黑色素瘤具有高度侵襲性，可局部侵犯骨骼，並經淋巴和血行途徑轉移至區域淋巴結和肺部。皮膚黑色素瘤的生物行為取決於位置和有絲分裂指數。約三分之一口腔黑色素瘤為無色素性（amelanotic），不呈黑色。",
    "diagnosis": {
      "overview": "細針抽吸或組織切片活檢確診，需完整分期評估以制定治療計畫。",
      "differentials": [
        "鱗狀細胞癌",
        "纖維肉瘤",
        "牙齦增生",
        "齒齦瘤（口腔型）",
        "肥大細胞瘤",
        "基底細胞瘤（皮膚型）"
      ],
      "initialDB": [
        "細針抽吸細胞學（注意amelanotic型可能誤診）",
        "胸腔X光三視圖（肺轉移篩檢）",
        "區域淋巴結抽吸細胞學",
        "CBC、生化檢查"
      ],
      "advanced": [
        "組織切片活檢（確認分級和有絲分裂指數）",
        "腹部超音波",
        "CT/MRI（評估局部侵犯範圍和手術計畫）",
        "免疫組織化學染色（amelanotic型）"
      ]
    },
    "treatment": {
      "overview": "口腔黑色素瘤以廣泛手術切除為主，輔以放射治療和/或免疫治療。皮膚型良性者手術切除即可。",
      "acute": [
        "口腔型：廣泛手術切除（需2 cm邊界，常需下頜骨切除）",
        "皮膚型：手術切除（良性者邊界1 cm即可）",
        "甲床型：截趾術",
        "區域淋巴結清除（若有轉移）"
      ],
      "chronic": [
        "犬黑色素瘤疫苗（Oncept，已核准用於口腔黑色素瘤輔助治療）",
        "放射治療（不完全切除或無法手術的病例）",
        "化療效果有限（carboplatin反應率約20%）",
        "口腔型定期追蹤轉移"
      ]
    },
    "prognosis": "口腔黑色素瘤預後差，中位生存時間：手術切除約17-18個月（I期）、5-6個月（III-IV期）。皮膚型良性黑色素瘤手術切除後預後極佳。甲床型中位生存時間約12個月。",
    "pearls": [
      "約1/3口腔黑色素瘤為amelanotic，外觀可呈粉紅色",
      "有絲分裂指數（MI）是最重要的預後因子",
      "皮膚黑色素瘤多為良性，但口腔和甲床型幾乎都是惡性",
      "犬黑色素瘤疫苗是獸醫腫瘤學中首個獲得許可的治療性疫苗",
      "所有口腔腫塊都應採樣，不要僅憑外觀判斷"
    ],
    "diagnosticAlgorithm": {
      "title": "黑色素瘤 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "檢查腫塊位置、大小、外觀，評估區域淋巴結",
          "findings": [
            "口腔/唇部/趾甲床色素性或無色素性腫塊",
            "皮膚色素性腫塊",
            "區域淋巴結腫大",
            "口腔腫塊可能伴有流涎或出血"
          ]
        },
        {
          "step": 2,
          "action": "細針抽吸細胞學",
          "details": "腫塊與區域淋巴結細針抽吸，細胞學評估",
          "findings": [
            "圓形至梭形細胞含黑色素顆粒",
            "細胞多形性與核異型性",
            "無色素型需特殊染色確認",
            "淋巴結轉移評估"
          ]
        },
        {
          "step": 3,
          "action": "分期檢查",
          "details": "胸腔X光（三視圖）、腹部超音波評估遠端轉移",
          "findings": [
            "肺部結節（肺轉移）",
            "腹腔臟器轉移灶",
            "口腔黑色素瘤高轉移率",
            "皮膚型良性率較高"
          ]
        },
        {
          "step": 4,
          "action": "組織病理學確診",
          "details": "切除或切開生檢，組織學分級與免疫組化檢測",
          "findings": [
            "組織學確認腫瘤類型與惡性程度",
            "有絲分裂指數評估",
            "Ki-67增殖指數",
            "Melan-A/PNL2免疫組化標記"
          ]
        }
      ]
    },
    "monitoring": [
      "術後每2-3個月胸腔X光和淋巴結評估",
      "局部復發監測",
      "口腔定期檢查",
      "使用疫苗者依療程追蹤"
    ],
    "reference": "Withrow SJ, Vail DM, Page RL: Withrow and MacEwen's Small Animal Clinical Oncology, 6th Ed. Elsevier, 2020"
  },
  "squamous-cell-carcinoma": {
    "zh": "鱗狀細胞癌",
    "en": "Squamous Cell Carcinoma",
    "definition": "源自鱗狀上皮細胞的惡性腫瘤，可發生於皮膚、口腔、鼻腔、肺臟、趾甲床等多種部位。在犬和貓中均為常見的上皮性惡性腫瘤。",
    "synonyms": [
      "SCC",
      "Epidermoid Carcinoma"
    ],
    "epidemiology": {
      "species": "犬貓皆可",
      "age": "中老年動物（犬平均9-10歲，貓平均12歲）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "紫外線暴露（白色或淺色皮膚/被毛）",
        "貓鼻平面和耳尖SCC與日曬高度相關",
        "犬口腔SCC（大型犬種）",
        "慢性炎症或疤痕組織",
        "貓：二手菸暴露可能增加口腔SCC風險",
        "犬趾甲床型好發於大型黑色犬種"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "皮膚型：不癒合的潰瘍或結痂，逐漸擴大",
        "口腔型：進食困難、流涎、口臭、口腔出血",
        "鼻型（貓）：鼻平面潰瘍、結痂、變形",
        "甲床型：趾頭腫脹和跛行"
      ],
      "physicalExam": [
        "皮膚型：潰瘍性或增生性腫塊，表面常有壞死和結痂",
        "口腔型：牙齦、舌頭或扁桃體腫塊，常侵犯骨骼",
        "貓鼻型：鼻平面紅斑→痂皮→潰瘍→組織破壞",
        "區域淋巴結評估（轉移率因部位而異）"
      ]
    },
    "pathophysiology": "SCC源自表皮或黏膜的鱗狀上皮細胞惡性轉化。紫外線（UVB）誘導DNA損傷導致p53腫瘤抑制基因突變，是日光性SCC的主要致病機制。腫瘤具局部侵襲性，可破壞周圍組織和骨骼。遠端轉移率依部位而異：皮膚型轉移率低，扁桃體型轉移率高。",
    "diagnosis": {
      "overview": "組織活檢為確診標準。細針抽吸可提示但因角質化特性有時困難。",
      "differentials": [
        "黑色素瘤",
        "纖維肉瘤",
        "肥大細胞瘤",
        "肉芽腫",
        "真菌感染",
        "異物反應"
      ],
      "initialDB": [
        "細針抽吸或組織活檢",
        "胸腔X光（轉移評估）",
        "區域淋巴結抽吸",
        "CBC、生化、尿液分析"
      ],
      "advanced": [
        "CT/MRI（評估局部侵犯範圍，特別是口腔和鼻腔型）",
        "腹部超音波",
        "骨骼侵犯評估"
      ]
    },
    "treatment": {
      "overview": "手術廣泛切除是多數SCC的首選治療。不完全切除或無法手術的病例可考慮放射治療。",
      "acute": [
        "手術廣泛切除（邊界至少1-2 cm）",
        "口腔型：可能需上/下頜骨切除",
        "貓鼻型：鼻平面切除術（nosectomy）",
        "趾甲床型：截趾術"
      ],
      "chronic": [
        "不完全切除：放射治療",
        "貓淺表型：光動力治療（PDT）、冷凍治療",
        "NSAIDs（piroxicam）可能有輔助抗腫瘤效果",
        "化療（carboplatin、mitoxantrone）用於轉移或無法手術者",
        "扁桃體SCC：預後差，考慮放射治療±化療"
      ]
    },
    "prognosis": "取決於腫瘤位置和分期。皮膚型完全切除後預後佳。貓鼻平面切除後中位生存>1年。口腔型犬預後中等（中位生存9-18個月）。扁桃體型預後差（中位3-6個月）。趾甲床型截趾後中位生存約1年。",
    "pearls": [
      "貓鼻平面SCC是日光性損傷的經典表現，限制日曬可預防",
      "犬多趾SCC應考慮肺原發腫瘤轉移的可能",
      "口腔SCC常侵犯骨骼，CT評估手術範圍很重要",
      "貓口腔（特別是舌下）SCC預後極差",
      "NSAIDs可能提供額外的抗腫瘤效益"
    ],
    "diagnosticAlgorithm": {
      "title": "鱗狀細胞癌 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "檢查腫塊特徵與位置（口腔、皮膚、趾甲床），評估誘因",
          "findings": [
            "潰瘍性或增生性腫塊",
            "白色被毛/無色素皮膚部位好發（日光性）",
            "口腔牙齦/舌下腫塊",
            "趾端腫脹伴趾骨溶解"
          ]
        },
        {
          "step": 2,
          "action": "細胞學與組織學檢查",
          "details": "細針抽吸細胞學初步評估，切開或切除生檢確診",
          "findings": [
            "角化鱗狀上皮細胞",
            "細胞多形性與異常角化",
            "組織學確認侵襲深度",
            "分化程度分級"
          ]
        },
        {
          "step": 3,
          "action": "局部侵犯評估",
          "details": "X光或CT評估骨骼侵犯，口腔型評估頜骨破壞",
          "findings": [
            "趾骨溶解（趾甲床型）",
            "頜骨骨溶解（口腔型）",
            "CT評估腫瘤邊界",
            "區域淋巴結腫大"
          ]
        },
        {
          "step": 4,
          "action": "遠端轉移篩查",
          "details": "胸腔X光、腹部超音波評估全身轉移情況",
          "findings": [
            "皮膚型轉移率低",
            "口腔型/趾甲床型轉移率較高",
            "肺轉移篩查",
            "淋巴結細針抽吸評估"
          ]
        }
      ]
    },
    "monitoring": [
      "術後每2-3個月局部和區域淋巴結評估",
      "定期胸腔X光",
      "貓皮膚型監測其他部位新病灶",
      "口腔型定期口腔檢查"
    ],
    "reference": "Withrow SJ, Vail DM, Page RL: Withrow and MacEwen's Small Animal Clinical Oncology, 6th Ed. Elsevier, 2020"
  },
  "soft-tissue-sarcoma": {
    "zh": "軟組織肉瘤",
    "en": "Soft Tissue Sarcoma",
    "definition": "源自間葉組織的一群惡性腫瘤統稱，包括纖維肉瘤、血管周細胞瘤、神經鞘瘤、脂肪肉瘤等。具有局部侵襲性強但轉移率相對較低的共同生物行為。",
    "synonyms": [
      "STS",
      "Fibrosarcoma",
      "Perivascular Wall Tumor",
      "Peripheral Nerve Sheath Tumor"
    ],
    "epidemiology": {
      "species": "犬較常見，貓也可發生（注意貓注射部位肉瘤）",
      "age": "中老年犬（平均9-10歲）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "大型犬種",
        "貓：注射部位肉瘤（feline injection-site sarcoma，與疫苗或注射相關）",
        "先前放射治療部位",
        "慢性異物反應"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "逐漸增大的皮下或皮膚腫塊",
        "通常無痛",
        "腫塊可能存在數週至數月才就診",
        "腫瘤增長速度可快可慢"
      ],
      "physicalExam": [
        "皮下堅實、界限看似清楚但實際有偽被膜的腫塊",
        "常位於軀幹或四肢",
        "觸診可能有一定活動度",
        "大型腫瘤可能有潰瘍",
        "觸診看似有界限但實際上有微觀浸潤",
        "區域淋巴結通常正常"
      ]
    },
    "pathophysiology": "軟組織肉瘤起源於間葉細胞，形成具有偽被膜的腫瘤。偽被膜是壓縮的腫瘤細胞和反應性纖維組織，腫瘤細胞實際延伸超出偽被膜界限。因此邊緣切除（marginal excision）復發率高。腫瘤沿筋膜平面擴展，呈指狀浸潤周圍組織。遠端轉移率與組織學分級相關。",
    "diagnosis": {
      "overview": "細針抽吸可提示間葉來源，但確定分級需組織切片。術前影像評估對手術計畫至關重要。",
      "differentials": [
        "脂肪瘤",
        "肥大細胞瘤",
        "黑色素瘤",
        "膿腫",
        "注射部位肉芽腫（貓）",
        "血管瘤/血管肉瘤"
      ],
      "initialDB": [
        "細針抽吸細胞學",
        "胸腔X光三視圖",
        "CBC、生化檢查",
        "術前切開活檢或Tru-Cut活檢（確定分級）"
      ],
      "advanced": [
        "CT/MRI（評估腫瘤範圍和制定手術計畫）",
        "組織切片分級（I-III級）",
        "手術切緣組織病理學評估"
      ]
    },
    "treatment": {
      "overview": "廣泛手術切除是首選治療，切緣至少3 cm且包含深層筋膜。不完全切除需追加放射治療或再次手術。",
      "acute": [
        "廣泛手術切除（邊界3 cm，深層需含一層完整筋膜平面）",
        "四肢腫瘤可能需截肢",
        "貓注射部位肉瘤需極廣泛切除（邊界5 cm）"
      ],
      "chronic": [
        "不完全切除：放射治療（降低復發率）",
        "高分級腫瘤（III級）：輔助化療（doxorubicin±cyclophosphamide）",
        "metronomic化療（low-dose cyclophosphamide）可用於預防轉移",
        "復發腫瘤：再次廣泛切除±放射治療"
      ]
    },
    "prognosis": "取決於組織學分級和手術切緣。完全切除的I級腫瘤：復發率<10%，轉移率<10%。III級腫瘤：復發率高，轉移率約50%。首次手術即達成廣泛切除的結果遠優於多次切除。",
    "pearls": [
      "第一刀最重要：首次手術即應以廣泛切除為目標",
      "外觀界限清楚≠不需要廣泛切緣，偽被膜外有微觀浸潤",
      "術前CT/MRI對四肢腫瘤的手術計畫極為重要",
      "貓注射部位肉瘤生物行為極具侵襲性，需比犬STS更激進的手術",
      "皮下腫塊如果堅實、固定、且快速增長，應盡早採樣"
    ],
    "diagnosticAlgorithm": {
      "title": "軟組織肉瘤 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估腫塊位置、大小、活動度、生長速度",
          "findings": [
            "皮下或深層軟組織腫塊",
            "腫塊質地firm，通常附著深層組織",
            "生長速度中等",
            "一般不疼痛除非壓迫神經"
          ]
        },
        {
          "step": 2,
          "action": "細針抽吸細胞學",
          "details": "腫塊細針抽吸，初步細胞學分類",
          "findings": [
            "梭形細胞群",
            "細胞外基質存在",
            "難以僅靠細胞學區分良惡性",
            "建議組織生檢確診"
          ]
        },
        {
          "step": 3,
          "action": "切開生檢與影像學",
          "details": "Tru-cut或切開生檢取得組織學診斷，CT/MRI評估腫瘤邊界",
          "findings": [
            "組織學分級（I-III級）",
            "有絲分裂指數與壞死比例",
            "CT/MRI確認腫瘤侵犯範圍",
            "手術可行性評估"
          ]
        },
        {
          "step": 4,
          "action": "分期與治療計劃",
          "details": "三視圖胸腔X光、區域淋巴結評估，制定多模式治療計劃",
          "findings": [
            "遠端轉移率約15-40%（依分級）",
            "局部復發率高（切緣不足時）",
            "需要3cm以上手術邊界",
            "考慮術後放射線治療"
          ]
        }
      ]
    },
    "monitoring": [
      "術後每3個月局部檢查和胸腔X光（前2年）",
      "之後每6個月追蹤",
      "III級腫瘤更頻繁追蹤",
      "貓注射部位肉瘤：密切追蹤，復發率高"
    ],
    "reference": "Withrow SJ, Vail DM, Page RL: Withrow and MacEwen's Small Animal Clinical Oncology, 6th Ed. Elsevier, 2020"
  },
  "feline-herpesvirus": {
    "zh": "貓疱疹病毒感染",
    "en": "Feline Herpesvirus Infection",
    "definition": "由第一型貓疱疹病毒（FHV-1）引起的高度傳染性上呼吸道感染，是貓上呼吸道疾病最主要的病原之一。感染後終生成為潛伏帶原者。",
    "synonyms": [
      "Feline Viral Rhinotracheitis",
      "FVR",
      "FHV-1 Infection"
    ],
    "epidemiology": {
      "species": "貓",
      "age": "幼貓最易感（6週-6月齡），但任何年齡均可感染",
      "sex": "無性別傾向",
      "riskFactors": [
        "多貓環境（收容所、繁殖場）",
        "未接種疫苗",
        "緊迫（轉換環境、手術、新貓加入）",
        "免疫抑制（FIV/FeLV感染）",
        "擁擠和通風不良環境"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "打噴嚏、鼻分泌物（漿液性→黏膿性）",
        "流淚、眼分泌物",
        "食慾下降、精神沉鬱",
        "發燒",
        "近期有緊迫事件或新環境接觸史",
        "帶原貓在緊迫後復發"
      ],
      "physicalExam": [
        "漿液性到黏膿性鼻分泌物和眼分泌物",
        "結膜充血和化學性結膜炎",
        "角膜樹枝狀潰瘍（dendritic ulcer，特徵性）",
        "口腔潰瘍（較FCV少見）",
        "發燒（39.5-40.5°C）",
        "脫水（因食慾差和發燒）",
        "幼貓可能出現肺炎"
      ]
    },
    "pathophysiology": "FHV-1經直接接觸（鼻、口、眼分泌物）或飛沫傳播。病毒在上呼吸道和結膜上皮細胞中複製，造成細胞壞死和炎症反應。急性感染後，病毒潛伏於三叉神經節，約80%感染貓成為終生帶原者。緊迫或免疫抑制可誘發病毒再活化。角膜病變是免疫介導和病毒直接損傷的結合。",
    "diagnosis": {
      "overview": "多數根據臨床表現即可推定診斷。樹枝狀角膜潰瘍幾乎為FHV-1特徵性病變。",
      "differentials": [
        "貓杯狀病毒感染",
        "貓衣原體感染",
        "貓支原體感染",
        "貓博德特菌感染"
      ],
      "initialDB": [
        "臨床表現評估",
        "眼科檢查（螢光素染色評估角膜潰瘍）",
        "FeLV/FIV檢測（評估免疫狀態）"
      ],
      "advanced": [
        "結膜或鼻腔拭子PCR檢測（最敏感）",
        "病毒分離（敏感度較低）",
        "注意：帶原貓PCR也可能陽性，需結合臨床判斷"
      ]
    },
    "treatment": {
      "overview": "以支持療法為主，控制繼發細菌感染，嚴重眼部病變需積極眼科治療。",
      "acute": [
        "支持療法：維持水分和營養攝入",
        "鼻塞嚴重時蒸氣吸入或生理食鹽水霧化",
        "繼發細菌感染：doxycycline 5 mg/kg PO BID 或 amoxicillin-clavulanate",
        "眼部：外用抗病毒眼藥（cidofovir 0.5% BID 或 idoxuridine）",
        "L-lysine 250-500 mg PO BID（證據有爭議但仍常使用）",
        "嚴重食慾不振：appetite stimulant（mirtazapine）或鼻胃管/食道胃管"
      ],
      "chronic": [
        "Famciclovir 90 mg/kg PO BID（慢性或反覆發作型）",
        "慢性角膜後遺症管理",
        "環境緊迫管理減少復發",
        "多貓家庭的隔離和衛生管理",
        "定期疫苗接種（無法預防感染但可減輕症狀）"
      ]
    },
    "prognosis": "免疫功能正常的成貓多在2-4週內自行恢復。幼貓或免疫抑制貓可能發生嚴重肺炎而致死。角膜後遺症（角膜黑壞死、慢性基質性角膜炎）可能導致永久視力損害。約80%感染貓成為終生帶原者，可間歇性排毒。",
    "pearls": [
      "樹枝狀角膜潰瘍幾乎為FHV-1的病徵特徵",
      "約80%感染貓成為終生潛伏帶原者",
      "緊迫是復發的主要誘因",
      "Famciclovir是目前犬貓可用最有效的口服抗疱疹藥",
      "疫苗無法預防感染但可顯著減輕臨床症狀",
      "貓角膜黑壞死（corneal sequestrum）與FHV-1高度相關"
    ],
    "diagnosticAlgorithm": {
      "title": "貓疱疹病毒感染 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估上呼吸道症狀與眼部表現，詢問疫苗史與壓力事件",
          "findings": [
            "打噴嚏與漿液性至膿性鼻分泌物",
            "結膜炎伴眼分泌物",
            "發燒與精神沉鬱",
            "角膜潰瘍（樹枝狀潰瘍為特徵）"
          ]
        },
        {
          "step": 2,
          "action": "眼科檢查",
          "details": "螢光素染色評估角膜完整性，裂隙燈檢查角膜深層病變",
          "findings": [
            "樹枝狀角膜潰瘍（特徵性）",
            "點狀角膜炎",
            "角膜基質炎（慢性）",
            "嗜酸性角膜炎"
          ]
        },
        {
          "step": 3,
          "action": "實驗室確診",
          "details": "結膜/咽喉拭子PCR檢測，必要時進行病毒分離",
          "findings": [
            "FHV-1 PCR陽性",
            "注意潛伏感染者PCR可能假陰性",
            "結膜細胞學見包涵體（早期）",
            "排除FCV共感染"
          ]
        },
        {
          "step": 4,
          "action": "慢性病例評估",
          "details": "慢性或復發病例評估免疫功能與共病",
          "findings": [
            "FIV/FeLV檢測",
            "慢性鼻竇炎評估",
            "嗜酸性角膜炎鑑別",
            "壓力因素識別與管理"
          ]
        }
      ]
    },
    "monitoring": [
      "急性期每日監測呼吸、食慾和體溫",
      "角膜潰瘍患者每週眼科追蹤直至癒合",
      "帶原貓在緊迫事件前後密切觀察",
      "多貓環境的疫苗計畫"
    ],
    "reference": "Sykes JE: Canine and Feline Infectious Diseases. Elsevier, 2014"
  },
  "feline-calicivirus": {
    "zh": "貓杯狀病毒感染",
    "en": "Feline Calicivirus Infection",
    "definition": "由貓杯狀病毒（FCV）引起的傳染性疾病，主要導致口腔潰瘍和上呼吸道症狀。毒力變異株（VS-FCV）可引起全身性致死性疾病。",
    "synonyms": [
      "FCV Infection",
      "Feline Caliciviral Disease"
    ],
    "epidemiology": {
      "species": "貓",
      "age": "幼貓最易感，但任何年齡均可感染",
      "sex": "無性別傾向",
      "riskFactors": [
        "多貓環境（收容所、繁殖場）",
        "未接種疫苗",
        "緊迫",
        "幼貓移行抗體下降期（6-12週齡）",
        "帶原貓持續排毒"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "口腔疼痛導致食慾下降",
        "流涎",
        "打噴嚏、鼻分泌物",
        "跛行（短暫性多發關節炎，幼貓）",
        "VS-FCV：高燒、黃疸、水腫、多器官衰竭"
      ],
      "physicalExam": [
        "口腔潰瘍（舌頭、硬顎，為特徵性表現）",
        "漿液性到黏膿性鼻和眼分泌物",
        "發燒",
        "跛行型：多關節腫脹和疼痛",
        "VS-FCV：皮膚水腫（特別是面部和四肢）、黃疸、皮膚潰瘍"
      ]
    },
    "pathophysiology": "FCV經直接接觸或氣溶膠傳播，在口咽部上皮細胞複製導致細胞壞死形成潰瘍。病毒有高度抗原變異性，不同毒株的毒力差異大。VS-FCV感染全身血管內皮細胞，導致DIC樣的全身性血管炎和多器官衰竭。約10-30%臨床康復貓成為慢性帶原者，持續從口咽部排毒。",
    "diagnosis": {
      "overview": "根據臨床表現（口腔潰瘍為主要線索）推定診斷，PCR確診。",
      "differentials": [
        "貓疱疹病毒感染",
        "貓慢性牙齦口炎",
        "貓衣原體感染",
        "腎衰竭導致的口腔潰瘍",
        "腐蝕性化學物質接觸"
      ],
      "initialDB": [
        "臨床表現評估",
        "口腔檢查",
        "FeLV/FIV檢測"
      ],
      "advanced": [
        "口咽拭子RT-PCR",
        "VS-FCV疑似：CBC（白血球減少、血小板減少）、生化（肝指數升高）、凝血檢測",
        "病毒分離"
      ]
    },
    "treatment": {
      "overview": "支持療法為主，控制繼發感染，維持營養。VS-FCV需積極支持治療。",
      "acute": [
        "支持療法：靜脈輸液維持水分",
        "疼痛管理：buprenorphine 0.01-0.02 mg/kg SL TID",
        "繼發感染：廣效抗生素（amoxicillin-clavulanate、doxycycline）",
        "食慾促進：mirtazapine、加溫食物增加氣味",
        "嚴重食慾不振：食道胃管放置",
        "VS-FCV：積極輸液、新鮮冷凍血漿、廣效抗生素"
      ],
      "chronic": [
        "慢性帶原管理",
        "多貓家庭隔離和衛生措施",
        "定期疫苗接種",
        "慢性口炎可能與FCV持續感染相關"
      ]
    },
    "prognosis": "一般FCV感染：免疫正常成貓多在1-2週康復，預後良好。幼貓可能較嚴重。VS-FCV：死亡率高達50-67%，即使已接種疫苗的成貓也可受影響。跛行型通常自限性，數天內改善。",
    "pearls": [
      "口腔潰瘍是FCV與FHV-1最重要的鑑別特徵",
      "跛行型FCV常在疫苗接種後出現，為自限性",
      "VS-FCV是獸醫急症，需嚴格隔離防控",
      "FCV抗原變異大，疫苗無法提供完全保護",
      "慢性口炎的治療反應與FCV帶原狀態相關"
    ],
    "diagnosticAlgorithm": {
      "title": "貓杯狀病毒感染 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估口腔與上呼吸道症狀，注意口腔潰瘍為特徵表現",
          "findings": [
            "口腔潰瘍（舌頭/硬顎/嘴唇）",
            "流涎",
            "打噴嚏與鼻分泌物",
            "跛行（病毒相關多發性關節炎）"
          ]
        },
        {
          "step": 2,
          "action": "臨床分型",
          "details": "區分典型感染與高毒力全身性感染（VS-FCV）",
          "findings": [
            "典型型：口腔潰瘍+URI",
            "VS-FCV：全身水腫、皮膚潰瘍",
            "VS-FCV：黃疸、出血傾向",
            "VS-FCV：高死亡率（>50%）"
          ]
        },
        {
          "step": 3,
          "action": "實驗室檢查",
          "details": "口腔/咽喉拭子RT-PCR或病毒分離，血液檢查評估全身狀態",
          "findings": [
            "FCV RT-PCR陽性",
            "注意：健康帶原者也可能陽性",
            "血液學：白血球減少或正常",
            "VS-FCV：肝腎功能異常、DIC"
          ]
        },
        {
          "step": 4,
          "action": "鑑別診斷",
          "details": "與其他上呼吸道病原及口腔疾病鑑別",
          "findings": [
            "FHV-1鑑別（角膜潰瘍較常見於FHV）",
            "慢性牙齦口炎鑑別",
            "免疫媒介性疾病排除",
            "腐蝕性物質攝入排除"
          ]
        }
      ]
    },
    "monitoring": [
      "急性期每日監測食慾、口腔症狀和體溫",
      "VS-FCV：持續監測凝血功能和器官功能",
      "多貓環境的疫病監控和隔離措施"
    ],
    "reference": "Sykes JE: Canine and Feline Infectious Diseases. Elsevier, 2014"
  },
  "feline-panleukopenia": {
    "zh": "貓泛白血球減少症",
    "en": "Feline Panleukopenia",
    "definition": "由貓泛白血球減少症病毒（FPV，貓小病毒）引起的高度傳染性且致命率高的疾病，主要影響幼貓。病毒攻擊快速分裂的細胞，導致嚴重白血球減少和腸炎。",
    "synonyms": [
      "Feline Parvovirus",
      "Feline Distemper",
      "Feline Infectious Enteritis",
      "FPV"
    ],
    "epidemiology": {
      "species": "貓（特別是幼貓）",
      "age": "3-5月齡幼貓最易感（移行抗體下降期）",
      "sex": "無性別傾向",
      "riskFactors": [
        "未接種疫苗",
        "幼貓",
        "收容所環境",
        "病毒在環境中可存活超過1年",
        "免疫抑制",
        "同時感染FeLV或FIV"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "急性發燒、嗜睡、食慾廢絕",
        "嘔吐（常為首發症狀）",
        "腹瀉（水樣到出血性）",
        "脫水迅速惡化",
        "可能有疫苗接種不完全或未接種的歷史",
        "超急性型可在無腸胃症狀下猝死"
      ],
      "physicalExam": [
        "嚴重脫水和精神沉鬱",
        "腹部觸診疼痛",
        "腸管觸診可能增厚或充液",
        "發燒（早期）或低體溫（後期休克）",
        "口腔黏膜蒼白或充血",
        "毛髮粗糙"
      ]
    },
    "pathophysiology": "FPV經糞口途徑傳播，病毒極為穩定可在環境中存活超過1年。病毒靶向快速分裂的細胞：腸道隱窩上皮（導致絨毛萎縮和腹瀉）、骨髓造血前驅細胞（導致泛白血球減少，特別是嗜中性球減少）、淋巴組織（免疫抑制）。子宮內或新生兒感染可導致小腦發育不全。腸道屏障破壞加上免疫抑制易致繼發敗血症。",
    "diagnosis": {
      "overview": "根據臨床症狀結合嚴重白血球減少症高度提示。犬小病毒糞便快篩可用於FPV檢測。",
      "differentials": [
        "其他腸道感染（沙門氏菌、曲狀桿菌）",
        "腸道異物",
        "中毒",
        "FeLV相關腸病",
        "腸套疊"
      ],
      "initialDB": [
        "CBC（白血球減少是關鍵發現，WBC常<2000/μL）",
        "生化和電解質（低鉀、低白蛋白、低血糖）",
        "犬小病毒糞便抗原快篩（對FPV交叉反應）",
        "FeLV/FIV檢測"
      ],
      "advanced": [
        "糞便PCR（最敏感的確診方法）",
        "腹部超音波（腸壁變化評估）",
        "血液培養（疑似敗血症時）"
      ]
    },
    "treatment": {
      "overview": "無特異性抗病毒藥，以積極支持療法為主。早期積極治療可顯著改善存活率。",
      "acute": [
        "積極靜脈輸液（糾正脫水和電解質失衡）",
        "止吐劑：maropitant 1 mg/kg SC q24h、ondansetron 0.1-0.2 mg/kg IV",
        "廣效靜脈抗生素（ampicillin-sulbactam + enrofloxacin 或 metronidazole）預防/治療敗血症",
        "低血糖矯正：葡萄糖添加至輸液",
        "低血鉀矯正：KCl添加至輸液",
        "嚴重貧血或低白蛋白：新鮮冷凍血漿或全血輸血",
        "NPO直至嘔吐停止，盡早恢復腸道營養"
      ],
      "chronic": [
        "康復期逐步恢復飲食（小量多餐高消化性食物）",
        "環境徹底消毒（漂白水1:32稀釋有效）",
        "康復貓可能排毒數週",
        "確保後續疫苗接種"
      ]
    },
    "prognosis": "未治療的幼貓死亡率高達90%。經積極支持治療，存活率可提升至50-80%。WBC<1000/μL預後較差。存活過前5天的幼貓通常可康復。成貓通常症狀較輕。",
    "pearls": [
      "WBC計數是最重要的預後指標，<1000/μL預後差",
      "犬CPV糞便快篩可用於FPV檢測但近期疫苗接種可能偽陽性",
      "環境消毒極重要，FPV可在環境中存活>1年",
      "子宮內感染可導致小腦發育不全（意向性震顫）",
      "疫苗預防極為有效，核心疫苗之一",
      "存活貓通常獲得長期免疫"
    ],
    "diagnosticAlgorithm": {
      "title": "貓泛白血球減少症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估嘔吐/腹瀉/脫水程度，詢問疫苗史、年齡（幼貓高風險）",
          "findings": [
            "急性嘔吐與出血性腹瀉",
            "嚴重脫水與精神極度沉鬱",
            "發燒後期轉低溫",
            "腹部觸診：腸管增厚、疼痛"
          ]
        },
        {
          "step": 2,
          "action": "血液學檢查",
          "details": "全血球計數為最重要的初步診斷工具",
          "findings": [
            "全白血球減少（<2000/μL為典型）",
            "淋巴球減少最先出現",
            "嗜中性球減少（感染風險指標）",
            "貧血與血小板減少（嚴重時）"
          ]
        },
        {
          "step": 3,
          "action": "快速抗原檢測",
          "details": "糞便犬小病毒SNAP快篩（交叉反應可用於FPV檢測）",
          "findings": [
            "糞便Parvo SNAP陽性",
            "注意：疫苗接種後5-12天可能假陽性",
            "低排毒量時可能假陰性",
            "配合臨床症狀與血液學綜合判斷"
          ]
        },
        {
          "step": 4,
          "action": "支持治療與監測",
          "details": "確認併發症，建立積極支持治療計劃",
          "findings": [
            "血糖監測（低血糖常見）",
            "電解質異常（低血鉀）",
            "繼發性細菌感染（敗血症風險）",
            "腸套疊排除（超音波）"
          ]
        }
      ]
    },
    "monitoring": [
      "每6-12小時監測：體重、水分狀態、電解質、血糖",
      "每日CBC追蹤白血球恢復",
      "體溫監測（低體溫提示預後不佳）",
      "嘔吐和腹瀉頻率記錄"
    ],
    "reference": "Sykes JE: Canine and Feline Infectious Diseases. Elsevier, 2014"
  },
  "kennel-cough": {
    "zh": "犬傳染性呼吸道疾病",
    "en": "Canine Infectious Respiratory Disease Complex (Kennel Cough)",
    "definition": "由多種病原（病毒和細菌）單獨或混合感染引起的高度傳染性呼吸道疾病複合體。最常見病原為犬副流感病毒（CPIV）和支氣管博德特菌（Bordetella bronchiseptica）。",
    "synonyms": [
      "Kennel Cough",
      "Infectious Tracheobronchitis",
      "CIRDC",
      "Canine Cough"
    ],
    "epidemiology": {
      "species": "犬",
      "age": "任何年齡，幼犬和老年犬症狀較重",
      "sex": "無性別傾向",
      "riskFactors": [
        "犬舍、寄宿、犬展、狗公園等群聚環境",
        "未接種疫苗",
        "緊迫和運輸",
        "免疫功能不全的幼犬或老年犬",
        "環境通風不良"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "突發性乾咳，似「鵝叫」聲",
        "咳嗽陣發性，可被運動、興奮或頸部壓迫誘發",
        "可能有近期犬舍寄宿或群聚接觸史",
        "大部分精神食慾正常（單純型）",
        "複雜型：精神沉鬱、食慾差、發燒"
      ],
      "physicalExam": [
        "氣管觸診敏感（tracheal pinch test陽性）",
        "單純型：體溫正常，其餘理學檢查正常",
        "複雜型：發燒、黏膿性鼻分泌物",
        "肺部聽診：單純型通常正常，複雜型可有粗糙呼吸音或囉音",
        "扁桃體可能腫大"
      ]
    },
    "pathophysiology": "多種病原協同作用：病毒（CPIV、犬腺病毒2型、犬呼吸道冠狀病毒、犬流感病毒）先破壞呼吸道纖毛上皮屏障，隨後細菌（B. bronchiseptica、支原體）繼發感染。B. bronchiseptica也可作為原發病原。病原經氣溶膠和直接接觸傳播，潛伏期3-10天。纖毛功能損傷導致黏膜清除功能下降，增加繼發細菌性肺炎風險。",
    "diagnosis": {
      "overview": "多數根據臨床表現和群聚接觸史推定診斷。複雜型需排除肺炎。",
      "differentials": [
        "犬心絲蟲病",
        "心臟病導致咳嗽",
        "氣管塌陷",
        "異物吸入",
        "肺腫瘤",
        "真菌性肺炎"
      ],
      "initialDB": [
        "病史和理學檢查",
        "胸腔X光（排除肺炎，單純型通常正常）",
        "CBC（複雜型可見白血球升高）"
      ],
      "advanced": [
        "氣管沖洗液細胞學和培養",
        "呼吸道病原PCR panel",
        "犬流感病毒抗體或PCR檢測",
        "支氣管鏡檢查（慢性病例）"
      ]
    },
    "treatment": {
      "overview": "單純型多為自限性，7-14天自行恢復。複雜型需抗生素治療。",
      "acute": [
        "單純型：休息、避免頸圈壓迫（改用胸背帶）",
        "止咳藥（hydrocodone 0.22 mg/kg PO BID-TID，僅限非生產性乾咳）",
        "抗生素（複雜型或高風險犬）：doxycycline 5 mg/kg PO BID 10-14天",
        "嚴重病例：amoxicillin-clavulanate或基於培養結果選擇",
        "霧化治療輔助",
        "環境加濕"
      ],
      "chronic": [
        "慢性咳嗽超過2週需進一步檢查排除其他病因",
        "確認疫苗接種狀態並更新",
        "多犬環境的隔離管理（隔離感染犬至少2週）"
      ]
    },
    "prognosis": "單純型預後極佳，多數7-14天自行康復。複雜型（繼發肺炎）需較長治療但預後通常仍良好。幼犬或免疫抑制犬可能發展為致命的支氣管肺炎。",
    "pearls": [
      "最常見的門診咳嗽原因之一",
      "止咳藥僅用於乾咳影響生活品質時，有分泌物時不應抑制咳嗽",
      "Doxycycline對Bordetella和Mycoplasma均有效，為首選抗生素",
      "疫苗預防（鼻內或注射型）可減輕但不能完全預防感染",
      "犬流感病毒（H3N8、H3N2）是近年需注意的新興病原",
      "群聚暴發時需嚴格隔離和環境消毒"
    ],
    "diagnosticAlgorithm": {
      "title": "犬傳染性呼吸道疾病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "詢問接觸史（犬舍/寄宿/狗公園），評估咳嗽型態",
          "findings": [
            "急性發作的乾咳或鵝鳴樣咳嗽",
            "近期群居接觸史",
            "氣管觸診誘咳陽性",
            "一般精神食慾尚可"
          ]
        },
        {
          "step": 2,
          "action": "理學檢查與初步排除",
          "details": "完整理學檢查排除其他咳嗽原因",
          "findings": [
            "體溫正常或輕度升高",
            "肺音通常正常",
            "漿液性至黏液膿性鼻分泌物",
            "排除心臟雜音"
          ]
        },
        {
          "step": 3,
          "action": "進階檢查（複雜病例）",
          "details": "症狀持續超過10-14天或惡化時進行進階檢查",
          "findings": [
            "胸腔X光排除肺炎",
            "CBC評估白血球變化",
            "呼吸道PCR面板（Bordetella/CPiV/CIV/Mycoplasma）",
            "氣管灌洗液細胞學與培養"
          ]
        },
        {
          "step": 4,
          "action": "併發症監測",
          "details": "監測是否進展為支氣管肺炎",
          "findings": [
            "持續發燒不退",
            "呼吸急促或呼吸困難",
            "肺部囉音",
            "食慾下降與精神沉鬱加重"
          ]
        }
      ]
    },
    "monitoring": [
      "7-10天後評估症狀改善",
      "持續咳嗽超過2週需進一步檢查",
      "群聚環境監控其他犬隻發病",
      "嚴重病例監測呼吸頻率和體溫"
    ],
    "reference": "Greene CE: Infectious Diseases of the Dog and Cat, 4th Ed. Elsevier, 2012"
  },
  "hookworm": {
    "zh": "鉤蟲感染",
    "en": "Hookworm Infection",
    "definition": "由鉤蟲（主要為犬鉤蟲 Ancylostoma caninum、巴西鉤蟲 A. braziliense、狹頭鉤蟲 Uncinaria stenocephala）感染引起的腸道寄生蟲病。成蟲附著於小腸壁吸血，可導致嚴重貧血，特別是幼犬。",
    "synonyms": [
      "Ancylostomiasis",
      "Hookworm Disease"
    ],
    "epidemiology": {
      "species": "犬較常見，貓也可感染（A. tubaeforme）",
      "age": "幼犬最嚴重（經胎盤和乳汁感染），成犬通常症狀較輕",
      "sex": "無性別傾向",
      "riskFactors": [
        "溫暖潮濕環境",
        "衛生條件差",
        "群養犬（犬舍、收容所）",
        "未定期驅蟲",
        "幼犬經胎盤或乳汁感染",
        "皮膚接觸受汙染土壤（經皮感染）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "幼犬：急性貧血、黑色糊狀糞便",
        "慢性感染：體重不增、被毛粗糙",
        "成犬：可能無症狀或輕度腹瀉",
        "飼主可能注意到足墊刺激（皮膚幼蟲移行）"
      ],
      "physicalExam": [
        "幼犬：黏膜蒼白（貧血）",
        "脫水",
        "消瘦和發育不良",
        "糞便黑色（melena）或暗色糊狀",
        "嚴重感染：低蛋白血症導致水腫",
        "成犬可能理學檢查正常"
      ]
    },
    "pathophysiology": "鉤蟲成蟲以口囊咬附小腸黏膜，分泌抗凝血物質持續吸血。每隻犬鉤蟲每天吸血約0.1-0.2 mL。大量感染時失血量可引起嚴重缺鐵性貧血。幼蟲可經口、經皮或經胎盤/乳汁傳播。體內幼蟲可在組織中休眠（somatic migration），懷孕時被活化經胎盤傳給胎兒。人畜共通：皮膚幼蟲移行症（cutaneous larva migrans）。",
    "diagnosis": {
      "overview": "糞便漂浮法檢出蟲卵為標準診斷。幼犬急性感染時可能蟲卵陰性（成蟲尚未成熟）。",
      "differentials": [
        "蛔蟲感染",
        "鞭蟲感染",
        "球蟲感染",
        "梨形鞭毛蟲",
        "腸道病毒感染",
        "出血性胃腸炎"
      ],
      "initialDB": [
        "糞便漂浮法鏡檢蟲卵",
        "CBC（再生性貧血、嗜酸性球增多）",
        "糞便潛血試驗",
        "血清總蛋白和白蛋白"
      ],
      "advanced": [
        "糞便PCR（鑑別蟲種）",
        "幼犬急性嚴重貧血時直接處理不等確診"
      ]
    },
    "treatment": {
      "overview": "驅蟲藥治療有效。幼犬嚴重貧血需支持療法。預防性定期驅蟲很重要。",
      "acute": [
        "驅蟲藥：fenbendazole 50 mg/kg PO q24h 3天",
        "或 pyrantel pamoate 5-10 mg/kg PO（2-3週後重複）",
        "或 milbemycin oxime（按體重劑量）",
        "幼犬嚴重貧血：輸血",
        "靜脈輸液和營養支持",
        "補充鐵劑"
      ],
      "chronic": [
        "每月預防性驅蟲（含有鉤蟲預防成分的心絲蟲預防藥）",
        "幼犬：2週齡起每2週驅蟲至8週齡，之後每月一次",
        "妊娠母犬：懷孕第40天起每日 fenbendazole 至產後2天",
        "環境管理：清除糞便、保持乾燥",
        "人畜共通防護教育"
      ]
    },
    "prognosis": "及時治療預後良好。幼犬未治療的嚴重急性感染可致死。慢性感染可能導致發育遲緩。定期預防性驅蟲可有效控制。",
    "pearls": [
      "幼犬急性鉤蟲感染是真正的急診，可在數天內致死",
      "胎盤傳播意味著幼犬出生時即可感染",
      "糞便檢查陰性不能排除（潛伏期蟲卵尚未排出）",
      "人畜共通：飼主赤腳接觸受汙染環境可得皮膚幼蟲移行症",
      "心絲蟲預防藥多數含有鉤蟲預防成分，每月使用可同時預防"
    ],
    "diagnosticAlgorithm": {
      "title": "鉤蟲感染 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估貧血徵象、營養狀態，詢問驅蟲史與生活環境",
          "findings": [
            "黏膜蒼白（貧血）",
            "黑色柏油便或血便",
            "體重減輕與發育遲緩（幼犬）",
            "皮膚幼蟲移行症（足部皮膚炎）"
          ]
        },
        {
          "step": 2,
          "action": "糞便寄生蟲學檢查",
          "details": "糞便浮游法檢查蟲卵，必要時連續3天採樣",
          "findings": [
            "典型鉤蟲卵（橢圓形、薄殼、含胚細胞）",
            "蟲卵計數評估感染程度",
            "注意：幼犬急性感染可能尚未排卵",
            "幼犬嚴重貧血時蟲卵可能陰性"
          ]
        },
        {
          "step": 3,
          "action": "血液學檢查",
          "details": "全血球計數評估貧血程度與類型",
          "findings": [
            "缺鐵性小球性低色素貧血",
            "嗜酸性球增多",
            "低白蛋白血症",
            "血容比顯著下降（嚴重感染）"
          ]
        }
      ]
    },
    "monitoring": [
      "治療後2-4週重複糞便檢查確認清除",
      "幼犬貧血恢復監測（PCV追蹤）",
      "每年例行糞便檢查",
      "確認預防性驅蟲計畫的執行"
    ],
    "reference": "Bowman DD: Georgis' Parasitology for Veterinarians, 11th Ed. Elsevier, 2021"
  },
  "roundworm": {
    "zh": "蛔蟲感染",
    "en": "Roundworm Infection",
    "definition": "由蛔蟲（犬弓首蛔蟲 Toxocara canis、貓弓首蛔蟲 T. cati、犬短首線蟲 Toxascaris leonina）引起的腸道寄生蟲病。是犬貓最常見的腸道寄生蟲之一，具有重要的人畜共通意義。",
    "synonyms": [
      "Toxocariasis",
      "Ascarid Infection"
    ],
    "epidemiology": {
      "species": "犬貓皆可",
      "age": "幼犬幼貓最常見且症狀最嚴重",
      "sex": "無性別傾向",
      "riskFactors": [
        "幼齡動物",
        "經胎盤感染（T. canis）",
        "經乳汁感染（T. canis和T. cati）",
        "未定期驅蟲",
        "接觸受汙染環境",
        "獵食行為（中間宿主如老鼠）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "幼犬幼貓：腹部膨大（pot-bellied appearance）",
        "嘔吐（可能吐出成蟲）",
        "腹瀉",
        "生長遲緩和體態消瘦",
        "被毛粗糙無光澤",
        "成年動物通常無症狀"
      ],
      "physicalExam": [
        "腹部膨脹",
        "體態評分偏低",
        "被毛品質差",
        "可能在嘔吐物或糞便中見到白色長條狀成蟲（10-15 cm）",
        "嚴重感染：脫水和黏膜蒼白"
      ]
    },
    "pathophysiology": "T. canis幼蟲經口攝入後穿透腸壁，經肝臟和肺臟進行肝肺移行（hepato-tracheal migration），最終回到小腸發育為成蟲。在成犬體內，幼蟲傾向進行體內移行（somatic migration）而停留在組織中休眠，懷孕時被活化經胎盤傳給胎兒。蛔蟲卵在環境中極為耐久，可存活數年。人畜共通：兒童誤食蟲卵可導致內臟幼蟲移行症（VLM）或眼幼蟲移行症（OLM）。",
    "diagnosis": {
      "overview": "糞便漂浮法檢出蟲卵為標準方法。幼犬經胎盤感染者可在糞便排卵前即出現症狀。",
      "differentials": [
        "鉤蟲感染",
        "球蟲感染",
        "梨形鞭毛蟲",
        "腸道異物",
        "腸套疊（大量蟲體時）"
      ],
      "initialDB": [
        "糞便漂浮法鏡檢（蟲卵為球形、深色、表面粗糙）",
        "直接目視成蟲（嘔吐物或糞便中）"
      ],
      "advanced": [
        "糞便PCR鑑別蟲種",
        "腹部X光（大量蟲體時可見腸腔內軟組織密度影像）"
      ]
    },
    "treatment": {
      "overview": "多種驅蟲藥有效，幼犬需重複驅蟲以清除組織中持續活化的幼蟲。",
      "acute": [
        "Pyrantel pamoate 5-10 mg/kg PO（安全，可用於2週齡幼犬）",
        "Fenbendazole 50 mg/kg PO q24h 3天",
        "嚴重腸阻塞（蟲團）：可能需手術",
        "支持療法：營養補充和脫水矯正"
      ],
      "chronic": [
        "幼犬：2週齡起每2週驅蟲至8週齡，之後每月一次至6月齡",
        "幼貓：3週齡起同樣方案",
        "成年動物：至少每3個月驅蟲一次或每月預防",
        "妊娠母犬：fenbendazole 25 mg/kg/day 從懷孕第40天至產後14天",
        "環境清潔：及時清除糞便減少蟲卵汙染"
      ]
    },
    "prognosis": "預後極佳，驅蟲藥對成蟲高度有效。但組織中休眠幼蟲需重複驅蟲。嚴重感染的幼犬偶可因蟲團導致腸阻塞。",
    "pearls": [
      "幾乎所有幼犬出生時即帶有T. canis（經胎盤感染）",
      "蟲卵在環境中可存活數年，常規清潔無法清除",
      "人畜共通風險高：兒童遊樂場汙染是公共衛生問題",
      "糞便中的蟲卵需2-4週才具感染力（發育至L3幼蟲）",
      "預防性驅蟲比治療性驅蟲更重要"
    ],
    "diagnosticAlgorithm": {
      "title": "蛔蟲感染 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估營養狀態與消化道症狀，詢問驅蟲史",
          "findings": [
            "腹部膨大（幼犬貓常見）",
            "嘔吐（可能吐出蟲體）",
            "腹瀉或便中見蟲體",
            "被毛粗糙、發育遲緩"
          ]
        },
        {
          "step": 2,
          "action": "糞便寄生蟲學檢查",
          "details": "糞便浮游法檢查蛔蟲卵",
          "findings": [
            "犬蛔蟲卵（圓形、厚殼、表面粗糙）",
            "貓蛔蟲卵（類似但稍小）",
            "大量蟲卵提示重度感染",
            "嘔吐物或糞便中可見成蟲（10-15cm長白色蟲體）"
          ]
        },
        {
          "step": 3,
          "action": "併發症評估",
          "details": "評估嚴重感染的併發症",
          "findings": [
            "腸阻塞（大量蟲體）",
            "膽管阻塞",
            "幼犬肺炎（幼蟲遷移）",
            "營養不良與生長遲緩"
          ]
        }
      ]
    },
    "monitoring": [
      "驅蟲後2-4週重複糞便檢查",
      "幼犬定期體重監測確認正常生長",
      "每年至少一次糞便寄生蟲檢查",
      "人畜共通風險教育"
    ],
    "reference": "Bowman DD: Georgis' Parasitology for Veterinarians, 11th Ed. Elsevier, 2021"
  },
  "uveitis": {
    "zh": "葡萄膜炎",
    "en": "Uveitis",
    "definition": "葡萄膜（虹膜、睫狀體、脈絡膜）的炎症。根據受影響部位分為前葡萄膜炎（虹膜炎/虹膜睫狀體炎）、後葡萄膜炎和全葡萄膜炎。是犬貓眼科常見且嚴重的疾病。",
    "synonyms": [
      "Iritis",
      "Iridocyclitis",
      "Anterior Uveitis",
      "Panuveitis"
    ],
    "epidemiology": {
      "species": "犬貓皆可",
      "age": "任何年齡",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "感染性疾病（犬：ehrlichiosis、leishmaniasis、leptospirosis；貓：FIP、FeLV、FIV、toxoplasmosis）",
        "免疫介導性疾病",
        "腫瘤（淋巴瘤最常見）",
        "晶體蛋白洩漏（白內障）",
        "創傷",
        "犬特發性葡萄膜炎"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "眼紅、流淚",
        "畏光、眨眼頻繁",
        "瞳孔縮小",
        "視力可能下降",
        "可能有全身性疾病症狀"
      ],
      "physicalExam": [
        "結膜和鞏膜充血",
        "角膜水腫（霧狀）",
        "前房閃輝（aqueous flare）",
        "瞳孔縮小（miosis）",
        "虹膜後黏連（posterior synechia）",
        "眼壓降低（<10 mmHg，為特徵性）",
        "前房積膿（hypopyon）或前房積血（hyphema）",
        "虹膜膨隆或虹膜結節",
        "晶體可能出現白內障變化"
      ]
    },
    "pathophysiology": "葡萄膜血管豐富，各種全身性疾病的免疫複合物可沉積於此。炎症導致血-房水屏障破壞，蛋白和細胞滲入前房（aqueous flare）。前列腺素釋放導致瞳孔縮小和眼壓降低。持續炎症可導致虹膜後黏連、繼發性青光眼、白內障、視網膜剝離和眼球萎縮（phthisis bulbi）。",
    "diagnosis": {
      "overview": "眼科檢查為主要診斷手段，確定原因需全身性檢查。約50-70%犬的葡萄膜炎為特發性。",
      "differentials": [
        "青光眼（需鑑別，因治療完全不同）",
        "結膜炎",
        "角膜潰瘍",
        "角膜內皮炎",
        "眼內腫瘤"
      ],
      "initialDB": [
        "完整眼科檢查（裂隙燈、眼底檢查、眼壓測量）",
        "螢光素染色（排除角膜潰瘍）",
        "CBC、生化、尿液分析",
        "犬：壁蝨傳播疾病篩檢",
        "貓：FeLV/FIV檢測、弓漿蟲抗體"
      ],
      "advanced": [
        "眼超音波（前房混濁無法檢查眼底時）",
        "前房穿刺液分析和細胞學",
        "感染性疾病完整篩檢panel",
        "胸腔X光和腹部超音波（腫瘤篩檢）",
        "貓：冠狀病毒抗體、FIP評估"
      ]
    },
    "treatment": {
      "overview": "控制眼部炎症、散瞳預防黏連、治療潛在原因。",
      "acute": [
        "外用類固醇眼藥：prednisolone acetate 1% q4-6h（無角膜潰瘍時）",
        "散瞳劑：atropine 1% q8-12h（預防虹膜後黏連）",
        "全身性NSAIDs：meloxicam（犬0.1 mg/kg，貓0.05 mg/kg）",
        "嚴重病例：全身性prednisolone 1-2 mg/kg/day",
        "外用NSAIDs眼藥（flurbiprofen、ketorolac）輔助"
      ],
      "chronic": [
        "長期低劑量外用類固醇維持治療",
        "治療潛在原因（感染性、免疫介導性、腫瘤性）",
        "監測繼發性併發症（青光眼、白內障）",
        "免疫介導性：可能需免疫抑制劑（azathioprine、cyclosporine）"
      ]
    },
    "prognosis": "取決於原因和嚴重程度。特發性和創傷性：治療反應好，預後佳。感染性：控制感染後通常改善。腫瘤性：預後較差。慢性反覆發作可導致永久性視力損害。",
    "pearls": [
      "眼壓低是前葡萄膜炎的特徵，與青光眼（眼壓高）相反",
      "務必區分葡萄膜炎和青光眼，因治療方向完全相反",
      "貓的葡萄膜炎高度提示FIP、淋巴瘤、弓漿蟲等全身性疾病",
      "Atropine散瞳可預防虹膜後黏連，是治療的關鍵",
      "犬約50-70%為特發性，但仍應進行全身性疾病篩檢",
      "角膜潰瘍時禁用外用類固醇"
    ],
    "diagnosticAlgorithm": {
      "title": "葡萄膜炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估眼部症狀，進行基本眼科檢查（對光反射、眼壓測量）",
          "findings": [
            "眼睛紅腫與疼痛（瞇眼、畏光、流淚）",
            "瞳孔縮小",
            "眼壓降低",
            "結膜與鞏膜充血"
          ]
        },
        {
          "step": 2,
          "action": "詳細眼科檢查",
          "details": "裂隙燈檢查前房、螢光素染色、眼底檢查",
          "findings": [
            "前房閃光（Aqueous flare）",
            "角膜後沉著物（KP）",
            "虹膜後黏連",
            "玻璃體混濁或視網膜病變"
          ]
        },
        {
          "step": 3,
          "action": "全身性病因調查",
          "details": "葡萄膜炎常為全身性疾病的眼部表現，需進行全面檢查",
          "findings": [
            "貓：FeLV/FIV/FIP/弓形蟲/淋巴瘤",
            "犬：Ehrlichia/Leishmania/Brucella/蜱媒疾病",
            "自體免疫性（晶體誘導性）",
            "腫瘤性（淋巴瘤/黑色素瘤）"
          ]
        },
        {
          "step": 4,
          "action": "併發症監測",
          "details": "監測慢性葡萄膜炎併發症",
          "findings": [
            "繼發性青光眼",
            "白內障形成",
            "視網膜剝離",
            "眼球萎縮（終末期）"
          ]
        }
      ]
    },
    "monitoring": [
      "治療初期每3-5天眼科追蹤",
      "眼壓定期測量（監測繼發性青光眼）",
      "長期外用類固醇需監測眼壓",
      "全身性類固醇副作用監測"
    ],
    "reference": "Maggs DJ, Miller PE, Ofri R: Slatter's Fundamentals of Veterinary Ophthalmology, 6th Ed. Elsevier, 2018"
  },
  "cherry-eye": {
    "zh": "第三眼瞼腺脫出",
    "en": "Cherry Eye (Prolapse of the Third Eyelid Gland)",
    "definition": "第三眼瞼（瞬膜）腺體的脫出，腺體從正常位置突出形成眼內角的紅色球形腫塊。常見於幼犬，可為單側或雙側。",
    "synonyms": [
      "Third Eyelid Gland Prolapse",
      "Nictitans Gland Prolapse"
    ],
    "epidemiology": {
      "species": "犬較常見，貓少見",
      "age": "多發生於2歲以下幼犬",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "短頭犬種（英國鬥牛犬、法國鬥牛犬、波士頓梗）",
        "獵犬品種（可卡犬、米格魯）",
        "紐芬蘭犬、大丹犬",
        "遺傳易感性（結締組織較弱）",
        "對側眼高復發率"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "眼內角出現紅色突起腫塊",
        "可能間歇性出現或持續性",
        "輕度流淚或眼分泌物",
        "通常無明顯疼痛",
        "可能先單側後變雙側"
      ],
      "physicalExam": [
        "眼內角光滑、紅色、球形腫塊",
        "第三眼瞼腺體暴露和充血",
        "結膜可能輕度充血",
        "觸診柔軟可推回但易復出",
        "評估是否有繼發結膜炎或乾眼症"
      ]
    },
    "pathophysiology": "第三眼瞼腺體正常由結締組織固定於眼眶骨膜。當此結締組織先天性薄弱或缺失時，腺體從正常位置脫出。暴露的腺體因機械刺激和空氣接觸而充血腫脹，使其更難自行復位。第三眼瞼腺負責產生約30-50%的淚液，切除會增加乾眼症風險。",
    "diagnosis": {
      "overview": "根據特徵性外觀即可診斷。需評估淚液產量作為基線。",
      "differentials": [
        "第三眼瞼腫瘤",
        "第三眼瞼軟骨外翻（scrolled cartilage）",
        "第三眼瞼濾泡性結膜炎",
        "眼眶腫塊推擠"
      ],
      "initialDB": [
        "眼科理學檢查",
        "Schirmer淚液試驗（STT，建立基線值）",
        "螢光素染色（排除角膜損傷）"
      ],
      "advanced": [
        "腺體細胞學或活檢（疑似腫瘤時）",
        "眼超音波（排除深部病變）"
      ]
    },
    "treatment": {
      "overview": "手術復位（tucking technique）為首選治療，保留腺體功能。不建議切除腺體。",
      "acute": [
        "手術復位：Morgan pocket technique（最常用）",
        "或 orbital rim anchoring technique",
        "術前外用抗炎藥減輕腫脹",
        "如需短期暫時處理：外用潤滑劑保護"
      ],
      "chronic": [
        "術後外用抗生素和抗炎眼藥1-2週",
        "術後佩戴伊莉莎白頸圈",
        "復發率約5-20%，可能需再次手術",
        "評估對側眼（雙側發病率高）",
        "長期監測淚液產量"
      ]
    },
    "prognosis": "手術復位成功率約80-95%。偶有復發需再次手術。保留腺體後淚液功能通常正常。切除腺體的犬約40-60%日後發展為乾眼症。",
    "pearls": [
      "絕對不要切除第三眼瞼腺體，會顯著增加乾眼症風險",
      "Morgan pocket technique是最廣泛使用的復位方法",
      "一側發生後對側發生機率高，應告知飼主",
      "短頭犬種復發率較高",
      "術前STT基線值很重要，可作為術後比較"
    ],
    "diagnosticAlgorithm": {
      "title": "第三眼瞼腺脫出 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "視診第三眼瞼區域紅色腫塊，評估單側或雙側",
          "findings": [
            "內眼角紅色圓形腫塊突出",
            "第三眼瞼腺暴露與充血",
            "結膜輕度紅腫",
            "通常不太疼痛"
          ]
        },
        {
          "step": 2,
          "action": "眼科評估",
          "details": "評估腺體大小與炎症程度，淚液分泌測試",
          "findings": [
            "Schirmer淚液試驗（基線值記錄）",
            "螢光素染色排除角膜損傷",
            "評估是否有結膜炎",
            "確認無其他眼部異常"
          ]
        },
        {
          "step": 3,
          "action": "鑑別診斷",
          "details": "排除第三眼瞼其他腫塊性病變",
          "findings": [
            "排除第三眼瞼腫瘤（淋巴瘤/腺癌）",
            "排除第三眼瞼軟骨外翻",
            "品種傾向確認（鬥牛犬/可卡犬/獵犬）",
            "老年動物腫塊建議細胞學評估"
          ]
        }
      ]
    },
    "monitoring": [
      "術後1-2週評估傷口癒合和腺體位置",
      "術後定期STT監測淚液產量",
      "觀察對側眼是否出現相同問題",
      "長期關注乾眼症跡象"
    ],
    "reference": "Maggs DJ, Miller PE, Ofri R: Slatter's Fundamentals of Veterinary Ophthalmology, 6th Ed. Elsevier, 2018"
  },
  "entropion": {
    "zh": "眼瞼內翻",
    "en": "Entropion",
    "definition": "眼瞼邊緣向內翻轉，導致睫毛和皮膚毛髮摩擦角膜和結膜，引起慢性刺激、疼痛和潛在的角膜損傷。是犬最常見的眼瞼畸形。",
    "synonyms": [
      "Eyelid Entropion",
      "Inverted Eyelid"
    ],
    "epidemiology": {
      "species": "犬較常見，貓也可發生",
      "age": "先天性/發育性：幼年發病；痙攣性/瘢痕性：任何年齡",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "短頭犬種（沙皮犬最典型）",
        "大型犬種（聖伯納、大丹犬、紐芬蘭犬）",
        "獵犬犬種（可卡犬、拉布拉多）",
        "沙皮犬（最嚴重）",
        "貓：波斯貓、緬因貓",
        "面部皮膚鬆弛的品種"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "流淚過多（epiphora）",
        "頻繁眨眼或瞇眼（blepharospasm）",
        "眼分泌物（黏液性到膿性）",
        "可能不自覺搓揉眼部",
        "幼犬可能在開眼後即出現症狀"
      ],
      "physicalExam": [
        "眼瞼邊緣向內翻轉（可為上瞼、下瞼或兩者）",
        "角膜表面可見毛髮接觸",
        "結膜充血",
        "角膜血管新生和色素沉著（慢性）",
        "角膜潰瘍（螢光素染色陽性）",
        "流淚和眼分泌物",
        "沙皮犬常合併額部皮膚皺褶壓迫"
      ]
    },
    "pathophysiology": "先天性/發育性眼瞼內翻與眼瞼形態、眼眶深度和面部結構相關的遺傳因素有關。內翻的眼瞼導致睫毛和皮膚毛髮持續摩擦角膜（trichiasis），引起機械性刺激。角膜刺激引發反射性眼瞼痙攣，進一步加重內翻（痙攣-內翻循環）。慢性摩擦導致角膜潰瘍、血管新生、色素沉著和疤痕化，最終可能影響視力。",
    "diagnosis": {
      "overview": "臨床檢查即可明確診斷。需評估內翻的原因（先天性 vs 痙攣性 vs 瘢痕性）和角膜損傷程度。",
      "differentials": [
        "睫毛倒生（distichiasis）",
        "異位睫毛（ectopic cilia）",
        "眼瞼外翻（ectropion）",
        "第三眼瞼異常",
        "角膜潰瘍的其他原因"
      ],
      "initialDB": [
        "完整眼科檢查",
        "螢光素染色（評估角膜潰瘍）",
        "Schirmer淚液試驗",
        "區分真正的結構性內翻和痙攣性內翻（局部麻醉後評估）"
      ],
      "advanced": [
        "局部麻醉點眼後重新評估（排除痙攣成分）",
        "幼犬需評估是否隨生長改善"
      ]
    },
    "treatment": {
      "overview": "手術矯正為根本治療。幼犬可暫時性固定等待面部生長穩定後再永久性矯正。",
      "acute": [
        "幼犬暫時性處置：眼瞼訂書針固定（eyelid tacking）或暫時性縫合",
        "角膜潰瘍治療：外用抗生素（ofloxacin或tobramycin q6h）",
        "潤滑劑保護角膜",
        "止痛和減輕眼瞼痙攣"
      ],
      "chronic": [
        "成犬永久性手術矯正：Hotz-Celsus手術（最常用）",
        "嚴重病例可能需合併手術技術",
        "沙皮犬可能需額部整形術（face lift）",
        "術後外用抗生素和抗炎眼藥",
        "伊莉莎白頸圈2週"
      ]
    },
    "prognosis": "手術矯正後預後極佳。適當手術後角膜病變通常改善或穩定。過度矯正可能導致醫源性眼瞼外翻。幼犬暫時性處置後可能需要成年後再永久矯正。",
    "pearls": [
      "沙皮犬幼犬可能需緊急眼瞼暫時固定以保護角膜",
      "幼犬面部尚未發育完成，不要過早進行永久性手術",
      "痙攣性眼瞼內翻需先治療原發眼部疼痛原因",
      "手術寧可輕微不足也不要過度矯正（外翻比內翻更難修復）",
      "慢性角膜色素沉著在手術矯正後可能持續改善數月"
    ],
    "diagnosticAlgorithm": {
      "title": "眼瞼內翻 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "觀察眼瞼位置與方向，評估眼部刺激症狀",
          "findings": [
            "眼瞼邊緣向內翻轉",
            "結膜充血與流淚",
            "眼睛瞇眼或痙攣",
            "黏液膿性眼分泌物"
          ]
        },
        {
          "step": 2,
          "action": "詳細眼科檢查",
          "details": "確認內翻類型、部位與嚴重程度，角膜完整性評估",
          "findings": [
            "上/下/外側眼瞼內翻定位",
            "睫毛或被毛接觸角膜",
            "螢光素染色見角膜潰瘍或磨損",
            "色素沉著性角膜炎（慢性）"
          ]
        },
        {
          "step": 3,
          "action": "病因分類與手術評估",
          "details": "區分先天性/後天性/痙攣性內翻，評估手術時機",
          "findings": [
            "先天性：品種相關（沙皮犬/鬥牛犬/鬆獅犬）",
            "痙攣性：因眼痛收縮加重",
            "後天性：體重下降/眼球內陷",
            "表面麻醉後內翻是否改善（區分痙攣性）"
          ]
        }
      ]
    },
    "monitoring": [
      "術後1-2週拆線和評估矯正效果",
      "角膜染色追蹤潰瘍癒合",
      "長期監測是否需要再次手術",
      "幼犬需在生長完成後重新評估"
    ],
    "reference": "Maggs DJ, Miller PE, Ofri R: Slatter's Fundamentals of Veterinary Ophthalmology, 6th Ed. Elsevier, 2018"
  },
  "progressive-retinal-atrophy": {
    "zh": "進行性視網膜萎縮",
    "en": "Progressive Retinal Atrophy",
    "definition": "一群遺傳性視網膜退行性疾病的統稱，特徵為光感受器（桿狀和錐狀細胞）的進行性退化，最終導致完全失明。是犬最常見的遺傳性眼疾。",
    "synonyms": [
      "PRA",
      "Generalized Progressive Retinal Atrophy",
      "Progressive Rod-Cone Degeneration"
    ],
    "epidemiology": {
      "species": "犬較常見，貓也可發生（較少見）",
      "age": "早發型（retinal dysplasia）：數月齡；晚發型（退化型）：3-5歲開始",
      "sex": "多為常染色體隱性遺傳，部分為X染色體連鎖",
      "riskFactors": [
        "品種遺傳：貴賓犬（迷你和玩具型）、可卡犬、拉布拉多、黃金獵犬",
        "愛爾蘭雪達犬（早發型）",
        "西伯利亞哈士奇（X連鎖遺傳）",
        "臘腸犬",
        "近親繁殖"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "夜盲症（nyctalopia）為最初徵兆",
        "暗處猶豫不前或撞到物品",
        "逐漸進展到日間視力喪失",
        "瞳孔看起來比以前大",
        "眼睛反光增強（tapetal hyperreflectivity）",
        "飼主可能在很晚才注意到（犬在熟悉環境中可適應良好）"
      ],
      "physicalExam": [
        "雙側瞳孔散大",
        "瞳孔對光反射遲鈍到消失（晚期）",
        "眼底檢查：視網膜血管萎細、tapetum hyperreflectivity",
        "視網膜變薄和色素變化",
        "晚期可能繼發白內障",
        "威脅反射（menace response）減弱或消失"
      ]
    },
    "pathophysiology": "PRA為一群遺傳性疾病，各有不同的基因突變但臨床表現相似。早發型（dysplasia）：光感受器發育異常，幼年即開始退化。晚發型（degeneration）：光感受器正常發育後逐漸退化。桿狀細胞通常先受影響（導致夜盲），隨後錐狀細胞也退化（全盲）。視網膜光感受器層逐漸變薄消失，RPE和反光毯暴露增加。",
    "diagnosis": {
      "overview": "眼底檢查和視網膜電圖（ERG）為主要診斷工具。基因檢測可在臨床前期確診。",
      "differentials": [
        "突發性後天性視網膜退化症候群（SARDS）",
        "視神經炎",
        "中樞性失明",
        "白內障導致視力障礙",
        "視網膜剝離",
        "營養性視網膜退化（牛磺酸缺乏，貓）"
      ],
      "initialDB": [
        "完整眼科檢查含眼底檢查",
        "威脅反射和瞳孔對光反射評估",
        "暗室和明室行為觀察",
        "障礙物迷宮測試"
      ],
      "advanced": [
        "視網膜電圖（ERG，可在眼底變化出現前檢測異常）",
        "DNA基因檢測（品種特異性基因panel）",
        "光學同調斷層掃描（OCT，評估視網膜厚度）"
      ]
    },
    "treatment": {
      "overview": "目前無有效治療可逆轉或停止PRA進展。管理重點在於併發症處理和環境適應。",
      "acute": [
        "無急性治療可用",
        "繼發白內障如引起晶體誘發性葡萄膜炎需治療"
      ],
      "chronic": [
        "抗氧化劑補充（維生素E、omega-3，理論上可能延緩進展但缺乏強力證據）",
        "繼發白內障手術評估（但PRA患犬白內障手術預後差）",
        "環境管理：保持家具位置不變、避免危險物品",
        "夜間小夜燈協助殘餘視力",
        "攜帶犬隻的安全輔具",
        "繁殖控制：確認的PRA攜帶者和患犬不應繁殖"
      ]
    },
    "prognosis": "PRA為進行性且無法治癒，最終導致完全失明。從夜盲到全盲的進展速度因品種和類型而異（數月到數年）。視力喪失但犬隻在穩定環境中通常可以適應良好，生活品質可維持。",
    "pearls": [
      "夜盲是最早的臨床徵兆，飼主常不易察覺",
      "ERG可在眼底出現明顯變化前數月至數年即檢測到異常",
      "基因檢測是繁殖犬篩檢的重要工具",
      "SARDS與PRA的鑑別：SARDS突發、ERG flat；PRA漸進、ERG逐漸降低",
      "PRA患犬的繼發白內障手術視力預後差，因視網膜功能已受損",
      "犬的適應能力強，失明犬在穩定環境中仍可有良好生活品質"
    ],
    "diagnosticAlgorithm": {
      "title": "進行性視網膜萎縮 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "詢問視力退化病史，評估暗環境行為改變",
          "findings": [
            "夜盲（初期表現）",
            "暗處行動不確定/碰撞物體",
            "瞳孔散大且對光反射減弱",
            "品種傾向（可卡犬/拉布拉多/貴賓犬等）"
          ]
        },
        {
          "step": 2,
          "action": "眼底檢查",
          "details": "散瞳後直接或間接眼底鏡檢查",
          "findings": [
            "視網膜血管變細",
            "反光膜反射增強（過度反光）",
            "視神經乳頭萎縮",
            "視網膜變薄與色素變化"
          ]
        },
        {
          "step": 3,
          "action": "視網膜電圖（ERG）",
          "details": "客觀評估視網膜光感受器功能",
          "findings": [
            "暗適應與明適應ERG波幅下降",
            "早期可在眼底變化前偵測異常",
            "桿體比錐體先受影響（典型型）",
            "可用於術前白內障手術評估"
          ]
        },
        {
          "step": 4,
          "action": "基因檢測",
          "details": "針對品種特異性基因突變進行DNA檢測",
          "findings": [
            "品種特異性PRA基因突變確認",
            "可用於繁殖篩檢",
            "確認遺傳型態（顯性/隱性）",
            "排除其他視網膜退化疾病"
          ]
        }
      ]
    },
    "monitoring": [
      "每6-12個月眼科追蹤",
      "監測白內障和葡萄膜炎的發展",
      "繁殖犬定期ERG篩檢和基因檢測",
      "評估犬隻生活品質和環境適應"
    ],
    "reference": "Maggs DJ, Miller PE, Ofri R: Slatter's Fundamentals of Veterinary Ophthalmology, 6th Ed. Elsevier, 2018"
  },
  "immune-mediated-thrombocytopenia": {
    "zh": "免疫性血小板減少症",
    "en": "Immune-Mediated Thrombocytopenia",
    "definition": "免疫系統產生抗血小板抗體，導致血小板被加速破壞或生成受抑制，造成嚴重血小板減少和出血傾向。可為原發性（特發性）或繼發性。",
    "synonyms": [
      "IMT",
      "ITP",
      "Idiopathic Thrombocytopenic Purpura",
      "Immune Thrombocytopenia"
    ],
    "epidemiology": {
      "species": "犬較常見，貓少見",
      "age": "中年犬（平均5-6歲）",
      "sex": "母犬發病率較高（約2:1）",
      "riskFactors": [
        "中年母犬",
        "可卡犬、老英國牧羊犬、貴賓犬、德國牧羊犬",
        "近期疫苗接種",
        "同時存在IMHA（Evans syndrome）",
        "感染性疾病觸發（ehrlichiosis、babesiosis）",
        "腫瘤性疾病",
        "藥物反應"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "皮膚出現瘀斑或瘀點",
        "牙齦出血",
        "鼻出血",
        "黑便或血便",
        "血尿",
        "嗜睡",
        "可能無明顯症狀而在例行血檢發現"
      ],
      "physicalExam": [
        "瘀點（petechiae）：皮膚、黏膜上的針點狀出血點",
        "瘀斑（ecchymoses）：較大面積的瘀血",
        "黏膜出血",
        "鞏膜出血",
        "腹部觸診可能無異常或脾臟腫大",
        "體溫通常正常",
        "嚴重貧血時黏膜蒼白"
      ]
    },
    "pathophysiology": "原發性IMT為免疫系統對自身血小板膜表面抗原（如GPIIb/IIIa）產生IgG抗體。抗體包被的血小板被脾臟和肝臟的巨噬細胞經Fc受體辨認而加速破壞（主要在脾臟）。部分病例同時存在骨髓巨核細胞生成受抑制。繼發性IMT可由感染、藥物、腫瘤或疫苗觸發。血小板計數<30,000-50,000/μL時出現自發性出血。",
    "diagnosis": {
      "overview": "血小板嚴重減少且排除其他原因後推定診斷。抗血小板抗體檢測可輔助但非必須。",
      "differentials": [
        "骨髓疾病（白血病、骨髓纖維化）",
        "DIC",
        "壁蝨傳播疾病（ehrlichiosis）",
        "藥物誘發性血小板減少",
        "脾臟扣留（脾腫大）",
        "假性血小板減少（EDTA抗凝劑偽影）"
      ],
      "initialDB": [
        "CBC含血小板計數（通常<30,000/μL）",
        "血液抹片檢查（確認血小板減少、排除偽影、評估形態）",
        "網狀紅血球計數",
        "凝血檢測（PT/aPTT/fibrinogen，排除DIC）",
        "生化、尿液分析"
      ],
      "advanced": [
        "骨髓抽吸/活檢（排除骨髓疾病，評估巨核細胞）",
        "抗血小板抗體檢測",
        "壁蝨傳播疾病篩檢panel",
        "腹部超音波（排除脾臟腫瘤）",
        "Coombs test（排除同時存在IMHA）",
        "胸腔X光"
      ]
    },
    "treatment": {
      "overview": "免疫抑制治療為主。嚴重出血需緊急處理。治療反應通常在3-7天內見到。",
      "acute": [
        "Prednisolone 2 mg/kg/day PO（免疫抑制劑量）",
        "嚴重病例加用第二線免疫抑制劑：mycophenolate 10 mg/kg PO BID 或 cyclosporine 5 mg/kg PO BID",
        "危及生命的出血：Vincristine 0.02 mg/kg IV 單次（可在24-48小時快速升高血小板）",
        "人類免疫球蛋白（hIVIG）0.5-1 g/kg IV（快速阻斷Fc受體）",
        "嚴重貧血需輸血",
        "避免肌肉注射和創傷性操作",
        "住院監護直至血小板穩定上升"
      ],
      "chronic": [
        "Prednisolone緩慢減量（4-6個月逐步減至最低有效劑量）",
        "維持治療可能需3-6個月或更長",
        "難治型：leflunomide、azathioprine",
        "脾臟切除術（藥物難治型的最後選擇）",
        "繼發型需治療潛在疾病"
      ]
    },
    "prognosis": "原發性IMT治療反應率約80%。復發率約30-50%。Evans syndrome（IMT+IMHA）預後較差。嚴重腦出血或肺出血可致死。大多數患犬經適當管理可長期控制。",
    "pearls": [
      "血液抹片必須先排除EDTA引起的假性血小板減少",
      "瘀點是血小板疾病的特徵性表現，凝血因子缺乏通常不會出現",
      "Vincristine可在24-48小時內緊急提升血小板計數",
      "停藥過快是復發的最常見原因，需緩慢減量",
      "約30%的IMT犬同時有Coombs test陽性（Evans syndrome）",
      "繼發性原因（ehrlichiosis、腫瘤）必須排除後才診斷原發性IMT"
    ],
    "diagnosticAlgorithm": {
      "title": "免疫性血小板減少症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估出血傾向，檢查黏膜與皮膚出血點",
          "findings": [
            "瘀斑或紫斑（皮膚/黏膜）",
            "鼻出血或牙齦出血",
            "黑便或血尿",
            "精神沉鬱與虛弱"
          ]
        },
        {
          "step": 2,
          "action": "血液學檢查",
          "details": "CBC與血液抹片檢查確認血小板數量與型態",
          "findings": [
            "血小板嚴重減少（<50,000/μL，常<20,000/μL）",
            "血液抹片確認非假性血小板減少",
            "大型血小板存在（再生反應）",
            "可能合併再生性貧血（Evans syndrome）"
          ]
        },
        {
          "step": 3,
          "action": "排除性檢查",
          "details": "排除其他血小板減少原因",
          "findings": [
            "蜱媒疾病篩查（Ehrlichia/Anaplasma）",
            "骨髓檢查（巨核球增生/正常提示周邊破壞）",
            "凝血功能檢測（排除DIC）",
            "FeLV/FIV檢測（貓）"
          ]
        },
        {
          "step": 4,
          "action": "治療反應評估",
          "details": "免疫抑制治療後監測血小板恢復",
          "findings": [
            "類固醇治療後3-7天血小板開始回升",
            "2-4週血小板恢復正常範圍",
            "加用免疫抑制劑（難治型）",
            "監測復發風險"
          ]
        }
      ]
    },
    "monitoring": [
      "治療初期每1-2天血小板計數",
      "穩定後每週一次直至正常範圍",
      "Prednisolone減量期間每2-4週血小板追蹤",
      "長期類固醇副作用監測（多飲多尿、肝指數）",
      "停藥後前6個月密切監測復發"
    ],
    "reference": "Weiss DJ, Wardrop KJ: Schalm's Veterinary Hematology, 6th Ed. Wiley-Blackwell, 2010"
  },
  "von-willebrand-disease": {
    "zh": "乏乙醯蘭特氏病",
    "en": "Von Willebrand Disease",
    "definition": "最常見的遺傳性出血性疾病，由 von Willebrand Factor（vWF）的量不足或功能異常所致。vWF在初級止血中扮演關鍵角色，缺乏時導致黏膜和手術出血。",
    "synonyms": [
      "vWD",
      "Von Willebrand's Disease"
    ],
    "epidemiology": {
      "species": "犬為主",
      "age": "先天性疾病，任何年齡可出現症狀",
      "sex": "常染色體遺傳（非性聯），公母犬均可",
      "riskFactors": [
        "Type 1（最常見）：杜賓犬（發生率高達70%）、德國牧羊犬、黃金獵犬、設得蘭牧羊犬",
        "Type 2：德國短毛指示犬、德國剛毛指示犬",
        "Type 3（最嚴重）：蘇格蘭梗、設得蘭牧羊犬、荷蘭獵鴿犬"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "黏膜出血（牙齦、鼻腔、泌尿生殖道）",
        "手術或創傷後過度出血",
        "母犬動情週期出血過多",
        "幼犬換牙期出血",
        "出血嚴重程度與vWD類型相關",
        "Type 1：輕到中度；Type 3：嚴重"
      ],
      "physicalExam": [
        "黏膜出血點",
        "手術或外傷傷口持續滲血",
        "血尿",
        "黑便（消化道出血）",
        "嚴重者：蒼白黏膜（貧血）",
        "關節血腫少見（與血友病不同）"
      ]
    },
    "pathophysiology": "vWF是由血管內皮和血小板合成的大分子蛋白，在初級止血中有兩大功能：(1)介導血小板與受損血管壁的黏附（GPIb受體）；(2)攜帶和穩定凝血因子VIII。vWF缺乏時血小板無法有效黏附於血管損傷處，導致初級止血障礙。Type 1：vWF量減少但功能正常；Type 2：vWF功能異常（缺乏高分子量多聚體）；Type 3：vWF完全缺乏。",
    "diagnosis": {
      "overview": "vWF抗原濃度測定是主要診斷工具。基因檢測可用於繁殖篩檢。",
      "differentials": [
        "血友病A（因子VIII缺乏）",
        "血友病B（因子IX缺乏）",
        "免疫性血小板減少症",
        "DIC",
        "rodenticide中毒",
        "肝臟疾病"
      ],
      "initialDB": [
        "vWF抗原濃度（vWF:Ag）：<50%為異常，<30%有臨床意義",
        "頰黏膜出血時間（BMBT）：延長（>4分鐘）",
        "CBC含血小板計數（通常正常）",
        "PT/aPTT（Type 3可能aPTT延長，因vWF攜帶的因子VIII減少）"
      ],
      "advanced": [
        "vWF多聚體分析（區分Type 1 vs Type 2）",
        "DNA基因檢測（品種特異性突變檢測）",
        "因子VIII活性測定",
        "血栓彈力圖（TEG/ROTEM）"
      ]
    },
    "treatment": {
      "overview": "無法根治。管理重點在於預防出血和出血時的支持治療。",
      "acute": [
        "活動性出血：新鮮冷凍血漿（FFP）6-10 mL/kg（補充vWF和因子VIII）",
        "冷沉澱物（cryoprecipitate）含高濃度vWF和因子VIII",
        "嚴重貧血需全血或紅血球輸血",
        "DDAVP（desmopressin）1 μg/kg SC（僅對Type 1有效，可在術前30分鐘使用）",
        "局部止血：壓迫、止血劑"
      ],
      "chronic": [
        "術前預防：DDAVP和/或FFP",
        "避免使用影響血小板功能的藥物（NSAIDs、aspirin）",
        "環境管理減少創傷風險",
        "繁殖管控：基因檢測篩檢攜帶者",
        "確診犬和攜帶者不應繁殖"
      ]
    },
    "prognosis": "Type 1（輕到中度）：多數犬在避免手術和創傷的情況下可正常生活，預後良好。Type 2和Type 3：出血風險較高，需嚴格管理，手術風險大。",
    "pearls": [
      "DDAVP僅對Type 1有效，對Type 2和Type 3無效",
      "杜賓犬是vWD最高發病品種，繁殖前應基因篩檢",
      "手術前高風險品種應檢測vWF:Ag",
      "vWD犬的血小板計數通常正常，但BMBT延長",
      "避免使用NSAIDs和其他影響血小板功能的藥物",
      "甲狀腺功能低下可降低vWF濃度，治療後vWF可改善"
    ],
    "diagnosticAlgorithm": {
      "title": "乏乙醯蘭特氏病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "詢問出血病史，確認品種傾向（杜賓犬、德牧、黃金獵犬等）",
          "findings": [
            "黏膜出血傾向（牙齦/鼻腔）",
            "手術或外傷後出血時間延長",
            "發情出血或分娩出血過多",
            "品種遺傳傾向"
          ]
        },
        {
          "step": 2,
          "action": "凝血篩檢",
          "details": "基礎凝血功能檢測與頰黏膜出血時間",
          "findings": [
            "頰黏膜出血時間延長（BMBT >4分鐘）",
            "PT和aPTT通常正常",
            "血小板計數正常",
            "血液抹片無異常"
          ]
        },
        {
          "step": 3,
          "action": "vWF抗原定量",
          "details": "von Willebrand因子抗原定量為確診金標準",
          "findings": [
            "vWF:Ag<50%為異常",
            "vWF:Ag<35%有臨床出血風險",
            "分型（第1/2/3型）",
            "基因檢測可確認攜帶者"
          ]
        },
        {
          "step": 4,
          "action": "術前評估",
          "details": "計劃手術前的風險評估與預防措施",
          "findings": [
            "評估出血風險等級",
            "備血或新鮮冷凍血漿",
            "Desmopressin（DDAVP）反應測試（第1型）",
            "避免影響血小板功能的藥物"
          ]
        }
      ]
    },
    "monitoring": [
      "手術前後密切監測出血",
      "定期vWF:Ag監測無必要（先天性穩定數值）",
      "繁殖犬基因篩檢",
      "監測是否有甲狀腺功能低下（可加重出血傾向）"
    ],
    "reference": "Weiss DJ, Wardrop KJ: Schalm's Veterinary Hematology, 6th Ed. Wiley-Blackwell, 2010"
  },
  "gallbladder-mucocele": {
    "zh": "膽囊黏液囊腫",
    "en": "Gallbladder Mucocele",
    "definition": "膽囊內黏液過度分泌和積聚，形成半固態的黏液團塊，導致膽囊擴張和可能的壞死穿孔。是犬膽囊手術最常見的適應症之一。",
    "synonyms": [
      "Biliary Mucocele",
      "Gallbladder Mucocoele"
    ],
    "epidemiology": {
      "species": "犬（貓極少見）",
      "age": "中老年犬（平均9-10歲）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "設得蘭牧羊犬（顯著高發）",
        "可卡犬",
        "迷你雪納瑞",
        "高脂血症",
        "甲狀腺功能低下",
        "腎上腺功能亢進",
        "ABCB4基因突變（設得蘭牧羊犬）",
        "膽囊運動障礙"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "可能無症狀（超音波意外發現）",
        "食慾下降、嘔吐",
        "嗜睡",
        "腹痛",
        "黃疸（膽管阻塞時）",
        "急性腹症（膽囊穿孔破裂時）"
      ],
      "physicalExam": [
        "右前腹部觸診疼痛",
        "黃疸（皮膚和黏膜黃染）",
        "發燒（感染或穿孔時）",
        "脫水",
        "腹壁緊張（腹膜炎時）",
        "部分犬理學檢查無顯著異常"
      ]
    },
    "pathophysiology": "膽囊上皮細胞黏液分泌亢進（cystic mucinous hyperplasia），產生過多的凝膠狀黏液。高脂血症、甲狀腺功能低下和腎上腺功能亢進等代謝疾病改變膽汁成分和膽囊運動功能，促進黏液囊腫形成。超音波呈現特徵性「奇異果切面」圖像。膽囊壁可能因過度擴張而壞死，導致穿孔和膽汁性腹膜炎，這是危及生命的急症。",
    "diagnosis": {
      "overview": "腹部超音波為最重要的診斷工具，特徵性圖像高度提示。",
      "differentials": [
        "膽囊炎",
        "膽石症",
        "膽囊腫瘤",
        "膽管阻塞",
        "肝臟疾病"
      ],
      "initialDB": [
        "腹部超音波（特徵性「奇異果」或「星芒狀」圖像）",
        "CBC（白血球升高提示感染或穿孔）",
        "生化：肝指數（ALT、ALP、GGT、bilirubin）",
        "膽汁酸"
      ],
      "advanced": [
        "腹部CT（評估是否穿孔或併發症）",
        "甲狀腺功能檢測（T4/TSH）",
        "腎上腺功能檢測（排除庫欣氏症）",
        "血脂分析（膽固醇、三酸甘油脂）",
        "凝血檢測（術前評估）"
      ]
    },
    "treatment": {
      "overview": "手術膽囊切除為有症狀或高風險黏液囊腫的首選治療。無症狀者的管理有爭議。",
      "acute": [
        "膽囊切除術（cholecystectomy）",
        "穿孔或膽汁性腹膜炎：緊急手術",
        "術中仔細評估膽管通暢性",
        "術中沖洗腹腔（穿孔時）",
        "圍手術期廣效抗生素",
        "靜脈輸液和電解質矯正",
        "止痛和止吐"
      ],
      "chronic": [
        "無症狀者的保守管理（爭議性）",
        "Ursodeoxycholic acid 10-15 mg/kg/day（膽汁稀釋和保肝）",
        "低脂飲食",
        "治療潛在代謝疾病（甲狀腺功能低下、高脂血症）",
        "S-adenosylmethionine（SAMe）保肝",
        "定期超音波追蹤（保守管理者）"
      ]
    },
    "prognosis": "選擇性膽囊切除術存活率約85-95%。膽囊穿孔後緊急手術存活率約50-70%。無症狀者保守管理有穿孔風險。治療潛在代謝疾病可能有助於預防。",
    "pearls": [
      "超音波「奇異果」圖像是特徵性診斷標誌",
      "設得蘭牧羊犬的品種風險顯著高於其他犬種",
      "無症狀的黏液囊腫有穿孔風險，是否預防性手術仍有爭議",
      "膽囊壁不連續提示即將或已經穿孔，需緊急手術",
      "甲狀腺功能低下和高脂血症是重要的可治療風險因素",
      "穿孔後的緊急手術死亡率比選擇性手術高很多"
    ],
    "diagnosticAlgorithm": {
      "title": "膽囊黏液囊腫 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估消化道症狀與肝膽系統體徵",
          "findings": [
            "嘔吐與食慾不振",
            "腹痛（上腹部觸診）",
            "黃疸",
            "精神沉鬱或虛弱"
          ]
        },
        {
          "step": 2,
          "action": "血液生化檢查",
          "details": "肝膽相關血液生化指標評估",
          "findings": [
            "ALP與GGT顯著升高",
            "總膽紅素升高（膽道阻塞時）",
            "ALT升高（肝損傷）",
            "膽固醇/三酸甘油酯升高"
          ]
        },
        {
          "step": 3,
          "action": "腹部超音波檢查",
          "details": "超音波為診斷膽囊黏液囊腫的關鍵工具",
          "findings": [
            "膽囊內星狀或奇異果樣高回音型態",
            "膽囊壁增厚",
            "膽管擴張",
            "膽囊周圍滲出（破裂風險）"
          ]
        },
        {
          "step": 4,
          "action": "手術與病因評估",
          "details": "評估手術指征，調查潛在內分泌異常",
          "findings": [
            "甲狀腺功能低下檢測",
            "腎上腺皮質功能亢進檢測",
            "高脂血症評估",
            "膽囊破裂風險評估（緊急手術指征）"
          ]
        }
      ]
    },
    "monitoring": [
      "保守管理者：每1-3個月腹部超音波追蹤膽囊變化",
      "肝指數定期檢測",
      "術後追蹤肝功能恢復",
      "潛在代謝疾病的治療效果監測",
      "高風險品種定期超音波篩檢"
    ],
    "reference": "Tobias KM, Johnston SA: Veterinary Surgery: Small Animal, 2nd Ed. Elsevier, 2018"
  },
  "intestinal-foreign-body": {
    "zh": "腸道異物",
    "en": "Intestinal Foreign Body",
    "definition": "無法消化的物體停留在小腸或大腸內，導致部分或完全性腸道阻塞。是犬貓常見的外科急症，線性異物（特別是貓）為特殊且危險的類型。",
    "synonyms": [
      "Intestinal Obstruction",
      "GI Foreign Body",
      "Bowel Obstruction"
    ],
    "epidemiology": {
      "species": "犬貓皆可",
      "age": "幼年動物最常見（好奇心強，愛咬東西）",
      "sex": "犬公犬略多",
      "riskFactors": [
        "幼犬幼貓",
        "異食癖行為",
        "犬：好咬玩具、骨頭、襪子、石頭",
        "貓：線性異物（線、緞帶、釣魚線、橡皮筋）",
        "缺乏監督的幼年動物",
        "實驗室犬種（拉布拉多）特別愛亂吃"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "急性嘔吐（可為間歇性或持續性）",
        "食慾廢絕",
        "精神沉鬱",
        "腹痛",
        "排便減少或停止",
        "飼主可能目睹吞食異物",
        "線性異物：嘔吐頻繁，可能看到線從口中或肛門垂出"
      ],
      "physicalExam": [
        "腹部觸診：可能觸及異物或腸管聚集（線性異物）",
        "腹痛",
        "脫水",
        "發燒（穿孔或壞死時）",
        "腸音增加（早期）或減少（晚期）",
        "舌下檢查（貓）：線性異物可能固定於舌根",
        "腹部觸診腸管摺疊聚集（plication，線性異物特徵）"
      ]
    },
    "pathophysiology": "異物阻塞腸腔後，近端腸管擴張積液和積氣。腸管擴張導致腸壁血循環障礙、黏膜缺血壞死和細菌移位。完全阻塞比部分阻塞危險性高。線性異物一端固定（常在舌根或幽門），腸道蠕動使腸管沿線摺疊（plication），線可切割腸管壁導致多處穿孔。腸穿孔導致敗血性腹膜炎，為致命併發症。",
    "diagnosis": {
      "overview": "病史、理學檢查和影像學綜合判斷。腹部X光和超音波為主要診斷工具。",
      "differentials": [
        "胃異物",
        "腸套疊",
        "腸扭轉",
        "腫瘤性阻塞",
        "嚴重便秘",
        "胰臟炎",
        "線性異物（貓需特別排除）"
      ],
      "initialDB": [
        "腹部X光（正面和側面，可見阻塞性氣體擴張模式、金屬或骨性異物）",
        "腹部超音波（評估腸壁變化、游離腹液、異物回聲）",
        "CBC（白血球升高提示壞死或穿孔）",
        "生化和電解質（評估脫水和代謝紊亂）"
      ],
      "advanced": [
        "腹部X光含鋇劑對比（可疑但常規影像不明確時）",
        "腹部CT（複雜病例）",
        "腹腔穿刺（疑似穿孔時，檢查腹液是否含菌或退化性嗜中性球）"
      ]
    },
    "treatment": {
      "overview": "手術取出異物是主要治療。術前穩定患犬狀態，術中評估腸管活力。",
      "acute": [
        "術前穩定：靜脈輸液矯正脫水和電解質失衡",
        "止吐（maropitant）和止痛",
        "廣效抗生素（特別是疑似穿孔時）",
        "手術：腸切開術（enterotomy）取出異物",
        "腸管壞死需腸切除吻合術（resection and anastomosis）",
        "線性異物：可能需多處腸切開",
        "術中評估腸管活力（顏色、蠕動、血管搏動）"
      ],
      "chronic": [
        "術後：NPO 12-24小時後少量多餐高消化性食物",
        "術後抗生素3-5天",
        "止痛管理",
        "監測吻合處是否滲漏",
        "預防未來再發：環境管理、行為訓練"
      ]
    },
    "prognosis": "非穿孔性異物手術取出預後良好（存活率>90%）。腸壞死需切除吻合者預後稍差。穿孔導致腹膜炎者預後較差（存活率50-80%）。線性異物若多處穿孔預後不佳。早期診斷和手術是影響預後的關鍵。",
    "pearls": [
      "貓舌下檢查是發現線性異物的關鍵步驟，切勿遺漏",
      "絕對不要拉出從口或肛門露出的線，可能切割腸壁",
      "腹部X光上的小腸聚集模式高度提示線性異物",
      "拉布拉多犬是最常吞食異物的犬種",
      "部分阻塞可能嘔吐間歇性，容易延誤診斷",
      "腸管活力不確定時寧可切除也不要保留（壞死腸管會導致敗血症）"
    ],
    "diagnosticAlgorithm": {
      "title": "腸道異物 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估與病史",
          "details": "詢問異物攝入史，評估嘔吐型態與腹部觸診",
          "findings": [
            "持續性嘔吐（進食後加劇）",
            "食慾廢絕或減退",
            "腹痛",
            "腹部觸診可能觸及異物或腸管群集"
          ]
        },
        {
          "step": 2,
          "action": "腹部X光檢查",
          "details": "腹部正側位X光評估阻塞徵象",
          "findings": [
            "局部腸管擴張積氣（阻塞近端）",
            "線狀異物：腸管皺褶或扇形排列",
            "放射不透明異物直接可見",
            "遠端腸管空虛"
          ]
        },
        {
          "step": 3,
          "action": "超音波檢查",
          "details": "腹部超音波評估腸壁與異物",
          "findings": [
            "異物回音影（acoustic shadow）",
            "腸壁水腫或增厚",
            "腸管擴張與蠕動異常",
            "腹腔積液（腸穿孔警訊）"
          ]
        },
        {
          "step": 4,
          "action": "手術決策",
          "details": "評估保守治療可能性與手術指征",
          "findings": [
            "完全阻塞需緊急手術",
            "線狀異物禁止催吐需手術",
            "評估腸壁活力",
            "腹腔汙染程度評估"
          ]
        }
      ]
    },
    "monitoring": [
      "術後24-72小時密切監測體溫、疼痛、嘔吐",
      "術後3-5天監測吻合處滲漏跡象（發燒、腹痛加重、腹水）",
      "逐步恢復飲食",
      "術後10-14天拆線和追蹤"
    ],
    "reference": "Tobias KM, Johnston SA: Veterinary Surgery: Small Animal, 2nd Ed. Elsevier, 2018"
  },
  "gastric-foreign-body": {
    "zh": "胃異物",
    "en": "Gastric Foreign Body",
    "definition": "無法消化的物體停留在胃中，可能導致嘔吐、食慾不振或幽門阻塞。部分異物可能在胃中長期存在而僅引起間歇性症狀。",
    "synonyms": [
      "Stomach Foreign Body",
      "Gastric Obstruction"
    ],
    "epidemiology": {
      "species": "犬較常見，貓也可發生（毛球為貓特有）",
      "age": "幼年動物最常見",
      "sex": "犬公犬略多",
      "riskFactors": [
        "幼犬（好奇心強）",
        "異食癖",
        "犬常見異物：玩具、骨頭、襪子、玉米芯、石頭",
        "貓：毛球、線團",
        "拉布拉多、黃金獵犬等品種特別愛亂吃",
        "無人看管的幼年動物"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "急性或間歇性嘔吐",
        "飼主可能目睹吞食行為",
        "食慾下降",
        "腹部不適",
        "慢性胃異物：間歇性嘔吐數天到數週",
        "幽門阻塞：嘔吐頻繁，無法進食"
      ],
      "physicalExam": [
        "腹部觸診可能在胃區觸及異物",
        "脫水（頻繁嘔吐時）",
        "腹痛或腹部觸診不適",
        "可能無明顯異常（小型異物或慢性存在）",
        "穿孔時：發燒、腹膜刺激徵"
      ]
    },
    "pathophysiology": "異物滯留在胃中可引起胃黏膜機械性刺激和局部炎症，導致嘔吐。較大的異物可阻塞幽門出口，導致胃排空障礙。尖銳異物可穿透胃壁導致局部或瀰漫性腹膜炎。某些異物（如硬幣含鋅）可導致金屬中毒。長期存在的異物可形成胃壁潰瘍和慢性胃炎。",
    "diagnosis": {
      "overview": "腹部X光是首選影像學檢查。非不透光異物需超音波或內視鏡診斷。",
      "differentials": [
        "急性胃腸炎",
        "胰臟炎",
        "腸道異物",
        "幽門狹窄",
        "胃擴張扭轉",
        "胃潰瘍",
        "中毒"
      ],
      "initialDB": [
        "腹部X光（正面和側面）",
        "不透光異物可直接可見",
        "非不透光異物：可能見到胃擴張或可疑軟組織密度",
        "CBC、生化和電解質"
      ],
      "advanced": [
        "腹部超音波（非不透光異物的評估）",
        "上消化道鋇劑造影（可疑但X光和超音波不確定時）",
        "內視鏡檢查（診斷兼治療）"
      ]
    },
    "treatment": {
      "overview": "取出異物為主要治療。內視鏡取出為首選（微創），無法內視鏡取出者需手術。",
      "acute": [
        "小型光滑異物（<2-3 cm）：可觀察是否自行排出",
        "催吐（apomorphine 犬0.03 mg/kg IV或結膜內；吞食<2小時、非尖銳異物）",
        "內視鏡取出（首選，成功率高，侵入性低）",
        "胃切開術（gastrotomy）：內視鏡無法取出或異物過大時",
        "術前穩定：輸液、止吐",
        "尖銳異物禁止催吐"
      ],
      "chronic": [
        "術後或內視鏡取出後：短期禁食後少量多餐",
        "胃黏膜保護劑（sucralfate、omeprazole）",
        "預防再發：環境管理、移除危險物品",
        "異食癖行為矯正"
      ]
    },
    "prognosis": "非穿孔性胃異物預後極佳。內視鏡取出安全且恢復快。手術取出存活率>95%。穿孔導致腹膜炎者預後較差。含鋅異物（硬幣）需注意鋅中毒的全身性影響。",
    "pearls": [
      "催吐窗口期約為吞食後2小時內，之後效果差",
      "尖銳異物和腐蝕性物質絕對禁止催吐",
      "內視鏡取出是胃異物的首選方法（創傷最小）",
      "含鋅物品（硬幣、螺絲）可引起嚴重溶血性貧血",
      "慢性間歇性嘔吐的犬應考慮胃異物",
      "部分異物可在胃中存在數週而僅有輕微症狀"
    ],
    "diagnosticAlgorithm": {
      "title": "胃異物 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估與病史",
          "details": "詢問可能的異物攝入事件、嘔吐時間與頻率",
          "findings": [
            "急性或間歇性嘔吐",
            "已知或疑似攝入異物",
            "食慾減退",
            "流涎或嘔吐未消化食物"
          ]
        },
        {
          "step": 2,
          "action": "腹部X光檢查",
          "details": "腹部正側位X光評估胃內異物",
          "findings": [
            "放射不透明異物（金屬/骨頭/石頭）",
            "胃擴張積氣",
            "放射可透過異物需顯影劑研究",
            "排除下游腸道阻塞"
          ]
        },
        {
          "step": 3,
          "action": "內視鏡檢查與取出",
          "details": "上消化道內視鏡直接觀察並嘗試內視鏡取出",
          "findings": [
            "內視鏡直接觀察異物類型",
            "評估胃黏膜損傷",
            "評估內視鏡取出可行性",
            "若無法內視鏡取出則轉手術"
          ]
        },
        {
          "step": 4,
          "action": "術後評估",
          "details": "取出後評估消化道損傷程度",
          "findings": [
            "胃壁穿孔排除",
            "腹膜炎徵象監測",
            "電解質與酸鹼平衡矯正",
            "逐漸恢復飲食"
          ]
        }
      ]
    },
    "monitoring": [
      "催吐後確認異物完整排出",
      "內視鏡取出後觀察4-6小時",
      "手術後監測嘔吐和食慾恢復",
      "含鋅異物：監測PCV和溶血指標"
    ],
    "reference": "Tobias KM, Johnston SA: Veterinary Surgery: Small Animal, 2nd Ed. Elsevier, 2018"
  },
  "feline-chronic-gingivostomatitis": {
    "zh": "貓慢性牙齦口炎",
    "en": "Feline Chronic Gingivostomatitis",
    "definition": "貓口腔黏膜（特別是牙齦和口咽部黏膜）的嚴重慢性炎症反應，常延伸至舌腭弓（caudal mucositis）。為貓最棘手的口腔疾病之一，被認為是對牙齒表面抗原（細菌和/或病毒）的異常免疫反應。",
    "synonyms": [
      "FCGS",
      "Feline Stomatitis",
      "Lymphocytic-Plasmacytic Stomatitis",
      "Caudal Stomatitis"
    ],
    "epidemiology": {
      "species": "貓",
      "age": "任何年齡，但成年貓較常見",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "FCV慢性帶原",
        "FIV或FeLV感染",
        "多貓環境",
        "品種：暹羅貓、阿比西尼亞貓可能較高",
        "免疫功能異常"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "進食困難、拒食或食慾下降",
        "流涎（常帶血絲）",
        "口臭嚴重",
        "體重減輕",
        "面部疼痛表現（拒絕觸碰臉部）",
        "被毛品質差（疼痛不理毛）",
        "用爪抓口部"
      ],
      "physicalExam": [
        "牙齦嚴重充血、腫脹和潰瘍",
        "口咽部（舌腭弓區域）增生性到潰瘍性黏膜炎",
        "觸碰口腔劇烈疼痛",
        "口腔惡臭",
        "可能有大量牙菌斑和牙結石",
        "體態評分偏低",
        "被毛凌亂（疼痛不理毛）",
        "頜下淋巴結腫大"
      ]
    },
    "pathophysiology": "確切病因未完全明瞭，目前認為是對口腔內抗原（牙菌斑細菌、FCV等病毒）的異常或過度免疫反應。組織學特徵為淋巴球和漿細胞的密集浸潤。FCV在病灶組織中的檢出率高。牙齒表面作為細菌和病毒的載體，是持續免疫刺激的來源，這解釋了為什麼拔牙治療有效。T細胞和B細胞免疫調節異常均參與致病。",
    "diagnosis": {
      "overview": "臨床表現典型，需排除其他口腔疾病。組織活檢確認但通常非必須。",
      "differentials": [
        "牙周病",
        "口腔鱗狀細胞癌",
        "嗜酸性球肉芽腫複合體",
        "腎衰竭導致的口腔潰瘍",
        "貓牙齒吸收"
      ],
      "initialDB": [
        "口腔檢查（通常需鎮靜或麻醉）",
        "全口X光評估牙齒和齒根狀態",
        "FeLV/FIV檢測",
        "CBC、生化（排除腎病等全身性疾病）"
      ],
      "advanced": [
        "口腔黏膜活檢組織病理學",
        "口腔病毒PCR（FCV）",
        "細菌培養和藥敏試驗",
        "免疫球蛋白電泳（常見多株高球蛋白血症）"
      ]
    },
    "treatment": {
      "overview": "全口或近全口拔牙是目前最有效的治療方法。約60-80%的貓在拔牙後顯著改善或痊癒。",
      "acute": [
        "全口拔牙或近全口拔牙（保留犬齒和門齒或全部拔除）",
        "手術後疼痛管理：buprenorphine 0.01-0.02 mg/kg SL TID",
        "術後抗生素：amoxicillin-clavulanate 或 clindamycin 7-10天",
        "術後軟食餵養"
      ],
      "chronic": [
        "拔牙後未完全緩解者（約20-30%）：",
        "免疫調節藥物：cyclosporine 5-7.5 mg/kg PO BID",
        "類固醇：prednisolone 1-2 mg/kg/day（長期使用副作用多，盡量避免）",
        "Interferon omega（如可取得）",
        "幹細胞治療（實驗性但前景看好）",
        "疼痛管理：gabapentin、buprenorphine",
        "口腔衛生維護：chlorhexidine漱口液"
      ]
    },
    "prognosis": "全口拔牙後約60%完全緩解，20%顯著改善，20%反應不佳需長期藥物管理。單純藥物治療效果不持久。預後良好的指標：較年輕、非FIV陽性、術前口腔感染控制良好。",
    "pearls": [
      "全口拔牙聽起來激進但是目前最有效的治療",
      "拔牙後的貓能用牙齦正常進食軟食和乾糧",
      "確保完整拔除齒根（殘留齒根是治療失敗的主因）",
      "術後X光確認無齒根殘留很重要",
      "FCV帶原與本病高度相關",
      "長期使用類固醇可增加糖尿病風險",
      "拔牙治療效果可能需要數週至數月才完全顯現"
    ],
    "diagnosticAlgorithm": {
      "title": "貓慢性牙齦口炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "觀察口腔症狀、進食行為與整體狀態",
          "findings": [
            "嚴重口臭",
            "流涎（可能帶血）",
            "進食困難或食慾廢絕",
            "體重減輕與被毛不整"
          ]
        },
        {
          "step": 2,
          "action": "口腔檢查",
          "details": "鎮靜或麻醉下完整口腔檢查",
          "findings": [
            "牙齦弓與口咽部嚴重紅腫增生",
            "尾側口炎（palatoglossal folds）",
            "潰瘍性病變",
            "牙齒可能有牙周病或吸收"
          ]
        },
        {
          "step": 3,
          "action": "實驗室與病原篩查",
          "details": "排除全身性疾病，評估免疫狀態",
          "findings": [
            "FeLV/FIV檢測",
            "FCV PCR（可能為慢性感染）",
            "CBC與生化評估全身狀態",
            "口腔組織活檢（排除腫瘤）"
          ]
        },
        {
          "step": 4,
          "action": "口腔X光與治療計劃",
          "details": "全口齒科X光評估牙齒狀態，制定治療計劃",
          "findings": [
            "牙齒吸收評估",
            "牙周骨質喪失程度",
            "評估全口拔牙或部分拔牙指征",
            "免疫調節治療評估"
          ]
        }
      ]
    },
    "monitoring": [
      "術後2-4週口腔檢查和疼痛評估",
      "拔牙後3-6個月評估長期治療效果",
      "體重和營養狀態監測",
      "使用cyclosporine者監測腎功能",
      "長期使用類固醇者監測血糖"
    ],
    "reference": "Niemiec BA: Veterinary Periodontology. Wiley-Blackwell, 2013"
  },
  "feline-tooth-resorption": {
    "zh": "貓牙齒吸收",
    "en": "Feline Tooth Resorption",
    "definition": "貓牙齒結構（牙本質、牙骨質、牙釉質）被破齒細胞（odontoclasts）進行性吸收破壞的疾病。是貓最常見的牙科疾病之一，影響約30-70%的成年貓。",
    "synonyms": [
      "Feline Odontoclastic Resorptive Lesions",
      "FORL",
      "Tooth Resorption",
      "TR",
      "Feline Resorptive Lesions"
    ],
    "epidemiology": {
      "species": "貓",
      "age": "隨年齡增加而增加，4歲以上較常見",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "年齡增加",
        "純種貓可能風險較高",
        "口腔炎症",
        "維生素D過量（飲食因素）",
        "確切原因不明"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "可能無症狀（飼主不易察覺）",
        "進食時突然甩頭或掉落食物",
        "用單側咀嚼",
        "食慾下降",
        "流涎",
        "觸碰口部時敏感",
        "偏好軟食"
      ],
      "physicalExam": [
        "牙齒表面可見紅色肉芽組織覆蓋病灶（牙齦增生覆蓋吸收處）",
        "牙齦線附近牙齒缺損",
        "探針觸及病灶時劇烈疼痛反應",
        "牙冠可能部分或完全被牙齦組織覆蓋",
        "牙齒可能在探查時斷裂",
        "可能同時存在牙周病"
      ]
    },
    "pathophysiology": "破齒細胞（odontoclasts）異常活化，吸收牙齒硬組織。確切觸發因素未明，可能與局部炎症信號、維生素D代謝異常和牙骨質修復缺陷有關。依據X光表現分型：Type 1：齒根結構保持正常密度，牙周韌帶間隙清晰可見；Type 2：齒根進行性吸收並被骨樣組織（ghost roots）替代，牙周韌帶間隙消失；Type 3：同一牙齒同時存在Type 1和Type 2病變。",
    "diagnosis": {
      "overview": "口腔檢查加全口齒科X光為診斷標準。僅靠臨床檢查會遺漏許多病灶。",
      "differentials": [
        "齲齒（貓極罕見）",
        "牙齒骨折",
        "牙周病",
        "口腔腫瘤"
      ],
      "initialDB": [
        "口腔理學檢查（通常需全身麻醉下進行）",
        "牙科探針檢查",
        "全口齒科X光（必須，許多病灶肉眼不可見）"
      ],
      "advanced": [
        "CBCT（cone-beam CT，更精確評估齒根吸收）",
        "組織活檢（排除腫瘤，如外觀不典型）"
      ]
    },
    "treatment": {
      "overview": "拔牙是唯一有效治療。治療方式取決於X光分型。無法恢復，所有修復性治療均會失敗。",
      "acute": [
        "Type 1病灶：完整拔牙（標準外科拔牙，需完整移除齒根）",
        "Type 2病灶：牙冠截斷術（crown amputation），因齒根已被骨替代且牙周韌帶消失",
        "Type 3：針對各齒根的類型分別處理",
        "術後止痛：buprenorphine 0.01-0.02 mg/kg SL、meloxicam短期使用",
        "術後抗生素（通常3-5天）"
      ],
      "chronic": [
        "定期口腔檢查和X光追蹤未受影響的牙齒",
        "疼痛管理（gabapentin長期使用）",
        "軟食或將乾糧泡軟",
        "無法預防新病灶形成"
      ]
    },
    "prognosis": "拔除病灶牙齒後疼痛迅速緩解，預後良好。但本病常為多牙齒受影響，且會持續出現新病灶。貓在多次拔牙甚至全口拔牙後仍能良好進食。",
    "pearls": [
      "全口齒科X光是診斷必須的，肉眼檢查會遺漏多數病灶",
      "Type 2病灶可行牙冠截斷術，不需強行挖掘已被骨替代的齒根",
      "任何修復性治療（補牙）都會失敗，拔牙是唯一選擇",
      "牙齦覆蓋的紅色肉芽組織是典型臨床表現",
      "飼主常驚訝於拔牙後貓的改善程度（很多貓在忍痛進食）",
      "發病率隨年齡增加，定期牙科檢查和X光很重要"
    ],
    "diagnosticAlgorithm": {
      "title": "貓牙齒吸收 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估進食行為異常與口腔疼痛徵象",
          "findings": [
            "進食時頭部甩動或掉食物",
            "偏側咀嚼",
            "流涎",
            "下頜顫抖（jaw chattering）"
          ]
        },
        {
          "step": 2,
          "action": "口腔檢查",
          "details": "鎮靜下仔細檢查牙齒表面，用探針探測齒頸部",
          "findings": [
            "齒頸部牙齦增生覆蓋病變",
            "牙齒表面可見粉紅色缺損",
            "探針探到吸收窩洞",
            "牙冠缺損或斷裂"
          ]
        },
        {
          "step": 3,
          "action": "口腔X光檢查",
          "details": "全口齒科X光為確診與分型的必要工具",
          "findings": [
            "第1型：齒根輪廓可見，牙周韌帶間隙正常",
            "第2型：齒根與骨融合，牙周韌帶間隙消失",
            "第3型：同一牙齒同時有第1、2型表現",
            "吸收範圍與嚴重程度分級"
          ]
        },
        {
          "step": 4,
          "action": "治療計劃",
          "details": "根據分型制定手術計劃",
          "findings": [
            "第1型：完整齒根拔除",
            "第2型：可考慮齒冠切除術",
            "評估受影響牙齒數量",
            "術後X光確認齒根完全移除"
          ]
        }
      ]
    },
    "monitoring": [
      "術後1-2週評估傷口癒合",
      "每年全身麻醉口腔檢查和全口X光",
      "觀察進食行為和口腔舒適度",
      "牙冠截斷術後X光追蹤齒根被骨吸收進展"
    ],
    "reference": "Niemiec BA: Veterinary Periodontology. Wiley-Blackwell, 2013"
  },
  "conjunctivitis": {
    "zh": "結膜炎",
    "en": "Conjunctivitis",
    "definition": "結膜（覆蓋眼球表面和眼瞼內側的黏膜）的炎症。是犬貓最常見的眼科疾病之一。病因多樣，包括感染性、過敏性、免疫介導性和機械刺激性。",
    "synonyms": [
      "Pink Eye",
      "Red Eye"
    ],
    "epidemiology": {
      "species": "犬貓皆可",
      "age": "任何年齡",
      "sex": "無性別傾向",
      "riskFactors": [
        "犬：過敏體質（異位性皮膚炎相關）",
        "貓：FHV-1和FCV感染、Chlamydia felis",
        "短頭犬種（眼球突出、眼瞼閉合不全）",
        "環境刺激物（灰塵、煙霧、風）",
        "乾眼症（KCS）繼發"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "眼睛發紅",
        "眼分泌物（漿液性到黏膿性）",
        "頻繁眨眼或搓揉眼睛",
        "晨起眼分泌物增多",
        "可為單側或雙側",
        "貓：常伴有打噴嚏（上呼吸道感染相關）"
      ],
      "physicalExam": [
        "結膜充血和水腫（chemosis）",
        "眼分泌物：漿液性（過敏/病毒）、黏液性（KCS）、膿性（細菌）",
        "眼瞼腫脹",
        "第三眼瞼突出（貓）",
        "濾泡增生（follicular conjunctivitis）",
        "評估角膜是否同時受影響"
      ]
    },
    "pathophysiology": "結膜血管豐富且暴露於外部環境，易受各種病原和刺激物侵害。感染性：細菌（犬葡萄球菌；貓衣原體和支原體）、病毒（貓FHV-1、FCV）直接侵犯結膜上皮。過敏性：IgE介導的第I型超敏反應導致肥大細胞脫顆粒。KCS繼發：淚液減少導致結膜缺乏潤滑和保護。不同病因導致不同類型的炎症反應和分泌物特徵。",
    "diagnosis": {
      "overview": "眼科基本檢查為主，需排除角膜疾病和乾眼症等潛在原因。",
      "differentials": [
        "角膜潰瘍",
        "前葡萄膜炎",
        "青光眼",
        "乾眼症（KCS）",
        "眼瞼內翻",
        "鼻淚管阻塞",
        "眼眶疾病"
      ],
      "initialDB": [
        "完整眼科檢查",
        "螢光素染色（排除角膜潰瘍）",
        "Schirmer淚液試驗（STT，排除KCS）",
        "眼壓測量（排除青光眼和葡萄膜炎）"
      ],
      "advanced": [
        "結膜刮片細胞學（嗜酸性球→過敏；包涵體→衣原體）",
        "細菌培養和藥敏試驗（反覆發作或治療無效時）",
        "貓：Chlamydia felis PCR",
        "貓：FHV-1 PCR",
        "過敏原檢測（犬反覆發作與過敏相關時）"
      ]
    },
    "treatment": {
      "overview": "治療取決於病因。經驗性治療前應完成基本眼科檢查以排除嚴重眼疾。",
      "acute": [
        "細菌性：外用抗生素眼藥（tobramycin、ofloxacin、fusidic acid）BID-QID",
        "貓衣原體：外用tetracycline或全身doxycycline 5 mg/kg PO BID 4週",
        "貓FHV-1相關：外用cidofovir 0.5% BID ± 全身famciclovir",
        "過敏性：外用抗組織胺或肥大細胞穩定劑（olopatadine）",
        "過敏性嚴重：短期外用類固醇（確認無角膜潰瘍後）",
        "KCS繼發：cyclosporine或tacrolimus眼藥+人工淚液"
      ],
      "chronic": [
        "過敏性：長期外用抗過敏眼藥",
        "KCS：長期免疫調節眼藥（cyclosporine 0.2% BID）",
        "環境管理（減少過敏原暴露）",
        "貓FHV-1：緊迫管理減少復發",
        "反覆發作需系統性評估潛在原因"
      ]
    },
    "prognosis": "多數感染性和過敏性結膜炎預後良好。KCS繼發需終生管理。貓FHV-1相關結膜炎可能反覆發作。",
    "pearls": [
      "螢光素染色和STT是結膜炎評估的必做檢查",
      "犬的結膜炎很少是原發性細菌感染，多為過敏或KCS繼發",
      "貓的結膜炎首先考慮FHV-1、FCV和衣原體",
      "單側結膜炎需排除鼻淚管阻塞、異物和角膜疾病",
      "外用類固醇使用前務必排除角膜潰瘍",
      "犬單純結膜炎若反覆發作，高度考慮過敏或KCS"
    ],
    "diagnosticAlgorithm": {
      "title": "結膜炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估眼部症狀、分泌物性質與分布（單側/雙側）",
          "findings": [
            "結膜紅腫充血",
            "眼分泌物（漿液性/黏液性/膿性）",
            "眨眼頻率增加",
            "輕度不適或搔癢"
          ]
        },
        {
          "step": 2,
          "action": "眼科基本檢查",
          "details": "角膜螢光素染色、Schirmer淚液試驗、眼壓測量",
          "findings": [
            "螢光素染色排除角膜潰瘍",
            "淚液分泌量（排除乾眼症）",
            "眼壓正常（排除青光眼/葡萄膜炎）",
            "瞳孔對光反射正常"
          ]
        },
        {
          "step": 3,
          "action": "病因調查",
          "details": "根據臨床表現與物種進行病因分類",
          "findings": [
            "感染性：FHV/Chlamydia/Mycoplasma（貓）",
            "過敏性：季節性，雙側",
            "細菌性：膿性分泌物，犬常見",
            "異物/刺激性：單側急性發作"
          ]
        },
        {
          "step": 4,
          "action": "進階檢查（慢性或反覆病例）",
          "details": "結膜拭子細胞學、培養或PCR檢測",
          "findings": [
            "結膜細胞學（嗜酸性球→過敏/嗜中性球→細菌/淋巴球→病毒）",
            "PCR檢測特定病原",
            "細菌培養與藥敏試驗",
            "眼瞼結構異常排除（內翻/倒睫）"
          ]
        }
      ]
    },
    "monitoring": [
      "治療後5-7天追蹤評估",
      "STT定期監測（KCS患者）",
      "過敏性結膜炎：季節性評估",
      "貓反覆發作者：FHV-1管理策略評估"
    ],
    "reference": "Maggs DJ, Miller PE, Ofri R: Slatter's Fundamentals of Veterinary Ophthalmology, 6th Ed. Elsevier, 2018"
  },
  "pemphigus-foliaceus": {
    "zh": "天疱瘡",
    "en": "Pemphigus Foliaceus",
    "definition": "最常見的自體免疫性皮膚病，自體抗體攻擊角質細胞間的黏附分子（橋粒），導致表皮內棘層鬆解及膿疱形成。",
    "synonyms": [
      "落葉型天疱瘡",
      "PF"
    ],
    "epidemiology": {
      "species": "犬貓皆可發生，犬較常見",
      "age": "中年至老年犬貓（平均4-6歲），先天性罕見",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "秋田犬、鬆獅犬、臘腸犬、比利時牧羊犬等品種好發",
        "藥物誘發（如甲硫咪唑）",
        "紫外線暴露可能加重",
        "慢性皮膚病史"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "面部對稱性結痂",
        "足墊增厚或潰瘍",
        "耳廓病變",
        "全身性脫毛和結痂",
        "搔癢程度不一",
        "病程呈漸進性惡化"
      ],
      "physicalExam": [
        "面部（鼻樑、耳廓、眼周）對稱性結痂和鱗屑",
        "足墊角質增生、龜裂、潰瘍",
        "膿疱（短暫，易破裂）",
        "表皮環狀剝離",
        "乳頭和腹股溝區可能受累",
        "貓常見甲床病變（甲溝炎）",
        "黏膜通常不受影響"
      ]
    },
    "pathophysiology": "自體抗體（主要為IgG）針對角質細胞間橋粒蛋白（Desmoglein-1），破壞細胞間黏附，導致表皮淺層棘層鬆解。角質細胞失去連接後形成棘層鬆解細胞，聚集形成表皮內膿疱。",
    "diagnosis": {
      "overview": "確診需結合臨床表現、皮膚細胞學和組織病理學檢查",
      "differentials": [
        "細菌性膿皮症",
        "皮膚黴菌感染",
        "落葉型天疱瘡與尋常型天疱瘡",
        "藥物疹",
        "紅斑性狼瘡",
        "鋅反應性皮膚病"
      ],
      "initialDB": [
        "皮膚細胞學（膿疱抹片見棘層鬆解細胞）",
        "全血球計數",
        "生化檢查",
        "皮膚刮片排除蠕形蟎"
      ],
      "advanced": [
        "皮膚組織病理學（表皮內棘層鬆解性膿疱）",
        "直接免疫螢光檢查（細胞間IgG沉積）",
        "ANA檢測排除狼瘡",
        "真菌培養排除皮膚黴菌"
      ]
    },
    "treatment": {
      "overview": "免疫抑制治療為主，通常需要長期維持治療",
      "acute": [
        "潑尼松龍（Prednisolone）2-4 mg/kg/day 誘導緩解",
        "嚴重病例可合併硫唑嘌呤（Azathioprine，犬）或苯丁酸氮芥（Chlorambucil，貓）",
        "繼發感染時給予抗生素",
        "外用類固醇輔助"
      ],
      "chronic": [
        "逐漸減量至最低有效劑量維持",
        "免疫抑制劑長期輔助（硫唑嘌呤、環孢靈、麥考酚酯）",
        "避免紫外線暴露",
        "定期監測藥物副作用"
      ]
    },
    "prognosis": "多數病例可達到緩解但難以完全治癒，需終身免疫抑制治療。犬的預後較好，約75%可控制。貓的預後中等。藥物誘發型停藥後可能自行緩解。",
    "pearls": [
      "膿疱抹片中看到棘層鬆解細胞（圓形角質細胞無連接）是高度提示性發現",
      "天疱瘡不影響黏膜（與尋常型天疱瘡不同）",
      "貓的甲床病變幾乎是天疱瘡的特徵性表現",
      "不要僅憑ANA陽性排除天疱瘡",
      "足墊病變是重要的診斷線索"
    ],
    "diagnosticAlgorithm": {
      "title": "天疱瘡 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估皮膚病變分布與型態特徵",
          "findings": [
            "面部/鼻樑/耳廓對稱性痂皮",
            "足墊增厚或潰瘍",
            "膿皰（短暫，易破裂）",
            "鱗屑與結痂為主要表現"
          ]
        },
        {
          "step": 2,
          "action": "皮膚細胞學",
          "details": "膿皰或痂皮下方壓印塗片鏡檢",
          "findings": [
            "棘層鬆解細胞（acantholytic cells）",
            "大量嗜中性球包圍棘層鬆解細胞",
            "無細菌感染證據",
            "不含退化性嗜中性球"
          ]
        },
        {
          "step": 3,
          "action": "皮膚組織病理學",
          "details": "多處皮膚活檢（選擇完整膿皰或新病變）",
          "findings": [
            "表皮內棘層鬆解形成裂隙",
            "嗜中性球/嗜酸性球浸潤",
            "棘層鬆解細胞在裂隙中",
            "基底層完整"
          ]
        },
        {
          "step": 4,
          "action": "鑑別診斷排除",
          "details": "排除其他類似皮膚疾病",
          "findings": [
            "排除細菌性膿皮症",
            "排除皮膚黴菌感染",
            "排除藥物反應",
            "排除紅斑性狼瘡"
          ]
        }
      ]
    },
    "monitoring": [
      "皮膚病變改善程度",
      "CBC和生化監測免疫抑制藥物副作用",
      "尿液分析（類固醇性糖尿病）",
      "體重和肌肉量",
      "繼發感染跡象"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "seborrhea": {
    "zh": "脂漏症",
    "en": "Seborrhea",
    "definition": "皮膚角化異常導致過度鱗屑和/或油脂分泌的皮膚病，可為原發性（遺傳性）或繼發於其他皮膚疾病。",
    "synonyms": [
      "脂漏性皮膚炎",
      "角化異常",
      "Seborrheic Dermatitis"
    ],
    "epidemiology": {
      "species": "犬較常見，貓較少見",
      "age": "原發性：幼年發病；繼發性：任何年齡",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "美國可卡犬、英國史賓格犬、西高地白梗、巴吉度獵犬等品種好發原發性脂漏症",
        "甲狀腺功能低下",
        "過敏性皮膚病",
        "寄生蟲感染",
        "營養不良"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "過度鱗屑（乾性或油性）",
        "皮膚異味（尤其油性脂漏）",
        "搔癢程度不一",
        "毛髮乾燥或油膩",
        "慢性反覆發作",
        "耳道問題常併發"
      ],
      "physicalExam": [
        "乾性脂漏（Seborrhea sicca）：乾燥白色鱗屑",
        "油性脂漏（Seborrhea oleosa）：油膩黃色鱗屑",
        "脂漏性皮膚炎：紅斑伴鱗屑和油脂",
        "皮膚皺褶處常加重",
        "外耳炎",
        "繼發性馬拉色菌或細菌感染"
      ]
    },
    "pathophysiology": "原發性脂漏症為遺傳性角化缺陷，表皮更新速度加快（正常犬約21天，脂漏犬約8天），導致角質層異常增厚和皮脂腺分泌異常。繼發性脂漏症由潛在疾病引起皮膚屏障功能障礙和角化異常。",
    "diagnosis": {
      "overview": "需排除潛在病因，原發性脂漏症為排除性診斷",
      "differentials": [
        "甲狀腺功能低下",
        "過敏性皮膚病（異位性皮膚炎、食物過敏）",
        "寄生蟲感染（蠕形蟎、疥蟎）",
        "皮膚黴菌感染",
        "天疱瘡",
        "鋅反應性皮膚病"
      ],
      "initialDB": [
        "皮膚細胞學（評估繼發感染）",
        "皮膚刮片",
        "甲狀腺功能檢查（T4、TSH）",
        "全血球計數和生化檢查"
      ],
      "advanced": [
        "皮膚組織病理學",
        "過敏原檢測",
        "食物排除試驗",
        "真菌培養",
        "皮膚超音波"
      ]
    },
    "treatment": {
      "overview": "治療潛在病因為首要目標，配合局部和全身性治療改善角化異常",
      "acute": [
        "抗脂漏洗毛精（含硫化硒、焦油、水楊酸、過氧化苯甲醯）",
        "每週洗澡2-3次直到改善",
        "治療繼發性細菌和馬拉色菌感染",
        "全身性抗生素（嚴重繼發感染）"
      ],
      "chronic": [
        "維持性洗浴（每1-2週）",
        "必需脂肪酸補充（Omega-3/6）",
        "治療和控制潛在病因",
        "維生素A補充（特定品種）",
        "局部保濕劑"
      ]
    },
    "prognosis": "繼發性脂漏症在控制潛在病因後預後良好。原發性脂漏症無法治癒但可控制，需終身管理。繼發感染若未控制會顯著影響預後。",
    "pearls": [
      "90%以上的脂漏症為繼發性，必須積極尋找潛在病因",
      "甲狀腺功能低下是最常被忽略的繼發原因之一",
      "洗毛精需接觸皮膚至少10分鐘才有效",
      "油性脂漏比乾性脂漏更常伴隨繼發感染",
      "可卡犬的原發性脂漏症可能伴發耳道角化異常"
    ],
    "diagnosticAlgorithm": {
      "title": "脂漏症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估皮膚油脂分泌異常與鱗屑型態",
          "findings": [
            "乾燥型鱗屑（脂漏sicca）或油膩型鱗屑（脂漏oleosa）",
            "皮膚異味",
            "被毛油膩或乾燥",
            "搔癢程度不等"
          ]
        },
        {
          "step": 2,
          "action": "繼發感染評估",
          "details": "皮膚細胞學檢查評估馬拉色菌與細菌繼發感染",
          "findings": [
            "馬拉色菌過度增殖",
            "細菌性膿皮症",
            "皮膚pH值變化",
            "耳道同時受影響"
          ]
        },
        {
          "step": 3,
          "action": "原發病因調查",
          "details": "脂漏症多為繼發性，需調查潛在原因",
          "findings": [
            "甲狀腺功能低下檢測",
            "過敏原調查（食物/環境）",
            "皮膚刮搔排除蟎蟲",
            "內分泌疾病篩查"
          ]
        },
        {
          "step": 4,
          "action": "組織病理學（必要時）",
          "details": "原發性脂漏症需組織活檢確認",
          "findings": [
            "表皮過度角化",
            "毛囊角化異常",
            "皮脂腺增生",
            "品種相關原發性脂漏（可卡犬/西高地白梗）"
          ]
        }
      ]
    },
    "monitoring": [
      "皮膚鱗屑和油脂程度",
      "繼發感染控制",
      "潛在病因的控制狀態",
      "甲狀腺激素水平（如適用）",
      "生活品質評估"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "malassezia-dermatitis": {
    "zh": "馬拉色菌皮膚炎",
    "en": "Malassezia Dermatitis",
    "definition": "由馬拉色菌（Malassezia pachydermatis）過度增生引起的皮膚和/或耳道感染，通常繼發於其他皮膚疾病。",
    "synonyms": [
      "酵母菌性皮膚炎",
      "糠秕馬拉色菌感染",
      "Yeast Dermatitis"
    ],
    "epidemiology": {
      "species": "犬較常見，貓較少見",
      "age": "任何年齡，但成年犬多見",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "西高地白梗、巴吉度獵犬、可卡犬、臘腸犬、拉布拉多等品種好發",
        "異位性皮膚炎",
        "甲狀腺功能低下",
        "皮膚皺褶多的品種",
        "潮濕環境",
        "免疫抑制",
        "長期使用抗生素"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "強烈搔癢",
        "皮膚異味（酵母菌特有的腐臭味）",
        "慢性或反覆發作",
        "對抗生素治療反應不佳",
        "季節性或全年性"
      ],
      "physicalExam": [
        "紅斑和油膩鱗屑",
        "皮膚增厚（苔蘚化）",
        "色素沉著（慢性）",
        "皮膚皺褶處（頸腹側、腋窩、腹股溝、趾間）好發",
        "外耳炎（耳道紅腫、褐色蠟狀分泌物）",
        "爪床周圍紅棕色分泌物"
      ]
    },
    "pathophysiology": "馬拉色菌為正常皮膚共生菌，當皮膚微環境改變（潮濕、皮脂過多、免疫功能異常）時過度增生。酵母菌代謝產物和菌體成分引發炎症反應和過敏反應，部分犬會產生對馬拉色菌的IgE介導超敏反應。",
    "diagnosis": {
      "overview": "皮膚細胞學為最快速可靠的診斷方法",
      "differentials": [
        "細菌性膿皮症",
        "蠕形蟎感染",
        "皮膚黴菌感染",
        "異位性皮膚炎",
        "接觸性皮膚炎",
        "脂漏症"
      ],
      "initialDB": [
        "皮膚細胞學（膠帶法或壓片法見花生形酵母菌）",
        "皮膚刮片排除蠕形蟎",
        "伍德氏燈檢查",
        "全血球計數和生化"
      ],
      "advanced": [
        "皮膚組織病理學",
        "真菌培養（通常不需要）",
        "甲狀腺功能檢查",
        "過敏原檢測（尋找潛在病因）"
      ]
    },
    "treatment": {
      "overview": "局部和/或全身性抗真菌治療，同時處理潛在病因",
      "acute": [
        "局部治療：含2%酮康唑或2%氯己定+2%咪康唑洗毛精",
        "洗浴頻率每週2-3次，持續2-4週",
        "全身性治療：酮康唑5-10 mg/kg/day或伊曲康唑5 mg/kg/day",
        "耳道感染：含抗真菌成分的耳藥"
      ],
      "chronic": [
        "維持性洗浴（每1-2週）",
        "控制潛在過敏性疾病",
        "保持皮膚皺褶乾燥清潔",
        "必需脂肪酸補充",
        "反覆感染考慮長期低劑量抗真菌維持"
      ]
    },
    "prognosis": "單純感染治療反應良好，2-4週可見明顯改善。但若潛在病因未控制，極易復發。過敏性犬可能需要長期管理。",
    "pearls": [
      "細胞學上每個高倍視野見到>2個酵母菌體即可診斷（部分品種閾值更低）",
      "馬拉色菌感染的特有異味是重要診斷線索",
      "與細菌性膿皮症常同時存在，需同時治療",
      "貓的馬拉色菌感染常與潛在免疫抑制相關",
      "趾間的紅棕色分泌物是常見但易被忽略的病灶"
    ],
    "diagnosticAlgorithm": {
      "title": "馬拉色菌皮膚炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估皮膚病變分布、搔癢程度與氣味",
          "findings": [
            "皮膚搔癢與紅斑",
            "特徵性酵母臭味",
            "皮膚油膩增厚",
            "腹側/腋下/趾間/耳道好發"
          ]
        },
        {
          "step": 2,
          "action": "細胞學檢查",
          "details": "膠帶壓貼法或壓印塗片，鏡檢酵母菌",
          "findings": [
            "花生形或雪人形馬拉色菌",
            "每高倍鏡視野>2個菌體為異常",
            "伴隨角質細胞增多",
            "可能同時見球菌"
          ]
        },
        {
          "step": 3,
          "action": "潛在誘因調查",
          "details": "馬拉色菌過度增殖通常有潛在誘因",
          "findings": [
            "過敏性皮膚炎（異位性/食物）",
            "內分泌疾病（甲低/庫欣）",
            "角化異常",
            "皮膚屏障功能障礙"
          ]
        },
        {
          "step": 4,
          "action": "治療反應監測",
          "details": "抗黴菌治療後複查細胞學",
          "findings": [
            "局部或全身抗黴菌治療反應",
            "治療後細胞學菌量減少",
            "搔癢改善但未完全→調查潛在過敏",
            "復發頻率評估"
          ]
        }
      ]
    },
    "monitoring": [
      "皮膚細胞學追蹤酵母菌數量",
      "搔癢程度改善",
      "繼發感染控制",
      "潛在病因管理",
      "肝功能（使用全身性唑類藥物時）"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "aspiration-pneumonia": {
    "zh": "吸入性肺炎",
    "en": "Aspiration Pneumonia",
    "definition": "因吸入胃內容物、食物或液體進入下呼吸道引起的肺部炎症和感染，為犬貓常見的嚴重呼吸系統疾病。",
    "synonyms": [
      "吸入性肺炎",
      "誤嚥性肺炎"
    ],
    "epidemiology": {
      "species": "犬較常見，貓較少見",
      "age": "任何年齡，幼犬和老年犬風險較高",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "嘔吐或反流",
        "巨食道症",
        "喉部麻痺",
        "麻醉後",
        "強迫灌食",
        "短頭犬種",
        "神經肌肉疾病",
        "食道疾病",
        "意識狀態改變"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "急性呼吸困難",
        "咳嗽（濕性）",
        "發燒",
        "嘔吐或反流病史",
        "近期麻醉史",
        "吞嚥困難",
        "鼻腔分泌物"
      ],
      "physicalExam": [
        "呼吸急促或呼吸困難",
        "發燒",
        "肺部囉音（尤其右中葉和前葉）",
        "濕性咳嗽",
        "鼻腔膿性分泌物",
        "脫水",
        "黏膜蒼白或發紺（嚴重時）"
      ]
    },
    "pathophysiology": "吸入物質直接損傷氣道上皮和肺泡，胃酸（pH<2.5）造成化學性灼傷，引發急性炎症反應。繼發細菌感染（口腔厭氧菌和革蘭氏陰性菌）加重肺損傷。重力依賴性肺葉（右中葉、右前葉）最常受影響。",
    "diagnosis": {
      "overview": "結合臨床病史、理學檢查和影像學檢查進行診斷",
      "differentials": [
        "細菌性肺炎（非吸入性）",
        "肺水腫",
        "肺栓塞",
        "肺腫瘤",
        "真菌性肺炎",
        "肺出血"
      ],
      "initialDB": [
        "胸部X光（腹側和右側肺葉實質化）",
        "全血球計數（嗜中性球增多伴左移）",
        "脈搏血氧飽和度",
        "動脈血氣分析"
      ],
      "advanced": [
        "氣管灌洗液細胞學和培養/藥敏",
        "CT掃描",
        "食道造影或內視鏡（評估潛在原因）",
        "血液培養（疑似敗血症）"
      ]
    },
    "treatment": {
      "overview": "支持療法、抗生素和治療潛在病因為治療核心",
      "acute": [
        "氧氣治療",
        "靜脈輸液（避免過度水合）",
        "廣譜抗生素（Ampicillin-Sulbactam + Enrofloxacin 或 Clindamycin）",
        "霧化治療和拍背（Coupage）促進排痰",
        "支氣管擴張劑（Aminophylline）",
        "禁食（嘔吐/反流者）",
        "抬高頭部體位"
      ],
      "chronic": [
        "抗生素療程至少3-6週",
        "治療潛在病因（巨食道症、喉麻痺等）",
        "飲食管理（抬高餵食、改變食物質地）",
        "避免誘發因素"
      ]
    },
    "prognosis": "輕至中度吸入性肺炎積極治療預後尚可（存活率約77-82%）。嚴重病例或併發ARDS預後較差。潛在病因可否矯正是影響長期預後的關鍵因素。",
    "pearls": [
      "右中葉是最常受影響的肺葉（重力依賴）",
      "麻醉後嘔吐是常見誘因，術前禁食很重要",
      "不建議預防性使用抗生素，但確診後應積極使用",
      "類固醇在吸入性肺炎中的使用有爭議，通常不建議",
      "霧化生理食鹽水配合拍背可有效促進分泌物排出"
    ],
    "diagnosticAlgorithm": {
      "title": "吸入性肺炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估與風險因子識別",
          "details": "詢問近期嘔吐/麻醉/強迫灌藥史，評估呼吸狀態",
          "findings": [
            "急性呼吸困難或呼吸急促",
            "濕性咳嗽",
            "發燒",
            "近期麻醉/嘔吐/巨食道/喉麻痺病史"
          ]
        },
        {
          "step": 2,
          "action": "胸腔X光檢查",
          "details": "評估肺部浸潤分布，典型為重力依賴性肺葉",
          "findings": [
            "右中肺葉與前腹側肺葉浸潤",
            "間質至肺泡浸潤型態",
            "支氣管空氣徵",
            "肺葉實質化"
          ]
        },
        {
          "step": 3,
          "action": "實驗室檢查",
          "details": "血液學與血氣分析，氣管灌洗液分析",
          "findings": [
            "白血球增多伴左移",
            "動脈血氣：低氧血症",
            "氣管灌洗液見退化性嗜中性球與細菌",
            "BAL培養與藥敏試驗"
          ]
        },
        {
          "step": 4,
          "action": "潛在病因調查",
          "details": "確認導致吸入的根本原因以防復發",
          "findings": [
            "巨食道症排除（食道造影）",
            "喉功能評估",
            "胃食道逆流評估",
            "神經肌肉疾病篩查"
          ]
        }
      ]
    },
    "monitoring": [
      "呼吸速率和型態",
      "體溫",
      "脈搏血氧飽和度",
      "胸部X光追蹤（48-72小時）",
      "白血球計數和C反應蛋白"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "pneumothorax": {
    "zh": "氣胸",
    "en": "Pneumothorax",
    "definition": "氣胸是指空氣異常進入胸膜腔導致肺臟塌陷的呼吸急症。分外傷性（肋骨骨折、穿刺傷、最常見）、自發性（肺泡破裂形成肺大泡，大型深胸犬好發）和張力性（空氣只進不出，快速致命）。臨床表現為呼吸急促、呼吸困難和胸部叩診鼓音。緊急胸腔穿刺排氣為首要處置。",
    "synonyms": [
      "胸腔積氣"
    ],
    "epidemiology": {
      "species": "犬貓皆可發生",
      "age": "創傷性：任何年齡；自發性：中老年犬",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "胸部創傷（車禍、咬傷）",
        "肺部腫瘤",
        "肺大疱或肺氣腫",
        "氣道疾病",
        "胸腔穿刺術後",
        "機械通氣"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "急性呼吸困難",
        "創傷史",
        "突然發作的呼吸窘迫",
        "運動不耐受",
        "開放性胸部傷口"
      ],
      "physicalExam": [
        "呼吸困難（限制型呼吸）",
        "心肺聽診減弱（背側）",
        "叩診呈過度共鳴音",
        "心搏過速",
        "黏膜蒼白或發紺",
        "張力性氣胸時可見頸靜脈怒張、休克",
        "皮下氣腫（部分病例）"
      ]
    },
    "pathophysiology": "空氣經由肺臟破裂處（創傷、肺泡破裂、肺大疱）或胸壁缺損進入胸膜腔。正常胸膜腔為負壓狀態，空氣積聚使負壓消失導致肺塌陷。張力性氣胸時，空氣持續進入但無法排出，胸腔內壓力持續升高，壓迫心臟和對側肺臟，造成生命威脅。",
    "diagnosis": {
      "overview": "胸部X光為主要診斷工具，緊急狀況可先進行治療性胸腔穿刺",
      "differentials": [
        "胸腔積液",
        "膈疝",
        "肺不張",
        "肺栓塞",
        "嚴重氣喘"
      ],
      "initialDB": [
        "胸部X光（肺臟退縮、胸膜腔透亮區）",
        "快速超音波評估（滑動徵消失）",
        "脈搏血氧飽和度",
        "全血球計數"
      ],
      "advanced": [
        "CT掃描（尋找肺大疱或腫瘤）",
        "治療性胸腔穿刺",
        "動脈血氣分析",
        "胸腔鏡檢查"
      ]
    },
    "treatment": {
      "overview": "根據嚴重程度採取觀察、胸腔穿刺或胸管引流",
      "acute": [
        "張力性氣胸：緊急胸腔穿刺減壓",
        "胸腔穿刺抽氣",
        "持續性氣胸：放置胸管持續引流",
        "氧氣治療",
        "開放性氣胸：傷口封閉",
        "休克治療（輸液、止痛）"
      ],
      "chronic": [
        "手術探查（持續漏氣>5天）",
        "肺葉切除（肺大疱、腫瘤）",
        "胸膜固定術（反覆自發性氣胸）",
        "限制運動至痊癒"
      ]
    },
    "prognosis": "創傷性氣胸經適當治療預後良好。自發性氣胸預後取決於潛在病因，肺腫瘤引起者預後較差。張力性氣胸若未及時治療可致命。",
    "pearls": [
      "張力性氣胸是急診，不應等待X光確認再治療",
      "胸部超音波可床邊快速評估（無滑動徵）",
      "自發性氣胸的犬應積極排查肺腫瘤",
      "小量氣胸可能自行吸收，但需密切觀察",
      "雙側氣胸比單側更危急"
    ],
    "diagnosticAlgorithm": {
      "title": "氣胸 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "緊急評估",
          "details": "快速評估呼吸窘迫程度，進行胸部聽診與叩診",
          "findings": [
            "急性呼吸困難",
            "胸部聽診背側呼吸音減弱",
            "叩診過度共鳴音",
            "限制性呼吸型態"
          ]
        },
        {
          "step": 2,
          "action": "影像學檢查",
          "details": "胸腔X光確認氣胸，評估嚴重程度",
          "findings": [
            "肺葉後縮離胸壁",
            "胸腔內透亮區無肺紋理",
            "心臟輪廓與肺葉間距增加",
            "張力性氣胸：縱膈移位"
          ]
        },
        {
          "step": 3,
          "action": "胸腔穿刺與分類",
          "details": "治療性胸腔穿刺抽氣，區分開放性/閉鎖性/張力性",
          "findings": [
            "抽出大量空氣",
            "穿刺後呼吸改善程度",
            "持續漏氣需胸管引流",
            "分類：外傷性/自發性/醫源性"
          ]
        },
        {
          "step": 4,
          "action": "病因調查",
          "details": "確認氣胸原因，評估手術需求",
          "findings": [
            "外傷史（肋骨骨折/穿透傷）",
            "自發性：肺大泡破裂",
            "腫瘤相關氣胸",
            "持續漏氣超過3-5天考慮手術"
          ]
        }
      ]
    },
    "monitoring": [
      "呼吸速率和型態",
      "胸管引流量和是否有持續漏氣",
      "胸部X光追蹤",
      "脈搏血氧飽和度",
      "有無皮下氣腫擴大"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "pyothorax": {
    "zh": "膿胸",
    "en": "Pyothorax",
    "definition": "膿胸是指胸膜腔內膿液蓄積的嚴重感染性疾病。貓最常見（可能與貓間咬傷相關），犬多與異物穿透或食道穿孔有關。致病菌多為混合厭氧菌和需氧菌。臨床表現為發燒、呼吸困難和全身毒血症。治療需胸管引流沖洗配合長期（4-6週）抗生素，內科治癒率約80-90%。",
    "synonyms": [
      "化膿性胸膜炎",
      "胸腔膿瘍",
      "Empyema"
    ],
    "epidemiology": {
      "species": "犬貓皆可發生，貓可能更常見",
      "age": "任何年齡，年輕至中年多見",
      "sex": "未絕育公貓風險較高（打架咬傷）",
      "riskFactors": [
        "穿透性胸部傷口",
        "咬傷",
        "異物吸入（草芒）",
        "食道穿孔",
        "肺部感染擴散",
        "胸腔手術後",
        "免疫抑制"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "進行性呼吸困難",
        "發燒",
        "厭食和消瘦",
        "嗜睡",
        "近期打架或外傷史",
        "病程數天至數週"
      ],
      "physicalExam": [
        "呼吸困難（限制型）",
        "發燒",
        "肺部腹側聽診減弱",
        "叩診濁音",
        "脫水",
        "消瘦",
        "黏膜蒼白",
        "胸部傷口（部分病例）",
        "口腔惡臭（厭氧菌）"
      ]
    },
    "pathophysiology": "細菌經由胸壁穿透、食道破裂、肺部感染直接擴散、血行播散或異物遷移進入胸膜腔。細菌增殖引發化膿性炎症，大量嗜中性球和壞死組織形成膿液。常見病原包括厭氧菌（Bacteroides, Fusobacterium, Peptostreptococcus）和需氧菌（Pasteurella, E. coli, Nocardia）。",
    "diagnosis": {
      "overview": "胸腔穿刺液分析和培養為確診關鍵",
      "differentials": [
        "心臟衰竭導致胸腔積液",
        "乳糜胸",
        "腫瘤性胸腔積液",
        "FIP（貓）",
        "血胸",
        "膈疝"
      ],
      "initialDB": [
        "胸部X光（胸腔積液）",
        "胸腔穿刺液分析（混濁或膿性、高蛋白、高細胞數）",
        "積液細胞學（退化性嗜中性球、細菌）",
        "全血球計數（嗜中性球增多伴左移）"
      ],
      "advanced": [
        "積液需氧和厭氧培養及藥敏試驗",
        "胸部CT（評估異物、腫塊）",
        "超音波引導穿刺",
        "血液培養"
      ]
    },
    "treatment": {
      "overview": "胸管引流配合全身性抗生素為治療基礎",
      "acute": [
        "雙側胸管放置和引流",
        "胸腔灌洗（溫生理食鹽水）",
        "全身性廣譜抗生素（Ampicillin-Sulbactam + Enrofloxacin 或 Metronidazole + Fluoroquinolone）",
        "靜脈輸液和營養支持",
        "止痛"
      ],
      "chronic": [
        "抗生素療程至少4-6週",
        "手術探查（異物、局限性膿瘍、治療無效）",
        "營養支持",
        "監測至積液完全清除"
      ]
    },
    "prognosis": "犬的存活率約80-90%，貓約60-75%。積極的胸管引流和適當抗生素是預後良好的關鍵。Nocardia和Actinomyces感染可能需要更長療程。",
    "pearls": [
      "胸腔積液中見到細菌即可確診",
      "厭氧菌培養需特殊採樣和送檢條件",
      "草芒異物是犬膿胸的重要原因，CT可幫助定位",
      "貓膿胸常與打架咬傷相關",
      "早期積極引流比僅靠抗生素效果更好"
    ],
    "diagnosticAlgorithm": {
      "title": "膿胸 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估呼吸窘迫程度與全身感染徵象",
          "findings": [
            "呼吸困難與呼吸急促",
            "發燒與精神極度沉鬱",
            "脫水與食慾廢絕",
            "腹側胸部叩診濁音"
          ]
        },
        {
          "step": 2,
          "action": "影像學與胸腔穿刺",
          "details": "胸腔X光/超音波確認積液，穿刺取樣",
          "findings": [
            "雙側胸腔積液常見",
            "超音波見高回音積液或纖維蛋白沉積",
            "穿刺抽出混濁惡臭液體",
            "液體呈乳白至黃綠色"
          ]
        },
        {
          "step": 3,
          "action": "積液分析",
          "details": "積液細胞學、生化分析、需氧及厭氧培養與藥敏",
          "findings": [
            "大量退化性嗜中性球",
            "細胞內外細菌",
            "蛋白質大於3g/dL",
            "葡萄糖偏低乳酸偏高"
          ]
        },
        {
          "step": 4,
          "action": "病因調查與治療",
          "details": "確認感染來源，建立胸管引流",
          "findings": [
            "穿透性異物（植物種子/草芒）",
            "食道穿孔",
            "肺膿腫破裂",
            "血行性播散"
          ]
        }
      ]
    },
    "monitoring": [
      "胸管引流量和性狀",
      "體溫",
      "胸部X光追蹤",
      "白血球計數",
      "積液培養追蹤"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "chylothorax": {
    "zh": "乳糜胸",
    "en": "Chylothorax",
    "definition": "乳糜胸是指富含乳糜微粒的淋巴液（乳糜）蓄積於胸膜腔的疾病。大多數犬貓為特發性，已知原因包括前縱膈腫瘤（淋巴瘤、胸腺瘤）、右心衰竭、心包疾病和胸導管損傷。Afghan Hound和暹羅貓可能有品種傾向。胸水呈乳白色，三酸甘油酯濃度高於血清為診斷依據。",
    "synonyms": [
      "乳糜性胸腔積液"
    ],
    "epidemiology": {
      "species": "犬貓皆可發生",
      "age": "犬：任何年齡；貓：老年貓較多",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "阿富汗獵犬和暹羅貓有品種好發性",
        "前縱膈腫瘤",
        "心臟病（尤其右心衰竭）",
        "創傷",
        "心絲蟲病",
        "先天性胸管異常"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "漸進性呼吸困難",
        "咳嗽",
        "運動不耐受",
        "厭食",
        "體重減輕"
      ],
      "physicalExam": [
        "呼吸困難（限制型）",
        "肺部腹側聽診減弱",
        "心音減弱",
        "叩診濁音",
        "消瘦",
        "可能觸及前縱膈腫塊"
      ]
    },
    "pathophysiology": "乳糜液為消化後的膳食脂肪經由腸道淋巴管匯集至胸管，正常經胸管排入靜脈系統。當胸管破裂（創傷）、阻塞（腫瘤、血栓）、或全身性淋巴壓力升高（右心衰竭、心包膜疾病）時，乳糜液滲漏至胸膜腔。特發性乳糜胸可能與胸管淋巴管擴張或發育異常有關。",
    "diagnosis": {
      "overview": "胸腔穿刺液分析確認乳糜液特性為診斷關鍵",
      "differentials": [
        "其他原因的胸腔積液",
        "假性乳糜胸（高膽固醇）",
        "心臟衰竭",
        "胸腔腫瘤",
        "膿胸"
      ],
      "initialDB": [
        "胸腔穿刺液分析（乳白色至粉紅色、三酸甘油酯高於血清值）",
        "積液三酸甘油酯和膽固醇測定",
        "胸部X光",
        "心臟超音波"
      ],
      "advanced": [
        "胸部CT（評估胸管和縱膈結構）",
        "淋巴管造影",
        "心絲蟲檢測",
        "前縱膈腫塊的細胞學或組織學"
      ]
    },
    "treatment": {
      "overview": "先尋找和治療潛在病因，保守治療無效時考慮手術",
      "acute": [
        "胸腔穿刺減壓緩解呼吸困難",
        "低脂飲食（中鏈三酸甘油酯為主）",
        "治療潛在病因（心臟病、腫瘤）",
        "Rutin（苯并吡喃酮類，50 mg/kg TID）"
      ],
      "chronic": [
        "手術治療：胸管結紮 + 心包膜切除術",
        "胸膜固定術（化學或機械性）",
        "反覆胸腔穿刺（姑息性）",
        "營養支持（補充蛋白質和脂溶性維生素）"
      ]
    },
    "prognosis": "取決於潛在病因。特發性乳糜胸手術治療（胸管結紮+心包膜切除）成功率約50-80%。繼發於可治療病因者預後較好。慢性乳糜胸可能導致纖維性胸膜炎，影響預後。",
    "pearls": [
      "積液三酸甘油酯>血清三酸甘油酯是確診乳糜液的標準",
      "禁食後積液可能不呈乳白色但仍為乳糜液",
      "慢性乳糜胸導致淋巴球流失，可能造成免疫抑制",
      "胸管結紮結合心包膜切除術比單獨手術效果好",
      "排除心臟疾病和前縱膈腫瘤是必要步驟"
    ],
    "diagnosticAlgorithm": {
      "title": "乳糜胸 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估呼吸困難程度與全身狀態",
          "findings": [
            "慢性進行性呼吸困難",
            "體重減輕",
            "咳嗽",
            "精神食慾下降"
          ]
        },
        {
          "step": 2,
          "action": "影像學與胸腔穿刺",
          "details": "胸腔X光確認積液，穿刺取樣分析",
          "findings": [
            "胸腔積液常為雙側",
            "穿刺液呈乳白色不透明",
            "進食後液體更白",
            "禁食後可能呈淡粉色"
          ]
        },
        {
          "step": 3,
          "action": "積液生化分析",
          "details": "確認乳糜液特徵",
          "findings": [
            "三酸甘油酯大於100mg/dL",
            "積液三酸甘油酯高於血清三酸甘油酯",
            "膽固醇低於血清膽固醇",
            "淋巴球為主的細胞學"
          ]
        },
        {
          "step": 4,
          "action": "病因調查",
          "details": "尋找導致乳糜液外漏的原因",
          "findings": [
            "心臟超音波排除心臟病",
            "縱膈腫瘤篩查",
            "淋巴管攝影術前定位",
            "特發性乳糜胸為排除性診斷"
          ]
        }
      ]
    },
    "monitoring": [
      "呼吸速率和努力程度",
      "胸腔積液量",
      "體重和營養狀態",
      "淋巴球計數",
      "心臟功能追蹤"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "osteochondritis-dissecans": {
    "zh": "剝脫性骨軟骨炎",
    "en": "Osteochondritis Dissecans",
    "definition": "發育性骨軟骨病的一種形式，關節軟骨及其下方骨骼的局灶性缺損導致軟骨瓣形成和關節炎症。",
    "synonyms": [
      "OCD",
      "骨軟骨炎",
      "剝離性骨軟骨炎"
    ],
    "epidemiology": {
      "species": "犬較常見，貓罕見",
      "age": "4-8月齡快速生長期幼犬",
      "sex": "公犬較常見（約2-3:1）",
      "riskFactors": [
        "大型和巨型犬種（大丹犬、拉布拉多、羅威那、黃金獵犬）",
        "快速生長",
        "高能量飲食",
        "過量鈣質攝取",
        "遺傳傾向"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "前肢跛行（最常見於肩關節）",
        "跛行在休息後加重、活動後略改善",
        "漸進性加重",
        "可能雙側發病",
        "運動後跛行加劇"
      ],
      "physicalExam": [
        "受影響關節的疼痛和活動度減少",
        "肩關節：屈曲時疼痛",
        "肘關節：內側壓痛",
        "踝關節和膝關節也可能受累",
        "肌肉萎縮（患肢）",
        "關節積液"
      ]
    },
    "pathophysiology": "正常軟骨內骨化過程中，深層軟骨細胞未能正常礦化和被骨骼取代，形成異常增厚的軟骨區域。此區域結構脆弱，承受力學壓力時發生龜裂，形成軟骨瓣或游離體。暴露的軟骨下骨引發關節炎症反應，游離體刺激滑膜導致關節積液。",
    "diagnosis": {
      "overview": "X光檢查為主要診斷工具，需拍攝對側關節對照",
      "differentials": [
        "肘關節發育不全",
        "前十字韌帶斷裂",
        "全骨炎",
        "骨腫瘤",
        "感染性關節炎",
        "肥大性骨病"
      ],
      "initialDB": [
        "關節X光（軟骨下骨缺損、關節內游離體）",
        "雙側關節X光對照",
        "骨科觸診"
      ],
      "advanced": [
        "CT掃描（精確評估病灶大小和位置）",
        "MRI",
        "關節鏡檢查（診斷兼治療）",
        "關節液分析"
      ]
    },
    "treatment": {
      "overview": "手術移除游離軟骨瓣為首選治療，保守治療適用於輕微病例",
      "acute": [
        "關節鏡手術移除軟骨瓣和刮除病灶",
        "開放性關節手術",
        "術後止痛（NSAIDs）",
        "術後限制運動4-6週"
      ],
      "chronic": [
        "體重管理",
        "關節保護劑（葡萄糖胺、軟骨素）",
        "適度運動",
        "NSAIDs控制疼痛",
        "物理治療和復健"
      ]
    },
    "prognosis": "肩關節OCD手術預後最佳（約85-90%恢復良好）。肘關節和踝關節預後稍差，取決於繼發性關節炎程度。早期手術預後優於延遲治療。",
    "pearls": [
      "肩關節是犬OCD最常見部位（尾側肱骨頭）",
      "約30-50%的病例為雙側性，需檢查對側",
      "高鈣飲食是可預防的風險因素",
      "關節鏡比開放手術恢復更快",
      "術後繼發性骨關節炎幾乎不可避免但通常可控制"
    ],
    "diagnosticAlgorithm": {
      "title": "剝脫性骨軟骨炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估跛行部位，確認年齡與品種傾向（大型犬幼犬）",
          "findings": [
            "前肢跛行為主（肩關節最常見）",
            "5-12月齡大型犬",
            "休息後跛行加重",
            "關節腫脹與活動範圍減少"
          ]
        },
        {
          "step": 2,
          "action": "X光檢查",
          "details": "受影響關節多角度X光，雙側比較",
          "findings": [
            "關節面軟骨下骨透亮區",
            "軟骨碎片鈣化影（游離體）",
            "關節內腫脹",
            "繼發性退行性關節變化"
          ]
        },
        {
          "step": 3,
          "action": "進階影像學",
          "details": "CT或MRI精確評估病變範圍與軟骨碎片",
          "findings": [
            "CT確認骨缺損範圍與深度",
            "MRI評估軟骨損傷程度",
            "游離體數量與位置",
            "對側關節篩查"
          ]
        },
        {
          "step": 4,
          "action": "關節鏡或手術",
          "details": "關節鏡探查確認診斷並同時治療",
          "findings": [
            "軟骨瓣或碎片確認",
            "軟骨下骨刮搔促進修復",
            "游離體移除",
            "關節軟骨損傷分級"
          ]
        }
      ]
    },
    "monitoring": [
      "術後跛行改善",
      "關節活動度",
      "X光追蹤骨關節炎進展",
      "體重控制",
      "對側關節監測"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "legg-calve-perthes": {
    "zh": "股骨頭無菌性壞死",
    "en": "Legg-Calvé-Perthes Disease",
    "definition": "股骨頭無菌性壞死（Legg-Calvé-Perthes病）是幼齡小型犬因股骨頭血液供應中斷導致股骨頭和頸部缺血性壞死的骨科疾病。Yorkshire Terrier、Poodle、West Highland White Terrier等5-8月齡小型犬好發。單側居多（85%）。疼痛性後肢跛行為主要表現。股骨頭切除術（FHO）為標準治療。",
    "synonyms": [
      "股骨頭缺血性壞死",
      "Avascular Necrosis of Femoral Head",
      "LCPD"
    ],
    "epidemiology": {
      "species": "犬（小型犬），貓極罕見",
      "age": "3-13月齡，多在5-8月齡發病",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "小型犬種（約克夏梗、迷你貴賓、西高地白梗、曼徹斯特梗、吉娃娃）",
        "遺傳因素（常染色體隱性遺傳）",
        "體重<12公斤"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "漸進性後肢跛行",
        "單側多見（約85%）",
        "不願承重",
        "跛行逐漸加重",
        "髖關節活動時疼痛",
        "病程數週至數月"
      ],
      "physicalExam": [
        "患側後肢肌肉萎縮",
        "髖關節外展和伸展時疼痛",
        "髖關節活動度減少",
        "患肢縮短（塌陷後）",
        "可能觸及骨摩擦感"
      ]
    },
    "pathophysiology": "股骨頭血供中斷（原因不完全明確，可能與血管異常或凝血異常有關）導致骨壞死。壞死骨在承重壓力下塌陷和碎裂，股骨頭變形。修復過程中新骨形成但股骨頭形狀已改變，導致關節不吻合和繼發性骨關節炎。",
    "diagnosis": {
      "overview": "X光檢查結合臨床表現可確診",
      "differentials": [
        "髖關節發育不全",
        "外傷性骨折",
        "感染性關節炎",
        "全骨炎",
        "骨腫瘤"
      ],
      "initialDB": [
        "骨盆X光（股骨頭密度不均、碎裂、塌陷）",
        "雙側髖關節對照",
        "骨科觸診"
      ],
      "advanced": [
        "CT掃描",
        "MRI（早期病變）",
        "關節液分析（排除感染）"
      ]
    },
    "treatment": {
      "overview": "手術治療為主要治療方式",
      "acute": [
        "股骨頭頸切除術（FHO/FHNE）為首選",
        "術後止痛",
        "術後早期物理治療"
      ],
      "chronic": [
        "積極的術後復健和物理治療",
        "游泳和水中跑步機",
        "體重管理",
        "長期運動維持肌肉量",
        "全髖關節置換術（少數病例）"
      ]
    },
    "prognosis": "股骨頭頸切除術後預後良好，大多數小型犬可恢復正常或接近正常的功能。術後積極復健對功能恢復至關重要。體重<15公斤的犬術後效果最佳。",
    "pearls": [
      "小型犬幼年發作的後肢跛行應首先考慮此診斷",
      "X光早期可能正常，2-3週後才出現典型變化",
      "雙側發病率約12-16%",
      "FHO術後物理治療是功能恢復的關鍵",
      "遺傳性疾病，應建議繁殖者不繁殖患犬"
    ],
    "diagnosticAlgorithm": {
      "title": "股骨頭無菌性壞死 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估後肢跛行，確認品種（小型犬）與年齡",
          "findings": [
            "單側後肢跛行漸進性加重",
            "小型犬4-11月齡",
            "後肢肌肉萎縮",
            "髖關節外展與伸展時疼痛"
          ]
        },
        {
          "step": 2,
          "action": "X光檢查",
          "details": "骨盆腹背位X光，雙側比較",
          "findings": [
            "股骨頭密度不均或透亮區",
            "股骨頭變形或塌陷",
            "股骨頸增寬或縮短",
            "繼發性退行性關節病變"
          ]
        },
        {
          "step": 3,
          "action": "進階影像與分期",
          "details": "必要時CT/MRI早期診斷，根據影像分期",
          "findings": [
            "早期MRI可偵測骨壞死",
            "中期骨密度變化與碎裂",
            "後期股骨頭塌陷變形",
            "髖臼繼發性變化"
          ]
        },
        {
          "step": 4,
          "action": "治療決策",
          "details": "根據嚴重程度決定保守或手術治療",
          "findings": [
            "股骨頭頸切除術為首選",
            "術前完整骨科檢查",
            "對側髖關節評估",
            "術後復健計劃"
          ]
        }
      ]
    },
    "monitoring": [
      "術後跛行改善",
      "患肢肌肉量恢復",
      "對側髖關節",
      "活動能力評估"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "panosteitis": {
    "zh": "全骨炎",
    "en": "Panosteitis",
    "definition": "全骨炎是幼齡大型犬長骨骨髓腔的自限性炎症性疾病，以急性起始的遊走性跛行為特徵。German Shepherd 5-18月齡最好發，公犬比母犬多4倍。X光可見骨髓腔內斑片狀骨質密度增加。通常在2歲前自行緩解，每次發作持續2-3週。止痛治療即可，無需手術。",
    "synonyms": [
      "全骨炎",
      "遊走性跛行",
      "Eosinophilic Panosteitis",
      "Pano"
    ],
    "epidemiology": {
      "species": "犬（中大型犬），貓極罕見",
      "age": "5-18月齡，偶見於更大年齡",
      "sex": "公犬較常見（約4:1）",
      "riskFactors": [
        "德國牧羊犬最常見（其他大型犬也可發生）",
        "快速生長",
        "高蛋白飲食",
        "遺傳傾向"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "急性跛行",
        "跛行可在不同肢體間移行",
        "發燒",
        "厭食",
        "間歇性發作和緩解",
        "自限性（通常2-5個月內自行緩解）"
      ],
      "physicalExam": [
        "長骨幹壓痛（深壓骨幹中段）",
        "跛行（可能嚴重到不願承重）",
        "發燒（39.5-40.5°C）",
        "肌肉萎縮（受影響肢體）",
        "前肢較後肢常見",
        "多個肢體可同時或先後受累"
      ]
    },
    "pathophysiology": "確切病因不明，可能與骨髓內脂肪細胞退化、骨母細胞活化和新骨形成有關。病理變化始於骨髓腔中央，脂肪骨髓被纖維血管組織取代，隨後新骨沉積。此過程引起骨內壓力升高和疼痛。病變具有自限性，通常在數週內消退。",
    "diagnosis": {
      "overview": "典型病史結合X光表現可確診",
      "differentials": [
        "肥大性骨病",
        "骨腫瘤（骨肉瘤）",
        "骨髓炎",
        "OCD",
        "肘關節發育不全",
        "前十字韌帶損傷"
      ],
      "initialDB": [
        "長骨X光（骨髓腔內斑塊狀或瀰漫性密度增加）",
        "骨幹觸診定位",
        "全血球計數（可能見嗜酸性球增多）"
      ],
      "advanced": [
        "多肢X光對照",
        "骨掃描（核醫學）",
        "CT掃描（排除其他病變）"
      ]
    },
    "treatment": {
      "overview": "支持療法和止痛為主，為自限性疾病",
      "acute": [
        "NSAIDs止痛（Carprofen或Meloxicam）",
        "限制運動",
        "嚴重病例可短期使用嗎啡類止痛",
        "發燒時支持療法"
      ],
      "chronic": [
        "依需要給予止痛藥",
        "避免過度運動",
        "均衡飲食（避免過高蛋白）",
        "等待自然緩解"
      ]
    },
    "prognosis": "預後極佳。為自限性疾病，大多數犬在1-2歲前完全康復，不留後遺症。少數病例可能反覆發作至2歲。",
    "pearls": [
      "骨幹中段深壓疼痛（而非關節）是關鍵診斷發現",
      "X光變化可能比臨床症狀晚1-2週出現",
      "移行性跛行是特徵性表現",
      "不要誤診為骨肉瘤（年齡是重要區分點）",
      "不需要抗生素治療",
      "德國牧羊犬幼犬跛行的最常見原因之一"
    ],
    "diagnosticAlgorithm": {
      "title": "全骨炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估遊走性跛行，確認年齡與品種",
          "findings": [
            "遊走性跛行不同肢體輪替",
            "大型犬5-18月齡",
            "長骨骨幹觸診疼痛",
            "輕度發燒與食慾下降"
          ]
        },
        {
          "step": 2,
          "action": "X光檢查",
          "details": "四肢長骨X光，多處檢查",
          "findings": [
            "長骨骨髓腔內斑塊狀密度增加",
            "骨膜反應",
            "尺骨最常受影響",
            "病變可在多處長骨出現"
          ]
        },
        {
          "step": 3,
          "action": "鑑別診斷排除",
          "details": "排除其他青年犬跛行原因",
          "findings": [
            "排除肥大性骨營養不良HOD",
            "排除OCD",
            "排除骨腫瘤",
            "排除骨折或關節感染"
          ]
        },
        {
          "step": 4,
          "action": "治療反應與預後",
          "details": "症狀治療後觀察自限性病程",
          "findings": [
            "NSAIDs治療反應良好",
            "自限性疾病數週至數月",
            "可能復發數次",
            "長期預後良好"
          ]
        }
      ]
    },
    "monitoring": [
      "跛行嚴重程度",
      "止痛藥效果",
      "體溫",
      "X光追蹤（必要時）",
      "生長發育"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "fracture": {
    "zh": "骨折",
    "en": "Fracture",
    "definition": "骨折是骨骼完整性遭破壞的創傷性或病理性疾病。犬貓最常見原因為交通事故和高處墜落。依骨折類型分橫斷、斜形、螺旋、粉碎和青枝骨折；依開放程度分閉鎖性和開放性（骨折端穿透皮膚）。長骨骨折（股骨、脛骨、肱骨、橈尺骨）最常見。治療以外科固定（接骨板、髓內釘、外固定架）為主。",
    "synonyms": [
      "Bone Fracture"
    ],
    "epidemiology": {
      "species": "犬貓皆常見",
      "age": "任何年齡，幼年和老年動物風險較高",
      "sex": "無明顯性別傾向，未絕育雄性因遊蕩行為風險稍高",
      "riskFactors": [
        "車禍",
        "高處墜落（貓）",
        "玩具犬種骨骼脆弱",
        "骨質疏鬆",
        "營養性次發性副甲狀腺亢進",
        "骨腫瘤（病理性骨折）",
        "代謝性骨病"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "急性跛行或無法承重",
        "外傷史",
        "墜落史",
        "突然尖叫或嗥叫",
        "無已知外傷（病理性骨折）"
      ],
      "physicalExam": [
        "患肢疼痛和腫脹",
        "肢體變形或縮短",
        "骨摩擦感（Crepitus）",
        "患肢異常活動",
        "無法承重",
        "軟組織腫脹和瘀傷",
        "開放性骨折：骨外露或傷口",
        "可能伴隨其他外傷（氣胸、腹部損傷）"
      ]
    },
    "pathophysiology": "外力超過骨骼彈性限度導致骨結構斷裂。根據斷裂方式分為橫斷、斜裂、螺旋、粉碎性等類型。骨折後出血形成血腫，啟動炎症和修復反應。修復過程包括：炎症期、軟骨痂形成、硬骨痂形成和骨重塑四個階段。",
    "diagnosis": {
      "overview": "X光為骨折的標準診斷工具",
      "differentials": [
        "脫臼",
        "韌帶損傷",
        "軟組織損傷",
        "病理性骨折（腫瘤）",
        "骨裂（應力性骨折）"
      ],
      "initialDB": [
        "至少兩個角度的X光（正面和側面）",
        "全身評估排除多發傷",
        "胸部X光（車禍患者）",
        "全血球計數和生化",
        "尿液分析（排除泌尿道損傷）"
      ],
      "advanced": [
        "CT掃描（複雜骨折或關節內骨折）",
        "MRI（懷疑軟組織損傷）",
        "病理性骨折需進行骨腫瘤評估",
        "凝血功能檢查（大量出血）"
      ]
    },
    "treatment": {
      "overview": "根據骨折類型、位置和患畜狀態選擇保守或手術治療",
      "acute": [
        "急救穩定（止血、止痛、輸液）",
        "臨時固定（夾板、Robert Jones繃帶）",
        "開放性骨折：傷口沖洗和抗生素",
        "手術固定：鋼板螺絲、髓內釘、外固定架",
        "止痛管理（多模式止痛）"
      ],
      "chronic": [
        "術後限制活動（6-12週）",
        "物理治療和復健",
        "營養支持",
        "不癒合或延遲癒合的處理",
        "拆除植入物（視情況）"
      ]
    },
    "prognosis": "取決於骨折類型、位置、治療方式和患畜年齡。單純骨折預後良好。開放性、粉碎性和感染性骨折預後較差。幼犬骨折癒合快（3-4週），老年犬較慢（8-12週）。病理性骨折取決於潛在病因。",
    "pearls": [
      "車禍患畜必須全身評估，骨折可能不是最危急問題",
      "幼年動物的不完全骨折（青枝骨折）易被忽略",
      "指骨、橈骨遠端和股骨是小型犬最常見骨折部位",
      "貓高處墜落常見多發性損傷（骨折+氣胸+口腔傷）",
      "病理性骨折需排查骨腫瘤",
      "術後感染率開放性骨折遠高於閉合性"
    ],
    "diagnosticAlgorithm": {
      "title": "骨折 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "緊急穩定與初步評估",
          "details": "優先處理危及生命的傷害，穩定後進行骨骼評估",
          "findings": [
            "疼痛與患肢不能負重",
            "局部腫脹與變形",
            "骨摩擦音或異常活動度",
            "外傷史（車禍/墜落/踩踏）"
          ]
        },
        {
          "step": 2,
          "action": "X光檢查",
          "details": "受傷部位至少兩個正交角度X光，含近遠端關節",
          "findings": [
            "骨折線型態（橫向/斜向/螺旋/粉碎）",
            "骨折移位程度",
            "關節面是否受累",
            "幼犬Salter-Harris分型"
          ]
        },
        {
          "step": 3,
          "action": "全身評估",
          "details": "多發傷動物全身影像學與實驗室檢查",
          "findings": [
            "胸腔X光排除氣胸/肺挫傷",
            "腹部超音波排除內臟損傷",
            "CBC/生化評估失血與臟器損傷",
            "尿液分析排除泌尿道損傷"
          ]
        },
        {
          "step": 4,
          "action": "治療計劃",
          "details": "根據骨折類型選擇固定方式",
          "findings": [
            "開放vs閉鎖骨折確認",
            "手術固定指征評估",
            "外固定vs內固定選擇",
            "軟組織損傷程度評估"
          ]
        }
      ]
    },
    "monitoring": [
      "術後X光追蹤（4-6週間隔）",
      "骨痂形成評估",
      "感染跡象",
      "植入物穩定性",
      "關節活動度和肌肉恢復",
      "止痛藥需求"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "canine-influenza": {
    "zh": "犬流感",
    "en": "Canine Influenza Virus (CIV)",
    "definition": "犬流感是由A型流感病毒（主要為H3N8和H3N2亞型）引起的急性呼吸道傳染病。H3N8最初由馬流感病毒適應犬隻而來，H3N2則源自禽流感病毒。幾乎所有未曾暴露的犬隻均為易感個體。",
    "synonyms": [
      "CIV",
      "Canine Flu",
      "犬A型流感"
    ],
    "epidemiology": {
      "species": "犬為主，H3N2亦可感染貓",
      "age": "所有年齡均可感染",
      "sex": "無性別傾向",
      "riskFactors": [
        "犬舍、寄宿設施、狗公園等群聚環境",
        "未接種流感疫苗",
        "免疫功能低下",
        "短頭種犬呼吸道結構異常",
        "運輸緊迫"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "持續性咳嗽（10-21天）",
        "漿液性至黏液膿性鼻分泌物",
        "發熱（39.5-40.5°C）",
        "精神沉鬱和食慾減退",
        "打噴嚏",
        "部分犬隻可發展為肺炎"
      ],
      "physicalExam": [
        "發熱",
        "漿液性或黏液膿性鼻分泌物",
        "肺部聽診可能有異常呼吸音（支氣管音或囉音）",
        "結膜充血",
        "下頷淋巴結腫大",
        "重症病例可見呼吸困難和發紺"
      ]
    },
    "pathophysiology": "犬流感病毒經飛沫和氣溶膠傳播，感染呼吸道上皮細胞。病毒在上呼吸道和下呼吸道上皮細胞中複製，導致上皮壞死、黏膜纖毛清除功能喪失和炎症反應。繼發性細菌感染（如支氣管敗血波氏桿菌、鏈球菌等）可導致嚴重的支氣管肺炎。約80%的感染犬會出現臨床症狀，其中大多數為輕症，但約5-8%可發展為重症肺炎。",
    "diagnosis": {
      "overview": "基於臨床症狀、流行病學背景和實驗室確認診斷",
      "differentials": [
        "犬傳染性氣管支氣管炎（犬舍咳）",
        "犬瘟熱",
        "細菌性肺炎",
        "黴漿菌感染",
        "犬腺病毒第二型感染",
        "真菌性肺炎",
        "心臟病相關咳嗽"
      ],
      "initialDB": [
        "鼻拭子或咽拭子PCR檢測（症狀出現後3-7天內最佳）",
        "CBC（可見白血球增多或正常）",
        "胸腔X光（評估肺炎程度）"
      ],
      "advanced": [
        "配對血清學檢測（急性期和恢復期間隔2-3週）",
        "病毒分離培養",
        "亞型鑑定（H3N8 vs H3N2）",
        "細菌培養和藥敏試驗（疑似繼發感染時）"
      ]
    },
    "treatment": {
      "overview": "輕症以支持療法為主，重症需積極治療繼發性細菌感染和呼吸支持",
      "acute": [
        "輕症：休息、營養支持、保持充足水分攝取",
        "止咳藥（hydrocodone 0.22 mg/kg PO q6-12h，僅限無肺炎時使用）",
        "繼發細菌感染時使用抗生素（doxycycline 5-10 mg/kg PO q12h）",
        "重症肺炎：靜脈輸液、氧氣治療",
        "霧化治療改善呼吸道濕化"
      ],
      "chronic": [
        "恢復期持續抗生素療程（10-14天）",
        "環境消毒和隔離管理",
        "營養支持促進恢復"
      ]
    },
    "prognosis": "大多數感染犬預後良好，輕症死亡率<1%。發展為重症肺炎的病例死亡率約5-8%。大多數犬隻在2-3週內完全恢復。",
    "pearls": [
      "犬流感與犬舍咳臨床表現極為相似，需實驗室檢測區分",
      "感染犬在出現症狀前即具傳染性，增加群體防控難度",
      "H3N2可感染貓，在多物種家庭中需注意交叉傳染",
      "病毒在環境表面存活不超過48小時，對常見消毒劑敏感",
      "約20%的感染犬為無症狀帶原者但仍可傳播病毒"
    ],
    "diagnosticAlgorithm": {
      "title": "犬流感 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "詢問群居接觸史，評估呼吸道症狀嚴重程度",
          "findings": [
            "持續性咳嗽10-21天",
            "漿液性至膿性鼻分泌物",
            "發燒",
            "犬舍/寄宿/狗聚集場所接觸史"
          ]
        },
        {
          "step": 2,
          "action": "臨床分型",
          "details": "區分輕症型與重症型犬流感",
          "findings": [
            "輕症型：咳嗽加鼻分泌物（80%犬）",
            "重症型：高燒加出血性肺炎",
            "繼發細菌性肺炎",
            "白血球增多或減少"
          ]
        },
        {
          "step": 3,
          "action": "實驗室確診",
          "details": "鼻咽拭子PCR或血清學雙份檢測",
          "findings": [
            "CIV RT-PCR（發病3-5天內最敏感）",
            "H3N2或H3N8亞型鑑定",
            "急性與恢復期雙份血清抗體四倍升高",
            "胸腔X光支氣管間質至肺泡浸潤"
          ]
        },
        {
          "step": 4,
          "action": "防疫措施",
          "details": "確認後啟動隔離與環境消毒",
          "findings": [
            "患犬隔離至少21天",
            "接觸犬觀察",
            "環境消毒",
            "群體疫苗接種評估"
          ]
        }
      ]
    },
    "monitoring": [
      "體溫每日監測",
      "呼吸頻率和呼吸型態",
      "鼻分泌物性質變化",
      "胸腔X光追蹤（肺炎病例）",
      "隔離期間至少持續至症狀消失後7天"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "feline-chlamydiosis": {
    "zh": "貓衣原體感染",
    "en": "Feline Chlamydiosis",
    "definition": "由貓衣原體（Chlamydia felis）引起的上呼吸道和結膜感染，以慢性結膜炎為主要表現。",
    "synonyms": [
      "貓衣原體結膜炎",
      "貓衣原體肺炎",
      "Feline Chlamydophilosis"
    ],
    "epidemiology": {
      "species": "貓",
      "age": "幼貓（5週至9月齡）最常見，成貓也可感染",
      "sex": "無性別傾向",
      "riskFactors": [
        "多貓家庭",
        "收容所環境",
        "未接種疫苗",
        "免疫功能低下",
        "與感染貓密切接觸",
        "應激因素"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "單側結膜炎（後轉為雙側）",
        "漿液性至膿性眼分泌物",
        "眨眼和流淚",
        "輕度鼻腔分泌物",
        "打噴嚏",
        "食慾可能正常或輕度下降"
      ],
      "physicalExam": [
        "結膜充血和水腫（化學性結膜炎）",
        "漿液性至黏膿性眼分泌物",
        "瞬膜突出",
        "眼瞼痙攣",
        "角膜通常不受影響",
        "輕度鼻腔分泌物",
        "罕見發燒"
      ]
    },
    "pathophysiology": "貓衣原體為專性細胞內寄生菌，主要感染結膜上皮細胞。病原體在細胞內形成包含體進行增殖，引發局部炎症反應。感染通常始於一側眼睛，5-7天後擴散至另一側。慢性感染可能與生殖道定殖有關。",
    "diagnosis": {
      "overview": "結膜拭子PCR為最敏感的確診方法",
      "differentials": [
        "貓疱疹病毒感染",
        "貓杯狀病毒感染",
        "黴漿菌感染",
        "細菌性結膜炎",
        "過敏性結膜炎"
      ],
      "initialDB": [
        "結膜拭子PCR",
        "結膜細胞學（上皮細胞內包含體，敏感度低）",
        "眼部螢光素染色（排除角膜潰瘍）"
      ],
      "advanced": [
        "結膜拭子培養",
        "血清學檢查（IgG/IgM）",
        "FeLV/FIV檢測",
        "上呼吸道病原體多重PCR"
      ]
    },
    "treatment": {
      "overview": "全身性和局部抗生素治療為主",
      "acute": [
        "Doxycycline 10 mg/kg PO SID（首選），療程至少4週",
        "四環素眼藥膏 TID-QID",
        "眼部清潔（溫生理食鹽水）",
        "多貓家庭全部貓同時治療"
      ],
      "chronic": [
        "延長Doxycycline療程（症狀消失後再續2週）",
        "環境消毒",
        "疫苗接種預防",
        "減少應激因素"
      ]
    },
    "prognosis": "適當抗生素治療預後良好，大多數貓在2-3週內改善。不治療可能慢性化持續數月。慢性帶原狀態可能存在。",
    "pearls": [
      "單側起始的結膜炎高度提示衣原體感染（疱疹病毒也可能）",
      "Doxycycline是首選，Azithromycin為替代",
      "治療不完全是復發的主要原因",
      "低人畜共通傳染風險（免疫抑制人群需注意）",
      "多貓環境中需同時治療所有貓以避免交叉感染"
    ],
    "diagnosticAlgorithm": {
      "title": "貓衣原體感染 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估結膜炎症狀，注意單側起始後雙側進展的典型過程",
          "findings": [
            "單側結膜炎起始後雙側進展",
            "明顯結膜水腫與充血",
            "漿液性至黏液膿性眼分泌物",
            "輕度上呼吸道症狀"
          ]
        },
        {
          "step": 2,
          "action": "鑑別檢查",
          "details": "與其他貓上呼吸道病原鑑別",
          "findings": [
            "角膜通常不受影響（與FHV區別）",
            "口腔潰瘍不常見（與FCV區別）",
            "打噴嚏可有可無",
            "幼貓或多貓家庭高風險"
          ]
        },
        {
          "step": 3,
          "action": "實驗室確診",
          "details": "結膜拭子PCR檢測",
          "findings": [
            "Chlamydia felis PCR陽性",
            "結膜細胞學可見包涵體敏感度低",
            "排除FHV/FCV共感染",
            "FIV/FeLV狀態評估"
          ]
        },
        {
          "step": 4,
          "action": "治療與控制",
          "details": "四環素類抗生素治療至少4週",
          "findings": [
            "Doxycycline為首選抗生素",
            "同居貓需同時治療",
            "治療不完全易復發",
            "疫苗可減輕症狀但不防止感染"
          ]
        }
      ]
    },
    "monitoring": [
      "眼部症狀改善",
      "治療完成後PCR追蹤",
      "同居貓的症狀",
      "疫苗接種時程"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "canine-brucellosis": {
    "zh": "犬布魯氏菌病",
    "en": "Canine Brucellosis",
    "definition": "由犬布魯氏菌（Brucella canis）引起的慢性全身性感染，主要影響生殖系統，為重要的人畜共通傳染病。",
    "synonyms": [
      "犬布氏桿菌感染",
      "Brucella canis Infection"
    ],
    "epidemiology": {
      "species": "犬",
      "age": "任何年齡，繁殖犬較常見",
      "sex": "兩性皆感染，繁殖犬風險最高",
      "riskFactors": [
        "繁殖犬舍",
        "未檢疫的繁殖犬",
        "接觸流產物質",
        "交配感染",
        "收容所環境"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "母犬：流產（懷孕後期）、不孕",
        "公犬：睪丸腫大後萎縮、不孕",
        "淋巴結腫大",
        "脊椎疼痛",
        "嗜睡",
        "部分犬無明顯症狀"
      ],
      "physicalExam": [
        "全身淋巴結腫大",
        "公犬：附睪腫大、睪丸萎縮",
        "母犬：陰道分泌物",
        "椎間盤脊椎炎（腰椎疼痛）",
        "眼前房積膿（葡萄膜炎）",
        "體況可能正常"
      ]
    },
    "pathophysiology": "犬布魯氏菌經口、鼻、結膜或生殖道黏膜入侵，被巨噬細胞攝入後在細胞內增殖。菌血症持續數月至數年，細菌定殖於生殖器官、脾臟、肝臟和淋巴結。在胎盤滋養層細胞中大量增殖導致流產。公犬中細菌定殖於附睪和前列腺。",
    "diagnosis": {
      "overview": "血清學篩檢結合血液培養確診",
      "differentials": [
        "其他流產原因（疱疹病毒、弓蟲）",
        "睪丸腫瘤",
        "前列腺疾病",
        "椎間盤脊椎炎其他原因",
        "系統性黴菌感染"
      ],
      "initialDB": [
        "快速玻片凝集試驗（RSAT，篩檢用）",
        "試管凝集試驗（TAT）",
        "全血球計數",
        "血液培養"
      ],
      "advanced": [
        "瓊脂凝膠免疫擴散試驗（AGID，確認試驗）",
        "血液PCR",
        "精液培養",
        "脊椎X光（椎間盤脊椎炎）"
      ]
    },
    "treatment": {
      "overview": "抗生素聯合治療，但難以完全清除感染，建議絕育",
      "acute": [
        "Doxycycline 12.5 mg/kg PO BID + Streptomycin 20 mg/kg IM（4週）",
        "替代方案：Doxycycline + Enrofloxacin",
        "絕育手術（公犬去勢、母犬卵巢子宮切除）"
      ],
      "chronic": [
        "長期抗生素（至少8-12週）",
        "定期血清學追蹤",
        "隔離感染犬",
        "繁殖犬退出繁殖計畫"
      ]
    },
    "prognosis": "抗生素治療可控制臨床症狀但難以完全清除細菌，復發常見。感染犬應視為終身帶原者。對繁殖犬舍可造成嚴重經濟損失。",
    "pearls": [
      "為重要的人畜共通傳染病，處理感染犬應戴手套",
      "血清學假陽性可能發生，需確認試驗",
      "繁殖犬配種前應常規檢測",
      "治療後血清學轉陰不代表完全清除",
      "流產物質含大量細菌，傳染性極高",
      "部分國家要求通報"
    ],
    "diagnosticAlgorithm": {
      "title": "犬布魯氏菌病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估與風險評估",
          "details": "詢問繁殖史、流產史、接觸史，評估臨床症狀",
          "findings": [
            "反覆流產懷孕後期",
            "死胎或虛弱幼犬",
            "公犬睾丸腫脹後萎縮或附睾炎",
            "脊椎椎間盤炎"
          ]
        },
        {
          "step": 2,
          "action": "血清學篩檢",
          "details": "快速凝集試驗（RSAT或2-ME RSAT）初步篩檢",
          "findings": [
            "RSAT陽性高敏感度但特異度較低",
            "2-ME RSAT可減少假陽性",
            "陽性結果需確認試驗",
            "陰性基本排除"
          ]
        },
        {
          "step": 3,
          "action": "確認檢測",
          "details": "AGID、IELISA或血液培養確認",
          "findings": [
            "AGID確認陽性高特異度",
            "血液培養分離Brucella canis",
            "PCR檢測",
            "連續3次血液培養提高敏感度"
          ]
        },
        {
          "step": 4,
          "action": "公衛與控制措施",
          "details": "布魯氏菌為人畜共通傳染病，需啟動防疫",
          "findings": [
            "通報相關主管機關",
            "接觸人員健康追蹤",
            "感染犬不建議用於繁殖",
            "治療困難難以完全清除"
          ]
        }
      ]
    },
    "monitoring": [
      "血清學每月追蹤至轉陰",
      "血液培養確認",
      "繁殖功能",
      "同群犬隻的篩檢",
      "人員暴露風險評估"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "tapeworm": {
    "zh": "絛蟲感染",
    "en": "Tapeworm Infection",
    "definition": "犬貓腸道內絛蟲（條蟲）寄生，最常見為犬複孔絛蟲（Dipylidium caninum）和包蟲屬絛蟲（Taenia/Echinococcus）。",
    "synonyms": [
      "條蟲感染",
      "Cestodiasis"
    ],
    "epidemiology": {
      "species": "犬貓皆常見",
      "age": "任何年齡",
      "sex": "無性別傾向",
      "riskFactors": [
        "跳蚤感染（Dipylidium）",
        "捕食中間宿主（齧齒類、兔子）",
        "餵食生肉或內臟",
        "戶外放養",
        "多寵物家庭"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "肛門周圍可見白色節片（似米粒或芝麻）",
        "肛門搔癢（蹭地）",
        "偶有嘔吐",
        "輕度腹瀉",
        "多數無明顯症狀",
        "大量感染時體重減輕"
      ],
      "physicalExam": [
        "通常理學檢查無異常",
        "肛門周圍或糞便中可見蟲體節片",
        "嚴重感染可能消瘦",
        "毛髮失去光澤",
        "腹部膨大（幼犬大量感染）"
      ]
    },
    "pathophysiology": "絛蟲需要中間宿主完成生活史。犬複孔絛蟲的中間宿主為跳蚤，犬貓吞食含囊尾幼蟲的跳蚤而感染。Taenia屬的中間宿主為齧齒類或兔子。成蟲以頭節附著於小腸壁，吸收宿主營養。孕節（含蟲卵）脫落後從肛門排出或隨糞便排出。",
    "diagnosis": {
      "overview": "糞便或肛門周圍發現蟲體節片即可診斷",
      "differentials": [
        "蛔蟲感染",
        "鉤蟲感染",
        "鞭蟲感染",
        "腸道原蟲感染",
        "其他腸道寄生蟲"
      ],
      "initialDB": [
        "肉眼觀察糞便或肛門周圍節片",
        "糞便浮游法（蟲卵包，但檢出率低）",
        "節片鏡檢鑑定蟲種"
      ],
      "advanced": [
        "糞便PCR（蟲種鑑定）",
        "腹部X光或超音波（大量蟲體）"
      ]
    },
    "treatment": {
      "overview": "驅蟲藥物治療，同時控制中間宿主",
      "acute": [
        "Praziquantel 5 mg/kg PO 或 SC 單次（首選）",
        "Epsiprantel 5.5 mg/kg PO（犬）或 2.75 mg/kg PO（貓）",
        "Fenbendazole 50 mg/kg PO SID x 3天（Taenia屬）"
      ],
      "chronic": [
        "控制跳蚤（Dipylidium的關鍵）",
        "限制捕食齧齒類和兔子",
        "定期驅蟲（每3-6個月）",
        "環境衛生管理"
      ]
    },
    "prognosis": "驅蟲治療效果極佳，但若中間宿主未控制易再感染。對動物健康影響通常輕微。Echinococcus屬具重要人畜共通傳染風險。",
    "pearls": [
      "糞便浮游法對絛蟲的檢出率低（約僅5-10%），肉眼觀察節片更可靠",
      "見到白色米粒狀物在肛門周圍移動幾乎可確診Dipylidium",
      "控制跳蚤是預防Dipylidium再感染的關鍵",
      "Echinococcus granulosus和E. multilocularis有重要人畜共通傳染意義",
      "驅蟲後可能在24-48小時內排出大量蟲體"
    ],
    "diagnosticAlgorithm": {
      "title": "絛蟲感染 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "觀察肛門周圍與糞便中蟲體，詢問跳蚤防控史",
          "findings": [
            "肛門周圍見白色米粒狀蟲節片",
            "糞便表面蟲節片",
            "肛門搔癢蹭地行為",
            "跳蚤感染史"
          ]
        },
        {
          "step": 2,
          "action": "糞便檢查",
          "details": "糞便浮游法與直接抹片檢查",
          "findings": [
            "糞便浮游法敏感度低蟲卵包在節片內",
            "節片壓片可見蟲卵包",
            "蟲卵特徵鑑定",
            "直接見到蟲節片即可確診"
          ]
        },
        {
          "step": 3,
          "action": "種類鑑定與公衛評估",
          "details": "確認絛蟲種類，評估人畜共患風險",
          "findings": [
            "瓜實絛蟲跳蚤傳播",
            "犬絛蟲獵食傳播",
            "包蟲人畜共患風險高",
            "確認跳蚤防控狀態"
          ]
        }
      ]
    },
    "monitoring": [
      "驅蟲後糞便觀察",
      "跳蚤控制效果",
      "再感染跡象",
      "定期糞便檢查"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "whipworm": {
    "zh": "鞭蟲感染",
    "en": "Whipworm Infection",
    "definition": "由犬鞭蟲（Trichuris vulpis）寄生於盲腸和結腸引起的腸道寄生蟲感染。",
    "synonyms": [
      "毛首線蟲感染",
      "Trichuriasis"
    ],
    "epidemiology": {
      "species": "犬較常見，貓罕見",
      "age": "任何年齡，成犬也常見",
      "sex": "無性別傾向",
      "riskFactors": [
        "戶外環境接觸污染土壤",
        "群體犬舍",
        "溫暖潮濕環境",
        "蟲卵在土壤中可存活數年"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "大腸性腹瀉（含黏液和/或鮮血）",
        "排便頻繁但量少",
        "裏急後重",
        "慢性間歇性腹瀉",
        "體重減輕",
        "部分犬無明顯症狀"
      ],
      "physicalExam": [
        "通常理學檢查無異常",
        "嚴重感染可能消瘦和脫水",
        "腹部觸診可能無異常",
        "糞便帶血和黏液"
      ]
    },
    "pathophysiology": "犬經口攝入含感染性幼蟲的鞭蟲卵。幼蟲在小腸孵化後遷移至盲腸和結腸，成蟲前端細如鞭子般鑽入黏膜吸食血液和組織液。蟲體對腸道黏膜造成機械性損傷和炎症反應，導致出血性或黏液性結腸炎。大量感染可造成顯著失血和電解質失衡（假性Addison病樣低鈉高鉀）。",
    "diagnosis": {
      "overview": "糞便浮游法檢出特徵性蟲卵即可診斷",
      "differentials": [
        "結腸炎",
        "鉤蟲感染",
        "梨形鞭毛蟲",
        "發炎性腸病",
        "結腸腫瘤",
        "腎上腺功能低下（因電解質異常）"
      ],
      "initialDB": [
        "糞便浮游法（特徵性檸檬形帶栓蟲卵）",
        "需多次檢查（間歇性排卵）",
        "全血球計數（可見貧血）",
        "生化檢查（低鈉高鉀）"
      ],
      "advanced": [
        "糞便PCR",
        "結腸鏡檢查（可見蟲體附著）",
        "ACTH刺激試驗（排除Addison病）"
      ]
    },
    "treatment": {
      "overview": "驅蟲藥物治療，需注意環境控制防止再感染",
      "acute": [
        "Fenbendazole 50 mg/kg PO SID x 3天（首選）",
        "Febantel-Pyrantel-Praziquantel複合驅蟲藥",
        "嚴重貧血需支持療法和輸血",
        "電解質矯正"
      ],
      "chronic": [
        "每月驅蟲3個月以清除再感染",
        "定期預防性驅蟲",
        "環境消毒（蟲卵抗性強，需徹底清理）",
        "限制接觸污染區域"
      ]
    },
    "prognosis": "驅蟲治療反應良好，但環境中蟲卵可存活數年導致反覆感染。控制環境污染是長期管理關鍵。",
    "pearls": [
      "鞭蟲感染可導致低鈉高鉀，臨床上模擬Addison病（假性Addison）",
      "糞便單次檢查陰性不能排除感染（間歇性排卵）",
      "蟲卵在土壤中可存活5-7年，環境控制困難",
      "某些每月心絲蟲預防藥（含Milbemycin或Moxidectin）可同時預防鞭蟲",
      "大腸性腹瀉在犬應考慮鞭蟲感染"
    ],
    "diagnosticAlgorithm": {
      "title": "鞭蟲感染 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估大腸性腹瀉症狀，詢問環境史",
          "findings": [
            "大腸性腹瀉黏液血便",
            "裡急後重",
            "體重減輕",
            "間歇性症狀"
          ]
        },
        {
          "step": 2,
          "action": "糞便寄生蟲學檢查",
          "details": "糞便浮游法需使用高比重浮游液",
          "findings": [
            "特徵性檸檬形雙蓋蟲卵",
            "需高比重液",
            "間歇性排卵需連續3天採樣",
            "蟲卵量可能很少"
          ]
        },
        {
          "step": 3,
          "action": "鑑別診斷",
          "details": "排除其他大腸性腹瀉原因",
          "findings": [
            "排除大腸性IBD",
            "排除腸道腫瘤",
            "排除梭菌性腸炎",
            "嚴重感染可致低鈉高鉀模擬Addison"
          ]
        }
      ]
    },
    "monitoring": [
      "糞便檢查追蹤",
      "腹瀉改善",
      "電解質正常化",
      "體重恢復",
      "環境管理效果"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "flea-infestation": {
    "zh": "跳蚤感染",
    "en": "Flea Infestation",
    "definition": "由貓蚤（Ctenocephalides felis）或犬蚤（C. canis）寄生引起的外寄生蟲感染，可導致搔癢、過敏性皮膚炎和絛蟲傳播。",
    "synonyms": [
      "蚤患",
      "跳蚤寄生"
    ],
    "epidemiology": {
      "species": "犬貓皆極為常見",
      "age": "任何年齡",
      "sex": "無性別傾向",
      "riskFactors": [
        "戶外活動",
        "未使用預防藥物",
        "溫暖潮濕季節",
        "多寵物家庭",
        "野生動物接觸",
        "地毯和軟墊家具環境"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "搔癢（可能劇烈）",
        "掉毛",
        "皮膚紅疹",
        "在寵物身上或環境中發現跳蚤或蚤糞",
        "過敏犬可能極度不適",
        "幼犬幼貓可能出現貧血"
      ],
      "physicalExam": [
        "跳蚤成蟲（快速移動的棕色小蟲）",
        "蚤糞（黑色逗點狀，水上溶解呈紅色）",
        "背部、尾根部、腹股溝區搔抓痕和脫毛",
        "丘疹性皮膚炎",
        "跳蚤過敏性皮膚炎：腰薦部嚴重脫毛和結痂",
        "幼年動物可能黏膜蒼白（跳蚤性貧血）"
      ]
    },
    "pathophysiology": "跳蚤刺咬吸血時注入唾液，唾液中的蛋白質（過敏原）可誘發第I型和第IV型超敏反應（跳蚤過敏性皮膚炎，FAD）。單次叮咬即可在致敏動物引發持續數日的劇烈搔癢。大量跳蚤寄生可造成顯著失血。跳蚤為犬複孔絛蟲和血巴東體的傳播媒介。",
    "diagnosis": {
      "overview": "臨床檢查發現跳蚤或蚤糞即可確診",
      "differentials": [
        "異位性皮膚炎",
        "食物過敏",
        "疥蟎感染",
        "蝨感染",
        "膿皮症"
      ],
      "initialDB": [
        "仔細檢查皮毛尋找跳蚤和蚤糞",
        "蚤糞試驗（蚤糞放在濕白紙上呈紅色暈開）",
        "梳理試驗（密齒蚤梳）",
        "皮膚刮片（排除其他寄生蟲）"
      ],
      "advanced": [
        "皮內過敏原試驗（FAD確認）",
        "血清IgE檢測",
        "全血球計數（排除貧血）",
        "糞便檢查（絛蟲）"
      ]
    },
    "treatment": {
      "overview": "殺滅跳蚤和環境控制並重",
      "acute": [
        "速效成蟲殺滅劑（Nitenpyram口服、Capstar）",
        "全身性殺蚤藥（Fluralaner/Bravecto、Sarolaner/Simparica、Afoxolaner/NexGard）",
        "搔癢控制：短期Prednisolone或Oclacitinib",
        "嚴重FAD：抗生素治療繼發感染"
      ],
      "chronic": [
        "全年每月預防用藥（Isoxazoline類或Selamectin等）",
        "環境控制：吸塵、清洗寢具、環境殺蟲劑（IGR）",
        "所有同居寵物同時治療",
        "跳蚤過敏犬需長期預防"
      ]
    },
    "prognosis": "使用現代殺蚤藥物控制效果極佳。跳蚤過敏性皮膚炎需嚴格預防以避免復發。環境中的蟲卵和蛹可存活數月，需持續預防。",
    "pearls": [
      "看不到跳蚤不代表沒有跳蚤感染（過敏犬可能已將跳蚤梳除）",
      "蚤糞試驗是簡單但非常有效的診斷工具",
      "環境中95%的跳蚤族群為卵、幼蟲和蛹，成蟲僅佔5%",
      "Isoxazoline類藥物是目前最有效的殺蚤藥物",
      "跳蚤過敏犬一個跳蚤叮咬就可引發嚴重反應",
      "環境處理需至少3個月才能打破跳蚤生活史"
    ],
    "diagnosticAlgorithm": {
      "title": "跳蚤感染 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估搔癢程度、皮膚病變分布，檢查跳蚤與蚤糞",
          "findings": [
            "搔癢腰背部/尾根部/腹股溝",
            "皮膚紅疹或丘疹性皮膚炎",
            "跳蚤或蚤糞黑色顆粒",
            "脫毛與自我創傷"
          ]
        },
        {
          "step": 2,
          "action": "跳蚤梳檢查",
          "details": "密齒梳全身梳理收集跳蚤與蚤糞",
          "findings": [
            "成蟲發現",
            "蚤糞確認水測試呈紅棕色溶解",
            "嚴重感染可能看到蚤卵",
            "低蟲量時可能找不到跳蚤"
          ]
        },
        {
          "step": 3,
          "action": "跳蚤過敏性皮膚炎評估",
          "details": "評估是否有跳蚤過敏FAD",
          "findings": [
            "腰薦部至尾根典型分布",
            "丘疹性痂皮性皮膚炎",
            "僅少量跳蚤即可引發嚴重搔癢",
            "貓粟粒性皮膚炎型態"
          ]
        }
      ]
    },
    "monitoring": [
      "跳蚤數量減少",
      "搔癢改善",
      "皮膚病變癒合",
      "預防藥物依從性",
      "環境控制效果"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "xylitol-toxicosis": {
    "zh": "木糖醇中毒",
    "en": "Xylitol Toxicosis",
    "definition": "犬攝入木糖醇（一種人工甜味劑）後引起的急性中毒，導致嚴重低血糖和/或急性肝衰竭。",
    "synonyms": [
      "木糖醇中毒",
      "Birch Sugar Toxicity"
    ],
    "epidemiology": {
      "species": "犬最敏感，貓和雪貂也可能受影響",
      "age": "任何年齡",
      "sex": "無性別傾向",
      "riskFactors": [
        "接觸含木糖醇產品（無糖口香糖、糖果、烘焙食品、花生醬、牙膏）",
        "好奇心強的犬"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "攝入含木糖醇產品",
        "嘔吐（30-60分鐘內）",
        "虛弱和嗜睡",
        "共濟失調",
        "癲癇發作",
        "攝入後12-72小時可能出現肝衰竭症狀"
      ],
      "physicalExam": [
        "低血糖症狀：虛弱、震顫、共濟失調、癲癇",
        "嘔吐",
        "心搏過速",
        "黃疸（肝衰竭時）",
        "出血傾向（DIC時）",
        "肝區觸診疼痛"
      ]
    },
    "pathophysiology": "犬攝入木糖醇後，引起胰臟大量釋放胰島素（為葡萄糖引起的2.5-7倍），導致急性低血糖（攝入後10-60分鐘）。高劑量（>0.5 g/kg）可直接導致肝細胞壞死和急性肝衰竭（攝入後12-72小時），機制可能涉及肝細胞ATP耗竭和氧化損傷。",
    "diagnosis": {
      "overview": "根據攝入史和臨床症狀進行診斷",
      "differentials": [
        "胰島素瘤",
        "其他原因的低血糖",
        "其他肝毒素",
        "感染性肝炎",
        "Addison病"
      ],
      "initialDB": [
        "血糖測定（低血糖）",
        "全血球計數",
        "生化檢查（肝酵素、膽紅素）",
        "凝血功能"
      ],
      "advanced": [
        "肝酵素序列監測",
        "凝血功能（PT/PTT/纖維蛋白原）",
        "電解質（低血鉀）",
        "血氨"
      ]
    },
    "treatment": {
      "overview": "緊急糾正低血糖和肝臟保護",
      "acute": [
        "靜脈葡萄糖推注（0.5-1 mL/kg 50%葡萄糖稀釋後緩慢靜推）",
        "持續葡萄糖靜脈輸注（2.5-5% Dextrose）",
        "攝入2小時內催吐（若未嘔吐且意識清醒）",
        "肝臟保護劑（S-Adenosylmethionine, N-Acetylcysteine）",
        "靜脈輸液"
      ],
      "chronic": [
        "持續監測血糖至少24小時",
        "肝酵素監測72小時",
        "凝血障礙治療（新鮮冷凍血漿）",
        "維生素K1（若凝血異常）",
        "肝臟保護劑持續使用"
      ]
    },
    "prognosis": "僅低血糖且迅速治療者預後良好。發展為肝衰竭者預後謹慎至差，死亡率可達20-50%。低劑量暴露（<0.1 g/kg）可能僅引起輕度低血糖。",
    "pearls": [
      "低血糖劑量>0.1 g/kg，肝毒性劑量>0.5 g/kg",
      "一片無糖口香糖可能含0.3-1 g木糖醇，對小型犬即可致命",
      "低血糖可在攝入後10-60分鐘內發生，需緊急處理",
      "肝衰竭可延遲至12-72小時後出現",
      "花生醬等意想不到的產品也可能含木糖醇",
      "貓不易中毒因為貓較少攝入甜食"
    ],
    "diagnosticAlgorithm": {
      "title": "木糖醇中毒 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "病史確認與劑量評估",
          "details": "確認攝入量與時間，計算木糖醇劑量",
          "findings": [
            "確認含木糖醇產品（口香糖/糖果/烘焙品/牙膏）",
            "計算攝入劑量",
            "攝入時間",
            "犬比貓更敏感"
          ]
        },
        {
          "step": 2,
          "action": "急性低血糖評估",
          "details": "攝入後30-60分鐘內可能發生低血糖",
          "findings": [
            "嘔吐（早期）",
            "虛弱與共濟失調",
            "血糖顯著下降",
            "癲癇發作（嚴重低血糖）"
          ]
        },
        {
          "step": 3,
          "action": "肝功能監測",
          "details": "攝入後12-72小時監測肝功能",
          "findings": [
            "ALT/AST持續升高",
            "膽紅素升高",
            "凝血功能異常PT/aPTT延長",
            "高磷血症"
          ]
        },
        {
          "step": 4,
          "action": "持續監測與併發症",
          "details": "密切監測肝衰竭與DIC徵象",
          "findings": [
            "急性肝衰竭（大劑量）",
            "DIC發展",
            "血糖持續監測每2-4小時",
            "肝酶48-72小時追蹤"
          ]
        }
      ]
    },
    "monitoring": [
      "血糖（每1-2小時監測直到穩定）",
      "肝酵素（每12-24小時共72小時）",
      "凝血功能",
      "電解質",
      "精神狀態"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "nsaid-toxicosis": {
    "zh": "非類固醇抗發炎藥中毒",
    "en": "NSAID Toxicosis",
    "definition": "犬貓攝入過量非類固醇抗發炎藥物（如Ibuprofen、Naproxen、Aspirin）引起的中毒，主要影響胃腸道、腎臟和肝臟。",
    "synonyms": [
      "NSAID中毒",
      "非甾體抗炎藥中毒"
    ],
    "epidemiology": {
      "species": "犬貓皆可發生，貓對NSAIDs更為敏感",
      "age": "任何年齡，幼年和老年動物風險較高",
      "sex": "無性別傾向",
      "riskFactors": [
        "接觸人用NSAIDs（Ibuprofen最常見）",
        "飼主自行給藥",
        "多重NSAID使用",
        "脫水",
        "腎功能不全",
        "合併使用類固醇"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "攝入人用止痛藥",
        "嘔吐（可能帶血）",
        "厭食",
        "黑便或血便",
        "嗜睡",
        "多飲多尿（腎損傷）",
        "黃疸（肝損傷，貓較常見）"
      ],
      "physicalExam": [
        "腹部疼痛",
        "嘔吐",
        "黑便或新鮮血便",
        "脫水",
        "黏膜蒼白（胃腸出血）",
        "少尿或無尿（急性腎衰竭）",
        "黃疸（貓）",
        "神經症狀（極高劑量：共濟失調、癲癇）"
      ]
    },
    "pathophysiology": "NSAIDs抑制環氧化酶（COX-1和COX-2），減少前列腺素合成。前列腺素對胃腸道黏膜保護、腎臟血流調節和血小板功能至關重要。過量攝入導致：1）胃腸道黏膜保護喪失引起潰瘍和出血；2）腎臟入球動脈收縮導致腎缺血和急性腎損傷；3）貓對藥物代謝慢，肝毒性風險更高。",
    "diagnosis": {
      "overview": "根據攝入史、臨床症狀和實驗室檢查診斷",
      "differentials": [
        "其他原因的胃腸道潰瘍",
        "腎前性或腎性急性腎損傷",
        "其他毒素（乙二醇、百合）",
        "出血性腸胃炎",
        "Addison危象"
      ],
      "initialDB": [
        "全血球計數（貧血、血小板減少）",
        "生化檢查（BUN/Creatinine升高、肝酵素升高）",
        "尿液分析（腎損傷指標）",
        "糞便潛血"
      ],
      "advanced": [
        "腹部超音波（胃壁增厚、潰瘍）",
        "內視鏡（直視潰瘍）",
        "凝血功能",
        "尿液γ-GT/肌酐比值（早期腎損傷）"
      ]
    },
    "treatment": {
      "overview": "去污染、胃腸道保護和腎臟支持治療",
      "acute": [
        "攝入2小時內催吐",
        "活性碳（1-2 g/kg PO）",
        "胃腸道保護劑：Omeprazole 1 mg/kg PO BID + Sucralfate 0.25-1 g PO TID + Misoprostol 2-5 μg/kg PO TID",
        "積極靜脈輸液保護腎功能",
        "止吐劑"
      ],
      "chronic": [
        "持續胃腸道保護藥物至少5-7天",
        "腎功能監測和輸液支持",
        "貧血嚴重需輸血",
        "飲食管理（低脂易消化食物）",
        "避免腎毒性藥物"
      ]
    },
    "prognosis": "早期治療預後良好。胃腸道潰瘍通常在適當治療後1-2週癒合。急性腎損傷若早期積極輸液治療可逆。腎功能衰竭或胃穿孔預後差。",
    "pearls": [
      "Ibuprofen是犬貓中毒最常見的NSAID",
      "貓對所有NSAIDs極為敏感，人用劑量即可致命",
      "低劑量引起胃腸症狀，中劑量引起腎損傷，高劑量引起神經症狀",
      "Ibuprofen犬毒性劑量>50 mg/kg（胃腸）、>100 mg/kg（腎）、>400 mg/kg（神經）",
      "不要給貓任何人用NSAID",
      "類固醇和NSAIDs合併使用大幅增加胃腸潰瘍風險"
    ],
    "diagnosticAlgorithm": {
      "title": "非類固醇抗發炎藥中毒 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "病史確認與劑量評估",
          "details": "確認NSAID種類、劑量、攝入時間",
          "findings": [
            "確認NSAID類型",
            "計算mg/kg攝入劑量",
            "攝入時間",
            "是否為急性單次或慢性過量"
          ]
        },
        {
          "step": 2,
          "action": "消化道評估",
          "details": "評估胃腸道潰瘍與出血",
          "findings": [
            "嘔吐可能帶血",
            "黑便或血便",
            "腹痛",
            "食慾廢絕"
          ]
        },
        {
          "step": 3,
          "action": "腎功能評估",
          "details": "監測腎功能與電解質",
          "findings": [
            "BUN/Creatinine升高",
            "尿液比重下降等張尿",
            "尿液沉渣異常管型",
            "高血鉀或低血鈉"
          ]
        },
        {
          "step": 4,
          "action": "全身監測",
          "details": "持續監測臟器功能與治療反應",
          "findings": [
            "肝酶升高",
            "凝血功能異常",
            "神經症狀極高劑量",
            "腎功能追蹤48-72小時"
          ]
        }
      ]
    },
    "monitoring": [
      "嘔吐和血便",
      "腎功能指標（BUN、Creatinine、尿量）",
      "PCV/TP（監測出血）",
      "肝酵素",
      "電解質"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "grape-raisin-toxicosis": {
    "zh": "葡萄/葡萄乾中毒",
    "en": "Grape and Raisin Toxicosis",
    "definition": "葡萄/葡萄乾中毒是犬攝入葡萄、葡萄乾、醋栗或含葡萄產品後引起的潛在致命性腎毒性。毒性物質疑為酒石酸（tartaric acid），且個體易感性差異極大。中毒劑量無明確閾值。臨床表現從輕度嘔吐到致命性急性腎小管壞死和無尿型腎衰竭。早期催吐和積極靜脈輸液是關鍵。",
    "synonyms": [
      "葡萄中毒",
      "葡萄乾中毒"
    ],
    "epidemiology": {
      "species": "犬（貓和雪貂也可能受影響）",
      "age": "任何年齡",
      "sex": "無性別傾向",
      "riskFactors": [
        "接觸葡萄、葡萄乾、醋栗、含葡萄乾的食品",
        "個體敏感性差異大（部分犬攝入後無症狀）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "攝入葡萄或葡萄乾",
        "嘔吐（攝入後數小時內）",
        "腹瀉",
        "厭食和嗜睡",
        "少尿或無尿（腎衰竭時）",
        "腹痛"
      ],
      "physicalExam": [
        "嘔吐（嘔吐物中可能含葡萄殘渣）",
        "腹部觸診疼痛（腎區）",
        "脫水",
        "口腔潰瘍（尿毒症）",
        "少尿或無尿",
        "嗜睡和虛弱"
      ]
    },
    "pathophysiology": "確切毒素成分尚未完全確定，近年研究認為酒石酸（tartaric acid）可能為主要毒素。攝入後引起急性近端腎小管壞死，導致急性腎損傷。個體間敏感性差異極大，部分犬攝入大量無恙，部分犬少量即可致命。毒性與葡萄品種和產地可能有關。",
    "diagnosis": {
      "overview": "根據攝入史和急性腎損傷表現診斷",
      "differentials": [
        "乙二醇中毒",
        "百合中毒（貓）",
        "鉤端螺旋體病",
        "NSAID腎毒性",
        "腎前性氮質血症",
        "急性腎損傷其他原因"
      ],
      "initialDB": [
        "全血球計數",
        "生化檢查（BUN、Creatinine，可能正常初期）",
        "尿液分析（糖尿、蛋白尿、管型）",
        "電解質（高血鉀、高血磷）"
      ],
      "advanced": [
        "腎臟超音波",
        "尿量監測",
        "血氣分析",
        "生化序列監測（每12-24小時）"
      ]
    },
    "treatment": {
      "overview": "早期去污染和積極靜脈輸液保護腎臟",
      "acute": [
        "攝入2小時內催吐",
        "活性碳（1-2 g/kg PO，可重複一次）",
        "積極靜脈輸液（2-3倍維持量，48-72小時）",
        "止吐劑（Maropitant）",
        "監測尿量"
      ],
      "chronic": [
        "持續靜脈輸液至腎功能穩定",
        "無尿或少尿：利尿劑（Furosemide、Mannitol）",
        "高血鉀處理",
        "透析治療（嚴重腎衰竭）",
        "腹膜透析或血液透析"
      ]
    },
    "prognosis": "早期去污染和積極輸液治療者預後良好。一旦發展為無尿性腎衰竭，預後極差。約50%發展為急性腎衰竭的犬死亡。未出現腎損傷者完全康復。",
    "pearls": [
      "目前無法確定安全攝入量，任何劑量都應視為潛在有毒",
      "葡萄乾比葡萄毒性更濃縮（脫水後）",
      "嘔吐通常在攝入後6-12小時內出現，是早期症狀",
      "攝入後48-72小時腎損傷可能才明顯",
      "BUN和Creatinine正常不代表腎臟安全，需持續監測",
      "近年研究指向酒石酸為潛在毒素成分"
    ],
    "diagnosticAlgorithm": {
      "title": "葡萄/葡萄乾中毒 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "病史確認",
          "details": "確認攝入量與時間，注意個體敏感性差異大",
          "findings": [
            "確認攝入量毒性劑量不定",
            "葡萄乾毒性高於葡萄",
            "攝入時間",
            "既往腎臟健康狀態"
          ]
        },
        {
          "step": 2,
          "action": "早期臨床評估",
          "details": "攝入後6-24小時內評估消化道症狀",
          "findings": [
            "嘔吐最早出現通常6-12小時內",
            "腹瀉",
            "食慾廢絕",
            "腹痛與精神沉鬱"
          ]
        },
        {
          "step": 3,
          "action": "腎功能監測",
          "details": "攝入後24-72小時密集監測腎功能",
          "findings": [
            "BUN/Creatinine升高",
            "寡尿或無尿預後不良指標",
            "高磷血症與高鈣血症",
            "尿液沉渣顆粒管型與葡萄糖尿"
          ]
        },
        {
          "step": 4,
          "action": "預後評估",
          "details": "根據腎功能與尿量評估預後",
          "findings": [
            "無尿預後極差",
            "寡尿需積極液體治療與利尿劑",
            "血液透析評估",
            "腎功能72小時追蹤"
          ]
        }
      ]
    },
    "monitoring": [
      "尿量（目標>2 mL/kg/hr）",
      "BUN和Creatinine（每12-24小時共72小時）",
      "電解質（尤其鉀和磷）",
      "尿液分析",
      "水合狀態"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "lily-toxicosis": {
    "zh": "百合中毒",
    "en": "Lily Toxicosis",
    "definition": "貓接觸或攝入百合屬（Lilium）或萱草屬（Hemerocallis）植物後引起的急性腎小管壞死和腎衰竭。",
    "synonyms": [
      "百合花中毒",
      "Lily Nephrotoxicosis"
    ],
    "epidemiology": {
      "species": "貓（犬不受影響或僅輕度胃腸症狀）",
      "age": "任何年齡",
      "sex": "無性別傾向",
      "riskFactors": [
        "室內擺放百合花",
        "好奇心強的貓",
        "復活節百合、虎百合、亞洲百合、東方百合為最危險品種"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "接觸或攝入百合花（任何部分包括花粉和花瓶水）",
        "嘔吐（攝入後1-6小時）",
        "厭食",
        "嗜睡",
        "多飲多尿（早期）",
        "少尿或無尿（腎衰竭後期）"
      ],
      "physicalExam": [
        "嘔吐",
        "脫水",
        "嗜睡和虛弱",
        "腎區疼痛",
        "口腔潰瘍（尿毒症）",
        "少尿或無尿（24-72小時後）",
        "發燒或體溫過低（晚期）"
      ]
    },
    "pathophysiology": "百合植物中的確切腎毒素尚未確定。所有部分（花瓣、葉子、莖、花粉甚至花瓶水）均有毒。毒素被吸收後直接損傷腎臟近端腎小管上皮細胞，引起急性腎小管壞死。腎損傷在攝入後24-72小時內進展迅速。極少量攝入（甚至僅舔舐花粉）即可導致致命性腎衰竭。",
    "diagnosis": {
      "overview": "根據貓接觸百合的病史和急性腎損傷確診",
      "differentials": [
        "乙二醇中毒",
        "葡萄/葡萄乾中毒",
        "NSAID腎毒性",
        "鉤端螺旋體病",
        "急性腎損傷其他原因",
        "尿路阻塞"
      ],
      "initialDB": [
        "生化檢查（BUN、Creatinine）",
        "尿液分析（等比重尿、管型、糖尿）",
        "全血球計數",
        "電解質"
      ],
      "advanced": [
        "腎臟超音波（腎臟腫大、皮質增亮）",
        "尿量監測",
        "血氣分析",
        "序列生化監測"
      ]
    },
    "treatment": {
      "overview": "早期去污染和積極靜脈輸液治療為關鍵",
      "acute": [
        "攝入2小時內催吐",
        "活性碳（1-2 g/kg PO）",
        "積極靜脈輸液（48-72小時，維持量的2-3倍）",
        "止吐劑",
        "監測尿量（目標>2 mL/kg/hr）"
      ],
      "chronic": [
        "持續輸液直到腎功能穩定",
        "利尿劑（無尿時：Mannitol或Furosemide）",
        "腹膜透析或血液透析（無尿性腎衰竭）",
        "電解質矯正",
        "營養支持"
      ]
    },
    "prognosis": "攝入後18小時內開始積極治療預後良好。延遲治療至出現無尿性腎衰竭後預後極差（死亡率接近100%）。早期治療的貓存活率可達90%以上。",
    "pearls": [
      "百合花的任何部分對貓都有致命毒性，包括花粉和花瓶水",
      "即使只是梳理沾有花粉的毛髮後舔舐也可中毒",
      "非百合屬植物如鈴蘭和和平百合毒性機制不同",
      "早期治療是存活的關鍵——18小時黃金窗口",
      "BUN/Creatinine可能在攝入後24小時才升高，不要因初期正常而放鬆警惕",
      "飼主教育是預防的核心——家中不要擺放百合花"
    ],
    "diagnosticAlgorithm": {
      "title": "百合中毒 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "病史確認與風險評估",
          "details": "確認百合種類與接觸方式，貓為高風險物種",
          "findings": [
            "確認真百合屬或萱草屬",
            "所有部位均有毒包含花粉",
            "舔舐花粉也可中毒",
            "貓特異性毒性犬不受影響"
          ]
        },
        {
          "step": 2,
          "action": "早期症狀評估",
          "details": "接觸後0-12小時內的初期表現",
          "findings": [
            "嘔吐通常2-4小時內開始",
            "流涎",
            "食慾廢絕",
            "精神沉鬱"
          ]
        },
        {
          "step": 3,
          "action": "腎功能密集監測",
          "details": "12-72小時內腎功能持續惡化",
          "findings": [
            "BUN/Creatinine進行性升高",
            "腎臟超音波腎臟腫大回音增強",
            "尿液分析管型蛋白尿等張尿",
            "寡尿或無尿24-72小時"
          ]
        },
        {
          "step": 4,
          "action": "積極治療與預後評估",
          "details": "靜脈輸液治療效果評估",
          "findings": [
            "早期6小時內治療預後較佳",
            "延遲治療超過18小時預後差",
            "無尿為嚴重預後不良指標",
            "腎臟替代療法評估"
          ]
        }
      ]
    },
    "monitoring": [
      "尿量（每小時記錄）",
      "BUN和Creatinine（每12小時共72小時）",
      "電解質（尤其鉀）",
      "水合狀態",
      "食慾和精神狀態"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "ethylene-glycol-toxicosis": {
    "zh": "乙二醇中毒",
    "en": "Ethylene Glycol Toxicosis",
    "definition": "犬貓攝入乙二醇（防凍液的主要成分）後引起的嚴重中毒，代謝產物導致急性腎衰竭和代謝性酸中毒。",
    "synonyms": [
      "防凍液中毒",
      "Antifreeze Poisoning"
    ],
    "epidemiology": {
      "species": "犬貓皆可發生，貓對毒性更敏感",
      "age": "任何年齡",
      "sex": "無性別傾向",
      "riskFactors": [
        "接觸防凍液洩漏",
        "乙二醇具甜味吸引動物",
        "冬季防凍液使用高峰期",
        "車庫或車道上的防凍液殘留"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "接觸或攝入防凍液",
        "第一階段（0.5-12小時）：類醉酒表現、嘔吐、多飲多尿",
        "第二階段（12-24小時）：心肺症狀",
        "第三階段（24-72小時）：少尿性腎衰竭"
      ],
      "physicalExam": [
        "早期：共濟失調、嗜睡、多飲、嘔吐",
        "中期：心搏過速、呼吸急促",
        "晚期：少尿或無尿、口腔潰瘍、腎區疼痛、昏迷",
        "脫水",
        "體溫過低"
      ]
    },
    "pathophysiology": "乙二醇本身毒性低，但經醇脫氫酶（ADH）代謝為乙醇酸和草酸，這些代謝產物導致嚴重代謝性酸中毒。草酸與鈣結合形成草酸鈣結晶，沉積於腎小管造成機械性損傷和阻塞，導致急性腎小管壞死和腎衰竭。最小致死劑量：犬6.6 mL/kg、貓1.5 mL/kg。",
    "diagnosis": {
      "overview": "攝入史結合代謝性酸中毒和草酸鈣結晶尿為診斷關鍵",
      "differentials": [
        "其他醇類中毒（甲醇、異丙醇）",
        "糖尿病酮酸中毒",
        "急性腎損傷其他原因",
        "中樞神經系統疾病"
      ],
      "initialDB": [
        "尿液分析（草酸鈣一水合物或二水合物結晶）",
        "血氣分析（代謝性酸中毒、陰離子間隙增大）",
        "生化檢查（BUN、Creatinine、鈣、磷）",
        "乙二醇快速檢測試劑",
        "血清滲透壓間隙增大"
      ],
      "advanced": [
        "乙二醇血清濃度",
        "乙醇酸濃度",
        "腎臟超音波",
        "伍德氏燈檢尿液（部分防凍液含螢光劑）"
      ]
    },
    "treatment": {
      "overview": "早期使用醇脫氫酶抑制劑阻止代謝，積極輸液和酸中毒矯正",
      "acute": [
        "攝入1小時內催吐",
        "首選解毒劑：Fomepizole（4-MP）犬20 mg/kg IV初始劑量",
        "替代解毒劑：20%乙醇 5.5 mL/kg IV q4h x 5次（犬）",
        "積極靜脈輸液",
        "碳酸氫鈉矯正酸中毒",
        "電解質矯正"
      ],
      "chronic": [
        "持續輸液和監測",
        "無尿性腎衰竭：腹膜透析或血液透析",
        "尿量監測和利尿劑",
        "營養支持",
        "長期腎功能追蹤"
      ]
    },
    "prognosis": "攝入後5小時內（犬）或3小時內（貓）開始治療預後良好。一旦發展為腎衰竭，預後極差。無尿性腎衰竭不進行透析幾乎100%死亡。貓因毒性劑量更低和治療窗口更短，預後通常更差。",
    "pearls": [
      "時間是最關鍵因素——越早治療越好",
      "Fomepizole對犬效果極佳但對貓效果較差（貓仍建議乙醇治療）",
      "尿液中草酸鈣結晶（信封形二水合物或啞鈴形一水合物）是重要發現",
      "伍德氏燈照射尿液可能見螢光（部分防凍液含螢光素鈉）",
      "最小致死劑量貓僅1.5 mL/kg（約一茶匙）",
      "預防重於治療——使用含丙二醇的安全防凍液"
    ],
    "diagnosticAlgorithm": {
      "title": "乙二醇中毒 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "病史與早期症狀",
          "details": "確認抗凍液接觸史，評估神經症狀",
          "findings": [
            "已知或疑似抗凍液攝入",
            "類似醉酒的共濟失調",
            "多飲多尿",
            "嘔吐"
          ]
        },
        {
          "step": 2,
          "action": "急診實驗室檢查",
          "details": "血液生化與尿液分析",
          "findings": [
            "嚴重代謝性酸中毒高陰離子間隙",
            "血清滲透壓間隙升高",
            "尿液見草酸鈣結晶",
            "Wood燈尿液螢光"
          ]
        },
        {
          "step": 3,
          "action": "乙二醇快篩與確認",
          "details": "乙二醇快速檢測或定量",
          "findings": [
            "乙二醇快篩陽性",
            "丙二醇可致假陽性",
            "攝入後6-12小時內檢測最敏感",
            "血清鈣降低草酸結合鈣"
          ]
        },
        {
          "step": 4,
          "action": "腎功能與預後監測",
          "details": "監測急性腎損傷發展",
          "findings": [
            "BUN/Creatinine升高24-72小時",
            "寡尿或無尿",
            "腎臟超音波腎皮質回音增強",
            "晚期治療預後差"
          ]
        }
      ]
    },
    "monitoring": [
      "尿量（每小時）",
      "血氣和酸鹼狀態",
      "BUN和Creatinine（每6-12小時）",
      "電解質（鈣、鉀）",
      "尿液分析和結晶",
      "精神狀態"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "acetaminophen-toxicosis": {
    "zh": "乙醯胺酚中毒",
    "en": "Acetaminophen Toxicosis",
    "definition": "犬貓攝入乙醯胺酚（Paracetamol/Tylenol）後引起的中毒，貓極為敏感，主要導致變性血紅素血症和肝損傷。",
    "synonyms": [
      "撲熱息痛中毒",
      "Paracetamol Toxicosis",
      "Tylenol中毒"
    ],
    "epidemiology": {
      "species": "貓極為敏感（缺乏葡萄糖醛酸結合能力），犬較耐受但高劑量也可中毒",
      "age": "任何年齡",
      "sex": "無性別傾向",
      "riskFactors": [
        "飼主自行給藥（最常見原因）",
        "接觸人用止痛藥",
        "含乙醯胺酚的複合藥物（感冒藥）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "給予或攝入含乙醯胺酚產品",
        "貓：面部和腳掌水腫、呼吸困難、褐色黏膜",
        "犬：嘔吐、厭食、黃疸（高劑量）",
        "嗜睡"
      ],
      "physicalExam": [
        "貓：變性血紅素血症（巧克力棕色黏膜）",
        "貓：面部和四肢水腫",
        "貓：呼吸困難和發紺",
        "犬：黃疸（肝損傷）",
        "犬：嘔吐和腹部疼痛",
        "抑鬱和虛弱"
      ]
    },
    "pathophysiology": "正常劑量乙醯胺酚主要經肝臟葡萄糖醛酸化和硫酸化代謝。貓缺乏葡萄糖醛酸轉移酶，無法有效代謝，大量藥物經細胞色素P450產生毒性代謝物NAPQI。NAPQI耗竭穀胱甘肽後氧化血紅素形成變性血紅素（貓為主），並導致肝細胞壞死（犬為主）。貓毒性劑量低至10 mg/kg，犬>150 mg/kg。",
    "diagnosis": {
      "overview": "根據攝入史和典型臨床表現診斷",
      "differentials": [
        "其他氧化性毒物（洋蔥、鋅）",
        "自體免疫性溶血性貧血",
        "急性肝炎",
        "其他原因的變性血紅素血症"
      ],
      "initialDB": [
        "全血球計數（Heinz小體、變性血紅素）",
        "變性血紅素濃度",
        "生化檢查（肝酵素）",
        "血氧飽和度（脈搏血氧儀可能偽正常）"
      ],
      "advanced": [
        "乙醯胺酚血清濃度",
        "凝血功能（肝衰竭時）",
        "血氣分析",
        "肝臟超音波"
      ]
    },
    "treatment": {
      "overview": "N-乙醯半胱胺酸（NAC）為特效解毒劑，配合支持療法",
      "acute": [
        "攝入2小時內催吐",
        "N-Acetylcysteine（NAC）140 mg/kg IV loading dose，然後70 mg/kg IV q4h x 7次",
        "活性碳（1-2 g/kg PO）",
        "氧氣治療（變性血紅素血症）",
        "靜脈輸液"
      ],
      "chronic": [
        "持續NAC治療",
        "S-Adenosylmethionine（SAMe）肝臟保護",
        "維生素C（抗氧化，20-30 mg/kg PO BID）",
        "嚴重貧血需輸血（使用新鮮全血）",
        "肝臟保護和支持治療"
      ]
    },
    "prognosis": "早期NAC治療預後良好（尤其攝入後8小時內）。延遲治療的貓預後差。輕度變性血紅素血症通常可逆。發展為急性肝衰竭的犬預後謹慎。",
    "pearls": [
      "一顆普通Tylenol（500 mg）即可殺死一隻成貓",
      "貓的巧克力棕色黏膜是變性血紅素血症的特徵",
      "貓的面部水腫幾乎是乙醯胺酚中毒的病徵",
      "NAC越早給予效果越好",
      "脈搏血氧儀在變性血紅素血症時讀數不準確（假正常）",
      "永遠不要給貓任何人用止痛藥"
    ],
    "diagnosticAlgorithm": {
      "title": "乙醯胺酚中毒 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "病史確認與物種差異",
          "details": "確認攝入劑量，注意貓極度敏感",
          "findings": [
            "確認攝入劑量貓10mg/kg即可致命",
            "貓比犬敏感10倍以上",
            "攝入時間",
            "可能來源人用感冒藥/止痛藥"
          ]
        },
        {
          "step": 2,
          "action": "臨床症狀評估",
          "details": "評估變性血紅素血症與肝損傷",
          "findings": [
            "黏膜發紺或巧克力色",
            "面部與爪部水腫貓特徵",
            "呼吸急促",
            "嘔吐與精神沉鬱"
          ]
        },
        {
          "step": 3,
          "action": "血液學與生化檢查",
          "details": "評估紅血球氧化損傷與肝功能",
          "findings": [
            "變性血紅素升高",
            "Heinz小體形成",
            "肝酶升高犬較明顯",
            "血液呈巧克力棕色"
          ]
        },
        {
          "step": 4,
          "action": "治療反應監測",
          "details": "N-乙醯半胱胺酸NAC治療反應追蹤",
          "findings": [
            "NAC治療後變性血紅素下降",
            "肝酶追蹤",
            "貧血程度監測可能需輸血",
            "腎功能監測"
          ]
        }
      ]
    },
    "monitoring": [
      "變性血紅素濃度",
      "PCV和血紅素",
      "肝酵素（每12-24小時）",
      "Heinz小體百分比",
      "臨床症狀（水腫、呼吸）",
      "尿液顏色"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "snake-envenomation": {
    "zh": "蛇咬傷中毒",
    "en": "Snake Envenomation",
    "definition": "蛇咬傷中毒是犬貓遭毒蛇咬傷後毒液引起的全身性中毒反應。台灣常見毒蛇包括龜殼花、青竹絲（出血性毒）、眼鏡蛇和雨傘節（神經性毒）。出血性蛇毒以凝血障礙、組織壞死和腫脹為主；神經性蛇毒以神經肌肉麻痺和呼吸衰竭為主。抗蛇毒血清為特異性治療。",
    "synonyms": [
      "蛇毒中毒",
      "Snake Bite Envenomation",
      "蛇咬中毒"
    ],
    "epidemiology": {
      "species": "犬較常見（好奇心驅使接近蛇），貓也可發生",
      "age": "任何年齡",
      "sex": "無性別傾向",
      "riskFactors": [
        "戶外活動",
        "農村或郊區環境",
        "好奇心強的犬",
        "溫暖季節（蛇活動高峰）",
        "黃昏和清晨時段"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "目擊蛇咬或懷疑蛇咬",
        "急性腫脹（咬傷部位）",
        "面部常見（犬探查蛇時）",
        "嘔吐",
        "虛弱和昏厥",
        "症狀進展迅速"
      ],
      "physicalExam": [
        "咬傷部位腫脹、疼痛和瘀斑",
        "穿刺傷（可能不明顯）",
        "蝮蛇毒：局部腫脹壞死、凝血障礙、低血壓",
        "眼鏡蛇/神經毒：瞳孔散大、肌肉麻痺、呼吸衰竭",
        "心搏過速和低血壓",
        "出血傾向（牙齦出血、血尿）"
      ]
    },
    "pathophysiology": "蛇毒成分因蛇種而異。蝮蛇科（響尾蛇、銅頭蛇等）毒液含蛋白酶、磷脂酶和金屬蛋白酶，導致局部組織壞死、凝血障礙（消耗性凝血病）和血管損傷。眼鏡蛇科毒液含神經毒素，阻斷神經肌肉接合處傳導導致癱瘓。部分蛇毒含心臟毒素和肌肉毒素。約25%蝮蛇咬傷為乾咬（無毒液注入）。",
    "diagnosis": {
      "overview": "根據病史、咬傷傷口和臨床症狀診斷",
      "differentials": [
        "蜂螫或其他昆蟲叮咬",
        "過敏性反應",
        "外傷",
        "蜘蛛咬傷",
        "血管性水腫"
      ],
      "initialDB": [
        "全血球計數（血小板減少、貧血）",
        "凝血功能（PT、PTT延長，纖維蛋白原降低）",
        "生化檢查（CK升高、腎功能）",
        "血型（備血）",
        "尿液分析（血紅蛋白尿、肌紅蛋白尿）"
      ],
      "advanced": [
        "蛇毒ELISA（部分地區可用）",
        "D-dimer",
        "血氣分析",
        "傷口超音波",
        "胸部X光（呼吸困難時）"
      ]
    },
    "treatment": {
      "overview": "抗蛇毒血清、支持療法和傷口處理",
      "acute": [
        "抗蛇毒血清（首選治療，越早使用效果越好）",
        "靜脈輸液和休克治療",
        "止痛（避免NSAIDs因凝血障礙）",
        "傷口處理（清潔、不切開不擠壓）",
        "廣譜抗生素（預防繼發感染）",
        "新鮮冷凍血漿（嚴重凝血障礙）",
        "輸血（嚴重貧血）"
      ],
      "chronic": [
        "傷口護理",
        "壞死組織清創",
        "持續抗生素（蛇口腔菌群污染）",
        "復健和物理治療",
        "監測器官功能恢復"
      ]
    },
    "prognosis": "犬對蝮蛇咬傷的整體存活率>95%（接受治療時）。貓存活率略低。未治療的嚴重咬傷死亡率顯著增加。神經毒性蛇咬傷若導致呼吸衰竭預後較差。體型小的動物預後較差（毒液/體重比高）。",
    "pearls": [
      "約25%蝮蛇咬傷為乾咬，但仍需觀察",
      "不要嘗試吸出毒液、切開傷口或使用止血帶",
      "抗蛇毒血清是唯一確切有效的治療",
      "凝血障礙可能在咬傷後數小時才出現",
      "Diphenhydramine不治療蛇毒但可減少抗蛇毒血清過敏反應",
      "面部咬傷的犬需注意呼吸道腫脹導致阻塞"
    ],
    "diagnosticAlgorithm": {
      "title": "蛇咬傷中毒 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "緊急評估",
          "details": "評估咬傷部位、腫脹進展與全身症狀",
          "findings": [
            "咬傷部位疼痛腫脹迅速進展",
            "可見咬痕一或兩個穿刺傷",
            "精神沉鬱與虛弱",
            "流涎或嘔吐"
          ]
        },
        {
          "step": 2,
          "action": "蛇種鑑定與中毒分類",
          "details": "根據地理位置與臨床表現判斷蛇種",
          "findings": [
            "出血毒：局部腫脹瘀斑出血",
            "神經毒：肌肉無力呼吸麻痺",
            "肌肉毒：橫紋肌溶解",
            "確認當地常見毒蛇種類"
          ]
        },
        {
          "step": 3,
          "action": "實驗室檢查",
          "details": "凝血功能、血液學與生化全面評估",
          "findings": [
            "凝血功能異常PT/aPTT延長",
            "血小板減少",
            "CK升高肌肉毒",
            "溶血性貧血"
          ]
        },
        {
          "step": 4,
          "action": "持續監測與併發症",
          "details": "密集監測臟器損傷進展",
          "findings": [
            "咬傷部位腫脹範圍標記追蹤",
            "DIC發展監測",
            "腎功能監測",
            "傷口壞死與繼發感染評估"
          ]
        }
      ]
    },
    "monitoring": [
      "凝血功能（每4-6小時共24小時）",
      "腫脹範圍標記和追蹤",
      "PCV/TP",
      "腎功能",
      "傷口癒合",
      "呼吸功能（面部咬傷）"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "sepsis-sirs": {
    "zh": "敗血症/全身炎症反應症候群",
    "en": "Sepsis / Systemic Inflammatory Response Syndrome",
    "definition": "敗血症為感染引起的失調性宿主反應導致的危及生命的器官功能障礙。SIRS為非感染性原因引起的全身性炎症反應。兩者臨床表現相似但病因不同。",
    "synonyms": [
      "SIRS",
      "敗血症",
      "Septicemia",
      "全身性炎症反應"
    ],
    "epidemiology": {
      "species": "犬貓皆可發生",
      "age": "任何年齡，幼年和老年動物風險較高",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "嚴重感染（腹膜炎、肺炎、腎盂腎炎、子宮蓄膿）",
        "免疫抑制",
        "糖尿病",
        "重大手術後",
        "創傷",
        "胰臟炎",
        "腫瘤",
        "留置導管",
        "新生兒"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "發燒或體溫過低",
        "嗜睡和虛弱",
        "厭食",
        "嘔吐和腹瀉",
        "呼吸急促",
        "原發感染源的症狀"
      ],
      "physicalExam": [
        "犬SIRS標準（符合2項以上）：體溫>39.7°C或<37.8°C、心率>160/min、呼吸>40/min、WBC>16000或<5000或帶狀>3%",
        "貓SIRS標準不同：體溫>40°C或<37.8°C、心率>225或<140/min、呼吸>40/min、WBC>19500或<5000",
        "黏膜蒼白或充血",
        "CRT延長（>2秒）或縮短（<1秒）",
        "脈搏品質異常（洪脈→弱脈）",
        "精神沉鬱",
        "四肢末端冰冷（晚期）"
      ]
    },
    "pathophysiology": "感染或損傷觸發先天免疫系統大量釋放促炎細胞因子（TNF-α、IL-1、IL-6），導致全身性炎症反應。失調的炎症導致：血管通透性增加（低血壓）、微循環障礙（組織缺氧）、凝血級聯活化（DIC）、多器官功能障礙（心臟、腎臟、肝臟、肺）。敗血性休克為敗血症合併頑固性低血壓和組織灌注不良。",
    "diagnosis": {
      "overview": "根據SIRS標準結合感染證據診斷敗血症，需積極尋找感染源",
      "differentials": [
        "其他原因的休克（心因性、出血性、過敏性）",
        "熱射病",
        "免疫媒介性疾病",
        "腫瘤相關症候群",
        "腎上腺危象"
      ],
      "initialDB": [
        "全血球計數（白血球增多或減少、左移、毒性變化）",
        "生化檢查（多器官評估）",
        "血糖（低血糖或高血糖）",
        "乳酸鹽（組織灌注指標）",
        "凝血功能（DIC篩檢）",
        "尿液分析",
        "血液培養（抗生素使用前）"
      ],
      "advanced": [
        "影像學尋找感染源（X光、超音波、CT）",
        "C反應蛋白或降鈣素原",
        "血氣分析",
        "中心靜脈壓",
        "腹腔穿刺液分析（疑似腹膜炎）"
      ]
    },
    "treatment": {
      "overview": "早期目標導向治療（EGDT）：感染控制、血流動力學穩定和器官支持",
      "acute": [
        "積極靜脈晶體液復甦（犬：20-40 mL/kg快速推注評估反應）",
        "廣譜靜脈抗生素（Ampicillin-Sulbactam + Enrofloxacin或Metronidazole）",
        "感染源控制（手術引流膿瘍、移除感染組織）",
        "升壓劑（液體復甦無效時：Norepinephrine首選）",
        "血糖控制",
        "止痛"
      ],
      "chronic": [
        "根據培養結果調整抗生素",
        "器官功能支持（腎臟、肝臟、肺）",
        "營養支持（早期腸內營養）",
        "DIC治療（新鮮冷凍血漿）",
        "監測和調整治療目標"
      ]
    },
    "prognosis": "敗血症的死亡率約30-50%（犬），貓可能更高。敗血性休克死亡率>50%。早期識別和積極治療顯著改善預後。多器官功能障礙數量與死亡率正相關。乳酸鹽水平>4 mmol/L和持續低血壓為不良預後指標。",
    "pearls": [
      "乳酸鹽是評估組織灌注和預後的重要指標",
      "敗血症的黃金1小時：第一小時內完成液體復甦和抗生素給予",
      "低血糖在敗血症中常見且為不良預後指標",
      "貓的SIRS標準與犬不同，貓可能表現為心搏過慢而非過速",
      "血液培養應在抗生素使用前採集，但不應延遲抗生素給予",
      "子宮蓄膿是犬最常見的敗血症原因之一"
    ],
    "diagnosticAlgorithm": {
      "title": "敗血症/全身炎症反應症候群 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "SIRS標準評估",
          "details": "確認是否符合SIRS診斷標準（犬需2項以上，貓需3項以上）",
          "findings": [
            "體溫異常",
            "心率加速",
            "呼吸急促",
            "白血球異常"
          ]
        },
        {
          "step": 2,
          "action": "感染源調查",
          "details": "確認SIRS加感染等於敗血症，尋找感染灶",
          "findings": [
            "腹腔感染腹膜炎/子宮蓄膿",
            "肺炎",
            "泌尿道感染",
            "皮膚/軟組織感染或手術部位感染"
          ]
        },
        {
          "step": 3,
          "action": "實驗室與培養",
          "details": "血液學、生化、凝血、血液培養",
          "findings": [
            "乳酸升高組織低灌流指標",
            "血糖低或高",
            "凝血異常DIC篩查",
            "血液培養抗生素使用前採集"
          ]
        },
        {
          "step": 4,
          "action": "器官功能評估",
          "details": "評估多器官功能障礙MODS",
          "findings": [
            "腎功能BUN/Creatinine升高寡尿",
            "肝功能膽紅素/ALT升高",
            "凝血DIC",
            "血壓低血壓需升壓劑"
          ]
        }
      ]
    },
    "monitoring": [
      "生命徵象（每1-4小時）",
      "乳酸鹽（每4-8小時）",
      "尿量（目標>1 mL/kg/hr）",
      "血壓（MAP目標>65 mmHg）",
      "血糖",
      "凝血功能",
      "器官功能指標"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "hepatic-tumor": {
    "zh": "肝臟腫瘤",
    "en": "Hepatic Tumor",
    "definition": "原發或轉移性肝臟腫瘤，原發性包括肝細胞癌、膽管細胞癌及肉瘤等，轉移性腫瘤較原發性更為常見。",
    "synonyms": [
      "肝臟癌",
      "肝腫瘤",
      "Liver Tumor",
      "Hepatic Neoplasia"
    ],
    "epidemiology": {
      "species": "犬貓皆可發生",
      "age": "老年動物（>10歲）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "高齡",
        "慢性肝病",
        "黃麴毒素暴露",
        "其他部位原發腫瘤轉移"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "食慾下降",
        "體重減輕",
        "嘔吐",
        "多飲多尿",
        "腹部膨大",
        "嗜睡"
      ],
      "physicalExam": [
        "肝臟腫大",
        "腹部觸診可及腫塊",
        "腹水",
        "黃疸",
        "前腹部疼痛",
        "黏膜蒼白（出血時）"
      ]
    },
    "pathophysiology": "原發性肝細胞癌為犬最常見原發肝腫瘤，可呈巨塊型、結節型或瀰漫型。膽管細胞癌侵襲性強且轉移率高。轉移性腫瘤經由門脈或全身循環到達肝臟，常見來源為脾臟血管肉瘤、胰臟腫瘤及消化道腫瘤。",
    "diagnosis": {
      "overview": "結合影像學、實驗室檢查及組織病理學確診",
      "differentials": [
        "肝臟結節性增生",
        "肝膿瘍",
        "肝囊腫",
        "肝血腫",
        "肉芽腫性肝炎"
      ],
      "initialDB": [
        "CBC/血液生化（ALT、ALP、GGT升高）",
        "腹部X光",
        "腹部超音波",
        "凝血功能檢查"
      ],
      "advanced": [
        "超音波引導細針抽吸或組織切片",
        "腹部CT掃描分期",
        "胸部X光（轉移評估）",
        "甲胎蛋白（AFP）檢測"
      ]
    },
    "treatment": {
      "overview": "巨塊型肝細胞癌手術切除為首選，轉移性或瀰漫型預後差",
      "acute": [
        "穩定血流動力學",
        "輸血（破裂出血時）",
        "止痛",
        "術前評估與準備"
      ],
      "chronic": [
        "肝葉切除術（巨塊型）",
        "化療（膽管細胞癌或轉移性）",
        "支持性護理",
        "營養管理"
      ]
    },
    "prognosis": "巨塊型肝細胞癌手術切除後中位存活超過1460天，預後良好。結節型和瀰漫型預後差，中位存活約270-428天。膽管細胞癌和轉移性腫瘤預後不佳。",
    "pearls": [
      "巨塊型肝細胞癌是最常見的原發肝腫瘤且手術預後極佳",
      "肝臟結節性增生是良性病變，需與腫瘤區分",
      "犬肝臟可切除多達75%而維持功能",
      "轉移性腫瘤比原發性更常見，需全面分期檢查"
    ],
    "diagnosticAlgorithm": {
      "title": "肝臟腫瘤 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估非特異性症狀與腹部觸診",
          "findings": [
            "食慾下降與體重減輕",
            "嘔吐",
            "腹部膨大",
            "黃疸"
          ]
        },
        {
          "step": 2,
          "action": "血液生化與影像學",
          "details": "肝功能檢測與腹部影像學",
          "findings": [
            "ALP/ALT/GGT升高",
            "腹部超音波見肝臟腫塊",
            "腹部X光肝臟腫大",
            "腹腔積液"
          ]
        },
        {
          "step": 3,
          "action": "細胞學或組織學",
          "details": "超音波引導細針抽吸或Tru-cut生檢",
          "findings": [
            "初步分類肝細胞癌/膽管癌/淋巴瘤/轉移癌",
            "組織學確診",
            "出血風險評估先檢查凝血功能",
            "肝細胞腺瘤vs肝細胞癌鑑別"
          ]
        },
        {
          "step": 4,
          "action": "分期與手術評估",
          "details": "全身轉移篩查與手術可行性",
          "findings": [
            "胸腔X光三視圖",
            "單一大型腫塊手術預後最佳",
            "區域淋巴結評估",
            "凝血功能完整評估"
          ]
        }
      ]
    },
    "monitoring": [
      "肝臟酵素",
      "腹部超音波追蹤",
      "胸部X光",
      "臨床症狀"
    ],
    "reference": "Liptak JM: Hepatobiliary Tumors. In Vail DM et al: Withrow & MacEwen's Small Animal Clinical Oncology, 6th Ed. Elsevier, 2020"
  },
  "splenic-tumor": {
    "zh": "脾臟腫瘤",
    "en": "Splenic Tumor",
    "definition": "原發於脾臟的腫瘤，最常見為血管肉瘤（惡性）和血腫/結節性增生（良性），約三分之二脾臟腫塊為惡性，其中血管肉瘤佔多數。",
    "synonyms": [
      "脾臟腫塊",
      "脾臟癌",
      "Splenic Mass",
      "Splenic Neoplasia"
    ],
    "epidemiology": {
      "species": "犬遠較貓常見",
      "age": "中老年犬（8-12歲）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "德國牧羊犬",
        "黃金獵犬",
        "拉布拉多犬",
        "大型犬種"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "急性虛脫（腫瘤破裂）",
        "間歇性虛弱",
        "食慾下降",
        "腹部膨大",
        "運動不耐受",
        "體重減輕"
      ],
      "physicalExam": [
        "腹部可觸及腫塊",
        "腹水（血腹）",
        "黏膜蒼白",
        "心搏過速",
        "脾臟腫大",
        "休克徵象（破裂時）"
      ]
    },
    "pathophysiology": "血管肉瘤起源於血管內皮細胞，具高度惡性及轉移傾向，常轉移至肝臟、心臟右心耳及肺臟。腫瘤血管結構脆弱，易發生自發性破裂導致腹腔出血及急性休克。良性腫塊包括血腫和結節性增生。",
    "diagnosis": {
      "overview": "影像學發現脾臟腫塊後需手術切除並送病理確診",
      "differentials": [
        "脾臟血腫",
        "結節性增生",
        "脾臟扭轉",
        "脾臟膿瘍",
        "其他脾臟肉瘤"
      ],
      "initialDB": [
        "CBC（貧血、裂紅血球）",
        "血液生化",
        "凝血功能",
        "腹部超音波",
        "腹部X光"
      ],
      "advanced": [
        "胸部X光三視圖",
        "心臟超音波（右心耳腫塊）",
        "腹部CT",
        "腹腔穿刺液分析"
      ]
    },
    "treatment": {
      "overview": "脾臟切除術為首選，血管肉瘤術後輔以化療",
      "acute": [
        "積極輸液復甦",
        "輸血（全血或pRBC）",
        "緊急脾臟切除術",
        "止痛"
      ],
      "chronic": [
        "脾臟切除術",
        "Doxorubicin為基礎的化療方案（血管肉瘤）",
        "I'm-Yunity蘑菇多醣體（輔助）",
        "定期分期檢查"
      ]
    },
    "prognosis": "良性脾臟腫塊切除後預後極佳。血管肉瘤預後差：僅手術中位存活1-3個月，手術加化療中位存活約5-7個月。右心耳同時受累者預後更差。",
    "pearls": [
      "犬脾臟腫塊約2/3為惡性，其中2/3為血管肉瘤",
      "急性血腹的老年大型犬應高度懷疑脾臟血管肉瘤",
      "裂紅血球和棘紅血球提示血管肉瘤",
      "心臟超音波檢查右心耳是分期必要步驟"
    ],
    "diagnosticAlgorithm": {
      "title": "脾臟腫瘤 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估急性或慢性症狀，注意血管肉瘤急性破裂",
          "findings": [
            "急性虛弱與蒼白破裂出血",
            "腹部膨大",
            "慢性食慾下降與體重減輕",
            "腹部觸診可觸及腫塊"
          ]
        },
        {
          "step": 2,
          "action": "緊急實驗室與影像學",
          "details": "評估貧血程度，腹部超音波確認",
          "findings": [
            "PCV下降急性出血性貧血",
            "腹部超音波脾臟腫塊",
            "腹腔積液出血性",
            "腹腔穿刺血性液體"
          ]
        },
        {
          "step": 3,
          "action": "術前分期",
          "details": "全身轉移篩查，心臟超音波評估",
          "findings": [
            "胸腔X光三視圖",
            "心臟超音波排除右心房腫塊",
            "肝臟超音波評估轉移",
            "凝血功能DIC篩查"
          ]
        },
        {
          "step": 4,
          "action": "脾臟切除與組織學",
          "details": "脾臟切除後組織病理學確診",
          "findings": [
            "血管肉瘤最常見惡性",
            "血腫/結節性增生良性約三分之一",
            "淋巴瘤或其他肉瘤",
            "術後化療評估"
          ]
        }
      ]
    },
    "monitoring": [
      "腹部超音波",
      "胸部X光",
      "心臟超音波",
      "CBC追蹤",
      "臨床症狀"
    ],
    "reference": "Thamm DH: Hemangiosarcoma. In Vail DM et al: Withrow & MacEwen's Small Animal Clinical Oncology, 6th Ed. Elsevier, 2020"
  },
  "pulmonary-neoplasia": {
    "zh": "肺腫瘤",
    "en": "Pulmonary Neoplasia",
    "definition": "原發性或轉移性肺臟腫瘤。原發性肺腫瘤以惡性上皮性腫瘤（肺腺癌）最為常見，轉移性肺腫瘤較原發性更為常見。",
    "synonyms": [
      "肺癌",
      "肺部腫瘤",
      "Lung Tumor",
      "Lung Cancer"
    ],
    "epidemiology": {
      "species": "犬較貓常見",
      "age": "老年動物（平均10-11歲）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "高齡",
        "都市環境",
        "二手菸暴露",
        "石綿暴露"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "慢性咳嗽",
        "呼吸困難",
        "運動不耐受",
        "體重減輕",
        "食慾下降",
        "咳血",
        "跛行（肥大性骨病變或指端轉移）"
      ],
      "physicalExam": [
        "肺部聽診異常",
        "呼吸急促",
        "呼吸困難",
        "體重減輕",
        "指端腫脹（肥大性骨病變）",
        "胸水"
      ]
    },
    "pathophysiology": "原發性肺腺癌起源於支氣管或肺泡上皮細胞，可為單一腫塊或多發結節。腫瘤生長導致氣道阻塞、肺實質破壞及胸腔積液。轉移性肺腫瘤經由血行途徑到達肺臟，常見來源包括骨肉瘤、乳腺腫瘤、甲狀腺癌等。",
    "diagnosis": {
      "overview": "胸部影像學發現肺部腫塊，組織病理學確診",
      "differentials": [
        "肺炎",
        "肺膿瘍",
        "肺真菌感染",
        "肺肉芽腫",
        "其他部位腫瘤轉移"
      ],
      "initialDB": [
        "胸部X光三視圖",
        "CBC/血液生化",
        "凝血功能",
        "動脈血氣分析"
      ],
      "advanced": [
        "胸部CT掃描",
        "支氣管鏡及灌洗",
        "超音波或CT引導細針抽吸",
        "淋巴結抽吸",
        "腹部超音波分期"
      ]
    },
    "treatment": {
      "overview": "單一肺葉原發腫瘤以手術切除為首選",
      "acute": [
        "氧氣支持",
        "胸腔穿刺引流（胸水）",
        "止痛"
      ],
      "chronic": [
        "肺葉切除術",
        "術後化療（轉移性或不完全切除）",
        "酪胺酸激酶抑制劑（Toceranib）",
        "緩和治療"
      ]
    },
    "prognosis": "單一腫塊完整切除、無淋巴結轉移者中位存活約12-20個月。腫瘤＜5cm、無淋巴結受累、分化良好者預後較佳。已有淋巴結或遠處轉移者預後差，中位存活約2-4個月。",
    "pearls": [
      "老年犬慢性咳嗽應考慮肺腫瘤",
      "貓肺腫瘤可表現為指端轉移（肺-趾症候群）",
      "CT比X光更敏感，可發現更小的結節",
      "孤立性腫塊較多發結節預後好"
    ],
    "diagnosticAlgorithm": {
      "title": "肺腫瘤 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估呼吸道症狀，注意老年動物慢性咳嗽",
          "findings": [
            "慢性非產性咳嗽",
            "呼吸困難或呼吸急促",
            "運動不耐受",
            "體重減輕與食慾下降"
          ]
        },
        {
          "step": 2,
          "action": "胸腔X光檢查",
          "details": "三視圖胸腔X光評估肺部腫塊",
          "findings": [
            "孤立性肺腫塊或多發結節",
            "肺葉實質化",
            "胸腔積液",
            "肺門淋巴結腫大"
          ]
        },
        {
          "step": 3,
          "action": "進階檢查與取樣",
          "details": "CT掃描精確評估，超音波或CT引導細針抽吸",
          "findings": [
            "CT定位腫塊大小與位置",
            "與支氣管/血管的關係",
            "細針抽吸細胞學",
            "區分原發性vs轉移性肺腫瘤"
          ]
        },
        {
          "step": 4,
          "action": "分期與手術評估",
          "details": "排除轉移性疾病，評估肺葉切除可行性",
          "findings": [
            "腹部超音波排除原發腫瘤",
            "區域淋巴結評估",
            "孤立性原發腫瘤手術預後較佳",
            "組織學分型（腺癌最常見）"
          ]
        }
      ]
    },
    "monitoring": [
      "胸部X光或CT追蹤",
      "呼吸功能評估",
      "淋巴結大小",
      "臨床症狀"
    ],
    "reference": "Selting KA: Pulmonary Neoplasia. In Vail DM et al: Withrow & MacEwen's Small Animal Clinical Oncology, 6th Ed. Elsevier, 2020"
  },
  "anal-sac-adenocarcinoma": {
    "zh": "肛門囊腺癌",
    "en": "Anal Sac Adenocarcinoma",
    "definition": "起源於肛門囊頂泌腺（apocrine gland）的惡性腫瘤，具高度局部侵襲性及轉移傾向，常伴隨副腫瘤性高鈣血症。",
    "synonyms": [
      "肛門囊頂泌腺癌",
      "AGASACA",
      "Apocrine Gland Anal Sac Adenocarcinoma"
    ],
    "epidemiology": {
      "species": "犬為主，貓極罕見",
      "age": "中老年犬（平均9-11歲）",
      "sex": "母犬稍多見，但公犬亦常發生",
      "riskFactors": [
        "英國可卡犬",
        "德國牧羊犬",
        "老年犬"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "排便困難",
        "糞便形狀改變（扁平）",
        "會陰部腫脹",
        "多飲多尿（高鈣血症）",
        "食慾下降",
        "後肢無力"
      ],
      "physicalExam": [
        "直腸觸診發現肛門囊硬實腫塊",
        "薦下淋巴結腫大",
        "會陰腫脹",
        "脫水",
        "肌肉無力"
      ]
    },
    "pathophysiology": "頂泌腺上皮細胞惡性增生形成腫瘤，具高度局部侵襲性。約25-50%病例分泌副甲狀腺激素相關蛋白（PTHrP）導致高鈣血症。腫瘤早期即可轉移至薦下（髂內）淋巴結，後續轉移至肺臟及肝臟。",
    "diagnosis": {
      "overview": "直腸觸診發現腫塊，血鈣升高為重要線索",
      "differentials": [
        "肛門囊炎",
        "肛門囊膿瘍",
        "肛周腺瘤/腺癌",
        "會陰疝",
        "直腸腫瘤"
      ],
      "initialDB": [
        "直腸觸診",
        "CBC/血液生化（離子鈣、總鈣）",
        "胸部X光三視圖",
        "腹部超音波"
      ],
      "advanced": [
        "腹部CT（薦下淋巴結評估）",
        "細針抽吸或組織切片",
        "PTHrP檢測",
        "淋巴結抽吸"
      ]
    },
    "treatment": {
      "overview": "手術切除腫瘤，必要時切除轉移淋巴結，術後化療或放療",
      "acute": [
        "靜脈輸液糾正高鈣血症",
        "利尿劑（Furosemide）",
        "雙磷酸鹽類藥物",
        "止痛"
      ],
      "chronic": [
        "手術切除腫瘤及淋巴結",
        "術後化療（Carboplatin或Mitoxantrone）",
        "放射治療（輔助或緩和）",
        "持續監控血鈣"
      ]
    },
    "prognosis": "中位存活時間約12-18個月（手術加化療）。腫瘤大小＜2.5cm及無淋巴結轉移者預後較佳。高鈣血症可隨腫瘤切除而改善，但復發時再現。",
    "pearls": [
      "每次直腸觸診都應檢查肛門囊",
      "副腫瘤性高鈣血症是重要臨床線索",
      "即使有薦下淋巴結轉移，手術切除仍可延長存活",
      "約50%病例在診斷時已有淋巴結轉移"
    ],
    "diagnosticAlgorithm": {
      "title": "肛門囊腺癌 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "肛門直腸觸診，評估排便症狀",
          "findings": [
            "肛門旁腫塊（直腸觸診）",
            "排便困難或糞便變細",
            "肛門區域腫脹",
            "蹭地行為或舔舐肛門"
          ]
        },
        {
          "step": 2,
          "action": "血液檢查與影像學",
          "details": "評估副腫瘤症候群與轉移",
          "findings": [
            "高鈣血症常見副腫瘤症候群",
            "腹部超音波：髂內淋巴結腫大",
            "腎前性氮血症（高鈣相關）",
            "多飲多尿（高鈣導致）"
          ]
        },
        {
          "step": 3,
          "action": "組織學確診",
          "details": "腫塊細針抽吸或切除活檢",
          "findings": [
            "腺癌細胞學特徵",
            "組織病理學確診",
            "淋巴結細針抽吸評估轉移",
            "分期影像（胸腔X光三視圖）"
          ]
        },
        {
          "step": 4,
          "action": "治療計劃",
          "details": "手術切除與輔助治療評估",
          "findings": [
            "手術切除腫瘤與受累淋巴結",
            "術後放射治療評估",
            "化療評估",
            "高鈣血症管理"
          ]
        }
      ]
    },
    "monitoring": [
      "直腸觸診",
      "血鈣濃度",
      "腹部超音波（淋巴結）",
      "胸部X光"
    ],
    "reference": "Williams LE et al: Carcinoma of the Apocrine Glands of the Anal Sac. In Vail DM et al: Withrow & MacEwen's Small Animal Clinical Oncology, 6th Ed. Elsevier, 2020"
  },
  "histiocytic-sarcoma": {
    "zh": "組織細胞肉瘤",
    "en": "Histiocytic Sarcoma",
    "definition": "起源於樹突狀細胞或巨噬細胞的高度惡性腫瘤，可為局部性或播散性（以前稱為惡性組織細胞增生症）。",
    "synonyms": [
      "惡性組織細胞增生症",
      "播散性組織細胞肉瘤",
      "Malignant Histiocytosis",
      "Disseminated Histiocytic Sarcoma"
    ],
    "epidemiology": {
      "species": "犬為主，貓罕見",
      "age": "中老年犬（6-11歲）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "伯恩山犬",
        "平毛獵犬",
        "黃金獵犬",
        "羅威納犬",
        "拉布拉多犬",
        "遺傳傾向"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "快速進行性消瘦",
        "食慾下降",
        "嗜睡",
        "呼吸困難",
        "跛行（關節周圍型）",
        "神經症狀（CNS侵犯）"
      ],
      "physicalExam": [
        "肝脾腫大",
        "淋巴結腫大",
        "肺部聽診異常",
        "可觸及皮膚或皮下腫塊",
        "關節腫脹",
        "貧血黏膜"
      ]
    },
    "pathophysiology": "樹突狀細胞或巨噬細胞惡性增生，局部型起源於單一部位（脾、肺、皮膚、關節周圍），播散型則多器官同時受累。腫瘤細胞具吞噬活性，可導致紅血球吞噬及嚴重貧血。遺傳因素在伯恩山犬和平毛獵犬中已被確認。",
    "diagnosis": {
      "overview": "組織病理學及免疫組織化學染色確診",
      "differentials": [
        "淋巴瘤",
        "其他圓細胞腫瘤",
        "肉芽腫性疾病",
        "免疫媒介性溶血性貧血",
        "脾臟血管肉瘤"
      ],
      "initialDB": [
        "CBC（貧血、血小板減少）",
        "血液生化",
        "腹部超音波",
        "胸部X光"
      ],
      "advanced": [
        "組織切片及免疫組織化學（CD18+, CD11c+）",
        "骨髓穿刺",
        "CT掃描全身分期",
        "細針抽吸細胞學"
      ]
    },
    "treatment": {
      "overview": "局部型以手術為主，播散型化療效果有限",
      "acute": [
        "輸血支持",
        "止痛",
        "穩定病患"
      ],
      "chronic": [
        "手術切除（局部型）",
        "CCNU（Lomustine）化療",
        "Doxorubicin",
        "緩和治療",
        "免疫療法（試驗性）"
      ]
    },
    "prognosis": "整體預後差。局部型手術切除後中位存活約6個月。播散型預後極差，中位存活約3-4個月。對化療反應率約50%但緩解期短。",
    "pearls": [
      "伯恩山犬和平毛獵犬為高風險品種",
      "播散型常表現為再生不良性貧血和血小板減少",
      "免疫組織化學染色是確診關鍵",
      "與反應性組織細胞增生症需鑑別"
    ],
    "diagnosticAlgorithm": {
      "title": "組織細胞肉瘤 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估非特異性全身症狀，確認品種傾向",
          "findings": [
            "體重減輕與食慾下降",
            "精神沉鬱",
            "品種傾向（伯恩山犬/金毛/拉布拉多）",
            "局部型：關節腫脹或皮膚腫塊"
          ]
        },
        {
          "step": 2,
          "action": "影像學檢查",
          "details": "全身影像學評估受累器官",
          "findings": [
            "脾臟/肝臟/肺臟腫塊",
            "多器官受累（播散型）",
            "骨溶解性病變",
            "淋巴結腫大"
          ]
        },
        {
          "step": 3,
          "action": "組織學與免疫組化",
          "details": "組織活檢與特殊染色確診",
          "findings": [
            "多形性圓形至梭形細胞",
            "吞噬作用明顯",
            "免疫組化：CD18+/CD11d+",
            "區分局部型vs播散型"
          ]
        },
        {
          "step": 4,
          "action": "分期與預後",
          "details": "完整分期評估",
          "findings": [
            "局部型預後優於播散型",
            "關節周圍型可手術",
            "播散型預後差",
            "化療評估（Lomustine/Doxorubicin）"
          ]
        }
      ]
    },
    "monitoring": [
      "CBC",
      "影像學追蹤",
      "臨床症狀",
      "體重"
    ],
    "reference": "Moore PF: Histiocytic Sarcoma Complex. In Vail DM et al: Withrow & MacEwen's Small Animal Clinical Oncology, 6th Ed. Elsevier, 2020"
  },
  "meningioma": {
    "zh": "腦膜瘤",
    "en": "Meningioma",
    "definition": "起源於腦膜蛛網膜絨毛帽狀細胞的腫瘤，為犬貓最常見的原發性顱內腫瘤。犬多為良性但可造成嚴重壓迫；貓亦多為良性。",
    "synonyms": [
      "蛛網膜瘤",
      "腦膜上皮瘤",
      "Meningeal Tumor"
    ],
    "epidemiology": {
      "species": "犬貓皆常見",
      "age": "老年動物（犬>7歲，貓>10歲）",
      "sex": "無明顯性別傾向（部分文獻報導母犬稍多）",
      "riskFactors": [
        "長頭犬種（金毛獵犬、拳師犬）",
        "短頭犬種（波士頓梗）",
        "高齡",
        "貓：可為多發性"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "癲癇發作",
        "行為改變",
        "轉圈",
        "視力喪失",
        "步態異常",
        "性格改變"
      ],
      "physicalExam": [
        "神經學定位異常（對側偏癱、面部感覺缺失）",
        "視覺障礙（威脅反應缺失）",
        "意識狀態改變",
        "顱神經缺損",
        "本體感覺缺失"
      ]
    },
    "pathophysiology": "腫瘤起源於蛛網膜帽狀細胞，多為緩慢生長的軸外腫瘤，向腦實質壓迫而非浸潤。隨腫瘤生長，引起周圍腦水腫、顱內壓升高及神經功能障礙。貓腦膜瘤可多發，且可能合併腦室內生長。",
    "diagnosis": {
      "overview": "MRI為首選影像學檢查，典型表現為均勻強化的軸外腫塊",
      "differentials": [
        "膠質瘤",
        "脈絡叢腫瘤",
        "轉移性腫瘤",
        "腦膿瘍",
        "肉芽腫性腦膜腦炎"
      ],
      "initialDB": [
        "完整神經學檢查",
        "CBC/血液生化",
        "胸部X光",
        "腹部超音波"
      ],
      "advanced": [
        "腦部MRI（首選，顯示硬腦膜尾徵）",
        "CT掃描",
        "腦脊液分析",
        "組織切片（手術時）"
      ]
    },
    "treatment": {
      "overview": "手術切除為首選，輔以抗癲癇藥物及類固醇控制水腫",
      "acute": [
        "Mannitol降低顱內壓",
        "類固醇（Dexamethasone）",
        "抗癲癇藥物",
        "支持性護理"
      ],
      "chronic": [
        "顱骨切開腫瘤切除術",
        "放射治療（輔助或無法手術時）",
        "立體定向放射外科",
        "長期抗癲癇治療"
      ]
    },
    "prognosis": "犬手術切除後中位存活約7-33個月，視腫瘤位置和完整切除程度而定。貓手術預後較犬好，中位存活可超過2年。放射治療可進一步延長存活。",
    "pearls": [
      "犬貓最常見的原發性顱內腫瘤",
      "MRI特徵性表現：均勻強化、硬腦膜尾徵、軸外腫塊",
      "貓腦膜瘤常可較完整切除因與腦實質界線清楚",
      "老年犬新發癲癇應將腦膜瘤列為首要考慮"
    ],
    "diagnosticAlgorithm": {
      "title": "腦膜瘤 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估神經症狀與進展速度",
          "findings": [
            "行為改變或性格異常",
            "癲癇發作（老年犬首次發作）",
            "步態異常或轉圈",
            "視力障礙"
          ]
        },
        {
          "step": 2,
          "action": "神經學檢查",
          "details": "完整神經學定位檢查",
          "findings": [
            "前腦徵象（行為/癲癇/視力）",
            "腦幹徵象（顱神經異常）",
            "小腦徵象（共濟失調/意向性震顫）",
            "神經定位判斷"
          ]
        },
        {
          "step": 3,
          "action": "進階影像學",
          "details": "MRI為腦部腫瘤診斷首選",
          "findings": [
            "MRI：腦外腫塊均勻強化",
            "寬基底附著腦膜",
            "dural tail sign",
            "犬常見腦膜瘤/貓也常見"
          ]
        },
        {
          "step": 4,
          "action": "治療計劃",
          "details": "根據位置與症狀評估手術或保守治療",
          "findings": [
            "表淺位置可手術切除",
            "手術難以完全切除則輔助放療",
            "類固醇減輕腦水腫",
            "抗癲癇藥物控制癲癇"
          ]
        }
      ]
    },
    "monitoring": [
      "神經學檢查",
      "癲癇頻率",
      "MRI追蹤",
      "抗癲癇藥物血中濃度"
    ],
    "reference": "Snyder JM et al: Canine Intracranial Neoplasia. In Vail DM et al: Withrow & MacEwen's Small Animal Clinical Oncology, 6th Ed. Elsevier, 2020"
  },
  "right-sided-heart-failure": {
    "zh": "右心衰竭",
    "en": "Right-Sided Congestive Heart Failure",
    "definition": "右心室無法有效將血液泵入肺循環，導致體循環靜脈壓升高、腹水及外周水腫的臨床症候群。",
    "synonyms": [
      "右側充血性心衰竭",
      "右心鬱血性心衰竭",
      "Right-Sided CHF"
    ],
    "epidemiology": {
      "species": "犬貓皆可發生",
      "age": "依基礎病因而異",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "三尖瓣退化性疾病",
        "心絲蟲感染",
        "肺動脈高壓",
        "先天性心臟病（肺動脈狹窄）",
        "心包膜疾病",
        "擴張型心肌病"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "腹部膨大",
        "運動不耐受",
        "體重增加（水腫液滯留）",
        "食慾下降",
        "呼吸困難（嚴重時）"
      ],
      "physicalExam": [
        "腹水",
        "頸靜脈擴張或搏動",
        "肝脾腫大（鬱血性）",
        "皮下水腫",
        "三尖瓣雜音",
        "心搏過速",
        "奔馬律"
      ]
    },
    "pathophysiology": "右心室功能不全或容量/壓力超負荷導致右心房壓力升高，繼而引起體循環靜脈壓升高。液體自靜脈端微血管滲出至組織間隙及體腔，形成腹水、胸水及皮下水腫。RAAS系統啟動進一步加重鈉水滯留。",
    "diagnosis": {
      "overview": "臨床表現結合心臟超音波確認右心結構及功能異常",
      "differentials": [
        "肝臟疾病引起的腹水",
        "低白蛋白血症",
        "腹腔腫瘤",
        "心包膜積液",
        "門脈高壓"
      ],
      "initialDB": [
        "胸部X光",
        "心臟超音波",
        "CBC/血液生化",
        "腹水分析",
        "心電圖"
      ],
      "advanced": [
        "NT-proBNP或cTnI",
        "心臟血管造影",
        "心導管檢查",
        "心絲蟲抗原檢測"
      ]
    },
    "treatment": {
      "overview": "利尿劑減輕容量過負荷，治療潛在心臟疾病",
      "acute": [
        "Furosemide（利尿劑）",
        "腹腔穿刺引流（大量腹水）",
        "氧氣支持",
        "限制鈉攝取"
      ],
      "chronic": [
        "口服Furosemide",
        "Spironolactone",
        "ACE抑制劑",
        "Pimobendan（依適應症）",
        "治療基礎心臟病",
        "限鈉飲食"
      ]
    },
    "prognosis": "取決於基礎病因。三尖瓣退化性疾病控制良好者可存活數月至數年。肺動脈高壓或擴張型心肌病引起者預後較差。心絲蟲感染治療後可改善。",
    "pearls": [
      "犬右心衰竭最常見原因為三尖瓣退化性疾病和心絲蟲感染",
      "腹水分析呈改良漏出液有助於區分心因性腹水",
      "頸靜脈擴張是右心衰竭的重要臨床指標",
      "治療右心衰竭時需注意不要過度利尿導致低血壓"
    ],
    "diagnosticAlgorithm": {
      "title": "右心衰竭 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估體循環淤血徵象",
          "findings": [
            "腹部膨大（腹水）",
            "頸靜脈怒張或肝頸靜脈回流陽性",
            "皮下水腫",
            "運動不耐受"
          ]
        },
        {
          "step": 2,
          "action": "影像學檢查",
          "details": "胸腹部X光與超音波評估",
          "findings": [
            "右心擴大",
            "後腔靜脈擴張",
            "胸腔積液",
            "腹部超音波確認腹水"
          ]
        },
        {
          "step": 3,
          "action": "心臟超音波",
          "details": "評估右心結構與功能，確認病因",
          "findings": [
            "三尖瓣反流",
            "右心室擴大或肥厚",
            "肺動脈高壓估算",
            "心包積液排除"
          ]
        },
        {
          "step": 4,
          "action": "病因調查",
          "details": "確認導致右心衰竭的根本原因",
          "findings": [
            "心絲蟲病篩查",
            "肺動脈高壓病因",
            "心包疾病排除",
            "先天性心臟病評估"
          ]
        }
      ]
    },
    "monitoring": [
      "呼吸頻率",
      "腹圍",
      "體重",
      "腎功能及電解質",
      "心臟超音波追蹤"
    ],
    "reference": "Côté E: Right-Sided Congestive Heart Failure. In Clinical Veterinary Advisor: Dogs and Cats, 4th Ed. Elsevier, 2020"
  },
  "myocarditis": {
    "zh": "心肌炎",
    "en": "Myocarditis",
    "definition": "心肌炎是心肌的炎症性疾病，可由感染（Trypanosoma cruzi、Parvovirus、Borrelia）、免疫介導、毒素或特發性因素引起。犬以感染性最常見，貓較罕見。輕度者無症狀，重度者以急性心衰、心律不整或猝死為表現。心肌肌鈣蛋白（cTnI）升高有診斷價值。確定診斷需心肌活檢。",
    "synonyms": [
      "心肌發炎",
      "Inflammatory Cardiomyopathy"
    ],
    "epidemiology": {
      "species": "犬貓皆可發生",
      "age": "任何年齡，幼犬（犬小病毒）及中年犬（免疫媒介性）較常見",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "犬小病毒感染",
        "錐蟲感染（Chagas病）",
        "細菌性心內膜炎",
        "免疫媒介性疾病",
        "藥物毒性（Doxorubicin）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "突發虛弱或昏厥",
        "運動不耐受",
        "呼吸困難",
        "猝死",
        "嘔吐腹瀉（犬小病毒時）"
      ],
      "physicalExam": [
        "心律不整",
        "奔馬律",
        "心雜音（二尖瓣逆流）",
        "肺水腫聽診異常",
        "脈搏弱",
        "低體溫（休克）"
      ]
    },
    "pathophysiology": "感染因子直接損傷心肌細胞或免疫反應介導的心肌發炎壞死。發炎導致心肌水腫、纖維化及心肌細胞死亡，繼而影響心臟收縮和傳導功能，可引起心律不整和心衰竭。犬小病毒心肌炎主要影響新生幼犬心肌細胞。",
    "diagnosis": {
      "overview": "臨床懷疑度高，確診需依賴心肌組織病理學，但臨床上常為排除性診斷",
      "differentials": [
        "擴張型心肌病",
        "犬小病毒感染",
        "心包膜積液",
        "心臟腫瘤",
        "敗血症相關心肌抑制"
      ],
      "initialDB": [
        "心電圖（心律不整）",
        "心臟超音波",
        "CBC/血液生化",
        "心肌肌鈣蛋白I（cTnI）升高"
      ],
      "advanced": [
        "心肌內膜活檢",
        "PCR檢測病原",
        "心臟MRI",
        "錐蟲抗體檢測（流行區）"
      ]
    },
    "treatment": {
      "overview": "治療基礎病因，支持心功能，控制心律不整",
      "acute": [
        "抗心律不整藥物（Lidocaine、Amiodarone）",
        "正性肌力藥物（Dobutamine）",
        "靜脈輸液（謹慎）",
        "氧氣支持"
      ],
      "chronic": [
        "ACE抑制劑",
        "Pimobendan",
        "抗心律不整藥物",
        "治療基礎感染",
        "免疫抑制劑（免疫媒介性）"
      ]
    },
    "prognosis": "取決於病因和嚴重程度。感染性心肌炎治療後可部分恢復。嚴重心律不整或急性心衰竭者可能猝死。犬小病毒心肌炎幼犬死亡率高。慢性心肌炎可進展為擴張型心肌病。",
    "pearls": [
      "犬小病毒心肌炎在廣泛疫苗接種後已少見",
      "cTnI是評估心肌損傷的敏感生物標記",
      "心律不整可能是唯一的臨床表現",
      "Chagas病在美洲南部犬為重要鑑別診斷"
    ],
    "diagnosticAlgorithm": {
      "title": "心肌炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估心臟功能異常與全身感染徵象",
          "findings": [
            "心律不整",
            "心動過速或奔馬律",
            "運動不耐受或突然虛弱",
            "發燒或近期感染史"
          ]
        },
        {
          "step": 2,
          "action": "心電圖與心臟標記物",
          "details": "連續ECG監測與心肌損傷標記物檢測",
          "findings": [
            "心室早期收縮或心室心動過速",
            "ST段變化",
            "心肌肌鈣蛋白I升高",
            "NT-proBNP升高"
          ]
        },
        {
          "step": 3,
          "action": "心臟超音波",
          "details": "評估心臟結構與收縮功能",
          "findings": [
            "局部或全面壁運動減低",
            "收縮功能下降",
            "心腔擴大",
            "心包積液"
          ]
        },
        {
          "step": 4,
          "action": "病因調查",
          "details": "確認感染性或免疫媒介性病因",
          "findings": [
            "病毒PCR檢測",
            "弓形蟲/巴貝斯蟲篩查",
            "蜱媒疾病篩查",
            "心肌活檢（少見執行）"
          ]
        }
      ]
    },
    "monitoring": [
      "心電圖（Holter監測）",
      "心臟超音波",
      "cTnI",
      "臨床症狀"
    ],
    "reference": "Côté E: Myocarditis. In Clinical Veterinary Advisor: Dogs and Cats, 4th Ed. Elsevier, 2020"
  },
  "restrictive-cardiomyopathy": {
    "zh": "限制型心肌病",
    "en": "Restrictive Cardiomyopathy",
    "definition": "以心室壁僵硬及舒張功能障礙為特徵的心肌疾病，心室壁厚度和收縮功能可正常或輕度異常，主要影響貓。",
    "synonyms": [
      "拘束型心肌病",
      "RCM",
      "中間型心肌病"
    ],
    "epidemiology": {
      "species": "貓為主，犬極罕見",
      "age": "中老年貓",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "心肌纖維化",
        "先前心肌炎",
        "心內膜纖維化"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "呼吸困難",
        "運動不耐受",
        "食慾下降",
        "突發後肢癱瘓（動脈血栓栓塞）",
        "猝死"
      ],
      "physicalExam": [
        "奔馬律（S3或S4）",
        "心搏過速",
        "肺部囉音",
        "心雜音",
        "胸水",
        "後肢冰冷無脈搏（ATE時）"
      ]
    },
    "pathophysiology": "心內膜或心肌纖維化導致心室順應性降低，舒張期充盈受阻，心房壓力升高。左心房擴大促進血栓形成，可導致動脈血栓栓塞症（ATE）。最終導致充血性心衰竭，以胸水為主要表現（貓）。分為心肌型（心室壁纖維化）和心內膜型（心內膜纖維增厚）。",
    "diagnosis": {
      "overview": "心臟超音波顯示心房擴大、心室壁僵硬但不肥厚，舒張功能異常",
      "differentials": [
        "肥厚型心肌病",
        "擴張型心肌病",
        "未分類心肌病",
        "心包膜疾病"
      ],
      "initialDB": [
        "胸部X光",
        "心臟超音波",
        "心電圖",
        "NT-proBNP"
      ],
      "advanced": [
        "組織都卜勒超音波（TDI）",
        "心臟MRI",
        "心肌內膜活檢",
        "凝血功能評估"
      ]
    },
    "treatment": {
      "overview": "無特異性治療，以控制心衰竭症狀及預防血栓為主",
      "acute": [
        "Furosemide（利尿）",
        "胸腔穿刺引流",
        "氧氣支持",
        "血栓栓塞急性治療"
      ],
      "chronic": [
        "Furosemide",
        "ACE抑制劑",
        "Clopidogrel（抗血栓）",
        "Diltiazem（改善舒張功能）",
        "Pimobendan（有爭議）"
      ]
    },
    "prognosis": "預後謹慎至不良，中位存活時間約3-12個月。併發動脈血栓栓塞者預後極差。比肥厚型心肌病預後差，因診斷時多已處於心衰竭狀態。",
    "pearls": [
      "限制型心肌病是貓第二或第三常見的心肌病",
      "心臟超音波與肥厚型心肌病的鑑別有時困難",
      "左心房嚴重擴大者血栓風險極高",
      "S3奔馬律是舒張功能障礙的重要聽診發現"
    ],
    "diagnosticAlgorithm": {
      "title": "限制型心肌病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估舒張功能障礙相關症狀，多見於貓",
          "findings": [
            "呼吸困難或呼吸急促",
            "運動不耐受",
            "精神沉鬱",
            "心雜音或奔馬律"
          ]
        },
        {
          "step": 2,
          "action": "胸腔X光與心電圖",
          "details": "評估心臟大小與肺部狀態",
          "findings": [
            "左心房擴大",
            "肺水腫或胸腔積液",
            "心電圖左心房擴大型態",
            "心律不整"
          ]
        },
        {
          "step": 3,
          "action": "心臟超音波",
          "details": "評估心室壁與舒張功能",
          "findings": [
            "心內膜纖維化或心室內瘢痕",
            "舒張功能異常限制性充盈模式",
            "左心房明顯擴大",
            "收縮功能可能正常或輕度下降"
          ]
        },
        {
          "step": 4,
          "action": "鑑別診斷",
          "details": "與其他心肌病鑑別",
          "findings": [
            "排除肥厚型心肌病",
            "排除擴張型心肌病",
            "心內膜心肌纖維化確認",
            "血栓風險評估"
          ]
        }
      ]
    },
    "monitoring": [
      "呼吸頻率",
      "胸部X光",
      "心臟超音波",
      "凝血功能"
    ],
    "reference": "Côté E: Restrictive Cardiomyopathy. In Clinical Veterinary Advisor: Dogs and Cats, 4th Ed. Elsevier, 2020"
  },
  "sick-sinus-syndrome": {
    "zh": "病竇症候群",
    "en": "Sick Sinus Syndrome",
    "definition": "竇房結功能障礙導致的一系列心律不整，包括竇性心搏過緩、竇房阻滯、竇性停止，可伴隨快速心房心律不整（慢快症候群）。",
    "synonyms": [
      "竇房結功能不全症候群",
      "SSS",
      "慢快症候群",
      "Brady-Tachy Syndrome"
    ],
    "epidemiology": {
      "species": "犬為主，貓罕見",
      "age": "中老年犬",
      "sex": "母犬稍多見",
      "riskFactors": [
        "迷你雪納瑞",
        "西高地白梗",
        "可卡犬",
        "臘腸犬",
        "拳師犬",
        "竇房結纖維化"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "間歇性虛弱",
        "昏厥（暈厥）",
        "運動不耐受",
        "嗜睡",
        "猝死（罕見）"
      ],
      "physicalExam": [
        "心搏過緩",
        "不規則心律",
        "長時間心搏間歇",
        "Atropine反應試驗不完全",
        "交替出現快速和緩慢心律"
      ]
    },
    "pathophysiology": "竇房結及其周圍組織退化性纖維化，導致起搏功能障礙和傳導異常。竇性心搏過緩或竇性停止導致心輸出量降低。部分病例同時存在心房肌異常，可產生快速心房心律不整（心房顫動或心房撲動）與緩慢心律交替出現（慢快症候群）。",
    "diagnosis": {
      "overview": "心電圖顯示竇性心搏過緩合併竇性停止，Atropine反應試驗反應不完全",
      "differentials": [
        "高度房室阻滯",
        "高迷走神經張力",
        "藥物引起的心搏過緩",
        "甲狀腺功能低下",
        "高鉀血症"
      ],
      "initialDB": [
        "心電圖",
        "Atropine反應試驗",
        "CBC/血液生化",
        "甲狀腺功能"
      ],
      "advanced": [
        "24小時Holter心電圖監測",
        "心臟超音波",
        "電解質完整分析"
      ]
    },
    "treatment": {
      "overview": "症狀輕微者可觀察，症狀嚴重者需植入永久心臟起搏器",
      "acute": [
        "Atropine（緊急）",
        "Isoproterenol靜脈滴注",
        "暫時性經靜脈起搏"
      ],
      "chronic": [
        "永久性心臟起搏器植入",
        "抗心律不整藥物（慢快症候群需謹慎使用）",
        "Theophylline（暫時性）",
        "避免使用減慢心率的藥物"
      ]
    },
    "prognosis": "起搏器植入後預後良好，多數犬可恢復正常活動。不治療者若症狀嚴重可能危及生命。迷你雪納瑞預後通常較好。",
    "pearls": [
      "迷你雪納瑞是最典型的好發品種",
      "Atropine反應試驗不完全反應（心率<150次/分）支持診斷",
      "慢快症候群需起搏器保護下才能安全使用抗心律不整藥物",
      "Holter監測可捕捉間歇性發作"
    ],
    "diagnosticAlgorithm": {
      "title": "病竇症候群 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估心搏過緩相關症狀",
          "findings": [
            "間歇性虛弱或暈厥",
            "運動不耐受",
            "心搏過緩",
            "品種傾向（迷你雪納瑞/可卡犬/西高地白梗）"
          ]
        },
        {
          "step": 2,
          "action": "心電圖檢查",
          "details": "靜態與動態心電圖監測",
          "findings": [
            "竇性心搏過緩",
            "竇性停搏",
            "快慢交替症候群",
            "房室傳導障礙"
          ]
        },
        {
          "step": 3,
          "action": "阿托品反應試驗",
          "details": "注射阿托品評估竇房結反應",
          "findings": [
            "阿托品反應不佳竇房結功能障礙",
            "心率未能適當上升",
            "排除迷走神經過度刺激",
            "持續心搏過緩"
          ]
        },
        {
          "step": 4,
          "action": "24小時Holter監測",
          "details": "動態心電圖記錄評估心律異常頻率",
          "findings": [
            "記錄暈厥事件與心律關係",
            "最低心率與停搏時間",
            "快慢交替頻率",
            "心律調節器植入評估"
          ]
        }
      ]
    },
    "monitoring": [
      "起搏器功能檢測",
      "心電圖",
      "臨床症狀",
      "心臟超音波"
    ],
    "reference": "Côté E: Sick Sinus Syndrome. In Clinical Veterinary Advisor: Dogs and Cats, 4th Ed. Elsevier, 2020"
  },
  "obesity": {
    "zh": "肥胖症",
    "en": "Obesity",
    "definition": "體重超過理想體重20%以上的營養代謝疾病，為小動物最常見的營養問題，與多種慢性疾病的發生及加重有關。",
    "synonyms": [
      "過度肥胖",
      "超重",
      "Overweight"
    ],
    "epidemiology": {
      "species": "犬貓皆極常見",
      "age": "中年動物較常見，絕育後風險增加",
      "sex": "絕育動物風險高於未絕育",
      "riskFactors": [
        "絕育",
        "過量餵食",
        "缺乏運動",
        "自由採食",
        "拉布拉多犬",
        "米格魯",
        "臘腸犬",
        "英國短毛貓",
        "室內貓",
        "POMC基因突變（拉布拉多）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "體重逐漸增加",
        "運動不耐受",
        "呼吸急促",
        "關節疼痛",
        "跛行"
      ],
      "physicalExam": [
        "體態評分（BCS）≥7/9",
        "腰線消失",
        "肋骨難以觸及",
        "腹部脂肪墊增厚",
        "皮下脂肪明顯增加"
      ]
    },
    "pathophysiology": "能量攝取長期超過消耗，多餘能量以脂肪形式儲存。脂肪組織不僅是能量儲存器官，也是活性內分泌器官，分泌促炎細胞因子（adipokines），導致慢性低度發炎狀態。肥胖增加骨關節炎、糖尿病（貓）、心血管疾病、呼吸功能障礙及某些腫瘤的風險。",
    "diagnosis": {
      "overview": "體態評分系統（BCS 9分制）和體重測量",
      "differentials": [
        "甲狀腺功能低下（犬）",
        "腎上腺皮質功能亢進",
        "腹水",
        "腹腔腫塊",
        "水腫"
      ],
      "initialDB": [
        "體態評分（BCS）",
        "肌肉狀態評分（MCS）",
        "體重記錄",
        "基礎血液生化"
      ],
      "advanced": [
        "甲狀腺功能檢測（犬）",
        "腎上腺功能檢測",
        "DEXA掃描（研究用）",
        "胰島素/血糖"
      ]
    },
    "treatment": {
      "overview": "多模式減重計畫包括飲食管理、運動增加及行為改變",
      "acute": [
        "計算理想體重和每日能量需求",
        "制定減重計畫（每週減輕1-2%體重）"
      ],
      "chronic": [
        "處方減重飼料（高蛋白高纖維低脂）",
        "精確量測食物",
        "增加運動量",
        "消除零食和人類食物",
        "環境豐富化（貓）",
        "定期體重追蹤"
      ]
    },
    "prognosis": "配合飼主積極參與，減重計畫可成功。減重可顯著改善相關疾病（骨關節炎、糖尿病緩解）。但長期維持是挑戰，復胖率高。研究顯示維持理想體重可延長犬壽命約2年。",
    "pearls": [
      "估計25-40%犬貓為過重或肥胖",
      "BCS每增加1分（9分制）相當於體重增加約10-15%",
      "貓肥胖是第二型糖尿病的最重要風險因素",
      "拉布拉多的POMC基因突變使其食慾特別旺盛",
      "飼主教育和依從性是成功減重的關鍵"
    ],
    "diagnosticAlgorithm": {
      "title": "肥胖症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "體態評分",
          "details": "使用體態評分系統BCS 1-9分評估肥胖程度",
          "findings": [
            "BCS 7/9以上為肥胖",
            "肋骨不易觸及",
            "腰線消失",
            "腹部下垂"
          ]
        },
        {
          "step": 2,
          "action": "飲食與生活型態評估",
          "details": "詳細詢問飲食量、零食、運動量",
          "findings": [
            "過量餵食",
            "高熱量零食或人食",
            "運動不足",
            "多寵物家庭競爭進食"
          ]
        },
        {
          "step": 3,
          "action": "內分泌疾病排除",
          "details": "排除導致肥胖的潛在內分泌疾病",
          "findings": [
            "甲狀腺功能低下檢測犬",
            "腎上腺皮質功能亢進排除",
            "絕育相關代謝改變",
            "胰島素阻抗評估"
          ]
        },
        {
          "step": 4,
          "action": "共病評估",
          "details": "評估肥胖相關共病",
          "findings": [
            "骨關節疾病評估",
            "糖尿病篩查",
            "心血管功能評估",
            "呼吸功能評估"
          ]
        }
      ]
    },
    "monitoring": [
      "每2-4週體重測量",
      "BCS追蹤",
      "血糖（貓）",
      "骨關節功能評估"
    ],
    "reference": "German AJ: Obesity in companion animals. JSAP 2016; Côté E: Obesity. In Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "hepatic-encephalopathy": {
    "zh": "肝性腦病",
    "en": "Hepatic Encephalopathy",
    "definition": "因嚴重肝功能不全或門體分流導致神經毒素（主要為氨）無法被肝臟代謝清除，而引起的神經精神功能障礙。",
    "synonyms": [
      "肝性腦症",
      "肝昏迷",
      "門體性腦病",
      "Portosystemic Encephalopathy"
    ],
    "epidemiology": {
      "species": "犬貓皆可發生",
      "age": "先天性門體分流多見於幼年動物，後天性見於各年齡",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "先天性門體分流",
        "急性肝衰竭",
        "慢性肝病",
        "約克夏梗",
        "馬爾濟斯",
        "愛爾蘭狼犬",
        "高蛋白飲食",
        "消化道出血"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "進食後行為異常",
        "定向障礙",
        "走路搖晃",
        "流口水（貓）",
        "癲癇發作",
        "昏迷（嚴重時）",
        "間歇性症狀"
      ],
      "physicalExam": [
        "行為改變（壓頭、轉圈、茫然凝視）",
        "共濟失調",
        "流涎（尤其貓）",
        "瞳孔散大",
        "體型偏小（先天性分流）",
        "黃疸（肝衰竭時）"
      ]
    },
    "pathophysiology": "肝功能不全時，腸道產生的氨、硫醇、短鏈脂肪酸及假性神經傳遞物質未能被肝臟有效代謝，經門體分流或體循環直接進入腦部。氨為主要毒素，在星狀膠質細胞中轉化為麩醯胺酸，引起細胞水腫及腦水腫，干擾神經傳遞功能。",
    "diagnosis": {
      "overview": "臨床神經症狀合併肝功能異常指標及血氨升高",
      "differentials": [
        "原發性癲癇",
        "中毒",
        "低血糖",
        "腦炎",
        "代謝性疾病（尿毒症）"
      ],
      "initialDB": [
        "CBC/血液生化（BUN偏低、白蛋白偏低）",
        "血氨濃度",
        "膽汁酸（空腹及餐後）",
        "尿液分析（尿酸銨結晶）"
      ],
      "advanced": [
        "腹部超音波（門體分流偵測）",
        "門靜脈造影",
        "CT血管造影",
        "腦部MRI",
        "肝臟切片"
      ]
    },
    "treatment": {
      "overview": "降低血氨及腸道毒素生成，治療基礎肝病",
      "acute": [
        "溫水灌腸（清除腸道毒素）",
        "Lactulose口服或灌腸",
        "靜脈輸液（避免含乳酸液）",
        "控制癲癇（Levetiracetam首選）",
        "停止蛋白質攝取"
      ],
      "chronic": [
        "Lactulose（口服，調整至軟便）",
        "限量優質蛋白飲食",
        "抗生素（Metronidazole或Neomycin）",
        "門體分流手術結紮（先天性）",
        "補充鋅"
      ]
    },
    "prognosis": "先天性門體分流手術結紮後預後良好。急性肝衰竭合併肝性腦病預後謹慎至不良。慢性肝病以藥物和飲食控制可維持生活品質。分級越高（昏迷）預後越差。",
    "pearls": [
      "幼犬幼貓的生長遲緩和進食後行為異常應考慮門體分流",
      "貓肝性腦病特徵性表現為大量流涎",
      "Lactulose是長期管理的基石藥物",
      "消化道出血是肝病患者急性肝性腦病的常見誘因",
      "避免使用經肝臟代謝的鎮靜藥物"
    ],
    "diagnosticAlgorithm": {
      "title": "肝性腦病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估神經行為異常與肝病關聯",
          "findings": [
            "進食後行為改變或精神異常",
            "無目的遊走或壓頭",
            "流涎貓常見",
            "癲癇發作"
          ]
        },
        {
          "step": 2,
          "action": "實驗室檢查",
          "details": "肝功能與血氨測定",
          "findings": [
            "空腹血氨升高",
            "飯後血氨更高",
            "低白蛋白血症",
            "低BUN尿素循環障礙"
          ]
        },
        {
          "step": 3,
          "action": "肝臟影像與血管評估",
          "details": "超音波評估肝臟大小與門靜脈系統",
          "findings": [
            "肝臟偏小",
            "門脈分流血管偵測",
            "腎結石/膀胱結石尿酸銨",
            "膽汁酸刺激試驗異常"
          ]
        },
        {
          "step": 4,
          "action": "病因確認",
          "details": "區分先天性門脈分流與後天性肝病",
          "findings": [
            "CT血管攝影確認門脈分流",
            "肝臟活檢評估慢性肝病",
            "年幼動物考慮先天性分流",
            "老年動物考慮後天性肝硬化"
          ]
        }
      ]
    },
    "monitoring": [
      "血氨濃度",
      "神經學狀態",
      "膽汁酸",
      "肝臟功能指標",
      "體重和營養狀態"
    ],
    "reference": "Côté E: Hepatic Encephalopathy. In Clinical Veterinary Advisor: Dogs and Cats, 4th Ed. Elsevier, 2020"
  },
  "hyperlipoproteinemia": {
    "zh": "高脂蛋白血症",
    "en": "Hyperlipoproteinemia",
    "definition": "血中脂蛋白濃度異常升高的代謝異常，表現為高三酸甘油酯血症和/或高膽固醇血症，可為原發性（遺傳性）或繼發於其他疾病。",
    "synonyms": [
      "高脂血症",
      "高三酸甘油酯血症",
      "高膽固醇血症",
      "Hyperlipidemia"
    ],
    "epidemiology": {
      "species": "犬貓皆可發生",
      "age": "中老年動物較常見（繼發性），原發性可在年輕時發病",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "迷你雪納瑞（原發性）",
        "甲狀腺功能低下",
        "糖尿病",
        "腎上腺皮質功能亢進",
        "腎病症候群",
        "膽汁鬱積",
        "高脂飲食",
        "肥胖"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "常為偶然發現（血清乳糜外觀）",
        "嘔吐",
        "腹痛",
        "癲癇發作（嚴重時）",
        "皮膚黃色瘤"
      ],
      "physicalExam": [
        "可能無異常發現",
        "腹部疼痛（胰臟炎時）",
        "皮膚/眼瞼黃色瘤（脂質沉積）",
        "肝腫大",
        "角膜脂質沉積"
      ]
    },
    "pathophysiology": "脂蛋白代謝異常導致血中乳糜微粒（富含三酸甘油酯）或VLDL/LDL（富含膽固醇）清除障礙或產生過多。迷你雪納瑞有原發性高三酸甘油酯血症的遺傳傾向。繼發性多因內分泌疾病影響脂蛋白代謝酶活性。嚴重高三酸甘油酯血症可誘發胰臟炎。",
    "diagnosis": {
      "overview": "空腹12小時後血清仍呈乳糜狀，三酸甘油酯和/或膽固醇升高",
      "differentials": [
        "甲狀腺功能低下",
        "糖尿病",
        "腎上腺皮質功能亢進",
        "腎病症候群",
        "膽汁鬱積",
        "餐後正常生理性升高"
      ],
      "initialDB": [
        "空腹血清外觀評估",
        "三酸甘油酯",
        "膽固醇",
        "CBC/血液生化"
      ],
      "advanced": [
        "甲狀腺功能檢測",
        "腎上腺功能檢測",
        "尿蛋白/肌酐比",
        "脂蛋白電泳",
        "cPLI/fPLI"
      ]
    },
    "treatment": {
      "overview": "治療基礎疾病為首要，輔以低脂飲食和必要時降脂藥物",
      "acute": [
        "治療胰臟炎（若合併）",
        "禁食後逐步恢復低脂飲食"
      ],
      "chronic": [
        "治療基礎內分泌疾病",
        "低脂處方飲食",
        "Omega-3脂肪酸補充",
        "Gemfibrozil（犬，降三酸甘油酯）",
        "Bezafibrate",
        "Niacin（謹慎使用）"
      ]
    },
    "prognosis": "繼發性高脂血症在基礎疾病控制後可改善。原發性高脂血症（迷你雪納瑞）需長期飲食管理，未控制者胰臟炎風險增加。單純高膽固醇血症較少引起臨床症狀。",
    "pearls": [
      "空腹12小時後採血是準確評估的前提",
      "迷你雪納瑞是原發性高三酸甘油酯血症的典型品種",
      "嚴重高三酸甘油酯血症（>500 mg/dL）可干擾其他血液檢查結果",
      "繼發性原因遠比原發性常見，需先排除"
    ],
    "diagnosticAlgorithm": {
      "title": "高脂蛋白血症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估血清脂質狀態，注意血清乳白色外觀",
          "findings": [
            "血清呈乳白色混濁脂血",
            "嘔吐與腹痛",
            "癲癇發作嚴重時",
            "品種傾向迷你雪納瑞"
          ]
        },
        {
          "step": 2,
          "action": "禁食脂質檢測",
          "details": "12小時禁食後三酸甘油酯與膽固醇測定",
          "findings": [
            "三酸甘油酯升高",
            "膽固醇可能升高",
            "禁食後仍異常確認非飲食性",
            "脂蛋白電泳分型"
          ]
        },
        {
          "step": 3,
          "action": "繼發性病因排除",
          "details": "排除導致高脂血症的潛在疾病",
          "findings": [
            "甲狀腺功能低下檢測",
            "腎上腺皮質功能亢進",
            "糖尿病篩查",
            "腎病症候群排除"
          ]
        },
        {
          "step": 4,
          "action": "併發症評估",
          "details": "評估高脂血症相關併發症",
          "findings": [
            "胰臟炎風險評估",
            "動脈粥樣硬化犬少見",
            "眼底脂質沉積",
            "肝臟脂肪浸潤"
          ]
        }
      ]
    },
    "monitoring": [
      "空腹三酸甘油酯和膽固醇",
      "基礎疾病指標",
      "cPLI/fPLI（胰臟炎風險）",
      "體重"
    ],
    "reference": "Xenoulis PG, Steiner JM: Canine Hyperlipidemia. JSAP 2015; Côté E: Hyperlipidemia. In Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "pulmonary-edema": {
    "zh": "肺水腫",
    "en": "Pulmonary Edema",
    "definition": "肺泡及/或肺間質內液體異常積聚，導致氣體交換障礙。可分為心因性（最常見）和非心因性。",
    "synonyms": [
      "肺積水",
      "Lung Edema"
    ],
    "epidemiology": {
      "species": "犬貓皆可發生",
      "age": "依基礎病因而異",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "充血性心衰竭",
        "電擊",
        "溺水",
        "上呼吸道阻塞",
        "頭部創傷",
        "癲癇持續狀態",
        "靜脈輸液過量"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "呼吸困難急性發作",
        "咳嗽（犬為主）",
        "端坐呼吸",
        "運動不耐受",
        "焦躁不安"
      ],
      "physicalExam": [
        "呼吸急促",
        "呼吸困難",
        "肺部囉音（濕囉音）",
        "口鼻泡沫狀分泌物（嚴重時）",
        "發紺",
        "心雜音（心因性）",
        "心搏過速"
      ]
    },
    "pathophysiology": "心因性：左心衰竭導致肺靜脈壓升高，液體自肺微血管滲出至間質和肺泡。非心因性：包括肺微血管通透性增加（ARDS、吸入性損傷）、低膠體滲透壓、神經性（頭部創傷後交感神經過度激活）及負壓性（上呼吸道阻塞後）等機制。",
    "diagnosis": {
      "overview": "胸部X光顯示肺泡或間質浸潤，結合臨床表現判斷病因",
      "differentials": [
        "肺炎",
        "肺出血",
        "肺纖維化",
        "ARDS",
        "胸水"
      ],
      "initialDB": [
        "胸部X光",
        "血氧飽和度/血氣分析",
        "心臟超音波",
        "CBC/血液生化",
        "心電圖"
      ],
      "advanced": [
        "NT-proBNP（區分心因性vs非心因性）",
        "支氣管灌洗液分析",
        "CT掃描",
        "凝血功能"
      ]
    },
    "treatment": {
      "overview": "氧氣支持、利尿（心因性）、治療基礎病因",
      "acute": [
        "氧氣治療",
        "Furosemide靜脈注射（心因性）",
        "減少緊迫",
        "坐姿或半坐姿",
        "Nitroglycerin軟膏（輔助）",
        "正壓通氣（嚴重時）"
      ],
      "chronic": [
        "口服Furosemide",
        "ACE抑制劑",
        "Pimobendan（心因性）",
        "治療基礎心臟病",
        "限鈉飲食"
      ]
    },
    "prognosis": "心因性肺水腫對利尿劑反應良好者短期預後可，長期取決於心臟疾病嚴重程度。非心因性取決於病因，電擊和神經性肺水腫治療後可完全恢復。ARDS預後較差。",
    "pearls": [
      "犬心因性肺水腫X光以肺門周圍（perihilar）分佈為典型",
      "貓心因性肺水腫X光分佈較不固定，可為斑塊狀",
      "NT-proBNP有助於區分心因性和非心因性呼吸困難",
      "處理呼吸困難患者時減少緊迫至關重要"
    ],
    "diagnosticAlgorithm": {
      "title": "肺水腫 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "緊急評估",
          "details": "評估呼吸窘迫程度與氧合狀態",
          "findings": [
            "嚴重呼吸困難",
            "端坐呼吸",
            "肺部濕囉音",
            "咳出粉紅色泡沫痰"
          ]
        },
        {
          "step": 2,
          "action": "胸腔X光",
          "details": "評估肺水腫分布型態",
          "findings": [
            "肺泡型浸潤",
            "心因性肺門周圍對稱分布犬斑塊分布貓",
            "非心因性背尾側分布",
            "心臟大小評估"
          ]
        },
        {
          "step": 3,
          "action": "病因分類",
          "details": "區分心因性與非心因性肺水腫",
          "findings": [
            "心臟超音波評估心臟功能",
            "NT-proBNP快篩",
            "電擊/溺水/上呼吸道阻塞史",
            "神經性肺水腫"
          ]
        },
        {
          "step": 4,
          "action": "治療反應監測",
          "details": "利尿劑與氧氣治療後評估",
          "findings": [
            "Furosemide反應評估",
            "呼吸頻率與努力度改善",
            "追蹤X光確認消退",
            "持續氧合監測"
          ]
        }
      ]
    },
    "monitoring": [
      "呼吸頻率和型態",
      "血氧飽和度",
      "胸部X光追蹤",
      "腎功能（利尿劑使用時）",
      "安靜呼吸頻率（SRR）"
    ],
    "reference": "Côté E: Pulmonary Edema. In Clinical Veterinary Advisor: Dogs and Cats, 4th Ed. Elsevier, 2020"
  },
  "pulmonary-thromboembolism": {
    "zh": "肺血栓栓塞症",
    "en": "Pulmonary Thromboembolism",
    "definition": "血栓阻塞肺動脈或其分支，導致肺血管阻力增加、通氣灌流失衡及低血氧的急性危及生命的疾病。",
    "synonyms": [
      "肺栓塞",
      "PTE",
      "Pulmonary Embolism"
    ],
    "epidemiology": {
      "species": "犬較貓常見（或犬診斷率較高）",
      "age": "中老年動物",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "免疫媒介性溶血性貧血",
        "腎上腺皮質功能亢進",
        "蛋白質流失性腎病",
        "腫瘤",
        "心絲蟲感染",
        "DIC",
        "敗血症",
        "手術後制動"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "突發呼吸困難",
        "急性虛脫",
        "咳嗽",
        "咳血（罕見）",
        "猝死"
      ],
      "physicalExam": [
        "嚴重呼吸急促",
        "呼吸困難",
        "發紺",
        "心搏過速",
        "肺部聽診正常或減弱音",
        "低血壓（大面積栓塞）"
      ]
    },
    "pathophysiology": "血栓來源通常為深靜脈或體循環靜脈系統（多因高凝狀態），經由右心隨血流到達肺動脈。血栓阻塞肺血管導致肺血管阻力增加、死腔通氣增加、通氣灌流失衡及低血氧。大面積栓塞可導致急性右心衰竭和休克。",
    "diagnosis": {
      "overview": "臨床懷疑度高是關鍵，確診需依賴影像學",
      "differentials": [
        "肺炎",
        "心因性肺水腫",
        "氣胸",
        "胸水",
        "肺腫瘤",
        "ARDS"
      ],
      "initialDB": [
        "動脈血氣分析（低PaO2、低PaCO2）",
        "D-dimer",
        "胸部X光",
        "心臟超音波（右心擴大）"
      ],
      "advanced": [
        "CT血管造影（CTA，金標準）",
        "核醫學通氣灌流掃描",
        "凝血功能全套",
        "血栓彈性分析（TEG/ROTEM）"
      ]
    },
    "treatment": {
      "overview": "支持性治療、抗凝治療及治療基礎高凝狀態",
      "acute": [
        "氧氣支持",
        "靜脈輸液（謹慎，避免過負荷）",
        "Heparin（未分段或低分子量）",
        "止痛",
        "tPA溶栓治療（危及生命時，風險高）"
      ],
      "chronic": [
        "低分子量Heparin過渡至口服抗凝",
        "Clopidogrel",
        "Rivaroxaban（試驗性）",
        "治療基礎疾病",
        "長期抗凝治療"
      ]
    },
    "prognosis": "預後謹慎至不良，死亡率約30-70%。取決於栓塞面積、血流動力學穩定性及基礎疾病。IMHA合併PTE預後極差。及時診斷和治療可改善存活率。",
    "pearls": [
      "有高凝風險疾病的動物突發呼吸困難應高度懷疑PTE",
      "胸部X光可能正常或僅有輕微異常",
      "動脈血氣呈低氧血症伴低碳酸血症是典型表現",
      "D-dimer正常有助排除，但升高不能確診",
      "IMHA是犬PTE最常見的基礎疾病"
    ],
    "diagnosticAlgorithm": {
      "title": "肺血栓栓塞症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估與風險因子",
          "details": "評估急性呼吸困難，識別高風險群",
          "findings": [
            "急性呼吸困難",
            "心動過速",
            "低血壓",
            "高風險IMHA/腎病/庫欣/腫瘤/心絲蟲"
          ]
        },
        {
          "step": 2,
          "action": "實驗室檢查",
          "details": "血氣分析與凝血功能評估",
          "findings": [
            "低氧血症對氧氣反應差",
            "D-dimer升高",
            "動脈血氣呼吸性鹼中毒",
            "PaO2/FiO2比值下降"
          ]
        },
        {
          "step": 3,
          "action": "影像學檢查",
          "details": "胸腔X光與進階影像",
          "findings": [
            "X光可能正常或肺血管截斷",
            "肺區域性低灌流",
            "CT血管攝影為金標準",
            "右心擴大"
          ]
        },
        {
          "step": 4,
          "action": "潛在病因調查",
          "details": "確認導致高凝狀態的原因",
          "findings": [
            "IMHA篩查",
            "腎病蛋白尿評估",
            "腎上腺皮質功能亢進",
            "腫瘤篩查"
          ]
        }
      ]
    },
    "monitoring": [
      "動脈血氣",
      "凝血功能",
      "D-dimer",
      "心臟超音波",
      "臨床症狀"
    ],
    "reference": "Goggs R et al: Pulmonary Thromboembolism. JVIM 2009; Côté E: Pulmonary Thromboembolism. In Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "pulmonary-contusion": {
    "zh": "肺挫傷",
    "en": "Pulmonary Contusion",
    "definition": "肺挫傷是外傷導致肺實質出血和水腫的常見急症，為犬貓胸部創傷最常見的損傷。多見於交通事故、高處墜落和動物攻擊。外傷動能傳遞至肺泡毛細血管→血管破裂→肺泡內出血→氣體交換障礙→低氧血症。影像學改變在受傷後12-24小時最明顯。輕中度多在3-5天自行吸收。",
    "synonyms": [
      "肺部挫傷",
      "Lung Contusion",
      "Lung Bruise"
    ],
    "epidemiology": {
      "species": "犬貓皆可發生",
      "age": "任何年齡",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "車禍",
        "高處墜落",
        "踢傷",
        "胸部鈍傷"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "已知胸部外傷",
        "呼吸困難",
        "車禍",
        "高處墜落",
        "咳血"
      ],
      "physicalExam": [
        "呼吸急促",
        "呼吸困難",
        "肺部囉音",
        "胸壁瘀傷",
        "發紺",
        "心搏過速",
        "可能合併肋骨骨折、氣胸"
      ]
    },
    "pathophysiology": "胸部鈍性創傷的衝擊力傳遞至肺實質，導致肺泡微血管破裂、出血滲入肺泡和間質。繼發性發炎反應在傷後24-48小時使病變擴大。嚴重者可進展為ARDS。注意X光變化可能在傷後12-48小時才完全顯現。",
    "diagnosis": {
      "overview": "外傷病史結合胸部X光肺泡浸潤",
      "differentials": [
        "氣胸",
        "血胸",
        "橫膈膜疝氣",
        "肺撕裂傷",
        "心因性肺水腫"
      ],
      "initialDB": [
        "胸部X光",
        "血氧飽和度",
        "CBC/血液生化",
        "TFAST超音波"
      ],
      "advanced": [
        "動脈血氣分析",
        "胸部CT",
        "連續X光追蹤（12-48小時後加重）",
        "凝血功能"
      ]
    },
    "treatment": {
      "overview": "主要為支持性治療，維持氧合，大多數可自行恢復",
      "acute": [
        "氧氣治療",
        "限制活動",
        "止痛（避免呼吸抑制）",
        "靜脈輸液（謹慎，避免過量加重水腫）",
        "處理合併傷（氣胸、骨折）"
      ],
      "chronic": [
        "漸進恢復活動",
        "監測二次併發感染",
        "營養支持"
      ]
    },
    "prognosis": "輕至中度肺挫傷預後良好，多在2-7天內改善。嚴重挫傷或進展為ARDS者預後差。合併多重外傷者預後取決於整體傷勢嚴重程度。",
    "pearls": [
      "肺挫傷X光變化在傷後數小時可能尚未完全表現，24-48小時後最明顯",
      "輸液量應謹慎控制，過多會加重肺水腫",
      "疼痛控制對維持通氣功能很重要",
      "多數輕中度病例48-72小時內開始改善"
    ],
    "diagnosticAlgorithm": {
      "title": "肺挫傷 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "緊急評估",
          "details": "外傷後評估呼吸功能",
          "findings": [
            "外傷後呼吸困難進行性加重",
            "咳血或血性鼻分泌物",
            "胸壁挫傷或擦傷",
            "呼吸急促與發紺"
          ]
        },
        {
          "step": 2,
          "action": "胸腔X光",
          "details": "注意挫傷可能在受傷後12-24小時才明顯",
          "findings": [
            "肺泡或間質浸潤",
            "非對稱性分布",
            "合併氣胸或肋骨骨折",
            "病變在24-48小時最嚴重"
          ]
        },
        {
          "step": 3,
          "action": "全身創傷評估",
          "details": "肺挫傷常伴隨其他創傷",
          "findings": [
            "氣胸合併評估",
            "肋骨骨折確認",
            "腹部臟器損傷排除",
            "血氣分析評估氧合"
          ]
        },
        {
          "step": 4,
          "action": "連續監測",
          "details": "挫傷可能在48小時內持續惡化",
          "findings": [
            "連續X光追蹤24-48小時",
            "氧合狀態監測",
            "72-96小時後應開始改善",
            "未改善考慮ARDS"
          ]
        }
      ]
    },
    "monitoring": [
      "呼吸頻率和型態",
      "血氧飽和度",
      "連續胸部X光",
      "動脈血氣（嚴重時）"
    ],
    "reference": "Côté E: Pulmonary Contusion. In Clinical Veterinary Advisor: Dogs and Cats, 4th Ed. Elsevier, 2020"
  },
  "feline-upper-respiratory-infection": {
    "zh": "貓上呼吸道感染",
    "en": "Feline Upper Respiratory Infection",
    "definition": "貓的上呼吸道急性感染性疾病，主要由貓疱疹病毒第一型（FHV-1）和貓杯狀病毒（FCV）引起，亦可合併細菌二次感染。",
    "synonyms": [
      "貓感冒",
      "貓鼻氣管炎",
      "貓流感",
      "Feline URI",
      "Cat Flu"
    ],
    "epidemiology": {
      "species": "貓",
      "age": "幼貓最易感，成貓亦可感染",
      "sex": "無性別傾向",
      "riskFactors": [
        "多貓環境",
        "收容所",
        "未接種疫苗",
        "幼貓",
        "免疫抑制（FIV/FeLV）",
        "緊迫"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "打噴嚏",
        "鼻分泌物",
        "眼分泌物",
        "食慾下降",
        "嗜睡",
        "新引入貓或收容所來源"
      ],
      "physicalExam": [
        "漿液至膿性鼻分泌物",
        "結膜炎",
        "角膜潰瘍（FHV-1）",
        "口腔潰瘍（FCV）",
        "發燒",
        "脫水",
        "鼻塞導致張口呼吸"
      ]
    },
    "pathophysiology": "FHV-1感染上呼吸道上皮細胞導致壞死和發炎，可導致慢性鼻竇炎和角膜炎，病毒終身潛伏於三叉神經節。FCV感染口腔和呼吸道上皮，引起口腔潰瘍。細菌（Bordetella、Mycoplasma、Chlamydia）可作為原發或二次感染因子。高毒力FCV可引起全身性疾病（VS-FCV）。",
    "diagnosis": {
      "overview": "多為臨床診斷，嚴重或慢性病例可進行病原檢測",
      "differentials": [
        "貓披衣菌感染",
        "鼻腔異物",
        "鼻腔腫瘤",
        "鼻真菌感染",
        "貓氣喘"
      ],
      "initialDB": [
        "臨床症狀評估",
        "眼科檢查（角膜螢光染色）",
        "基礎血液檢查"
      ],
      "advanced": [
        "PCR檢測（FHV-1、FCV、Chlamydia）",
        "細菌培養",
        "鼻腔X光或CT（慢性病例）",
        "FIV/FeLV檢測"
      ]
    },
    "treatment": {
      "overview": "支持性治療為主，維持水分和營養攝取，必要時抗生素控制二次感染",
      "acute": [
        "皮下或靜脈輸液",
        "營養支持（加溫食物增加適口性）",
        "鼻腔通暢措施（生理食鹽水滴鼻、蒸氣）",
        "Doxycycline（二次感染或Chlamydia）",
        "Famciclovir（FHV-1嚴重時）"
      ],
      "chronic": [
        "L-Lysine補充（爭議性）",
        "Famciclovir（FHV-1復發）",
        "慢性鼻竇炎管理",
        "環境緊迫管理",
        "疫苗接種"
      ]
    },
    "prognosis": "多數免疫正常的成貓在7-14天內自行恢復。幼貓、免疫抑制貓可能病情嚴重或致命。FHV-1終身潛伏，緊迫時可復發。慢性鼻竇炎為常見後遺症。",
    "pearls": [
      "FHV-1和FCV合計佔貓URI約80-90%",
      "FHV-1導致角膜潰瘍，FCV導致口腔潰瘍是鑑別要點",
      "嗅覺喪失是貓食慾下降的重要原因，鼻腔通暢有助恢復食慾",
      "收容所環境發病率可達100%",
      "核心疫苗可減輕但不能完全預防感染"
    ],
    "diagnosticAlgorithm": {
      "title": "貓上呼吸道感染 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估上呼吸道症狀嚴重程度",
          "findings": [
            "打噴嚏與鼻分泌物",
            "結膜炎與眼分泌物",
            "發燒與精神沉鬱",
            "食慾下降嗅覺喪失"
          ]
        },
        {
          "step": 2,
          "action": "臨床病原推測",
          "details": "根據臨床特徵初步判斷病原",
          "findings": [
            "FHV-1角膜潰瘍樹枝狀潰瘍",
            "FCV口腔潰瘍跛行",
            "Chlamydia結膜炎為主",
            "Bordetella/Mycoplasma下呼吸道擴展"
          ]
        },
        {
          "step": 3,
          "action": "實驗室檢查",
          "details": "重症或慢性病例進行病原檢測",
          "findings": [
            "呼吸道PCR面板",
            "FIV/FeLV狀態評估",
            "CBC排除免疫抑制",
            "慢性病例CT排除鼻腔結構問題"
          ]
        },
        {
          "step": 4,
          "action": "併發症評估",
          "details": "評估幼貓或免疫抑制貓的嚴重併發症",
          "findings": [
            "脫水與營養不良不進食",
            "繼發性細菌性肺炎",
            "角膜穿孔FHV重症",
            "慢性鼻竇炎發展"
          ]
        }
      ]
    },
    "monitoring": [
      "食慾和水分攝取",
      "體重",
      "呼吸狀態",
      "眼部症狀",
      "脫水程度"
    ],
    "reference": "Côté E: Feline Upper Respiratory Infection. In Clinical Veterinary Advisor: Dogs and Cats, 4th Ed. Elsevier, 2020"
  },
  "feline-triaditis": {
    "zh": "貓三體炎",
    "en": "Feline Triaditis",
    "definition": "貓同時發生膽管炎/膽管肝炎、胰臟炎和炎症性腸病（IBD）三種炎症性疾病的臨床症候群。",
    "synonyms": [
      "三體發炎",
      "Triaditis"
    ],
    "epidemiology": {
      "species": "貓",
      "age": "中老年貓較常見",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "炎症性腸病",
        "慢性胰臟炎",
        "膽管炎",
        "腸道細菌移行"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "嘔吐",
        "食慾下降或厭食",
        "體重減輕",
        "腹瀉",
        "嗜睡",
        "黃疸"
      ],
      "physicalExam": [
        "脫水",
        "黃疸",
        "腹部疼痛",
        "體重減輕",
        "腸壁增厚（觸診）",
        "發燒"
      ]
    },
    "pathophysiology": "貓解剖上胰管和總膽管在十二指腸乳頭處共同開口，使腸道細菌易逆行感染至膽管和胰管。IBD改變腸道通透性促進細菌移行，導致膽管炎和胰臟炎。三個器官的發炎互相促進形成惡性循環。淋巴球性膽管炎和淋巴球漿細胞性腸炎常同時存在。",
    "diagnosis": {
      "overview": "需同時評估肝膽、胰臟和腸道三個系統",
      "differentials": [
        "單獨膽管炎",
        "單獨胰臟炎",
        "單獨IBD",
        "腸道淋巴瘤",
        "肝脂肪沉積症"
      ],
      "initialDB": [
        "CBC/血液生化（肝臟酵素、膽紅素）",
        "fPLI（胰臟炎）",
        "腹部超音波",
        "凝血功能"
      ],
      "advanced": [
        "肝臟細針抽吸或切片",
        "膽汁培養",
        "內視鏡腸道切片",
        "鈷胺素和葉酸濃度",
        "腹部CT"
      ]
    },
    "treatment": {
      "overview": "同時治療三個器官系統的發炎，營養支持極為重要",
      "acute": [
        "靜脈輸液",
        "止吐（Maropitant）",
        "止痛",
        "抗生素（膽管炎）",
        "營養管放置（必要時）"
      ],
      "chronic": [
        "Ursodiol（利膽）",
        "低敏或水解蛋白飲食",
        "鈷胺素（B12）補充",
        "免疫調節劑（Prednisolone或Chlorambucil，IBD成分）",
        "Metronidazole",
        "S-Adenosylmethionine（SAMe，肝臟保護）"
      ]
    },
    "prognosis": "視嚴重程度而定。輕度至中度三體炎經適當治療可控制。嚴重合併肝脂肪沉積或敗血性膽管炎預後較差。需要長期管理。",
    "pearls": [
      "貓的三體炎與其獨特的膽胰管解剖密切相關",
      "厭食超過3-5天的貓應考慮放置食管餵食管",
      "鈷胺素缺乏在貓三體炎中極常見且影響預後",
      "黃疸貓應同時評估三個器官系統",
      "慢性嘔吐的貓應篩檢三體炎三個成分"
    ],
    "diagnosticAlgorithm": {
      "title": "貓三體炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估同時涉及肝膽/胰臟/腸道的症狀",
          "findings": [
            "嘔吐與食慾廢絕",
            "精神極度沉鬱",
            "黃疸",
            "腹痛與脫水"
          ]
        },
        {
          "step": 2,
          "action": "實驗室檢查",
          "details": "肝膽/胰臟/腸道相關指標全面評估",
          "findings": [
            "肝酶ALT/ALP/GGT升高",
            "膽紅素升高",
            "fPLI升高胰臟炎",
            "低白蛋白/低鈷胺素腸道吸收不良"
          ]
        },
        {
          "step": 3,
          "action": "腹部超音波",
          "details": "評估三個器官的影像變化",
          "findings": [
            "膽管擴張或膽囊壁增厚",
            "胰臟腫大或周圍脂肪回音增強",
            "腸壁增厚",
            "腸系膜淋巴結腫大"
          ]
        },
        {
          "step": 4,
          "action": "組織學確診",
          "details": "肝臟/腸道活檢確認炎症型態",
          "findings": [
            "膽管炎淋巴球性或嗜中性球性",
            "胰臟炎確認",
            "炎症性腸病IBD",
            "三者同時發生確認三體炎"
          ]
        }
      ]
    },
    "monitoring": [
      "肝臟酵素和膽紅素",
      "fPLI",
      "體重和食慾",
      "鈷胺素濃度",
      "糞便品質"
    ],
    "reference": "Simpson KW: Pancreatitis and Triaditis in the Cat. JFMS 2015; Côté E: Cholangitis/Cholangiohepatitis. In Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "chronic-hepatitis": {
    "zh": "慢性肝炎",
    "en": "Chronic Hepatitis",
    "definition": "肝臟持續性發炎伴隨肝細胞壞死和纖維化，持續時間超過數週至數月，最終可進展為肝硬化。",
    "synonyms": [
      "慢性活動性肝炎",
      "慢性肝病",
      "Chronic Active Hepatitis"
    ],
    "epidemiology": {
      "species": "犬較常見，貓少見",
      "age": "中老年犬",
      "sex": "母犬稍多見（某些品種相關型）",
      "riskFactors": [
        "杜賓犬",
        "可卡犬",
        "拉布拉多犬",
        "貝靈頓梗（銅蓄積）",
        "西高地白梗",
        "達爾馬提亞犬",
        "斯凱梗",
        "銅蓄積",
        "藥物反應",
        "感染"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "食慾下降",
        "體重減輕",
        "嘔吐",
        "多飲多尿",
        "嗜睡",
        "腹部膨大（腹水）",
        "黃疸"
      ],
      "physicalExam": [
        "肝臟腫大或縮小",
        "黃疸",
        "腹水",
        "消瘦",
        "肝性腦病徵象",
        "出血傾向"
      ]
    },
    "pathophysiology": "多種病因（銅蓄積、免疫媒介、感染性、藥物性、特發性）引起的肝細胞持續損傷，導致慢性發炎、肝細胞壞死和再生。反覆的損傷修復循環促進纖維化進展。纖維化改變肝臟微循環和門脈血流，最終導致肝硬化、門脈高壓和肝功能衰竭。",
    "diagnosis": {
      "overview": "肝臟切片是確診和分類的金標準",
      "differentials": [
        "急性肝炎",
        "肝臟腫瘤",
        "膽管炎",
        "肝脂肪沉積症（貓）",
        "腎上腺皮質功能亢進",
        "反應性肝病"
      ],
      "initialDB": [
        "CBC/血液生化（ALT、ALP、GGT升高）",
        "膽汁酸",
        "白蛋白",
        "凝血功能",
        "腹部超音波"
      ],
      "advanced": [
        "肝臟切片（楔狀或腹腔鏡）",
        "肝臟銅定量",
        "免疫組織化學",
        "傳染病篩檢",
        "腹水分析"
      ]
    },
    "treatment": {
      "overview": "依病因治療，輔以肝臟保護劑和支持性治療",
      "acute": [
        "穩定凝血功能",
        "維生素K1",
        "輸液支持",
        "肝性腦病治療"
      ],
      "chronic": [
        "銅螯合劑（D-Penicillamine或Trientine，銅蓄積型）",
        "免疫抑制劑（Prednisolone、Azathioprine，免疫媒介型）",
        "Ursodiol（利膽保肝）",
        "SAMe（抗氧化）",
        "維生素E",
        "限量優質蛋白飲食",
        "低銅飲食（銅蓄積型）",
        "鋅補充（減少銅吸收）"
      ]
    },
    "prognosis": "取決於診斷時纖維化程度和病因。早期診斷和適當治療可延緩進展。已進展至肝硬化者預後差。杜賓犬慢性肝炎預後通常較差。貝靈頓梗銅蓄積若早期治療可控制。",
    "pearls": [
      "杜賓犬慢性肝炎是品種特異性疾病，母犬更常見",
      "肝臟切片是唯一可確定纖維化程度和病因的檢查",
      "銅蓄積可為原發或繼發於膽汁鬱滯",
      "ALT可在疾病晚期（肝硬化）反而降低",
      "凝血功能應在肝臟切片前評估"
    ],
    "diagnosticAlgorithm": {
      "title": "慢性肝炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估慢性肝病相關症狀",
          "findings": [
            "食慾下降與體重減輕",
            "間歇性嘔吐或腹瀉",
            "多飲多尿",
            "腹水晚期"
          ]
        },
        {
          "step": 2,
          "action": "血液生化檢查",
          "details": "肝功能與肝臟損傷指標",
          "findings": [
            "ALT持續升高",
            "ALP/GGT升高",
            "白蛋白下降",
            "膽汁酸刺激試驗異常"
          ]
        },
        {
          "step": 3,
          "action": "腹部超音波",
          "details": "評估肝臟型態與併發症",
          "findings": [
            "肝臟回音異常",
            "肝臟大小改變",
            "腹水",
            "門脈高壓徵象"
          ]
        },
        {
          "step": 4,
          "action": "肝臟活檢確診",
          "details": "超音波引導或腹腔鏡肝臟活檢",
          "findings": [
            "淋巴球漿細胞性肝炎",
            "纖維化程度分級",
            "銅蓄積評估品種相關",
            "鑑別感染性/免疫媒介性/銅相關"
          ]
        }
      ]
    },
    "monitoring": [
      "肝臟酵素",
      "膽汁酸",
      "白蛋白",
      "凝血功能",
      "腹部超音波",
      "定期肝臟切片（評估治療反應）"
    ],
    "reference": "Webster CRL: Chronic Hepatitis in Dogs. JVIM 2019; Côté E: Hepatitis, Chronic. In Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "acute-hepatic-failure": {
    "zh": "急性肝衰竭",
    "en": "Acute Hepatic Failure",
    "definition": "先前健康的肝臟在短時間內（數天至數週）發生嚴重功能衰竭，導致凝血障礙、肝性腦病及多器官功能障礙。",
    "synonyms": [
      "急性肝功能衰竭",
      "暴發性肝衰竭",
      "Acute Liver Failure",
      "Fulminant Hepatic Failure"
    ],
    "epidemiology": {
      "species": "犬貓皆可發生",
      "age": "任何年齡",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "藥物中毒（NSAID、Phenobarbital、Acetaminophen）",
        "毒素攝入（蘇鐵、鵝膏蕈、黃麴毒素、木糖醇）",
        "嚴重感染",
        "缺血性損傷",
        "中暑"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "急性嘔吐",
        "厭食",
        "嗜睡",
        "已知毒物或藥物暴露",
        "行為改變",
        "出血",
        "黃疸"
      ],
      "physicalExam": [
        "黃疸",
        "肝臟腫大或正常大小",
        "腹部疼痛",
        "出血傾向（瘀斑、消化道出血）",
        "肝性腦病徵象",
        "脫水",
        "低體溫"
      ]
    },
    "pathophysiology": "大量肝細胞急性壞死導致肝臟合成、代謝和解毒功能急劇喪失。凝血因子合成不足引起凝血障礙；氨等毒素無法清除導致肝性腦病；膽紅素代謝障礙導致黃疸；血糖調節喪失導致低血糖。可繼發DIC、SIRS和多器官功能衰竭。",
    "diagnosis": {
      "overview": "急性發作的肝功能異常伴凝血障礙和/或腦病",
      "differentials": [
        "慢性肝病急性惡化",
        "膽管阻塞",
        "敗血症",
        "中毒",
        "溶血性疾病"
      ],
      "initialDB": [
        "CBC/血液生化（ALT極度升高、膽紅素升高、低血糖、低白蛋白）",
        "凝血功能（PT/aPTT延長）",
        "血氨",
        "電解質"
      ],
      "advanced": [
        "腹部超音波",
        "毒物篩檢",
        "肝臟切片（凝血允許時）",
        "傳染病檢測",
        "乳酸"
      ]
    },
    "treatment": {
      "overview": "積極支持性治療為主，去除病因，維持生命徵象穩定",
      "acute": [
        "靜脈輸液（含葡萄糖）",
        "N-Acetylcysteine（NAC，抗氧化保護）",
        "維生素K1",
        "新鮮冷凍血漿（凝血因子補充）",
        "Lactulose和灌腸（肝性腦病）",
        "抗生素（預防菌血症）",
        "止吐（Maropitant）",
        "胃黏膜保護劑"
      ],
      "chronic": [
        "去除或治療基礎病因",
        "肝臟保護劑（SAMe、Silymarin）",
        "營養支持",
        "長期監測肝功能恢復"
      ]
    },
    "prognosis": "預後謹慎至不良，死亡率高（約50-70%）。取決於病因、壞死範圍和支持治療的及時性。藥物毒性若早期發現並停藥可改善。蘇鐵和鵝膏蕈中毒預後極差。存活者肝臟有再生能力。",
    "pearls": [
      "Acetaminophen對貓有極高毒性，微量即可致命",
      "N-Acetylcysteine是急性肝毒性的重要解毒劑",
      "低血糖是急性肝衰竭的嚴重併發症，需頻繁監測",
      "肝臟有強大再生能力，若能度過急性期可恢復功能",
      "凝血障礙先於臨床黃疸出現"
    ],
    "diagnosticAlgorithm": {
      "title": "急性肝衰竭 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "緊急評估",
          "details": "評估急性肝衰竭徵象",
          "findings": [
            "急性黃疸",
            "嘔吐與食慾廢絕",
            "凝血障礙出血",
            "精神意識改變肝性腦病"
          ]
        },
        {
          "step": 2,
          "action": "實驗室檢查",
          "details": "肝功能與凝血功能全面評估",
          "findings": [
            "ALT/AST極度升高",
            "膽紅素升高",
            "PT/aPTT延長",
            "低血糖"
          ]
        },
        {
          "step": 3,
          "action": "病因調查",
          "details": "確認急性肝衰竭原因",
          "findings": [
            "毒物攝入史",
            "感染性鈎端螺旋體/ICH",
            "缺氧性肝損傷",
            "急性膽道阻塞"
          ]
        },
        {
          "step": 4,
          "action": "併發症監測",
          "details": "監測多器官衰竭發展",
          "findings": [
            "DIC發展",
            "肝性腦病進展",
            "腎功能惡化",
            "酸鹼電解質失衡"
          ]
        }
      ]
    },
    "monitoring": [
      "凝血功能（每6-12小時）",
      "血糖（每2-4小時）",
      "肝臟酵素",
      "血氨",
      "神經學狀態",
      "電解質"
    ],
    "reference": "Côté E: Hepatic Failure, Acute. In Clinical Veterinary Advisor: Dogs and Cats, 4th Ed. Elsevier, 2020"
  },
  "septic-peritonitis": {
    "zh": "敗血性腹膜炎",
    "en": "Septic Peritonitis",
    "definition": "腹腔因細菌感染導致的嚴重發炎，通常繼發於消化道穿孔、腹腔手術併發症或泌尿道破裂，為危及生命的外科急症。",
    "synonyms": [
      "感染性腹膜炎",
      "化膿性腹膜炎",
      "Bacterial Peritonitis"
    ],
    "epidemiology": {
      "species": "犬貓皆可發生",
      "age": "任何年齡",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "消化道穿孔（異物、腫瘤、潰瘍）",
        "消化道吻合處滲漏",
        "腹腔手術後",
        "肝膽破裂",
        "尿腹症",
        "子宮蓄膿破裂",
        "穿透性腹部創傷"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "急性腹痛",
        "嘔吐",
        "厭食",
        "嗜睡",
        "近期腹腔手術",
        "已知異物攝入"
      ],
      "physicalExam": [
        "腹部緊繃疼痛",
        "發燒或低體溫",
        "心搏過速",
        "脈搏弱",
        "黏膜發紅或蒼白",
        "延長的CRT",
        "腹水",
        "脫水",
        "敗血性休克徵象"
      ]
    },
    "pathophysiology": "腹腔污染（消化道內容物、細菌、膽汁或尿液）引起劇烈腹膜發炎反應。細菌和內毒素吸收入血導致全身性發炎反應症候群（SIRS）和敗血症。未治療迅速進展為感染性休克、DIC和多器官衰竭。腹膜大面積的吸收表面使毒素迅速進入全身循環。",
    "diagnosis": {
      "overview": "腹腔穿刺液分析是快速診斷的關鍵",
      "differentials": [
        "無菌性腹膜炎",
        "胰臟炎",
        "腸阻塞",
        "子宮蓄膿",
        "腹腔腫瘤"
      ],
      "initialDB": [
        "CBC/血液生化",
        "腹部超音波（游離腹水）",
        "腹腔穿刺及液體分析",
        "腹水葡萄糖與血糖比較",
        "腹水乳酸"
      ],
      "advanced": [
        "腹水細菌培養及藥敏試驗",
        "腹水細胞學（退化嗜中性球+細菌）",
        "腹部X光（游離氣體）",
        "凝血功能",
        "乳酸"
      ]
    },
    "treatment": {
      "overview": "緊急手術探查修補感染源，配合積極靜脈抗生素和支持治療",
      "acute": [
        "積極靜脈輸液復甦",
        "廣效靜脈抗生素（Ampicillin-Sulbactam + Enrofloxacin或Metronidazole）",
        "緊急手術探查",
        "腹腔沖洗",
        "開放式或封閉式腹腔引流",
        "止痛",
        "血管升壓劑（必要時）"
      ],
      "chronic": [
        "依培養結果調整抗生素",
        "營養支持（早期腸道營養）",
        "傷口護理",
        "引流管管理"
      ]
    },
    "prognosis": "整體死亡率約20-68%，取決於病因、治療延遲時間和合併症。消化道穿孔修補後預後較好（存活率約50-80%）。合併敗血性休克或多器官衰竭者預後差。早期手術介入和積極支持治療可顯著改善預後。",
    "pearls": [
      "腹水葡萄糖比血糖低20 mg/dL以上高度提示敗血性腹膜炎",
      "腹水乳酸高於血液乳酸也支持診斷",
      "細胞學見退化嗜中性球和細胞內細菌可即時診斷",
      "手術延遲每小時存活率下降",
      "術後開放腹腔引流可提高存活率但需密集護理"
    ],
    "diagnosticAlgorithm": {
      "title": "敗血性腹膜炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "緊急評估",
          "details": "評估急性腹部與全身感染徵象",
          "findings": [
            "嚴重腹痛與腹部繃緊",
            "發燒或低體溫",
            "心動過速與低血壓",
            "嘔吐與精神極度沉鬱"
          ]
        },
        {
          "step": 2,
          "action": "腹腔穿刺",
          "details": "診斷性腹腔穿刺為最重要的診斷步驟",
          "findings": [
            "抽出混濁或膿性腹水",
            "腹水葡萄糖低於血清差值大於20mg/dL",
            "腹水乳酸高於血清",
            "細胞學見退化性嗜中性球與細菌"
          ]
        },
        {
          "step": 3,
          "action": "影像學與實驗室",
          "details": "確認感染來源",
          "findings": [
            "腹部超音波游離腹腔液/腸壁異常",
            "腹部X光游離氣體穿孔徵象",
            "白血球增多伴左移",
            "血液培養"
          ]
        },
        {
          "step": 4,
          "action": "手術探查",
          "details": "確認並處理感染來源",
          "findings": [
            "腸穿孔修補或切除",
            "子宮蓄膿破裂處理",
            "膽囊破裂處理",
            "腹腔大量灌洗"
          ]
        }
      ]
    },
    "monitoring": [
      "生命徵象",
      "乳酸",
      "引流液量和性狀",
      "CBC和血液生化",
      "凝血功能",
      "體溫"
    ],
    "reference": "Côté E: Peritonitis, Septic. In Clinical Veterinary Advisor: Dogs and Cats, 4th Ed. Elsevier, 2020"
  },
  "gastritis": {
    "zh": "胃炎",
    "en": "Gastritis",
    "definition": "胃黏膜的發炎性疾病，可分為急性和慢性。急性胃炎常為自限性，慢性胃炎可因多種病因引起持續性胃黏膜發炎。",
    "synonyms": [
      "胃黏膜炎",
      "Gastric Inflammation"
    ],
    "epidemiology": {
      "species": "犬貓皆極常見",
      "age": "任何年齡",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "飲食不當",
        "NSAID使用",
        "類固醇使用",
        "幽門螺旋桿菌樣菌",
        "異物攝入",
        "緊迫",
        "肝腎疾病"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "嘔吐（急性或慢性）",
        "食慾下降",
        "噁心（流涎、舔嘴唇、吞嚥動作）",
        "腹部不適",
        "體重減輕（慢性）"
      ],
      "physicalExam": [
        "脫水（急性嚴重嘔吐）",
        "上腹部壓痛",
        "可能無異常發現",
        "消瘦（慢性）"
      ]
    },
    "pathophysiology": "急性胃炎多由直接刺激因子（食物、藥物、毒素）損傷胃黏膜屏障引起。慢性胃炎涉及持續性發炎浸潤（淋巴球漿細胞性、嗜酸性球性等），可由免疫媒介性反應、慢性幽門螺旋桿菌樣菌感染、過敏或特發性因素引起。胃黏膜屏障損傷暴露黏膜下層組織於胃酸和胃蛋白酶。",
    "diagnosis": {
      "overview": "急性胃炎多為臨床診斷，慢性胃炎需內視鏡活檢確診",
      "differentials": [
        "飲食不當",
        "異物",
        "胃潰瘍",
        "胃腫瘤",
        "胰臟炎",
        "腎臟病",
        "肝病",
        "腎上腺功能低下"
      ],
      "initialDB": [
        "CBC/血液生化",
        "糞便檢查",
        "腹部X光",
        "腹部超音波"
      ],
      "advanced": [
        "胃腸內視鏡及黏膜活檢",
        "組織病理學分類",
        "幽門螺旋桿菌檢測",
        "食物過敏排除試驗"
      ]
    },
    "treatment": {
      "overview": "急性胃炎以支持性治療為主，慢性胃炎依組織病理分類治療",
      "acute": [
        "短暫禁食（12-24小時）後少量多餐清淡飲食",
        "止吐（Maropitant、Ondansetron）",
        "胃酸抑制劑（Omeprazole、Famotidine）",
        "輸液（脫水時）",
        "胃黏膜保護劑（Sucralfate）"
      ],
      "chronic": [
        "飲食管理（低敏或水解蛋白飲食）",
        "Omeprazole",
        "免疫抑制劑（IBD型：Prednisolone）",
        "停用致病藥物",
        "驅蟲",
        "益生菌"
      ]
    },
    "prognosis": "急性胃炎大多數自限性，預後極佳。慢性胃炎預後取決於病因：飲食相關型控制良好；IBD型需長期管理但多可控制；幽門肥大或腫瘤性預後較差。",
    "pearls": [
      "急性嘔吐<3天的年輕健康犬通常不需要廣泛檢查",
      "慢性嘔吐（>3週）應進行系統性檢查",
      "NSAID引起的胃炎應使用Omeprazole而非Famotidine",
      "內視鏡活檢是區分慢性胃炎類型的唯一可靠方法",
      "排除全身性疾病後再考慮原發性胃病"
    ],
    "diagnosticAlgorithm": {
      "title": "胃炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估嘔吐型態與持續時間",
          "findings": [
            "急性嘔吐食物/膽汁/泡沫",
            "食慾下降",
            "腹部不適",
            "脫水程度評估"
          ]
        },
        {
          "step": 2,
          "action": "基本檢查",
          "details": "排除嚴重併發症",
          "findings": [
            "腹部X光排除異物/阻塞",
            "血液檢查評估脫水/電解質",
            "排除全身性疾病",
            "糞便檢查排除寄生蟲"
          ]
        },
        {
          "step": 3,
          "action": "慢性胃炎進階檢查",
          "details": "持續超過2-3週需進階調查",
          "findings": [
            "腹部超音波評估胃壁厚度",
            "內視鏡與胃黏膜活檢",
            "幽門螺旋桿菌相關胃炎犬",
            "嗜酸性/淋巴球漿細胞性胃炎分型"
          ]
        }
      ]
    },
    "monitoring": [
      "嘔吐頻率",
      "食慾和體重",
      "糞便品質",
      "治療反應評估"
    ],
    "reference": "Côté E: Gastritis. In Clinical Veterinary Advisor: Dogs and Cats, 4th Ed. Elsevier, 2020"
  },
  "dietary-indiscretion": {
    "zh": "飲食不當",
    "en": "Dietary Indiscretion",
    "definition": "因攝入不適當食物（變質食物、垃圾、過油食物、非食物物品等）引起的急性自限性胃腸道症狀。",
    "synonyms": [
      "飲食不慎",
      "垃圾腸胃炎",
      "Garbage Gut",
      "Dietary Intolerance"
    ],
    "epidemiology": {
      "species": "犬遠較貓常見",
      "age": "任何年齡，幼犬最常見",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "幼犬好奇心強",
        "戶外活動",
        "接觸垃圾桶",
        "飲食突然改變",
        "餵食人類食物",
        "食物過敏體質"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "急性嘔吐",
        "腹瀉（可能帶血）",
        "食慾下降",
        "已知攝入不當食物",
        "腹部不適"
      ],
      "physicalExam": [
        "輕度脫水",
        "腹部輕壓痛",
        "腸蠕動音增加",
        "多數生命徵象正常"
      ]
    },
    "pathophysiology": "攝入的不適當食物直接刺激胃腸黏膜引起發炎反應。變質食物中的細菌毒素或不易消化物質導致胃腸蠕動異常和分泌增加。高脂食物可誘發急性胰臟炎。大多數情況下，一旦刺激物排出體外，胃腸道可自行修復。",
    "diagnosis": {
      "overview": "主要依據病史和排除其他更嚴重疾病",
      "differentials": [
        "中毒",
        "胃腸異物",
        "急性胰臟炎",
        "出血性胃腸炎（HGE/AHDS）",
        "傳染性腸炎",
        "腸套疊"
      ],
      "initialDB": [
        "病史評估（攝入物確認）",
        "基礎體檢",
        "脫水程度評估"
      ],
      "advanced": [
        "CBC/血液生化（嚴重或持續時）",
        "糞便檢查",
        "腹部X光（排除異物）",
        "cPLI/fPLI（排除胰臟炎）"
      ]
    },
    "treatment": {
      "overview": "支持性治療為主，大多數自限性",
      "acute": [
        "短暫禁食（12-24小時）或少量清淡飲食",
        "漸進恢復正常飲食",
        "口服或皮下輸液（脫水時）",
        "止吐（必要時）",
        "益生菌"
      ],
      "chronic": [
        "飲食教育（飼主）",
        "環境管理（限制接觸垃圾）",
        "逐步換食法則"
      ]
    },
    "prognosis": "預後極佳，大多數在24-72小時內完全恢復。極少數可併發急性胰臟炎（高脂食物攝入）或出血性胃腸炎而變得嚴重。",
    "pearls": [
      "飲食不當是犬急性嘔吐腹瀉最常見的原因",
      "症狀超過48小時不改善應重新評估診斷",
      "高脂食物攝入需警惕急性胰臟炎併發",
      "飼主教育是預防復發的關鍵",
      "確認無毒物攝入史非常重要"
    ],
    "diagnosticAlgorithm": {
      "title": "飲食不當 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "病史確認",
          "details": "詳細詢問近期飲食變化或垃圾攝入史",
          "findings": [
            "攝入不當食物或垃圾",
            "突然更換飲食",
            "進食量過大",
            "攝入高脂肪食物"
          ]
        },
        {
          "step": 2,
          "action": "臨床評估",
          "details": "評估消化道症狀與脫水程度",
          "findings": [
            "急性嘔吐與腹瀉",
            "腹部不適但無嚴重腹痛",
            "精神食慾輕度下降",
            "脫水程度評估"
          ]
        },
        {
          "step": 3,
          "action": "排除嚴重病因",
          "details": "確認非異物/毒物/胰臟炎等嚴重問題",
          "findings": [
            "腹部X光排除異物",
            "排除毒物攝入",
            "嚴重時排除胰臟炎",
            "排除腸道感染"
          ]
        }
      ]
    },
    "monitoring": [
      "嘔吐和腹瀉頻率",
      "水分攝取",
      "食慾恢復",
      "脫水程度"
    ],
    "reference": "Côté E: Dietary Intolerance. In Clinical Veterinary Advisor: Dogs and Cats, 4th Ed. Elsevier, 2020"
  },
  "feline-mycoplasma": {
    "zh": "貓黴漿菌感染",
    "en": "Feline Mycoplasma Infection",
    "definition": "貓黴漿菌（主要為Mycoplasma haemofelis及其他嗜血黴漿菌）感染紅血球導致的溶血性疾病，以及非嗜血性黴漿菌引起的呼吸道和結膜感染。",
    "synonyms": [
      "貓血黴漿菌症",
      "貓嗜血黴漿菌感染",
      "貓傳染性貧血",
      "Feline Hemoplasma",
      "Feline Infectious Anemia",
      "Hemobartonellosis"
    ],
    "epidemiology": {
      "species": "貓",
      "age": "任何年齡，年輕成貓較常見",
      "sex": "公貓稍多見（戶外行為）",
      "riskFactors": [
        "戶外接觸",
        "跳蚤寄生",
        "貓咬傷",
        "FIV/FeLV共感染",
        "免疫抑制",
        "脾臟切除後"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "嗜睡",
        "食慾下降",
        "虛弱",
        "呼吸急促",
        "間歇性症狀（菌血症波動性）"
      ],
      "physicalExam": [
        "黏膜蒼白",
        "黃疸",
        "脾臟腫大",
        "心搏過速",
        "發燒",
        "體重減輕"
      ]
    },
    "pathophysiology": "Mycoplasma haemofelis（致病力最強）附著於紅血球表面，導致免疫媒介性紅血球破壞。巨噬細胞系統識別被感染的紅血球並將其吞噬清除，造成血管外溶血。菌血症呈周期性波動，臨床症狀也隨之起伏。Candidatus Mycoplasma haemominutum和Candidatus Mycoplasma turicensis致病力較弱，多在免疫抑制時才引起臨床疾病。",
    "diagnosis": {
      "overview": "PCR檢測為金標準，血液抹片敏感度低",
      "differentials": [
        "免疫媒介性溶血性貧血",
        "FeLV相關貧血",
        "Cytauxzoon felis",
        "Babesia感染",
        "氧化性溶血（洋蔥中毒）"
      ],
      "initialDB": [
        "CBC（再生性貧血）",
        "血液抹片（紅血球表面小點，敏感度低）",
        "網狀紅血球計數",
        "血液生化（膽紅素升高）"
      ],
      "advanced": [
        "PCR檢測（敏感度和特異度最高）",
        "FIV/FeLV檢測",
        "Coombs試驗",
        "腹部超音波（脾腫大）"
      ]
    },
    "treatment": {
      "overview": "抗生素治療和支持性護理",
      "acute": [
        "Doxycycline（首選，28天）",
        "輸血（嚴重貧血PCV<12-15%）",
        "Prednisolone（合併嚴重免疫媒介性溶血時）",
        "輸液支持"
      ],
      "chronic": [
        "完成Doxycycline療程",
        "Marbofloxacin（替代藥物）",
        "治療共感染（FIV/FeLV管理）",
        "跳蚤預防"
      ]
    },
    "prognosis": "M. haemofelis感染免疫正常貓經治療後預後良好，但可能成為慢性帶菌者。FIV/FeLV共感染者預後較差。脾臟切除貓風險最高。治療後PCR可能仍為陽性（帶菌狀態）。",
    "pearls": [
      "血液抹片敏感度僅約50%，PCR才是可靠的診斷工具",
      "菌血症呈周期性波動，單次檢測可能為假陰性",
      "所有貓黴漿菌感染都應檢測FIV和FeLV",
      "Doxycycline可能無法完全清除感染，貓可成為終身帶菌者",
      "跳蚤被認為是主要傳播媒介"
    ],
    "diagnosticAlgorithm": {
      "title": "貓黴漿菌感染 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估上呼吸道與眼部症狀",
          "findings": [
            "結膜炎",
            "上呼吸道症狀",
            "貧血Mycoplasma haemofelis",
            "精神沉鬱與發燒"
          ]
        },
        {
          "step": 2,
          "action": "血液學檢查",
          "details": "CBC與血液抹片評估",
          "findings": [
            "再生性貧血血液黴漿菌",
            "血液抹片見紅血球表面小體",
            "白血球變化",
            "Coombs試驗陽性"
          ]
        },
        {
          "step": 3,
          "action": "PCR確診",
          "details": "血液PCR檢測黴漿菌DNA",
          "findings": [
            "M. haemofelis PCR陽性",
            "M. haemominutum鑑別",
            "FIV/FeLV共感染評估",
            "定量PCR評估菌量"
          ]
        },
        {
          "step": 4,
          "action": "共感染與免疫評估",
          "details": "評估免疫抑制狀態",
          "findings": [
            "FIV/FeLV檢測",
            "免疫抑制藥物使用史",
            "壓力因素評估",
            "治療反應監測"
          ]
        }
      ]
    },
    "monitoring": [
      "PCV/HCT",
      "網狀紅血球",
      "臨床症狀",
      "PCR追蹤（治療反應）"
    ],
    "reference": "Tasker S: Haemotropic Mycoplasmas. In Greene CE: Infectious Diseases of the Dog and Cat, 4th Ed. Elsevier, 2012; Côté E: Hemoplasma Infection. In Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "lyme-disease": {
    "zh": "萊姆病",
    "en": "Lyme Disease",
    "definition": "由伯氏疏螺旋體（Borrelia burgdorferi）經硬蜱（Ixodes屬）叮咬傳播的多系統感染性疾病，可引起關節炎、腎炎及心臟病變。",
    "synonyms": [
      "萊姆疏螺旋體病",
      "蜱媒疏螺旋體病",
      "Lyme Borreliosis"
    ],
    "epidemiology": {
      "species": "犬為主，貓極罕見",
      "age": "任何年齡",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "蜱蟲流行區（美國東北、中西部、太平洋沿岸）",
        "戶外活動",
        "未使用蜱蟲預防產品",
        "拉布拉多犬",
        "黃金獵犬（萊姆腎炎）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "間歇性跛行（移行性）",
        "發燒",
        "食慾下降",
        "嗜睡",
        "關節腫脹",
        "淋巴結腫大"
      ],
      "physicalExam": [
        "一個或多個關節腫脹疼痛",
        "發燒",
        "淋巴結腫大",
        "蛋白質流失性腎炎徵象（水腫、腹水）"
      ]
    },
    "pathophysiology": "Ixodes蜱叮咬後至少36-48小時才能傳播B. burgdorferi。螺旋體在宿主體內散播，主要定植於關節滑膜引起免疫媒介性關節炎。在某些犬種（拉布拉多、黃金獵犬），免疫複合物沉積於腎小球導致蛋白質流失性腎小球腎炎（萊姆腎炎），為最嚴重的併發症。",
    "diagnosis": {
      "overview": "抗體檢測結合臨床症狀，注意區分感染暴露和臨床疾病",
      "differentials": [
        "免疫媒介性多發性關節炎",
        "其他蜱媒疾病（Ehrlichiosis、Anaplasmosis）",
        "敗血性關節炎",
        "骨關節炎",
        "系統性紅斑狼瘡"
      ],
      "initialDB": [
        "C6抗體SNAP檢測（4Dx Plus）",
        "CBC/血液生化",
        "尿液分析（UPC比值）",
        "關節液分析"
      ],
      "advanced": [
        "Lyme Quant C6抗體定量",
        "Western blot確認",
        "尿蛋白/肌酐比（UPC）",
        "腎臟超音波",
        "PCR檢測（關節液）"
      ]
    },
    "treatment": {
      "overview": "Doxycycline為首選抗生素，萊姆腎炎需積極腎臟支持",
      "acute": [
        "Doxycycline 10 mg/kg PO BID，28天",
        "NSAID止痛（確認腎功能正常後）",
        "輸液支持"
      ],
      "chronic": [
        "完成抗生素療程",
        "萊姆腎炎治療（ACE抑制劑、低蛋白飲食、免疫抑制）",
        "蜱蟲預防產品",
        "環境蜱蟲控制",
        "疫苗接種（流行區）"
      ]
    },
    "prognosis": "單純關節炎型對Doxycycline反應良好，多數在24-48小時內改善。萊姆腎炎預後極差，通常進展為致命性腎衰竭。多數血清陽性犬（>90%）從未發展臨床症狀。",
    "pearls": [
      "C6抗體陽性僅代表暴露，不等於臨床疾病",
      "多數血清陽性犬為無症狀感染，不需要治療",
      "蜱叮咬需超過36-48小時才能傳播，及時移除蜱蟲可預防",
      "萊姆腎炎（蛋白質流失性腎炎）是最嚴重的併發症",
      "拉布拉多和黃金獵犬對萊姆腎炎有品種易感性"
    ],
    "diagnosticAlgorithm": {
      "title": "萊姆病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估跛行與全身症狀，確認蜱蟲暴露史",
          "findings": [
            "遊走性跛行",
            "發燒",
            "淋巴結腫大",
            "蜱蟲暴露區域生活史"
          ]
        },
        {
          "step": 2,
          "action": "血清學篩檢",
          "details": "Borrelia burgdorferi抗體檢測",
          "findings": [
            "SNAP 4Dx或C6抗體陽性",
            "區分疫苗抗體vs自然感染",
            "C6抗體特異性高",
            "陽性率高但臨床疾病少"
          ]
        },
        {
          "step": 3,
          "action": "確認臨床意義",
          "details": "區分感染與臨床疾病",
          "findings": [
            "Quant C6定量評估",
            "尿蛋白肌酸酐比值排除腎炎",
            "關節液分析排除其他關節炎",
            "CBC/生化排除共感染蜱媒疾病"
          ]
        },
        {
          "step": 4,
          "action": "治療反應",
          "details": "Doxycycline治療反應評估",
          "findings": [
            "治療後24-48小時跛行改善",
            "28天療程",
            "治療後6個月追蹤C6",
            "腎炎型預後較差"
          ]
        }
      ]
    },
    "monitoring": [
      "C6抗體定量（治療反應）",
      "UPC比值（腎臟監測）",
      "關節症狀",
      "腎功能"
    ],
    "reference": "Littman MP et al: ACVIM Consensus Statement on Lyme Disease in Dogs. JVIM 2018; Côté E: Lyme Disease. In Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "hemophilia": {
    "zh": "血友病",
    "en": "Hemophilia",
    "definition": "遺傳性凝血因子缺乏症，血友病A為第VIII因子缺乏，血友病B為第IX因子缺乏，導致自發性或創傷後出血不止。",
    "synonyms": [
      "Hemophilia A",
      "Hemophilia B",
      "Christmas Disease",
      "第八因子缺乏症",
      "第九因子缺乏症"
    ],
    "epidemiology": {
      "species": "犬較常見，貓罕見",
      "age": "幼年即可出現症狀，通常於首次手術或創傷時發現",
      "sex": "X染色體連鎖隱性遺傳，雄性發病，雌性為帶原者",
      "riskFactors": [
        "德國牧羊犬（血友病A）",
        "凱恩梗（血友病B）",
        "拉布拉多犬",
        "近親繁殖"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "反覆自發性出血",
        "手術或拔牙後出血不止",
        "跛行（關節內出血）",
        "血尿",
        "皮下血腫"
      ],
      "physicalExam": [
        "皮下或肌肉血腫",
        "關節腫脹（血關節）",
        "黏膜蒼白（嚴重出血時）",
        "瘀斑較少見（與血小板疾病不同）"
      ]
    },
    "pathophysiology": "X染色體連鎖隱性遺傳導致凝血因子VIII（血友病A）或IX（血友病B）缺乏或功能異常。內源性凝血路徑受損，導致凝血酶生成不足，無法形成穩定的纖維蛋白凝塊。出血通常表現為深層組織出血，如關節腔、肌肉和體腔內出血。",
    "diagnosis": {
      "overview": "根據臨床出血表現、凝血功能檢查和特定因子活性測定確診",
      "differentials": [
        "乙乙華氏病（vWD）",
        "其他凝血因子缺乏症",
        "抗凝血劑中毒",
        "DIC",
        "血小板減少症"
      ],
      "initialDB": [
        "CBC（可見再生性貧血）",
        "PT正常",
        "aPTT延長",
        "血小板計數正常",
        "頰黏膜出血時間正常"
      ],
      "advanced": [
        "特定凝血因子活性測定（VIII或IX）",
        "基因檢測",
        "凝血因子混合試驗",
        "血栓彈力圖（TEG）"
      ]
    },
    "treatment": {
      "overview": "急性出血時補充缺乏的凝血因子，長期管理避免出血風險",
      "acute": [
        "新鮮冷凍血漿（FFP）輸注",
        "冷沉澱物（富含因子VIII，適用於血友病A）",
        "全血輸注（嚴重貧血時）",
        "局部止血（壓迫、明膠海綿）",
        "Desmopressin（DDAVP，輕度血友病A可短暫提升VIII）"
      ],
      "chronic": [
        "避免手術和創傷",
        "避免使用影響凝血的藥物（NSAIDs）",
        "基因諮詢避免繁殖帶原動物",
        "環境管理減少受傷風險"
      ]
    },
    "prognosis": "輕度病例（因子活性>5%）預後較好，可正常生活；重度病例（因子活性<1%）預後謹慎，有自發性致命出血風險。避免繁殖受影響動物及帶原者。",
    "pearls": [
      "aPTT延長而PT正常是血友病的典型凝血特徵",
      "血友病A比B常見約4-5倍",
      "雌性純合子極罕見但理論上可發病",
      "DDAVP僅對輕度血友病A有短暫效果"
    ],
    "diagnosticAlgorithm": {
      "title": "血友病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "詢問出血史與家族史",
          "findings": [
            "深層出血關節/肌肉/體腔",
            "手術後異常出血",
            "幼年動物首次出血事件",
            "X連鎖遺傳公犬為主"
          ]
        },
        {
          "step": 2,
          "action": "凝血篩檢",
          "details": "基礎凝血功能評估",
          "findings": [
            "aPTT明顯延長",
            "PT正常",
            "血小板計數正常",
            "BMBT正常"
          ]
        },
        {
          "step": 3,
          "action": "凝血因子定量",
          "details": "特定凝血因子活性測定",
          "findings": [
            "A型第VIII因子活性下降",
            "B型第IX因子活性下降",
            "嚴重型因子活性小於1%",
            "中度型因子活性1-5%"
          ]
        },
        {
          "step": 4,
          "action": "基因檢測與繁殖建議",
          "details": "確認攜帶者狀態",
          "findings": [
            "基因檢測確認突變",
            "母犬攜帶者鑑定",
            "繁殖建議",
            "出血緊急處理計劃"
          ]
        }
      ]
    },
    "monitoring": [
      "出血事件頻率",
      "術前凝血功能檢查",
      "關節功能評估",
      "輸血反應監測"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "anemia-of-chronic-disease": {
    "zh": "慢性病貧血",
    "en": "Anemia of Chronic Disease",
    "definition": "繼發於慢性發炎、感染或腫瘤等疾病的非再生性正球性正色素性貧血，由鐵代謝異常和紅血球生成素反應減低所致。",
    "synonyms": [
      "Anemia of Inflammation",
      "慢性發炎貧血",
      "ACD"
    ],
    "epidemiology": {
      "species": "犬貓皆可",
      "age": "任何年齡，但中老年動物較常見（因基礎疾病盛行率較高）",
      "sex": "無性別傾向",
      "riskFactors": [
        "慢性感染",
        "腫瘤性疾病",
        "免疫媒介性疾病",
        "慢性腎臟病",
        "慢性肝病"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "漸進性活動力下降",
        "食慾減退",
        "體重下降",
        "與基礎疾病相關的症狀"
      ],
      "physicalExam": [
        "黏膜蒼白（通常為輕至中度）",
        "心搏過速",
        "基礎疾病的相關發現（淋巴結腫大、腹部腫塊等）"
      ]
    },
    "pathophysiology": "慢性發炎刺激肝臟產生Hepcidin，抑制腸道鐵吸收和巨噬細胞鐵釋放，導致功能性鐵缺乏。同時，發炎性細胞激素（IL-1、TNF-α、IL-6）抑制紅血球生成素產生和骨髓紅血球前驅細胞增殖，縮短紅血球壽命。",
    "diagnosis": {
      "overview": "排除性診斷，需確認存在慢性基礎疾病且排除其他貧血原因",
      "differentials": [
        "缺鐵性貧血",
        "慢性腎臟病貧血",
        "骨髓疾病",
        "慢性失血",
        "溶血性貧血"
      ],
      "initialDB": [
        "CBC（輕至中度非再生性貧血，Hct通常25-35%）",
        "網織紅血球計數低",
        "血清鐵降低",
        "TIBC降低或正常（與缺鐵性貧血的TIBC升高不同）"
      ],
      "advanced": [
        "血清Ferritin升高（與缺鐵性貧血區別的關鍵）",
        "骨髓檢查（鐵染色陽性）",
        "EPO濃度",
        "基礎疾病的進一步檢查"
      ]
    },
    "treatment": {
      "overview": "治療基礎疾病為首要目標，貧血通常隨基礎疾病改善而緩解",
      "acute": [
        "治療基礎疾病（感染、腫瘤、免疫疾病等）",
        "嚴重貧血時輸血（Hct<15%或有臨床症狀）"
      ],
      "chronic": [
        "持續管理基礎疾病",
        "營養支持",
        "重組EPO（rHuEPO，僅用於對治療反應差者，注意抗體產生風險）",
        "鐵劑補充通常無效且不建議"
      ]
    },
    "prognosis": "取決於基礎疾病的可控性。若基礎疾病可治癒，貧血通常在數週內改善。慢性不可逆疾病則貧血持續存在。",
    "pearls": [
      "血清Ferritin升高是區分慢性病貧血與缺鐵性貧血的關鍵",
      "鐵劑補充對慢性病貧血無效且可能有害",
      "貧血程度通常為輕至中度，Hct很少低於20%",
      "治療基礎疾病比直接治療貧血更重要"
    ],
    "diagnosticAlgorithm": {
      "title": "慢性病貧血 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估貧血徵象，確認慢性疾病存在",
          "findings": [
            "輕度至中度貧血",
            "伴隨慢性炎症/感染/腫瘤",
            "精神食慾下降",
            "黏膜蒼白"
          ]
        },
        {
          "step": 2,
          "action": "血液學評估",
          "details": "CBC與網織紅血球計數",
          "findings": [
            "正球性正色素性貧血",
            "網織紅血球計數低非再生性",
            "白血球可能異常依原發病",
            "血小板可能異常"
          ]
        },
        {
          "step": 3,
          "action": "鐵代謝評估",
          "details": "區分慢性病貧血與缺鐵性貧血",
          "findings": [
            "血清鐵降低",
            "TIBC正常或降低",
            "鐵蛋白正常或升高",
            "轉鐵蛋白飽和度下降"
          ]
        },
        {
          "step": 4,
          "action": "原發病因調查",
          "details": "治療原發疾病為根本",
          "findings": [
            "慢性感染篩查",
            "腫瘤篩查",
            "慢性炎症性疾病評估",
            "治療原發病後貧血改善"
          ]
        }
      ]
    },
    "monitoring": [
      "Hct/PCV追蹤",
      "基礎疾病控制情況",
      "網織紅血球反應",
      "血清鐵和Ferritin"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "iron-deficiency-anemia": {
    "zh": "缺鐵性貧血",
    "en": "Iron Deficiency Anemia",
    "definition": "因體內鐵儲備耗竭導致血紅素合成不足，引起小球性低色素性貧血。成年動物最常見的原因為慢性失血。",
    "synonyms": [
      "IDA",
      "鐵缺乏性貧血"
    ],
    "epidemiology": {
      "species": "犬貓皆可",
      "age": "幼年動物（營養性）和成年至老年動物（慢性失血）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "慢性胃腸道失血",
        "嚴重跳蚤感染（幼貓幼犬）",
        "胃腸道腫瘤（老年動物）",
        "慢性泌尿道出血",
        "凝血障礙"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "漸進性虛弱和嗜睡",
        "運動不耐受",
        "食慾減退",
        "可能有黑便或血便",
        "幼年動物生長遲緩"
      ],
      "physicalExam": [
        "黏膜蒼白",
        "心搏過速",
        "收縮期心雜音（貧血性）",
        "異食癖（少見）",
        "被毛粗糙"
      ]
    },
    "pathophysiology": "鐵是血紅素合成的必要元素。慢性失血導致鐵儲備逐漸耗竭，骨髓無法合成足夠血紅素，紅血球變小（小球性）且血紅素含量降低（低色素性）。幼年動物因快速生長、母乳鐵含量低和體內鐵儲備有限，也易發生缺鐵。嚴重跳蚤或鉤蟲感染可造成顯著失血。",
    "diagnosis": {
      "overview": "根據典型的小球性低色素性貧血特徵和鐵代謝指標確診，並尋找失血原因",
      "differentials": [
        "慢性病貧血",
        "門脈分流（肝臟疾病相關小球性貧血）",
        "銅缺乏",
        "鉛中毒",
        "骨髓疾病"
      ],
      "initialDB": [
        "CBC（小球性低色素性貧血：MCV降低、MCHC降低）",
        "血液抹片（靶形紅血球、低色素紅血球）",
        "網織紅血球計數（可能升高或正常）",
        "糞便潛血試驗"
      ],
      "advanced": [
        "血清鐵降低",
        "TIBC升高（與慢性病貧血的TIBC正常/降低區別）",
        "血清Ferritin降低",
        "骨髓檢查（鐵染色陰性）",
        "腹部超音波/內視鏡（尋找出血源）"
      ]
    },
    "treatment": {
      "overview": "找到並治療失血原因，同時補充鐵劑",
      "acute": [
        "嚴重貧血時輸血",
        "治療急性失血原因",
        "口服硫酸亞鐵（犬：100-300mg/天；貓：50-100mg/天）"
      ],
      "chronic": [
        "持續口服鐵劑補充（至少1-3個月至鐵儲備恢復）",
        "治療基礎失血原因（驅蟲、腫瘤切除等）",
        "幼年動物改善營養",
        "非腸胃外鐵劑（Iron dextran IM，口服不耐受時）"
      ]
    },
    "prognosis": "若能找到並控制失血原因，預後良好。鐵劑補充後1-2週可見網織紅血球反應，Hct恢復通常需要1-2個月。胃腸道腫瘤導致者預後取決於腫瘤類型和分期。",
    "pearls": [
      "成年動物缺鐵性貧血幾乎等同於慢性失血，必須尋找出血源",
      "MCV降低是犬貓缺鐵性貧血的較晚期發現",
      "血小板增多症常伴隨缺鐵性貧血出現",
      "幼犬幼貓嚴重跳蚤/鉤蟲感染是常被忽略的原因"
    ],
    "diagnosticAlgorithm": {
      "title": "缺鐵性貧血 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估貧血徵象，詢問出血史",
          "findings": [
            "黏膜蒼白",
            "運動不耐受",
            "慢性失血史消化道/泌尿道",
            "幼犬嚴重鉤蟲感染"
          ]
        },
        {
          "step": 2,
          "action": "血液學檢查",
          "details": "CBC與紅血球形態分析",
          "findings": [
            "小球性低色素性貧血",
            "紅血球大小不等",
            "血小板可能反應性增多",
            "網織紅血球反應依階段"
          ]
        },
        {
          "step": 3,
          "action": "鐵代謝檢測",
          "details": "血清鐵與鐵蛋白測定",
          "findings": [
            "血清鐵降低",
            "TIBC升高",
            "鐵蛋白降低",
            "轉鐵蛋白飽和度降低"
          ]
        },
        {
          "step": 4,
          "action": "出血源調查",
          "details": "確認慢性失血原因",
          "findings": [
            "糞便潛血試驗",
            "消化道內視鏡",
            "寄生蟲檢查鉤蟲/鞭蟲",
            "泌尿道出血排除"
          ]
        }
      ]
    },
    "monitoring": [
      "Hct和網織紅血球計數（每1-2週）",
      "血清鐵和Ferritin",
      "持續評估失血原因",
      "鐵劑副作用（胃腸道不適）"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "cardiopulmonary-arrest": {
    "zh": "心肺驟停",
    "en": "Cardiopulmonary Arrest",
    "definition": "心臟有效搏出停止合併呼吸停止的緊急狀態，若未立即進行心肺復甦術（CPR）將導致死亡。",
    "synonyms": [
      "CPA",
      "心跳停止",
      "Cardiac Arrest"
    ],
    "epidemiology": {
      "species": "犬貓皆可",
      "age": "任何年齡，麻醉期間和重症患者風險最高",
      "sex": "無性別傾向",
      "riskFactors": [
        "全身麻醉",
        "嚴重電解質異常（高血鉀）",
        "嚴重創傷",
        "敗血症",
        "心臟病",
        "呼吸衰竭",
        "藥物過量"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "突然倒下無反應",
        "麻醉中監測異常",
        "已知嚴重系統性疾病",
        "之前可能有心律不整或呼吸窘迫"
      ],
      "physicalExam": [
        "無意識",
        "無可觸及脈搏",
        "無自主呼吸或瀕死喘息",
        "瞳孔散大（晚期）",
        "黏膜蒼白或發紺",
        "ECG：心室停止、無脈性電氣活動（PEA）或心室顫動"
      ]
    },
    "pathophysiology": "心臟有效機械活動停止，導致全身循環中斷。腦組織在缺氧4-6分鐘後開始發生不可逆損傷。心跳停止的機制包括：心室停止（asystole）、心室顫動（VF）、無脈性電氣活動（PEA）。犬貓最常見的停止心律為心室停止和PEA。",
    "diagnosis": {
      "overview": "臨床診斷，基於無意識、無脈搏和無呼吸三聯徵，立即開始CPR",
      "differentials": [
        "深度麻醉",
        "嚴重低血壓",
        "嚴重心動過緩"
      ],
      "initialDB": [
        "ECG監測（確認停止心律類型）",
        "ETCO2監測（評估CPR品質和ROSC）"
      ],
      "advanced": [
        "動脈血氣分析",
        "電解質（K+、Ca2+）",
        "床邊超音波（確認心臟活動、心包積液）"
      ]
    },
    "treatment": {
      "overview": "依據RECOVER指南進行CPR：基本生命支持（BLS）和進階生命支持（ALS）",
      "acute": [
        "胸部按壓（100-120次/分鐘，1/3-1/2胸壁深度）",
        "氣管插管和正壓通氣（10次/分鐘）",
        "Epinephrine低劑量（0.01 mg/kg IV，每3-5分鐘）",
        "心室顫動：電擊去顫（外部2-4 J/kg，內部0.2-0.4 J/kg）",
        "Atropine（0.04 mg/kg IV，迷走張力相關）",
        "2分鐘不間斷按壓循環",
        "靜脈輸液",
        "可逆原因處理（4H4T）"
      ],
      "chronic": [
        "ROSC後護理：血壓維持",
        "機械通氣支持",
        "神經保護（避免高體溫、控制癲癇）",
        "持續ECG監測",
        "電解質和酸鹼校正"
      ]
    },
    "prognosis": "整體ROSC率約35-45%，出院存活率僅6-7%。貓ROSC率略高於犬但出院率類似。麻醉相關CPA預後較非麻醉好。CPR超過20分鐘未獲ROSC者預後極差。",
    "pearls": [
      "ETCO2>15 mmHg提示有效CPR，ETCO2突然升高提示ROSC",
      "犬貓最常見的停止心律為asystole和PEA，非VF",
      "高劑量Epinephrine不建議使用",
      "側臥按壓適用於大多數犬貓，桶狀胸犬可用仰臥位"
    ],
    "diagnosticAlgorithm": {
      "title": "心肺驟停 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "立即辨識",
          "details": "快速確認心肺驟停",
          "findings": [
            "無意識/無反應",
            "無呼吸或瀕死呼吸",
            "無可觸及脈搏",
            "瞳孔散大"
          ]
        },
        {
          "step": 2,
          "action": "啟動CPR同時評估",
          "details": "立即開始胸部按壓同時評估心律",
          "findings": [
            "ECG心搏停止/無脈電氣活動/心室纖維顫動",
            "建立靜脈通路",
            "氣管插管確保氣道",
            "記錄驟停時間"
          ]
        },
        {
          "step": 3,
          "action": "可逆原因篩查",
          "details": "CPR過程中快速排查可逆因素",
          "findings": [
            "低血容量出血",
            "低氧血症",
            "酸中毒",
            "高血鉀或低血鉀"
          ]
        },
        {
          "step": 4,
          "action": "自主循環恢復後評估",
          "details": "ROSC後全面評估",
          "findings": [
            "持續ECG監測",
            "血壓與氧合監測",
            "神經功能評估",
            "原發病因處理"
          ]
        }
      ]
    },
    "monitoring": [
      "ECG持續監測",
      "ETCO2（CPR品質指標）",
      "動脈血壓（ROSC後）",
      "神經功能評估",
      "尿量"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "bite-wound": {
    "zh": "咬傷",
    "en": "Bite Wound",
    "definition": "動物間咬咬造成的穿刺傷、撕裂傷或壓碎傷，常伴隨深層組織損傷和細菌感染，實際損傷範圍往往遠超皮膚表面傷口。",
    "synonyms": [
      "Animal Bite Injury",
      "咬傷感染",
      "Fight Wound"
    ],
    "epidemiology": {
      "species": "犬貓皆常見",
      "age": "任何年齡，年輕未絕育雄性最常見",
      "sex": "未絕育雄性風險最高",
      "riskFactors": [
        "未絕育",
        "戶外活動",
        "多動物家庭",
        "流浪動物接觸",
        "領域行為"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "已知或疑似動物打鬥",
        "突然跛行或疼痛",
        "傷口處腫脹或流膿",
        "發燒和食慾下降（感染後）"
      ],
      "physicalExam": [
        "穿刺傷口（可能很小但深層損傷嚴重）",
        "皮下氣腫",
        "蜂窩性組織炎",
        "膿腫形成（尤其貓）",
        "組織壞死和皮瓣分離",
        "區域淋巴結腫大",
        "發燒"
      ]
    },
    "pathophysiology": "咬傷造成的損傷遠比表面傷口嚴重。犬的強力咬合可造成深層肌肉壓碎、撕裂和血管損傷。貓的犬齒造成深穿刺傷，將口腔細菌（Pasteurella、厭氧菌）深植皮下，傷口表面迅速癒合但深層感染持續發展，常形成膿腫。大型犬咬小型犬或貓時，胸腹壁穿透可能導致氣胸、腹腔污染等危及生命的併發症。",
    "diagnosis": {
      "overview": "臨床檢查評估傷口深度和範圍，影像學評估深層結構損傷",
      "differentials": [
        "其他穿刺傷",
        "異物",
        "膿皮症",
        "蜂窩性組織炎（其他原因）"
      ],
      "initialDB": [
        "徹底傷口探查（可能需鎮靜/麻醉）",
        "胸腹部X光（大型犬咬傷，排除體腔穿透）",
        "CBC（白血球升高）"
      ],
      "advanced": [
        "傷口培養和藥敏試驗",
        "超音波（評估膿腫或積液）",
        "CT（複雜傷口評估）"
      ]
    },
    "treatment": {
      "overview": "傷口沖洗清創、引流、抗生素治療和疼痛管理",
      "acute": [
        "大量生理鹽水沖洗（每個傷口至少250-500ml）",
        "清創移除壞死組織",
        "建立引流（Penrose引流管或開放引流）",
        "廣效抗生素（Amoxicillin-clavulanate為首選）",
        "止痛（Opioids、NSAIDs）",
        "穿透性胸腹傷需緊急手術探查"
      ],
      "chronic": [
        "傷口換藥管理",
        "抗生素療程7-14天",
        "膿腫切開引流",
        "延遲一期縫合或二期癒合",
        "絕育以減少打鬥行為"
      ]
    },
    "prognosis": "單純皮膚軟組織咬傷預後良好。穿透胸腔或腹腔者預後謹慎至不良。小型動物被大型犬咬傷致死率可達10-15%。延遲就醫增加嚴重感染和壞死風險。",
    "pearls": [
      "冰山效應：表面傷口小但深層損傷可能巨大",
      "貓咬傷幾乎100%會感染，犬咬傷感染率約50%",
      "所有咬傷都應視為污染傷口，不應一期縫合",
      "小型犬被大型犬咬傷應常規X光檢查排除體腔穿透"
    ],
    "diagnosticAlgorithm": {
      "title": "咬傷 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估傷口範圍與深度，穩定生命徵象",
          "findings": [
            "皮膚穿刺傷或撕裂傷",
            "皮下廣泛挫傷冰山現象",
            "疼痛與腫脹",
            "胸腹壁穿透傷排除"
          ]
        },
        {
          "step": 2,
          "action": "傷口探查",
          "details": "鎮靜/麻醉下完整傷口探查",
          "findings": [
            "皮下死腔範圍遠大於皮膚傷口",
            "深層組織損傷程度",
            "異物或汙染評估",
            "體腔穿透確認"
          ]
        },
        {
          "step": 3,
          "action": "影像學與實驗室",
          "details": "評估深層損傷與全身影響",
          "findings": [
            "X光排除骨折或體腔穿透",
            "超音波評估腹腔或胸腔",
            "CBC/生化基線評估",
            "傷口培養感染時"
          ]
        },
        {
          "step": 4,
          "action": "感染風險評估",
          "details": "評估傷口感染風險與預防",
          "findings": [
            "超過6小時傷口感染風險高",
            "需氧加厭氧菌混合感染常見",
            "抗生素選擇",
            "狂犬病暴露風險評估"
          ]
        }
      ]
    },
    "monitoring": [
      "傷口癒合進度",
      "體溫監測",
      "白血球計數",
      "引流量和性質",
      "疼痛評估"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "vehicular-trauma": {
    "zh": "車禍創傷",
    "en": "Vehicular Trauma",
    "definition": "動物遭車輛撞擊導致的多系統創傷，為小動物急診最常見的創傷類型之一，常涉及多器官損傷。",
    "synonyms": [
      "HBC (Hit By Car)",
      "交通事故創傷",
      "Motor Vehicle Trauma"
    ],
    "epidemiology": {
      "species": "犬貓皆常見",
      "age": "任何年齡，年輕活潑動物和老年感覺退化動物風險較高",
      "sex": "未絕育雄性（漫遊行為）風險較高",
      "riskFactors": [
        "未牽繩戶外活動",
        "未絕育",
        "住家鄰近交通繁忙道路",
        "夜間活動（貓）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "目擊或疑似車輛撞擊",
        "突然跛行或無法行走",
        "呼吸困難",
        "出血或外傷"
      ],
      "physicalExam": [
        "皮膚擦傷和撕裂傷",
        "骨折（骨盆、肢體最常見）",
        "呼吸困難（氣胸、肺挫傷）",
        "腹部膨脹和疼痛（腹腔出血或膀胱破裂）",
        "休克徵象（心搏過速、黏膜蒼白、CRT延長）",
        "神經功能異常",
        "血尿"
      ]
    },
    "pathophysiology": "車輛撞擊產生巨大動能轉移至動物體內，造成直接組織損傷（骨折、器官破裂）和間接損傷（減速傷、剪力傷）。常見損傷包括：骨盆骨折（最常見）、肺挫傷和氣胸、膀胱破裂、脾臟或肝臟撕裂、創傷性心肌炎、脊椎和神經損傷。多系統創傷患者常出現創傷性休克。",
    "diagnosis": {
      "overview": "系統性創傷評估，優先處理危及生命的損傷",
      "differentials": [
        "其他創傷原因（墜落、踩踏）",
        "凝血障礙（解釋出血傾向）"
      ],
      "initialDB": [
        "快速評估（ABC：氣道、呼吸、循環）",
        "胸腹部X光",
        "AFAST/TFAST超音波（評估體腔積液）",
        "PCV/TS（評估失血）",
        "血氣分析",
        "尿液分析（血尿提示泌尿道損傷）"
      ],
      "advanced": [
        "全身CT掃描",
        "對比劑尿路攝影（疑似膀胱/尿道破裂）",
        "心電圖（創傷性心律不整）",
        "凝血功能檢查"
      ]
    },
    "treatment": {
      "overview": "依據創傷嚴重度分級處理，優先穩定生命徵象，再處理個別損傷",
      "acute": [
        "靜脈輸液復甦（晶體液和/或膠體液）",
        "氧氣治療",
        "胸管放置（張力性氣胸）",
        "止痛（Opioids為首選）",
        "傷口初步處理和覆蓋",
        "緊急手術（活動性大出血、膀胱破裂）",
        "骨折臨時固定"
      ],
      "chronic": [
        "骨折手術修復",
        "傷口長期管理",
        "物理復健",
        "疼痛管理",
        "營養支持"
      ]
    },
    "prognosis": "取決於損傷嚴重度和受累器官。單純骨折預後良好。合併胸腹腔損傷或脊髓損傷預後謹慎至不良。整體死亡率約10-25%，早期積極治療可改善預後。",
    "pearls": [
      "創傷性心律不整常在受傷後24-72小時出現",
      "骨盆骨折常合併泌尿道損傷，務必評估排尿功能",
      "肺挫傷X光變化可能在受傷後12-24小時才明顯",
      "皮膚看似完整但深層可能有嚴重損傷"
    ],
    "diagnosticAlgorithm": {
      "title": "車禍創傷 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初始穩定與快速評估",
          "details": "ABCDE急救流程穩定生命徵象",
          "findings": [
            "氣道通暢確認",
            "呼吸功能評估氣胸/肺挫傷",
            "循環評估休克/出血",
            "意識與神經功能初步評估"
          ]
        },
        {
          "step": 2,
          "action": "全身影像學檢查",
          "details": "胸腹部X光與FAST超音波",
          "findings": [
            "胸腔X光氣胸/血胸/肺挫傷/肋骨骨折",
            "FAST超音波腹腔積液",
            "骨盆X光骨盆骨折",
            "脊椎X光脊椎骨折"
          ]
        },
        {
          "step": 3,
          "action": "實驗室檢查",
          "details": "評估內出血與臟器損傷",
          "findings": [
            "PCV/TP連續監測",
            "乳酸評估組織灌流",
            "尿液分析排除泌尿道損傷",
            "凝血功能評估"
          ]
        },
        {
          "step": 4,
          "action": "二次評估",
          "details": "穩定後完整二次評估",
          "findings": [
            "完整神經學檢查",
            "四肢骨科檢查",
            "皮膚傷口完整評估",
            "48-72小時後複查延遲性損傷"
          ]
        }
      ]
    },
    "monitoring": [
      "生命徵象（每1-4小時）",
      "PCV/TS（評估持續出血）",
      "尿量和排尿功能",
      "ECG（創傷性心律不整）",
      "呼吸功能",
      "疼痛評分"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "acute-abdomen": {
    "zh": "急性腹部疾病",
    "en": "Acute Abdomen",
    "definition": "以急性腹痛為主要表現的臨床症候群，涵蓋多種需要緊急評估和可能手術介入的腹腔疾病。",
    "synonyms": [
      "急腹症",
      "Surgical Abdomen"
    ],
    "epidemiology": {
      "species": "犬貓皆可",
      "age": "任何年齡，不同年齡有不同常見病因",
      "sex": "無明顯性別傾向（但某些病因如子宮蓄膿限於雌性）",
      "riskFactors": [
        "未絕育雌性（子宮蓄膿）",
        "大型深胸犬（GDV）",
        "異食癖犬（腸阻塞）",
        "老年動物（腫瘤破裂）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "急性腹痛和不安",
        "嘔吐",
        "食慾廢絕",
        "腹部膨脹",
        "虛脫",
        "排便異常"
      ],
      "physicalExam": [
        "腹部觸診疼痛",
        "腹壁緊張（腹膜炎）",
        "腹部膨脹",
        "休克徵象",
        "發燒或低體溫",
        "脫水",
        "姿勢異常（祈禱姿勢）"
      ]
    },
    "pathophysiology": "急性腹部疾病的病因多樣，包括：機械性（胃擴張扭轉、腸阻塞、腸套疊）、感染性（腹膜炎、子宮蓄膿破裂、膿腫）、缺血性（腸繫膜扭轉、脾臟扭轉）、出血性（脾臟腫瘤破裂、肝臟破裂）、代謝性（急性胰臟炎、尿路阻塞）和炎症性（急性胰臟炎、膽囊炎）。腹腔內病變刺激腹膜引起內臟痛和體壁痛。",
    "diagnosis": {
      "overview": "快速系統性評估以區分手術性和非手術性急腹症",
      "differentials": [
        "胃擴張扭轉",
        "腸阻塞/異物",
        "脾臟腫瘤破裂",
        "子宮蓄膿",
        "腹膜炎",
        "急性胰臟炎",
        "尿道阻塞",
        "腸繫膜扭轉"
      ],
      "initialDB": [
        "腹部X光（含對側位）",
        "腹部FAST超音波",
        "CBC、生化、電解質",
        "PCV/TS",
        "腹腔穿刺和積液分析"
      ],
      "advanced": [
        "腹部超音波全面評估",
        "腹部CT",
        "對比劑研究",
        "腹腔灌洗液分析（細菌、膽汁、尿液）"
      ]
    },
    "treatment": {
      "overview": "穩定後盡快進行手術探查（手術性急腹症）或積極內科治療（非手術性）",
      "acute": [
        "靜脈輸液復甦和休克治療",
        "止痛（Opioids）",
        "廣效抗生素（疑似敗血性腹膜炎）",
        "緊急手術探查（GDV、腸阻塞、出血性病變）",
        "胃減壓（GDV）"
      ],
      "chronic": [
        "術後護理和監測",
        "營養支持（早期腸道營養）",
        "持續抗生素治療",
        "原發疾病的長期管理"
      ]
    },
    "prognosis": "高度取決於具體病因和治療時機。GDV早期手術預後良好（存活率>90%）；敗血性腹膜炎預後謹慎（存活率50-70%）；腸繫膜扭轉預後極差。延遲手術顯著增加死亡率。",
    "pearls": [
      "腹腔積液中細菌或退化性嗜中性球提示敗血性腹膜炎，需緊急手術",
      "腹腔積液肌酐>血清肌酐2倍提示尿腹症",
      "腹腔積液膽紅素>血清膽紅素2倍提示膽汁性腹膜炎",
      "祈禱姿勢是前腹部疼痛的典型姿勢"
    ],
    "diagnosticAlgorithm": {
      "title": "急性腹部疾病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "緊急評估",
          "details": "評估腹痛嚴重程度與全身狀態",
          "findings": [
            "嚴重腹痛祈禱姿勢/不願移動",
            "腹部膨大或繃緊",
            "嘔吐",
            "心動過速與虛弱"
          ]
        },
        {
          "step": 2,
          "action": "影像學檢查",
          "details": "腹部X光與超音波快速評估",
          "findings": [
            "X光腸阻塞/胃擴張扭轉/游離氣體",
            "超音波腹腔積液/腸壁異常",
            "腹腔穿刺液分析",
            "器官腫大或腫塊"
          ]
        },
        {
          "step": 3,
          "action": "實驗室檢查",
          "details": "全面血液學與生化評估",
          "findings": [
            "CBC白血球異常",
            "乳酸升高",
            "生化評估臟器功能",
            "凝血功能"
          ]
        },
        {
          "step": 4,
          "action": "手術決策",
          "details": "判斷是否需要緊急探查手術",
          "findings": [
            "GDV緊急手術",
            "腸穿孔緊急手術",
            "脾臟破裂緊急手術",
            "穩定觀察vs立即手術決策"
          ]
        }
      ]
    },
    "monitoring": [
      "生命徵象",
      "腹部觸診",
      "PCV/TS",
      "乳酸",
      "尿量",
      "體溫"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "high-rise-syndrome": {
    "zh": "高樓墜落症候群",
    "en": "High-Rise Syndrome",
    "definition": "貓從高處（通常二樓以上）墜落導致的特徵性多系統創傷模式，因貓的空中翻正反射和著地姿勢而產生獨特的損傷型態。",
    "synonyms": [
      "High-Rise Fall",
      "貓墜落傷",
      "Feline High-Rise Syndrome"
    ],
    "epidemiology": {
      "species": "貓為主（犬偶見但損傷模式不同）",
      "age": "年輕貓較常見（好奇心強、缺乏高處經驗）",
      "sex": "未絕育雄性略多",
      "riskFactors": [
        "高樓居住且窗戶無防護",
        "年輕好奇貓",
        "未絕育（漫遊傾向）",
        "陽台無圍網"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "已知或疑似從高處墜落",
        "突然出現跛行或呼吸困難",
        "口鼻出血"
      ],
      "physicalExam": [
        "顏面創傷（下頷骨折、硬顎裂開）",
        "氣胸和肺挫傷",
        "四肢骨折（前肢較常見）",
        "膀胱破裂",
        "休克",
        "口鼻出血"
      ]
    },
    "pathophysiology": "貓從高處墜落時，翻正反射使其四肢朝下著地。低樓層（<5層）墜落時仍在加速，損傷較嚴重；中高樓層（>7層）達到終端速度（約97 km/h）後，貓傾向展開四肢增加空氣阻力，類似降落傘效應，著地時衝擊力分散。典型損傷模式：前肢著地造成四肢骨折，下巴撞擊地面造成下頷骨折和硬顎裂開，胸部衝擊造成氣胸和肺挫傷。",
    "diagnosis": {
      "overview": "系統性創傷評估，特別注意高樓墜落症候群的典型損傷模式",
      "differentials": [
        "其他創傷原因",
        "虐待"
      ],
      "initialDB": [
        "全身X光（胸部、腹部、四肢、頭部）",
        "AFAST/TFAST超音波",
        "PCV/TS",
        "尿液分析（排除膀胱破裂）",
        "口腔檢查（硬顎完整性）"
      ],
      "advanced": [
        "CT掃描",
        "對比劑尿路攝影",
        "心電圖",
        "血氣分析"
      ]
    },
    "treatment": {
      "overview": "依損傷嚴重度分級處理，先穩定後修復",
      "acute": [
        "氧氣治療和胸管（氣胸）",
        "靜脈輸液復甦",
        "止痛",
        "骨折臨時固定",
        "顏面傷口處理",
        "膀胱破裂手術修復"
      ],
      "chronic": [
        "骨折手術固定",
        "硬顎裂開修復",
        "下頷骨骨折固定",
        "物理復健",
        "環境改善（安裝窗戶防護網）"
      ]
    },
    "prognosis": "整體存活率約90%，高於預期。7層以上墜落的存活率不低於低樓層（終端速度理論）。顏面創傷和骨折修復後功能恢復通常良好。合併嚴重胸腔或腹腔損傷者預後較差。",
    "pearls": [
      "7層以上墜落不一定比低樓層嚴重（終端速度達到後衝擊力不再增加）",
      "硬顎裂開是高樓墜落貓的特徵性損傷",
      "約10%有膀胱破裂，所有病例應評估排尿功能",
      "肺挫傷可能在24-48小時後才完全顯現"
    ],
    "diagnosticAlgorithm": {
      "title": "高樓墜落症候群 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "緊急穩定",
          "details": "ABCDE急救流程穩定生命徵象",
          "findings": [
            "呼吸困難氣胸/肺挫傷",
            "口鼻出血",
            "休克徵象",
            "意識評估"
          ]
        },
        {
          "step": 2,
          "action": "典型損傷模式評估",
          "details": "貓高樓墜落特有的損傷模式",
          "findings": [
            "硬顎裂開貓特徵性損傷",
            "前肢骨折著地衝擊",
            "氣胸",
            "膀胱破裂"
          ]
        },
        {
          "step": 3,
          "action": "全身影像學",
          "details": "胸腹部X光與超音波",
          "findings": [
            "胸腔X光氣胸/肺挫傷",
            "腹部超音波腹腔積液/膀胱破裂",
            "四肢X光骨折評估",
            "頜面X光硬顎評估"
          ]
        },
        {
          "step": 4,
          "action": "延遲損傷監測",
          "details": "部分損傷可能延遲出現",
          "findings": [
            "48-72小時內持續監測",
            "肺挫傷可能延遲加重",
            "泌尿道損傷延遲表現",
            "腹壁疝氣評估"
          ]
        }
      ]
    },
    "monitoring": [
      "呼吸功能（24-48小時）",
      "排尿功能",
      "神經功能",
      "骨折癒合",
      "疼痛評估"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "cryptorchidism": {
    "zh": "隱睾症",
    "en": "Cryptorchidism",
    "definition": "一側或雙側睾丸未正常下降至陰囊，滯留於腹腔或腹股溝管中。為犬最常見的先天性生殖系統異常。",
    "synonyms": [
      "Retained Testicle",
      "Undescended Testicle",
      "睾丸未降"
    ],
    "epidemiology": {
      "species": "犬較常見（發生率1-15%），貓較少見（約1-2%）",
      "age": "出生時即存在，通常在6個月齡前下降完成，超過6個月未降即確診",
      "sex": "僅雄性",
      "riskFactors": [
        "小型犬和玩具犬品種",
        "吉娃娃",
        "約克夏梗",
        "博美犬",
        "貴賓犬",
        "遺傳因素",
        "近親繁殖"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "陰囊內觸摸不到一側或雙側睾丸",
        "繁殖者或飼主發現",
        "可能無症狀直到腫瘤形成"
      ],
      "physicalExam": [
        "陰囊內缺少一個或兩個睾丸",
        "睾丸可能在腹股溝區觸摸到",
        "腹腔內睾丸通常不可觸及",
        "若已發生腫瘤可能有腹部腫塊、雌性化症狀"
      ]
    },
    "pathophysiology": "睾丸在胚胎發育期間從腎臟附近遷移至陰囊。遷移過程受引帶（gubernaculum）、睾丸下降激素（INSL3）和雄激素調控。基因或荷爾蒙異常導致下降過程中斷，睾丸滯留於腹腔或腹股溝管。未下降的睾丸因腹腔溫度較高，精子生成受損但仍具內分泌功能。長期留置的隱睾發生腫瘤的風險為正常睾丸的9-14倍，以Sertoli細胞瘤和精原細胞瘤最常見。",
    "diagnosis": {
      "overview": "體檢觸診確認睾丸位置，影像學定位腹腔內隱睾",
      "differentials": [
        "先前已絕育（單側）",
        "睾丸發育不全",
        "異位睾丸"
      ],
      "initialDB": [
        "仔細觸診陰囊和腹股溝區",
        "腹部超音波（定位腹腔內睾丸）"
      ],
      "advanced": [
        "hCG或GnRH刺激試驗（驗證是否存在睾丸組織）",
        "血清睾固酮測定",
        "腹腔鏡探查",
        "CT或MRI（難以定位時）"
      ]
    },
    "treatment": {
      "overview": "手術摘除隱睾為標準治療，不建議嘗試荷爾蒙誘導下降",
      "acute": [
        "腹腔內隱睾：開腹或腹腔鏡摘除術",
        "腹股溝隱睾：腹股溝切開摘除術",
        "建議同時絕育（摘除兩側睾丸）"
      ],
      "chronic": [
        "術後監測傷口癒合",
        "遺傳諮詢（不建議繁殖隱睾動物及其父母和同窩幼犬）"
      ]
    },
    "prognosis": "手術摘除後預後極佳。若不治療，腫瘤風險隨年齡顯著增加。Sertoli細胞瘤可產生雌激素導致骨髓抑制，此併發症預後較差。",
    "pearls": [
      "隱睾腫瘤風險為正常睾丸的9-14倍",
      "荷爾蒙治療（hCG、GnRH）誘導下降成功率低且不建議",
      "為多基因遺傳性狀，受影響動物不應繁殖",
      "右側隱睾比左側常見約2倍"
    ],
    "diagnosticAlgorithm": {
      "title": "隱睾症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "陰囊觸診確認睾丸數量與位置",
          "findings": [
            "單側或雙側陰囊內無睾丸",
            "腹股溝區域觸診可能觸及",
            "6月齡後未降確認為隱睾",
            "品種傾向確認"
          ]
        },
        {
          "step": 2,
          "action": "超音波定位",
          "details": "腹部超音波定位未降睾丸",
          "findings": [
            "腹股溝管內定位",
            "腹腔內定位",
            "睾丸大小與回音型態",
            "排除睾丸腫瘤"
          ]
        },
        {
          "step": 3,
          "action": "荷爾蒙確認",
          "details": "無法觸及時確認睾丸是否存在",
          "findings": [
            "hCG刺激試驗後測睾固酮",
            "基礎睾固酮測定",
            "區分隱睾vs先前已去勢",
            "AMH測定"
          ]
        },
        {
          "step": 4,
          "action": "手術計劃",
          "details": "建議手術摘除因腫瘤風險高",
          "findings": [
            "隱睾腫瘤風險比正常高13倍",
            "Sertoli細胞瘤/精原細胞瘤風險",
            "建議同時去勢",
            "遺傳性不建議繁殖"
          ]
        }
      ]
    },
    "monitoring": [
      "術後傷口",
      "若延遲手術，定期超音波監測腫瘤發展",
      "繁殖建議諮詢"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "pseudopregnancy": {
    "zh": "假懷孕",
    "en": "Pseudopregnancy",
    "definition": "未懷孕的雌性動物在黃體期後出現類似懷孕的生理和行為變化，包括乳腺發育、泌乳和築巢行為。為犬的正常生理現象，但症狀嚴重時需要治療。",
    "synonyms": [
      "False Pregnancy",
      "Pseudocyesis",
      "假孕",
      "Phantom Pregnancy"
    ],
    "epidemiology": {
      "species": "犬非常常見（幾乎所有未絕育母犬都有某種程度的假懷孕），貓極罕見",
      "age": "任何性成熟後的年齡",
      "sex": "僅未絕育雌性",
      "riskFactors": [
        "未絕育",
        "發情後2-3個月",
        "某些品種較易表現明顯症狀"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "發情後6-12週出現乳腺腫脹和泌乳",
        "築巢行為",
        "攜帶玩具當作幼犬",
        "食慾改變",
        "焦慮或母性攻擊行為"
      ],
      "physicalExam": [
        "乳腺腫脹和泌乳",
        "腹部輕度膨脹",
        "外陰輕度腫脹",
        "行為改變（焦慮、保護性行為）"
      ]
    },
    "pathophysiology": "犬的黃體在發情後無論是否懷孕都會存在約2個月。當黃體退化、黃體素下降時，催乳素（prolactin）分泌增加，刺激乳腺發育和泌乳。這是犬正常的荷爾蒙週期，但個體間臨床表現差異很大。某些母犬症狀輕微或不明顯，而其他則出現顯著的泌乳和行為改變。",
    "diagnosis": {
      "overview": "臨床診斷為主，需排除真正懷孕和其他乳腺疾病",
      "differentials": [
        "真正懷孕",
        "子宮蓄膿",
        "乳腺腫瘤",
        "甲狀腺功能低下（罕見相關）"
      ],
      "initialDB": [
        "病史（最近發情時間）",
        "腹部觸診或超音波（排除懷孕和子宮蓄膿）"
      ],
      "advanced": [
        "血清黃體素測定",
        "Relaxin測試（排除懷孕）",
        "乳腺細胞學（排除腫瘤）"
      ]
    },
    "treatment": {
      "overview": "多數病例自限性，1-3週自行消退。嚴重症狀需藥物治療或考慮絕育",
      "acute": [
        "輕度：不治療，避免刺激乳腺",
        "移除築巢材料和「領養」的玩具",
        "限制自我舔吮乳腺（伊莉莎白圈）",
        "Cabergoline（催乳素抑制劑，0.005 mg/kg/天，5-10天）"
      ],
      "chronic": [
        "卵巢子宮切除術（絕育為根本預防）",
        "注意：症狀期間不要絕育（可能延長假懷孕）",
        "等症狀消退後再安排絕育手術"
      ]
    },
    "prognosis": "預後極佳。為自限性生理現象，通常1-3週自行消退。絕育可永久預防復發。未絕育者每次發情後都可能再次出現。",
    "pearls": [
      "避免刺激乳腺（不要擠壓或清洗），會延長泌乳",
      "不要在假懷孕症狀期間進行絕育手術",
      "Cabergoline（多巴胺激動劑）是治療嚴重假懷孕的首選藥物",
      "在犬是正常生理現象，在貓則極罕見且可能提示內分泌異常"
    ],
    "diagnosticAlgorithm": {
      "title": "假懷孕 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估未絕育母犬發情後的乳腺與行為變化",
          "findings": [
            "乳腺腫脹與泌乳",
            "築巢行為",
            "對玩具的母性行為",
            "食慾變化"
          ]
        },
        {
          "step": 2,
          "action": "排除真懷孕",
          "details": "腹部超音波排除真實懷孕",
          "findings": [
            "超音波未見胎兒",
            "發情後4-8週出現症狀",
            "黃體酮下降後發生",
            "正常生理現象"
          ]
        },
        {
          "step": 3,
          "action": "鑑別診斷",
          "details": "排除其他乳腺或荷爾蒙異常",
          "findings": [
            "排除乳腺腫瘤",
            "排除甲狀腺功能低下",
            "排除子宮蓄膿嚴重時",
            "腹部超音波子宮正常"
          ]
        }
      ]
    },
    "monitoring": [
      "乳腺消腫情況",
      "行為正常化",
      "乳腺炎監測（泌乳期間）"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "prostatic-abscess": {
    "zh": "前列腺膿腫",
    "en": "Prostatic Abscess",
    "definition": "前列腺實質內膿液積聚形成的感染性囊腔，為細菌性前列腺炎的嚴重併發症，可導致敗血症和腹膜炎。",
    "synonyms": [
      "Prostatic Abscessation",
      "前列腺化膿"
    ],
    "epidemiology": {
      "species": "犬（僅見於未絕育雄犬），貓極罕見",
      "age": "中老年未絕育雄犬（通常>5歲）",
      "sex": "僅雄性",
      "riskFactors": [
        "未絕育",
        "前列腺增生（BPH）",
        "慢性前列腺炎",
        "泌尿道感染",
        "免疫抑制"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "排尿困難或排便困難",
        "血尿或尿道膿性分泌物",
        "發燒和精神沉鬱",
        "後肢僵硬步態",
        "食慾下降"
      ],
      "physicalExam": [
        "直腸觸診前列腺腫大、不對稱、疼痛",
        "發燒",
        "腹部後段疼痛",
        "脫水",
        "尿道口可能有膿性分泌物"
      ]
    },
    "pathophysiology": "通常繼發於細菌性前列腺炎，最常見的致病菌為大腸桿菌。未絕育雄犬在雄激素作用下前列腺增生，增生的前列腺易受細菌感染（逆行感染或血行感染）。感染進展為化膿性發炎，形成膿腫囊腔。膿腫可破裂導致敗血性腹膜炎，為危及生命的併發症。前列腺囊腫也可繼發感染形成膿腫。",
    "diagnosis": {
      "overview": "影像學確認前列腺內囊腔性病變，配合感染指標和細菌培養確診",
      "differentials": [
        "前列腺囊腫",
        "前列腺腫瘤",
        "細菌性前列腺炎",
        "前列腺旁囊腫",
        "良性前列腺增生"
      ],
      "initialDB": [
        "腹部超音波（前列腺內低回音囊腔性病變）",
        "CBC（白血球升高伴左移）",
        "尿液分析和培養",
        "前列腺液培養（超音波引導穿刺）"
      ],
      "advanced": [
        "腹部CT（評估膿腫範圍和併發症）",
        "血液培養（疑似敗血症）",
        "凝血功能（排除DIC）"
      ]
    },
    "treatment": {
      "overview": "手術引流合併絕育為標準治療，配合長期抗生素",
      "acute": [
        "靜脈輸液和休克治療",
        "廣效抗生素（待培養結果再調整）",
        "手術引流和沖洗",
        "同時進行絕育（去勢術）",
        "嚴重者可能需前列腺切除或造口術"
      ],
      "chronic": [
        "長期抗生素治療（4-6週，依培養和藥敏結果）",
        "術後影像追蹤",
        "若未絕育，絕育可減少復發"
      ]
    },
    "prognosis": "手術引流加絕育的預後良好。未手術僅用抗生素復發率高。膿腫破裂致敗血性腹膜炎預後謹慎至不良。絕育可使前列腺萎縮，大幅降低復發風險。",
    "pearls": [
      "直腸觸診時避免過度用力，以防膿腫破裂",
      "絕育是治療的關鍵步驟，可使前列腺在數週內顯著萎縮",
      "抗生素必須能穿透前列腺屏障（Fluoroquinolones、TMP-SMX、Chloramphenicol）",
      "前列腺膿腫破裂是外科急症"
    ],
    "diagnosticAlgorithm": {
      "title": "前列腺膿腫 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估未去勢公犬的泌尿/排便症狀",
          "findings": [
            "排尿困難或血尿",
            "排便困難前列腺腫大壓迫直腸",
            "發燒與全身不適",
            "後肢僵硬步態"
          ]
        },
        {
          "step": 2,
          "action": "直腸觸診與影像學",
          "details": "直腸觸診前列腺並進行超音波評估",
          "findings": [
            "前列腺腫大不對稱",
            "觸診疼痛",
            "超音波見前列腺內液體腔",
            "前列腺周圍滲出"
          ]
        },
        {
          "step": 3,
          "action": "實驗室檢查",
          "details": "血液學與尿液分析",
          "findings": [
            "白血球增多伴左移",
            "尿液分析膿尿菌尿",
            "尿液細菌培養與藥敏",
            "血液培養敗血症時"
          ]
        },
        {
          "step": 4,
          "action": "治療計劃",
          "details": "手術引流與去勢",
          "findings": [
            "超音波引導穿刺引流",
            "去勢減少前列腺大小",
            "長期抗生素治療4-6週",
            "追蹤超音波評估消退"
          ]
        }
      ]
    },
    "monitoring": [
      "體溫和白血球計數",
      "超音波追蹤前列腺大小",
      "尿液培養（治療結束後確認清除）",
      "排尿和排便功能"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "nephrotic-syndrome": {
    "zh": "腎病症候群",
    "en": "Nephrotic Syndrome",
    "definition": "以大量蛋白尿、低白蛋白血症、水腫和高脂血症四聯徵為特徵的臨床症候群，反映嚴重的腎小球損傷和蛋白質流失。",
    "synonyms": [
      "Nephrosis",
      "腎病綜合徵"
    ],
    "epidemiology": {
      "species": "犬較常見，貓較少見",
      "age": "中年至老年犬較常見",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "腎小球腎炎",
        "類澱粉沉積症",
        "全身性紅斑性狼瘡",
        "慢性感染性疾病",
        "腫瘤",
        "利什曼病"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "四肢或腹部水腫",
        "腹部膨脹（腹水）",
        "體重增加（水腫液）",
        "嗜睡",
        "食慾下降"
      ],
      "physicalExam": [
        "四肢凹陷性水腫（尤其遠端肢體）",
        "腹水",
        "皮下水腫",
        "肌肉消耗",
        "可能有血栓栓塞的徵象（呼吸困難、急性肢體疼痛）"
      ]
    },
    "pathophysiology": "腎小球基底膜損傷導致通透性增加，大量白蛋白從尿液流失（尿蛋白:肌酐比>3.5）。白蛋白流失導致低白蛋白血症，血漿膠體滲透壓下降，液體從血管內移至組織間隙造成水腫和腹水。肝臟代償性增加脂蛋白合成導致高脂血症。同時，抗凝血蛋白（如Antithrombin III）也從尿液流失，加上其他凝血因子改變，造成高凝血狀態，增加血栓栓塞風險。",
    "diagnosis": {
      "overview": "確認四聯徵（蛋白尿、低白蛋白、水腫、高脂血），並尋找基礎腎臟疾病病因",
      "differentials": [
        "蛋白質流失性腸病（PLE）",
        "肝臟衰竭",
        "充血性心衰竭",
        "血管炎"
      ],
      "initialDB": [
        "尿液分析（蛋白尿）",
        "尿蛋白:肌酐比（UPC）>3.5",
        "血清白蛋白降低（<2.0 g/dL）",
        "血清膽固醇和三酸甘油酯升高",
        "BUN/Creatinine",
        "CBC"
      ],
      "advanced": [
        "Antithrombin III測定",
        "腎臟超音波",
        "腎臟活檢（確定腎小球病變類型）",
        "感染性疾病篩檢（Ehrlichia、Leishmania、Lyme等）",
        "ANA測試"
      ]
    },
    "treatment": {
      "overview": "治療基礎病因、減少蛋白尿、管理併發症（水腫、血栓風險）",
      "acute": [
        "治療基礎病因（感染、免疫疾病等）",
        "ACE抑制劑（Enalapril或Benazepril，減少蛋白尿）",
        "抗血栓治療（Aspirin低劑量或Clopidogrel）",
        "利尿劑（Furosemide，嚴重水腫時謹慎使用）",
        "腹水穿刺引流（呼吸困難時）"
      ],
      "chronic": [
        "持續ACE抑制劑",
        "低鈉飲食",
        "適度蛋白質限制",
        "Omega-3脂肪酸補充",
        "免疫抑制劑（免疫媒介性腎小球腎炎）",
        "持續抗血栓治療",
        "監測腎功能"
      ]
    },
    "prognosis": "整體預後謹慎至不良。取決於基礎病因和腎功能。可治療的基礎病因（如感染）預後較好。免疫媒介性腎小球腎炎和類澱粉沉積症預後較差。血栓栓塞是主要的致命併發症。",
    "pearls": [
      "血栓栓塞是腎病症候群最嚴重的併發症，AT-III<75%時風險顯著增加",
      "UPC>3.5高度提示腎小球疾病",
      "不要過度限制蛋白質攝入，會加速肌肉流失",
      "腎臟活檢是確定腎小球病變類型的唯一方法"
    ],
    "diagnosticAlgorithm": {
      "title": "腎病症候群 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估水腫與蛋白尿相關症狀",
          "findings": [
            "皮下水腫四肢/腹側",
            "腹水",
            "體重增加",
            "泡沫尿"
          ]
        },
        {
          "step": 2,
          "action": "實驗室檢查",
          "details": "確認腎病症候群四特徵",
          "findings": [
            "重度蛋白尿UPC大於3.5",
            "低白蛋白血症",
            "高膽固醇血症",
            "水腫/腹水"
          ]
        },
        {
          "step": 3,
          "action": "腎臟評估",
          "details": "超音波與腎功能評估",
          "findings": [
            "腎臟超音波型態",
            "BUN/Creatinine評估",
            "血壓測量高血壓常見",
            "尿蛋白電泳"
          ]
        },
        {
          "step": 4,
          "action": "病因與併發症",
          "details": "確認腎小球疾病病因並監測併發症",
          "findings": [
            "感染性疾病篩查",
            "腎臟活檢確認腎小球病變類型",
            "血栓風險評估抗凝血酶III下降",
            "免疫複合物沉積性vs膜性腎病"
          ]
        }
      ]
    },
    "monitoring": [
      "UPC（每2-4週）",
      "血清白蛋白",
      "BUN/Creatinine",
      "血壓",
      "AT-III（若可測定）",
      "水腫程度",
      "體重"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "polyradiculoneuritis": {
    "zh": "多發性神經根神經炎",
    "en": "Polyradiculoneuritis",
    "definition": "周邊神經根和神經的急性發炎性脫髓鞘疾病，導致快速進展的上行性弛緩性癱瘓。類似於人類的乙乙蘭巴瑞症候群（Guillain-Barré Syndrome）。",
    "synonyms": [
      "Coonhound Paralysis",
      "Acute Canine Polyradiculoneuritis",
      "ACP",
      "浣熊獵犬癱瘓"
    ],
    "epidemiology": {
      "species": "犬較常見，貓罕見",
      "age": "任何年齡，成犬較多",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "浣熊唾液接觸（北美）",
        "近期疫苗接種（罕見）",
        "近期感染",
        "免疫媒介機制"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "急性進展的四肢無力（通常後肢先開始）",
        "數天內進展至四肢癱瘓",
        "可能有近期浣熊接觸史或疫苗接種史",
        "發聲改變"
      ],
      "physicalExam": [
        "四肢弛緩性癱瘓（下運動神經元型）",
        "脊髓反射減弱或消失",
        "肌肉張力降低",
        "嚴重者呼吸肌無力",
        "顏面神經麻痺（部分病例）",
        "痛覺通常保留",
        "膀胱功能通常保留"
      ]
    },
    "pathophysiology": "免疫媒介機制導致周邊神經根（尤其腹側運動神經根）發炎和脫髓鞘。T細胞和巨噬細胞浸潤神經根，破壞髓鞘導致神經傳導障礙。在北美，浣熊唾液中的蛋白質可觸發免疫反應。病變主要影響腹側（運動）神經根，因此運動功能受損遠大於感覺功能。嚴重病例可累及肋間神經和膈神經，導致呼吸衰竭。",
    "diagnosis": {
      "overview": "臨床表現為主要診斷依據，EMG和神經傳導檢查可確認周邊神經病變",
      "differentials": [
        "蜱蟲癱瘓",
        "肉毒桿菌中毒",
        "重症肌無力",
        "脊髓疾病",
        "有機磷中毒"
      ],
      "initialDB": [
        "完整神經學檢查（下運動神經元徵象）",
        "排除蜱蟲感染（全身仔細檢查蜱蟲）",
        "CBC和生化（通常正常）"
      ],
      "advanced": [
        "肌電圖（EMG，2-3週後見自發電位）",
        "神經傳導速度檢查（減慢）",
        "腦脊液分析（蛋白質升高、細胞數正常或輕度升高）",
        "神經活檢（確診但少用）"
      ]
    },
    "treatment": {
      "overview": "支持性護理為主，目前無特效治療，等待自發性恢復",
      "acute": [
        "護理性支持（翻身、墊褥瘡墊）",
        "物理治療（被動關節活動）",
        "呼吸監測（嚴重者可能需要機械通氣）",
        "營養支持",
        "排尿管理（必要時導尿）"
      ],
      "chronic": [
        "持續物理治療和復健",
        "水療",
        "漸進式運動訓練",
        "營養支持",
        "褥瘡預防和處理"
      ]
    },
    "prognosis": "多數病例在3-6週開始恢復，完全恢復可能需要2-6個月。約60-80%可完全或接近完全恢復。呼吸衰竭是最嚴重的併發症，可能致命。嚴重萎縮和失神經支配的病例恢復較慢。",
    "pearls": [
      "急性弛緩性四肢癱瘓首先要排除蜱蟲癱瘓（移除蜱蟲後24-48小時即可改善）",
      "痛覺保留是與脊髓疾病鑑別的重要特徵",
      "恢復順序通常與發病順序相反（先恢復前肢）",
      "免疫抑制劑治療的效果未被證實"
    ],
    "diagnosticAlgorithm": {
      "title": "多發性神經根神經炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估急性進行性四肢無力",
          "findings": [
            "急性發作後肢無力上行至前肢",
            "下運動神經元徵象",
            "脊椎反射減弱或消失",
            "疼痛感覺保留"
          ]
        },
        {
          "step": 2,
          "action": "神經學檢查",
          "details": "完整神經學定位",
          "findings": [
            "四肢肌張力下降",
            "膝反射/撓側反射減弱",
            "顱神經評估面癱/聲帶麻痺",
            "膀胱功能評估"
          ]
        },
        {
          "step": 3,
          "action": "鑑別診斷",
          "details": "排除其他急性癱瘓原因",
          "findings": [
            "肌電圖去神經電位",
            "腦脊髓液蛋白升高細胞正常",
            "排除蜱麻痺",
            "排除肉毒桿菌中毒"
          ]
        },
        {
          "step": 4,
          "action": "病因與預後",
          "details": "確認誘發因素並評估恢復",
          "findings": [
            "浣熊咬傷/接觸史",
            "近期疫苗接種史",
            "恢復期通常3-6週",
            "呼吸肌受累需監護"
          ]
        }
      ]
    },
    "monitoring": [
      "呼吸功能（呼吸頻率、潮氣量）",
      "肌肉萎縮程度",
      "運動功能恢復進度",
      "褥瘡預防",
      "營養狀態"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "wobbler-syndrome": {
    "zh": "搖擺犬症候群",
    "en": "Wobbler Syndrome",
    "definition": "頸椎脊髓壓迫性疾病的統稱，因椎間盤突出、椎體畸形或韌帶肥厚導致頸段脊髓受壓，引起進行性步態不協調。",
    "synonyms": [
      "Cervical Spondylomyelopathy",
      "CSM",
      "頸椎脊髓病變",
      "Cervical Vertebral Instability",
      "CVI"
    ],
    "epidemiology": {
      "species": "犬（大型和巨型犬），貓極罕見",
      "age": "兩種型態：年輕大丹犬（骨相關型，<2歲）和中老年杜賓犬（椎間盤相關型，>3歲）",
      "sex": "雄性略多",
      "riskFactors": [
        "杜賓犬",
        "大丹犬",
        "其他大型犬種",
        "快速生長",
        "營養過剩（幼犬期）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "漸進性後肢步態不協調",
        "後肢無力",
        "搖擺不穩的步態",
        "嚴重者前肢也受影響",
        "頸部疼痛（部分病例）"
      ],
      "physicalExam": [
        "後肢共濟失調（通常比前肢嚴重）",
        "廣基步態",
        "指節拖行（後肢為主）",
        "四肢本體感覺減退",
        "頸部可能有疼痛反應",
        "上運動神經元後肢徵象",
        "下運動神經元前肢徵象（嚴重壓迫時）"
      ]
    },
    "pathophysiology": "頸椎脊髓受壓的機制因型態而異。椎間盤相關型（杜賓犬型）：慢性椎間盤退化和突出壓迫腹側脊髓，常合併背側韌帶肥厚加重壓迫。骨相關型（大丹犬型）：椎體畸形、椎弓板增厚、關節突增生造成椎管狹窄。兩種型態都導致頸段脊髓慢性壓迫、脫髓鞘和軸突退化。後肢較早受影響是因為外側和腹側索的長傳導束先受壓。",
    "diagnosis": {
      "overview": "MRI是首選影像學檢查，可確認壓迫位置、程度和性質",
      "differentials": [
        "椎間盤疾病",
        "脊髓腫瘤",
        "退化性脊髓病變",
        "椎間盤脊椎炎",
        "纖維軟骨栓塞"
      ],
      "initialDB": [
        "神經學檢查定位",
        "頸部X光（椎體畸形、椎間隙狹窄）"
      ],
      "advanced": [
        "MRI（金標準：顯示壓迫位置和脊髓病變）",
        "CT/脊髓攝影",
        "動態研究（屈曲/伸展位置評估不穩定性）",
        "CSF分析"
      ]
    },
    "treatment": {
      "overview": "輕症可保守治療，進行性或嚴重病例需手術減壓和穩定",
      "acute": [
        "止痛和抗炎（Gabapentin、NSAIDs）",
        "活動限制",
        "使用頸部護具（短期）",
        "Corticosteroids（急性惡化時短期使用）"
      ],
      "chronic": [
        "手術治療：腹側開窗減壓（ventral slot）",
        "椎間盤切除和椎體融合",
        "背側椎弓板切除術",
        "保守治療：長期止痛、活動管理",
        "物理復健"
      ]
    },
    "prognosis": "保守治療約50%短期改善但多數最終進展。手術治療成功率約70-80%，但鄰近節段可能發生新的壓迫（domino effect）。杜賓犬的退化性脊髓病變可能同時存在，影響預後評估。",
    "pearls": [
      "後肢共濟失調比前肢嚴重是頸椎脊髓病變的特徵",
      "杜賓犬需同時考慮退化性脊髓病變的可能",
      "頸部過度屈曲可加重壓迫，檢查時需謹慎",
      "鄰近節段退化（domino effect）是術後長期併發症"
    ],
    "diagnosticAlgorithm": {
      "title": "搖擺犬症候群 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估頸部疼痛與四肢共濟失調",
          "findings": [
            "後肢共濟失調步態",
            "頸部疼痛或僵硬",
            "前肢步幅縮短",
            "品種傾向杜賓犬/大丹犬"
          ]
        },
        {
          "step": 2,
          "action": "神經學檢查",
          "details": "完整神經學定位確認頸椎病變",
          "findings": [
            "上運動神經元後肢徵象",
            "下運動神經元前肢徵象C6-T2",
            "頸部屈曲疼痛",
            "本體感覺異常"
          ]
        },
        {
          "step": 3,
          "action": "進階影像學",
          "details": "MRI為首選診斷工具",
          "findings": [
            "MRI頸椎脊髓壓迫",
            "椎間盤突出或椎體不穩定",
            "脊髓水腫或壞死",
            "多節段受累常見"
          ]
        },
        {
          "step": 4,
          "action": "治療決策",
          "details": "保守治療vs手術減壓",
          "findings": [
            "內科管理抗發炎加活動限制",
            "手術腹側減壓或椎間融合",
            "動態vs靜態壓迫區分",
            "術後復健計劃"
          ]
        }
      ]
    },
    "monitoring": [
      "神經功能評估",
      "步態分析",
      "術後影像追蹤",
      "疼痛管理",
      "復健進度"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "spinal-fracture-luxation": {
    "zh": "脊椎骨折脫位",
    "en": "Spinal Fracture-Luxation",
    "definition": "脊椎骨折脫位是外傷導致脊椎骨折和/或椎體間脫位的急症，以胸腰段交界處（T11-L2）最常見（此處為活動度高/低的轉換區）。嚴重度取決於脊髓損傷程度，從輕度不全癱到深層痛覺喪失的完全癱瘓。犬貓最常見原因為交通事故。三柱理論（three-column theory）指導手術穩定的決策。",
    "synonyms": [
      "Vertebral Fracture",
      "Spinal Luxation",
      "脊椎骨折",
      "脊椎脫位"
    ],
    "epidemiology": {
      "species": "犬貓皆可",
      "age": "任何年齡，年輕活動量大的動物較多",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "車禍",
        "高處墜落",
        "被重物撞擊",
        "骨質疏鬆（老年或代謝性骨病）",
        "脊椎腫瘤（病理性骨折）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "已知創傷事件",
        "突然無法行走或後肢癱瘓",
        "脊椎疼痛",
        "排尿排便失控"
      ],
      "physicalExam": [
        "脊椎觸診疼痛和可能的錯位感",
        "癱瘓或不全癱瘓（取決於損傷程度和位置）",
        "相應脊髓節段以下的神經功能缺損",
        "深部痛覺評估（關鍵預後指標）",
        "膀胱功能異常",
        "Schiff-Sherrington姿勢（胸腰段嚴重損傷）"
      ]
    },
    "pathophysiology": "外力造成脊椎骨折和/或椎間韌帶損傷導致脫位。脊髓損傷分為原發性（直接機械損傷）和繼發性（缺血、水腫、自由基損傷、發炎反應）。胸腰椎交界處（T11-L2）是最常見的骨折脫位部位，因為此處為相對固定的胸椎和活動度較大的腰椎的轉換區。三室模型（背側、中間、腹側）用於評估脊椎穩定性，三室中兩室以上損傷視為不穩定。",
    "diagnosis": {
      "overview": "X光確認骨折脫位位置，神經學檢查評估脊髓損傷程度",
      "differentials": [
        "椎間盤急性突出",
        "纖維軟骨栓塞",
        "脊髓腫瘤（病理性骨折）",
        "椎間盤脊椎炎"
      ],
      "initialDB": [
        "脊椎X光（正位和側位，搬動時注意脊椎保護）",
        "完整神經學檢查（尤其深部痛覺）",
        "全身創傷評估"
      ],
      "advanced": [
        "CT掃描（評估骨折碎片和椎管侵犯程度）",
        "MRI（評估脊髓損傷和壓迫）",
        "脊髓攝影（CT/MRI不可用時）"
      ]
    },
    "treatment": {
      "overview": "穩定脊椎和保護脊髓，手術或保守治療取決於穩定性和神經功能",
      "acute": [
        "脊椎保護（搬運時固定於硬板上）",
        "Methylprednisolone（爭議性，受傷8小時內：30 mg/kg IV）",
        "止痛",
        "手術固定和減壓（不穩定骨折、神經功能進行性惡化）",
        "保守治療（穩定骨折、輕度神經缺損：外固定/籠內休息6-8週）"
      ],
      "chronic": [
        "物理復健",
        "膀胱管理（導尿或手動擠壓）",
        "褥瘡預防",
        "漸進式活動恢復",
        "長期神經功能復健"
      ]
    },
    "prognosis": "深部痛覺是最重要的預後指標。深部痛覺存在者，約50-80%可恢復行走功能。深部痛覺喪失超過48小時者，功能恢復率<5%，預後極差。骨折穩定性和治療時機也影響預後。",
    "pearls": [
      "深部痛覺喪失>48小時是功能恢復的極差預後指標",
      "搬運脊椎損傷動物時必須保護脊椎（避免屈曲旋轉）",
      "Schiff-Sherrington姿勢不代表預後不良，需評估深部痛覺",
      "Methylprednisolone的使用目前有爭議，需在受傷極早期使用才可能有益"
    ],
    "diagnosticAlgorithm": {
      "title": "脊椎骨折脫位 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "緊急穩定與固定",
          "details": "避免二次損傷，脊椎固定",
          "findings": [
            "急性癱瘓",
            "脊椎疼痛",
            "外傷史",
            "固定患者避免脊椎移動"
          ]
        },
        {
          "step": 2,
          "action": "神經學評估",
          "details": "精確神經定位與深層痛覺評估",
          "findings": [
            "癱瘓部位定位",
            "深層痛覺存在與否關鍵預後指標",
            "膀胱功能評估",
            "肛門反射"
          ]
        },
        {
          "step": 3,
          "action": "影像學檢查",
          "details": "脊椎X光與CT/MRI",
          "findings": [
            "X光骨折/脫位確認",
            "CT骨骼損傷詳細評估",
            "MRI脊髓損傷程度",
            "不穩定性評估"
          ]
        },
        {
          "step": 4,
          "action": "治療與預後",
          "details": "根據穩定性與神經功能決策",
          "findings": [
            "深層痛覺喪失預後差",
            "不穩定骨折需手術固定",
            "穩定骨折可保守治療",
            "復健計劃"
          ]
        }
      ]
    },
    "monitoring": [
      "神經功能（每日評估）",
      "膀胱功能和尿液培養",
      "褥瘡預防",
      "骨折癒合（X光追蹤）",
      "復健進度"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "salivary-mucocele": {
    "zh": "唾液腺囊腫",
    "en": "Salivary Mucocele",
    "definition": "唾液腺或其導管破裂導致唾液外漏至周圍組織，形成被結締組織包圍的唾液積聚囊腫。為犬最常見的唾液腺疾病。",
    "synonyms": [
      "Sialocele",
      "Salivary Cyst",
      "唾液囊腫",
      "Ranula（舌下型）"
    ],
    "epidemiology": {
      "species": "犬較常見，貓少見",
      "age": "任何年齡，2-4歲較常見",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "德國牧羊犬",
        "貴賓犬",
        "臘腸犬",
        "創傷",
        "唾液腺結石（罕見）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "頸部或下頷區緩慢增大的軟性腫脹",
        "可能無痛",
        "進食困難（舌下型）",
        "呼吸困難（咽部型，罕見）"
      ],
      "physicalExam": [
        "頸腹側軟性波動性腫脹（頸部型最常見）",
        "舌下腫脹（Ranula，舌下型）",
        "咽部腫脹（咽部型）",
        "眼眶周圍腫脹（顴骨型）",
        "無痛或輕度疼痛",
        "穿刺可抽出黏稠透明至黃褐色液體"
      ]
    },
    "pathophysiology": "唾液腺（最常見為舌下腺和下頷腺）或其導管受損後，唾液外漏至周圍組織間隙。滲出的唾液引起慢性肉芽組織反應，形成纖維組織壁包裹的假囊腫（無上皮內襯）。隨著唾液持續外漏，囊腫漸進性增大。損傷原因多數不明，可能與創傷、唾液腺結石或自發性導管破裂有關。",
    "diagnosis": {
      "overview": "臨床表現和穿刺液特性可初步診斷，影像學幫助定位受影響的唾液腺",
      "differentials": [
        "唾液腺腫瘤",
        "膿腫",
        "淋巴結腫大",
        "血腫",
        "甲狀腺腫瘤",
        "鰓裂囊腫"
      ],
      "initialDB": [
        "細針穿刺和細胞學（黏稠、低細胞性、含巨噬細胞的黏液性液體）",
        "穿刺液黏液蛋白染色陽性"
      ],
      "advanced": [
        "頸部超音波",
        "CT或MRI（定位受影響唾液腺）",
        "唾液腺造影術（少用）"
      ]
    },
    "treatment": {
      "overview": "手術切除受影響的唾液腺和導管為根本治療",
      "acute": [
        "穿刺引流（暫時緩解但會復發）",
        "舌下型可做造袋術（marsupialization）作為初期處理"
      ],
      "chronic": [
        "下頷腺和舌下腺整組切除術（最常見手術）",
        "顴骨唾液腺切除（顴骨型）",
        "術後引流管放置（必要時）"
      ]
    },
    "prognosis": "手術切除後預後極佳，復發率很低。單純穿刺引流復發率接近100%。舌下型的造袋術成功率中等。手術併發症少見，但需注意保護舌下神經和血管。",
    "pearls": [
      "穿刺液的黏稠拉絲特性是唾液腺囊腫的特徵",
      "頸部型需確定是左側還是右側唾液腺受影響",
      "單純引流會100%復發，必須切除唾液腺",
      "唾液腺囊腫是假囊腫，無上皮內襯"
    ],
    "diagnosticAlgorithm": {
      "title": "唾液腺囊腫 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估頸部或口腔軟性腫塊",
          "findings": [
            "頸部腹側軟性無痛腫塊頸部型",
            "舌下藍紫色腫塊蛤蟆腫",
            "咽部腫塊咽部型",
            "逐漸增大"
          ]
        },
        {
          "step": 2,
          "action": "細針抽吸",
          "details": "腫塊細針抽吸確認內容物",
          "findings": [
            "抽出黏稠透明至血色液體",
            "低細胞性黏液",
            "與膿腫/血腫鑑別",
            "唾液成分分析"
          ]
        },
        {
          "step": 3,
          "action": "影像學定位",
          "details": "確認受累唾液腺",
          "findings": [
            "超音波定位囊腫與相關腺體",
            "下頜腺/舌下腺最常受累",
            "CT協助術前定位",
            "雙側評估"
          ]
        },
        {
          "step": 4,
          "action": "手術計劃",
          "details": "手術摘除受累唾液腺為根治方法",
          "findings": [
            "下頜腺-舌下腺整體摘除",
            "單純引流易復發",
            "確認受累側",
            "咽部型注意氣道安全"
          ]
        }
      ]
    },
    "monitoring": [
      "術後腫脹消退",
      "進食功能",
      "傷口癒合",
      "復發監測"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "otitis-media": {
    "zh": "中耳炎",
    "en": "Otitis Media",
    "definition": "中耳炎是中耳腔（鼓室）的感染或炎症性疾病，超過50%的慢性外耳炎犬合併中耳炎。最常見為外耳炎經鼓膜蔓延而來，致病菌包括Staphylococcus、Pseudomonas和Malassezia。貓的中耳炎可繼發於鼻咽息肉或上呼吸道感染經耳咽管逆行感染。可導致周邊前庭症狀和面神經麻痺（Horner症候群）。",
    "synonyms": [
      "Middle Ear Infection",
      "中耳感染"
    ],
    "epidemiology": {
      "species": "犬貓皆可",
      "age": "任何年齡，與慢性外耳炎相關",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "慢性或反覆發作的外耳炎",
        "垂耳犬種",
        "耳道狹窄犬種",
        "鼻咽息肉（貓）",
        "過敏性皮膚病",
        "異物"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "慢性外耳炎治療反應差",
        "頭部傾斜",
        "搖頭",
        "耳朵疼痛",
        "聽力下降",
        "面神經麻痺"
      ],
      "physicalExam": [
        "鼓膜異常（不透明、膨出、穿孔或缺失）",
        "外耳道分泌物",
        "頭部傾斜向患側",
        "Horner氏症候群（貓較常見）",
        "面神經癱瘓（眼瞼下垂、唇下垂）",
        "耳朵觸診疼痛"
      ]
    },
    "pathophysiology": "最常見的發生機制為慢性外耳炎導致鼓膜穿孔或退化，細菌和酵母菌侵入中耳腔。在貓，鼻咽息肉可經歐氏管延伸至中耳。中耳感染導致黏膜腫脹、分泌物積聚和骨性鼓泡壁增厚。發炎可影響經過中耳的面神經和交感神經（導致Horner氏症候群）。若感染穿破至內耳可造成前庭功能障礙。",
    "diagnosis": {
      "overview": "耳鏡檢查評估鼓膜，影像學確認中耳病變",
      "differentials": [
        "外耳炎",
        "內耳炎",
        "鼻咽息肉（貓）",
        "中耳腫瘤",
        "膽脂瘤"
      ],
      "initialDB": [
        "耳鏡檢查（鼓膜完整性）",
        "耳道分泌物細胞學和培養",
        "頭部X光（鼓泡壁增厚、鼓泡內密度增加）"
      ],
      "advanced": [
        "CT掃描（金標準影像：評估鼓泡骨壁和內容物）",
        "MRI（評估軟組織和內耳）",
        "中耳穿刺（myringotomy）和培養",
        "視頻耳鏡"
      ]
    },
    "treatment": {
      "overview": "治療感染、建立引流和處理基礎外耳炎",
      "acute": [
        "鼓膜穿刺（myringotomy）建立引流",
        "中耳沖洗",
        "全身性抗生素（依培養結果，至少4-6週）",
        "局部耳用藥物（避免耳毒性藥物：Aminoglycosides、Chlorhexidine）",
        "止痛"
      ],
      "chronic": [
        "治療基礎外耳炎和過敏",
        "鼓泡骨切開術（ventral bulla osteotomy，嚴重或難治病例）",
        "全耳道切除合併鼓泡骨切開術（TECA-BO，嚴重慢性病例）",
        "貓鼻咽息肉牽引摘除"
      ]
    },
    "prognosis": "早期治療預後良好。慢性病例可能需要手術。面神經癱瘓在感染控制後多數可恢復。TECA-BO術後約85-90%的動物疼痛和感染得到控制。貓鼻咽息肉牽引摘除後約30-50%復發。",
    "pearls": [
      "慢性外耳炎治療反應差時應高度懷疑中耳炎",
      "50-80%的慢性外耳炎合併中耳炎",
      "鼓膜完整不能排除中耳炎（鼓膜可能已癒合但感染持續）",
      "中耳沖洗時避免使用Chlorhexidine和Aminoglycosides（耳毒性）"
    ],
    "diagnosticAlgorithm": {
      "title": "中耳炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估耳部症狀與神經徵象",
          "findings": [
            "慢性外耳炎病史",
            "頭部傾斜",
            "疼痛搖頭",
            "Horner氏症候群或面癱"
          ]
        },
        {
          "step": 2,
          "action": "耳鏡與影像學",
          "details": "鎮靜下耳鏡檢查與影像學評估",
          "findings": [
            "鼓膜混濁膨出或破裂",
            "外耳道分泌物增多",
            "CT見鼓室密度增加",
            "骨質變化評估"
          ]
        },
        {
          "step": 3,
          "action": "鼓室採樣",
          "details": "經鼓膜穿刺或破裂處採樣",
          "findings": [
            "中耳液體細胞學",
            "細菌培養與藥敏需氧加厭氧",
            "膽脂瘤排除",
            "黏液性或膿性分泌物"
          ]
        },
        {
          "step": 4,
          "action": "治療與監測",
          "details": "全身與局部抗生素評估手術需求",
          "findings": [
            "全身抗生素4-6週",
            "中耳灌洗",
            "難治性考慮鼓室切開或骨泡截骨",
            "聽力評估"
          ]
        }
      ]
    },
    "monitoring": [
      "臨床症狀改善",
      "耳鏡追蹤",
      "影像追蹤（CT）",
      "面神經和Horner氏症候群恢復",
      "聽力評估"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "cleft-palate": {
    "zh": "顎裂",
    "en": "Cleft Palate",
    "definition": "先天性硬顎和/或軟顎發育不全導致的口鼻腔相通缺陷，造成吸吮困難和吸入性肺炎風險。",
    "synonyms": [
      "Palatoschisis",
      "顎裂畸形",
      "Cleft Lip and Palate"
    ],
    "epidemiology": {
      "species": "犬貓皆可",
      "age": "先天性，出生即存在",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "短頭犬品種（波士頓梗、鬥牛犬、拳師犬）",
        "暹羅貓",
        "基因遺傳",
        "懷孕期間暴露於致畸物質（類固醇、Griseofulvin）",
        "營養缺乏（葉酸）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "新生仔畜吸吮困難",
        "餵食後鼻腔流出奶液",
        "反覆打噴嚏",
        "生長遲緩",
        "反覆呼吸道感染"
      ],
      "physicalExam": [
        "口腔檢查可見硬顎正中線缺損",
        "軟顎裂開",
        "可能合併唇裂",
        "鼻腔分泌物",
        "營養不良和體重過輕",
        "肺部聽診異常（吸入性肺炎）"
      ]
    },
    "pathophysiology": "胚胎發育過程中，上顎突和鼻中隔未能正常融合導致顎裂。正常融合發生在妊娠第25-28天（犬）。基因因素和環境因素（致畸物質暴露）都可能導致融合失敗。顎裂造成口腔和鼻腔相通，食物和液體可進入鼻腔和氣管，導致鼻炎和吸入性肺炎。新生仔畜無法形成有效的負壓吸吮，導致營養攝取不足。",
    "diagnosis": {
      "overview": "出生後口腔視覺檢查即可診斷",
      "differentials": [
        "創傷性硬顎缺損",
        "腫瘤造成的顎骨破壞",
        "後天性口鼻瘻管"
      ],
      "initialDB": [
        "口腔詳細視覺檢查",
        "胸部X光（評估吸入性肺炎）"
      ],
      "advanced": [
        "CT掃描（評估缺損範圍和計畫手術）",
        "全面先天異常篩檢"
      ]
    },
    "treatment": {
      "overview": "手術修復為根本治療，術前需管飼維持營養直至可手術年齡",
      "acute": [
        "管飼餵養（胃管或食道造口管）",
        "避免經口餵食",
        "治療吸入性肺炎（抗生素）",
        "營養支持確保生長"
      ],
      "chronic": [
        "手術修復（通常在8-12週齡時）",
        "黏膜皮瓣技術（overlapping flap technique）",
        "多次手術可能需要（大範圍缺損）",
        "術後軟食2-3週"
      ]
    },
    "prognosis": "手術修復成功率約80-90%，但大範圍缺損可能需要多次手術。術後口鼻瘻管復發（裂開）是最常見的併發症。不治療者預後極差，多因吸入性肺炎或營養不良死亡。",
    "pearls": [
      "所有新生仔畜出生時應檢查口腔排除顎裂",
      "管飼餵養是術前維持營養的關鍵",
      "手術時機通常在8-12週齡，此時組織有足夠量進行修復",
      "受影響動物不應繁殖（遺傳性狀）"
    ],
    "diagnosticAlgorithm": {
      "title": "顎裂 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "新生兒評估",
          "details": "出生時即可診斷",
          "findings": [
            "吸奶時奶液從鼻孔流出",
            "打噴嚏與鼻分泌物",
            "吸奶困難體重增長差",
            "口腔檢查見硬顎或軟顎裂開"
          ]
        },
        {
          "step": 2,
          "action": "裂型分類",
          "details": "確認裂縫位置與範圍",
          "findings": [
            "原發性唇裂vs繼發性顎裂",
            "單側vs雙側",
            "硬顎和/或軟顎受累",
            "裂縫寬度與長度測量"
          ]
        },
        {
          "step": 3,
          "action": "併發症評估",
          "details": "評估吸入性肺炎與營養不良",
          "findings": [
            "吸入性肺炎胸腔X光",
            "營養不良與脫水",
            "其他先天性異常排除",
            "體重監測"
          ]
        },
        {
          "step": 4,
          "action": "手術計劃",
          "details": "評估手術修補時機",
          "findings": [
            "通常3-4月齡手術",
            "術前管飼維持營養",
            "手術方式選擇",
            "術後復發風險評估"
          ]
        }
      ]
    },
    "monitoring": [
      "術後癒合",
      "體重增長",
      "呼吸功能",
      "口鼻瘻管是否復發"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "perineal-hernia": {
    "zh": "會陰疝",
    "en": "Perineal Hernia",
    "definition": "骨盆隔膜肌肉（提肛肌、尾骨肌）萎縮或斷裂導致腹腔或骨盆腔器官經會陰部突出，為未絕育老年雄犬的常見疾病。",
    "synonyms": [
      "Perineal Herniation",
      "會陰赫尼亞"
    ],
    "epidemiology": {
      "species": "犬為主（幾乎專限於雄犬），貓極罕見",
      "age": "中老年雄犬（7-9歲高峰）",
      "sex": "未絕育雄性（>95%）",
      "riskFactors": [
        "未絕育雄犬",
        "中老年",
        "波士頓梗",
        "柯基犬",
        "拳師犬",
        "柯利牧羊犬",
        "慢性排便困難",
        "前列腺增生"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "會陰部單側或雙側腫脹",
        "排便困難（裡急後重）",
        "排尿困難（膀胱逆行時）",
        "會陰腫脹可還納或不可還納"
      ],
      "physicalExam": [
        "會陰部可還納性軟組織腫脹（肛門側方）",
        "直腸觸診可能觸及直腸偏移或擴張",
        "前列腺增大",
        "膀胱可能逆行至疝囊內（緊急情況）",
        "雙側性約40%"
      ]
    },
    "pathophysiology": "雄激素的長期作用導致骨盆隔膜肌肉（提肛肌、尾骨肌、外肛門括約肌）萎縮和退化。合併前列腺增生造成排便困難，長期腹壓增加進一步削弱骨盆隔膜。肌肉萎縮形成缺損後，直腸、前列腺脂肪、甚至膀胱可經缺損突出至會陰皮下。膀胱逆行至疝囊是危及生命的緊急情況，可造成尿路阻塞和腎後性氮血症。",
    "diagnosis": {
      "overview": "體檢觸診即可初步診斷，影像學確認疝內容物",
      "differentials": [
        "會陰腫瘤",
        "肛門囊腫瘤",
        "肛門旁腺瘤",
        "膿腫"
      ],
      "initialDB": [
        "直腸觸診（評估直腸偏移和前列腺大小）",
        "腹部/會陰X光（確認膀胱位置）",
        "腹部超音波"
      ],
      "advanced": [
        "逆行性尿道造影（確認膀胱逆行）",
        "CT（複雜或復發病例）"
      ]
    },
    "treatment": {
      "overview": "手術修復疝缺損合併絕育為標準治療",
      "acute": [
        "膀胱逆行：緊急導尿或穿刺減壓",
        "輸液治療（腎後性氮血症）",
        "緊急手術還納膀胱"
      ],
      "chronic": [
        "會陰疝修補術（傳統修補或內閉鎖肌轉位術）",
        "同時進行絕育（去勢術）",
        "結腸固定術（直腸偏移嚴重時）",
        "前列腺切除或引流（前列腺疾病時）",
        "術後軟化糞便管理"
      ]
    },
    "prognosis": "手術修復加絕育成功率約80-90%。內閉鎖肌轉位術復發率較傳統修補低。不絕育復發率高。對側發生率約40%。膀胱逆行若未及時處理可致命。",
    "pearls": [
      "膀胱逆行至疝囊是緊急情況，需立即處理",
      "絕育是手術的必要部分，可使前列腺萎縮並降低復發",
      "內閉鎖肌轉位術是目前首選的修補技術",
      "術後糞便軟化劑使用2-4週有助癒合"
    ],
    "diagnosticAlgorithm": {
      "title": "會陰疝 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估肛門旁腫塊與排便困難",
          "findings": [
            "肛門旁單側或雙側腫脹",
            "排便困難或裡急後重",
            "未去勢老年公犬多發",
            "腫塊可還納"
          ]
        },
        {
          "step": 2,
          "action": "直腸觸診",
          "details": "直腸觸診評估骨盆膈肌缺損",
          "findings": [
            "骨盆膈肌薄弱或缺損可觸及",
            "疝內容物確認脂肪/直腸/膀胱",
            "前列腺腫大評估",
            "雙側檢查"
          ]
        },
        {
          "step": 3,
          "action": "影像學檢查",
          "details": "X光或超音波評估疝內容物",
          "findings": [
            "X光膀胱後移至會陰膀胱疝出",
            "超音波確認疝內容物",
            "前列腺大小評估",
            "排除骨盆腫瘤"
          ]
        },
        {
          "step": 4,
          "action": "手術計劃",
          "details": "手術修補加去勢",
          "findings": [
            "會陰疝修補術",
            "同時去勢減少復發",
            "膀胱疝出需緊急處理",
            "雙側修補評估"
          ]
        }
      ]
    },
    "monitoring": [
      "術後排便和排尿功能",
      "傷口癒合和感染",
      "復發監測",
      "對側發生監測"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "umbilical-hernia": {
    "zh": "臍疝",
    "en": "Umbilical Hernia",
    "definition": "腹壁臍環未能完全閉合，導致腹腔內容物（通常為脂肪或大網膜）經臍部缺損突出至皮下。為小動物最常見的先天性腹壁缺損。",
    "synonyms": [
      "Umbilical Herniation",
      "臍赫尼亞"
    ],
    "epidemiology": {
      "species": "犬較常見，貓少見",
      "age": "先天性，出生後即可發現",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "遺傳傾向",
        "艾爾代爾梗",
        "巴吉度獵犬",
        "北京犬",
        "牽拉臍帶過度"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "出生後腹部正中臍部可見軟性腫脹",
        "通常無症狀",
        "偶見嵌頓時疼痛和嘔吐"
      ],
      "physicalExam": [
        "臍部可還納性軟組織突出",
        "觸診可感受腹壁缺損環",
        "內容物通常為脂肪或大網膜",
        "嵌頓時腫脹變硬、疼痛、不可還納"
      ]
    },
    "pathophysiology": "胚胎發育時臍帶通過腹壁的臍環，正常在出生後臍環閉合。若腹壁肌肉和筋膜未能完全閉合，即形成臍疝。小的缺損（<1 cm）僅有脂肪或大網膜突出，通常無臨床意義。大的缺損可能允許腸管突出，有嵌頓和絞窄風險。嵌頓是指突出的器官無法還納，絞窄則為血供受阻導致缺血壞死，為緊急情況。",
    "diagnosis": {
      "overview": "體檢觸診即可診斷，影像學用於評估嵌頓或複雜病例",
      "differentials": [
        "臍膿腫",
        "臍部腫瘤",
        "腹壁疝（非臍部）"
      ],
      "initialDB": [
        "體檢觸診（確認缺損大小和內容物可還納性）"
      ],
      "advanced": [
        "腹部超音波（確認疝內容物）",
        "腹部X光（嵌頓時評估腸管）"
      ]
    },
    "treatment": {
      "overview": "小且可還納的臍疝可觀察，大的或嵌頓的需手術修復",
      "acute": [
        "嵌頓性臍疝：緊急手術還納和修復",
        "嵌頓腸管若有壞死需切除"
      ],
      "chronic": [
        "小臍疝（<1 cm）可觀察至6個月齡，部分可自行閉合",
        "大臍疝或持續存在者手術修復",
        "常在絕育手術時同時修復",
        "手術方式：直接縫合缺損或網片修復（大缺損）"
      ]
    },
    "prognosis": "預後極佳。手術修復成功率接近100%。小的臍疝部分可在6個月齡前自行閉合。嵌頓但未絞窄者手術後預後良好。腸管絞窄壞死需切除者預後較謹慎。",
    "pearls": [
      "小的可還納臍疝可等到絕育時一併修復",
      "大的不可還納臍疝應儘早手術以防嵌頓",
      "有遺傳傾向，受影響動物的繁殖應慎重考慮",
      "嵌頓是緊急情況，需立即手術"
    ],
    "diagnosticAlgorithm": {
      "title": "臍疝 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "觸診臍部腫塊",
          "findings": [
            "臍部軟性腫塊",
            "通常可還納",
            "幼犬常見",
            "大小不一"
          ]
        },
        {
          "step": 2,
          "action": "疝環評估",
          "details": "觸診疝環大小與是否可還納",
          "findings": [
            "疝環大小測量",
            "內容物是否可還納",
            "不可還納需緊急評估嵌頓風險",
            "疝囊內容物判斷"
          ]
        },
        {
          "step": 3,
          "action": "影像學必要時",
          "details": "大型或不可還納疝需影像確認",
          "findings": [
            "超音波確認疝內容物脂肪/網膜/腸管",
            "腸管嵌頓排除",
            "腹腔其他異常排除",
            "小型可還納疝可能自行閉合"
          ]
        }
      ]
    },
    "monitoring": [
      "觀察期間監測大小變化和可還納性",
      "術後傷口癒合",
      "復發（罕見）"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "skin-mass-lipoma": {
    "zh": "脂肪瘤",
    "en": "Lipoma",
    "definition": "起源於成熟脂肪細胞的良性腫瘤，為犬最常見的軟組織腫瘤。通常位於皮下，生長緩慢，很少造成臨床問題。",
    "synonyms": [
      "Fatty Tumor",
      "皮下脂肪瘤",
      "Adipocyte Tumor"
    ],
    "epidemiology": {
      "species": "犬非常常見，貓少見",
      "age": "中老年犬（>8歲）",
      "sex": "雌性和肥胖動物較常見",
      "riskFactors": [
        "肥胖",
        "中老年",
        "雌性",
        "拉布拉多犬",
        "杜賓犬",
        "迷你雪納瑞",
        "混種犬"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "皮下緩慢增大的軟性腫塊",
        "通常無痛",
        "可能多發",
        "存在數月至數年"
      ],
      "physicalExam": [
        "皮下軟性、圓形或橢圓形、邊界清晰的腫塊",
        "觸感柔軟、可移動",
        "無疼痛",
        "皮膚表面正常",
        "可能多處同時存在",
        "浸潤性脂肪瘤：邊界不清、與深層組織黏連"
      ]
    },
    "pathophysiology": "成熟脂肪細胞增生形成的良性腫瘤，被纖維囊膜包裹。腫瘤由正常外觀的脂肪細胞組成，生長緩慢。大多數脂肪瘤為單純型（良性、有包膜、可移動），少數為浸潤性脂肪瘤（無包膜，浸潤至肌肉和筋膜間，局部侵襲性但不轉移）。脂肪肉瘤（惡性）極罕見。腫瘤形成的確切機制不明，可能與脂肪代謝和荷爾蒙因素有關。",
    "diagnosis": {
      "overview": "細針穿刺細胞學通常可確診，浸潤性脂肪瘤需影像學評估範圍",
      "differentials": [
        "脂肪肉瘤",
        "肥大細胞瘤",
        "軟組織肉瘤",
        "膿腫",
        "血清腫",
        "其他皮下腫瘤"
      ],
      "initialDB": [
        "細針穿刺細胞學（大量脂肪滴和成熟脂肪細胞）"
      ],
      "advanced": [
        "組織病理學（切除後確認，或可疑病例）",
        "超音波（評估大小和邊界）",
        "CT/MRI（浸潤性脂肪瘤術前評估範圍）"
      ]
    },
    "treatment": {
      "overview": "多數良性脂肪瘤不需治療。影響功能或快速增大時考慮手術切除",
      "acute": [
        "大多數不需治療，定期監測即可"
      ],
      "chronic": [
        "手術切除的適應症：快速增大、影響行動功能、位於不利位置（腋下、腹股溝）",
        "邊緣切除即可（良性型）",
        "浸潤性脂肪瘤需廣泛切除",
        "減重可能減緩新發脂肪瘤",
        "脂肪抽吸（少用，效果不確定）"
      ]
    },
    "prognosis": "良性脂肪瘤預後極佳，不影響壽命。手術切除後復發率低。浸潤性脂肪瘤局部復發率較高（約36%），因為難以達到完整切除邊緣，但不會轉移。",
    "pearls": [
      "細針穿刺可確診大多數脂肪瘤，避免不必要的手術",
      "快速增大、質地較硬或固定不動的腫塊應懷疑非脂肪瘤",
      "浸潤性脂肪瘤術前CT/MRI評估範圍很重要",
      "減重不會使已存在的脂肪瘤縮小"
    ],
    "diagnosticAlgorithm": {
      "title": "脂肪瘤 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "觸診腫塊特徵",
          "findings": [
            "皮下軟性可動腫塊",
            "生長緩慢",
            "通常不疼痛",
            "中老年犬多發"
          ]
        },
        {
          "step": 2,
          "action": "細針抽吸細胞學",
          "details": "腫塊細針抽吸確認性質",
          "findings": [
            "抽出油脂樣物質",
            "成熟脂肪細胞大型透明細胞",
            "排除脂肪肉瘤",
            "排除其他軟組織腫瘤"
          ]
        },
        {
          "step": 3,
          "action": "浸潤性評估",
          "details": "評估是否為浸潤性脂肪瘤",
          "findings": [
            "浸潤性脂肪瘤附著深層組織",
            "活動度差",
            "觸診邊界不清",
            "MRI或CT評估浸潤範圍"
          ]
        }
      ]
    },
    "monitoring": [
      "定期測量大小（尺寸紀錄或照片）",
      "監測生長速度",
      "新發腫塊的穿刺評估"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "cutaneous-histiocytoma": {
    "zh": "皮膚組織細胞瘤",
    "en": "Cutaneous Histiocytoma",
    "definition": "起源於表皮朗格漢斯細胞（Langerhans cells）的良性皮膚腫瘤，為犬常見的皮膚腫瘤，具有自發消退特性。",
    "synonyms": [
      "Button Tumor",
      "鈕扣瘤",
      "Canine Cutaneous Histiocytoma"
    ],
    "epidemiology": {
      "species": "犬常見，貓極罕見",
      "age": "年輕犬最常見（<3歲佔50%），但任何年齡可發生",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "年輕犬",
        "拳師犬",
        "臘腸犬",
        "可卡犬",
        "大丹犬",
        "雪達犬",
        "扁臉犬種"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "快速出現的單一皮膚腫塊",
        "生長快速（數週內）",
        "通常無痛",
        "最常見於頭部、耳朵和四肢"
      ],
      "physicalExam": [
        "單一、圓形、隆起、無毛的皮膚結節",
        "直徑通常<2 cm",
        "質地硬實",
        "表面可能潰瘍",
        "皮膚呈粉紅色至紅色",
        "常位於頭部、耳殼、四肢"
      ]
    },
    "pathophysiology": "起源於表皮樹突細胞（朗格漢斯細胞）的良性增生性腫瘤。腫瘤快速生長，由均一的圓形組織細胞組成，浸潤真皮和表皮。最獨特的特性是自發性免疫媒介消退：T淋巴細胞浸潤腫瘤，引發免疫攻擊導致腫瘤在數週至數月內自行消退。免疫組織化學上表現為CD1a+、CD11c+、MHC II+，證實其朗格漢斯細胞起源。",
    "diagnosis": {
      "overview": "細針穿刺細胞學可初步診斷，組織病理學可確診",
      "differentials": [
        "肥大細胞瘤（最重要的鑑別診斷）",
        "黑色素瘤",
        "皮膚淋巴瘤",
        "漿細胞瘤",
        "傳染性性器腫瘤（TVT）"
      ],
      "initialDB": [
        "細針穿刺細胞學（均一的圓形細胞，豐富淡色細胞質，無顆粒）"
      ],
      "advanced": [
        "組織病理學（確診）",
        "免疫組織化學（CD1a、CD11c、E-cadherin陽性）",
        "與肥大細胞瘤的鑑別（Toluidine blue染色）"
      ]
    },
    "treatment": {
      "overview": "多數可自發消退不需治療，持續存在或診斷不確定時考慮切除",
      "acute": [
        "觀察等待（多數在3個月內自發消退）"
      ],
      "chronic": [
        "手術切除（3個月未消退、快速增大、或診斷不確定時）",
        "冷凍治療",
        "邊緣切除即足夠",
        "多發性組織細胞瘤應考慮其他組織細胞增生性疾病"
      ]
    },
    "prognosis": "預後極佳。約90%在3個月內自發消退。手術切除後很少復發。多發性或反覆發生的病例需排除其他組織細胞增生性疾病（反應性組織細胞增生症、組織細胞肉瘤）。",
    "pearls": [
      "最重要的鑑別診斷是肥大細胞瘤，兩者外觀可能相似",
      "年輕犬快速出現的單一皮膚結節高度提示組織細胞瘤",
      "自發消退是本病的特徵，可先觀察3個月",
      "多發性組織細胞瘤需進一步排除系統性組織細胞增生疾病"
    ],
    "diagnosticAlgorithm": {
      "title": "皮膚組織細胞瘤 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "觀察腫塊特徵與生長速度",
          "findings": [
            "快速生長的圓形粉紅色腫塊",
            "通常單一",
            "3歲以下年輕犬多見",
            "頭部/耳朵/四肢好發"
          ]
        },
        {
          "step": 2,
          "action": "細針抽吸細胞學",
          "details": "腫塊細針抽吸確認",
          "findings": [
            "大量圓形組織細胞",
            "核圓形至豆形",
            "細胞質豐富淡染",
            "混合淋巴球浸潤消退期"
          ]
        },
        {
          "step": 3,
          "action": "觀察或切除",
          "details": "多數可自行消退",
          "findings": [
            "自發消退通常2-3個月",
            "持續不消退考慮手術切除",
            "排除肥大細胞瘤等惡性腫瘤",
            "組織學確認切除時"
          ]
        }
      ]
    },
    "monitoring": [
      "腫塊大小追蹤",
      "3個月消退觀察期",
      "新發腫塊評估"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "sebaceous-adenoma": {
    "zh": "皮脂腺腺瘤",
    "en": "Sebaceous Adenoma",
    "definition": "起源於皮脂腺的良性腫瘤，為犬常見的皮膚腫瘤之一，常見於老年犬，呈多發性疣狀或花椰菜樣外觀。",
    "synonyms": [
      "Sebaceous Gland Tumor",
      "皮脂腺瘤",
      "Sebaceous Epithelioma"
    ],
    "epidemiology": {
      "species": "犬非常常見，貓少見",
      "age": "老年犬（>8歲）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "老年",
        "可卡犬",
        "迷你雪納瑞",
        "貴賓犬",
        "臘腸犬",
        "英國獵犬"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "皮膚表面緩慢增大的疣狀腫塊",
        "可能多發",
        "偶有出血（自我創傷）",
        "通常無症狀"
      ],
      "physicalExam": [
        "疣狀或花椰菜樣隆起結節",
        "直徑通常<2 cm",
        "表面可能分葉或潰瘍",
        "質地蠟樣或油膩感",
        "單一或多發",
        "常見於頭部、眼瞼、軀幹"
      ]
    },
    "pathophysiology": "起源於毛囊附屬的皮脂腺上皮細胞的良性增生。皮脂腺腫瘤包含多種組織亞型：皮脂腺增生（最常見，非真正腫瘤）、皮脂腺腺瘤、皮脂腺上皮瘤和皮脂腺腺癌（罕見，為惡性）。良性腫瘤由增生的皮脂腺細胞組成，保留正常的腺體分化特徵，局部生長不轉移。",
    "diagnosis": {
      "overview": "臨床外觀和細胞學可初步診斷，組織病理學確診並排除惡性",
      "differentials": [
        "皮脂腺腺癌",
        "乳頭狀瘤（疣）",
        "基底細胞瘤",
        "肥大細胞瘤",
        "黑色素瘤",
        "毛母質瘤"
      ],
      "initialDB": [
        "細針穿刺細胞學（成簇的皮脂腺細胞，含脂質空泡）"
      ],
      "advanced": [
        "組織病理學（切除後確認亞型和排除惡性）"
      ]
    },
    "treatment": {
      "overview": "良性腫瘤多數不需治療，影響美觀或功能時可切除",
      "acute": [
        "觀察（大多數為良性，不需緊急處理）"
      ],
      "chronic": [
        "手術切除（出血、影響功能如眼瞼、美觀考量）",
        "冷凍治療（小型病變）",
        "雷射消融",
        "邊緣切除即足夠"
      ]
    },
    "prognosis": "預後極佳。良性皮脂腺腫瘤不影響壽命。手術切除後很少復發。新發病變在其他部位常見（多中心起源）。皮脂腺腺癌局部侵襲性較高但轉移率低。",
    "pearls": [
      "老年犬頭部和眼瞼的疣狀腫塊最常見為皮脂腺腫瘤",
      "多數不需治療，除非影響功能或反覆出血",
      "與乳頭狀瘤的臨床外觀可能相似但治療方式不同",
      "皮脂腺腺癌罕見但需組織病理排除"
    ],
    "diagnosticAlgorithm": {
      "title": "皮脂腺腺瘤 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "觀察腫塊外觀特徵",
          "findings": [
            "花椰菜樣或疣狀突起",
            "皮膚表面有蒂或無蒂",
            "老年犬常見",
            "可能多發"
          ]
        },
        {
          "step": 2,
          "action": "細針抽吸或切除",
          "details": "細胞學確認腺體來源",
          "findings": [
            "皮脂腺細胞團",
            "細胞質含脂質空泡",
            "良性型態",
            "排除皮脂腺癌"
          ]
        },
        {
          "step": 3,
          "action": "治療決策",
          "details": "根據位置與大小決定處理方式",
          "findings": [
            "良性通常不需治療",
            "影響功能或美觀考慮切除",
            "潰瘍出血考慮切除",
            "冷凍治療或手術切除"
          ]
        }
      ]
    },
    "monitoring": [
      "觀察大小變化",
      "出血或潰瘍",
      "新發病變評估"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "feline-acne": {
    "zh": "貓粉刺",
    "en": "Feline Acne (Feline Chin Acne)",
    "definition": "貓粉刺是貓下巴部位毛囊角化異常導致的常見皮膚病，表現為下巴的粉刺（comedones）、丘疹和膿疱。確切病因不明，可能與毛囊角質化障礙、皮脂分泌異常或局部免疫反應有關。輕度病例可能僅有美容性問題，嚴重者可發展為深層毛囊炎和蜂窩組織炎。",
    "synonyms": [
      "Feline Chin Acne",
      "Feline Follicular Keratinization",
      "貓下巴粉刺"
    ],
    "epidemiology": {
      "species": "貓",
      "age": "任何年齡",
      "sex": "無性別傾向",
      "riskFactors": [
        "使用塑膠餵食碗（接觸性因素）",
        "毛髮梳理不良",
        "皮脂分泌異常",
        "免疫功能低下",
        "病毒感染（FeLV、FIV）",
        "壓力"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "下巴出現黑色小點（粉刺）",
        "輕度病例飼主可能未注意",
        "嚴重時下巴腫脹和疼痛",
        "可能有搔抓下巴的行為"
      ],
      "physicalExam": [
        "下巴皮膚上散布黑色粉刺",
        "輕度：黑頭粉刺群集於下巴和下唇",
        "中度：紅色丘疹和膿疱",
        "嚴重：下巴腫脹、蜂窩組織炎、癤腫",
        "嚴重時觸診疼痛",
        "可能伴隨下頷淋巴結腫大"
      ]
    },
    "pathophysiology": "貓粉刺的確切病因不明。推測機制涉及下巴部位毛囊的角質化異常——角質細胞過度堆積堵塞毛囊開口，形成粉刺。堵塞的毛囊中皮脂和角質蓄積提供了細菌（通常為Staphylococcus）增殖的環境。繼發性細菌感染導致毛囊炎和膿疱形成。嚴重的深層感染可發展為癤腫和蜂窩組織炎。塑膠碗的接觸可能因過敏或細菌生物膜而加重病情。Malassezia酵母菌也可能在部分病例中起到致病作用。",
    "diagnosis": {
      "overview": "依據特徵性的臨床表現進行診斷，需排除類似病變",
      "differentials": [
        "蠕形蟎感染",
        "皮膚黴菌感染",
        "嗜酸球性肉芽腫",
        "下巴接觸性皮膚炎",
        "下巴部位的腫瘤"
      ],
      "initialDB": [
        "臨床檢查（典型病變分布）",
        "皮膚刮片（排除蠕形蟎）",
        "皮膚細胞學（壓印塗片——細菌、酵母菌、炎症細胞）",
        "黴菌培養（排除皮膚黴菌）"
      ],
      "advanced": [
        "細菌培養和藥敏試驗（嚴重或難治性病例）",
        "皮膚組織病理學（排除腫瘤或自體免疫疾病）",
        "FeLV/FIV檢測"
      ]
    },
    "treatment": {
      "overview": "輕度病例局部治療為主，嚴重感染需全身性抗生素",
      "acute": [
        "更換餵食碗為不銹鋼或陶瓷材質",
        "溫和清潔下巴（含chlorhexidine 2-3%的清潔液或墊片）",
        "局部benzoyl peroxide凝膠（2.5%，注意可能刺激貓皮膚）",
        "局部mupirocin軟膏（細菌感染時）",
        "嚴重感染：全身性抗生素（amoxicillin-clavulanate 12.5-25 mg/kg PO q12h）"
      ],
      "chronic": [
        "定期下巴清潔預防復發",
        "維持不銹鋼或陶瓷碗",
        "局部含水楊酸的清潔墊維持",
        "難治性病例：局部tacrolimus 0.1%",
        "omega-3脂肪酸補充"
      ]
    },
    "prognosis": "輕度粉刺預後極佳，可能自行緩解或經簡單治療控制。嚴重的深層感染需要較積極的治療但通常可控制。部分貓有復發傾向，需要長期維護性治療。",
    "pearls": [
      "更換塑膠碗為不銹鋼或陶瓷碗是簡單有效的第一步措施",
      "輕度貓粉刺是美容性問題，不一定需要積極治療",
      "下巴的「髒污」外觀可能被飼主誤認為只是食物殘渣",
      "嚴重的貓粉刺可發展為疼痛的蜂窩組織炎，不應輕忽",
      "benzoyl peroxide在貓的使用濃度應低於犬，且可能引起刺激"
    ],
    "diagnosticAlgorithm": {
      "title": "貓粉刺 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估下巴部位特徵性病變",
          "findings": [
            "下巴黑色粉刺",
            "毛囊堵塞",
            "輕度至重度發展",
            "下巴腫脹嚴重時"
          ]
        },
        {
          "step": 2,
          "action": "分級與繼發感染評估",
          "details": "評估嚴重程度與細菌感染",
          "findings": [
            "輕度粉刺為主",
            "中度膿皰與紅腫",
            "重度毛囊炎與蜂窩組織炎",
            "細胞學檢查細菌感染"
          ]
        },
        {
          "step": 3,
          "action": "鑑別診斷",
          "details": "排除其他下巴病變",
          "findings": [
            "排除蠕形蟎",
            "排除皮膚黴菌感染",
            "排除嗜酸性肉芽腫",
            "排除腫瘤老年貓下巴腫塊"
          ]
        }
      ]
    },
    "monitoring": [
      "治療後2-4週評估反應",
      "清潔和局部治療依從性追蹤",
      "復發性病例定期追蹤"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "miliary-dermatitis": {
    "zh": "粟粒性皮膚炎",
    "en": "Miliary Dermatitis",
    "definition": "貓特有的皮膚反應模式，以全身散佈的細小丘疹結痂為特徵，並非特定疾病而是多種病因引起的共同皮膚反應型態。最常見的原因為跳蚤過敏性皮膚炎。",
    "synonyms": [
      "Feline Miliary Dermatitis",
      "Scabby Cat Disease",
      "貓粟粒狀皮膚炎"
    ],
    "epidemiology": {
      "species": "貓（為貓特有的反應模式）",
      "age": "任何年齡",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "跳蚤暴露（最常見原因）",
        "食物過敏",
        "環境過敏原",
        "外寄生蟲（耳疥蟎、疥蟎）",
        "皮癬菌感染"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "搔癢（程度不等）",
        "過度理毛",
        "皮膚上有細小結痂",
        "脫毛",
        "可能有跳蚤暴露史"
      ],
      "physicalExam": [
        "全身散佈的細小丘疹和結痂（觸診比視覺更容易發現）",
        "主要分佈於背部、頸部和頭部",
        "脫毛（過度理毛造成）",
        "皮膚發紅",
        "可能發現跳蚤或跳蚤糞便"
      ]
    },
    "pathophysiology": "粟粒性皮膚炎是貓皮膚對多種刺激的非特異性炎症反應模式。過敏原（跳蚤唾液、食物蛋白、環境過敏原）觸發免疫反應，嗜酸性白血球和肥大細胞浸潤毛囊周圍和真皮層，導致毛囊炎和表皮丘疹形成。丘疹頂部形成痂皮，觸診時有特徵性的粗糙「穀粒」感。跳蚤過敏性皮膚炎是最常見的原因，僅需少量跳蚤叮咬即可在過敏動物引發廣泛的皮膚反應。",
    "diagnosis": {
      "overview": "確認粟粒性皮膚炎的反應模式後，系統性排查基礎病因",
      "differentials": [
        "跳蚤過敏性皮膚炎（最常見）",
        "食物不良反應",
        "環境過敏（特異性皮膚炎）",
        "皮癬菌感染",
        "疥蟎感染",
        "藥物反應",
        "嗜酸性白血球增多症候群"
      ],
      "initialDB": [
        "詳細病史（跳蚤預防、飲食、環境）",
        "跳蚤梳檢查",
        "皮膚刮片（排除寄生蟲）",
        "黴菌培養（排除皮癬菌）",
        "皮膚細胞學"
      ],
      "advanced": [
        "嚴格食物排除試驗（8-12週，新型蛋白或水解蛋白飲食）",
        "過敏原特異性血清學或皮內試驗",
        "皮膚活檢（排除不常見病因）"
      ]
    },
    "treatment": {
      "overview": "治療基礎病因為根本，同時控制搔癢和繼發感染",
      "acute": [
        "跳蚤控制（所有病例均應先試驗性除蚤治療）",
        "環境除蚤（所有同住動物和環境）",
        "Glucocorticoids短期控制搔癢（Prednisolone 1-2 mg/kg/天，漸減）",
        "繼發感染時抗生素治療"
      ],
      "chronic": [
        "持續跳蚤預防（每月外用或口服除蚤藥）",
        "食物排除試驗和飲食管理（食物過敏）",
        "環境過敏的長期管理（Cyclosporine、Oclacitinib）",
        "Omega-3脂肪酸補充",
        "環境過敏原減敏治療"
      ]
    },
    "prognosis": "取決於基礎病因。跳蚤過敏在有效控制跳蚤後預後極佳。食物過敏透過飲食管理可良好控制。環境過敏需要長期管理但多數可控制。不明原因者可能需要長期對症治療。",
    "pearls": [
      "觸診背部比視覺檢查更容易發現粟粒性皮膚炎的結痂",
      "即使未發現跳蚤也應先進行跳蚤控制試驗（跳蚤過敏最常見）",
      "粟粒性皮膚炎是反應模式而非診斷，必須尋找基礎病因",
      "食物排除試驗需要嚴格執行8-12週才能判定"
    ],
    "diagnosticAlgorithm": {
      "title": "粟粒性皮膚炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "觸診全身皮膚評估粟粒性丘疹分布",
          "findings": [
            "背部/頸部多發細小痂皮性丘疹",
            "觸診如小米粒",
            "搔癢程度不等",
            "脫毛"
          ]
        },
        {
          "step": 2,
          "action": "病因排查",
          "details": "系統性排除常見原因",
          "findings": [
            "跳蚤檢查與跳蚤梳",
            "皮膚刮搔排除蟎蟲",
            "皮膚黴菌培養",
            "糞便寄生蟲檢查排除腸道寄生蟲"
          ]
        },
        {
          "step": 3,
          "action": "過敏原調查",
          "details": "排除感染原因後評估過敏",
          "findings": [
            "跳蚤過敏性皮膚炎最常見原因",
            "食物過敏排除飲食試驗",
            "環境過敏原",
            "藥物反應"
          ]
        },
        {
          "step": 4,
          "action": "皮膚活檢必要時",
          "details": "反覆發作或治療無效時進行",
          "findings": [
            "嗜酸性球浸潤過敏",
            "嗜中性球浸潤感染",
            "特徵性反應型態鑑定",
            "排除腫瘤性皮膚病"
          ]
        }
      ]
    },
    "monitoring": [
      "皮膚病變改善程度",
      "搔癢評分",
      "跳蚤控制有效性",
      "食物排除試驗依從性",
      "藥物副作用"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "canine-coronavirus": {
    "zh": "犬冠狀病毒腸炎",
    "en": "Canine Coronavirus Enteritis (CCoV)",
    "definition": "犬冠狀病毒（CCoV）是一種高度傳染性的腸道RNA病毒，屬於冠狀病毒科α屬，主要感染犬隻小腸絨毛上皮細胞，導致急性自限性腸炎。單獨感染時症狀通常較輕微，但與犬小病毒（CPV）混合感染時可顯著加重病情。",
    "synonyms": [
      "CCoV Enteritis",
      "Canine Enteric Coronavirus"
    ],
    "epidemiology": {
      "species": "犬",
      "age": "幼犬較易感染且症狀較嚴重，成犬通常為亞臨床感染",
      "sex": "無性別傾向",
      "riskFactors": [
        "犬舍或收容所等高密度飼養環境",
        "免疫力低下或未完成疫苗接種的幼犬",
        "與犬小病毒混合感染",
        "環境衛生不良",
        "斷奶期間的緊迫"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "急性發作的軟便或水樣腹瀉",
        "食慾減退",
        "嘔吐（通常輕微）",
        "精神沉鬱",
        "與其他腸道病原體混合感染時症狀加重"
      ],
      "physicalExam": [
        "輕度至中度脫水",
        "腸蠕動音增加",
        "腹部觸診可能有輕度不適",
        "體溫通常正常或輕微升高",
        "嚴重混合感染時可見明顯脫水和消瘦"
      ]
    },
    "pathophysiology": "犬冠狀病毒經糞口途徑傳播，感染小腸絨毛尖端的成熟上皮細胞。病毒複製導致絨毛萎縮和融合，減少腸道吸收面積，造成滲透性和分泌性腹瀉。與犬小病毒不同，CCoV不攻擊腸道隱窩細胞，因此絨毛再生能力保留，疾病通常具自限性。然而當與CPV混合感染時，隱窩和絨毛同時受損，導致嚴重的出血性腸炎。",
    "diagnosis": {
      "overview": "診斷主要依靠臨床症狀結合實驗室檢測，需排除其他腸道感染性疾病",
      "differentials": [
        "犬小病毒腸炎",
        "犬瘟熱",
        "寄生蟲性腸炎",
        "細菌性腸炎（沙門氏菌、彎曲桿菌）",
        "飲食不當",
        "異物攝入",
        "腸套疊"
      ],
      "initialDB": [
        "糞便PCR檢測CCoV",
        "糞便抗原快速檢測（ELISA）",
        "CBC（通常無明顯變化，混合感染時可見白血球減少）",
        "生化檢查（評估脫水和電解質狀態）"
      ],
      "advanced": [
        "電子顯微鏡檢查糞便中病毒顆粒",
        "病毒分離培養",
        "糞便寄生蟲學檢查排除混合感染",
        "犬小病毒ELISA排除混合感染"
      ]
    },
    "treatment": {
      "overview": "以支持性治療為主，維持水分和電解質平衡，預防繼發性細菌感染",
      "acute": [
        "靜脈或皮下輸液矯正脫水",
        "電解質補充（特別是鉀和鈉）",
        "止吐藥（maropitant 1 mg/kg SC q24h）",
        "廣效抗生素預防繼發感染（ampicillin 22 mg/kg IV q8h）",
        "禁食12-24小時後逐漸恢復易消化飲食"
      ],
      "chronic": [
        "通常不需慢性治療",
        "恢復期給予高消化性飲食",
        "益生菌輔助腸道菌群恢復"
      ]
    },
    "prognosis": "單獨CCoV感染預後良好，大多數犬隻在7-10天內自行恢復。與CPV混合感染時預後較差，幼犬死亡率可顯著升高。",
    "pearls": [
      "CCoV單獨感染通常為自限性疾病，臨床意義主要在於與CPV的混合感染",
      "糞便中病毒排出可持續數週，即使臨床症狀已消失",
      "環境中病毒可存活數天，需使用含氯消毒劑徹底消毒",
      "CCoV疫苗存在但非核心疫苗，其臨床保護效力仍有爭議"
    ],
    "diagnosticAlgorithm": {
      "title": "犬冠狀病毒腸炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估臨床症狀與病史，注意幼犬、群居環境及疫苗接種狀態",
          "findings": [
            "急性水樣腹瀉",
            "輕度嘔吐",
            "食慾下降",
            "輕度脫水"
          ]
        },
        {
          "step": 2,
          "action": "基本檢查",
          "details": "進行血液學與生化檢查評估全身狀態",
          "findings": [
            "血液學變化通常輕微",
            "輕度白血球減少",
            "電解質輕度失衡"
          ]
        },
        {
          "step": 3,
          "action": "糞便檢查",
          "details": "進行糞便抗原檢測與PCR確認病原",
          "findings": [
            "糞便CCoV抗原快篩陽性",
            "糞便PCR檢測CCoV RNA陽性",
            "需排除犬小病毒共感染"
          ]
        },
        {
          "step": 4,
          "action": "確診與鑑別",
          "details": "綜合臨床表現與實驗室結果確診，排除其他腸炎病因",
          "findings": [
            "確認CCoV感染",
            "排除CPV-2共感染",
            "評估是否有繼發性細菌感染"
          ]
        }
      ]
    },
    "monitoring": [
      "每日體重和水合狀態評估",
      "糞便性狀觀察",
      "食慾和精神狀態監測",
      "混合感染時監測白血球計數"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "infectious-canine-hepatitis": {
    "zh": "犬傳染性肝炎",
    "en": "Infectious Canine Hepatitis (ICH)",
    "definition": "犬傳染性肝炎由犬腺病毒第一型（CAV-1）引起，是一種急性、高度傳染性的全身性疾病，主要影響肝臟、腎臟、眼睛和血管內皮細胞。未接種疫苗的幼犬感染後可能迅速致命。",
    "synonyms": [
      "ICH",
      "Rubarth Disease",
      "CAV-1 Infection",
      "犬腺病毒第一型感染"
    ],
    "epidemiology": {
      "species": "犬及其他犬科動物（狐狸、狼、熊等）",
      "age": "未接種疫苗的幼犬（< 1歲）最易感",
      "sex": "無性別傾向",
      "riskFactors": [
        "未完成核心疫苗接種",
        "接觸野生犬科動物",
        "犬舍或收容所環境",
        "免疫功能不全"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "突然發熱（>40°C）",
        "食慾廢絕",
        "嘔吐和腹瀉",
        "腹痛（特別是肝區）",
        "嗜睡和虛弱",
        "超急性病例可在數小時內死亡"
      ],
      "physicalExam": [
        "發熱（雙峰熱型）",
        "肝腫大及肝區疼痛",
        "扁桃腺腫大",
        "全身性淋巴結腫大",
        "皮下水腫（特別是頭頸部）",
        "黃疸（嚴重病例）",
        "瘀斑或出血傾向",
        "前葡萄膜炎和角膜水腫（藍眼病，恢復期）"
      ]
    },
    "pathophysiology": "CAV-1經口鼻途徑感染，首先在扁桃腺和局部淋巴結複製，隨後經病毒血症擴散至全身。病毒具有嗜肝性和嗜內皮性，在肝臟實質細胞和血管內皮細胞中大量複製，導致肝細胞壞死和DIC。腎臟腎小球基底膜可沉積免疫複合物，導致間質性腎炎。恢復期的角膜水腫（藍眼病）是免疫複合物沉積於角膜的結果。",
    "diagnosis": {
      "overview": "依據臨床症狀、疫苗史和實驗室檢查綜合診斷",
      "differentials": [
        "犬瘟熱",
        "鉤端螺旋體病",
        "犬小病毒腸炎",
        "中毒性肝炎",
        "其他病毒性肝炎",
        "膽管炎",
        "DIC其他原因"
      ],
      "initialDB": [
        "CBC（白血球減少，血小板減少）",
        "生化檢查（ALT和AST顯著升高，膽紅素升高）",
        "凝血功能檢查（PT和APTT延長）",
        "尿液分析（蛋白尿）"
      ],
      "advanced": [
        "CAV-1 PCR檢測（血液或組織）",
        "血清學配對抗體效價",
        "腹部超音波（肝腫大、腹水）",
        "肝臟組織病理學（肝細胞壞死、核內包涵體）"
      ]
    },
    "treatment": {
      "overview": "無特異性抗病毒治療，以積極支持療法維持生命徵象和器官功能為主",
      "acute": [
        "積極靜脈輸液治療",
        "新鮮冷凍血漿輸注（補充凝血因子）",
        "廣效抗生素預防繼發感染",
        "止吐藥（maropitant）",
        "肝臟保護劑（SAMe 20 mg/kg PO q24h）",
        "維生素K1補充（若凝血功能異常）",
        "DIC治療（如適用）"
      ],
      "chronic": [
        "恢復期肝臟保護飲食",
        "持續監測肝功能",
        "前葡萄膜炎的局部治療（局部類固醇和散瞳劑）"
      ]
    },
    "prognosis": "超急性病例預後極差，死亡率極高。急性病例經積極治療後存活率約50-70%。恢復後可能遺留慢性肝炎或腎臟損傷。藍眼病通常在數週內自行消退。由於廣泛疫苗接種，此病在已開發國家已相當少見。",
    "pearls": [
      "疫苗接種使用CAV-2（而非CAV-1），因CAV-2不引起藍眼病且可同時提供對CAV-1和犬傳染性喉氣管炎的保護",
      "康復犬可從腎臟排出病毒長達6-9個月",
      "超急性病例可在出現臨床症狀前數小時內死亡，類似中毒",
      "藍眼病（角膜水腫）發生在感染後1-3週，是免疫複合物反應的結果"
    ],
    "diagnosticAlgorithm": {
      "title": "犬傳染性肝炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估臨床表現，注意急性發熱、腹痛及疫苗史",
          "findings": [
            "高燒（>40°C）",
            "腹部疼痛與肝區觸痛",
            "扁桃腺腫大",
            "出血傾向"
          ]
        },
        {
          "step": 2,
          "action": "血液檢查",
          "details": "進行CBC與生化檢查評估肝功能與凝血狀態",
          "findings": [
            "ALT/AST顯著升高",
            "白血球減少後反彈性增多",
            "凝血時間延長",
            "低白蛋白血症"
          ]
        },
        {
          "step": 3,
          "action": "影像學檢查",
          "details": "腹部超音波評估肝臟形態與其他腹腔器官",
          "findings": [
            "肝臟腫大",
            "肝實質回聲異常",
            "膽囊壁水腫增厚"
          ]
        },
        {
          "step": 4,
          "action": "確診",
          "details": "透過病毒學檢測確認CAV-1感染",
          "findings": [
            "PCR檢測CAV-1陽性",
            "血清學抗體效價上升",
            "特徵性藍眼症（角膜水腫）"
          ]
        }
      ]
    },
    "monitoring": [
      "每日肝功能指標（ALT、AST、膽紅素）",
      "凝血功能監測",
      "體液狀態和電解質平衡",
      "眼科檢查（前葡萄膜炎監測）",
      "腎功能指標"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "bartonellosis": {
    "zh": "巴爾通體感染",
    "en": "Bartonellosis",
    "definition": "巴爾通體感染是由巴爾通體屬（Bartonella spp.）革蘭氏陰性菌引起的人畜共通傳染病。貓為B. henselae的主要自然宿主，通常無症狀帶菌。犬感染較少見但臨床表現更為嚴重，可引起心內膜炎、肝臟紫斑病和血管增生性病變。",
    "synonyms": [
      "Bartonella Infection",
      "Cat Scratch Disease Agent",
      "貓抓病病原"
    ],
    "epidemiology": {
      "species": "貓為主要帶原者（B. henselae），犬亦可感染多種巴爾通體",
      "age": "幼貓（< 1歲）菌血症盛行率較高",
      "sex": "無性別傾向",
      "riskFactors": [
        "蚤蟲感染（主要傳播媒介）",
        "戶外活動的貓",
        "免疫功能低下",
        "多貓家庭",
        "溫暖潮濕的氣候（蚤蟲盛行區域）",
        "人類免疫缺陷者接觸感染貓的風險較高"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "貓：多數無臨床症狀",
        "貓：偶見發熱、淋巴結腫大、口腔炎",
        "犬：間歇性發熱",
        "犬：鼻出血或其他出血傾向",
        "犬：跛行",
        "犬：食慾減退和體重減輕"
      ],
      "physicalExam": [
        "貓：通常理學檢查正常",
        "貓：偶見淋巴結腫大或口腔炎",
        "犬：發熱",
        "犬：心雜音（心內膜炎時）",
        "犬：關節腫脹",
        "犬：肝脾腫大",
        "犬：淋巴結腫大"
      ]
    },
    "pathophysiology": "巴爾通體主要透過蚤蟲糞便污染傷口或黏膜而傳播。細菌侵入紅血球和內皮細胞內寄生，逃避宿主免疫反應。在貓體內，B. henselae可在紅血球內持續存活導致慢性菌血症。在犬體內，細菌感染可引起血管增生（桿菌性血管瘤病）、肉芽腫性炎症、心內膜炎和多器官受累。免疫複合物沉積可導致關節炎和腎小球腎炎。",
    "diagnosis": {
      "overview": "診斷具挑戰性，需結合血清學、PCR和培養等多種方法",
      "differentials": [
        "血巴東蟲感染",
        "艾利希體感染",
        "萊姆病",
        "感染性心內膜炎（其他病原）",
        "全身性黴菌感染",
        "淋巴瘤",
        "免疫媒介性多關節炎"
      ],
      "initialDB": [
        "CBC（可能正常或輕度貧血、血小板減少）",
        "生化檢查",
        "Bartonella血清學IFA抗體效價",
        "血液PCR檢測"
      ],
      "advanced": [
        "血液培養（需特殊培養基，培養期長達6週）",
        "心臟超音波（排除心內膜炎）",
        "組織PCR（淋巴結、肝臟活檢）",
        "組織病理學（Warthin-Starry銀染色）"
      ]
    },
    "treatment": {
      "overview": "抗生素治療為主，療程通常較長（4-6週以上）",
      "acute": [
        "azithromycin 5-10 mg/kg PO q24h（貓首選）",
        "doxycycline 5-10 mg/kg PO q12h",
        "犬心內膜炎：aminoglycoside + fluoroquinolone聯合療法",
        "支持性療法"
      ],
      "chronic": [
        "長療程抗生素治療（至少4-6週）",
        "蚤蟲防治（環境和動物體表）",
        "定期監測抗體效價評估治療反應",
        "人畜共通疾病衛教"
      ]
    },
    "prognosis": "貓的巴爾通體感染預後良好，多數自然清除或抗生素治療有效。犬的預後取決於受累器官，心內膜炎病例預後較差。免疫低下的人類接觸帶菌貓有感染風險。",
    "pearls": [
      "蚤蟲防治是預防巴爾通體傳播最重要的措施",
      "貓的慢性無症狀菌血症可持續數月至數年",
      "陰性血清學結果不能完全排除感染",
      "犬的巴爾通體感染應考慮心內膜炎的可能性",
      "此為重要人畜共通傳染病，需告知免疫缺陷飼主防護措施"
    ],
    "diagnosticAlgorithm": {
      "title": "巴爾通體感染 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估臨床症狀與跳蚤暴露史",
          "findings": [
            "間歇性發熱",
            "淋巴結腫大",
            "鼻出血或其他黏膜出血",
            "心內膜炎相關症狀"
          ]
        },
        {
          "step": 2,
          "action": "基本檢查",
          "details": "血液學與生化檢查",
          "findings": [
            "輕度非再生性貧血",
            "血小板減少",
            "肝酶輕度升高",
            "高球蛋白血症"
          ]
        },
        {
          "step": 3,
          "action": "專項檢測",
          "details": "進行血清學與PCR確認感染",
          "findings": [
            "Bartonella IFA抗體效價升高",
            "血液PCR檢測陽性",
            "血液培養陽性（需特殊培養基）"
          ]
        },
        {
          "step": 4,
          "action": "確診與評估",
          "details": "綜合評估感染範圍與併發症",
          "findings": [
            "心臟超音波排除心內膜炎",
            "確認感染種別",
            "評估眼部與關節併發症"
          ]
        }
      ]
    },
    "monitoring": [
      "治療後4-6週複檢血清學效價",
      "蚤蟲感染狀態定期評估",
      "犬心內膜炎病例需定期心臟超音波追蹤",
      "PCR追蹤確認菌血症清除"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "tick-borne-disease": {
    "zh": "壁蝨傳播疾病",
    "en": "Tick-Borne Diseases (Overview)",
    "definition": "壁蝨傳播疾病是由硬蜱科壁蝨叮咬傳播的一組感染性疾病的總稱，包括艾利希體症（Ehrlichiosis）、乏漿體症（Anaplasmosis）、巴貝斯焦蟲症（Babesiosis）、肝簇蟲症（Hepatozoonosis）和落磯山斑點熱（RMSF）等。這些疾病在熱帶和亞熱帶地區廣泛流行，可同時合併感染。",
    "synonyms": [
      "Tick-Borne Infections",
      "Vector-Borne Diseases",
      "壁蝨媒介疾病"
    ],
    "epidemiology": {
      "species": "犬貓皆可，犬較常見",
      "age": "所有年齡均可感染",
      "sex": "無性別傾向",
      "riskFactors": [
        "居住或旅行至壁蝨流行地區",
        "戶外活動頻繁",
        "未使用壁蝨預防藥物",
        "草地、樹林等壁蝨棲息環境暴露",
        "農村或郊區生活型態",
        "合併免疫抑制狀態"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "發現壁蝨叮咬史",
        "間歇性或持續性發熱",
        "食慾減退和體重減輕",
        "精神沉鬱和嗜睡",
        "跛行或關節僵硬",
        "鼻出血或其他出血",
        "運動不耐受"
      ],
      "physicalExam": [
        "發熱",
        "脾腫大",
        "淋巴結腫大",
        "瘀斑或瘀點（特別是腹部和耳翼）",
        "關節腫脹和疼痛",
        "蒼白黏膜（貧血）",
        "前葡萄膜炎或視網膜出血",
        "體表可能發現壁蝨"
      ]
    },
    "pathophysiology": "各種壁蝨傳播病原體有不同的致病機制：艾利希體和乏漿體感染白血球（單核球或顆粒球），在細胞內繁殖形成桑椹小體；巴貝斯焦蟲寄生紅血球導致溶血性貧血；肝簇蟲感染白血球和肌肉組織。共同的病理特徵包括免疫媒介性破壞（血球減少症）、血管炎、免疫複合物沉積（關節炎、腎小球腎炎）和骨髓抑制。慢性感染可導致骨髓發育不全和全血球減少。",
    "diagnosis": {
      "overview": "結合壁蝨暴露史、臨床症狀和實驗室確認診斷，需考慮合併感染的可能",
      "differentials": [
        "免疫媒介性血小板減少症",
        "免疫媒介性溶血性貧血",
        "全身性紅斑狼瘡",
        "淋巴瘤或其他腫瘤",
        "骨髓疾病",
        "鉤端螺旋體病",
        "全身性黴菌感染"
      ],
      "initialDB": [
        "CBC（血小板減少、貧血、白血球減少或增多）",
        "血液抹片檢查桑椹體或寄生蟲",
        "SNAP 4Dx或等效快速檢測（Ehrlichia、Anaplasma、Borrelia、Heartworm）",
        "生化檢查（低白蛋白血症、高球蛋白血症、肝腎指標）"
      ],
      "advanced": [
        "特定病原體PCR檢測",
        "血清學IFA效價（配對急性期和恢復期）",
        "骨髓穿刺（全血球減少時）",
        "血清蛋白電泳（多株增高）",
        "尿液分析（評估蛋白尿）",
        "腹部超音波（脾腫大）"
      ]
    },
    "treatment": {
      "overview": "抗生素治療為主，輔以支持療法。不同病原體的治療方案有所不同",
      "acute": [
        "doxycycline 5-10 mg/kg PO q12h（艾利希體、乏漿體的首選藥物，療程至少28天）",
        "imidocarb dipropionate 6.6 mg/kg IM（巴貝斯焦蟲症）",
        "嚴重貧血時考慮輸血",
        "靜脈輸液和電解質矯正",
        "免疫媒介性併發症嚴重時短期使用免疫抑制劑"
      ],
      "chronic": [
        "慢性艾利希體症：延長doxycycline療程（6-8週）",
        "持續壁蝨預防藥物使用",
        "定期監測CBC和血清學效價",
        "蛋白流失性腎病的管理"
      ]
    },
    "prognosis": "急性期感染經適當治療預後通常良好。慢性艾利希體症伴骨髓抑制預後較差。巴貝斯焦蟲症的預後取決於種別和嚴重程度。合併感染和免疫抑制個體預後較差。",
    "pearls": [
      "壁蝨傳播疾病可合併感染多種病原體，初始治療應涵蓋最常見的病原",
      "doxycycline是治療大多數壁蝨傳播細菌疾病的首選藥物",
      "血小板減少是壁蝨傳播疾病最常見的實驗室異常",
      "抗體陽性不一定代表活動性感染，需結合臨床症狀判斷",
      "壁蝨預防是最重要的防控策略"
    ],
    "diagnosticAlgorithm": {
      "title": "壁蝨傳播疾病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估壁蝨暴露史與臨床症狀",
          "findings": [
            "發熱與嗜睡",
            "關節腫痛或跛行",
            "皮膚發現壁蝨或叮咬痕跡",
            "出血點或瘀斑"
          ]
        },
        {
          "step": 2,
          "action": "基本血液檢查",
          "details": "CBC與生化全套檢查",
          "findings": [
            "血小板減少",
            "貧血",
            "白血球減少或增多",
            "肝腎指數異常"
          ]
        },
        {
          "step": 3,
          "action": "專項血清學檢測",
          "details": "進行壁蝨傳播疾病多重篩檢",
          "findings": [
            "SNAP 4Dx Plus快篩（Ehrlichia/Anaplasma/Borrelia/Heartworm）",
            "血液抹片可見桑葚體",
            "IFA抗體效價確認"
          ]
        },
        {
          "step": 4,
          "action": "確診與分型",
          "details": "確認具體病原並評估器官損傷程度",
          "findings": [
            "PCR鑑定特定病原種別",
            "尿蛋白/肌酐比值評估腎損傷",
            "關節液分析排除免疫介導性關節炎"
          ]
        }
      ]
    },
    "monitoring": [
      "治療後2-4週複檢CBC",
      "血清學效價追蹤（治療後3-6個月）",
      "定期檢查體表壁蝨",
      "腎功能和尿蛋白監測（特別是Ehrlichia canis慢性感染）"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "contact-dermatitis": {
    "zh": "接觸性皮膚炎",
    "en": "Contact Dermatitis",
    "definition": "接觸性皮膚炎是皮膚因直接接觸外界刺激物或過敏原而引起的炎症反應。分為刺激性接觸性皮膚炎（非免疫媒介，較常見）和過敏性接觸性皮膚炎（第四型延遲性過敏反應）兩類。病變通常局限於毛髮稀少且與接觸物直接接觸的皮膚區域。",
    "synonyms": [
      "Allergic Contact Dermatitis",
      "Irritant Contact Dermatitis",
      "接觸性過敏"
    ],
    "epidemiology": {
      "species": "犬貓皆可，犬較常見",
      "age": "任何年齡，過敏性接觸性皮膚炎需先致敏（通常>2歲）",
      "sex": "無性別傾向",
      "riskFactors": [
        "接觸地毯清潔劑、殺蟲劑、植物",
        "接觸塑膠或橡膠餵食碗",
        "局部藥物過敏（如neomycin）",
        "水泥地面、化學除草劑",
        "特定品種可能有較高過敏傾向"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "皮膚發紅和搔癢",
        "症狀局限於接觸區域",
        "移除接觸物後症狀改善",
        "反覆暴露後症狀加重（過敏性）",
        "可追溯到新環境或新產品使用"
      ],
      "physicalExam": [
        "無毛或少毛區域的紅斑和丘疹",
        "腹部、腋窩、會陰、趾間皮膚受影響",
        "急性期可見水疱和糜爛",
        "慢性期可見苔蘚化、色素沉著",
        "病變分布與接觸模式一致",
        "塑膠碗引起的下巴和嘴唇紅斑"
      ]
    },
    "pathophysiology": "刺激性接觸性皮膚炎由外界物質直接損傷角質形成細胞和皮膚屏障，引起先天性免疫反應和炎症。過敏性接觸性皮膚炎則為第四型延遲性過敏反應：初次接觸時半抗原穿透皮膚與蛋白質結合，被朗格漢斯細胞攝取呈現給T淋巴球完成致敏；再次接觸時活化的記憶T細胞釋放細胞因子引起局部炎症反應，通常在接觸後24-72小時出現。",
    "diagnosis": {
      "overview": "依據病變分布特徵和暴露史進行臨床診斷，確診需透過隔離和激發試驗",
      "differentials": [
        "異位性皮膚炎",
        "食物過敏",
        "疥癬",
        "皮膚黴菌感染",
        "細菌性膿皮症",
        "自體免疫性皮膚病"
      ],
      "initialDB": [
        "詳細的病史和暴露史調查",
        "皮膚刮片排除外寄生蟲",
        "皮膚細胞學（表面和壓印塗片）",
        "黴菌培養排除皮膚黴菌感染"
      ],
      "advanced": [
        "隔離試驗（限制接觸可疑物質2-3週觀察改善）",
        "激發試驗（re-exposure確認因果關係）",
        "皮膚貼片試驗（patch test）",
        "皮膚組織病理學（表皮海綿化、淋巴球浸潤）"
      ]
    },
    "treatment": {
      "overview": "首要措施是識別並避免接觸致病物質，輔以症狀控制",
      "acute": [
        "移除或避免接觸致病物質",
        "溫和清潔受影響皮膚",
        "局部糖皮質激素（hydrocortisone aceponate噴劑）",
        "短期口服prednisolone 0.5-1 mg/kg q24h（5-7天）",
        "抗組織胺輔助止癢",
        "繼發感染時使用抗生素"
      ],
      "chronic": [
        "持續避免接觸致病物質",
        "更換餵食碗材質（不銹鋼或陶瓷替代塑膠）",
        "環境管理（避免特定清潔劑或化學品）",
        "皮膚屏障修復產品"
      ]
    },
    "prognosis": "識別並避免接觸致病物質後預後極佳。若無法完全避免接觸，可能需要長期管理。過敏性接觸性皮膚炎一旦致敏通常為終身狀態。",
    "pearls": [
      "接觸性皮膚炎的病變分布是診斷的關鍵線索——無毛區域和接觸面",
      "塑膠碗過敏是下巴粉刺樣病變的常見原因，應建議更換不銹鋼碗",
      "過敏性接觸性皮膚炎需要先前致敏期，首次接觸不會立即出現症狀",
      "診斷常需要排除更常見的過敏性皮膚病（異位性皮膚炎、食物過敏）"
    ],
    "diagnosticAlgorithm": {
      "title": "接觸性皮膚炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "詳細詢問環境暴露史與皮膚病變分布",
          "findings": [
            "無毛或少毛區域紅疹",
            "腹部、腋下、腹股溝好發",
            "接觸刺激物後發作",
            "瘙癢程度不等"
          ]
        },
        {
          "step": 2,
          "action": "皮膚學檢查",
          "details": "仔細檢查皮膚病變型態與分布",
          "findings": [
            "界線分明的紅斑與丘疹",
            "病變限於接觸區域",
            "可能有水泡或糜爛",
            "慢性病例出現苔蘚化"
          ]
        },
        {
          "step": 3,
          "action": "排除性診斷",
          "details": "皮膚刮片與細胞學排除其他皮膚病",
          "findings": [
            "皮膚刮片排除疥蟎",
            "細胞學排除細菌或酵母菌感染",
            "排除食物過敏與異位性皮膚炎"
          ]
        },
        {
          "step": 4,
          "action": "確診",
          "details": "移除可疑接觸物觀察改善，必要時進行貼膚試驗",
          "findings": [
            "移除可疑物後皮膚改善",
            "貼膚試驗確認致敏原",
            "皮膚切片顯示表皮海綿水腫與淋巴球浸潤"
          ]
        }
      ]
    },
    "monitoring": [
      "避免接觸後2-3週評估改善程度",
      "繼發感染的追蹤",
      "若使用糖皮質激素需監測副作用"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "alopecia-x": {
    "zh": "X脫毛症",
    "en": "Alopecia X",
    "definition": "X脫毛症是一種病因不明的非炎症性脫毛症，主要影響北歐品種犬（如博美犬、哈士奇）。表現為對稱性軀幹脫毛，保留頭部和四肢遠端毛髮，無搔癢。曾被認為與腎上腺性荷爾蒙失調有關，但確切病因仍未完全釐清。",
    "synonyms": [
      "Black Skin Disease",
      "Adrenal Hyperplasia-Like Syndrome",
      "Growth Hormone Responsive Alopecia",
      "BSD",
      "毛髮週期停滯"
    ],
    "epidemiology": {
      "species": "犬",
      "age": "通常1-5歲發病",
      "sex": "公犬略多，尤其是未絕育公犬",
      "riskFactors": [
        "北歐絨毛品種（博美犬、阿拉斯加雪橇犬、薩摩耶、哈士奇、鬆獅犬）",
        "未絕育",
        "遺傳傾向"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "漸進性對稱性軀幹脫毛",
        "無搔癢",
        "毛髮質地改變（變乾燥、棉花狀）",
        "剃毛後毛髮不再生長",
        "僅影響外觀，動物健康狀態良好"
      ],
      "physicalExam": [
        "對稱性軀幹脫毛",
        "頭部和四肢毛髮保留",
        "脫毛區域皮膚色素沉著加深（黑色）",
        "皮膚質地正常、無炎症",
        "無搔癢表現",
        "剩餘毛髮可能質地粗糙或棉花狀"
      ]
    },
    "pathophysiology": "確切病因不明。推測可能與腎上腺性荷爾蒙代謝異常（特別是性荷爾蒙前驅物如17-hydroxyprogesterone）、毛囊週期調控異常或生長激素缺乏有關。組織病理學顯示毛囊處於休止期（catagen/telogen）停滯狀態，稱為毛囊營養不良。毛囊角質化異常（flame follicles）是特徵性發現。皮膚色素沉著可能與毛囊黑色素代謝改變有關。",
    "diagnosis": {
      "overview": "排除性診斷——必須先排除所有其他導致對稱性脫毛的內分泌疾病",
      "differentials": [
        "甲狀腺功能低下症",
        "腎上腺皮質機能亢進（庫欣氏症）",
        "性荷爾蒙相關脫毛",
        "季節性側腹脫毛",
        "毛囊發育不良"
      ],
      "initialDB": [
        "CBC和生化檢查（通常正常）",
        "甲狀腺功能檢查（T4、fT4、TSH）",
        "腎上腺功能檢查（LDDS、ACTH刺激試驗）",
        "尿液皮質醇/肌酐比值"
      ],
      "advanced": [
        "皮膚組織病理學（毛囊休止期停滯、flame follicles）",
        "ACTH刺激試驗含性荷爾蒙panel（17-OHP）",
        "生長激素測定（可行性有限）",
        "腹部超音波排除腎上腺腫瘤"
      ]
    },
    "treatment": {
      "overview": "治療效果不一致且不可預測。此為美容性問題，不影響健康。治療決策應與飼主充分溝通",
      "acute": [
        "絕育手術（未絕育者的首選初始治療，部分病例可促進毛髮再生）"
      ],
      "chronic": [
        "melatonin 3-6 mg PO q8-12h（安全性高，約30-40%有效）",
        "trilostane（低劑量，需謹慎監測腎上腺功能）",
        "methyltestosterone（有肝毒性風險，已少用）",
        "定期剃毛可能刺激部分毛髮再生",
        "接受美容性問題而不治療亦為合理選擇"
      ]
    },
    "prognosis": "不影響壽命和整體健康。毛髮再生的可預測性低，部分犬隻可自發性毛髮再生或對治療有反應，但復發常見。此為終身美容性問題。",
    "pearls": [
      "Alopecia X是排除性診斷，必須先徹底排除甲狀腺和腎上腺疾病",
      "絕育手術是最安全的初始治療選擇",
      "melatonin因安全性高常作為藥物治療首選",
      "毛髮再生後可能再次脫落，飼主應有合理期待",
      "剃毛後毛髮不再生長是本病的經典特徵"
    ],
    "diagnosticAlgorithm": {
      "title": "X脫毛症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估脫毛型態與品種傾向，注意北歐犬種（博美、阿拉斯加雪橇犬）",
          "findings": [
            "雙側對稱性脫毛",
            "軀幹脫毛，頭部與四肢保留",
            "無瘙癢",
            "皮膚色素沉著"
          ]
        },
        {
          "step": 2,
          "action": "內分泌篩檢",
          "details": "排除其他內分泌性脫毛",
          "findings": [
            "甲狀腺功能正常（T4/TSH正常）",
            "腎上腺功能正常（ACTH刺激試驗正常）",
            "性荷爾蒙檢測可能異常"
          ]
        },
        {
          "step": 3,
          "action": "皮膚切片",
          "details": "組織病理學檢查確認特徵性變化",
          "findings": [
            "毛囊萎縮與角化過度",
            "火焰狀毛囊（flame follicle）",
            "表皮萎縮",
            "缺乏炎症細胞浸潤"
          ]
        },
        {
          "step": 4,
          "action": "確診",
          "details": "排除性診斷：排除所有已知脫毛病因後確認",
          "findings": [
            "排除甲狀腺低下",
            "排除庫欣氏症",
            "排除性荷爾蒙相關脫毛",
            "確認為X脫毛症"
          ]
        }
      ]
    },
    "monitoring": [
      "使用trilostane時需定期ACTH刺激試驗監測",
      "照片記錄毛髮變化",
      "定期排除新發展的內分泌疾病"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "angular-limb-deformity": {
    "zh": "肢體角度畸形",
    "en": "Angular Limb Deformity (ALD)",
    "definition": "肢體角度畸形是指長骨生長板不對稱生長或過早閉合導致的肢體彎曲、旋轉或長度不等的骨骼發育異常。最常見於前肢遠端（橈骨/尺骨），因尺骨遠端生長板過早閉合而導致前肢外翻或橈骨彎曲。",
    "synonyms": [
      "ALD",
      "Premature Physeal Closure",
      "生長板過早閉合",
      "前肢外翻"
    ],
    "epidemiology": {
      "species": "犬為主",
      "age": "生長期幼犬（3-8月齡發病）",
      "sex": "無明確性別傾向",
      "riskFactors": [
        "外傷導致生長板損傷（Salter-Harris骨折）",
        "軟骨發育不良品種（巴吉度、臘腸犬、柯乃克小型獵犬）",
        "大型和巨型品種快速生長",
        "營養不均衡（鈣磷比例不當）",
        "骨軟骨病（OCD）",
        "肥大性骨營養不良"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "漸進性肢體彎曲",
        "跛行或步態異常",
        "生長期幼犬",
        "可能有前肢外傷史",
        "活動意願下降"
      ],
      "physicalExam": [
        "肢體可見彎曲或外翻畸形",
        "前肢最常見（橈骨/尺骨）",
        "受影響肢體可能較短",
        "關節活動範圍異常或疼痛",
        "腕關節外翻",
        "肘關節可能不合或半脫位"
      ]
    },
    "pathophysiology": "長骨的縱向生長依賴生長板（骺板）的軟骨內骨化。當配對骨（如橈骨和尺骨）中的一根骨骼生長板因外傷、感染或先天因素而過早閉合時，該骨骼停止生長而配對骨繼續生長，導致彎曲和旋轉畸形。尺骨遠端生長板是最常受影響的部位，其過早閉合導致橈骨相對過長而彎曲、腕關節外翻和肘關節不合。畸形的嚴重程度取決於生長板閉合時動物的年齡——越年幼閉合，畸形越嚴重。",
    "diagnosis": {
      "overview": "依據臨床檢查和影像學評估畸形的類型和嚴重程度",
      "differentials": [
        "軟骨發育不良（品種特徵）",
        "佝僂病",
        "骨折不當癒合",
        "骨軟骨病",
        "肥大性骨營養不良"
      ],
      "initialDB": [
        "前後位和側位X光（雙側比較）",
        "評估生長板狀態",
        "測量機械軸和解剖軸角度",
        "評估關節（特別是肘關節）的合適度"
      ],
      "advanced": [
        "CT掃描（精確評估三維畸形和手術計劃）",
        "關節鏡檢查（評估肘關節內部病變）",
        "骨齡評估（決定治療時機）"
      ]
    },
    "treatment": {
      "overview": "治療選擇取決於動物年齡、畸形嚴重程度和剩餘生長潛力",
      "acute": [
        "仍在生長期：尺骨切除術（ulnar ostectomy）釋放牽制力",
        "仍在生長期：暫時性骺板釘固定術（transphyseal bridging）矯正",
        "生長板已閉合：矯正性截骨術（corrective osteotomy）",
        "嚴重肘關節不合可能需要近端尺骨截骨"
      ],
      "chronic": [
        "術後嚴格限制活動4-8週",
        "物理治療恢復關節活動範圍",
        "疼痛管理（NSAIDs如meloxicam 0.1 mg/kg PO q24h）",
        "繼發性退化性關節病的長期管理"
      ]
    },
    "prognosis": "早期發現和治療預後較好，特別是在生長板仍有生長潛力時。嚴重畸形或延遲治療可能導致永久性關節損傷。繼發性退化性關節病是常見的長期併發症。",
    "pearls": [
      "尺骨遠端生長板貢獻尺骨約85%的縱向生長，是最常受影響的生長板",
      "早期介入（生長板仍開放時）的治療效果遠優於生長完成後的矯正",
      "軟骨發育不良品種的輕度彎曲可能是品種正常變異而非病理性畸形",
      "CT掃描對於制定精確的矯正截骨計劃至關重要"
    ],
    "diagnosticAlgorithm": {
      "title": "肢體角度畸形 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估步態異常與肢體外觀，詢問受傷史及生長期異常",
          "findings": [
            "肢體外翻或內翻",
            "步態異常或跛行",
            "前肢（橈骨/尺骨）最常見",
            "生長期間進行性惡化"
          ]
        },
        {
          "step": 2,
          "action": "骨科學檢查",
          "details": "詳細觸診與關節活動度評估",
          "findings": [
            "肢體軸線偏移",
            "關節活動範圍受限",
            "骨長度不對稱",
            "肌肉萎縮"
          ]
        },
        {
          "step": 3,
          "action": "影像學檢查",
          "details": "X光攝影確認畸形程度與骨骺狀態",
          "findings": [
            "骨骼軸線角度異常",
            "生長板早期閉合",
            "關節面不協調",
            "CT可精確測量旋轉角度"
          ]
        },
        {
          "step": 4,
          "action": "確診與手術計畫",
          "details": "確認畸形類型並制定矯正方案",
          "findings": [
            "確認受影響骨骼與生長板",
            "測量CORA角度",
            "評估是否需矯正截骨術"
          ]
        }
      ]
    },
    "monitoring": [
      "術後定期X光追蹤骨癒合和矯正維持",
      "幼犬需密切追蹤（每2-4週）監測生長和矯正效果",
      "長期監測退化性關節病發展"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "luxation-joint": {
    "zh": "關節脫位",
    "en": "Joint Luxation",
    "definition": "關節脫位是指構成關節的骨骼端失去正常解剖對位關係的狀態。可為完全脫位（luxation）或半脫位（subluxation）。依病因分為外傷性（最常見）和先天性脫位。最常見的部位包括髖關節、肘關節、肩關節和腕/跗關節。",
    "synonyms": [
      "Luxation",
      "Dislocation",
      "Subluxation",
      "關節脫臼"
    ],
    "epidemiology": {
      "species": "犬貓皆可",
      "age": "外傷性脫位任何年齡，先天性脫位幼年動物",
      "sex": "無性別傾向",
      "riskFactors": [
        "交通事故等高能量外傷",
        "高處墜落（貓較常見）",
        "先天性關節發育不良",
        "韌帶鬆弛",
        "髖關節發育不良（繼發性脫位）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "突發性劇烈跛行",
        "外傷史（交通事故、墜落、扭傷）",
        "受影響肢體無法負重",
        "疼痛和腫脹",
        "先天性脫位：慢性進行性跛行"
      ],
      "physicalExam": [
        "受影響關節變形",
        "嚴重疼痛和腫脹",
        "關節活動範圍異常",
        "骨性標誌位置異常",
        "肌肉痙攣",
        "髖關節脫位：肢體縮短和外旋（頭背側脫位）",
        "肘關節脫位：肘部腫脹和前肢固定在半屈曲位"
      ]
    },
    "pathophysiology": "關節脫位需要施加足夠力量克服關節囊、韌帶和周圍軟組織的穩定作用。外傷性脫位通常伴隨關節囊撕裂和韌帶損傷。髖關節脫位最常見為頭背側方向，因髖關節圓韌帶、關節囊和周圍肌肉撕裂。脫位後，周圍肌肉痙攣和腫脹可阻礙自發復位。延遲治療會導致關節囊纖維化、關節面軟骨退化和肌肉攣縮，增加復位和維持的困難。",
    "diagnosis": {
      "overview": "依據臨床檢查和影像學確認脫位方向並評估伴隨損傷",
      "differentials": [
        "骨折",
        "韌帶撕裂（不伴隨脫位）",
        "軟組織損傷",
        "退化性關節病急性加重",
        "骨腫瘤病理性骨折"
      ],
      "initialDB": [
        "至少兩個方向的X光片（確認脫位方向和排除骨折）",
        "對側肢體X光比較",
        "全身性評估排除多發性外傷"
      ],
      "advanced": [
        "CT掃描（複雜脫位或復位後評估）",
        "MRI（評估韌帶和軟組織損傷程度）",
        "超音波（評估關節積液和軟組織）"
      ]
    },
    "treatment": {
      "overview": "目標是恢復正常解剖對位並維持關節穩定性。優先考慮閉合復位，失敗則需手術",
      "acute": [
        "閉合復位（需全身麻醉和肌肉鬆弛）",
        "髖關節：Ehmer繃帶固定7-14天（頭背側脫位後）",
        "肘關節：復位後夾板固定2-3週",
        "閉合復位失敗：開放手術復位",
        "髖關節開放復位：關節囊修補、toggle pin固定或人工韌帶",
        "疼痛管理（NSAIDs、opioids）"
      ],
      "chronic": [
        "慢性或復發性髖關節脫位：股骨頭頸切除術（FHO）或全髖關節置換術（THR）",
        "物理治療恢復關節功能",
        "體重管理減輕關節負擔",
        "退化性關節病的長期管理"
      ]
    },
    "prognosis": "急性外傷性脫位及時復位預後良好。閉合復位成功率約50-70%（髖關節）。手術修復通常提供更穩定的結果。延遲超過3-5天的脫位復位困難度和復發率增加。先天性脫位預後取決於嚴重程度和治療方式。",
    "pearls": [
      "髖關節脫位閉合復位後應立即拍X光確認復位成功",
      "閉合復位的時機很重要——超過72小時成功率顯著下降",
      "貓的髖關節脫位閉合復位成功率較犬高",
      "復位後的外固定（Ehmer繃帶）維持時間不應超過2週以避免關節僵硬",
      "多發性外傷的動物應先穩定生命徵象再處理脫位"
    ],
    "diagnosticAlgorithm": {
      "title": "關節脫位 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估外傷史與患肢功能狀態",
          "findings": [
            "急性非負重性跛行",
            "關節腫脹與變形",
            "疼痛與活動受限",
            "外傷史（車禍、跳躍、墜落）"
          ]
        },
        {
          "step": 2,
          "action": "骨科學檢查",
          "details": "觸診確認脫位方向與穩定性",
          "findings": [
            "關節解剖位置異常",
            "關節不穩定",
            "周圍軟組織腫脹",
            "神經血管功能評估"
          ]
        },
        {
          "step": 3,
          "action": "影像學檢查",
          "details": "X光確認脫位並排除骨折",
          "findings": [
            "關節面失去正常對合",
            "確認脫位方向",
            "排除伴隨骨折",
            "評估關節退行性變化"
          ]
        },
        {
          "step": 4,
          "action": "確診與治療計畫",
          "details": "確認脫位類型並決定復位方式",
          "findings": [
            "急性vs慢性脫位分類",
            "評估閉合復位可行性",
            "確認是否需要手術固定"
          ]
        }
      ]
    },
    "monitoring": [
      "復位後24-48小時X光確認維持對位",
      "外固定移除後逐步增加活動量",
      "2週和4週追蹤X光",
      "長期監測退化性關節病"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "hypertrophic-osteodystrophy": {
    "zh": "肥大性骨營養不良",
    "en": "Hypertrophic Osteodystrophy (HOD)",
    "definition": "肥大性骨營養不良是大型和巨型品種幼犬的一種發育性骨骼疾病，特徵為長骨幹骺端的骨化障礙。臨床表現為發熱、骨腫痛和跛行。病因不完全清楚，可能與感染、疫苗反應或營養因素有關。",
    "synonyms": [
      "HOD",
      "Metaphyseal Osteopathy",
      "Barlow Disease",
      "幹骺端骨病"
    ],
    "epidemiology": {
      "species": "犬",
      "age": "大型和巨型品種幼犬，2-8月齡",
      "sex": "公犬略多",
      "riskFactors": [
        "大型和巨型品種（大丹犬、魏瑪犬、德國牧羊犬、愛爾蘭雪達犬）",
        "快速生長期",
        "過度營養補充（鈣、維生素D）",
        "近期疫苗接種（特別是犬瘟熱疫苗）",
        "遺傳傾向"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "突然發作的跛行（通常雙側前肢）",
        "高熱（可達41°C）",
        "食慾廢絕",
        "不願站立或行走",
        "疼痛叫聲",
        "症狀可反覆發作和緩解"
      ],
      "physicalExam": [
        "幹骺端（腕關節近端和跗關節近端）腫脹和劇烈疼痛",
        "高熱",
        "精神極度沉鬱",
        "可見雙側對稱性前肢遠端腫脹",
        "嚴重病例可見腹瀉和眼鼻分泌物",
        "觸診幹骺端時劇烈疼痛反應"
      ]
    },
    "pathophysiology": "確切病因未明。病理變化發生在生長板的幹骺端側，表現為骨化前沿的骨小梁壞死和中性球浸潤。正常的軟骨內骨化過程受到干擾，導致幹骺端不規則的骨破壞和新骨形成。推測可能的致病機制包括：犬瘟熱病毒感染或疫苗誘發的免疫反應、維生素C缺乏、營養過剩導致的骨代謝異常。嚴重病例可累及多個長骨並可能發展為永久性生長板損傷。",
    "diagnosis": {
      "overview": "依據典型的品種、年齡、臨床表現和放射線學特徵診斷",
      "differentials": [
        "全骨炎",
        "肥大性骨關節病",
        "骨髓炎",
        "骨肉瘤（年齡通常較大）",
        "多關節炎",
        "鉤端螺旋體病"
      ],
      "initialDB": [
        "長骨X光片（特徵性的幹骺端「雙線徵」——生長板旁的透亮線和不規則骨化）",
        "CBC（白血球增多、中性球左移）",
        "生化檢查（通常正常或CRP升高）"
      ],
      "advanced": [
        "影像學追蹤評估進展",
        "關節液分析（排除感染性關節炎）",
        "骨組織病理學（罕需）"
      ]
    },
    "treatment": {
      "overview": "以支持療法和疼痛控制為主，多數病例為自限性但可反覆發作",
      "acute": [
        "NSAIDs疼痛控制（carprofen 2.2 mg/kg PO q12h或meloxicam 0.1 mg/kg PO q24h）",
        "嚴重病例可短期使用糖皮質激素（prednisolone 1-2 mg/kg q24h，逐漸減量）",
        "靜脈輸液支持",
        "營養支持和強制餵食（必要時）",
        "嚴格限制活動"
      ],
      "chronic": [
        "避免過度營養補充",
        "轉換為適合大型幼犬的均衡飲食",
        "避免額外鈣和維生素補充",
        "復發時重複治療"
      ]
    },
    "prognosis": "多數輕至中度病例預後良好，隨生長板閉合而自然緩解。嚴重或反覆發作的病例可能導致永久性生長板損傷和肢體畸形。極少數嚴重病例可致命。",
    "pearls": [
      "X光上幹骺端的「雙線徵」（透亮線平行於生長板）是本病的特徵性影像學發現",
      "不應過度補充鈣和維生素D，因可能加重病情",
      "犬瘟熱疫苗接種後出現的HOD可能與疫苗病毒的骨嗜性有關",
      "嚴重的HOD與犬瘟熱病毒感染之間可能存在關聯",
      "魏瑪犬的HOD往往特別嚴重且可能致命"
    ],
    "diagnosticAlgorithm": {
      "title": "肥大性骨營養不良 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估年齡與品種（大型犬幼犬2-8月齡好發）",
          "findings": [
            "四肢遠端腫脹（幹骺端）",
            "高燒與嗜睡",
            "跛行或不願行走",
            "食慾下降"
          ]
        },
        {
          "step": 2,
          "action": "理學檢查",
          "details": "觸診骨骼並評估全身狀態",
          "findings": [
            "幹骺端腫脹與壓痛",
            "雙側對稱性受累",
            "橈骨/尺骨遠端最常見",
            "可能伴有腹瀉"
          ]
        },
        {
          "step": 3,
          "action": "影像學檢查",
          "details": "X光檢查確認特徵性骨骼變化",
          "findings": [
            "幹骺端出現雙線征（double physis sign）",
            "骨膜增生與不規則鈣化",
            "幹骺端硬化帶",
            "軟組織腫脹"
          ]
        },
        {
          "step": 4,
          "action": "確診",
          "details": "根據臨床表現與影像學特徵確診",
          "findings": [
            "典型影像學表現確診",
            "排除骨髓炎與骨腫瘤",
            "評估是否與疫苗接種相關"
          ]
        }
      ]
    },
    "monitoring": [
      "每日體溫和疼痛評估",
      "2-4週X光追蹤",
      "生長和肢體對稱性長期監測",
      "營養計劃調整"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "ectropion": {
    "zh": "眼瞼外翻",
    "en": "Ectropion",
    "definition": "眼瞼外翻是指下眼瞼邊緣向外翻轉，導致結膜暴露的眼瞼位置異常。可為先天性（品種相關）或後天性（瘢痕性、神經性、老年性）。暴露的結膜和角膜易受環境刺激和感染。",
    "synonyms": [
      "Eversion of Eyelid",
      "下眼瞼外翻"
    ],
    "epidemiology": {
      "species": "犬為主，貓罕見",
      "age": "先天性者幼年即可發現，後天性者任何年齡",
      "sex": "無性別傾向",
      "riskFactors": [
        "品種傾向（聖伯納犬、紐芬蘭犬、英國鬥牛犬、巴吉度、大丹犬、可卡犬）",
        "皮膚鬆弛的品種",
        "眼瞼手術後瘢痕攣縮",
        "顏面神經麻痺",
        "老年性肌肉鬆弛",
        "快速體重減輕"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "眼睛經常流淚",
        "結膜充血",
        "反覆性結膜炎",
        "黏液性或黏液膿性眼分泌物",
        "部分犬隻可能同時有眼瞼內翻（鑽石眼）"
      ],
      "physicalExam": [
        "下眼瞼向外翻轉，暴露結膜",
        "結膜充血和腫脹",
        "淚液滯留在下結膜囊",
        "角膜可能有暴露性角膜炎",
        "黏液性分泌物累積",
        "部分品種可見合併性眼瞼內翻"
      ]
    },
    "pathophysiology": "先天性眼瞼外翻與品種特徵性的眼瞼和面部皮膚結構有關，鬆弛的皮膚和過長的眼瞼裂使下眼瞼無法維持正常貼合眼球的位置。結膜持續暴露於環境中導致乾燥、刺激和慢性炎症，正常的淚膜分布受到影響，異物和微生物更容易進入結膜囊造成反覆感染。後天性眼瞼外翻可因瘢痕組織牽拉（手術或外傷後）、顏面神經功能喪失（失去眼輪匝肌張力）或老年性組織鬆弛而發生。",
    "diagnosis": {
      "overview": "臨床視診即可診斷，需評估嚴重程度和併發症",
      "differentials": [
        "眼瞼內翻",
        "結膜炎（其他原因）",
        "乾眼症",
        "第三眼瞼突出",
        "眼眶腫瘤"
      ],
      "initialDB": [
        "完整眼科檢查",
        "淚液試紙試驗（Schirmer tear test）排除乾眼症",
        "螢光素染色排除角膜潰瘍",
        "眼瞼功能和位置評估"
      ],
      "advanced": [
        "細菌培養（反覆感染時）",
        "眼瞼組織病理學（腫瘤疑慮時）"
      ]
    },
    "treatment": {
      "overview": "輕度病例可保守治療，中重度或有併發症者需手術矯正",
      "acute": [
        "人工淚液維持眼表濕潤",
        "局部抗生素治療繼發感染（如tobramycin眼藥水q8h）",
        "角膜潰瘍的適當治療"
      ],
      "chronic": [
        "輕度無症狀者可不需治療",
        "中重度：V-Y瞼成型術（V-Y blepharoplasty）",
        "Kühnt-Szymanowski手術（縮短眼瞼）",
        "楔形切除術",
        "合併眼瞼內翻時需一併矯正",
        "術後局部抗生素和抗炎藥物"
      ]
    },
    "prognosis": "手術矯正後預後良好。先天性眼瞼外翻可能隨年齡和面部結構變化而變化，幼犬手術應等到頭部發育接近成熟。保守治療可有效控制輕度病例的症狀。",
    "pearls": [
      "某些品種的輕度眼瞼外翻被視為品種標準而非疾病",
      "部分品種（如聖伯納犬）可同時存在眼瞼外翻和眼瞼內翻——稱為鑽石眼",
      "幼犬的手術矯正應推遲到頭部發育接近完成（約6-12月齡）",
      "過度矯正可能導致醫源性眼瞼內翻"
    ],
    "diagnosticAlgorithm": {
      "title": "眼瞼外翻 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估品種傾向與眼瞼異常程度",
          "findings": [
            "下眼瞼向外翻轉",
            "結膜暴露發紅",
            "慢性流淚或分泌物",
            "好發於聖伯納、巴吉度等品種"
          ]
        },
        {
          "step": 2,
          "action": "眼科學檢查",
          "details": "詳細眼科檢查評估繼發性損傷",
          "findings": [
            "結膜充血與增厚",
            "角膜血管新生",
            "淚液測試（Schirmer test）",
            "螢光素染色排除角膜潰瘍"
          ]
        },
        {
          "step": 3,
          "action": "確診與分級",
          "details": "確認外翻程度與繼發損傷",
          "findings": [
            "先天性vs後天性分類",
            "輕度/中度/重度分級",
            "評估是否合併眼瞼內翻",
            "確認手術矯正需求"
          ]
        }
      ]
    },
    "monitoring": [
      "術後7-14天拆線和評估矯正效果",
      "長期監測角膜健康",
      "結膜炎復發情況"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "distichiasis": {
    "zh": "雙行睫",
    "en": "Distichiasis",
    "definition": "雙行睫是指睫毛從瞼板腺（Meibomian gland）開口異常生長的眼瞼疾病。這些多餘的睫毛從眼瞼內緣長出，可能接觸並刺激角膜和結膜，導致不適、流淚和角膜損傷。是犬最常見的睫毛異常。",
    "synonyms": [
      "Distichiae",
      "Double Row of Eyelashes",
      "異位睫毛"
    ],
    "epidemiology": {
      "species": "犬為主，貓極罕見",
      "age": "通常6月齡後開始出現症狀",
      "sex": "無性別傾向",
      "riskFactors": [
        "品種傾向（美國可卡犬、英國可卡犬、迷你長毛臘腸犬、英國鬥牛犬、拳師犬、西施犬、拉薩犬、黃金獵犬）",
        "遺傳性（常染色體顯性遺傳）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "過度流淚（溢淚）",
        "眨眼頻率增加",
        "眼部不適感（搔眼、磨蹭）",
        "黏液性眼分泌物",
        "部分犬隻可完全無症狀"
      ],
      "physicalExam": [
        "眼瞼緣瞼板腺開口處可見細小睫毛",
        "上眼瞼較常見但下眼瞼亦可能",
        "結膜充血",
        "角膜表面刺激或淺層血管新生",
        "嚴重者可見角膜潰瘍或色素沉著",
        "需使用裂隙燈或放大鏡仔細檢查"
      ]
    },
    "pathophysiology": "雙行睫的異常睫毛起源於瞼板腺的分化異常，正常應產生脂質分泌物的瞼板腺上皮細胞異常分化為產生毛髮的毛囊結構。這些異常睫毛從瞼板腺導管開口長出，位於眼瞼後緣，方向朝向眼球表面。柔軟的睫毛可能不引起症狀，但粗硬的睫毛持續摩擦角膜會導致角膜上皮損傷、反射性溢淚、角膜血管新生、色素沉著，嚴重時可造成角膜潰瘍。",
    "diagnosis": {
      "overview": "需在良好照明和放大條件下仔細檢查眼瞼緣",
      "differentials": [
        "異位睫毛（ectopic cilia）——從眼瞼結膜面穿出",
        "倒睫（trichiasis）——正常位置睫毛方向異常",
        "眼瞼內翻",
        "乾眼症",
        "其他角膜刺激原因"
      ],
      "initialDB": [
        "裂隙燈生物顯微鏡檢查（確認異常睫毛位置和數量）",
        "螢光素角膜染色（評估角膜損傷）",
        "Schirmer淚液試驗"
      ],
      "advanced": [
        "角膜細胞學（排除其他角膜疾病）"
      ]
    },
    "treatment": {
      "overview": "無症狀者可監測觀察。有症狀者需永久性移除異常睫毛",
      "acute": [
        "人工淚液緩解症狀",
        "角膜潰瘍的適當治療",
        "手動拔除（epilation）僅提供暫時緩解，4-6週後復發"
      ],
      "chronic": [
        "電燒灼術（electroepilation）——電流破壞毛囊",
        "冷凍手術（cryoepilation）——液態氮冷凍瞼板腺區域",
        "手術切除含毛囊的瞼板腺組織",
        "冷凍手術是最常用且有效的永久性治療方法",
        "術後局部抗生素和人工淚液"
      ]
    },
    "prognosis": "冷凍手術後永久治癒率約80-90%，部分病例可能需要重複治療。手動拔除僅為暫時措施。無症狀的雙行睫可能終身不需治療。",
    "pearls": [
      "雙行睫是犬最常見的睫毛異常，但不一定需要治療",
      "需區分雙行睫和異位睫毛——後者從結膜面穿出，幾乎總是引起症狀且需要治療",
      "冷凍手術可能導致暫時性眼瞼腫脹和去色素化",
      "部分無症狀的雙行睫隨年齡增長可能變得有症狀"
    ],
    "diagnosticAlgorithm": {
      "title": "雙行睫 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估眼部刺激症狀與品種傾向",
          "findings": [
            "流淚增多",
            "眨眼頻率增加",
            "結膜充血",
            "好發於可卡犬、鬥牛犬等"
          ]
        },
        {
          "step": 2,
          "action": "裂隙燈檢查",
          "details": "使用裂隙燈或放大鏡檢查瞼板腺開口處異常睫毛",
          "findings": [
            "瞼板腺開口處生長異常睫毛",
            "睫毛接觸角膜表面",
            "單根或多根異常睫毛"
          ]
        },
        {
          "step": 3,
          "action": "角膜評估",
          "details": "評估異常睫毛對角膜的損傷程度",
          "findings": [
            "螢光素染色檢查角膜潰瘍",
            "角膜點狀上皮缺損",
            "慢性病例角膜色素沉著",
            "淚液分泌量評估"
          ]
        },
        {
          "step": 4,
          "action": "確診與治療計畫",
          "details": "確認異常睫毛數量、位置並制定治療方案",
          "findings": [
            "記錄異常睫毛位置與數量",
            "區分雙行睫與異位睫",
            "評估電燒灼或冷凍治療適應症"
          ]
        }
      ]
    },
    "monitoring": [
      "治療後2-4週評估效果和角膜恢復",
      "定期眼科檢查監測新的異常睫毛生長",
      "角膜健康追蹤"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "retinal-detachment": {
    "zh": "視網膜脫離",
    "en": "Retinal Detachment",
    "definition": "視網膜脫離是指神經視網膜（感覺層）從下方的視網膜色素上皮（RPE）層分離的病理狀態。依機制分為漿液性/滲出性（最常見於犬貓）、牽引性和裂孔性三類。是導致急性失明的重要原因。",
    "synonyms": [
      "Retinal Separation",
      "視網膜剝離"
    ],
    "epidemiology": {
      "species": "犬貓皆可",
      "age": "老年動物較常見（與全身性疾病相關），但先天性亦可能",
      "sex": "無性別傾向",
      "riskFactors": [
        "全身性高血壓（貓最常見原因）",
        "慢性腎臟病",
        "甲狀腺功能亢進（貓）",
        "凝血障礙",
        "腎上腺皮質機能亢進",
        "眼內腫瘤",
        "前葡萄膜炎",
        "白內障手術後",
        "嚴重外傷"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "突然失明（部分或完全）",
        "瞳孔散大",
        "碰撞家具或行為改變",
        "可能伴隨全身性疾病的症狀",
        "可為單側或雙側"
      ],
      "physicalExam": [
        "散瞳後眼底檢查可見脫離的視網膜",
        "瞳孔散大且直接和間接瞳孔光反射減弱或消失",
        "視網膜前方或下方可見液體",
        "可能伴隨玻璃體出血",
        "漿液性脫離：視網膜呈灰白色隆起",
        "全身性高血壓時可見視網膜血管迂曲和出血"
      ]
    },
    "pathophysiology": "漿液性/滲出性脫離是犬貓最常見的類型，由液體（血清、血液或滲出物）在神經視網膜和RPE之間積聚引起。全身性高血壓導致脈絡膜血管損傷和漏出是最常見的機制，特別是在貓。牽引性脫離由玻璃體或視網膜表面的纖維增生牽拉所致（如白內障手術後或慢性葡萄膜炎）。裂孔性脫離因視網膜裂孔允許玻璃體液進入視網膜下腔而發生，在犬貓中較少見。視網膜一旦脫離，感光細胞失去RPE的營養支持，數小時至數天內即開始退化。",
    "diagnosis": {
      "overview": "眼底檢查確認脫離，同時須查找潛在病因",
      "differentials": [
        "突發性後天視網膜退化症（SARDS）",
        "視神經炎",
        "中樞性失明",
        "青光眼",
        "前葡萄膜炎"
      ],
      "initialDB": [
        "完整眼科檢查（含散瞳眼底檢查）",
        "間接眼底鏡或眼底攝影",
        "血壓測量（必要！）",
        "CBC和生化檢查",
        "甲狀腺功能（貓）",
        "尿液分析"
      ],
      "advanced": [
        "眼部超音波（白內障等媒質混濁時評估後段）",
        "視網膜電圖（ERG，評估視網膜功能）",
        "凝血功能檢查",
        "腎上腺功能評估（疑似庫欣時）",
        "胸腔X光和腹部超音波（排除轉移性腫瘤）"
      ]
    },
    "treatment": {
      "overview": "治療根本病因是關鍵。早期治療才能保留視力",
      "acute": [
        "治療潛在病因為首要（降壓藥、腎病管理等）",
        "高血壓性：amlodipine 0.125-0.25 mg/kg PO q24h（貓首選降壓藥）",
        "炎症性：全身性和/或局部糖皮質激素",
        "嚴重高血壓急症：amlodipine + hydralazine"
      ],
      "chronic": [
        "持續控制全身性血壓",
        "定期眼底檢查監測視網膜復位",
        "慢性腎臟病的管理",
        "甲狀腺功能亢進的控制"
      ]
    },
    "prognosis": "預後取決於脫離的原因、範圍和持續時間。高血壓性脫離若及早（24-48小時內）控制血壓，視網膜可能復位並恢復部分視力。完全且持續時間長的脫離視力恢復機會低。",
    "pearls": [
      "貓的突然失明首先要測量血壓——高血壓是最常見的可治療原因",
      "視網膜脫離後越早治療越有機會恢復視力",
      "所有新診斷的貓高血壓都應進行眼底檢查",
      "SARDS和視網膜脫離都表現為急性失明，但ERG可區分兩者"
    ],
    "diagnosticAlgorithm": {
      "title": "視網膜脫離 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估視覺功能喪失程度與發病速度",
          "findings": [
            "突發性失明",
            "瞳孔散大且對光反射減弱",
            "犬貓可能撞到物品",
            "可能單側或雙側"
          ]
        },
        {
          "step": 2,
          "action": "眼科學檢查",
          "details": "直接與間接眼底鏡檢查",
          "findings": [
            "視網膜離位浮起",
            "視網膜血管走向異常",
            "視網膜下液體蓄積",
            "可能見到視網膜裂孔"
          ]
        },
        {
          "step": 3,
          "action": "進階檢查",
          "details": "超音波與全身檢查尋找病因",
          "findings": [
            "B-scan超音波確認脫離範圍",
            "血壓測量排除高血壓性視網膜病變",
            "血液檢查排除全身性疾病",
            "視網膜電圖（ERG）評估視網膜功能"
          ]
        },
        {
          "step": 4,
          "action": "確診與病因分類",
          "details": "確認脫離類型與潛在病因",
          "findings": [
            "滲出性/牽引性/裂孔性分類",
            "高血壓相關（貓最常見）",
            "免疫介導性或腫瘤性病因",
            "評估視覺恢復可能性"
          ]
        }
      ]
    },
    "monitoring": [
      "治療後每週眼底檢查追蹤視網膜復位",
      "血壓定期監測（每週至穩定，之後每1-3個月）",
      "腎功能和甲狀腺功能定期追蹤"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "sudden-acquired-retinal-degeneration": {
    "zh": "突發性後天視網膜退化症",
    "en": "Sudden Acquired Retinal Degeneration Syndrome (SARDS)",
    "definition": "突發性後天視網膜退化症（SARDS）是犬的一種特發性疾病，特徵為突然完全且不可逆的失明。視網膜感光細胞功能急性喪失，但初期眼底外觀可能正常。確診依靠視網膜電圖（ERG）顯示平坦反應。",
    "synonyms": [
      "SARDS",
      "Silent Retina Syndrome",
      "突發性視網膜退化"
    ],
    "epidemiology": {
      "species": "犬（貓極罕見）",
      "age": "中老年犬（平均7-10歲）",
      "sex": "母犬（特別是已絕育母犬）略多",
      "riskFactors": [
        "中老年小型至中型品種",
        "臘腸犬、迷你雪納瑞、巴乎犬、可卡犬",
        "肥胖",
        "常伴隨庫欣樣症狀（多喝多尿、多食）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "急性完全失明（數天至數週內發展）",
        "碰撞物品、行為改變、焦慮",
        "部分病例有多喝多尿和多食的病史",
        "體重增加",
        "飼主可能誤以為行為問題"
      ],
      "physicalExam": [
        "雙側瞳孔完全散大",
        "直接和間接瞳孔光反射消失或極度減弱",
        "眼底檢查初期可能完全正常",
        "數月後可見視網膜血管萎縮和視神經盤蒼白",
        "數月後可見反射性視網膜退化（hyperreflectivity）",
        "威脅反射消失"
      ]
    },
    "pathophysiology": "SARDS的確切病因不明。推測機制包括免疫媒介性感光細胞凋亡、神經退化性過程或代謝性因素。感光細胞的外節（outer segments）急性功能喪失，但初期形態學上可能正常，這解釋了為何初期眼底檢查可能正常。約有50%的SARDS犬在診斷時有腎上腺皮質功能異常（肝酶升高、高膽固醇、低比重尿），但不符合典型庫欣氏症的診斷標準，被稱為「非典型庫欣症候群」或「SARDS相關內分泌病」。感光細胞隨後逐漸退化和萎縮，導致典型的視網膜退化眼底變化。",
    "diagnosis": {
      "overview": "ERG是確診的關鍵檢查，需排除其他急性失明原因",
      "differentials": [
        "視神經炎",
        "視網膜脫離",
        "中樞性失明（腦部病變）",
        "青光眼",
        "前葡萄膜炎",
        "白內障"
      ],
      "initialDB": [
        "完整眼科檢查（散瞳眼底檢查）",
        "瞳孔光反射評估",
        "血壓測量",
        "CBC和生化檢查（常見肝酶升高、高膽固醇）",
        "尿液分析（可能低比重尿）"
      ],
      "advanced": [
        "視網膜電圖（ERG）——確診性檢查，顯示平坦或極度減弱反應",
        "腎上腺功能評估（LDDS、ACTH刺激試驗）",
        "腦部MRI（排除中樞性原因）",
        "眼部超音波（排除視網膜脫離）"
      ]
    },
    "treatment": {
      "overview": "目前無有效治療。失明為永久性且不可逆。治療重點在於輔助動物適應失明和處理伴隨的內分泌異常",
      "acute": [
        "確診後與飼主充分溝通預後",
        "排除可治療的失明原因"
      ],
      "chronic": [
        "環境管理幫助失明犬適應（保持家具位置固定、使用聲音引導）",
        "伴隨的內分泌異常監測和管理",
        "靜脈注射免疫球蛋白（IVIg）療法——部分研究報告有限療效，但證據不足",
        "部分眼科專科醫師嘗試免疫抑制療法但效果未確認"
      ]
    },
    "prognosis": "視力喪失為永久性且不可逆。大多數犬隻在數週至數月內良好適應失明生活。整體生活品質通常維持良好。壽命不受SARDS本身影響，但需監測相關的內分泌異常。",
    "pearls": [
      "SARDS的特徵是眼底正常但ERG平坦——眼底看起來正常不代表視網膜功能正常",
      "約50%的SARDS犬有庫欣樣實驗室異常但不符合典型庫欣標準",
      "ERG是區分SARDS和視神經炎/中樞性失明的關鍵檢查",
      "大多數犬隻能很好地適應失明，飼主的支持和環境調整是關鍵",
      "SARDS目前無有效的治療方法，應避免給飼主不實的期望"
    ],
    "diagnosticAlgorithm": {
      "title": "突發性後天視網膜退化症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估突發性失明的臨床表現",
          "findings": [
            "急性完全失明（數天內）",
            "瞳孔散大固定",
            "威嚇反應消失",
            "中老年犬常見，常伴多飲多尿"
          ]
        },
        {
          "step": 2,
          "action": "眼科學檢查",
          "details": "眼底鏡與基本眼科檢查",
          "findings": [
            "早期眼底可能外觀正常",
            "瞳孔對光反射消失或減弱",
            "晚期可見視網膜血管萎縮",
            "晚期視網膜反射增強"
          ]
        },
        {
          "step": 3,
          "action": "視網膜電圖",
          "details": "ERG為確診金標準",
          "findings": [
            "ERG呈平坦波形（消失性反應）",
            "明暗適應ERG均無反應",
            "與視神經疾病鑑別的關鍵檢查"
          ]
        },
        {
          "step": 4,
          "action": "確診與鑑別",
          "details": "排除其他急性失明原因",
          "findings": [
            "ERG無反應確診SARDS",
            "排除視神經炎（MRI正常）",
            "排除中樞性失明",
            "內分泌篩檢（可能伴庫欣氏症表現）"
          ]
        }
      ]
    },
    "monitoring": [
      "3-6個月後複檢眼底觀察退化性變化",
      "定期生化檢查監測肝功能和膽固醇",
      "腎上腺功能追蹤",
      "行為適應評估"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "proptosis": {
    "zh": "眼球脫出",
    "en": "Proptosis (Traumatic Globe Prolapse)",
    "definition": "眼球脫出是指眼球被推移至眼瞼之前的急性眼科急症，通常由頭部外傷導致。眼瞼痙攣性閉合於眼球赤道後方，使眼球無法自行復位。是需要緊急處理的真正眼科急症。",
    "synonyms": [
      "Globe Proptosis",
      "Traumatic Globe Prolapse",
      "Eyeball Prolapse",
      "眼球突出脫位"
    ],
    "epidemiology": {
      "species": "犬貓皆可，短頭種犬最常見",
      "age": "任何年齡",
      "sex": "無性別傾向",
      "riskFactors": [
        "短頭種犬（北京犬、巴乎犬、西施犬、波士頓㹴、法國鬥牛犬）",
        "淺眼窩和大眼瞼裂",
        "頭部外傷（交通事故、動物咬傷、墜落）",
        "過度頸部束縛"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "頭部外傷後眼球突出",
        "眼球暴露在眼瞼之外",
        "劇烈疼痛",
        "短頭種犬可能因輕微外傷即發生"
      ],
      "physicalExam": [
        "眼球位於眼瞼之前，被痙攣的眼瞼固定",
        "角膜乾燥和暴露",
        "結膜嚴重充血和水腫",
        "前房出血（前房積血）",
        "瞳孔散大",
        "可能伴隨眼外肌撕裂",
        "可能伴隨視神經牽拉損傷",
        "評估其他頭部外傷"
      ]
    },
    "pathophysiology": "頭部鈍性外傷或眶後壓力突然增加將眼球推出眼眶。眼球通過眼瞼裂後，眼輪匝肌痙攣使眼瞼閉合在眼球赤道後方，形成鉗夾效應阻止自行復位。短頭種犬因眼窩淺、眼球突出且眼瞼裂大，所需外力較小。眼球脫出後的損傷包括：眼外肌（特別是內直肌）牽拉撕裂、視神經拉伸損傷、角膜暴露性乾燥、眼內出血和虹膜脫出。長時間脫出會導致不可逆的視神經損傷和眼球萎縮。",
    "diagnosis": {
      "overview": "診斷明確，重點在評估眼球和視力的可挽救性",
      "differentials": [
        "眶後腫瘤或膿瘍（非急性）",
        "眶後蜂窩組織炎"
      ],
      "initialDB": [
        "評估整體創傷嚴重程度和生命徵象",
        "評估瞳孔光反射（若可能）",
        "評估眼外肌完整性",
        "頭部X光排除骨折"
      ],
      "advanced": [
        "CT掃描（評估眼眶骨折和眶後損傷）",
        "眼部超音波（評估眼球內部結構完整性）"
      ]
    },
    "treatment": {
      "overview": "這是真正的眼科急症，需在全身麻醉下盡速復位或摘除",
      "acute": [
        "立即保護角膜（生理食鹽水濕紗布覆蓋）",
        "全身穩定和止痛",
        "全身麻醉下嘗試復位：外側眥切開術擴大眼瞼裂、輕柔推回眼球",
        "復位後暫時性眼瞼縫合術（temporary tarsorrhaphy）2-3週",
        "嚴重損傷無法復位時：眼球摘除術（enucleation）",
        "全身性抗生素和抗炎藥物",
        "E-collar防止自殘"
      ],
      "chronic": [
        "拆除眼瞼縫合後評估視力和眼球運動",
        "長期人工淚液",
        "斜視（內斜視最常見，因內直肌損傷）的管理",
        "乾眼症的長期管理"
      ]
    },
    "prognosis": "預後取決於物種、外傷嚴重程度和就診速度。短頭種犬預後較非短頭種好（因所需外力較小）。不良預後指標包括：超過3條眼外肌斷裂、前房積血、瞳孔固定散大、視神經撕裂、貓或長頭種犬（表示外力極大）。總體保留眼球率約40-60%，但有功能視力的比例更低。",
    "pearls": [
      "眼球脫出是真正的急症——就診速度直接影響預後",
      "短頭種犬飼主應了解此風險並避免頸圈過度束縛",
      "超過3條眼外肌斷裂或瞳孔固定散大時保留功能視力的機會極低",
      "復位後的暫時性眼瞼縫合至關重要，過早拆除會導致再脫出",
      "貓的眼球脫出通常表示極嚴重的外傷，預後較犬差"
    ],
    "diagnosticAlgorithm": {
      "title": "眼球脫出 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "緊急評估",
          "details": "評估外傷程度與眼球存活力",
          "findings": [
            "眼球突出於眼眶外",
            "眼瞼嵌頓於眼球赤道後方",
            "角膜暴露乾燥",
            "眼周出血與腫脹"
          ]
        },
        {
          "step": 2,
          "action": "眼科學評估",
          "details": "評估眼球存活預後指標",
          "findings": [
            "瞳孔對光反射評估",
            "眼外肌完整性（>2條斷裂預後差）",
            "前房出血程度",
            "角膜完整性評估"
          ]
        },
        {
          "step": 3,
          "action": "全身評估",
          "details": "評估其他伴隨外傷",
          "findings": [
            "頭部外傷評估",
            "口腔與顎骨骨折檢查",
            "神經學檢查",
            "胸腹部X光排除其他損傷"
          ]
        },
        {
          "step": 4,
          "action": "確診與治療決策",
          "details": "決定眼球保留或摘除",
          "findings": [
            "評估視覺恢復可能性",
            "短頭種犬預後較佳",
            "嚴重眼外肌斷裂考慮摘除",
            "立即復位與暫時瞼緣縫合"
          ]
        }
      ]
    },
    "monitoring": [
      "術後每日評估角膜狀態（透過縫合間隙）",
      "2-3週後拆除眼瞼縫合評估",
      "視力和瞳孔反射追蹤",
      "眼壓監測",
      "乾眼症篩查（Schirmer test）"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "obstructive-shock": {
    "zh": "阻塞性休克",
    "en": "Obstructive Shock",
    "definition": "阻塞性休克是由心臟或大血管的機械性阻塞導致心輸出量急劇下降而引起的休克狀態。常見原因包括心包膜填塞、張力性氣胸、肺動脈血栓栓塞和胃扭轉-擴張症候群（GDV）。",
    "synonyms": [
      "Obstructive Cardiovascular Shock",
      "機械性休克"
    ],
    "epidemiology": {
      "species": "犬貓皆可",
      "age": "任何年齡，取決於潛在病因",
      "sex": "無性別傾向",
      "riskFactors": [
        "心包膜積液（腫瘤性最常見）",
        "胸腔創傷（張力性氣胸）",
        "GDV好發品種（大丹犬、德國牧羊犬、標準貴賓犬）",
        "心絲蟲重度感染（腔靜脈症候群）",
        "凝血障礙（肺栓塞）",
        "橫膈膜疝氣"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "急性虛脫",
        "呼吸困難",
        "運動不耐受",
        "腹部膨脹（GDV）",
        "已知心臟腫瘤或心包膜積液病史"
      ],
      "physicalExam": [
        "心跳加速但脈搏微弱",
        "頸靜脈怒張",
        "蒼白或發紺黏膜",
        "延長的毛細血管再充填時間",
        "心音減弱（心包膜填塞）",
        "單側呼吸音消失（氣胸）",
        "奇脈（pulsus paradoxus）",
        "腹部鼓脹和鼓音（GDV）"
      ]
    },
    "pathophysiology": "阻塞性休克的核心機制是心臟充盈或射出受到機械性阻礙。心包膜填塞時，心包腔內液體壓迫心室使舒張期充盈受限；張力性氣胸時，胸腔內正壓壓迫心臟和大血管減少靜脈回流；肺動脈栓塞時，右心室後負荷急劇增加導致右心衰竭；GDV時，擴張扭轉的胃壓迫後腔靜脈減少靜脈回流。共同的最終結果是心輸出量急劇下降、組織灌注不足和細胞缺氧，若不及時解除阻塞因素，將迅速進展為不可逆休克和死亡。",
    "diagnosis": {
      "overview": "需快速識別休克類型和潛在阻塞原因以指導緊急治療",
      "differentials": [
        "心因性休克",
        "低血容性休克",
        "分布性休克（敗血性、過敏性）"
      ],
      "initialDB": [
        "TFAST/AFAST超音波（快速評估心包積液、胸腔積液/氣胸、腹腔積液）",
        "胸腔和腹部X光",
        "心電圖",
        "血壓測量",
        "血氣分析和乳酸"
      ],
      "advanced": [
        "心臟超音波",
        "凝血功能檢查",
        "D-dimer（疑似肺栓塞時）",
        "CT血管造影（肺栓塞確診）"
      ]
    },
    "treatment": {
      "overview": "立即解除機械性阻塞是救命的關鍵，同時進行休克復甦",
      "acute": [
        "心包膜填塞：緊急心包穿刺引流",
        "張力性氣胸：緊急胸腔穿刺排氣或胸管置入",
        "GDV：胃減壓（口胃管或經皮穿刺）後緊急手術",
        "靜脈輸液復甦（但心包填塞時需謹慎避免過度）",
        "氧氣治療",
        "血管升壓藥（若單獨輸液無法維持血壓）",
        "止痛"
      ],
      "chronic": [
        "心包膜填塞反覆發作：心包切除術（pericardiectomy）",
        "GDV術後：胃固定術預防復發",
        "心絲蟲腔靜脈症候群：手術取蟲",
        "潛在腫瘤的化療評估"
      ]
    },
    "prognosis": "取決於潛在病因和解除阻塞的速度。張力性氣胸和心包填塞經及時引流後預後可良好。GDV經手術治療存活率約70-80%。腫瘤性心包積液的長期預後較差。肺栓塞的預後取決於栓塞範圍。",
    "pearls": [
      "阻塞性休克的特徵是頸靜脈怒張伴隨低血壓——與低血容性休克的頸靜脈塌陷形成對比",
      "TFAST/AFAST是快速診斷阻塞性休克病因的最有價值工具",
      "心包填塞時過度輸液可能暫時改善但不能替代穿刺引流",
      "GDV是犬阻塞性休克的常見原因之一，不應忘記檢查腹部"
    ],
    "diagnosticAlgorithm": {
      "title": "阻塞性休克 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "緊急評估",
          "details": "快速辨識休克表現與阻塞性病因",
          "findings": [
            "低血壓與心搏過速",
            "頸靜脈怒張",
            "呼吸困難",
            "心音減弱（心包填塞）"
          ]
        },
        {
          "step": 2,
          "action": "緊急檢查",
          "details": "快速床邊檢查確認病因",
          "findings": [
            "TFAST超音波發現心包積液",
            "胸腔X光顯示張力性氣胸",
            "腹部超音波評估大血管栓塞",
            "血氣分析顯示代謝性酸中毒"
          ]
        },
        {
          "step": 3,
          "action": "病因鑑別",
          "details": "區分不同阻塞性休克病因",
          "findings": [
            "心包填塞：心包穿刺抽液",
            "張力性氣胸：胸腔穿刺減壓",
            "肺栓塞：D-dimer升高",
            "GDV：腹部X光確認"
          ]
        },
        {
          "step": 4,
          "action": "確診與穩定",
          "details": "確認病因並進行緊急處置",
          "findings": [
            "血流動力學監測",
            "中心靜脈壓升高",
            "確認阻塞解除後血壓改善"
          ]
        }
      ]
    },
    "monitoring": [
      "持續心電圖監測",
      "血壓和中心靜脈壓",
      "尿量監測",
      "連續乳酸測定評估組織灌注恢復",
      "引流後重複超音波評估"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "marijuana-toxicosis": {
    "zh": "大麻中毒",
    "en": "Marijuana Toxicosis (Cannabis Intoxication)",
    "definition": "大麻中毒是犬貓因攝入含有四氫大麻酚（THC）的大麻植物、食品或相關產品而引起的中毒。犬的大麻素受體（CB1和CB2）密度高於人類，因此對THC更為敏感。近年來隨著大麻合法化，寵物中毒病例顯著增加。",
    "synonyms": [
      "Cannabis Toxicosis",
      "THC Intoxication",
      "Pot Poisoning",
      "大麻素中毒"
    ],
    "epidemiology": {
      "species": "犬貓皆可，犬較常見（因飲食行為較不謹慎）",
      "age": "任何年齡，幼犬因好奇心強而風險較高",
      "sex": "無性別傾向",
      "riskFactors": [
        "家中存放大麻產品",
        "含THC的食品（大麻餅乾、布朗尼等）",
        "大麻合法化地區",
        "散步時接觸丟棄的大麻產品",
        "二手煙暴露"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "攝入大麻產品或暴露於大麻煙霧",
        "攝入後30-90分鐘出現症狀",
        "步態不穩、行為異常",
        "嗜睡或過度興奮",
        "飼主可能不願承認暴露史"
      ],
      "physicalExam": [
        "共濟失調和步態不穩",
        "瞳孔散大",
        "嗜睡到昏迷（劑量依賴）",
        "尿失禁",
        "心跳過緩或過速",
        "低體溫",
        "對刺激的誇張反應（驚嚇反射增強）",
        "流涎",
        "嘔吐",
        "嚴重中毒：抽搐、昏迷"
      ]
    },
    "pathophysiology": "THC是高度脂溶性的，攝入後迅速被腸道吸收並分布至脂肪組織、腦部和其他器官。THC作用於中樞和周邊神經系統的大麻素受體CB1和CB2。CB1受體主要分布於腦部（小腦、基底核、海馬迴），其活化導致共濟失調、鎮靜、行為改變和感覺異常。犬的腦部CB1受體密度高於人類，解釋了犬對THC的高敏感性。THC經肝臟代謝，部分代謝物經膽汁排出後在腸道再吸收（腸肝循環），延長了中毒持續時間。含THC的食品若同時含有巧克力或木糖醇可導致額外的中毒風險。",
    "diagnosis": {
      "overview": "依據暴露史和特徵性臨床症狀進行臨床診斷",
      "differentials": [
        "乙二醇中毒",
        "酒精中毒",
        "苯二氮平類藥物中毒",
        "鴉片類藥物暴露",
        "前庭疾病",
        "肝性腦病",
        "低血糖"
      ],
      "initialDB": [
        "詳細暴露史（需敏感地詢問，不帶評判）",
        "CBC和生化檢查",
        "血糖監測",
        "人用尿液THC快速檢測（敏感度有限，假陰性常見）"
      ],
      "advanced": [
        "血液或尿液THC及代謝物（11-OH-THC、THC-COOH）定量",
        "如同時攝入巧克力：監測心電圖和theophylline/theobromine濃度"
      ]
    },
    "treatment": {
      "overview": "以支持療法為主，大多數病例在12-24小時內恢復",
      "acute": [
        "誘導嘔吐（若攝入在2小時內且神經狀態允許）",
        "活性碳 1-2 g/kg PO（減少吸收和腸肝循環）",
        "靜脈輸液維持水合和循環",
        "保溫（低體溫時）",
        "心跳過緩：atropine（若有臨床影響）",
        "嚴重抽搐：diazepam 0.5 mg/kg IV",
        "嚴重中樞抑制：intralipid 20%（脂質乳劑療法 1.5 mL/kg IV bolus）"
      ],
      "chronic": [
        "通常不需慢性治療",
        "飼主衛教避免再次暴露",
        "安全存放大麻產品"
      ]
    },
    "prognosis": "大多數病例預後良好，症狀在12-24小時內消退，嚴重病例可持續72小時。死亡罕見但可發生於攝入高濃度THC製品（如濃縮物）或合併巧克力/木糖醇中毒時。",
    "pearls": [
      "飼主可能不願承認大麻暴露——以不帶評判的方式詢問對診斷至關重要",
      "人用尿液THC快速檢測在犬的假陰性率高，陰性結果不能排除中毒",
      "含有巧克力的大麻食品是雙重中毒風險",
      "活性碳在THC中毒中特別有用，因為可中斷腸肝循環",
      "脂質乳劑療法（intralipid）對嚴重THC中毒可能有效"
    ],
    "diagnosticAlgorithm": {
      "title": "大麻中毒 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "詳細詢問暴露史與評估神經症狀",
          "findings": [
            "共濟失調與步態不穩",
            "瞳孔散大",
            "嗜睡或過度興奮",
            "尿失禁"
          ]
        },
        {
          "step": 2,
          "action": "理學檢查",
          "details": "全身神經學與生命徵象評估",
          "findings": [
            "心搏過緩或心搏過速",
            "體溫過低",
            "對聲音過度敏感",
            "流涎"
          ]
        },
        {
          "step": 3,
          "action": "實驗室檢查",
          "details": "排除其他中毒與代謝異常",
          "findings": [
            "基本生化檢查通常正常",
            "尿液THC快篩（人用試劑可用但敏感度有限）",
            "排除其他神經毒物暴露"
          ]
        },
        {
          "step": 4,
          "action": "確診",
          "details": "根據暴露史與臨床表現推斷性診斷",
          "findings": [
            "典型臨床症狀組合",
            "飼主承認暴露史",
            "支持性治療後12-24小時改善",
            "排除其他CNS抑制劑中毒"
          ]
        }
      ]
    },
    "monitoring": [
      "神經狀態每1-2小時評估",
      "心率和體溫監測",
      "血糖監測",
      "尿量觀察"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "organophosphate-toxicosis": {
    "zh": "有機磷中毒",
    "en": "Organophosphate Toxicosis",
    "definition": "有機磷中毒是因接觸或攝入有機磷類殺蟲劑導致的急性膽鹼能危機。有機磷不可逆地抑制乙醯膽鹼酯酶（AChE），導致乙醯膽鹼在突觸間隙過度蓄積，引起毒蕈鹼型和菸鹼型膽鹼能症狀。",
    "synonyms": [
      "OP Toxicosis",
      "Anticholinesterase Poisoning",
      "有機磷殺蟲劑中毒"
    ],
    "epidemiology": {
      "species": "犬貓皆可，貓對有機磷更敏感",
      "age": "任何年齡",
      "sex": "無性別傾向",
      "riskFactors": [
        "接觸農業殺蟲劑",
        "不當使用跳蚤除蟲產品",
        "將犬用除蟲產品使用於貓",
        "攝入殺蟲劑污染的食物或水源",
        "農業環境暴露"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "已知殺蟲劑暴露或噴灑接觸",
        "急性發作的流涎和嘔吐",
        "腹瀉",
        "呼吸困難",
        "肌肉震顫和無力",
        "症狀通常在暴露後數分鐘至數小時內出現"
      ],
      "physicalExam": [
        "SLUD徵候（Salivation流涎、Lacrimation流淚、Urination排尿、Defecation排便）",
        "瞳孔縮小（縮瞳）",
        "心跳過緩",
        "支氣管分泌物增加和支氣管痙攣",
        "肌肉束狀收縮和震顫",
        "全身肌肉無力",
        "嚴重時抽搐和呼吸衰竭",
        "可能聞到殺蟲劑氣味"
      ]
    },
    "pathophysiology": "有機磷類化合物與乙醯膽鹼酯酶的活性位點形成共價鍵結合，不可逆地抑制酶活性（與氨基甲酸酯類的可逆性抑制不同）。AChE被抑制後，乙醯膽鹼在蕈毒鹼型受體（副交感神經末梢）和菸鹼型受體（神經肌肉接合處和自主神經節）大量蓄積。毒蕈鹼型效應包括SLUD症狀、縮瞳、心跳過緩和支氣管痙攣；菸鹼型效應包括肌肉束狀收縮、震顫、無力和癱瘓。若不及時用atropine拮抗和pralidoxime再活化AChE，過度的膽鹼能刺激最終導致呼吸肌麻痺和死亡。隨時間推移，AChE-OP結合物會發生「老化」反應，使pralidoxime失去再活化能力。",
    "diagnosis": {
      "overview": "依據暴露史和典型膽鹼能症狀進行臨床診斷，實驗室確認可測定AChE活性",
      "differentials": [
        "氨基甲酸酯殺蟲劑中毒（症狀相似但較輕且較短暫）",
        "蟾蜍中毒",
        "毒蕈中毒（含毒蕈鹼的蘑菇）",
        "擬副交感神經藥物過量",
        "重症肌無力"
      ],
      "initialDB": [
        "全血或血漿膽鹼酯酶活性（降低>50%具診斷意義）",
        "血氣分析",
        "CBC和生化檢查",
        "心電圖"
      ],
      "advanced": [
        "胃內容物或嘔吐物的毒物學分析",
        "視網膜AChE活性（研究用途）"
      ]
    },
    "treatment": {
      "overview": "穩定氣道和呼吸優先，atropine拮抗毒蕈鹼型症狀，pralidoxime再活化AChE",
      "acute": [
        "氣道管理和氧氣治療（最優先）",
        "atropine 0.04-0.1 mg/kg IV（先給1/4劑量測試反應）——僅拮抗毒蕈鹼型症狀",
        "根據症狀反覆給予atropine（目標：分泌物減少和心率正常化，非散瞳）",
        "pralidoxime (2-PAM) 20 mg/kg IM/slow IV q8-12h（盡早給予，在老化前再活化AChE）",
        "皮膚去污染（溫水和洗碗精徹底清洗）",
        "誘導嘔吐（若攝入在1-2小時內且神經狀態允許）",
        "活性碳 1-2 g/kg PO",
        "diazepam 0.5-1 mg/kg IV控制抽搐"
      ],
      "chronic": [
        "持續atropine給藥直至AChE活性恢復",
        "pralidoxime持續24-48小時",
        "監測呼吸功能",
        "可能需要機械通氣支持"
      ]
    },
    "prognosis": "及時治療的預後良好至中等。死亡主要因呼吸衰竭。延遲治療或大量暴露預後較差。完全恢復可能需要數天至數週（需新合成AChE）。部分有機磷可導致遲發性神經病變。",
    "pearls": [
      "atropine僅拮抗毒蕈鹼型症狀，不治療菸鹼型症狀（肌肉無力/震顫）",
      "pralidoxime必須盡早給予——AChE-OP結合物老化後即無效",
      "atropine劑量的判斷標準是分泌物減少，而非瞳孔散大",
      "貓對有機磷特別敏感，不可使用犬用有機磷除蟲產品",
      "區分有機磷和氨基甲酸酯很重要：後者症狀較短暫，atropine通常足夠"
    ],
    "diagnosticAlgorithm": {
      "title": "有機磷中毒 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "緊急評估",
          "details": "辨識膽鹼激性危象的典型表現（SLUDGE/DUMBELS）",
          "findings": [
            "流涎與流淚過多",
            "嘔吐與腹瀉",
            "縮瞳",
            "肌肉震顫與痙攣"
          ]
        },
        {
          "step": 2,
          "action": "理學檢查",
          "details": "評估膽鹼激性症狀嚴重度",
          "findings": [
            "心搏過緩",
            "支氣管分泌物增多與呼吸困難",
            "排尿排便失禁",
            "肌束顫動"
          ]
        },
        {
          "step": 3,
          "action": "實驗室確認",
          "details": "血液膽鹼酯酶活性測定",
          "findings": [
            "全血或血漿膽鹼酯酶活性顯著降低",
            "活性降至正常值25%以下具診斷意義",
            "活性降低與臨床嚴重度相關"
          ]
        },
        {
          "step": 4,
          "action": "確診與治療反應",
          "details": "阿托品試驗性治療確認診斷",
          "findings": [
            "阿托品給予後症狀改善",
            "確認暴露來源（殺蟲劑、除蚤產品）",
            "排除氨基甲酸酯中毒（類似但可逆）"
          ]
        }
      ]
    },
    "monitoring": [
      "呼吸頻率和血氧飽和度持續監測",
      "心率和心電圖",
      "每4-6小時評估膽鹼能症狀",
      "膽鹼酯酶活性追蹤（若可行）"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "toad-toxicosis": {
    "zh": "蟾蜍中毒",
    "en": "Toad Toxicosis (Bufo Toad Poisoning)",
    "definition": "蟾蜍中毒是犬貓（主要是犬）因口腔接觸蟾蜍腮腺（parotoid glands）分泌的毒素而引起的急性中毒。毒素含有bufotoxin和bufogenin等強心苷類和兒茶酚胺類物質，可引起嚴重的心律不整和神經症狀。海蟾蜍（Bufo marinus/Rhinella marina）和科羅拉多河蟾蜍（Incilius alvarius）毒性最強。",
    "synonyms": [
      "Bufo Toad Poisoning",
      "Bufotoxin Poisoning",
      "蟾蜍毒素中毒"
    ],
    "epidemiology": {
      "species": "犬為主（好奇心驅使舔舐或咬住蟾蜍），貓偶見",
      "age": "任何年齡，幼犬和好奇的犬隻風險較高",
      "sex": "無性別傾向",
      "riskFactors": [
        "居住在蟾蜍棲息地區（熱帶和亞熱帶）",
        "夜間和雨後戶外活動",
        "好奇或喜歡追逐小動物的犬隻",
        "體型小的犬隻（相對毒素劑量較高）",
        "庭院有水源吸引蟾蜍"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "目擊犬隻舔舐或咬住蟾蜍",
        "接觸後數分鐘內立即出現症狀",
        "劇烈流涎和口腔搔抓",
        "嘔吐",
        "行為異常和不安"
      ],
      "physicalExam": [
        "大量黏稠流涎（常為磚紅色）",
        "口腔黏膜充血",
        "心律不整（心跳過緩、心跳過速或複雜心律不整）",
        "瞳孔散大",
        "高體溫",
        "抽搐",
        "共濟失調",
        "嚴重時心臟驟停"
      ]
    },
    "pathophysiology": "蟾蜍毒素中的bufadienolides是強心苷類物質，其作用機制類似毛地黃，抑制心肌細胞膜的Na+/K+-ATPase，導致細胞內鈉和鈣濃度升高，引起心律不整（房室傳導阻滯、室性心搏過速、心室纖維顫動）。毒素中的兒茶酚胺成分直接刺激腎上腺素能受體。bufotoxin還具有局部刺激性，造成口腔黏膜劇烈疼痛和炎症。5-HT（血清素）類成分可能導致幻覺和行為異常。毒素經口腔黏膜迅速吸收，症狀可在數分鐘內出現，嚴重中毒在15-30分鐘內可致命。",
    "diagnosis": {
      "overview": "依據暴露史和急性臨床症狀進行臨床診斷",
      "differentials": [
        "有機磷中毒",
        "巧克力中毒",
        "毛地黃中毒",
        "百合中毒（貓）",
        "其他心臟毒性物質"
      ],
      "initialDB": [
        "心電圖（評估心律不整類型和嚴重度）",
        "電解質（特別是鉀離子——高血鉀與強心苷毒性相關）",
        "血糖",
        "體溫"
      ],
      "advanced": [
        "連續心電圖監測",
        "血氣分析",
        "毒素濃度測定（通常不可行或不即時）"
      ]
    },
    "treatment": {
      "overview": "立即口腔去污染和心臟監護是最關鍵的治療步驟",
      "acute": [
        "立即大量清水沖洗口腔（從口角向外沖洗，避免吞嚥）——最重要的初步急救",
        "不要誘導嘔吐（毒素已經黏膜吸收）",
        "心電圖持續監測",
        "心跳過緩：atropine 0.04 mg/kg IV",
        "室性心律不整：lidocaine 2 mg/kg IV bolus（犬）",
        "嚴重心律不整考慮digoxin-specific Fab fragments（若可取得）",
        "高血鉀：regular insulin + dextrose、calcium gluconate",
        "抽搐控制：diazepam 0.5-1 mg/kg IV",
        "降溫（高體溫時）",
        "靜脈輸液支持"
      ],
      "chronic": [
        "嚴重中毒後持續心電圖監測24-48小時",
        "電解質監測和矯正"
      ]
    },
    "prognosis": "輕度中毒（僅口腔刺激和流涎）經口腔沖洗後預後良好。中度至重度中毒伴心律不整預後謹慎。海蟾蜍中毒如未治療，小型犬可在15分鐘內死亡。及時口腔去污染和心臟監護可顯著改善預後。",
    "pearls": [
      "立即口腔沖洗是最重要的急救措施——可大幅減少毒素吸收",
      "口腔沖洗時應從口角向外沖洗，避免讓犬吞嚥沖洗液",
      "蟾蜍毒素的心臟效應類似毛地黃中毒，治療原則相同",
      "海蟾蜍（Bufo marinus）是毒性最強的種類",
      "高血鉀是蟾蜍中毒心臟毒性的加重因素，需積極矯正"
    ],
    "diagnosticAlgorithm": {
      "title": "蟾蜍中毒 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "緊急評估",
          "details": "評估蟾蜍接觸史與心臟毒性症狀",
          "findings": [
            "大量流涎與口腔黏膜紅腫",
            "嘔吐",
            "心律不整",
            "共濟失調與痙攣"
          ]
        },
        {
          "step": 2,
          "action": "心血管評估",
          "details": "ECG與心血管監測",
          "findings": [
            "心電圖顯示心律不整",
            "高鉀血症樣ECG變化",
            "室性心搏過速",
            "房室傳導阻滯"
          ]
        },
        {
          "step": 3,
          "action": "實驗室檢查",
          "details": "電解質與心臟生物標記檢查",
          "findings": [
            "高鉀血症",
            "血清強心配醣體檢測（digoxin-like）",
            "乳酸升高",
            "心肌酵素可能升高"
          ]
        },
        {
          "step": 4,
          "action": "確診",
          "details": "根據暴露史與心臟毒性表現確診",
          "findings": [
            "目擊蟾蜍接觸史",
            "典型口腔與心臟症狀",
            "沖洗口腔後流涎改善",
            "蟾蜍品種鑑定評估毒性程度"
          ]
        }
      ]
    },
    "monitoring": [
      "持續心電圖監測（至少12-24小時）",
      "電解質每2-4小時監測",
      "體溫監測",
      "神經狀態評估"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "pregnancy-toxemia": {
    "zh": "妊娠毒血症",
    "en": "Pregnancy Toxemia",
    "definition": "妊娠毒血症是懷孕末期（尤其是多胎妊娠）的母犬或母貓因能量攝取不足以滿足胎兒快速生長的需求，導致脂肪過度動員和嚴重酮血症/酮尿症的代謝性急症。本質上是懷孕誘發的負能量平衡和肝脂肪變性。",
    "synonyms": [
      "Ketosis of Pregnancy",
      "Gestational Ketoacidosis",
      "懷孕酮症"
    ],
    "epidemiology": {
      "species": "犬貓皆可，犬較常見",
      "age": "懷孕動物，通常在妊娠末期（最後1-2週）",
      "sex": "僅雌性",
      "riskFactors": [
        "多胎妊娠",
        "肥胖或營養不良",
        "妊娠末期食慾下降",
        "緊迫",
        "懷孕期間疾病導致食慾減退",
        "小型犬種",
        "初產或高齡母犬"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "懷孕末期食慾減退或廢絕",
        "精神沉鬱和虛弱",
        "嘔吐",
        "不協調或步態不穩",
        "可能有體重減輕"
      ],
      "physicalExam": [
        "精神沉鬱到昏迷",
        "脫水",
        "呼吸急促（代謝性酸中毒代償）",
        "口腔有水果味（丙酮味）",
        "低體溫",
        "觸診可確認妊娠（可感受胎動減弱）",
        "嚴重時可見黃疸"
      ]
    },
    "pathophysiology": "妊娠末期胎兒快速生長，葡萄糖需求急劇增加。當母體能量攝取不足時，脂肪組織大量分解以提供能量。肝臟中游離脂肪酸氧化增加，產生大量酮體（乙醯乙酸、β-羥丁酸和丙酮）。酮體蓄積導致代謝性酸中毒。同時，大量脂肪酸湧入肝臟導致肝脂肪變性（脂肪肝），進一步損害肝臟代謝功能。低血糖加重腦部功能障礙。肥胖個體更容易發展肝脂肪變性。惡性循環最終導致多器官功能衰竭。",
    "diagnosis": {
      "overview": "依據懷孕末期的臨床表現結合代謝性檢查確診",
      "differentials": [
        "子癇（低血鈣）",
        "糖尿病酮酸中毒",
        "敗血症",
        "胎兒死亡和子宮感染",
        "其他原因的肝臟疾病"
      ],
      "initialDB": [
        "血糖（通常顯著低下）",
        "尿液試紙（酮尿、糖尿）",
        "血氣分析（代謝性酸中毒）",
        "CBC和生化檢查（肝酶升高、高膽紅素）",
        "電解質",
        "腹部超音波確認胎兒存活"
      ],
      "advanced": [
        "血清β-羥丁酸濃度",
        "凝血功能（DIC篩查）",
        "肝臟超音波（脂肪肝評估）"
      ]
    },
    "treatment": {
      "overview": "緊急穩定母體代謝狀態，必要時盡速終止妊娠",
      "acute": [
        "靜脈輸注含葡萄糖晶體液（5% dextrose in LRS）",
        "矯正低血糖（50% dextrose 0.5-1 mL/kg IV稀釋後緩慢推注）",
        "電解質矯正",
        "碳酸氫鈉治療嚴重酸中毒（pH<7.1時考慮）",
        "如胎兒成熟：緊急剖腹產是最有效的治療",
        "營養支持（鼻胃管餵食或部分腸外營養）"
      ],
      "chronic": [
        "術後持續葡萄糖輸液和營養支持",
        "肝臟保護劑",
        "仔犬哺乳的營養管理",
        "預防復發：懷孕末期營養充足的飲食管理"
      ]
    },
    "prognosis": "早期發現並積極治療（包括剖腹產）預後中等至良好。延遲治療或嚴重肝脂肪變性預後差。母體死亡率在未治療情況下高。胎兒存活率取決於妊娠階段和母體狀態。",
    "pearls": [
      "懷孕末期的食慾減退不應被忽視——可能是妊娠毒血症的早期徵兆",
      "剖腹產既是治療母體的最有效方法也是拯救胎兒的方式",
      "妊娠毒血症和子癇（低血鈣）可同時發生但治療不同",
      "預防勝於治療：懷孕末期應提供高能量密度的飲食",
      "肥胖母犬的風險更高，但懷孕期不應減重"
    ],
    "diagnosticAlgorithm": {
      "title": "妊娠毒血症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估妊娠晚期母畜代謝狀態",
          "findings": [
            "妊娠晚期食慾廢絕",
            "嗜睡與虛弱",
            "可能伴有嘔吐",
            "多胎妊娠或肥胖犬貓"
          ]
        },
        {
          "step": 2,
          "action": "代謝評估",
          "details": "血液生化與酮體檢測",
          "findings": [
            "低血糖",
            "酮血症與酮尿",
            "代謝性酸中毒",
            "肝酶升高"
          ]
        },
        {
          "step": 3,
          "action": "影像學檢查",
          "details": "評估胎兒狀態與數量",
          "findings": [
            "腹部超音波確認胎兒心跳",
            "胎兒數量評估",
            "評估是否需要緊急剖腹產"
          ]
        },
        {
          "step": 4,
          "action": "確診",
          "details": "根據妊娠史與代謝異常確診",
          "findings": [
            "妊娠晚期+低血糖+酮症確診",
            "排除糖尿病",
            "評估母畜預後與分娩計畫"
          ]
        }
      ]
    },
    "monitoring": [
      "每2-4小時血糖監測",
      "尿酮監測",
      "酸鹼平衡",
      "胎兒心率超音波監測",
      "肝功能追蹤"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "renal-tubular-acidosis": {
    "zh": "腎小管酸中毒",
    "en": "Renal Tubular Acidosis (RTA)",
    "definition": "腎小管酸中毒是指腎小管在維持正常或接近正常腎絲球過濾率的情況下，無法適當酸化尿液或重吸收碳酸氫鹽，導致高氯性代謝性酸中毒的一組疾病。依據受影響的腎小管部位分為第一型（遠端RTA）、第二型（近端RTA）和第四型（高血鉀性RTA）。",
    "synonyms": [
      "RTA",
      "Tubular Acidosis",
      "腎管酸中毒"
    ],
    "epidemiology": {
      "species": "犬貓皆可，較罕見",
      "age": "任何年齡，取決於病因",
      "sex": "無性別傾向",
      "riskFactors": [
        "范乃尼症候群（Fanconi syndrome，特別是巴乎犬）",
        "腎盂腎炎",
        "藥物性腎小管損傷（氨基糖苷類、兩性黴素B）",
        "銅儲積性肝病",
        "腎臟淋巴瘤",
        "先天性腎臟發育不良"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "多飲多尿",
        "食慾減退和體重減輕",
        "肌肉無力",
        "嘔吐",
        "生長遲緩（幼年動物）"
      ],
      "physicalExam": [
        "脫水",
        "肌肉無力（低血鉀相關）",
        "代償性呼吸急促（Kussmaul呼吸）",
        "營養不良或消瘦",
        "骨骼異常（嚴重慢性病例——骨軟化症）"
      ]
    },
    "pathophysiology": "第一型（遠端）RTA：遠端腎小管的閏細胞無法分泌氫離子進入管腔，尿液無法被酸化至正常的最低pH值（<5.5）。導致代謝性酸中毒、低血鉀（因鉀離子替代氫離子被分泌）和高鈣尿（可導致腎結石）。第二型（近端）RTA：近端腎小管重吸收碳酸氫鹽的能力降低，大量碳酸氫鹽在尿中流失，通常為范乃尼症候群的一部分（同時有糖尿、胺基酸尿和磷酸鹽尿）。第四型RTA：醛固酮缺乏或抗性導致遠端腎小管鉀和氫離子分泌減少，造成高血鉀性代謝性酸中毒。",
    "diagnosis": {
      "overview": "需辨識高氯性正陰離子間隙代謝性酸中毒並區分RTA類型",
      "differentials": [
        "慢性腎臟病",
        "腎上腺皮質功能低下（Addison病）",
        "腹瀉（碳酸氫鹽流失）",
        "糖尿病酮酸中毒"
      ],
      "initialDB": [
        "血氣分析（代謝性酸中毒、正常陰離子間隙）",
        "電解質（低血鉀見於I型和II型，高血鉀見於IV型）",
        "尿液分析（尿pH、尿糖、尿胺基酸）",
        "BUN和creatinine（通常正常或輕度升高）",
        "血清氯離子（升高）"
      ],
      "advanced": [
        "碳酸氫鹽負荷試驗（區分I型和II型）",
        "尿液陰離子間隙計算",
        "腎臟超音波（結石、結構異常）",
        "范乃尼症候群相關檢查（尿糖、尿磷、尿胺基酸）",
        "醛固酮和皮質醇測定（排除IV型）"
      ]
    },
    "treatment": {
      "overview": "補充碳酸氫鹽矯正酸中毒，治療潛在病因",
      "acute": [
        "嚴重酸中毒：靜脈注射碳酸氫鈉",
        "低血鉀矯正（KCl補充）",
        "脫水矯正"
      ],
      "chronic": [
        "口服碳酸氫鈉或檸檬酸鉀補充（1-2 mEq/kg/day，依據酸中毒程度調整）",
        "I型RTA：檸檬酸鉀（同時矯正酸中毒和低血鉀、減少腎結石風險）",
        "II型RTA：需要較大劑量碳酸氫鹽且可能不完全矯正",
        "治療潛在病因（如范乃尼症候群、腎盂腎炎）",
        "飲食管理"
      ]
    },
    "prognosis": "取決於潛在病因。先天性或遺傳性RTA需要終身補充碳酸氫鹽但壽命可正常。藥物性腎小管損傷在停藥後可能改善。范乃尼症候群的預後取決於腎臟損傷程度。",
    "pearls": [
      "正常陰離子間隙的代謝性酸中毒應考慮RTA或腸道碳酸氫鹽流失",
      "巴乎犬的范乃尼症候群是犬最常見的RTA相關疾病",
      "尿pH在酸中毒時仍>5.5提示遠端RTA",
      "低血鉀和代謝性酸中毒的組合高度提示I型或II型RTA",
      "第四型RTA與Addison病的鑑別需要激素測定"
    ],
    "diagnosticAlgorithm": {
      "title": "腎小管酸中毒 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估代謝性酸中毒的臨床表現",
          "findings": [
            "慢性嘔吐與食慾下降",
            "多飲多尿",
            "生長遲緩（幼年動物）",
            "肌肉無力"
          ]
        },
        {
          "step": 2,
          "action": "血液檢查",
          "details": "血氣分析與電解質評估",
          "findings": [
            "高氯性代謝性酸中毒",
            "血清碳酸氫鹽降低",
            "陰離子間隙正常",
            "低鉀血症"
          ]
        },
        {
          "step": 3,
          "action": "尿液分析",
          "details": "評估腎小管酸化功能",
          "findings": [
            "尿液pH不當偏鹼（>5.5）",
            "尿液陰離子間隙陽性",
            "尿液電解質異常",
            "可能出現糖尿或胺基酸尿"
          ]
        },
        {
          "step": 4,
          "action": "確診與分型",
          "details": "區分RTA類型並尋找潛在病因",
          "findings": [
            "Type I（遠端）：NH4Cl負荷試驗異常",
            "Type II（近端）：碳酸氫鹽排泄分數升高",
            "排除藥物或毒物引起",
            "影像學排除腎結石"
          ]
        }
      ]
    },
    "monitoring": [
      "定期血氣和電解質監測",
      "尿液pH追蹤治療反應",
      "腎功能定期評估",
      "生長曲線監測（幼年動物）"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "mesenteric-volvulus": {
    "zh": "腸繫膜扭轉",
    "en": "Mesenteric Volvulus",
    "definition": "腸繫膜扭轉是小腸沿腸繫膜根部軸線旋轉導致腸管血供阻斷的急性外科急症。扭轉導致腸繫膜靜脈和動脈閉塞，引起大範圍腸壁壞死、內毒素血症和快速致命性休克。是犬最致命的急腹症之一。",
    "synonyms": [
      "Intestinal Volvulus",
      "Mesenteric Torsion",
      "小腸扭轉"
    ],
    "epidemiology": {
      "species": "犬為主，貓極罕見",
      "age": "任何年齡，但大型犬較常見",
      "sex": "公犬可能略多",
      "riskFactors": [
        "大型和巨型品種犬（德國牧羊犬、大丹犬）",
        "劇烈運動後大量進食",
        "既往腹部手術",
        "腸繫膜淋巴瘤",
        "胃擴張-扭轉手術後",
        "腸外胰分泌不足（German Shepherds）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "超急性腹痛",
        "反覆嘔吐（可能含血）",
        "極度不安或虛脫",
        "腹部急性膨脹",
        "快速惡化的精神狀態"
      ],
      "physicalExam": [
        "嚴重腹痛和腹部膨脹",
        "嚴重低血壓和休克",
        "蒼白或發紺黏膜",
        "心跳過速和脈搏微弱",
        "腹部觸診極度疼痛和張力增加",
        "腹壁肌肉僵硬",
        "血性腹瀉（後期）",
        "體溫可能降低（晚期休克）"
      ]
    },
    "pathophysiology": "小腸沿腸繫膜上動脈根部旋轉，導致腸繫膜上動脈和靜脈同時閉塞。靜脈回流阻斷先於動脈供血喪失，造成腸壁充血和水腫。隨後動脈供血完全中斷導致大範圍腸壁缺血和壞死。壞死的腸壁通透性增加，腸道細菌和內毒素進入腹腔和血液循環，引起腹膜炎和內毒素性休克。大量液體隔離在腸管和腹腔中加重低血容性休克。再灌注損傷可在手術解旋後進一步加重組織損傷。這一連串事件可在數小時內致命。",
    "diagnosis": {
      "overview": "臨床高度懷疑時應立即準備手術探查，不應因檢查延誤手術",
      "differentials": [
        "胃擴張-扭轉（GDV）",
        "腸套疊",
        "腸阻塞（異物）",
        "腸繫膜血栓栓塞",
        "急性胰臟炎",
        "腹膜炎（其他原因）"
      ],
      "initialDB": [
        "腹部X光（小腸廣泛擴張、腸壁增厚、腹腔積液）",
        "腹部超音波（腸壁水腫、蠕動消失、腹腔游離液體）",
        "CBC（白血球可能升高或降低）",
        "乳酸（顯著升高）"
      ],
      "advanced": [
        "腹腔穿刺液分析（血性、細菌）",
        "凝血功能（DIC篩查）"
      ]
    },
    "treatment": {
      "overview": "這是極度緊急的外科急症，需要立即積極復甦和緊急剖腹探查",
      "acute": [
        "大量靜脈輸液復甦（shock dose crystalloids）",
        "廣效靜脈注射抗生素（ampicillin-sulbactam + enrofloxacin或metronidazole）",
        "止痛（fentanyl 2-5 mcg/kg IV或CRI）",
        "緊急剖腹探查和腸管解旋",
        "壞死腸段切除和吻合",
        "評估腸管存活性（顏色、蠕動、脈搏）",
        "術中和術後積極輸液"
      ],
      "chronic": [
        "術後加護監護至少48-72小時",
        "持續靜脈抗生素",
        "逐步恢復口服攝食",
        "營養支持（必要時部分腸外營養）",
        "短腸症候群的管理（若大範圍切除）"
      ]
    },
    "prognosis": "預後極差，整體死亡率高達70-100%。即使手術，許多犬隻因再灌注損傷、DIC或多器官衰竭而死亡。早期發現和極積極治療可略微改善存活率。存活的犬隻若切除大量小腸可能面臨短腸症候群。",
    "pearls": [
      "腸繫膜扭轉是犬最致命的急腹症之一，死亡率極高",
      "不應為了完善檢查而延誤手術——如臨床高度懷疑，應立即手術探查",
      "乳酸濃度是評估組織灌注和預後的重要指標",
      "德國牧羊犬可能有較高的易感性",
      "術後再灌注損傷可能比初始缺血更具破壞性"
    ],
    "diagnosticAlgorithm": {
      "title": "腸繫膜扭轉 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "緊急評估",
          "details": "辨識急腹症與休克表現",
          "findings": [
            "急性劇烈腹痛",
            "血性嘔吐或腹瀉",
            "迅速進展的休克",
            "腹部膨脹"
          ]
        },
        {
          "step": 2,
          "action": "理學檢查與復甦",
          "details": "快速評估並同時進行休克復甦",
          "findings": [
            "嚴重低血壓與心搏過速",
            "腹部觸診劇痛",
            "黏膜蒼白或發紺",
            "體溫過低"
          ]
        },
        {
          "step": 3,
          "action": "影像學檢查",
          "details": "腹部X光與超音波急診評估",
          "findings": [
            "腸管廣泛擴張",
            "腸壁增厚或氣腫",
            "腹腔游離液（血性）",
            "超音波顯示腸繫膜血管異常"
          ]
        },
        {
          "step": 4,
          "action": "確診與手術",
          "details": "緊急剖腹探查確診並治療",
          "findings": [
            "手術中確認腸繫膜扭轉",
            "評估腸管存活力",
            "大範圍腸壞死預後極差",
            "乳酸值與預後相關"
          ]
        }
      ]
    },
    "monitoring": [
      "術後持續血壓和心電圖監測",
      "乳酸每2-4小時追蹤",
      "凝血功能（DIC監測）",
      "體溫和尿量",
      "腹圍和腹部疼痛評估",
      "白蛋白和總蛋白"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "otitis-externa-acute": {
    "zh": "急性外耳炎",
    "en": "Acute Otitis Externa",
    "definition": "急性外耳炎是外耳道上皮和腺體的急性炎症，是犬最常見的耳部疾病。病因通常為多因素性，包括原發因素（過敏、異物、寄生蟲）、易感因素（耳道結構、濕度）和持續因素（細菌和酵母菌繼發感染）。",
    "synonyms": [
      "Acute Ear Infection",
      "External Ear Canal Inflammation",
      "急性耳道炎"
    ],
    "epidemiology": {
      "species": "犬貓皆可，犬遠較貓常見",
      "age": "任何年齡，過敏相關者通常1-3歲開始",
      "sex": "無性別傾向",
      "riskFactors": [
        "垂耳品種（可卡犬、巴吉度、比乎犬、拉布拉多）",
        "耳道毛多的品種（貴賓犬、雪納瑞）",
        "異位性皮膚炎或食物過敏",
        "游泳或洗澡後耳道潮濕",
        "耳道異物（草芒）",
        "耳蟎感染（幼犬幼貓）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "搔耳或甩頭",
        "耳部異味",
        "耳道分泌物",
        "耳根觸摸時疼痛或不適",
        "頭部傾斜（可能）",
        "可能與過敏症狀（搔癢、足部舔舐）相關"
      ],
      "physicalExam": [
        "耳翼內側和耳道充血腫脹",
        "耳道分泌物（黃棕色蠟狀=酵母菌；黃綠色膿性=細菌）",
        "耳道狹窄（腫脹所致）",
        "觸壓耳根疼痛",
        "耳道壁紅腫和增厚",
        "嚴重時可見潰瘍",
        "檢查鼓膜完整性（可能因腫脹而無法觀察）"
      ]
    },
    "pathophysiology": "外耳炎的發展遵循原發因素-易感因素-持續因素的框架。原發因素（如異位性皮膚炎）啟動耳道炎症，破壞正常的耳道上皮屏障和自清機制。易感因素（垂耳造成的通風不良、耳道毛過多、耳道結構狹窄）創造有利於微生物增殖的環境。炎症導致耳道腺體（皮脂腺和耵聹腺）分泌增加和上皮增生。繼發性細菌（Staphylococcus, Pseudomonas）和酵母菌（Malassezia pachydermatis）在此環境中過度增殖，成為維持炎症的持續因素。慢性反覆感染導致耳道不可逆的增生和狹窄。",
    "diagnosis": {
      "overview": "耳鏡檢查和耳道細胞學是診斷的基礎",
      "differentials": [
        "中耳炎",
        "耳道腫瘤或息肉",
        "耳道異物",
        "自體免疫性皮膚病",
        "耳蟎感染"
      ],
      "initialDB": [
        "耳鏡檢查（評估耳道狀態和鼓膜完整性）",
        "耳道分泌物細胞學（革蘭氏染色或Diff-Quik染色——細菌型態、酵母菌、炎症細胞）",
        "耳蟎檢查（礦物油標本）"
      ],
      "advanced": [
        "細菌培養和藥敏試驗（慢性/難治性或疑似Pseudomonas感染時）",
        "頭部X光或CT（疑似中耳炎時）",
        "過敏原檢測（反覆發作者）",
        "甲狀腺功能檢查（老年犬反覆外耳炎）"
      ]
    },
    "treatment": {
      "overview": "治療包括耳道清潔、局部抗微生物治療和處理原發因素",
      "acute": [
        "耳道清潔（溫和清耳液，如含ceruminolytic成分的產品）",
        "細菌感染：含抗生素的耳滴劑（如polymyxin B-miconazole-prednisolone）",
        "酵母菌感染：含抗黴菌成分的耳滴劑（miconazole、clotrimazole）",
        "嚴重發炎：含類固醇的耳滴劑",
        "疼痛嚴重時短期口服NSAIDs",
        "Pseudomonas感染：含fluoroquinolone的耳滴劑或tris-EDTA沖洗"
      ],
      "chronic": [
        "識別和管理原發因素（過敏管理）",
        "定期耳道清潔維護",
        "預防性耳道乾燥（游泳後）",
        "嚴重增生性外耳炎：口服糖皮質激素減少增生",
        "末期增生性耳道：全耳道切除術+鼓泡截骨術（TECA-LBO）"
      ]
    },
    "prognosis": "急性首次發作經適當治療預後良好。過敏相關的外耳炎傾向於反覆發作，需要長期管理原發因素。Pseudomonas感染和慢性增生性外耳炎較難治療。",
    "pearls": [
      "外耳炎通常是潛在問題（特別是過敏）的表現，而非獨立疾病",
      "耳道細胞學是選擇初始治療的關鍵——球菌vs桿菌vs酵母菌的治療不同",
      "鼓膜破裂時許多耳用藥物（特別是aminoglycosides）禁用",
      "反覆外耳炎的犬應評估異位性皮膚炎和食物過敏",
      "不應在未確認鼓膜完整性的情況下使用耳毒性藥物"
    ],
    "diagnosticAlgorithm": {
      "title": "急性外耳炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估耳部症狀與既往史",
          "findings": [
            "甩頭與搔抓耳部",
            "耳道分泌物增多",
            "耳部疼痛與紅腫",
            "耳廓內側紅斑"
          ]
        },
        {
          "step": 2,
          "action": "耳鏡檢查",
          "details": "使用耳鏡評估耳道與鼓膜",
          "findings": [
            "耳道紅腫與狹窄",
            "分泌物性質（蠟狀/膿性/褐色）",
            "鼓膜完整性評估",
            "耳道異物或腫塊排除"
          ]
        },
        {
          "step": 3,
          "action": "耳分泌物細胞學",
          "details": "耳拭子採樣做細胞學檢查",
          "findings": [
            "球菌或桿菌感染",
            "馬拉色菌（酵母菌）增生",
            "嗜中性球與炎症細胞",
            "耳蟎蟲體或蟲卵"
          ]
        },
        {
          "step": 4,
          "action": "確診與病因分析",
          "details": "確認感染類型並追究潛在病因",
          "findings": [
            "確認細菌/酵母菌/寄生蟲感染類型",
            "評估過敏性疾病作為主要病因",
            "評估耳道構造異常（垂耳犬種）",
            "必要時進行細菌培養與藥敏試驗"
          ]
        }
      ]
    },
    "monitoring": [
      "治療後7-14天複診評估反應",
      "細胞學複查確認感染控制",
      "反覆發作者每1-3個月定期耳道檢查",
      "過敏管理的長期追蹤"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "transitional-cell-carcinoma": {
    "zh": "移行上皮細胞癌",
    "en": "Transitional Cell Carcinoma (TCC/Urothelial Carcinoma)",
    "definition": "移行上皮細胞癌是犬最常見的膀胱腫瘤，起源於泌尿道移行上皮（尿路上皮）。最常見於膀胱三角區（trigone），經常侵犯尿道和輸尿管開口，導致泌尿道阻塞。具有局部侵襲性和遠端轉移潛力。",
    "synonyms": [
      "TCC",
      "Urothelial Carcinoma",
      "Bladder Cancer",
      "膀胱移行細胞癌"
    ],
    "epidemiology": {
      "species": "犬為主，貓罕見",
      "age": "中老年犬（平均9-11歲）",
      "sex": "母犬略多（約1.5-2倍）",
      "riskFactors": [
        "蘇格蘭㹴（風險為其他品種18-20倍）",
        "其他好發品種（西高地白㹴、比高犬、喜樂蒂牧羊犬、米格魯）",
        "肥胖",
        "舊型殺蟲劑暴露（已禁用的環己烷類）",
        "環境致癌物（除草劑）",
        "cyclophosphamide長期使用"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "血尿（最常見的主訴）",
        "頻尿和排尿困難",
        "反覆性「泌尿道感染」對抗生素反應不佳",
        "排尿疼痛",
        "晚期：排尿困難或完全無法排尿",
        "體重減輕"
      ],
      "physicalExam": [
        "直腸觸診可能觸及膀胱三角區或尿道增厚",
        "膀胱觸診可能感覺增厚或腫塊",
        "腹部觸診可能有不適",
        "晚期可見膀胱膨大（阻塞時）",
        "轉移時可見髂下淋巴結腫大（直腸檢查）"
      ]
    },
    "pathophysiology": "TCC起源於膀胱移行上皮細胞的惡性轉化，涉及多個基因突變。BRAF V595E突變在犬TCC中極為常見（約80%），成為重要的診斷生物標記。腫瘤好發於膀胱三角區，可能與該區域尿液中致癌物濃度和接觸時間較高有關。腫瘤呈乳頭狀或浸潤性生長，侵入膀胱壁肌層和漿膜層。三角區的位置使腫瘤容易阻塞輸尿管開口（導致腎後性腎衰竭）和尿道（導致排尿困難）。區域淋巴結轉移和遠端肺轉移是常見的轉移途徑。",
    "diagnosis": {
      "overview": "結合影像學、細胞學/組織學和分子診斷確診",
      "differentials": [
        "細菌性膀胱炎",
        "膀胱結石",
        "膀胱息肉",
        "其他膀胱腫瘤（鱗狀細胞癌、腺癌）",
        "前列腺疾病",
        "尿道狹窄"
      ],
      "initialDB": [
        "腹部超音波（膀胱壁增厚或腫塊，最常見於三角區）",
        "尿液分析和尿液細胞學（可見異型上皮細胞，但敏感度中等）",
        "尿液培養排除感染",
        "CBC和生化檢查",
        "BRAF V595E突變尿液PCR檢測（高度特異性）"
      ],
      "advanced": [
        "創傷性導尿管活檢（traumatic catheterization）",
        "膀胱鏡檢查和活檢",
        "腹部和胸腔影像學評估轉移（三視X光、CT）",
        "直腸檢查評估尿道和髂下淋巴結",
        "注意：不建議經皮膀胱穿刺活檢（腫瘤植入風險）"
      ]
    },
    "treatment": {
      "overview": "因腫瘤位置多無法完全手術切除，以化療和NSAIDs為主要治療",
      "acute": [
        "確診後開始NSAIDs治療（piroxicam 0.3 mg/kg PO q24h或meloxicam）",
        "化療：mitoxantrone 5 mg/m² IV q3w或vinblastine 2 mg/m² IV q2w",
        "合併NSAIDs + 化療效果優於單一治療",
        "尿道阻塞時：尿道支架（stent）置放"
      ],
      "chronic": [
        "持續NSAIDs治療（具直接抗腫瘤活性）",
        "定期化療療程",
        "新型標靶治療：口服toceranib（Palladia）",
        "膀胱部分切除術（僅適用於非三角區的局限性腫瘤，<5%的病例）",
        "腎後性阻塞：輸尿管支架或皮下輸尿管旁路（SUB系統）"
      ]
    },
    "prognosis": "中位存活時間：僅NSAIDs約6個月，NSAIDs+化療約10-12個月。蘇格蘭㹴的預後可能略好。尿道或輸尿管完全阻塞是常見的死亡原因。遠端轉移在確診時約15-20%，但最終約50%會發展遠端轉移。",
    "pearls": [
      "反覆「泌尿道感染」對抗生素反應差的中老年犬應考慮TCC",
      "不要進行經皮膀胱穿刺活檢——有腫瘤沿針道植入的風險",
      "BRAF V595E尿液突變檢測是非侵入性的高特異性診斷工具",
      "piroxicam/meloxicam具有直接的抗TCC活性，不僅僅是止痛",
      "蘇格蘭㹴因極高的品種風險可考慮篩檢計劃"
    ],
    "diagnosticAlgorithm": {
      "title": "移行上皮細胞癌 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估泌尿道症狀與品種傾向",
          "findings": [
            "慢性血尿",
            "頻尿與排尿困難",
            "反覆泌尿道感染治療無效",
            "好發於蘇格蘭梗犬"
          ]
        },
        {
          "step": 2,
          "action": "影像學檢查",
          "details": "腹部超音波評估膀胱",
          "findings": [
            "膀胱三角區腫塊",
            "不規則軟組織團塊",
            "可能侵犯尿道",
            "區域淋巴結腫大"
          ]
        },
        {
          "step": 3,
          "action": "尿液與組織學檢查",
          "details": "尿液細胞學與組織取樣",
          "findings": [
            "尿液沉渣見異型上皮細胞",
            "BRAF突變檢測（犬特異性）",
            "經導管或膀胱鏡活檢",
            "避免經腹穿刺（腫瘤播散風險）"
          ]
        },
        {
          "step": 4,
          "action": "確診與分期",
          "details": "組織病理學確診並進行臨床分期",
          "findings": [
            "組織病理確認移行上皮細胞癌",
            "胸腔X光排除肺轉移",
            "腹部CT評估局部侵犯範圍",
            "TNM分期指導治療計畫"
          ]
        }
      ]
    },
    "monitoring": [
      "腹部超音波每4-8週評估腫瘤大小和阻塞",
      "腎功能定期監測（輸尿管阻塞風險）",
      "尿液分析和培養",
      "胸腔X光每2-3個月評估肺轉移",
      "NSAIDs使用時監測腎功能和胃腸道副作用"
    ],
    "reference": "Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "nasal-aspergillosis": {
    "zh": "鼻腔麴菌病",
    "en": "Nasal Aspergillosis",
    "definition": "鼻腔麴菌病是由麴菌屬真菌（主要為 Aspergillus fumigatus）感染鼻腔和鼻竇引起的真菌性鼻炎。犬為最常見的宿主，感染通常局限於鼻腔（鼻竇型），但免疫抑制動物可發展為播散型。麴菌為環境中的腐生真菌，經吸入孢子後在鼻腔定殖並破壞鼻甲骨。",
    "synonyms": [
      "Sinonasal Aspergillosis",
      "Aspergillus Rhinitis",
      "Fungal Rhinitis",
      "鼻竇麴菌感染"
    ],
    "epidemiology": {
      "species": "犬較常見，貓罕見（貓多為播散型）",
      "age": "犬：中年犬（平均3-7歲），貓：無明確年齡好發",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "中長頭型犬種（德國牧羊犬、Rottweiler、Golden Retriever）",
        "免疫功能正常的犬也可感染",
        "鼻腔異物或腫瘤導致局部免疫防禦受損",
        "免疫抑制狀態（播散型）",
        "長期使用免疫抑制藥物"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "慢性單側（後期可能雙側）鼻分泌物，持續數週至數月",
        "鼻分泌物由漿液性轉為黏液膿性或血性",
        "反覆性鼻出血",
        "打噴嚏",
        "鼻樑疼痛或不適",
        "對先前抗生素治療反應不佳",
        "食慾和活力通常正常"
      ],
      "physicalExam": [
        "單側或雙側鼻分泌物（黏液膿性至血性）",
        "鼻樑可能有潰瘍或去色素化",
        "鼻孔周圍結痂",
        "鼻樑觸診可能疼痛",
        "面部對稱性通常正常（除非嚴重鼻甲骨破壞）",
        "眼結膜可能充血",
        "齒齦和硬腭通常正常（與鼻腔腫瘤鑑別）"
      ]
    },
    "pathophysiology": "Aspergillus fumigatus 孢子經吸入進入鼻腔後，在黏膜表面萌發形成菌絲體。真菌分泌蛋白酶和彈性酶等外毒素，直接破壞鼻甲骨和鼻中隔軟骨。局部免疫反應（嗜中性球和巨噬細胞浸潤）加重組織損傷。真菌斑塊（fungal plaque）附著於鼻甲骨表面，形成生物膜樣結構，增加治療難度。鼻甲骨進行性破壞導致鼻腔空腔化（turbinate destruction），嚴重時可穿透篩板影響前顱窩。犬的鼻腔麴菌感染通常不會播散至全身，因為宿主有足夠的全身免疫力；然而局部黏膜防禦機制的缺陷允許真菌在鼻腔定殖。",
    "diagnosis": {
      "overview": "結合影像學、內視鏡、真菌學和血清學進行綜合診斷，單一檢查不足以確診",
      "differentials": [
        "鼻腔腫瘤（淋巴瘤、腺癌、軟骨肉瘤）",
        "細菌性鼻炎",
        "牙齒疾病相關鼻炎",
        "鼻腔異物",
        "特發性鼻炎（淋巴漿細胞性鼻炎）",
        "隱球菌鼻炎",
        "鼻蟎感染"
      ],
      "initialDB": [
        "鼻腔X光或CT（首選CT）——典型表現為鼻甲骨溶解和額竇積液",
        "Aspergillus 血清抗體檢測（AGID或ELISA）——犬鼻竇型敏感度70-90%",
        "CBC/生化——通常正常",
        "鼻分泌物細胞學——可見真菌菌絲但敏感度低"
      ],
      "advanced": [
        "鼻腔CT掃描（金標準影像學）——評估鼻甲骨破壞程度和篩板完整性",
        "鼻腔內視鏡——直視真菌斑塊（白色至灰綠色）並採集活檢",
        "組織病理學——PAS或GMS染色顯示真菌菌絲侵入組織",
        "真菌培養（需數天至數週）",
        "PCR檢測"
      ]
    },
    "treatment": {
      "overview": "首選經鼻腔灌注抗真菌藥物（局部治療），嚴重或難治病例需全身性抗真菌治療",
      "acute": [
        "鼻腔灌注 clotrimazole 1%溶液（最常用且療效最佳）——全身麻醉下進行，灌注60分鐘",
        "替代方案：enilconazole 鼻腔灌注",
        "灌注前需經內視鏡清除可見的真菌斑塊（debridement）",
        "確認篩板完整後方可進行灌注（避免藥物進入顱腔）"
      ],
      "chronic": [
        "難治病例：口服 itraconazole 5 mg/kg q12-24h，療程至少8-12週",
        "替代：fluconazole 5 mg/kg q12h",
        "可能需要多次灌注治療（約15-20%病例需二次灌注）",
        "嚴重鼻甲骨破壞者考慮鼻竇探查和清創"
      ]
    },
    "prognosis": "單次 clotrimazole 灌注的治癒率約65-85%，二次灌注可提高至90%以上。早期診斷和治療預後良好。篩板受損或播散型預後較差。貓的播散型麴菌感染預後不良。",
    "pearls": [
      "鼻腔麴菌病是犬慢性鼻分泌物最常見的真菌原因",
      "CT是評估鼻甲骨破壞和篩板完整性的金標準，灌注前必須確認篩板完整",
      "Aspergillus血清學陰性不能排除感染（敏感度70-90%）",
      "與鼻腔腫瘤的鑑別至關重要——腫瘤傾向軟組織腫塊，麴菌傾向鼻甲骨溶解伴空腔化",
      "clotrimazole局部灌注療效優於全身性抗真菌藥物"
    ],
    "diagnosticAlgorithm": {
      "title": "鼻腔麴菌病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估慢性鼻部症狀，注意中大型犬長頭種",
          "findings": [
            "慢性單側膿性或血性鼻分泌物",
            "鼻鏡去色素化與潰瘍",
            "打噴嚏與鼻部不適",
            "對抗生素治療無反應"
          ]
        },
        {
          "step": 2,
          "action": "影像學檢查",
          "details": "CT或X光評估鼻腔結構",
          "findings": [
            "鼻甲介骨溶解破壞",
            "鼻腔內不透明密度增加",
            "篩板完整性評估",
            "額竇可能受累"
          ]
        },
        {
          "step": 3,
          "action": "鼻腔鏡檢查",
          "details": "直接可視化鼻腔內部",
          "findings": [
            "可見白色或綠色真菌菌落",
            "鼻甲介骨破壞與壞死",
            "採集組織活檢與培養樣本"
          ]
        },
        {
          "step": 4,
          "action": "確診",
          "details": "綜合影像學、鏡檢與實驗室檢查確診",
          "findings": [
            "真菌培養陽性（Aspergillus fumigatus）",
            "Aspergillus血清學抗體陽性",
            "組織病理見真菌菌絲",
            "鼻腔鏡直接可見菌落"
          ]
        }
      ]
    },
    "monitoring": [
      "治療後4-6週複查CT評估反應",
      "鼻分泌物改善情況臨床追蹤",
      "血清抗體滴度變化（下降提示治療反應，但不完全可靠）",
      "治癒後仍需追蹤6-12個月以偵測復發"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "cryptococcosis": {
    "zh": "隱球菌病",
    "en": "Cryptococcosis",
    "definition": "隱球菌病是由隱球菌屬真菌（主要為 Cryptococcus neoformans 和 C. gattii）引起的系統性真菌感染。經吸入環境中的酵母菌或擔孢子進入呼吸道後，可播散至鼻腔、中樞神經系統、眼睛和皮膚。貓為最常見的受感染家畜。",
    "synonyms": [
      "Cryptococcal Infection",
      "European Blastomycosis",
      "隱球菌感染"
    ],
    "epidemiology": {
      "species": "貓較常見（為犬的5-6倍），犬亦可感染",
      "age": "貓：中年（中位數5歲），犬：平均3.5歲",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "接觸鴿糞或含有機物的土壤（C. neoformans）",
        "接觸桉樹（C. gattii）",
        "FeLV或FIV感染（貓）",
        "免疫抑制狀態",
        "長期使用糖皮質類固醇",
        "戶外活動"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "貓：慢性鼻分泌物（漿液性至黏液膿性）和打噴嚏",
        "鼻樑或面部腫脹（典型的「蛤蟆鼻」外觀）",
        "皮膚結節或潰瘍",
        "眼睛問題（視力模糊、瞳孔不等大）",
        "犬：常表現為中樞神經症狀",
        "體重減輕和食慾下降"
      ],
      "physicalExam": [
        "鼻樑腫脹（firm swelling）——貓最典型的表現",
        "鼻腔黏液膿性或血性分泌物",
        "皮膚結節（堅實、無痛，可潰瘍）",
        "下頜淋巴結腫大",
        "眼底檢查：脈絡膜視網膜炎、視神經乳頭水腫",
        "神經症狀：共濟失調、旋轉、抽搐、行為改變、失明",
        "發熱（不一定）"
      ]
    },
    "pathophysiology": "C. neoformans 主要存在於鴿糞和土壤中，C. gattii 與桉樹相關。吸入乾燥的酵母菌或擔孢子後，首先在鼻腔和下呼吸道定殖。隱球菌的主要毒力因子為多醣莢膜（主要含葡萄糖醛酸木聚醣/GXM），可抑制吞噬作用、補體活化和T細胞免疫反應。真菌經血行播散至具有高氧分壓的器官——中樞神經系統（具有高腦脊液葡萄糖和低補體水平的優勢環境）、皮膚和眼睛。貓的鼻腔感染最常見，可能與其解剖學和免疫學特點有關。犬的CNS感染較貓更常見，且常伴有免疫抑制基礎疾病。",
    "diagnosis": {
      "overview": "乳膠凝集抗原檢測（LCAT）是最實用且敏感的篩查工具，結合細胞學和培養確診",
      "differentials": [
        "鼻腔腫瘤",
        "鼻腔麴菌病",
        "細菌性鼻炎",
        "鼻息肉",
        "其他系統性真菌感染",
        "弓漿蟲腦炎",
        "FIP神經型"
      ],
      "initialDB": [
        "隱球菌莢膜抗原乳膠凝集試驗（LCAT）——血清和/或CSF——敏感度>95%，可同時定量作為治療監測",
        "鼻分泌物或皮膚結節細胞學——墨汁染色（India ink）顯示有莢膜的酵母菌",
        "CBC/生化——通常無特異性變化",
        "FeLV/FIV檢測（貓）"
      ],
      "advanced": [
        "真菌培養（Sabouraud agar，需1-5天）",
        "鼻腔/鼻竇CT掃描（評估骨溶解範圍）",
        "腦脊液分析——LCAT陽性、嗜中性球或混合細胞增多、蛋白升高",
        "眼底鏡檢查（篩查眼部受累）",
        "胸腔X光（評估肺部受累）",
        "組織病理學——PAS染色和Mayer mucicarmine染色"
      ]
    },
    "treatment": {
      "overview": "長期口服抗真菌藥物，療程通常數月至超過一年",
      "acute": [
        "fluconazole 50 mg/cat q12h 或 5-10 mg/kg q12h（首選——良好的CNS滲透力）",
        "itraconazole 5-10 mg/kg q12-24h（鼻腔和皮膚型有效）",
        "CNS受累：fluconazole為首選（優異的BBB滲透）",
        "嚴重病例：amphotericin B 0.5-0.8 mg/kg IV（脂質體配方較安全）+ flucytosine 25-50 mg/kg q6-8h（聯合誘導治療）"
      ],
      "chronic": [
        "fluconazole或itraconazole持續治療至抗原滴度降至陰性後再持續2-3個月",
        "平均治療時間6-18個月",
        "LCAT滴度每2-3個月監測以指導療程",
        "避免過早停藥導致復發"
      ]
    },
    "prognosis": "鼻腔型預後良好（治癒率約80-90%）。皮膚型預後良好。CNS受累預後謹慎至不良。合併FeLV/FIV感染預後較差。犬的預後通常比貓差（因CNS受累更常見）。",
    "pearls": [
      "LCAT抗原檢測是診斷隱球菌病最實用的工具，且滴度可用於監測治療反應",
      "貓的隱球菌病不一定需要免疫抑制背景——許多感染貓FeLV/FIV陰性",
      "鼻樑腫脹（蛤蟆鼻）是貓隱球菌病最具特徵性的臨床表現",
      "fluconazole因其優異的CNS滲透力，是有CNS受累時的首選",
      "停藥標準：LCAT滴度陰性後再持續治療至少2個月"
    ],
    "diagnosticAlgorithm": {
      "title": "隱球菌病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估鼻腔、CNS或皮膚症狀，貓較犬常見",
          "findings": [
            "慢性鼻分泌物與鼻樑腫脹",
            "皮膚結節或潰瘍",
            "神經症狀（CNS型）",
            "眼部病變（脈絡膜視網膜炎）"
          ]
        },
        {
          "step": 2,
          "action": "細胞學檢查",
          "details": "病灶細針抽吸或分泌物細胞學",
          "findings": [
            "墨汁染色見大莢膜酵母菌",
            "細針抽吸見特徵性厚莢膜酵母菌體",
            "周圍炎症反應通常輕微"
          ]
        },
        {
          "step": 3,
          "action": "血清學檢測",
          "details": "隱球菌莢膜抗原檢測",
          "findings": [
            "乳膠凝集試驗（LCAT）陽性",
            "抗原效價與疾病嚴重度相關",
            "可用於監測治療反應"
          ]
        },
        {
          "step": 4,
          "action": "確診與範圍評估",
          "details": "確認感染範圍並進行分期",
          "findings": [
            "真菌培養確認Cryptococcus neoformans/gattii",
            "CNS評估（MRI或CSF分析）",
            "胸腔X光排除肺部感染",
            "FeLV/FIV檢測評估免疫狀態"
          ]
        }
      ]
    },
    "monitoring": [
      "LCAT抗原滴度每2-3個月監測",
      "肝腎功能監測（長期抗真菌治療）",
      "眼底檢查評估眼部病變變化",
      "神經系統評估",
      "治療結束後6-12個月追蹤監測復發"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "blastomycosis": {
    "zh": "芽生黴菌病",
    "en": "Blastomycosis",
    "definition": "芽生黴菌病是由雙相性真菌 Blastomyces dermatitidis 引起的系統性真菌感染。真菌以黴菌型存在於環境中（潮濕酸性土壤），經吸入分生孢子進入肺部後轉為酵母型並引起肺部感染，可經血行播散至皮膚、眼睛、骨骼和淋巴結等器官。犬為最常見的受感染物種。",
    "synonyms": [
      "North American Blastomycosis",
      "Gilchrist's Disease",
      "芽生菌病",
      "北美芽生黴菌病"
    ],
    "epidemiology": {
      "species": "犬較常見，貓罕見（犬：貓約10：1）",
      "age": "犬：年輕至中年（1-5歲），大型犬居多",
      "sex": "公犬較多（可能與戶外活動行為有關）",
      "riskFactors": [
        "居住在流行地區（北美五大湖區、俄亥俄河谷和密西西比河谷）",
        "接觸潮濕的沙質酸性土壤",
        "靠近水域（河岸、湖邊、沼澤）",
        "狩獵犬和戶外活動犬",
        "大型運動犬種",
        "挖掘行為"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "慢性咳嗽和呼吸困難",
        "運動不耐",
        "食慾下降和體重減輕",
        "皮膚結節或潰瘍性病灶",
        "跛行（骨骼受累時）",
        "眼睛紅腫、視力下降",
        "發熱",
        "病程通常數週"
      ],
      "physicalExam": [
        "呼吸音增強或異常（囉音、哮鳴音）",
        "呼吸困難和呼吸急促",
        "皮膚結節或潰瘍（引流竇道，排出血性至膿性分泌物）",
        "多處周邊淋巴結腫大",
        "眼部：前葡萄膜炎、脈絡膜視網膜炎、青光眼、視網膜剝離",
        "發熱",
        "跛行和骨骼腫脹",
        "體重減輕和肌肉消瘦"
      ]
    },
    "pathophysiology": "B. dermatitidis 在環境中以黴菌型生長於潮濕酸性土壤中。分生孢子（直徑2-10 μm）經吸入進入終末細支氣管和肺泡後，在37°C體溫下轉化為大型厚壁酵母型（8-25 μm），此為致病型態。酵母菌表面的黏附素BAD1（Blastomyces adhesin 1）促進與宿主細胞的黏附並抑制TNF-α的產生。肺部感染引起肉芽腫性至化膿性炎症反應。酵母菌經血行和淋巴播散至皮膚（40-50%犬）、眼睛（20-50%犬）、骨骼（30%犬）和淋巴結。細胞免疫（Th1反應）是控制感染的關鍵——免疫功能不全的宿主更易發生播散型感染。",
    "diagnosis": {
      "overview": "細胞學直接鏡檢發現特徵性酵母菌是最快且最可靠的診斷方法",
      "differentials": [
        "肺部腫瘤",
        "細菌性肺炎",
        "其他系統性真菌感染（組織漿菌、球孢子菌）",
        "結核分枝桿菌",
        "全身性淋巴瘤"
      ],
      "initialDB": [
        "細胞學檢查（引流皮膚病灶、淋巴結穿刺、肺灌洗液）——特徵性大型（8-25 μm）厚壁寬基底出芽酵母菌",
        "胸腔X光——瀰漫性結節性間質型至支氣管肺泡型浸潤",
        "尿液 Blastomyces 抗原檢測（MiraVista）——敏感度>90%",
        "CBC——嗜中性球增多，可能貧血"
      ],
      "advanced": [
        "真菌培養（需生物安全等級3實驗室，生長緩慢2-4週）",
        "組織病理學——肉芽腫性至化膿性炎症伴酵母菌",
        "眼科完整檢查（裂隙燈、眼底鏡、眼壓）",
        "骨骼X光（懷疑骨受累時）",
        "血清抗體（Agar gel immunodiffusion）——敏感度較低（40-90%）"
      ]
    },
    "treatment": {
      "overview": "長期口服抗真菌藥物為主，嚴重病例可用 amphotericin B 誘導治療",
      "acute": [
        "itraconazole 5 mg/kg q24h 與食物同服（首選，治癒率約70-75%）",
        "嚴重肺部受累或危及生命：amphotericin B（脂質體配方 1 mg/kg IV 每週2-3次，累積劑量12-15 mg/kg）",
        "支持療法：氧氣治療、輸液",
        "眼部受累：局部和全身抗炎治療"
      ],
      "chronic": [
        "itraconazole持續治療至少4-6個月",
        "尿液抗原轉陰後再持續1-2個月",
        "fluconazole 5 mg/kg q12h（替代方案，CNS或眼部受累時可考慮）",
        "嚴重眼部炎症需併用抗炎藥物"
      ]
    },
    "prognosis": "整體治癒率約70-75%。輕度至中度肺部感染預後良好。嚴重瀰漫性肺部感染（呼吸衰竭）預後不良。腦部受累預後差。嚴重眼部受累可能導致永久性視力喪失。治療初期可能因酵母菌死亡釋放抗原而出現暫時性惡化。",
    "pearls": [
      "細胞學是最快的診斷工具——厚壁寬基底出芽酵母菌是病原特徵",
      "尿液抗原檢測敏感度高且可用於監測治療反應",
      "治療初期呼吸症狀可能暫時惡化（死亡酵母菌引起的炎症反應）",
      "與組織漿菌的鑑別：芽生黴菌酵母菌較大（8-25 μm）且厚壁寬基底出芽",
      "眼部受累是芽生黴菌病的重要特徵，所有確診病例均應接受完整眼科檢查"
    ],
    "diagnosticAlgorithm": {
      "title": "芽生黴菌病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估呼吸道與全身症狀，注意地理分布（北美水域附近）",
          "findings": [
            "慢性咳嗽與呼吸困難",
            "發熱與體重減輕",
            "皮膚結節或排膿性病灶",
            "眼部病變（葡萄膜炎）"
          ]
        },
        {
          "step": 2,
          "action": "影像學檢查",
          "details": "胸腔X光評估肺部病變",
          "findings": [
            "肺部結節性或瀰漫性間質浸潤",
            "肺門淋巴結腫大",
            "胸腔積液（部分病例）"
          ]
        },
        {
          "step": 3,
          "action": "細胞學與組織學",
          "details": "病灶採樣進行細胞學診斷",
          "findings": [
            "細胞學見大型厚壁廣基出芽酵母菌",
            "肉芽腫性炎症反應",
            "BAL或淋巴結FNA採樣"
          ]
        },
        {
          "step": 4,
          "action": "確診",
          "details": "綜合微生物學與血清學確診",
          "findings": [
            "Blastomyces抗原尿液檢測陽性",
            "真菌培養（需BSL-3實驗室）",
            "組織病理學見特徵性酵母菌體",
            "血清學抗體檢測輔助診斷"
          ]
        }
      ]
    },
    "monitoring": [
      "尿液 Blastomyces 抗原滴度每2-3個月監測",
      "胸腔X光追蹤肺部病灶",
      "肝功能監測（itraconazole肝毒性）",
      "眼科定期檢查",
      "停藥後監測6-12個月偵測復發"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "histoplasmosis": {
    "zh": "組織漿菌病",
    "en": "Histoplasmosis",
    "definition": "組織漿菌病是由雙相性真菌 Histoplasma capsulatum 引起的系統性真菌感染。真菌存在於含有鳥糞或蝙蝠糞的土壤中，經吸入微分生孢子進入肺部，隨後可播散至胃腸道、肝、脾、骨髓和淋巴結。貓和犬均可感染，犬以肺部型為主，貓以播散型多見。",
    "synonyms": [
      "Ohio Valley Disease",
      "Cave Disease",
      "Darling's Disease",
      "組織胞漿菌病"
    ],
    "epidemiology": {
      "species": "犬貓皆可，貓略多於犬",
      "age": "犬：年輕犬（<4歲），貓：年輕至中年",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "居住在流行地區（美國俄亥俄河谷和密西西比河谷）",
        "接觸鳥糞或蝙蝠糞污染的土壤",
        "接觸雞舍、鴿棚、洞穴",
        "免疫抑制狀態（FeLV/FIV）",
        "戶外活動"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "犬：慢性咳嗽、呼吸困難、運動不耐",
        "貓：體重減輕、食慾下降、嗜睡為主要表現",
        "慢性腹瀉（尤其犬的GI型）",
        "發熱",
        "跛行",
        "病程通常數週至數月"
      ],
      "physicalExam": [
        "犬肺部型：呼吸音增強、囉音",
        "GI型（犬多見）：大腸性腹瀉伴鮮血和黏液、腸壁增厚",
        "肝脾腫大",
        "全身淋巴結腫大",
        "黃疸（肝受累嚴重時）",
        "貧血的蒼白黏膜",
        "骨病灶：骨溶解性跛行",
        "眼部：脈絡膜視網膜炎、前葡萄膜炎",
        "消瘦和惡病質"
      ]
    },
    "pathophysiology": "H. capsulatum 在環境中以黴菌型存在於含有鳥糞或蝙蝠糞的富氮土壤中。微分生孢子和小分生孢子（2-5 μm）經吸入到達肺泡後，被肺泡巨噬細胞吞噬。在巨噬細胞內，真菌轉化為小型酵母菌（2-4 μm）並在吞噬溶酶體中存活繁殖——這是其主要致病機制。組織漿菌調節吞噬溶酶體的pH值並獲取鐵和鈣以支持其胞內生存。感染的巨噬細胞經血行和淋巴播散至富含單核吞噬細胞系統的器官（肝、脾、骨髓、淋巴結）。犬的胃腸道受累非常常見，可能透過吞入含有真菌的呼吸道分泌物或經血行播散至腸壁。有效的細胞免疫反應（Th1型）形成肉芽腫限制感染擴散。",
    "diagnosis": {
      "overview": "細胞學或組織病理學發現胞內酵母菌是確診基礎，配合抗原檢測提高診斷率",
      "differentials": [
        "炎症性腸病（GI型）",
        "腸道淋巴瘤",
        "其他系統性真菌感染",
        "分枝桿菌感染",
        "利什曼病",
        "全身性淋巴瘤"
      ],
      "initialDB": [
        "細胞學（骨髓穿刺、淋巴結穿刺、直腸刮片、肺灌洗液）——巨噬細胞內小型（2-4 μm）酵母菌",
        "尿液/血清 Histoplasma 抗原檢測（MiraVista）——敏感度高",
        "CBC——非再生性貧血、血小板減少、嗜中性球減少或增多（骨髓受累）",
        "生化——肝酶升高、低白蛋白、高球蛋白"
      ],
      "advanced": [
        "組織病理學——肉芽腫性炎症伴巨噬細胞內酵母菌（GMS或PAS染色）",
        "胸腔X光——結節性間質型浸潤或肺門淋巴結腫大",
        "腹部超音波——肝脾腫大、腸壁增厚",
        "骨髓穿刺細胞學（高敏感度）",
        "真菌培養（需BSL-3，生長2-4週）"
      ]
    },
    "treatment": {
      "overview": "長期口服 itraconazole 為首選治療",
      "acute": [
        "itraconazole 10 mg/kg q24h 與食物同服",
        "嚴重播散型：amphotericin B（脂質體配方）誘導治療2-4週後轉換為itraconazole",
        "支持療法：輸液、營養支持、必要時輸血",
        "GI型嚴重吸收不良時可能需要靜脈營養"
      ],
      "chronic": [
        "itraconazole持續治療至少4-6個月",
        "抗原轉陰後再持續1-2個月",
        "fluconazole 為替代方案（CNS受累時）",
        "嚴重GI型可能需要更長療程"
      ]
    },
    "prognosis": "輕度肺部型預後良好。播散型預後謹慎。GI型治療反應通常良好但療程長。骨髓嚴重受累導致全血球減少者預後不良。合併FeLV/FIV感染預後差。治癒率約50-70%取決於受累範圍和嚴重程度。",
    "pearls": [
      "組織漿菌酵母菌非常小（2-4 μm），必須仔細在巨噬細胞內尋找",
      "犬的GI型組織漿菌病可模擬炎症性腸病——慢性大腸性腹瀉患犬在流行區應考慮此診斷",
      "骨髓穿刺是播散型最敏感的診斷方法之一",
      "與芽生黴菌的鑑別：組織漿菌酵母菌小得多（2-4 μm vs 8-25 μm）且為胞內寄生"
    ],
    "diagnosticAlgorithm": {
      "title": "組織漿菌病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估呼吸道與GI症狀，注意地理分布（河流流域）",
          "findings": [
            "慢性咳嗽與呼吸困難",
            "慢性腹瀉與體重減輕（GI型常見於犬）",
            "發熱與嗜睡",
            "肝脾腫大"
          ]
        },
        {
          "step": 2,
          "action": "基本檢查",
          "details": "CBC、生化與影像學檢查",
          "findings": [
            "非再生性貧血",
            "血小板減少",
            "肝酶升高",
            "胸腔X光見瀰漫性間質浸潤"
          ]
        },
        {
          "step": 3,
          "action": "細胞學檢查",
          "details": "病灶或血液細胞學診斷",
          "findings": [
            "單核球/巨噬細胞內見小型酵母菌體（2-4μm）",
            "直腸刮片或淋巴結FNA",
            "肺灌洗液細胞學",
            "骨髓塗片可能見菌體"
          ]
        },
        {
          "step": 4,
          "action": "確診",
          "details": "綜合微生物學與抗原檢測確診",
          "findings": [
            "Histoplasma抗原尿液/血清檢測",
            "真菌培養（需2-4週）",
            "組織病理見肉芽腫性炎症與菌體",
            "PCR檢測輔助確認"
          ]
        }
      ]
    },
    "monitoring": [
      "尿液/血清 Histoplasma 抗原滴度每2-3個月監測",
      "CBC追蹤貧血和血球減少恢復情況",
      "肝功能監測",
      "體重和營養狀態評估",
      "胸腔X光和腹部超音波追蹤"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "coccidioidomycosis": {
    "zh": "球孢子菌病",
    "en": "Coccidioidomycosis",
    "definition": "球孢子菌病（又稱谷熱/Valley Fever）是由雙相性真菌 Coccidioides immitis 或 C. posadasii 引起的系統性真菌感染。真菌以黴菌型存在於乾燥半乾旱地區的土壤中，經吸入關節孢子引起肺部感染，可播散至骨骼、皮膚、眼睛和中樞神經系統。犬為最常見的受感染動物。",
    "synonyms": [
      "Valley Fever",
      "San Joaquin Fever",
      "Desert Rheumatism",
      "谷熱"
    ],
    "epidemiology": {
      "species": "犬較常見，貓罕見",
      "age": "犬：年輕至中年（1-4歲為高峰）",
      "sex": "公犬略多",
      "riskFactors": [
        "居住在或曾旅行至流行地區（美國西南部、墨西哥、中南美洲）",
        "土壤擾動活動（建設工地、挖掘）",
        "沙塵暴後暴露",
        "大型犬種（Boxer、Pointer、Australian Shepherd）",
        "免疫抑制狀態"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "慢性咳嗽（乾咳至濕咳）",
        "運動不耐和呼吸困難",
        "發熱",
        "食慾下降和體重減輕",
        "跛行（骨骼受累，最常見的播散部位）",
        "皮膚結節或引流竇道",
        "病程數週至數月",
        "居住於或曾旅行至美國西南部"
      ],
      "physicalExam": [
        "肺部聽診異常",
        "跛行和骨骼腫脹（長骨遠端最常見）",
        "周邊淋巴結腫大",
        "皮膚結節或潰瘍伴引流竇道",
        "發熱（間歇性）",
        "消瘦",
        "眼部：前葡萄膜炎、脈絡膜視網膜炎",
        "神經症狀（腦膜炎型）：抽搐、行為改變、頸部疼痛"
      ]
    },
    "pathophysiology": "Coccidioides spp. 在乾旱半乾旱地區的鹼性土壤中以黴菌型生長，形成菌絲和關節孢子。土壤被擾動（風、建設、挖掘）後，關節孢子（2-5 μm）散佈於空氣中被吸入。在肺泡中，關節孢子轉化為獨特的球形體（spherule，20-200 μm），球形體內產生大量內孢子（endospores，2-5 μm）。球形體破裂釋放數百個內孢子，每個內孢子可發展為新的球形體，導致感染呈指數擴散。球形體的大尺寸阻礙吞噬作用，是重要的毒力機制。約60%的犬感染為亞臨床或自限性。播散型感染最常累及骨骼（尤其長骨遠端和脊椎）、皮膚和淋巴結。CNS受累（腦膜炎）是最嚴重的併發症。",
    "diagnosis": {
      "overview": "結合血清學、影像學和細胞學/組織病理學進行診斷",
      "differentials": [
        "其他系統性真菌感染",
        "骨腫瘤（骨受累時）",
        "肺部腫瘤",
        "細菌性骨髓炎",
        "椎間盤疾病（脊椎受累時）"
      ],
      "initialDB": [
        "球孢子菌血清抗體檢測（AGID或ELISA）——敏感度和特異度高",
        "胸腔X光——肺門淋巴結腫大、結節性間質浸潤",
        "受累骨骼X光——骨溶解性和增生性病灶混合",
        "CBC/生化——輕度非再生性貧血、高球蛋白血症"
      ],
      "advanced": [
        "細胞學或組織病理學——特徵性球形體（spherules）含內孢子",
        "CT/MRI（骨或CNS受累評估）",
        "腦脊液分析（懷疑腦膜炎時）——嗜酸性球增多具提示意義",
        "真菌培養（需BSL-3，高度危險）",
        "尿液 Coccidioides 抗原檢測"
      ]
    },
    "treatment": {
      "overview": "長期三唑類抗真菌藥物治療，播散型需終生或超長療程",
      "acute": [
        "fluconazole 5-10 mg/kg q12h（首選，良好的骨和CNS滲透）",
        "itraconazole 5 mg/kg q12h（替代）",
        "嚴重肺部型：amphotericin B 脂質體配方作為誘導",
        "支持療法和止痛"
      ],
      "chronic": [
        "fluconazole長期治療至少12個月",
        "播散型（尤其骨骼受累）：可能需要終生治療",
        "CNS受累：終生fluconazole治療",
        "血清學滴度指導療程",
        "停藥後密切監測復發"
      ]
    },
    "prognosis": "肺部局限型預後良好（多數自限性或對治療反應好）。骨骼播散型預後謹慎，需要長期治療且復發率高。CNS受累（腦膜炎）預後不良，通常需終生治療。整體播散型治癒率低於肺部型。",
    "pearls": [
      "Valley Fever是美國西南部犬最常見的系統性真菌感染",
      "骨骼是犬球孢子菌病最常見的播散部位——慢性跛行犬在流行區應考慮此診斷",
      "球形體（spherule）是球孢子菌病獨有的組織型態，具確診價值",
      "fluconazole因其骨和CNS滲透性佳，是治療首選",
      "培養非常危險（BSL-3），必須在懷疑時通知實驗室"
    ],
    "diagnosticAlgorithm": {
      "title": "球孢子菌病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估呼吸道與骨骼症狀，注意地理分布（美國西南部乾旱區）",
          "findings": [
            "慢性咳嗽",
            "跛行與骨骼疼痛",
            "發熱與體重減輕",
            "皮膚排膿性病灶"
          ]
        },
        {
          "step": 2,
          "action": "影像學檢查",
          "details": "胸腔與骨骼X光評估",
          "findings": [
            "肺部結節或肺門淋巴結腫大",
            "骨骼溶解性病灶",
            "骨膜增生反應",
            "關節腫脹"
          ]
        },
        {
          "step": 3,
          "action": "血清學檢測",
          "details": "Coccidioides抗體與抗原檢測",
          "findings": [
            "AGID或ELISA抗體陽性",
            "抗體效價與預後相關",
            "高效價提示播散性感染"
          ]
        },
        {
          "step": 4,
          "action": "確診",
          "details": "細胞學或組織學確認",
          "findings": [
            "組織中見大型球形體（spherule）含內生孢子",
            "細胞學或活檢確認",
            "真菌培養（高度危險，需BSL-3）",
            "PCR輔助鑑定"
          ]
        }
      ]
    },
    "monitoring": [
      "血清抗體滴度每3-4個月監測",
      "骨骼X光追蹤（每2-3個月）",
      "肝腎功能監測（長期三唑類治療）",
      "停藥後至少追蹤12個月",
      "CNS型需終生監測"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "sporotrichosis": {
    "zh": "孢子絲菌病",
    "en": "Sporotrichosis",
    "definition": "孢子絲菌病是由雙相性真菌 Sporothrix schenckii（及相關種 S. brasiliensis）引起的慢性真菌感染。感染通常經皮膚傷口接種（穿刺傷、刺傷）引起局部皮膚和淋巴管感染。貓是重要的傳播來源，其皮膚病灶含有大量酵母菌，具有人畜共通傳染風險。",
    "synonyms": [
      "Rose Gardener's Disease",
      "孢子絲菌感染",
      "園丁病"
    ],
    "epidemiology": {
      "species": "貓較常見且臨床表現較嚴重，犬亦可感染但較少見",
      "age": "無明確年齡好發",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "戶外活動的貓",
        "穿刺傷或外傷史",
        "接觸被感染的貓（S. brasiliensis 在巴西為貓間流行）",
        "接觸腐爛植物、乾草、苔蘚",
        "熱帶和亞熱帶地區",
        "免疫抑制狀態"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "慢性皮膚結節或潰瘍，治療效果不佳",
        "結節沿淋巴管擴展（淋巴管型）",
        "傷口引流不癒合",
        "貓：面部和四肢多處潰瘍性病灶",
        "犬：通常較局限性"
      ],
      "physicalExam": [
        "皮膚結節（堅實、無痛或微痛）",
        "結節潰瘍化伴引流",
        "沿淋巴管線性排列的結節鏈（淋巴管型——經典表現）",
        "區域淋巴結腫大",
        "貓：面部、鼻、耳和四肢多處潰瘍，分泌物量大",
        "播散型：全身皮膚多處病灶、骨關節受累、肺部受累"
      ]
    },
    "pathophysiology": "S. schenckii 在環境中以黴菌型存在於土壤和腐爛植物中。真菌經皮膚破損處接種後轉為酵母型，引起局部肉芽腫性至化膿肉芽腫性炎症反應。感染可沿淋巴管擴散（淋巴管型，最經典的臨床形式）。貓的孢子絲菌病通常更為嚴重，皮膚病灶中含有大量酵母菌（與犬不同，犬的組織中酵母菌較少），這使得貓成為重要的傳染源，尤其 S. brasiliensis 可經貓直接傳播給人和其他貓。播散型感染可累及骨骼、關節、肺部和CNS，免疫抑制個體風險較高。",
    "diagnosis": {
      "overview": "貓的細胞學通常即可確診（大量酵母菌），犬需依賴培養和組織病理學",
      "differentials": [
        "其他真菌感染（隱球菌、皮膚黴菌）",
        "分枝桿菌感染",
        "諾卡菌感染",
        "細菌性膿瘍",
        "皮膚腫瘤",
        "嗜酸性肉芽腫複合體（貓）"
      ],
      "initialDB": [
        "細胞學（病灶穿刺或壓片）——貓：大量圓形至雪茄形酵母菌（3-9 μm）在巨噬細胞內外；犬：酵母菌很少，敏感度低",
        "真菌培養（Sabouraud agar）——25°C長出黴菌型，37°C轉為酵母型，生長需1-4週",
        "CBC/生化——通常正常"
      ],
      "advanced": [
        "組織病理學——化膿肉芽腫性炎症，PAS和GMS染色尋找酵母菌",
        "PCR鑑定種別（S. schenckii vs S. brasiliensis）",
        "播散型評估：胸腔X光、骨骼X光"
      ]
    },
    "treatment": {
      "overview": "長期口服抗真菌藥物，注意人畜共通傳染風險的防護",
      "acute": [
        "itraconazole 10 mg/kg q24h（貓首選）",
        "犬：itraconazole 5-10 mg/kg q24h 或 potassium iodide（SSKI）",
        "嚴重播散型：amphotericin B 脂質體配方"
      ],
      "chronic": [
        "itraconazole持續治療至臨床痊癒後再持續4-8週",
        "平均療程2-6個月",
        "terbinafine 30-40 mg/kg q24h（替代或併用方案）",
        "potassium iodide 飽和溶液（犬可用，貓禁用——碘中毒風險）"
      ]
    },
    "prognosis": "皮膚淋巴管型預後良好（治癒率高）。固定皮膚型預後最佳。播散型預後謹慎至不良。貓的治療通常反應良好但需要較長療程。FIV/FeLV陽性貓預後較差。",
    "pearls": [
      "孢子絲菌病是重要的人畜共通傳染病——處理感染貓時必須戴手套",
      "貓的皮膚病灶含大量酵母菌，細胞學敏感度高；犬則酵母菌稀少，需依賴培養",
      "沿淋巴管排列的結節鏈（淋巴管型）是孢子絲菌病最經典的臨床表現",
      "potassium iodide可用於犬但貓禁用（碘敏感）",
      "S. brasiliensis（主要在巴西）可經貓直接傳播，具流行病學意義"
    ],
    "diagnosticAlgorithm": {
      "title": "孢子絲菌病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估皮膚病灶與暴露史，注意人畜共通風險（特別是貓）",
          "findings": [
            "皮膚結節性潰瘍",
            "沿淋巴管分布的結節",
            "好發於四肢與頭部",
            "貓的病灶含大量菌體"
          ]
        },
        {
          "step": 2,
          "action": "細胞學檢查",
          "details": "病灶細針抽吸或分泌物細胞學",
          "findings": [
            "貓：大量酵母菌體易於發現",
            "犬：菌體數量少，較難發現",
            "肉芽腫性至化膿性炎症",
            "雪茄形酵母菌體"
          ]
        },
        {
          "step": 3,
          "action": "真菌培養",
          "details": "病灶採樣進行真菌培養",
          "findings": [
            "Sporothrix schenckii培養確認",
            "25°C絲狀型與37°C酵母型雙型性",
            "培養需1-4週"
          ]
        },
        {
          "step": 4,
          "action": "確診與公衛評估",
          "details": "確認診斷並評估人畜共通風險",
          "findings": [
            "培養確診為金標準",
            "組織病理見肉芽腫性皮膚炎",
            "告知飼主人畜共通傳播風險",
            "貓抓傷或咬傷為主要傳播途徑"
          ]
        }
      ]
    },
    "monitoring": [
      "皮膚病灶大小和數量追蹤",
      "培養轉陰確認",
      "肝功能監測（長期itraconazole）",
      "飼主和醫護人員的感染預防教育"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "pythiosis": {
    "zh": "卵菌病",
    "en": "Pythiosis",
    "definition": "卵菌病是由水生卵菌 Pythium insidiosum 引起的慢性肉芽腫性感染。P. insidiosum 不是真正的真菌而是原生生物界的卵菌綱，因此對傳統抗真菌藥物多無反應。主要引起犬的胃腸道型和皮膚型感染，貓罕見。接觸被游動孢子污染的溫暖停滯水域是主要感染途徑。",
    "synonyms": [
      "Oomycosis",
      "Pythium Infection",
      "Swamp Cancer (equine term)",
      "水黴菌感染"
    ],
    "epidemiology": {
      "species": "犬為主，貓罕見",
      "age": "犬：年輕至中年大型犬（平均3歲）",
      "sex": "公犬略多",
      "riskFactors": [
        "居住在熱帶和亞熱帶地區（美國東南部墨西哥灣沿岸）",
        "接觸溫暖停滯水域（池塘、沼澤、稻田）",
        "狩獵犬和水上活動犬",
        "大型犬種（Labrador Retriever、German Shepherd）",
        "秋季和冬初（游動孢子釋放季節）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "GI型（最常見）：慢性嘔吐、腹瀉、體重急劇減輕",
        "皮膚型：慢性不癒合的皮膚潰瘍或腫塊",
        "近期曾接觸溫暖水域",
        "對抗生素治療無反應",
        "食慾下降但有些犬食慾正常"
      ],
      "physicalExam": [
        "GI型：腹部觸診可觸及腸壁或胃壁的堅實腫塊",
        "顯著體重減輕和消瘦",
        "腸繫膜淋巴結腫大",
        "皮膚型：堅實的結節或腫塊伴潰瘍和引流竇道",
        "皮膚型好發於四肢、尾基部、會陰區域",
        "病灶內可能有組織壞死（壞死核心）"
      ]
    },
    "pathophysiology": "P. insidiosum 生活在溫暖（>20°C）的淡水環境中。游動孢子（zoospores）具有趨化性，被動物組織的化學信號吸引後附著於皮膚或胃腸道黏膜。由於卵菌的細胞壁含有纖維素和β-葡聚醣而非幾丁質（真菌特有），因此作用於麥角固醇或幾丁質合成的傳統抗真菌藥物無效。感染引起嚴重的嗜酸性球和肉芽腫性炎症反應，組織中可見大量嗜酸性球浸潤和壞死。GI型中，腸壁增厚形成腫塊樣病灶（可厚達數公分），常模擬腸道腫瘤。「kunkers」（壞死組織和菌絲的聚集物）是組織學特徵之一。",
    "diagnosis": {
      "overview": "高度懷疑來自病史（接觸水域、流行區）和臨床表現（腸壁腫塊），需血清學和組織病理確認",
      "differentials": [
        "腸道腫瘤（淋巴瘤、腺癌）",
        "炎症性腸病",
        "其他真菌感染（組織漿菌、芽生黴菌）",
        "異物肉芽腫",
        "肥大細胞瘤（皮膚型）"
      ],
      "initialDB": [
        "Pythium 血清抗體ELISA——敏感度和特異度較好",
        "腹部超音波——腸壁嚴重增厚、層狀結構消失、區域淋巴結腫大",
        "CBC——嗜酸性球增多（重要線索）、貧血",
        "生化——低白蛋白"
      ],
      "advanced": [
        "組織病理學（內視鏡活檢或手術活檢）——嗜酸性球和肉芽腫性炎症伴寬大無隔菌絲（GMS染色）",
        "免疫組織化學——抗Pythium抗體標記",
        "PCR鑑定",
        "培養（需特殊培養基，生長緩慢）"
      ]
    },
    "treatment": {
      "overview": "早期積極手術切除是最重要的治療，抗真菌藥物療效有限",
      "acute": [
        "手術切除（wide margin excision）——是治癒的最佳機會",
        "GI型：受累腸段切除吻合術",
        "皮膚型：廣泛切除",
        "手術前影像學評估擴散範圍"
      ],
      "chronic": [
        "術後輔助：itraconazole 10 mg/kg q24h + terbinafine 5-10 mg/kg q24h 聯合治療",
        "免疫治療：Pythium immunotherapy（PIT疫苗）——在部分病例顯示療效",
        "mefenoxam（殺卵菌劑）已有實驗性使用",
        "單純藥物治療的治癒率極低（<25%）"
      ]
    },
    "prognosis": "整體預後謹慎至不良。早期手術完全切除者預後最佳（治癒率可達50-80%）。GI型因通常發現時已廣泛侵犯，手術切除困難，預後差。單純藥物治療效果不佳（治癒率<25%），因卵菌對傳統抗真菌藥物天然抗性。延遲診斷是預後不良的主要因素。",
    "pearls": [
      "Pythium不是真正的真菌——傳統抗真菌藥物多無效",
      "嗜酸性球增多症是GI型Pythiosis的重要線索（真菌感染通常不引起嗜酸性球增多）",
      "手術是治癒的最佳途徑——藥物單獨治療效果差",
      "臨床上GI型常被誤診為腸道腫瘤",
      "接觸溫暖停滯水域的狩獵犬在流行區應高度懷疑"
    ],
    "diagnosticAlgorithm": {
      "title": "卵菌病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估GI或皮膚症狀，注意溫暖潮濕地區水域暴露史",
          "findings": [
            "慢性嘔吐與腹瀉（GI型）",
            "皮膚非癒合性肉芽腫（皮膚型）",
            "體重減輕",
            "腹部可觸及腫塊"
          ]
        },
        {
          "step": 2,
          "action": "影像學檢查",
          "details": "腹部超音波與影像評估",
          "findings": [
            "腸壁局部增厚或腫塊",
            "區域淋巴結腫大",
            "可能有腸梗阻表現"
          ]
        },
        {
          "step": 3,
          "action": "組織學檢查",
          "details": "手術或內視鏡活檢取樣",
          "findings": [
            "肉芽腫性至化膿性炎症",
            "GMS或PAS染色見寬大、少隔膜菌絲",
            "嗜酸性肉芽腫反應"
          ]
        },
        {
          "step": 4,
          "action": "確診",
          "details": "特異性檢測確認Pythium insidiosum",
          "findings": [
            "Pythium特異性血清學ELISA",
            "PCR檢測確認",
            "培養鑑定（需特殊培養基）",
            "與真菌性肉芽腫鑑別"
          ]
        }
      ]
    },
    "monitoring": [
      "術後影像學追蹤復發",
      "血清抗體滴度（下降提示治療反應）",
      "體重和營養狀態",
      "長期追蹤至少12個月"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "dermatophytosis-systemic": {
    "zh": "全身性皮膚黴菌病",
    "en": "Systemic Dermatophytosis (Dermatophytic Pseudomycetoma)",
    "definition": "全身性皮膚黴菌病是指皮膚黴菌（主要為 Microsporum canis 或 Trichophyton spp.）突破皮膚屏障侵入真皮和皮下組織形成深部感染的罕見情況。最典型的形式為皮膚黴菌假菌瘤（dermatophytic pseudomycetoma），在貓（尤其波斯貓和喜馬拉雅貓）中較常報告，與宿主細胞免疫缺陷相關。",
    "synonyms": [
      "Dermatophytic Pseudomycetoma",
      "Dermatophytic Granuloma",
      "Majocchi's Granuloma",
      "皮膚真菌假菌瘤",
      "深部皮膚黴菌感染"
    ],
    "epidemiology": {
      "species": "貓較常見（尤其長毛品種），犬罕見",
      "age": "無明確年齡好發",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "波斯貓和喜馬拉雅貓（品種傾向）",
        "長毛貓",
        "免疫抑制（FIV/FeLV、糖皮質類固醇使用）",
        "細胞免疫功能缺陷",
        "先前存在的皮膚黴菌感染治療不當"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "慢性皮膚結節或腫塊，對常規抗黴菌治療反應不佳",
        "可能有先前淺表皮膚黴菌感染病史",
        "結節可能引流或潰瘍",
        "全身症狀較少（除非播散嚴重）"
      ],
      "physicalExam": [
        "皮下堅實結節（單發或多發）",
        "結節可能潰瘍伴引流",
        "好發於軀幹、四肢",
        "周圍可能有典型淺表皮膚黴菌感染的脫毛環",
        "淋巴結可能腫大",
        "播散型：內臟受累（罕見）"
      ]
    },
    "pathophysiology": "正常的皮膚黴菌感染局限於角質化組織（皮膚、毛髮、指甲），因為皮膚黴菌無法在37°C和存在血清抑制因子的深部組織中生存。在全身性皮膚黴菌病中，宿主的細胞免疫功能缺陷（尤其T細胞介導免疫）允許真菌突破皮膚屏障侵入真皮和皮下組織。波斯貓被認為可能有品種特異性的免疫缺陷。在組織中，真菌菌絲聚集形成緻密的團塊（grain/granule），周圍被Splendore-Hoeppli反應（嗜酸性物質沉積）包圍，形成假菌瘤結構。這與真正的真菌性菌瘤不同，後者由非皮膚黴菌的真菌引起。",
    "diagnosis": {
      "overview": "組織病理學是確診的關鍵，需與其他深部真菌感染和腫瘤鑑別",
      "differentials": [
        "皮膚腫瘤（肥大細胞瘤、纖維肉瘤）",
        "其他深部真菌感染（孢子絲菌、隱球菌）",
        "分枝桿菌感染",
        "諾卡菌感染",
        "異物肉芽腫",
        "真菌性菌瘤"
      ],
      "initialDB": [
        "皮膚刮片和Wood's lamp檢查（評估淺表皮膚黴菌感染）",
        "細針穿刺細胞學——化膿肉芽腫性炎症",
        "DTM培養或真菌培養",
        "FeLV/FIV檢測（貓）"
      ],
      "advanced": [
        "組織病理學（活檢）——真皮/皮下肉芽腫性至化膿性炎症，含真菌菌絲granules伴Splendore-Hoeppli反應",
        "GMS和PAS特殊染色顯示菌絲",
        "真菌培養鑑定種別",
        "PCR種別鑑定",
        "免疫功能評估"
      ]
    },
    "treatment": {
      "overview": "手術切除結合長期全身性抗真菌藥物治療",
      "acute": [
        "手術切除可及的結節（完整切除）",
        "itraconazole 10 mg/kg q24h（貓首選口服抗真菌藥）",
        "terbinafine 30-40 mg/kg q24h（替代或併用）"
      ],
      "chronic": [
        "長期口服抗真菌藥物（至少3-6個月，可能更長）",
        "治療至臨床痊癒後再持續4-8週",
        "免疫抑制因素的矯正（停用類固醇、治療FIV/FeLV）",
        "環境去污染"
      ]
    },
    "prognosis": "預後謹慎。手術完全切除結合抗真菌藥物者預後較好。多發性或播散型預後不良。免疫抑制無法矯正者復發率高。波斯貓的品種相關型可能需要終生管理。",
    "pearls": [
      "全身性皮膚黴菌病是罕見疾病，波斯貓有明確的品種傾向",
      "正常免疫功能的動物幾乎不會發展為全身性皮膚黴菌感染",
      "假菌瘤（pseudomycetoma）是特徵性的組織學型態",
      "治療需結合手術和長期全身性抗真菌藥物",
      "必須評估和矯正潛在的免疫抑制因素"
    ],
    "diagnosticAlgorithm": {
      "title": "全身性皮膚黴菌病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估免疫狀態與廣泛性皮膚病灶",
          "findings": [
            "多發性皮下結節",
            "結節可能排膿",
            "免疫抑制背景",
            "常規抗黴菌治療無效"
          ]
        },
        {
          "step": 2,
          "action": "皮膚學檢查",
          "details": "病灶採樣與細胞學檢查",
          "findings": [
            "細針抽吸見肉芽腫性炎症",
            "可能見真菌結構",
            "Wood's燈檢查（部分Microsporum canis螢光）"
          ]
        },
        {
          "step": 3,
          "action": "真菌培養與組織學",
          "details": "組織活檢與真菌培養確認",
          "findings": [
            "真菌培養鑑定皮黴菌種",
            "組織病理見假黴菌瘤（pseudomycetoma）",
            "PAS/GMS染色見真菌菌絲與孢子",
            "深部組織侵犯"
          ]
        },
        {
          "step": 4,
          "action": "確診與免疫評估",
          "details": "確認全身性感染並評估免疫狀態",
          "findings": [
            "免疫功能評估",
            "排除FeLV/FIV（貓）",
            "影像學排除內臟播散",
            "波斯貓品種傾向"
          ]
        }
      ]
    },
    "monitoring": [
      "臨床檢查追蹤結節復發",
      "真菌培養確認治療效果",
      "肝功能監測（長期抗真菌藥物）",
      "免疫狀態評估"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "nocardiosis": {
    "zh": "諾卡菌病",
    "en": "Nocardiosis",
    "definition": "諾卡菌病是由諾卡菌屬（Nocardia spp.，主要為 N. asteroides、N. brasiliensis、N. nova）引起的慢性至亞急性感染。諾卡菌為革蘭氏陽性、部分抗酸染色陽性的絲狀細菌（非真菌）。感染途徑包括傷口接種和呼吸道吸入。常引起化膿肉芽腫性皮膚感染、胸腔積液和播散型感染。",
    "synonyms": [
      "Nocardia Infection",
      "諾卡菌感染"
    ],
    "epidemiology": {
      "species": "犬貓皆可，犬略多",
      "age": "年輕犬略多（可能與免疫發育和戶外活動有關）",
      "sex": "公犬略多",
      "riskFactors": [
        "免疫抑制狀態",
        "長期使用糖皮質類固醇或免疫抑制劑",
        "穿刺傷或外傷",
        "FIV/FeLV感染（貓）",
        "戶外活動接觸土壤"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "慢性引流皮膚病灶（引流竇道）",
        "外傷後傷口不癒合",
        "呼吸困難（胸腔型）",
        "發熱",
        "食慾下降和體重減輕",
        "跛行（骨受累）"
      ],
      "physicalExam": [
        "皮膚型：皮下結節伴引流竇道，排出帶有顆粒的膿性分泌物",
        "胸腔型：呼吸困難、胸腔積液的叩診和聽診異常",
        "發熱",
        "全身淋巴結腫大",
        "腹腔播散：腹水",
        "CNS受累：神經症狀（罕見）",
        "多器官播散的消瘦和衰弱"
      ]
    },
    "pathophysiology": "Nocardia spp. 為腐生性需氧絲狀細菌，廣泛分布於土壤中。感染經皮膚傷口接種（皮膚型）或呼吸道吸入（肺型和胸腔型）。諾卡菌的細胞壁含有分枝酸和海藻糖二黴菌酸酯，能抵抗吞噬細胞的殺菌作用，類似於分枝桿菌的逃避機制。細菌在巨噬細胞內存活並抑制吞噬溶酶體融合。感染引起化膿性至化膿肉芽腫性炎症。在免疫抑制個體中，可經血行播散至多器官（腦、腎、骨骼）。胸腔積液是犬貓諾卡菌感染的常見表現，積液通常為膿性至血膿性。",
    "diagnosis": {
      "overview": "細胞學和培養是診斷基礎，部分抗酸染色陽性是重要線索",
      "differentials": [
        "放線菌感染（臨床非常相似）",
        "分枝桿菌感染",
        "真菌感染（孢子絲菌、芽生黴菌）",
        "異物引起的引流竇道",
        "胸腔積液的其他原因（腫瘤、FIP、膿胸）"
      ],
      "initialDB": [
        "引流液/積液細胞學——化膿性炎症伴絲狀分枝細菌",
        "改良抗酸染色（Modified Ziehl-Neelsen）——部分抗酸染色陽性（重要鑑別特徵，與放線菌的抗酸染色陰性區別）",
        "細菌培養（需氧培養數天至數週，需通知實驗室延長培養時間）",
        "胸腔積液分析（膿性，蛋白高，嗜中性球為主）"
      ],
      "advanced": [
        "組織病理學——化膿肉芽腫性炎症伴Splendore-Hoeppli反應",
        "16S rRNA基因PCR和定序（種別鑑定）",
        "藥物敏感性試驗（指導抗生素選擇）",
        "胸腔X光或CT",
        "播散型評估：腹部影像學、CNS影像學"
      ]
    },
    "treatment": {
      "overview": "長期抗生素治療，通常需數月，結合外科引流和清創",
      "acute": [
        "TMP-SMX（trimethoprim-sulfamethoxazole）15 mg/kg q12h（首選）",
        "替代：amikacin、imipenem（嚴重病例）",
        "胸腔積液：胸腔引流管放置和持續引流",
        "皮膚型：外科清創和引流"
      ],
      "chronic": [
        "TMP-SMX持續治療至少2-4個月",
        "臨床痊癒後再持續4-6週",
        "根據藥敏結果調整",
        "部分菌株對minocycline、amoxicillin-clavulanate有感受性"
      ]
    },
    "prognosis": "皮膚局限型預後良好至中等。胸腔型預後謹慎。播散型預後不良。免疫抑制因素無法矯正者預後差。治療時間通常較長（數月），且復發率不低。",
    "pearls": [
      "諾卡菌vs放線菌的鑑別：諾卡菌為部分抗酸染色陽性（需氧），放線菌為抗酸染色陰性（厭氧/兼性厭氧）",
      "諾卡菌培養需要延長培養時間——必須通知實驗室可能的診斷",
      "TMP-SMX是諾卡菌病的首選治療",
      "免疫抑制是重要的易感因素——應評估潛在免疫抑制原因",
      "胸腔積液伴絲狀細菌的鑑別診斷主要為諾卡菌和放線菌"
    ],
    "diagnosticAlgorithm": {
      "title": "諾卡菌病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估化膿性病灶與免疫狀態",
          "findings": [
            "皮膚排膿性傷口或竇道",
            "胸腔積液或肺炎",
            "發熱與嗜睡",
            "免疫抑制動物好發"
          ]
        },
        {
          "step": 2,
          "action": "細胞學與染色",
          "details": "病灶分泌物或積液細胞學檢查",
          "findings": [
            "改良Ziehl-Neelsen染色見部分抗酸性分枝桿菌樣菌體",
            "化膿性至肉芽腫性炎症",
            "可見硫磺顆粒（sulfur granules）"
          ]
        },
        {
          "step": 3,
          "action": "影像學檢查",
          "details": "胸腔與腹腔影像評估",
          "findings": [
            "胸腔X光見結節性浸潤或積液",
            "腹部超音波排除腹腔播散",
            "可能有骨骼病灶"
          ]
        },
        {
          "step": 4,
          "action": "確診",
          "details": "細菌培養與分子鑑定",
          "findings": [
            "需氧培養見Nocardia菌落",
            "培養需2-7天以上",
            "分子鑑定確認菌種",
            "藥敏試驗指導治療"
          ]
        }
      ]
    },
    "monitoring": [
      "臨床症狀改善追蹤",
      "胸腔X光追蹤積液消退",
      "培養轉陰確認",
      "肝腎功能監測（長期TMP-SMX）",
      "免疫狀態監測"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "actinomycosis": {
    "zh": "放線菌病",
    "en": "Actinomycosis",
    "definition": "放線菌病是由放線菌屬（Actinomyces spp.，主要為 A. viscosus、A. hordeovulneris、A. bovis）引起的慢性化膿肉芽腫性感染。放線菌為革蘭氏陽性厭氧至兼性厭氧絲狀細菌，是口腔和上呼吸道的共生菌。感染通常與穿入性外傷（植物芒刺/grass awns）或咬傷相關。",
    "synonyms": [
      "Actinomyces Infection",
      "放線菌感染",
      "Lumpy Jaw（牛的傳統稱法）"
    ],
    "epidemiology": {
      "species": "犬較常見，貓亦可感染",
      "age": "無明確年齡好發，戶外活動犬多見",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "植物芒刺（grass awn/foxtail）穿入（美國西部和地中海氣候區常見）",
        "咬傷",
        "口腔手術或牙齒疾病",
        "穿入性外傷",
        "戶外活動尤其在高草地區"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "慢性引流竇道（數週至數月）",
        "反覆膿瘍形成",
        "咬傷或外傷後感染不癒合",
        "呼吸困難（胸腔型，常與芒刺吸入相關）",
        "發熱（間歇性）",
        "曾在高草地區活動"
      ],
      "physicalExam": [
        "皮下膿瘍伴引流竇道",
        "排出帶有「硫磺顆粒」的膿性分泌物（黃色顆粒物）",
        "頸面部好發（口源性感染）",
        "胸壁引流竇道（胸腔型）",
        "胸腔積液的聽診和叩診異常",
        "發熱",
        "體重減輕"
      ]
    },
    "pathophysiology": "Actinomyces spp. 是口腔、上呼吸道和胃腸道的正常共生菌。當黏膜屏障破損（外傷、咬傷、植物芒刺穿入）時，細菌侵入深部組織引起感染。植物芒刺（尤其是foxtail/草芒）是犬放線菌病的重要病因——芒刺穿入皮膚或經吸入進入呼吸道後，攜帶放線菌深入組織。放線菌為厭氧至兼性厭氧菌，常與其他厭氧菌形成混合感染。感染引起化膿肉芽腫性炎症，形成多房性膿瘍，可穿透至皮膚表面形成引流竇道。組織中的菌落聚集形成特徵性的「硫磺顆粒」（sulfur granules）——實際為菌絲團周圍的Splendore-Hoeppli反應物質，非真正含硫。",
    "diagnosis": {
      "overview": "引流液中發現硫磺顆粒高度提示診斷，結合培養確認",
      "differentials": [
        "諾卡菌病（最重要的鑑別）",
        "分枝桿菌感染",
        "深部真菌感染",
        "異物（芒刺）相關膿瘍",
        "腫瘤伴引流"
      ],
      "initialDB": [
        "引流液/膿液細胞學——化膿性炎症伴絲狀細菌和硫磺顆粒",
        "改良抗酸染色——陰性（與諾卡菌的部分抗酸染色陽性區別）",
        "厭氧培養（需7-14天或更長，需通知實驗室）",
        "胸腔積液分析（膿性，pH低，葡萄糖低）"
      ],
      "advanced": [
        "組織病理學——化膿肉芽腫性炎症伴硫磺顆粒",
        "胸腔X光/CT（評估胸腔病灶和異物）",
        "超音波引導穿刺",
        "16S rRNA PCR和定序",
        "影像學尋找異物（芒刺可能不顯影）"
      ]
    },
    "treatment": {
      "overview": "長期抗生素治療結合外科引流和異物移除",
      "acute": [
        "amoxicillin-clavulanate 12.5-25 mg/kg q12h（首選）",
        "替代：clindamycin 11 mg/kg q12h",
        "外科引流和清創",
        "異物（芒刺）移除（若可定位）",
        "胸腔積液：胸腔引流管"
      ],
      "chronic": [
        "長期抗生素治療至少4-6週，通常需要2-3個月",
        "臨床痊癒後再持續2-4週",
        "penicillin類為最有效的抗生素",
        "混合感染時需兼顧厭氧菌覆蓋（metronidazole併用）"
      ]
    },
    "prognosis": "皮膚型預後良好（尤其可成功移除異物時）。胸腔型預後謹慎（芒刺難以定位和移除）。異物無法移除者復發率高。早期積極治療可獲得良好結果。",
    "pearls": [
      "放線菌vs諾卡菌的快速鑑別：放線菌=抗酸染色陰性+厭氧；諾卡菌=部分抗酸染色陽性+需氧",
      "硫磺顆粒（sulfur granules）是放線菌病的特徵，但不是100%特異（Actinobacillus也可產生）",
      "植物芒刺（foxtail/grass awn）是犬放線菌病最常見的觸發因素",
      "培養需要厭氧環境和延長培養時間",
      "penicillin類是治療放線菌感染最有效的抗生素"
    ],
    "diagnosticAlgorithm": {
      "title": "放線菌病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估慢性化膿性病灶，注意外傷或異物穿入史",
          "findings": [
            "慢性排膿性竇道",
            "頸面部腫脹（頸面型）",
            "胸腔或腹腔積液",
            "草芒異物穿入史"
          ]
        },
        {
          "step": 2,
          "action": "細胞學與分泌物檢查",
          "details": "分泌物直接檢查與細胞學",
          "findings": [
            "分泌物中見硫磺顆粒",
            "革蘭氏陽性分枝狀桿菌",
            "化膿性炎症反應",
            "可能合併其他厭氧菌"
          ]
        },
        {
          "step": 3,
          "action": "影像學檢查",
          "details": "評估感染範圍",
          "findings": [
            "X光見軟組織腫脹與骨溶解",
            "超音波評估膿腫範圍",
            "CT評估竇道走向與深度"
          ]
        },
        {
          "step": 4,
          "action": "確診",
          "details": "細菌培養確認（需厭氧培養）",
          "findings": [
            "厭氧培養見Actinomyces菌",
            "培養需7-14天",
            "組織病理見硫磺顆粒與菌絲",
            "尋找並移除異物來源"
          ]
        }
      ]
    },
    "monitoring": [
      "引流竇道的癒合追蹤",
      "影像學追蹤胸腔病灶",
      "治療完成後監測復發",
      "體重和全身狀態評估"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "rocky-mountain-spotted-fever": {
    "zh": "落磯山斑點熱",
    "en": "Rocky Mountain Spotted Fever",
    "definition": "落磯山斑點熱（RMSF）是由立克次體 Rickettsia rickettsii 引起的急性蜱媒介性疾病。R. rickettsii 主要感染血管內皮細胞，引起全身性小血管炎。犬是最重要的家畜宿主，人類亦可經蜱叮咬感染。主要蜱媒介為美洲犬蜱（Dermacentor variabilis）和落磯山木蜱（D. andersoni）。",
    "synonyms": [
      "RMSF",
      "Spotted Fever",
      "Tick Fever",
      "立克次體斑點熱"
    ],
    "epidemiology": {
      "species": "犬為主要家畜宿主，貓罕見",
      "age": "任何年齡，年輕犬可能症狀更嚴重",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "居住在蜱活躍地區（美國東南部和中大西洋州最常見）",
        "春季和夏季（蜱活躍季節）",
        "戶外活動犬",
        "未使用蜱預防產品",
        "德國牧羊犬（可能有品種易感性）",
        "純種犬"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "急性發病（2-14天潛伏期後）",
        "突發高燒",
        "嗜睡和食慾下降",
        "四肢和關節疼痛/跛行",
        "近期蜱暴露史（但未必記得被叮咬）",
        "嘔吐和腹瀉",
        "鼻出血或其他出血傾向"
      ],
      "physicalExam": [
        "高燒（通常>40°C）",
        "皮膚瘀點和瘀斑（腹部、耳翼、黏膜、包皮/陰囊）",
        "四肢和面部水腫",
        "眼結膜充血和瘀點",
        "關節腫脹和疼痛",
        "前葡萄膜炎",
        "全身淋巴結腫大",
        "腹痛",
        "神經症狀（重症）：共濟失調、前庭症狀、抽搐",
        "DIC表現（嚴重時）"
      ]
    },
    "pathophysiology": "R. rickettsii 經蜱叮咬傳播（蜱需附著至少5-20小時才能傳播）。細菌靶向全身小血管和微血管的內皮細胞，在細胞質和細胞核中複製。內皮細胞感染導致直接細胞損傷和凋亡、血管壁通透性增加、血管周圍炎症和水腫。全身性血管炎導致多器官功能障礙：皮膚（瘀點、瘀斑、壞死）、腎臟（急性腎損傷）、中樞神經系統（腦膜腦炎）、肺（非心源性肺水腫）。血小板消耗和DIC是嚴重病例的重要併發症。內皮損傷活化凝血級聯反應，消耗血小板和凝血因子。",
    "diagnosis": {
      "overview": "臨床懷疑度高時應立即經驗性治療，不應等待實驗室確認",
      "differentials": [
        "犬艾利希體病",
        "無形體病（Anaplasmosis）",
        "免疫介導性血小板減少症",
        "免疫介導性溶血性貧血",
        "彌漫性血管內凝血（DIC）",
        "鉤端螺旋體病"
      ],
      "initialDB": [
        "CBC——血小板減少（最一致的發現）、輕度貧血、白血球變化不定",
        "生化——低白蛋白、肝酶升高、BUN/Creatinine可能升高",
        "凝血指標——PT/PTT延長（DIC時）",
        "尿液分析——蛋白尿"
      ],
      "advanced": [
        "急性期和恢復期（2-4週後）配對血清IFA——滴度4倍以上升高確診",
        "R. rickettsii PCR（全血）——急性期敏感度中等",
        "R. rickettsii IFA IgG——單次滴度≥1:1024高度提示",
        "組織免疫組織化學（皮膚活檢）"
      ]
    },
    "treatment": {
      "overview": "doxycycline是首選且唯一推薦的治療，臨床懷疑即應開始治療",
      "acute": [
        "doxycycline 5 mg/kg q12h PO或IV（首選——臨床懷疑即開始，不等待實驗室結果）",
        "治療持續至退燒後至少3天，最少7-14天",
        "支持療法：靜脈輸液",
        "嚴重血小板減少或DIC：輸新鮮全血或血漿",
        "避免使用糖皮質類固醇（可能加重感染）"
      ],
      "chronic": [
        "通常不需要慢性治療",
        "doxycycline完成療程後預後良好",
        "合併蜱媒介感染時可能需要延長治療"
      ]
    },
    "prognosis": "及時doxycycline治療預後良好（大多數犬在24-48小時內改善）。延遲治療預後差——RMSF可在數天內致死。DIC和多器官衰竭是死亡主要原因。德國牧羊犬可能預後較差。致死率未治療時可達5-10%。",
    "pearls": [
      "RMSF是蜱媒介疾病中最致命的——臨床懷疑即應立即開始doxycycline治療",
      "血小板減少是最一致的實驗室發現",
      "蜱需附著5-20小時才能傳播R. rickettsii——及時移除蜱可預防感染",
      "配對血清（急性期vs恢復期）是血清學確診的標準方法",
      "RMSF是人畜共通傳染病——但犬不直接傳播給人，是經蜱叮咬傳播"
    ],
    "diagnosticAlgorithm": {
      "title": "落磯山斑點熱 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估壁蝨暴露史與急性全身症狀",
          "findings": [
            "急性高燒",
            "皮膚瘀斑與點狀出血",
            "關節疼痛與肌肉僵硬",
            "眼部充血與結膜出血"
          ]
        },
        {
          "step": 2,
          "action": "血液檢查",
          "details": "CBC與生化檢查",
          "findings": [
            "血小板減少",
            "白血球減少或正常",
            "低白蛋白血症",
            "低鈉血症"
          ]
        },
        {
          "step": 3,
          "action": "血清學檢測",
          "details": "Rickettsia rickettsii抗體檢測",
          "findings": [
            "急性期與恢復期配對血清IFA效價四倍升高",
            "單次高效價具參考意義",
            "PCR檢測壁蝨或血液樣本"
          ]
        },
        {
          "step": 4,
          "action": "確診與治療反應",
          "details": "綜合判斷並觀察多西環素治療反應",
          "findings": [
            "多西環素治療24-48小時退燒",
            "臨床症狀快速改善",
            "排除其他壁蝨傳播疾病",
            "治療反應支持推斷性診斷"
          ]
        }
      ]
    },
    "monitoring": [
      "體溫每日監測直至退燒",
      "血小板計數追蹤恢復",
      "腎功能監測",
      "凝血指標追蹤（DIC病例）"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "canine-papillomatosis": {
    "zh": "犬乳突狀瘤病毒感染",
    "en": "Canine Papillomatosis (Canine Viral Papillomas)",
    "definition": "犬乳突狀瘤病毒感染是由犬乳頭瘤病毒（Canine Papillomavirus, CPV，多種型別）引起的良性上皮增生性疾病。最常見的形式為口腔乳頭瘤病（oral papillomatosis），主要影響年輕犬。病毒具有嚴格的宿主和組織嗜性。大多數病灶在數週至數月內自行消退。",
    "synonyms": [
      "Canine Viral Papillomas",
      "Canine Warts",
      "Oral Papillomatosis",
      "犬疣",
      "犬乳頭瘤"
    ],
    "epidemiology": {
      "species": "犬特異性",
      "age": "口腔型：年輕犬（<2歲）最常見，皮膚型：老年犬",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "年幼和免疫未成熟犬",
        "與感染犬密切接觸（犬舍、狗公園、訓練班）",
        "免疫抑制狀態（年齡或藥物相關）",
        "共用玩具或食碗"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "口腔內或嘴唇出現多發性小腫塊",
        "通常無疼痛",
        "偶有流涎增加或口臭",
        "可能影響進食（大量病灶時）",
        "近期與其他犬接觸",
        "數週內逐漸增多後開始消退"
      ],
      "physicalExam": [
        "口腔乳頭瘤：白色至灰色菜花樣（花椰菜樣）腫塊，多發",
        "好發於嘴唇、舌、咽部、軟腭",
        "皮膚乳頭瘤：圓形、表面粗糙的突起（多見於老年犬）",
        "結膜乳頭瘤：結膜表面的小突起",
        "足墊乳頭瘤（倒生型）：足墊上堅硬的角化性結節",
        "通常體溫和全身狀態正常"
      ]
    },
    "pathophysiology": "犬乳頭瘤病毒（CPV）為雙股DNA病毒，目前已鑑定超過20種型別。病毒經直接接觸（口鼻接觸）或間接接觸（污染物品）傳播。病毒感染基底層角質細胞，利用宿主細胞的分裂機制進行複製。感染導致表皮增生和角化過度，形成外生性乳頭狀腫瘤。在免疫正常個體中，細胞免疫反應（主要CD8+ T細胞）最終清除感染，病灶在4-8週（最長可至6個月）內自行消退。消退後通常獲得持久免疫。在免疫抑制個體中，病灶可能持續不消退或轉化為鱗狀細胞癌（罕見）。",
    "diagnosis": {
      "overview": "典型臨床外觀通常足以診斷，不典型或持續性病灶需要組織病理學確認",
      "differentials": [
        "口腔鱗狀細胞癌",
        "口腔纖維瘤",
        "口腔黑色素瘤",
        "口腔表皮樣囊腫",
        "傳染性性病腫瘤（TVT）"
      ],
      "initialDB": [
        "臨床外觀——年輕犬口腔內多發性菜花樣腫塊高度提示診斷",
        "觀察數週看是否自行消退"
      ],
      "advanced": [
        "組織病理學——乳頭狀表皮增生伴角化過度和koilocytes（氣球樣變性的角質細胞，含病毒包涵體）",
        "免疫組織化學——乳頭瘤病毒抗原",
        "PCR型別鑑定"
      ]
    },
    "treatment": {
      "overview": "大多數病例自行消退無需治療，持續或嚴重病例有多種治療選項",
      "acute": [
        "觀察等待（大多數在4-8週內自行消退）",
        "嚴重口腔病灶影響進食：手術切除或冷凍療法",
        "azithromycin 10 mg/kg q24h（有報告可加速消退）"
      ],
      "chronic": [
        "持續不消退（>3-6個月）的病灶：手術切除",
        "冷凍療法（液態氮）",
        "自體疫苗（autogenous vaccine）——研磨病灶組織製成",
        "imiquimod 5% cream 外用（免疫調節）",
        "免疫抑制犬：矯正免疫抑制因素",
        "惡性轉化（SCC）的病灶需徹底切除"
      ]
    },
    "prognosis": "免疫正常犬預後極佳（幾乎100%自行消退）。免疫抑制犬可能持續不消退或極罕見地惡性轉化。消退後通常獲得持久免疫，復發少見。",
    "pearls": [
      "犬口腔乳頭瘤病是年輕犬最常見的口腔腫塊原因",
      "大多數病例4-8週自行消退——不必急於治療",
      "免疫抑制犬的病灶可能不消退且有惡性轉化風險",
      "病毒具犬特異性——不傳播給人或貓",
      "azithromycin可能有助於加速消退（可能透過免疫調節作用）"
    ],
    "diagnosticAlgorithm": {
      "title": "犬乳突狀瘤病毒感染 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估口腔或皮膚增生性病灶，注意幼犬年齡",
          "findings": [
            "口腔內多發性花椰菜狀腫塊",
            "唇部與舌頭好發",
            "幼犬或免疫抑制犬",
            "通常無痛無癢"
          ]
        },
        {
          "step": 2,
          "action": "臨床檢查",
          "details": "詳細檢查病灶分布與形態",
          "findings": [
            "典型菜花狀或指狀突起",
            "表面粗糙灰白色",
            "單發或多發",
            "皮膚型呈圓形丘疹"
          ]
        },
        {
          "step": 3,
          "action": "組織學確認",
          "details": "必要時進行活檢",
          "findings": [
            "組織病理見表皮乳突狀增生",
            "角質化過度",
            "可見核內包涵體",
            "排除鱗狀細胞癌"
          ]
        },
        {
          "step": 4,
          "action": "確診",
          "details": "根據典型外觀與年齡確診",
          "findings": [
            "典型臨床外觀通常足以診斷",
            "免疫正常犬多於1-5個月內自行消退",
            "持續不消退或快速增大需活檢排除惡性"
          ]
        }
      ]
    },
    "monitoring": [
      "每2-4週觀察病灶大小和數量變化",
      "超過3-6個月不消退的病灶建議活檢排除惡性轉化",
      "免疫抑制犬需更密切監測"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "feline-poxvirus": {
    "zh": "貓痘病毒感染",
    "en": "Feline Poxvirus Infection (Cowpox Virus Infection in Cats)",
    "definition": "貓痘病毒感染主要由牛痘病毒（Cowpox virus, CPXV）引起，為正痘病毒屬的DNA病毒。貓通常從嚙齒類動物（田鼠、家鼠）經咬傷或獵捕接觸感染。初始病灶通常為單個咬傷處的皮膚結節或潰瘍，隨後可經病毒血症播散為多發性皮膚病灶。本病具人畜共通傳染風險。",
    "synonyms": [
      "Cowpox Virus Infection in Cats",
      "Feline Cowpox",
      "貓牛痘感染"
    ],
    "epidemiology": {
      "species": "貓為主要家畜宿主",
      "age": "任何年齡，年輕戶外貓多見",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "戶外活動的獵捕貓",
        "接觸嚙齒類動物（田鼠是主要儲存宿主）",
        "秋季和冬初（嚙齒類活躍季節）",
        "歐洲和亞洲（牛痘病毒分布地區）",
        "免疫抑制狀態（FIV/FeLV）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "初始為單個皮膚結節或潰瘍（通常在頭部、頸部或前肢——咬傷部位）",
        "1-2週後出現多發性皮膚病灶",
        "輕度嗜睡和食慾下降",
        "已知有獵捕嚙齒類行為",
        "接觸史可能不明確"
      ],
      "physicalExam": [
        "初級病灶（primary lesion）：單個皮膚結節或潰瘍，常在頭部或前肢",
        "二級病灶（secondary lesions）：廣泛分布的多發性丘疹→水泡→膿泡→結痂",
        "痘樣病灶（典型：中央凹陷的膿泡）",
        "結痂脫落後留下脫毛疤痕",
        "輕度發熱",
        "下頜淋巴結腫大",
        "免疫抑制貓可能出現嚴重播散性或出血性病灶",
        "肺炎（罕見但嚴重的併發症）"
      ]
    },
    "pathophysiology": "牛痘病毒經嚙齒類動物咬傷傳播至貓。病毒在咬傷處皮膚上皮細胞中複製，形成初級病灶。約1-3週後，病毒經病毒血症播散至全身皮膚，形成多發性痘樣病灶。病毒在角質細胞中複製引起細胞腫脹（氣球樣變性）和壞死，形成特徵性的表皮內水泡和膿泡。組織學上可見特徵性的胞質內嗜酸性包涵體（A型包涵體）。在免疫正常貓中，感染通常為自限性，細胞免疫反應在3-5週內清除病毒。免疫抑制貓（尤其FIV陽性）可能發展為致命的播散型或肺炎。",
    "diagnosis": {
      "overview": "臨床表現和組織病理學（包涵體）為診斷基礎，PCR確認",
      "differentials": [
        "嗜酸性肉芽腫複合體",
        "貓痤瘡",
        "皮膚黴菌感染",
        "細菌性膿皮症",
        "鱗狀細胞癌",
        "皮膚型隱球菌",
        "貓杯狀病毒皮膚感染"
      ],
      "initialDB": [
        "皮膚病灶壓片細胞學——氣球樣變性的角質細胞和嗜酸性胞質包涵體",
        "組織病理學——表皮壞死、氣球樣變性、嗜酸性胞質內包涵體（A型）",
        "FeLV/FIV檢測"
      ],
      "advanced": [
        "痘病毒PCR（病灶痂皮或組織）",
        "病毒分離（細胞培養）",
        "電子顯微鏡——典型正痘病毒顆粒",
        "血清學（中和抗體）"
      ]
    },
    "treatment": {
      "overview": "免疫正常貓通常自限性，支持療法為主。免疫抑制貓需積極治療",
      "acute": [
        "免疫正常貓：支持療法和傷口護理",
        "防止二次細菌感染：廣譜抗生素（amoxicillin-clavulanate）",
        "伊麗莎白圈防止自殘",
        "隔離防止傳播（包括人畜共通傳染風險）"
      ],
      "chronic": [
        "免疫抑制貓：考慮抗病毒治療（cidofovir外用）",
        "避免使用糖皮質類固醇（加重感染和免疫抑制）",
        "營養支持",
        "嚴重播散型：預後不良，支持療法"
      ]
    },
    "prognosis": "免疫正常貓預後良好（自限性，3-5週痊癒）。免疫抑制貓（FIV/FeLV陽性）預後不良至極差。全身性播散或肺炎是致死原因。痊癒後可能留下皮膚疤痕。",
    "pearls": [
      "貓痘病毒感染是人畜共通傳染病——處理感染貓時應戴手套，免疫抑制者（HIV陽性、化療中）風險特別高",
      "糖皮質類固醇絕對禁用——可導致致命的播散",
      "初級病灶（單個結節/潰瘍在頭或前肢）是重要的診斷線索",
      "免疫正常貓的感染通常自限性，支持療法即可",
      "本病分布在歐洲和亞洲——北美不存在牛痘病毒"
    ],
    "diagnosticAlgorithm": {
      "title": "貓痘病毒感染 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估皮膚病灶與獵捕小型齧齒類動物史",
          "findings": [
            "頭頸部或前肢單發性原發病灶",
            "續發全身性丘疹與結痂",
            "輕度發熱與嗜睡",
            "戶外貓或有獵捕行為"
          ]
        },
        {
          "step": 2,
          "action": "皮膚學檢查",
          "details": "病灶細胞學與形態學評估",
          "findings": [
            "典型痘瘡樣病灶（臍窩狀凹陷）",
            "細胞學見大型嗜酸性胞漿包涵體",
            "表皮壞死與結痂"
          ]
        },
        {
          "step": 3,
          "action": "實驗室確認",
          "details": "病毒學檢測確認",
          "findings": [
            "病灶組織PCR檢測痘病毒DNA",
            "電子顯微鏡見典型正痘病毒粒子",
            "病毒分離培養"
          ]
        },
        {
          "step": 4,
          "action": "確診與公衛評估",
          "details": "確認診斷並評估人畜共通風險",
          "findings": [
            "PCR或培養確診",
            "組織病理見特徵性包涵體",
            "評估免疫抑制（FeLV/FIV）",
            "告知飼主人畜共通傳播風險"
          ]
        }
      ]
    },
    "monitoring": [
      "皮膚病灶進展和消退追蹤",
      "監測呼吸狀態（警惕肺炎併發症）",
      "隔離直至所有痂皮脫落（此時不再具傳染性）",
      "同居貓和飼主的健康監測"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "tetanus": {
    "zh": "破傷風",
    "en": "Tetanus",
    "definition": "破傷風是由厭氧梭菌 Clostridium tetani 產生的外毒素（tetanospasmin）引起的神經系統疾病。細菌經傷口污染進入組織，在厭氧環境中繁殖並產生毒素。毒素經軸突逆行運輸至中樞神經系統，阻斷抑制性神經傳遞物質（GABA和甘胺酸）的釋放，導致肌肉強直性痙攣。貓對破傷風毒素的天然抗性高於犬。",
    "synonyms": [
      "Lockjaw",
      "Clostridium tetani Infection",
      "破傷風桿菌感染"
    ],
    "epidemiology": {
      "species": "犬較常見（但整體少見），貓極罕見（天然抗性為犬的10-100倍）",
      "age": "任何年齡",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "穿刺傷或深部組織傷口",
        "手術傷口（尤其是鑄型絲線）",
        "去勢或子宮卵巢摘除術後",
        "開放性骨折",
        "咬傷",
        "犬隻未接種破傷風疫苗（犬通常不列入常規疫苗）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "傷口或手術後3-21天（平均5-10天）出現症狀",
        "進行性肌肉僵硬",
        "行走困難",
        "吞嚥困難",
        "面部表情異常",
        "可能找不到明確的傷口"
      ],
      "physicalExam": [
        "局部型：傷口附近肌肉僵硬和痙攣",
        "全身型（犬多見）：四肢伸展僵硬（鋸木馬姿勢）",
        "耳朵豎立",
        "嘴巴緊閉（牙關緊閉/trismus）",
        "眉間皺紋和嘴角後拉（苦笑面容/risus sardonicus）",
        "第三眼瞼突出",
        "尾巴僵直",
        "瞳孔散大",
        "聲響或觸摸引發肌肉痙攣加重",
        "嚴重時呼吸困難（呼吸肌痙攣）",
        "發熱（肌肉持續收縮產熱）"
      ]
    },
    "pathophysiology": "C. tetani 的芽孢在環境中廣泛存在（土壤）。經傷口進入組織後，在厭氧環境（壞死組織、異物）中萌發為營養體並產生兩種外毒素：tetanolysin（溶血素，促進組織壞死維持厭氧環境）和tetanospasmin（痙攣毒素，主要致病毒素）。Tetanospasmin是已知最強力的毒素之一（致死劑量極低）。毒素在神經肌肉接合處被攝入運動神經末梢，經軸突逆行運輸至脊髓和腦幹的抑制性中間神經元。毒素的輕鏈（鋅金屬蛋白酶）裂解VAMP/synaptobrevin蛋白，阻斷抑制性神經傳遞物質（GABA和甘胺酸）的突觸前釋放。失去抑制性控制後，運動神經元過度興奮，導致肌肉強直性痙攣。毒素一旦與突觸結合即不可逆，恢復需要新突觸的生成。",
    "diagnosis": {
      "overview": "依據特徵性臨床表現和病史進行臨床診斷，沒有可靠的確認性檢驗",
      "differentials": [
        "有機磷或氨基甲酸酯中毒",
        "士的寧中毒",
        "低血鈣抽搐",
        "腦膜腦炎",
        "狂犬病",
        "咀嚼肌肌炎（顳顎關節受限時）",
        "破傷風體（tetany）"
      ],
      "initialDB": [
        "臨床診斷為主——特徵性的鋸木馬姿勢、牙關緊閉、第三眼瞼突出",
        "尋找傷口（可能已癒合或很小）",
        "CBC/生化——通常正常",
        "CK可能升高（肌肉持續痙攣）"
      ],
      "advanced": [
        "厭氧培養傷口分泌物（敏感度低，C. tetani難以分離）",
        "肌電圖（EMG）——持續性運動單位活化",
        "毒素檢測（小鼠中和試驗——研究用途，臨床上不實用）"
      ]
    },
    "treatment": {
      "overview": "中和循環毒素、消滅傷口細菌、控制肌肉痙攣、支持療法",
      "acute": [
        "破傷風抗毒素（TAT）500-5000 IU/kg IV（中和尚未結合的循環毒素，已結合的無法中和）",
        "TAT前先小劑量皮內試驗排除過敏",
        "傷口清創和沖洗（去除厭氧環境）",
        "metronidazole 10-15 mg/kg q8h IV/PO（首選抗生素，殺滅傷口中的C. tetani）",
        "肌肉痙攣控制：diazepam 0.5-1 mg/kg IV/PO q6-8h 或持續輸注",
        "重症：methocarbamol 44-220 mg/kg IV（肌肉鬆弛劑）",
        "安靜暗室環境（減少外部刺激觸發痙攣）"
      ],
      "chronic": [
        "持續鎮靜和肌肉鬆弛治療2-4週",
        "營養支持（管飼或食道造口管，因吞嚥困難）",
        "輸液維持水合",
        "膀胱導尿（排尿困難時）",
        "物理治療防止關節攣縮",
        "呼吸困難時需機械通氣支持",
        "耐心的長期護理——恢復期通常2-4週"
      ]
    },
    "prognosis": "整體存活率約50-90%（取決於嚴重程度和治療品質）。局部型預後良好至極佳。全身型預後謹慎至中等，需要密集護理。恢復期長（2-4週），因為需要新突觸的再生。死亡原因通常為呼吸衰竭。貓的破傷風極罕見但發生時多為局部型，預後較好。",
    "pearls": [
      "破傷風的診斷是臨床診斷——鋸木馬姿勢+牙關緊閉+第三眼瞼突出三聯徵",
      "毒素一旦與突觸結合即不可逆——TAT只能中和循環中的游離毒素",
      "metronidazole優於penicillin作為抗生素選擇（penicillin可能加重GABA阻斷）",
      "安靜暗室環境非常重要——外部刺激可觸發致命性全身痙攣",
      "貓對破傷風毒素天然抗性極高，感染極罕見"
    ],
    "diagnosticAlgorithm": {
      "title": "破傷風 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估肌肉僵硬與近期傷口史",
          "findings": [
            "全身肌肉僵硬與痙攣",
            "鎖頜（張口困難）",
            "耳朵豎立與瞬膜脫出",
            "步態僵硬（木馬樣）"
          ]
        },
        {
          "step": 2,
          "action": "神經學檢查",
          "details": "評估肌張力異常與反射",
          "findings": [
            "四肢伸直僵硬",
            "角弓反張",
            "對聲光觸覺刺激過度反應",
            "尾巴僵直"
          ]
        },
        {
          "step": 3,
          "action": "尋找感染源",
          "details": "檢查可能的傷口或手術部位",
          "findings": [
            "穿刺傷口或深部傷口",
            "近期手術或去勢傷口",
            "異物或壞死組織",
            "傷口可能已表面癒合"
          ]
        },
        {
          "step": 4,
          "action": "確診",
          "details": "主要依靠臨床表現診斷",
          "findings": [
            "典型臨床表現即可確診",
            "傷口厭氧培養可能分離C. tetani",
            "排除士的寧中毒",
            "犬較貓易感（貓相對抵抗）"
          ]
        }
      ]
    },
    "monitoring": [
      "肌肉張力和痙攣嚴重程度每日評估",
      "呼吸頻率和呼吸努力（警惕呼吸衰竭）",
      "體溫（肌肉持續痙攣可致高體溫）",
      "營養和水合狀態",
      "褥瘡預防"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "botulism": {
    "zh": "肉毒桿菌中毒",
    "en": "Botulism",
    "definition": "肉毒桿菌中毒是由肉毒桿菌（Clostridium botulinum）產生的神經毒素引起的急性下運動神經元麻痺。毒素阻斷神經肌肉接合處乙醯膽鹼的釋放，導致弛緩性麻痺。犬通常經攝入腐敗食物（含有預形成毒素）或動物屍體而感染。最常涉及的毒素型別為C型。",
    "synonyms": [
      "Botulinum Toxicosis",
      "Clostridium botulinum Intoxication",
      "肉毒梭菌中毒"
    ],
    "epidemiology": {
      "species": "犬較常見，貓極罕見（可能因飲食行為較謹慎）",
      "age": "任何年齡",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "攝入腐敗食物或動物屍體",
        "接觸死禽或腐敗肉類",
        "垃圾翻食行為",
        "生食飲食",
        "農村或郊區環境"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "攝入可疑食物後12-72小時內出現進行性無力",
        "從後肢開始的上行性弛緩性麻痺",
        "可能有嘔吐或腹瀉的前驅症狀",
        "吞嚥困難",
        "聲音改變",
        "面部表情減少"
      ],
      "physicalExam": [
        "弛緩性四肢麻痺（與破傷風的強直性痙攣相反）",
        "上行性麻痺（通常從後肢開始）",
        "下運動神經元徵兆：肌張力下降、腱反射減弱至消失",
        "瞳孔散大（對光反射遲鈍）",
        "吞嚥困難和流涎",
        "聲音改變（喉麻痺）",
        "面部肌肉無力",
        "尾巴鬆弛",
        "呼吸困難（呼吸肌麻痺——最危險）",
        "意識清楚（毒素不影響中樞神經元）",
        "疼痛感覺保留"
      ]
    },
    "pathophysiology": "C. botulinum 在厭氧環境下（腐敗食物、動物屍體）產生肉毒桿菌毒素（botulinum neurotoxin, BoNT）。犬最常見的感染途徑是攝入含有預形成毒素的食物（食物型肉毒桿菌中毒）。BoNT是已知最毒的天然物質。毒素經腸道吸收進入血液循環，結合於膽鹼能神經末梢的突觸前膜（重鏈負責結合和內化）。毒素的輕鏈（鋅金屬蛋白酶）裂解SNARE蛋白（SNAP-25、VAMP/synaptobrevin或syntaxin，取決於毒素型別），阻斷乙醯膽鹼突觸囊泡的融合和釋放。結果是神經肌肉傳導阻斷，導致弛緩性麻痺。與破傷風相反，肉毒桿菌毒素作用於周邊膽鹼能神經末梢（而非中樞抑制性突觸）。恢復需要新的神經末梢和突觸的再生。",
    "diagnosis": {
      "overview": "依據特徵性臨床表現（急性弛緩性麻痺伴可疑飲食史）進行臨床診斷，實驗室確認困難",
      "differentials": [
        "蜱麻痺（臨床非常相似）",
        "多發性神經根神經炎（Coonhound paralysis）",
        "重症肌無力",
        "有機磷中毒",
        "珊瑚蛇咬傷",
        "低血鉀麻痺"
      ],
      "initialDB": [
        "臨床診斷為主——急性上行性弛緩性麻痺伴飲食暴露史",
        "仔細排除蜱麻痺（全身搜索蜱蟲）",
        "CBC/生化——通常正常",
        "CK通常正常（與肌病鑑別）"
      ],
      "advanced": [
        "小鼠中和生物檢測——血清或食物/糞便中毒素檢測（金標準但耗時且需特殊實驗室）",
        "電生理學——EMG正常或低振幅CMAP、重複神經刺激遞減反應",
        "糞便中 C. botulinum 培養（敏感度低）",
        "食物來源毒素檢測"
      ]
    },
    "treatment": {
      "overview": "支持療法為主，嚴重病例需密集護理包括呼吸支持",
      "acute": [
        "支持療法和密集護理（最重要）",
        "多價抗毒素（如可取得）——僅能中和循環中的游離毒素",
        "呼吸支持：必要時機械通氣",
        "靜脈輸液維持水合",
        "營養支持（管飼——因吞嚥困難）",
        "膀胱護理（必要時導尿）",
        "防止吸入性肺炎（抬高頭部）"
      ],
      "chronic": [
        "持續支持療法直至恢復（通常1-3週）",
        "物理治療維持關節活動度",
        "柔軟墊褥防止褥瘡",
        "每2-4小時翻身（長期臥床動物）",
        "恢復期漸進式活動"
      ]
    },
    "prognosis": "輕度至中度病例（可維持獨立呼吸）預後良好，大多數在1-3週內恢復。需要機械通氣的嚴重病例預後謹慎至不良。死亡原因主要為呼吸衰竭和吸入性肺炎。貓極少報告但預後同犬。",
    "pearls": [
      "肉毒桿菌中毒=弛緩性麻痺；破傷風=強直性痙攣——兩者都是梭菌毒素引起但機制和表現完全相反",
      "蜱麻痺是最重要的鑑別診斷——所有弛緩性麻痺犬都必須仔細全身搜索蜱蟲",
      "意識清楚但全身麻痺是肉毒桿菌中毒的特點（毒素不通過BBB）",
      "恢復需時1-3週（新神經末梢再生）",
      "攝入腐敗食物/動物屍體的病史是關鍵診斷線索"
    ],
    "diagnosticAlgorithm": {
      "title": "肉毒桿菌中毒 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估急性弛緩性麻痺與食物暴露史",
          "findings": [
            "急性對稱性下運動神經元麻痺",
            "從後肢開始上行性癱瘓",
            "吞嚥困難與發聲困難",
            "腐敗食物或動物屍體攝食史"
          ]
        },
        {
          "step": 2,
          "action": "神經學檢查",
          "details": "詳細神經學評估",
          "findings": [
            "四肢弛緩性癱瘓",
            "脊髓反射減弱或消失",
            "顱神經功能異常（面部肌肉無力）",
            "感覺功能保留"
          ]
        },
        {
          "step": 3,
          "action": "排除性診斷",
          "details": "排除其他神經肌肉疾病",
          "findings": [
            "EMG可見傳導異常",
            "Tensilon試驗排除重症肌無力",
            "CSF分析通常正常",
            "排除壁蝨麻痺"
          ]
        },
        {
          "step": 4,
          "action": "確診",
          "details": "毒素檢測確認（耗時且不易取得）",
          "findings": [
            "血清或糞便肉毒桿菌毒素檢測",
            "小鼠生物測定法",
            "嫌疑食物來源分析",
            "臨床表現+暴露史推斷性診斷常用"
          ]
        }
      ]
    },
    "monitoring": [
      "呼吸頻率和努力程度持續監測（最關鍵——呼吸衰竭是主要死因）",
      "每日神經功能評估追蹤恢復進程",
      "褥瘡和泌尿道感染監測",
      "營養攝入和體重"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "mycobacterial-infection": {
    "zh": "分枝桿菌感染",
    "en": "Mycobacterial Infection",
    "definition": "分枝桿菌感染是由分枝桿菌屬（Mycobacterium spp.）引起的慢性感染性疾病。犬貓可感染多種分枝桿菌，包括結核群（M. tuberculosis, M. bovis, M. microti）、非結核分枝桿菌（NTM，如 M. avium complex）和速生分枝桿菌（M. fortuitum, M. smegmatis）。臨床表現取決於菌種和受累器官。",
    "synonyms": [
      "Mycobacteriosis",
      "Tuberculosis (TB群)",
      "Atypical Mycobacteriosis (NTM)",
      "分枝桿菌病"
    ],
    "epidemiology": {
      "species": "犬貓皆可，貓較常見（尤其NTM）",
      "age": "成年至老年多見",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "接觸結核病患者（M. bovis, M. tuberculosis）",
        "接觸受感染的牛奶（M. bovis）",
        "接觸土壤和水源（NTM）",
        "免疫抑制（FIV/FeLV）",
        "Siamese和Abyssinian貓（M. avium complex易感性）",
        "穿刺傷（速生分枝桿菌）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "慢性皮膚結節或潰瘍治療效果不佳",
        "引流竇道",
        "體重減輕和食慾下降",
        "慢性呼吸症狀（肺結核時）",
        "腹瀉（腸道型）",
        "淋巴結腫大"
      ],
      "physicalExam": [
        "皮膚結節（堅實、無痛或微痛），可潰瘍並引流",
        "好發於腹部、鼠蹊部、四肢（速生NTM）",
        "全身淋巴結腫大（播散型或TB）",
        "肝脾腫大（播散型）",
        "肺部聽診異常（肺結核）",
        "腹部腫塊或腸壁增厚（腸道型M. avium）",
        "消瘦和惡病質"
      ]
    },
    "pathophysiology": "分枝桿菌細胞壁含有大量分枝酸和脂質，形成蠟質外層使細菌具有抗酸染色特性、抵抗乾燥和消毒劑。細菌被巨噬細胞吞噬後，透過抑制吞噬溶酶體融合和酸化，在巨噬細胞內存活和複製（類似組織漿菌的胞內寄生策略）。宿主形成肉芽腫試圖包裹感染——特徵性的結核性肉芽腫由上皮樣巨噬細胞、Langhans巨細胞和周圍的淋巴細胞組成，中央可能有乾酪性壞死。細胞免疫（CD4+ T細胞和IFN-γ）是控制感染的關鍵。M. avium complex在Siamese和Abyssinian貓中的高易感性可能與品種特異性的免疫缺陷有關。速生NTM（M. fortuitum等）通常經皮膚傷口接種引起局部感染。",
    "diagnosis": {
      "overview": "抗酸染色細胞學是初步診斷的關鍵，培養和PCR用於種別鑑定",
      "differentials": [
        "其他深部真菌感染",
        "諾卡菌病（也為部分抗酸染色陽性）",
        "放線菌病",
        "異物肉芽腫",
        "腫瘤（淋巴瘤、肥大細胞瘤）"
      ],
      "initialDB": [
        "細胞學或組織壓片——Ziehl-Neelsen（ZN）抗酸染色尋找抗酸桿菌（acid-fast bacilli, AFB）",
        "注意：NTM在組織中菌量可能很少，抗酸染色可能陰性",
        "CBC/生化——非再生性貧血、高球蛋白、低白蛋白",
        "FeLV/FIV檢測（貓）"
      ],
      "advanced": [
        "分枝桿菌培養（需特殊培養基如Lowenstein-Jensen，TB群生長需4-8週，速生NTM數天至1週）",
        "組織病理學——肉芽腫性至化膿肉芽腫性炎症伴抗酸桿菌",
        "PCR和基因定序（種別鑑定）",
        "藥物敏感性試驗（指導治療極為重要）",
        "胸腔X光和腹部超音波評估播散",
        "公共衛生注意：M. tuberculosis和M. bovis為法定報告傳染病"
      ]
    },
    "treatment": {
      "overview": "長期多藥併用抗生素治療，結核群感染具公共衛生考量",
      "acute": [
        "NTM皮膚感染：clarithromycin 62.5 mg/cat q12h + fluoroquinolone（如pradofloxacin 5 mg/kg q24h）",
        "速生NTM：doxycycline + fluoroquinolone",
        "M. avium complex：clarithromycin + rifampin + ethambutol（三聯療法）"
      ],
      "chronic": [
        "治療至少4-6個月（NTM皮膚型）",
        "M. avium complex播散型：6-12個月或更長",
        "TB群：安樂死可能是公共衛生建議（M. tuberculosis和M. bovis為人畜共通傳染病）",
        "皮膚病灶手術切除可輔助藥物治療",
        "根據藥敏結果調整方案"
      ]
    },
    "prognosis": "速生NTM皮膚型：手術+藥物預後良好。M. avium complex播散型（尤其Siamese貓）：預後不良。TB群感染：因公共衛生風險，通常建議安樂死。整體預後取決於菌種、受累範圍和免疫狀態。",
    "pearls": [
      "M. tuberculosis和M. bovis感染是法定報告傳染病——具人畜共通傳染風險，診斷後需通知公共衛生單位",
      "Siamese和Abyssinian貓對M. avium complex有品種易感性",
      "諾卡菌也是部分抗酸染色陽性——需與分枝桿菌鑑別（諾卡菌為絲狀，分枝桿菌為桿狀）",
      "藥物敏感性試驗對指導治療至關重要——NTM的抗藥性模式差異很大",
      "培養生長緩慢（TB群需4-8週）——PCR可提供快速鑑定"
    ],
    "diagnosticAlgorithm": {
      "title": "分枝桿菌感染 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估慢性非癒合性病灶與全身症狀",
          "findings": [
            "慢性皮膚結節或潰瘍",
            "引流不止的竇道",
            "體重減輕與食慾下降",
            "淋巴結腫大"
          ]
        },
        {
          "step": 2,
          "action": "細胞學與染色",
          "details": "病灶細針抽吸與抗酸性染色",
          "findings": [
            "Ziehl-Neelsen抗酸性染色陽性桿菌",
            "肉芽腫性至化膿性炎症",
            "巨噬細胞內可見菌體"
          ]
        },
        {
          "step": 3,
          "action": "組織學檢查",
          "details": "活檢組織病理與特殊染色",
          "findings": [
            "肉芽腫性炎症伴壞死",
            "抗酸性桿菌數量不等",
            "快速生長型vs緩慢生長型表現不同"
          ]
        },
        {
          "step": 4,
          "action": "確診與分型",
          "details": "培養與分子鑑定確認菌種",
          "findings": [
            "分枝桿菌培養（需數週至數月）",
            "PCR鑑定菌種",
            "區分典型vs非典型分枝桿菌",
            "藥敏試驗指導長期抗菌治療"
          ]
        }
      ]
    },
    "monitoring": [
      "臨床症狀改善追蹤",
      "培養追蹤治療反應",
      "肝腎功能監測（長期多藥治療）",
      "胸腔和腹部影像追蹤",
      "公共衛生追蹤（TB群）"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "protothecosis": {
    "zh": "原藻菌病",
    "en": "Protothecosis",
    "definition": "原藻菌病是由無色藻類 Prototheca spp.（主要為 P. wickerhamii 和 P. zopfii）引起的罕見感染。Prototheca 是缺乏葉綠素的藻類（非真菌），與綠藻（Chlorella）親緣關係近。犬以播散型為主（尤其結腸和眼部受累），貓以皮膚型為主。",
    "synonyms": [
      "Prototheca Infection",
      "藻菌感染",
      "原藻感染"
    ],
    "epidemiology": {
      "species": "犬貓皆可，犬較常見",
      "age": "成年犬（中年至老年）",
      "sex": "母犬略多",
      "riskFactors": [
        "接觸污染的停滯水源（下水道、污水）",
        "免疫抑制狀態",
        "大型犬種",
        "Collie犬種（可能有品種傾向）",
        "農村和潮濕環境"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "犬：慢性大腸性腹瀉（血性黏液便），體重減輕",
        "進行性視力下降至失明",
        "皮膚結節或潰瘍",
        "對抗生素治療無反應",
        "貓：慢性皮膚結節"
      ],
      "physicalExam": [
        "犬播散型：大腸性腹瀉（新鮮血、黏液、裡急後重）",
        "眼部：嚴重脈絡膜視網膜炎伴視網膜剝離、失明",
        "前葡萄膜炎",
        "皮膚結節或潰瘍",
        "神經症狀（CNS播散時）",
        "消瘦",
        "貓：四肢或軀幹的皮下結節"
      ]
    },
    "pathophysiology": "Prototheca spp. 是廣泛存在於環境中（污水、土壤、動物糞便）的腐生性無色藻類。感染途徑可能為攝入（GI型）或皮膚傷口（皮膚型）。在組織中，Prototheca通過內孢子形成（endosporulation）進行無性繁殖——母細胞內產生2-20個內孢子，成熟後母細胞壁破裂釋放內孢子。犬的感染通常為播散型，經腸道進入後血行播散至眼、CNS和其他器官。嚴重的肉芽腫性至化膿肉芽腫性炎症反應伴隨大量藻體。細胞免疫缺陷是發病的重要因素。犬的結腸受累非常突出，類似肉芽腫性結腸炎。",
    "diagnosis": {
      "overview": "細胞學或組織病理學發現特徵性的內孢子形成型態即可確診",
      "differentials": [
        "炎症性腸病（GI型）",
        "組織漿菌病GI型",
        "腸道淋巴瘤",
        "隱球菌病（眼部型）",
        "系統性真菌感染"
      ],
      "initialDB": [
        "直腸刮片或糞便細胞學——大型（8-25 μm）球形至橢圓形細胞伴內孢子形成",
        "眼底檢查——脈絡膜視網膜炎和視網膜剝離",
        "CBC/生化——可能正常或輕度異常"
      ],
      "advanced": [
        "組織病理學——肉芽腫性炎症伴大量藻體（PAS和GMS陽性）",
        "培養（Sabouraud agar，37°C數天即可生長）",
        "結腸內視鏡活檢",
        "CSF分析（CNS受累時）"
      ]
    },
    "treatment": {
      "overview": "治療極為困難，犬的播散型幾乎無有效治療",
      "acute": [
        "itraconazole 10 mg/kg q24h + amphotericin B（脂質體配方）——有限療效",
        "局部皮膚型（貓）：手術切除"
      ],
      "chronic": [
        "長期抗真菌藥物（itraconazole、fluconazole）聯合治療",
        "犬的播散型：通常對治療反應極差",
        "貓的皮膚型：手術切除+抗真菌藥物，預後較好"
      ]
    },
    "prognosis": "犬的播散型預後極差至無望——大多數犬最終被安樂死。貓的皮膚局限型預後較好，手術切除可能治癒。目前無有效的犬播散型治療方案。",
    "pearls": [
      "Prototheca不是真菌而是無色藻類——但對部分抗真菌藥物有一定敏感性",
      "犬播散型Protothecosis的三聯徵：慢性血性大腸性腹瀉 + 失明 + 神經症狀",
      "直腸刮片是最簡單的診斷方法——可見特徵性的內孢子形成型態",
      "犬播散型目前幾乎無有效治療——預後極差",
      "與組織漿菌GI型的鑑別：Prototheca較大且有特徵性的內孢子形成"
    ],
    "diagnosticAlgorithm": {
      "title": "原藻菌病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估慢性腹瀉或眼部症狀，注意免疫狀態",
          "findings": [
            "慢性出血性腹瀉（犬常見）",
            "眼部病變（失明、葡萄膜炎）",
            "皮膚結節性病灶",
            "體重減輕"
          ]
        },
        {
          "step": 2,
          "action": "細胞學檢查",
          "details": "病灶或分泌物細胞學",
          "findings": [
            "見特徵性無色藻類菌體（內孢囊）",
            "大型球形菌體含內生孢子",
            "肉芽腫性炎症反應"
          ]
        },
        {
          "step": 3,
          "action": "組織學檢查",
          "details": "活檢組織病理學",
          "findings": [
            "PAS與GMS染色見Prototheca菌體",
            "肉芽腫性至化膿性肉芽腫性炎症",
            "直腸全層活檢（GI型）"
          ]
        },
        {
          "step": 4,
          "action": "確診",
          "details": "培養與分子鑑定",
          "findings": [
            "Prototheca培養（Sabouraud培養基）",
            "種別鑑定（P. zopfii vs P. wickerhamii）",
            "播散性感染預後極差",
            "評估全身播散範圍"
          ]
        }
      ]
    },
    "monitoring": [
      "眼科檢查追蹤視力變化",
      "糞便品質和頻率",
      "神經功能評估",
      "生活品質評估（犬播散型通常需要安樂死討論）"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "hepatozoonosis": {
    "zh": "肝簇蟲病",
    "en": "Hepatozoonosis",
    "definition": "肝簇蟲病是由頂複門原蟲 Hepatozoon spp. 引起的蜱媒介性疾病。犬有兩個主要病原種：H. canis（較溫和，全球分布）和 H. americanum（較嚴重，美國南部）。獨特的傳播方式：犬經攝入（吞食）含有成熟卵囊的感染蜱而感染，而非經蜱叮咬。",
    "synonyms": [
      "Hepatozoon Infection",
      "American Canine Hepatozoonosis (H. americanum)",
      "肝簇蟲感染"
    ],
    "epidemiology": {
      "species": "犬為主要宿主，貓罕見",
      "age": "任何年齡",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "蜱暴露（吞食蜱蟲——梳理行為中攝入）",
        "H. canis：棕色犬蜱（Rhipicephalus sanguineus）為媒介",
        "H. americanum：墨西哥灣海岸蜱（Amblyomma maculatum）為媒介",
        "免疫抑制狀態（加重H. canis感染）",
        "多蜱環境",
        "戶外活動犬"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "H. canis（溫和型）：多數為亞臨床，嚴重時發熱和肌肉疼痛",
        "H. americanum（嚴重型）：高燒、嚴重肌肉疼痛和僵硬、體重減輕",
        "食慾下降",
        "不願行走（肌肉疼痛）",
        "間歇性發熱",
        "眼分泌物"
      ],
      "physicalExam": [
        "H. canis：貧血蒼白黏膜、脾腫大、消瘦",
        "H. americanum：高燒、嚴重肌肉疼痛和僵硬（尤其脊柱旁肌群）",
        "肌肉萎縮",
        "骨膜增生（長骨——X光可見）",
        "膿性眼分泌物",
        "全身淋巴結腫大",
        "惡病質"
      ]
    },
    "pathophysiology": "犬在梳理過程中吞食含有成熟卵囊的感染蜱（與其他蜱媒介疾病經叮咬傳播不同）。卵囊在腸道釋放子孢子，穿透腸壁進入血液循環。H. canis的裂殖體主要在嗜中性球和單核球中發育（可在血塗片中看到配子母細胞）。H. americanum的裂殖體在骨骼肌和心肌中發育，引起嚴重的化膿肉芽腫性肌炎和骨膜增生。肌肉中的裂殖體（meront）被巨噬細胞包圍形成「洋蔥皮」樣肉芽腫。H. americanum的骨膜增生可能與肌肉附著處的炎症刺激有關。H. canis在免疫正常犬通常為低寄生蟲血症的亞臨床感染，但免疫抑制時可發展為高寄生蟲血症和嚴重臨床疾病。",
    "diagnosis": {
      "overview": "H. canis可在血塗片中發現配子母細胞，H. americanum需要肌肉活檢",
      "differentials": [
        "多發性肌炎（免疫介導性）",
        "骨骼腫瘤（骨膜增生時）",
        "其他蜱媒介疾病",
        "全身性紅斑狼瘡",
        "多發性骨髓炎"
      ],
      "initialDB": [
        "血塗片——H. canis：嗜中性球或單核球內的配子母細胞（橢圓形包涵體）",
        "CBC——H. canis：嗜中性球增多（通常非常顯著，可>100,000/μL）；H. americanum：嗜中性球增多",
        "生化——高鹼性磷酸酶",
        "骨骼X光——H. americanum：長骨骨膜增生"
      ],
      "advanced": [
        "肌肉活檢——H. americanum：骨骼肌中的肉芽腫性炎症和裂殖體（meronts）",
        "PCR鑑別H. canis和H. americanum",
        "血清學",
        "CK升高"
      ]
    },
    "treatment": {
      "overview": "H. canis和H. americanum的治療方案不同",
      "acute": [
        "H. canis：imidocarb dipropionate 5 mg/kg IM，間隔14天重複",
        "H. americanum（TCP方案）：trimethoprim-sulfadiazine 15 mg/kg q12h + clindamycin 10 mg/kg q8h + pyrimethamine 0.25 mg/kg q24h，共14天",
        "H. americanum的疼痛管理：NSAIDs",
        "支持療法"
      ],
      "chronic": [
        "H. americanum：TCP方案後轉為 decoquinate 10-20 mg/kg q12h 長期維持",
        "H. canis：可能需要反覆imidocarb治療",
        "蜱預防（極為重要——防止再感染）",
        "H. americanum通常無法根治——需終生管理"
      ]
    },
    "prognosis": "H. canis：預後良好（大多數病例對治療反應好）。H. americanum：預後謹慎至不良——通常無法根治，需要終生decoquinate維持治療，復發常見。不治療的H. americanum致死率高。",
    "pearls": [
      "犬經吞食（不是被叮咬）感染蜱而感染——獨特的傳播方式",
      "嗜中性球內的配子母細胞（血塗片）是H. canis的診斷線索",
      "極端的嗜中性球增多症（>100,000/μL）是H. canis的特徵",
      "H. americanum導致骨膜增生——在鑑別骨腫瘤時需考慮",
      "H. americanum通常無法根治——需終生decoquinate維持"
    ],
    "diagnosticAlgorithm": {
      "title": "肝簇蟲病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估患畜臨床症狀，注意發熱、肌肉疼痛、步態僵硬及體重下降等表現，詢問蜱蟲接觸史",
          "findings": [
            "間歇性發熱",
            "肌肉疼痛及僵硬步態",
            "嗜睡與食慾下降"
          ]
        },
        {
          "step": 2,
          "action": "血液學檢查",
          "details": "進行CBC及血液抹片檢查，尋找嗜中性球內的肝簇蟲配子體，評估白血球計數變化",
          "findings": [
            "嗜中性球內發現肝簇蟲配子體",
            "明顯白血球增多症",
            "非再生性貧血"
          ]
        },
        {
          "step": 3,
          "action": "影像與骨骼評估",
          "details": "進行X光檢查評估骨骼變化，尤其是骨膜增生反應",
          "findings": [
            "骨膜增生性骨病變",
            "肌肉肌炎影像學表現"
          ]
        },
        {
          "step": 4,
          "action": "確診",
          "details": "結合肌肉活檢發現蟲體囊腫及PCR分子檢測確認感染",
          "findings": [
            "肌肉活檢發現肝簇蟲囊腫",
            "PCR檢測陽性確診"
          ]
        }
      ]
    },
    "monitoring": [
      "血塗片追蹤寄生蟲血症（H. canis）",
      "CBC追蹤嗜中性球數量",
      "骨骼X光追蹤骨膜增生變化",
      "CK和肌肉疼痛評估",
      "蜱預防的遵從性"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "neosporosis": {
    "zh": "新孢子蟲病",
    "en": "Neosporosis",
    "definition": "新孢子蟲病是由頂複門原蟲 Neospora caninum 引起的感染性疾病。犬既是終末宿主（腸道內有性繁殖並排出卵囊）也是中間宿主（組織內無性繁殖引起疾病）。幼犬的經胎盤感染是最重要的傳播途徑，可導致嚴重的上行性麻痺和多器官感染。",
    "synonyms": [
      "Neospora caninum Infection",
      "新孢子蟲感染"
    ],
    "epidemiology": {
      "species": "犬為主要宿主（終末和中間宿主），貓極罕見",
      "age": "先天性感染：幼犬（<6月齡）最常見且最嚴重；後天性感染：任何年齡",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "母犬為帶原者（經胎盤垂直傳播）",
        "攝入含有卵囊的牛組織或胎盤",
        "農場環境（接觸牛群）",
        "免疫抑制狀態"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "幼犬（先天性）：後肢進行性僵硬和麻痺，通常3-6週齡開始出現",
        "同窩多隻幼犬可能受影響",
        "吞嚥困難",
        "成犬：多灶性神經症狀",
        "肌肉萎縮"
      ],
      "physicalExam": [
        "幼犬：後肢進行性過伸（hyperextension）和肌肉攣縮——最典型的表現",
        "上行性麻痺（由後肢向前肢進展）",
        "後肢肌肉嚴重萎縮",
        "下運動神經元徵兆",
        "吞嚥困難和咀嚼困難",
        "嘴巴無法完全張開",
        "成犬：共濟失調、抽搐、行為改變",
        "多灶性CNS徵兆",
        "多發性肌炎",
        "皮膚結節（罕見）"
      ]
    },
    "pathophysiology": "N. caninum 的生活史類似弓漿蟲（Toxoplasma gondii），但犬為終末宿主（貓是弓漿蟲的終末宿主）。主要傳播途徑：(1) 經胎盤垂直傳播（最重要）——帶原母犬在妊娠期經胎盤將速殖體（tachyzoites）傳播給胎兒；(2) 水平傳播——攝入含有卵囊或組織包囊的感染組織。速殖體是急性感染的活躍增殖型態，可侵入神經細胞、肌細胞、巨噬細胞和其他細胞。慢性感染時，速殖體轉為緩殖體（bradyzoites）形成組織包囊，主要在腦和肌肉中。先天性感染的幼犬，N. caninum 主要侵犯脊髓腰薦節段和周邊神經，引起嚴重的非化膿性腦脊髓炎和多發性根神經炎。肌肉中的炎症和纖維化導致不可逆的肌肉攣縮（尤其後肢伸肌）。",
    "diagnosis": {
      "overview": "幼犬的後肢過伸/攣縮是高度特徵性的臨床線索，血清學和CSF分析支持診斷",
      "differentials": [
        "弓漿蟲病",
        "犬瘟熱神經型",
        "多發性肌炎（免疫介導性）",
        "脊髓灰質炎",
        "先天性脊椎畸形"
      ],
      "initialDB": [
        "N. caninum IFA或ELISA血清抗體——陽性支持診斷但無法區分暴露和活動性感染",
        "CSF分析——混合細胞增多、蛋白升高",
        "CK升高（肌肉受累）",
        "CBC/生化——通常無特異性"
      ],
      "advanced": [
        "CSF N. caninum PCR",
        "肌肉活檢——非化膿性肌炎伴速殖體（免疫組織化學標記）",
        "腦脊髓MRI",
        "免疫組織化學——區分Neospora和Toxoplasma（形態學相似）",
        "母犬抗體檢測（評估垂直傳播風險）"
      ]
    },
    "treatment": {
      "overview": "抗原蟲治療需早期開始，幼犬肌肉攣縮一旦形成通常不可逆",
      "acute": [
        "clindamycin 12.5-25 mg/kg q12h PO（首選）",
        "替代：TMP-SMX 15 mg/kg q12h",
        "嚴重病例：clindamycin + pyrimethamine 1 mg/kg q24h（加葉酸5 mg/day防止骨髓抑制）"
      ],
      "chronic": [
        "clindamycin持續治療至少4-8週",
        "物理治療嘗試改善肌肉攣縮（效果有限）",
        "帶原母犬不建議再繁殖"
      ]
    },
    "prognosis": "幼犬先天性感染伴肌肉攣縮：預後不良至無望（攣縮不可逆）。成犬後天性感染：預後謹慎，早期治療可能有效。CNS廣泛受累者預後差。治療可能無法完全清除包囊型態。",
    "pearls": [
      "幼犬後肢過伸（膝關節和跗關節固定伸展）是Neosporosis最具特徵性的表現",
      "經胎盤傳播是最重要的感染途徑——帶原母犬可在連續懷孕中反覆傳播",
      "形態學上Neospora與Toxoplasma幾乎無法區別——需免疫組織化學或PCR鑑別",
      "肌肉攣縮一旦形成即不可逆——早期診斷和治療至關重要",
      "感染母犬不應再用於繁殖"
    ],
    "diagnosticAlgorithm": {
      "title": "新孢子蟲病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估神經肌肉症狀，注意後肢進行性癱瘓、肌肉萎縮和多發性神經根炎表現，幼犬尤其注意",
          "findings": [
            "後肢進行性麻痺",
            "肌肉萎縮與僵硬",
            "幼犬後肢過度伸展"
          ]
        },
        {
          "step": 2,
          "action": "血清學檢查",
          "details": "進行抗Neospora caninum抗體IFA或ELISA檢測，評估抗體效價",
          "findings": [
            "血清抗體效價顯著升高",
            "CSF抗體陽性"
          ]
        },
        {
          "step": 3,
          "action": "進階檢查與確診",
          "details": "進行CSF分析、MRI檢查評估CNS病變，PCR檢測確認病原",
          "findings": [
            "CSF蛋白升高及混合性細胞增多",
            "MRI顯示腦脊髓炎病灶",
            "PCR檢測確認新孢子蟲DNA"
          ]
        }
      ]
    },
    "monitoring": [
      "神經功能和肌肉狀態定期評估",
      "抗體滴度追蹤（但滴度與疾病活性不完全相關）",
      "同窩其他幼犬的評估",
      "母犬和繁殖管理建議"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "leishmaniasis": {
    "zh": "利什曼病",
    "en": "Leishmaniasis",
    "definition": "利什曼病是由利什曼原蟲屬（Leishmania spp.，主要為 L. infantum/L. chagasi）引起的慢性系統性疾病。經白蛉（sand fly）叮咬傳播。原蟲在巨噬細胞內以無鞭毛體（amastigote）型態寄生和複製。犬是地中海地區和中南美洲的主要儲存宿主，具有重要的人畜共通傳染意義。",
    "synonyms": [
      "Canine Leishmaniosis",
      "Kala-azar (visceral form)",
      "利什曼原蟲病",
      "黑熱病"
    ],
    "epidemiology": {
      "species": "犬為主要宿主和儲存宿主，貓偶見",
      "age": "雙峰分布：<3歲和>7歲",
      "sex": "公犬略多",
      "riskFactors": [
        "居住在或旅行至流行地區（地中海沿岸、中南美洲、中東）",
        "白蛉活躍地區",
        "戶外活動和夜間暴露（白蛉為夜行性）",
        "免疫反應以Th2為主的個體（無法有效控制感染）",
        "某些品種可能有遺傳易感性（Boxer、Cocker Spaniel、Rottweiler）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "慢性體重減輕伴食慾正常或下降",
        "皮膚問題（脫毛、鱗屑、潰瘍）",
        "運動不耐",
        "多飲多尿",
        "鼻出血",
        "跛行",
        "病程通常數月至數年",
        "可能有旅行至流行區的病史"
      ],
      "physicalExam": [
        "皮膚：非搔癢性對稱脫毛、乾燥鱗屑（石棉樣皮屑）、潰瘍（尤其壓力點和耳翼）",
        "指甲異常增長（onychogryphosis——幾乎是特徵性的）",
        "全身淋巴結腫大",
        "脾腫大",
        "肌肉萎縮（尤其頭部顳肌）",
        "鼻出血",
        "眼部：前葡萄膜炎、角結膜炎",
        "關節腫脹（多發性關節炎）",
        "黏膜蒼白（貧血）"
      ]
    },
    "pathophysiology": "L. infantum 以前鞭毛體（promastigote）型態存在於白蛉腸道中。白蛉叮咬犬時，前鞭毛體進入皮膚被巨噬細胞吞噬，在吞噬溶酶體內轉為無鞭毛體（amastigote）並大量複製。感染的巨噬細胞將原蟲播散至富含巨噬細胞的器官（脾、肝、骨髓、淋巴結）。疾病的嚴重程度主要取決於宿主的免疫反應類型：Th1反應（IFN-γ、IL-2）可有效控制感染並可能維持亞臨床狀態；Th2反應（IL-4、IL-10）伴大量抗體產生但無法殺滅胞內寄生蟲，導致進行性疾病。過量的抗體產生導致高球蛋白血症和免疫複合物沉積——引起腎小球腎炎（最重要的致死原因）、關節炎、血管炎和葡萄膜炎。蛋白尿和腎功能不全的進展決定預後。",
    "diagnosis": {
      "overview": "結合血清學、細胞學/病理學和臨床病理學進行綜合診斷",
      "differentials": [
        "免疫介導性多系統疾病（SLE）",
        "淋巴瘤",
        "多發性骨髓瘤",
        "艾利希體病",
        "皮膚黴菌感染",
        "落葉型天皰瘡"
      ],
      "initialDB": [
        "Leishmania血清抗體IFAT或ELISA——定量滴度有助於分期和治療決策",
        "CBC——非再生性貧血、血小板減少",
        "生化——高球蛋白血症、白蛋白/球蛋白比值倒置（<0.6-0.8）、BUN/Creatinine可能升高",
        "尿液分析——蛋白尿（UPC比值）",
        "血清蛋白電泳——多株性丙種球蛋白增高"
      ],
      "advanced": [
        "細胞學（骨髓、淋巴結、皮膚穿刺）——巨噬細胞內無鞭毛體（kinetoplast可見）",
        "組織病理學（皮膚活檢）——肉芽腫性皮膚炎伴巨噬細胞內無鞭毛體",
        "Leishmania PCR（血液、骨髓、淋巴結）",
        "腎臟活檢（評估腎小球腎炎分期）"
      ]
    },
    "treatment": {
      "overview": "多藥聯合治療降低寄生蟲量和控制免疫介導併發症，通常無法完全清除感染",
      "acute": [
        "meglumine antimoniate 100 mg/kg q24h SC 共28天（歐洲標準方案）+ allopurinol 10 mg/kg q12h PO",
        "替代：miltefosine 2 mg/kg q24h PO 共28天 + allopurinol",
        "腎功能不全時劑量調整"
      ],
      "chronic": [
        "allopurinol 10 mg/kg q12h PO 長期維持（至少6-12個月，部分需終生）",
        "腎小球腎炎管理：ACE抑制劑（benazepril）、低蛋白飲食",
        "定期監測腎功能和蛋白尿",
        "復發時重複meglumine或miltefosine療程"
      ]
    },
    "prognosis": "取決於臨床分期（LeishVet分期系統）。第I-II期（輕度至中度）：長期管理下預後良好。第III期（嚴重）：預後謹慎。第IV期（嚴重腎衰竭）：預後不良。腎功能是最重要的預後因素。犬通常無法完全清除感染——終生帶原者。",
    "pearls": [
      "指甲異常增長（onychogryphosis）幾乎是犬利什曼病的特徵性發現",
      "白蛋白/球蛋白比值倒置是重要的實驗室線索",
      "腎小球腎炎是最重要的致死原因——蛋白尿（UPC）是關鍵監測指標",
      "犬是L. infantum的儲存宿主——具重大公共衛生意義",
      "旅行至地中海地區的犬應在返回後篩檢",
      "allopurinol長期使用可能導致黃嘌呤尿結石——需監測尿液"
    ],
    "diagnosticAlgorithm": {
      "title": "利什曼病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估皮膚病變、淋巴結腫大、體重下降和腎功能異常等全身性表現，詢問流行地區旅行史",
          "findings": [
            "非搔癢性鱗屑性皮膚炎",
            "全身性淋巴結腫大",
            "進行性消瘦與肌肉萎縮"
          ]
        },
        {
          "step": 2,
          "action": "實驗室檢查",
          "details": "進行CBC、生化檢查評估腎功能及蛋白電泳，注意高球蛋白血症",
          "findings": [
            "多株系高球蛋白血症",
            "蛋白尿與氮質血症",
            "非再生性貧血"
          ]
        },
        {
          "step": 3,
          "action": "病原學與血清學確診",
          "details": "進行淋巴結/骨髓細針抽吸細胞學檢查，結合IFAT或ELISA血清學及PCR檢測",
          "findings": [
            "細胞學發現巨噬細胞內利什曼原蟲無鞭毛體",
            "IFAT抗體效價顯著升高",
            "PCR確認利什曼原蟲DNA"
          ]
        }
      ]
    },
    "monitoring": [
      "腎功能（BUN、Creatinine）和蛋白尿（UPC）每1-3個月",
      "Leishmania定量抗體滴度每3-6個月",
      "CBC和生化每2-3個月",
      "血清蛋白電泳追蹤",
      "allopurinol引起的黃嘌呤尿石監測（尿液沉渣）"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "salmon-poisoning-disease": {
    "zh": "鮭魚中毒症",
    "en": "Salmon Poisoning Disease",
    "definition": "鮭魚中毒症是由立克次體 Neorickettsia helminthoeca 引起的犬急性致命性疾病。病原經複雜的生物傳播鏈傳播：犬攝入含有感染囊蚴的生鮭科魚類 → 吸蟲 Nanophyetus salmincola 在犬腸道成熟 → 釋放寄生於吸蟲體內的 N. helminthoeca → 立克次體感染犬的巨噬細胞。本病幾乎僅見於美國太平洋西北部。",
    "synonyms": [
      "SPD",
      "Neorickettsia helminthoeca Infection",
      "鮭魚病"
    ],
    "epidemiology": {
      "species": "犬特異性（犬科動物高度易感），貓極罕見",
      "age": "任何年齡",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "居住在美國太平洋西北部（華盛頓州、俄勒岡州、北加州）",
        "攝入生的或未充分烹煮的鮭科魚類（鮭魚、鱒魚、虹鱒）",
        "接觸太平洋沿岸河流的鮭魚洄游",
        "狩獵犬和釣魚環境中的犬"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "攝入生鮭魚後5-7天（最長可至33天）出現症狀",
        "急性高燒",
        "完全食慾廢絕",
        "嘔吐和劇烈血性腹瀉",
        "極度嗜睡和虛弱",
        "快速消瘦",
        "病程急性——不治療時7-10天死亡"
      ],
      "physicalExam": [
        "高燒（初期可達40-42°C，後期可轉為低體溫）",
        "全身淋巴結顯著腫大（幾乎是普遍性的）",
        "嚴重脫水",
        "黏膜蒼白或充血",
        "腹痛",
        "血性腹瀉",
        "漿液性至膿性鼻分泌物和眼分泌物",
        "後期：低體溫、休克、DIC"
      ]
    },
    "pathophysiology": "吸蟲 N. salmincola 的囊蚴寄生在鮭科魚類的組織中，而立克次體 N. helminthoeca 則寄生於吸蟲體內。犬攝入含有感染囊蚴的生魚後，吸蟲在犬的腸道發育為成蟲，同時釋放 N. helminthoeca。立克次體感染腸道上皮後進入血液，靶向全身淋巴結和其他單核吞噬細胞系統的巨噬細胞。在巨噬細胞內大量繁殖引起嚴重的全身性炎症反應和淋巴結腫大。腸道受累引起嚴重的出血性腸炎。不治療時致死率高達90%。吸蟲本身（N. salmincola）可引起較溫和的症狀，但立克次體是致死的主要原因。相關但較溫和的疾病「Elokomin fluke fever」由另一種Neorickettsia引起。",
    "diagnosis": {
      "overview": "流行病學背景（太平洋西北部+攝入生鮭魚）結合特徵性臨床表現即可高度懷疑",
      "differentials": [
        "犬小病毒腸炎",
        "犬瘟熱",
        "出血性胃腸炎（HGE）",
        "鉤端螺旋體病",
        "其他蜱媒介疾病"
      ],
      "initialDB": [
        "糞便鏡檢——吸蟲 N. salmincola 的蟲卵（小型、有蓋、褐色，約87×45 μm）",
        "淋巴結穿刺細胞學——反應性增生伴巨噬細胞內Neorickettsia包涵體（需Giemsa或Wright染色仔細尋找）",
        "CBC——白血球減少（初期）後轉為白血球增多、血小板減少",
        "生化——低白蛋白、電解質失衡"
      ],
      "advanced": [
        "N. helminthoeca PCR（血液或淋巴結穿刺）",
        "血清學（IFA）",
        "組織病理學（淋巴結或腸道）——巨噬細胞內包涵體"
      ]
    },
    "treatment": {
      "overview": "doxycycline為特效治療，結合驅蟲和支持療法",
      "acute": [
        "doxycycline 10 mg/kg q12h PO/IV 共7-10天（立克次體特效治療——可在24-72小時內退燒）",
        "praziquantel 20 mg/kg PO 單次（驅殺吸蟲 N. salmincola）",
        "積極靜脈輸液糾正脫水和電解質",
        "止吐藥（maropitant）",
        "必要時輸血（嚴重出血或貧血）"
      ],
      "chronic": [
        "完成doxycycline療程",
        "營養支持和漸進式恢復飲食",
        "避免再次暴露（不餵食生鮭魚）"
      ]
    },
    "prognosis": "不治療致死率約90%。及時doxycycline治療預後極佳（大多數犬24-72小時內顯著改善）。治癒後通常獲得持久免疫。延遲治療增加死亡風險。",
    "pearls": [
      "鮭魚中毒症幾乎100%致死但100%可治癒——doxycycline是救命藥",
      "地理分布極度限制——僅美國太平洋西北部（吸蟲中間宿主蝸牛的分布範圍）",
      "糞便中發現N. salmincola蟲卵是簡單快速的診斷線索",
      "充分烹煮或冷凍（-20°C > 7天）可殺死囊蚴，預防感染",
      "全身淋巴結腫大+生鮭魚攝入史在太平洋西北部高度提示本病"
    ],
    "diagnosticAlgorithm": {
      "title": "鮭魚中毒症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "詢問是否有食入生鮭魚或鱒魚的病史，評估急性發熱、嘔吐、血便及淋巴結腫大",
          "findings": [
            "急性高熱（40-42°C）",
            "嚴重出血性腹瀉",
            "全身性淋巴結顯著腫大"
          ]
        },
        {
          "step": 2,
          "action": "糞便與淋巴結檢查",
          "details": "進行糞便沉澱檢查尋找吸蟲卵，淋巴結細針抽吸尋找Neorickettsia helminthoeca",
          "findings": [
            "糞便發現Nanophyetus salmincola蟲卵",
            "淋巴結抹片發現立克次體包涵體"
          ]
        },
        {
          "step": 3,
          "action": "確診與分級",
          "details": "結合流行病學、臨床表現及實驗室檢查綜合確診，PCR可進一步確認",
          "findings": [
            "臨床表現與流行病學高度吻合",
            "PCR確認Neorickettsia helminthoeca"
          ]
        }
      ]
    },
    "monitoring": [
      "體溫每日監測（應在24-72小時內退燒）",
      "脫水狀態和電解質",
      "糞便品質",
      "血小板計數"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "plague": {
    "zh": "鼠疫",
    "en": "Plague (Yersinia pestis Infection)",
    "definition": "鼠疫是由革蘭氏陰性桿菌 Yersinia pestis 引起的急性嚴重細菌感染。經跳蚤叮咬或接觸受感染的嚙齒類動物傳播。貓對Y. pestis高度易感，可表現為腺鼠疫（淋巴結型）、敗血型或肺型。犬通常抗性較高。鼠疫是重要的法定報告人畜共通傳染病。",
    "synonyms": [
      "Yersinia pestis Infection",
      "Bubonic Plague",
      "Black Death",
      "黑死病",
      "鼠疫桿菌感染"
    ],
    "epidemiology": {
      "species": "貓高度易感，犬通常抗性較高（多為亞臨床血清轉化）",
      "age": "任何年齡",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "居住在流行地區（美國西部、東南亞、非洲）",
        "接觸野生嚙齒類（松鼠、草原犬）",
        "狩獵行為的戶外貓",
        "跳蚤暴露",
        "農村或郊區環境"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "急性高燒",
        "食慾廢絕和嗜睡",
        "下頜或頸部淋巴結急性腫大",
        "可能有接觸死亡嚙齒類的歷史",
        "呼吸困難（肺型）"
      ],
      "physicalExam": [
        "腺鼠疫（最常見）：一或多個淋巴結急性腫大、疼痛、發炎（bubo）——頭頸部淋巴結最常受累",
        "高燒（40-41°C）",
        "脫水",
        "黏膜蒼白",
        "敗血型：休克、DIC、多器官衰竭",
        "肺型：呼吸困難、咳嗽、含血痰",
        "口腔潰瘍和舌壞死（貓）",
        "腹痛"
      ]
    },
    "pathophysiology": "Y. pestis 主要經跳蚤叮咬傳播，也可經直接接觸感染動物或吸入感染飛沫傳播。細菌在跳蚤前胃中大量繁殖，阻塞消化道，導致跳蚤在叮咬時反流細菌入宿主。注入皮膚後，Y. pestis 利用其III型分泌系統（T3SS）注入效應蛋白（Yop蛋白）至巨噬細胞，抑制吞噬作用和促炎反應。細菌沿淋巴管到達區域淋巴結引起急性壞死性淋巴結炎（bubo）。若免疫無法控制，細菌進入血流引起敗血症。肺型鼠疫可由敗血型繼發（繼發性肺鼠疫）或直接吸入感染飛沫引起（原發性肺鼠疫）。貓的高易感性可能與其不同的免疫反應有關。犬通常僅出現輕度症狀或亞臨床感染，但可作為跳蚤的媒介將感染帶入家庭。",
    "diagnosis": {
      "overview": "高度懷疑時立即開始治療和通報公共衛生單位，診斷由培養和血清學確認",
      "differentials": [
        "其他原因的急性淋巴結腫大（淋巴瘤、細菌性淋巴結炎）",
        "土拉倫病",
        "貓抓病（Bartonella）",
        "膿瘍"
      ],
      "initialDB": [
        "淋巴結穿刺細胞學——大量嗜中性球伴革蘭氏陰性雙極染色桿菌（safety pin appearance）",
        "血液和淋巴結穿刺培養——需通知實驗室疑似鼠疫（BSL-3生物安全措施）",
        "CBC——白血球增多伴核左移"
      ],
      "advanced": [
        "Y. pestis 特異性抗原檢測（F1 antigen）",
        "急性期和恢復期配對血清學",
        "PCR確認",
        "公共衛生實驗室確認性試驗"
      ]
    },
    "treatment": {
      "overview": "立即使用對Y. pestis有效的抗生素，同時通報公共衛生單位",
      "acute": [
        "gentamicin 5-7 mg/kg IV/IM q24h（首選）",
        "替代：doxycycline 5 mg/kg q12h IV/PO",
        "替代：enrofloxacin 5-10 mg/kg q24h（fluoroquinolones有效）",
        "支持療法：靜脈輸液、營養支持",
        "膿瘍引流（成熟的bubo）"
      ],
      "chronic": [
        "抗生素治療至少10-14天",
        "跳蚤控制（極為重要——防止傳播）",
        "隔離感染動物（尤其肺型——飛沫傳播風險）"
      ]
    },
    "prognosis": "腺鼠疫及時治療預後良好。敗血型和肺型預後謹慎至不良。不治療的貓鼠疫致死率>50%。犬通常預後良好（較少重症）。",
    "pearls": [
      "鼠疫是法定報告傳染病——確診或高度懷疑時必須通報公共衛生機關",
      "貓的肺型鼠疫可經飛沫傳播給人——嚴重的公共衛生風險",
      "犬的主要風險不是犬本身發病，而是將帶菌跳蚤帶入家庭",
      "革蘭氏染色的雙極染色桿菌（safety pin appearance）是Y. pestis的特徵",
      "處理疑似鼠疫動物時需嚴格防護措施"
    ],
    "diagnosticAlgorithm": {
      "title": "鼠疫 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估急性發熱、淋巴結腫大和全身敗血症表現，詢問嚙齒類動物接觸史及流行地區居住史",
          "findings": [
            "急性高熱與精神沉鬱",
            "下頜或頸部淋巴結顯著腫大（腺鼠疫型）",
            "呼吸困難（肺鼠疫型）"
          ]
        },
        {
          "step": 2,
          "action": "實驗室與病原學檢查",
          "details": "進行CBC、淋巴結抽吸物革蘭氏染色及培養，注意安全等級要求",
          "findings": [
            "淋巴結抽吸物發現雙極染色桿菌",
            "白血球增多伴核左移",
            "血培養Yersinia pestis陽性"
          ]
        },
        {
          "step": 3,
          "action": "確診與通報",
          "details": "PCR確認病原，此為法定通報傳染病，須立即通報相關單位",
          "findings": [
            "PCR確認鼠疫桿菌",
            "為法定通報傳染病需立即通報"
          ]
        }
      ]
    },
    "monitoring": [
      "體溫和臨床反應（應在24-48小時內改善）",
      "隔離措施直至完成治療",
      "接觸者（人和動物）的監測",
      "跳蚤控制效果評估"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "tularemia": {
    "zh": "土拉倫病",
    "en": "Tularemia",
    "definition": "土拉倫病是由革蘭氏陰性球桿菌 Francisella tularensis 引起的急性細菌感染。傳播途徑多樣：蜱叮咬、接觸或攝入感染的野生動物（兔、嚙齒類）、吸入。貓比犬更易感且症狀更嚴重。本病為法定報告的人畜共通傳染病。",
    "synonyms": [
      "Rabbit Fever",
      "Deer Fly Fever",
      "Francisella tularensis Infection",
      "兔熱病",
      "野兔病"
    ],
    "epidemiology": {
      "species": "貓較犬更易感且症狀更嚴重",
      "age": "任何年齡",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "接觸野兔或嚙齒類動物（尤其獵捕）",
        "蜱暴露",
        "飲用受污染的水源",
        "戶外活動的獵捕貓",
        "北美、歐洲和亞洲流行地區"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "急性高燒",
        "嗜睡和食慾廢絕",
        "淋巴結腫大",
        "近期有獵捕兔子或接觸嚙齒類的歷史",
        "蜱暴露史",
        "口腔潰瘍"
      ],
      "physicalExam": [
        "高燒",
        "全身淋巴結腫大（尤其頭頸部和下頜）",
        "口腔和舌潰瘍",
        "肝脾腫大",
        "黃疸（嚴重時）",
        "脫水",
        "腹痛",
        "呼吸困難（肺型）",
        "皮膚潰瘍（蜱叮咬處）"
      ]
    },
    "pathophysiology": "F. tularensis 是高度感染性的胞內寄生菌（極少量細菌即可引起感染）。經蜱叮咬、皮膚傷口接觸感染動物組織、攝入或吸入感染。細菌被巨噬細胞吞噬後逃出吞噬溶酶體，在巨噬細胞質中大量繁殖。經淋巴和血行播散至肝、脾和肺引起多灶性壞死性肉芽腫。貓比犬更易發展為全身性疾病——犬通常只出現輕度症狀或亞臨床感染。F. tularensis 有兩個主要亞種：A型（北美，更毒力）和B型（歐洲和亞洲，毒力較低）。",
    "diagnosis": {
      "overview": "高度懷疑時開始治療並通報公共衛生單位，培養需BSL-3設施",
      "differentials": [
        "鼠疫",
        "貓抓病（Bartonella）",
        "淋巴瘤",
        "其他蜱媒介疾病",
        "弓漿蟲病"
      ],
      "initialDB": [
        "CBC——白血球增多或減少、血小板減少",
        "生化——肝酶升高、膽紅素升高",
        "血液和淋巴結穿刺培養（需通知實驗室——BSL-3處理）"
      ],
      "advanced": [
        "F. tularensis PCR（血液、淋巴結）",
        "急性期和恢復期配對血清（microagglutination）",
        "組織病理學——多灶性壞死性肉芽腫",
        "直接免疫螢光染色"
      ]
    },
    "treatment": {
      "overview": "胺基糖苷類或fluoroquinolone為首選，立即開始經驗性治療",
      "acute": [
        "gentamicin 5-7 mg/kg IV/IM q24h（首選）",
        "替代：doxycycline 5 mg/kg q12h PO/IV",
        "替代：enrofloxacin 5 mg/kg q24h",
        "支持療法：靜脈輸液、營養支持"
      ],
      "chronic": [
        "抗生素治療10-14天",
        "嚴格隔離和防護（人畜共通傳染病風險）"
      ]
    },
    "prognosis": "貓：不治療致死率高（可達60%），及時治療預後改善但仍謹慎。犬：通常症狀輕微，預後良好。嚴重播散型伴多器官受累預後不良。",
    "pearls": [
      "土拉倫病是法定報告傳染病——確診後必須通報",
      "F. tularensis極度感染性——實驗室人員感染風險高，必須通知實驗室",
      "貓比犬更易發展為嚴重全身性疾病",
      "與鼠疫臨床相似——流行地區需列入鑑別",
      "處理疑似感染動物時需嚴格手套和防護"
    ],
    "diagnosticAlgorithm": {
      "title": "土拉倫病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估急性發熱、淋巴結腫大、口腔潰瘍等表現，詢問蜱蟲叮咬或野兔接觸史，貓比犬更易感",
          "findings": [
            "急性高熱與嗜睡",
            "局部淋巴結腫大伴壓痛",
            "口腔潰瘍或皮膚潰瘍"
          ]
        },
        {
          "step": 2,
          "action": "實驗室檢查",
          "details": "進行CBC及生化檢查，注意肝功能異常，血清學檢測抗體效價",
          "findings": [
            "白血球增多或減少",
            "肝酵素升高",
            "血清凝集抗體效價升高"
          ]
        },
        {
          "step": 3,
          "action": "確診",
          "details": "透過PCR或特殊培養（需BSL-3實驗室）確認Francisella tularensis，此為人畜共通傳染病",
          "findings": [
            "PCR確認Francisella tularensis",
            "需通報為人畜共通傳染病"
          ]
        }
      ]
    },
    "monitoring": [
      "體溫和臨床改善追蹤",
      "肝功能監測",
      "腎功能監測（gentamicin腎毒性）",
      "接觸者監測"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "angiostrongylus-vasorum": {
    "zh": "犬心肺蟲感染",
    "en": "Angiostrongylus vasorum Infection (French Heartworm)",
    "definition": "犬心肺蟲感染是由轉染蟲 Angiostrongylus vasorum 引起的犬心肺血管寄生蟲病。成蟲寄生於肺動脈和右心室。犬經攝入含有第三期幼蟲（L3）的中間宿主（蝸牛、蛞蝓）或接觸其黏液而感染。第一期幼蟲（L1）在肺泡中排出，經咳出吞入後由糞便排出。可引起凝血障礙和呼吸困難。",
    "synonyms": [
      "French Heartworm",
      "Canine Angiostrongylosis",
      "法國心絲蟲",
      "犬肺蟲感染"
    ],
    "epidemiology": {
      "species": "犬特異性（狐狸為重要野生動物儲存宿主），貓不感染",
      "age": "年輕犬（<2歲）風險較高（可能因好奇食入蝸牛/蛞蝓）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "居住在流行地區（歐洲西部和南部、英國和愛爾蘭、加拿大東部、南美洲部分地區）",
        "接觸蝸牛和蛞蝓",
        "飲用含蝸牛黏液的水碗",
        "幼犬的好奇行為",
        "戶外活動"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "慢性咳嗽",
        "運動不耐",
        "呼吸困難",
        "不明原因的出血傾向（鼻出血、皮膚瘀斑、血尿）",
        "體重減輕",
        "嘔吐和腹瀉",
        "突然死亡（大量感染時）"
      ],
      "physicalExam": [
        "呼吸音增強或異常（囉音、哮鳴音）",
        "運動後呼吸困難加重",
        "出血傾向：瘀點、瘀斑、黏膜出血、注射部位出血不止",
        "右心衰竭徵兆（嚴重時）：腹水、頸靜脈怒張",
        "蒼白黏膜",
        "體重減輕",
        "神經症狀（腦或脊髓出血時）：抽搐、共濟失調、麻痺"
      ]
    },
    "pathophysiology": "犬攝入含有L3幼蟲的蝸牛/蛞蝓（或其黏液污染的食物/水）。L3在腸壁穿透後經腸繫膜淋巴結發育，最終經門脈系統到達右心和肺動脈成為成蟲。成蟲在肺動脈中交配產卵，蟲卵嵌入肺微血管發育為L1。L1穿破肺泡壁進入呼吸道，經咳出吞入後由糞便排出至環境。肺動脈內的成蟲和肺泡中的蟲卵/幼蟲引起肉芽腫性肺動脈炎和肺間質炎症。凝血障礙是A. vasorum感染的重要特徵——機制可能包括：DIC（寄生蟲引起的持續性血管內凝血活化）、消耗性凝血病變、抑制凝血因子活性。嚴重感染可導致肺動脈高壓和右心衰竭。腦脊髓出血是致命性併發症。",
    "diagnosis": {
      "overview": "糞便Baermann法檢測L1幼蟲和抗原檢測是主要診斷工具",
      "differentials": [
        "犬心絲蟲感染（Dirofilaria immitis）",
        "肺部腫瘤",
        "細菌性肺炎",
        "免疫介導性血小板減少症",
        "免疫介導性溶血性貧血",
        "抗凝血劑中毒"
      ],
      "initialDB": [
        "糞便Baermann法——檢測第一期幼蟲（L1，帶有S形尾端扭曲和背嵴）",
        "A. vasorum 快速抗原檢測（IDEXX Angio Detect）",
        "CBC——輕度嗜酸性球增多、可能貧血和血小板減少",
        "凝血功能——PT/aPTT可能延長、纖維蛋白原下降",
        "胸腔X光——肺動脈擴張、瀰漫性間質至肺泡型浸潤"
      ],
      "advanced": [
        "支氣管肺泡灌洗——嗜酸性球增多和可能找到L1幼蟲",
        "心臟超音波——肺動脈和右心中可能見到成蟲",
        "CT掃描（肺部病灶詳細評估）",
        "凝血因子分析",
        "A. vasorum 血清抗體ELISA"
      ]
    },
    "treatment": {
      "overview": "抗寄生蟲藥物殺蟲，處理凝血障礙和呼吸支持",
      "acute": [
        "fenbendazole 25-50 mg/kg q24h PO 共20天（首選，漸進殺蟲減少急性反應）",
        "替代：milbemycin oxime 0.5 mg/kg PO 每週一次共4週",
        "moxidectin/imidacloprid spot-on（Advocate/Advantage Multi）——單次使用即可（歐洲常用）",
        "凝血障礙：新鮮冷凍血漿輸注",
        "嚴重呼吸困難：氧氣治療、cage rest"
      ],
      "chronic": [
        "完成驅蟲療程",
        "每月預防性投藥（milbemycin、moxidectin）防止再感染",
        "嚴重肺動脈高壓和右心衰竭的管理",
        "殺蟲後的肺部炎症反應可能需要短期低劑量糖皮質類固醇"
      ]
    },
    "prognosis": "輕度至中度感染：治療預後良好。嚴重凝血障礙或CNS出血：預後不良。右心衰竭：預後謹慎。及早診斷和治療大大改善預後。每月預防性投藥可有效防止感染。",
    "pearls": [
      "不明原因的凝血障礙犬在流行區應考慮A. vasorum感染",
      "A. vasorum的凝血障礙可模擬抗凝血劑中毒——在流行區必須列入鑑別",
      "Baermann法必須用新鮮糞便（L1活動性好有助於檢出）",
      "與D. immitis不同：A. vasorum的微絲蟲排在糞便中（不在血液中）",
      "快速抗原檢測（Angio Detect）是方便的診所內篩查工具",
      "每月預防用藥（moxidectin spot-on）在流行區推薦"
    ],
    "diagnosticAlgorithm": {
      "title": "犬心肺蟲感染 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估慢性咳嗽、運動不耐受、凝血異常等症狀，詢問蝸牛/蛞蝓接觸史",
          "findings": [
            "慢性咳嗽與呼吸困難",
            "運動不耐受",
            "異常出血傾向"
          ]
        },
        {
          "step": 2,
          "action": "糞便與血液檢查",
          "details": "進行Baermann糞便檢查尋找第一期幼蟲，CBC及凝血功能檢測",
          "findings": [
            "Baermann法檢出L1幼蟲",
            "嗜酸性球增多",
            "凝血時間延長（PT/aPTT）"
          ]
        },
        {
          "step": 3,
          "action": "影像學與確診",
          "details": "進行胸腔X光及心臟超音波評估肺動脈和右心變化，抗原快篩輔助確診",
          "findings": [
            "胸腔X光顯示肺動脈擴張及間質性肺病變",
            "心臟超音波可見肺動脈內蟲體",
            "商用抗原快篩陽性"
          ]
        }
      ]
    },
    "monitoring": [
      "治療後糞便Baermann法追蹤（應在治療後轉陰）",
      "凝血功能恢復監測",
      "胸腔X光追蹤肺部病灶消退",
      "治療後可能出現短暫性呼吸惡化（死蟲引起炎症）"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "dirofilaria-immitis-cat": {
    "zh": "貓心絲蟲感染",
    "en": "Feline Heartworm Disease (Dirofilaria immitis in Cats)",
    "definition": "貓心絲蟲感染是由犬心絲蟲 Dirofilaria immitis 感染貓所引起的心肺疾病。貓為非典型宿主，感染蟲數少（通常1-6隻），但因貓的肺血管直徑小，即使少量成蟲也可引起嚴重的肺動脈炎和急性呼吸窘迫。未成熟蟲體死亡時引起的免疫反應（HARD, Heartworm Associated Respiratory Disease）是貓心絲蟲病的獨特病理特徵。",
    "synonyms": [
      "Feline Heartworm Disease",
      "Feline Dirofilariasis",
      "HARD (Heartworm Associated Respiratory Disease)",
      "貓心絲蟲病"
    ],
    "epidemiology": {
      "species": "貓（非典型宿主，犬為自然宿主）",
      "age": "任何年齡，室內貓也有風險",
      "sex": "公貓略多",
      "riskFactors": [
        "居住在犬心絲蟲流行地區",
        "蚊蟲暴露（即使室內貓也有風險）",
        "未使用心絲蟲預防藥物",
        "戶外活動貓風險較高但室內貓也可感染"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "間歇性咳嗽和呼吸困難（常被誤診為貓哮喘）",
        "嘔吐（非胃腸道相關——可能與蟲體遷移的迷走神經刺激有關）",
        "嗜睡和運動不耐",
        "體重減輕",
        "食慾下降",
        "突然死亡（無先前症狀）"
      ],
      "physicalExam": [
        "呼吸急促和呼吸困難",
        "肺部聽診：呼吸音增強或哮鳴音",
        "心雜音（罕見，與犬不同）",
        "嘔吐",
        "多數體檢可能正常（間歇性症狀）",
        "急性危象時：嚴重呼吸窘迫、發紺、休克",
        "突然死亡可為首發表現"
      ]
    },
    "pathophysiology": "貓經蚊蟲叮咬感染D. immitis第三期幼蟲（L3）。在貓體內，幼蟲發育至第五期（L5）和成蟲的過程中，大約75-90%的幼蟲被貓的免疫系統殺滅（犬僅殺滅約30%）。存活的未成熟蟲體到達肺動脈時引起嚴重的嗜酸性球性肺動脈炎和肺間質炎症——此即HARD（Heartworm Associated Respiratory Disease），可在蟲體成熟前即引起呼吸症狀。即使僅1-2隻成蟲，在貓的細小肺動脈中也可引起顯著的血管阻塞、肺動脈高壓和右心衰竭。成蟲死亡時（自然死亡或治療殺蟲）可引起急性肺動脈栓塞和嚴重的急性呼吸窘迫——這是貓心絲蟲病最危險的時刻。貓的微絲蟲血症罕見且短暫（與犬不同）。",
    "diagnosis": {
      "overview": "貓心絲蟲病的診斷比犬困難得多——需結合多種檢測方法",
      "differentials": [
        "貓哮喘",
        "慢性支氣管炎",
        "肺部腫瘤",
        "心肌病",
        "乳糜胸",
        "其他肺寄生蟲"
      ],
      "initialDB": [
        "心絲蟲抗體檢測——偵測暴露（敏感度較高但不區分過去和現在感染）",
        "心絲蟲抗原檢測——犬的標準篩檢但貓敏感度低（僅偵測成熟雌蟲，貓蟲數少且可能只有雄蟲）",
        "抗體(+)/抗原(-)的組合最常見——提示暴露或僅雄蟲感染",
        "胸腔X光——肺動脈擴張（尤其尾葉動脈）、支氣管周圍和間質型浸潤",
        "CBC——嗜酸性球增多和嗜鹼性球增多"
      ],
      "advanced": [
        "心臟超音波——可在肺動脈或右心室中直接見到蟲體（「=」號樣平行迴聲線）",
        "CT血管造影",
        "支氣管肺泡灌洗——嗜酸性球增多",
        "抗體和抗原聯合檢測提高診斷率"
      ]
    },
    "treatment": {
      "overview": "貓心絲蟲病的治療以穩定化和支持療法為主——不建議使用犬的殺成蟲藥物（melarsomine），因蟲體死亡可致命",
      "acute": [
        "急性呼吸窘迫：氧氣治療+dexamethasone 1 mg/kg IV",
        "支氣管擴張劑（terbutaline 0.01 mg/kg SC）",
        "嚴重時可能需要機械通氣",
        "不使用melarsomine（犬的殺成蟲藥）——貓的蟲體死亡可引起致命性肺栓塞"
      ],
      "chronic": [
        "觀察等待策略（allow worms to die naturally，成蟲壽命在貓約2-4年）",
        "prednisolone 1-2 mg/kg q24-48h（控制HARD的炎症反應）",
        "每月ivermectin預防藥（殺滅新感染的幼蟲，不影響成蟲）",
        "限制運動（減少肺栓塞風險）",
        "外科取蟲（interventional heartworm removal via jugular vein）——少數嚴重病例的選項"
      ]
    },
    "prognosis": "預後不確定且變異大。許多貓可存活至成蟲自然死亡（2-4年）。急性蟲體死亡（自然或治療相關）可導致突然死亡。約10-20%的感染貓以突然死亡為首發表現。長期管理下部分貓可正常生活。預防遠優於治療。",
    "pearls": [
      "貓心絲蟲病的最佳策略是預防——治療選項有限且風險高",
      "不可使用犬的殺成蟲藥melarsomine——蟲體急性死亡可致貓死亡",
      "抗體(+)/抗原(-)是貓最常見的檢測結果——不代表排除感染",
      "HARD（心絲蟲相關呼吸疾病）可在蟲體成熟前即發生",
      "貓哮喘是最常見的誤診——流行區的「貓哮喘」都應考慮心絲蟲病",
      "室內貓也有感染風險——蚊蟲可進入室內",
      "心臟超音波直接見到蟲體是確診的最可靠方法"
    ],
    "diagnosticAlgorithm": {
      "title": "貓心絲蟲感染 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估慢性呼吸道症狀，注意間歇性咳嗽、嘔吐、呼吸困難，貓心絲蟲常模擬貓氣喘",
          "findings": [
            "間歇性咳嗽與呼吸困難",
            "嘔吐（非胃腸道原因）",
            "急性呼吸窘迫或猝死"
          ]
        },
        {
          "step": 2,
          "action": "血液與血清學檢查",
          "details": "進行CBC、抗體及抗原檢測，注意貓的抗原檢測敏感度較低",
          "findings": [
            "嗜酸性球增多（早期）",
            "抗體檢測陽性提示暴露",
            "抗原檢測陽性（但假陰性率高）"
          ]
        },
        {
          "step": 3,
          "action": "影像學確診",
          "details": "進行胸腔X光及心臟超音波，評估肺動脈及右心變化",
          "findings": [
            "胸腔X光顯示尾葉肺動脈擴張",
            "心臟超音波可見肺動脈內線狀蟲體回聲",
            "綜合抗體、抗原及影像學結果確診"
          ]
        }
      ]
    },
    "monitoring": [
      "每6個月胸腔X光追蹤",
      "抗體和抗原定期重複檢測",
      "心臟超音波追蹤蟲體和心臟功能",
      "呼吸症狀追蹤",
      "限制運動的遵從性",
      "每月預防藥物使用"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "sebaceous-adenitis": {
    "zh": "皮脂腺炎",
    "en": "Sebaceous Adenitis",
    "definition": "一種免疫介導的皮膚附屬器官疾病，以皮脂腺的肉芽腫性破壞為特徵，導致毛囊角化異常、鱗屑堆積及脫毛。",
    "synonyms": [
      "SA",
      "Granulomatous Sebaceous Adenitis"
    ],
    "epidemiology": {
      "species": "犬較常見，貓罕見",
      "age": "青年至中年犬（1-5歲）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "品種遺傳（標準型貴賓犬為自體隱性遺傳）",
        "秋田犬",
        "薩摩耶犬",
        "匈牙利維茲拉犬"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "進行性脫毛",
        "鱗屑增多",
        "被毛質地變差、乾燥無光澤",
        "不搔癢或輕度搔癢（繼發感染時加重）"
      ],
      "physicalExam": [
        "對稱性脫毛（背部、頭頂、耳廓）",
        "毛囊性角質栓（follicular casting）",
        "銀白色鱗屑緊密附著於毛幹",
        "長毛犬：鱗屑性脫毛；短毛犬：環形脫毛伴輕度鱗屑",
        "繼發性細菌性毛囊炎"
      ]
    },
    "pathophysiology": "推測為免疫介導性機制，自體免疫反應針對皮脂腺導致淋巴球和組織球浸潤，形成肉芽腫性炎症，最終完全破壞皮脂腺。皮脂腺喪失導致毛囊角化異常和皮膚乾燥。",
    "diagnosis": {
      "overview": "確診需要皮膚切片活檢，顯示皮脂腺周圍肉芽腫性炎症或皮脂腺完全缺失。",
      "differentials": [
        "甲狀腺功能低下",
        "皮膚真菌感染",
        "毛囊蟲症",
        "落葉型天疱瘡",
        "原發性皮脂溢",
        "維生素A反應性皮膚病"
      ],
      "initialDB": [
        "皮膚刮片（排除毛囊蟲）",
        "真菌培養（排除皮癬菌）",
        "甲狀腺功能檢查",
        "皮膚細胞學"
      ],
      "advanced": [
        "皮膚穿刺切片活檢（punch biopsy）：早期見皮脂腺周圍肉芽腫性炎症；晚期見皮脂腺完全缺失，被纖維組織取代",
        "多處取樣提高診斷率"
      ]
    },
    "treatment": {
      "overview": "無法治癒，以控制症狀為主。治療包括局部保濕、口服必需脂肪酸和免疫調節。",
      "acute": [
        "治療繼發性細菌感染（全身性抗生素）",
        "油浴療法（嬰兒油或礦物油浸泡2小時後藥浴沖洗）",
        "外用丙二醇（50-75%溶液）每日塗抹"
      ],
      "chronic": [
        "定期油浴療法（每1-2週）",
        "口服必需脂肪酸（omega-3/6）",
        "環孢素（5mg/kg PO q24h）用於嚴重病例",
        "口服維生素A（10,000-30,000 IU/天）",
        "外用他克莫司（tacrolimus 0.1%）"
      ]
    },
    "prognosis": "標準型貴賓犬預後謹慎，通常需終身治療且反應不一。短毛犬種（如維茲拉犬）預後較好，可能自發緩解。環孢素治療可顯著改善部分病例。",
    "pearls": [
      "毛囊性角質栓（follicular cast）是本病的特徵性表現",
      "標準型貴賓犬為自體隱性遺傳，建議繁殖前篩查",
      "油浴療法是長毛犬最有效的局部治療",
      "繼發感染是導致搔癢的主因"
    ],
    "diagnosticAlgorithm": {
      "title": "皮脂腺炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估皮膚病變特徵，注意對稱性脫毛、毛囊栓子及銀白色鱗屑，好發於赤獵犬、貴賓犬及秋田犬",
          "findings": [
            "對稱性脫毛伴銀白色鱗屑",
            "毛囊角質栓",
            "毛髮乾燥易斷"
          ]
        },
        {
          "step": 2,
          "action": "皮膚活檢",
          "details": "進行多處皮膚全層活檢送病理學檢查，這是確診的關鍵步驟",
          "findings": [
            "皮脂腺周圍肉芽腫性炎症",
            "皮脂腺萎縮或消失",
            "毛囊角質過度增生"
          ]
        },
        {
          "step": 3,
          "action": "確診與鑑別",
          "details": "根據組織病理學結果確診，排除甲狀腺功能低下、蠕形蟎及皮黴菌感染",
          "findings": [
            "組織病理學確認皮脂腺炎",
            "甲狀腺功能及皮黴菌培養正常排除其他病因"
          ]
        }
      ]
    },
    "monitoring": [
      "皮膚和被毛狀態",
      "繼發感染頻率",
      "環孢素使用時監測腎功能",
      "定期皮膚切片評估治療反應"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "eosinophilic-granuloma-complex": {
    "zh": "嗜酸性肉芽腫複合體",
    "en": "Eosinophilic Granuloma Complex",
    "definition": "貓最常見的皮膚反應模式之一，包含三種臨床型態：嗜酸性潰瘍（無痛性潰瘍）、嗜酸性斑塊及嗜酸性肉芽腫（線狀肉芽腫），代表一種過敏性或免疫介導性反應模式。",
    "synonyms": [
      "EGC",
      "貓嗜酸球性皮膚病",
      "Feline Eosinophilic Dermatoses"
    ],
    "epidemiology": {
      "species": "貓極常見，犬偶見（主要為口腔嗜酸性肉芽腫）",
      "age": "任何年齡，幼貓至中年貓較常見",
      "sex": "嗜酸性潰瘍和斑塊：母貓較多見",
      "riskFactors": [
        "潛在過敏（跳蚤、食物、環境過敏原）",
        "遺傳傾向",
        "免疫異常"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "皮膚潰瘍或腫塊",
        "搔癢程度不一（斑塊型最癢）",
        "反覆發作",
        "可能有跳蚤暴露或食物變化史"
      ],
      "physicalExam": [
        "嗜酸性潰瘍：上唇邊緣界限清楚的紅棕色潰瘍，通常無痛",
        "嗜酸性斑塊：腹部或大腿內側界限清楚的紅色隆起病變，常有糜爛",
        "線狀肉芽腫：後肢後方線狀隆起的黃粉色結節",
        "口腔肉芽腫：舌頭或硬顎的結節",
        "可能伴隨周邊血液嗜酸球增多"
      ]
    },
    "pathophysiology": "代表一種嗜酸球介導的過度免疫反應，多數病例有潛在的過敏性病因（跳蚤過敏、食物過敏、異位性皮膚炎）。嗜酸球釋放的顆粒蛋白（主要鹼性蛋白）造成組織損傷和膠原蛋白退化。部分病例為特發性。",
    "diagnosis": {
      "overview": "臨床外觀高度提示，但需細胞學或組織病理學確認，並尋找潛在病因。",
      "differentials": [
        "鱗狀細胞癌（尤其唇部潰瘍）",
        "肥大細胞瘤",
        "皮膚真菌感染",
        "細菌性膿腫",
        "蚊叮咬過敏"
      ],
      "initialDB": [
        "皮膚細胞學（嗜酸球為主的發炎反應）",
        "CBC（可能見周邊嗜酸球增多）",
        "皮膚刮片排除外寄生蟲",
        "嚴格跳蚤防治試驗"
      ],
      "advanced": [
        "皮膚切片活檢（嗜酸球浸潤、膠原蛋白退化、火焰狀圖樣）",
        "食物排除試驗（8-12週）",
        "真菌培養",
        "過敏原檢測"
      ]
    },
    "treatment": {
      "overview": "首先尋找並處理潛在病因。症狀治療以糖皮質激素或免疫調節劑為主。",
      "acute": [
        "潑尼松龍（prednisolone）1-2 mg/kg PO q24h，逐漸減量",
        "甲基潑尼松龍（methylprednisolone acetate）20 mg/cat SC（長效注射）",
        "治療繼發感染"
      ],
      "chronic": [
        "尋找並控制潛在過敏原",
        "嚴格跳蚤預防",
        "食物過敏排除飲食",
        "環孢素（cyclosporine）7 mg/kg PO q24h",
        "氯化胺苯蝶啶（chlorambucil）用於頑固病例",
        "口服必需脂肪酸輔助"
      ]
    },
    "prognosis": "如能找到並控制潛在過敏原則預後良好。特發性病例可能反覆發作需長期管理。頑固病例可能需要免疫抑制劑長期控制。",
    "pearls": [
      "三種型態可同時存在於同一隻貓",
      "80%以上的病例有潛在的過敏性病因",
      "上唇無痛性潰瘍必須與鱗狀細胞癌鑑別",
      "犬的口腔嗜酸性肉芽腫好發於哈士奇和騎士查理王獵犬"
    ],
    "diagnosticAlgorithm": {
      "title": "嗜酸性肉芽腫複合體 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估貓的皮膚和口腔病變特徵，區分嗜酸性潰瘍（唇部）、嗜酸性斑塊（腹部）及線性肉芽腫",
          "findings": [
            "唇部邊緣界限分明的潰瘍",
            "腹部或大腿紅色隆起斑塊",
            "口腔或後肢線性肉芽腫病變"
          ]
        },
        {
          "step": 2,
          "action": "細胞學與血液檢查",
          "details": "進行病灶細胞學抹片及CBC，評估嗜酸性球浸潤程度",
          "findings": [
            "細胞學顯示大量嗜酸性球浸潤",
            "周邊血液嗜酸性球增多",
            "膠原蛋白退化"
          ]
        },
        {
          "step": 3,
          "action": "活檢確診與病因調查",
          "details": "皮膚活檢確認組織病理特徵，同時進行過敏原檢測尋找潛在觸發因素",
          "findings": [
            "組織病理學確認嗜酸性肉芽腫",
            "過敏原檢測幫助識別潛在過敏原",
            "排除真菌及細菌感染"
          ]
        }
      ]
    },
    "monitoring": [
      "病變大小和外觀變化",
      "搔癢程度",
      "CBC嗜酸球計數",
      "類固醇副作用（多飲多尿、體重增加）"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "uveodermatologic-syndrome": {
    "zh": "葡萄膜皮膚症候群",
    "en": "Uveodermatologic Syndrome",
    "definition": "一種自體免疫性疾病，免疫系統攻擊含有黑色素的細胞（黑色素細胞），導致雙側肉芽腫性前葡萄膜炎合併皮膚和被毛的色素脫失。類似人類的Vogt-小柳-原田（VKH）症候群。",
    "synonyms": [
      "VKH-like Syndrome",
      "Vogt-Koyanagi-Harada-like Syndrome",
      "VKH症候群"
    ],
    "epidemiology": {
      "species": "犬，貓極罕見",
      "age": "青年至中年犬（1.5-6歲）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "品種遺傳（秋田犬最常見）",
        "薩摩耶犬",
        "西伯利亞哈士奇",
        "其他北極犬種",
        "澳洲牧羊犬"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "急性眼睛疼痛和畏光",
        "眼睛發紅",
        "鼻鏡或唇部顏色變淺",
        "被毛白化（白毛症）",
        "眼部症狀通常先於皮膚症狀"
      ],
      "physicalExam": [
        "雙側前葡萄膜炎（瞳孔縮小、房水閃光、角膜水腫）",
        "繼發性青光眼",
        "視網膜剝離",
        "鼻鏡色素脫失（由黑變粉紅）",
        "唇、眼瞼、肉墊色素脫失",
        "白毛症（被毛灰白化）",
        "皮膚潰瘍和結痂"
      ]
    },
    "pathophysiology": "T細胞介導的自體免疫反應針對黑色素細胞表面的酪胺酸酶相關蛋白。CD4+ T淋巴球攻擊眼部葡萄膜和皮膚中的黑色素細胞，導致肉芽腫性炎症和黑色素細胞破壞。眼部病變為主要威脅。",
    "diagnosis": {
      "overview": "根據特徵性的雙側葡萄膜炎合併皮膚色素脫失做出臨床診斷，皮膚切片可確認。",
      "differentials": [
        "全身性感染性葡萄膜炎（犬瘟熱、Ehrlichia）",
        "淋巴肉瘤性葡萄膜炎",
        "白斑病（vitiligo，無眼部病變）",
        "盤狀紅斑狼瘡",
        "鼻部日光性皮膚炎"
      ],
      "initialDB": [
        "眼科全面檢查（裂隙燈、眼壓測量、眼底檢查）",
        "CBC/血液生化（排除全身性疾病）",
        "傳染病篩檢"
      ],
      "advanced": [
        "皮膚切片活檢（界面皮膚炎伴組織球和淋巴球浸潤、黑色素細胞缺失）",
        "眼部超音波（評估後節病變、視網膜剝離）",
        "免疫組織化學染色"
      ]
    },
    "treatment": {
      "overview": "積極的全身性和局部免疫抑制治療，以保護視力為首要目標。早期積極治療至關重要。",
      "acute": [
        "全身性免疫抑制劑量的類固醇（潑尼松龍2-4 mg/kg/day）",
        "外用眼用類固醇（醋酸潑尼松龍1%眼藥水q4-6h）",
        "阿托品眼藥水（散瞳、止痛、預防後粘連）",
        "眼壓升高時加用降眼壓藥物"
      ],
      "chronic": [
        "長期口服免疫抑制劑（硫唑嘌呤azathioprine 2mg/kg q48h併用潑尼松龍）",
        "環孢素（口服或外用眼藥水）",
        "逐漸減量類固醇但不可完全停藥",
        "長期外用眼部抗炎藥物"
      ],
      "monitoring": [
        "每1-2週眼科追蹤（急性期）",
        "眼壓監測",
        "視力評估",
        "皮膚色素變化",
        "CBC（使用硫唑嘌呤時監測骨髓抑制）"
      ]
    },
    "prognosis": "眼部預後謹慎至不良，即使積極治療仍有高風險發展為繼發性青光眼和失明。早期診斷和積極治療可改善預後。皮膚病變為美觀問題，不影響健康。需終身治療。",
    "pearls": [
      "眼部症狀通常先於皮膚症狀數週至數月",
      "秋田犬是最好發的犬種",
      "一旦懷疑應立即開始積極治療，延遲治療顯著惡化預後",
      "繼發性青光眼是最常見的致盲併發症"
    ],
    "diagnosticAlgorithm": {
      "title": "葡萄膜皮膚症候群 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估雙側前葡萄膜炎合併皮膚色素脫失的典型表現，好發於秋田犬、哈士奇等北方犬種",
          "findings": [
            "雙側前葡萄膜炎（眼紅、畏光、流淚）",
            "鼻鏡、唇部皮膚色素脫失",
            "被毛白化（白毛症）"
          ]
        },
        {
          "step": 2,
          "action": "眼科與皮膚檢查",
          "details": "進行完整眼科檢查（裂隙燈、眼底鏡），同時評估皮膚色素變化分布",
          "findings": [
            "前房閃光及角膜後沉積物",
            "視網膜剝離或脈絡膜炎",
            "皮膚活檢顯示黑色素細胞消失"
          ]
        },
        {
          "step": 3,
          "action": "組織病理確診",
          "details": "皮膚活檢顯示淋巴細胞性界面性皮膚炎伴黑色素細胞破壞，為自體免疫性疾病",
          "findings": [
            "活檢顯示淋巴細胞浸潤攻擊黑色素細胞",
            "組織病理學與Vogt-小柳-原田症候群一致",
            "確診為自體免疫介導的色素細胞破壞"
          ]
        }
      ]
    },
    "monitoring": [
      "眼壓和眼底變化",
      "視力狀態",
      "皮膚色素變化",
      "免疫抑制劑副作用（骨髓抑制、肝功能）"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "dermatomyositis": {
    "zh": "皮肌炎",
    "en": "Dermatomyositis",
    "definition": "一種遺傳性免疫介導的炎症性疾病，同時影響皮膚和肌肉，主要見於牧羊犬種。以面部和四肢遠端的皮膚病變以及咀嚼肌和四肢肌肉萎縮為特徵。",
    "synonyms": [
      "犬家族性皮肌炎",
      "Canine Familial Dermatomyositis",
      "牧羊犬皮肌炎"
    ],
    "epidemiology": {
      "species": "犬，貓極罕見",
      "age": "幼犬期發病（通常<6月齡），可持續至成年",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "品種遺傳（喜樂蒂牧羊犬、可麗牧羊犬為自體顯性遺傳伴不完全外顯率）",
        "波利犬（Beauceron）",
        "威爾士柯基犬偶見"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "幼犬期面部出現皮膚病變",
        "脫毛和結痂",
        "咀嚼困難（嚴重病例）",
        "肌肉無力",
        "症狀嚴重度個體差異大"
      ],
      "physicalExam": [
        "面部病變：眼周、唇、耳尖脫毛、紅斑、鱗屑、結痂和潰瘍",
        "四肢遠端（趾尖、肉墊）病變",
        "尾尖病變",
        "骨突處潰瘍",
        "咀嚼肌萎縮（顳肌、咬肌）",
        "全身性肌肉萎縮（嚴重病例）",
        "吞嚥困難和巨食道（罕見但嚴重）"
      ]
    },
    "pathophysiology": "遺傳性免疫介導疾病，涉及自體顯性遺傳伴不完全外顯率和不同表現度。免疫攻擊針對皮膚基底膜和肌纖維，導致界面性皮膚炎和炎症性肌病。血管病變和缺血性機制也參與發病。",
    "diagnosis": {
      "overview": "根據品種、發病年齡和特徵性臨床表現做出臨床診斷，皮膚和肌肉切片確認。",
      "differentials": [
        "皮膚真菌感染",
        "毛囊蟲症",
        "落葉型天疱瘡",
        "紅斑狼瘡",
        "缺血性皮膚病"
      ],
      "initialDB": [
        "皮膚刮片（排除毛囊蟲）",
        "真菌培養",
        "CBC/血液生化",
        "肌酸激酶（CK）可能升高"
      ],
      "advanced": [
        "皮膚切片活檢（界面性皮膚炎、基底細胞空泡化、淋巴球浸潤）",
        "肌肉切片活檢（肌纖維萎縮和退化、炎症細胞浸潤）",
        "肌電圖（EMG）",
        "基因檢測（喜樂蒂和可麗犬已有商業化檢測）"
      ]
    },
    "treatment": {
      "overview": "無法治癒，治療以控制症狀為主。避免日曬、創傷和壓力。嚴重度差異大，輕度病例可能僅需最低限度治療。",
      "acute": [
        "避免日光曝曬（UV加重病變）",
        "外用他克莫司（tacrolimus 0.1%）",
        "口服必需脂肪酸",
        "pentoxifylline 改善微循環（10-25 mg/kg PO q8-12h）"
      ],
      "chronic": [
        "pentoxifylline長期口服",
        "維生素E補充（400-800 IU/天）",
        "口服必需脂肪酸",
        "避免繁殖（遺傳性疾病）",
        "嚴重病例考慮免疫抑制劑（類固醇、硫唑嘌呤）"
      ]
    },
    "prognosis": "輕度至中度病例預後良好至謹慎，多數在成年後症狀穩定或改善。嚴重伴巨食道的病例預後不良（吸入性肺炎風險）。患犬不應用於繁殖。",
    "pearls": [
      "是少數有明確基因檢測的遺傳性皮膚病",
      "症狀嚴重度在同窩幼犬間可有極大差異",
      "日曬和創傷是已知的加重因素",
      "巨食道是最嚴重的併發症，可致命"
    ],
    "diagnosticAlgorithm": {
      "title": "皮肌炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估幼犬面部、耳尖和四肢遠端的皮膚病變，注意肌肉萎縮，好發於可利牧羊犬和喜樂蒂",
          "findings": [
            "面部、耳尖脫毛伴結痂",
            "四肢遠端及尾尖病變",
            "顳肌和咀嚼肌萎縮"
          ]
        },
        {
          "step": 2,
          "action": "肌電圖與肌酶檢查",
          "details": "進行肌電圖評估肌肉病變，檢測血清CK值",
          "findings": [
            "肌電圖異常自發電位",
            "血清CK可能輕度升高",
            "肌肉萎縮程度評估"
          ]
        },
        {
          "step": 3,
          "action": "皮膚及肌肉活檢確診",
          "details": "同時進行皮膚和肌肉活檢送病理學檢查確診",
          "findings": [
            "皮膚活檢顯示界面性皮膚炎",
            "肌肉活檢顯示肌纖維萎縮及炎性浸潤",
            "組織病理學確認皮肌炎診斷"
          ]
        }
      ]
    },
    "monitoring": [
      "皮膚病變範圍和嚴重度",
      "肌肉質量和力量",
      "吞嚥功能",
      "體重和營養狀態"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "sterile-nodular-panniculitis": {
    "zh": "無菌性結節性脂膜炎",
    "en": "Sterile Nodular Panniculitis",
    "definition": "一種以皮下脂肪組織發炎為特徵的疾病，形成深部皮下結節，組織培養為無菌。可為特發性或繼發於免疫介導疾病、胰臟炎或藥物反應。",
    "synonyms": [
      "無菌性脂膜炎",
      "Idiopathic Sterile Panniculitis",
      "Weber-Christian Disease (舊稱)"
    ],
    "epidemiology": {
      "species": "犬較常見，貓偶見",
      "age": "中年犬（平均5-7歲）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "腊腸犬品種傾向",
        "貴賓犬",
        "潛在胰臟疾病",
        "免疫介導性疾病",
        "疫苗注射部位反應"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "皮下腫塊（單發或多發）",
        "結節可能破潰流出油性或血性分泌物",
        "發燒",
        "食慾下降",
        "嗜睡",
        "反覆發作"
      ],
      "physicalExam": [
        "深部皮下結節（1-10 cm不等）",
        "好發於軀幹",
        "結節可能波動、破潰排出油性至血性液體",
        "局部疼痛",
        "全身性症狀（發燒、淋巴結腫大）",
        "嚴重病例可見腹部脂肪壞死"
      ]
    },
    "pathophysiology": "皮下脂肪組織發生無菌性炎症反應，脂肪細胞壞死釋放脂質，引發肉芽腫性和化膿性炎症。特發性病例推測為免疫介導。繼發性病例可由胰臟酵素異常釋放（胰臟炎相關型）或藥物/疫苗反應引起。",
    "diagnosis": {
      "overview": "確診需要深部皮膚切片（須包含皮下脂肪組織）顯示脂膜炎且組織培養為陰性。",
      "differentials": [
        "感染性脂膜炎（細菌、真菌、分枝桿菌）",
        "外來物反應",
        "注射部位反應",
        "皮膚淋巴瘤",
        "肥大細胞瘤",
        "脂肪瘤"
      ],
      "initialDB": [
        "細針抽吸細胞學（化膿性至肉芽腫性炎症伴脂肪壞死）",
        "CBC（可能嗜中性球增多或嗜酸球增多）",
        "血液生化（評估胰臟功能）",
        "尿液分析"
      ],
      "advanced": [
        "深部切片活檢（楔形切片含皮下脂肪）",
        "組織培養（細菌和真菌，必須為陰性）",
        "特殊染色（排除分枝桿菌和真菌感染）",
        "腹部超音波（排除胰臟炎）",
        "cPLI/fPLI（胰臟脂肪酶）"
      ]
    },
    "treatment": {
      "overview": "特發性病例以免疫抑制治療為主。繼發性病例需同時治療潛在病因。",
      "acute": [
        "潑尼松龍（2 mg/kg/day），臨床改善後逐漸減量",
        "對類固醇反應不佳時加用硫唑嘌呤或環孢素",
        "疼痛管理",
        "清潔破潰結節"
      ],
      "chronic": [
        "維持劑量免疫抑制劑",
        "環孢素（5-10 mg/kg PO q24h）作為類固醇替代",
        "維生素E（400 IU PO q12h）可能有輔助效果",
        "監測並預防復發"
      ]
    },
    "prognosis": "特發性病例以適當免疫抑制治療預後良好至謹慎，但常需長期治療且可能復發。胰臟炎相關型預後取決於原發疾病控制。腊腸犬的反覆發作率較高。",
    "pearls": [
      "切片必須包含足夠的皮下脂肪組織",
      "組織培養陰性是確診的必要條件",
      "胰臟炎相關型需特別注意",
      "腊腸犬有品種傾向且預後較差"
    ],
    "diagnosticAlgorithm": {
      "title": "無菌性結節性脂膜炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估皮下結節的分布、大小及是否有瘻管形成，注意全身性症狀如發熱和嗜睡",
          "findings": [
            "單發或多發皮下結節",
            "結節可能潰破排出油性分泌物",
            "間歇性發熱與嗜睡"
          ]
        },
        {
          "step": 2,
          "action": "細胞學與細菌培養",
          "details": "進行結節細針抽吸細胞學檢查，同時送細菌及真菌培養排除感染性原因",
          "findings": [
            "細胞學顯示脂肪壞死伴巨噬細胞浸潤",
            "細菌培養陰性",
            "真菌培養陰性"
          ]
        },
        {
          "step": 3,
          "action": "活檢確診",
          "details": "進行皮下結節切除活檢送病理學檢查，確認為無菌性脂膜炎",
          "findings": [
            "組織病理學顯示脂肪小葉壞死",
            "以巨噬細胞和中性球為主的炎性浸潤",
            "無微生物感染證據確認無菌性"
          ]
        }
      ]
    },
    "monitoring": [
      "結節數量和大小",
      "全身性症狀（發燒、食慾）",
      "免疫抑制劑副作用",
      "胰臟功能（相關病例）"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "zinc-responsive-dermatosis": {
    "zh": "鋅反應性皮膚病",
    "en": "Zinc-Responsive Dermatosis",
    "definition": "因鋅缺乏或鋅吸收不良導致的皮膚病，分為兩型：第I型見於北極犬種（吸收障礙），第II型見於快速生長的大型幼犬（飲食缺乏或高穀物飲食干擾吸收）。",
    "synonyms": [
      "鋅缺乏性皮膚病",
      "Zinc-Deficiency Dermatosis",
      "致死性肢端皮膚炎（牛頭梗）"
    ],
    "epidemiology": {
      "species": "犬，貓極罕見",
      "age": "第I型：青年至成年；第II型：快速生長期幼犬",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "第I型：西伯利亞哈士奇、阿拉斯加雪橇犬",
        "第II型：大型犬幼犬、高穀物/高植酸飲食",
        "鈣質補充過多干擾鋅吸收",
        "牛頭梗致死性肢端皮膚炎（遺傳性）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "眼周和口周結痂",
        "趾間紅腫",
        "皮膚乾燥和鱗屑",
        "幼犬生長不良（第II型）"
      ],
      "physicalExam": [
        "第I型：黏膜皮膚交界處（眼周、口周、耳、外生殖器）對稱性紅斑、鱗屑、厚痂",
        "第II型：全身性鱗屑、被毛粗糙、肉墊過度角化",
        "趾間紅腫和角化",
        "肉墊龜裂和過度角化",
        "壓力點角化（肘、飛節）",
        "繼發性細菌或酵母菌感染"
      ]
    },
    "pathophysiology": "鋅是超過200種酵素的輔因子，對上皮細胞分化、免疫功能和傷口癒合至關重要。第I型為遺傳性鋅吸收障礙，第II型為飲食性鋅攝取不足或高植酸/高鈣飲食干擾鋅吸收。鋅缺乏導致表皮角化異常（角化不全）。",
    "diagnosis": {
      "overview": "根據品種、臨床表現和對鋅補充的治療反應做出診斷。",
      "differentials": [
        "落葉型天疱瘡",
        "紅斑狼瘡",
        "皮膚真菌感染",
        "毛囊蟲症",
        "泛發性皮膚真菌感染",
        "肝皮症候群（表皮壞死性遊走性紅斑）"
      ],
      "initialDB": [
        "皮膚刮片",
        "皮膚細胞學",
        "真菌培養",
        "飲食史詳細詢問"
      ],
      "advanced": [
        "皮膚切片活檢（顯著的表皮和毛囊角化不全伴表皮增生）",
        "血清鋅濃度（可能偏低但不一定可靠）",
        "診斷性鋅補充試驗（4-6週）"
      ]
    },
    "treatment": {
      "overview": "鋅補充和飲食矯正。第I型通常需終身補充。",
      "acute": [
        "口服鋅補充劑：硫酸鋅（10 mg/kg/day）或甲硫胺酸鋅（2 mg/kg/day）與食物分開服用",
        "治療繼發感染",
        "外用保濕和去角質"
      ],
      "chronic": [
        "第I型：終身口服鋅補充",
        "第II型：矯正飲食（改用優質均衡狗糧）並暫時補鋅",
        "嚴重病例或吸收不良者：靜脈注射鋅（硫酸鋅）",
        "避免高鈣、高植酸飲食"
      ]
    },
    "prognosis": "第I型需終身補充鋅，控制良好下預後佳。第II型矯正飲食後預後極佳，可能不需長期補鋅。牛頭梗致死性肢端皮膚炎預後極差。",
    "pearls": [
      "硫酸鋅空腹服用吸收最好但可能引起嘔吐",
      "甲硫胺酸鋅的胃腸耐受性較好",
      "治療反應通常在2-6週內可見",
      "鈣質過量補充是第II型最常見的原因之一"
    ],
    "diagnosticAlgorithm": {
      "title": "鋅反應性皮膚病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估皮膚病變分布，注意眼周、口周、耳廓及足墊的結痂和角化過度，區分I型（北方犬種）和II型（快速生長幼犬）",
          "findings": [
            "眼周和口周紅斑、結痂及鱗屑",
            "耳廓邊緣角化過度",
            "足墊過度角化龜裂"
          ]
        },
        {
          "step": 2,
          "action": "血液與飲食評估",
          "details": "檢測血清鋅濃度，評估飲食組成是否含過量植酸或鈣影響鋅吸收",
          "findings": [
            "血清鋅濃度低於正常範圍",
            "飲食中植酸或鈣含量過高",
            "CBC可能顯示輕度貧血"
          ]
        },
        {
          "step": 3,
          "action": "活檢確診與治療反應",
          "details": "皮膚活檢確認特徵性組織病理學變化，鋅補充後臨床改善進一步支持診斷",
          "findings": [
            "活檢顯示表皮角化不全伴明顯角化過度",
            "鋅補充2-4週後臨床顯著改善",
            "確診為鋅反應性皮膚病"
          ]
        }
      ]
    },
    "monitoring": [
      "皮膚病變改善程度",
      "鋅補充劑的胃腸耐受性",
      "幼犬的生長狀態",
      "繼發感染控制"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "canine-juvenile-cellulitis": {
    "zh": "犬幼年蜂窩組織炎",
    "en": "Canine Juvenile Cellulitis",
    "definition": "一種幼犬的肉芽腫性和化膿性皮膚病，以急性面部腫脹（尤其唇部和眼瞼）、膿皰性耳炎和下頜淋巴結腫大為特徵。又稱幼犬悶燒或幼犬絞扼。病因為免疫介導而非感染性。",
    "synonyms": [
      "Puppy Strangles",
      "幼犬悶燒",
      "Juvenile Pyoderma",
      "幼犬膿皮症"
    ],
    "epidemiology": {
      "species": "犬",
      "age": "3週至6月齡幼犬",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "品種傾向（黃金獵犬、腊腸犬、拉布拉多、戈登雪達犬）",
        "同窩多隻發病提示遺傳因素"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "急性面部腫脹",
        "眼瞼和唇部膿疱",
        "耳道分泌物",
        "食慾下降",
        "發燒",
        "疼痛"
      ],
      "physicalExam": [
        "面部急性腫脹（唇部、眼瞼、口吻部）",
        "膿疱和痂皮",
        "下頜淋巴結顯著腫大（可能膿腫化和破潰）",
        "化膿性耳炎",
        "關節疼痛（偶見無菌性關節炎）",
        "全身性症狀（發燒、嗜睡）"
      ]
    },
    "pathophysiology": "推測為免疫介導的肉芽腫性炎症，可能與免疫系統異常反應有關。並非真正的感染性疾病，雖然組織培養通常無菌，但繼發性細菌感染常見。遺傳因素在發病中扮演重要角色。",
    "diagnosis": {
      "overview": "根據年齡、品種和特徵性臨床表現做出臨床診斷。細胞學和切片可確認。",
      "differentials": [
        "毛囊蟲症",
        "皮膚真菌感染",
        "細菌性膿皮症",
        "血管性水腫",
        "外傷"
      ],
      "initialDB": [
        "皮膚細胞學（膿性化膿性至肉芽腫性炎症，無菌或繼發感染）",
        "皮膚刮片（排除毛囊蟲）",
        "細菌培養和藥敏（排除原發性細菌感染）"
      ],
      "advanced": [
        "皮膚切片活檢（肉芽腫性至化膿性皮膚炎和脂膜炎）",
        "淋巴結細針抽吸（化膿性至肉芽腫性淋巴結炎）"
      ]
    },
    "treatment": {
      "overview": "免疫抑制劑量的類固醇是主要治療，需早期積極治療以減少瘢痕形成。",
      "acute": [
        "潑尼松龍（2 mg/kg/day PO）持續至病變消退後逐漸減量，總療程約3-4週",
        "全身性抗生素治療繼發感染（頭孢氨苄25 mg/kg PO q12h）",
        "溫濕敷幫助清潔"
      ],
      "chronic": [
        "類固醇逐漸減量（通常3-4週內完成）",
        "多數病例為自限性，不復發",
        "嚴重病例可能留下面部瘢痕"
      ]
    },
    "prognosis": "早期積極治療預後良好。延遲治療可能導致永久性面部瘢痕和脫毛。多數病例治療反應良好且不復發。偶見成犬復發（極罕見）。",
    "pearls": [
      "類固醇是主治藥物，不是抗生素",
      "儘管外觀像嚴重細菌感染，但本質是免疫介導疾病",
      "早期治療可顯著減少永久性瘢痕",
      "同窩多隻發病時應考慮此診斷"
    ],
    "diagnosticAlgorithm": {
      "title": "犬幼年蜂窩組織炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估3-16週齡幼犬的急性面部腫脹、耳道膿瘡及下頜淋巴結腫大",
          "findings": [
            "急性面部腫脹伴膿瘡",
            "耳道內膿性分泌物",
            "下頜淋巴結顯著腫大可能化膿"
          ]
        },
        {
          "step": 2,
          "action": "細胞學檢查",
          "details": "進行膿瘡及淋巴結細胞學抹片，排除感染性原因",
          "findings": [
            "細胞學顯示化膿性肉芽腫性炎症",
            "細菌培養通常陰性（無菌性）",
            "大量巨噬細胞和中性球"
          ]
        },
        {
          "step": 3,
          "action": "確診",
          "details": "根據年齡、臨床表現及無菌性化膿性肉芽腫性炎症確診，必要時活檢確認",
          "findings": [
            "組織病理學確認化膿性肉芽腫性皮膚炎",
            "無感染性病原體",
            "對皮質類固醇治療反應良好支持診斷"
          ]
        }
      ]
    },
    "monitoring": [
      "面部腫脹和病變消退",
      "淋巴結大小",
      "食慾和體溫",
      "類固醇減量期間有無復發"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "acral-lick-dermatitis": {
    "zh": "肢端舔舐性皮膚炎",
    "en": "Acral Lick Dermatitis",
    "definition": "因持續性舔舐導致四肢遠端（通常為腕關節或跗關節背側）出現的局灶性、增厚性、潰瘍性皮膚病變。為多因素疾病，涉及行為、過敏、骨科及神經病學因素。",
    "synonyms": [
      "舔舐性肉芽腫",
      "Lick Granuloma",
      "Acral Pruritic Nodule"
    ],
    "epidemiology": {
      "species": "犬較常見，貓偶見",
      "age": "中年至老年犬",
      "sex": "公犬較常見",
      "riskFactors": [
        "大型犬品種（杜賓犬、大丹犬、拉布拉多、黃金獵犬、德國牧羊犬）",
        "獨居或活動量不足",
        "潛在過敏（異位性皮膚炎）",
        "潛在骨科疼痛",
        "焦慮或強迫行為"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "持續性舔舐某一特定部位",
        "病變逐漸增大和增厚",
        "治療後常復發",
        "可能有孤獨或焦慮的行為史"
      ],
      "physicalExam": [
        "腕關節或跗關節背側的單發性隆起斑塊",
        "病變界限清楚、硬實、脫毛",
        "中央可能潰瘍伴滲出",
        "病變增厚（苔蘚化）和色素沉著",
        "周圍皮膚因唾液浸漬而變色"
      ]
    },
    "pathophysiology": "多因素疾病。初始刺激可為過敏、骨關節疾病、神經病變或行為因素。持續舔舐引發炎症→搔癢→更多舔舐的正回饋循環。慢性舔舐導致表皮增厚、毛囊破壞、纖維化和深部細菌感染，進一步維持搔癢和舔舐行為。內源性腦啡肽釋放可能使舔舐行為具有自我強化作用。",
    "diagnosis": {
      "overview": "臨床外觀典型且易辨識，但重要的是尋找並處理潛在病因。",
      "differentials": [
        "皮膚腫瘤（肥大細胞瘤、組織球瘤）",
        "皮膚真菌感染（深部）",
        "毛囊蟲症",
        "外來物反應",
        "皮膚鈣質沉著症"
      ],
      "initialDB": [
        "皮膚細胞學（深部膿皮症）",
        "皮膚刮片",
        "過敏評估（跳蚤控制、食物排除試驗）",
        "病變部位X光（排除骨科問題）"
      ],
      "advanced": [
        "皮膚切片活檢（排除腫瘤）",
        "深部細菌培養和藥敏",
        "關節影像學",
        "神經學評估（排除感覺神經病變）"
      ]
    },
    "treatment": {
      "overview": "多模式治療：治療潛在病因、控制感染、阻斷舔舐行為、處理行為因素。",
      "acute": [
        "長期全身性抗生素（基於培養，通常6-8週以上）",
        "物理阻隔（伊莉莎白頸圈、繃帶）",
        "外用藥物（mupirocin、類固醇/DMSO混合液）"
      ],
      "chronic": [
        "行為矯正（增加運動和環境豐富化）",
        "行為藥物（fluoxetine 1 mg/kg PO q24h或clomipramine 1-3 mg/kg PO q12h）",
        "雷射治療（CO2雷射消融）",
        "放射線治療（低劑量）",
        "針灸",
        "處理潛在過敏原"
      ]
    },
    "prognosis": "謹慎。治療反應不一且復發率高。找到並成功處理潛在病因的病例預後較好。行為因素為主的病例需長期管理。早期小型病變的治療反應優於慢性大型病變。",
    "pearls": [
      "舔舐肉芽腫必須排除潛在病因，不應僅視為行為問題",
      "深部細菌感染幾乎都存在，需長期抗生素治療",
      "行為藥物需4-8週才能見效",
      "阻止舔舐的同時不處理根本原因通常無效"
    ],
    "diagnosticAlgorithm": {
      "title": "肢端舔舐性皮膚炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估四肢遠端（常見腕關節背側）的慢性增厚、潰瘍性斑塊，確認反覆舔舐行為",
          "findings": [
            "腕關節或跗關節背側界限分明的增厚斑塊",
            "病灶表面脫毛伴潰瘍",
            "持續性強迫性舔舐行為"
          ]
        },
        {
          "step": 2,
          "action": "排除潛在病因",
          "details": "進行皮膚刮搔、皮黴菌培養、X光檢查排除骨關節疾病，評估過敏和甲狀腺功能",
          "findings": [
            "皮膚刮搔排除蠕形蟎",
            "X光排除骨關節病變",
            "排除或確認潛在過敏或內分泌疾病"
          ]
        },
        {
          "step": 3,
          "action": "活檢與行為評估確診",
          "details": "必要時進行活檢排除腫瘤，結合行為評估確認心因性或身體性原因",
          "findings": [
            "活檢顯示慢性纖維化及表皮增生",
            "排除肥大細胞瘤等腫瘤",
            "綜合評估行為焦慮因素"
          ]
        }
      ]
    },
    "monitoring": [
      "病變大小和外觀",
      "舔舐行為頻率",
      "感染控制",
      "行為改善評估"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "vasculitis": {
    "zh": "血管炎",
    "en": "Vasculitis",
    "definition": "血管壁的炎症性疾病，導致血管損傷、血栓形成和組織缺血壞死。可為免疫介導性、感染性、藥物誘發性或特發性，以皮膚血管炎最為常見。",
    "synonyms": [
      "皮膚血管炎",
      "Cutaneous Vasculitis",
      "Immune-Mediated Vasculitis"
    ],
    "epidemiology": {
      "species": "犬較常見，貓偶見",
      "age": "任何年齡",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "免疫介導疾病",
        "藥物反應（磺胺類、頭孢類）",
        "疫苗反應（狂犬病疫苗）",
        "傳染病（Ehrlichia、Rickettsia、FeLV）",
        "品種傾向（格雷伊獵犬、傑克羅素梗、德國牧羊犬）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "皮膚潰瘍或壞死",
        "四肢末端腫脹",
        "跛行",
        "近期用藥或疫苗接種史",
        "耳尖壞死"
      ],
      "physicalExam": [
        "耳尖、尾尖、肉墊、口腔黏膜的紫斑、潰瘍或壞死",
        "四肢末端凹陷性水腫",
        "網狀青斑（livedo reticularis）",
        "皮膚梗塞（界限清楚的壞死區域）",
        "狂犬病疫苗注射部位脫毛和潰瘍",
        "全身性症狀（發燒、關節痛、嗜睡）"
      ]
    },
    "pathophysiology": "免疫複合物沉積於血管壁引發第III型過敏反應，活化補體系統導致嗜中性球浸潤和血管壁破壞。亦可為直接的抗體介導或T細胞介導損傷。血管損傷導致血栓形成、組織缺血和壞死。",
    "diagnosis": {
      "overview": "皮膚切片活檢為確診金標準，需顯示血管壁炎症和壞死。同時需尋找潛在病因。",
      "differentials": [
        "冷凝集素病",
        "瀰漫性血管內凝血（DIC）",
        "凍傷",
        "蛇咬傷",
        "缺血性皮膚病",
        "紅斑狼瘡"
      ],
      "initialDB": [
        "CBC/血液生化/尿液分析",
        "凝血功能檢查",
        "傳染病篩檢（Ehrlichia、Rickettsia、Leishmania）",
        "ANA抗核抗體"
      ],
      "advanced": [
        "皮膚切片活檢（白血球碎裂性血管炎或淋巴球性血管炎）",
        "直接免疫螢光檢查",
        "尿蛋白/肌酸酐比（評估腎臟血管炎）",
        "關節液分析"
      ]
    },
    "treatment": {
      "overview": "治療潛在病因，輔以免疫抑制和支持療法。停用可疑藥物。",
      "acute": [
        "停用所有可疑藥物",
        "潑尼松龍（1-2 mg/kg/day）",
        "pentoxifylline（改善微循環，10-25 mg/kg PO q8-12h）",
        "傷口護理"
      ],
      "chronic": [
        "長期pentoxifylline",
        "dapsone或磺胺吡啶（sulphasalazine）用於頑固病例",
        "環孢素用於免疫介導型",
        "避免已知觸發因素（特定藥物或疫苗）",
        "維生素E和必需脂肪酸輔助"
      ]
    },
    "prognosis": "取決於潛在病因。藥物誘發型停藥後預後良好。感染相關型治療感染後多可緩解。特發性免疫介導型需長期治療，預後謹慎。嚴重全身性血管炎可能致命。",
    "pearls": [
      "狂犬病疫苗注射部位血管炎是經典的疫苗反應型",
      "耳尖壞死是血管炎的高度提示性病變",
      "pentoxifylline是血管炎輔助治療的基石",
      "必須排除感染性病因後才能使用免疫抑制劑"
    ],
    "diagnosticAlgorithm": {
      "title": "血管炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估皮膚紫斑、壞死、潰瘍等血管損傷表現，注意耳尖、足墊、尾巴等末端部位",
          "findings": [
            "耳尖或尾尖皮膚壞死",
            "足墊腫脹潰瘍",
            "紫斑及網狀青斑"
          ]
        },
        {
          "step": 2,
          "action": "實驗室檢查",
          "details": "進行CBC、生化、尿液分析及凝血功能檢測，評估系統性受累程度",
          "findings": [
            "血小板減少或正常",
            "蛋白尿提示腎臟血管受累",
            "發炎指標升高"
          ]
        },
        {
          "step": 3,
          "action": "活檢確診與病因調查",
          "details": "進行皮膚活檢確認血管壁炎症及壞死，同時調查潛在病因（藥物、感染、免疫介導）",
          "findings": [
            "活檢顯示血管壁纖維蛋白壞死",
            "血管周圍中性球或淋巴細胞浸潤",
            "排除或確認潛在觸發因素（藥物反應、感染等）"
          ]
        }
      ]
    },
    "monitoring": [
      "皮膚病變範圍和癒合",
      "全身性症狀",
      "腎功能（排除腎臟血管炎）",
      "CBC和凝血功能"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "allergic-rhinitis": {
    "zh": "過敏性鼻炎",
    "en": "Allergic Rhinitis",
    "definition": "鼻腔黏膜因接觸環境過敏原引發的免疫介導性炎症反應，導致慢性鼻涕、打噴嚏和鼻塞。犬貓較少作為獨立診斷，多為異位性皮膚炎的鼻部表現。",
    "synonyms": [
      "過敏性鼻腔炎",
      "Atopic Rhinitis",
      "鼻過敏"
    ],
    "epidemiology": {
      "species": "犬貓皆可，犬較常被診斷",
      "age": "青年至中年（1-5歲首次出現）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "異位性體質",
        "品種傾向（長鼻型犬種）",
        "環境過敏原暴露（花粉、塵蟎、黴菌）",
        "同時有異位性皮膚炎"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "慢性或季節性鼻涕",
        "反覆打噴嚏",
        "鼻塞和鼻鼾聲",
        "面部搔癢和摩擦",
        "可能伴有皮膚搔癢症狀"
      ],
      "physicalExam": [
        "漿液性至黏液性雙側鼻涕",
        "鼻黏膜充血水腫",
        "反覆打噴嚏",
        "鼻鏡色素減退或紅斑",
        "可能伴有結膜炎",
        "面部搓揉痕跡"
      ]
    },
    "pathophysiology": "環境過敏原經鼻腔黏膜吸入後，被抗原呈現細胞捕獲並刺激Th2免疫反應，產生過敏原特異性IgE。IgE結合鼻黏膜肥大細胞，再次暴露時引發即時型過敏反應，釋放組織胺和白三烯等發炎介質，導致黏膜水腫、分泌增加和搔癢。",
    "diagnosis": {
      "overview": "排除性診斷，需排除感染性、腫瘤性和異物性鼻炎後方可考慮。",
      "differentials": [
        "鼻腔異物",
        "細菌性鼻炎",
        "真菌性鼻炎（麴菌症）",
        "鼻腔腫瘤",
        "牙根膿腫",
        "淋巴漿細胞性鼻炎"
      ],
      "initialDB": [
        "鼻涕細胞學（嗜酸球增多提示過敏）",
        "頭部X光",
        "CBC（可能周邊嗜酸球增多）",
        "鼻腔沖洗液細胞學"
      ],
      "advanced": [
        "鼻腔CT或MRI",
        "鼻鏡檢查和切片活檢（排除腫瘤和真菌）",
        "過敏原特異性IgE檢測",
        "皮內過敏原測試",
        "真菌培養"
      ]
    },
    "treatment": {
      "overview": "避免過敏原暴露、抗炎治療和免疫調節。多與異位性皮膚炎一併治療。",
      "acute": [
        "短期口服類固醇（潑尼松龍0.5-1 mg/kg/day）",
        "抗組織胺（氯雷他定、西替利嗪）",
        "鼻腔沖洗（生理食鹽水）"
      ],
      "chronic": [
        "過敏原特異性免疫治療（減敏療法）",
        "環境過敏原控制（空氣清淨機、減少塵蟎）",
        "長期抗組織胺",
        "口服必需脂肪酸",
        "嚴重病例考慮環孢素或oclacitinib"
      ]
    },
    "prognosis": "無法治癒但可良好控制。季節性病例管理較容易。全年性過敏原暴露的病例需持續治療。免疫治療可能在60-70%的病例中提供長期改善。",
    "pearls": [
      "犬貓過敏性鼻炎很少作為獨立診斷，多伴隨異位性皮膚炎",
      "漿液性雙側鼻涕提示過敏性或非特異性炎症",
      "單側鼻涕更應懷疑異物、牙根膿腫或腫瘤",
      "必須排除鼻腔腫瘤等嚴重病因後才能歸為過敏性鼻炎"
    ],
    "diagnosticAlgorithm": {
      "title": "過敏性鼻炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估慢性噴嚏、漿液性或黏液性鼻分泌物、鼻部搔癢等症狀，注意季節性或環境相關性",
          "findings": [
            "反覆噴嚏發作",
            "雙側漿液性鼻分泌物",
            "鼻部搔癢和揉臉行為"
          ]
        },
        {
          "step": 2,
          "action": "影像學與排除性檢查",
          "details": "進行鼻腔X光或CT排除腫瘤、異物及真菌感染，鼻腔鏡檢查評估黏膜狀態",
          "findings": [
            "X光/CT排除鼻腔腫塊",
            "鼻腔鏡見黏膜充血水腫",
            "排除鼻腔異物及真菌感染"
          ]
        },
        {
          "step": 3,
          "action": "過敏原檢測與確診",
          "details": "進行皮內過敏原試驗或血清特異性IgE檢測，鼻腔沖洗液細胞學確認嗜酸性球增多",
          "findings": [
            "皮內試驗或血清IgE陽性反應",
            "鼻腔沖洗液嗜酸性球增多",
            "臨床對抗組織胺或類固醇反應良好"
          ]
        }
      ]
    },
    "monitoring": [
      "鼻涕量和性狀",
      "打噴嚏頻率",
      "伴隨皮膚症狀",
      "治療副作用"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "pannus": {
    "zh": "角膜血管翳",
    "en": "Pannus (Chronic Superficial Keratitis)",
    "definition": "一種慢性、進行性、免疫介導的角膜表面炎症，以角膜血管新生、色素沉著和肉芽組織增生為特徵。又稱慢性淺層角膜炎（CSK），好發於德國牧羊犬。",
    "synonyms": [
      "慢性淺層角膜炎",
      "CSK",
      "Chronic Superficial Keratitis",
      "Uberreiter's Syndrome"
    ],
    "epidemiology": {
      "species": "犬，貓極罕見",
      "age": "中年犬（通常4-7歲開始）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "品種傾向（德國牧羊犬最常見、比利時牧羊犬、格雷伊獵犬、邊境牧羊犬）",
        "高海拔地區（紫外線暴露增加）",
        "紫外線暴露"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "眼睛逐漸變紅",
        "角膜表面出現紅色或棕色病變",
        "視力可能逐漸下降",
        "通常雙側但可不對稱"
      ],
      "physicalExam": [
        "角膜外側腹方開始的血管新生和色素沉著",
        "病變逐漸向角膜中央擴展",
        "角膜表面不規則的肉芽組織",
        "第三眼瞼增厚和色素沉著（漿細胞性第三眼瞼炎）",
        "通常雙側受累",
        "慢性病例角膜大面積色素沉著影響視力"
      ]
    },
    "pathophysiology": "免疫介導的角膜炎症，涉及T淋巴球和漿細胞浸潤角膜淺層基質。紫外線輻射是重要的環境促發因素，高海拔地區更嚴重。慢性炎症導致角膜血管新生、纖維化和黑色素沉積。",
    "diagnosis": {
      "overview": "根據品種、臨床外觀和病變特徵做出臨床診斷。角膜細胞學可確認。",
      "differentials": [
        "角膜色素性角膜炎（短頭種）",
        "乾眼症（KCS）相關角膜病變",
        "角膜瘢痕",
        "角膜腫瘤（鱗狀細胞癌，罕見）"
      ],
      "initialDB": [
        "裂隙燈檢查",
        "螢光素染色（角膜是否有潰瘍）",
        "淚液分泌測試（Schirmer test，排除KCS）"
      ],
      "advanced": [
        "角膜細胞學（淋巴球和漿細胞浸潤）",
        "角膜切片活檢（少見需要）"
      ]
    },
    "treatment": {
      "overview": "無法治癒，需終身治療控制炎症和色素沉著。目標是維持角膜透明和視力。",
      "acute": [
        "外用環孢素眼藥水（0.2-2%）或他克莫司眼藥膏（0.02-0.03%）q12h",
        "外用類固醇眼藥水（地塞米松或潑尼松龍 q8-12h）",
        "結膜下注射曲安奈德（嚴重病例）"
      ],
      "chronic": [
        "終身外用環孢素或他克莫司（維持q12-24h）",
        "減少紫外線暴露（避免正午戶外活動）",
        "犬用UV防護眼鏡（Doggles）",
        "嚴重病例考慮角膜表面切除術（superficial keratectomy）"
      ]
    },
    "prognosis": "適當治療下預後良好至謹慎。需終身治療，停藥後必然復發。高海拔和強紫外線環境下較難控制。嚴重未治療病例可能因角膜色素沉著而失明。",
    "pearls": [
      "德國牧羊犬是最典型的好發犬種",
      "高海拔地區的病例較難控制",
      "外用免疫調節劑（環孢素/他克莫司）是治療基石",
      "第三眼瞼增厚（漿細胞性第三眼瞼炎）常伴隨發生"
    ],
    "diagnosticAlgorithm": {
      "title": "角膜血管翳 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估角膜表面進行性血管新生和色素沉著，好發於德國牧羊犬，注意紫外線暴露史",
          "findings": [
            "角膜邊緣血管新生向中央延伸",
            "角膜色素沉著（黑色素沉積）",
            "雙側對稱性病變"
          ]
        },
        {
          "step": 2,
          "action": "眼科檢查",
          "details": "進行完整眼科檢查，包括裂隙燈、螢光素染色及淚液測試",
          "findings": [
            "裂隙燈見角膜淺層血管化伴肉芽組織",
            "螢光素染色通常陰性（表面完整）",
            "可能合併第三眼瞼漿細胞性浸潤"
          ]
        },
        {
          "step": 3,
          "action": "確診",
          "details": "根據品種、臨床特徵及雙側對稱性病變確診，嚴重時可角膜細胞學或活檢確認",
          "findings": [
            "臨床表現結合品種傾向確診",
            "角膜細胞學見漿細胞和淋巴細胞浸潤",
            "排除其他角膜炎病因"
          ]
        }
      ]
    },
    "monitoring": [
      "角膜血管新生和色素沉著的範圍",
      "視力變化",
      "治療依從性",
      "每3-6個月眼科追蹤"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "iris-melanoma": {
    "zh": "虹膜黑色素瘤",
    "en": "Iris Melanoma",
    "definition": "起源於虹膜黑色素細胞的腫瘤。犬的虹膜黑色素瘤多為良性，而貓的虹膜黑色素瘤（彌漫性虹膜黑色素瘤）具有較高的惡性潛力和轉移風險。",
    "synonyms": [
      "虹膜黑色素細胞瘤",
      "Uveal Melanoma",
      "Anterior Uveal Melanoma"
    ],
    "epidemiology": {
      "species": "犬貓皆可，臨床意義不同",
      "age": "中年至老年",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "犬：拉布拉多、黃金獵犬",
        "貓：任何品種，虹膜雀斑（melanosis）可能為前驅病變"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "虹膜顏色改變",
        "瞳孔形狀異常",
        "眼睛變色（貓：虹膜上出現棕色/黑色斑塊）",
        "可能無症狀（偶然發現）"
      ],
      "physicalExam": [
        "犬：虹膜上界限清楚的色素性腫塊",
        "貓：虹膜表面平坦或輕微隆起的色素斑，可逐漸擴大（彌漫性虹膜黑色素瘤）",
        "瞳孔變形（dyscoria）",
        "繼發性青光眼（腫瘤堵塞房水排出）",
        "前房出血（hyphema）",
        "葡萄膜炎"
      ]
    },
    "pathophysiology": "犬的虹膜黑色素瘤多為低惡性度的黑色素細胞瘤，生長緩慢。貓的彌漫性虹膜黑色素瘤起始為虹膜黑色素增生（melanosis），可逐漸進展為惡性黑色素瘤，並可沿房水排出途徑轉移至全身（肝臟、肺臟最常見）。",
    "diagnosis": {
      "overview": "眼科檢查為主要診斷手段。貓的虹膜色素變化需長期監測以評估惡性轉化。",
      "differentials": [
        "虹膜黑色素增生（melanosis，貓）",
        "虹膜囊腫",
        "虹膜肉芽腫",
        "淋巴肉瘤",
        "轉移性腫瘤"
      ],
      "initialDB": [
        "完整眼科檢查（裂隙燈、隅角鏡檢查gonioscopy）",
        "眼壓測量",
        "眼底檢查",
        "虹膜攝影記錄基線"
      ],
      "advanced": [
        "眼部超音波（評估腫瘤大小和後節侵犯）",
        "胸腔X光和腹部超音波（分期，尤其貓）",
        "前房穿刺細胞學（風險：出血、腫瘤播種）",
        "摘除眼球後組織病理學"
      ]
    },
    "treatment": {
      "overview": "犬的小型良性腫瘤可監測觀察。貓的虹膜黑色素瘤有惡性風險，需較積極處理。",
      "acute": [
        "繼發性青光眼的藥物控制",
        "繼發性葡萄膜炎的抗炎治療"
      ],
      "chronic": [
        "犬良性小型腫瘤：定期監測（每3-6個月攝影記錄）",
        "犬局部腫瘤：雷射光凝固術或虹膜切除術",
        "貓彌漫性虹膜黑色素瘤：早期眼球摘除（enucleation）是推薦治療",
        "眼球摘除後組織病理分期",
        "轉移性病例：化療效果有限"
      ]
    },
    "prognosis": "犬：多為良性，預後良好。貓：彌漫性虹膜黑色素瘤預後謹慎至不良，約50-60%可能轉移。早期摘除眼球可改善預後。已有遠端轉移時預後不良。",
    "pearls": [
      "貓的虹膜「雀斑」需定期監測，可能進展為惡性黑色素瘤",
      "貓虹膜色素擴展、虹膜表面隆起或瞳孔變形是惡性化的警示徵象",
      "犬的虹膜黑色素瘤多為良性，不要急於摘除眼球",
      "貓的早期眼球摘除優於等待腫瘤進展"
    ],
    "diagnosticAlgorithm": {
      "title": "虹膜黑色素瘤 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估虹膜表面色素變化，區分良性虹膜黑色素沉著與惡性黑色素瘤，犬大多良性而貓大多惡性",
          "findings": [
            "虹膜表面局部色素增加或腫塊",
            "瞳孔形狀改變（變形瞳孔）",
            "貓的虹膜色素擴散（瀰漫性虹膜黑色素瘤）"
          ]
        },
        {
          "step": 2,
          "action": "眼科詳細檢查",
          "details": "進行裂隙燈檢查評估腫瘤深度和範圍，隅角鏡檢查評估前房角浸潤，監測眼壓",
          "findings": [
            "裂隙燈顯示虹膜增厚或隆起",
            "隅角鏡可見前房角色素浸潤",
            "眼壓升高提示繼發性青光眼"
          ]
        },
        {
          "step": 3,
          "action": "影像學與確診",
          "details": "進行眼部超音波評估腫瘤範圍，必要時眼球摘除後組織病理學確診",
          "findings": [
            "超音波顯示虹膜/睫狀體腫塊",
            "組織病理學確認黑色素瘤類型及惡性程度",
            "貓應評估轉移風險"
          ]
        }
      ]
    },
    "monitoring": [
      "定期虹膜攝影比較",
      "眼壓變化",
      "瞳孔形狀",
      "貓：胸腔X光和腹部超音波（每3-6個月）"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "retrobulbar-abscess": {
    "zh": "眼球後膿腫",
    "en": "Retrobulbar Abscess",
    "definition": "眼球後方（眼眶內）的膿液積聚，通常由口腔或鼻竇感染、外來物穿透或血行性感染引起。導致急性眼球突出、疼痛和張口困難。",
    "synonyms": [
      "眶後膿腫",
      "Orbital Abscess",
      "眼眶膿腫"
    ],
    "epidemiology": {
      "species": "犬較常見，貓偶見",
      "age": "任何年齡，青年至中年犬較多",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "咀嚼骨頭或木棍（口腔穿透傷）",
        "牙周病",
        "上顎臼齒牙根感染",
        "鼻腔/鼻竇感染",
        "外來物（草芒）",
        "免疫抑制"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "急性單側眼球突出",
        "張嘴疼痛",
        "食慾下降",
        "發燒",
        "眼周腫脹",
        "近期咀嚼異物史"
      ],
      "physicalExam": [
        "急性單側眼球突出（exophthalmos）",
        "第三眼瞼突出",
        "結膜充血和水腫",
        "張口劇痛",
        "口腔後方（上顎弓後方）腫脹和波動感",
        "眼球後推抵抗增加",
        "可能有發燒和頜下淋巴結腫大"
      ]
    },
    "pathophysiology": "感染源（口腔外來物穿透翼突肌、牙根膿腫延伸、鼻竇感染擴散或血行性播種）進入眼眶後腔隙，細菌增殖導致膿液積聚。膿腫佔位效應使眼球向前突出，壓迫翼突肌導致張口疼痛。常見致病菌包括厭氧菌、金黃色葡萄球菌和鏈球菌。",
    "diagnosis": {
      "overview": "根據急性單側眼球突出合併張口疼痛的特徵性表現做出臨床診斷。影像學可確認。",
      "differentials": [
        "眼眶腫瘤",
        "咀嚼肌肌炎",
        "顴骨肌炎",
        "眼眶蜂窩組織炎",
        "眼眶外來物"
      ],
      "initialDB": [
        "完整眼科檢查",
        "口腔檢查（上顎弓後方腫脹）",
        "口腔X光（評估牙根）",
        "CBC（嗜中性球增多伴左移）"
      ],
      "advanced": [
        "頭部CT或MRI（最佳影像學檢查）",
        "眼部超音波",
        "超音波導引下穿刺抽吸和培養",
        "口腔後方穿刺引流和培養"
      ]
    },
    "treatment": {
      "overview": "引流膿液並給予全身性抗生素。口腔後方引流是標準治療方式。",
      "acute": [
        "口腔後方切開引流（在上顎最後臼齒後方黏膜切開）",
        "膿液培養和藥敏",
        "全身性廣譜抗生素（阿莫西林克拉維酸25 mg/kg PO q12h或clindamycin 11 mg/kg PO q12h）",
        "止痛藥（NSAIDs或曲馬多）",
        "溫熱敷"
      ],
      "chronic": [
        "抗生素療程至少2-4週",
        "處理原發病因（牙根拔除、異物移除）",
        "口腔衛生維護",
        "複查確認膿腫完全消退"
      ]
    },
    "prognosis": "及時引流和適當抗生素治療下預後良好。多數病例在引流後24-48小時內顯著改善。需處理原發病因以預防復發。合併眶後外來物的病例需徹底移除才能根治。",
    "pearls": [
      "張口劇痛是眼球後膿腫最特徵性的表現，與眼眶腫瘤鑑別",
      "口腔後方觸診有波動感時可直接穿刺引流",
      "厭氧菌培養非常重要",
      "需同時評估牙齒狀況尋找感染來源"
    ],
    "diagnosticAlgorithm": {
      "title": "眼球後膿腫 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估急性單側眼球突出、張口疼痛和結膜充血水腫",
          "findings": [
            "急性單側眼球突出",
            "張口時劇烈疼痛",
            "結膜充血水腫伴第三眼瞼突出"
          ]
        },
        {
          "step": 2,
          "action": "口腔與影像檢查",
          "details": "口腔檢查注意最後臼齒後方黏膜腫脹，進行眼眶超音波或CT/MRI評估",
          "findings": [
            "最後臼齒後方口腔黏膜腫脹或波動感",
            "超音波顯示眼球後方低回聲/無回聲區",
            "CT/MRI顯示眼眶後方膿腫腔"
          ]
        },
        {
          "step": 3,
          "action": "穿刺引流與確診",
          "details": "經口腔最後臼齒後方穿刺引流膿液，進行細菌培養及藥敏試驗",
          "findings": [
            "穿刺引出膿性分泌物",
            "細菌培養鑑定致病菌（常為口腔厭氧菌）",
            "藥敏試驗指導抗生素選擇"
          ]
        }
      ]
    },
    "monitoring": [
      "眼球位置恢復正常",
      "張口功能恢復",
      "體溫",
      "複查影像確認膿腫消退"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "orbital-tumor": {
    "zh": "眼眶腫瘤",
    "en": "Orbital Tumor",
    "definition": "發生於眼眶內的原發性或繼發性腫瘤，導致漸進性眼球突出。犬最常見的為骨肉瘤和腦膜瘤，貓最常見的為淋巴瘤和鱗狀細胞癌。",
    "synonyms": [
      "眶內腫瘤",
      "Orbital Neoplasia",
      "眼眶新生物"
    ],
    "epidemiology": {
      "species": "犬貓皆可",
      "age": "中年至老年",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "老年動物",
        "犬：杜賓犬和黃金獵犬偏好",
        "貓：FeLV陽性（淋巴瘤相關）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "漸進性單側眼球突出（數週至數月）",
        "眼球方向改變",
        "視力下降",
        "食慾正常或輕度下降（與眼球後膿腫不同）",
        "通常無急性疼痛"
      ],
      "physicalExam": [
        "漸進性單側眼球突出",
        "眼球偏移（方向取決於腫瘤位置）",
        "第三眼瞼突出",
        "眼球後推抵抗增加",
        "結膜充血",
        "暴露性角膜炎（眼球突出致眼瞼閉合不全）",
        "張口可能疼痛但不如膿腫劇烈",
        "視力受損",
        "可能觸及眶緣骨質破壞"
      ]
    },
    "pathophysiology": "原發性眼眶腫瘤起源於眼眶內的各種組織（骨、肌肉、神經、血管、腺體）。繼發性腫瘤可由鄰近結構直接侵犯（鼻腔腫瘤、口腔腫瘤）或遠端轉移而來。腫瘤在密閉的眼眶腔內生長，推擠眼球向前突出。",
    "diagnosis": {
      "overview": "影像學是評估眼眶腫瘤的關鍵，CT或MRI為首選。確診需組織學。",
      "differentials": [
        "眼球後膿腫",
        "咀嚼肌肌炎",
        "眶內蜂窩組織炎",
        "眶內異物",
        "唾液囊腫（顴骨唾液腺）"
      ],
      "initialDB": [
        "完整眼科檢查",
        "頭部X光（可見骨溶解或腫塊效應）",
        "胸腔X光（腫瘤分期）",
        "CBC/血液生化"
      ],
      "advanced": [
        "頭部CT（首選）或MRI",
        "超音波導引細針抽吸（FNA）",
        "組織切片活檢（可能需手術探查）",
        "腹部超音波（腫瘤分期）",
        "貓：FeLV/FIV檢測"
      ]
    },
    "treatment": {
      "overview": "取決於腫瘤類型和分期。外科和放射線治療為主要選項。",
      "acute": [
        "暴露性角膜炎的保護（人工淚液、暫時性瞼縫合tarsorrhaphy）",
        "止痛"
      ],
      "chronic": [
        "眼球摘除伴眶內容清除（orbitotomy/exenteration）",
        "放射線治療（淋巴瘤和部分肉瘤）",
        "化學治療（淋巴瘤對化療反應良好）",
        "姑息治療（晚期或不宜手術的病例）"
      ]
    },
    "prognosis": "取決於腫瘤類型。淋巴瘤對化療反應佳，緩解率高。原發性骨肉瘤和腦膜瘤預後謹慎至不良（中位存活時間數月至1年）。鄰近結構侵犯的腫瘤預後較差。早期發現和治療可改善預後。",
    "pearls": [
      "漸進性眼球突出（數週至數月）高度提示腫瘤，急性突出提示膿腫或出血",
      "CT是評估眼眶腫瘤範圍的最佳工具",
      "貓眼眶淋巴瘤常與FeLV相關",
      "鼻腔腫瘤直接侵犯眼眶是繼發性眼眶腫瘤的常見原因"
    ],
    "diagnosticAlgorithm": {
      "title": "眼眶腫瘤 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估漸進性單側眼球突出、眼球運動受限和視力變化，注意病程緩慢（區別於膿腫的急性發作）",
          "findings": [
            "漸進性單側眼球突出",
            "眼球運動受限或偏位",
            "眼底檢查可見脈絡膜皺褶"
          ]
        },
        {
          "step": 2,
          "action": "進階影像學檢查",
          "details": "進行眼眶CT或MRI評估腫瘤位置、大小和侵犯範圍",
          "findings": [
            "CT/MRI顯示眼眶內佔位性病變",
            "評估骨骼侵蝕程度",
            "評估腫瘤與周圍結構的關係"
          ]
        },
        {
          "step": 3,
          "action": "活檢確診",
          "details": "進行CT引導或超音波引導細針抽吸或切開活檢，送病理學及細胞學檢查",
          "findings": [
            "細胞學或組織病理學確認腫瘤類型",
            "常見類型包括腺癌、淋巴瘤、骨肉瘤",
            "評估轉移風險（胸腔X光、淋巴結檢查）"
          ]
        }
      ]
    },
    "monitoring": [
      "影像學追蹤腫瘤大小",
      "對側眼睛狀態",
      "全身轉移評估",
      "化療副作用（血球計數）"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "anterior-lens-luxation": {
    "zh": "前房水晶體脫位",
    "en": "Anterior Lens Luxation",
    "definition": "水晶體懸韌帶（睫狀小帶）完全斷裂，導致水晶體向前移位進入前房。為眼科急症，可迅速導致繼發性青光眼和失明。",
    "synonyms": [
      "前方水晶體脫位",
      "Primary Lens Luxation",
      "水晶體前脫位"
    ],
    "epidemiology": {
      "species": "犬較常見，貓偶見",
      "age": "原發性：3-8歲；繼發性：任何年齡",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "梗犬品種（傑克羅素梗、迷你牛頭梗、西藏梗、夏戴爾梗）為遺傳性",
        "ADAMTS17基因突變",
        "繼發於慢性青光眼、葡萄膜炎或眼內腫瘤",
        "繼發於水晶體過熟性白內障"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "急性眼睛疼痛（瞇眼、流淚）",
        "眼睛突然變紅",
        "突然失明",
        "角膜混濁",
        "另一眼可能有類似病史（原發性為雙側）"
      ],
      "physicalExam": [
        "前房內可見水晶體（半透明圓盤）",
        "角膜水腫（水晶體直接接觸角膜內皮）",
        "瞳孔形狀異常",
        "眼壓升高（繼發性青光眼）",
        "前房深度不均",
        "無晶體弧（aphakic crescent）",
        "虹膜震顫（iridodonesis）"
      ]
    },
    "pathophysiology": "原發性水晶體脫位為遺傳性懸韌帶退化（ADAMTS17基因突變），懸韌帶逐漸斷裂直至水晶體完全脫位。水晶體向前移位至前房時，堵塞瞳孔和房角導致房水排出受阻，眼壓急速升高造成繼發性青光眼。水晶體接觸角膜內皮導致角膜水腫。",
    "diagnosis": {
      "overview": "裂隙燈檢查可直接觀察到前房內的水晶體，為眼科急症需立即處理。",
      "differentials": [
        "後房水晶體脫位（較不急）",
        "原發性青光眼",
        "前葡萄膜炎伴眼壓升高",
        "角膜水腫（其他原因）"
      ],
      "initialDB": [
        "裂隙燈檢查",
        "眼壓測量（通常顯著升高>40 mmHg）",
        "對側眼的完整檢查（評估懸韌帶鬆弛徵象）"
      ],
      "advanced": [
        "眼部超音波（評估後節、排除腫瘤）",
        "隅角鏡檢查（gonioscopy）",
        "基因檢測（ADAMTS17突變）"
      ]
    },
    "treatment": {
      "overview": "眼科急症！前房水晶體脫位需緊急手術摘除水晶體。同時控制眼壓。",
      "acute": [
        "緊急降眼壓（靜脈注射mannitol 1-2 g/kg over 20 min）",
        "局部降眼壓藥物（latanoprost除外，可能使水晶體更前移）",
        "縮瞳劑暫時穩定水晶體位置（但不可延遲手術）",
        "緊急手術：經角膜緣水晶體摘除術（intracapsular lens extraction, ICLE）"
      ],
      "chronic": [
        "對側眼預防性治療（縮瞳劑pilocarpine 1-2% q8-12h）",
        "基因檢測陽性犬的對側眼密切監測",
        "術後長期抗炎和降眼壓",
        "已失明且疼痛的眼睛考慮摘除"
      ]
    },
    "prognosis": "早期手術（24-48小時內）且眼壓控制良好的病例可保留視力（約50-80%）。延遲治療導致視神經損傷後預後不良。原發性脫位的對側眼在數月至數年內極可能發生相同問題。",
    "pearls": [
      "前房水晶體脫位是眼科急症，延遲處理每小時都在損害視力",
      "不要使用latanoprost，因為它可能使水晶體更向前移",
      "梗犬品種的對側眼需預防性使用縮瞳劑",
      "ADAMTS17基因檢測可在發病前識別高風險個體"
    ],
    "diagnosticAlgorithm": {
      "title": "前房水晶體脫位 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估急性眼痛、角膜水腫、眼壓升高等表現，注意犬種傾向（梗犬類）",
          "findings": [
            "急性眼痛伴流淚",
            "角膜水腫（霧濁）",
            "前房內可見水晶體邊緣"
          ]
        },
        {
          "step": 2,
          "action": "眼科檢查",
          "details": "進行裂隙燈檢查確認水晶體位置，測量眼壓，評估瞳孔反射",
          "findings": [
            "裂隙燈確認水晶體在前房內",
            "眼壓顯著升高（繼發性青光眼）",
            "虹膜震顫（iridodonesis）"
          ]
        },
        {
          "step": 3,
          "action": "確診與緊急處理評估",
          "details": "根據臨床檢查確診，評估對側眼風險，屬眼科急症需緊急處理",
          "findings": [
            "臨床確認前房水晶體脫位",
            "對側眼懸韌帶鬆弛評估",
            "眼科急症需盡快手術摘除"
          ]
        }
      ]
    },
    "monitoring": [
      "術後眼壓",
      "角膜透明度",
      "對側眼的懸韌帶狀態",
      "視力評估"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "feline-eosinophilic-keratitis": {
    "zh": "貓嗜酸性角膜炎",
    "en": "Feline Eosinophilic Keratitis",
    "definition": "貓特有的角膜疾病，以角膜表面白色至粉紅色的斑塊狀浸潤為特徵，組織學顯示嗜酸球和肥大細胞浸潤。可能與貓疱疹病毒-1型（FHV-1）感染相關。",
    "synonyms": [
      "FEK",
      "Feline Proliferative Keratoconjunctivitis",
      "貓增殖性角結膜炎"
    ],
    "epidemiology": {
      "species": "貓",
      "age": "任何年齡，但中年至老年貓較常見",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "FHV-1感染或潛伏感染",
        "免疫抑制",
        "慢性角膜刺激",
        "應激誘發的病毒再活化"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "眼睛出現白色或粉紅色病變",
        "眼分泌物",
        "可能瞇眼",
        "可能有上呼吸道感染病史"
      ],
      "physicalExam": [
        "角膜表面白色至粉白色、乾酪樣斑塊狀浸潤",
        "角膜血管新生",
        "病變通常從角膜邊緣開始向中央擴展",
        "可能伴有角膜潰瘍",
        "通常單側但可雙側",
        "結膜充血"
      ]
    },
    "pathophysiology": "推測為角膜對FHV-1感染或其他慢性刺激的異常免疫反應。嗜酸球和肥大細胞浸潤角膜淺層基質，釋放細胞毒性蛋白導致角膜損傷。FHV-1 DNA可在約75%的FEK病例中被檢出，但確切因果關係尚未完全釐清。",
    "diagnosis": {
      "overview": "角膜細胞學是最重要的診斷工具，顯示嗜酸球即可確診。",
      "differentials": [
        "角膜隔離體（corneal sequestrum）",
        "角膜真菌感染",
        "FHV-1角膜炎（樹突狀潰瘍）",
        "角膜腫瘤（鱗狀細胞癌）"
      ],
      "initialDB": [
        "裂隙燈檢查",
        "螢光素染色",
        "角膜刮片細胞學（顯示大量嗜酸球即可確診）"
      ],
      "advanced": [
        "FHV-1 PCR（角膜拭子）",
        "角膜切片活檢（少見需要）",
        "結膜培養（排除感染）"
      ]
    },
    "treatment": {
      "overview": "外用類固醇或免疫調節劑為主要治療。同時建議併用抗病毒藥物。",
      "acute": [
        "外用類固醇眼藥水（地塞米松或潑尼松龍 q6-8h）",
        "併用外用抗病毒藥物（cidofovir 0.5% q12h或idoxuridine q6h）",
        "有潰瘍時先控制潰瘍再用類固醇"
      ],
      "chronic": [
        "逐漸減量外用類固醇至最低有效頻率",
        "外用環孢素或他克莫司作為類固醇替代",
        "口服famciclovir（90 mg/kg PO q8h）輔助",
        "口服離胺酸（L-lysine 250-500 mg/cat PO daily）",
        "減少應激因素"
      ]
    },
    "prognosis": "治療反應通常良好，但復發率高。需長期維持治療。嚴重或反覆發作的病例可能導致角膜瘢痕和視力受損。併用抗病毒藥物可能減少復發。",
    "pearls": [
      "角膜刮片細胞學是最簡單快速的確診方法",
      "外用類固醇效果顯著但不可在有角膜潰瘍時使用",
      "約75%的病例可檢出FHV-1 DNA",
      "復發常見，需長期追蹤"
    ],
    "diagnosticAlgorithm": {
      "title": "貓嗜酸性角膜炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估貓角膜表面白粉色隆起斑塊、血管新生和角膜水腫",
          "findings": [
            "角膜表面白粉色肉芽組織斑塊",
            "角膜血管新生",
            "輕度至中度眼部不適"
          ]
        },
        {
          "step": 2,
          "action": "角膜細胞學檢查",
          "details": "進行角膜刮搔細胞學檢查，確認嗜酸性球浸潤",
          "findings": [
            "大量嗜酸性球浸潤",
            "可能發現肥大細胞",
            "排除角膜感染"
          ]
        },
        {
          "step": 3,
          "action": "確診與病因調查",
          "details": "根據細胞學確診，檢測FHV-1（貓疱疹病毒）感染作為潛在觸發因素",
          "findings": [
            "細胞學確認嗜酸性角膜炎",
            "FHV-1 PCR可能陽性",
            "對局部類固醇或環孢素治療反應良好"
          ]
        }
      ]
    },
    "monitoring": [
      "角膜病變範圍和外觀",
      "螢光素染色（監測潰瘍）",
      "治療反應和復發",
      "類固醇副作用"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "hordeolum-chalazion": {
    "zh": "麥粒腫與霰粒腫",
    "en": "Hordeolum and Chalazion",
    "definition": "麥粒腫（hordeolum）為眼瞼腺體的急性細菌性感染，分為外麥粒腫（Zeis或Moll腺）和內麥粒腫（Meibomian腺）。霰粒腫（chalazion）為Meibomian腺的慢性脂肪性肉芽腫，通常為麥粒腫未完全消退的後遺症。",
    "synonyms": [
      "針眼",
      "Stye",
      "Meibomian Gland Granuloma",
      "瞼板腺肉芽腫"
    ],
    "epidemiology": {
      "species": "犬較常見，貓偶見",
      "age": "任何年齡",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "Meibomian腺功能障礙",
        "慢性眼瞼炎",
        "過敏性皮膚病",
        "免疫抑制"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "眼瞼腫塊",
        "麥粒腫：急性疼痛性腫脹",
        "霰粒腫：慢性無痛性結節",
        "眼分泌物"
      ],
      "physicalExam": [
        "麥粒腫：眼瞼邊緣紅腫、疼痛性結節，可能有膿頭",
        "外麥粒腫：眼瞼皮膚面",
        "內麥粒腫：眼瞼結膜面（翻瞼可見）",
        "霰粒腫：堅實、無痛性眼瞼結節",
        "結膜充血",
        "可能有瞼板腺開口阻塞"
      ]
    },
    "pathophysiology": "麥粒腫為眼瞼腺體（Meibomian腺、Zeis腺或Moll腺）的急性細菌性感染（最常見葡萄球菌），導致局部化膿性炎症。霰粒腫為Meibomian腺管阻塞後脂質外溢引發的慢性脂肪性肉芽腫反應，是一種無菌性炎症。",
    "diagnosis": {
      "overview": "臨床檢查即可診斷。需與眼瞼腫瘤鑑別，尤其慢性或復發性病例。",
      "differentials": [
        "眼瞼腫瘤（Meibomian腺腺瘤/腺癌、鱗狀細胞癌）",
        "眼瞼膿腫",
        "組織球瘤",
        "乳突狀瘤"
      ],
      "initialDB": [
        "眼瞼觸診和視診",
        "翻瞼檢查結膜面",
        "裂隙燈檢查"
      ],
      "advanced": [
        "細針抽吸細胞學（排除腫瘤）",
        "切除性切片活檢（反覆發作或不典型病例）"
      ]
    },
    "treatment": {
      "overview": "麥粒腫多為自限性，溫熱敷可促進引流。霰粒腫可能需手術刮除。",
      "acute": [
        "溫熱敷（每日3-4次，每次10-15分鐘）促進引流",
        "外用抗生素眼藥膏（氯黴素或紅黴素）q8-12h",
        "較大膿腫可切開引流",
        "全身性抗生素用於嚴重或多發病例"
      ],
      "chronic": [
        "霰粒腫：結膜面切開刮除術（chalazion curettage）",
        "外用溫熱敷維持Meibomian腺暢通",
        "處理潛在的眼瞼炎或Meibomian腺功能障礙",
        "反覆發作送切片排除腫瘤"
      ]
    },
    "prognosis": "麥粒腫預後良好，多數在1-2週內自行消退。霰粒腫刮除術後預後良好。反覆發作者需評估潛在的Meibomian腺功能障礙。任何不消退的眼瞼腫塊應切片排除腫瘤。",
    "pearls": [
      "溫熱敷是最簡單有效的初始治療",
      "不消退的眼瞼結節必須排除腫瘤，尤其老年犬",
      "犬眼瞼腫瘤約75%為良性（Meibomian腺腺瘤）",
      "反覆發作的霰粒腫需懷疑Meibomian腺腺癌"
    ],
    "diagnosticAlgorithm": {
      "title": "麥粒腫與霰粒腫 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估眼瞼腫塊特徵，麥粒腫為急性紅腫疼痛，霰粒腫為慢性無痛性結節",
          "findings": [
            "眼瞼邊緣急性紅腫壓痛（麥粒腫）",
            "眼瞼內慢性無痛性堅實結節（霰粒腫）",
            "局部結膜充血"
          ]
        },
        {
          "step": 2,
          "action": "臨床檢查",
          "details": "翻轉眼瞼檢查瞼板腺，評估腫塊大小和對角膜的影響",
          "findings": [
            "瞼板面可見腺體腫脹或黃色分泌物",
            "評估角膜有無摩擦性潰瘍",
            "區分良性病變與眼瞼腫瘤"
          ]
        },
        {
          "step": 3,
          "action": "確診與治療方針",
          "details": "根據臨床特徵確診，反覆發作或不消退者考慮活檢排除腫瘤",
          "findings": [
            "臨床表現典型可確診",
            "反覆發作需排除瞼板腺癌",
            "不消退者建議切除活檢"
          ]
        }
      ]
    },
    "monitoring": [
      "腫塊大小變化",
      "有無復發",
      "Meibomian腺功能",
      "老年犬需追蹤排除腫瘤"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "eyelid-tumor": {
    "zh": "眼瞼腫瘤",
    "en": "Eyelid Tumor",
    "definition": "發生於眼瞼的各種良性或惡性腫瘤。犬以Meibomian腺腺瘤最常見（約75%為良性），貓以鱗狀細胞癌最常見且多為惡性。",
    "synonyms": [
      "眼瞼新生物",
      "Eyelid Neoplasia",
      "Meibomian Gland Adenoma"
    ],
    "epidemiology": {
      "species": "犬貓皆可，犬更常見",
      "age": "中年至老年",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "犬：老年、品種傾向（可卡犬、拉布拉多、貴賓犬、比格犬）",
        "貓：白色被毛或色素缺乏的眼瞼（紫外線曝曬相關鱗狀細胞癌）",
        "貓：戶外生活"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "眼瞼逐漸增大的腫塊",
        "眼分泌物增加",
        "瞇眼或流淚（腫瘤摩擦角膜）",
        "眼瞼出血"
      ],
      "physicalExam": [
        "犬：眼瞼邊緣的圓形、光滑、有蒂或無蒂腫塊（Meibomian腺腺瘤）",
        "犬：乳突狀瘤（年輕犬病毒性、老年犬自發性）",
        "貓：眼瞼邊緣不規則潰瘍性病變（鱗狀細胞癌）",
        "腫瘤摩擦角膜導致血管新生或潰瘍",
        "結膜充血",
        "過多眼分泌物"
      ]
    },
    "pathophysiology": "犬眼瞼腫瘤多源自Meibomian腺（瞼板腺），為良性腺瘤或上皮瘤，生長緩慢。貓眼瞼腫瘤多為鱗狀細胞癌，與紫外線長期曝曬相關（尤其白色無色素眼瞼），具有局部侵襲性。其他類型包括肥大細胞瘤、淋巴瘤、黑色素瘤、纖維肉瘤等。",
    "diagnosis": {
      "overview": "臨床外觀可初步判斷，確診需組織病理學。",
      "differentials": [
        "霰粒腫",
        "麥粒腫",
        "眼瞼肉芽腫",
        "眼瞼囊腫",
        "組織球瘤"
      ],
      "initialDB": [
        "完整眼科檢查",
        "腫瘤大小和位置記錄",
        "評估角膜有無繼發損傷"
      ],
      "advanced": [
        "切除性切片活檢（首選）",
        "細針抽吸細胞學（術前評估）",
        "區域淋巴結評估",
        "貓：胸腔X光（SCC分期）"
      ]
    },
    "treatment": {
      "overview": "手術切除為主要治療。犬多為良性，預後極佳。貓需完整切除和可能的輔助治療。",
      "acute": [
        "小型腫瘤（<1/3眼瞼長度）：楔形全層切除",
        "中型腫瘤（1/3-1/2眼瞼）：切除後H型或旋轉皮瓣重建",
        "大型腫瘤（>1/2眼瞼）：分期手術或唇黏膜皮瓣"
      ],
      "chronic": [
        "犬良性腫瘤切除後通常治癒",
        "貓鱗狀細胞癌：完整切除，必要時冷凍治療或放射線治療",
        "不適合手術者：冷凍手術、光動力療法",
        "防曬措施預防貓SCC復發"
      ]
    },
    "prognosis": "犬：約75%為良性Meibomian腺腫瘤，完整切除後預後極佳。貓：鱗狀細胞癌完整切除後預後謹慎至良好，但可能復發或對側發生。不完整切除後復發率高。",
    "pearls": [
      "犬眼瞼腫瘤約75%為良性，但仍建議切片確認",
      "貓白色眼瞼的鱗狀細胞癌與紫外線密切相關",
      "眼瞼手術需保留足夠長度避免術後眼瞼閉合不全",
      "小腫瘤切除比等腫瘤長大再手術容易得多"
    ],
    "diagnosticAlgorithm": {
      "title": "眼瞼腫瘤 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估眼瞼腫塊特徵，犬以良性瞼板腺瘤最常見，貓眼瞼腫瘤多為惡性（鱗狀上皮細胞癌）",
          "findings": [
            "眼瞼邊緣有蒂或寬基底腫塊",
            "可能伴隨眼部分泌物增加",
            "腫塊摩擦角膜引起不適"
          ]
        },
        {
          "step": 2,
          "action": "細胞學檢查",
          "details": "進行細針抽吸或印壓細胞學初步評估腫瘤性質",
          "findings": [
            "細胞學初步評估腫瘤類型",
            "犬常見瞼板腺瘤/黑色素瘤",
            "貓常見鱗狀上皮細胞癌"
          ]
        },
        {
          "step": 3,
          "action": "手術切除與組織病理確診",
          "details": "手術切除腫塊送組織病理學檢查確認腫瘤類型和切除邊緣",
          "findings": [
            "組織病理學確認腫瘤類型與良惡性",
            "評估手術切除邊緣是否乾淨",
            "惡性腫瘤需評估區域淋巴結"
          ]
        }
      ]
    },
    "monitoring": [
      "手術部位復發",
      "角膜狀態",
      "眼瞼閉合功能",
      "貓：對側眼瞼和鼻鏡的新生病變"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "neonatal-isoerythrolysis": {
    "zh": "新生兒同族溶血症",
    "en": "Neonatal Isoerythrolysis",
    "definition": "新生幼畜經初乳吸收母體的抗紅血球抗體，導致紅血球被破壞的溶血性貧血。主要見於A型或AB型小貓吸食B型母貓的初乳，犬極罕見。",
    "synonyms": [
      "NI",
      "新生兒溶血病",
      "Hemolytic Disease of the Newborn",
      "初乳介導性溶血"
    ],
    "epidemiology": {
      "species": "貓遠比犬常見",
      "age": "新生兒（出生後24-72小時發病）",
      "sex": "無性別傾向",
      "riskFactors": [
        "B型母貓與A型公貓交配",
        "高B型血型頻率品種（英國短毛貓、德文捲毛貓、阿比西尼亞貓、波斯貓、伯曼貓）",
        "犬：DEA 1.1陰性母犬曾接受DEA 1.1陽性輸血後懷孕"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "出生時正常的幼貓在吸乳後12-24小時內發病",
        "停止吸乳",
        "漸進性虛弱",
        "同窩中可能僅部分幼畜發病（取決於血型）",
        "深色（褐色至紅色）尿液"
      ],
      "physicalExam": [
        "蒼白或黃疸性黏膜",
        "嗜睡和虛弱",
        "尾尖壞死（末梢壞死）",
        "血紅素尿（深色尿液）",
        "呼吸急促",
        "低體溫",
        "突然死亡（嚴重病例）"
      ]
    },
    "pathophysiology": "B型貓天然含有高效價的抗A型抗體。A型幼貓出生後吸食B型母貓的初乳，經腸道吸收母體的抗A抗體（主要在出生後16小時內，腸道通透性最高期間）。這些抗體結合幼貓的A型紅血球，引發補體介導的血管內溶血和抗體介導的血管外溶血。",
    "diagnosis": {
      "overview": "根據母貓血型（B型）、幼貓血型（A型或AB型）和特徵性臨床表現做出診斷。",
      "differentials": [
        "新生兒感染（敗血症）",
        "先天性心臟病",
        "衰弱幼貓症候群",
        "創傷",
        "低血糖"
      ],
      "initialDB": [
        "母貓和幼貓血型鑑定",
        "PCV/TP（貧血、蛋白可能正常或升高）",
        "血液抹片（球形紅血球、紅血球凝集）",
        "尿液外觀（血紅素尿）"
      ],
      "advanced": [
        "Coombs試驗（直接抗球蛋白試驗，陽性）",
        "膽紅素（升高）",
        "血液培養（排除敗血症）"
      ]
    },
    "treatment": {
      "overview": "立即停止吸乳！支持療法和嚴重病例的輸血。預防重於治療。",
      "acute": [
        "立即將幼貓與母貓分離，停止吸乳",
        "出生後16-24小時後可恢復吸乳（腸道通透性已降低）",
        "分離期間以人工哺乳或找A型代理母貓",
        "嚴重貧血時輸血（使用洗滌過的B型母貓紅血球或A型供體全血）",
        "保溫和支持療法（補液、葡萄糖）"
      ],
      "chronic": [
        "存活幼貓通常完全恢復",
        "尾尖壞死可能需截除",
        "未來繁殖計畫需考慮血型配對"
      ]
    },
    "prognosis": "輕度病例如果及時停止吸乳可完全恢復。嚴重病例（延遲發現）死亡率高。預防措施（繁殖前血型鑑定）可完全避免此病。存活個體通常無長期後遺症。",
    "pearls": [
      "繁殖前為母貓和公貓做血型鑑定是最佳預防措施",
      "B型母貓與A型公貓的組合是高風險配對",
      "出生後前16小時是關鍵窗口期，此時腸道可吸收完整抗體",
      "尾尖壞死是本病的特徵性表現"
    ],
    "diagnosticAlgorithm": {
      "title": "新生兒同族溶血症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估出生後24-72小時內幼畜出現進行性黃疸、貧血和血紅蛋白尿，確認母畜血型",
          "findings": [
            "出生後數天內進行性黃疸",
            "蒼白黏膜伴嗜睡",
            "深色（血紅蛋白）尿"
          ]
        },
        {
          "step": 2,
          "action": "血液學檢查",
          "details": "進行幼畜及母畜血型鑑定，進行交叉配血試驗，評估貧血程度",
          "findings": [
            "幼畜紅血球與母畜血清交叉凝集陽性",
            "再生性貧血（網織紅血球增多）",
            "貓A型幼畜與B型母畜血型不合"
          ]
        },
        {
          "step": 3,
          "action": "確診與緊急處理",
          "details": "根據血型不合、臨床表現及陽性交叉配血試驗確診，立即停止哺乳",
          "findings": [
            "母幼血型不合確認",
            "交叉配血陽性確診",
            "需立即停止哺乳並提供相容血型輸血"
          ]
        }
      ]
    },
    "monitoring": [
      "PCV追蹤（每數小時至每日）",
      "黏膜顏色",
      "尿液顏色",
      "體溫和活力"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "fading-puppy-kitten-syndrome": {
    "zh": "衰弱幼犬/幼貓症候群",
    "en": "Fading Puppy/Kitten Syndrome",
    "definition": "泛指新生幼犬或幼貓在出生後前數週內逐漸衰弱和死亡的非特異性臨床症候群。並非單一疾病，而是多種潛在病因（感染、先天缺陷、環境因素、營養不良）的共同臨床表現。",
    "synonyms": [
      "新生兒衰弱症",
      "Fading Neonatal Syndrome",
      "新生兒死亡症候群"
    ],
    "epidemiology": {
      "species": "犬貓皆可",
      "age": "出生後0-3週",
      "sex": "無性別傾向",
      "riskFactors": [
        "初次分娩母畜",
        "難產",
        "母畜營養不良",
        "不潔環境",
        "初乳攝取不足",
        "先天性異常",
        "感染性病原（犬疱疹病毒、FeLV、FIP、細菌敗血症）",
        "環境溫度不當"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "出生時看似正常但逐漸衰弱",
        "停止吸乳",
        "體重不增或下降",
        "與母畜和同窩分離",
        "持續哭叫或異常安靜",
        "同窩多隻受影響"
      ],
      "physicalExam": [
        "體重低於正常（出生後應每日增加5-10%體重）",
        "脫水",
        "低體溫",
        "虛弱和活動減少",
        "腹部膨大（可能腹瀉或腹脹）",
        "黏膜蒼白或黃疸",
        "呼吸困難",
        "異常分泌物"
      ]
    },
    "pathophysiology": "多因素疾病。常見潛在病因包括：(1)感染：犬疱疹病毒（CHV-1）、細菌敗血症（大腸桿菌、鏈球菌）、FeLV、FIP；(2)先天缺陷：心臟畸形、腎臟發育不全、腭裂；(3)環境因素：低溫（新生兒無法自主調節體溫）、不潔環境；(4)營養因素：初乳攝取不足導致免疫球蛋白缺乏、母乳不足。新生兒的免疫系統不成熟和有限的代謝儲備使其極易受到不良因素影響。",
    "diagnosis": {
      "overview": "診斷重點在於尋找可治療的潛在病因。系統性評估母畜、環境和幼畜。",
      "differentials": [
        "新生兒同族溶血症",
        "先天性心臟病",
        "新生兒敗血症",
        "犬疱疹病毒感染",
        "先天性異常（腎臟、心臟）",
        "低血糖",
        "脫水和低溫"
      ],
      "initialDB": [
        "體重監測（每日秤重）",
        "體溫測量",
        "血糖測定",
        "PCV/TP",
        "母畜評估（泌乳量、健康狀態）",
        "環境評估（溫度、衛生）"
      ],
      "advanced": [
        "血液培養和藥敏（敗血症）",
        "死亡幼畜的完整屍檢和組織病理學",
        "病毒檢測（CHV-1 PCR、FeLV、FIP）",
        "先天性缺陷的影像學評估"
      ]
    },
    "treatment": {
      "overview": "積極的支持療法和尋找可治療的病因。環境管理至關重要。",
      "acute": [
        "保溫（第一週環境溫度30-32°C，每週遞減2-3°C）",
        "補充營養（人工哺乳或管灌餵食）",
        "糾正低血糖（口服或皮下5-10%葡萄糖溶液）",
        "皮下補液糾正脫水",
        "經驗性抗生素（懷疑敗血症時）"
      ],
      "chronic": [
        "確保充足初乳攝取（出生後12-24小時內）",
        "環境衛生管理",
        "母畜健康評估和營養支持",
        "監測體重增長曲線",
        "懷疑犬疱疹病毒時提高環境溫度"
      ]
    },
    "prognosis": "取決於潛在病因。環境因素和營養不良造成的衰弱經適當處理預後良好。感染性和先天缺陷的預後謹慎至不良。犬疱疹病毒感染在3週齡以下幼犬死亡率極高。整體而言新生幼畜死亡率約15-30%。",
    "pearls": [
      "新生幼畜每日體重增加5-10%是健康的重要指標",
      "低體溫是新生兒最致命的威脅之一",
      "犬疱疹病毒感染在3週齡以下幼犬幾乎100%致命",
      "屍檢是確定衰弱幼畜死因的最重要工具"
    ],
    "diagnosticAlgorithm": {
      "title": "衰弱幼犬/幼貓症候群 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估新生幼畜（0-2週齡）進行性虛弱、體重下降、不吸奶和持續哭叫",
          "findings": [
            "持續性哭叫或異常安靜",
            "無法有效吸奶",
            "體重停滯或下降"
          ]
        },
        {
          "step": 2,
          "action": "全面體檢與環境評估",
          "details": "測量體溫（低體溫常見）、血糖，評估脫水程度，檢查先天異常，評估環境溫度和母畜泌乳",
          "findings": [
            "低體溫（<35°C）",
            "低血糖",
            "脫水和體重過輕"
          ]
        },
        {
          "step": 3,
          "action": "病因調查",
          "details": "進行感染篩檢（犬疱疹病毒、細菌培養），檢查先天性異常（腭裂、心臟畸形），評估母畜健康",
          "findings": [
            "排除或確認犬疱疹病毒感染",
            "排除先天性畸形（腭裂等）",
            "評估母畜泌乳品質與母性行為"
          ]
        }
      ]
    },
    "monitoring": [
      "每日體重",
      "體溫",
      "吸乳能力和頻率",
      "活動力",
      "大小便情形"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "swimmer-puppy-syndrome": {
    "zh": "游泳犬症候群",
    "en": "Swimmer Puppy Syndrome",
    "definition": "一種新生幼犬的運動發育障礙，以四肢向兩側伸展、無法正常站立行走為特徵，幼犬呈現平趴姿勢如同在游泳。主要影響胸廓發育導致扁平胸。",
    "synonyms": [
      "游泳幼犬",
      "Swimmers Syndrome",
      "Flat-Chested Puppy Syndrome",
      "扁平胸幼犬"
    ],
    "epidemiology": {
      "species": "犬較常見，貓偶見",
      "age": "出生後2-4週開始明顯",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "矮腿犬種（腊腸犬、巴塞特獵犬、英國鬥牛犬、法國鬥牛犬）",
        "肥胖幼犬",
        "光滑地面飼養",
        "小窩數（過度營養）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "幼犬2-3週齡仍無法站立",
        "四肢向兩側攤開",
        "像游泳般划動四肢但無法行走",
        "在光滑地面上更嚴重"
      ],
      "physicalExam": [
        "四肢向兩側伸展呈蛙腿姿勢",
        "無法正常站立和行走",
        "胸廓背腹向扁平（扁平胸）",
        "腹部觸地",
        "可能伴有吸入性肺炎（胸廓壓迫）",
        "肌肉張力可能正常",
        "神經反射通常正常"
      ]
    },
    "pathophysiology": "確切病因不明，推測為多因素：(1)神經肌肉發育延遲；(2)光滑地面上缺乏適當牽引力，無法正常負重訓練；(3)過度營養導致體重過重，加重骨骼和關節負擔；(4)遺傳因素。長期平趴導致胸廓在體重壓力下背腹向扁平，可能壓迫肺臟和心臟。",
    "diagnosis": {
      "overview": "根據特徵性姿勢和年齡做出臨床診斷。需排除神經肌肉疾病。",
      "differentials": [
        "先天性脊髓疾病",
        "重症肌無力（先天性）",
        "代謝性骨病",
        "髖關節發育不良",
        "先天性神經肌肉病變"
      ],
      "initialDB": [
        "完整神經學檢查（反射通常正常）",
        "胸腔X光（評估胸廓扁平程度和肺臟）",
        "觸診四肢關節（排除脫位）"
      ],
      "advanced": [
        "脊髓X光",
        "肌電圖（排除神經肌肉疾病）",
        "血液生化（排除代謝性疾病）"
      ]
    },
    "treatment": {
      "overview": "物理治療和環境改善為主。早期介入預後良好。",
      "acute": [
        "提供粗糙地面（毛巾、瑜伽墊、草地）增加牽引力",
        "物理治療：每日數次輕柔地將四肢置於正常位置並鼓勵負重",
        "用繃帶或Hobble裝置將四肢固定於正常位置（每日數小時）",
        "控制體重（避免過度餵食）"
      ],
      "chronic": [
        "持續物理治療直到正常行走",
        "逐漸增加活動量",
        "體重管理",
        "嚴重扁平胸者需監測呼吸功能"
      ]
    },
    "prognosis": "早期介入（3-4週齡開始）預後良好至極佳，多數幼犬在6-8週齡可正常行走。延遲治療或嚴重扁平胸的病例預後較差。合併吸入性肺炎的病例預後謹慎。不建議患犬用於繁殖。",
    "pearls": [
      "粗糙地面是最簡單有效的預防和治療措施",
      "早期介入是成功治療的關鍵",
      "過度營養和光滑地面是最常見的可控風險因素",
      "嚴重扁平胸可能壓迫心肺導致呼吸困難"
    ],
    "diagnosticAlgorithm": {
      "title": "游泳犬症候群 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估2-3週齡幼犬無法站立、四肢向外張開呈蛙腿姿勢、胸腹扁平",
          "findings": [
            "四肢向外側展開（蛙腿姿勢）",
            "無法正常站立或行走",
            "胸廓和腹部背腹扁平"
          ]
        },
        {
          "step": 2,
          "action": "骨骼與神經學評估",
          "details": "進行X光檢查評估胸廓和四肢骨骼，神經學檢查排除神經肌肉疾病",
          "findings": [
            "X光顯示胸廓背腹扁平",
            "四肢骨骼結構正常（非先天骨骼畸形）",
            "神經反射正常排除神經病變"
          ]
        },
        {
          "step": 3,
          "action": "確診",
          "details": "根據年齡、典型姿勢和體型特徵臨床確診，排除其他先天性骨骼或神經疾病",
          "findings": [
            "臨床表現典型即可確診",
            "排除先天性骨骼發育異常",
            "早期物理治療預後良好"
          ]
        }
      ]
    },
    "monitoring": [
      "站立和行走能力進展",
      "胸廓形狀恢復",
      "體重增長（避免過重）",
      "呼吸功能"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "tooth-root-abscess": {
    "zh": "牙根膿腫",
    "en": "Tooth Root Abscess",
    "definition": "牙齒根尖周圍的細菌感染和膿液積聚，通常繼發於嚴重牙周病或牙齒外傷/磨損導致的牙髓暴露。上顎第四前臼齒（裂齒）最常受影響。",
    "synonyms": [
      "根尖膿腫",
      "Periapical Abscess",
      "齒根膿腫",
      "Apical Abscess"
    ],
    "epidemiology": {
      "species": "犬貓皆可",
      "age": "中年至老年，但咀嚼硬物的犬可任何年齡",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "嚴重牙周病",
        "咀嚼硬物（骨頭、鹿角、蹄）導致牙齒斷裂",
        "牙齒外傷",
        "未治療的齲齒",
        "犬：上顎第四前臼齒（108/208）最常見"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "面部腫脹（尤其眼下方或鼻側）",
        "單側鼻涕或噴嚏",
        "食慾下降或偏一側咀嚼",
        "口臭",
        "面部瘺管流膿"
      ],
      "physicalExam": [
        "上顎裂齒膿腫：眼下方面部腫脹或瘺管（infraorbital fistula）",
        "患齒周圍牙齦紅腫和疼痛",
        "觸診患齒疼痛",
        "牙齒變色（灰色或粉紅色表示牙髓壞死）",
        "牙冠斷裂伴牙髓暴露",
        "口腔惡臭",
        "單側化膿性鼻涕（上顎牙根穿入鼻腔時）"
      ]
    },
    "pathophysiology": "牙周病或牙齒損傷導致細菌進入牙髓腔，引起牙髓壞死。感染沿根管向根尖擴散，在根尖周圍形成膿腫。上顎裂齒的腭側根尖位於眼眶底部下方，膿腫可沿最薄弱處破潰至面部皮膚（眼下瘺管）或穿入鼻腔。常見致病菌為口腔厭氧菌和需氧菌混合感染。",
    "diagnosis": {
      "overview": "口腔檢查結合牙科X光為確診標準。面部瘺管指向牙根膿腫。",
      "differentials": [
        "面部腫瘤",
        "眼球後膿腫",
        "鼻腔腫瘤",
        "唾液囊腫",
        "面部外傷",
        "骨髓炎"
      ],
      "initialDB": [
        "完整口腔檢查（需全身麻醉）",
        "牙科探針評估牙周囊袋深度",
        "牙科X光（根尖周圍透射區提示膿腫）"
      ],
      "advanced": [
        "CT掃描（評估骨質破壞範圍和鼻腔侵犯）",
        "細菌培養和藥敏（瘺管或手術採樣）",
        "面部瘺管探針追蹤"
      ]
    },
    "treatment": {
      "overview": "拔除患齒或根管治療。單純抗生素無法治癒牙根膿腫。",
      "acute": [
        "全身性抗生素開始治療（阿莫西林克拉維酸或clindamycin）",
        "止痛（NSAIDs或曲馬多）",
        "盡快安排全身麻醉下的牙科手術"
      ],
      "chronic": [
        "患齒拔除（extraction）是首選治療",
        "多根齒需分根拔除",
        "根管治療（endodontic therapy）用於希望保留牙齒的病例",
        "拔除後清創沖洗齒槽",
        "術後抗生素5-10天",
        "術後定期牙科檢查和潔牙預防復發"
      ]
    },
    "prognosis": "拔除患齒後預後極佳，面部瘺管通常在2-4週內癒合。根管治療成功率約85-95%。未治療的牙根膿腫可能導致嚴重併發症（骨髓炎、眼球後感染、口鼻瘺管）。",
    "pearls": [
      "面部（眼下方）反覆不癒合的瘺管首先考慮上顎裂齒牙根膿腫",
      "牙科X光是診斷牙根膿腫不可或缺的工具",
      "單純使用抗生素可暫時改善但無法根治",
      "牙齒變灰色提示牙髓壞死，即使無明顯斷裂也需評估"
    ],
    "diagnosticAlgorithm": {
      "title": "牙根膿腫 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估面部腫脹（常見於眼下或下頜），流膿性瘻管，食慾下降和咀嚼困難",
          "findings": [
            "面部局部腫脹或瘻管",
            "口臭伴流涎",
            "患側咀嚼疼痛"
          ]
        },
        {
          "step": 2,
          "action": "口腔與影像學檢查",
          "details": "進行口腔檢查評估牙齒完整性，牙科X光確認牙根病變",
          "findings": [
            "患牙鬆動或變色",
            "牙科X光顯示牙根周圍透射區",
            "牙周韌帶增寬或牙根吸收"
          ]
        },
        {
          "step": 3,
          "action": "確診與治療計畫",
          "details": "根據臨床表現和X光確診，制定拔牙或根管治療計畫",
          "findings": [
            "X光確認牙根膿腫範圍",
            "評估受影響牙齒是否可保留",
            "制定手術拔牙或根管治療方案"
          ]
        }
      ]
    },
    "monitoring": [
      "術後面部瘺管癒合",
      "食慾和咀嚼功能恢復",
      "定期牙科檢查",
      "口腔衛生維護"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "esophageal-stricture": {
    "zh": "食道狹窄",
    "en": "Esophageal Stricture",
    "definition": "食道管腔的異常縮窄，導致食物通過障礙。最常見為繼發於食道炎、腐蝕性損傷或手術後的纖維性狹窄。導致進行性吞嚥困難和反流。",
    "synonyms": [
      "食道狹窄症",
      "Esophageal Stenosis",
      "食道纖維性狹窄"
    ],
    "epidemiology": {
      "species": "犬貓皆可",
      "age": "任何年齡",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "全身麻醉後的胃食道逆流",
        "口服腐蝕性藥物（如doxycycline乾嚥）",
        "食道異物移除後",
        "食道手術後",
        "嚴重持續性嘔吐",
        "貓：口服doxycycline片劑後不飲水"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "進行性吞嚥困難",
        "進食後反流（regurgitation）",
        "初期可耐受液體食物但固體食物反流",
        "體重下降",
        "近期有麻醉、食道異物或口服藥物史",
        "可能有吸入性肺炎病史"
      ],
      "physicalExam": [
        "消瘦和脫水",
        "反流（被動排出未消化食物，與嘔吐不同）",
        "可能有發燒和呼吸異常（吸入性肺炎）",
        "頸部觸診通常正常"
      ]
    },
    "pathophysiology": "食道黏膜損傷（化學性、機械性或缺血性）引發炎症反應，繼而形成纖維組織增生和瘢痕收縮，導致管腔永久性縮窄。麻醉中胃食道逆流是最常見原因，胃酸和膽汁接觸食道黏膜導致嚴重化學性食道炎。貓口服doxycycline片劑後在食道停滯可造成局部嚴重腐蝕。",
    "diagnosis": {
      "overview": "食道造影（鋇劑吞嚥）和食道內視鏡為主要診斷工具。",
      "differentials": [
        "食道異物",
        "食道腫瘤",
        "食道外壓迫（縱膈腫瘤、血管環異常）",
        "巨食道",
        "食道運動障礙"
      ],
      "initialDB": [
        "胸腔X光（可能見食道擴張或吸入性肺炎）",
        "食道鋇劑造影（顯示管腔狹窄和近端擴張）"
      ],
      "advanced": [
        "食道內視鏡（可直接觀察狹窄程度和黏膜狀態，同時可治療）",
        "CT掃描（評估食道壁和周圍結構）",
        "螢光透視下鋇劑吞嚥動態評估"
      ]
    },
    "treatment": {
      "overview": "氣球擴張術（balloon dilation）為首選治療。可能需要多次擴張。",
      "acute": [
        "食道內視鏡下氣球擴張術（首選）",
        "探條擴張術（bougie dilation）",
        "擴張後局部注射曲安奈德（triamcinolone）減少再狹窄",
        "治療吸入性肺炎",
        "短期胃造口管（嚴重營養不良者）"
      ],
      "chronic": [
        "可能需要多次擴張（每2-4週，通常需3-5次）",
        "口服sucralfate保護食道黏膜",
        "口服omeprazole抑制胃酸",
        "軟食或流質飲食",
        "高位餵食（Bailey chair姿勢）",
        "預防復發：貓口服藥物後必須飲水"
      ]
    },
    "prognosis": "單一狹窄且及早治療預後良好至謹慎（約75%經氣球擴張可改善）。多處狹窄預後較差。嚴重狹窄可能需多次擴張。反覆吸入性肺炎惡化預後。手術切除（食道吻合術）併發症多，通常不是首選。",
    "pearls": [
      "麻醉後反流是食道狹窄最常見的原因",
      "貓口服doxycycline後務必給予水或食物確保藥片到達胃部",
      "氣球擴張後局部注射類固醇可減少再狹窄",
      "反流和嘔吐不同：反流為被動排出未消化食物，無腹部收縮"
    ],
    "diagnosticAlgorithm": {
      "title": "食道狹窄 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估進食固體食物後反覆嘔吐（實為食道逆流），注意先前食道損傷（異物、腐蝕劑、麻醉逆流）病史",
          "findings": [
            "進食固體食物後數分鐘內逆流",
            "能進食液體但固體食物困難",
            "進行性體重下降"
          ]
        },
        {
          "step": 2,
          "action": "影像學檢查",
          "details": "進行胸腔X光和鋇劑吞嚥攝影評估食道狹窄位置和程度",
          "findings": [
            "X光可能顯示食道狹窄前段擴張",
            "鋇劑攝影明確顯示狹窄位置和程度",
            "評估狹窄數量（單一或多處）"
          ]
        },
        {
          "step": 3,
          "action": "內視鏡確診",
          "details": "食道內視鏡檢查直接觀察狹窄程度，同時可進行球囊擴張治療",
          "findings": [
            "內視鏡確認狹窄位置和嚴重程度",
            "評估黏膜狀態和纖維化程度",
            "可同時進行球囊擴張治療"
          ]
        }
      ]
    },
    "monitoring": [
      "吞嚥功能改善",
      "體重恢復",
      "反流頻率",
      "吸入性肺炎徵象"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "gastroesophageal-reflux": {
    "zh": "胃食道逆流",
    "en": "Gastroesophageal Reflux",
    "definition": "胃內容物（胃酸、膽汁、消化酵素）不正常地逆流至食道，導致食道黏膜損傷和食道炎。常見於全身麻醉期間和之後，也可能為慢性問題。",
    "synonyms": [
      "GERD",
      "胃食道逆流病",
      "Gastroesophageal Reflux Disease",
      "逆流性食道炎"
    ],
    "epidemiology": {
      "species": "犬貓皆可，犬較常被診斷",
      "age": "任何年齡",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "全身麻醉（尤其術前未禁食）",
        "肥胖",
        "食道裂孔疝",
        "慢性嘔吐",
        "幽門功能障礙",
        "短頭種犬",
        "高脂飲食"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "反流（被動排出液體或黏液狀內容物）",
        "吞嚥困難或疼痛性吞嚥",
        "過度流涎",
        "食慾下降",
        "反覆吞嚥動作（lip licking）",
        "嘔吐後體位不適",
        "麻醉後症狀出現"
      ],
      "physicalExam": [
        "多數理學檢查正常",
        "消瘦（慢性病例）",
        "喉部或食道觸診可能不適",
        "口腔黏膜可能偏紅（酸逆流）"
      ]
    },
    "pathophysiology": "正常情況下下食道括約肌（LES）防止胃內容物逆流。當LES張力降低（麻醉藥物、腹壓增加、食道裂孔疝）或胃排空延遲時，胃酸和膽汁接觸食道黏膜，導致化學性食道炎。黏膜損傷引發炎症、疼痛和潛在的潰瘍形成。慢性逆流可導致食道狹窄。",
    "diagnosis": {
      "overview": "主要為臨床診斷，食道內視鏡可確認食道炎的存在和嚴重程度。",
      "differentials": [
        "食道異物",
        "食道狹窄",
        "巨食道",
        "食道腫瘤",
        "食道運動障礙",
        "食道裂孔疝"
      ],
      "initialDB": [
        "胸腔X光（排除巨食道、異物、裂孔疝）",
        "詳細病史（麻醉史、飲食、嘔吐模式）"
      ],
      "advanced": [
        "食道內視鏡（觀察食道黏膜紅斑、糜爛、潰瘍）",
        "螢光透視下鋇劑吞嚥（評估逆流和食道運動）",
        "食道pH監測（研究用，臨床少見）"
      ]
    },
    "treatment": {
      "overview": "飲食管理、抗酸藥物和促胃腸動力藥物為治療三支柱。",
      "acute": [
        "禁食12-24小時後給予少量多餐的低脂軟食",
        "質子幫浦抑制劑（omeprazole 1 mg/kg PO q12-24h）",
        "sucralfate黏膜保護劑（0.5-1g PO q8h，餐前30分鐘）",
        "止吐藥（maropitant 1 mg/kg PO q24h）"
      ],
      "chronic": [
        "少量多餐、低脂飲食",
        "餵食後保持直立姿勢15-20分鐘",
        "長期omeprazole或famotidine",
        "促胃腸動力藥（metoclopramide 0.2-0.5 mg/kg PO q8h或cisapride）",
        "體重控制",
        "短頭種犬考慮矯正性手術（裂孔疝修補）"
      ]
    },
    "prognosis": "麻醉相關的急性逆流性食道炎通常在適當治療下1-2週內恢復。慢性GERD需長期管理但多數可良好控制。合併食道裂孔疝的病例可能需手術。如已形成食道狹窄則預後較差。",
    "pearls": [
      "麻醉前適當禁食（犬6-12小時、貓4-6小時）可減少逆流風險",
      "反流和嘔吐的區別：反流為被動排出，嘔吐有腹部收縮前驅",
      "短頭種犬的胃食道逆流發生率較高",
      "長期使用omeprazole時注意B12和鎂吸收"
    ],
    "diagnosticAlgorithm": {
      "title": "胃食道逆流 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估頻繁嘔吐白色泡沫、吞嚥困難、食後不適和過度流涎等表現",
          "findings": [
            "頻繁逆流或嘔吐白色泡沫",
            "吞嚥時表現不適或嘗試多次吞嚥",
            "過度舔舐嘴唇和流涎"
          ]
        },
        {
          "step": 2,
          "action": "影像學檢查",
          "details": "進行胸腔X光排除食道異物和巨食道，鋇劑攝影評估胃食道功能",
          "findings": [
            "X光排除食道異物或巨食道",
            "透視下可見胃食道逆流",
            "排除裂孔疝"
          ]
        },
        {
          "step": 3,
          "action": "內視鏡確診",
          "details": "食道內視鏡檢查評估食道黏膜炎症程度，必要時活檢",
          "findings": [
            "食道黏膜充血糜爛",
            "食道遠端黏膜炎症（逆流性食道炎）",
            "排除食道狹窄或腫瘤"
          ]
        }
      ]
    },
    "monitoring": [
      "反流頻率和嚴重度",
      "食慾和體重",
      "吞嚥舒適度",
      "有無吸入性肺炎徵象"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "megacolon-feline": {
    "zh": "貓特發性巨結腸症",
    "en": "Feline Idiopathic Megacolon",
    "definition": "貓的結腸異常擴張伴結腸平滑肌功能障礙，導致嚴重的慢性便秘和糞便嵌塞。特發性（原發性）巨結腸佔貓巨結腸病例的60%以上，為結腸平滑肌固有的功能缺陷。",
    "synonyms": [
      "貓巨結腸",
      "Feline Megacolon",
      "特發性巨結腸"
    ],
    "epidemiology": {
      "species": "貓",
      "age": "中年至老年貓（平均5-8歲）",
      "sex": "公貓較多見（約70%）",
      "riskFactors": [
        "中年公貓",
        "肥胖",
        "室內貓",
        "低纖維飲食",
        "脫水",
        "骨盆骨折癒合後狹窄（繼發性巨結腸）",
        "曼島貓（薦椎發育不全）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "慢性便秘逐漸惡化",
        "排便困難和排便痛（裡急後重tenesmus）",
        "糞便乾硬",
        "可能伴有嘔吐",
        "食慾下降",
        "體重減輕",
        "少量水樣便（糞便嵌塞周圍的黏液/水分排出）"
      ],
      "physicalExam": [
        "腹部觸診可觸及巨大的充滿硬糞便的結腸",
        "脫水",
        "消瘦",
        "肛門檢查可觸及直腸內硬糞便",
        "可能有脫水性黏膜"
      ]
    },
    "pathophysiology": "特發性巨結腸的根本原因為結腸平滑肌的固有功能障礙，平滑肌無法正常收縮推動糞便。長期糞便滯留導致結腸進一步擴張，平滑肌進一步受損，形成惡性循環。結腸最終失去收縮能力，成為不可逆的擴張。繼發性巨結腸可由骨盆狹窄、神經損傷或內分泌疾病（甲狀腺功能低下）引起。",
    "diagnosis": {
      "overview": "腹部X光可見顯著擴張的結腸充滿糞便。需排除繼發性原因。",
      "differentials": [
        "骨盆骨折後狹窄",
        "結腸腫瘤",
        "神經病變（薦椎疾病、曼島貓）",
        "甲狀腺功能低下",
        "高鈣血症",
        "藥物性便秘（鴉片類）"
      ],
      "initialDB": [
        "腹部X光（結腸明顯擴張、充滿糞便）",
        "骨盆X光（排除骨盆狹窄）",
        "CBC/血液生化（排除代謝性原因如高鈣血症、低鉀血症）",
        "T4甲狀腺功能"
      ],
      "advanced": [
        "神經學檢查（排除薦椎病變）",
        "直腸指診（排除結腸腫塊或狹窄）",
        "結腸鏡和切片（排除腫瘤或炎症性腸病）"
      ]
    },
    "treatment": {
      "overview": "分階段治療：先解除糞便嵌塞，再以飲食和藥物預防復發。頑固病例考慮手術。",
      "acute": [
        "灌腸解除糞便嵌塞（溫水+少量液態石蠟，需全身麻醉下手動碎塊排出）",
        "靜脈輸液糾正脫水和電解質異常",
        "禁止使用含磷酸鈉的灌腸液（對貓有致命毒性）"
      ],
      "chronic": [
        "高纖維飲食（增加糞便體積）或低殘渣飲食（減少糞便產量）——效果因個體而異",
        "lactulose口服軟便劑（0.5 ml/kg PO q8-12h）",
        "cisapride促結腸動力（0.5-1 mg/kg PO q8-12h）",
        "充足飲水（濕食優於乾食）",
        "聚乙二醇（PEG 3350/Miralax）作為軟便劑替代",
        "頑固病例：結腸次全切除術（subtotal colectomy）"
      ]
    },
    "prognosis": "輕度至中度病例以藥物治療可控制數月至數年。嚴重或反覆嵌塞的病例最終多需手術。結腸次全切除術的預後良好，約90%的貓術後生活品質顯著改善，長期（數週至數月後）糞便由軟便逐漸恢復成形。",
    "pearls": [
      "禁止使用含磷酸鈉的人用灌腸液（Fleet灌腸液），對貓有致命的高磷血症風險",
      "cisapride是最有效的促結腸動力藥物",
      "結腸次全切除術是治療頑固性巨結腸最有效的方法",
      "貓的特發性巨結腸是不可逆的，早期手術介入優於等待結腸進一步退化"
    ],
    "diagnosticAlgorithm": {
      "title": "貓特發性巨結腸症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估慢性頑固性便秘、排便困難和腹部觸診可觸及巨大糞便團塊",
          "findings": [
            "慢性便秘和排便困難",
            "腹部觸診可觸及堅硬巨大糞塊",
            "嘔吐、食慾下降和體重減輕"
          ]
        },
        {
          "step": 2,
          "action": "影像學檢查",
          "details": "腹部X光評估結腸擴張程度和糞便蓄積，排除骨盆骨折狹窄等機械性原因",
          "findings": [
            "X光顯示結腸顯著擴張充滿糞便",
            "排除骨盆腔狹窄",
            "排除腸道內/外腫塊壓迫"
          ]
        },
        {
          "step": 3,
          "action": "病因分類與確診",
          "details": "排除繼發性原因（骨盆骨折、神經病變、代謝疾病）後診斷為特發性巨結腸症",
          "findings": [
            "排除骨盆骨折後遺症",
            "排除甲狀腺功能異常及低鉀血症",
            "確診為特發性巨結腸（結腸平滑肌功能障礙）"
          ]
        }
      ]
    },
    "monitoring": [
      "排便頻率和糞便質地",
      "體重和食慾",
      "腹部觸診（結腸充盈度）",
      "定期腹部X光評估"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "atrial-fibrillation": {
    "zh": "心房顫動",
    "en": "Atrial Fibrillation",
    "definition": "心房顫動是一種常見的室上性心律不整，特徵為心房肌肉快速、不規則且無組織的電活動，導致心房有效收縮功能喪失。在犬貓中，通常繼發於嚴重心房擴大的心臟疾病。",
    "synonyms": [
      "AF",
      "AFib",
      "Auricular Fibrillation"
    ],
    "epidemiology": {
      "species": "犬較常見，貓少見",
      "age": "中老年犬多見，大型犬好發",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "擴張型心肌病（DCM）",
        "二尖瓣退化性疾病晚期",
        "嚴重心房擴大",
        "大型至巨型犬種（愛爾蘭獵狼犬、大丹犬、紐芬蘭犬）",
        "先天性心臟病伴心房擴大"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "運動不耐",
        "呼吸急促或困難",
        "咳嗽",
        "腹部膨大（腹水）",
        "昏厥",
        "突然虛弱"
      ],
      "physicalExam": [
        "心率快速且不規則",
        "脈搏短絀（pulse deficit）",
        "心音強度不一致",
        "可能有心雜音",
        "肺部囉音（若有肺水腫）",
        "頸靜脈怒張",
        "腹水"
      ]
    },
    "pathophysiology": "心房內存在多個微折返迴路（multiple micro-reentrant circuits），導致心房肌肉以350-600次/分的速率不協調顫動。房室結（AV node）作為濾波器，僅傳導部分衝動至心室，但心室率仍常過快（150-250 bpm）。心房有效收縮喪失使心輸出量減少15-25%，加上快速心室率導致心肌耗氧增加及舒張充盈時間縮短，可加速心衰竭惡化。",
    "diagnosis": {
      "overview": "心電圖（ECG）為確診工具，顯示無P波、不規則的f波基線及不規則RR間距。",
      "differentials": [
        "室上性心搏過速",
        "多焦性心房心搏過速",
        "心房撲動",
        "竇性心律不整"
      ],
      "initialDB": [
        "心電圖（ECG）：無P波、不規則基線（f波）、不規則RR間距",
        "胸腔X光：評估心臟大小及肺部狀態",
        "心臟超音波：評估心房大小、心室功能、瓣膜疾病"
      ],
      "advanced": [
        "24小時Holter心電圖監測",
        "血壓測量",
        "BNP/NT-proBNP",
        "甲狀腺功能檢查（排除甲狀腺功能亢進）",
        "電解質檢查"
      ]
    },
    "treatment": {
      "overview": "治療目標為控制心室率而非轉復為竇性節律。大多數犬貓的心房顫動無法成功轉復，治療重點為心率控制及潛在心臟病的管理。",
      "acute": [
        "Diltiazem 0.5-1.5 mg/kg IV緩慢注射（緊急心率控制）",
        "靜脈輸液支持（若有低血壓）",
        "氧氣治療（若有肺水腫）",
        "Furosemide 2-4 mg/kg IV（若有充血性心衰竭）"
      ],
      "chronic": [
        "Diltiazem 1.5-3.5 mg/kg PO q8-12h（心率控制首選）",
        "Digoxin 0.005-0.01 mg/kg PO q12h（可與diltiazem合併使用）",
        "Atenolol 0.25-1 mg/kg PO q12-24h（替代選擇）",
        "針對潛在心臟病的治療（ACE抑制劑、利尿劑等）",
        "限制鈉攝取"
      ]
    },
    "prognosis": "預後取決於潛在心臟病的嚴重程度。孤立性心房顫動（lone AF，無結構性心臟病）在巨型犬中預後較好。伴隨DCM或嚴重瓣膜疾病的心房顫動預後較差，中位生存期數月至1-2年。有效的心率控制可顯著改善生活品質。",
    "pearls": [
      "愛爾蘭獵狼犬可出現孤立性心房顫動，可能不需積極治療",
      "心率控制目標：犬靜息心率<140-160 bpm",
      "Digoxin中毒風險：監測血清濃度（目標0.8-1.5 ng/mL）",
      "貓的心房顫動幾乎總是伴隨嚴重心臟病，預後較差",
      "脈搏短絀程度可作為心率控制效果的簡易評估指標"
    ],
    "diagnosticAlgorithm": {
      "title": "心房顫動 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估不規則心律、心率增快和心衰竭症狀，大型犬更常見",
          "findings": [
            "聽診心律絕對不整",
            "脈搏短缺（心率>脈搏率）",
            "運動不耐受或呼吸困難"
          ]
        },
        {
          "step": 2,
          "action": "心電圖檢查",
          "details": "進行標準6導程心電圖確認心房顫動的特徵性變化",
          "findings": [
            "缺乏P波，代之以不規則基線波動（f波）",
            "R-R間距完全不規則",
            "QRS波群形態通常正常"
          ]
        },
        {
          "step": 3,
          "action": "心臟超音波與病因評估",
          "details": "進行心臟超音波評估心臟結構和功能，尋找潛在心臟病",
          "findings": [
            "評估左心房大小（通常擴大）",
            "評估心肌收縮功能",
            "鑑別潛在心臟病（DCM、瓣膜疾病等）"
          ]
        }
      ]
    },
    "monitoring": [
      "定期ECG評估心率控制",
      "Holter監測評估24小時平均心率",
      "Digoxin血清濃度監測",
      "腎功能及電解質監測",
      "心臟超音波追蹤心臟功能"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "supraventricular-tachycardia": {
    "zh": "室上性心搏過速",
    "en": "Supraventricular Tachycardia",
    "definition": "室上性心搏過速（SVT）是起源於希氏束以上（包括心房及房室結）的快速心律不整，心率通常超過正常範圍且節律規則。常見機制包括房室折返性心搏過速（AVRT）及房室結折返性心搏過速（AVNRT）。",
    "synonyms": [
      "SVT",
      "室上速",
      "Paroxysmal Supraventricular Tachycardia",
      "PSVT"
    ],
    "epidemiology": {
      "species": "犬貓皆可",
      "age": "任何年齡，中年犬較常見",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "結構性心臟病",
        "副傳導束（accessory pathway）",
        "拉布拉多犬",
        "電解質異常",
        "心臟手術後"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "陣發性虛弱",
        "昏厥",
        "運動不耐",
        "呼吸急促",
        "不安或焦躁",
        "發作可突然開始和停止"
      ],
      "physicalExam": [
        "心率非常快（犬>250 bpm，貓>300 bpm）",
        "節律規則",
        "脈搏微弱但規則",
        "黏膜蒼白",
        "毛細血管充盈時間延長",
        "可能有心雜音"
      ]
    },
    "pathophysiology": "SVT最常見的機制為折返（reentry），即電衝動在心房或房室結區域形成循環迴路，持續自我激活。房室折返性心搏過速（AVRT）涉及副傳導束（如Kent束），電衝動經正常傳導系統下傳，再經副傳導束回傳至心房。持續的快速心率可導致心搏過速性心肌病（tachycardia-induced cardiomyopathy），造成心室功能進行性惡化。",
    "diagnosis": {
      "overview": "心電圖為主要診斷工具，顯示規則、窄QRS波群的快速心律。迷走神經刺激可協助診斷。",
      "differentials": [
        "竇性心搏過速",
        "心房撲動",
        "心房顫動",
        "心室性心搏過速（寬QRS波群時）"
      ],
      "initialDB": [
        "心電圖（ECG）：規則窄QRS心搏過速、P波可能隱藏在QRS或T波中",
        "迷走神經刺激試驗（頸動脈竇按摩或眼球壓迫）",
        "胸腔X光",
        "血液生化及電解質"
      ],
      "advanced": [
        "24小時Holter心電圖監測",
        "心臟超音波",
        "心內電生理檢查（cardiac electrophysiology study）",
        "甲狀腺功能檢查"
      ]
    },
    "treatment": {
      "overview": "急性發作以迷走神經刺激及靜脈注射抗心律不整藥物終止。慢性管理依發作頻率決定是否需長期口服藥物或導管消融術。",
      "acute": [
        "迷走神經刺激（頸動脈竇按摩、眼球壓迫）",
        "Adenosine 6-12 mg快速IV推注（犬，診斷及治療用）",
        "Diltiazem 0.15-0.25 mg/kg IV緩慢推注",
        "Lidocaine 2-4 mg/kg IV（若懷疑寬QRS波群SVT）",
        "同步電復律（若血行動力不穩定）"
      ],
      "chronic": [
        "Diltiazem 1.5-3.5 mg/kg PO q8h",
        "Atenolol 0.25-1 mg/kg PO q12-24h",
        "Sotalol 1-3 mg/kg PO q12h",
        "Mexiletine合併atenolol（頑固病例）",
        "射頻導管消融術（副傳導束相關SVT）"
      ]
    },
    "prognosis": "若能有效控制心率，預後通常良好。副傳導束相關SVT經導管消融後可治癒。心搏過速性心肌病若及早控制心率，心肌功能可部分或完全恢復。未治療的持續性SVT可發展為嚴重心衰竭。",
    "pearls": [
      "迷走神經刺激可瞬間終止AVRT/AVNRT，此反應具診斷價值",
      "竇性心搏過速對迷走神經刺激僅有暫時減速而非突然終止",
      "心搏過速性心肌病是可逆的——控制心率後心功能可改善",
      "拉布拉多犬是副傳導束相關SVT的好發品種",
      "貓的SVT需排除甲狀腺功能亢進"
    ],
    "diagnosticAlgorithm": {
      "title": "室上性心搏過速 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估發作性心率過快、虛弱、暈厥等症狀，注意陣發性和持續性的區分",
          "findings": [
            "突發性心搏過速（犬>220 bpm）",
            "發作時虛弱或暈厥",
            "發作間期可能完全正常"
          ]
        },
        {
          "step": 2,
          "action": "心電圖診斷",
          "details": "進行心電圖確認窄QRS波群心搏過速，必要時進行迷走神經刺激試驗",
          "findings": [
            "規則窄QRS波群心搏過速",
            "P波可能隱藏在T波中或缺如",
            "迷走神經刺激可終止（與竇性心搏過速鑑別）"
          ]
        },
        {
          "step": 3,
          "action": "病因評估與確診",
          "details": "心臟超音波排除結構性心臟病，評估甲狀腺功能等系統性原因",
          "findings": [
            "心臟超音波排除結構性心臟病",
            "排除甲狀腺功能亢進等代謝原因",
            "確認SVT類型（AVRT、AVNRT等）"
          ]
        }
      ]
    },
    "monitoring": [
      "ECG監測治療反應",
      "Holter評估發作頻率",
      "心臟超音波追蹤心室功能",
      "藥物副作用監測（低血壓、心跳過慢）"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "ventricular-tachycardia": {
    "zh": "心室性心搏過速",
    "en": "Ventricular Tachycardia",
    "definition": "心室性心搏過速（VT）是起源於心室肌肉或浦金氏纖維的快速心律不整，定義為連續三個或以上的心室早期收縮（VPC），心率通常>100 bpm。VT可為持續性（>30秒）或非持續性，可能危及生命。",
    "synonyms": [
      "VT",
      "V-tach",
      "心室速脈"
    ],
    "epidemiology": {
      "species": "犬較常見，貓少見",
      "age": "中老年犬多見",
      "sex": "拳師犬ARVC雄性較多",
      "riskFactors": [
        "拳師犬心律不整型右心室心肌病（ARVC）",
        "杜賓犬擴張型心肌病",
        "胃扭轉（GDV）",
        "脾臟腫瘤",
        "心肌炎",
        "嚴重電解質異常（低鉀、低鎂）",
        "洋地黃中毒",
        "外傷性心肌損傷"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "突發昏厥",
        "運動不耐",
        "虛弱",
        "突然死亡",
        "呼吸困難",
        "可能無臨床症狀（偶然發現）"
      ],
      "physicalExam": [
        "心率快速（通常>180 bpm）",
        "節律可規則或略不規則",
        "脈搏微弱或缺失",
        "黏膜蒼白至發紺",
        "毛細血管充盈時間延長",
        "心音分裂或第一心音強度不一"
      ]
    },
    "pathophysiology": "VT的主要機制包括：(1) 折返——心室肌肉中的疤痕或纖維化區域形成單向傳導阻滯，電衝動繞行形成迴路；(2) 自動性增強——受損心肌細胞自發除極頻率增加；(3) 觸發活動——早期後除極（EAD）或延遲後除極（DAD）。快速心室率導致心室充盈不足、心輸出量下降，可進展為心室顫動及猝死。",
    "diagnosis": {
      "overview": "ECG顯示寬QRS波群（>0.06秒犬/>0.04秒貓）的快速規則心律，與心房活動分離（AV dissociation）。",
      "differentials": [
        "室上性心搏過速伴束支傳導阻滯",
        "預激症候群的前向傳導SVT",
        "加速性心室自主節律"
      ],
      "initialDB": [
        "心電圖（ECG）：寬QRS波群心搏過速、AV分離、融合波（fusion beats）、捕獲波（capture beats）",
        "血液生化及電解質（K+、Mg2+）",
        "肌鈣蛋白I（cardiac troponin I）",
        "胸腔X光"
      ],
      "advanced": [
        "24小時Holter心電圖（VPC負荷量化）",
        "心臟超音波",
        "腹部超音波（排除脾臟腫瘤）",
        "心內電生理檢查"
      ]
    },
    "treatment": {
      "overview": "治療取決於血行動力穩定性。不穩定的VT需緊急處理。穩定但持續的VT需藥物控制。治療同時應矯正潛在病因。",
      "acute": [
        "Lidocaine 2 mg/kg IV快速推注，可重複至8 mg/kg總量（犬）",
        "Lidocaine CRI 25-80 μg/kg/min（維持）",
        "若lidocaine無效：Procainamide 6-8 mg/kg IV緩慢注射",
        "電復律（若血行動力不穩定）",
        "矯正電解質異常（補鉀、補鎂）",
        "MgSO4 0.15-0.3 mEq/kg IV over 5-15 min（多型性VT/Torsades de Pointes）"
      ],
      "chronic": [
        "Sotalol 1.5-3.5 mg/kg PO q12h（首選）",
        "Mexiletine 5-8 mg/kg PO q8h合併atenolol",
        "Amiodarone 10 mg/kg PO q12h×7天→5 mg/kg q24h（頑固病例）",
        "針對潛在病因治療",
        "限制劇烈運動"
      ]
    },
    "prognosis": "預後取決於潛在病因及VT嚴重程度。拳師犬ARVC為進行性疾病，但藥物控制可延長生存期（中位2-3年）。GDV或脾臟腫瘤相關VT在原發病治療後可能消退。持續性多型性VT或極快心率（>300 bpm）有猝死風險。",
    "pearls": [
      "拳師犬出現昏厥應高度懷疑ARVC相關VT，需Holter評估",
      "GDV術後48小時內VT發生率高達40%，需持續ECG監測",
      "Lidocaine對貓效果差且有神經毒性風險，貓VT考慮atenolol或sotalol",
      "VPC>24小時Holter總數的15-20%可能導致心搏過速性心肌病",
      "低鎂血症可降低抗心律不整藥物效果，應同時補充"
    ],
    "diagnosticAlgorithm": {
      "title": "心室性心搏過速 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估急性虛弱、暈厥、猝死風險，注意潛在心臟病或全身性疾病",
          "findings": [
            "急性虛弱或暈厥",
            "聽診心率極快且可能不規則",
            "黏膜蒼白或發紺"
          ]
        },
        {
          "step": 2,
          "action": "心電圖診斷",
          "details": "進行心電圖確認寬QRS波群心搏過速，評估血流動力學穩定性",
          "findings": [
            "寬大畸形QRS波群（>0.06秒犬）",
            "心率>160-180 bpm",
            "房室分離（P波與QRS無關）"
          ]
        },
        {
          "step": 3,
          "action": "病因評估與分級",
          "details": "進行心臟超音波、電解質和心肌肌鈣蛋白檢測，尋找潛在病因",
          "findings": [
            "心臟超音波評估心肌病變",
            "心肌肌鈣蛋白升高提示心肌損傷",
            "排除電解質異常、脾臟腫瘤、胃扭轉等系統性原因"
          ]
        }
      ]
    },
    "monitoring": [
      "連續ECG監測（住院期間）",
      "24小時Holter評估治療效果",
      "心臟超音波定期追蹤",
      "電解質監測",
      "Amiodarone使用時監測肝腎功能及甲狀腺功能"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "third-degree-av-block": {
    "zh": "第三度房室傳導阻滯",
    "en": "Third-Degree Atrioventricular Block",
    "definition": "第三度房室傳導阻滯（完全性房室傳導阻滯）是指心房與心室之間的電衝動傳導完全中斷，心房和心室各自獨立以不同頻率跳動。心室節律由房室結以下的逸搏節律維持，心率通常緩慢。",
    "synonyms": [
      "Complete AV Block",
      "Complete Heart Block",
      "3rd Degree AV Block",
      "完全性房室傳導阻滯"
    ],
    "epidemiology": {
      "species": "犬貓皆可，犬較常見",
      "age": "老年犬多見（退化性傳導系統疾病），先天性可見於幼犬",
      "sex": "母犬可能較多見",
      "riskFactors": [
        "老年退化性傳導系統纖維化",
        "可卡犬、西高地白梗、臘腸犬",
        "心肌炎（萊姆病、犬瘟熱）",
        "心內膜炎",
        "洋地黃中毒",
        "嚴重高鉀血症",
        "心臟腫瘤浸潤",
        "先天性中隔缺損修復術後"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "運動不耐",
        "昏厥（Adams-Stokes發作）",
        "嗜睡",
        "虛弱",
        "可能無症狀（若逸搏心率足夠）"
      ],
      "physicalExam": [
        "心跳緩慢（犬<50 bpm，貓<80 bpm）",
        "規則的心室節律",
        "大砲a波（cannon a waves）於頸靜脈",
        "第一心音強度變化",
        "收縮壓可能偏低",
        "黏膜可能蒼白"
      ]
    },
    "pathophysiology": "房室結或希氏束-浦金氏系統的傳導完全中斷，導致心房衝動無法傳導至心室。心室由位於阻斷點以下的逸搏起搏點維持節律：房室結阻斷產生結性逸搏（40-60 bpm），希氏束以下阻斷產生心室逸搏（20-40 bpm，QRS寬大）。心率緩慢導致心輸出量不足，可引發昏厥、運動不耐或心衰竭。代償性每搏輸出量增加（Frank-Starling機制）可部分彌補。",
    "diagnosis": {
      "overview": "ECG顯示P波與QRS波群各自獨立，心房率快於心室率，PR間距完全無規律性。",
      "differentials": [
        "第二度II型房室傳導阻滯（高度）",
        "心房靜止（atrial standstill）",
        "竇性心跳過慢",
        "迷走神經張力過高"
      ],
      "initialDB": [
        "心電圖（ECG）：AV分離，P波數目>QRS數目，QRS可窄或寬",
        "血液生化及電解質（排除高鉀血症）",
        "胸腔X光",
        "肌鈣蛋白I"
      ],
      "advanced": [
        "心臟超音波（排除結構性心臟病、腫瘤）",
        "萊姆病及其他蜱媒疾病血清學檢查",
        "Atropine反應試驗（排除迷走神經過度活化）",
        "24小時Holter監測"
      ]
    },
    "treatment": {
      "overview": "有症狀的第三度AVB通常需要永久性心臟起搏器植入。藥物治療僅為暫時措施。",
      "acute": [
        "Atropine 0.04 mg/kg IV/IM（測試迷走神經張力，通常對三度AVB無效）",
        "Isoproterenol 0.04-0.08 μg/kg/min CRI（暫時增加逸搏頻率）",
        "Terbutaline 0.01 mg/kg SC/IV（替代方案）",
        "經皮暫時性心臟起搏",
        "靜脈輸液支持"
      ],
      "chronic": [
        "永久性心臟起搏器植入（唯一有效長期治療）",
        "單腔VVI或雙腔DDD起搏器",
        "Terbutaline 0.1-0.2 mg/kg PO q8-12h（等待起搏器期間暫用）",
        "Theophylline 10 mg/kg PO q12h（替代暫時方案）",
        "治療潛在病因（抗生素治療萊姆病等）"
      ]
    },
    "prognosis": "未治療有症狀的三度AVB預後差，有猝死風險。起搏器植入後預後良好，多數犬可恢復正常生活品質，中位生存期可達數年。先天性三度AVB的幼犬若早期植入起搏器預後佳。貓的三度AVB較少見但起搏器同樣有效。",
    "pearls": [
      "Atropine反應試驗陽性（心率上升）提示迷走神經介導而非結構性病變",
      "萊姆病相關AVB可經抗生素治療逆轉，應在考慮起搏器前排除",
      "起搏器植入後需定期程式器追蹤（q6-12個月）",
      "高鉀血症可造成暫時性三度AVB，緊急降鉀後可恢復",
      "先天性三度AVB在巴哥犬有遺傳傾向"
    ],
    "diagnosticAlgorithm": {
      "title": "第三度房室傳導阻滯 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估嚴重心搏過緩、運動不耐受和暈厥發作（Adams-Stokes症候群）",
          "findings": [
            "嚴重心搏過緩（犬<40-60 bpm）",
            "反覆暈厥發作",
            "運動極度不耐受"
          ]
        },
        {
          "step": 2,
          "action": "心電圖確診",
          "details": "進行心電圖確認心房和心室完全獨立跳動的特徵",
          "findings": [
            "P波與QRS波群完全無關（房室分離）",
            "心房率>心室率",
            "逸搏心律規則但緩慢"
          ]
        },
        {
          "step": 3,
          "action": "病因評估",
          "details": "進行心臟超音波排除結構性心臟病，評估是否需要永久性心臟起搏器",
          "findings": [
            "心臟超音波評估心臟結構",
            "排除心肌炎、心內膜炎或腫瘤浸潤",
            "評估永久性起搏器植入指徵"
          ]
        }
      ]
    },
    "monitoring": [
      "起搏器功能定期程式器檢查",
      "ECG追蹤",
      "胸腔X光確認起搏器導線位置",
      "電池壽命監測（通常5-8年）",
      "感染監測（起搏器植入處）"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "constrictive-pericarditis": {
    "zh": "縮窄性心包炎",
    "en": "Constrictive Pericarditis",
    "definition": "縮窄性心包炎是指心包膜因慢性發炎、纖維化或鈣化而增厚變硬，限制心室舒張期充盈，導致舒張性心衰竭。與心包積液不同，此病的限制來自僵硬的心包膜而非液體壓迫。",
    "synonyms": [
      "Constrictive Pericardial Disease",
      "Pericardial Constriction"
    ],
    "epidemiology": {
      "species": "犬較常見，貓罕見",
      "age": "中老年犬",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "反覆心包積液引流後",
        "感染性心包炎",
        "異物穿透（植物芒）",
        "先前心包切開術",
        "鈷菌體（Coccidioides）感染",
        "特發性心包積液慢性化"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "腹部膨大（腹水）",
        "運動不耐",
        "體重減輕",
        "呼吸急促",
        "慢性進行性病程"
      ],
      "physicalExam": [
        "腹水",
        "頸靜脈怒張",
        "Kussmaul徵象（吸氣時頸靜脈壓上升）",
        "心音減弱",
        "肝腫大",
        "周邊水腫",
        "脈搏壓差縮小"
      ]
    },
    "pathophysiology": "慢性心包發炎導致心包膜纖維化、增厚及可能鈣化，形成堅硬的外殼包裹心臟。這限制了心室在舒張期的擴張，造成舒張末期壓力上升且左右心室舒張壓趨於相等。早期舒張充盈可能正常（心包膜彈性尚存），但中後期充盈受限，產生特徵性的「方根號」（square root sign）舒張壓波形。右心充盈壓升高導致全身性靜脈充血（腹水、頸靜脈怒張）。",
    "diagnosis": {
      "overview": "診斷困難，需結合臨床表現、影像學及血行動力學評估。與限制型心肌病的鑑別是主要挑戰。",
      "differentials": [
        "限制型心肌病",
        "右心衰竭（三尖瓣疾病）",
        "心包積液",
        "肝硬化",
        "蛋白流失性腸病"
      ],
      "initialDB": [
        "胸腔X光：心影可能正常或略小，可見心包鈣化",
        "心臟超音波：心包增厚、室中隔彈跳運動（septal bounce）、呼吸性中隔移位",
        "ECG：低電壓、可能有心房顫動",
        "腹部超音波：腹水、肝充血"
      ],
      "advanced": [
        "CT或MRI：評估心包增厚程度（最佳影像工具）",
        "心導管檢查：左右心室舒張壓相等、方根號波形",
        "心包積液分析（若有殘餘積液）",
        "組織病理學"
      ]
    },
    "treatment": {
      "overview": "確定性治療為心包切除術（pericardiectomy）。藥物治療僅能暫時緩解症狀。",
      "acute": [
        "利尿劑緩解充血（Furosemide 1-2 mg/kg IV/PO）",
        "腹水引流（大量腹水影響呼吸時）",
        "低鈉飲食"
      ],
      "chronic": [
        "心包切除術（pericardiectomy）為唯一有效治療",
        "術前穩定化：利尿劑、低鈉飲食",
        "術後持續監測心功能",
        "針對病因治療（抗黴菌藥物等）"
      ]
    },
    "prognosis": "未手術治療預後差，進行性惡化。心包切除術後預後取決於心肌是否已受不可逆損傷及殘餘心外膜纖維化程度。早期手術預後較好，心功能可顯著改善。合併嚴重心肌纖維化或心外膜受累者術後改善有限。",
    "pearls": [
      "與心包積液的鑑別：縮窄性心包炎通常無大量積液但有心包增厚",
      "「方根號」舒張壓波形為經典但非特異性血行動力學發現",
      "CT/MRI對心包厚度評估優於超音波",
      "植物芒（grass awn）穿透是犬縮窄性心包炎的重要病因",
      "術後可能出現低輸出量症候群，需密切監測"
    ],
    "diagnosticAlgorithm": {
      "title": "縮窄性心包炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估右心衰竭表現，包括腹水、頸靜脈怒張和肝腫大，注意先前心包炎病史",
          "findings": [
            "腹水為主要表現",
            "頸靜脈怒張",
            "運動不耐受伴肝腫大"
          ]
        },
        {
          "step": 2,
          "action": "影像學檢查",
          "details": "進行胸腔X光和心臟超音波評估心包厚度和心臟舒張功能",
          "findings": [
            "X光可能顯示心包鈣化",
            "心臟超音波見心包增厚",
            "舒張期心室充盈受限"
          ]
        },
        {
          "step": 3,
          "action": "進階檢查與確診",
          "details": "CT/MRI更精確評估心包厚度，心導管檢查確認舒張壓均等化",
          "findings": [
            "CT/MRI顯示心包顯著增厚（>4mm）",
            "心導管顯示雙心室舒張壓均等化",
            "確診需手術心包切除及病理檢查"
          ]
        }
      ]
    },
    "monitoring": [
      "術後心臟超音波追蹤",
      "術後ECG監測心律不整",
      "腹水量追蹤",
      "肝功能指標",
      "體重及運動耐受度"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "polycythemia-vera": {
    "zh": "真性紅血球增多症",
    "en": "Polycythemia Vera",
    "definition": "真性紅血球增多症（PV）是一種骨髓增殖性腫瘤，特徵為紅血球系的克隆性增殖，導致紅血球壓積（PCV/HCT）異常升高，與紅血球生成素（EPO）無關。屬於原發性絕對性紅血球增多症。",
    "synonyms": [
      "PV",
      "Primary Polycythemia",
      "Primary Erythrocytosis",
      "原發性紅血球增多症"
    ],
    "epidemiology": {
      "species": "犬貓皆可",
      "age": "中老年犬貓",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "無明確已知風險因素",
        "為骨髓增殖性疾病的一種"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "嗜睡",
        "虛弱",
        "食慾下降",
        "多飲多尿",
        "紅色黏膜",
        "鼻出血",
        "行為改變（神經症狀）",
        "昏厥"
      ],
      "physicalExam": [
        "黏膜磚紅色（brick-red mucous membranes）",
        "脾腫大",
        "結膜充血",
        "視網膜血管擴張迂曲",
        "心雜音（血液黏稠度增加）",
        "神經學異常（嚴重時）"
      ]
    },
    "pathophysiology": "骨髓紅血球前驅細胞的克隆性增殖導致紅血球過度生產，不受EPO正常回饋調節。PCV升高使血液黏稠度顯著增加，導致微循環障礙、組織灌流不良及血栓形成風險增加。黏稠血液增加心臟後負荷，可導致心臟擴大。中樞神經系統對缺血最敏感，故常出現神經症狀。與人類不同，犬貓PV較少伴隨白血球或血小板增多。",
    "diagnosis": {
      "overview": "診斷為排除法——需排除繼發性紅血球增多症（EPO升高）的所有原因後方可診斷。",
      "differentials": [
        "脫水（相對性紅血球增多）",
        "慢性低氧（心肺疾病、右至左分流）",
        "腎臟EPO分泌腫瘤",
        "腎囊腫",
        "脾臟收縮（興奮型紅血球增多）"
      ],
      "initialDB": [
        "CBC：PCV顯著升高（犬>65%，貓>55%）",
        "血液生化：排除脫水（BUN/Cr、TP）",
        "動脈血氣分析：PaO2正常（排除低氧性原因）",
        "EPO濃度：正常至降低（關鍵鑑別指標）"
      ],
      "advanced": [
        "腹部超音波：排除腎臟腫瘤或囊腫、評估脾臟大小",
        "心臟超音波：排除右至左分流",
        "骨髓穿刺：紅血球系增生但非特異性",
        "JAK2突變檢測（若可取得）"
      ]
    },
    "treatment": {
      "overview": "治療目標為降低PCV至正常範圍上限（犬<55%，貓<45%），減少高黏稠度相關併發症。",
      "acute": [
        "治療性放血（phlebotomy）：抽取10-20 mL/kg血液，同時輸注等量晶體液",
        "靜脈輸液（降低黏稠度）"
      ],
      "chronic": [
        "Hydroxyurea 30-50 mg/kg PO q24h（犬），初始劑量，依PCV調整",
        "Hydroxyurea 25 mg/kg PO q72h（貓），較低劑量",
        "定期放血維持目標PCV",
        "充足飲水",
        "低劑量Aspirin 0.5-1 mg/kg q24h（犬，抗血栓）"
      ]
    },
    "prognosis": "以放血及hydroxyurea控制後，中位生存期可達數年（犬報告中位生存期約2-3年以上）。需終身治療及監測。可能轉化為急性白血病但罕見。未治療的嚴重紅血球增多可因血栓或出血導致死亡。",
    "pearls": [
      "PCV>75%有極高血栓風險，需緊急放血",
      "EPO濃度是鑑別原發性與繼發性紅血球增多的關鍵指標",
      "放血時應以等量晶體液替換，避免低血容量",
      "Hydroxyurea需監測CBC（可能抑制白血球及血小板）",
      "興奮或緊張的犬貓可因脾臟收縮導致PCV暫時升高——休息後複測"
    ],
    "diagnosticAlgorithm": {
      "title": "真性紅血球增多症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估黏膜磚紅色、嗜睡、多尿多渴和神經症狀（因血液高黏度）",
          "findings": [
            "黏膜呈磚紅色",
            "嗜睡與運動不耐受",
            "多尿多渴或神經症狀"
          ]
        },
        {
          "step": 2,
          "action": "血液學檢查",
          "details": "進行CBC確認紅血球壓積顯著升高，測量血清EPO濃度排除繼發性原因",
          "findings": [
            "紅血球壓積顯著升高（犬>65%，貓>55%）",
            "血清EPO正常或降低",
            "排除脫水引起的相對性紅血球增多"
          ]
        },
        {
          "step": 3,
          "action": "排除繼發性病因與確診",
          "details": "排除腎臟腫瘤、慢性低氧等繼發性紅血球增多症的原因後確診",
          "findings": [
            "動脈血氧飽和度正常排除低氧性原因",
            "腹部超音波排除腎臟腫瘤或EPO分泌腫瘤",
            "確診為原發性真性紅血球增多症"
          ]
        }
      ]
    },
    "monitoring": [
      "定期CBC追蹤PCV（初期每1-2週，穩定後每1-3個月）",
      "Hydroxyurea使用期間每2-4週監測CBC",
      "血清生化及尿液分析",
      "神經學狀態評估",
      "眼底檢查"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "multiple-myeloma": {
    "zh": "多發性骨髓瘤",
    "en": "Multiple Myeloma",
    "definition": "多發性骨髓瘤是漿細胞（plasma cell）的惡性腫瘤，起源於骨髓，特徵為單株免疫球蛋白（M蛋白）的過度生產、溶骨性骨病變、骨髓浸潤及可能的腎臟損傷。",
    "synonyms": [
      "Plasma Cell Myeloma",
      "Myeloma",
      "漿細胞骨髓瘤"
    ],
    "epidemiology": {
      "species": "犬較常見，貓少見",
      "age": "老年犬（中位年齡8-9歲）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "老年",
        "德國牧羊犬可能過度代表",
        "慢性抗原刺激（理論性）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "跛行或骨痛",
        "嗜睡",
        "虛弱",
        "出血傾向（鼻出血、牙齦出血）",
        "多飲多尿",
        "食慾下降",
        "體重減輕",
        "反覆感染"
      ],
      "physicalExam": [
        "蒼白黏膜（貧血）",
        "淋巴結可能腫大",
        "脾腫大（部分病例）",
        "骨骼觸痛",
        "視網膜出血或血管擴張（高黏稠度）",
        "出血斑點（瘀點、瘀斑）",
        "脫水"
      ]
    },
    "pathophysiology": "惡性漿細胞在骨髓中克隆性增殖，分泌大量單株免疫球蛋白。骨髓浸潤抑制正常造血功能（貧血、血小板減少、白血球減少）。腫瘤細胞釋放破骨細胞活化因子（osteoclast-activating factors）導致溶骨性病變及高鈣血症。M蛋白可導致血液高黏稠度（特別是IgM及IgA型）。輕鏈蛋白（Bence Jones protein）腎毒性可造成腎衰竭。免疫抑制（正常免疫球蛋白減少）增加感染風險。",
    "diagnosis": {
      "overview": "經典診斷標準需符合以下至少兩項：骨髓漿細胞>20%、血清或尿液M蛋白、溶骨性骨病變。",
      "differentials": [
        "淋巴瘤",
        "慢性淋巴球性白血病",
        "其他單株免疫球蛋白病（MGUS）",
        "骨肉瘤（溶骨性病變）",
        "其他高鈣血症原因"
      ],
      "initialDB": [
        "CBC：不可再生性貧血、血小板減少",
        "血清生化：高蛋白血症、高鈣血症、氮血症",
        "血清蛋白電泳（SPEP）：單株M蛋白尖峰",
        "尿液分析：Bence Jones蛋白尿",
        "骨骼X光：溶骨性病變（「穿鑿樣」punch-out lesions）"
      ],
      "advanced": [
        "骨髓穿刺及活檢：漿細胞>20%",
        "免疫固定電泳（確定M蛋白類型）",
        "全身骨骼X光調查",
        "血液黏稠度測量",
        "免疫球蛋白定量（IgG、IgM、IgA）"
      ]
    },
    "treatment": {
      "overview": "化學治療為主，最常用Melphalan合併Prednisolone方案。高黏稠度需緊急治療。",
      "acute": [
        "靜脈輸液（高鈣血症、脫水）",
        "Dexamethasone 0.1-0.2 mg/kg IV（緊急降鈣）",
        "治療性血漿置換（高黏稠度症候群緊急治療）",
        "輸血（嚴重貧血）"
      ],
      "chronic": [
        "Melphalan 0.1 mg/kg PO q24h×10天，然後0.05 mg/kg q24h",
        "Prednisolone 0.5 mg/kg PO q24h（逐漸減量）",
        "替代方案：Cyclophosphamide 200-300 mg/m² PO q3週",
        "Chlorambucil 0.2 mg/kg PO q24h（替代melphalan）",
        "雙磷酸鹽（Pamidronate 1-2 mg/kg IV q3-4週）治療溶骨性病變",
        "疼痛管理"
      ]
    },
    "prognosis": "化學治療反應率約75-90%，中位生存期約540天（犬）。高鈣血症和Bence Jones蛋白尿為負面預後因素。IgA型預後較IgG型差。貓的多發性骨髓瘤預後較差。完全緩解罕見，大多數病例最終復發。",
    "pearls": [
      "血清蛋白電泳的單株尖峰是最具特徵性的發現",
      "「CRAB」記憶法：Calcium（高鈣）、Renal（腎衰）、Anemia（貧血）、Bone（骨病變）",
      "Melphalan為烷化劑，長期使用有致白血病風險",
      "高黏稠度症候群在IgM型最常見（Waldenström巨球蛋白血症）",
      "溶骨性病變在肋骨、椎體、骨盆和四肢長骨最常見"
    ],
    "diagnosticAlgorithm": {
      "title": "多發性骨髓瘤 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估骨痛/跛行、嗜睡、出血傾向等表現，注意老年犬更常見",
          "findings": [
            "骨骼疼痛或病理性骨折",
            "嗜睡與體重下降",
            "黏膜出血或鼻出血"
          ]
        },
        {
          "step": 2,
          "action": "實驗室檢查",
          "details": "進行CBC、血清蛋白電泳、尿液分析和骨骼X光",
          "findings": [
            "血清蛋白電泳見單株M蛋白帶",
            "尿液Bence-Jones蛋白陽性",
            "X光顯示多處骨質溶解性病變"
          ]
        },
        {
          "step": 3,
          "action": "骨髓檢查確診",
          "details": "進行骨髓抽吸和活檢確認漿細胞增生程度",
          "findings": [
            "骨髓漿細胞>20%",
            "漿細胞異型性明顯",
            "符合骨髓瘤診斷標準（M蛋白+骨溶解+骨髓漿細胞增生）"
          ]
        }
      ]
    },
    "monitoring": [
      "每2-4週CBC監測骨髓抑制",
      "血清蛋白電泳追蹤M蛋白量（治療反應指標）",
      "血清鈣濃度",
      "腎功能指標",
      "骨骼X光追蹤"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "cutaneous-lymphoma": {
    "zh": "皮膚淋巴瘤",
    "en": "Cutaneous Lymphoma",
    "definition": "皮膚淋巴瘤是原發於皮膚的淋巴球惡性腫瘤，分為上皮趨性（epitheliotropic，T細胞來源，又稱蕈樣黴菌病/mycosis fungoides）和非上皮趨性（non-epitheliotropic）兩大類。上皮趨性型較常見且臨床特徵較具特異性。",
    "synonyms": [
      "Mycosis Fungoides",
      "蕈樣黴菌病",
      "Epitheliotropic Lymphoma",
      "Cutaneous T-cell Lymphoma",
      "CTCL"
    ],
    "epidemiology": {
      "species": "犬較常見，貓亦可見",
      "age": "老年犬貓（中位年齡9-12歲）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "老年",
        "可卡犬可能過度代表",
        "慢性皮膚疾病（可能延遲診斷）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "慢性進行性皮膚病變",
        "對皮膚病治療反應不佳",
        "皮膚搔癢（可嚴重）",
        "鱗屑增多",
        "皮膚結節或斑塊",
        "口腔潰瘍",
        "全身症狀（晚期）"
      ],
      "physicalExam": [
        "紅斑期：瀰漫性紅斑、脫屑、脫色斑",
        "斑塊期：浸潤性斑塊、黏膜受累",
        "腫瘤期：皮膚結節、潰瘍",
        "皮膚黏膜交界處受累（口唇、眼瞼、外陰）",
        "廣泛脫毛",
        "淋巴結腫大（晚期）",
        "口腔黏膜結節或潰瘍"
      ]
    },
    "pathophysiology": "上皮趨性皮膚淋巴瘤為成熟T淋巴球（通常為CD8+犬/CD4+人）的惡性增殖，具有向表皮浸潤的特性，在表皮內形成Pautrier微膿瘍（Pautrier microabscesses）。疾病通常從紅斑期經斑塊期進展至腫瘤期，反映腫瘤負荷增加。晚期可播散至淋巴結及內臟（白血病化稱為Sézary syndrome）。非上皮趨性型為B或T細胞來源，表現為皮下結節，進展較快。",
    "diagnosis": {
      "overview": "皮膚活檢組織病理學為確診標準。細胞學可提示但不能確診。",
      "differentials": [
        "過敏性皮膚炎",
        "皮膚真菌感染",
        "自體免疫性皮膚病（天疱瘡、紅斑性狼瘡）",
        "組織細胞增多症",
        "肥大細胞瘤",
        "其他皮膚腫瘤"
      ],
      "initialDB": [
        "皮膚活檢組織病理學：表皮趨性淋巴球浸潤、Pautrier微膿瘍",
        "細胞學（FNA或壓片）",
        "CBC及血液生化",
        "胸腹部影像學（分期）"
      ],
      "advanced": [
        "免疫組織化學：CD3（T細胞）、CD79a（B細胞）標記",
        "PARR（PCR for antigen receptor rearrangement）克隆性分析",
        "骨髓穿刺（排除全身播散）",
        "外周血塗片（排除Sézary syndrome）",
        "淋巴結細胞學或活檢"
      ]
    },
    "treatment": {
      "overview": "治療以緩解症狀、改善生活品質為主，完全治癒困難。單一皮膚病灶可考慮手術或放射治療。多發病灶需全身治療。",
      "acute": [
        "Prednisolone 1-2 mg/kg PO q24h（初始緩解）",
        "局部類固醇（單一病灶）"
      ],
      "chronic": [
        "Lomustine (CCNU) 60-90 mg/m² PO q3週（最常用且有效）",
        "Prednisolone合併CCNU",
        "Retinoids（isotretinoin 1-3 mg/kg PO q24h）",
        "放射治療（局部病灶）",
        "局部nitrogen mustard（mechlorethamine）",
        "手術切除（孤立病灶）",
        "Omega-3脂肪酸補充",
        "止癢治療（Oclacitinib）"
      ]
    },
    "prognosis": "預後差，中位生存期約6個月（未治療）至12-18個月（CCNU治療）。上皮趨性型進展較緩慢但最終不可治癒。非上皮趨性型進展較快，預後更差。早期（紅斑期）診斷治療反應較好。口腔黏膜受累為負面預後因素。",
    "pearls": [
      "慢性反覆發作且對常規治療反應不佳的皮膚病應活檢排除皮膚淋巴瘤",
      "表皮趨性是組織病理學的特徵性發現",
      "CCNU（Lomustine）為目前最有效的化療藥物，但有肝毒性風險",
      "多點活檢（至少3處）可提高診斷率",
      "Sézary syndrome（白血病化）為疾病晚期表現，預後極差"
    ],
    "diagnosticAlgorithm": {
      "title": "皮膚淋巴瘤 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估慢性進行性皮膚病變，注意鱗屑性紅斑、結節、潰瘍或脫色素斑塊的分布",
          "findings": [
            "廣泛性鱗屑性紅斑（蕈狀肉芽腫型）",
            "皮膚結節或腫塊（結節型）",
            "黏膜皮膚交界處潰瘍"
          ]
        },
        {
          "step": 2,
          "action": "細胞學與活檢",
          "details": "進行病灶細針抽吸細胞學及皮膚全層活檢送病理學檢查",
          "findings": [
            "細胞學見異型淋巴球",
            "組織病理學見表皮嗜性淋巴球浸潤",
            "Pautrier微膿腫（T細胞上皮嗜性淋巴瘤特徵）"
          ]
        },
        {
          "step": 3,
          "action": "免疫表型與分期",
          "details": "進行免疫組織化學確認T細胞或B細胞來源，全身分期評估",
          "findings": [
            "免疫組織化學確認細胞來源（多為T細胞）",
            "淋巴結和臟器評估（超音波、X光）",
            "確認疾病分期"
          ]
        }
      ]
    },
    "monitoring": [
      "定期皮膚檢查評估治療反應",
      "CCNU治療前及治療後7-10天查CBC",
      "肝功能指標（ALT、ALP）每次CCNU前檢查",
      "胸腹部影像追蹤分期",
      "生活品質評估"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "thymoma": {
    "zh": "胸腺瘤",
    "en": "Thymoma",
    "definition": "胸腺瘤是起源於胸腺上皮細胞的腫瘤，位於前縱隔腔。雖然在組織學上通常為良性或低度惡性，但可因局部壓迫效應及副腫瘤症候群（特別是重症肌無力）造成嚴重臨床問題。",
    "synonyms": [
      "Thymic Epithelial Tumor",
      "Thymic Neoplasia"
    ],
    "epidemiology": {
      "species": "犬貓皆可",
      "age": "中老年（犬中位年齡9歲，貓10歲）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "中大型犬種（德國牧羊犬、拉布拉多犬）",
        "老年"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "呼吸困難（進行性）",
        "咳嗽",
        "運動不耐",
        "吞嚥困難",
        "肌肉無力（重症肌無力相關）",
        "反覆巨食道嘔吐"
      ],
      "physicalExam": [
        "前胸部聽診呼吸音減弱或消失",
        "胸前叩診濁音",
        "頸靜脈怒張或前肢/面部水腫（前腔靜脈症候群）",
        "全身肌肉無力",
        "巨食道表現"
      ]
    },
    "pathophysiology": "胸腺上皮細胞異常增殖形成腫塊，位於前縱隔腔，可壓迫氣管、食道、前腔靜脈及心臟。副腫瘤症候群包括：(1) 重症肌無力（MG）——腫瘤相關的抗乙醯膽鹼受體抗體導致神經肌肉接合功能障礙，犬約30-47%、貓約25%伴發MG；(2) 高鈣血症；(3) 皮膚病（多形性紅斑、落葉型天疱瘡）。貓的胸腺瘤還可伴隨胸腔積液。",
    "diagnosis": {
      "overview": "胸腔影像學發現前縱隔腫塊後，需結合細胞學或組織學確診，並評估副腫瘤症候群。",
      "differentials": [
        "縱隔淋巴瘤",
        "異位甲狀腺腫瘤",
        "胸腺囊腫",
        "心基底腫瘤",
        "縱隔脂肪瘤"
      ],
      "initialDB": [
        "胸腔X光：前縱隔腫塊、可能有胸腔積液或巨食道",
        "CBC及血液生化（含鈣濃度）",
        "FNA細胞學（超音波或CT導引）",
        "乙醯膽鹼受體抗體（AChR Ab）測定"
      ],
      "advanced": [
        "胸部CT：腫瘤範圍及侵犯程度評估",
        "組織活檢（確定組織學分型）",
        "Tensilon試驗（Edrophonium）評估重症肌無力",
        "食道造影（評估巨食道）",
        "胸腔積液細胞學"
      ]
    },
    "treatment": {
      "overview": "手術完全切除為首選治療。不可切除者可考慮放射治療。副腫瘤症候群需同時處理。",
      "acute": [
        "胸腔積液引流（呼吸困難時）",
        "重症肌無力處理：Pyridostigmine 0.5-3 mg/kg PO q8-12h",
        "吸入性肺炎預防及治療"
      ],
      "chronic": [
        "手術切除（經胸骨正中切開或肋間開胸）",
        "放射治療（不可切除或術後殘留）",
        "術後繼續Pyridostigmine（若有MG）",
        "Prednisolone（免疫抑制劑量，若MG嚴重）",
        "Azathioprine 2 mg/kg PO q24h（免疫抑制輔助）"
      ]
    },
    "prognosis": "手術完全切除後預後良好，犬中位生存期>790天。有重症肌無力併發症者預後較差，特別是伴有巨食道和吸入性肺炎風險者。MG在胸腺瘤切除後可能改善、不變或惡化。貓手術後中位生存期約1-2年。非侵犯性胸腺瘤預後優於侵犯性。",
    "pearls": [
      "前縱隔腫塊+重症肌無力高度提示胸腺瘤",
      "胸腺淋巴瘤（特別是貓）是最重要的鑑別診斷——免疫表型區分",
      "術後重症肌無力可能暫時惡化（肌無力危象），需準備機械通氣",
      "貓胸腺瘤的FNA可能難以與淋巴瘤區分，需組織活檢",
      "巨食道患者的麻醉需特別注意吸入性肺炎風險"
    ],
    "diagnosticAlgorithm": {
      "title": "胸腺瘤 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估前縱隔腫塊引起的呼吸困難和運動不耐受，注意伴隨的副腫瘤症候群",
          "findings": [
            "呼吸困難和運動不耐受",
            "前腔靜脈症候群（頭頸部水腫）",
            "可能合併重症肌無力或皮膚病變"
          ]
        },
        {
          "step": 2,
          "action": "影像學檢查",
          "details": "進行胸腔X光和CT評估前縱隔腫塊的大小和範圍",
          "findings": [
            "胸腔X光顯示前縱隔腫塊",
            "CT精確評估腫塊範圍和侵犯程度",
            "可能伴隨胸腔積液"
          ]
        },
        {
          "step": 3,
          "action": "細胞學/組織學確診",
          "details": "進行CT引導細針抽吸或開胸活檢，同時評估重症肌無力等副腫瘤症候群",
          "findings": [
            "細胞學或組織學確認胸腺瘤",
            "區分胸腺瘤與淋巴瘤",
            "乙醯膽鹼受體抗體檢測評估重症肌無力"
          ]
        }
      ]
    },
    "monitoring": [
      "術後胸腔X光追蹤復發",
      "AChR抗體追蹤（MG患者）",
      "食道功能評估",
      "肌力評估",
      "鈣濃度追蹤"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "chondrosarcoma": {
    "zh": "軟骨肉瘤",
    "en": "Chondrosarcoma",
    "definition": "軟骨肉瘤是起源於軟骨細胞的惡性腫瘤，為犬第二常見的原發性骨腫瘤（僅次於骨肉瘤）。好發於扁平骨（肋骨、鼻腔、骨盆），也可見於四肢長骨。",
    "synonyms": [
      "CSA",
      "Chondrosarcoma of Bone"
    ],
    "epidemiology": {
      "species": "犬較常見，貓罕見",
      "age": "中老年犬（中位年齡6-8歲）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "大型犬種",
        "金毛獵犬、德國牧羊犬",
        "扁平骨部位"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "局部腫脹（進行性）",
        "跛行（四肢骨時）",
        "鼻出血或面部變形（鼻腔時）",
        "呼吸困難（肋骨時）",
        "疼痛"
      ],
      "physicalExam": [
        "堅硬、不可移動的骨性腫塊",
        "局部腫脹",
        "鼻腔：單側鼻出血、面部不對稱",
        "肋骨：胸壁腫塊、呼吸受限",
        "患肢跛行及肌肉萎縮"
      ]
    },
    "pathophysiology": "軟骨肉瘤起源於軟骨細胞或其前驅細胞的惡性轉化，腫瘤細胞產生軟骨基質。與骨肉瘤相比，軟骨肉瘤生長較緩慢，轉移率較低（約20-30%，主要至肺部），但局部侵犯力強。鼻腔軟骨肉瘤可擴展至顱腔。組織學分級（I-III級）與預後密切相關，低級別腫瘤生長最慢、轉移率最低。",
    "diagnosis": {
      "overview": "影像學發現骨溶解性或混合溶解/增生性病變，組織學確診。需與骨肉瘤鑑別。",
      "differentials": [
        "骨肉瘤",
        "纖維肉瘤",
        "多分葉性骨腫瘤（MLO）",
        "骨轉移瘤",
        "真菌性骨髓炎"
      ],
      "initialDB": [
        "受累區域X光：溶骨性病變、軟骨基質鈣化（典型點狀或弧狀鈣化）",
        "胸腔X光三視圖（肺轉移篩檢）",
        "FNA細胞學（可能不具診斷性）"
      ],
      "advanced": [
        "組織活檢（切開式活檢或Jamshidi骨穿針）",
        "CT或MRI：評估腫瘤範圍",
        "全身骨掃描（bone scintigraphy）",
        "區域淋巴結評估"
      ]
    },
    "treatment": {
      "overview": "手術廣泛切除為首選治療。軟骨肉瘤對化療和放射治療的反應較骨肉瘤差。",
      "acute": [
        "疼痛控制：NSAIDs（Meloxicam 0.1 mg/kg q24h）合併Gabapentin",
        "Tramadol 2-5 mg/kg PO q8-12h（額外鎮痛）"
      ],
      "chronic": [
        "四肢：截肢術（首選，完全切除）",
        "肋骨：胸壁切除及重建",
        "鼻腔：放射治療（姑息性）或根治性鼻切除術",
        "輔助化療效果有限但可考慮：Carboplatin 300 mg/m² IV q3週",
        "姑息性放射治療（不可切除病例）"
      ]
    },
    "prognosis": "手術完全切除後預後優於骨肉瘤。四肢截肢後中位生存期約980天（相較骨肉瘤的約300天）。肋骨軟骨肉瘤完全切除後中位生存期>1年。鼻腔軟骨肉瘤放射治療後中位生存期約12-18個月。高級別腫瘤預後較差，轉移率較高。",
    "pearls": [
      "犬第二常見的原發性骨腫瘤，佔骨腫瘤的5-10%",
      "與骨肉瘤的鑑別需組織學——軟骨肉瘤預後明顯較好",
      "轉移率較低（20-30%），但局部復發率可能較高若切除不完全",
      "鼻腔軟骨肉瘤的X光可見典型點狀鈣化（stippled calcification）",
      "化療對軟骨肉瘤的效果遠不如骨肉瘤，手術為關鍵"
    ],
    "diagnosticAlgorithm": {
      "title": "軟骨肉瘤 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估骨骼或鼻腔局部腫脹，注意好發部位（扁平骨、鼻腔、肋骨），大型犬多見",
          "findings": [
            "局部堅硬腫脹和疼痛",
            "鼻腔型可見鼻出血和面部變形",
            "漸進性跛行（四肢骨型）"
          ]
        },
        {
          "step": 2,
          "action": "影像學檢查",
          "details": "進行X光和CT評估骨骼病變特徵和範圍",
          "findings": [
            "X光顯示溶骨性和成骨性混合病變",
            "軟骨基質鈣化（點狀或環狀鈣化）",
            "CT評估腫瘤侵犯範圍"
          ]
        },
        {
          "step": 3,
          "action": "活檢確診與分期",
          "details": "進行骨活檢送組織病理學檢查，胸腔X光評估轉移",
          "findings": [
            "組織病理學確認軟骨肉瘤及分級",
            "胸腔X光評估肺轉移",
            "軟骨肉瘤轉移率低於骨肉瘤"
          ]
        }
      ]
    },
    "monitoring": [
      "術後每2-3個月胸腔X光（肺轉移篩檢）",
      "術後局部影像追蹤復發",
      "截肢後功能評估",
      "疼痛評估"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "peripheral-nerve-sheath-tumor": {
    "zh": "周邊神經鞘瘤",
    "en": "Peripheral Nerve Sheath Tumor",
    "definition": "周邊神經鞘瘤（PNST）是起源於周邊神經的施旺細胞（Schwann cells）或神經束膜細胞的腫瘤。包括良性（神經鞘瘤/schwannoma、神經纖維瘤/neurofibroma）和惡性（惡性PNST/malignant PNST）型態。臂神經叢是犬最常見的好發位置。",
    "synonyms": [
      "PNST",
      "Schwannoma",
      "Neurofibroma",
      "Neurofibrosarcoma",
      "神經鞘瘤",
      "施旺氏瘤"
    ],
    "epidemiology": {
      "species": "犬較常見，貓少見",
      "age": "中老年犬（中位年齡7-10歲）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "中大型犬種",
        "金毛獵犬可能過度代表"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "進行性單肢跛行",
        "肌肉萎縮（受影響肢體）",
        "前肢較後肢常見",
        "對NSAIDs反應不佳",
        "疼痛（可能觸碰敏感或自殘）",
        "Horner氏症（臂神經叢受累時）"
      ],
      "physicalExam": [
        "單肢進行性肌肉萎縮",
        "受影響神經分布區的感覺減退或過敏",
        "可觸知的腫塊（沿神經走行，部分病例）",
        "下運動神經元徵象：肌張力降低、反射減弱",
        "Horner氏症候群（瞳孔縮小、眼瞼下垂、眼球內陷）",
        "根部徵象（root signature）：特定神經根分布區疼痛"
      ]
    },
    "pathophysiology": "腫瘤起源於周邊神經的支持細胞，沿神經束生長，壓迫並破壞正常神經纖維。臂神經叢PNST可沿神經根向椎管內延伸，壓迫脊髓。惡性PNST具有局部侵犯性強的特點，可沿神經蔓延至遠處。轉移率相對較低（約20%），主要至肺部及區域淋巴結。良性型態通常為包膜完整的腫塊，預後明顯較好。",
    "diagnosis": {
      "overview": "根據臨床表現（進行性單肢LMN徵象）、影像學及組織學診斷。",
      "differentials": [
        "骨肉瘤或其他骨腫瘤",
        "關節疾病",
        "椎間盤疾病",
        "纖維肉瘤",
        "脊髓腫瘤"
      ],
      "initialDB": [
        "神經學檢查：定位病變神經",
        "受累區域X光（排除骨骼病變）",
        "電生理學：EMG顯示去神經化電位"
      ],
      "advanced": [
        "MRI（最佳影像工具）：評估腫瘤範圍、脊髓壓迫及椎管侵犯",
        "CT",
        "超音波導引FNA或組織活檢",
        "免疫組織化學（S100、GFAP、vimentin）"
      ]
    },
    "treatment": {
      "overview": "手術切除為主要治療。臂神經叢腫瘤可能需要截肢合併神經根切除。放射治療可作為輔助。",
      "acute": [
        "疼痛管理：Gabapentin 5-10 mg/kg PO q8-12h",
        "NSAIDs",
        "Amitriptyline 1-2 mg/kg PO q12-24h（神經性疼痛）"
      ],
      "chronic": [
        "截肢合併盡可能廣泛的神經根切除（臂神經叢腫瘤首選）",
        "局部廣泛切除（可完全切除的孤立腫瘤）",
        "放射治療（輔助或不可完全切除時）",
        "化療效果有限但可考慮Carboplatin"
      ]
    },
    "prognosis": "手術切除後預後中等。截肢後中位生存期約1-2年，但局部復發率高（特別是椎管內延伸者）。不完全切除後復發率高。惡性PNST預後較良性差。椎管內延伸至脊髓者預後差。早期截肢（腫瘤小、無椎管侵犯）預後較好。",
    "pearls": [
      "前肢進行性LMN徵象+肌肉萎縮+Horner氏症=高度懷疑臂神經叢PNST",
      "MRI可評估椎管內延伸程度，影響手術計畫及預後",
      "截肢時需盡可能將切斷點延伸至椎管附近以減少復發",
      "EMG可幫助確定受累神經範圍",
      "與纖維肉瘤的鑑別需免疫組織化學"
    ],
    "diagnosticAlgorithm": {
      "title": "周邊神經鞘瘤 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估漸進性單側前肢跛行和肌肉萎縮，注意神經缺損的進展模式",
          "findings": [
            "進行性單側前肢跛行",
            "受累肢體肌肉顯著萎縮",
            "本體感覺缺損和反射減弱"
          ]
        },
        {
          "step": 2,
          "action": "影像學與電生理檢查",
          "details": "進行MRI評估臂神經叢和脊髓，肌電圖評估去神經支配",
          "findings": [
            "MRI顯示神經根或臂神經叢腫塊",
            "肌電圖顯示受累神經去神經支配",
            "評估腫瘤是否侵犯椎管"
          ]
        },
        {
          "step": 3,
          "action": "活檢確診",
          "details": "進行CT/MRI引導活檢或手術探查活檢，送組織病理學和免疫組織化學",
          "findings": [
            "組織病理學確認周邊神經鞘瘤",
            "免疫組織化學S-100蛋白陽性",
            "評估手術切除可能性"
          ]
        }
      ]
    },
    "monitoring": [
      "術後MRI追蹤局部復發",
      "胸腔X光（肺轉移篩檢）",
      "神經學檢查追蹤",
      "對側肢體功能評估（截肢後）"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "hyperviscosity-syndrome": {
    "zh": "高黏性症候群",
    "en": "Hyperviscosity Syndrome",
    "definition": "高黏性症候群是因血清中蛋白質（通常為免疫球蛋白）異常增加導致血液黏稠度上升，引起微循環障礙、出血傾向及器官功能障礙的臨床症候群。最常見於多發性骨髓瘤及淋巴瘤分泌的單株免疫球蛋白。",
    "synonyms": [
      "HVS",
      "血液高黏稠度症候群",
      "Serum Hyperviscosity"
    ],
    "epidemiology": {
      "species": "犬較常見，貓少見",
      "age": "中老年（與潛在腫瘤年齡分布一致）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "多發性骨髓瘤（IgM、IgA型）",
        "Waldenström巨球蛋白血症（淋巴漿細胞淋巴瘤）",
        "慢性淋巴球性白血病",
        "Ehrlichia canis感染（多株高免疫球蛋白血症）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "出血傾向（鼻出血、牙齦出血）",
        "視力障礙或失明",
        "神經症狀（癲癇、行為改變、共濟失調）",
        "嗜睡",
        "食慾不振",
        "多飲多尿"
      ],
      "physicalExam": [
        "出血徵象（瘀點、瘀斑、鼻出血）",
        "眼底檢查：視網膜血管擴張迂曲、出血、視網膜剝離",
        "神經學異常",
        "黏膜蒼白",
        "心雜音（血液黏稠度增加）",
        "淋巴結或脾臟腫大"
      ]
    },
    "pathophysiology": "大量單株免疫球蛋白（特別是IgM五聚體，分子量最大）使血清黏稠度顯著上升。高黏稠度導致：(1) 微循環血流緩慢及淤滯，組織缺氧；(2) 血小板功能障礙（免疫球蛋白包覆血小板）及凝血因子功能異常；(3) 紅血球聚集（rouleaux formation增加）。最易受影響的器官為眼、腦、腎，因這些器官依賴良好的微循環灌流。正常犬血清黏度為1.2-1.8 cP，症狀通常在>4-5 cP時出現。",
    "diagnosis": {
      "overview": "血清黏稠度測量結合臨床症狀及潛在疾病診斷。眼底檢查為重要的床邊評估工具。",
      "differentials": [
        "凝血障礙",
        "血小板減少症",
        "DIC",
        "中樞神經系統疾病",
        "其他出血性疾病"
      ],
      "initialDB": [
        "血清黏稠度測定（正常犬1.2-1.8 cP，>5 cP通常有症狀）",
        "CBC：可見Rouleaux formation",
        "血清總蛋白及球蛋白（顯著升高）",
        "血清蛋白電泳：單株免疫球蛋白尖峰",
        "眼底檢查"
      ],
      "advanced": [
        "免疫球蛋白定量及分型",
        "骨髓穿刺",
        "全身影像學（尋找潛在腫瘤）",
        "凝血功能檢查",
        "尿液Bence Jones蛋白"
      ]
    },
    "treatment": {
      "overview": "緊急治療以治療性血漿置換降低黏稠度，同時治療潛在病因。",
      "acute": [
        "治療性血漿置換（plasmapheresis）：最有效的緊急降黏稠度方法",
        "替代方案：放血（抽取15-20 mL/kg）合併晶體液輸注",
        "靜脈輸液稀釋",
        "症狀性治療（止血、抗癲癇等）"
      ],
      "chronic": [
        "針對潛在疾病的化療（多發性骨髓瘤：Melphalan/Prednisolone）",
        "淋巴瘤化療方案",
        "定期監測血清黏稠度",
        "需要時重複血漿置換或放血"
      ]
    },
    "prognosis": "取決於潛在病因。急性降黏稠度治療通常能快速改善症狀。長期預後取決於潛在腫瘤對化療的反應。多發性骨髓瘤伴HVS經治療後中位生存期約540天。Ehrlichia相關者經適當抗生素治療後可完全恢復。視網膜剝離若及時治療可能恢復。",
    "pearls": [
      "眼底檢查是評估高黏稠度最簡便且最敏感的臨床工具",
      "IgM型最容易引起HVS（五聚體結構，分子量大）",
      "血漿置換不是所有醫院都能進行——放血+輸液為替代方案",
      "Ehrlichia canis可造成多株高免疫球蛋白血症及HVS，治療後可逆",
      "血清黏稠度>8 cP通常有嚴重神經症狀"
    ],
    "diagnosticAlgorithm": {
      "title": "高黏性症候群 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估出血傾向、視力異常和神經症狀，通常繼發於多發性骨髓瘤或淋巴瘤",
          "findings": [
            "自發性黏膜出血或鼻出血",
            "視力障礙（視網膜血管擴張扭曲）",
            "神經症狀（嗜睡、共濟失調）"
          ]
        },
        {
          "step": 2,
          "action": "實驗室檢查",
          "details": "進行血清蛋白電泳、血液黏度測量和眼底檢查",
          "findings": [
            "血清蛋白電泳見單株高球蛋白血症",
            "血液黏度顯著升高",
            "眼底檢查見視網膜血管擴張和出血"
          ]
        },
        {
          "step": 3,
          "action": "病因確認",
          "details": "尋找引起高黏度的潛在腫瘤性疾病，進行骨髓檢查和全身分期",
          "findings": [
            "骨髓檢查確認多發性骨髓瘤或其他漿細胞腫瘤",
            "全身分期評估",
            "緊急治療性血漿分離術"
          ]
        }
      ]
    },
    "monitoring": [
      "血清黏稠度定期追蹤",
      "眼底檢查",
      "血清蛋白電泳追蹤M蛋白",
      "神經學狀態評估",
      "CBC及凝血功能"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "amyloidosis": {
    "zh": "類澱粉沉積症",
    "en": "Amyloidosis",
    "definition": "類澱粉沉積症是一組以不溶性纖維蛋白（類澱粉）異常沉積於組織器官為特徵的疾病。犬貓最常見的為AA型（反應性）類澱粉沉積，繼發於慢性發炎或感染。腎臟是最常受累的器官，可導致蛋白尿及進行性腎衰竭。",
    "synonyms": [
      "Amyloid Disease",
      "AA Amyloidosis",
      "Reactive Amyloidosis",
      "類澱粉變性"
    ],
    "epidemiology": {
      "species": "犬貓皆可",
      "age": "犬中老年（遺傳型可能較年輕），貓中年（沙皮犬家族性型可<2歲發病）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "沙皮犬（家族性腎臟類澱粉沉積症）",
        "阿比西尼亞貓（家族性腎臟類澱粉沉積症）",
        "暹羅貓（肝臟類澱粉沉積症）",
        "英國短毛貓",
        "慢性感染或發炎性疾病",
        "牛頭獵犬",
        "獵狐犬"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "多飲多尿",
        "食慾下降",
        "體重減輕",
        "嘔吐",
        "嗜睡",
        "腹部膨大（腹水/肝腫大）",
        "水腫",
        "沙皮犬：反覆發熱及關節腫脹（沙皮犬熱）"
      ],
      "physicalExam": [
        "腎腫大（早期）或腎縮小（晚期）",
        "周邊水腫（低白蛋白血症）",
        "腹水",
        "肝腫大（肝臟受累時）",
        "黏膜蒼白",
        "脫水",
        "口腔潰瘍（尿毒症）"
      ]
    },
    "pathophysiology": "AA型類澱粉沉積症中，慢性發炎使肝臟持續產生血清類澱粉A蛋白（SAA），當SAA超過正常清除能力時，其降解產物錯誤折疊形成不溶性β-摺疊纖維，沉積於組織中。腎臟沉積主要在腎絲球（犬）或腎髓質間質（貓），破壞正常組織結構。犬腎絲球沉積導致蛋白尿（腎病症候群）、最終腎絲球硬化及腎衰竭。貓腎髓質沉積可導致腎乳頭壞死。沙皮犬的家族性類澱粉沉積與過度的IL-6介導發炎反應相關。",
    "diagnosis": {
      "overview": "確診需組織活檢剛果紅染色。臨床上高度蛋白尿的腎病加上好發品種可高度懷疑。",
      "differentials": [
        "腎絲球腎炎",
        "腎病症候群其他原因",
        "慢性腎臟病",
        "蛋白流失性腸病",
        "肝硬化"
      ],
      "initialDB": [
        "尿液分析：嚴重蛋白尿（UPC>2-3）",
        "血液生化：低白蛋白血症、高膽固醇血症、氮血症",
        "CBC",
        "凝血功能（AT-III可能降低）"
      ],
      "advanced": [
        "腎臟活檢：剛果紅染色陽性、偏光顯微鏡下蘋果綠雙折射",
        "腹部超音波：腎臟大小及回聲評估",
        "血壓測量",
        "SAA蛋白濃度",
        "基因檢測（沙皮犬家族性型）"
      ]
    },
    "treatment": {
      "overview": "無特異性治療可溶解已沉積的類澱粉。治療著重於控制發炎來源、減緩沉積進程及管理腎衰竭。",
      "acute": [
        "靜脈輸液治療脫水及腎前性氮血症",
        "血栓預防：低劑量Aspirin或Clopidogrel",
        "利尿劑（嚴重水腫）",
        "白蛋白輸注（嚴重低白蛋白血症）"
      ],
      "chronic": [
        "Colchicine 0.01-0.03 mg/kg PO q24h（減少SAA生成，沙皮犬家族性型）",
        "治療潛在發炎或感染源",
        "ACE抑制劑（Enalapril 0.5 mg/kg PO q12-24h）減少蛋白尿",
        "腎臟飲食",
        "Omega-3脂肪酸補充",
        "DMSO（Dimethyl sulfoxide）外用或口服——效果存疑",
        "血栓栓塞預防（低劑量aspirin）"
      ]
    },
    "prognosis": "預後差至謹慎。一旦出現腎衰竭，疾病通常為進行性。沙皮犬家族性類澱粉沉積預後差，中位生存期在診斷後數月至1年。阿比西尼亞貓的腎臟類澱粉沉積預後亦差。早期診斷及積極管理可延緩進展。腎病症候群伴血栓栓塞併發症為主要死因之一。",
    "pearls": [
      "沙皮犬反覆發熱+關節腫脹（沙皮犬熱）=家族性類澱粉沉積高風險，應早期監測UPC",
      "阿比西尼亞貓及暹羅貓為貓類澱粉沉積的好發品種",
      "腎絲球類澱粉沉積（犬）vs 腎髓質類澱粉沉積（貓）——不同的病理表現",
      "UPC>3.5合併低白蛋白血症在好發品種高度提示",
      "Colchicine對家族性型可能有預防價值，但對已沉積的類澱粉無溶解效果"
    ],
    "diagnosticAlgorithm": {
      "title": "類澱粉沉積症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估腎臟型（蛋白尿、腎衰竭）或肝臟型（肝腫大、肝破裂），沙皮犬有品種傾向",
          "findings": [
            "蛋白尿伴漸進性腎衰竭（腎臟型）",
            "肝腫大或急性腹腔出血（肝臟型，沙皮犬常見）",
            "反覆性發熱史（沙皮犬家族性澱粉沉積症）"
          ]
        },
        {
          "step": 2,
          "action": "實驗室檢查",
          "details": "進行尿液分析、生化檢查評估腎臟和肝臟功能",
          "findings": [
            "顯著蛋白尿（尿蛋白/肌酐比升高）",
            "低白蛋白血症",
            "氮質血症（腎臟型）或肝酵素升高（肝臟型）"
          ]
        },
        {
          "step": 3,
          "action": "活檢確診",
          "details": "進行腎臟或肝臟活檢，剛果紅染色確認類澱粉蛋白沉積",
          "findings": [
            "剛果紅染色陽性（蘋果綠雙折射）",
            "組織病理學確認AA型類澱粉蛋白沉積",
            "評估臟器損害程度"
          ]
        }
      ]
    },
    "monitoring": [
      "UPC定期追蹤（每1-3個月）",
      "血清白蛋白及膽固醇",
      "腎功能指標（BUN、Creatinine、SDMA）",
      "血壓",
      "凝血功能（AT-III）"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "feline-hyperesthesia-syndrome": {
    "zh": "貓皮膚感覺過敏症候群",
    "en": "Feline Hyperesthesia Syndrome",
    "definition": "貓皮膚感覺過敏症候群（FHS）是一種行為及可能的神經學疾病，特徵為陣發性背部皮膚抽動（rippling skin）、過度自我理毛或自殘、瞳孔散大及激動行為。病因不明，可能涉及神經學、皮膚學及行為學因素的交互作用。",
    "synonyms": [
      "FHS",
      "Rolling Skin Disease",
      "Twitchy Cat Disease",
      "Neurocutaneous Syndrome",
      "貓抽搐皮膚症候群"
    ],
    "epidemiology": {
      "species": "貓（犬不發生）",
      "age": "年輕至中年貓（1-5歲多見）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "暹羅貓、緬甸貓、阿比西尼亞貓及波斯貓可能過度代表",
        "緊張、焦慮傾向的貓",
        "室內飼養",
        "環境變化或壓力"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "背部皮膚波動抽搐（rippling/rolling skin）",
        "突發性瘋狂奔跑",
        "尾巴追咬或自殘",
        "腰背部過度理毛",
        "對觸碰背部過度反應",
        "瞳孔散大",
        "發作性嚎叫",
        "發作後恢復正常"
      ],
      "physicalExam": [
        "觸碰腰背部引起皮膚抽動及過度反應",
        "可能有自殘造成的脫毛及皮膚損傷",
        "瞳孔散大（發作時）",
        "尾巴基部區域敏感",
        "發作間期神經學及皮膚檢查通常正常"
      ]
    },
    "pathophysiology": "確切病因不明，目前假說包括：(1) 部分性癲癇——某些病例EEG顯示癲癇樣放電；(2) 強迫症（OCD）——行為學疾病伴血清素系統異常；(3) 背部皮膚的感覺神經過敏；(4) 潛在皮膚病（跳蚤過敏、食物過敏）引起的神經敏感化。FHS可能是多種不同病因導致相似臨床表現的症候群，而非單一疾病。部分病例對抗癲癇藥或抗焦慮藥有反應支持不同的病理機制。",
    "diagnosis": {
      "overview": "為排除性診斷——需排除所有可能的皮膚、神經及行為學疾病後方可診斷。",
      "differentials": [
        "跳蚤過敏性皮膚炎",
        "食物過敏",
        "皮黴菌感染",
        "脊髓疾病（椎間盤突出、腫瘤）",
        "骨關節炎（腰薦部）",
        "癲癇",
        "尾部外傷或感染"
      ],
      "initialDB": [
        "完整皮膚學檢查：刮片、皮毛梳檢（跳蚤）、Wood氏燈",
        "CBC及血液生化",
        "T4（排除甲狀腺功能亢進）",
        "嚴格跳蚤預防試驗"
      ],
      "advanced": [
        "食物排除試驗（8-12週）",
        "皮膚活檢",
        "腰薦部X光或MRI",
        "腦脊髓液分析",
        "EEG（若可取得）",
        "行為學評估"
      ]
    },
    "treatment": {
      "overview": "治療為多模式方法，結合環境管理、行為修正及藥物治療。需先排除並治療所有潛在病因。",
      "acute": [
        "嚴格跳蚤預防（即使未見到跳蚤）",
        "環境豐富化（遊戲、攀爬架、互動玩具）",
        "減少環境壓力源"
      ],
      "chronic": [
        "Gabapentin 5-10 mg/kg PO q8-12h（神經性疼痛/過敏控制）",
        "Fluoxetine 0.5-1 mg/kg PO q24h（OCD/焦慮相關）",
        "Clomipramine 0.25-0.5 mg/kg PO q24h（替代抗焦慮）",
        "Phenobarbital 2-3 mg/kg PO q12h（癲癇相關型）",
        "Prednisolone短期低劑量（排除過敏性成分）",
        "費洛蒙（Feliway）擴散器",
        "行為修正治療"
      ]
    },
    "prognosis": "預後變異大。部分病例對環境管理及藥物反應良好，可有效控制症狀。其他病例可能對治療反應有限。自殘嚴重的病例需積極管理。此為慢性疾病，需長期管理而非治癒。若能確認並治療潛在病因（如跳蚤過敏），預後改善。",
    "pearls": [
      "FHS是排除性診斷——必須排除跳蚤過敏、食物過敏及脊髓疾病",
      "嚴格跳蚤預防是第一步，即使在室內貓",
      "暹羅貓及東方短毛貓系列品種似乎較易罹患",
      "部分病例實際上是跳蚤過敏——試驗性治療非常重要",
      "Gabapentin是目前最常推薦的初始藥物選擇"
    ],
    "diagnosticAlgorithm": {
      "title": "貓皮膚感覺過敏症候群 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估發作性背部皮膚波動、尾巴追咬、突然奔跑和瞳孔散大等典型行為",
          "findings": [
            "發作性背部皮膚波動抽搐",
            "突然瘋狂奔跑或攻擊自己尾巴",
            "瞳孔散大伴異常發聲"
          ]
        },
        {
          "step": 2,
          "action": "排除性檢查",
          "details": "進行完整皮膚學檢查排除跳蚤過敏和其他皮膚病，神經學檢查排除癲癇",
          "findings": [
            "皮膚檢查排除跳蚤過敏和其他過敏性皮膚炎",
            "排除脊椎病變引起的疼痛",
            "排除甲狀腺功能亢進"
          ]
        },
        {
          "step": 3,
          "action": "臨床確診",
          "details": "排除所有器質性病因後根據典型行為特徵臨床確診",
          "findings": [
            "排除所有器質性病因後臨床確診",
            "行為特徵符合典型症候群表現",
            "對加巴噴丁或抗焦慮藥物可能有反應"
          ]
        }
      ]
    },
    "monitoring": [
      "行為日誌（發作頻率及嚴重度）",
      "皮膚及毛髮狀況評估",
      "藥物副作用監測",
      "體重（過度理毛可能影響進食）",
      "生活品質評估"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "cerebellar-hypoplasia": {
    "zh": "小腦發育不全",
    "en": "Cerebellar Hypoplasia",
    "definition": "小腦發育不全是指小腦在胎兒期或新生兒期發育不完全，通常因病毒感染破壞快速分裂的小腦顆粒細胞層所致。最典型的原因為貓泛白血球減少症病毒（FPV）子宮內感染及犬犬瘟熱病毒新生兒感染。",
    "synonyms": [
      "Cerebellar Abiotrophy",
      "CH",
      "小腦未發育"
    ],
    "epidemiology": {
      "species": "貓較常見（FPV相關），犬亦可見",
      "age": "出生時即存在，開始行走時（2-3週齡）症狀明顯",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "母貓妊娠期感染FPV",
        "母貓妊娠期接種活毒FPV疫苗",
        "幼犬新生兒期犬瘟熱感染",
        "某些品種的遺傳性小腦退化（需與小腦發育不全區分）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "出生後開始行走時即出現共濟失調",
        "同窩仔貓/仔犬可能部分或全部受影響",
        "症狀不進行（非進行性）",
        "能進食、活動但動作笨拙",
        "母貓妊娠期可能有感染史"
      ],
      "physicalExam": [
        "對稱性小腦性共濟失調",
        "意向性震顫（intention tremor，接近目標時頭部震顫加劇）",
        "寬基步態（wide-based stance）",
        "測距障礙（dysmetria，過衝步態hypermetria）",
        "缺乏威脅反應但視力正常",
        "姿勢反應延遲",
        "意識及智力正常"
      ]
    },
    "pathophysiology": "FPV或CDV感染正在快速分裂的小腦外顆粒細胞層，導致細胞壞死及小腦發育不全。FPV感染發生在妊娠後期至新生兒早期（小腦發育最活躍的時期），病毒具有對快速分裂細胞的趨性。CDV在幼犬新生兒期同樣影響小腦發育。受損的小腦無法適當調控運動的協調、平衡及精細動作，但因病變為非進行性（病毒清除後不再破壞），臨床症狀穩定不惡化。部分個體可隨時間學習代償性運動策略。",
    "diagnosis": {
      "overview": "根據典型病史（子宮內FPV/CDV暴露）及出生即有的非進行性小腦症狀即可臨床診斷。",
      "differentials": [
        "小腦退化/萎縮（cerebellar abiotrophy/degeneration，進行性）",
        "蓄積症（storage diseases）",
        "先天性腦積水",
        "小腦腫瘤（罕見於幼年動物）",
        "中毒"
      ],
      "initialDB": [
        "完整神經學檢查",
        "CBC、血液生化（排除代謝性病因）",
        "FPV抗體檢測（母貓或患貓）"
      ],
      "advanced": [
        "MRI：小腦明顯縮小、小腦溝裂加深",
        "CT（替代MRI）",
        "腦脊髓液分析（排除感染性腦炎）",
        "基因檢測（排除遺傳性小腦退化，特定品種）"
      ]
    },
    "treatment": {
      "overview": "無特異性治療。小腦發育不全為不可逆但非進行性病變，重點為支持性護理及環境管理。",
      "acute": [
        "無需急性治療"
      ],
      "chronic": [
        "環境調整：移除危險物品、提供止滑地面",
        "室內飼養（避免戶外危險）",
        "抬高食碗（減少頭部震顫對進食的影響）",
        "確保充分營養攝取",
        "物理治療及環境豐富化",
        "預防接種（避免其他感染）"
      ]
    },
    "prognosis": "預後取決於嚴重程度。輕至中度病例可有良好的生活品質，能適應日常生活。症狀不會惡化，部分動物隨年齡可學習代償。重度病例（無法行走或進食）預後較差，可能需考慮安樂死。多數輕中度病例可作為良好的室內寵物，壽命正常。",
    "pearls": [
      "非進行性是與小腦退化（abiotrophy）鑑別的關鍵——退化型會惡化",
      "同窩仔貓/犬受影響程度可能不同，取決於感染時的胎兒發育階段",
      "母貓妊娠期絕對不可接種活毒FPV疫苗",
      "MRI可見小腦明顯縮小但其他腦結構正常",
      "許多輕中度病例的飼主表示動物適應良好，生活品質佳"
    ],
    "diagnosticAlgorithm": {
      "title": "小腦發育不全 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估幼畜出生後即出現的非進行性共濟失調，貓常因子宮內感染FPV（貓瘟），犬較少見",
          "findings": [
            "出生後即出現的共濟失調",
            "意向性震顫（吃東西時頭部晃動）",
            "寬基步態伴過度跨步"
          ]
        },
        {
          "step": 2,
          "action": "神經學檢查",
          "details": "進行完整神經學檢查確認小腦功能障礙，確認症狀非進行性",
          "findings": [
            "小腦性共濟失調（非前庭性）",
            "威脅反射缺失伴視力正常",
            "確認症狀非進行性（不惡化）"
          ]
        },
        {
          "step": 3,
          "action": "影像學確診",
          "details": "MRI確認小腦體積減小，排除其他小腦疾病",
          "findings": [
            "MRI顯示小腦體積明顯縮小",
            "排除小腦腫瘤或炎症性疾病",
            "確診為先天性小腦發育不全"
          ]
        }
      ]
    },
    "monitoring": [
      "定期神經學評估（確認非進行性）",
      "體重及營養狀態",
      "生活品質評估",
      "無需影像學追蹤（病變穩定）"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "canine-chronic-bronchitis": {
    "zh": "犬慢性支氣管炎",
    "en": "Canine Chronic Bronchitis",
    "definition": "犬慢性支氣管炎定義為持續超過2個月的每日咳嗽，且排除了其他導致慢性咳嗽的疾病。特徵為氣道黏膜的慢性發炎、黏液分泌增加及氣道壁增厚，導致氣道阻塞及呼吸功能下降。",
    "synonyms": [
      "COPD（犬）",
      "Chronic Obstructive Pulmonary Disease",
      "Chronic Airway Disease"
    ],
    "epidemiology": {
      "species": "犬（貓的類似疾病為貓氣喘）",
      "age": "中老年犬（通常>6歲）",
      "sex": "小型犬母犬可能較多",
      "riskFactors": [
        "小型犬至中型犬（西高地白梗、可卡犬、貴賓犬）",
        "肥胖",
        "二手菸暴露",
        "空氣污染",
        "牙周病（細菌微量吸入）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "持續性咳嗽（>2個月）",
        "乾咳或濕咳",
        "晨間或運動後咳嗽加劇",
        "呼吸急促",
        "運動不耐",
        "興奮時咳嗽發作",
        "可能有終末期喘鳴"
      ],
      "physicalExam": [
        "氣管觸診引發咳嗽",
        "肺部聽診：呼氣性囉音（wheezes）、粗糙呼吸音",
        "呼氣相延長",
        "肥胖（常見共病）",
        "發紺（嚴重時）",
        "腹式呼吸（嚴重時）"
      ]
    },
    "pathophysiology": "慢性氣道發炎導致：(1) 杯狀細胞增生及黏液腺肥大→黏液過度分泌；(2) 氣道壁纖維化及平滑肌肥厚→氣道壁增厚；(3) 黏膜纖毛清除功能下降→黏液滯留。這些變化造成氣道阻塞（主要為小氣道），增加氣道阻力。長期病程可導致支氣管擴張症（bronchiectasis）——不可逆的氣道擴張及結構破壞。動態氣道塌陷可加劇阻塞。",
    "diagnosis": {
      "overview": "排除性診斷——需排除心臟病、肺炎、氣管塌陷、腫瘤等其他慢性咳嗽原因。支氣管鏡及BAL為金標準。",
      "differentials": [
        "充血性心衰竭",
        "氣管塌陷",
        "肺炎（感染性/吸入性）",
        "肺腫瘤",
        "肺絲蟲",
        "過敏性氣道疾病"
      ],
      "initialDB": [
        "胸腔X光：支氣管壁增厚（doughnut/tram-line signs）、過度充氣",
        "CBC及血液生化",
        "糞便檢查（排除肺絲蟲）",
        "心臟評估（NT-proBNP、超音波排除心臟病）"
      ],
      "advanced": [
        "支氣管鏡：氣道黏膜發紅、腫脹、黏液增多",
        "支氣管肺泡灌洗（BAL）：細胞學及細菌培養",
        "胸部CT：支氣管擴張評估",
        "動脈血氣分析",
        "透視檢查（氣道動態塌陷評估）"
      ]
    },
    "treatment": {
      "overview": "治療以減少氣道發炎、控制咳嗽及改善生活品質為目標。無法治癒，需終身管理。",
      "acute": [
        "急性惡化：短效支氣管擴張劑（Terbutaline 0.01 mg/kg SC）",
        "氧氣治療（呼吸窘迫時）",
        "Butorphanol 0.05-0.1 mg/kg IV/IM（嚴重咳嗽鎮咳）"
      ],
      "chronic": [
        "吸入型類固醇：Fluticasone MDI via spacer 125-250 μg q12h（首選長期抗炎）",
        "口服Prednisolone 0.5-1 mg/kg PO q24h×7-14天→逐漸減量（急性期）",
        "支氣管擴張劑：Theophylline 10 mg/kg PO q12h",
        "Albuterol MDI 吸入（急性支氣管痙攣）",
        "減重（肥胖者必須）",
        "避免環境刺激物（菸煙、粉塵）",
        "Hydrocodone 0.22 mg/kg PO q6-12h（頑固性咳嗽鎮咳）"
      ]
    },
    "prognosis": "為慢性進行性疾病，不可治癒但可有效管理。適當治療下多數犬可維持良好生活品質數年。已發展為支氣管擴張症者預後較差，反覆感染風險增加。肥胖顯著惡化預後。合併氣管塌陷者治療更困難。",
    "pearls": [
      "慢性咳嗽犬必須先排除心臟病——NT-proBNP是有用的篩檢工具",
      "吸入型類固醇可避免全身性副作用，是長期抗炎治療的首選",
      "減重是肥胖犬慢性支氣管炎管理最重要的非藥物措施",
      "BAL細胞學以嗜中性球為主提示感染性成分，嗜酸性球為主提示過敏性成分",
      "支氣管擴張症（bronchiectasis）是不可逆的終末期變化"
    ],
    "diagnosticAlgorithm": {
      "title": "犬慢性支氣管炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估持續2個月以上的慢性咳嗽，排除其他呼吸道和心臟疾病",
          "findings": [
            "持續性咳嗽超過2個月",
            "咳嗽可能在運動或興奮時加劇",
            "可能有黏液性痰液產生"
          ]
        },
        {
          "step": 2,
          "action": "影像學與排除性檢查",
          "details": "進行胸腔X光排除心臟病和腫瘤，心臟超音波評估心功能",
          "findings": [
            "X光顯示支氣管壁增厚（甜甜圈和軌道線徵象）",
            "排除心臟擴大和充血性心衰竭",
            "排除肺腫瘤"
          ]
        },
        {
          "step": 3,
          "action": "支氣管鏡與確診",
          "details": "進行支氣管鏡檢查和支氣管肺泡灌洗液（BAL）分析確認炎症類型",
          "findings": [
            "支氣管鏡見黏膜充血和黏液增加",
            "BAL細胞學顯示中性球或混合性炎症",
            "排除感染性原因後確診"
          ]
        }
      ]
    },
    "monitoring": [
      "臨床症狀評估（咳嗽頻率、運動耐受度）",
      "定期胸腔X光",
      "BAL追蹤（評估治療反應，必要時）",
      "體重管理追蹤",
      "動脈血氧飽和度"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "eosinophilic-bronchopneumopathy": {
    "zh": "嗜酸性支氣管肺病",
    "en": "Eosinophilic Bronchopneumopathy",
    "definition": "嗜酸性支氣管肺病（EBP）是犬的一種氣道及肺實質的嗜酸性球浸潤性疾病，特徵為氣道分泌物及肺組織中大量嗜酸性球浸潤。多數為特發性，可能與過敏或免疫介導反應相關。為犬的慢性咳嗽重要鑑別診斷之一。",
    "synonyms": [
      "EBP",
      "Pulmonary Infiltrate with Eosinophilia",
      "PIE Syndrome",
      "Eosinophilic Pneumonia"
    ],
    "epidemiology": {
      "species": "犬較常見",
      "age": "年輕至中年犬（中位年齡4-6歲）",
      "sex": "雌犬可能略多",
      "riskFactors": [
        "哈士奇及阿拉斯加雪橇犬（可能過度代表）",
        "過敏體質",
        "寄生蟲暴露（肺絲蟲、心絲蟲幼蟲遷移）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "慢性咳嗽（可持續數週至數月）",
        "呼吸困難",
        "運動不耐",
        "鼻分泌物",
        "打噴嚏",
        "可能有嘔吐或食慾不振"
      ],
      "physicalExam": [
        "肺部聽診：粗糙呼吸音、囉音（crackles）或喘鳴（wheezes）",
        "黏膜鼻黏膜可能有鼻分泌物",
        "可能有輕微發燒",
        "一般狀態通常良好"
      ]
    },
    "pathophysiology": "氣道及肺泡組織受到大量嗜酸性球浸潤，這些細胞釋放的顆粒蛋白（主要鹼性蛋白、嗜酸性陽離子蛋白等）造成組織損傷及發炎。免疫機制可能涉及Th2免疫反應過度活化、IgE介導的過敏反應。已知觸發因素包括寄生蟲幼蟲遷移（Angiostrongylus vasorum、Crenosoma vulpis、心絲蟲幼蟲）及環境過敏原，但多數病例為特發性。嗜酸性球浸潤可影響氣管支氣管（支氣管型）、肺實質（肺泡型）或兩者（混合型）。",
    "diagnosis": {
      "overview": "BAL細胞學顯示嗜酸性球>20%（通常>50%）為診斷關鍵。需排除寄生蟲病因。",
      "differentials": [
        "肺絲蟲感染（Angiostrongylus、Crenosoma）",
        "心絲蟲病",
        "犬慢性支氣管炎",
        "肺腫瘤",
        "過敏性支氣管炎",
        "真菌性肺炎"
      ],
      "initialDB": [
        "胸腔X光：支氣管壁增厚、肺泡或間質浸潤、可能有支氣管擴張",
        "CBC：周邊血嗜酸性球增多（常見但非絕對）",
        "糞便Baermann檢查（排除肺絲蟲）",
        "心絲蟲檢測"
      ],
      "advanced": [
        "支氣管肺泡灌洗（BAL）：嗜酸性球>20%（診斷關鍵）",
        "支氣管鏡：黏膜發紅、腫脹、黏液栓塞",
        "BAL細菌培養",
        "過敏原檢測",
        "寄生蟲血清學"
      ]
    },
    "treatment": {
      "overview": "口服類固醇為治療主軸，多數病例反應良好。需排除並治療所有寄生蟲病因。",
      "acute": [
        "Prednisolone 1-2 mg/kg PO q12h×7-14天（誘導緩解）",
        "驅蟲治療（排除寄生蟲前先行治療）：Fenbendazole 50 mg/kg PO q24h×14天"
      ],
      "chronic": [
        "Prednisolone逐漸減量至最低有效劑量（目標q48h或更低）",
        "吸入型Fluticasone（減少全身類固醇用量）",
        "環境過敏原控制",
        "Cyclosporine 5 mg/kg PO q24h（類固醇節約劑）",
        "月型驅蟲持續進行",
        "Omega-3脂肪酸補充"
      ]
    },
    "prognosis": "預後良好。多數病例對類固醇治療反應優異。約75%的犬可達到良好的臨床控制。復發常見於類固醇減量或停藥後，部分病例需長期低劑量維持治療。寄生蟲相關者經適當驅蟲後可完全恢復。少數頑固病例可能進展為肺纖維化。",
    "pearls": [
      "BAL嗜酸性球>20%是EBP診斷的關鍵指標",
      "開始類固醇治療前務必先驅蟲——寄生蟲病例用類固醇可能惡化",
      "哈士奇及阿拉斯加雪橇犬為好發品種",
      "周邊血嗜酸性球可能正常——BAL才是金標準",
      "年輕犬出現慢性咳嗽應將EBP列入鑑別診斷前列"
    ],
    "diagnosticAlgorithm": {
      "title": "嗜酸性支氣管肺病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估慢性咳嗽、運動不耐受和鼻分泌物，注意年輕犬更常見",
          "findings": [
            "慢性咳嗽伴呼吸困難",
            "黏液膿性鼻分泌物",
            "運動不耐受"
          ]
        },
        {
          "step": 2,
          "action": "血液與影像檢查",
          "details": "進行CBC評估嗜酸性球計數，胸腔X光評估肺部病變模式",
          "findings": [
            "周邊血液嗜酸性球顯著增多",
            "X光顯示支氣管間質性和肺泡性浸潤",
            "可能見肺門淋巴結腫大"
          ]
        },
        {
          "step": 3,
          "action": "BAL分析與確診",
          "details": "進行支氣管肺泡灌洗液分析確認嗜酸性球浸潤，排除寄生蟲和真菌感染",
          "findings": [
            "BAL嗜酸性球>20%",
            "糞便浮游法排除肺蟲感染",
            "排除真菌感染後確診"
          ]
        }
      ]
    },
    "monitoring": [
      "臨床症狀改善程度",
      "BAL追蹤（評估嗜酸性球比例變化）",
      "胸腔X光追蹤",
      "類固醇副作用監測（PU/PD、肝指數）",
      "糞便寄生蟲複查"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "pulmonary-fibrosis": {
    "zh": "肺纖維化",
    "en": "Pulmonary Fibrosis",
    "definition": "肺纖維化是指肺間質（肺泡壁、支氣管周圍組織）的進行性纖維化，導致肺順應性降低、氣體交換功能下降及限制性通氣障礙。犬的特發性肺纖維化（IPF）在西高地白梗中有品種傾向。",
    "synonyms": [
      "IPF",
      "Idiopathic Pulmonary Fibrosis",
      "Interstitial Lung Disease",
      "特發性肺纖維化"
    ],
    "epidemiology": {
      "species": "犬較常見（IPF），貓罕見",
      "age": "中老年犬（通常>9歲）",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "西高地白梗（品種特異性IPF）",
        "其他梗犬品種",
        "長期暴露於環境毒素",
        "慢性肺部疾病終末期"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "進行性運動不耐",
        "呼吸急促",
        "乾咳",
        "發紺（運動後或嚴重時）",
        "進展緩慢（數月至數年）"
      ],
      "physicalExam": [
        "呼吸頻率增加",
        "限制性呼吸模式（淺快呼吸）",
        "肺部聽診：吸氣末爆裂音（end-inspiratory crackles/Velcro crackles）",
        "發紺（運動後或晚期）",
        "可能有右心衰竭徵象（晚期肺心症）"
      ]
    },
    "pathophysiology": "正常肺泡壁的上皮-內皮屏障受損後，異常的傷口修復過程導致成纖維細胞過度增殖、膠原沉積及細胞外基質重塑。纖維化組織取代正常肺泡結構，使肺泡壁增厚，氣體擴散距離增加，導致低血氧症。肺順應性降低增加呼吸功，肺血管床破壞可導致肺動脈高壓及右心衰竭（肺心症）。西高地白梗的IPF可能有遺傳因素。疾病為不可逆且進行性。",
    "diagnosis": {
      "overview": "高解析度CT（HRCT）為最佳影像工具。確診需肺活檢但臨床上少執行。",
      "differentials": [
        "充血性心衰竭（左心）",
        "肺炎",
        "肺腫瘤（瀰漫性）",
        "嗜酸性支氣管肺病",
        "肺水腫（非心因性）"
      ],
      "initialDB": [
        "胸腔X光：間質紋理增加、毛玻璃狀密度增高、支氣管壁增厚",
        "脈搏血氧測定（pulse oximetry）：SpO2降低",
        "動脈血氣分析：低PaO2",
        "心臟超音波：排除左心病及評估肺動脈高壓"
      ],
      "advanced": [
        "高解析度CT（HRCT）：網狀紋理、蜂窩狀改變、牽引性支氣管擴張",
        "BAL：通常非特異性（嗜中性球或混合型增加）",
        "肺活檢（經胸腔鏡或開胸）：確定性診斷但少執行",
        "6分鐘步行試驗（評估功能性運動耐受度）"
      ]
    },
    "treatment": {
      "overview": "無法治癒。治療以支持性護理、改善症狀及減緩進展為目標。",
      "acute": [
        "氧氣治療（低血氧發作時）",
        "Butorphanol 0.05-0.1 mg/kg PRN（嚴重呼吸窘迫時鎮靜）"
      ],
      "chronic": [
        "低劑量Prednisolone 0.5 mg/kg PO q24h（抗發炎，效果有限）",
        "Sildenafil 1-2 mg/kg PO q8-12h（肺動脈高壓治療）",
        "支氣管擴張劑：Theophylline 10 mg/kg PO q12h",
        "氧氣治療（居家氧氣濃縮器）",
        "避免過度運動及熱應激",
        "體重管理",
        "N-acetylcysteine 70 mg/kg PO q12h（抗氧化，理論性益處）"
      ]
    },
    "prognosis": "預後差。疾病為進行性且不可逆，多數犬在診斷後數月至2年內因呼吸衰竭或嚴重低血氧安樂死。西高地白梗IPF中位生存期約18個月。Sildenafil可改善肺動脈高壓症狀但不改變疾病進程。早期診斷及支持性護理可改善生活品質。",
    "pearls": [
      "西高地白梗>9歲+進行性呼吸困難+吸氣末爆裂音=高度懷疑IPF",
      "Velcro crackles（類似撕開魔鬼氈的聲音）是IPF的特徵性聽診發現",
      "運動後SpO2下降是早期發現的敏感指標",
      "HRCT對肺纖維化的診斷優於普通X光",
      "肺動脈高壓是IPF晚期的常見併發症，Sildenafil可改善"
    ],
    "diagnosticAlgorithm": {
      "title": "肺纖維化 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估漸進性呼吸困難和運動不耐受，好發於中老年西高地白梗犬",
          "findings": [
            "漸進性呼吸困難",
            "運動不耐受加劇",
            "聽診肺部可聞爆裂音（velcro音）"
          ]
        },
        {
          "step": 2,
          "action": "影像學檢查",
          "details": "進行胸腔X光和高解析度CT（HRCT）評估肺部纖維化模式",
          "findings": [
            "X光顯示瀰漫性間質性肺病變",
            "HRCT顯示蜂窩狀或網狀病變",
            "可能伴隨肺動脈高壓"
          ]
        },
        {
          "step": 3,
          "action": "排除性診斷與確診",
          "details": "排除其他間質性肺病因，動脈血氣分析評估氧合功能，必要時肺活檢",
          "findings": [
            "動脈血氣分析顯示低氧血症",
            "排除感染性和腫瘤性間質性肺病",
            "肺活檢可確認纖維化類型但風險較高"
          ]
        }
      ]
    },
    "monitoring": [
      "SpO2定期測量（靜息及運動後）",
      "呼吸頻率追蹤",
      "胸腔X光或CT追蹤",
      "心臟超音波（肺動脈壓評估）",
      "生活品質評估"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "diaphragmatic-hernia-traumatic": {
    "zh": "外傷性膈疝",
    "en": "Traumatic Diaphragmatic Hernia",
    "definition": "外傷性膈疝是因外力（通常為車禍或墜落）造成橫膈膜破裂，腹腔臟器經破裂口疝入胸腔，導致肺臟壓迫及呼吸功能障礙的急症。為犬貓最常見的膈疝類型。",
    "synonyms": [
      "Traumatic Diaphragmatic Rupture",
      "TDH"
    ],
    "epidemiology": {
      "species": "犬貓皆可",
      "age": "任何年齡，年輕動物較常見（戶外活動多）",
      "sex": "雄性可能較多（戶外活動多）",
      "riskFactors": [
        "車禍",
        "高處墜落",
        "被踢踹",
        "其他腹部鈍傷",
        "戶外活動"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "已知外傷史",
        "急性呼吸困難",
        "運動不耐",
        "食慾下降",
        "嘔吐或乾嘔",
        "慢性病例可能數週至數月後才發現"
      ],
      "physicalExam": [
        "呼吸困難（限制性呼吸模式）",
        "腹部觸診：臟器缺失感（空腹感）",
        "胸部聽診：一側肺音減弱或消失",
        "胸部聽診：可聽到腸蠕動音",
        "心音移位或減弱",
        "同時存在其他外傷徵象（擦傷、骨折）",
        "休克徵象（急性）"
      ]
    },
    "pathophysiology": "腹腔壓力突然升高（鈍力外傷）而聲門關閉，造成胸腹壓差急劇增加，撕裂橫膈膜（最常見於肌性部分）。腹腔臟器（肝臟、胃、腸、脾臟、網膜最常見）經破裂口進入胸腔，壓迫肺臟，減少有效通氣容積。嚴重時可導致縱隔移位、大血管扭曲及回心血量減少。疝入的胃可能擴張或扭轉，腸管可能嵌頓壞死。慢性膈疝可形成胸腔粘連。左側膈疝較右側常見（肝臟對右側提供部分保護）。",
    "diagnosis": {
      "overview": "胸腔X光及超音波為主要診斷工具。可以造影劑研究確認。",
      "differentials": [
        "先天性膈疝（腹膜心包膈疝PPDH）",
        "胸腔積液其他原因",
        "肺塌陷",
        "肺炎",
        "肺挫傷"
      ],
      "initialDB": [
        "胸腔X光：橫膈膜線中斷、胸腔內可見腹腔臟器影像、心影移位",
        "腹部X光：腹腔臟器減少",
        "TFAST超音波：快速評估胸腔"
      ],
      "advanced": [
        "正性上消化道造影（確認胃/腸管疝入）",
        "胸腔超音波：評估疝入臟器",
        "CT：精確定位破裂口及疝入臟器",
        "腹膜灌洗造影（celiography）"
      ]
    },
    "treatment": {
      "overview": "手術修復為唯一確定性治療。急性病例需先穩定後再手術。慢性膈疝也應手術修復。",
      "acute": [
        "ABC穩定化：氣道-呼吸-循環",
        "氧氣治療",
        "靜脈輸液抗休克（晶體液加減膠體液）",
        "胸腔穿刺減壓（大量胸腔積液時）",
        "疼痛管理",
        "禁止壓迫腹部",
        "保持前高後低體位（減少臟器疝入）"
      ],
      "chronic": [
        "手術修復（正中開腹入路最常用）",
        "將疝入臟器回納腹腔",
        "評估臟器存活性（壞死者需切除）",
        "膈膜破裂口修復（直接縫合或使用補片）",
        "胸管放置及術後引流",
        "術後正壓通氣支持"
      ]
    },
    "prognosis": "手術修復成功率高，存活率約80-90%。急性病例（24小時內）存活率略高於慢性病例。預後不良因素包括：胃疝入擴張、臟器壞死、伴隨嚴重多重外傷、術後再擴張性肺水腫。術後再擴張性肺水腫（re-expansion pulmonary edema）為重要併發症，好發於慢性膈疝修復後。同時存在多重外傷者預後取決於整體傷勢。",
    "pearls": [
      "車禍犬貓必須胸腔X光篩檢膈疝——症狀可能延遲出現",
      "左側膈疝較右側常見",
      "慢性膈疝也需要手術——臟器嵌頓壞死風險持續存在",
      "術後再擴張性肺水腫好發於慢性膈疝修復後——需緩慢重新擴張肺臟",
      "腹部觸診的空腹感——腹腔臟器已疝入胸腔",
      "胃疝入胸腔後擴張是緊急情況——需立即手術"
    ],
    "diagnosticAlgorithm": {
      "title": "外傷性膈疝 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估外傷後呼吸困難，注意車禍、墜落等創傷病史，腹部可能觸診空虛",
          "findings": [
            "創傷後急性呼吸困難",
            "聽診胸腔可聞腸蠕動音",
            "腹部觸診感覺器官缺失"
          ]
        },
        {
          "step": 2,
          "action": "影像學檢查",
          "details": "進行胸腔和腹腔X光評估，必要時鋇劑或陽性對比劑確認",
          "findings": [
            "胸腔X光見腹腔器官影像（胃、腸、肝）",
            "膈肌輪廓中斷或消失",
            "腹部器官位移至胸腔"
          ]
        },
        {
          "step": 3,
          "action": "確診與手術準備",
          "details": "超音波輔助確認疝入器官，評估患畜穩定度準備手術修復",
          "findings": [
            "超音波確認疝入胸腔的器官類型",
            "評估併發創傷（肺挫傷、氣胸等）",
            "穩定後手術修復為唯一根治方法"
          ]
        }
      ]
    },
    "monitoring": [
      "術後連續SpO2監測",
      "胸管引流量追蹤",
      "術後胸腔X光確認肺復張",
      "呼吸功能評估",
      "腹部觸診（排除復發）"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "fanconi-syndrome": {
    "zh": "范乳尼症候群",
    "en": "Fanconi Syndrome",
    "definition": "范乳尼症候群是近端腎小管功能廣泛障礙的疾病，導致正常由腎小管再吸收的物質（葡萄糖、胺基酸、磷酸鹽、碳酸氫根、鈉、鉀、尿酸等）異常流失於尿液中。可為遺傳性（巴辛吉犬）或後天性。",
    "synonyms": [
      "Fanconi-like Syndrome",
      "Renal Tubular Dysfunction",
      "近端腎小管功能障礙"
    ],
    "epidemiology": {
      "species": "犬較常見，貓罕見",
      "age": "遺傳性：巴辛吉犬2-5歲發病；後天性：任何年齡",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "巴辛吉犬（遺傳性，體染色體隱性遺傳）",
        "雞肉乾零食攝入（後天性，特定產品）",
        "過期四環素類抗生素",
        "重金屬中毒",
        "銅蓄積症",
        "其他腎毒性藥物"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "多飲多尿",
        "體重減輕",
        "食慾下降",
        "嗜睡",
        "肌肉無力",
        "脫水",
        "攝入雞肉乾零食史（後天性）"
      ],
      "physicalExam": [
        "脫水",
        "體態消瘦",
        "肌肉無力",
        "骨骼疼痛（嚴重磷酸鹽流失時）",
        "黏膜乾燥",
        "一般狀態沈鬱"
      ]
    },
    "pathophysiology": "近端腎小管上皮細胞功能廣泛受損，導致正常過濾後應被再吸收的溶質大量流失於尿液中。關鍵後果包括：(1) 糖尿（血糖正常但尿糖陽性——腎性糖尿）；(2) 胺基酸尿；(3) 碳酸氫根流失導致近端腎小管酸中毒（Type II RTA）及代謝性酸中毒；(4) 磷酸鹽流失導致低磷血症及骨軟化症；(5) 鈉、鉀流失導致電解質異常。巴辛吉犬的遺傳型與近端腎小管轉運蛋白的基因缺陷有關。疾病進展可能導致慢性腎衰竭。",
    "diagnosis": {
      "overview": "正常血糖伴糖尿為最初線索。尿液分析及血液生化可確認多種溶質異常流失。",
      "differentials": [
        "糖尿病（真性糖尿）",
        "原發性腎小管酸中毒",
        "慢性腎臟病",
        "腎絲球腎炎"
      ],
      "initialDB": [
        "尿液分析：糖尿（正常血糖下）、蛋白尿",
        "血糖：正常（排除糖尿病）",
        "血液生化：代謝性酸中毒、低磷血症、低鉀血症",
        "尿液胺基酸分析"
      ],
      "advanced": [
        "碳酸氫根分泌分數測定",
        "磷酸鹽排泄分數",
        "腎臟超音波",
        "腎臟活檢（評估腎小管損傷程度）",
        "基因檢測（巴辛吉犬遺傳型）"
      ]
    },
    "treatment": {
      "overview": "治療以補充流失的溶質及矯正代謝異常為主。針對病因治療（若為後天性）。",
      "acute": [
        "靜脈輸液矯正脫水及電解質異常",
        "碳酸氫鈉補充（矯正代謝性酸中毒）",
        "磷酸鹽補充（嚴重低磷血症）",
        "鉀補充"
      ],
      "chronic": [
        "碳酸氫鈉 8-12 mEq/kg/天 PO（分次給予，矯正酸中毒）",
        "磷酸鹽補充",
        "鉀補充（視需要）",
        "維生素D補充（骨軟化症預防）",
        "蛋白質及熱量充足的飲食",
        "停止致病藥物或毒素暴露",
        "巴辛吉犬：依Fanconi Disease Management Protocol管理"
      ]
    },
    "prognosis": "遺傳性（巴辛吉犬）：長期預後謹慎至差，多數犬在數年內進展為慢性腎衰竭，但積極管理可延緩進展。後天性（雞肉乾零食相關）：停止暴露後多數犬可改善或恢復，預後較好。藥物誘發性：停藥後通常可逆。早期診斷及積極管理電解質失衡是改善預後的關鍵。",
    "pearls": [
      "巴辛吉犬+正常血糖糖尿=高度懷疑遺傳性Fanconi syndrome",
      "雞肉乾零食（jerky treats）與後天性Fanconi syndrome的關聯已被FDA確認",
      "正常血糖伴糖尿是最典型且最早的臨床發現",
      "碳酸氫鈉補充是治療核心——需監測酸鹼狀態調整劑量",
      "巴辛吉犬主人應每月進行尿液葡萄糖試紙篩檢"
    ],
    "diagnosticAlgorithm": {
      "title": "范乳尼症候群 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估多尿多渴、體重下降和肌肉無力，巴仙吉犬有遺傳傾向",
          "findings": [
            "多尿多渴",
            "體重下降伴食慾可能正常",
            "肌肉無力與嗜睡"
          ]
        },
        {
          "step": 2,
          "action": "尿液與血液分析",
          "details": "進行完整尿液分析（特別是尿糖和胺基酸）和血液生化檢查",
          "findings": [
            "糖尿伴正常血糖（腎性糖尿）",
            "尿液胺基酸升高",
            "代謝性酸中毒（碳酸氫鹽降低）"
          ]
        },
        {
          "step": 3,
          "action": "確診與病因調查",
          "details": "確認近端腎小管功能障礙的多重溶質流失，區分遺傳性和獲得性",
          "findings": [
            "尿液磷酸鹽、尿酸和電解質流失增加",
            "巴仙吉犬品種相關為遺傳性",
            "排除藥物或毒素引起的獲得性原因"
          ]
        }
      ]
    },
    "monitoring": [
      "定期血液生化（電解質、BUN、Cr）",
      "血氣分析（酸鹼狀態）",
      "尿液分析",
      "體重追蹤",
      "腎功能進展評估（SDMA）"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "hypernatremia": {
    "zh": "高鈉血症",
    "en": "Hypernatremia",
    "definition": "高鈉血症定義為血清鈉濃度高於正常範圍（犬>155 mEq/L，貓>162 mEq/L）。本質上反映的是體內自由水相對於鈉的不足，可由水分攝取不足、過量水分喪失或罕見的鈉過量攝入引起。",
    "synonyms": [
      "Hypernatraemia",
      "高血鈉"
    ],
    "epidemiology": {
      "species": "犬貓皆可",
      "age": "任何年齡，幼年及老年動物較易發生",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "無法自主飲水的動物",
        "尿崩症",
        "嚴重嘔吐或腹瀉",
        "高滲透性利尿",
        "中樞神經系統疾病影響渴感",
        "鈉過量攝入（鹽中毒、高滲鹽水過量輸注）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "嗜睡或昏迷",
        "食慾不振",
        "嘔吐",
        "已知水分攝取受限或大量水分喪失",
        "多飲多尿（尿崩症相關時）",
        "癲癇發作"
      ],
      "physicalExam": [
        "神經學異常（嗜睡、昏迷、癲癇）",
        "黏膜乾燥",
        "皮膚彈性降低（脫水型）",
        "肌肉震顫或僵硬",
        "高體溫",
        "心跳加速"
      ]
    },
    "pathophysiology": "血清鈉升高使細胞外液滲透壓上升，水分從細胞內移向細胞外，導致細胞脫水。腦細胞脫水是最危險的後果，可導致腦組織縮小、橋靜脈撕裂及腦出血。慢性高鈉血症（超過24-48小時）時，腦細胞產生有機滲透物質（idiogenic osmoles）使腦容積部分恢復。因此，快速矯正慢性高鈉血症同樣危險——可導致腦水腫。矯正速度不應超過0.5-1 mEq/L/小時（每天不超過10-12 mEq/L）。",
    "diagnosis": {
      "overview": "血清鈉濃度測定即可確診。需進一步釐清病因。",
      "differentials": [
        "中樞性尿崩症",
        "腎源性尿崩症",
        "純水喪失（無法飲水）",
        "低張液體喪失（嘔吐、腹瀉、腎臟）",
        "鈉過量攝入"
      ],
      "initialDB": [
        "血清電解質：Na+升高",
        "血清滲透壓（計算或測量）",
        "尿液分析：尿比重及尿液滲透壓（鑑別尿崩症）",
        "BUN/Creatinine",
        "血糖"
      ],
      "advanced": [
        "水禁止試驗（water deprivation test，穩定後考慮）",
        "去氨加壓素（DDAVP）試驗（鑑別中樞vs腎源性尿崩症）",
        "腦部MRI（排除中樞病變）",
        "腎上腺功能檢查"
      ]
    },
    "treatment": {
      "overview": "治療重點為安全地補充自由水，降低血鈉濃度。矯正速度過快可致腦水腫。同時治療潛在病因。",
      "acute": [
        "5% Dextrose in Water (D5W) 靜脈輸注（純水喪失型首選）",
        "0.45%生理鹽水（低張液體喪失型）",
        "矯正速度：不超過0.5-1 mEq/L/小時，每日不超過10-12 mEq/L",
        "頻繁監測血鈉（每2-4小時）",
        "Mannitol 0.5-1 g/kg IV（若有腦水腫徵象）"
      ],
      "chronic": [
        "治療潛在病因",
        "中樞性尿崩症：DDAVP滴鼻或皮下注射",
        "確保充足飲水",
        "監測並維持正常鈉濃度"
      ]
    },
    "prognosis": "取決於病因、嚴重程度及矯正是否得當。輕度高鈉血症若適當矯正預後良好。重度（>180 mEq/L）或伴嚴重神經症狀者預後謹慎至差。矯正過快導致的腦水腫為重要醫源性風險。尿崩症經適當治療後預後良好。",
    "pearls": [
      "矯正速度是治療成敗的關鍵——不超過0.5-1 mEq/L/小時",
      "慢性高鈉血症快速矯正比高鈉血症本身更危險（腦水腫）",
      "尿比重可快速鑑別病因：極低尿比重提示尿崩症，正常濃縮尿提示水攝取不足",
      "鈉中毒在犬中可見於攝入食鹽麵團或路邊除冰鹽",
      "無法自主飲水的住院動物是高鈉血症高風險群"
    ],
    "diagnosticAlgorithm": {
      "title": "高鈉血症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估神經症狀（煩躁、震顫、抽搐）和脫水表現，詢問飲水限制或鈉攝入過多病史",
          "findings": [
            "神經症狀（煩躁、抽搐、昏迷）",
            "嚴重脫水表現",
            "皮膚彈性異常（黏性皮膚）"
          ]
        },
        {
          "step": 2,
          "action": "實驗室檢查",
          "details": "測量血清鈉濃度，評估血漿滲透壓和尿液分析",
          "findings": [
            "血清鈉>155 mEq/L",
            "血漿滲透壓升高",
            "尿液濃縮程度評估腎臟濃縮功能"
          ]
        },
        {
          "step": 3,
          "action": "病因分類與確診",
          "details": "根據體液狀態分類（高容量、等容量、低容量型），尋找潛在病因",
          "findings": [
            "低容量型：水分流失>鈉流失（最常見）",
            "排除中樞性尿崩症或腎性尿崩症",
            "評估是否為鈉過量攝入（鹽中毒）"
          ]
        }
      ]
    },
    "monitoring": [
      "血鈉每2-4小時監測（矯正期間）",
      "神經學狀態密切觀察",
      "尿量追蹤",
      "體重（評估水分狀態）",
      "血滲透壓"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "hyponatremia": {
    "zh": "低鈉血症",
    "en": "Hyponatremia",
    "definition": "低鈉血症定義為血清鈉濃度低於正常範圍（犬<140 mEq/L，貓<149 mEq/L）。反映的是體內自由水相對於鈉過多。可見於多種臨床情境，從輕微到危及生命不等。",
    "synonyms": [
      "Hyponatraemia",
      "低血鈉"
    ],
    "epidemiology": {
      "species": "犬貓皆可",
      "age": "任何年齡",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "腎上腺皮質功能低下症（Addison病）",
        "充血性心衰竭",
        "肝硬化",
        "腎衰竭",
        "SIADH",
        "利尿劑使用過量",
        "大量低張液體輸注"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "嗜睡",
        "食慾不振",
        "嘔吐",
        "虛弱",
        "癲癇（急性嚴重低鈉時）",
        "震顫",
        "可能有潛在疾病症狀"
      ],
      "physicalExam": [
        "神經學異常（嗜睡至昏迷）",
        "肌肉震顫",
        "癲癇（嚴重時）",
        "脫水徵象（低容量型）",
        "水腫或腹水（高容量型）",
        "低血壓（Addison病）"
      ]
    },
    "pathophysiology": "血清鈉降低使細胞外液滲透壓下降，水分從細胞外移入細胞內，導致細胞腫脹。腦細胞腫脹在顱骨限制下可導致腦水腫及腦疝。急性低鈉血症比慢性更危險，因腦細胞尚未啟動代償機制。分類：(1) 低容量性——鈉和水均流失但鈉流失更多（Addison病、腹瀉）；(2) 等容量性——水分保留但鈉正常（SIADH）；(3) 高容量性——鈉和水均保留但水保留更多（心衰、肝硬化）。",
    "diagnosis": {
      "overview": "血清鈉測定確診。需評估容量狀態及病因。",
      "differentials": [
        "腎上腺皮質功能低下症（最重要鑑別）",
        "充血性心衰竭",
        "肝硬化/肝衰竭",
        "腎衰竭",
        "SIADH",
        "假性低鈉血症（高脂血症、高蛋白血症）",
        "利尿劑過量"
      ],
      "initialDB": [
        "血清電解質：Na+, K+（Na/K比值小於27高度懷疑Addison病）",
        "血液生化",
        "尿液分析（尿鈉、尿滲透壓）",
        "血清滲透壓"
      ],
      "advanced": [
        "ACTH刺激試驗（排除Addison病）",
        "基礎Cortisol",
        "胸腔X光（排除心衰）",
        "腹部超音波（肝臟、腎上腺評估）",
        "TSH（排除甲狀腺功能低下）"
      ]
    },
    "treatment": {
      "overview": "治療依病因及嚴重度而異。急性嚴重低鈉伴神經症狀需謹慎提升血鈉。慢性低鈉矯正不可過快（風險：滲透壓脫髓鞘症候群）。",
      "acute": [
        "有症狀嚴重低鈉：3%高滲鹽水 1-2 mL/kg/hr IV",
        "矯正速度：不超過0.5 mEq/L/小時，每日不超過10-12 mEq/L",
        "止癲癇：Diazepam 0.5-1 mg/kg IV",
        "Addison病：0.9% NaCl輸液加Dexamethasone 0.1-0.2 mg/kg IV"
      ],
      "chronic": [
        "治療潛在病因",
        "Addison病：Fludrocortisone或DOCP長期替代治療",
        "心衰：利尿劑加ACE抑制劑",
        "限制水分攝入（SIADH）",
        "停用致病藥物"
      ]
    },
    "prognosis": "取決於病因及嚴重程度。Addison病相關低鈉血症經適當治療後預後良好。急性嚴重低鈉伴神經症狀若處理不當預後差。慢性低鈉快速矯正可致滲透壓脫髓鞘症候群，為不可逆神經損傷。心衰或肝硬化相關低鈉反映疾病晚期，預後較差。",
    "pearls": [
      "犬低鈉血症+高鉀血症（Na/K比值小於27）：首先排除Addison病",
      "矯正慢性低鈉過快可致滲透壓脫髓鞘症候群導致不可逆腦損傷",
      "假性低鈉血症：嚴重高脂或高蛋白血症可影響鈉測量值",
      "年輕雌犬加嘔吐加低鈉高鉀=典型Addison病表現",
      "急性vs慢性低鈉血症的矯正策略完全不同"
    ],
    "diagnosticAlgorithm": {
      "title": "低鈉血症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估嗜睡、嘔吐、肌肉震顫和神經症狀，注意急性與慢性的區別",
          "findings": [
            "嗜睡和虛弱",
            "嘔吐和食慾下降",
            "嚴重時抽搐或昏迷"
          ]
        },
        {
          "step": 2,
          "action": "實驗室檢查",
          "details": "測量血清鈉濃度，同時評估血糖、血脂排除假性低鈉血症",
          "findings": [
            "血清鈉<140 mEq/L",
            "血漿滲透壓降低",
            "排除高血糖或高脂血症引起的假性低鈉"
          ]
        },
        {
          "step": 3,
          "action": "病因分類與確診",
          "details": "根據體液狀態和尿鈉濃度分類，尋找潛在病因",
          "findings": [
            "評估是否為腎上腺皮質功能低下（Addison's）",
            "排除胃腸道大量流失（嘔吐腹瀉）",
            "評估SIADH或水中毒可能性"
          ]
        }
      ]
    },
    "monitoring": [
      "血鈉每2-4小時監測（矯正期間）",
      "神經學狀態",
      "血鉀（特別是Addison病）",
      "尿量",
      "心電圖（電解質異常時）"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "hypermagnesemia": {
    "zh": "高鎂血症",
    "en": "Hypermagnesemia",
    "definition": "高鎂血症定義為血清鎂濃度高於正常範圍（犬>2.5 mg/dL，貓>2.6 mg/dL）。臨床上較少見，最常見於腎衰竭（鎂排泄減少）或醫源性鎂過量攝入。可導致神經肌肉傳導障礙及心臟功能抑制。",
    "synonyms": [
      "Hypermagnesaemia",
      "高血鎂"
    ],
    "epidemiology": {
      "species": "犬貓皆可",
      "age": "任何年齡，老年動物（腎衰竭好發）較多見",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "急性或慢性腎衰竭（最常見原因）",
        "醫源性（含鎂瀉劑、制酸劑過量）",
        "腎上腺皮質功能低下症",
        "尿路阻塞",
        "鎂鹽灌腸",
        "嚴重組織破壞（橫紋肌溶解）"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "可能無臨床症狀（輕度）",
        "嗜睡",
        "肌肉無力",
        "嘔吐",
        "低血壓",
        "已知腎衰竭史",
        "使用含鎂藥物史"
      ],
      "physicalExam": [
        "肌肉無力至弛緩性麻痺",
        "深部腱反射減弱至消失",
        "低血壓",
        "心跳減慢（嚴重時）",
        "嗜睡至昏迷（嚴重時）",
        "呼吸抑制（極嚴重時）"
      ]
    },
    "pathophysiology": "鎂離子在神經肌肉接合處競爭性抑制鈣離子的作用，減少乙醯膽鹼的釋放，導致神經肌肉傳導障礙。在心臟，高鎂減緩房室傳導，抑制竇房結自動性，延長傳導時間。極高濃度可導致心臟停搏。正常腎臟可有效排泄過量鎂，因此高鎂血症幾乎總是伴隨腎功能障礙。",
    "diagnosis": {
      "overview": "血清鎂濃度測定確診。需評估腎功能及尋找病因。",
      "differentials": [
        "腎衰竭相關（最常見）",
        "藥物相關",
        "腎上腺功能低下",
        "代謝性酸中毒（鎂從細胞內移出）"
      ],
      "initialDB": [
        "血清鎂升高",
        "血液生化（BUN、Creatinine評估腎功能）",
        "電解質全套（鈣、鉀常同時異常）",
        "ECG：PR間距延長、QRS波群增寬、T波增高"
      ],
      "advanced": [
        "離子鎂測定（ionized magnesium）",
        "尿液鎂排泄分數",
        "ACTH刺激試驗（排除Addison病）",
        "腹部超音波（腎臟評估）"
      ]
    },
    "treatment": {
      "overview": "輕度高鎂通常僅需停止鎂攝入及治療腎臟疾病。嚴重高鎂伴心律不整或神經肌肉症狀需緊急處理。",
      "acute": [
        "停止所有含鎂藥物及輸液",
        "10% Calcium gluconate 50-150 mg/kg IV緩慢注射（鎂的生理性拮抗劑，ECG監測下給予）",
        "積極靜脈輸液利尿（0.9% NaCl促進腎臟排鎂）",
        "Furosemide 2-4 mg/kg IV（增加腎臟排鎂）",
        "透析（嚴重腎衰竭伴危及生命的高鎂時）"
      ],
      "chronic": [
        "治療潛在腎臟疾病",
        "避免含鎂藥物（制酸劑、瀉劑）",
        "監測並維持正常鎂濃度",
        "腎臟飲食"
      ]
    },
    "prognosis": "取決於病因及嚴重程度。輕度高鎂經停藥及治療腎臟疾病後預後良好。嚴重高鎂伴心律不整需緊急處理但通常可矯正。預後主要取決於潛在腎臟疾病的嚴重程度。醫源性高鎂停藥後通常快速恢復。",
    "pearls": [
      "高鎂血症幾乎總是伴隨腎功能障礙——腎功能正常者極難發生",
      "Calcium gluconate是高鎂血症的特異性拮抗劑",
      "深部腱反射消失是臨床上判斷嚴重高鎂的重要指標",
      "含鎂制酸劑及瀉劑在腎衰竭動物中禁忌使用",
      "ECG變化與高鉀類似——PR延長、QRS增寬"
    ],
    "diagnosticAlgorithm": {
      "title": "高鎂血症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估肌肉無力、低血壓和心搏過緩等表現，注意腎功能狀態和含鎂藥物使用",
          "findings": [
            "肌肉無力和嗜睡",
            "低血壓",
            "心搏過緩"
          ]
        },
        {
          "step": 2,
          "action": "實驗室與心電圖檢查",
          "details": "測量血清鎂濃度，進行心電圖監測，評估腎功能",
          "findings": [
            "血清鎂>2.5 mg/dL",
            "心電圖可見PR間期延長",
            "腎功能評估（BUN、肌酐）"
          ]
        },
        {
          "step": 3,
          "action": "病因確認",
          "details": "確認腎衰竭或醫源性原因（含鎂灌腸劑、含鎂制酸劑）",
          "findings": [
            "腎衰竭為最常見原因",
            "檢查是否有含鎂藥物過量使用",
            "Addison's病也可能導致"
          ]
        }
      ]
    },
    "monitoring": [
      "血清鎂濃度",
      "ECG持續監測（嚴重時）",
      "腎功能指標",
      "深部腱反射",
      "血壓"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "hypomagnesemia": {
    "zh": "低鎂血症",
    "en": "Hypomagnesemia",
    "definition": "低鎂血症定義為血清鎂濃度低於正常範圍（犬貓均<1.5 mg/dL）。臨床上可能被低估，因血清鎂僅反映全身鎂的1%。低鎂可導致心律不整、肌肉痙攣及頑固性低鈣或低鉀血症。",
    "synonyms": [
      "Hypomagnesaemia",
      "低血鎂",
      "Magnesium Deficiency"
    ],
    "epidemiology": {
      "species": "犬貓皆可",
      "age": "任何年齡",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "長期禁食或營養不良",
        "慢性腸道疾病（吸收不良）",
        "利尿劑長期使用（特別是loop利尿劑）",
        "糖尿病酮酸中毒",
        "急性胰臟炎",
        "再餵食症候群（refeeding syndrome）",
        "Aminoglycoside類抗生素",
        "Cisplatin化療",
        "腎小管疾病"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "肌肉震顫",
        "虛弱",
        "食慾不振",
        "心律不整",
        "癲癇（嚴重時）",
        "對低鈣或低鉀治療反應不佳"
      ],
      "physicalExam": [
        "肌肉震顫或痙攣",
        "心律不整",
        "肌肉無力",
        "嗜睡",
        "共濟失調",
        "癲癇（嚴重時）",
        "低體溫"
      ]
    },
    "pathophysiology": "鎂是300多種酶的輔因子，在能量代謝、核酸合成及神經肌肉功能中扮演關鍵角色。低鎂影響：(1) 神經肌肉興奮性增加——鎂正常時抑制突觸前乙醯膽鹼釋放及穩定肌肉細胞膜，缺乏時導致過度興奮；(2) 心肌電穩定性下降——增加心律不整風險；(3) PTH分泌及作用受損——導致頑固性低鈣血症；(4) 腎臟保鉀能力下降——導致頑固性低鉀血症。",
    "diagnosis": {
      "overview": "血清鎂測定。注意血清鎂可能正常但組織鎂不足。頑固性低鈣或低鉀血症應懷疑低鎂。",
      "differentials": [
        "低鈣血症（常合併）",
        "低鉀血症（常合併）",
        "低磷血症",
        "代謝性鹼中毒"
      ],
      "initialDB": [
        "血清鎂降低",
        "離子鎂（ionized magnesium，更準確）",
        "電解質全套（鈣、鉀常同時降低）",
        "ECG：QT延長、T波低平、可能有心律不整"
      ],
      "advanced": [
        "尿液鎂排泄分數（鑑別腎臟流失vs攝入不足）",
        "離子鈣",
        "PTH濃度",
        "血液生化全套"
      ]
    },
    "treatment": {
      "overview": "補充鎂為首要治療。嚴重低鎂伴心律不整或癲癇需靜脈注射鎂鹽。同時矯正其他電解質異常。",
      "acute": [
        "MgSO4 0.15-0.3 mEq/kg IV over 15-20分鐘（嚴重症狀時）",
        "MgSO4 CRI 0.75-1 mEq/kg/天 IV（維持）",
        "MgCl2 0.75-1 mEq/kg/天 IV（替代）",
        "ECG監測下給予",
        "同時矯正低鈣及低鉀"
      ],
      "chronic": [
        "口服鎂補充劑（MgO或Mg gluconate）",
        "治療潛在病因",
        "調整利尿劑（可能時換用保鎂利尿劑）",
        "充足飲食中鎂含量"
      ]
    },
    "prognosis": "若病因可矯正，預後通常良好。補充鎂後心律不整及神經肌肉症狀可快速改善。再餵食症候群相關低鎂若及時補充預後良好。需持續處理潛在病因以防復發。",
    "pearls": [
      "頑固性低鈣血症對鈣補充無反應時應檢查鎂",
      "頑固性低鉀血症對鉀補充無反應時應檢查鎂",
      "血清鎂僅反映全身鎂的1%——可能低估鎂缺乏程度",
      "再餵食症候群是低鎂的重要原因——長期禁食的動物重新餵食時需監測",
      "低鎂可降低毛地黃耐受性，增加中毒風險",
      "Loop利尿劑（如furosemide）長期使用可致低鎂"
    ],
    "diagnosticAlgorithm": {
      "title": "低鎂血症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估肌肉震顫、抽搐和心律不整等表現，注意常伴隨低鈣和低鉀血症",
          "findings": [
            "肌肉震顫和抽搐",
            "心律不整",
            "難治性低鈣或低鉀血症"
          ]
        },
        {
          "step": 2,
          "action": "實驗室檢查",
          "details": "測量血清鎂、鈣和鉀濃度，進行心電圖監測",
          "findings": [
            "血清鎂<1.5 mg/dL",
            "可能併發低鈣和低鉀血症",
            "心電圖可見心律不整"
          ]
        },
        {
          "step": 3,
          "action": "病因確認",
          "details": "調查鎂流失原因，包括胃腸道流失、腎臟流失和攝入不足",
          "findings": [
            "胃腸道流失（慢性腹瀉、嘔吐）",
            "腎臟流失（利尿劑使用）",
            "長期靜脈營養不含鎂補充"
          ]
        }
      ]
    },
    "monitoring": [
      "血清鎂濃度",
      "ECG監測",
      "同時監測鈣、鉀濃度",
      "腎功能",
      "臨床症狀改善"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "hypervitaminosis-d": {
    "zh": "維生素D過多症",
    "en": "Hypervitaminosis D",
    "definition": "維生素D過多症是由於維生素D或其活性代謝物攝入過量導致的中毒狀態。主要造成持續性高鈣血症及高磷血症，導致軟組織鈣化（特別是腎臟、胃腸道、心血管系統）及急性腎損傷。",
    "synonyms": [
      "Vitamin D Toxicosis",
      "Cholecalciferol Toxicosis",
      "維生素D中毒"
    ],
    "epidemiology": {
      "species": "犬貓皆可，犬較常見（因飲食不慎）",
      "age": "任何年齡",
      "sex": "無明顯性別傾向",
      "riskFactors": [
        "攝入滅鼠劑（cholecalciferol維生素D3鼠藥）",
        "攝入含維生素D的牛皮癬藥膏",
        "寵物食品配方錯誤（維生素D過量添加）",
        "攝入人用維生素D補充劑",
        "攝入含calcipotriol的藥膏",
        "長期過量補充維生素D"
      ]
    },
    "clinicalPresentation": {
      "history": [
        "已知攝入維生素D來源",
        "多飲多尿",
        "食慾不振",
        "嘔吐",
        "便秘",
        "嗜睡",
        "虛弱",
        "通常在攝入後12-36小時出現症狀"
      ],
      "physicalExam": [
        "脫水",
        "口渴",
        "黏膜乾燥",
        "心律不整",
        "肌肉無力",
        "腹部疼痛"
      ]
    },
    "pathophysiology": "維生素D3（cholecalciferol）在肝臟代謝為25(OH)D3（calcidiol），再在腎臟轉化為活性形式1,25(OH)2D3（calcitriol）。過量攝入使25(OH)D3濃度極高，繞過正常調節機制直接促進腸道鈣磷吸收及骨骼鈣動員，導致：(1) 嚴重高鈣血症——心律不整、腎損傷、中樞神經抑制；(2) 高磷血症——與鈣結合形成磷酸鈣沉積於軟組織；(3) 腎臟鈣化導致急性腎損傷至可能不可逆腎衰竭。Cholecalciferol鼠藥的毒性劑量犬約為0.5 mg/kg（可致高鈣血症），2 mg/kg以上可致死。",
    "diagnosis": {
      "overview": "已知暴露史合併高鈣血症、高磷血症為高度診斷依據。25(OH)D3濃度可確認。",
      "differentials": [
        "惡性腫瘤相關高鈣血症（淋巴瘤、肛門腺癌）",
        "原發性副甲狀腺機能亢進",
        "腎上腺皮質功能低下症",
        "肉芽腫性疾病（真菌感染）",
        "其他中毒"
      ],
      "initialDB": [
        "血清鈣（total Ca、ionized Ca）：顯著升高",
        "血清磷：升高（與腫瘤性高鈣血症的低磷不同）",
        "BUN/Creatinine：可能升高（腎損傷）",
        "電解質",
        "尿液分析"
      ],
      "advanced": [
        "血清25(OH)D3濃度（確認性檢測）",
        "PTH濃度（應為低至不可測，被高鈣抑制）",
        "PTHrP（排除腫瘤性高鈣血症）",
        "腹部超音波（腎臟鈣化評估）",
        "ECG（QT間距縮短、心律不整）"
      ]
    },
    "treatment": {
      "overview": "治療重點為降低血鈣、促進鈣排泄、減少腸道鈣吸收及保護腎臟。高鈣血症可持續數週（cholecalciferol脂溶性，半衰期長）。",
      "acute": [
        "積極靜脈輸液（0.9% NaCl）促進利尿排鈣",
        "Furosemide 2-5 mg/kg IV q8-12h（促進腎臟排鈣）",
        "Dexamethasone 0.1-0.2 mg/kg IV q12h（減少腸道鈣吸收）",
        "Pamidronate 1.3-2 mg/kg IV over 2-4小時（二磷酸鹽，抑制骨吸收）",
        "攝入後數小時內可考慮催吐及活性炭",
        "Cholestyramine 0.5-1 g/kg PO q8h（結合膽酸促進維生素D排泄）"
      ],
      "chronic": [
        "低鈣低磷飲食",
        "持續輸液治療（可能需1-3週）",
        "Aluminum hydroxide 30-90 mg/kg PO q8h（腸道磷酸鹽結合劑）",
        "監測並矯正腎功能",
        "Pamidronate可視需要重複（每2-4週）",
        "避免日曬（減少內源性維生素D合成）"
      ]
    },
    "prognosis": "取決於攝入劑量、治療開始時間及腎損傷程度。早期發現且積極治療預後良好。高鈣血症可持續2-3週甚至更長（cholecalciferol脂溶性）。已發生嚴重腎臟鈣化及不可逆腎衰竭者預後差。Pamidronate的使用顯著改善了中毒預後。",
    "pearls": [
      "高鈣血症加高磷血症的組合高度提示維生素D中毒（腫瘤性高鈣通常磷正常或低）",
      "Cholecalciferol鼠藥是犬維生素D中毒最常見原因",
      "高鈣血症可持續數週——需要長期積極治療",
      "Pamidronate是治療cholecalciferol中毒的重要藥物",
      "25(OH)D3濃度確認暴露但不完全與臨床嚴重度相關",
      "寵物食品召回事件中維生素D過量添加曾造成大規模中毒"
    ],
    "diagnosticAlgorithm": {
      "title": "維生素D過多症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估多尿多渴、嘔吐、食慾下降等高鈣血症表現，詢問維生素D補充劑或殺鼠劑暴露史",
          "findings": [
            "多尿多渴",
            "嘔吐和食慾下降",
            "嗜睡與虛弱"
          ]
        },
        {
          "step": 2,
          "action": "實驗室檢查",
          "details": "測量血清鈣、磷、25(OH)D和1,25(OH)2D濃度，評估腎功能",
          "findings": [
            "高鈣血症",
            "高磷血症",
            "血清25(OH)D或骨化三醇濃度升高"
          ]
        },
        {
          "step": 3,
          "action": "病因確認與併發症評估",
          "details": "確認維生素D來源（補充劑、殺鼠劑、牛皮癬藥膏），評估軟組織鈣化",
          "findings": [
            "確認維生素D暴露來源",
            "X光或超音波評估軟組織鈣化（腎臟、胃壁）",
            "評估腎功能損害程度"
          ]
        }
      ]
    },
    "monitoring": [
      "血清鈣及磷每12-24小時監測（急性期）",
      "BUN/Creatinine（腎功能）",
      "尿量",
      "ECG",
      "待穩定後每週監測直至血鈣正常化"
    ],
    "reference": "Gough A, Murphy K: Differential Diagnosis in Small Animal Medicine, 2nd Ed. Wiley, 2015; Côté E: Clinical Veterinary Advisor, 4th Ed. Elsevier, 2020"
  },
  "narcolepsy-cataplexy": {
    "zh": "猝睡症-猝倒症",
    "en": "Narcolepsy-Cataplexy",
    "definition": "猝睡症-猝倒症是一種中樞神經系統的睡眠-覺醒調節障礙，特徵為突發性且不可抗拒的嗜睡發作（narcolepsy）以及由情緒激動或興奮誘發的短暫性肌張力喪失伴弛緩性癱瘓（cataplexy），但意識通常不受影響。本病在犬較為常見，可為遺傳性（與 hypocretin/orexin 受體基因突變相關）或後天獲得性（因下視丘 hypocretin 神經元損傷所致）。遺傳性形式已在 Doberman Pinscher 和 Labrador Retriever 中確認為體染色體隱性遺傳。",
    "synonyms": [
      "嗜睡症-猝倒症",
      "發作性嗜睡症",
      "Narcolepsy",
      "Cataplexy"
    ],
    "epidemiology": {
      "species": "犬較常見，貓罕見但有報告",
      "breed": "遺傳性好發品種：Doberman Pinscher、Labrador Retriever、Dachshund、Poodle；後天性形式無品種特異性",
      "age": "遺傳性形式通常在出生後數週至 6 個月齡開始出現症狀；後天性形式可發生於任何年齡",
      "sex": "無明顯性別傾向",
      "prevalence": "整體罕見，但在好發品種中發生率較高；Doberman Pinscher 中因 HCRTR2 基因突變導致的遺傳性形式已被充分描述"
    },
    "clinicalPresentation": {
      "symptoms": [
        "突發性且不可抗拒的嗜睡發作，動物在活動中突然入睡",
        "猝倒發作：突發性肌張力喪失導致動物倒地，呈弛緩性癱瘓",
        "猝倒發作常由進食、玩耍、興奮等正向情緒激動誘發",
        "發作持續數秒至數分鐘，動物可被輕觸或聲音喚醒",
        "發作間期完全正常，無神經功能缺損",
        "反覆出現的嗜睡週期，表現為間歇性昏昏欲睡",
        "過度日間嗜睡（excessive daytime sleepiness, EDS）",
        "睡眠癱瘓（sleep paralysis）：入睡或甦醒時的短暫全身癱瘓",
        "入睡前幻覺樣行為（hypnagogic hallucinations）",
        "快速動眼期（REM）睡眠異常提早出現",
        "部分猝倒發作僅影響後肢或頭頸部，表現為局部肌張力喪失",
        "嚴重病例可出現頻繁發作影響日常活動和進食"
      ],
      "physicalExam": [
        "發作間期理學檢查和神經學檢查完全正常",
        "猝倒發作時可見全身性弛緩性癱瘓，但眼球運動可能存在",
        "發作時瞳孔反射正常，意識通常保留（與癲癇區別的關鍵點）",
        "以食物誘發測試（food-elicited cataplexy test, FECT）可重現發作",
        "發作時心率和呼吸通常正常或僅輕度變化",
        "無肌肉萎縮、疼痛反應或本體感覺缺失"
      ]
    },
    "pathophysiology": "遺傳性猝睡症-猝倒症在犬中與 hypocretin（orexin）受體 2 基因（HCRTR2）突變相關，導致下視丘的 hypocretin 信號傳導缺陷。Hypocretin 是維持覺醒狀態和調節 REM 睡眠的關鍵神經肽。當 hypocretin 系統功能障礙時，正常的睡眠-覺醒週期調節失序，導致 REM 睡眠異常侵入覺醒期。猝倒發作被認為是 REM 睡眠肌張力抑制機制在覺醒狀態下異常激活所致。後天性形式可能與下視丘 hypocretin 分泌神經元的自體免疫破壞或其他結構性損傷有關。",
    "diagnosis": {
      "primary": [
        "食物誘發猝倒測試（FECT）：將多塊食物排列，觀察犬在進食過程中是否出現猝倒發作，為最具特異性的臨床診斷方法",
        "詳細病史和臨床症狀特徵分析：反覆的可預測誘發因素、發作間期正常、發作時意識保留",
        "腦脊髓液（CSF）hypocretin/orexin 濃度測定：後天性形式 CSF 中 hypocretin-1 濃度降低或測不到",
        "基因檢測：Doberman Pinscher 和 Labrador Retriever 可檢測 HCRTR2 基因突變",
        "排除其他原因的發作性疾病：完整的神經學檢查、腦部 MRI 和腦電圖（EEG）排除癲癇和其他結構性疾病"
      ],
      "differential": [
        "癲癇（epilepsy）：發作時有意識喪失、自主神經症狀、發作後混亂期",
        "暈厥（syncope）：心因性或血管迷走神經性，需心電圖和心臟超音波排除",
        "低血糖發作（hypoglycemic episodes）：需血糖監測排除",
        "前庭疾病（vestibular disease）：伴有頭傾斜、眼球震顫",
        "重症肌無力（myasthenia gravis）：運動後肌無力加劇，tensilon test 陽性",
        "急性多發性神經根神經炎（acute polyradiculoneuritis）：進行性下運動神經元癱瘓"
      ],
      "labFindings": [
        "常規血液學和生化檢查通常正常",
        "CSF 分析通常正常（細胞數和蛋白質正常），但 hypocretin-1 濃度可能降低（後天性形式）",
        "腦部 MRI 通常無異常發現（排除結構性病變）",
        "EEG 在發作時顯示直接進入 REM 睡眠模式",
        "基因檢測可確認 HCRTR2 突變（遺傳性形式，特定品種）"
      ]
    },
    "treatment": {
      "acute": "猝倒發作為自限性，通常不需要急性期治療。發作時輕觸或聲音刺激可喚醒動物。確保發作環境安全，避免從高處跌落或溺水風險。",
      "chronic": "長期藥物治療旨在減少發作頻率和嚴重程度。環境管理：避免過度興奮的誘發因素、維持規律的作息時間表。遺傳性形式為終身疾病，需終身用藥。",
      "medications": [
        "Imipramine（三環抗憂鬱劑）：0.5-1.0 mg/kg PO BID-TID，為治療猝倒的首選藥物",
        "Clomipramine：1-3 mg/kg PO BID，對猝倒發作有效",
        "Protriptyline：5-10 mg/犬 PO BID，另一種三環抗憂鬱劑選擇",
        "Modafinil（莫達非尼）：用於控制過度嗜睡，但在犬的使用經驗有限",
        "Methylphenidate（利他能）：用於日間嗜睡的輔助治療",
        "Dextroamphetamine：可用於嚴重嗜睡，但需注意副作用"
      ],
      "surgery": "不適用，本病無手術治療選項"
    },
    "prognosis": "猝睡症-猝倒症為終身疾病，無法治癒但可透過藥物控制。遺傳性形式的症狀在成年後可能部分穩定或輕微改善。透過適當藥物治療和環境管理，大多數患犬可維持良好的生活品質。本病本身不影響壽命，但需注意發作時的安全風險（如游泳時猝倒導致溺水）。",
    "pearls": [
      "猝倒與癲癇的關鍵區別：猝倒發作時意識保留且可被外界刺激喚醒，癲癇則伴有意識喪失",
      "食物誘發猝倒測試（FECT）是診斷犬猝睡症-猝倒症最實用且特異性最高的臨床方法",
      "Doberman Pinscher 的猝睡症為體染色體隱性遺傳，HCRTR2 基因突變可透過基因檢測確認",
      "三環抗憂鬱劑主要用於控制猝倒發作（抑制 REM 睡眠），而中樞興奮劑用於控制嗜睡",
      "後天性猝睡症可能與下視丘腫瘤或發炎性疾病相關，需進行腦部 MRI 排除"
    ],
    "diagnosticAlgorithm": {
      "title": "猝睡症-猝倒症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估發作性突然入睡和情緒誘發的肌張力喪失，好發於杜賓犬和拉布拉多",
          "findings": [
            "突發性入睡發作（猝睡）",
            "進食或玩耍時突然肌張力喪失倒地（猝倒）",
            "發作後迅速恢復正常"
          ]
        },
        {
          "step": 2,
          "action": "食物誘發試驗",
          "details": "進行食物激發試驗觀察是否誘發猝倒發作，排除癲癇和心因性暈厥",
          "findings": [
            "食物激發試驗誘發典型猝倒發作",
            "腦電圖排除癲癇",
            "心電圖排除心源性暈厥"
          ]
        },
        {
          "step": 3,
          "action": "藥物試驗確診",
          "details": "靜脈注射atropine或physostigmine觀察是否誘發或緩解發作，CSF下視丘分泌素檢測",
          "findings": [
            "Physostigmine靜脈注射誘發猝倒發作",
            "CSF下視丘分泌素（orexin）濃度降低",
            "對imipramine或fluoxetine治療反應良好"
          ]
        }
      ]
    },
    "monitoring": [
      "記錄發作頻率、持續時間和誘發因素的日誌",
      "藥物治療後定期評估發作控制情形和副作用",
      "三環抗憂鬱劑使用時監測心電圖（可能引起心律不整）",
      "定期神經學檢查確認無新的神經功能缺損出現",
      "後天性形式需定期腦部影像追蹤排除進展性病變"
    ],
    "reference": "Clinical Veterinary Advisor: Dogs and Cats / Blackwell's Five-Minute Veterinary Consult / Platt & Olby: Manual of Canine and Feline Neurology"
  },
  "lung-lobe-torsion": {
    "zh": "肺葉扭轉",
    "en": "Lung Lobe Torsion",
    "definition": "肺葉扭轉是指肺葉沿其支氣管-血管蒂（bronchovascular pedicle）發生軸向旋轉，導致支氣管阻塞和肺血管壓迫，進而引起肺葉充血、壞死和胸腔積液。本病可為自發性（原發性）或繼發於胸腔手術、胸腔積液、膈疝或肺葉萎陷後再膨脹等情況。右中葉（right middle lung lobe）最常受累，在犬中本病以深胸大型犬最為好發。",
    "synonyms": [
      "肺扭轉",
      "肺葉旋轉",
      "Pulmonary Torsion",
      "Lung Torsion"
    ],
    "epidemiology": {
      "species": "犬較常見，貓罕見但有報告",
      "breed": "好發於深胸大型犬：Afghan Hound（最高風險）、Borzoi、Irish Wolfhound、Great Dane、German Shepherd、Labrador Retriever；小型犬中 Pug 有較高發生率",
      "age": "任何年齡皆可發生，多見於中年犬（4-8 歲）",
      "sex": "無明確性別傾向，部分文獻報告公犬稍多",
      "prevalence": "罕見但為需要緊急手術的嚴重疾病；深胸犬種中相對較常見"
    },
    "clinicalPresentation": {
      "symptoms": [
        "急性呼吸困難（dyspnea）和呼吸急促（tachypnea）",
        "持續性非生產性咳嗽或偶有咳血（hemoptysis）",
        "運動不耐（exercise intolerance）",
        "食慾下降和精神沉鬱（lethargy）",
        "發熱（fever），可持續且對抗生素反應不佳",
        "嘔吐和反胃",
        "胸腔積液相關症狀：呼吸窘迫、端坐呼吸（orthopnea）",
        "腹部用力呼吸（abdominal effort breathing）",
        "發紺（cyanosis）：嚴重病例出現黏膜發紺",
        "急性休克症狀：心搏過速、脈搏微弱、毛細血管再充填時間延長",
        "慢性病例可見進行性體重減輕和消瘦",
        "部分病例表現為非特異性不適，初始症狀輕微"
      ],
      "physicalExam": [
        "胸部聽診：受影響側肺音減弱或消失，可能聽到支氣管呼吸音",
        "胸部叩診：受影響區域呈濁音（dullness），提示胸腔積液或肺實質化",
        "發熱（38.9-40.5°C 或更高）",
        "心搏過速（tachycardia）和呼吸急促",
        "胸腔抽液後呼吸仍未顯著改善（與單純胸腔積液的區別要點）",
        "脫水和灌流不良的跡象：毛細血管再充填時間延長、黏膜蒼白或發紺",
        "嚴重病例可見休克徵象"
      ]
    },
    "pathophysiology": "肺葉沿其支氣管-血管蒂發生旋轉後，支氣管被扭曲阻塞導致氣道閉鎖，而肺動脈和肺靜脈因壓迫導致血流受阻。靜脈回流阻塞先於動脈閉塞，造成受累肺葉嚴重充血、水腫和出血性壞死。肺葉腫脹後無法自行復位，壞死組織釋放的發炎介質和血液成分滲漏至胸腔，形成出血性或乳糜性胸腔積液。持續的組織壞死和感染風險可導致敗血症和全身性發炎反應。深胸犬種因胸腔空間大且肺葉活動度較高，加上右中葉蒂部相對纖細，因此較容易發生扭轉。",
    "diagnosis": {
      "primary": [
        "胸部 X 光：可見不透明的實質化肺葉、支氣管截斷征（bronchial cutoff sign）、肺葉位置異常、伴隨胸腔積液",
        "胸腔超音波：評估胸腔積液量和性質，受累肺葉呈現實質化（hepatization）",
        "胸腔積液分析：常為出血性或修正型漏出液，偶為乳糜性；細胞學可見大量中性球和巨噬細胞",
        "胸部 CT 掃描：為最敏感的影像診斷工具，可清楚顯示肺葉扭轉、血管蒂旋轉和受累範圍",
        "支氣管鏡檢查：可見支氣管扭曲閉塞（但通常非必要，CT 已可確診）"
      ],
      "differential": [
        "肺炎（pneumonia）：細菌性、吸入性或黴菌性",
        "肺腫瘤（lung neoplasia）：原發性肺癌或轉移性腫瘤",
        "膈疝（diaphragmatic hernia）：創傷後或先天性",
        "肺血栓栓塞（pulmonary thromboembolism）",
        "胸腔積液其他原因：心臟衰竭、膿胸、乳糜胸",
        "肺膿瘍（lung abscess）"
      ],
      "labFindings": [
        "CBC：白血球增多伴左移（嗜中性球增多），可能有貧血（因肺葉內出血）",
        "生化：可能出現低白蛋白血症、肝酶升高（缺氧性肝損傷）",
        "胸腔積液分析：出血性或修正型漏出液，蛋白質含量升高（>3.0 g/dL），有核細胞數升高",
        "血液氣體分析：低血氧症（hypoxemia）、可能伴有呼吸性酸中毒",
        "凝血功能：通常正常，但嚴重病例可能出現 DIC 相關異常"
      ]
    },
    "treatment": {
      "acute": "穩定呼吸功能為首要任務：氧氣補充（oxygen supplementation）、治療性胸腔穿刺引流積液以緩解呼吸窘迫、靜脈輸液復甦（crystalloid/colloid）。糾正電解質和酸鹼失衡。術前穩定循環狀態。",
      "chronic": "肺葉扭轉為需要緊急手術的疾病，不適合長期藥物管理。術後需監測對側肺功能、胸腔引流管管理和預防感染。",
      "medications": [
        "廣效抗生素：Amoxicillin-Clavulanate 20 mg/kg PO BID 或 Enrofloxacin 5 mg/kg PO SID",
        "術後止痛：Buprenorphine 0.01-0.02 mg/kg IV q6-8h 或持續速率輸注（CRI）fentanyl",
        "Metoclopramide 0.2-0.5 mg/kg PO/SC TID 用於術後止吐",
        "靜脈輸液：Lactated Ringer's solution 維持灌流和水合狀態",
        "術後胸腔引流管沖洗和管理"
      ],
      "surgery": "肺葉切除術（lung lobectomy）為唯一有效的確定性治療。術中確認受累肺葉後，需在解除扭轉之前先結紮血管蒂（避免壞死組織的毒素大量回流至全身循環）。經由側胸切開術（lateral thoracotomy）或正中胸骨切開術（median sternotomy）進入胸腔。"
    },
    "prognosis": "早期診斷和及時手術治療的預後良好至中等（存活率約 50-75%）。延遲診斷、嚴重敗血症或 DIC 併發症會顯著降低存活率。Afghan Hound 有較高的復發風險（對側肺葉扭轉）。自發性肺葉扭轉相對於繼發性（術後）形式可能預後較好，取決於診斷時機。",
    "pearls": [
      "右中葉（right middle lobe）是犬最常發生扭轉的肺葉，因為其蒂部較長且纖細",
      "胸腔積液引流後呼吸仍未顯著改善是高度提示肺葉扭轉的臨床線索",
      "手術中必須先結紮血管蒂再解除扭轉，避免再灌注損傷和毒素釋放導致全身性反應",
      "Afghan Hound 發生自發性肺葉扭轉的風險特別高，飼主教育很重要",
      "Pug 雖為小型犬，但在報告中肺葉扭轉的發生率並不低，臨床上不應因體型而排除此診斷"
    ],
    "diagnosticAlgorithm": {
      "title": "肺葉扭轉 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估急性呼吸困難、咳嗽和精神沉鬱，注意大型深胸犬（阿富汗獵犬）和巴哥犬好發",
          "findings": [
            "急性或亞急性呼吸困難",
            "非生產性咳嗽",
            "精神沉鬱和食慾下降"
          ]
        },
        {
          "step": 2,
          "action": "影像學檢查",
          "details": "進行胸腔X光評估肺葉位置和充氣狀態，注意胸腔積液",
          "findings": [
            "受累肺葉不透明度增加伴氣管偏移",
            "胸腔積液",
            "受累肺葉支氣管走向異常"
          ]
        },
        {
          "step": 3,
          "action": "進階影像與確診",
          "details": "CT血管造影或支氣管鏡確認肺葉扭轉，胸腔積液分析",
          "findings": [
            "CT顯示受累肺葉血管中斷和扭轉",
            "支氣管鏡見支氣管阻塞或扭曲",
            "胸腔積液為血性或乳糜樣"
          ]
        }
      ]
    },
    "monitoring": [
      "術後密切監測呼吸速率和型態、血氧飽和度（SpO2）",
      "胸腔引流管的引流量、性質和氣密性",
      "術後 24-72 小時重複胸部 X 光評估殘餘肺葉膨脹情形",
      "CBC 和生化追蹤：評估感染控制和器官功能恢復",
      "長期追蹤：定期胸部 X 光監測有無復發（尤其高風險品種）"
    ],
    "reference": "Clinical Veterinary Advisor: Dogs and Cats / Textbook of Veterinary Internal Medicine (Ettinger & Feldman) / BSAVA Manual of Canine and Feline Thoracic Imaging"
  },
  "bile-peritonitis": {
    "zh": "膽汁性腹膜炎",
    "en": "Bile Peritonitis",
    "definition": "膽汁性腹膜炎是指膽汁洩漏至腹腔引起的嚴重腹膜發炎反應。膽汁外漏可由膽囊破裂、膽管損傷（穿透性創傷、手術併發症）、膽囊壞死（膽囊黏液囊腫 mucocele、膽結石 cholelithiasis）或自發性膽道穿孔引起。膽汁中的膽鹽（bile salts）對腹膜具有強烈的化學刺激性，初期為無菌性化學性腹膜炎，繼發細菌感染後可迅速發展為感染性腹膜炎和敗血症，死亡率極高。",
    "synonyms": [
      "膽性腹膜炎",
      "膽汁腹膜炎",
      "Biliary Peritonitis",
      "Bile Leakage Peritonitis",
      "Choleperitoneum"
    ],
    "epidemiology": {
      "species": "犬和貓均可發生，犬較常見",
      "breed": "無明確品種傾向；Shetland Sheepdog 和 Cocker Spaniel 因膽囊黏液囊腫好發而間接增加風險",
      "age": "中老年犬貓較常見（>6 歲），但創傷性原因可見於任何年齡",
      "sex": "無明確性別傾向",
      "prevalence": "相對少見但為急診常見的嚴重腹部急症；膽囊黏液囊腫繼發破裂是犬最常見的原因"
    },
    "clinicalPresentation": {
      "symptoms": [
        "嘔吐（vomiting）：為最常見的初始症狀",
        "食慾廢絕（anorexia）和拒食",
        "虛弱無力（weakness）和精神極度沉鬱（severe lethargy）",
        "多飲多尿（polydipsia/polyuria）",
        "體重減輕（weight loss）",
        "腹部疼痛和腹部膨脹",
        "進行性腹部脹大（腹腔積液增加）",
        "發熱或低體溫（取決於疾病嚴重程度和敗血症狀態）",
        "黃疸（icterus/jaundice）：皮膚和黏膜黃染",
        "脫水和灌流不良的症狀",
        "腹瀉或糞便顏色異常（陶土色糞便提示膽管完全阻塞）",
        "呼吸急促（因腹腔積液壓迫橫膈或疼痛所致）"
      ],
      "physicalExam": [
        "腹部觸診疼痛（abdominal pain），可能有腹部防禦反應（guarding）",
        "腹部膨脹伴液體波動感（fluid wave）",
        "黃疸：鞏膜（scleral icterus）、耳翼內側和口腔黏膜黃染",
        "發熱（>39.5°C）或低體溫（<37.5°C，提示敗血性休克）",
        "心搏過速、脈搏微弱、毛細血管再充填時間延長（循環衰竭徵象）",
        "脫水徵象：皮膚帳篷持續時間延長、黏膜乾燥、眼球凹陷"
      ]
    },
    "pathophysiology": "當膽囊或膽管發生穿孔時，膽汁滲漏至腹腔。膽汁中的膽鹽（bile salts）具有界面活性劑特性，能破壞腹膜間皮細胞的磷脂雙層膜結構，導致嚴重的化學性腹膜炎。膽鹽亦增加腹膜通透性，促進液體和電解質大量流失至腹腔（third space loss），導致低血容量和休克。無菌性膽汁腹膜炎在數小時至數天內常繼發細菌感染（來自膽汁中原有的細菌或經由腸道轉位），轉變為感染性腹膜炎和敗血症。膽汁引起的腹膜損傷還會導致腸蠕動減少（ileus）和全身性發炎反應症候群（SIRS）。",
    "diagnosis": {
      "primary": [
        "腹腔穿刺術（abdominocentesis）：抽取腹腔積液進行分析，膽汁性腹腔積液呈黃綠色，腹腔積液的總膽紅素濃度高於同時血清膽紅素濃度（比值 >2:1 高度診斷性）",
        "腹部超音波：評估膽囊完整性（膽囊壁連續性中斷、膽囊塌陷、膽囊周圍積液）、腹腔積液量和分布",
        "腹部 X 光：可見腹腔積液的磨砂玻璃樣密度增加、腸管漿膜面不清楚（loss of serosal detail）",
        "腹腔積液細胞學和生化分析：含膽汁色素的滲出液，有核細胞數升高，可見退化性中性球和細菌（感染性）",
        "FAST 超音波掃描（Focused Assessment with Sonography for Trauma）：快速評估腹腔積液"
      ],
      "differential": [
        "其他原因的腹膜炎：胃腸道穿孔、胰臟炎、尿腹症（uroperitoneum）",
        "腹腔膿瘍（abdominal abscess）",
        "出血性腹腔積液：脾臟腫瘤破裂、肝臟腫瘤破裂、凝血障礙",
        "腹膜癌症（peritoneal carcinomatosis）",
        "急性胰臟炎（acute pancreatitis）",
        "感染性腹膜炎（FIP，貓傳染性腹膜炎，限貓）"
      ],
      "labFindings": [
        "CBC：白血球增多伴左移（成熟和不成熟嗜中性球增多），嚴重敗血症可見白血球減少伴毒性變化",
        "生化：高膽紅素血症（hyperbilirubinemia）、肝酶升高（ALT、ALP、GGT）、低白蛋白血症、BUN 和 creatinine 可能升高（prerenal azotemia）",
        "腹腔積液膽紅素：腹腔積液總膽紅素 / 血清總膽紅素 >2:1 具高度診斷意義",
        "腹腔積液細菌培養和藥敏試驗：常見 E. coli、Enterococcus spp.、Clostridium spp.",
        "凝血功能：PT/APTT 可能延長（肝功能障礙或 DIC）",
        "電解質：可能出現低鉀血症、低鈉血症"
      ]
    },
    "treatment": {
      "acute": "緊急穩定：積極靜脈輸液復甦（crystalloid 和 colloid 組合）矯正低血容量和休克。廣效靜脈抗生素立即給予（覆蓋革蘭氏陰性菌和厭氧菌）。止痛（opioid 為首選）。糾正電解質和酸鹼失衡。穩定後儘速手術探查。",
      "chronic": "本病為急性外科急症，不適合慢性藥物管理。術後需長期抗生素治療（根據培養藥敏結果調整）、營養支持（食管造口管或空腸造口管灌食如需要）、肝臟保護治療。",
      "medications": [
        "Ampicillin-Sulbactam 20-30 mg/kg IV q6-8h + Enrofloxacin 5-10 mg/kg IV SID + Metronidazole 10-15 mg/kg IV q12h（三聯抗生素覆蓋）",
        "止痛：Fentanyl CRI 2-5 μg/kg/hr IV 或 Methadone 0.1-0.3 mg/kg IV q4-6h",
        "Maropitant（Cerenia）1 mg/kg IV SID 止吐",
        "Ursodiol（熊去氧膽酸）10-15 mg/kg PO SID 用於術後膽汁酸代謝支持",
        "S-Adenosylmethionine (SAMe) 20 mg/kg PO SID 肝臟保護",
        "新鮮冷凍血漿（FFP）補充凝血因子和白蛋白（如有 DIC 或嚴重低白蛋白血症）"
      ],
      "surgery": "探查性剖腹手術（exploratory laparotomy）為確定性治療。根據病因進行：膽囊切除術（cholecystectomy）最常見、膽管修補或重建、膽腸吻合術（cholecystoenterostomy 或 choledochoenterostomy）。術中大量溫生理食鹽水腹腔灌洗（abdominal lavage），術後放置腹腔引流管。"
    },
    "prognosis": "預後謹慎至不良，死亡率約 40-68%，取決於診斷延遲時間、有無繼發感染和全身狀態。無菌性膽汁性腹膜炎（無細菌感染）的預後優於感染性膽汁性腹膜炎。早期診斷和及時手術介入是改善預後的關鍵因素。術前已出現 DIC 或多器官功能障礙的病例預後極差。",
    "pearls": [
      "腹腔積液總膽紅素 / 血清總膽紅素比值 >2:1 是膽汁性腹膜炎的高度診斷性指標",
      "膽囊黏液囊腫（gallbladder mucocele）是犬膽汁性腹膜炎最常見的前驅病因，Shetland Sheepdog 為高風險品種",
      "手術中切勿遺漏腹腔的徹底灌洗——殘留膽汁會持續造成化學性腹膜炎",
      "膽汁性腹膜炎的死亡率很高，早期識別和積極手術介入是存活的關鍵",
      "即使無明確穿透性創傷史，膽囊壞死或自發性穿孔也可導致膽汁外漏"
    ],
    "diagnosticAlgorithm": {
      "title": "膽汁性腹膜炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估急性腹痛、嘔吐和黃疸等表現，注意外傷、膽囊疾病或手術史",
          "findings": [
            "急性腹痛和腹部緊張",
            "嘔吐和食慾廢絕",
            "進行性黃疸"
          ]
        },
        {
          "step": 2,
          "action": "腹腔積液分析",
          "details": "進行腹腔穿刺取樣，比較腹水和血清膽紅素濃度",
          "findings": [
            "腹水膽紅素濃度>血清膽紅素2倍",
            "腹水呈黃綠色",
            "腹水細胞學可見中性球增多"
          ]
        },
        {
          "step": 3,
          "action": "影像學與確診",
          "details": "進行腹部超音波評估膽囊和膽道完整性，確認膽汁滲漏來源",
          "findings": [
            "超音波可見腹腔積液",
            "膽囊壁不連續或膽囊破裂",
            "可能見膽總管破裂或膽囊黏液囊腫"
          ]
        }
      ]
    },
    "monitoring": [
      "術後密切監測生命徵象（心率、血壓、體溫）和尿量（目標 >1 mL/kg/hr）",
      "每 12-24 小時複查 CBC、生化（特別是膽紅素、白蛋白、肝酶）和凝血功能",
      "腹腔引流管的引流量和性質（顏色從膽汁色逐漸轉為漿液性為好轉跡象）",
      "腹部超音波追蹤腹腔積液消退情形",
      "連續乳酸（lactate）監測：持續升高提示灌流不足或持續感染"
    ],
    "reference": "Clinical Veterinary Advisor: Dogs and Cats / Tobias & Johnston: Veterinary Surgery: Small Animal / BSAVA Manual of Canine and Feline Gastroenterology"
  },
  "hepatic-abscess": {
    "zh": "肝膿瘍",
    "en": "Hepatic Abscess",
    "definition": "肝膿瘍是肝臟實質內局限性的細菌感染化膿性病灶，可為單發或多發，大小和分布各異。感染來源包括：門脈系統血行播散（源自腸道細菌轉位或腸道疾病）、膽管上行感染（膽管炎 cholangitis）、肝動脈血行播散（全身性菌血症）、鄰近器官直接蔓延（如胰臟膿瘍、腸道穿孔）或穿透性外傷。犬貓均可發生，臨床表現通常為非特異性全身症狀。",
    "synonyms": [
      "肝臟膿瘍",
      "肝化膿",
      "Liver Abscess",
      "Hepatic Suppuration"
    ],
    "epidemiology": {
      "species": "犬和貓均可發生，犬的報告較多",
      "breed": "無明確品種傾向",
      "age": "中老年犬貓較常見，但任何年齡均可發生",
      "sex": "無明確性別傾向",
      "prevalence": "相對少見；常為其他腹腔疾病或全身感染的併發症"
    },
    "clinicalPresentation": {
      "symptoms": [
        "食慾下降或完全廢絕（anorexia）",
        "嘔吐（vomiting），可為間歇性或持續性",
        "精神沉鬱和嗜睡（lethargy/depression）",
        "發熱（fever），可為間歇性或持續性高熱，常對抗生素反應不完全",
        "體重減輕（weight loss）：慢性病例可見明顯消瘦",
        "腹部疼痛，尤其觸壓右前腹部時",
        "多飲多尿（PU/PD）",
        "黃疸（jaundice）：部分病例可見黏膜和皮膚黃染",
        "腹瀉（diarrhea）",
        "腹部膨脹（腹腔積液或肝腫大）",
        "虛弱無力和運動不耐",
        "膿瘍破裂時可出現急性腹膜炎和敗血性休克症狀"
      ],
      "physicalExam": [
        "發熱（39.5-41°C），可為間歇性",
        "觸診肝腫大（hepatomegaly）伴疼痛",
        "右前腹部觸診敏感或防禦反應",
        "黏膜可見黃疸（icterus）",
        "脫水徵象",
        "心搏過速和呼吸急促（因疼痛、發熱和全身感染）",
        "嚴重病例可見休克徵象：低血壓、脈搏微弱、毛細血管再充填時間延長"
      ]
    },
    "pathophysiology": "肝膿瘍的形成通常涉及細菌經由多種途徑到達肝臟實質。最常見的途徑包括：(1) 門脈血行播散——腸道細菌（如 E. coli、Clostridium spp.）經門靜脈系統進入肝臟，常見於腸道通透性增加的情況（inflammatory bowel disease、腸道手術後）；(2) 膽道上行感染——膽管炎或膽道阻塞導致細菌在膽管系統增殖並侵入肝實質；(3) 肝動脈血行播散——全身性菌血症時細菌經肝動脈到達肝臟；(4) 直接蔓延——鄰近器官感染直接侵入肝臟。細菌在肝實質內引起局限性化膿性壞死，周圍形成纖維性包膜。多發性微膿瘍常見於血行播散和瀰漫性化膿性肝炎。",
    "diagnosis": {
      "primary": [
        "腹部超音波：為最佳初始診斷工具，可見肝實質內低回音或混合回音的囊性病灶，可能有厚壁和內部回音（膿液碎片）",
        "超音波引導下細針抽吸術（FNA）和培養：抽取膿瘍內容物進行細胞學檢查和需氧/厭氧細菌培養及藥敏試驗",
        "腹部 CT 掃描：可更精確評估膿瘍數量、大小、位置和與周圍結構的關係",
        "血液培養（blood culture）：嚴重病例應進行需氧和厭氧血液培養以確認菌血症"
      ],
      "differential": [
        "肝臟腫瘤：肝細胞癌（hepatocellular carcinoma）、膽管細胞癌（cholangiocarcinoma）、轉移性腫瘤",
        "肝囊腫（hepatic cyst）：先天性或後天性",
        "肝臟血腫（hepatic hematoma）",
        "結節性增生（nodular hyperplasia）",
        "肉芽腫性肝炎（granulomatous hepatitis）",
        "膽囊黏液囊腫（gallbladder mucocele）"
      ],
      "labFindings": [
        "CBC：白血球增多伴嗜中性球增多和左移，可見毒性變化（toxic neutrophils）",
        "生化：肝酶升高（ALT、ALP、GGT），高膽紅素血症，低白蛋白血症，高球蛋白血症",
        "膿瘍抽吸液細胞學：大量退化性中性球伴細胞內細菌，壞死碎片",
        "膿瘍細菌培養：常見 E. coli、Clostridium spp.、Bacteroides spp.、Enterococcus spp.、混合感染常見",
        "凝血功能：PT/APTT 可能延長（肝功能受損影響凝血因子合成）",
        "C 反應蛋白（CRP）顯著升高（>100 mg/L）"
      ]
    },
    "treatment": {
      "acute": "靜脈輸液復甦、矯正電解質失衡、廣效靜脈抗生素治療（在培養結果出來前經驗性使用覆蓋革蘭氏陰性菌和厭氧菌的組合）。止痛和支持性照護。評估手術或經皮引流的可行性。",
      "chronic": "根據細菌培養和藥敏結果調整抗生素，長期抗生素療程通常需要 4-8 週。定期超音波追蹤膿瘍大小變化。肝臟保護和營養支持。治療潛在病因（如膽道疾病、腸道疾病）。",
      "medications": [
        "Amoxicillin-Clavulanate 20-25 mg/kg PO BID（口服轉換期）或 Ampicillin-Sulbactam 20-30 mg/kg IV q6-8h（急性期）",
        "Metronidazole 10-15 mg/kg PO/IV q12h（覆蓋厭氧菌）",
        "Enrofloxacin 5 mg/kg PO/IV SID（覆蓋革蘭氏陰性菌，犬用）或 Marbofloxacin 2 mg/kg PO SID（貓用）",
        "S-Adenosylmethionine (SAMe) 20 mg/kg PO SID 空腹（肝臟保護）",
        "Ursodiol 10-15 mg/kg PO SID（膽汁酸代謝支持）",
        "止痛：Buprenorphine 0.01-0.02 mg/kg IV/IM q6-8h 或 Tramadol 2-5 mg/kg PO BID-TID"
      ],
      "surgery": "手術適應症包括：大型單發膿瘍（>5 cm）、經皮引流失敗、膿瘍破裂、或多發膿瘍伴嚴重全身感染。手術選項包括：肝葉切除術（lobectomy）或膿瘍切開引流和 omentalisation。超音波引導下經皮穿刺引流（percutaneous drainage）適用於較小且易接近的膿瘍。"
    },
    "prognosis": "預後取決於膿瘍數量、大小、潛在病因和治療反應。單發性肝膿瘍經適當手術引流和抗生素治療後預後較好。多發性微膿瘍或瀰漫性化膿性肝炎預後較差。合併敗血症和多器官功能障礙的病例預後不良。總體死亡率約 30-50%。",
    "pearls": [
      "肝膿瘍常為其他腹腔疾病的併發症，診斷時需同時尋找和治療潛在病因",
      "超音波引導下 FNA 和細菌培養是確診和指導抗生素治療的關鍵步驟",
      "厭氧菌培養非常重要——肝膿瘍常涉及厭氧菌，必須同時進行需氧和厭氧培養",
      "抗生素療程通常需要 4-8 週，不應過早停藥，需以超音波確認膿瘍消退",
      "間歇性發熱且對常規抗生素反應不佳的病例應高度懷疑肝膿瘍，需進行腹部超音波檢查"
    ],
    "diagnosticAlgorithm": {
      "title": "肝膿瘍 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估發熱、腹痛、食慾下降和黃疸等非特異性表現",
          "findings": [
            "間歇性或持續性發熱",
            "前腹部疼痛",
            "食慾下降和嗜睡"
          ]
        },
        {
          "step": 2,
          "action": "實驗室與影像學檢查",
          "details": "進行CBC、生化檢查和腹部超音波",
          "findings": [
            "白血球增多伴核左移",
            "肝酵素和膽紅素升高",
            "超音波顯示肝臟內低回聲或混合回聲腔性病變"
          ]
        },
        {
          "step": 3,
          "action": "穿刺確診",
          "details": "進行超音波引導細針抽吸和培養",
          "findings": [
            "抽出膿性液體",
            "細菌培養鑑定致病菌（常為厭氧菌或腸道菌）",
            "藥敏試驗指導抗生素選擇"
          ]
        }
      ]
    },
    "monitoring": [
      "每 1-2 週腹部超音波追蹤膿瘍大小和回音性質變化",
      "定期 CBC 評估白血球數和嗜中性球變化",
      "肝功能生化監測：ALT、ALP、膽紅素、白蛋白",
      "體溫監測：發熱消退通常是治療有效的早期指標",
      "CRP 或 SAA（血清澱粉樣蛋白 A）追蹤發炎程度",
      "完成抗生素療程後繼續超音波追蹤確認無復發"
    ],
    "reference": "Clinical Veterinary Advisor: Dogs and Cats / Ettinger & Feldman: Textbook of Veterinary Internal Medicine / BSAVA Manual of Canine and Feline Gastroenterology"
  },
  "myocardial-contusion": {
    "zh": "心肌挫傷",
    "en": "Myocardial Contusion",
    "definition": "心肌挫傷是鈍性胸部創傷導致的心肌損傷，特徵為心肌細胞壞死而非發炎反應。最常見的原因為交通事故（被車撞擊, hit by car）、高處墜落和胸部鈍擊。心肌損傷常伴隨心律不整，尤其是心室性心律不整（ventricular arrhythmias），這些心律不整可能在創傷後 24-72 小時內出現，為潛在致命性併發症。值得注意的是，即使沒有直接的心臟損傷，創傷後的全身發炎反應和兒茶酚胺（catecholamine）釋放也可能導致心律不整。",
    "synonyms": [
      "心肌鈍傷",
      "創傷性心肌損傷",
      "Cardiac Contusion",
      "Traumatic Myocardial Injury",
      "Blunt Cardiac Injury"
    ],
    "epidemiology": {
      "species": "犬較常見（因交通事故和創傷暴露較多），貓也可發生",
      "breed": "無品種傾向，但大型犬因活動範圍大、暴露於交通事故和創傷的風險較高",
      "age": "任何年齡，年輕犬因行為活躍和戶外活動多而風險較高",
      "sex": "無明確性別傾向，但未結紮公犬因遊蕩行為較多可能風險稍高",
      "prevalence": "鈍性胸部創傷患畜中心肌挫傷的發生率估計為 40-50%，但臨床上因缺乏敏感性檢測工具而可能被低估"
    },
    "clinicalPresentation": {
      "symptoms": [
        "心律不整（arrhythmia）：心室早期收縮（VPCs）、心室頻脈（ventricular tachycardia）最常見",
        "心搏過速（tachycardia）或心搏過緩（bradycardia）",
        "胸部創傷的相關症狀：胸壁疼痛、瘀傷、呼吸困難",
        "虛弱（weakness）和運動不耐",
        "暈厥（syncope）：嚴重心律不整時可出現",
        "蒼白黏膜或發紺",
        "心輸出量下降的症狀：低血壓、脈搏微弱",
        "伴隨其他創傷損傷的症狀：肋骨骨折、氣胸、肺挫傷",
        "精神沉鬱和嗜睡",
        "突然死亡（心室顫動時）",
        "腹部疼痛（伴隨腹部創傷時）",
        "因疼痛而煩躁不安或姿勢異常"
      ],
      "physicalExam": [
        "心臟聽診：心律不整（irregularly irregular rhythm）、心音減弱（心包積液時）、異常心音或奔馬律（gallop rhythm）",
        "胸壁觸診可能發現瘀傷（bruising）、腫脹或捻髮音（crepitus，肋骨骨折或皮下氣腫）",
        "脈搏品質異常：脈搏不規則、脈搏缺損（pulse deficit）、脈搏微弱",
        "低血壓（systolic BP <90 mmHg）",
        "毛細血管再充填時間延長（>2 秒）",
        "心包填塞（cardiac tamponade）時可見頸靜脈怒張（jugular distension）、心音減弱、低血壓（Beck's triad）",
        "全身創傷評估可能發現其他多系統損傷"
      ]
    },
    "pathophysiology": "鈍性胸部創傷時，心臟被胸壁和脊椎之間的力量壓迫，導致心肌細胞直接機械性損傷和壞死。右心室因其前方位置（位於胸壁後方）最常受累。心肌壞死區域引起局部電傳導異常，導致心室性心律不整（VPCs、VT）。此外，創傷引起的兒茶酚胺大量釋放（catecholamine surge）、低血氧、酸中毒、電解質失衡和全身發炎反應（SIRS）都可加重心律不整的發生。心律不整的高峰期通常在創傷後 24-72 小時，這個時間窗口是心肌壞死和再灌注損傷最活躍的時期。嚴重病例可發生心室顫動導致猝死。心包損傷伴出血可導致心包積液和心包填塞。",
    "diagnosis": {
      "primary": [
        "連續心電圖（ECG）監測：為最重要的診斷和監測工具，可偵測心室早期收縮（VPCs）、心室頻脈（VT）、ST 段異常等心律不整",
        "心臟生物標記：血清心肌肌鈣蛋白 I（cardiac troponin I, cTnI）升高為心肌損傷的敏感指標",
        "心臟超音波（echocardiography）：評估心肌運動異常（wall motion abnormality）、心包積液、心室功能",
        "胸部 X 光：評估胸腔創傷（肋骨骨折、氣胸、肺挫傷、心臟輪廓大小）"
      ],
      "differential": [
        "原發性心律不整（primary cardiac arrhythmia）：擴張型心肌病、瓣膜疾病",
        "創傷性心包積液（traumatic pericardial effusion）不伴心肌挫傷",
        "張力性氣胸（tension pneumothorax）引起的循環衰竭",
        "低血容量性休克（hypovolemic shock）：內出血",
        "創傷性膈疝（traumatic diaphragmatic hernia）",
        "電解質失衡引起的心律不整：高血鉀、低血鈣"
      ],
      "labFindings": [
        "心肌肌鈣蛋白 I（cTnI）升高：>0.10-0.20 ng/mL 提示心肌損傷，連續監測趨勢比單一值更有意義",
        "心肌肌鈣蛋白 T（cTnT）升高（備選標記）",
        "ECG 發現：心室早期收縮（VPCs）、心室頻脈、ST 段升高或壓低、T 波異常",
        "CBC：可能有壓力性白血球增多（stress leukogram）",
        "生化：可能因創傷和灌流不足出現乳酸升高、肝酶升高、腎指數異常",
        "血液氣體：可能顯示低血氧症和代謝性酸中毒"
      ]
    },
    "treatment": {
      "acute": "所有鈍性胸部創傷患畜應進行至少 48-72 小時的連續 ECG 監測。穩定生命徵象：靜脈輸液、氧氣補充、止痛。治療其他合併創傷（氣胸引流、骨折固定等）。對血流動力學顯著的心室性心律不整給予抗心律不整藥物。",
      "chronic": "大多數創傷後心律不整在 3-7 天內自行消退，通常不需要長期抗心律不整治療。嚴重心肌損傷可能導致永久性心功能受損，需要長期心臟病管理。定期心臟超音波追蹤心功能恢復。",
      "medications": [
        "Lidocaine 2 mg/kg IV bolus 後接 CRI 40-80 μg/kg/min（犬，心室性心律不整首選）",
        "Mexiletine 5-8 mg/kg PO TID（犬，口服抗心律不整藥物轉換期）",
        "Sotalol 1-2 mg/kg PO BID（犬，頑固性心室頻脈的替代選擇）",
        "止痛：Methadone 0.1-0.3 mg/kg IV q4-6h 或 Fentanyl CRI 2-5 μg/kg/hr",
        "Lactated Ringer's solution 或 0.9% NaCl 靜脈輸液維持灌流",
        "Atenolol 0.5-1.0 mg/kg PO BID（貓的心室性心律不整選擇）"
      ],
      "surgery": "心肌挫傷本身不需要手術。但合併的創傷可能需要手術處理：張力性氣胸需胸腔引流、心包填塞需心包穿刺引流（pericardiocentesis）、嚴重心包出血可能需要手術止血。"
    },
    "prognosis": "預後取決於心肌損傷程度和合併創傷的嚴重性。輕度心肌挫傷伴偶發性 VPCs 的預後良好，心律不整通常在 3-7 天內消退。嚴重且持續的心室頻脈或心室顫動預後不良。合併多系統創傷的病例預後較差。早期識別和適當監測是改善結果的關鍵。",
    "pearls": [
      "所有鈍性胸部創傷患畜都應進行至少 48-72 小時的連續 ECG 監測，因為心律不整可能延遲出現",
      "心律不整的高峰期通常在創傷後 24-72 小時，即使初始 ECG 正常也不能排除後續心律不整",
      "心肌肌鈣蛋白 I（cTnI）是犬心肌損傷最敏感的生物標記，但升高程度不一定與臨床嚴重性直接相關",
      "只有血流動力學顯著的心律不整才需要抗心律不整治療（VPC 頻率 >20-30/min 或 R-on-T 現象或心室頻脈）",
      "即使沒有直接心臟創傷，全身性創傷、疼痛和兒茶酚胺釋放也可引起心律不整——需區分創傷性心律不整和真正的心肌挫傷"
    ],
    "diagnosticAlgorithm": {
      "title": "心肌挫傷 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估胸部外傷後心律不整，注意車禍等高能量創傷病史",
          "findings": [
            "胸部外傷病史",
            "心律不整（心室早期收縮最常見）",
            "心搏過速或低血壓"
          ]
        },
        {
          "step": 2,
          "action": "心臟監測與生物標記",
          "details": "進行持續心電圖監測和心肌肌鈣蛋白I/T檢測",
          "findings": [
            "心電圖顯示心室早期收縮或心室性心搏過速",
            "心肌肌鈣蛋白I升高",
            "ST段改變"
          ]
        },
        {
          "step": 3,
          "action": "心臟超音波評估",
          "details": "進行心臟超音波評估心肌收縮功能和心包積液",
          "findings": [
            "局部心壁運動異常",
            "可能伴隨心包積液",
            "評估心輸出量和整體收縮功能"
          ]
        }
      ]
    },
    "monitoring": [
      "連續 ECG 監測至少 48-72 小時（可使用 Holter monitor）",
      "連續血壓監測（arterial blood pressure）",
      "心肌肌鈣蛋白 I（cTnI）：入院時和 12-24 小時後複查評估趨勢",
      "血氧飽和度（SpO2）和血液氣體分析",
      "尿量監測（目標 >1 mL/kg/hr）評估心輸出量和灌流",
      "出院後 1-2 週追蹤 ECG 和心臟超音波評估心功能恢復"
    ],
    "reference": "Clinical Veterinary Advisor: Dogs and Cats / Bonagura & Twedt: Kirk's Current Veterinary Therapy / Silverstein & Hopper: Small Animal Critical Care Medicine"
  },
  "pemphigus-vulgaris": {
    "zh": "天疱瘡（尋常型）",
    "en": "Pemphigus Vulgaris",
    "definition": "尋常型天疱瘡是一種嚴重且罕見的自體免疫性水泡性皮膚病，自體抗體（主要為 IgG）攻擊表皮深層的棘狀細胞間黏附分子——橋粒核蛋白（desmoglein 3，及部分 desmoglein 1），導致表皮基底層上方的棘層鬆解（suprabasilar acantholysis），形成鬆弛性水泡（flaccid bullae）。水泡極易破裂，臨床上更常見到糜爛（erosion）和潰瘍（ulceration）而非完整水泡。本病主要侵犯黏膜（口腔、鼻、眼結膜、外陰等）和皮膚黏膜交界處，病變可擴展至皮膚。在犬貓中極為罕見，是所有天疱瘡亞型中最嚴重的一種。",
    "synonyms": [
      "尋常型天疱瘡",
      "PV",
      "Pemphigus Vulgaris"
    ],
    "epidemiology": {
      "species": "犬和貓均有報告，犬較常見但整體極罕見",
      "breed": "無明確品種傾向；部分報告提及 German Shepherd、Collie、Chow Chow 可能較多見",
      "age": "中老年犬較常見（平均 5-7 歲），但任何年齡可發生",
      "sex": "無明確性別傾向",
      "prevalence": "極罕見，為天疱瘡亞型中最少見的一種（天疱瘡落葉型 P. foliaceus 在犬中更常見）"
    },
    "clinicalPresentation": {
      "symptoms": [
        "口腔黏膜的糜爛和潰瘍：為最常見的首發症狀，涉及齒齦、頰黏膜、舌頭、硬顎",
        "口腔疼痛導致流涎（ptyalism/drooling）和吞嚥困難（dysphagia）",
        "食慾下降或拒食（因口腔疼痛）",
        "鬆弛性水泡（flaccid bullae）：極易破裂，臨床上很少見到完整水泡",
        "皮膚糜爛和潰瘍：常見於腋下、腹股溝、甲床等區域",
        "鼻平面（nasal planum）的糜爛和結痂",
        "眼結膜充血和潰瘍",
        "外陰或包皮黏膜的潰瘍",
        "甲床炎（paronychia）：指甲周圍的糜爛和化膿",
        "Nikolsky 徵陽性：輕壓外觀正常的皮膚可使表皮滑動剝離",
        "體重減輕（因口腔疼痛導致攝食不足）",
        "繼發細菌感染的症狀：膿性分泌物、發熱"
      ],
      "physicalExam": [
        "口腔檢查：廣泛的齒齦、頰黏膜和硬顎糜爛和潰瘍，伴出血性結痂",
        "鬆弛性水泡（如尚未破裂）：薄壁、清澈至混濁液體、輕壓即破",
        "Nikolsky sign 陽性：以手指橫向推壓外觀正常的皮膚可使表皮剝離",
        "皮膚黏膜交界處（mucocutaneous junctions）的糜爛：唇、鼻孔、肛門、外陰",
        "腋下和腹股溝的潮濕糜爛面",
        "可能伴有發熱（繼發感染時）",
        "淋巴結腫大（regionallymphadenopathy）"
      ]
    },
    "pathophysiology": "尋常型天疱瘡的核心機制是自體抗體（主要為 IgG4 和 IgG1）針對橋粒核蛋白 3（desmoglein 3, Dsg3）的攻擊。Dsg3 是表皮基底層和棘狀層深處角質形成細胞間橋粒（desmosome）的關鍵黏附蛋白。抗體結合 Dsg3 後，透過直接干擾黏附功能和誘導細胞內信號傳導（p38 MAPK 等途徑），導致角質形成細胞間的黏附喪失（acantholysis）。棘層鬆解主要發生在基底層上方（suprabasilar），基底層細胞雖然失去與上方細胞的連接但仍附著在基底膜上（呈「墓碑石」排列）。由於黏膜主要表達 Dsg3 而 Dsg1 表達較低，因此黏膜病變為本病的主要和早期表現。當抗體同時針對 Dsg1 時，皮膚病變也會出現。",
    "diagnosis": {
      "primary": [
        "皮膚組織病理學（histopathology）：為確診的金標準，特徵為基底層上方棘層鬆解（suprabasilar acantholysis），基底層呈「墓碑石」排列，水泡腔內有游離的棘層細胞（acantholytic cells）",
        "直接免疫螢光（direct immunofluorescence, DIF）：凍切片可見細胞間 IgG 和/或 C3 沉積呈「蜂巢狀」或「網狀」模式",
        "細胞學塗片（Tzanck smear）：從新鮮水泡底部刮取，可見圓形的棘層鬆解細胞（acantholytic cells），快速但非特異性",
        "間接免疫螢光（indirect immunofluorescence）：血清中檢測抗橋粒抗體"
      ],
      "differential": [
        "天疱瘡落葉型（pemphigus foliaceus）：最常見的天疱瘡亞型，但水泡位於表皮淺層（subcorneal），通常不侵犯黏膜",
        "類天疱瘡（bullous pemphigoid）：表皮下水泡，水泡較緊張",
        "全身性紅斑狼瘡（systemic lupus erythematosus, SLE）",
        "藥物不良反應（drug eruption）：特別是磺胺類藥物",
        "多形性紅斑（erythema multiforme）",
        "中毒性表皮壞死溶解症（toxic epidermal necrolysis, TEN）",
        "黏膜皮膚念珠菌感染（mucocutaneous candidiasis）"
      ],
      "labFindings": [
        "組織病理學：基底層上方棘層鬆解，水泡腔內游離棘層細胞，基底層「墓碑石」排列",
        "DIF：細胞間 IgG（+/- C3）沉積",
        "CBC：可能有輕度貧血（慢性病）和嗜中性球增多（繼發感染）",
        "生化：低白蛋白血症（蛋白質從糜爛面流失）",
        "細菌培養：繼發性細菌感染常見，Staphylococcus spp. 為最常見"
      ]
    },
    "treatment": {
      "acute": "高劑量免疫抑制治療：Prednisolone/Prednisone 2-4 mg/kg/day PO（分兩次給予），需在 2-3 週內觀察到臨床改善。同時啟動二線免疫抑制劑以減少類固醇用量。繼發感染需全身性抗生素治療。傷口護理：溫和清洗糜爛面，避免進一步創傷。營養支持（軟食或管灌）。",
      "chronic": "長期免疫抑制治療是必要的。逐步將 Prednisolone 減至最低有效劑量（理想為隔日給予）。大多數病例需要類固醇和二線免疫抑制劑的組合維持治療。定期監測藥物副作用。完全緩解後仍需維持低劑量治療，停藥常導致復發。",
      "medications": [
        "Prednisolone 2-4 mg/kg/day PO 初始，逐漸減量至最低有效劑量（目標 0.5-1.0 mg/kg 隔日）",
        "Azathioprine（硫唑嘌呤）2 mg/kg PO SID（犬）作為類固醇節約劑（steroid-sparing agent），起效需 3-6 週",
        "Mycophenolate Mofetil（黴酚酸酯）10-20 mg/kg PO BID（替代 Azathioprine）",
        "Chlorambucil 0.1-0.2 mg/kg PO SID-QOD（貓的首選免疫抑制劑，因貓禁用 Azathioprine）",
        "Ciclosporin（環孢素）5-10 mg/kg PO BID（頑固性病例的輔助治療）",
        "人類靜脈免疫球蛋白（Human IVIG）0.5-1.0 g/kg IV（嚴重頑固性病例的挽救治療）",
        "全身性抗生素治療繼發感染：Cephalexin 22-30 mg/kg PO BID"
      ],
      "surgery": "不適用。天疱瘡為全身性自體免疫疾病，手術無治療角色。"
    },
    "prognosis": "預後謹慎至不良。尋常型天疱瘡是天疱瘡亞型中最嚴重的一種，需要終身免疫抑制治療。完全緩解困難，多數病例僅能達到部分控制。長期高劑量免疫抑制治療帶來的副作用（感染、糖尿病、Cushing 樣症候群）是重要的致病和致死因素。繼發性敗血症是常見的死亡原因。部分病例因治療反應不佳或嚴重副作用而接受安樂死。",
    "pearls": [
      "口腔黏膜的糜爛和潰瘍是尋常型天疱瘡最常見和最早的表現，任何持續性口腔潰瘍都應考慮本病",
      "尋常型天疱瘡與落葉型天疱瘡的關鍵區別：尋常型侵犯黏膜且水泡位於基底層上方，落葉型通常不侵犯黏膜且水泡位於表皮淺層",
      "Nikolsky 徵陽性高度提示天疱瘡但非特異性，也可見於其他嚴重水泡性皮膚病",
      "組織病理學切片應取自新鮮水泡邊緣或完整水泡，而非陳舊的糜爛面（已失去特徵性組織學改變）",
      "犬最常見的天疱瘡亞型是落葉型（P. foliaceus），而非尋常型——臨床上遇到天疱瘡時應仔細區分"
    ],
    "diagnosticAlgorithm": {
      "title": "天疱瘡（尋常型）診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估口腔和皮膚黏膜交界處的水疱和潰瘍，注意Nikolsky徵象",
          "findings": [
            "口腔黏膜廣泛潰瘍和糜爛",
            "皮膚黏膜交界處水疱",
            "Nikolsky徵象陽性（輕壓表皮剝離）"
          ]
        },
        {
          "step": 2,
          "action": "細胞學檢查",
          "details": "進行水疱底部印壓細胞學，尋找棘皮鬆解的角質細胞",
          "findings": [
            "細胞學見圓形棘皮鬆解角質細胞（Tzanck細胞）",
            "基底層以上的棘皮鬆解",
            "中性球和嗜酸性球浸潤"
          ]
        },
        {
          "step": 3,
          "action": "活檢與免疫學確診",
          "details": "進行新鮮水疱邊緣活檢及直接免疫螢光檢查",
          "findings": [
            "組織病理學見基底層以上的棘皮鬆解",
            "直接免疫螢光見細胞間IgG沉積",
            "確診為自體免疫性天疱瘡"
          ]
        }
      ]
    },
    "monitoring": [
      "每 2-4 週臨床評估病變範圍和嚴重程度，記錄新病變出現和舊病變癒合",
      "使用免疫抑制劑時每 2 週檢查 CBC（特別是 Azathioprine 使用初期監測骨髓抑制）",
      "每月生化檢查：肝功能（Azathioprine 的肝毒性）、腎功能、血糖（類固醇的代謝副作用）",
      "尿液分析和尿培養：長期類固醇治療增加泌尿道感染風險",
      "定期體重和體態評估：監測類固醇的 Cushing 樣副作用",
      "皮膚細菌培養：出現新的膿性病變時評估繼發感染"
    ],
    "reference": "Clinical Veterinary Advisor: Dogs and Cats / Muller & Kirk's Small Animal Dermatology / Miller, Griffin & Campbell: Muller & Kirk's Small Animal Dermatology"
  },
  "bullous-pemphigoid": {
    "zh": "類天疱瘡",
    "en": "Bullous Pemphigoid",
    "definition": "類天疱瘡（水泡性類天疱瘡）是一種表皮下自體免疫性水泡性皮膚病，自體抗體（IgG 和/或 IgE）針對表皮基底膜帶（basement membrane zone, BMZ）的半橋粒蛋白（hemidesmosomes），特別是 BP180（XVII 型膠原蛋白/BPAG2）和 BP230（BPAG1），導致表皮與真皮之間的黏附喪失，形成表皮下水泡。與天疱瘡不同，類天疱瘡的水泡位於基底膜下方（subepidermal），因此水泡壁較厚、較緊張且不易破裂。本病在犬貓中均極罕見。",
    "synonyms": [
      "水泡性類天疱瘡",
      "BP",
      "Bullous Pemphigoid"
    ],
    "epidemiology": {
      "species": "犬和貓均有報告，犬的報告較多但整體極罕見",
      "breed": "無明確品種傾向；Doberman Pinscher 和 Collie 在部分報告中略多",
      "age": "中老年犬較常見",
      "sex": "無明確性別傾向",
      "prevalence": "極罕見；在犬的自體免疫性水泡性皮膚病中，比天疱瘡落葉型少見許多"
    },
    "clinicalPresentation": {
      "symptoms": [
        "緊張性水泡（tense bullae）：為本病特徵，水泡壁較厚不易破裂",
        "水泡破裂後形成大面積糜爛和潰瘍",
        "病變好發於腋下、腹股溝、口腔黏膜和皮膚黏膜交界處",
        "口腔黏膜的糜爛和潰瘍（較尋常型天疱瘡少見但可發生）",
        "蕁麻疹樣（urticarial）或紅斑性斑塊可為水泡的前驅病變",
        "嚴重搔癢（pruritus）：部分病例搔癢明顯",
        "皮膚疼痛和不適",
        "食慾下降（口腔受累時）",
        "結痂（crusting）和鱗屑",
        "甲床受累：甲溝炎（paronychia）和指甲脫落（onychomadesis）",
        "繼發細菌感染的症狀：膿性分泌物、發熱",
        "精神沉鬱和體重減輕（慢性病例）"
      ],
      "physicalExam": [
        "緊張性水泡（tense blisters）：為與天疱瘡區別的重要特徵，水泡壁較厚、內容液體清澈或血性",
        "水泡破裂後的大面積淺層糜爛面，邊緣有水泡殘壁",
        "皮膚黏膜交界處的糜爛：唇、鼻孔、外陰、肛門",
        "紅斑性或蕁麻疹樣斑塊（可為水泡的前驅病變）",
        "Nikolsky 徵可能陽性（但不如天疱瘡典型）",
        "腋下和腹股溝的病變分布",
        "口腔黏膜可能有糜爛和潰瘍"
      ]
    },
    "pathophysiology": "自體抗體（主要為 IgG）針對基底膜帶的半橋粒蛋白 BP180 和 BP230。BP180 是一種 II 型跨膜蛋白，其胞外域（NC16A domain）是主要的自體抗原表位。抗體結合後激活補體系統（特別是 C3），募集嗜中性球和嗜酸性球至基底膜帶，釋放蛋白酶降解基底膜帶的結構蛋白。同時，IgE 抗體介導的肥大細胞脫顆粒也參與病理過程。最終導致基底膜帶的黏附功能喪失，表皮與真皮分離，形成表皮下水泡。水泡腔內常含嗜酸性球。由於水泡位於表皮下方（有完整的表皮作為水泡頂蓋），因此水泡較天疱瘡的水泡更為緊張和堅實。",
    "diagnosis": {
      "primary": [
        "皮膚組織病理學（histopathology）：特徵為表皮下裂隙（subepidermal cleft/vesicle），水泡腔內含有嗜酸性球和嗜中性球，表皮基底層細胞完整（與天疱瘡的棘層鬆解區別）",
        "直接免疫螢光（DIF）：凍切片可見基底膜帶呈線狀（linear）IgG 和/或 C3 沉積",
        "間接免疫螢光（IIF）：血清中可檢測抗基底膜帶抗體",
        "免疫組織化學（immunohistochemistry）：使用抗 BP180 和 BP230 的抗體進行特異性確認"
      ],
      "differential": [
        "天疱瘡（尋常型和落葉型）：棘層鬆解（表皮內水泡）而非表皮下裂隙",
        "全身性紅斑狼瘡（SLE）：基底膜帶免疫沉積但通常為顆粒狀而非線狀",
        "表皮鬆解性水泡症（epidermolysis bullosa）：遺傳性結構蛋白缺陷",
        "多形性紅斑（erythema multiforme）和 Stevens-Johnson 症候群",
        "藥物不良反應（drug eruption）",
        "線狀 IgA 皮膚病（linear IgA dermatosis）"
      ],
      "labFindings": [
        "組織病理學：表皮下水泡，水泡腔內嗜酸性球和嗜中性球浸潤",
        "DIF：基底膜帶線狀 IgG 和/或 C3 沉積（關鍵診斷依據）",
        "CBC：可能有外周血嗜酸性球增多（eosinophilia）",
        "生化：低白蛋白血症（嚴重病例，蛋白質從糜爛面流失）",
        "1M NaCl 分離皮膚的免疫螢光（salt-split skin IIF）：抗體位於表皮側（epidermal side），有助於區分其他表皮下水泡性疾病"
      ]
    },
    "treatment": {
      "acute": "免疫抑制治療：Prednisolone 2-4 mg/kg/day PO 初始劑量。同時開始二線免疫抑制劑。傷口護理：溫和清洗，避免破壞完整水泡（水泡頂蓋可作為天然生物敷料保護傷口）。繼發感染需全身性抗生素。",
      "chronic": "類固醇逐漸減量至最低有效劑量，搭配二線免疫抑制劑長期維持。部分病例可能達到長期緩解並成功停藥，預後較尋常型天疱瘡好。定期監測藥物副作用。",
      "medications": [
        "Prednisolone 2-4 mg/kg/day PO 初始，逐漸減至最低有效劑量",
        "Azathioprine 2 mg/kg PO SID（犬）作為類固醇節約劑",
        "Doxycycline 5-10 mg/kg PO BID + Niacinamide 250-500 mg PO TID（犬）：作為溫和的免疫調節替代方案，適用於輕度病例",
        "Chlorambucil 0.1-0.2 mg/kg PO QOD（貓）",
        "Mycophenolate Mofetil 10-20 mg/kg PO BID（替代選擇）",
        "Topical tacrolimus 0.1% 軟膏用於局限性病變",
        "全身性抗生素治療繼發感染：Cephalexin 22-30 mg/kg PO BID"
      ],
      "surgery": "不適用，本病為自體免疫性疾病。"
    },
    "prognosis": "預後中等至謹慎，但通常優於尋常型天疱瘡。部分病例對治療反應良好，可達到長期緩解甚至成功停藥。Doxycycline/Niacinamide 組合對輕度病例可能有效，可避免長期高劑量免疫抑制的副作用。嚴重或頑固性病例仍需長期免疫抑制治療。繼發感染和藥物副作用是影響預後的主要因素。",
    "pearls": [
      "類天疱瘡的水泡為「緊張性水泡」（表皮下），天疱瘡的水泡為「鬆弛性水泡」（表皮內）——這是臨床區分的關鍵點",
      "直接免疫螢光顯示基底膜帶的「線狀」沉積是類天疱瘡的典型發現，與天疱瘡的「蜂巢狀」細胞間沉積不同",
      "Doxycycline + Niacinamide 組合是犬類天疱瘡輕度病例的有效且副作用較少的替代治療方案",
      "不要主動刺破完整的水泡——水泡頂蓋作為天然生物敷料可促進下方傷口癒合",
      "外周血嗜酸性球增多在類天疱瘡中較為常見，可作為輔助鑑別線索"
    ],
    "diagnosticAlgorithm": {
      "title": "類天疱瘡 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估皮膚大型緊張性水疱、潰瘍和結痂，注意口腔和皮膚黏膜交界處受累",
          "findings": [
            "皮膚大型緊張性水疱",
            "水疱破裂後形成潰瘍和結痂",
            "腋窩和腹股溝等皺褶處好發"
          ]
        },
        {
          "step": 2,
          "action": "細胞學與組織病理",
          "details": "進行活檢檢查水疱形成的位置（基底膜帶），區別於天疱瘡",
          "findings": [
            "組織病理學見表皮下水疱形成",
            "基底膜帶分離（非棘皮鬆解）",
            "嗜酸性球和中性球浸潤"
          ]
        },
        {
          "step": 3,
          "action": "免疫學確診",
          "details": "進行直接免疫螢光檢查確認基底膜帶免疫球蛋白沉積",
          "findings": [
            "直接免疫螢光見基底膜帶線性IgG沉積",
            "區別於天疱瘡的細胞間沉積模式",
            "確診為自體免疫性類天疱瘡"
          ]
        }
      ]
    },
    "monitoring": [
      "每 2-4 週臨床評估新水泡出現和舊病變癒合情形",
      "CBC 每 2 週（特別是 Azathioprine 使用初期監測骨髓抑制和嗜酸性球變化）",
      "肝功能和腎功能定期監測（免疫抑制劑的器官毒性）",
      "血糖監測（長期類固醇的糖尿病風險）",
      "嘗試類固醇減量時密切觀察有無復發",
      "皮膚細菌培養（繼發感染時）"
    ],
    "reference": "Clinical Veterinary Advisor: Dogs and Cats / Muller & Kirk's Small Animal Dermatology / Miller, Griffin & Campbell: Muller & Kirk's Small Animal Dermatology"
  },
  "oral-fibrosarcoma": {
    "zh": "口腔纖維肉瘤",
    "en": "Oral Fibrosarcoma",
    "definition": "口腔纖維肉瘤是犬口腔中第三常見的惡性腫瘤（次於惡性黑色素瘤和鱗狀上皮細胞癌），起源於口腔軟組織的纖維母細胞（fibroblasts）。腫瘤具有高度局部侵襲性，常侵犯上顎骨（maxilla）或下顎骨（mandible），導致骨質溶解和破壞。組織學上腫瘤細胞分化程度不一，部分組織學上呈低度惡性表現的腫瘤臨床行為卻具有高度侵襲性（所謂的「histologically low-grade, biologically high-grade」纖維肉瘤）。遠端轉移率相對較低（約 20-30%），但局部復發率極高，特別是切緣不足的病例。",
    "synonyms": [
      "口腔纖維肉瘤",
      "Oral FSA",
      "Fibrosarcoma of the Oral Cavity"
    ],
    "epidemiology": {
      "species": "犬最常見，貓也可發生但較少見",
      "breed": "大型犬較常見：Golden Retriever、Labrador Retriever、German Shepherd、Doberman Pinscher、Irish Setter",
      "age": "中老年犬好發（平均 7-9 歲），但可見於任何年齡（年輕大型犬也有報告）",
      "sex": "公犬略多於母犬",
      "prevalence": "約佔犬所有口腔惡性腫瘤的 10-20%，為犬口腔第三常見的惡性腫瘤"
    },
    "clinicalPresentation": {
      "symptoms": [
        "飼主發現口腔內進行性增大的腫塊為最常見的就診原因",
        "口臭（halitosis）：腫瘤表面壞死和繼發感染",
        "流涎（drooling/ptyalism）：常伴血性涎液",
        "口腔出血（oral hemorrhage）：自發性或進食時出血",
        "吞嚥困難（dysphagia）和進食困難",
        "食慾下降和體重減輕",
        "咀嚼困難和偏側咀嚼",
        "牙齒鬆動或脫落（腫瘤侵犯牙槽骨）",
        "顏面腫脹（facial swelling）或不對稱",
        "鼻腔分泌物（腫瘤侵犯鼻腔時）：可為血性或膿性",
        "打噴嚏（sneezing）：上顎腫瘤侵犯鼻腔時",
        "眼球突出（exophthalmos）：腫瘤向後方擴展侵犯眼眶時"
      ],
      "physicalExam": [
        "口腔內可觸及堅實的腫塊，通常表面平滑或分葉狀，黏膜可能完整或潰瘍出血",
        "腫瘤好發於上顎（maxilla）和齒齦（gingiva），下顎較少",
        "腫瘤固定於深層組織和骨骼，不可移動",
        "同側下顎淋巴結（mandibular lymph node）可能腫大（反應性增生或轉移）",
        "進階病例可見顏面骨骼變形和不對稱",
        "觸診可能引起疼痛反應",
        "嚴重病例可見惡病質（cachexia）的全身表現"
      ]
    },
    "pathophysiology": "口腔纖維肉瘤起源於口腔軟組織中的間質纖維母細胞，腫瘤細胞產生膠原纖維基質。腫瘤具有浸潤性生長特性，沿組織平面擴展並侵犯鄰近的骨骼組織，引起骨質溶解和破壞。犬口腔纖維肉瘤有一種獨特的亞型被稱為「histologically low-grade, biologically high-grade fibrosarcoma」，其組織學表現看似良性（低有絲分裂指數、分化良好），但臨床行為卻具有高度侵襲性和高局部復發率。這種生物學行為的不一致使得預後評估和治療計畫的制定更加困難。遠端轉移主要經血行途徑至肺部，淋巴結轉移相對少見（約 5-10%）。",
    "diagnosis": {
      "primary": [
        "切片或切開活檢（incisional biopsy）送組織病理學：為確診的金標準，評估腫瘤類型和分級",
        "細針抽吸細胞學（FNA）：可提供初步診斷線索但確診率低（纖維肉瘤的細胞脫落性差）",
        "口腔和頭部 CT 掃描：評估腫瘤範圍、骨骼侵犯程度和手術計畫的制定為最重要的術前影像學檢查",
        "胸部三切面 X 光：評估肺部轉移",
        "區域淋巴結的細針抽吸細胞學或切除活檢：評估轉移"
      ],
      "differential": [
        "惡性黑色素瘤（malignant melanoma）：犬口腔最常見的惡性腫瘤",
        "鱗狀上皮細胞癌（squamous cell carcinoma）",
        "棘皮瘤性性牙瘤（acanthomatous ameloblastoma）：局部侵襲性但不轉移",
        "骨肉瘤（osteosarcoma）：原發性口腔骨肉瘤",
        "周邊神經鞘瘤（peripheral nerve sheath tumor）",
        "纖維瘤性齦瘤（fibromatous epulis / peripheral odontogenic fibroma）：良性腫瘤"
      ],
      "labFindings": [
        "組織病理學：梭形細胞腫瘤，纖維母細胞排列成交織束狀（herringbone pattern），膠原基質豐富程度不一",
        "免疫組織化學：vimentin 陽性、S-100 陰性（與黑色素瘤區別）、cytokeratin 陰性（與癌區別）",
        "CBC 和生化通常正常，除非有嚴重出血導致貧血",
        "CT 影像：軟組織腫塊伴鄰近骨骼溶解性破壞",
        "胸部 X 光：評估肺轉移灶（結節性病變）"
      ]
    },
    "treatment": {
      "acute": "腫瘤確診後應盡快制定治療計畫。CT 掃描評估腫瘤範圍是手術計畫的基礎。根治性手術切除是治療的基石。",
      "chronic": "術後追蹤：定期口腔檢查和影像學追蹤檢測復發和轉移。輔助放射治療用於切緣不足或無法手術的病例。輔助化療的效果尚有爭議。",
      "medications": [
        "術後止痛：Meloxicam 0.1 mg/kg PO SID（犬）或 Carprofen 2-4 mg/kg PO BID",
        "圍手術期抗生素：Amoxicillin-Clavulanate 20 mg/kg PO BID 持續 7-14 天",
        "化療（輔助性，效果有爭議）：Doxorubicin 30 mg/m² IV q3 weeks 共 5-6 次",
        "Carboplatin 300 mg/m² IV q3 weeks（替代化療選擇）",
        "Toceranib phosphate（Palladia）2.5-2.75 mg/kg PO EOD（靶向治療，個案報告顯示部分效果）",
        "術後 Tramadol 2-5 mg/kg PO BID-TID 用於疼痛管理"
      ],
      "surgery": "根治性手術切除為首選治療，需確保充足的手術邊緣（理想為腫瘤各方向 2-3 cm 邊緣和至少一個組織平面的深部邊緣）。常見術式包括：部分上顎切除術（partial maxillectomy）、下顎切除術（mandibulectomy），可能需要包括骨骼的大範圍切除。犬對大範圍的上下顎切除術耐受性良好，術後外觀和功能恢復通常令人滿意。"
    },
    "prognosis": "預後取決於腫瘤位置、大小、手術邊緣完整性和組織學分級。根治性手術切除且切緣乾淨（clean margins）的中位生存時間約 18-26 個月。切緣不完整的病例局部復發率高達 50-70%。輔助放射治療可改善局部控制率。遠端轉移率約 20-30%（主要轉移至肺部）。所謂的「histologically low-grade, biologically high-grade」亞型容易被低估其惡性程度，即使組織學分級為低度也不應過於樂觀。",
    "pearls": [
      "口腔纖維肉瘤的細針抽吸細胞學確診率低，因為梭形細胞不易脫落——建議直接進行切片活檢",
      "犬口腔纖維肉瘤存在「histologically low-grade, biologically high-grade」的特殊亞型，組織學表現溫和但臨床行為侵襲性強",
      "CT 掃描是術前評估最重要的工具，可精確判斷骨骼侵犯範圍，對手術計畫至關重要",
      "犬對部分上顎切除術和下顎切除術的耐受性比飼主預期的要好得多——術後功能和美觀恢復通常良好",
      "口腔纖維肉瘤的遠端轉移率（~20-30%）低於口腔惡性黑色素瘤（>80%），但局部復發是主要的治療失敗原因"
    ],
    "diagnosticAlgorithm": {
      "title": "口腔纖維肉瘤 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估口腔內堅硬的腫塊，注意流涎、進食困難和口臭等表現",
          "findings": [
            "口腔內固定堅硬腫塊",
            "進食困難伴流涎",
            "口臭或口腔出血"
          ]
        },
        {
          "step": 2,
          "action": "影像學檢查",
          "details": "進行口腔X光或CT評估骨骼侵蝕程度和腫瘤範圍",
          "findings": [
            "X光/CT顯示顎骨溶骨性病變",
            "評估腫瘤侵犯骨骼的範圍",
            "胸腔X光評估肺轉移"
          ]
        },
        {
          "step": 3,
          "action": "活檢確診",
          "details": "進行切開活檢送組織病理學檢查，注意纖維肉瘤可能低度惡性但局部侵犯性強",
          "findings": [
            "組織病理學確認纖維肉瘤",
            "評估組織學分級",
            "局部侵犯性強但遠端轉移率較低"
          ]
        }
      ]
    },
    "monitoring": [
      "術後每 2-3 個月口腔檢查評估局部復發",
      "每 2-3 個月胸部三切面 X 光評估肺轉移",
      "術後 CT 追蹤（每 3-6 個月）評估局部復發，特別是切緣不完整的病例",
      "區域淋巴結的定期觸診和 FNA（如腫大）",
      "使用化療時：每次化療前 CBC 評估骨髓抑制，定期腎功能監測（Carboplatin）或心臟超音波（Doxorubicin）",
      "營養和體重監測：確保充分營養攝入"
    ],
    "reference": "Clinical Veterinary Advisor: Dogs and Cats / Withrow & MacEwen's Small Animal Clinical Oncology / North & Banks: Small Animal Oncology"
  },
  "nasal-adenocarcinoma": {
    "zh": "鼻腔腺癌",
    "en": "Nasal Adenocarcinoma",
    "definition": "鼻腔腺癌是犬鼻腔最常見的惡性上皮性腫瘤之一，起源於鼻腔或副鼻竇的腺體上皮細胞。此腫瘤具有局部侵襲性強的特點，可破壞鼻甲骨、篩板及周圍骨骼結構，並可能侵犯眼眶或顱腔。在犬中，腺癌佔所有鼻腔腫瘤的約31.5%，較鱗狀細胞癌更為常見；在貓中，腺癌與淋巴瘤為最常見的鼻腔腫瘤類型。遠端轉移率相對較低，但局部復發率高。",
    "synonyms": [
      "鼻腺癌",
      "鼻腔腺性惡性腫瘤",
      "Nasal Glandular Carcinoma"
    ],
    "epidemiology": {
      "species": "犬較貓常見；犬為鼻腔腫瘤的主要患病物種",
      "breed": "長鼻型品種（Dolichocephalic breeds）風險較高，包括可麗牧羊犬（Collie）、德國牧羊犬（German Shepherd）、拉布拉多犬（Labrador Retriever）、巴吉度獵犬（Basset Hound）及古代牧羊犬（Old English Sheepdog）",
      "age": "中老年犬，平均發病年齡約10歲（範圍7-15歲）",
      "sex": "公犬略多於母犬，但性別差異不顯著",
      "prevalence": "犬鼻腔腫瘤佔所有犬腫瘤的1-2%，其中腺癌約佔31.5%。都市犬因暴露於環境污染物風險可能較高"
    },
    "clinicalPresentation": {
      "symptoms": [
        "單側或雙側鼻分泌物（初期為漿液性，後期轉為黏膿性或血性）",
        "鼻出血（Epistaxis），為最具特徵性的症狀",
        "打噴嚏頻率增加",
        "呼吸時鼻部有雜音（Stertor）",
        "面部不對稱腫脹或變形",
        "眼球突出（Exophthalmos）或眼球移位",
        "漿液性或黏膿性眼分泌物",
        "食慾下降與體重減輕",
        "行為改變（若侵犯腦部）",
        "癲癇發作（若穿透篩板侵入顱腔）",
        "牙齦或硬顎腫脹（若腫瘤向腹側擴展）",
        "慢性對抗生素治療無反應的鼻炎"
      ],
      "physicalExam": [
        "患側鼻孔氣流減少或阻塞",
        "鼻背部或面部骨骼隆起或不對稱",
        "觸診鼻部或面部可感到腫塊或骨骼破壞",
        "同側下頷淋巴結腫大（Submandibular lymphadenopathy）",
        "眼球突出或第三眼瞼脫出（若侵犯眼眶）",
        "口腔檢查可見硬顎變形或軟組織腫塊"
      ]
    },
    "pathophysiology": "鼻腔腺癌起源於鼻黏膜的分泌腺體上皮細胞，腫瘤細胞具有腺管狀或乳頭狀排列的組織學特徵。腫瘤局部生長具有高度侵襲性，可逐步破壞鼻甲骨（turbinates）、鼻中隔、眶骨及篩板（cribriform plate）。篩板被破壞後，腫瘤可直接侵入前顱窩引起神經系統症狀。環境因素如二手菸、室內煤炭燃燒及都市空氣污染物被認為可能增加長鼻型犬種的罹患風險。遠端轉移通常發生在疾病晚期，常見轉移部位包括局部淋巴結和肺臟。",
    "diagnosis": {
      "primary": [
        "頭部電腦斷層掃描（CT）：評估腫瘤範圍、骨骼破壞程度及篩板完整性，為放射治療計畫的必要檢查",
        "鼻腔鏡檢查（Rhinoscopy）配合組織切片：直視下觀察腫塊並取樣進行組織病理學確診",
        "組織病理學檢查（Histopathology）：確認腫瘤類型及分級，區分腺癌、鱗狀細胞癌或其他類型",
        "頭部X光片：可見鼻腔內軟組織密度增加及鼻甲骨溶解，但敏感度低於CT"
      ],
      "differential": [
        "鼻腔鱗狀細胞癌（Squamous Cell Carcinoma）",
        "鼻腔淋巴瘤（Nasal Lymphoma）",
        "黴菌性鼻炎（Fungal Rhinitis，如麴菌症 Aspergillosis）",
        "慢性細菌性鼻炎",
        "鼻腔異物",
        "牙根膿瘍引起的鼻竇炎",
        "鼻腔纖維肉瘤（Fibrosarcoma）",
        "鼻腔軟骨肉瘤（Chondrosarcoma）"
      ],
      "labFindings": [
        "血液學檢查通常無特異性異常",
        "慢性鼻出血患者可能出現輕度再生性貧血",
        "細胞學檢查可見惡性上皮細胞群，具有高核漿比、核仁明顯及細胞多形性",
        "凝血功能檢查通常正常（需與凝血障礙引起的鼻出血鑑別）",
        "胸腔X光檢查評估肺轉移（晚期約10-40%有肺轉移）"
      ]
    },
    "treatment": {
      "acute": "支持性治療控制鼻出血，包括鎮靜、冷敷及局部血管收縮劑。嚴重貧血時需輸血支持",
      "chronic": "放射治療（Radiation therapy）為首選治療方式，包括確定性放療（definitive protocol，15-19次分割）或姑息性放療（palliative protocol，3-4次大分割）。放射治療可顯著延長存活時間",
      "medications": [
        "非類固醇消炎藥（NSAIDs）如 Piroxicam 0.3 mg/kg PO q24h 或 Meloxicam，可能具有抗腫瘤輔助效果",
        "Toceranib phosphate（Palladia）作為標靶治療的輔助用藥",
        "止痛藥物：Tramadol 2-5 mg/kg PO q8-12h 或 Gabapentin 5-10 mg/kg PO q8-12h",
        "抗生素治療繼發性細菌感染（如 Amoxicillin-Clavulanate）",
        "化療藥物（Carboplatin 或 Cisplatin）可作為放療的輔助治療"
      ],
      "surgery": "鼻腔切除術（Rhinotomy）通常不作為單一治療，因為很難達到完全切緣陰性。手術可與放射治療合併使用以減少腫瘤體積。根治性手術（Dorsal rhinotomy）加放療可能改善預後"
    },
    "prognosis": "單獨手術的中位存活時間約3-6個月。放射治療（確定性方案）的中位存活時間約12-16個月，1年存活率約50-60%。姑息性放療的中位存活時間約6-9個月。預後不良因素包括篩板破壞、顱內侵犯及就診時已有遠端轉移。",
    "pearls": [
      "單側鼻出血在中老年長鼻型犬種應高度懷疑鼻腔腫瘤，尤其是對抗生素治療無反應時",
      "CT是評估腫瘤範圍和制定放射治療計畫的金標準影像學檢查",
      "鼻腔淋巴瘤在貓中與腺癌同樣常見，但治療方式和預後截然不同，組織學確診極為重要",
      "環境因素（二手菸、都市污染）可能增加長鼻型犬的鼻腔腫瘤風險"
    ],
    "diagnosticAlgorithm": {
      "title": "鼻腔腺癌 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估慢性單側鼻出血、鼻分泌物和打噴嚏，注意面部變形等晚期表現",
          "findings": [
            "慢性單側鼻出血或黏膿性分泌物",
            "面部對稱性喪失或腫脹",
            "打噴嚏和呼吸困難"
          ]
        },
        {
          "step": 2,
          "action": "影像學檢查",
          "details": "進行鼻腔CT評估腫瘤範圍、骨骼破壞和顱內延伸",
          "findings": [
            "CT顯示鼻腔內軟組織腫塊",
            "鼻甲骨破壞",
            "評估篩板完整性和顱內侵犯"
          ]
        },
        {
          "step": 3,
          "action": "鼻腔鏡活檢確診",
          "details": "進行鼻腔鏡檢查和活檢送組織病理學確診",
          "findings": [
            "鼻腔鏡見腫瘤組織",
            "組織病理學確認腺癌類型",
            "評估區域淋巴結和遠端轉移"
          ]
        }
      ]
    },
    "monitoring": [
      "放射治療期間每週評估急性放射反應（口腔黏膜炎、皮膚反應）",
      "治療後每2-3個月進行CT追蹤評估腫瘤反應",
      "定期胸腔X光檢查監測肺轉移",
      "監測鼻分泌物性質和鼻出血頻率",
      "評估食慾、體重及生活品質"
    ],
    "reference": "Clinical Veterinary Advisor / Blackwell's Five-Minute Veterinary Consult / Withrow & MacEwen's Small Animal Clinical Oncology"
  },
  "lymphangiectasia": {
    "zh": "腸淋巴管擴張症",
    "en": "Intestinal Lymphangiectasia",
    "definition": "腸淋巴管擴張症是一種以小腸黏膜和黏膜下層淋巴管異常擴張為特徵的疾病，導致富含蛋白質的淋巴液滲漏入腸腔，造成蛋白質流失性腸病（Protein-Losing Enteropathy, PLE）。此病可為原發性（先天性淋巴管發育異常）或繼發性（因腸道炎症、腫瘤或淋巴管阻塞所致）。臨床表現以低白蛋白血症、腹瀉及體重減輕為主，嚴重時可出現腹水、胸水及周邊水腫。",
    "synonyms": [
      "淋巴管擴張",
      "蛋白質流失性腸病",
      "PLE",
      "Protein-Losing Enteropathy",
      "腸道淋巴管擴張"
    ],
    "epidemiology": {
      "species": "犬較貓常見",
      "breed": "約克夏㹴犬（Yorkshire Terrier）為最好發品種，其次包括馬爾濟斯（Maltese）、挪威倫德獵犬（Norwegian Lundehund）、軟毛麥色㹴犬（Soft Coated Wheaten Terrier）、沙皮犬（Shar Pei）及羅威那犬（Rottweiler）",
      "age": "可發生於任何年齡，先天性型多在幼犬至青年犬發現，繼發性型多見於中老年犬",
      "sex": "無明顯性別傾向",
      "prevalence": "為犬蛋白質流失性腸病的常見原因之一。約克夏㹴犬的發病率顯著高於其他品種，具有品種遺傳傾向"
    },
    "clinicalPresentation": {
      "symptoms": [
        "慢性小腸性腹瀉（量多、無裡急後重）",
        "體重減輕，進行性消瘦",
        "腹部膨大（腹水）",
        "四肢或腹部皮下水腫",
        "食慾可能正常、增加或減退",
        "嘔吐（間歇性）",
        "嗜睡與活動力下降",
        "呼吸困難（若有胸水）",
        "毛髮品質變差",
        "間歇性厭食",
        "脂肪瀉（Steatorrhea）：糞便呈灰白色油膩狀",
        "血栓栓塞事件（因抗凝血蛋白流失，如肺血栓栓塞症）"
      ],
      "physicalExam": [
        "腹部觸診可感到波動感（腹水）",
        "體態評分（BCS）降低，肌肉量減少",
        "皮下水腫，尤其在四肢遠端及腹壁",
        "腸管觸診可能增厚",
        "聽診呼吸音減弱（若有胸水）",
        "黏膜顏色正常或蒼白"
      ]
    },
    "pathophysiology": "正常情況下，腸道淋巴管負責吸收消化後的長鏈脂肪酸（以乳糜微粒形式）並將富含蛋白質的淋巴液回送至血液循環。當淋巴管因先天性發育異常、炎症浸潤或外在壓迫而擴張破裂時，富含白蛋白、球蛋白及淋巴球的淋巴液滲漏入腸腔。持續的蛋白質流失導致低白蛋白血症，當血清白蛋白降至1.5 g/dL以下時，膠體滲透壓不足以維持血管內液體，液體滲出至第三間隙形成腹水、胸水和周邊水腫。同時，抗凝血蛋白（如抗凝血酶III, AT-III）的流失增加血栓形成風險。淋巴球的流失也會導致淋巴球減少症，影響免疫功能。",
    "diagnosis": {
      "primary": [
        "血清白蛋白測定：低白蛋白血症（通常 < 2.0 g/dL）是核心發現",
        "腸道組織切片（內視鏡或全層手術切片）：可見黏膜及黏膜下層淋巴管明顯擴張，絨毛腫脹呈白色（lipogranuloma）",
        "腹部超音波：可見小腸壁增厚、黏膜層高回音條紋（mucosal striations）及腹水",
        "全層腸道切片（Full-thickness biopsy）：優於內視鏡切片，可評估黏膜下層和肌層的淋巴管變化"
      ],
      "differential": [
        "炎症性腸病（IBD）引起的蛋白質流失",
        "腸道淋巴瘤",
        "慢性腸炎（嗜酸性、淋巴漿細胞性）",
        "肝臟疾病引起的低白蛋白血症",
        "蛋白質流失性腎病（PLN）",
        "充血性心衰竭",
        "腸道組織漿細胞增生症",
        "黴菌性腸炎（如組織漿菌症）"
      ],
      "labFindings": [
        "低白蛋白血症（Hypoalbuminemia）：血清白蛋白 < 2.0 g/dL",
        "低球蛋白血症（Hypoglobulinemia）：與僅低白蛋白的肝病或腎病不同，PLE常同時流失白蛋白和球蛋白",
        "淋巴球減少症（Lymphopenia）：因淋巴球隨淋巴液流失",
        "低膽固醇血症（Hypocholesterolemia）：脂質吸收障礙",
        "低鈣血症：因鈣與白蛋白結合流失（離子鈣可能正常）",
        "糞便α1-蛋白酶抑制劑（α1-PI）濃度升高：確認腸道蛋白質流失的非侵入性檢查",
        "凝血時間可能延長（抗凝血因子流失）",
        "低鎂血症"
      ]
    },
    "treatment": {
      "acute": "嚴重低白蛋白血症伴腹水者需住院管理：靜脈輸注膠體液（如 Hetastarch 或新鮮冷凍血漿 FFP）提高膠體滲透壓。大量腹水造成呼吸困難時可進行腹腔穿刺放液。血栓風險高的患者給予抗凝血治療",
      "chronic": "長期管理以超低脂飲食為核心，配合免疫抑制治療（若有並存的炎症性腸病）。飲食中脂肪含量應低於15%乾物質基礎，使用中鏈三酸甘油酯（MCT oil）代替長鏈脂肪作為能量來源。定期監測血清白蛋白和體重",
      "medications": [
        "超低脂處方飼料（如 Royal Canin Gastrointestinal Low Fat 或自製超低脂飲食）",
        "中鏈三酸甘油酯油（MCT oil）1-2 mL/kg/day 作為脂肪替代來源",
        "Prednisolone 1-2 mg/kg PO q12h（初始劑量），逐漸減量至最低有效劑量",
        "Chlorambucil 2-6 mg/m² PO q24-48h（若單用類固醇反應不佳）",
        "Mycophenolate mofetil 或 Cyclosporine 作為類固醇減量替代",
        "Clopidogrel 1-2 mg/kg PO q24h（預防血栓栓塞）",
        "Cobalamin（維生素B12）補充：250-1500 μg SC q7d（因吸收不良常缺乏）",
        "利尿劑 Furosemide 1-2 mg/kg PO q12h（控制嚴重水腫，需謹慎使用）"
      ],
      "surgery": "全層腸道切片用於確診。若有局部性淋巴管擴張（如限於某段腸道），手術切除受影響腸段可能有幫助，但大多數病例為瀰漫性病變，手術價值有限"
    },
    "prognosis": "預後因病因和嚴重程度而異。原發性淋巴管擴張症在約克夏㹴犬中，若對飲食管理反應良好，中位存活時間可達1-2年以上。嚴重低白蛋白血症（< 1.0 g/dL）、併發血栓栓塞或對治療反應不佳者預後較差。繼發於淋巴瘤的病例預後不良。持續的飲食管理是長期控制的關鍵。",
    "pearls": [
      "約克夏㹴犬出現慢性腹瀉加低白蛋白血症時，淋巴管擴張症應列為首要鑑別診斷",
      "PLE的特徵是白蛋白和球蛋白同時降低，若僅白蛋白降低應考慮肝病或腎病",
      "超低脂飲食是治療的基石，很多病例單靠飲食管理即可顯著改善",
      "血栓栓塞是PLE的致命併發症，白蛋白 < 1.5 g/dL時應預防性給予抗血栓治療",
      "內視鏡切片可能遺漏黏膜下層病變，全層切片診斷率更高"
    ],
    "diagnosticAlgorithm": {
      "title": "腸淋巴管擴張症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估慢性腹瀉、體重下降和低蛋白血症引起的腹水或四肢水腫",
          "findings": [
            "慢性小腸型腹瀉",
            "進行性體重下降",
            "腹水或皮下水腫"
          ]
        },
        {
          "step": 2,
          "action": "實驗室檢查",
          "details": "進行生化檢查評估蛋白質流失程度，注意泛低蛋白血症和淋巴球減少",
          "findings": [
            "嚴重低白蛋白血症和低球蛋白血症",
            "低膽固醇血症",
            "淋巴球減少"
          ]
        },
        {
          "step": 3,
          "action": "內視鏡活檢確診",
          "details": "進行十二指腸內視鏡檢查和全層活檢確認淋巴管擴張",
          "findings": [
            "內視鏡見小腸黏膜白色顆粒狀突起",
            "活檢顯示黏膜和黏膜下層淋巴管顯著擴張",
            "排除其他蛋白質流失性腸病"
          ]
        }
      ]
    },
    "monitoring": [
      "每2-4週監測血清白蛋白和總蛋白，直到穩定",
      "定期監測體重和體態評分",
      "監測糞便性狀和排便頻率",
      "定期檢測全血球計數（注意淋巴球數）",
      "監測血清鈣、鎂及維生素B12濃度",
      "使用免疫抑制藥物時定期檢查肝腎功能",
      "注意血栓栓塞的臨床徵兆（急性呼吸困難、肢體疼痛）"
    ],
    "reference": "Clinical Veterinary Advisor / Blackwell's Five-Minute Veterinary Consult / ACVIM Consensus Statement on PLE"
  },
  "exocrine-pancreatic-neoplasia": {
    "zh": "外分泌胰腺腫瘤",
    "en": "Exocrine Pancreatic Neoplasia",
    "definition": "外分泌胰腺腫瘤是起源於胰臟外分泌腺（腺泡細胞或導管上皮）的惡性腫瘤，包括胰腺腺癌（Pancreatic Adenocarcinoma）和腺泡細胞癌（Acinar Cell Carcinoma）。此類腫瘤在犬貓中罕見但極具侵襲性，通常在診斷時已發生局部或遠端轉移。細胞學特徵包括多變的核漿比、深嗜鹼性細胞質、明顯的核及核仁多形性。臨床表現多為非特異性，常因晚期發現而預後極差。",
    "synonyms": [
      "胰臟外分泌腺腫瘤",
      "胰腺腺癌",
      "胰臟癌",
      "Pancreatic Adenocarcinoma",
      "Pancreatic Carcinoma",
      "Acinar Cell Carcinoma"
    ],
    "epidemiology": {
      "species": "犬和貓均可發生，貓的發病率相對較犬高",
      "breed": "犬中拳師犬（Boxer）和可卡犬（Cocker Spaniel）可能有較高風險。貓中無明確品種傾向",
      "age": "中老年動物，犬平均發病年齡約10歲，貓約12歲",
      "sex": "母犬可能有略高的發病風險，但數據有限",
      "prevalence": "罕見腫瘤，佔犬所有腫瘤的不到0.5%，佔貓所有腫瘤的約2%。因臨床表現非特異性，實際發病率可能被低估"
    },
    "clinicalPresentation": {
      "symptoms": [
        "食慾減退或厭食",
        "進行性體重減輕和消瘦",
        "嘔吐（間歇性至持續性）",
        "腹瀉或脂肪瀉",
        "腹部疼痛（表現為弓背、不願移動、腹部觸診抗拒）",
        "腹部膨大（腹水或腫塊效應）",
        "黃疸（若腫瘤壓迫或侵犯膽管）",
        "嗜睡和精神沉鬱",
        "多飲多尿（Polyuria/Polydipsia，若引起副腫瘤性糖尿病）",
        "血栓栓塞相關症狀（急性呼吸困難、後肢無力）",
        "後肢或腹部皮膚結節性脂膜炎（Nodular panniculitis，副腫瘤症候群）",
        "糞便顏色變淺（若膽道阻塞）"
      ],
      "physicalExam": [
        "前腹部可觸及腫塊（約50%的病例）",
        "腹部觸診疼痛反應",
        "黃疸（皮膚、黏膜及鞏膜黃染）",
        "體態評分降低，肌肉量減少",
        "腹部波動感（腹水）",
        "皮下結節（副腫瘤性脂膜炎，質硬、可移動、可能有潰瘍）"
      ]
    },
    "pathophysiology": "外分泌胰腺腫瘤主要分為導管型腺癌和腺泡細胞型腺癌。導管型較為常見且侵襲性更強。腫瘤細胞快速增殖並侵犯周圍組織，包括十二指腸壁、胃壁、膽總管及腸系膜。腫瘤產生的胰酶釋放可引起局部胰臟炎和脂肪壞死。副腫瘤症候群包括：腫瘤釋放脂肪酶引起皮下脂膜炎和多關節炎；胰島素受體抗體或胰島破壞導致糖尿病；腫瘤促凝因子導致瀰漫性血管內凝血（DIC）或血栓栓塞。轉移途徑主要經淋巴或血行途徑至肝臟、腹膜和肺臟。",
    "diagnosis": {
      "primary": [
        "腹部超音波檢查：可見胰臟區域低回音或混合回音腫塊，評估肝臟轉移及膽管擴張",
        "超音波引導下細針抽吸（FNA）細胞學檢查：可見惡性上皮細胞，核漿比多變，深嗜鹼性細胞質，核及核仁多形性明顯",
        "腹部CT掃描：評估腫瘤大小、血管侵犯及轉移範圍，為手術計畫提供重要資訊",
        "組織病理學檢查（手術或超音波引導粗針切片）：確認腫瘤類型和分級"
      ],
      "differential": [
        "急性或慢性胰臟炎",
        "胰臟膿瘍或假性囊腫",
        "胰島素瘤（胰島細胞腫瘤，為內分泌型）",
        "膽管癌或肝臟腫瘤侵犯胰臟",
        "十二指腸腫瘤",
        "腸系膜淋巴結腫瘤（淋巴瘤）",
        "胰臟結節性增生（良性）"
      ],
      "labFindings": [
        "血清脂肪酶（Lipase）及犬特異性胰脂肪酶（cPLI/Spec cPL）可能升高",
        "肝指數升高：ALP、GGT、ALT（因膽道阻塞或肝轉移）",
        "總膽紅素升高（膽道阻塞性黃疸）",
        "高血糖（副腫瘤性糖尿病，約25-30%的病例）",
        "白血球增多症（嗜中性球增多）",
        "輕度至中度貧血（慢性病貧血）",
        "血清白蛋白降低",
        "凝血功能異常（PT、aPTT延長，若有DIC）"
      ]
    },
    "treatment": {
      "acute": "穩定患者狀態：靜脈輸液糾正脫水和電解質失衡，止吐（Maropitant 1 mg/kg SC/IV q24h），疼痛管理（Buprenorphine 0.01-0.02 mg/kg IV/IM q6-8h 或持續速率輸注 CRI），糖尿病患者需胰島素治療",
      "chronic": "由於大多數病例在診斷時已晚期，治療主要為姑息性。化療效果有限，但可嘗試以改善生活品質。支持性照護包括營養管理、疼痛控制及併發症處理",
      "medications": [
        "止痛藥物：Tramadol 2-5 mg/kg PO q8h，Gabapentin 5-10 mg/kg PO q8-12h，或 Amantadine 3-5 mg/kg PO q24h",
        "化療藥物：Gemcitabine 800 mg/m² IV（每2週一次）可能有部分療效",
        "Toceranib phosphate（Palladia）2.5-2.75 mg/kg PO 隔天一次（作為姑息性治療選項）",
        "止吐藥：Maropitant（Cerenia）2 mg/kg PO q24h",
        "胰酶補充劑（若有外分泌功能不全）",
        "質子泵抑制劑：Omeprazole 1 mg/kg PO q12-24h（控制胃酸）",
        "胰島素治療（若併發糖尿病）"
      ],
      "surgery": "手術切除是唯一可能治癒的選項，但僅適用於腫瘤局限且無轉移的少數病例。手術方式包括部分胰臟切除或胰十二指腸切除術（Pancreaticoduodenectomy, Whipple procedure），後者在獸醫學中技術複雜且併發症率高。手術切除率僅約10-20%"
    },
    "prognosis": "預後極差。未治療的中位存活時間通常僅數天至數週。即使手術完全切除（罕見），中位存活時間也僅約6個月。大多數病例在診斷後1-3個月內死亡或因生活品質惡化而安樂死。副腫瘤性脂膜炎的出現通常提示已有廣泛轉移，預後更差。",
    "pearls": [
      "中老年犬貓出現不明原因的體重減輕、腹痛及黃疸三聯徵時，應考慮外分泌胰腺腫瘤",
      "皮下結節性脂膜炎是胰腺腺癌的經典副腫瘤症候群，其出現可早於腫瘤的其他臨床表現",
      "超音波引導FNA的細胞學陽性率較高，但需注意與胰臟炎的鑑別",
      "胰臟腫瘤常與胰臟炎並存，單純影像學檢查可能難以區分兩者"
    ],
    "diagnosticAlgorithm": {
      "title": "外分泌胰腺腫瘤 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估嘔吐、腹痛、黃疸和體重下降等非特異性表現，老年動物好發",
          "findings": [
            "嘔吐和食慾下降",
            "腹痛（前腹部）",
            "進行性黃疸（膽總管壓迫）"
          ]
        },
        {
          "step": 2,
          "action": "影像學檢查",
          "details": "進行腹部超音波和CT評估胰腺腫塊及周圍侵犯",
          "findings": [
            "超音波顯示胰腺區域腫塊",
            "CT精確評估腫塊範圍和血管侵犯",
            "可能見腹膜播種結節"
          ]
        },
        {
          "step": 3,
          "action": "細胞學/組織學確診",
          "details": "進行超音波引導細針抽吸或手術活檢，送病理學檢查",
          "findings": [
            "細胞學或組織病理學確認腺癌或腺瘤",
            "評估手術切除可能性",
            "外分泌胰腺腺癌預後差，常已轉移"
          ]
        }
      ]
    },
    "monitoring": [
      "治療期間每1-2週監測血糖、肝指數及膽紅素",
      "定期腹部超音波評估腫瘤大小變化及轉移",
      "監測體重、食慾及疼痛評分",
      "化療期間每週檢測全血球計數（監測骨髓抑制）",
      "監測凝血功能（警惕DIC風險）",
      "評估生活品質以決定是否繼續治療"
    ],
    "reference": "Clinical Veterinary Advisor / Blackwell's Five-Minute Veterinary Consult / Withrow & MacEwen's Small Animal Clinical Oncology"
  },
  "tracheal-foreign-body": {
    "zh": "氣管異物",
    "en": "Tracheal Foreign Body",
    "definition": "氣管異物是指異物被吸入並嵌塞於氣管、支氣管或更遠端的下呼吸道。最常見的異物為植物材料（如草芒 grass awns、穀芒及小樹枝），其他還包括小型玩具碎片、骨頭碎片及食物顆粒。植物性異物被吸入肺臟後可能穿越肺實質遷移至胸膜腔，引起膿胸或氣胸。此病為急性呼吸急症，需要及時診斷和處理。",
    "synonyms": [
      "氣管內異物",
      "支氣管異物",
      "下呼吸道異物",
      "Tracheal/Bronchial Foreign Body",
      "Airway Foreign Body"
    ],
    "epidemiology": {
      "species": "犬較貓常見，尤其是工作犬和戶外活動頻繁的犬隻",
      "breed": "運動犬種和獵犬品種風險較高，包括拉布拉多犬（Labrador Retriever）、英國史賓格犬（English Springer Spaniel）、德國短毛指示犬（German Shorthaired Pointer）。幼犬因好奇心強也較易發生",
      "age": "任何年齡均可發生，幼犬和年輕成犬較常見",
      "sex": "無明顯性別傾向",
      "prevalence": "在戶外活動頻繁的犬隻中發生率較高，季節性與植物成熟期相關（草芒在夏秋季節最多見）。整體在犬呼吸道疾病中屬於不常見但重要的急症"
    },
    "clinicalPresentation": {
      "symptoms": [
        "突發性劇烈咳嗽（異物吸入時的最初反應）",
        "持續性頑固咳嗽（對止咳藥物無反應）",
        "呼吸困難（Dyspnea）",
        "運動不耐受",
        "喘鳴音（Wheezing）或喘氣聲（Stridor）",
        "咳血（Hemoptysis）",
        "發燒（繼發感染時）",
        "食慾下降",
        "鼻分泌物（黏膿性，若異物引起鼻後滴漏或肺部感染）",
        "呼吸急促（Tachypnea）",
        "反覆發作的肺炎（若異物長期存在引起慢性感染）",
        "黏膜發紺（嚴重氣道阻塞時）"
      ],
      "physicalExam": [
        "聽診可聞及局限性喘鳴音（Wheeze）或囉音（Crackles），通常位於異物所在側",
        "呼吸型態異常：吸氣性呼吸困難（上氣管異物）或呼氣性呼吸困難（下支氣管異物）",
        "呼吸急促，可能伴有輔助呼吸肌的使用",
        "單側肺部呼吸音減弱（若異物完全阻塞一側支氣管）",
        "觸診氣管時可引發咳嗽反射（氣管敏感度增加）",
        "發燒（繼發細菌感染時，體溫 > 39.5°C）",
        "黏膜發紺（嚴重阻塞）或正常"
      ]
    },
    "pathophysiology": "異物吸入通常發生在劇烈喘氣、吠叫、進食或戶外奔跑時，因聲門反射不足而使異物進入氣管。較大的異物可能停留在氣管或隆突（carina），而較小的異物則傾向被帶入右主支氣管（因其角度較直且管徑較大）。異物的存在導致局部氣道黏膜炎症、水腫和肉芽組織增生，可部分或完全阻塞氣道。植物性異物（尤其是草芒）具有逆鉤狀結構，會隨呼吸運動向遠端遷移，可穿透支氣管壁進入肺實質，進而遷移至胸膜腔引起膿胸或膈肌穿孔。細菌感染常伴隨異物發生，導致吸入性肺炎或肺膿瘍。",
    "diagnosis": {
      "primary": [
        "胸腔X光片：可能見到不透射影的異物（金屬或骨骼類）、局部肺葉塌陷（atelectasis）、肺實質浸潤或胸水",
        "支氣管鏡檢查（Bronchoscopy）：為診斷和治療的金標準，可直接觀察異物位置並在直視下取出",
        "透視檢查（Fluoroscopy）：動態觀察呼吸時的氣道運動，可見空氣陷閉（air trapping）或縱膈擺動",
        "CT掃描：對於植物性異物的定位特別有價值，可清楚顯示異物所在位置和周圍組織變化"
      ],
      "differential": [
        "犬傳染性氣管支氣管炎（Kennel Cough）",
        "氣管塌陷（Tracheal Collapse）",
        "慢性支氣管炎",
        "吸入性肺炎（無異物）",
        "氣道腫瘤（氣管或支氣管腫瘤）",
        "肺葉扭轉",
        "嗜酸性支氣管肺病",
        "心因性肺水腫（咳嗽伴呼吸困難）"
      ],
      "labFindings": [
        "全血球計數可見嗜中性球增多（左移，若有感染）",
        "C反應蛋白（CRP）升高（炎症指標）",
        "氣管沖洗液（Transtracheal wash, TTW）細胞學：大量嗜中性球和細菌，可進行培養及藥敏試驗",
        "動脈血氣分析可見低氧血症（PaO2降低）",
        "胸水分析（若有胸水）：化膿性胸水提示膿胸"
      ]
    },
    "treatment": {
      "acute": "確保氣道通暢為首要任務。嚴重呼吸窘迫時先給予氧氣支持（flow-by oxygen 或氧氣籠）。準備緊急氣管插管或環甲膜切開術（cricothyrotomy）的設備。穩定後盡快安排支氣管鏡檢查取出異物",
      "chronic": "異物取出後，根據感染嚴重程度給予2-6週的抗生素治療。慢性異物伴肺膿瘍或肺葉實質化者可能需要手術介入（肺葉切除）。遷移至胸膜腔的異物需要開胸探查",
      "medications": [
        "廣效抗生素（根據培養結果調整）：初始經驗性治療可用 Amoxicillin-Clavulanate 12.5-25 mg/kg PO q12h",
        "若有厭氧菌感染：加用 Metronidazole 10-15 mg/kg PO q12h",
        "支氣管擴張劑：Terbutaline 0.01 mg/kg SC 或 Albuterol 霧化吸入（緩解支氣管痙攣）",
        "短期使用類固醇減輕氣道水腫：Dexamethasone 0.1-0.2 mg/kg IV（僅在異物取出前後短期使用）",
        "止痛藥：Butorphanol 0.2-0.4 mg/kg IV/IM q6-8h（同時具有鎮咳效果）",
        "霧化治療（Nebulization）配合叩擊排痰（Coupage）促進分泌物清除",
        "靜脈輸液維持水合狀態"
      ],
      "surgery": "支氣管鏡取出異物為首選治療方式，可在透過內視鏡鉗或取石網籃（basket）直視下取出。若支氣管鏡無法取出或異物已遷移至肺實質/胸膜腔，則需要開胸手術（Thoracotomy）。手術可能包括支氣管切開取物（Bronchotomy）、肺葉切除術（Lobectomy）或異物移除合併膿胸引流"
    },
    "prognosis": "若異物能早期發現並完整取出，預後良好。支氣管鏡成功取出率約70-90%。延遲診斷或異物遷移至肺實質/胸膜腔者預後較差，需更複雜的手術且併發症風險增加。草芒等植物性異物若遷移引起膿胸，治療後預後仍可謹慎樂觀。異物長期嵌頓導致肺膿瘍或支氣管擴張症者需長期管理。",
    "pearls": [
      "突發性劇烈咳嗽後轉為慢性頑固咳嗽且對藥物治療無效，應高度懷疑氣管或支氣管異物",
      "植物性異物（草芒）在X光上通常不可見，CT和支氣管鏡為必要的診斷工具",
      "異物傾向進入右側支氣管（因角度較直且管徑較大），單側肺病變應引起警覺",
      "草芒等植物性異物具有遷移特性，可穿透肺組織進入胸膜腔或腹膜腔，形成膿胸或腹膜後膿瘍",
      "反覆發作的單側肺炎且對抗生素反應不佳，應考慮隱匿的支氣管異物"
    ],
    "diagnosticAlgorithm": {
      "title": "氣管異物 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估急性發作的嚴重咳嗽、呼吸困難和喘鳴音，詢問異物吸入病史",
          "findings": [
            "突發性劇烈咳嗽",
            "吸氣性呼吸困難和喘鳴音",
            "發紺或呼吸窘迫"
          ]
        },
        {
          "step": 2,
          "action": "影像學檢查",
          "details": "進行頸部和胸腔X光評估異物位置，注意不透射性和透射性異物",
          "findings": [
            "X光可見氣管或支氣管內不透射性異物",
            "局部肺葉過度充氣或肺不張",
            "透射性異物可能需透視檢查"
          ]
        },
        {
          "step": 3,
          "action": "支氣管鏡確診與取出",
          "details": "進行支氣管鏡檢查直接觀察並取出異物",
          "findings": [
            "支氣管鏡直接觀察到異物",
            "評估氣管黏膜損傷程度",
            "支氣管鏡引導下取出異物"
          ]
        }
      ]
    },
    "monitoring": [
      "異物取出後24-48小時密切監測呼吸型態和血氧飽和度",
      "取出後1-2週複查胸腔X光確認肺部浸潤消退",
      "完成抗生素療程後再次複查X光確認完全清除",
      "監測體溫以確認感染控制",
      "術後監測食慾、活動力及咳嗽頻率",
      "若有胸膜腔引流管，監測引流量和性狀"
    ],
    "reference": "Clinical Veterinary Advisor / Blackwell's Five-Minute Veterinary Consult / BSAVA Manual of Canine and Feline Thoracic Imaging"
  },
  "pericardioperitoneal-diaphragmatic-hernia": {
    "zh": "腹膜心包橫膈疝",
    "en": "Pericardioperitoneal Diaphragmatic Hernia (PPDH)",
    "definition": "腹膜心包橫膈疝（PPDH）是一種先天性膈肌發育異常，源於胚胎期橫中隔（septum transversum）的不完全發育，導致腹膜腔與心包腔之間存在異常通道。腹腔內臟器（最常見為肝臟、脂肪組織、小腸及膽囊）可經此通道疝入心包腔。此為最常見的先天性心包異常，多數病例可能終生無症狀而偶然發現，但部分病例因疝入臟器壓迫心臟而出現心血管或呼吸系統症狀。",
    "synonyms": [
      "心包膈疝",
      "心包腹膜疝",
      "先天性心包膈疝",
      "PPDH",
      "Peritoneopericardial Diaphragmatic Hernia"
    ],
    "epidemiology": {
      "species": "犬和貓均可發生",
      "breed": "貓中長毛貓和喜馬拉雅貓發生率較高；犬中威瑪獵犬（Weimaraner）和可卡犬（Cocker Spaniel）可能有較高風險。常伴隨其他先天性畸形，如胸骨缺損、臍疝及心臟缺損",
      "age": "先天性疾病，可在任何年齡被發現。多在幼年至中年因其他原因進行影像學檢查時偶然發現，或在出現症狀時才診斷",
      "sex": "公犬可能略多於母犬，但差異不大",
      "prevalence": "為最常見的先天性心包缺陷。確切發病率不明，因多數病例無症狀。貓的發病率估計約0.06%，犬的報導較少"
    },
    "clinicalPresentation": {
      "symptoms": [
        "許多病例終生無症狀（偶然發現）",
        "運動不耐受",
        "呼吸困難或氣喘（Dyspnea）",
        "嘔吐（腸道疝入心包腔引起扭曲或嵌頓）",
        "食慾減退",
        "腹瀉",
        "腹部脹滿感",
        "體重增長不良（幼年動物）",
        "咳嗽",
        "昏厥或暈倒（Syncope，心臟被壓迫時）",
        "餐後不適加重（疝入腸道的症狀在進食後加劇）",
        "腹部觸診時感覺臟器減少（「空腹」感）"
      ],
      "physicalExam": [
        "心音減弱（心包腔內有臟器導致聽診音傳導異常）",
        "心臟區域可聽到腸鳴音（GI sounds over heart），為本病的經典發現",
        "腹部觸診可感到臟器缺失或位移",
        "伴隨腹壁缺損時可見臍疝或上腹部疝",
        "胸骨前方可觸及凹陷或缺損（胸骨缺損）",
        "心跳節律可能不規則（心臟受壓迫引起心律不整）"
      ]
    },
    "pathophysiology": "在胚胎發育過程中，橫中隔（septum transversum）和胸腹膜褶（pleuroperitoneal folds）共同形成膈肌，將胸腔與腹腔分隔。橫中隔同時參與心包腹側部分的形成。當橫中隔發育不完全時，腹膜腔與心包腔之間留下持續性通道。腹腔內臟器因重力和腹內壓可通過此通道進入心包腔。疝入的臟器佔據心包腔空間，可壓迫心臟導致心室充盈受限（類似填塞效應），引起心輸出量下降。若腸道疝入並發生嵌頓或扭轉，可引起急性腹部症狀和腸壞死。PPDH常與其他中線先天性缺陷並存，包括腹壁缺損（臍疝）、胸骨裂（sternal clefts）及心室中隔缺損（VSD）。",
    "diagnosis": {
      "primary": [
        "胸腔X光片：可見心臟輪廓增大且形狀異常（球形或不規則），可能在心影中見到腸道氣體影或肝臟密度影",
        "腹部及胸腔超音波檢查：可直接觀察到心包腔內有腹腔臟器（肝臟、脂肪、腸道），為診斷的最佳非侵入性工具",
        "心臟超音波（Echocardiography）：可在心包腔內見到非心臟組織（如肝臟實質或腸管），同時評估心臟功能",
        "上消化道鋇劑造影或CT掃描：可清楚顯示腸道經膈肌缺損進入心包腔的路徑"
      ],
      "differential": [
        "心包積液（Pericardial Effusion）",
        "心臟腫瘤（心基部腫瘤或血管肉瘤）",
        "擴張型心肌症（Dilated Cardiomyopathy）",
        "創傷性膈疝（Traumatic Diaphragmatic Hernia）",
        "縱膈腫塊",
        "先天性心臟病（心室中隔缺損、法洛四聯症）",
        "胸腔腫瘤"
      ],
      "labFindings": [
        "血液學和血液化學檢查通常正常",
        "若肝臟疝入可能見到肝指數輕度升高（ALT、ALP）",
        "若腸道嵌頓壞死，可見白血球增多、代謝性酸中毒",
        "心電圖可能顯示低電壓或電軸偏移",
        "動脈血氣分析在嚴重病例可見低氧血症"
      ]
    },
    "treatment": {
      "acute": "若疝入臟器發生嵌頓或絞窄，需緊急手術。術前穩定包括：氧氣支持、靜脈輸液及疼痛管理。若有心臟填塞徵象，避免使用過多靜脈輸液以防加重心臟負擔",
      "chronic": "無症狀的PPDH是否需要手術修復仍有爭議。多數外科醫師建議即使無症狀也進行選擇性修復，以預防日後可能發生的臟器嵌頓。有症狀的病例則明確需要手術治療",
      "medications": [
        "術前穩定：靜脈輸液（Lactated Ringer's solution）維持循環",
        "止痛：Buprenorphine 0.01-0.02 mg/kg IV q6-8h 或 Methadone 0.1-0.3 mg/kg IV q4-6h",
        "止吐：Maropitant（Cerenia）1 mg/kg IV/SC q24h（若有嘔吐）",
        "術後抗生素：Cefazolin 22 mg/kg IV q2h（術中預防性使用）",
        "術後疼痛管理：多模式鎮痛（opioids + NSAIDs + 局部麻醉）"
      ],
      "surgery": "手術修復為確定性治療。經正中腹部切開進入腹腔，辨認膈肌缺損後將疝入心包腔的臟器小心還納回腹腔，檢查臟器活力後直接縫合關閉膈肌缺損。需注意：還納臟器時可能突然改變心臟前負荷，需監測心血管功能。若伴有腹壁缺損（臍疝），一併修復。術中需排除心包腔內殘餘空氣和液體"
    },
    "prognosis": "手術修復的預後良好，手術死亡率低（約3-14%）。多數動物術後恢復完全正常。未手術的無症狀病例也可長期存活，但存在日後臟器嵌頓的風險。若伴隨嚴重的心臟或其他先天性畸形，預後取決於合併異常的嚴重程度。臟器嵌頓伴壞死的急診病例風險較高。",
    "pearls": [
      "心臟區域聽到腸鳴音是PPDH的經典但非常見的臨床發現",
      "X光上心臟輪廓增大且形態不規則時，應將PPDH列入鑑別診斷，尤其是年輕動物",
      "PPDH常合併其他中線先天性缺陷，發現一處缺損時應系統性檢查有無其他異常",
      "多數PPDH在行常規影像學檢查或其他手術中偶然發現",
      "即使無症狀，建議選擇性手術修復以預防日後可能的臟器嵌頓併發症"
    ],
    "diagnosticAlgorithm": {
      "title": "腹膜心包橫膈疝 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "收集病史與臨床症狀評估，許多病例為偶然發現，注意呼吸困難、嘔吐、食慾不振等非特異性症狀",
          "findings": [
            "呼吸困難或運動不耐",
            "間歇性嘔吐或腹部不適",
            "心音減弱或移位",
            "部分病例無明顯臨床症狀"
          ]
        },
        {
          "step": 2,
          "action": "影像學檢查",
          "details": "進行胸腹部X光檢查，觀察心臟輪廓異常及腹腔臟器移位",
          "findings": [
            "心臟輪廓增大且形狀異常",
            "心影內可見腸道氣體或軟組織密度",
            "橫膈連續性中斷",
            "腹腔臟器數量減少"
          ]
        },
        {
          "step": 3,
          "action": "超音波檢查",
          "details": "進行心臟超音波及腹部超音波確認疝入心包腔的器官",
          "findings": [
            "心包腔內可見腸道、肝臟或網膜等腹腔臟器",
            "心包積液",
            "心臟受壓移位"
          ]
        },
        {
          "step": 4,
          "action": "確診與手術評估",
          "details": "根據影像學確認診斷，評估是否需要手術修復",
          "findings": [
            "影像學可明確診斷",
            "評估疝入臟器的血液循環狀態",
            "術前血液學檢查排除其他併發症"
          ]
        }
      ]
    },
    "monitoring": [
      "術後24-48小時密切監測心率、心律及血壓",
      "術後監測呼吸型態，注意有無氣胸徵兆",
      "術後1-2週複查胸腔X光確認修復完整且無復發",
      "術後監測食慾和消化功能恢復情況",
      "長期追蹤通常不需要，除非有其他先天性心臟異常",
      "未手術的病例建議每年進行胸腔影像學追蹤"
    ],
    "reference": "Clinical Veterinary Advisor / Blackwell's Five-Minute Veterinary Consult / BSAVA Manual of Canine and Feline Cardiorespiratory Medicine"
  },
  "immune-complex-disease": {
    "zh": "免疫複合體疾病",
    "en": "Immune Complex Disease (Type III Hypersensitivity)",
    "definition": "免疫複合體疾病是第三型（Type III）過敏反應的臨床表現，其發生機制為抗原-抗體形成的免疫複合體（immune complex）在組織中沉積，活化補體系統並引發嗜中性球浸潤，導致組織損傷和血管炎。當正常的吞噬系統無法有效清除大量免疫複合體時，這些複合體便沉積在血管壁、腎絲球基底膜、關節滑膜及其他組織中。免疫複合體沉積可為局部性（如Arthus反應）或全身性（如血清病樣反應），常見於慢性感染、自體免疫疾病及藥物反應。",
    "synonyms": [
      "第三型過敏反應",
      "免疫複合物疾病",
      "Type III Hypersensitivity",
      "Immune Complex Hypersensitivity",
      "血清病",
      "Serum Sickness-like Reaction"
    ],
    "epidemiology": {
      "species": "犬和貓均可發生",
      "breed": "犬中德國牧羊犬可能較易發生全身性免疫複合體血管炎；喜樂蒂牧羊犬（Shetland Sheepdog）及柯基犬（Welsh Corgi）與免疫介導性多關節炎相關",
      "age": "可發生於任何年齡，中年犬較常見",
      "sex": "無明顯性別傾向",
      "prevalence": "作為免疫病理機制存在於多種疾病中，確切發病率難以統計。免疫介導性多關節炎和腎絲球腎炎是最常見的臨床表現形式"
    },
    "clinicalPresentation": {
      "symptoms": [
        "發燒（間歇性或持續性）",
        "多關節腫脹和疼痛（多關節炎）",
        "跛行（移行性或多肢）",
        "皮膚紫斑或瘀點（血管炎表現）",
        "皮膚潰瘍或壞死灶（尤其在耳尖、尾尖、指墊及鼻鏡）",
        "食慾下降和體重減輕",
        "全身僵硬（不願移動）",
        "嗜睡和精神沉鬱",
        "蛋白尿（腎絲球腎炎時）",
        "淋巴結腫大（全身性）",
        "水腫（面部或四肢）",
        "眼部病變（前葡萄膜炎、視網膜血管炎）"
      ],
      "physicalExam": [
        "多關節腫脹、觸痛及活動度受限（尤其是腕關節、跗關節、肘關節）",
        "皮膚可見紫斑、瘀點、蕁麻疹或壞死性皮膚病變",
        "發燒（體溫 39.5-41°C）",
        "全身淋巴結腫大",
        "腎區觸診疼痛（腎絲球腎炎時）",
        "關節活動時可感到波動感（關節積液）"
      ]
    },
    "pathophysiology": "第三型過敏反應的核心機制是免疫複合體在組織中的沉積和隨後的炎症反應。當抗原（如感染性病原體、藥物代謝物或自體抗原）與抗體結合形成免疫複合體後，正常情況下由單核巨噬細胞系統清除。然而，當免疫複合體產生量超過吞噬系統的清除能力，或複合體的大小和組成不利於被清除時，這些複合體便沉積在具有高濾過壓力的組織中（如腎絲球、關節滑膜、血管壁）。沉積的免疫複合體活化經典補體途徑（C1-C4-C2-C3），產生趨化因子C3a和C5a吸引嗜中性球至沉積部位。嗜中性球嘗試吞噬免疫複合體時釋放溶酶體酶和活性氧自由基，直接損傷周圍組織，導致血管炎、腎絲球腎炎和關節炎。",
    "diagnosis": {
      "primary": [
        "關節液分析（Arthrocentesis）：非化膿性關節炎的關節液呈無菌性炎症反應，白血球增多（以嗜中性球為主但無細菌），為免疫介導性多關節炎的核心診斷",
        "腎臟活檢合併免疫螢光染色：可在腎絲球基底膜見到IgG、IgM和C3的顆粒狀沉積（granular pattern），確認免疫複合體沉積",
        "皮膚切片組織病理學：可見白血球碎裂性血管炎（leukocytoclastic vasculitis），血管壁有纖維素壞死和嗜中性球浸潤",
        "尿液分析：蛋白尿（尿蛋白/肌酐比 UPC > 0.5）提示腎絲球損傷"
      ],
      "differential": [
        "感染性多關節炎（細菌性、黴菌性）",
        "系統性紅斑狼瘡（SLE）",
        "類風濕性關節炎",
        "蝶形紅斑（Erythema multiforme）",
        "血小板減少性紫斑",
        "藥物不良反應",
        "反應性關節炎（腸道或泌尿道感染後）",
        "萊姆病（Borrelia burgdorferi 感染）",
        "播散性血管內凝血（DIC）"
      ],
      "labFindings": [
        "全血球計數：嗜中性球增多或正常，可能有輕度貧血（慢性炎症）",
        "生化檢查：低白蛋白血症（腎絲球流失）、球蛋白升高（高免疫球蛋白血症）",
        "尿液分析：蛋白尿、可能有血尿和管型",
        "尿蛋白/肌酐比（UPC）升高（> 2.0 通常提示腎絲球病變）",
        "補體C3濃度可能降低（因免疫複合體活化補體被消耗）",
        "抗核抗體（ANA）可能陽性（若為SLE相關）",
        "類風濕因子（RF）可能陽性",
        "Coombs試驗可能陽性（若有自體免疫性溶血性貧血並存）",
        "關節液細胞學：高白血球數（5,000-100,000/μL），以非退化性嗜中性球為主，培養無菌"
      ]
    },
    "treatment": {
      "acute": "急性期以免疫抑制為主要治療。高劑量糖皮質激素快速控制炎症反應。嚴重血管炎或腎絲球腎炎病例可能需要住院靜脈輸液支持。若有確認的感染性原因（如萊姆病），需同時給予抗微生物治療",
      "chronic": "慢性管理目標為長期免疫調控，使用最低有效劑量的免疫抑制藥物維持緩解。需定期監測以調整藥物劑量，並注意免疫抑制的副作用。尋找並治療潛在的基礎病因（慢性感染、腫瘤）對長期控制至關重要",
      "medications": [
        "Prednisolone 2-4 mg/kg/day PO 分兩次給予（誘導劑量），症狀改善後逐漸減量至隔天最低有效劑量",
        "Mycophenolate mofetil 10-20 mg/kg PO q12h（作為類固醇減量的輔助藥物）",
        "Azathioprine 2 mg/kg PO q24h（犬，2-3週後改為隔天給藥；禁用於貓）",
        "Cyclosporine 5-10 mg/kg PO q12-24h（替代性免疫抑制劑）",
        "Leflunomide 2-4 mg/kg PO q24h（難治性多關節炎）",
        "腎絲球腎炎患者加用 ACE抑制劑：Enalapril 0.5 mg/kg PO q12-24h（減少蛋白尿）",
        "Clopidogrel 1-2 mg/kg PO q24h 或低劑量 Aspirin（預防血栓，腎絲球腎炎患者）",
        "Omega-3 脂肪酸補充（抗炎輔助作用）"
      ],
      "surgery": "通常不需要外科介入。腎臟活檢可通過超音波引導經皮穿刺或腹腔鏡輔助進行。皮膚壞死灶可能需要清創處理"
    },
    "prognosis": "預後取決於受影響的器官系統和基礎病因。特發性免疫介導性多關節炎對免疫抑制治療通常反應良好，多數犬可長期緩解，但約50%可能復發。腎絲球腎炎的預後較差，取決於診斷時的腎功能損傷程度和蛋白尿嚴重度。全身性血管炎的預後中等至謹慎。若能找到並消除基礎病因（如治療感染、停用致敏藥物），預後改善。",
    "pearls": [
      "不明原因的多關節炎合併發燒在犬中，免疫介導性（第三型過敏反應）比感染性更常見",
      "關節液分析是區分免疫介導性和感染性多關節炎的關鍵：免疫介導性為無菌性炎症",
      "免疫複合體沉積偏好高濾過壓的組織，因此腎絲球、關節和小血管是最常受累的部位",
      "治療前應系統性搜尋可能的潛在原因（慢性感染、腫瘤），因約25-50%的免疫介導性多關節炎有可辨認的基礎病因",
      "蛋白尿是腎絲球免疫複合體沉積的早期指標，所有免疫複合體疾病的患者都應進行尿液分析"
    ],
    "diagnosticAlgorithm": {
      "title": "免疫複合體疾病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "收集病史，評估發熱、關節疼痛、皮膚病變等全身性症狀",
          "findings": [
            "多系統受累表現（皮膚、關節、腎臟）",
            "發熱與全身性炎症",
            "皮膚紫癜或血管炎樣病變",
            "多發性關節炎"
          ]
        },
        {
          "step": 2,
          "action": "實驗室檢查",
          "details": "進行全血計數、生化檢查及尿液分析",
          "findings": [
            "貧血或血小板減少",
            "低白蛋白血症",
            "蛋白尿",
            "補體水平下降"
          ]
        },
        {
          "step": 3,
          "action": "免疫學檢查",
          "details": "進行抗核抗體、類風濕因子及免疫複合體相關檢測",
          "findings": [
            "抗核抗體（ANA）陽性",
            "循環免疫複合體升高",
            "補體C3/C4降低",
            "Coombs試驗可能陽性"
          ]
        },
        {
          "step": 4,
          "action": "組織病理學檢查",
          "details": "對受累組織進行活檢及免疫螢光檢查",
          "findings": [
            "血管壁免疫複合體沉積",
            "白血球碎裂性血管炎",
            "腎絲球免疫複合體沉積",
            "免疫螢光顯示IgG/IgM/C3沉積"
          ]
        }
      ]
    },
    "monitoring": [
      "治療初期每1-2週監測全血球計數和生化指標",
      "每月監測尿蛋白/肌酐比（UPC）評估腎絲球功能",
      "每2-4週臨床評估關節腫脹和疼痛程度",
      "使用免疫抑制藥物時監測肝腎功能和血球計數",
      "Azathioprine使用者需監測骨髓抑制（白血球和血小板減少）",
      "長期使用類固醇監測多飲多尿、Cushing症候群及尿路感染",
      "定期評估是否可逐步減量免疫抑制藥物"
    ],
    "reference": "Clinical Veterinary Advisor / Blackwell's Five-Minute Veterinary Consult / BSAVA Manual of Canine and Feline Clinical Pathology"
  },
  "canine-leproid-granuloma": {
    "zh": "犬麻風樣肉芽腫",
    "en": "Canine Leproid Granuloma (CLG)",
    "definition": "犬麻風樣肉芽腫是一種由不可培養的非結核分枝桿菌（Mycobacterium sp.，暫定名為 Candidatus Mycobacterium lepraemurium 相關種或新分枝桿菌物種）引起的皮膚結節性肉芽腫疾病。臨床上表現為一個或多個界限清楚、無痛的皮膚或皮下結節，大小從2毫米至5公分不等，最常見於頭部和耳廓。本病具有良好的自限性傾向，通常不伴隨全身性疾病症狀，主要影響短毛大型犬種。",
    "synonyms": [
      "犬麻風肉芽腫",
      "犬痲瘋樣肉芽腫症候群",
      "Canine Leprosy",
      "CLG",
      "Mycobacterial Granuloma of Dogs"
    ],
    "epidemiology": {
      "species": "僅見於犬",
      "breed": "短毛大型犬種好發，包括拳師犬（Boxer）、大丹犬（Great Dane）、羅威那犬（Rottweiler）、短毛指示犬（Pointer）、史塔福郡㹴犬（Staffordshire Bull Terrier）及杜賓犬（Doberman）",
      "age": "以青年至中年犬最常見，典型發病年齡1-5歲",
      "sex": "無明顯性別傾向",
      "prevalence": "主要報導於澳洲、紐西蘭、巴西及南非等溫暖潮濕地區。在溫帶和亞熱帶地區散發性發生。確切傳播途徑不明，推測與昆蟲叮咬（如蚊蟲或沙蠅）有關"
    },
    "clinicalPresentation": {
      "symptoms": [
        "一個或多個無痛性皮膚結節",
        "結節界限清楚，質地堅實",
        "結節大小從2毫米至5公分不等",
        "結節主要位於頭部、耳廓及面部",
        "結節表面可能無毛或輕微脫毛",
        "結節可能潰瘍並排出少量分泌物",
        "無全身性疾病症狀（無發燒、無食慾減退、無體重減輕）",
        "結節生長通常緩慢",
        "偶爾結節自發消退",
        "無瘙癢或疼痛反應",
        "肢端（四肢遠端）偶爾可見結節",
        "多發性結節可能集中在同一區域（如單側耳廓）"
      ],
      "physicalExam": [
        "一個或多個界限清楚的真皮或皮下結節",
        "結節質地堅實至硬實，可移動或輕度固定於底層組織",
        "結節表面皮膚完整或有局部脫毛",
        "部分結節可能潰瘍並有漿液性至輕度化膿性分泌物",
        "區域淋巴結通常正常（不腫大）",
        "全身身體檢查其他方面正常"
      ]
    },
    "pathophysiology": "犬麻風樣肉芽腫由不可在常規培養基上培養的分枝桿菌引起。確切的病原體尚未完全鑑定，但分子研究（16S rRNA基因定序）顯示為新型非結核分枝桿菌（NTM），與鼠麻風分枝桿菌（M. lepraemurium）相關但不同。傳播途徑推測為昆蟲（蚊蟲或咬蠅）叮咬接種至皮膚，這解釋了病變好發於暴露部位（頭部、耳廓）的原因。感染後在真皮層引發肉芽腫性炎症反應，特徵為巨噬細胞聚集形成肉芽腫結構，含有大量抗酸染色陽性的桿菌（多桿菌型）或少量桿菌（少桿菌型）。宿主的細胞免疫反應決定了臨床表現：良好的Th1型免疫反應導致少桿菌型（結核樣肉芽腫，預後佳），而不足的細胞免疫則導致多桿菌型（瀰漫性巨噬細胞浸潤含大量桿菌）。",
    "diagnosis": {
      "primary": [
        "細針抽吸細胞學（FNA）配合抗酸染色（Ziehl-Neelsen stain）：可見巨噬細胞內和細胞外的抗酸陽性桿菌，肉芽腫性炎症背景",
        "組織切片病理學檢查：真皮層結節性至瀰漫性肉芽腫炎症，由上皮樣巨噬細胞和多核巨細胞組成，抗酸染色可見桿菌",
        "PCR檢測（16S rRNA基因或特異性引子）：確認分枝桿菌DNA，可鑑定物種層級",
        "抗酸染色（Ziehl-Neelsen 或 Fite-Faraco stain）：在組織或細胞學標本中染出紅色桿菌為診斷關鍵"
      ],
      "differential": [
        "其他分枝桿菌感染（如結核病、非結核分枝桿菌皮膚感染）",
        "皮膚組織細胞瘤（Histiocytoma）",
        "肥大細胞瘤（Mast Cell Tumor）",
        "皮脂腺腺瘤（Sebaceous Adenoma）",
        "黴菌性肉芽腫（如孢子絲菌症 Sporothricosis、隱球菌症）",
        "異物反應性肉芽腫",
        "無菌性結節性脂膜炎",
        "皮膚淋巴瘤"
      ],
      "labFindings": [
        "全血球計數和生化檢查通常完全正常",
        "細針抽吸細胞學：肉芽腫性炎症，大量上皮樣巨噬細胞、少量嗜中性球和淋巴球",
        "抗酸染色（Ziehl-Neelsen）：多桿菌型可見大量細胞內抗酸陽性桿菌；少桿菌型桿菌數量少需仔細搜尋",
        "細菌培養：常規培養陰性（因病原體不可培養），此結果本身即有診斷價值",
        "PCR分子檢測：可確認分枝桿菌DNA並排除結核病"
      ]
    },
    "treatment": {
      "acute": "多數病例不需要緊急治療，因疾病進展緩慢且不影響全身健康。潰瘍性結節需局部傷口護理和防止繼發感染",
      "chronic": "治療選項包括手術切除和/或抗分枝桿菌藥物治療。單發性結節可選擇手術切除。多發性結節或不適合手術的病例以藥物治療為主。值得注意的是，CLG有自限性傾向，部分病例未經治療也可在1-6個月內自發消退",
      "medications": [
        "Clarithromycin 10-15 mg/kg PO q12h（新型大環內酯類，為首選藥物之一）",
        "Rifampicin 10-15 mg/kg PO q24h（合併使用以防止抗藥性）",
        "Doxycycline 5-10 mg/kg PO q12h（替代選擇或合併用藥）",
        "Clofazimine 1-4 mg/kg PO q24h（傳統抗麻風藥物，獲取較困難）",
        "藥物治療療程通常為2-3個月或直至病變消退",
        "Fluoroquinolones（如 Pradofloxacin 或 Moxifloxacin）作為替代方案"
      ],
      "surgery": "手術切除是單發結節的有效治療選項，完全切除後復發率低。多發性結節若可一次切除則手術仍可行。對於手術邊緣不完整的病例，建議輔以藥物治療"
    },
    "prognosis": "預後良好至極佳。CLG是一種局限性、自限性的皮膚疾病，不會發展為全身性感染。手術完全切除的治癒率高。藥物治療通常在數週至數月內使結節消退。部分未治療的病例也可自發痊癒。復發偶爾發生但不常見，對再次治療反應良好。此病不具有人畜共通傳染的風險。",
    "pearls": [
      "頭部和耳廓的無痛性結節在短毛大型犬中，CLG應列為主要鑑別診斷",
      "「無全身症狀」是CLG的重要特徵——有助於與全身性分枝桿菌感染（如結核病）鑑別",
      "常規細菌培養陰性但抗酸染色陽性是CLG的典型診斷模式",
      "CLG有自限性傾向，輕微病例可選擇監測觀察策略而非積極治療",
      "傳播途徑推測與昆蟲叮咬有關，預防叮咬（防蟲措施）理論上可降低風險",
      "不同於犬結核病，CLG不具人畜共通傳染性，飼主教育應強調此點"
    ],
    "diagnosticAlgorithm": {
      "title": "犬麻風樣肉芽腫 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "檢查皮膚結節分布，CLG常見於短毛犬品種的耳廓、頭部和四肢",
          "findings": [
            "單發或多發性皮膚結節",
            "結節多位於耳廓、鼻樑或肢端",
            "結節表面可能潰瘍",
            "通常無全身性症狀"
          ]
        },
        {
          "step": 2,
          "action": "細胞學檢查",
          "details": "對結節進行細針抽吸細胞學檢查",
          "findings": [
            "肉芽腫性炎症表現",
            "巨噬細胞內可見抗酸染色陽性桿菌",
            "多核巨細胞",
            "Ziehl-Neelsen染色可見分枝桿菌"
          ]
        },
        {
          "step": 3,
          "action": "組織病理學檢查",
          "details": "進行皮膚切除活檢及組織病理學分析",
          "findings": [
            "結節性至瀰漫性肉芽腫性皮膚炎",
            "上皮樣巨噬細胞聚集",
            "抗酸染色陽性桿菌",
            "纖維化包裹"
          ]
        },
        {
          "step": 4,
          "action": "分子診斷",
          "details": "進行PCR檢測確認分枝桿菌種類",
          "findings": [
            "PCR檢測分枝桿菌DNA陽性",
            "鑑定為犬麻風分枝桿菌或相關種",
            "細菌培養通常困難"
          ]
        }
      ]
    },
    "monitoring": [
      "藥物治療期間每2-4週評估結節大小變化",
      "拍照記錄結節消退情況以客觀追蹤治療反應",
      "使用Rifampicin時每月監測肝功能指標（ALT、ALP）",
      "治療結束後每3個月追蹤檢查是否復發，持續6-12個月",
      "監測治療期間是否出現新結節",
      "若選擇觀察策略，每月追蹤結節是否自行消退或增大"
    ],
    "reference": "Clinical Veterinary Advisor / Blackwell's Five-Minute Veterinary Consult / BSAVA Manual of Canine and Feline Dermatology"
  },
  "idiopathic-vestibular-disease-feline": {
    "zh": "貓特發性前庭疾病",
    "en": "Feline Idiopathic Vestibular Disease",
    "definition": "貓特發性前庭疾病是貓最常見的急性周邊前庭障礙，病因不明，表現為突發性嚴重前庭功能失調。此疾病通常為自限性（self-limiting），大多數貓在數天至數週內自發改善。與犬的老年前庭疾病不同，貓的特發性前庭疾病可發生於任何年齡，無明顯年齡偏好。病變被認為位於周邊前庭系統（內耳前庭神經或前庭器官），而非中樞神經系統。",
    "synonyms": [
      "貓特發性前庭症候群",
      "貓急性前庭症候群",
      "Feline idiopathic vestibular syndrome"
    ],
    "epidemiology": {
      "species": "貓（任何年齡均可發生）",
      "breed": "無品種偏好，所有品種均可發生",
      "age": "任何年齡，與犬不同，不限於老年動物",
      "sex": "無性別偏好",
      "prevalence": "貓最常見的急性前庭疾病原因之一，夏季和秋季發病率可能略高"
    },
    "clinicalPresentation": {
      "symptoms": [
        "突發性嚴重頭部傾斜（head tilt），通常偏向病變側",
        "旋轉性眼球震顫（rotatory nystagmus），快相朝向對側",
        "嚴重共濟失調（ataxia），行走搖晃如醉酒",
        "傾倒或翻滾（rolling），尤其在急性發作初期",
        "噁心和嘔吐，因前庭刺激引起",
        "食慾減退或完全拒食",
        "定向障礙（disorientation），顯得困惑和焦慮",
        "水平或旋轉性眼球震顫",
        "行走時偏向病變側",
        "嚴重病例可出現無法站立",
        "流涎（drooling），因噁心引起",
        "瞳孔大小可能不對稱（anisocoria）較少見"
      ],
      "physicalExam": [
        "明顯的頭部傾斜，偏向一側",
        "自發性眼球震顫（水平或旋轉性），快相方向恆定",
        "姿勢反應正常（與中樞性前庭疾病的重要鑑別點）",
        "意識狀態正常（無精神抑鬱，除非因不適而焦慮）",
        "耳鏡檢查通常正常，無中耳炎徵象"
      ]
    },
    "pathophysiology": "確切病理生理學機制尚不明確。目前認為病變位於周邊前庭系統，可能涉及前庭神經或前庭感覺上皮的急性功能障礙。有假說認為可能與病毒感染、血管痙攣或免疫介導性機制有關，但均未獲得確切證實。前庭器官的急性功能障礙導致兩側前庭輸入不對稱，大腦接收到不平衡的位置和運動信號，因此產生眩暈、眼球震顫和共濟失調等症狀。隨著中樞代償機制啟動，症狀逐漸改善。",
    "diagnosis": {
      "primary": [
        "臨床病史和神經學檢查（周邊 vs 中樞前庭徵象鑑別）",
        "耳鏡檢查排除中耳/內耳疾病",
        "顳骨 X 光或 CT 排除鼓室骨病變",
        "排除性診斷（diagnosis of exclusion）：排除其他已知原因後確診"
      ],
      "differential": [
        "中耳炎/內耳炎（otitis media/interna）",
        "鼻咽息肉（nasopharyngeal polyp）",
        "耳毒性藥物（aminoglycosides、metronidazole）",
        "腫瘤（鱗狀上皮癌、淋巴瘤）",
        "中樞性前庭疾病（腦幹腫瘤、腦膜腦炎）",
        "甲狀腺功能低下（犬較常見，貓罕見）"
      ],
      "labFindings": [
        "血液學和生化檢查通常正常",
        "甲狀腺功能檢查（T4）排除甲狀腺功能低下",
        "FeLV/FIV 檢測排除逆轉錄病毒感染",
        "如懷疑中樞病變，腦脊液（CSF）分析可能需要"
      ]
    },
    "treatment": {
      "acute": "支持性療法為主：止吐藥（maropitant 1 mg/kg SC q24h 或 meclizine 12.5 mg PO q24h）控制噁心嘔吐；嚴重病例需靜脈輸液維持水合狀態；提供安靜暗室環境減少前庭刺激；必要時短期鎮靜（如 gabapentin）",
      "chronic": "大多數病例為自限性，2-3 天開始改善，1-3 週顯著恢復。部分貓可能殘留輕微頭部傾斜，但不影響生活品質。復發可能但不常見。不需要長期藥物治療。",
      "medications": [
        "Maropitant (Cerenia) 1 mg/kg SC/PO q24h — 止吐",
        "Meclizine 12.5 mg/cat PO q8-12h — 抗組織胺止暈",
        "Ondansetron 0.1-0.2 mg/kg IV — 嚴重嘔吐時使用",
        "Gabapentin 5-10 mg/kg PO q8-12h — 鎮靜和抗焦慮（視需要）"
      ],
      "surgery": "不適用，此疾病為自限性，不需手術介入"
    },
    "prognosis": "預後良好至極佳。大多數貓在 2-3 天內開始改善，1-3 週內顯著恢復。部分病例可能殘留輕微持續性頭部傾斜，但通常不影響日常功能和生活品質。少數病例可能復發。",
    "pearls": [
      "與犬不同，貓特發性前庭疾病不限於老年動物，任何年齡均可發生",
      "鑑別周邊 vs 中樞前庭疾病至關重要：姿勢反應異常、垂直眼球震顫、精神狀態改變提示中樞病變",
      "不要因症狀看起來嚴重就建議安樂死——大多數病例會自發改善",
      "耳鏡檢查和鼓室影像學是排除中耳疾病的關鍵步驟"
    ],
    "diagnosticAlgorithm": {
      "title": "貓特發性前庭疾病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "進行神經學檢查，評估前庭功能障礙的嚴重程度和類型",
          "findings": [
            "急性發作的頭部傾斜",
            "水平或旋轉性眼球震顫",
            "共濟失調與身體傾倒",
            "無意識障礙"
          ]
        },
        {
          "step": 2,
          "action": "耳鏡檢查與基本實驗室",
          "details": "排除中耳/內耳感染，進行血液學和生化檢查排除代謝性疾病",
          "findings": [
            "耳道與鼓膜外觀正常",
            "血液學和生化指標正常",
            "甲狀腺功能正常",
            "無感染徵象"
          ]
        },
        {
          "step": 3,
          "action": "進階影像學",
          "details": "視情況進行頭顱X光或CT/MRI排除結構性病變",
          "findings": [
            "鼓泡X光無異常",
            "MRI排除腫瘤或炎症性病變",
            "無中耳積液",
            "腦幹結構正常"
          ]
        },
        {
          "step": 4,
          "action": "排除性確診",
          "details": "排除所有已知原因後做出特發性前庭疾病的排除性診斷",
          "findings": [
            "所有檢查結果正常",
            "症狀在數日至數週內自行改善",
            "頭部傾斜可能持續存在",
            "確認為周邊性前庭病變"
          ]
        }
      ]
    },
    "monitoring": [
      "每日神經學評估追蹤改善進度",
      "監測食慾和水合狀態",
      "觀察眼球震顫方向和強度變化",
      "若 72 小時內無改善或出現新神經徵象，需重新評估排除中樞病變"
    ],
    "reference": "Clinical Veterinary Advisor / Blackwell's Five-Minute Veterinary Consult"
  },
  "pancytopenia": {
    "zh": "全血球減少症",
    "en": "Pancytopenia",
    "definition": "全血球減少症（pancytopenia）是指周邊血液中三種主要血球系列同時減少：紅血球減少（貧血）、白血球減少（白血球低下症）及血小板減少（血小板低下症）。此為一種實驗室發現而非單一疾病，反映骨髓造血功能的嚴重障礙。最嚴重的形式為再生不良性貧血（aplastic anemia），其特徵為骨髓造血細胞被脂肪組織取代，主要源自早期造血前驅細胞的損傷。犬貓均可發生，常見原因包括感染性疾病、藥物毒性、免疫介導性疾病及骨髓腫瘤。",
    "synonyms": [
      "全血球低下症",
      "再生不良性貧血",
      "骨髓衰竭",
      "Aplastic anemia",
      "Bone marrow failure"
    ],
    "epidemiology": {
      "species": "犬和貓均可發生",
      "breed": "無特定品種偏好，但某些品種對特定藥物敏感性較高（如 Collie 對 estrogen）",
      "age": "任何年齡，老年動物因腫瘤風險增加而較常見",
      "sex": "未絕育母犬因 estrogen 過量風險較高（Sertoli cell tumor 在公犬也可引起）",
      "prevalence": "不常見但臨床重要，貓以 FeLV 相關性最常見"
    },
    "clinicalPresentation": {
      "symptoms": [
        "進行性虛弱和嗜睡（因貧血）",
        "運動不耐（exercise intolerance）",
        "黏膜蒼白（貧血表現）",
        "發燒或反覆感染（因白血球低下）",
        "自發性出血（因血小板低下）",
        "瘀斑（petechiae）和瘀青（ecchymoses）",
        "牙齦出血或鼻出血（epistaxis）",
        "食慾減退和體重減輕",
        "呼吸急促和心搏過速（貧血代償機制）",
        "黑色柏油樣便（melena）或血尿",
        "皮膚和皮下出血點",
        "淋巴結腫大（依病因而定）"
      ],
      "physicalExam": [
        "黏膜蒼白（pallor），毛細血管充盈時間延長（CRT > 2 秒）",
        "心搏過速（tachycardia），可能有收縮期心雜音（貧血性雜音）",
        "瘀斑和瘀青分布於皮膚、黏膜",
        "脾臟腫大（splenomegaly），依病因而定",
        "發燒（如合併感染），或低體溫（末期）",
        "淋巴結腫大（如為腫瘤或感染性病因）"
      ]
    },
    "pathophysiology": "全血球減少症的核心機制為骨髓造血功能障礙。在再生不良性貧血中，早期多潛能造血幹細胞（pluripotent hematopoietic stem cells）受到損傷或破壞，導致紅血球系（erythroid）、白血球系（myeloid）和巨核細胞系（megakaryocytic）的產生均受抑制。損傷機制可能為直接毒性（藥物、化學物質）、免疫介導性破壞（T 細胞攻擊造血幹細胞）、感染性因素（FeLV 感染骨髓前驅細胞、Ehrlichia 骨髓抑制）或腫瘤浸潤取代正常造血組織（myelophthisis）。骨髓生檢典型表現為造血細胞顯著減少，被脂肪組織取代。",
    "diagnosis": {
      "primary": [
        "全血球計數（CBC）：確認貧血、白血球低下和血小板低下同時存在",
        "網織紅血球計數（reticulocyte count）：評估骨髓紅血球再生能力",
        "骨髓穿刺和活檢（bone marrow aspirate and biopsy）：確定骨髓細胞分布和病理變化",
        "周邊血液抹片（blood smear）：評估血球型態學"
      ],
      "differential": [
        "FeLV 相關骨髓抑制（貓最常見原因）",
        "Ehrlichiosis 慢性期骨髓抑制",
        "藥物/毒素引起的骨髓毒性（estrogen、chloramphenicol、phenylbutazone、化療藥物）",
        "骨髓腫瘤浸潤（白血病、淋巴瘤、多發性骨髓瘤）",
        "免疫介導性骨髓破壞",
        "骨髓壞死或骨髓纖維化（myelofibrosis）"
      ],
      "labFindings": [
        "非再生性貧血（reticulocyte count 低），PCV 常 < 20%",
        "嗜中性白血球低下（neutropenia），WBC 常 < 3000/μL",
        "血小板低下（thrombocytopenia），PLT 常 < 50,000/μL",
        "骨髓活檢顯示造血細胞減少，脂肪組織增加（脂肪：造血比例增加）",
        "FeLV/FIV 抗原/抗體檢測",
        "Ehrlichia/Anaplasma 血清學或 PCR 檢測",
        "血清鐵、TIBC 和鐵蛋白（排除鐵缺乏）"
      ]
    },
    "treatment": {
      "acute": "穩定生命徵象：嚴重貧血時輸血（packed RBC 或全血）；嚴重嗜中性球低下合併敗血症時，廣效抗生素治療（如 ampicillin-sulbactam + enrofloxacin）；血小板嚴重低下伴出血時考慮新鮮全血或血小板輸注",
      "chronic": "針對病因治療：停止懷疑的骨髓毒性藥物；FeLV 陽性貓的支持性照護；免疫介導性病因可嘗試免疫抑制治療（prednisone + cyclosporine 或 mycophenolate）；考慮 erythropoietin 或 darbepoetin 刺激紅血球生成",
      "medications": [
        "Doxycycline 5-10 mg/kg PO q12h — 經驗性治療 tick-borne 感染",
        "Prednisone 2 mg/kg PO q12h — 免疫介導性病因",
        "Cyclosporine 5 mg/kg PO q12h — 免疫抑制輔助",
        "Filgrastim (G-CSF) 5 μg/kg SC q24h — 嗜中性球低下時刺激白血球生成",
        "Darbepoetin 1 μg/kg SC q 週 — 刺激紅血球生成",
        "廣效抗生素（ampicillin-sulbactam、enrofloxacin）— 感染預防和治療"
      ],
      "surgery": "一般不需手術，除非病因為可切除之腫瘤（如 Sertoli cell tumor 的睪丸切除）"
    },
    "prognosis": "預後取決於病因和嚴重程度。藥物引起的骨髓抑制在停藥後可能恢復（預後較好）。FeLV 相關的骨髓衰竭預後謹慎至不良。嚴重再生不良性貧血若骨髓無恢復跡象，預後不良。免疫介導性病因對免疫抑制治療可能有反應。整體而言，全血球減少症是嚴重的臨床發現，需要積極診治。",
    "pearls": [
      "全血球減少症是實驗室發現，不是最終診斷——必須找出根本病因",
      "骨髓穿刺和活檢是確定病因的關鍵檢查，不應省略",
      "貓的全血球減少症首先排除 FeLV 感染",
      "藥物引起的骨髓抑制可能在停藥後 1-3 週才開始恢復",
      "嗜中性球 < 1000/μL 的患者有極高敗血症風險，需預防性抗生素"
    ],
    "diagnosticAlgorithm": {
      "title": "全血球減少症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估與血液學檢查",
          "details": "進行全血計數確認三系血球同時減少",
          "findings": [
            "白血球減少",
            "紅血球減少（貧血）",
            "血小板減少",
            "可能伴有發熱、出血傾向、虛弱"
          ]
        },
        {
          "step": 2,
          "action": "血液抹片與生化檢查",
          "details": "仔細檢查血液抹片形態，進行全套生化及感染篩檢",
          "findings": [
            "異常細胞或母細胞存在",
            "網狀紅血球計數評估骨髓再生能力",
            "生化評估肝腎功能",
            "壁蝨媒介疾病篩檢"
          ]
        },
        {
          "step": 3,
          "action": "骨髓穿刺檢查",
          "details": "進行骨髓抽吸和/或核心活檢以確定全血球減少的原因",
          "findings": [
            "骨髓增生不良提示再生不良性貧血",
            "異常細胞增生提示白血病或骨髓增生異常",
            "骨髓纖維化",
            "傳染性病原體（如利什曼原蟲）"
          ]
        },
        {
          "step": 4,
          "action": "病因學鑑別",
          "details": "根據骨髓結果和輔助檢查確定具體病因",
          "findings": [
            "藥物或毒物暴露史（如化療藥物、氯黴素）",
            "感染性病因（Ehrlichia、Leishmania等）",
            "免疫介導性破壞",
            "骨髓腫瘤浸潤"
          ]
        }
      ]
    },
    "monitoring": [
      "每日至每隔一日 CBC 追蹤血球恢復趨勢",
      "體溫監測（嗜中性球低下時感染風險極高）",
      "出血徵象監測（瘀斑、黑便、血尿）",
      "骨髓活檢追蹤（治療 2-4 週後評估恢復情況）",
      "網織紅血球計數追蹤再生跡象"
    ],
    "reference": "Clinical Veterinary Advisor / Blackwell's Five-Minute Veterinary Consult"
  },
  "reactive-thrombocytosis": {
    "zh": "反應性血小板增多症",
    "en": "Reactive Thrombocytosis",
    "definition": "反應性血小板增多症是指血小板數量增加（通常 > 500,000/μL），作為骨髓對慢性出血、發炎、感染或其他系統性疾病的繼發性反應。與原發性血小板增多症（骨髓增生性疾病）不同，反應性血小板增多症通常為輕度至中度升高，血小板功能正常，且不需要針對血小板本身的治療。矯正潛在疾病後血小板計數通常會恢復正常。此為犬貓血小板增多症最常見的原因。",
    "synonyms": [
      "繼發性血小板增多症",
      "Secondary thrombocytosis",
      "Reactive thrombocythemia"
    ],
    "epidemiology": {
      "species": "犬和貓均可發生，犬較常被報告",
      "breed": "無品種偏好",
      "age": "任何年齡，依潛在疾病而定",
      "sex": "無性別偏好",
      "prevalence": "血小板增多症中最常見的類型，占所有血小板增多症病例的 > 80%"
    },
    "clinicalPresentation": {
      "symptoms": [
        "症狀通常反映潛在疾病而非血小板增多本身",
        "慢性出血相關：虛弱、蒼白黏膜、黑便",
        "發炎/感染相關：發燒、食慾減退、體重減輕",
        "缺鐵性貧血症狀：嗜睡、運動不耐",
        "腫瘤相關：進行性消瘦、腫塊",
        "脾臟切除後：術後反應性升高",
        "腸胃道疾病：慢性嘔吐、腹瀉",
        "骨折或組織創傷後的反應性升高",
        "慢性皮膚病或傷口感染",
        "免疫介導性溶血性貧血的伴隨發現",
        "腎上腺皮質功能亢進相關的血小板升高",
        "長期皮質類固醇使用後的血小板升高"
      ],
      "physicalExam": [
        "理學檢查發現取決於潛在疾病",
        "慢性出血病例：黏膜蒼白、心搏過速",
        "發炎/感染病例：發燒、區域淋巴結腫大",
        "脾臟切除術後：腹部觸診無脾臟",
        "缺鐵性貧血：黏膜蒼白、異食癖（pica）可能存在"
      ]
    },
    "pathophysiology": "反應性血小板增多症的機制涉及促血小板生成素（thrombopoietin, TPO）和發炎細胞激素的調控。在慢性出血或缺鐵性貧血中，骨髓代償性增加巨核細胞生成。發炎狀態下，IL-6 等促發炎細胞激素刺激肝臟產生 TPO，促進巨核細胞增殖和血小板釋放。脾臟切除後由於血小板庫減少，循環血小板數量升高。腎上腺皮質功能亢進和外源性糖皮質激素可增加 TPO 產生。與原發性血小板增多症不同，反應性血小板增多症的血小板功能通常正常，血栓風險不顯著增加。",
    "diagnosis": {
      "primary": [
        "全血球計數（CBC）：確認血小板計數升高（通常 500,000-1,000,000/μL）",
        "周邊血液抹片：確認血小板增多並評估血小板型態",
        "詳細病史和全面理學檢查：尋找潛在疾病線索",
        "鐵代謝檢查（血清鐵、TIBC、鐵蛋白）：排除缺鐵狀態"
      ],
      "differential": [
        "原發性/自發性血小板增多症（essential thrombocythemia）—骨髓增生性疾病",
        "慢性髓性白血病伴血小板增多",
        "慢性缺鐵性貧血",
        "慢性發炎性疾病（IBD、胰臟炎、免疫介導性疾病）",
        "感染性疾病",
        "腫瘤性疾病（作為副腫瘤症候群）"
      ],
      "labFindings": [
        "血小板計數升高（通常 500,000-1,000,000/μL，偶爾更高）",
        "血小板型態通常正常（大小正常，無異常顆粒）",
        "潛在疾病的相關異常：缺鐵性貧血表現小球性低色素性貧血",
        "發炎指標可能升高（C-reactive protein、纖維蛋白原）",
        "血清鐵降低、TIBC 升高（缺鐵時）",
        "凝血功能通常正常"
      ]
    },
    "treatment": {
      "acute": "反應性血小板增多症本身通常不需要急性治療。重點為識別和治療潛在疾病。極端血小板增多（> 1,500,000/μL）且有血栓徵象時，可考慮低劑量 aspirin。",
      "chronic": "治療潛在疾病即可：矯正慢性出血源、治療感染或發炎、補充鐵劑（缺鐵時）。血小板計數通常在潛在疾病改善後 1-3 週內恢復正常。",
      "medications": [
        "針對潛在疾病的特異性治療（抗生素、抗發炎藥等）",
        "鐵劑補充（ferrous sulfate 5-10 mg/kg PO q24h）— 缺鐵性貧血時",
        "低劑量 Aspirin 0.5-1 mg/kg PO q24h — 僅在極端血小板增多伴血栓風險時考慮",
        "不建議常規使用抗血小板藥物或細胞減少劑"
      ],
      "surgery": "不適用於反應性血小板增多症本身，但可能需要手術處理潛在疾病（如出血性腫瘤切除）"
    },
    "prognosis": "預後取決於潛在疾病。反應性血小板增多症本身為良性發現，矯正潛在疾病後血小板計數通常恢復正常。血栓併發症極為罕見。與原發性血小板增多症不同，不需長期監控血小板數量。",
    "pearls": [
      "反應性血小板增多症是血小板增多症最常見的原因（> 80%），原發性極為罕見",
      "反應性血小板增多症本身不需治療，重點是找出並治療潛在疾病",
      "血小板計數 > 1,000,000/μL 時應更積極排除原發性骨髓增生性疾病",
      "脾臟切除後血小板增多是預期的正常反應，通常在數週至數月內穩定",
      "缺鐵性貧血是犬反應性血小板增多症常被忽略的原因"
    ],
    "diagnosticAlgorithm": {
      "title": "反應性血小板增多症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "血液學確認",
          "details": "全血計數確認血小板計數顯著升高，排除假性血小板增多",
          "findings": [
            "血小板計數 >600,000/μL",
            "血液抹片確認真性血小板增多",
            "血小板形態通常正常",
            "排除EDTA引起的假性血小板減少"
          ]
        },
        {
          "step": 2,
          "action": "基礎病因篩檢",
          "details": "進行全套生化、感染篩檢和影像學尋找潛在原因",
          "findings": [
            "急性或慢性炎症指標升高",
            "缺鐵性貧血",
            "感染或膿瘍證據",
            "腫瘤性疾病"
          ]
        },
        {
          "step": 3,
          "action": "排除原發性血小板增多",
          "details": "透過骨髓檢查及臨床排除排除原發性（腫瘤性）血小板增多症",
          "findings": [
            "骨髓巨核球增生但形態正常",
            "無骨髓纖維化",
            "無其他骨髓增殖性腫瘤證據",
            "血小板功能通常正常"
          ]
        },
        {
          "step": 4,
          "action": "病因治療與追蹤",
          "details": "針對基礎病因治療，追蹤血小板計數回復",
          "findings": [
            "治療基礎疾病後血小板下降",
            "排除脾臟切除後反應",
            "排除長期皮質類固醇使用",
            "確認反應性而非自主性增生"
          ]
        }
      ]
    },
    "monitoring": [
      "定期 CBC 追蹤血小板計數恢復趨勢",
      "潛在疾病的治療反應監測",
      "鐵代謝指標（缺鐵性貧血病例）",
      "極端血小板增多病例監測血栓徵象"
    ],
    "reference": "Clinical Veterinary Advisor / Blackwell's Five-Minute Veterinary Consult"
  },
  "hypereosinophilic-syndrome": {
    "zh": "高嗜酸性球症候群",
    "en": "Hypereosinophilic Syndrome (HES)",
    "definition": "高嗜酸性球症候群是一種罕見但嚴重的疾病，特徵為持續性周邊血液嗜酸性球增多（eosinophilia），伴隨嗜酸性球浸潤多個器官導致器官功能障礙。常見浸潤部位包括胃腸道、肝臟、脾臟、淋巴結和肺臟。在貓中較犬常見，需與其他引起嗜酸性球增多的疾病（如寄生蟲感染、過敏、嗜酸性球性腸炎）鑑別。此症候群的病因可能為免疫失調或嗜酸性球克隆性增殖，部分病例可能進展為嗜酸性球性白血病。",
    "synonyms": [
      "嗜酸性球增多症候群",
      "過度嗜酸性球增多症",
      "HES",
      "Idiopathic hypereosinophilic syndrome"
    ],
    "epidemiology": {
      "species": "貓較犬常見",
      "breed": "無明確品種偏好",
      "age": "中年至老年動物較常見（貓平均 5-8 歲）",
      "sex": "貓可能有輕微母貓偏好，但數據有限",
      "prevalence": "罕見疾病，但在持續性嗜酸性球增多的鑑別診斷中具重要性"
    },
    "clinicalPresentation": {
      "symptoms": [
        "慢性腹瀉（嗜酸性球浸潤腸道所致）",
        "嘔吐和食慾減退",
        "進行性體重減輕和消瘦",
        "嗜睡和虛弱",
        "腹部不適或疼痛",
        "呼吸困難或咳嗽（肺臟浸潤時）",
        "皮膚病變（嗜酸性球性肉芽腫或潰瘍，貓較常見）",
        "發燒（間歇性或持續性）",
        "肝脾腫大引起的腹部膨脹",
        "周邊淋巴結腫大",
        "偶見神經症狀（中樞神經系統浸潤時）",
        "心臟受累可能出現心律不整或心衰竭徵象"
      ],
      "physicalExam": [
        "觸診肝臟腫大（hepatomegaly）",
        "脾臟腫大（splenomegaly）",
        "腸道觸診增厚或腸系膜淋巴結腫大",
        "周邊淋巴結腫大（generalized lymphadenopathy）",
        "體況評分下降（body condition score 低）",
        "貓可能有皮膚嗜酸性球性肉芽腫複合症病變"
      ]
    },
    "pathophysiology": "高嗜酸性球症候群的確切病因尚不完全明確。可能涉及 T 細胞功能異常導致過度產生嗜酸性球趨化因子（如 IL-5、IL-3、GM-CSF），驅動骨髓嗜酸性球過度增殖和釋放。嗜酸性球浸潤組織後釋放其顆粒內容物（主要鹼性蛋白 MBP、嗜酸性球陽離子蛋白 ECP、嗜酸性球過氧化酶 EPO），這些物質具有強大的組織毒性，導致發炎、纖維化和器官損傷。胃腸道浸潤最常見，導致黏膜損傷、吸收不良和蛋白質流失性腸病。肝臟浸潤可導致膽管炎和肝功能障礙。部分病例可能代表低度嗜酸性球性白血病的早期表現。",
    "diagnosis": {
      "primary": [
        "全血球計數（CBC）：確認持續性顯著嗜酸性球增多（通常 > 1,500/μL，常 > 5,000/μL）",
        "腹腔超音波：評估肝臟、脾臟、淋巴結和腸壁變化",
        "受累器官的組織活檢和病理學檢查：確認嗜酸性球浸潤",
        "骨髓穿刺和活檢：評估嗜酸性球成熟度和骨髓浸潤程度"
      ],
      "differential": [
        "寄生蟲感染（heartworm、腸道寄生蟲、Toxocara 幼蟲移行症）",
        "過敏性疾病（食物過敏、跳蚤過敏性皮膚炎、環境過敏）",
        "嗜酸性球性腸炎（eosinophilic enteritis）",
        "嗜酸性球性肉芽腫複合症（貓）",
        "嗜酸性球性白血病（eosinophilic leukemia）",
        "肥大細胞腫瘤（mast cell tumor）",
        "肺臟嗜酸性球浸潤（PIE syndrome）"
      ],
      "labFindings": [
        "顯著且持續性嗜酸性球增多（絕對值常 > 5,000-20,000/μL）",
        "周邊血液抹片：成熟嗜酸性球為主，可能有少量未成熟形態",
        "低白蛋白血症（蛋白質流失性腸病所致）",
        "肝臟酵素升高（ALT、ALP，肝臟浸潤時）",
        "骨髓顯示嗜酸性球系列增生，嗜酸性球比例升高",
        "組織病理學：受累器官廣泛嗜酸性球浸潤",
        "糞便檢查和寄生蟲檢測陰性（排除寄生蟲原因）"
      ]
    },
    "treatment": {
      "acute": "嚴重器官功能障礙時需積極治療：高劑量 prednisolone 2-4 mg/kg/day 起始，快速抑制嗜酸性球增殖和組織浸潤；嚴重腸道疾病伴低白蛋白血症時需支持性照護（膠體輸液、營養支持）",
      "chronic": "免疫抑制治療為主：prednisolone 逐漸減量至最低有效劑量；需加入額外免疫抑制劑以減少類固醇用量。治療通常需終生維持。部分病例對 imatinib（酪胺酸激酶抑制劑）有反應。",
      "medications": [
        "Prednisolone 2-4 mg/kg PO q24h 起始，逐漸減量至 0.5-1 mg/kg q48h",
        "Chlorambucil 2 mg/cat PO q48-72h — 類固醇反應不良或減量困難時",
        "Cyclosporine 5-7 mg/kg PO q12-24h — 輔助免疫抑制",
        "Imatinib mesylate（Gleevec）— 酪胺酸激酶抑制劑，部分病例有效",
        "Hydroxyurea 25-50 mg/kg PO 每週 3-4 次 — 嚴重病例",
        "支持性治療：止吐、營養支持、白蛋白補充"
      ],
      "surgery": "一般不需手術，除非需要診斷性組織活檢"
    },
    "prognosis": "預後謹慎至不良。部分病例對免疫抑制治療反應良好，可長期控制。但許多病例需終生治療且可能出現復發或進展。嗜酸性球性白血病的進展預後極差。器官損傷程度（尤其是心臟和肝臟纖維化）影響長期預後。貓的中位生存期報告差異大，從數月至數年不等。",
    "pearls": [
      "高嗜酸性球症候群是排除性診斷——必須先排除寄生蟲、過敏和其他已知原因的嗜酸性球增多",
      "貓的嗜酸性球增多常見原因依序為：寄生蟲 > 過敏 > 嗜酸性球性腸炎 > HES > 嗜酸性球性白血病",
      "區分 HES 和嗜酸性球性白血病有時困難，骨髓檢查和嗜酸性球成熟度是關鍵",
      "胃腸道和肝臟是最常見的浸潤部位",
      "治療反應可作為預後指標：類固醇快速反應者預後較好"
    ],
    "diagnosticAlgorithm": {
      "title": "高嗜酸性球症候群 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "確認持續性嗜酸性球增多，評估多器官受累症狀",
          "findings": [
            "持續性嗜酸性球增多（>1500/μL）",
            "胃腸道症狀（嘔吐、腹瀉）",
            "皮膚病變",
            "可能有呼吸道或肝臟受累"
          ]
        },
        {
          "step": 2,
          "action": "排除常見原因",
          "details": "系統性排除寄生蟲、過敏和其他已知嗜酸性球增多原因",
          "findings": [
            "糞便檢查排除腸道寄生蟲",
            "心絲蟲篩檢陰性",
            "過敏原檢測評估過敏可能",
            "排除肥大細胞瘤或淋巴瘤"
          ]
        },
        {
          "step": 3,
          "action": "器官受累評估",
          "details": "進行受累器官的活檢和影像學檢查",
          "findings": [
            "腸道壁嗜酸性球浸潤",
            "肝臟嗜酸性球浸潤",
            "骨髓嗜酸性球前驅細胞增加",
            "腹腔/胸腔積液可能富含嗜酸性球"
          ]
        },
        {
          "step": 4,
          "action": "確診",
          "details": "排除所有已知病因後，確診為高嗜酸性球症候群",
          "findings": [
            "持續嗜酸性球增多超過6個月",
            "多器官嗜酸性球浸潤",
            "排除所有已知引起嗜酸性球增多的疾病",
            "可能為克隆性或特發性"
          ]
        }
      ]
    },
    "monitoring": [
      "定期 CBC 追蹤嗜酸性球計數和治療反應",
      "腹腔超音波監測器官浸潤程度變化",
      "肝臟酵素和白蛋白監測",
      "體重和體況評分追蹤",
      "免疫抑制治療的副作用監測（血糖、感染風險）"
    ],
    "reference": "Clinical Veterinary Advisor / Blackwell's Five-Minute Veterinary Consult"
  },
  "meningitis-encephalitis-unknown-etiology": {
    "zh": "不明原因腦膜腦炎",
    "en": "Meningoencephalitis of Unknown Etiology (MUE)",
    "definition": "不明原因腦膜腦炎（MUE，舊稱 MUO - meningoencephalomyelitis of unknown origin）是犬貓中樞神經系統（CNS）非感染性炎性疾病的統稱，可表現為局灶性、多灶性或瀰漫性病變。此術語涵蓋了多種在生前無法進一步區分的免疫介導性 CNS 疾病，包括肉芽腫性腦膜腦炎（GME）、壞死性腦炎（NME/NLE）和壞死性白質腦炎（NLE）。確切的組織學亞型通常需要腦組織活檢或屍檢才能確定。MUE 是犬最常見的中樞神經系統炎性疾病。",
    "synonyms": [
      "不明原因腦膜腦脊髓炎",
      "MUO",
      "MUE",
      "免疫介導性腦炎",
      "Meningoencephalomyelitis of unknown origin",
      "GME/NME/NLE complex"
    ],
    "epidemiology": {
      "species": "犬較貓常見",
      "breed": "小型犬品種風險較高：Maltese、Yorkshire Terrier、Chihuahua、Pug、French Bulldog、Boston Terrier、Shih Tzu",
      "age": "年輕至中年犬最常見（1-7 歲），但任何年齡均可發生",
      "sex": "母犬可能有輕微偏好（GME 亞型）",
      "prevalence": "犬最常見的非感染性中樞神經系統炎性疾病，占 CNS 炎性疾病的大多數"
    },
    "clinicalPresentation": {
      "symptoms": [
        "急性或亞急性發作的神經症狀",
        "癲癇發作（seizures），局灶性或全身性",
        "定向障礙和行為改變",
        "共濟失調（ataxia），前庭性或小腦性",
        "盲目或視力障礙（視神經炎或枕葉病變）",
        "頭部傾斜和眼球震顫（前庭核受累時）",
        "頸部疼痛和頸部僵硬",
        "輕癱或癱瘓（脊髓受累時）",
        "精神抑鬱和嗜睡",
        "厭食和體重減輕",
        "面神經麻痺或其他顱神經障礙",
        "繞圈行走（circling），通常偏向病變側"
      ],
      "physicalExam": [
        "神經學檢查異常：姿勢反應缺損、腦神經障礙",
        "頸部疼痛和過度敏感（cervical hyperesthesia）",
        "瞳孔反射異常（PLR），可能出現威脅反應缺失",
        "本體感覺缺損（proprioceptive deficits）",
        "發燒（部分病例，尤其是 GME 播散型）",
        "肌張力異常或肌肉萎縮（慢性病例）"
      ]
    },
    "pathophysiology": "MUE 被認為是免疫介導性疾病，涉及自體免疫 T 細胞和/或抗體攻擊中樞神經系統組織。確切的觸發因素不明，可能涉及遺傳易感性（小型犬品種的 MHC 基因型）、環境因素或先前的感染事件觸發分子模擬（molecular mimicry）。不同的組織學亞型反映不同的免疫病理機制：GME 以血管周圍肉芽腫性炎症為主，涉及巨噬細胞和 T 細胞；NME（如 Pug encephalitis）以皮質壞死和淋巴球浸潤為主；NLE 以白質壞死為特徵。所有亞型的共同特徵是 CNS 內的炎症反應導致神經組織損傷、水腫和功能障礙。",
    "diagnosis": {
      "primary": [
        "MRI（磁振造影）：偵測 CNS 病變的位置、範圍和特徵（為最佳影像學檢查）",
        "腦脊液（CSF）分析：典型表現為淋巴球性或混合性細胞增多，蛋白質升高",
        "排除感染性病因：CSF PCR（distemper、Toxoplasma、Neospora、Cryptococcus）",
        "感染性疾病血清學檢測：排除已知感染原因"
      ],
      "differential": [
        "犬瘟熱病毒（canine distemper）腦炎",
        "弓漿蟲病（toxoplasmosis）",
        "新孢子蟲病（neosporosis）",
        "隱球菌症（cryptococcosis）",
        "CNS 淋巴瘤或其他腦腫瘤",
        "腦梗塞（ischemic stroke）",
        "細菌性腦膜炎",
        "類固醇反應性腦膜炎-動脈炎（SRMA）"
      ],
      "labFindings": [
        "CSF：單核球性或混合性細胞增多（WBC > 5 cells/μL），以淋巴球和單核球為主",
        "CSF 蛋白質升高（> 25 mg/dL）",
        "MRI：腦實質單灶或多灶高信號病變（T2W/FLAIR），可能有對比增強",
        "血液學和生化通常正常或非特異性變化",
        "CSF 感染性 PCR 和培養陰性",
        "抗體指數（antibody index）可輔助排除感染"
      ]
    },
    "treatment": {
      "acute": "免疫抑制劑量的糖皮質激素：prednisolone 2-4 mg/kg/day 或 dexamethasone 0.25-0.5 mg/kg IV（急性惡化時）；癲癇發作控制：levetiracetam 或 phenobarbital；顱內壓升高時考慮 mannitol 0.5-1 g/kg IV",
      "chronic": "長期多藥免疫抑制治療：prednisolone 逐漸減量至最低有效劑量（通常 0.5-1 mg/kg q48h）加上第二線免疫抑制劑。治療通常需數月至終生。突然停藥可導致致命性復發。",
      "medications": [
        "Prednisolone 2-4 mg/kg PO q24h 起始，4-8 週逐漸減量",
        "Cytarabine (Ara-C) 200 mg/m² SC 分兩天給予 q3-4 週 — 最常用的第二線藥物",
        "Mycophenolate mofetil 10-20 mg/kg PO q12h — 替代第二線免疫抑制劑",
        "Cyclosporine 5-10 mg/kg PO q12-24h — 另一選擇",
        "Levetiracetam 20-60 mg/kg PO q8h — 抗癲癇",
        "Phenobarbital 2-5 mg/kg PO q12h — 抗癲癇（替代選擇）"
      ],
      "surgery": "一般不適用，偶爾局灶性 GME 形成腫塊效應（mass lesion）時可考慮減壓手術或活檢"
    },
    "prognosis": "預後謹慎至謹慎偏差。存活時間差異大：部分病例在積極免疫抑制治療下可存活數月至數年（中位生存期約 3-14 個月，依亞型和治療反應而定）。GME 播散型預後最差；局灶型預後較好。NME/NLE 預後通常較差。早期積極治療、對免疫抑制藥物良好反應者預後較好。癲癇難以控制的病例預後不良。",
    "pearls": [
      "MUE 是生前臨床診斷——確切的組織學亞型（GME/NME/NLE）通常需要腦活檢或屍檢確認",
      "小型犬品種（Maltese、Yorkie、Pug、Chihuahua）出現急性神經症狀時，MUE 應列為首要考慮",
      "CSF 採集前必須排除顱內壓升高（先做 MRI），避免腦疝風險",
      "突然停止免疫抑制治療可導致致命性復發——必須緩慢減量",
      "Cytarabine 被認為能穿越血腦屏障，是 MUE 治療的重要輔助藥物"
    ],
    "diagnosticAlgorithm": {
      "title": "不明原因腦膜腦炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "神經學檢查",
          "details": "進行完整神經學檢查，評估中樞神經系統受累範圍",
          "findings": [
            "癲癇發作",
            "意識狀態改變",
            "共濟失調或圓圈運動",
            "頸部疼痛與僵硬"
          ]
        },
        {
          "step": 2,
          "action": "實驗室檢查",
          "details": "進行全血計數、生化及感染性疾病篩檢",
          "findings": [
            "白血球計數可能升高",
            "C反應蛋白升高",
            "壁蝨媒介疾病PCR/血清學",
            "弓漿蟲、隱球菌抗原檢測"
          ]
        },
        {
          "step": 3,
          "action": "進階影像學",
          "details": "進行MRI檢查評估腦部病變範圍和性質",
          "findings": [
            "多灶性腦實質病變",
            "T2加權和FLAIR高信號",
            "腦膜增強",
            "病變分布模式有助於分類（GME、NME、NLE）"
          ]
        },
        {
          "step": 4,
          "action": "腦脊髓液分析",
          "details": "進行CSF採集與分析，確認炎症性質",
          "findings": [
            "CSF蛋白升高",
            "有核細胞增多",
            "單核球或混合性炎症",
            "感染性病原體培養和PCR陰性"
          ]
        },
        {
          "step": 5,
          "action": "排除性確診",
          "details": "排除感染性和腫瘤性病因後，確診為MUE",
          "findings": [
            "所有感染篩檢陰性",
            "MRI與CSF表現一致",
            "腦組織活檢為最終確診手段（非常規）",
            "臨床分類為GME、NME或NLE亞型"
          ]
        }
      ]
    },
    "monitoring": [
      "定期神經學評估（每 2-4 週，穩定後每 1-3 個月）",
      "追蹤 MRI 評估病變進展或縮小（治療 2-3 個月後）",
      "免疫抑制藥物副作用監測（血糖、肝腎功能、感染）",
      "抗癲癇藥物血中濃度監測（phenobarbital）",
      "CSF 復查評估治療反應（選擇性）"
    ],
    "reference": "Clinical Veterinary Advisor / Blackwell's Five-Minute Veterinary Consult"
  },
  "hepatic-nodular-hyperplasia": {
    "zh": "肝結節性增生",
    "en": "Hepatic Nodular Hyperplasia",
    "definition": "肝結節性增生是老年犬常見的良性肝臟病變，特徵為肝實質內出現單個或多個結節性增生灶。此病變僅見於犬，發生率隨年齡增加，通常從 6 歲開始出現。肝結節性增生不是顯著肝功能障礙的原因或結果，是一種良性的年齡相關性變化。臨床上最大的挑戰在於將其與惡性肝腫瘤（如肝細胞癌或轉移性腫瘤）區分，因兩者在影像學上可能相似。",
    "synonyms": [
      "肝臟結節性再生性增生",
      "Nodular regenerative hyperplasia",
      "Hepatic nodular regeneration"
    ],
    "epidemiology": {
      "species": "僅見於犬（貓極為罕見）",
      "breed": "無明確品種偏好，所有品種均可發生",
      "age": "6 歲以上犬，發生率隨年齡顯著增加，老年犬非常常見",
      "sex": "無性別偏好",
      "prevalence": "老年犬非常常見，屍檢研究顯示 > 8 歲犬中約 70-100% 有不同程度的結節性增生"
    },
    "clinicalPresentation": {
      "symptoms": [
        "大多數病例無臨床症狀（incidental finding）",
        "血液檢查偶然發現 ALP 升高",
        "超音波檢查偶然發現肝臟結節",
        "極少數大結節可能造成腹部膨脹",
        "偶爾結節破裂可導致急性腹腔出血（罕見）",
        "食慾和精神狀態通常正常",
        "排便排尿正常",
        "無黃疸（除非合併其他肝臟疾病）",
        "無腹水（除非合併其他疾病）",
        "體重維持正常",
        "活動力正常",
        "可能因其他原因就診時偶然發現"
      ],
      "physicalExam": [
        "理學檢查通常完全正常",
        "偶爾腹部觸診可觸及肝臟結節（大結節時）",
        "肝臟大小通常正常或輕度增大",
        "無黃疸、無腹水",
        "黏膜顏色正常"
      ]
    },
    "pathophysiology": "肝結節性增生被認為是肝細胞對年齡相關性微循環改變的適應性反應。隨著年齡增長，肝臟微循環出現局部灌注差異，灌注較好的區域肝細胞增殖形成結節，而灌注較差的區域可能萎縮。結節由形態正常的肝細胞組成，排列方式與正常肝小葉略有不同，但維持正常的肝細胞功能。結節內可能含有空泡變性的肝細胞、脂肪變化或糖原蓄積。重要的是，這些結節不具有惡性潛能，不會轉變為肝細胞癌。門脈三聯管和中央靜脈結構在結節內可能被壓迫但不被破壞。",
    "diagnosis": {
      "primary": [
        "腹腔超音波：肝臟內可見單個或多個等回音至高回音結節",
        "細針穿刺細胞學（FNA）：可能看到正常或輕度增生的肝細胞，但敏感度有限",
        "組織活檢（Tru-Cut 或楔形活檢）：確定診斷的金標準",
        "影像學追蹤：結節大小穩定不變支持良性診斷"
      ],
      "differential": [
        "肝細胞癌（hepatocellular carcinoma）— 最重要的鑑別診斷",
        "肝細胞腺瘤（hepatocellular adenoma）",
        "轉移性腫瘤（來自脾臟、胰臟、腸道等）",
        "淋巴瘤肝臟浸潤",
        "肝膿瘍",
        "肉芽腫性肝炎"
      ],
      "labFindings": [
        "ALP 可能輕度至中度升高（因結節內的空泡變性肝細胞誘導 ALP）",
        "ALT 通常正常或僅輕度升高",
        "膽紅素、白蛋白、BUN 通常正常",
        "凝血功能正常",
        "膽汁酸（bile acids）通常正常",
        "超音波：肝實質內局灶性結節，回音性變異大（低、等或高回音）",
        "CT 或 MRI：可提供更精確的結節特徵描述"
      ]
    },
    "treatment": {
      "acute": "不需要急性治療。極罕見的結節破裂出血病例需要急診穩定（輸液復甦、輸血）和手術介入。",
      "chronic": "肝結節性增生不需要治療。重點在於準確診斷和與惡性腫瘤的鑑別。如果無法確定良惡性，可選擇定期超音波追蹤或手術活檢確診。",
      "medications": [
        "不需要特定藥物治療",
        "合併其他肝臟疾病時依該疾病治療",
        "SAMe（S-adenosylmethionine）和 silybin 可作為肝臟保健補充劑（非必要）"
      ],
      "surgery": "通常不需手術。以下情況可考慮：(1) 無法通過 FNA 或影像學確定良惡性時，手術活檢確診；(2) 大結節造成臨床症狀時；(3) 結節破裂出血時需緊急手術"
    },
    "prognosis": "預後極佳。肝結節性增生是良性的年齡相關性變化，不影響肝功能，不具惡性轉化潛能，不影響壽命。主要的臨床意義在於避免將其誤診為惡性腫瘤而進行不必要的激進治療。",
    "pearls": [
      "肝結節性增生是老年犬最常見的肝臟結節性病變——遠比肝腫瘤常見",
      "僅見於犬，貓極為罕見",
      "ALP 升高 + 超音波見肝臟結節在老年犬非常常見，不要過度反應",
      "FNA 細胞學區分結節性增生和分化良好的肝細胞癌可能困難，組織活檢是金標準",
      "最重要的臨床價值是避免將良性病變誤診為惡性腫瘤"
    ],
    "diagnosticAlgorithm": {
      "title": "肝結節性增生 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "多數為老年犬偶然發現，評估是否有肝臟疾病症狀",
          "findings": [
            "通常無臨床症狀",
            "體檢偶然觸及肝臟結節",
            "老年犬常見",
            "肝功能通常正常"
          ]
        },
        {
          "step": 2,
          "action": "實驗室檢查",
          "details": "進行肝臟相關血液學和生化檢查",
          "findings": [
            "ALP可能輕微升高",
            "ALT通常正常或輕微升高",
            "膽汁酸和膽紅素正常",
            "凝血功能正常"
          ]
        },
        {
          "step": 3,
          "action": "影像學檢查",
          "details": "進行腹部超音波評估肝臟結節特徵",
          "findings": [
            "單發或多發肝臟結節",
            "結節回音性不均一",
            "需與肝細胞癌及轉移性腫瘤鑑別",
            "無門脈高壓或腹水徵象"
          ]
        },
        {
          "step": 4,
          "action": "組織病理學確診",
          "details": "進行細針抽吸或核心活檢以區分良性與惡性病變",
          "findings": [
            "肝細胞增生但無異型性",
            "正常的門脈三聯結構",
            "空泡化肝細胞增生",
            "排除肝細胞腺瘤或肝細胞癌"
          ]
        }
      ]
    },
    "monitoring": [
      "如未做組織活檢：每 3-6 個月超音波追蹤確認結節大小穩定",
      "定期血液生化（每 6-12 個月）監測肝臟指標",
      "結節快速增大時需重新評估並考慮活檢",
      "已確診為結節性增生者不需要頻繁追蹤"
    ],
    "reference": "Clinical Veterinary Advisor / Blackwell's Five-Minute Veterinary Consult"
  },
  "copper-associated-hepatitis": {
    "zh": "銅相關性肝炎",
    "en": "Copper-Associated Hepatitis",
    "definition": "銅相關性肝炎是由肝臟銅蓄積導致的慢性進行性肝炎。銅蓄積可能為原發性遺傳缺陷（如 Bedlington Terrier 的 COMMD1 基因突變導致銅排泄障礙）或繼發於膽汁排泄障礙（膽汁鬱積導致銅排出減少）。過量的銅在肝細胞中蓄積，引起氧化損傷、細胞壞死和慢性發炎反應，最終可能進展為肝硬化和肝衰竭。近年來研究顯示，除了已知的遺傳性品種外，許多犬品種的銅相關性肝病發病率有增加趨勢，可能與商業飼料中銅含量偏高有關。",
    "synonyms": [
      "銅蓄積性肝病",
      "銅中毒性肝炎",
      "Bedlington 肝炎",
      "慢性活動性肝炎",
      "Copper storage hepatopathy",
      "Bedlington hepatitis",
      "Chronic Cu toxicity"
    ],
    "epidemiology": {
      "species": "犬（貓極為罕見）",
      "breed": "Bedlington Terrier（遺傳性，COMMD1 基因突變）、Labrador Retriever、Doberman Pinscher、West Highland White Terrier、Dalmatian、Skye Terrier 等多品種均有報告，近年 Labrador Retriever 報告增加",
      "age": "Bedlington Terrier 從 2-6 歲開始出現肝損傷；其他品種通常中年至老年（4-7 歲以上）",
      "sex": "Bedlington Terrier 無性別偏好；Labrador Retriever 和 Doberman 可能母犬偏好",
      "prevalence": "Bedlington Terrier 中約 25-50% 為隱性遺傳攜帶者；其他品種盛行率不一，但近年報告增加"
    },
    "clinicalPresentation": {
      "symptoms": [
        "早期可能完全無症狀（亞臨床期）",
        "食慾減退和進行性體重減輕",
        "嗜睡和活動力下降",
        "間歇性嘔吐",
        "多飲多尿（polydipsia/polyuria）",
        "黃疸（icterus）— 疾病進展至中晚期時",
        "腹水（ascites）— 肝硬化和門脈高壓時",
        "急性溶血性危象（Bedlington Terrier，大量銅釋放入血循環時）",
        "黑便（melena）或消化道出血（凝血功能障礙時）",
        "神經症狀（肝性腦病）：定向障礙、繞圈、癲癇",
        "慢性腹瀉",
        "皮膚和鞏膜黃染"
      ],
      "physicalExam": [
        "肝臟觸診可能縮小（晚期肝硬化）或正常大小",
        "黃疸（皮膚、鞏膜、黏膜黃染）",
        "腹部膨脹（腹水）",
        "體況評分下降，肌肉消耗",
        "黏膜蒼白（溶血性貧血時，尤其 Bedlington Terrier）",
        "神經學異常（肝性腦病時）"
      ]
    },
    "pathophysiology": "正常情況下，飲食中的銅經腸道吸收後由門靜脈運送至肝臟，肝細胞將多餘的銅結合到膽汁排出。在銅相關性肝炎中，銅的排泄或代謝機制出現缺陷。Bedlington Terrier 的 COMMD1（copper metabolism domain containing 1）基因突變導致銅從肝細胞排入膽汁的能力受損，銅在肝細胞溶酶體中持續蓄積。當細胞內銅濃度超過安全閾值（通常 > 400 μg/g 乾重），游離銅離子催化 Fenton 反應產生活性氧自由基（ROS），引起脂質過氧化、蛋白質氧化和 DNA 損傷，導致肝細胞壞死。壞死引發炎症反應和纖維化，慢性進展最終導致肝硬化。急性大量肝細胞壞死可釋放大量銅進入血液循環，導致急性溶血性危象。",
    "diagnosis": {
      "primary": [
        "肝臟組織活檢並進行定量銅測定（gold standard）：銅含量 > 400 μg/g 乾重為異常",
        "肝臟活檢組織的銅特殊染色（Rhodanine 或 Rubeanic acid 染色）",
        "腹腔超音波：評估肝臟大小、回音性和是否有腹水",
        "血液生化檢查：肝臟酵素和肝功能評估"
      ],
      "differential": [
        "其他原因的慢性肝炎（免疫介導性、感染性、藥物性）",
        "膽汁鬱積性肝病（繼發性銅蓄積）",
        "肝臟腫瘤",
        "傳染性肝炎（犬腺病毒、Leptospira）",
        "門脈分流（portosystemic shunt）",
        "犬 Lobular Dissecting Hepatitis"
      ],
      "labFindings": [
        "ALT 升高（肝細胞損傷指標），可能間歇性波動",
        "ALP 升高（膽汁鬱積指標）",
        "低白蛋白血症（慢性肝病/肝硬化時）",
        "高膽紅素血症（進展期）",
        "凝血時間延長（PT/aPTT，嚴重肝病時）",
        "肝臟活檢銅含量 > 400 μg/g 乾重（正常 < 200 μg/g）",
        "Rhodanine 染色陽性：肝細胞內銅顆粒",
        "組織學：慢性肝炎伴纖維化、肝細胞壞死、銅蓄積（初期位於 zone 3）",
        "Bedlington Terrier 可進行 COMMD1 基因檢測"
      ]
    },
    "treatment": {
      "acute": "急性溶血性危象（Bedlington Terrier）：積極輸液治療、輸血、利尿促進銅排泄。急性肝衰竭：支持性照護、lactulose（肝性腦病）、vitamin K1（凝血功能障礙）、膠體和晶體輸液。",
      "chronic": "銅螯合治療為主：D-penicillamine 是首選銅螯合劑，與餐前給予促進銅排泄。低銅飲食。肝臟保護劑（SAMe、silybin、vitamin E）減少氧化損傷。鋅劑可阻斷腸道銅吸收。治療需長期甚至終生。定期監測肝臟銅含量（每 6-12 個月活檢）。",
      "medications": [
        "D-Penicillamine 10-15 mg/kg PO q12h（空腹，餐前 30 分鐘）— 首選銅螯合劑",
        "Trientine (2,2,2-tetramine) 10-15 mg/kg PO q12h — D-penicillamine 不耐受時的替代",
        "Zinc gluconate 或 zinc acetate 5-10 mg/kg PO q12h（與螯合劑分開給予）— 阻斷腸道銅吸收",
        "SAMe (S-adenosylmethionine) 20 mg/kg PO q24h 空腹 — 肝臟抗氧化保護",
        "Vitamin E 10-15 IU/kg PO q24h — 抗氧化劑",
        "Ursodiol (UDCA) 10-15 mg/kg PO q24h — 利膽和肝臟保護",
        "Lactulose 0.5 mL/kg PO q8-12h — 肝性腦病時"
      ],
      "surgery": "一般不需手術，除非需要肝臟活檢確診。終末期肝硬化在人醫可考慮肝臟移植，但獸醫學中尚未常規進行。"
    },
    "prognosis": "預後取決於診斷時的疾病階段。早期診斷並積極銅螯合治療的病例預後良好，肝臟損傷可部分逆轉。已進展至肝硬化的病例預後謹慎至不良，治療可延緩但無法逆轉纖維化。Bedlington Terrier 的急性溶血性危象預後謹慎。早期篩檢和預防性飲食管理可顯著改善預後。",
    "pearls": [
      "不要繁殖受影響的 Bedlington Terrier 或已知攜帶者（COMMD1 基因檢測可用於篩檢）",
      "繼發性銅蓄積（因膽汁鬱積）vs 原發性銅蓄積的鑑別很重要——治療方向不同",
      "肝臟銅含量的定量測定需要足夠大的活檢樣本（至少 5 mg 乾重）",
      "D-penicillamine 最常見的副作用是嘔吐——可逐漸增加劑量或改用 trientine",
      "近年 Labrador Retriever 銅相關性肝病增加，可能與商業飼料銅含量偏高有關",
      "鋅劑和螯合劑應分開至少 2 小時給予，否則鋅會螯合螯合劑降低效果"
    ],
    "diagnosticAlgorithm": {
      "title": "銅相關性肝炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "收集品種史（Bedlington Terrier、Labrador等高風險品種）和臨床症狀",
          "findings": [
            "高風險品種背景",
            "慢性嘔吐、食慾不振",
            "漸進性體重減輕",
            "黃疸（進展期）"
          ]
        },
        {
          "step": 2,
          "action": "實驗室檢查",
          "details": "進行全套肝功能相關生化檢查",
          "findings": [
            "ALT和AST顯著升高",
            "ALP升高",
            "膽紅素升高（進展期）",
            "白蛋白降低（慢性）"
          ]
        },
        {
          "step": 3,
          "action": "影像學檢查",
          "details": "進行腹部超音波評估肝臟結構",
          "findings": [
            "肝實質回音性異常",
            "肝臟大小可能增大或縮小",
            "腹水（進展期）",
            "可能見到肝臟結節性變化"
          ]
        },
        {
          "step": 4,
          "action": "肝臟活檢與銅定量",
          "details": "進行肝臟活檢進行組織病理學和肝銅定量分析",
          "findings": [
            "肝銅含量 >400 μg/g 乾重",
            "小葉中心性肝細胞壞死",
            "銅特殊染色（Rhodanine/Rubeanic acid）陽性",
            "不同程度纖維化至肝硬化"
          ]
        }
      ]
    },
    "monitoring": [
      "肝臟酵素（ALT、ALP）每 4-8 週監測至穩定，之後每 3-6 個月",
      "肝臟活檢和定量銅測定：治療 6-12 個月後追蹤",
      "白蛋白、膽紅素、凝血功能監測肝功能",
      "D-penicillamine 副作用監測：嘔吐、蛋白尿",
      "低銅飲食的依從性評估"
    ],
    "reference": "Clinical Veterinary Advisor / Blackwell's Five-Minute Veterinary Consult"
  },
  "megaesophagus-acquired": {
    "zh": "後天性巨食道症",
    "en": "Acquired Megaesophagus",
    "definition": "後天性巨食道症是食道的瀰漫性擴張伴隨運動功能障礙，導致食物和液體在食道中滯留而無法正常輸送至胃。此為犬最常見的食道疾病之一。後天性巨食道症可為特發性（原因不明，最常見）或繼發於其他疾病，包括重症肌無力（myasthenia gravis，最重要的可治療原因）、甲狀腺功能低下、腎上腺皮質功能低下、多發性肌炎、自主神經失調症（dysautonomia）及食道炎（慢性嘔吐或胃食道逆流引起）。吸入性肺炎是最常見和最致命的併發症。",
    "synonyms": [
      "後天性食道擴張",
      "繼發性巨食道症",
      "Acquired esophageal dilatation",
      "Secondary megaesophagus"
    ],
    "epidemiology": {
      "species": "犬較貓常見（貓罕見）",
      "breed": "German Shepherd、Golden Retriever、Irish Setter、Great Dane、Labrador Retriever 等大型犬較常見；先天性巨食道症好發品種：Wire Fox Terrier、Miniature Schnauzer、Chinese Shar-Pei",
      "age": "後天性可發生於任何年齡，但成年至老年犬最常見（> 5 歲），尤其是特發性和重症肌無力相關型",
      "sex": "無明確性別偏好",
      "prevalence": "犬最常見的食道疾病之一，特發性占後天性病例的 25-50%"
    },
    "clinicalPresentation": {
      "symptoms": [
        "反流（regurgitation）：被動性、無腹部用力，通常在進食後數分鐘至數小時發生",
        "反流物為未消化的食物，呈管狀或香腸狀",
        "體重進行性減輕和肌肉消耗",
        "食慾通常正常或增加（despite 營養不良）",
        "進食時喉嚨發出咕嚕聲或吞嚥困難",
        "口臭（食物在擴張食道中發酵）",
        "咳嗽和呼吸困難（吸入性肺炎徵象）",
        "發燒（吸入性肺炎時）",
        "流涎（ptyalism）",
        "鼻分泌物（反流物經鼻腔排出）",
        "進食姿勢異常（可能伸長頸部）",
        "全身性肌肉無力（如合併重症肌無力）"
      ],
      "physicalExam": [
        "體況評分低，明顯消瘦",
        "頸部觸診可能感覺到擴張的頸段食道",
        "肺部聽診異常（如合併吸入性肺炎：囉音、支氣管音）",
        "發燒（吸入性肺炎時）",
        "脫水徵象（皮膚彈性下降、黏膜乾燥）",
        "全身性肌肉萎縮",
        "如合併重症肌無力：誘發性肌肉無力、可能有巨食道症以外的肌無力表現"
      ]
    },
    "pathophysiology": "食道的正常蠕動功能依賴完整的迷走神經傳入和傳出通路、食道壁內神經叢（Auerbach's plexus）和橫紋肌（犬食道全程為橫紋肌）的協調運作。後天性巨食道症的機制因病因而異：重症肌無力中，自體抗體攻擊食道橫紋肌的乙醯膽鹼受體（nicotinic AChR），導致神經肌肉傳導障礙和食道蠕動衰竭；甲狀腺功能低下可能通過神經病變影響迷走神經功能；自主神經失調症（dysautonomia）影響食道壁內神經叢；食道炎導致黏膜損傷和肌肉層發炎纖維化。無論病因為何，最終結果都是食道喪失有效蠕動能力，食物滯留導致食道進一步被動性擴張，形成惡性循環。吸入性肺炎是因反流物誤吸入氣道所致，是最常見的死因。",
    "diagnosis": {
      "primary": [
        "胸腔 X 光：側位和腹背位可見食道擴張（氣體或食物/液體充盈的食道影像）",
        "食道造影（contrast esophagogram）：鋇劑或碘造影劑確認食道擴張和蠕動功能障礙",
        "乙醯膽鹼受體（AChR）抗體效價：篩檢重症肌無力（最重要的可治療病因）",
        "甲狀腺功能檢查（Total T4、free T4、TSH）：排除甲狀腺功能低下"
      ],
      "differential": [
        "重症肌無力（focal 或 generalized myasthenia gravis）",
        "甲狀腺功能低下（hypothyroidism）",
        "腎上腺皮質功能低下（hypoadrenocorticism/Addison's disease）",
        "多發性肌炎（polymyositis）或皮肌炎",
        "自主神經失調症（dysautonomia）",
        "食道異物或食道狹窄",
        "食道腫瘤",
        "鉛或有機磷中毒",
        "特發性巨食道症（排除所有已知原因後）"
      ],
      "labFindings": [
        "胸腔 X 光：食道擴張影像（氣管背側的軟組織/氣體密度影像）",
        "可能合併吸入性肺炎影像（右中葉和右前葉肺泡型浸潤）",
        "AChR 抗體效價：陽性確診重症肌無力（犬 > 0.6 nmol/L）",
        "Total T4 / free T4 降低提示甲狀腺功能低下",
        "基礎 cortisol 或 ACTH 刺激試驗排除 Addison's disease",
        "CK（creatine kinase）升高可能提示肌炎",
        "電解質異常（低鈉高鉀）提示 Addison's disease",
        "透視檢查（fluoroscopy）：動態評估食道蠕動功能"
      ]
    },
    "treatment": {
      "acute": "吸入性肺炎的積極治療：廣效抗生素（amoxicillin-clavulanate + fluoroquinolone 或基於培養結果）、氧氣治療、靜脈輸液；嚴重脫水和營養不良的矯正；放置胃管（gastrostomy tube）確保營養攝入和減少反流風險",
      "chronic": "營養管理為核心：高處餵食（Bailey chair，讓動物直立進食）、餵食後保持直立姿勢 15-30 分鐘；食物質地試驗（部分動物對液態食物反應較好，部分對固態食團較好）；治療潛在疾病（重症肌無力：pyridostigmine；甲狀腺功能低下：levothyroxine；Addison's disease：DOCP + prednisone）",
      "medications": [
        "Pyridostigmine 0.5-3 mg/kg PO q8-12h — 重症肌無力的乙醯膽鹼酯酶抑制劑",
        "Levothyroxine 0.02 mg/kg PO q12h — 甲狀腺功能低下時",
        "Cisapride 0.1-0.5 mg/kg PO q8-12h — 促進胃排空（輔助）",
        "Metoclopramide 0.2-0.4 mg/kg PO q8h — 促動力劑（效果有限）",
        "Omeprazole 1 mg/kg PO q24h — 減少胃酸逆流引起的食道炎",
        "Sucralfate 0.5-1 g PO q8h — 食道黏膜保護",
        "廣效抗生素 — 吸入性肺炎時（amoxicillin-clavulanate 12.5-25 mg/kg PO q12h）"
      ],
      "surgery": "胃造管（gastrostomy tube, G-tube）置放：提供繞過食道的營養途徑，減少反流和吸入風險。是嚴重巨食道症的重要管理手段。食道本身的手術選項非常有限。"
    },
    "prognosis": "預後取決於病因和併發症。繼發於可治療疾病（如重症肌無力、甲狀腺功能低下、Addison's disease）的巨食道症，治療潛在疾病後食道功能可能改善（重症肌無力治療後約 50-60% 可恢復）。特發性巨食道症預後謹慎至不良，因為食道功能難以恢復。吸入性肺炎是最常見的死因和安樂死原因。飼主的長期護理意願和投入程度顯著影響預後。",
    "pearls": [
      "反流（regurgitation）不等於嘔吐（vomiting）——區分兩者是診斷巨食道症的第一步",
      "所有巨食道症病例都必須檢測 AChR 抗體——重症肌無力是最重要的可治療原因",
      "Bailey chair（高處直立餵食椅）是管理巨食道症的核心工具",
      "吸入性肺炎是巨食道症最常見的死因——預防重於治療",
      "部分重症肌無力可能僅表現為局灶性巨食道症（focal MG），無全身性肌無力",
      "食物質地試驗很重要——每隻動物對液態 vs 固態食物的耐受性不同"
    ],
    "diagnosticAlgorithm": {
      "title": "後天性巨食道症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估典型的反流症狀及相關併發症",
          "findings": [
            "被動性反流（非嘔吐）",
            "體重減輕與肌肉消耗",
            "反覆性吸入性肺炎",
            "食物為未消化狀態"
          ]
        },
        {
          "step": 2,
          "action": "影像學檢查",
          "details": "進行胸部X光評估食道擴張程度",
          "findings": [
            "食道全段或節段性擴張",
            "食道內可見食物或液體滯留",
            "氣管向腹側移位",
            "可能見到吸入性肺炎徵象"
          ]
        },
        {
          "step": 3,
          "action": "病因學篩檢",
          "details": "進行全套檢查尋找後天性巨食道症的潛在原因",
          "findings": [
            "乙醯膽鹼受體抗體檢測（排除重症肌無力）",
            "甲狀腺功能檢查",
            "腎上腺功能檢查（排除Addison病）",
            "鉛中毒篩檢"
          ]
        },
        {
          "step": 4,
          "action": "進階評估",
          "details": "視情況進行食道鏡檢或進階神經肌肉評估",
          "findings": [
            "食道鏡排除結構性阻塞或狹窄",
            "肌電圖評估神經肌肉功能",
            "透視攝影評估食道蠕動功能",
            "多數病例為特發性"
          ]
        }
      ]
    },
    "monitoring": [
      "體重和體況評分定期追蹤",
      "胸腔 X 光監測吸入性肺炎（每次呼吸症狀發作時）",
      "AChR 抗體效價追蹤（重症肌無力病例，每 4-8 週）",
      "甲狀腺功能追蹤（甲狀腺功能低下病例）",
      "營養狀態和脫水評估",
      "飼主教育：辨識吸入性肺炎早期徵象（咳嗽、呼吸急促、發燒）"
    ],
    "reference": "Clinical Veterinary Advisor / Blackwell's Five-Minute Veterinary Consult"
  },
  "hepatocellular-carcinoma": {
    "zh": "肝細胞癌",
    "en": "Hepatocellular Carcinoma",
    "definition": "肝細胞癌是源自肝臟實質細胞的惡性腫瘤，為犬貓最常見的原發性肝臟惡性腫瘤。可分為巨塊型（massive）、結節型（nodular）和瀰漫型（diffuse），其中巨塊型預後最佳。",
    "synonyms": [
      "肝癌",
      "原發性肝細胞癌",
      "HCC"
    ],
    "epidemiology": {
      "species": "犬多於貓，犬佔原發性肝腫瘤約50%",
      "breed": "無明顯品種好發傾向",
      "age": "好發於10歲以上老年犬貓",
      "sex": "雄性犬略多",
      "prevalence": "佔犬所有腫瘤約1-1.5%"
    },
    "clinicalPresentation": {
      "symptoms": [
        "厭食",
        "體重減輕",
        "嗜睡",
        "多飲多尿",
        "腹部膨脹",
        "嘔吐",
        "腹瀉",
        "黃疸",
        "腹水",
        "急性腹腔內出血（腫瘤破裂）"
      ],
      "physicalExam": [
        "肝腫大（觸診可及前腹部腫塊）",
        "腹部膨脹",
        "黏膜蒼白或黃染",
        "腹水波動感",
        "體況評分下降"
      ]
    },
    "pathophysiology": "肝細胞經歷多步驟致癌過程，包括慢性肝損傷、再生結節形成、不典型增生，最終轉化為惡性腫瘤。腫瘤細胞失去正常肝小葉結構，形成小梁狀、腺管狀或實心片狀排列。巨塊型通常為單一大腫塊，轉移率較低；瀰漫型侵犯多個肝葉，預後極差。",
    "diagnosis": {
      "primary": [
        "腹部超音波（評估腫塊型態及肝臟結構）",
        "CT/MRI（手術前分期）",
        "細針抽吸細胞學（FNA）",
        "組織病理學（確診金標準）"
      ],
      "differential": [
        "肝結節性增生",
        "膽管細胞癌",
        "肝轉移性腫瘤",
        "肝血管肉瘤",
        "肝臟淋巴瘤",
        "肝膿瘍"
      ],
      "labFindings": [
        "ALT/AST升高",
        "ALP顯著升高",
        "低白蛋白血症",
        "凝血時間延長",
        "貧血（腫瘤破裂出血時）"
      ]
    },
    "treatment": {
      "acute": "腫瘤破裂出血時需輸血及穩定血流動力學",
      "chronic": "巨塊型可行肝葉切除術；結節型和瀰漫型治療選擇有限",
      "medications": [
        "Toceranib（犬）",
        "Doxorubicin（輔助化療）",
        "止痛藥（Tramadol、Gabapentin）",
        "保肝藥（SAMe、Silymarin）"
      ],
      "surgery": "巨塊型：肝葉切除術為首選，切除率高且預後良好；結節型/瀰漫型通常不適合手術"
    },
    "prognosis": "巨塊型肝葉切除後中位存活時間超過1460天（>4年），預後良好。結節型中位存活約270-428天。瀰漫型預後極差，中位存活不足6個月。",
    "pearls": [
      "巨塊型HCC手術切除後預後極佳，即使腫塊巨大也應積極評估手術可能性",
      "犬的肝結節性增生非常常見，細胞學有時難以與高分化HCC區分，建議組織病理確診",
      "ALP持續顯著升高而無明顯膽道阻塞原因時應懷疑HCC",
      "瀰漫型HCC常被誤診為慢性肝炎"
    ],
    "diagnosticAlgorithm": {
      "title": "肝細胞癌 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估臨床症狀，老年犬多見",
          "findings": [
            "腹部膨大或可觸及腫塊",
            "食慾不振與體重減輕",
            "嘔吐或腹瀉",
            "部分病例因腫瘤破裂急性腹痛"
          ]
        },
        {
          "step": 2,
          "action": "實驗室檢查",
          "details": "進行肝功能相關生化檢查及全血計數",
          "findings": [
            "ALP和ALT顯著升高",
            "低血糖（副腫瘤症候群）",
            "紅血球增多症（部分病例）",
            "凝血時間延長"
          ]
        },
        {
          "step": 3,
          "action": "影像學檢查",
          "details": "進行腹部超音波和/或CT評估腫瘤特徵及分期",
          "findings": [
            "肝臟巨大單一腫塊（最常見型態）",
            "結節型或瀰漫型較少見",
            "評估是否有遠端轉移",
            "腹腔積液"
          ]
        },
        {
          "step": 4,
          "action": "組織病理學確診",
          "details": "進行細針抽吸或活檢確認腫瘤類型",
          "findings": [
            "肝細胞異型增生",
            "細胞學可見高度異型肝細胞",
            "組織學確認分化程度",
            "與肝結節性增生和肝腺瘤鑑別"
          ]
        }
      ]
    },
    "monitoring": [
      "術後每3個月腹部超音波追蹤",
      "肝指數（ALT、ALP）每月監測",
      "胸腔X光評估肺轉移",
      "凝血功能監測"
    ],
    "reference": "Blackwell's Five-Minute Veterinary Consult"
  },
  "intestinal-adenocarcinoma": {
    "zh": "腸腺癌",
    "en": "Intestinal Adenocarcinoma",
    "definition": "腸腺癌是源自腸道腺體上皮細胞的惡性腫瘤，為犬貓最常見的腸道惡性腫瘤之一。貓以小腸好發，犬則小腸和大腸均可發生。腫瘤具有局部侵犯性強且易發生區域淋巴結轉移的特性。",
    "synonyms": [
      "腸道腺癌",
      "腸癌",
      "消化道腺癌"
    ],
    "epidemiology": {
      "species": "犬貓均可發生，貓略多",
      "breed": "犬：德國牧羊犬、可卡犬、拳師犬；貓：暹羅貓好發",
      "age": "犬平均9歲，貓平均10-12歲",
      "sex": "雄性犬略多",
      "prevalence": "佔犬腸道腫瘤約20-30%，貓腸道腫瘤中僅次於淋巴瘤"
    },
    "clinicalPresentation": {
      "symptoms": [
        "慢性嘔吐",
        "體重減輕",
        "厭食",
        "腹瀉（可為血便）",
        "排便困難（大腸型）",
        "裡急後重",
        "腹痛",
        "腸梗阻症狀",
        "漸進性消瘦",
        "脫水"
      ],
      "physicalExam": [
        "腹部觸診可及腫塊",
        "腸管增厚",
        "腸繫膜淋巴結腫大",
        "體況評分下降",
        "直腸指檢可觸及腫塊（大腸型）",
        "脫水徵象"
      ]
    },
    "pathophysiology": "腺癌起源於腸黏膜腺體上皮，呈環狀狹窄（annular stenosing）生長模式為主，導致腸腔漸進性狹窄和阻塞。腫瘤細胞穿透腸壁各層，侵犯漿膜面後可能導致腹膜播種（carcinomatosis）。區域淋巴結轉移發生率高達50-70%。",
    "diagnosis": {
      "primary": [
        "腹部超音波（腸壁增厚、失去分層結構）",
        "內視鏡及活檢（十二指腸/結腸型）",
        "剖腹探查及全層活檢",
        "腹部CT（分期評估）"
      ],
      "differential": [
        "腸道淋巴瘤",
        "發炎性腸病（IBD）",
        "腸道平滑肌肉瘤",
        "腸道GIST",
        "腸套疊",
        "異物阻塞"
      ],
      "labFindings": [
        "低白蛋白血症",
        "貧血（慢性失血）",
        "低血糖（偶見）",
        "電解質失衡",
        "糞便潛血陽性"
      ]
    },
    "treatment": {
      "acute": "腸阻塞時需緊急手術減壓、輸液矯正電解質失衡",
      "chronic": "手術切除為主要治療，輔助化療效果不一",
      "medications": [
        "Carboplatin（輔助化療）",
        "Cyclophosphamide",
        "Piroxicam（COX-2抑制）",
        "止吐藥（Maropitant）",
        "營養支持"
      ],
      "surgery": "腸段切除吻合術為首選；需確保足夠手術邊界（>5cm）；同時切除區域淋巴結"
    },
    "prognosis": "犬腸腺癌手術切除後中位存活時間約10-15個月。有淋巴結轉移者預後較差（約6個月）。貓小腸腺癌手術後中位存活約5-15個月。大腸型比小腸型預後略好。",
    "pearls": [
      "貓小腸腺癌與淋巴瘤的鑑別極為重要，治療方式完全不同",
      "環狀狹窄型生長是腸腺癌的典型影像特徵，有助於與淋巴瘤區分",
      "術中應仔細評估腸繫膜淋巴結，轉移率很高",
      "暹羅貓是腸腺癌的高危品種，慢性消化道症狀應高度警覺"
    ],
    "diagnosticAlgorithm": {
      "title": "腸腺癌 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估慢性腸道症狀和全身狀態",
          "findings": [
            "慢性嘔吐和/或腹瀉",
            "體重減輕與食慾下降",
            "可能觸及腹部腫塊",
            "偶見便血或黑便"
          ]
        },
        {
          "step": 2,
          "action": "實驗室檢查",
          "details": "進行全血計數和生化檢查",
          "findings": [
            "貧血（慢性失血性）",
            "低白蛋白血症",
            "電解質紊亂",
            "炎症指標升高"
          ]
        },
        {
          "step": 3,
          "action": "影像學檢查",
          "details": "進行腹部超音波評估腸壁和區域淋巴結",
          "findings": [
            "局灶性腸壁增厚",
            "腸壁正常層次結構破壞",
            "區域淋巴結腫大",
            "腸腔狹窄或阻塞"
          ]
        },
        {
          "step": 4,
          "action": "內視鏡或手術活檢",
          "details": "進行消化道內視鏡或探查性剖腹術取得組織樣本",
          "findings": [
            "腸壁潰瘍性或增生性腫塊",
            "全層活檢顯示腺癌",
            "評估腫瘤浸潤深度",
            "區域淋巴結轉移評估"
          ]
        }
      ]
    },
    "monitoring": [
      "術後每2-3個月腹部超音波",
      "體重及營養狀態追蹤",
      "白蛋白及血球計數監測",
      "胸腔X光（轉移評估）"
    ],
    "reference": "Veterinary Surgical Oncology"
  },
  "apocrine-gland-adenocarcinoma": {
    "zh": "頂漿腺癌（肛囊腺癌）",
    "en": "Apocrine Gland Adenocarcinoma of the Anal Sac",
    "definition": "肛囊頂漿腺癌是源自肛囊壁頂漿腺（apocrine gland）的高度惡性腫瘤，為犬最常見的肛囊惡性腫瘤。約25-50%病例會產生副腫瘤性高鈣血症（paraneoplastic hypercalcemia），且診斷時常已有區域淋巴結轉移。",
    "synonyms": [
      "肛囊腺癌",
      "AGASACA",
      "肛囊頂漿腺癌",
      "肛門囊腺癌"
    ],
    "epidemiology": {
      "species": "主要見於犬，貓極少見",
      "breed": "英國可卡犬、德國牧羊犬、黃金獵犬好發",
      "age": "中老年犬（中位數9-11歲）",
      "sex": "無明顯性別差異（早期報告雌性多但近年研究無顯著差異）",
      "prevalence": "佔犬肛周腫瘤約17%，為第二常見肛周腫瘤"
    },
    "clinicalPresentation": {
      "symptoms": [
        "肛門旁腫塊",
        "排便困難",
        "裡急後重",
        "糞便帶狀變形",
        "多飲多尿（高鈣血症）",
        "厭食",
        "嗜睡",
        "體重減輕",
        "肛門區舔舐",
        "後肢無力（嚴重高鈣血症）"
      ],
      "physicalExam": [
        "直腸指檢觸及肛囊硬實腫塊",
        "腹股下淋巴結腫大",
        "脫水",
        "心律不整（高鈣血症）",
        "肌肉無力"
      ]
    },
    "pathophysiology": "腫瘤起源於肛囊壁的頂漿腺上皮，呈侵犯性生長。約25-50%的AGASACA會分泌PTHrP（副甲狀腺素相關蛋白），導致副腫瘤性高鈣血症，引起腎臟損傷、多飲多尿、心律不整等全身性症狀。腫瘤早期即傾向經淋巴管轉移至髂內/髂下淋巴結。",
    "diagnosis": {
      "primary": [
        "直腸指檢（基本篩檢）",
        "細針抽吸細胞學",
        "腹部超音波（評估髂下淋巴結）",
        "胸腹部CT（完整分期）"
      ],
      "differential": [
        "肛周腺瘤",
        "肛周腺癌",
        "肛門囊炎/膿腫",
        "直腸息肉",
        "肛門周圍肥大細胞瘤"
      ],
      "labFindings": [
        "高鈣血症（total Ca >12 mg/dL）",
        "低磷血症",
        "PTHrP升高",
        "氮血症（高鈣致腎損傷）",
        "PTH抑制（低正常或低）"
      ]
    },
    "treatment": {
      "acute": "高鈣血症危象：靜脈輸液生理食鹽水、Furosemide利尿、Bisphosphonate",
      "chronic": "手術切除原發腫瘤+輔助化療控制轉移",
      "medications": [
        "Carboplatin（每3週一次）",
        "Mitoxantrone",
        "Toceranib（TKI）",
        "Zoledronic acid（控制高鈣血症）",
        "Pamidronate"
      ],
      "surgery": "肛囊切除術為首選；腫大的髂下淋巴結可行手術摘除以緩解阻塞症狀"
    },
    "prognosis": "手術切除後中位存活時間約12-18個月。手術結合化療可延長至約18-24個月。有高鈣血症者預後較無高鈣血症者差。早期發現（腫瘤<2.5cm）預後顯著較好。",
    "pearls": [
      "每次例行理學檢查都應進行直腸指檢，AGASACA早期發現可顯著改善預後",
      "不明原因高鈣血症的犬必須進行直腸指檢排除AGASACA",
      "即使有淋巴結轉移，手術切除原發腫瘤+淋巴結摘除仍可提供良好的姑息效果",
      "腹部超音波應評估髂下淋巴結大小，轉移率非常高"
    ],
    "diagnosticAlgorithm": {
      "title": "頂漿腺癌（肛囊腺癌）診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "進行直腸檢查和肛門區域觸診",
          "findings": [
            "肛囊區域堅硬腫塊",
            "排便困難或裡急後重",
            "會陰區域腫脹",
            "多飲多尿（高鈣血症）"
          ]
        },
        {
          "step": 2,
          "action": "實驗室檢查",
          "details": "進行全套血液檢查，特別注意鈣離子水平",
          "findings": [
            "高鈣血症（25-50%病例）",
            "副甲狀腺激素相關蛋白（PTHrP）升高",
            "氮質血症（繼發於高鈣血症）",
            "腎功能可能受損"
          ]
        },
        {
          "step": 3,
          "action": "影像學分期",
          "details": "進行腹部超音波和胸部X光評估轉移",
          "findings": [
            "腰下淋巴結腫大（常見轉移部位）",
            "胸部X光評估肺轉移",
            "肛囊區域腫塊超音波特徵",
            "可能有脊椎或骨盆骨轉移"
          ]
        },
        {
          "step": 4,
          "action": "組織病理學確診",
          "details": "進行細針抽吸或切除活檢確診",
          "findings": [
            "頂漿腺分化的腺癌細胞",
            "上皮細胞呈片狀或腺管狀排列",
            "細胞核大且異型性明顯",
            "確認腫瘤分級"
          ]
        }
      ]
    },
    "monitoring": [
      "術後每2-3個月血鈣監測",
      "腹部超音波追蹤髂下淋巴結",
      "直腸指檢評估局部復發",
      "腎功能（BUN/Creatinine）監測"
    ],
    "reference": "Blackwell's Five-Minute Veterinary Consult"
  },
  "basal-cell-tumor": {
    "zh": "基底細胞瘤",
    "en": "Basal Cell Tumor",
    "definition": "基底細胞瘤是源自表皮基底層或毛囊外根鞘細胞的皮膚腫瘤。在犬多為良性（基底細胞瘤），少數為惡性（基底細胞癌）；在貓中是最常見的皮膚腫瘤之一，大多為良性，手術切除後預後極佳。",
    "synonyms": [
      "基底細胞上皮瘤",
      "毛母質瘤",
      "Basaloid tumor"
    ],
    "epidemiology": {
      "species": "犬貓均常見，貓尤其多",
      "breed": "犬：可卡犬、貴賓犬；貓：暹羅貓、波斯貓、喜馬拉雅貓好發",
      "age": "中老年（犬平均7-10歲，貓6-13歲）",
      "sex": "無明顯性別差異",
      "prevalence": "貓第二常見皮膚腫瘤（僅次於肥大細胞瘤），犬皮膚腫瘤約4-6%"
    },
    "clinicalPresentation": {
      "symptoms": [
        "皮膚圓形隆起腫塊",
        "緩慢生長",
        "通常無痛",
        "腫塊表面可能潰瘍",
        "頭頸部好發",
        "腫塊質地堅實",
        "色素沉著（黑色）常見",
        "偶有多發性"
      ],
      "physicalExam": [
        "圓形、界限清楚的真皮或皮下腫塊",
        "質地堅實",
        "表面光滑或輕度潰瘍",
        "常見於頭部、頸部、肩部",
        "通常<3cm",
        "可能含有黑色素沉著"
      ]
    },
    "pathophysiology": "基底細胞瘤起源於表皮基底層的多潛能幹細胞或毛囊外根鞘細胞。良性型呈膨脹性生長，細胞排列整齊呈柵欄狀（palisading pattern）。惡性型（基底細胞癌）較少見，具有局部侵犯性但遠端轉移極罕見。貓的基底細胞瘤常含有大量黑色素，故又稱黑色素性基底細胞瘤。",
    "diagnosis": {
      "primary": [
        "細針抽吸細胞學（典型基底樣細胞群）",
        "組織病理學（確診及分級）",
        "切除活檢"
      ],
      "differential": [
        "肥大細胞瘤",
        "毛囊瘤",
        "皮脂腺腫瘤",
        "惡性黑色素瘤",
        "鱗狀上皮細胞癌",
        "纖維肉瘤"
      ],
      "labFindings": [
        "細胞學：小型均一基底樣細胞成群",
        "低核分裂指數（良性型）",
        "通常血液學無異常"
      ]
    },
    "treatment": {
      "acute": "通常不需緊急處理",
      "chronic": "手術切除為標準治療，治癒率極高",
      "medications": [
        "術後止痛（Meloxicam短期使用）",
        "抗生素（若有感染）",
        "Imiquimod外用（犬基底細胞癌文獻報導）"
      ],
      "surgery": "手術切除（邊界1cm），良性型通常治癒性切除即可；惡性型需較寬邊界"
    },
    "prognosis": "良性基底細胞瘤手術切除後預後極佳，治癒率接近100%。基底細胞癌局部復發率低，遠端轉移極罕見。貓的基底細胞瘤預後優於犬。",
    "pearls": [
      "貓頭頸部的黑色皮膚腫塊最常見的診斷是基底細胞瘤，而非黑色素瘤",
      "細針抽吸通常即可獲得高度懷疑的診斷",
      "多發性基底細胞瘤在貓偶爾可見，每個腫塊應獨立評估",
      "犬的基底細胞癌雖名為『癌』但生物行為溫和，不應過度治療"
    ],
    "diagnosticAlgorithm": {
      "title": "基底細胞瘤 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "檢查皮膚腫塊特徵和位置",
          "findings": [
            "頭頸部或軀幹常見",
            "圓形、界線明確的腫塊",
            "表面可能色素沉著或潰瘍",
            "單發性多見"
          ]
        },
        {
          "step": 2,
          "action": "細胞學檢查",
          "details": "進行細針抽吸細胞學評估",
          "findings": [
            "小型至中型均一基底樣細胞",
            "細胞排列呈片狀或欄柵狀",
            "黑色素可能存在",
            "低度有絲分裂活性"
          ]
        },
        {
          "step": 3,
          "action": "組織病理學確診",
          "details": "進行切除活檢和組織病理學分析",
          "findings": [
            "基底樣細胞增生呈島狀或索狀",
            "周邊細胞呈欄柵狀排列",
            "良性表現居多（犬）",
            "貓的基底細胞瘤多為良性"
          ]
        }
      ]
    },
    "monitoring": [
      "術後2-4週傷口癒合追蹤",
      "每6個月全身皮膚檢查（多發性傾向）",
      "惡性型術後每3個月觸診局部"
    ],
    "reference": "Cancer Management in Small Animal Practice"
  },
  "ceruminous-gland-adenocarcinoma": {
    "zh": "耵聹腺腺癌",
    "en": "Ceruminous Gland Adenocarcinoma",
    "definition": "耵聹腺腺癌是源自外耳道耵聹腺（ceruminous gland，一種特化的頂漿汗腺）的惡性腫瘤。為貓最常見的外耳道腫瘤，犬較少見。腫瘤具有局部侵犯性強的特性，可侵犯鼓泡和中耳。",
    "synonyms": [
      "耳道腺癌",
      "外耳道腺癌",
      "耳垢腺腺癌"
    ],
    "epidemiology": {
      "species": "貓多於犬",
      "breed": "無明顯品種好發傾向",
      "age": "老年動物（貓平均11-12歲，犬平均9-10歲）",
      "sex": "無明顯性別差異",
      "prevalence": "貓外耳道腫瘤中最常見的惡性類型"
    },
    "clinicalPresentation": {
      "symptoms": [
        "單側耳道分泌物增加",
        "耳道出血",
        "惡臭耳分泌物",
        "搖頭",
        "抓耳",
        "慢性外耳炎反覆發作",
        "聽力下降",
        "面神經麻痺（侵犯中耳）",
        "Horner氏症候群",
        "頭部歪斜"
      ],
      "physicalExam": [
        "耳鏡檢查見耳道內腫塊",
        "外耳道狹窄或阻塞",
        "耳道分泌物（血性或膿性）",
        "耳根部腫脹",
        "面神經功能異常（眼瞼下垂、唇下垂）"
      ]
    },
    "pathophysiology": "耵聹腺腺癌可能與慢性外耳炎的長期發炎刺激有關，尤其在貓。腫瘤起源於外耳道的耵聹腺上皮，呈侵犯性生長，可穿透軟骨侵犯周圍組織、鼓泡及中耳結構。局部淋巴結轉移率約10-15%，遠端轉移率約10%（主要至肺）。",
    "diagnosis": {
      "primary": [
        "耳鏡檢查及活檢",
        "CT掃描（評估骨骼侵犯及鼓泡累及程度）",
        "細針抽吸細胞學",
        "組織病理學"
      ],
      "differential": [
        "耵聹腺腺瘤",
        "發炎性息肉",
        "鱗狀上皮細胞癌",
        "耳道良性腫瘤",
        "慢性增生性外耳炎"
      ],
      "labFindings": [
        "通常血液學無特異性變化",
        "細胞學可見惡性上皮細胞特徵",
        "CT顯示鼓泡溶骨性破壞（晚期）"
      ]
    },
    "treatment": {
      "acute": "繼發感染時先控制感染（局部及全身性抗生素）",
      "chronic": "手術切除為主要治療，放射線治療可作為輔助",
      "medications": [
        "全身性抗生素（Enrofloxacin等，基於培養結果）",
        "局部耳藥（術前感染控制）",
        "止痛藥（Meloxicam、Gabapentin）",
        "Toceranib（少數報告）"
      ],
      "surgery": "全耳道切除術（TECA）合併側鼓泡截骨術（LBO）為標準治療；侵犯範圍廣時可能需擴大切除"
    },
    "prognosis": "貓TECA-LBO術後中位存活時間約11-17個月。完全切除者預後較佳。犬的預後與貓相似或略差。有鼓泡侵犯者預後較差，中位存活時間約6個月。",
    "pearls": [
      "慢性反覆發作的單側外耳炎，尤其在老年貓，應高度懷疑耵聹腺腺癌",
      "CT是術前評估的關鍵，可判斷鼓泡是否受侵犯以決定手術範圍",
      "即使腫瘤已侵犯鼓泡，TECA-LBO仍可提供合理的存活時間",
      "術後面神經麻痺是常見併發症，術前應告知飼主"
    ],
    "diagnosticAlgorithm": {
      "title": "耵聹腺腺癌 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估外耳道症狀，常見於貓",
          "findings": [
            "單側耳道出血或分泌物",
            "耳道內可見腫塊",
            "慢性外耳炎病史",
            "頭部傾斜或疼痛"
          ]
        },
        {
          "step": 2,
          "action": "耳鏡與影像學檢查",
          "details": "進行耳鏡檢查和頭顱CT/MRI評估腫瘤範圍",
          "findings": [
            "耳道內息肉樣或潰瘍性腫塊",
            "CT評估鼓泡是否受侵犯",
            "區域淋巴結評估",
            "排除中耳受累"
          ]
        },
        {
          "step": 3,
          "action": "組織病理學確診",
          "details": "進行活檢確認腫瘤類型和分級",
          "findings": [
            "耵聹腺分化的腺癌",
            "管狀或乳頭狀結構",
            "局部浸潤性生長",
            "評估血管和神經侵犯"
          ]
        },
        {
          "step": 4,
          "action": "分期檢查",
          "details": "進行全身分期評估轉移風險",
          "findings": [
            "區域淋巴結細針抽吸",
            "胸部X光排除肺轉移",
            "腹部超音波排除腹腔轉移",
            "評估手術切除可行性"
          ]
        }
      ]
    },
    "monitoring": [
      "術後每3個月CT或局部檢查",
      "觀察面神經功能恢復",
      "胸腔X光評估肺轉移（每3-6個月）",
      "對側耳道定期檢查"
    ],
    "reference": "Withrow & MacEwen's Small Animal Clinical Oncology"
  },
  "thyroid-adenoma": {
    "zh": "甲狀腺腺瘤",
    "en": "Thyroid Adenoma",
    "definition": "甲狀腺腺瘤是甲狀腺濾泡上皮細胞的良性腫瘤。在貓極為常見，是貓甲狀腺功能亢進症的最主要原因（約98%）。犬的甲狀腺腫瘤則多為惡性（甲狀腺癌），腺瘤相對少見。",
    "synonyms": [
      "甲狀腺良性腫瘤",
      "甲狀腺濾泡腺瘤",
      "Thyroid follicular adenoma"
    ],
    "epidemiology": {
      "species": "貓極為常見；犬少見（犬甲狀腺腫瘤70-75%為惡性）",
      "breed": "貓無明顯品種好發（暹羅貓可能風險略低）；犬：拳師犬、米格魯",
      "age": "貓平均12-13歲；犬平均9-11歲",
      "sex": "貓無明顯性別差異",
      "prevalence": "貓甲狀腺功能亢進發生率約10%（>10歲貓），幾乎全為腺瘤"
    },
    "clinicalPresentation": {
      "symptoms": [
        "體重減輕（食慾正常或增加）",
        "多食",
        "多飲多尿",
        "嘔吐",
        "腹瀉",
        "過動/躁動",
        "毛髮品質變差",
        "呼吸急促",
        "心跳加速",
        "行為改變（攻擊性增加）"
      ],
      "physicalExam": [
        "頸部觸診可及甲狀腺結節",
        "心搏過速（>240 bpm）",
        "心雜音（收縮期雜音）",
        "體況評分低",
        "被毛粗糙/脫毛",
        "高血壓相關視網膜病變"
      ]
    },
    "pathophysiology": "貓甲狀腺腺瘤為功能性腫瘤，自主性分泌過量甲狀腺素（T4），不受TSH負回饋調控。腫瘤通常為雙側性（約70%兩側均受影響）。過量的T4導致代謝率全面增加，影響心血管、消化、神經等多系統。長期甲亢可導致甲亢性心肌病和繼發性高血壓。",
    "diagnosis": {
      "primary": [
        "血清總T4（tT4）升高",
        "游離T4（fT4）升高",
        "頸部觸診",
        "甲狀腺核醫掃描（Tc-99m pertechnetate）"
      ],
      "differential": [
        "甲狀腺癌（犬為主）",
        "甲狀腺囊腫",
        "甲狀腺增生",
        "其他頸部腫塊（淋巴結、唾液腺）",
        "隱匿性甲亢（tT4正常但fT4升高）"
      ],
      "labFindings": [
        "tT4升高（>4.0 ug/dL）",
        "fT4升高",
        "ALT/ALP輕度升高",
        "BUN/Creatinine正常或輕度升高",
        "紅血球增多症（PCV升高）"
      ]
    },
    "treatment": {
      "acute": "甲亢危象（thyroid storm）：靜脈輸液、Beta-blocker控制心率",
      "chronic": "口服抗甲狀腺藥物、放射性碘治療、手術或處方飲食",
      "medications": [
        "Methimazole（首選口服藥物，起始2.5mg BID）",
        "Carbimazole（前驅藥物）",
        "Atenolol（控制心率）",
        "Amlodipine（控制高血壓）",
        "Hill's y/d（碘限制飲食）"
      ],
      "surgery": "甲狀腺切除術：單側或雙側；術前需Methimazole穩定2-4週；注意保留副甲狀腺"
    },
    "prognosis": "貓甲狀腺腺瘤預後良好。放射性碘治療治癒率>95%。Methimazole可長期良好控制。手術治癒率高但有低血鈣風險。治療後需監測腎功能，部分貓會顯露隱藏的慢性腎病。",
    "pearls": [
      "開始治療甲亢前務必評估腎功能——甲亢可掩蓋潛在的CKD",
      "建議先用Methimazole試驗性治療2-4週，監測腎功能後再決定永久性治療",
      "觸診陰性不代表無甲亢——異位甲狀腺組織可位於胸腔入口",
      "雙側甲狀腺切除術後最危險的併發症是低血鈣（副甲狀腺損傷）"
    ],
    "diagnosticAlgorithm": {
      "title": "甲狀腺腺瘤 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估甲狀腺功能亢進症狀（貓常見）或頸部腫塊（犬）",
          "findings": [
            "體重減輕伴食慾增加（貓）",
            "多飲多尿",
            "頸部可觸及結節",
            "心搏過速"
          ]
        },
        {
          "step": 2,
          "action": "內分泌檢查",
          "details": "進行甲狀腺功能檢測",
          "findings": [
            "總T4升高（貓甲亢）",
            "游離T4升高",
            "TSH降低",
            "犬甲狀腺腺瘤功能可正常"
          ]
        },
        {
          "step": 3,
          "action": "影像學檢查",
          "details": "進行頸部超音波和/或核醫學掃描",
          "findings": [
            "甲狀腺結節超音波特徵",
            "Tc-99m甲狀腺掃描顯示熱結節",
            "評估腫瘤大小和血供",
            "排除異位甲狀腺組織"
          ]
        },
        {
          "step": 4,
          "action": "組織病理學確診",
          "details": "手術切除後進行組織病理學分析",
          "findings": [
            "良性濾泡性腺瘤",
            "有包膜且無浸潤",
            "與甲狀腺癌鑑別",
            "確認完整切除"
          ]
        }
      ]
    },
    "monitoring": [
      "tT4每4-6週監測（調藥期）；穩定後每6個月",
      "腎功能（BUN/Creatinine/SDMA）",
      "血壓監測",
      "心臟超音波評估甲亢性心肌病恢復"
    ],
    "reference": "Withrow & MacEwen's Small Animal Clinical Oncology"
  },
  "chemodectoma": {
    "zh": "化學感受器瘤",
    "en": "Chemodectoma (Aortic/Carotid Body Tumor)",
    "definition": "化學感受器瘤是源自主動脈體（aortic body）或頸動脈體（carotid body）化學感受器細胞的腫瘤。主動脈體瘤更為常見，位於心臟基底部。腫瘤通常生長緩慢，但可造成心包積液和心臟壓塞。",
    "synonyms": [
      "主動脈體瘤",
      "頸動脈體瘤",
      "副神經節瘤",
      "Heart base tumor",
      "Paraganglioma"
    ],
    "epidemiology": {
      "species": "主要見於犬，貓極罕見",
      "breed": "短頭犬種（brachycephalic）高度好發：英國鬥牛犬、拳師犬、波士頓梗",
      "age": "中老年犬（平均7-15歲）",
      "sex": "雄性犬為雌性的2-3倍",
      "prevalence": "佔犬心臟腫瘤的第二常見（僅次於血管肉瘤）"
    },
    "clinicalPresentation": {
      "symptoms": [
        "運動不耐",
        "呼吸困難",
        "咳嗽",
        "暈厥",
        "腹水",
        "嗜睡",
        "厭食",
        "突然虛脫",
        "頸部腫塊（頸動脈體型）",
        "體重減輕"
      ],
      "physicalExam": [
        "心音減弱（心包積液）",
        "頸靜脈怒張",
        "腹水",
        "肝腫大（右心衰竭）",
        "脈搏減弱",
        "黏膜蒼白或發紺"
      ]
    },
    "pathophysiology": "化學感受器瘤源自副神經節的化學感受器主細胞（chief cells）。短頭犬種因慢性缺氧刺激化學感受器增生，被認為是好發的原因。主動脈體瘤位於主動脈根部和肺動脈之間，可壓迫大血管或侵犯心包膜導致心包積液。腫瘤通常生長緩慢，轉移率約20-30%。",
    "diagnosis": {
      "primary": [
        "胸腔X光（心臟基底部腫塊、心影擴大）",
        "心臟超音波（心包積液、心基底部腫塊）",
        "CT（精確定位和分期）",
        "心包積液細胞學"
      ],
      "differential": [
        "血管肉瘤（右心房）",
        "甲狀腺癌（異位或轉移）",
        "淋巴瘤",
        "心包膜間皮瘤",
        "特發性心包積液"
      ],
      "labFindings": [
        "心包積液通常為血性",
        "細胞學常為非診斷性（反應性間皮細胞為主）",
        "心肌肌鈣蛋白可能升高",
        "ECG可能顯示低電壓或電交替"
      ]
    },
    "treatment": {
      "acute": "心臟壓塞：緊急心包穿刺引流",
      "chronic": "心包切除術可長期控制症狀；腫瘤完全切除通常不可行",
      "medications": [
        "Furosemide（控制充血性心衰竭）",
        "Pimobendan",
        "Toceranib（有限報告）",
        "止痛藥"
      ],
      "surgery": "次全心包切除術（subtotal pericardiectomy）為主要姑息治療；腫瘤根治性切除極少可行因與大血管緊密粘連"
    },
    "prognosis": "化學感受器瘤生長緩慢，心包切除術後中位存活時間約660-730天。未治療者因反覆心臟壓塞預後差。轉移發生緩慢，多數犬死於局部疾病進展而非遠端轉移。",
    "pearls": [
      "短頭犬種出現心包積液，化學感受器瘤應列為首要鑑別診斷",
      "心包積液細胞學通常無法區分化學感受器瘤和血管肉瘤",
      "心包切除術雖為姑息性，但可提供長期的良好生活品質",
      "與血管肉瘤不同，化學感受器瘤生長緩慢，不應因診斷而立即放棄治療"
    ],
    "diagnosticAlgorithm": {
      "title": "化學感受器瘤 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估心臟基底部腫瘤相關症狀，好發於短頭犬品種",
          "findings": [
            "運動不耐或暈厥",
            "呼吸困難",
            "心包積液徵象",
            "短頭犬品種（拳師犬、波士頓㹴等）"
          ]
        },
        {
          "step": 2,
          "action": "心臟超音波",
          "details": "進行心臟超音波評估心臟基底部腫塊",
          "findings": [
            "心臟基底部腫塊（主動脈體或頸動脈體）",
            "心包積液",
            "腫塊與大血管的關係",
            "心臟功能評估"
          ]
        },
        {
          "step": 3,
          "action": "進階影像學",
          "details": "進行CT/MRI精確評估腫瘤範圍",
          "findings": [
            "腫瘤大小和浸潤範圍",
            "與周圍結構的關係",
            "區域淋巴結評估",
            "遠端轉移篩檢"
          ]
        },
        {
          "step": 4,
          "action": "組織病理學確診",
          "details": "手術或活檢取得組織樣本確認診斷",
          "findings": [
            "多角形腫瘤細胞呈巢狀排列",
            "豐富的血管基質",
            "免疫組織化學標記陽性",
            "與甲狀腺腫瘤和淋巴瘤鑑別"
          ]
        }
      ]
    },
    "monitoring": [
      "心臟超音波每3個月追蹤腫瘤大小",
      "評估心衰竭徵象",
      "胸腔X光監測肺轉移",
      "生活品質評估"
    ],
    "reference": "Clinical Veterinary Advisor: Dogs and Cats"
  },
  "mesothelioma": {
    "zh": "間皮瘤",
    "en": "Mesothelioma",
    "definition": "間皮瘤是源自體腔漿膜（胸膜、腹膜、心包膜）間皮細胞的罕見惡性腫瘤。在犬貓中均為罕見腫瘤，以胸膜型最常見。腫瘤呈瀰漫性漿膜面生長，導致大量體腔積液。",
    "synonyms": [
      "間皮細胞瘤",
      "漿膜腫瘤",
      "Malignant mesothelioma"
    ],
    "epidemiology": {
      "species": "犬多於貓，均為罕見",
      "breed": "無明顯品種好發傾向；愛爾蘭雪達犬有個案報告",
      "age": "中老年犬（平均7-14歲）",
      "sex": "雄性犬可能略多",
      "prevalence": "極罕見，犬腫瘤中<0.5%"
    },
    "clinicalPresentation": {
      "symptoms": [
        "呼吸困難（胸膜型）",
        "腹部膨脹（腹膜型）",
        "運動不耐",
        "厭食",
        "體重減輕",
        "嗜睡",
        "咳嗽",
        "嘔吐（腹膜型）",
        "暈厥",
        "心音減弱（心包型）"
      ],
      "physicalExam": [
        "胸腔聽診減弱（積液）",
        "腹部波動感（腹水）",
        "呼吸窘迫",
        "黏膜蒼白",
        "頸靜脈怒張（心包型）",
        "體況評分下降"
      ]
    },
    "pathophysiology": "間皮瘤起源於體腔漿膜面的間皮細胞，呈瀰漫性片狀或結節狀沿漿膜表面生長。與人類不同，犬貓間皮瘤與石棉暴露的關聯性尚未確立。腫瘤可分為上皮型、肉瘤型和混合型。腫瘤廣泛播種於漿膜面，導致大量漿液性或改良型漏出液積聚。遠端轉移較少見，但局部進展迅速。",
    "diagnosis": {
      "primary": [
        "體腔積液細胞學",
        "CT（評估漿膜增厚和結節）",
        "胸腔鏡/腹腔鏡活檢",
        "組織病理學合併免疫組織化學"
      ],
      "differential": [
        "惡性積液（轉移性腺癌）",
        "心衰竭性積液",
        "特發性乳糜胸",
        "膿胸",
        "腹膜轉移性腫瘤（carcinomatosis）",
        "FIP（貓）"
      ],
      "labFindings": [
        "體腔積液：改良型漏出液或滲出液",
        "細胞學：反應性間皮細胞vs.惡性間皮細胞（鑑別困難）",
        "免疫組織化學：Cytokeratin(+)、Vimentin(+)",
        "低白蛋白血症"
      ]
    },
    "treatment": {
      "acute": "胸腔/腹腔穿刺引流緩解呼吸窘迫",
      "chronic": "腔內化療為主要姑息治療方式",
      "medications": [
        "Intracavitary Cisplatin（腔內注射）",
        "Intracavitary Carboplatin",
        "Doxorubicin（全身性）",
        "止痛藥",
        "Piroxicam"
      ],
      "surgery": "瀰漫性生長通常不適合根治性手術；心包切除術可用於心包型"
    },
    "prognosis": "預後謹慎至不良。中位存活時間約3-6個月。腔內Cisplatin化療可能延長存活至6-12個月。完全緩解罕見，治療以控制積液和維持生活品質為目標。",
    "pearls": [
      "反覆引流不乾淨的體腔積液，細胞學呈現異常間皮細胞時要高度懷疑間皮瘤",
      "間皮細胞學上區分反應性增生和惡性極為困難，常需組織活檢合併免疫組化",
      "腔內化療（尤其Cisplatin）對控制積液有較好效果",
      "犬貓間皮瘤不像人類與石棉有明確關聯"
    ],
    "diagnosticAlgorithm": {
      "title": "間皮瘤 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估體腔積液相關症狀",
          "findings": [
            "進行性腹部膨大或呼吸困難",
            "體腔積液（胸腔、腹腔或心包腔）",
            "體重減輕",
            "老年動物多見"
          ]
        },
        {
          "step": 2,
          "action": "積液分析",
          "details": "進行積液採集和細胞學分析",
          "findings": [
            "改良型滲出液或滲出液",
            "間皮細胞顯著增生",
            "反應性與腫瘤性間皮細胞鑑別困難",
            "可能見到異型間皮細胞簇"
          ]
        },
        {
          "step": 3,
          "action": "影像學檢查",
          "details": "排液後進行超音波和/或CT評估",
          "findings": [
            "體腔漿膜面結節或增厚",
            "多發性漿膜腫塊",
            "可能同時累及多個體腔",
            "腫塊與腸系膜或大網膜相連"
          ]
        },
        {
          "step": 4,
          "action": "組織病理學確診",
          "details": "進行漿膜活檢或腹腔鏡/胸腔鏡取樣",
          "findings": [
            "上皮型、肉瘤型或混合型間皮瘤",
            "免疫組織化學輔助鑑別",
            "Calretinin和CK陽性",
            "與轉移性腺癌鑑別"
          ]
        }
      ]
    },
    "monitoring": [
      "體腔積液量和引流頻率",
      "呼吸頻率和努力程度",
      "體重和食慾追蹤",
      "生活品質評估"
    ],
    "reference": "Geriatrics & Gerontology of the Dog and Cat"
  },
  "hemangioma": {
    "zh": "血管瘤",
    "en": "Hemangioma",
    "definition": "血管瘤是源自血管內皮細胞的良性腫瘤，可發生於皮膚、皮下組織或內臟器官。與其惡性對應物血管肉瘤（hemangiosarcoma）不同，血管瘤為良性且手術切除後預後極佳。需注意與血管肉瘤的鑑別。",
    "synonyms": [
      "良性血管瘤",
      "海綿狀血管瘤",
      "毛細血管瘤",
      "Cavernous hemangioma"
    ],
    "epidemiology": {
      "species": "犬多於貓",
      "breed": "犬無明顯品種好發；部分報告指出短毛犬如惠比特犬、義大利灰獵犬皮膚型較常見",
      "age": "中老年犬（平均8-10歲）",
      "sex": "無明顯性別差異",
      "prevalence": "佔犬皮膚腫瘤約0.5-1%；內臟型更為少見"
    },
    "clinicalPresentation": {
      "symptoms": [
        "皮膚紅色或暗紫色腫塊",
        "緩慢生長",
        "通常無痛",
        "偶有出血（表面潰瘍時）",
        "日光暴露部位好發（皮膚型）",
        "腹部器官型可能無症狀",
        "偶因創傷出血發現",
        "單發為主"
      ],
      "physicalExam": [
        "皮膚型：紅色至暗紫色、柔軟、界限清楚的腫塊",
        "壓迫後可能暫時褪色",
        "好發於腹側皮膚、耳廓",
        "通常<2cm",
        "表面偶有潰瘍和痂皮"
      ]
    },
    "pathophysiology": "血管瘤由分化良好的血管內皮細胞構成，形成充滿血液的血管腔隙。根據血管腔大小可分為毛細血管型（小血管腔）和海綿狀型（大血管腔）。皮膚型可能與紫外線暴露有關（日光性血管瘤），尤其在淺色或無毛皮膚。與血管肉瘤不同，血管瘤的內皮細胞無異型性，核分裂少見。",
    "diagnosis": {
      "primary": [
        "組織病理學（確診金標準）",
        "切除活檢",
        "細針抽吸（通常僅得到血液）",
        "超音波（內臟型）"
      ],
      "differential": [
        "血管肉瘤（最重要的鑑別）",
        "血腫",
        "日光性角化症",
        "黑色素瘤",
        "脾臟結節性增生",
        "肥大細胞瘤（皮膚紅色腫塊）"
      ],
      "labFindings": [
        "FNA通常為非診斷性（大量血液稀釋）",
        "組織學：分化良好的血管結構，無異型性",
        "血液學通常正常",
        "內臟型超音波顯示均質高回音結節"
      ]
    },
    "treatment": {
      "acute": "出血時壓迫止血",
      "chronic": "手術切除為標準且通常為治癒性治療",
      "medications": [
        "術後止痛（Meloxicam）",
        "抗生素（若有感染）"
      ],
      "surgery": "手術切除（邊界0.5-1cm）通常即可治癒；皮膚型手術簡單且效果優異"
    },
    "prognosis": "手術切除後預後極佳，復發罕見。關鍵在於與血管肉瘤的準確鑑別——一旦確認為血管瘤，飼主可大幅放心。",
    "pearls": [
      "FNA通常無法區分血管瘤和血管肉瘤——組織病理學是唯一可靠的鑑別方法",
      "淺色皮膚犬腹側的紅色小腫塊常為日光性血管瘤",
      "脾臟結節並非全部為血管肉瘤——約50%為良性（血管瘤或結節性增生）",
      "內臟型血管瘤超音波外觀可能與血管肉瘤相似，手術切除後需病理確認"
    ],
    "diagnosticAlgorithm": {
      "title": "血管瘤 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "檢查皮膚或皮下腫塊特徵",
          "findings": [
            "深紅色或紫色皮膚腫塊",
            "柔軟可壓縮",
            "皮膚型或皮下型",
            "日光誘發型常見於腹部無毛區"
          ]
        },
        {
          "step": 2,
          "action": "細胞學檢查",
          "details": "進行細針抽吸細胞學評估",
          "findings": [
            "抽出血液樣液體",
            "細胞量通常較少",
            "血管內皮細胞散在",
            "需與血管肉瘤鑑別"
          ]
        },
        {
          "step": 3,
          "action": "組織病理學確診",
          "details": "切除活檢進行組織病理學分析",
          "findings": [
            "良性血管內皮增生",
            "管腔形成完整",
            "無細胞異型性",
            "與血管肉瘤（惡性）明確鑑別"
          ]
        }
      ]
    },
    "monitoring": [
      "術後2週傷口追蹤",
      "皮膚型：建議減少日光暴露",
      "內臟型：術後超音波追蹤確認無復發"
    ],
    "reference": "Withrow & MacEwen's Small Animal Clinical Oncology"
  },
  "histiocytic-ulcerative-colitis": {
    "zh": "組織球性潰瘍性結腸炎",
    "en": "Histiocytic Ulcerative Colitis",
    "definition": "組織球性潰瘍性結腸炎（又稱肉芽腫性結腸炎）是一種好發於拳師犬和法國鬥牛犬的特殊型大腸炎症，以結腸黏膜固有層大量PAS陽性組織球浸潤、潰瘍形成和黏膜增厚為特徵。近年研究已確認其病因與黏附侵入性大腸桿菌（AIEC）感染密切相關。",
    "synonyms": [
      "肉芽腫性結腸炎",
      "拳師犬結腸炎",
      "GC",
      "Granulomatous colitis",
      "Boxer colitis"
    ],
    "epidemiology": {
      "species": "犬（貓極罕見）",
      "breed": "拳師犬高度好發；法國鬥牛犬、英國鬥牛犬也有報告",
      "age": "年輕犬好發（通常<4歲發病）",
      "sex": "無明顯性別差異",
      "prevalence": "拳師犬中為最重要的大腸疾病之一"
    },
    "clinicalPresentation": {
      "symptoms": [
        "大腸性腹瀉（頻繁、少量）",
        "血便（鮮血附著於糞便表面）",
        "黏液便",
        "裡急後重",
        "排便困難",
        "體重減輕",
        "厭食",
        "嘔吐（偶見）",
        "漸進性惡化",
        "脫水"
      ],
      "physicalExam": [
        "體況評分下降",
        "脫水徵象",
        "腹部觸診可能有大腸增厚",
        "直腸指檢可觸及增厚黏膜",
        "肛周可能有糞便沾附",
        "黏膜蒼白（慢性失血）"
      ]
    },
    "pathophysiology": "組織球性潰瘍性結腸炎的病因已確認為黏附侵入性大腸桿菌（adherent and invasive E. coli, AIEC）感染。這些細菌侵入結腸黏膜固有層的巨噬細胞內，引發PAS陽性組織球大量浸潤和肉芽腫性炎症反應。拳師犬可能因先天免疫缺陷（如NCF1基因突變影響嗜中性球氧化殺菌功能）而易感。持續的炎症導致黏膜潰瘍、增厚和纖維化。",
    "diagnosis": {
      "primary": [
        "結腸鏡檢查及深部活檢",
        "組織病理學（PAS染色見大量陽性巨噬細胞）",
        "FISH（螢光原位雜交法偵測黏膜內E. coli）",
        "糞便培養"
      ],
      "differential": [
        "發炎性腸病（IBD/淋巴球漿細胞性結腸炎）",
        "腸道淋巴瘤",
        "腸道組織球肉瘤",
        "鞭蟲感染",
        "結腸腺癌",
        "梭菌感染"
      ],
      "labFindings": [
        "組織病理：黏膜固有層大量PAS陽性巨噬細胞",
        "FISH：組織內可見E. coli",
        "低白蛋白血症（嚴重時）",
        "貧血（慢性失血）",
        "糞便培養可分離侵入性E. coli"
      ]
    },
    "treatment": {
      "acute": "脫水和電解質失衡矯正、止血",
      "chronic": "Fluoroquinolone抗生素為主要治療——效果通常顯著",
      "medications": [
        "Enrofloxacin（5 mg/kg PO SID，療程6-8週或更長）",
        "Sulfasalazine（輔助）",
        "Metronidazole（輔助）",
        "益生菌",
        "飲食管理（高消化性或新型蛋白飲食）"
      ],
      "surgery": "通常不需要手術治療"
    },
    "prognosis": "使用Fluoroquinolone治療後預後良好至極佳，多數犬可達到臨床緩解。早期診斷和治療的反應率高。未治療或延誤治療的病例可能出現嚴重的蛋白質流失性腸病。少數病例對抗生素反應不佳。",
    "pearls": [
      "年輕拳師犬出現慢性大腸性腹瀉，首先考慮組織球性潰瘍性結腸炎",
      "PAS染色是診斷關鍵——可見黏膜固有層大量PAS陽性巨噬細胞",
      "Fluoroquinolone是特效治療，對此病的反應通常比一般IBD更為戲劇性",
      "法國鬥牛犬近年報告增多，不再僅限於拳師犬"
    ],
    "diagnosticAlgorithm": {
      "title": "組織球性潰瘍性結腸炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估慢性大腸性腹瀉症狀，常見於年輕拳師犬和法國鬥牛犬",
          "findings": [
            "慢性血便和黏液便",
            "裡急後重和排便頻繁",
            "體重減輕",
            "品種易感性（拳師犬、法鬥等）"
          ]
        },
        {
          "step": 2,
          "action": "實驗室檢查",
          "details": "進行基本血液學和糞便檢查",
          "findings": [
            "低白蛋白血症",
            "貧血",
            "糞便培養排除其他感染",
            "C反應蛋白升高"
          ]
        },
        {
          "step": 3,
          "action": "結腸鏡與活檢",
          "details": "進行結腸鏡檢查和多點活檢",
          "findings": [
            "結腸黏膜潰瘍和出血",
            "黏膜肉芽組織增生",
            "PAS染色陽性的巨噬細胞浸潤",
            "FISH檢測黏膜內E. coli"
          ]
        },
        {
          "step": 4,
          "action": "確診與病原鑑定",
          "details": "透過組織病理學和分子檢測確認診斷",
          "findings": [
            "組織球內含黏膜侵入性大腸桿菌",
            "PAS陽性巨噬細胞為特徵性發現",
            "FISH證實組織內細菌存在",
            "恩諾沙星治療後追蹤確認"
          ]
        }
      ]
    },
    "monitoring": [
      "臨床症狀改善追蹤（糞便性狀、排便頻率）",
      "體重和白蛋白監測",
      "抗生素療程完成後觀察復發",
      "必要時追蹤結腸鏡確認黏膜癒合"
    ],
    "reference": "Clinical Veterinary Advisor: Dogs and Cats"
  },
  "salmonellosis": {
    "zh": "沙門氏菌感染",
    "en": "Salmonellosis",
    "definition": "沙門氏菌感染是由沙門氏菌屬（Salmonella spp.，主要為S. enterica亞種）引起的細菌性感染。犬貓可為無症狀帶原者或出現急性胃腸炎，嚴重者可發展為敗血症。此為重要的人畜共通傳染病（zoonosis）。",
    "synonyms": [
      "沙門桿菌病",
      "沙門菌症",
      "Salmonella infection"
    ],
    "epidemiology": {
      "species": "犬貓均可感染",
      "breed": "無明顯品種好發",
      "age": "幼年、老年或免疫抑制動物症狀較嚴重",
      "sex": "無性別差異",
      "prevalence": "犬無症狀帶原率約1-36%（視族群和檢測方法）；生食飲食犬帶原率更高"
    },
    "clinicalPresentation": {
      "symptoms": [
        "急性水樣腹瀉",
        "血便",
        "嘔吐",
        "發燒",
        "厭食",
        "腹痛",
        "脫水",
        "嗜睡",
        "黏液便",
        "慢性間歇性腹瀉（帶原者偶發）"
      ],
      "physicalExam": [
        "發燒（39.5-41°C）",
        "脫水徵象",
        "腹部觸診疼痛",
        "腸蠕動音增加",
        "黏膜乾燥",
        "心搏過速（脫水/敗血症）"
      ]
    },
    "pathophysiology": "沙門氏菌經口攝入後，侵入小腸和大腸黏膜上皮細胞，利用第三型分泌系統（T3SS）注入效應蛋白觸發細胞內吞。細菌在巨噬細胞內存活並增殖，引發急性炎症反應，導致腸黏膜水腫、潰瘍和分泌性腹瀉。嚴重時細菌穿越腸黏膜屏障進入血流，引起菌血症和敗血症，可能導致多器官感染。",
    "diagnosis": {
      "primary": [
        "糞便細菌培養（金標準）",
        "血液培養（敗血症時）",
        "PCR檢測",
        "糞便直接抹片"
      ],
      "differential": [
        "曲狀桿菌感染",
        "梭菌感染（C. perfringens/C. difficile）",
        "犬細小病毒",
        "犬瘟熱",
        "寄生蟲性腸炎",
        "出血性胃腸炎（HGE）"
      ],
      "labFindings": [
        "糞便培養陽性（特殊培養基：XLD、SS agar）",
        "白血球增多或減少（敗血症時左移）",
        "電解質失衡",
        "低白蛋白血症",
        "代謝性酸中毒"
      ]
    },
    "treatment": {
      "acute": "靜脈輸液矯正脫水和電解質失衡；敗血症時需全身性抗生素",
      "chronic": "無症狀帶原者通常不建議抗生素治療（可能延長排菌時間）",
      "medications": [
        "Enrofloxacin（敗血症時）",
        "Ampicillin（敗血症時）",
        "Metronidazole（輔助）",
        "Maropitant（止吐）",
        "靜脈輸液和電解質補充"
      ],
      "surgery": "通常不需手術"
    },
    "prognosis": "免疫力正常的成年犬貓預後良好，多數自限性。幼年動物、免疫抑制或發展為敗血症者預後謹慎。無症狀帶原者可持續排菌數週至數月。",
    "pearls": [
      "餵食生肉飲食（raw diet）的犬排菌風險顯著增加——飼主諮詢時應告知人畜共通風險",
      "無併發症的沙門氏菌腸炎不建議使用抗生素，以免延長帶原時間和促進抗藥性",
      "免疫抑制犬（化療、使用免疫抑制劑）感染沙門氏菌風險更高",
      "糞便培養陽性的犬貓飼主應加強手部衛生——重要的公共衛生議題"
    ],
    "diagnosticAlgorithm": {
      "title": "沙門氏菌感染 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "收集飲食史和暴露史，評估胃腸道和全身性症狀",
          "findings": [
            "急性水樣或血性腹瀉",
            "發熱和腹痛",
            "嘔吐和脫水",
            "生食餵養或接觸受汙染食物史"
          ]
        },
        {
          "step": 2,
          "action": "實驗室檢查",
          "details": "進行全血計數和生化檢查評估全身狀態",
          "findings": [
            "白血球減少或增多",
            "嗜中性球左移",
            "低白蛋白血症",
            "電解質紊亂"
          ]
        },
        {
          "step": 3,
          "action": "細菌培養與鑑定",
          "details": "進行糞便和/或血液培養確認沙門氏菌",
          "findings": [
            "糞便培養分離出沙門氏菌",
            "血液培養陽性（敗血症病例）",
            "血清型鑑定",
            "抗生素藥敏試驗"
          ]
        },
        {
          "step": 4,
          "action": "併發症評估",
          "details": "評估是否有全身性播散或敗血症",
          "findings": [
            "敗血症指標監測",
            "腹部超音波排除腹膜炎",
            "關節液分析（敗血性關節炎風險）",
            "公共衛生風險評估"
          ]
        }
      ]
    },
    "monitoring": [
      "脫水狀態和電解質",
      "糞便培養追蹤（是否持續排菌）",
      "抗藥性檢測（選擇適當抗生素）",
      "家中免疫低下成員的健康狀況"
    ],
    "reference": "Pathologic Basis of Veterinary Disease"
  },
  "campylobacteriosis": {
    "zh": "曲狀桿菌感染",
    "en": "Campylobacteriosis",
    "definition": "曲狀桿菌感染是由曲狀桿菌屬（Campylobacter spp.，主要為C. jejuni和C. coli）引起的細菌性腸道感染。犬貓可為無症狀帶原者或出現水樣至黏液血性腹瀉。為重要的人畜共通傳染病。",
    "synonyms": [
      "彎曲桿菌感染",
      "彎曲菌症",
      "Campylobacter enteritis"
    ],
    "epidemiology": {
      "species": "犬貓均常見",
      "breed": "無品種好發",
      "age": "幼犬幼貓和年輕犬貓（<6個月）症狀較明顯",
      "sex": "無性別差異",
      "prevalence": "犬帶原率約5-45%（幼犬和收容所犬較高）；貓帶原率約10-25%"
    },
    "clinicalPresentation": {
      "symptoms": [
        "水樣腹瀉",
        "黏液血便",
        "裡急後重",
        "腹痛",
        "發燒（輕度）",
        "嘔吐",
        "厭食",
        "脫水",
        "腹部絞痛",
        "自限性（多數5-15天）"
      ],
      "physicalExam": [
        "輕度脫水",
        "腹部觸診輕度疼痛",
        "肛周糞便沾附",
        "體溫正常或輕度升高",
        "腸蠕動音活躍"
      ]
    },
    "pathophysiology": "Campylobacter經糞口途徑傳播，定殖於小腸和大腸黏膜。細菌產生細胞致死膨脹毒素（CDT）和其他毒力因子，破壞腸上皮細胞間的緊密連接，導致發炎性和分泌性腹瀉。幼年動物因腸道免疫尚未成熟而症狀較嚴重。成年免疫正常動物常為無症狀帶原。",
    "diagnosis": {
      "primary": [
        "糞便細菌培養（需特殊微需氧培養條件，42°C）",
        "糞便PCR",
        "糞便暗視野顯微鏡（典型海鷗翅膀形態）",
        "抗原快篩試劑"
      ],
      "differential": [
        "沙門氏菌感染",
        "梭菌感染",
        "犬細小病毒",
        "鉤蟲感染",
        "鞭蟲感染",
        "食物不耐受性腹瀉"
      ],
      "labFindings": [
        "培養：微需氧環境42°C生長",
        "暗視野：細長S形或海鷗翅形革蘭氏陰性菌",
        "血液學通常正常或輕度白血球增多",
        "電解質可能因腹瀉失衡"
      ]
    },
    "treatment": {
      "acute": "輕症以支持療法和輸液為主",
      "chronic": "持續症狀或幼年動物可考慮抗生素",
      "medications": [
        "Erythromycin（25-50 mg/kg/day，分3次，7-10天）",
        "Azithromycin（替代選擇）",
        "Metronidazole（輔助）",
        "Maropitant（止吐）",
        "口服或靜脈輸液"
      ],
      "surgery": "不需手術"
    },
    "prognosis": "免疫正常成年犬貓預後極佳，多為自限性。幼年動物適當治療後預後良好。嚴重脫水或敗血症者預後謹慎。",
    "pearls": [
      "幼犬腹瀉不要只想到Parvo——Campylobacter在收容所幼犬中非常常見",
      "糞便培養需特殊條件（微需氧、42°C），一般培養可能漏診",
      "治療前應考慮是否真正致病還是僅為帶原——成年免疫正常犬帶原不一定需要治療",
      "重要人畜共通傳染病——幼兒和免疫低下飼主需特別注意衛生"
    ],
    "diagnosticAlgorithm": {
      "title": "曲狀桿菌感染 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "收集病史，評估腹瀉特徵和暴露風險",
          "findings": [
            "水樣至黏液性腹瀉",
            "可能含血",
            "幼齡動物或免疫抑制動物多見",
            "犬舍或收容所環境"
          ]
        },
        {
          "step": 2,
          "action": "糞便檢查",
          "details": "進行糞便直接塗片和培養",
          "findings": [
            "暗視野或相差顯微鏡下見典型螺旋形運動",
            "糞便PCR檢測Campylobacter spp.",
            "糞便培養需微好氧條件",
            "42°C培養有助於C. jejuni分離"
          ]
        },
        {
          "step": 3,
          "action": "種別鑑定",
          "details": "進行分子生物學鑑定確認菌種",
          "findings": [
            "PCR鑑定C. jejuni或C. coli",
            "抗生素藥敏試驗",
            "排除同時存在的其他腸道病原",
            "評估人畜共通傳播風險"
          ]
        }
      ]
    },
    "monitoring": [
      "腹瀉症狀和脫水狀態",
      "幼年動物體重追蹤",
      "糞便品質改善評估",
      "家中成員健康狀況（人畜共通風險）"
    ],
    "reference": "Clinical Veterinary Advisor: Dogs and Cats"
  },
  "hemotropic-mycoplasma": {
    "zh": "嗜血性黴漿菌感染",
    "en": "Hemotropic Mycoplasma Infection (Hemoplasma)",
    "definition": "嗜血性黴漿菌（hemoplasma）感染是由附著於紅血球表面的黴漿菌引起的溶血性疾病。貓的主要病原為M. haemofelis（貓血巴東體）和'Candidatus M. haemominutum'；犬為M. haemocanis。感染可導致嚴重的免疫介導性溶血性貧血。",
    "synonyms": [
      "血巴東體感染",
      "貓血巴東體症",
      "Feline hemoplasma",
      "Haemobartonellosis",
      "貓傳染性貧血"
    ],
    "epidemiology": {
      "species": "貓多於犬（犬多為免疫抑制後發病）",
      "breed": "無明顯品種好發",
      "age": "任何年齡，但年輕公貓（戶外活動）較多",
      "sex": "雄性略多（與打架傳播有關）",
      "prevalence": "貓帶原率因地區和族群而異，約5-30%（PCR檢測）"
    },
    "clinicalPresentation": {
      "symptoms": [
        "貧血（蒼白黏膜）",
        "嗜睡",
        "厭食",
        "體重減輕",
        "發燒",
        "脾腫大",
        "黃疸",
        "呼吸急促",
        "運動不耐",
        "脫水",
        "間歇性發病"
      ],
      "physicalExam": [
        "黏膜蒼白",
        "黃疸（黏膜和皮膚）",
        "心搏過速",
        "收縮期心雜音（貧血性）",
        "脾腫大",
        "發燒（39.5-41°C）"
      ]
    },
    "pathophysiology": "嗜血性黴漿菌經跳蚤叮咬或直接血液接觸（打架、輸血）傳播。病原體附著於紅血球表面，導致紅血球膜損傷。受損的紅血球被脾臟巨噬細胞辨識並清除（血管外溶血），同時可誘發繼發性免疫介導性溶血。貓若同時感染FeLV或FIV，疾病嚴重度顯著增加。病原體呈周期性菌血症，血抹片陽性率波動大。",
    "diagnosis": {
      "primary": [
        "PCR檢測（金標準，靈敏度最高）",
        "血液抹片（紅血球表面可見小體，但敏感度低）",
        "CBC（再生性貧血）",
        "FeLV/FIV篩檢（排除共感染）"
      ],
      "differential": [
        "免疫介導性溶血性貧血（IMHA）",
        "FeLV相關貧血",
        "Babesia感染",
        "Cytauxzoon felis感染",
        "洋蔥/大蒜中毒",
        "Heinz body貧血"
      ],
      "labFindings": [
        "再生性貧血（網織紅血球增多）",
        "球形紅血球增多（繼發性IMHA）",
        "膽紅素升高",
        "Coombs test可能陽性",
        "血液抹片可見紅血球表面附著的小球形至環形微生物"
      ]
    },
    "treatment": {
      "acute": "嚴重貧血（PCV<15%）需輸血；同時開始抗生素治療",
      "chronic": "Doxycycline療程至少28天",
      "medications": [
        "Doxycycline（10 mg/kg PO SID，28天）",
        "Prednisolone（若繼發IMHA，2 mg/kg/day漸減）",
        "Marbofloxacin（替代選擇）",
        "跳蚤預防（Fipronil等）"
      ],
      "surgery": "不需手術（脾臟切除會加重感染，禁忌）"
    },
    "prognosis": "M. haemofelis感染適當治療後預後良好，但可能成為慢性帶原者。'Ca. M. haemominutum'致病力較低，單獨感染通常亞臨床。FeLV/FIV共感染者預後較差。犬的M. haemocanis主要在脾臟切除或免疫抑制犬發病。",
    "pearls": [
      "貧血貓一定要做FeLV/FIV篩檢和血液抹片——hemoplasma常與反轉錄病毒共感染",
      "血液抹片敏感度僅約20-50%，陰性不能排除——PCR是確診首選",
      "Doxycycline可降低菌量但通常無法完全清除感染——多數貓成為慢性帶原者",
      "脾臟切除犬出現貧血應考慮M. haemocanis重新活化"
    ],
    "diagnosticAlgorithm": {
      "title": "嗜血性黴漿菌感染 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估貧血相關症狀和風險因子",
          "findings": [
            "蒼白黏膜和虛弱",
            "發熱",
            "脾臟腫大",
            "外寄生蟲暴露史或免疫抑制"
          ]
        },
        {
          "step": 2,
          "action": "血液學檢查",
          "details": "進行全血計數和血液抹片檢查",
          "findings": [
            "再生性溶血性貧血",
            "球形紅血球增多",
            "網狀紅血球增加",
            "血液抹片可能見到紅血球表面小體（敏感度低）"
          ]
        },
        {
          "step": 3,
          "action": "分子診斷",
          "details": "進行PCR檢測確認嗜血性黴漿菌感染",
          "findings": [
            "PCR檢測M. haemofelis（貓）或M. haemocanis（犬）陽性",
            "定量PCR評估菌血程度",
            "Coombs試驗可能陽性",
            "排除FeLV/FIV合併感染（貓）"
          ]
        },
        {
          "step": 4,
          "action": "基礎疾病排查",
          "details": "評估免疫抑制或其他促發因子",
          "findings": [
            "FeLV/FIV篩檢（貓）",
            "脾臟切除史",
            "免疫抑制藥物使用",
            "合併感染評估"
          ]
        }
      ]
    },
    "monitoring": [
      "PCV/網織紅血球每週追蹤直至穩定",
      "治療後PCR追蹤（評估帶原狀態）",
      "FeLV/FIV狀態追蹤",
      "跳蚤防治確認"
    ],
    "reference": "BSAVA Manual of Canine and Feline Haematology and Transfusion Medicine"
  },
  "yersiniosis": {
    "zh": "耶爾森菌感染",
    "en": "Yersiniosis",
    "definition": "耶爾森菌感染是由耶爾森菌屬（Yersinia spp.，主要為Y. enterocolitica和Y. pseudotuberculosis）引起的細菌性感染。在犬貓中為相對少見的消化道病原，可導致急性腸炎和腸繫膜淋巴結炎，為人畜共通傳染病。",
    "synonyms": [
      "假結核耶爾森菌感染",
      "小腸結腸炎耶爾森菌感染",
      "Yersinia infection"
    ],
    "epidemiology": {
      "species": "犬貓均可感染，臨床病例少見",
      "breed": "無品種好發",
      "age": "幼年和免疫抑制動物較易發病",
      "sex": "無性別差異",
      "prevalence": "不常見；流行病學資料有限，推估帶原率低(<5%)"
    },
    "clinicalPresentation": {
      "symptoms": [
        "急性腹瀉",
        "水樣便或黏液便",
        "腹痛",
        "發燒",
        "厭食",
        "嘔吐",
        "脫水",
        "淋巴結腫大（腸繫膜）",
        "慢性消化不良（少見）",
        "體重減輕"
      ],
      "physicalExam": [
        "腹部觸診疼痛",
        "腸繫膜淋巴結可能腫大（超音波）",
        "輕度脫水",
        "發燒",
        "腸蠕動增加"
      ]
    },
    "pathophysiology": "Y. enterocolitica和Y. pseudotuberculosis經糞口途徑傳播，主要透過受污染的水源或食物（豬肉為重要來源）。細菌在小腸和近端結腸定殖，穿越M細胞侵入Peyer's patches和腸繫膜淋巴結。細菌利用第三型分泌系統注入Yop蛋白，抑制宿主吞噬作用和發炎反應。可導致腸壁肉芽腫性炎症和淋巴結膿瘍形成。",
    "diagnosis": {
      "primary": [
        "糞便細菌培養（需冷增菌法提高陽性率）",
        "PCR檢測",
        "腹部超音波（腸繫膜淋巴結腫大）",
        "血液培養（敗血症時）"
      ],
      "differential": [
        "沙門氏菌感染",
        "曲狀桿菌感染",
        "腸道淋巴瘤",
        "腸結核",
        "發炎性腸病",
        "鞭蟲感染"
      ],
      "labFindings": [
        "糞便培養：冷增菌（4°C培養2-3週）可提高陽性率",
        "白血球增多伴左移",
        "CRP升高",
        "超音波見腸繫膜淋巴結腫大"
      ]
    },
    "treatment": {
      "acute": "輸液矯正脫水、抗生素治療",
      "chronic": "療程通常7-14天",
      "medications": [
        "Trimethoprim-Sulfonamide（15 mg/kg BID）",
        "Enrofloxacin",
        "Doxycycline",
        "Gentamicin（嚴重敗血症時）",
        "輸液和電解質補充"
      ],
      "surgery": "通常不需手術；罕見情況下腸繫膜淋巴結膿瘍可能需要引流"
    },
    "prognosis": "免疫正常動物適當治療後預後良好。嚴重敗血症或免疫抑制動物預後謹慎。多數犬貓可完全恢復。",
    "pearls": [
      "Yersiniosis在犬貓中常被低估——常規糞便培養條件下可能漏診",
      "冷增菌法（4°C長期培養）是提高培養陽性率的關鍵技術",
      "腸繫膜淋巴結明顯腫大伴腹瀉時要考慮Yersinia（類似人類的『假性闌尾炎』表現）",
      "人畜共通風險——提醒飼主避免餵食生豬肉"
    ],
    "diagnosticAlgorithm": {
      "title": "耶爾森菌感染 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "收集暴露史和胃腸道症狀",
          "findings": [
            "急性腹瀉（可能血性）",
            "嘔吐和腹痛",
            "發熱",
            "接觸受汙染食物或水源"
          ]
        },
        {
          "step": 2,
          "action": "實驗室檢查",
          "details": "進行血液學和糞便檢查",
          "findings": [
            "白血球增多伴左移",
            "糞便可見紅血球和白血球",
            "急性期反應蛋白升高",
            "生化評估脫水和電解質狀態"
          ]
        },
        {
          "step": 3,
          "action": "細菌培養與確診",
          "details": "進行糞便培養鑑定耶爾森菌",
          "findings": [
            "冷增菌培養提高檢出率",
            "Y. enterocolitica或Y. pseudotuberculosis分離",
            "PCR快速鑑定",
            "藥敏試驗指導治療"
          ]
        }
      ]
    },
    "monitoring": [
      "腹瀉症狀改善追蹤",
      "體溫監測",
      "脫水矯正評估",
      "人畜共通風險衛教"
    ],
    "reference": "Clinical Veterinary Advisor: Dogs and Cats"
  },
  "streptococcal-infection": {
    "zh": "鏈球菌感染",
    "en": "Streptococcal Infection",
    "definition": "鏈球菌感染是由鏈球菌屬（Streptococcus spp.）引起的細菌性感染。犬貓常見的致病種包括S. canis（最常見）、S. equi subsp. zooepidemicus和GBS。可引起多種臨床表現，從皮膚感染到敗血症和壞死性筋膜炎。",
    "synonyms": [
      "鏈球菌症",
      "鏈球菌病",
      "Strep infection"
    ],
    "epidemiology": {
      "species": "犬貓均可感染",
      "breed": "無明顯品種好發；收容所犬群聚感染較多",
      "age": "幼年動物和老年免疫抑制動物風險較高",
      "sex": "無性別差異",
      "prevalence": "S. canis為犬貓正常口腔和皮膚菌群的一部分，伺機性感染"
    },
    "clinicalPresentation": {
      "symptoms": [
        "皮膚膿瘍",
        "蜂窩性組織炎",
        "發燒",
        "嗜睡",
        "厭食",
        "關節腫痛（化膿性關節炎）",
        "呼吸困難（肺炎時）",
        "子宮蓄膿",
        "泌尿道感染",
        "新生兒敗血症",
        "壞死性筋膜炎（S. equi zooepidemicus）"
      ],
      "physicalExam": [
        "發燒（39.5-41°C）",
        "局部紅腫熱痛（皮膚感染）",
        "關節腫脹和疼痛",
        "淋巴結腫大",
        "心雜音（心內膜炎時）",
        "漿液性或膿性分泌物"
      ]
    },
    "pathophysiology": "鏈球菌透過皮膚傷口、呼吸道或黏膜侵入。S. canis產生多種毒力因子，包括M蛋白（抗吞噬）、溶血素（streptolysin）、透明質酸酶和鏈激酶。這些因子幫助細菌逃避免疫系統、破壞組織屏障和促進擴散。嚴重感染可導致毒性休克樣症候群（Streptococcal Toxic Shock Syndrome）。S. equi subsp. zooepidemicus在犬可引起出血性肺炎和壞死性筋膜炎的爆發。",
    "diagnosis": {
      "primary": [
        "細菌培養和藥敏試驗",
        "血液培養（敗血症時）",
        "感染部位抹片革蘭氏染色",
        "PCR（菌種鑑定）"
      ],
      "differential": [
        "葡萄球菌感染",
        "巴氏桿菌感染",
        "大腸桿菌感染",
        "厭氧菌感染",
        "黴菌感染",
        "免疫介導性多發性關節炎（化膿性關節炎的鑑別）"
      ],
      "labFindings": [
        "培養：beta溶血性、Lancefield分群",
        "革蘭氏染色：鏈狀排列的革蘭氏陽性球菌",
        "白血球增多伴左移",
        "CRP顯著升高",
        "敗血症時血液培養陽性"
      ]
    },
    "treatment": {
      "acute": "敗血症或壞死性筋膜炎需積極靜脈抗生素和支持療法",
      "chronic": "根據培養結果選擇適當抗生素，療程依感染部位而定",
      "medications": [
        "Amoxicillin-Clavulanate（首選）",
        "Ampicillin（靜脈注射，重症）",
        "Cephalexin",
        "Clindamycin（骨骼或深部感染）",
        "Penicillin G（靜脈注射）"
      ],
      "surgery": "膿瘍引流；壞死性筋膜炎需積極清創；化膿性關節炎需關節灌洗"
    },
    "prognosis": "局限性皮膚感染預後良好。化膿性關節炎適當治療後預後中等。壞死性筋膜炎和敗血症預後謹慎至不良。新生兒敗血症死亡率高。",
    "pearls": [
      "S. canis對Penicillin類抗生素通常高度敏感——是治療首選",
      "S. equi subsp. zooepidemicus在收容所犬群可引起爆發性出血性肺炎，致死率高",
      "犬的化膿性關節炎最常見病原之一即為鏈球菌——關節液需送培養",
      "新生犬敗血症中鏈球菌是重要病原——母犬產道感染可垂直傳播"
    ],
    "diagnosticAlgorithm": {
      "title": "鏈球菌感染 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估感染部位和嚴重程度",
          "findings": [
            "皮膚軟組織感染",
            "發熱與全身性炎症",
            "新生幼犬敗血症",
            "呼吸道或泌尿道感染"
          ]
        },
        {
          "step": 2,
          "action": "實驗室檢查",
          "details": "進行全血計數和炎症指標檢查",
          "findings": [
            "白血球增多伴嗜中性球增多",
            "左移",
            "C反應蛋白升高",
            "纖維蛋白原升高"
          ]
        },
        {
          "step": 3,
          "action": "細菌培養與鑑定",
          "details": "從感染部位採樣進行細菌培養",
          "findings": [
            "血液或病灶培養分離鏈球菌",
            "溶血類型鑑定（α、β、γ）",
            "Lancefield分群",
            "抗生素藥敏試驗"
          ]
        },
        {
          "step": 4,
          "action": "感染源與併發症評估",
          "details": "評估感染來源和可能的併發症",
          "findings": [
            "傷口或手術部位感染源",
            "心內膜炎風險評估",
            "腎小球腎炎篩檢",
            "多部位感染評估"
          ]
        }
      ]
    },
    "monitoring": [
      "感染指標（WBC、CRP）追蹤",
      "抗生素療程足夠（通常至少14-21天）",
      "化膿性關節炎需追蹤關節液改善",
      "收容所爆發需隔離和環境消毒"
    ],
    "reference": "Canine and Feline Infectious Diseases"
  },
  "helicobacter-infection": {
    "zh": "螺旋桿菌感染",
    "en": "Helicobacter Infection",
    "definition": "螺旋桿菌感染是由螺旋桿菌屬（Helicobacter spp.）引起的胃部感染。犬貓胃中常見多種Helicobacter species（如H. felis、H. bizzozeronii、H. heilmannii），與人類的H. pylori不同。其在犬貓的致病角色仍有爭議，因為健康動物帶原率也很高。",
    "synonyms": [
      "幽門螺旋桿菌感染",
      "胃螺旋菌感染",
      "Gastric Helicobacter infection"
    ],
    "epidemiology": {
      "species": "犬貓均非常常見",
      "breed": "無品種好發",
      "age": "任何年齡；帶原率隨年齡增加",
      "sex": "無性別差異",
      "prevalence": "犬貓胃黏膜Helicobacter spp.帶原率極高（67-100%），但臨床意義尚有爭議"
    },
    "clinicalPresentation": {
      "symptoms": [
        "慢性間歇性嘔吐",
        "食慾不振",
        "噯氣",
        "流涎",
        "腹部不適",
        "體重減輕（慢性時）",
        "嘔吐物可含膽汁或鮮血",
        "草食行為增加",
        "多數犬貓無症狀帶原"
      ],
      "physicalExam": [
        "通常無特異性發現",
        "輕度脫水（頻繁嘔吐時）",
        "腹部觸診可能有輕度不適",
        "體況正常或輕度下降"
      ]
    },
    "pathophysiology": "犬貓的胃Helicobacter spp.定殖於胃黏膜表面和胃腺深處。這些細菌產生尿素酶，分解尿素產生氨以中和局部胃酸，創造有利的微環境。細菌可能引起淋巴球漿細胞性胃炎和淋巴濾泡增生。然而，與人類H. pylori不同，犬貓Helicobacter的致病角色尚未完全確立——大量健康動物也有感染。可能在某些易感個體中作為胃炎和消化性疾病的共同因子。",
    "diagnosis": {
      "primary": [
        "胃鏡檢查及活檢（Warthin-Starry銀染色或H&E）",
        "快速尿素酶試驗（胃活檢組織）",
        "胃活檢組織PCR",
        "胃活檢壓片細胞學"
      ],
      "differential": [
        "食物不耐受/食物過敏",
        "發炎性腸病（IBD）",
        "胃異物",
        "慢性胰臟炎",
        "腎臟疾病",
        "胃腫瘤（淋巴瘤、腺癌）"
      ],
      "labFindings": [
        "胃活檢：黏膜固有層淋巴球漿細胞浸潤和淋巴濾泡增生",
        "銀染色或Giemsa染色見大型螺旋狀細菌",
        "快速尿素酶試驗陽性",
        "血液學通常正常"
      ]
    },
    "treatment": {
      "acute": "對症止吐和保護胃黏膜",
      "chronic": "三聯療法（Triple therapy）用於臨床上懷疑Helicobacter致病的病例",
      "medications": [
        "Amoxicillin（20 mg/kg BID）",
        "Metronidazole（15 mg/kg BID）",
        "Omeprazole（1 mg/kg SID）",
        "Clarithromycin（替代Metronidazole）",
        "Bismuth subsalicylate（輔助）"
      ],
      "surgery": "不需手術"
    },
    "prognosis": "治療後根除率約50-90%，但高復發/再感染率。部分動物治療後臨床症狀改善，但也有動物根除後症狀無變化。預後取決於Helicobacter是否為症狀的真正原因。",
    "pearls": [
      "犬貓Helicobacter帶原率極高，陽性結果不等於致病原因——需排除其他嘔吐原因後再歸因",
      "治療前應完善胃鏡評估，因為胃淋巴瘤等嚴重疾病可能表現類似",
      "三聯療法療程通常14天，需飼主良好配合",
      "Helicobacter spp.具有人畜共通潛力——免疫低下飼主應注意"
    ],
    "diagnosticAlgorithm": {
      "title": "螺旋桿菌感染 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估上消化道症狀",
          "findings": [
            "慢性間歇性嘔吐",
            "食慾不振",
            "噯氣或流涎",
            "體重減輕（嚴重病例）"
          ]
        },
        {
          "step": 2,
          "action": "胃鏡檢查",
          "details": "進行上消化道內視鏡檢查和胃黏膜活檢",
          "findings": [
            "胃黏膜充血或糜爛",
            "多點胃黏膜活檢取樣",
            "胃液pH值測定",
            "胃竇和胃體多點取樣"
          ]
        },
        {
          "step": 3,
          "action": "病原體鑑定",
          "details": "對活檢樣本進行螺旋桿菌檢測",
          "findings": [
            "組織學Warthin-Starry銀染色見螺旋形菌",
            "快速尿素酶試驗陽性",
            "PCR鑑定Helicobacter種",
            "多數犬貓胃內有Helicobacter定殖但致病意義不明"
          ]
        }
      ]
    },
    "monitoring": [
      "嘔吐頻率和症狀改善追蹤",
      "治療4-8週後可考慮追蹤胃鏡評估",
      "體重和食慾監測",
      "長期復發率評估"
    ],
    "reference": "Blackwell's Five-Minute Veterinary Consult"
  },
  "encephalitozoonosis": {
    "zh": "腦炎微孢子蟲感染",
    "en": "Encephalitozoonosis",
    "definition": "腦炎微孢子蟲感染是由Encephalitozoon cuniculi引起的微孢子蟲感染症。E. cuniculi為專性細胞內寄生蟲，主要宿主為兔，但可感染犬貓等多種哺乳動物。感染主要影響腎臟、腦和眼睛，尤其在免疫抑制動物中可造成嚴重的肉芽腫性腦炎和腎炎。",
    "synonyms": [
      "兔腦炎微孢子蟲症",
      "E. cuniculi感染",
      "Microsporidiosis"
    ],
    "epidemiology": {
      "species": "兔為主要宿主；犬（尤其幼犬）可感染；貓少見",
      "breed": "犬無明顯品種好發",
      "age": "幼犬（<3個月）和免疫抑制犬較易發病",
      "sex": "無性別差異",
      "prevalence": "兔帶原率可達50%以上；犬的臨床感染罕見"
    },
    "clinicalPresentation": {
      "symptoms": [
        "神經症狀（共濟失調、頭歪、眼球震顫）",
        "腎衰竭（多飲多尿）",
        "白內障（水晶體破裂性葡萄膜炎）",
        "後肢無力或癱瘓",
        "行為改變",
        "癲癇發作",
        "厭食",
        "體重減輕",
        "眼內炎",
        "嗜睡"
      ],
      "physicalExam": [
        "前庭症狀（頭歪、眼球震顫）",
        "共濟失調",
        "後肢本體感覺缺失",
        "白內障（兔常見）",
        "腎臟觸診可能腫大並不規則",
        "體況評分下降"
      ]
    },
    "pathophysiology": "E. cuniculi孢子經口或吸入感染後，在腸道被吸收進入血流，播散至腎臟、腦和眼等靶器官。孢子在靶器官細胞內增殖，形成特徵性肉芽腫性炎症反應。腎臟內形成慢性間質性腎炎和纖維化；腦部以肉芽腫性腦炎為主，影響腦幹和小腦導致前庭症狀；眼部侵犯水晶體導致晶狀體誘發性葡萄膜炎。免疫抑制時病原體大量增殖導致嚴重臨床病。",
    "diagnosis": {
      "primary": [
        "血清抗體檢測（IFA或ELISA）",
        "尿液PCR（孢子排出）",
        "腦脊液分析",
        "MRI（腦部病變評估）"
      ],
      "differential": [
        "犬瘟熱（腦炎）",
        "弓形蟲感染",
        "隱球菌感染",
        "前庭疾病（中耳炎）",
        "腦膜腦炎（GME/NME）",
        "腎臟疾病其他原因"
      ],
      "labFindings": [
        "血清IgG抗體陽性（高效價提示活躍感染）",
        "尿PCR可偵測孢子排出",
        "CSF：輕度蛋白質升高和單核細胞增多",
        "BUN/Creatinine升高（腎臟受累）",
        "組織病理：肉芽腫性炎症伴微孢子蟲"
      ]
    },
    "treatment": {
      "acute": "支持療法：靜脈輸液、抗癲癇藥（若有癲癇）",
      "chronic": "長期抗微孢子蟲藥物治療",
      "medications": [
        "Fenbendazole（20 mg/kg PO SID，28天或更長）",
        "Albendazole（替代選擇，注意骨髓抑制風險）",
        "Dexamethasone（減少腦部炎症）",
        "抗癲癇藥（Levetiracetam）",
        "輸液（腎功能支持）"
      ],
      "surgery": "白內障：水晶體摘除術（phacoemulsification）可用於兔的眼部病變"
    },
    "prognosis": "預後取決於感染的器官系統和免疫狀態。輕度腎臟受累者治療後可穩定。嚴重神經症狀者預後謹慎至不良。免疫抑制動物預後差。兔適當治療後預後中等。",
    "pearls": [
      "與兔共養的犬貓出現神經症狀時應考慮E. cuniculi感染",
      "血清抗體陽性不等於臨床疾病——很多動物為無症狀帶原",
      "Fenbendazole是目前最被接受的治療選擇，療程需足夠長（至少28天）",
      "此為人畜共通傳染病，免疫抑制人群（HIV患者等）需特別注意"
    ],
    "diagnosticAlgorithm": {
      "title": "腦炎微孢子蟲感染 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估神經系統和腎臟症狀，常見於兔但也可感染犬",
          "findings": [
            "頭部傾斜和眼球震顫",
            "後肢無力或癱瘓",
            "腎功能不全",
            "白內障或虹膜炎"
          ]
        },
        {
          "step": 2,
          "action": "血清學檢查",
          "details": "進行E. cuniculi抗體檢測",
          "findings": [
            "IgG抗體效價升高",
            "IgM陽性提示活動性感染",
            "配對血清效價上升有意義",
            "單次高效價需結合臨床判斷"
          ]
        },
        {
          "step": 3,
          "action": "輔助檢查",
          "details": "進行尿液檢查和影像學評估",
          "findings": [
            "尿液PCR可能檢出孢子",
            "尿液鏡檢可見微孢子蟲孢子",
            "MRI可能見腦部肉芽腫性病變",
            "腎臟超音波可見腎皮質病變"
          ]
        },
        {
          "step": 4,
          "action": "確診",
          "details": "綜合血清學、PCR和臨床表現確診",
          "findings": [
            "確定性診斷需組織病理學",
            "腎臟或腦組織內見微孢子蟲",
            "Gram染色陽性孢子",
            "治療性診斷（fenbendazole反應）"
          ]
        }
      ]
    },
    "monitoring": [
      "神經症狀改善評估",
      "腎功能追蹤",
      "尿PCR追蹤孢子排出",
      "抗體效價變化"
    ],
    "reference": "Fowler's Zoo and Wild Animal Medicine"
  },
  "canine-herpesvirus": {
    "zh": "犬疱疹病毒感染",
    "en": "Canine Herpesvirus Infection (CHV-1)",
    "definition": "犬疱疹病毒感染是由犬疱疹病毒第一型（Canine Herpesvirus-1, CHV-1）引起的感染症。對新生幼犬（<3週齡）可導致致命性的全身性出血壞死性疾病，是新生幼犬死亡的重要原因之一（fading puppy syndrome）。成犬感染通常為亞臨床或輕度呼吸道症狀。",
    "synonyms": [
      "犬疱疹病毒病",
      "CHV-1感染",
      "幼犬衰弱症候群",
      "Fading puppy syndrome"
    ],
    "epidemiology": {
      "species": "犬",
      "breed": "所有品種均可感染",
      "age": "新生幼犬（<3週齡）最嚴重；成犬多為亞臨床",
      "sex": "無性別差異",
      "prevalence": "犬族群血清陽性率約20-80%（因地區而異）；為重要的繁殖場疾病"
    },
    "clinicalPresentation": {
      "symptoms": [
        "新生幼犬：突然厭食",
        "虛弱哀嚎",
        "腹部疼痛",
        "糞便黃綠色或出血",
        "鼻腔漿液性分泌物",
        "呼吸困難",
        "低體溫",
        "急速惡化死亡（24-48小時內）",
        "成犬：輕度鼻炎、陰道/包皮水泡",
        "母犬：流產或死產"
      ],
      "physicalExam": [
        "新生幼犬：低體溫（<36°C）",
        "腹部膨脹和疼痛",
        "黏膜出血點",
        "呼吸窘迫",
        "全身無力",
        "成犬：陰道/包皮黏膜小水泡",
        "鼻腔輕度充血"
      ]
    },
    "pathophysiology": "CHV-1是Alpha-herpesvirus，對溫度敏感——在39°C增殖受抑制而在35-36°C增殖良好。這解釋了新生幼犬（體溫調節能力差，體溫較低）為何特別易感。病毒經鼻口或陰道接觸傳播，也可經胎盤垂直傳播。在新生幼犬體內，病毒在低體溫的環境下大量複製，造成腎臟、肝臟、肺臟、腎上腺的瀰漫性壞死和出血。成犬感染後病毒潛伏於三叉神經節和腰薦神經節，可在緊迫時重新活化。",
    "diagnosis": {
      "primary": [
        "屍檢和組織病理學（特徵性多器官出血壞死）",
        "PCR檢測（組織或拭子）",
        "病毒分離培養",
        "血清學（配對血清）"
      ],
      "differential": [
        "犬細小病毒（新生幼犬）",
        "細菌性敗血症",
        "弓形蟲感染",
        "犬瘟熱",
        "新生兒溶血",
        "犬布魯氏菌感染（流產）"
      ],
      "labFindings": [
        "屍檢：腎臟特徵性多焦點出血壞死斑（pathognomonic）",
        "組織病理：嗜酸性核內包涵體",
        "PCR陽性（組織、口鼻拭子）",
        "肝酶升高",
        "血小板減少（DIC）"
      ]
    },
    "treatment": {
      "acute": "新生幼犬：支持療法為主——維持體溫（保溫至37-39°C是關鍵）、補液",
      "chronic": "成犬通常不需特殊治療",
      "medications": [
        "維持體溫為最重要治療（保溫箱38-39°C）",
        "皮下或靜脈輸液",
        "抗病毒藥物效果有限（Acyclovir嘗試性使用）",
        "廣效抗生素（預防繼發感染）",
        "母犬繁殖管理"
      ],
      "surgery": "不適用"
    },
    "prognosis": "新生幼犬（<3週齡）感染後死亡率極高（>80%）。存活幼犬可能有永久性腎臟和神經損傷。>3週齡幼犬感染後多可存活。成犬預後極佳。母犬經歷一次CHV-1相關流產後，後續繁殖通常正常（已有免疫力）。",
    "pearls": [
      "新生幼犬突然死亡首先要考慮CHV-1——腎臟的多焦點出血壞死斑是特徵性病變",
      "保溫是最重要的治療和預防措施——維持環境溫度在38-39°C可抑制病毒複製",
      "歐洲有CHV-1疫苗（Eurican Herpes 205），建議繁殖母犬於配種時和分娩前注射",
      "一窩幼犬中若有一隻發病，其他幼犬可能已感染——立即加強保溫措施"
    ],
    "diagnosticAlgorithm": {
      "title": "犬疱疹病毒感染 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估臨床表現，新生幼犬和成犬表現差異大",
          "findings": [
            "新生幼犬急性死亡或衰竭",
            "幼犬持續哭叫和不吸奶",
            "成犬通常無症狀或輕微呼吸道症狀",
            "繁殖障礙（流產、死產）"
          ]
        },
        {
          "step": 2,
          "action": "實驗室檢查",
          "details": "進行血液學和相關生化檢查",
          "findings": [
            "幼犬血小板減少",
            "肝腎指標異常（幼犬）",
            "DIC相關凝血異常",
            "成犬血液學通常正常"
          ]
        },
        {
          "step": 3,
          "action": "病毒學檢測",
          "details": "進行PCR和/或病毒分離確認感染",
          "findings": [
            "PCR檢測CHV-1 DNA陽性",
            "鼻腔、陰道或陰莖分泌物PCR",
            "血清學配對效價上升",
            "病理解剖見特徵性多臟器壞死灶（幼犬）"
          ]
        },
        {
          "step": 4,
          "action": "病理學確診（死亡病例）",
          "details": "對死亡幼犬進行病理解剖確認",
          "findings": [
            "多臟器散在出血壞死灶",
            "腎臟特徵性灶狀壞死和出血",
            "肝臟壞死灶",
            "組織學見嗜酸性核內包涵體"
          ]
        }
      ]
    },
    "monitoring": [
      "新生幼犬體溫每2小時監測",
      "同窩幼犬密切觀察",
      "母犬後續繁殖追蹤",
      "繁殖場血清學篩檢"
    ],
    "reference": "Drug Therapy for Infectious Diseases of the Dog and Cat"
  },
  "feline-coronavirus-enteric": {
    "zh": "貓腸道冠狀病毒感染",
    "en": "Feline Enteric Coronavirus Infection (FECV)",
    "definition": "貓腸道冠狀病毒（FECV）感染是由貓冠狀病毒（Feline Coronavirus, FCoV）的低致病力生物型引起的腸道感染。大多數感染為亞臨床或輕度腹瀉，但FECV可在宿主體內突變為高致病力的貓傳染性腹膜炎病毒（FIPV），導致致命性的FIP。",
    "synonyms": [
      "貓冠狀病毒腸炎",
      "FECV感染",
      "FCoV感染"
    ],
    "epidemiology": {
      "species": "貓",
      "breed": "純種貓群（多貓環境）感染率較高；緬甸貓、孟加拉貓、阿比西尼亞貓FIP風險可能較高",
      "age": "幼貓（<2歲）感染率和FIP發展風險最高",
      "sex": "無性別差異（但公貓FIP風險可能略高）",
      "prevalence": "多貓家庭FCoV血清陽性率可達80-90%；單貓家庭約10-50%"
    },
    "clinicalPresentation": {
      "symptoms": [
        "多數無症狀",
        "輕度自限性腹瀉",
        "軟便",
        "偶有嘔吐",
        "幼貓可能有短暫厭食",
        "通常1-2週自行緩解",
        "慢性帶原（持續排毒）",
        "少數發展為FIP時出現嚴重全身症狀"
      ],
      "physicalExam": [
        "多數理學檢查正常",
        "輕度腹瀉時可能有輕度脫水",
        "腸蠕動音可能活躍",
        "體況通常良好"
      ]
    },
    "pathophysiology": "FCoV為Alpha-coronavirus，經糞口途徑傳播，在貓小腸上皮細胞（腸道絨毛頂端）複製。FECV生物型主要局限於腸道上皮複製，引起輕微的絨毛萎縮和輕度炎症。約5-10%感染FECV的貓體內，病毒發生關鍵突變（尤其在S基因和ORF3c區域），獲得巨噬細胞趨向性，轉變為FIPV生物型，導致全身性免疫介導性血管炎（FIP）。大多數感染貓會持續排毒數月至數年，成為環境中的持續感染源。",
    "diagnosis": {
      "primary": [
        "糞便RT-PCR（偵測FCoV排毒）",
        "血清抗體測定（FCoV抗體效價）",
        "臨床症狀評估",
        "排除其他腹瀉原因"
      ],
      "differential": [
        "寄生蟲性腸炎（球蟲、梨形鞭毛蟲）",
        "細菌性腸炎",
        "貓泛白血球減少症",
        "飲食不當/食物不耐受",
        "發炎性腸病",
        "腸道淋巴瘤"
      ],
      "labFindings": [
        "糞便RT-PCR陽性（注意：陽性僅表示排毒，不代表會發展為FIP）",
        "FCoV抗體效價升高",
        "血液學通常正常（單純FECV感染）",
        "高球蛋白血症和低A/G比（發展為FIP時）"
      ]
    },
    "treatment": {
      "acute": "輕度腹瀉：支持療法和飲食管理",
      "chronic": "無特異性抗病毒治療用於單純FECV腸炎",
      "medications": [
        "輸液療法（脫水時）",
        "益生菌",
        "飲食管理（高消化性飲食）",
        "Maropitant（止吐，必要時）",
        "GS-441524或Molnupiravir（僅用於FIP，非單純FECV）"
      ],
      "surgery": "不適用"
    },
    "prognosis": "單純FECV腸道感染預後極佳，大多數貓為亞臨床或輕度自限性腹瀉。約5-10%感染貓會發展為FIP，此時若未治療預後極差（近年GS-441524等抗病毒藥物已大幅改善FIP預後）。",
    "pearls": [
      "FCoV抗體陽性不等於FIP——大多數抗體陽性貓永遠不會發展為FIP",
      "多貓環境中減少貓密度和增加貓砂盆數量可降低傳播",
      "幼貓（<2歲）和緊迫（手術、搬家、收容所）是FECV突變為FIPV的風險因子",
      "糞便PCR陽性僅代表排毒，對FIP診斷無直接意義"
    ],
    "diagnosticAlgorithm": {
      "title": "貓腸道冠狀病毒感染 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估腸道症狀，通常為輕微自限性",
          "findings": [
            "輕度至中度腹瀉",
            "幼貓較成貓症狀明顯",
            "多貓環境常見",
            "通常自限性，1-2天恢復"
          ]
        },
        {
          "step": 2,
          "action": "糞便檢測",
          "details": "進行糞便病毒檢測",
          "findings": [
            "糞便RT-PCR檢測冠狀病毒RNA",
            "糞便抗原快速檢測",
            "間歇性排毒使陰性結果不能完全排除",
            "排除其他腸道病原"
          ]
        },
        {
          "step": 3,
          "action": "血清學與鑑別",
          "details": "進行冠狀病毒抗體檢測，與FIP鑑別",
          "findings": [
            "冠狀病毒抗體效價（無法區分FECV和FIPV）",
            "高抗體效價不等於FIP",
            "Rivalta試驗（排除FIP）",
            "全身性症狀缺如支持FECV而非FIP"
          ]
        }
      ]
    },
    "monitoring": [
      "多貓環境定期糞便PCR追蹤排毒狀態",
      "抗體效價變化追蹤（升高不一定代表FIP）",
      "觀察FIP早期症狀（持續發燒、體重下降、腹水）",
      "新進貓隔離2-4週並檢測"
    ],
    "reference": "Clinical Veterinary Advisor: Dogs and Cats"
  },
  "coccidiosis": {
    "zh": "球蟲症",
    "en": "Coccidiosis",
    "definition": "球蟲症是由球蟲屬原蟲（主要為Isospora/Cystoisospora spp.）引起的腸道寄生蟲感染。犬主要感染C. canis和C. ohioensis；貓主要感染C. felis和C. rivolta。幼年動物和免疫抑制動物較易出現臨床症狀，成年免疫正常動物多為自限性。",
    "synonyms": [
      "球蟲感染",
      "等孢球蟲症",
      "Isosporiasis",
      "Cystoisospora感染"
    ],
    "epidemiology": {
      "species": "犬貓均常見",
      "breed": "無品種好發",
      "age": "幼犬幼貓（<6個月）最常發病",
      "sex": "無性別差異",
      "prevalence": "收容所和繁殖場幼犬幼貓感染率可高達20-50%以上"
    },
    "clinicalPresentation": {
      "symptoms": [
        "水樣腹瀉",
        "血便（小腸或大腸型）",
        "黏液便",
        "腹痛",
        "裡急後重",
        "脫水",
        "體重減輕",
        "生長遲緩",
        "厭食",
        "嘔吐（偶見）",
        "嚴重時直腸脫出"
      ],
      "physicalExam": [
        "脫水徵象",
        "腹部觸診可能有腸管脹氣",
        "肛周糞便沾附",
        "體況評分差",
        "幼年動物發育不良",
        "直腸脫出（嚴重裡急後重時）"
      ]
    },
    "pathophysiology": "球蟲卵囊（oocyst）經口攝入後在腸道釋出孢子體（sporozoite），侵入小腸上皮細胞進行無性和有性生殖。裂殖體（schizont）在上皮細胞內大量複製後破壞細胞釋出裂殖子（merozoite），造成腸上皮細胞大面積破壞。黏膜損傷導致吸收不良、分泌增加和出血。幼年動物因腸道免疫尚未成熟，無法有效控制寄生蟲增殖，故症狀較嚴重。環境汙染的卵囊需1-2天sporulation才具感染力。",
    "diagnosis": {
      "primary": [
        "糞便浮游法（偵測卵囊）",
        "糞便直接塗片",
        "糞便PCR（敏感度更高）",
        "臨床症狀結合環境因素"
      ],
      "differential": [
        "梨形鞭毛蟲感染",
        "鉤蟲感染",
        "鞭蟲感染",
        "犬細小病毒",
        "曲狀桿菌/沙門氏菌感染",
        "食物不耐受",
        "隱孢子蟲感染"
      ],
      "labFindings": [
        "糞便浮游法見典型卵囊（橢圓形、雙層壁）",
        "卵囊大小因種而異（C. canis最大，約38x30um）",
        "血液學可能正常或輕度嗜酸性球增多",
        "低白蛋白血症（嚴重時）"
      ]
    },
    "treatment": {
      "acute": "嚴重脫水需輸液和電解質補充",
      "chronic": "抗球蟲藥物治療和環境衛生管理",
      "medications": [
        "Sulfadimethoxine（50-60 mg/kg首日，之後25 mg/kg SID，10-14天）",
        "Trimethoprim-Sulfonamide（15-30 mg/kg BID，10-14天）",
        "Ponazuril（50 mg/kg SID，犬3-5天；貓20 mg/kg SID，3-5天）",
        "Toltrazuril（10-20 mg/kg 單次或連續3天）",
        "輸液和營養支持"
      ],
      "surgery": "直腸脫出時可能需手術復位和暫時性荷包縫合"
    },
    "prognosis": "適當治療後預後良好。幼年動物嚴重脫水未及時治療可能致死。成年免疫正常動物多為自限性。環境控制是預防復發的關鍵。",
    "pearls": [
      "糞便中偵測到少量球蟲卵囊不一定需要治療——成年健康動物可為自限性",
      "Ponazuril和Toltrazuril為新一代首選藥物，療程短且效果優於傳統磺胺類",
      "環境消毒是控制球蟲的關鍵——卵囊對大多數消毒劑有抗性，高溫蒸氣和10%氨水有效",
      "收容所新進幼犬幼貓應預防性篩檢和治療球蟲"
    ],
    "diagnosticAlgorithm": {
      "title": "球蟲症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估腹瀉症狀和風險因子",
          "findings": [
            "水樣至黏液性腹瀉",
            "幼犬幼貓最易感",
            "可能含血",
            "犬舍或收容所環境"
          ]
        },
        {
          "step": 2,
          "action": "糞便檢查",
          "details": "進行糞便浮游法檢查球蟲卵囊",
          "findings": [
            "糞便浮游法見Isospora/Cystoisospora卵囊",
            "卵囊大小和形態鑑定種類",
            "犬：C. canis、C. ohioensis等",
            "貓：C. felis、C. rivolta等"
          ]
        },
        {
          "step": 3,
          "action": "嚴重度評估",
          "details": "評估脫水程度和併發症",
          "findings": [
            "脫水程度評估",
            "電解質紊亂",
            "併發細菌感染評估",
            "免疫狀態評估（免疫抑制動物症狀更嚴重）"
          ]
        }
      ]
    },
    "monitoring": [
      "治療後7-14天追蹤糞便浮游法",
      "體重和生長發育追蹤",
      "環境衛生管理評估",
      "同窩/同群動物篩檢"
    ],
    "reference": "Clinical Veterinary Advisor: Dogs and Cats"
  },
  "bromethalin-toxicosis": {
    "zh": "溴鼠隆中毒",
    "en": "Bromethalin Toxicosis",
    "definition": "溴鼠隆（bromethalin）是一種神經毒性殺鼠劑，作用機制為解偶聯氧化磷酸化，導致中樞神經系統髓鞘內水腫。犬貓誤食後可出現急性或遲發性神經症狀，嚴重者可致死。此毒物無特異性解毒劑，治療以支持療法為主。",
    "synonyms": [
      "溴鼠靈中毒",
      "Bromethalin rodenticide poisoning"
    ],
    "epidemiology": {
      "species": "犬最常見，貓亦可發生",
      "breed": "無品種好發性，所有品種均可能誤食",
      "age": "幼犬因好奇心強較易誤食，但各年齡均可發生",
      "sex": "無性別差異",
      "prevalence": "在使用溴鼠隆殺鼠劑的地區常見，為小動物急診常見中毒原因之一"
    },
    "clinicalPresentation": {
      "symptoms": [
        "後肢無力或癱瘓",
        "步態不穩/共濟失調",
        "全身性肌肉震顫",
        "癲癇發作",
        "意識狀態改變（嗜睡至昏迷）",
        "瞳孔散大",
        "角弓反張（opisthotonus）",
        "食慾廢絕",
        "嘔吐（急性期）",
        "進行性四肢麻痺"
      ],
      "physicalExam": [
        "中樞神經系統抑制或過度興奮",
        "本體感覺缺失",
        "脊髓反射異常（上運動神經元徵象）",
        "瞳孔散大且對光反射減弱",
        "肌張力異常增加"
      ]
    },
    "pathophysiology": "溴鼠隆在體內代謝為去甲基溴鼠隆（desmethyl-bromethalin），此活性代謝物解偶聯粒線體氧化磷酸化，導致 ATP 合成減少。ATP 不足使 Na+/K+-ATPase 功能障礙，細胞內鈉離子蓄積引起腦及脊髓白質的空泡性髓鞘水腫（spongy degeneration），造成顱內壓升高及進行性神經功能障礙。",
    "diagnosis": {
      "primary": [
        "暴露史（接觸殺鼠劑的病史）",
        "典型神經學症狀（急性後肢無力、震顫、癲癇）",
        "腦脊髓液分析（蛋白質可能升高）",
        "胃內容物或組織的毒物化學分析確認"
      ],
      "differential": [
        "其他殺鼠劑中毒（抗凝血劑、膽鈣化醇）",
        "鉛中毒",
        "有機磷/氨基甲酸酯中毒",
        "腦炎/腦膜炎",
        "椎間盤疾病",
        "原發性癲癇"
      ],
      "labFindings": [
        "一般血液學及生化多無特異性變化",
        "凝血功能正常（與抗凝血劑殺鼠劑鑑別）",
        "腦脊髓液蛋白質可能輕度升高",
        "組織病理學顯示中樞神經白質空泡性髓鞘水腫"
      ]
    },
    "treatment": {
      "acute": "誤食後 2 小時內催吐（apomorphine 犬用，或 3% 過氧化氫），之後給予活性炭（1-2 g/kg）每 8 小時重複給予共 2-3 次以減少腸肝循環再吸收",
      "chronic": "支持療法為主；甘露醇（mannitol）0.5-1 g/kg IV 緩解腦水腫；控制癲癇發作；維持體液及電解質平衡",
      "medications": [
        "活性炭（Activated charcoal）1-2 g/kg PO 每 8 小時",
        "甘露醇（Mannitol）0.5-1 g/kg IV 緩慢輸注",
        "地西泮（Diazepam）0.5-1 mg/kg IV 控制癲癇",
        "地塞米松（Dexamethasone）0.1 mg/kg IV 減少腦水腫"
      ],
      "surgery": "無手術適應症"
    },
    "prognosis": "取決於攝入劑量與就診時間。犬致死劑量約 2.5-4.7 mg/kg，貓約 0.45 mg/kg。輕度暴露且早期除污染者預後尚可；一旦出現嚴重神經症狀（昏迷、角弓反張），預後極差。",
    "pearls": [
      "溴鼠隆中毒無特異性解毒劑，與抗凝血劑殺鼠劑不同，維生素 K 無效",
      "活性炭的反覆給予非常重要，因溴鼠隆有腸肝循環",
      "貓對溴鼠隆的敏感度遠高於犬（致死劑量約為犬的 1/5）",
      "症狀可能在誤食後 10-24 小時才出現，高劑量暴露可在 2-4 小時內發病"
    ],
    "diagnosticAlgorithm": {
      "title": "溴鼠隆中毒 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估與暴露史確認",
          "details": "確認可能的暴露源和時間，評估神經系統症狀",
          "findings": [
            "已知接觸滅鼠劑",
            "急性神經症狀（震顫、癲癇）",
            "後肢共濟失調或癱瘓",
            "意識狀態改變"
          ]
        },
        {
          "step": 2,
          "action": "神經學檢查",
          "details": "進行完整神經學評估",
          "findings": [
            "上運動神經元或下運動神經元徵象",
            "瞳孔散大和反射遲鈍",
            "漸進性後肢無力",
            "嚴重者出現角弓反張和去大腦姿勢"
          ]
        },
        {
          "step": 3,
          "action": "實驗室與影像學",
          "details": "進行支持性實驗室檢查和腦部影像",
          "findings": [
            "常規血液學和生化通常正常",
            "CSF蛋白可能升高",
            "MRI可能見腦水腫",
            "凝血功能正常（區別於抗凝血滅鼠劑）"
          ]
        },
        {
          "step": 4,
          "action": "毒物學確認",
          "details": "透過毒物學分析確認診斷",
          "findings": [
            "胃內容物或組織樣本毒物學分析",
            "脂肪組織中bromethalin及其代謝物desmethylbromethalin檢測",
            "多數為推定性診斷（基於暴露史和臨床表現）",
            "死後腦組織病理學見海綿狀腦白質病變"
          ]
        }
      ]
    },
    "monitoring": [
      "每 4-6 小時評估神經學狀態",
      "監測意識程度與瞳孔反射",
      "觀察癲癇發作頻率",
      "住院期間持續監測至少 72 小時"
    ],
    "reference": "Blackwell's Five-Minute Veterinary Consult"
  },
  "mushroom-toxicosis": {
    "zh": "蘑菇中毒",
    "en": "Mushroom Toxicosis",
    "definition": "犬貓因誤食有毒蘑菇導致的中毒症候群，依蘑菇種類不同可引起肝毒性、神經毒性、腸胃毒性或溶血性反應。最危險的為含鵝膏毒素（amatoxin）的毒鵝膏（Amanita phalloides），可導致急性爆發性肝衰竭。臨床表現因毒素種類而異，從輕微胃腸症狀到多重器官衰竭均可能。",
    "synonyms": [
      "毒蕈中毒",
      "真菌中毒",
      "Mycetism"
    ],
    "epidemiology": {
      "species": "犬最常見（戶外活動時誤食），貓較少見",
      "breed": "無品種好發性，好奇心強或嗅覺導向覓食行為的犬隻風險較高",
      "age": "幼犬較常見，但各年齡均可發生",
      "sex": "無性別差異",
      "prevalence": "春季及秋季多雨潮濕季節發生率較高，溫暖潮濕地區更為常見"
    },
    "clinicalPresentation": {
      "symptoms": [
        "嘔吐（通常為首發症狀）",
        "腹瀉（可能帶血）",
        "腹痛",
        "流涎",
        "黃疸（肝毒性蘑菇）",
        "嗜睡/精神沈鬱",
        "共濟失調/步態不穩",
        "癲癇發作（神經毒性蘑菇）",
        "瞳孔縮小或散大（視毒素種類）",
        "少尿或無尿（腎衰竭時）",
        "出血傾向（肝衰竭時）"
      ],
      "physicalExam": [
        "脫水（黏膜乾燥、皮膚彈性下降）",
        "黃疸（肝毒性類型）",
        "腹部觸診疼痛",
        "心動過緩或心動過速（視毒素種類）",
        "體溫可能升高或降低",
        "神經學異常（視毒素種類）"
      ]
    },
    "pathophysiology": "有毒蘑菇含多種毒素類型：(1) 鵝膏毒素（amatoxins）抑制 RNA 聚合酶 II，導致蛋白質合成停止，引起肝細胞壞死；(2) 毒蠅鹼（muscarine）為膽鹼激性毒素，激活副交感神經系統；(3) 異噁唑衍生物（ibotenic acid/muscimol）作用於 GABA 受體引起神經興奮或抑制；(4) 鬼傘素（coprine）抑制乙醛脫氫酶。不同毒素的潛伏期從 30 分鐘到 24 小時不等。",
    "diagnosis": {
      "primary": [
        "誤食蘑菇的病史與蘑菇殘留物鑑定",
        "臨床症狀的時間序列分析（潛伏期有助判斷毒素類型）",
        "血液生化學（ALT、AST、膽紅素、BUN、肌酐）",
        "凝血功能檢測（PT、aPTT）"
      ],
      "differential": [
        "其他食物中毒",
        "急性胰臟炎",
        "急性肝炎（感染性或藥物性）",
        "有機磷中毒",
        "巧克力中毒",
        "異物性腸阻塞"
      ],
      "labFindings": [
        "ALT、AST 顯著升高（肝毒性類型可達數千 U/L）",
        "膽紅素升高",
        "低血糖（爆發性肝衰竭）",
        "PT、aPTT 延長（凝血因子合成障礙）",
        "BUN 及肌酐升高（腎功能損害時）"
      ]
    },
    "treatment": {
      "acute": "誤食後盡早催吐；給予活性炭（1-2 g/kg PO）；積極靜脈輸液維持灌流與排泄；鵝膏毒素中毒可考慮水飛薊素（silibinin）及 N-乙醯半胱氨酸（NAC）作為肝保護劑",
      "chronic": "肝衰竭患者需長期肝臟支持療法；監測凝血功能並視需要補充新鮮冷凍血漿；維持營養支持",
      "medications": [
        "活性炭（Activated charcoal）1-2 g/kg PO",
        "水飛薊素（Silibinin）5 mg/kg IV 每 6 小時（鵝膏毒素中毒）",
        "N-乙醯半胱氨酸（NAC）140 mg/kg IV 首次劑量，後 70 mg/kg 每 6 小時",
        "阿托品（Atropine）0.02-0.04 mg/kg IV（毒蠅鹼中毒）",
        "止吐劑（Maropitant）1 mg/kg SC 每 24 小時"
      ],
      "surgery": "無手術適應症；極端肝衰竭病例理論上可考慮肝移植但實務上不可行"
    },
    "prognosis": "取決於蘑菇種類及攝入量。毒蠅鹼型及胃腸刺激型預後良好（多數 24 小時內恢復）。鵝膏毒素型預後極差，死亡率可達 50-90%，即使積極治療仍可能因爆發性肝衰竭死亡。",
    "pearls": [
      "鵝膏毒素中毒的典型病程有「假性恢復期」：初期腸胃症狀 → 6-12 小時後症狀改善 → 24-72 小時後爆發肝衰竭",
      "蘑菇鑑定困難，建議保留殘餘蘑菇或嘔吐物送真菌學專家鑑定",
      "潛伏期超過 6 小時的蘑菇中毒應高度懷疑鵝膏毒素，預後較差",
      "後院或花園中的蘑菇不等於安全，許多劇毒蘑菇外觀普通"
    ],
    "diagnosticAlgorithm": {
      "title": "蘑菇中毒 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估與蘑菇鑑定",
          "details": "確認蘑菇暴露和種類鑑定",
          "findings": [
            "目擊或疑似蘑菇攝入",
            "蘑菇樣本收集供鑑定",
            "症狀發作時間（快速vs延遲）",
            "延遲發作（>6小時）提示肝毒性蘑菇"
          ]
        },
        {
          "step": 2,
          "action": "臨床症狀評估",
          "details": "根據症狀類型分類毒素類型",
          "findings": [
            "胃腸道型：嘔吐、腹瀉（最常見）",
            "肝毒性型：延遲性肝衰竭（Amanita phalloides）",
            "神經毒性型：震顫、癲癇、幻覺",
            "腎毒性型：急性腎損傷"
          ]
        },
        {
          "step": 3,
          "action": "實驗室監測",
          "details": "進行連續性實驗室監測評估器官損傷",
          "findings": [
            "肝酶連續監測（ALT、AST、ALP）",
            "腎功能指標",
            "凝血功能（肝毒性型）",
            "血糖監測（Amanita致低血糖）"
          ]
        },
        {
          "step": 4,
          "action": "毒物學與專家諮詢",
          "details": "必要時進行毒物學檢測和專家鑑定",
          "findings": [
            "蘑菇種類專家鑑定",
            "尿液amatoxin檢測（疑似Amanita）",
            "肝臟活檢（嚴重肝損傷病例）",
            "動物毒物控制中心諮詢"
          ]
        }
      ]
    },
    "monitoring": [
      "每 12-24 小時監測肝酵素（ALT、AST）",
      "監測凝血功能（PT、aPTT）",
      "監測血糖（低血糖提示肝衰竭）",
      "尿量監測（評估腎功能）"
    ],
    "reference": "Blackwell's Five-Minute Veterinary Clinical Companion"
  },
  "macadamia-nut-toxicosis": {
    "zh": "夏威夷豆中毒",
    "en": "Macadamia Nut Toxicosis",
    "definition": "犬因攝入夏威夷豆（Macadamia integrifolia 或 M. tetraphylla）而引起的中毒症候群，主要表現為後肢無力、嘔吐、高熱及震顫。確切毒性成分尚未明確。此毒性為犬特有，貓未有報導。多數病例為自限性，預後良好。",
    "synonyms": [
      "澳洲堅果中毒",
      "Macadamia nut poisoning"
    ],
    "epidemiology": {
      "species": "僅犬有報導，貓未有確認病例",
      "breed": "所有犬種均可發生，無特定品種好發性",
      "age": "各年齡犬隻均可發生",
      "sex": "無性別差異",
      "prevalence": "在夏威夷豆作為零食或烘焙食材普及的家庭中偶見，節日期間（人類食品分享增加時）發生率上升"
    },
    "clinicalPresentation": {
      "symptoms": [
        "後肢無力（最具特徵性）",
        "無法站立或行走",
        "嘔吐",
        "震顫",
        "發熱（體溫可達 40-41°C）",
        "精神沈鬱/嗜睡",
        "腹痛",
        "關節腫脹/僵硬感",
        "食慾下降"
      ],
      "physicalExam": [
        "後肢肌力減退或無法負重",
        "體溫升高（39.5-41°C）",
        "腹部觸診不適",
        "黏膜色澤正常至蒼白",
        "四肢關節可能腫脹或觸痛"
      ]
    },
    "pathophysiology": "夏威夷豆的確切毒性成分至今尚未完全闡明。推測可能與堅果中的某些脂溶性化合物有關，該毒素似乎特異性地影響犬的骨骼肌及體溫調節中樞。中毒劑量約為 2.4-62.4 g/kg 體重。毒素可能干擾肌肉的正常代謝功能，導致暫時性的肌肉無力及全身性炎症反應。",
    "diagnosis": {
      "primary": [
        "明確的夏威夷豆攝入病史",
        "典型臨床表現（後肢無力 + 發熱 + 震顫三聯徵）",
        "排除其他導致後肢無力的原因",
        "攝入後 12 小時內出現症狀具診斷意義"
      ],
      "differential": [
        "椎間盤疾病",
        "髖關節發育不良",
        "免疫媒介性多發性關節炎",
        "蜱麻痺（tick paralysis）",
        "溴鼠隆中毒",
        "肉毒桿菌中毒"
      ],
      "labFindings": [
        "血液學多無顯著異常",
        "血清三酸甘油酯可能升高",
        "血清脂肪酶可能輕度升高",
        "CK（肌酸激酶）可能升高"
      ]
    },
    "treatment": {
      "acute": "若攝入時間短（<2 小時）可催吐；活性炭 1-2 g/kg PO；支持性靜脈輸液療法",
      "chronic": "通常不需要長期治療，症狀為自限性，多在 24-48 小時內自行緩解",
      "medications": [
        "活性炭（Activated charcoal）1-2 g/kg PO（早期給予）",
        "止吐劑（Maropitant）1 mg/kg SC 每日一次",
        "曲馬多（Tramadol）2-5 mg/kg PO 每 8-12 小時（止痛）",
        "靜脈輸液（乳酸林格氏液）維持水合狀態"
      ],
      "surgery": "無手術適應症"
    },
    "prognosis": "預後極佳。多數犬在 24-48 小時內完全恢復，無後遺症。死亡病例極為罕見，通常僅在大量攝入且合併巧克力（巧克力夏威夷豆）中毒時才可能出現嚴重後果。",
    "pearls": [
      "夏威夷豆中毒是少數已知僅影響犬而不影響貓的食物中毒",
      "巧克力裹覆的夏威夷豆會同時造成可可鹼中毒，需評估兩種毒素的累加效應",
      "即使外觀嚴重（完全無法站立），預後通常仍然良好",
      "中毒劑量個體差異大，少量攝入即可能在敏感犬隻引起症狀"
    ],
    "diagnosticAlgorithm": {
      "title": "夏威夷豆中毒 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "暴露史確認",
          "details": "確認夏威夷豆攝入量和時間",
          "findings": [
            "確認或疑似攝入夏威夷豆",
            "攝入量評估（>2.4g/kg可致症狀）",
            "症狀通常在攝入後12小時內出現",
            "犬特別敏感"
          ]
        },
        {
          "step": 2,
          "action": "臨床評估",
          "details": "評估典型臨床表現",
          "findings": [
            "後肢虛弱或無法站立",
            "嘔吐",
            "發熱（體溫升高）",
            "肌肉震顫和關節僵硬"
          ]
        },
        {
          "step": 3,
          "action": "實驗室檢查與支持性診斷",
          "details": "進行基本實驗室檢查排除其他病因",
          "findings": [
            "血液學通常正常",
            "三酸甘油脂可能升高",
            "脂肪酶可能輕微升高",
            "診斷主要基於暴露史和典型症狀"
          ]
        }
      ]
    },
    "monitoring": [
      "每 6-8 小時評估後肢肌力恢復情況",
      "監測體溫直至恢復正常",
      "確認 24-48 小時內症狀完全消退",
      "若合併巧克力攝入則需心電圖監測"
    ],
    "reference": "Clinical Veterinary Advisor: Dogs and Cats"
  },
  "onion-garlic-toxicosis": {
    "zh": "洋蔥大蒜中毒",
    "en": "Onion and Garlic Toxicosis",
    "definition": "犬貓因攝入蔥屬植物（Allium spp.）包括洋蔥、大蒜、韭菜、青蔥等引起的氧化性溶血性貧血。蔥屬植物中的有機硫化物在體內代謝後產生氧化劑，損傷紅血球膜及血紅蛋白，形成亨氏小體（Heinz bodies），最終導致紅血球溶破。貓較犬更為敏感。",
    "synonyms": [
      "蔥屬植物中毒",
      "Allium toxicosis",
      "洋蔥中毒"
    ],
    "epidemiology": {
      "species": "犬貓均可發生，貓更敏感（紅血球氧化損傷敏感度較高）",
      "breed": "日本品種犬（秋田犬、柴犬）因遺傳性紅血球特性可能更易受損",
      "age": "各年齡均可發生",
      "sex": "無性別差異",
      "prevalence": "常見的家庭食物中毒原因，尤其在餵食含洋蔥的剩菜或嬰兒食品時"
    },
    "clinicalPresentation": {
      "symptoms": [
        "精神沈鬱/嗜睡",
        "運動不耐受",
        "呼吸急促/呼吸困難",
        "黏膜蒼白或黃疸",
        "嘔吐",
        "腹瀉",
        "食慾下降",
        "心搏過速",
        "紅棕色尿（血紅蛋白尿）",
        "虛弱無力"
      ],
      "physicalExam": [
        "黏膜蒼白（貧血）",
        "黏膜黃染（溶血性黃疸）",
        "心搏過速",
        "呼吸急促",
        "脾臟腫大（脾臟代償性造血及紅血球清除）"
      ]
    },
    "pathophysiology": "蔥屬植物含有多種有機硫化物（如丙基二硫化物及硫代亞磺酸酯），攝入後在體內被代謝為高度氧化性化合物。這些氧化劑使血紅蛋白變性，形成亨氏小體（Heinz bodies）及離心體（eccentrocytes）。受損的紅血球被脾臟巨噬細胞識別並清除，導致血管外溶血。貓的血紅蛋白含有更多可氧化的巰基，因此較犬更易形成亨氏小體。犬的中毒劑量約為 15-30 g/kg，貓約 5 g/kg。",
    "diagnosis": {
      "primary": [
        "蔥屬植物攝入病史",
        "全血球計數顯示再生性貧血",
        "血液抹片發現亨氏小體及離心體（eccentrocytes）",
        "血紅蛋白血症/血紅蛋白尿"
      ],
      "differential": [
        "免疫媒介性溶血性貧血（IMHA）",
        "鋅中毒（攝入鋅製硬幣或金屬）",
        "對乙醯胺基酚（acetaminophen）中毒",
        "紅血球寄生蟲感染（焦蟲症、血巴東蟲症）",
        "磷化鋅殺鼠劑中毒",
        "先天性酵素缺乏症（PFK 缺乏症、PK 缺乏症）"
      ],
      "labFindings": [
        "PCV/HCT 下降（再生性貧血，網織紅血球增加）",
        "血液抹片見亨氏小體（新亞甲藍染色更清晰）",
        "離心體（eccentrocytes）",
        "血清膽紅素升高（間接為主）",
        "血紅蛋白血症及血紅蛋白尿"
      ]
    },
    "treatment": {
      "acute": "早期催吐與活性炭除污染；嚴重貧血（PCV<15-20%）需輸血；靜脈輸液維持腎臟灌流（預防血紅蛋白尿致腎損傷）",
      "chronic": "移除所有蔥屬植物來源的食物；支持療法直至紅血球再生恢復正常；嚴重病例可能需數週恢復",
      "medications": [
        "活性炭（Activated charcoal）1-2 g/kg PO（早期給予）",
        "靜脈輸液（0.9% NaCl 或乳酸林格氏液）",
        "濃縮紅血球或全血輸注（嚴重貧血時）",
        "N-乙醯半胱氨酸（NAC）140 mg/kg 負荷劑量 IV（抗氧化支持）",
        "止吐劑（Maropitant）1 mg/kg SC"
      ],
      "surgery": "無手術適應症"
    },
    "prognosis": "輕度至中度中毒且及時治療者預後良好，紅血球通常在 10-14 天內再生恢復。大量攝入導致嚴重貧血（PCV<12%）且未及時輸血者預後謹慎至不良。慢性少量攝入可能導致持續性亞臨床貧血。",
    "pearls": [
      "大蒜的毒性約為洋蔥的 3-5 倍（以每公斤體重計），但烹調可部分降低毒性",
      "症狀可能在攝入後 1-5 天才出現，因溶血有延遲效應",
      "某些嬰兒食品和調味料含洋蔥粉，飼主可能不自覺地給予寵物",
      "日本犬種（秋田犬、柴犬）的紅血球對氧化損傷更敏感，應特別警惕"
    ],
    "diagnosticAlgorithm": {
      "title": "洋蔥大蒜中毒 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "暴露史確認",
          "details": "確認蔥屬植物（洋蔥、大蒜、韭菜等）攝入",
          "findings": [
            "確認攝入蔥屬植物",
            "攝入量評估",
            "可能為直接食用或含蔥屬食物",
            "症狀延遲1-5天出現"
          ]
        },
        {
          "step": 2,
          "action": "血液學檢查",
          "details": "進行全血計數和血液抹片檢查",
          "findings": [
            "乃乃氏小體（Heinz bodies）",
            "偏心球形紅血球（eccentrocytes）",
            "再生性溶血性貧血",
            "網狀紅血球增加"
          ]
        },
        {
          "step": 3,
          "action": "溶血評估",
          "details": "評估溶血嚴重程度",
          "findings": [
            "PCV/Hct持續下降",
            "血紅素尿或血尿",
            "高膽紅素血症",
            "黏膜蒼白或黃疸"
          ]
        },
        {
          "step": 4,
          "action": "監測與鑑別",
          "details": "連續監測並排除其他溶血原因",
          "findings": [
            "連續PCV監測（溶血可能持續數天）",
            "排除其他Heinz body貧血原因",
            "Coombs試驗排除IMHA",
            "腎功能監測（血紅素腎病風險）"
          ]
        }
      ]
    },
    "monitoring": [
      "每 12-24 小時監測 PCV/HCT 追蹤貧血程度",
      "監測尿液顏色（血紅蛋白尿）",
      "評估網織紅血球計數（骨髓再生反應）",
      "監測腎功能（BUN、肌酐，預防血紅蛋白引起的腎損傷）"
    ],
    "reference": "BSAVA Manual of Canine and Feline Haematology and Transfusion Medicine"
  },
  "ssri-toxicosis": {
    "zh": "SSRI 血清素症候群中毒",
    "en": "SSRI Toxicosis / Serotonin Syndrome",
    "definition": "犬貓因誤食選擇性血清素再回收抑制劑（SSRIs）如 fluoxetine、sertraline、paroxetine 等藥物，導致中樞及周邊血清素過度活化的中毒症候群。臨床特徵為認知/行為改變、神經肌肉過度興奮及自律神經功能異常的三聯徵。嚴重者可導致高熱、癲癇及死亡。",
    "synonyms": [
      "血清素中毒",
      "選擇性血清素再回收抑制劑中毒",
      "Serotonin toxicity"
    ],
    "epidemiology": {
      "species": "犬較常見（因人類抗憂鬱藥物使用普遍），貓亦可發生",
      "breed": "無品種好發性",
      "age": "各年齡均可發生，幼犬因咬嚼藥瓶行為較常見",
      "sex": "無性別差異",
      "prevalence": "隨人類 SSRI 處方量增加而逐年上升，為小動物常見藥物中毒類型之一"
    },
    "clinicalPresentation": {
      "symptoms": [
        "躁動不安/過度興奮",
        "嘔吐",
        "腹瀉",
        "震顫",
        "肌躍症（myoclonus）",
        "癲癇發作",
        "高熱（體溫 >40°C）",
        "心搏過速",
        "瞳孔散大",
        "精神狀態改變（定向力障礙、嗜睡或過度激動）",
        "共濟失調",
        "過度流涎"
      ],
      "physicalExam": [
        "心搏過速",
        "高血壓",
        "體溫升高（可超過 41°C）",
        "瞳孔散大",
        "腸蠕動音亢進",
        "肌張力增高或肌躍症"
      ]
    },
    "pathophysiology": "SSRIs 阻斷突觸前血清素轉運體（SERT），使突觸間隙血清素濃度過度升高。過量的血清素同時激活中樞及周邊的 5-HT1A 及 5-HT2A 受體，導致：(1) 認知與行為異常（5-HT2A 過度激活）；(2) 神經肌肉興奮性增高、震顫、肌躍症（脊髓 5-HT1A/2A）；(3) 自律神經功能紊亂包括高熱、心搏過速、高血壓（交感神經過度興奮）。嚴重者的惡性高熱可導致橫紋肌溶解、DIC 及多器官衰竭。",
    "diagnosis": {
      "primary": [
        "SSRI 藥物暴露/攝入病史",
        "典型三聯徵（精神狀態改變 + 神經肌肉過度活動 + 自律神經異常）",
        "症狀在攝入後 30 分鐘至數小時內出現",
        "排除其他導致高熱及癲癇的原因"
      ],
      "differential": [
        "有機磷/氨基甲酸酯中毒",
        "安非他命中毒",
        "巧克力（甲基黃嘌呤）中毒",
        "番木鱉鹼中毒",
        "感染性腦炎",
        "中暑"
      ],
      "labFindings": [
        "多數一般血液學和生化無特異性變化",
        "嚴重者可見 CK 升高（橫紋肌溶解）",
        "代謝性酸中毒（乳酸堆積）",
        "凝血功能異常（DIC 時）"
      ]
    },
    "treatment": {
      "acute": "催吐（若攝入 <1 小時且未出現神經症狀）；活性炭 1-2 g/kg；靜脈輸液；控制體溫（主動降溫）；控制癲癇及躁動",
      "chronic": "持續支持療法直至藥物代謝排除（半衰期因藥物而異，fluoxetine 在犬為 24-72 小時）",
      "medications": [
        "賽庚啶（Cyproheptadine）1.1 mg/kg PO 或經直腸（血清素拮抗劑，為特異性治療）",
        "地西泮（Diazepam）0.5-1 mg/kg IV（控制癲癇及肌肉過度活動）",
        "活性炭（Activated charcoal）1-2 g/kg PO",
        "丙泊酚（Propofol）1-4 mg/kg IV（嚴重癲癇或持續躁動時）",
        "靜脈輸液（乳酸林格氏液）維持循環及促進排泄"
      ],
      "surgery": "無手術適應症"
    },
    "prognosis": "輕度至中度中毒經適當治療後預後良好，多數在 24-72 小時內恢復。嚴重病例（體溫 >41.5°C、持續癲癇、DIC）預後謹慎至不良。與單胺氧化酶抑制劑（MAOIs）合併攝入時毒性顯著增加。",
    "pearls": [
      "賽庚啶（cyproheptadine）是血清素症候群的特異性拮抗劑，應在藥物清單中備用",
      "不要使用 acepromazine 鎮靜，因其可能降低癲癇閾值且加重低血壓",
      "體溫控制極為重要 — 高熱（>41°C）是預後不良的主要指標",
      "如果犬正在服用治療劑量的 SSRI，同時攝入其他血清素作用藥物（如 tramadol）也可引發血清素症候群"
    ],
    "diagnosticAlgorithm": {
      "title": "SSRI 血清素症候群中毒 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "暴露史與臨床評估",
          "details": "確認SSRI藥物攝入和劑量",
          "findings": [
            "已知SSRI藥物攝入（fluoxetine、sertraline等）",
            "發作時間評估（通常數小時內）",
            "躁動不安",
            "高體溫"
          ]
        },
        {
          "step": 2,
          "action": "神經肌肉評估",
          "details": "評估血清素症候群特徵性表現",
          "findings": [
            "肌陣攣和震顫",
            "過度反射和肌肉僵硬",
            "瞳孔散大",
            "腹瀉和嘔吐"
          ]
        },
        {
          "step": 3,
          "action": "監測與支持性檢查",
          "details": "進行持續性生命徵象和實驗室監測",
          "findings": [
            "體溫持續監測（可致命性高熱）",
            "心電圖監測（心律不整風險）",
            "血壓監測",
            "CK升高（嚴重肌肉活動）"
          ]
        },
        {
          "step": 4,
          "action": "鑑別診斷",
          "details": "排除其他類似表現的中毒",
          "findings": [
            "與抗膽鹼藥物中毒鑑別",
            "與交感神經興奮劑中毒鑑別",
            "排除惡性高熱",
            "藥物交互作用評估（MAOIs等）"
          ]
        }
      ]
    },
    "monitoring": [
      "持續體溫監測（目標 <39.5°C）",
      "心電圖及血壓監測",
      "每 4-6 小時評估神經學狀態",
      "監測 CK 及腎功能（橫紋肌溶解風險）"
    ],
    "reference": "Blackwell's Five-Minute Veterinary Consult"
  },
  "amphetamine-toxicosis": {
    "zh": "安非他命中毒",
    "en": "Amphetamine Toxicosis",
    "definition": "犬貓因誤食安非他命或其衍生物（包括甲基安非他命、MDMA、合法處方的 Adderall 等）引起的中毒。安非他命促進單胺類神經傳導物質（多巴胺、正腎上腺素、血清素）釋放，導致嚴重的交感神經過度興奮。臨床主要表現為躁動、心搏過速、高熱及癲癇。",
    "synonyms": [
      "苯丙胺中毒",
      "甲基安非他命中毒",
      "Methamphetamine toxicosis"
    ],
    "epidemiology": {
      "species": "犬較常見，貓亦可發生",
      "breed": "無品種好發性",
      "age": "各年齡均可發生",
      "sex": "無性別差異",
      "prevalence": "與人類藥物濫用流行程度相關，在非法藥物使用率較高的地區更常見；處方 ADHD 藥物（如 Adderall）誤食亦日漸增加"
    },
    "clinicalPresentation": {
      "symptoms": [
        "極度躁動/過度興奮",
        "心搏過速",
        "高血壓",
        "高熱（體溫可超過 41°C）",
        "瞳孔散大",
        "震顫",
        "癲癇發作",
        "嘔吐",
        "過度喘息",
        "刻板行為（反覆踱步、轉圈）",
        "攻擊性增加"
      ],
      "physicalExam": [
        "嚴重心搏過速",
        "高血壓",
        "體溫顯著升高",
        "瞳孔散大",
        "黏膜充血（磚紅色）",
        "脫水"
      ]
    },
    "pathophysiology": "安非他命進入突觸前神經末梢後，反轉單胺轉運體的運輸方向，促使多巴胺、正腎上腺素及血清素大量釋放至突觸間隙。同時抑制單胺氧化酶（MAO），阻止神經傳導物質分解。兒茶酚胺過度釋放導致廣泛的交感神經興奮：心搏過速、血管收縮、高血壓、高熱。血清素過度活化可引發血清素症候群樣症狀。持續的高熱及交感風暴可導致橫紋肌溶解、DIC、心律不整及多器官衰竭。",
    "diagnosis": {
      "primary": [
        "安非他命類藥物暴露病史",
        "典型交感神經過度興奮的臨床表現",
        "人用尿液藥物快篩（可用於犬，但敏感度較低）",
        "排除其他導致高熱及躁動的原因"
      ],
      "differential": [
        "巧克力（甲基黃嘌呤）中毒",
        "SSRI 中毒/血清素症候群",
        "可卡因中毒",
        "擬交感神經藥物中毒（pseudoephedrine）",
        "中暑",
        "甲狀腺風暴"
      ],
      "labFindings": [
        "代謝性酸中毒",
        "CK 升高（橫紋肌溶解）",
        "高血糖",
        "肌紅蛋白尿",
        "凝血功能異常（DIC 時）"
      ]
    },
    "treatment": {
      "acute": "催吐（僅限攝入後 30 分鐘內且無癲癇症狀時）；活性炭 1-2 g/kg；積極靜脈輸液；主動降溫；控制癲癇及躁動",
      "chronic": "持續監測直至藥物代謝完成（安非他命在犬的半衰期約 4-6 小時）；腎臟支持療法（預防肌紅蛋白腎病變）",
      "medications": [
        "地西泮（Diazepam）0.5-2 mg/kg IV（控制躁動及癲癇）",
        "Acepromazine 0.05-0.1 mg/kg IM（嚴重躁動時，注意低血壓風險）",
        "活性炭（Activated charcoal）1-2 g/kg PO",
        "靜脈輸液（0.9% NaCl）維持尿量促進排泄",
        "賽庚啶（Cyproheptadine）1.1 mg/kg PO（合併血清素症狀時）"
      ],
      "surgery": "無手術適應症"
    },
    "prognosis": "輕度中毒經鎮靜及支持療法後預後良好。嚴重病例（持續高熱 >41°C、癲癇重積狀態、DIC）預後謹慎至不良。及時降溫與控制躁動是改善預後的關鍵。",
    "pearls": [
      "安非他命中毒時不應催吐已出現神經興奮症狀的動物，以免誘發吸入性肺炎",
      "尿液酸化理論上可加速安非他命排泄，但實務上因增加肌紅蛋白腎毒性風險而不建議",
      "人用毒物快篩試紙可用於犬的尿液檢測，但假陰性率較高",
      "與 SSRI 中毒臨床表現高度相似，治療原則亦相似，重點在控制體溫及躁動"
    ],
    "diagnosticAlgorithm": {
      "title": "安非他命中毒 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "暴露史確認",
          "details": "確認安非他命類藥物暴露",
          "findings": [
            "已知接觸ADHD藥物（如methylphenidate、amphetamine）",
            "非法藥物暴露可能",
            "症狀快速發作",
            "劑量評估"
          ]
        },
        {
          "step": 2,
          "action": "臨床評估",
          "details": "評估交感神經興奮症狀",
          "findings": [
            "極度躁動和焦慮",
            "心搏過速和高血壓",
            "高體溫",
            "瞳孔散大和震顫"
          ]
        },
        {
          "step": 3,
          "action": "實驗室監測",
          "details": "進行持續實驗室和心臟監測",
          "findings": [
            "心電圖監測（心律不整）",
            "血壓持續監測",
            "體溫監測",
            "酸鹼和電解質評估"
          ]
        },
        {
          "step": 4,
          "action": "毒物學確認",
          "details": "必要時進行毒物學檢測",
          "findings": [
            "尿液藥物篩檢",
            "血漿安非他命濃度",
            "診斷主要基於暴露史和臨床表現",
            "排除其他交感神經興奮劑中毒"
          ]
        }
      ]
    },
    "monitoring": [
      "持續心電圖監測（心律不整風險）",
      "每 30 分鐘至 1 小時監測體溫",
      "血壓監測",
      "尿量及尿液顏色監測（肌紅蛋白尿）"
    ],
    "reference": "Blackwell's Five-Minute Veterinary Consult"
  },
  "salt-toxicosis": {
    "zh": "鹽/鈉中毒",
    "en": "Salt Toxicosis / Sodium Ion Toxicosis",
    "definition": "犬貓因攝入過量鈉鹽或飲水受限導致高鈉血症，進而引起中樞神經系統損傷的中毒症候群。高鈉血症造成腦細胞脫水與收縮，嚴重者可導致腦出血、腦水腫及死亡。常見鈉鹽來源包括食鹽、岩鹽、鹹水麵團、除冰鹽及油漆球（paintballs）。",
    "synonyms": [
      "高鈉血症",
      "食鹽中毒",
      "Hypernatremia",
      "Sodium chloride poisoning"
    ],
    "epidemiology": {
      "species": "犬較常見（因不慎攝食行為），貓較少見但亦可發生",
      "breed": "無品種好發性",
      "age": "幼犬因好奇心強較常見，但各年齡均可發生",
      "sex": "無性別差異",
      "prevalence": "冬季（道路除冰鹽）及節日（自製鹹水麵團裝飾品）發生率較高"
    },
    "clinicalPresentation": {
      "symptoms": [
        "極度口渴/多飲",
        "嘔吐",
        "腹瀉（可能水樣）",
        "精神沈鬱/嗜睡",
        "震顫",
        "癲癇發作",
        "共濟失調",
        "肌肉僵硬",
        "昏迷（嚴重者）",
        "腹部膨脹（鹹水麵團發酵時）"
      ],
      "physicalExam": [
        "脫水徵象",
        "黏膜乾燥",
        "心搏過速",
        "神經學異常（震顫、頭部傾斜、失明）",
        "體溫可能升高"
      ]
    },
    "pathophysiology": "過量的鈉攝入導致血清鈉濃度急劇升高（正常犬 140-155 mEq/L）。高滲透壓使腦細胞內水分流向細胞外，造成腦細胞脫水與收縮。腦細胞為適應高滲環境會生成有機滲透質（idiogenic osmoles）。若治療時過快降低血鈉，水分反向進入已適應的腦細胞，可造成致命性腦水腫。嚴重高鈉血症還可導致腦微血管破裂出血。犬的鈉致死劑量約為 4 g/kg 體重。",
    "diagnosis": {
      "primary": [
        "高鈉鹽攝入病史或飲水受限史",
        "血清鈉濃度測定（>160 mEq/L 具診斷意義）",
        "神經學檢查",
        "血氣及電解質分析"
      ],
      "differential": [
        "其他導致癲癇的原因（癲癇症、腦瘤）",
        "尿崩症（中樞性或腎源性）",
        "乙二醇（防凍液）中毒",
        "低血糖",
        "腦炎",
        "中暑"
      ],
      "labFindings": [
        "血清鈉顯著升高（>170 mEq/L 提示中毒）",
        "血清滲透壓升高",
        "可能合併高氯血症",
        "BUN 及肌酐可能因脫水而升高"
      ]
    },
    "treatment": {
      "acute": "催吐（僅限攝入後極短時間內）；以 0.45% NaCl 或 5% 葡萄糖水緩慢靜脈輸液糾正高鈉血症；血清鈉每小時下降速率不應超過 0.5-1 mEq/L，每 24 小時不超過 10-12 mEq/L",
      "chronic": "持續緩慢糾正高鈉血症；癲癇控制；支持療法；可能需要 2-3 天才能安全將血鈉降至正常",
      "medications": [
        "0.45% NaCl 或 5% 葡萄糖水 IV（逐步降低血鈉）",
        "地西泮（Diazepam）0.5-1 mg/kg IV（控制癲癇）",
        "甘露醇（Mannitol）0.5-1 g/kg IV（腦水腫時）",
        "止吐劑（Maropitant）1 mg/kg SC"
      ],
      "surgery": "無手術適應症"
    },
    "prognosis": "取決於血鈉升高程度及持續時間。血清鈉 <170 mEq/L 且及時治療者預後良好。血清鈉 >180 mEq/L 或已出現嚴重神經症狀（昏迷、持續癲癇）者預後謹慎至不良。治療中過快降鈉導致的醫源性腦水腫是最大風險。",
    "pearls": [
      "糾正高鈉血症最危險的錯誤是降鈉過快 — 必須在 48-72 小時內緩慢糾正",
      "每 2-4 小時監測血清鈉濃度，確保下降速率在安全範圍內",
      "自製鹹水麵團（鹽麵團）可含極高鈉量，同時麵團在胃中發酵膨脹可造成胃擴張",
      "油漆球（paintballs）含高濃度山梨醇及可能的鈉鹽，也是常見鈉中毒來源"
    ],
    "diagnosticAlgorithm": {
      "title": "鹽/鈉中毒 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "暴露史與臨床評估",
          "details": "確認過量鹽攝入或限水導致的高鈉血症",
          "findings": [
            "攝入大量含鹽食物或自製鹽黏土",
            "限水後突然大量飲水",
            "嘔吐和腹瀉",
            "神經症狀（震顫、癲癇）"
          ]
        },
        {
          "step": 2,
          "action": "電解質與血液檢查",
          "details": "進行電解質和滲透壓檢測",
          "findings": [
            "高鈉血症（Na+ >160 mEq/L）",
            "血漿滲透壓升高",
            "可能伴有高氯血症",
            "BUN/Creatinine可能升高"
          ]
        },
        {
          "step": 3,
          "action": "神經學評估",
          "details": "評估中樞神經系統受累程度",
          "findings": [
            "共濟失調和盲目行走",
            "癲癇發作",
            "意識障礙至昏迷",
            "肌肉僵硬"
          ]
        },
        {
          "step": 4,
          "action": "監測與糾正",
          "details": "監測鈉濃度並緩慢糾正",
          "findings": [
            "連續鈉離子監測（每2-4小時）",
            "糾正速度不超過0.5 mEq/L/小時",
            "腦水腫風險評估",
            "尿比重和尿鈉監測"
          ]
        }
      ]
    },
    "monitoring": [
      "每 2-4 小時監測血清鈉濃度",
      "持續神經學評估",
      "尿量及尿比重監測",
      "每日體重監測（評估體液狀態）"
    ],
    "reference": "Clinical Veterinary Advisor: Dogs and Cats"
  },
  "iron-toxicosis": {
    "zh": "鐵中毒",
    "en": "Iron Toxicosis",
    "definition": "犬貓因攝入過量含鐵製劑（如人用鐵補充劑、維生素含鐵錠、暖暖包內含鐵粉等）引起的中毒。鐵離子的直接腐蝕性損傷腸胃道黏膜，同時游離鐵進入循環後產生自由基，導致細胞膜脂質過氧化，造成肝壞死、心血管衰竭及代謝性酸中毒。",
    "synonyms": [
      "鐵劑中毒",
      "Iron supplement poisoning"
    ],
    "epidemiology": {
      "species": "犬較常見（因誤食鐵錠），貓較少見",
      "breed": "無品種好發性",
      "age": "幼犬因咬嚼行為較常見",
      "sex": "無性別差異",
      "prevalence": "在家中存放人用鐵劑補充品或孕婦維生素的環境中偶見"
    },
    "clinicalPresentation": {
      "symptoms": [
        "嘔吐（可能帶血，早期出現）",
        "血便或黑便",
        "腹痛/腹部不適",
        "嗜睡/精神沈鬱",
        "休克症狀（蒼白、心搏過速、低血壓）",
        "黃疸（肝損傷期）",
        "腹瀉",
        "食慾廢絕"
      ],
      "physicalExam": [
        "腹部觸診疼痛",
        "脫水",
        "黏膜蒼白（出血或休克）",
        "心搏過速",
        "黃疸（24-48 小時後出現）"
      ]
    },
    "pathophysiology": "鐵中毒的病程分為四期：(1) 腐蝕期（0-6 小時）：鐵離子直接腐蝕胃腸黏膜，引起出血性胃腸炎；(2) 假性恢復期（6-24 小時）：症狀暫時改善，但游離鐵持續吸收；(3) 全身毒性期（12-96 小時）：游離鐵催化 Fenton 反應產生羥基自由基，造成肝細胞壞死、心肌損傷、代謝性酸中毒及凝血障礙；(4) 腸阻塞期（2-6 週後）：胃腸道瘢痕狹窄可能導致腸阻塞。元素鐵的中毒劑量犬約為 20-60 mg/kg。",
    "diagnosis": {
      "primary": [
        "含鐵製劑攝入病史",
        "腹部 X 光（鐵錠在 X 光下可見不透光影像）",
        "血清鐵濃度測定",
        "臨床病程符合鐵中毒分期"
      ],
      "differential": [
        "其他腐蝕性物質中毒",
        "異物性腸阻塞",
        "急性出血性胃腸炎",
        "急性胰臟炎",
        "抗凝血劑殺鼠劑中毒",
        "NSAIDs 中毒致胃腸出血"
      ],
      "labFindings": [
        "血清鐵濃度 >300-500 μg/dL 提示中毒",
        "代謝性酸中毒（血氣分析）",
        "ALT、AST 升高（肝損傷）",
        "低血糖（肝衰竭時）",
        "白血球增多"
      ]
    },
    "treatment": {
      "acute": "催吐（攝入後 1 小時內）；注意：活性炭對鐵無效；全腸灌洗（whole bowel irrigation）以聚乙二醇溶液清除腸道殘餘鐵錠；嚴重中毒使用去鐵胺（deferoxamine）螯合療法",
      "chronic": "持續監測肝功能；支持療法包括靜脈輸液及電解質糾正；2-6 週後注意腸道瘢痕狹窄的可能性",
      "medications": [
        "去鐵胺（Deferoxamine）15 mg/kg/hr IV 持續輸注（鐵特異性螯合劑）",
        "聚乙二醇電解質溶液（GoLYTELY）全腸灌洗 25 mL/kg/hr 經口或管飼",
        "靜脈輸液（0.9% NaCl 或乳酸林格氏液）維持循環",
        "碳酸氫鈉 1-2 mEq/kg IV（糾正代謝性酸中毒）"
      ],
      "surgery": "若腹部 X 光顯示大量鐵錠團塊且灌洗無法排出，可能需要胃切開術取出；晚期腸道瘢痕狹窄可能需手術修復"
    },
    "prognosis": "攝入元素鐵 <20 mg/kg 通常無臨床症狀。20-60 mg/kg 可致輕度至中度中毒，及時治療預後良好。>60 mg/kg 預後謹慎，>100 mg/kg 預後不良。假性恢復期的存在可能讓飼主誤以為動物已好轉而延誤就醫。",
    "pearls": [
      "活性炭不能有效吸附鐵離子，鐵中毒時不應依賴活性炭除污染",
      "注意鐵錠標示的「元素鐵含量」與「鐵鹽總量」不同 — 硫酸亞鐵含約 20% 元素鐵",
      "去鐵胺使用後尿液會變成「vin rosé」（玫瑰酒色）粉紅色，這是正常的鐵-去鐵胺複合物排出",
      "鐵中毒有「假性恢復期」，類似鵝膏毒素中毒的雙峰病程"
    ],
    "diagnosticAlgorithm": {
      "title": "鐵中毒 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "暴露史確認",
          "details": "確認鐵劑或含鐵產品攝入量",
          "findings": [
            "攝入含鐵補充劑或維生素",
            "攝入量評估（>20mg/kg元素鐵為毒性劑量）",
            "手溫器或氧氣吸收劑攝入",
            "症狀分期評估"
          ]
        },
        {
          "step": 2,
          "action": "臨床分期評估",
          "details": "根據中毒分期評估症狀",
          "findings": [
            "第一期（0-6小時）：嘔吐、腹瀉、腹痛",
            "第二期（6-24小時）：表面穩定期",
            "第三期（12-96小時）：休克、肝衰竭",
            "第四期：肝衰竭和代謝性酸中毒"
          ]
        },
        {
          "step": 3,
          "action": "實驗室檢查",
          "details": "進行血清鐵和代謝功能評估",
          "findings": [
            "血清鐵濃度升高（>300 μg/dL提示中毒）",
            "代謝性酸中毒",
            "肝功能指標升高",
            "凝血功能異常"
          ]
        },
        {
          "step": 4,
          "action": "影像與監測",
          "details": "進行腹部X光和持續監測",
          "findings": [
            "腹部X光可見含鐵異物（不透光）",
            "連續肝腎功能監測",
            "凝血功能連續追蹤",
            "酸鹼平衡監測"
          ]
        }
      ]
    },
    "monitoring": [
      "每 4-6 小時監測血清鐵濃度",
      "每 12 小時監測肝酵素（ALT、AST）",
      "血氣分析監測酸鹼平衡",
      "連續腹部 X 光評估腸道鐵錠清除情況"
    ],
    "reference": "Blackwell's Five-Minute Veterinary Clinical Companion"
  },
  "strychnine-toxicosis": {
    "zh": "番木鱉鹼中毒",
    "en": "Strychnine Toxicosis",
    "definition": "犬貓因攝入含番木鱉鹼（strychnine）的毒餌或殺鼠劑導致的急性中毒。番木鱉鹼為競爭性甘胺酸（glycine）受體拮抗劑，阻斷脊髓及腦幹的抑制性突觸傳遞，導致全身性骨骼肌強直性痙攣。此中毒為急診情況，未及時治療死亡率極高。",
    "synonyms": [
      "馬錢子鹼中毒",
      "士的寧中毒",
      "Strychnine poisoning"
    ],
    "epidemiology": {
      "species": "犬最常見（因攝食毒餌），貓較少見但同樣敏感",
      "breed": "無品種好發性",
      "age": "各年齡均可發生",
      "sex": "無性別差異",
      "prevalence": "在某些地區仍被非法使用為殺鼠劑或惡意投毒，在合法管制後發生率下降但仍有案例"
    },
    "clinicalPresentation": {
      "symptoms": [
        "全身性強直性痙攣/肌肉僵直",
        "角弓反張（opisthotonus）",
        "苦笑面容（risus sardonicus）— 面部肌肉痙攣",
        "對觸覺、聲音、光線極度敏感（感覺過敏觸發痙攣）",
        "呼吸困難（呼吸肌痙攣）",
        "瞳孔散大",
        "過度流涎",
        "嘔吐（早期，痙攣前）",
        "發紺（缺氧時）",
        "意識清醒但無法控制痙攣"
      ],
      "physicalExam": [
        "四肢伸直強直性痙攣",
        "頸部過度伸展（角弓反張）",
        "觸碰或聲音刺激即誘發痙攣",
        "高熱（肌肉持續收縮產熱）",
        "黏膜發紺",
        "心搏過速"
      ]
    },
    "pathophysiology": "番木鱉鹼競爭性阻斷脊髓前角及腦幹的甘胺酸（glycine）受體，甘胺酸為主要的抑制性神經傳導物質之一。抑制性傳遞被阻斷後，運動神經元失去正常的拮抗肌抑制機制，導致所有骨骼肌同時收縮，產生全身性強直性痙攣。死亡通常因呼吸肌持續痙攣導致窒息，或因持續肌肉收縮引起高熱及代謝性酸中毒。犬的致死劑量約為 0.75-2 mg/kg。",
    "diagnosis": {
      "primary": [
        "可能的毒餌接觸史或惡意投毒懷疑",
        "典型的全身性強直性痙攣伴感覺過敏",
        "胃內容物或嘔吐物的毒物學分析",
        "症狀在攝入後 10-120 分鐘急性發作"
      ],
      "differential": [
        "破傷風（tetanus）",
        "有機磷/氨基甲酸酯中毒",
        "除蟲菊精中毒（貓）",
        "美他醛（metaldehyde）蝸牛餌中毒",
        "癲癇重積狀態",
        "低鈣血症性抽搐"
      ],
      "labFindings": [
        "CK 顯著升高（橫紋肌溶解）",
        "代謝性酸中毒（乳酸堆積）",
        "高血鉀（肌肉細胞破壞）",
        "肌紅蛋白尿",
        "尿液或胃內容物毒物學分析可檢出番木鱉鹼"
      ]
    },
    "treatment": {
      "acute": "立即控制痙攣（最高優先級）；最小限度的外界刺激（暗室、安靜環境）；氣管插管確保呼吸道暢通；催吐僅限尚未出現痙攣的極早期病例",
      "chronic": "持續鎮靜 24-72 小時直至毒素代謝排出；積極靜脈輸液促進腎排泄；支持療法包括營養及體溫管理",
      "medications": [
        "地西泮（Diazepam）0.5-2 mg/kg IV（首選初期控制痙攣）",
        "苯巴比妥（Phenobarbital）2-6 mg/kg IV（維持鎮靜）",
        "甲氧嘧啶（Methocarbamol）55-220 mg/kg IV 緩慢給予（中樞性肌肉鬆弛劑）",
        "丙泊酚（Propofol）1-4 mg/kg IV 後 0.1-0.4 mg/kg/min CRI（難治性痙攣）",
        "活性炭（Activated charcoal）1-2 g/kg PO（痙攣控制後給予）"
      ],
      "surgery": "無手術適應症"
    },
    "prognosis": "未治療者死亡率極高。及時給予肌肉鬆弛及鎮靜藥物且能維持呼吸功能者，存活率可達 50-75%。若能撐過最初 24-48 小時（毒素代謝排出），通常可完全恢復無後遺症。橫紋肌溶解導致的急性腎衰竭是存活病例的主要併發症。",
    "pearls": [
      "番木鱉鹼中毒與破傷風最重要的鑑別點：番木鱉鹼中毒意識完全清醒，破傷風通常伴有鎖顎（trismus）",
      "處理痙攣中的動物時避免不必要的刺激 — 光線、聲音、觸碰都可加重痙攣",
      "Methocarbamol 是控制番木鱉鹼引起的肌肉僵直特別有效的藥物",
      "番木鱉鹼代謝相對快速（半衰期約 10 小時），撐過急性期後恢復良好"
    ],
    "diagnosticAlgorithm": {
      "title": "番木鱉鹼中毒 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "暴露史與急性評估",
          "details": "確認可能的中毒源和急性症狀",
          "findings": [
            "已知接觸含番木鱉鹼的毒餌",
            "急性發作（15-120分鐘內）",
            "對刺激極度敏感",
            "嚴重肌肉僵硬和角弓反張"
          ]
        },
        {
          "step": 2,
          "action": "臨床特徵評估",
          "details": "評估特徵性肌肉痙攣表現",
          "findings": [
            "間歇性強直性痙攣",
            "觸覺或聲音刺激誘發痙攣",
            "痙攣間期意識清醒",
            "四肢伸直僵硬（鋸馬姿勢）"
          ]
        },
        {
          "step": 3,
          "action": "毒物學確認",
          "details": "採集樣本進行毒物學分析",
          "findings": [
            "胃內容物毒物學分析",
            "尿液番木鱉鹼檢測",
            "嘔吐物或可疑毒餌分析",
            "診斷常基於暴露史和典型臨床表現"
          ]
        },
        {
          "step": 4,
          "action": "鑑別與併發症監測",
          "details": "排除其他強直性痙攣原因並監測併發症",
          "findings": [
            "與破傷風鑑別（破傷風為持續性）",
            "與metaldehyde中毒鑑別",
            "監測體溫（高熱性橫紋肌溶解風險）",
            "腎功能監測（肌紅蛋白尿風險）"
          ]
        }
      ]
    },
    "monitoring": [
      "持續呼吸功能監測（SpO2、呼吸頻率）",
      "體溫監測（高熱需主動降溫）",
      "CK 及腎功能監測（橫紋肌溶解風險）",
      "每 1-2 小時評估鎮靜深度及痙攣控制情況"
    ],
    "reference": "Clinical Veterinary Advisor: Dogs and Cats"
  },
  "permethrin-toxicosis": {
    "zh": "除蟲菊精中毒",
    "en": "Permethrin Toxicosis",
    "definition": "主要發生於貓的中毒症候群，因接觸或被誤用犬用高濃度除蟲菊精（permethrin）產品而引起。除蟲菊精為合成擬除蟲菊酯類殺蟲劑，貓缺乏有效的葡萄糖醛酸結合酶（glucuronyltransferase），無法有效代謝此類化合物，導致神經毒性。臨床主要表現為全身性肌肉震顫及癲癇。",
    "synonyms": [
      "合成除蟲菊酯中毒",
      "擬除蟲菊酯中毒",
      "Pyrethroid toxicosis"
    ],
    "epidemiology": {
      "species": "貓為主要受影響物種（對除蟲菊精極度敏感），犬很少發生嚴重中毒",
      "breed": "所有貓品種均可發生",
      "age": "各年齡貓均可發生，幼貓因體型小可能更易出現嚴重症狀",
      "sex": "無性別差異",
      "prevalence": "在飼主誤將犬用跳蚤滴劑（含高濃度 permethrin 45-65%）使用於貓的情況中非常常見，為貓最常見的中毒原因之一"
    },
    "clinicalPresentation": {
      "symptoms": [
        "全身性肌肉震顫（最具特徵性）",
        "耳尖抽動（ear twitching）",
        "爪掌翻動（paw flicking）",
        "癲癇發作",
        "過度流涎",
        "嘔吐",
        "共濟失調",
        "過度敏感（觸覺/聽覺）",
        "瞳孔散大",
        "體溫升高（肌肉持續震顫產熱）",
        "呼吸困難"
      ],
      "physicalExam": [
        "全身性細微到粗大肌肉震顫",
        "觸碰或聲音可加重震顫",
        "體溫升高（39.5-41°C）",
        "心搏過速",
        "瞳孔散大",
        "皮膚可能有油膩感（局部用藥殘留）"
      ]
    },
    "pathophysiology": "除蟲菊精延長神經細胞鈉通道的開放時間，導致反覆除極化及神經過度興奮。Type II 擬除蟲菊酯（如 permethrin）使鈉通道長時間開放，產生「CS 症候群」（choreoathetosis/salivation）。貓缺乏有效的肝臟葡萄糖醛酸結合酶，無法快速將除蟲菊精結合為水溶性代謝物排出，導致毒物在體內蓄積。這使得貓對除蟲菊精的敏感度遠高於犬，同等劑量下貓的毒性反應遠為嚴重。",
    "diagnosis": {
      "primary": [
        "除蟲菊精產品接觸或使用病史（特別是犬用產品誤用於貓）",
        "典型的全身性震顫臨床表現",
        "皮膚或毛髮上可檢測到除蟲菊精殘留",
        "排除其他導致震顫及癲癇的原因"
      ],
      "differential": [
        "有機磷/氨基甲酸酯中毒",
        "番木鱉鹼中毒",
        "美他醛（metaldehyde）中毒",
        "低鈣血症",
        "原發性癲癇",
        "特發性震顫症候群"
      ],
      "labFindings": [
        "一般血液學及生化多無特異性變化",
        "CK 可能升高（持續肌肉震顫）",
        "輕度代謝性酸中毒（持續肌肉活動）",
        "血糖可能因持續震顫而降低"
      ]
    },
    "treatment": {
      "acute": "立即以溫水及洗碗精徹底清洗皮膚去除殘留產品（戴手套操作）；控制震顫及癲癇；靜脈輸液支持；體溫控制",
      "chronic": "持續鎮靜及支持療法直至毒素代謝排出，通常需要 24-72 小時；嚴重者可能需要 ICU 護理",
      "medications": [
        "甲氧嘧啶（Methocarbamol）55-220 mg/kg IV 緩慢給予（控制震顫首選）",
        "地西泮（Diazepam）0.5-1 mg/kg IV（控制癲癇）",
        "丙泊酚（Propofol）1-4 mg/kg IV 後 CRI（嚴重難治性震顫）",
        "靜脈輸液（0.9% NaCl 或乳酸林格氏液）",
        "靜脈脂肪乳劑（Intralipid 20%）1.5 mL/kg IV bolus 後 0.25 mL/kg/min CRI 15 分鐘（脂質吸附療法）"
      ],
      "surgery": "無手術適應症"
    },
    "prognosis": "及時治療者預後良好至極佳，多數貓在 24-72 小時的支持療法後完全恢復。未治療或延遲治療的嚴重病例（持續癲癇、嚴重高熱）預後較差。脂肪乳劑療法（Intralipid）的引入顯著改善了嚴重病例的預後。",
    "pearls": [
      "犬用跳蚤滴劑產品對貓可能致命 — 即使是少量殘留（如與剛使用產品的犬同住）也可引起症狀",
      "靜脈脂肪乳劑（Intralipid/ILE）是近年來除蟲菊精中毒治療的重要進展，可有效吸附脂溶性毒素",
      "Methocarbamol 比 diazepam 更能有效控制除蟲菊精引起的肌肉震顫",
      "中毒後不要使用阿托品 — 除蟲菊精不是膽鹼酯酶抑制劑，阿托品無效且可能有害"
    ],
    "diagnosticAlgorithm": {
      "title": "除蟲菊精中毒 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "暴露史確認",
          "details": "確認除蟲菊精暴露，貓對permethrin極度敏感",
          "findings": [
            "貓誤用犬用除蚤產品",
            "接觸經permethrin處理的犬",
            "症狀在暴露後數小時出現",
            "貓為最常見受害動物"
          ]
        },
        {
          "step": 2,
          "action": "臨床評估",
          "details": "評估神經肌肉毒性症狀",
          "findings": [
            "肌肉震顫（尤其耳部和肢端）",
            "共濟失調",
            "癲癇發作（嚴重者）",
            "流涎和嘔吐"
          ]
        },
        {
          "step": 3,
          "action": "支持性診斷",
          "details": "進行基本實驗室檢查排除其他病因",
          "findings": [
            "血液學和生化通常正常",
            "排除有機磷中毒（膽鹼酯酶正常）",
            "診斷基於暴露史和典型症狀",
            "體表可能殘留產品氣味"
          ]
        }
      ]
    },
    "monitoring": [
      "持續評估震顫嚴重程度（從1到5級評分）",
      "體溫監測（高熱需主動降溫）",
      "血糖監測（持續震顫消耗葡萄糖）",
      "每 4-6 小時評估鎮靜藥物需求直至震顫消退"
    ],
    "reference": "Clinical Veterinary Advisor: Dogs and Cats"
  },
  "status-epilepticus": {
    "zh": "癲癇重積狀態",
    "en": "Status Epilepticus",
    "definition": "定義為持續超過 5 分鐘的癲癇發作，或在兩次發作之間未恢復正常意識的連續癲癇發作。癲癇重積狀態是神經科急症，持續的癲癇活動會導致不可逆的腦損傷、全身性併發症（高熱、橫紋肌溶解、腦水腫）甚至死亡。早期積極治療是改善預後的關鍵。",
    "synonyms": [
      "持續性癲癇",
      "癲癇持續狀態",
      "SE"
    ],
    "epidemiology": {
      "species": "犬較常見，貓亦可發生",
      "breed": "好發於有癲癇病史的品種：德國牧羊犬、比利時牧羊犬、拉布拉多、金毛、邊境牧羊犬、澳洲牧羊犬",
      "age": "任何年齡均可發生；已知癲癇症犬的癲癇重積風險較高",
      "sex": "無明顯性別差異",
      "prevalence": "約 0.5-2% 的犬在一生中至少經歷一次癲癇重積狀態，特發性癲癇犬中約 40-60% 可能在病程中發生"
    },
    "clinicalPresentation": {
      "symptoms": [
        "全身性強直-陣攣性癲癇發作持續超過 5 分鐘",
        "連續多次發作間意識未恢復",
        "四肢划水樣運動",
        "口吐泡沫/過度流涎",
        "大小便失禁",
        "瞳孔散大",
        "意識喪失或嚴重意識障礙",
        "發紺（低血氧時）",
        "高熱（肌肉持續收縮產熱）",
        "嘔吐",
        "發作後精神狀態異常（發作後期）"
      ],
      "physicalExam": [
        "全身性強直-陣攣性肌肉收縮",
        "體溫升高（可超過 41°C）",
        "心搏過速",
        "瞳孔散大",
        "黏膜發紺或充血"
      ]
    },
    "pathophysiology": "癲癇重積狀態的發生源於腦部興奮性（glutamate, NMDA 受體）與抑制性（GABA）神經傳導失衡。持續的癲癇活動導致 GABA-A 受體從突觸膜內化（internalization），使苯二氮平類藥物效力逐漸降低（藥物抗性）。同時 NMDA 受體向突觸膜移動，加劇興奮性毒性。持續的神經元放電耗盡能量儲備，鈣離子大量內流啟動凋亡途徑，造成不可逆的選擇性神經元壞死，尤其是海馬迴、丘腦及大腦皮質。全身性併發症包括高熱、橫紋肌溶解、代謝性酸中毒、DIC 及呼吸衰竭。",
    "diagnosis": {
      "primary": [
        "臨床觀察癲癇發作持續 >5 分鐘或連續發作間無意識恢復",
        "完整神經學檢查（發作控制後）",
        "基礎血液學及生化（排除代謝性原因）",
        "腦脊髓液分析（排除感染性/炎症性原因）"
      ],
      "differential": [
        "低血糖",
        "肝腦病變",
        "中毒（有機磷、番木鱉鹼、美他醛等）",
        "顱內腫瘤",
        "腦炎（感染性或免疫媒介性）",
        "電解質異常（低鈣、低鈉）"
      ],
      "labFindings": [
        "CK 升高（橫紋肌溶解）",
        "代謝性酸中毒（乳酸堆積）",
        "血糖初期升高後可能降低",
        "白血球增多（應激反應）",
        "肝腎指標可能異常（持續缺氧/低灌流）"
      ]
    },
    "treatment": {
      "acute": "ABC（呼吸道-呼吸-循環）→ 地西泮 IV 止痙 → 如果 2 次地西泮無效則進階至苯巴比妥或丙泊酚/麻醉；同時處理高熱、低血糖及代謝性酸中毒",
      "chronic": "確立癲癇病因後給予長期抗癲癇藥物（苯巴比妥、左乙拉西坦、溴化鉀）；教育飼主識別癲癇前驅症狀及居家直腸給藥地西泮",
      "medications": [
        "地西泮（Diazepam）0.5-1 mg/kg IV，可重複 2-3 次",
        "苯巴比妥（Phenobarbital）2-4 mg/kg IV 每 20-30 分鐘至效果出現（最高 24 mg/kg/24hr）",
        "左乙拉西坦（Levetiracetam）20-60 mg/kg IV（可與苯巴比妥併用）",
        "丙泊酚（Propofol）1-6 mg/kg IV bolus 後 0.1-0.6 mg/kg/min CRI（難治性癲癇重積）",
        "甘露醇（Mannitol）0.5-1 g/kg IV（腦水腫時）"
      ],
      "surgery": "若癲癇原因為可切除的腦瘤，在急性期穩定後可考慮神經外科手術"
    },
    "prognosis": "早期控制（<30 分鐘內止痙）者預後尚可。持續超過 60 分鐘的難治性癲癇重積狀態死亡率約 25-40%。基礎病因顯著影響預後：特發性癲癇較好，腦瘤或腦炎較差。存活者可能有永久性神經功能缺損。",
    "pearls": [
      "地西泮超過 2 次無效後不應繼續追加 — 因為 GABA 受體內化使苯二氮平類效力遞減",
      "癲癇發作時首要任務是確保呼吸道通暢，而非立即止痙",
      "飼主可準備地西泮直腸灌注器（0.5 mg/kg）作為癲癇發作的居家急救措施",
      "所有癲癇重積狀態病例在穩定後均需系統性排查病因，不應僅歸因為特發性癲癇"
    ],
    "diagnosticAlgorithm": {
      "title": "癲癇重積狀態 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "緊急穩定",
          "details": "立即評估生命徵象並建立靜脈通路，同時控制癲癇發作",
          "findings": [
            "持續性癲癇發作超過5分鐘",
            "連續發作間無意識恢復",
            "高體溫",
            "心搏過速和高血壓"
          ]
        },
        {
          "step": 2,
          "action": "急診實驗室檢查",
          "details": "快速進行基本血液學和生化排除代謝性原因",
          "findings": [
            "血糖水平（低血糖為常見可逆原因）",
            "電解質紊亂（鈣、鈉）",
            "肝腎功能",
            "毒物暴露史評估"
          ]
        },
        {
          "step": 3,
          "action": "抗癲癇治療與監測",
          "details": "階梯式抗癲癇藥物治療並監測反應",
          "findings": [
            "Diazepam或midazolam初始治療反應",
            "需要持續輸注（CRI）提示難治性SE",
            "Phenobarbital負荷劑量",
            "Levetiracetam輔助治療"
          ]
        },
        {
          "step": 4,
          "action": "病因學調查",
          "details": "穩定後進行全面病因調查",
          "findings": [
            "頭顱MRI排除結構性病變",
            "CSF分析排除腦炎",
            "抗癲癇藥物血藥濃度",
            "壁蝨媒介疾病和弓漿蟲篩檢"
          ]
        },
        {
          "step": 5,
          "action": "併發症評估",
          "details": "評估癲癇重積導致的繼發性損傷",
          "findings": [
            "橫紋肌溶解（CK升高）",
            "DIC篩檢",
            "腦水腫評估",
            "吸入性肺炎風險"
          ]
        }
      ]
    },
    "monitoring": [
      "持續 ECG 及 SpO2 監測",
      "每 15-30 分鐘評估癲癇控制狀態及意識水平",
      "每 1-2 小時監測體溫、血糖、電解質",
      "苯巴比妥給藥後監測血藥濃度（目標 20-35 μg/mL）"
    ],
    "reference": "Clinical Veterinary Advisor: Dogs and Cats"
  },
  "cerebellar-abiotrophy": {
    "zh": "小腦萎縮症",
    "en": "Cerebellar Abiotrophy",
    "definition": "一組遺傳性神經退化性疾病，特徵為正常發育的小腦神經元在出生後逐漸變性壞死。與小腦發育不全（cerebellar hypoplasia）不同，小腦萎縮症的小腦在出生時形態正常，之後才發生進行性退化。臨床表現為進行性小腦共濟失調，發病年齡因品種而異。目前無有效治療方法。",
    "synonyms": [
      "小腦皮質萎縮",
      "遺傳性小腦退化",
      "Cerebellar cortical degeneration",
      "Cerebellar neuronal degeneration"
    ],
    "epidemiology": {
      "species": "犬貓均可發生，犬更常見且品種特異性明顯",
      "breed": "犬：澳洲凱爾乳犬（Kelpie）、Gordon Setter、Old English Sheepdog、Brittany Spaniel、美國斯塔福郡㹴、Beagle、Finnish Harrier 等；貓：較少見，曾報導於家貓",
      "age": "發病年齡因品種而異：新生兒至幼年期（數週至數月齡）或年輕成犬期（1-4 歲）",
      "sex": "無性別差異（常染色體隱性遺傳為主）",
      "prevalence": "在好發品種中為已知的遺傳性疾病，某些品種已有基因檢測可用"
    },
    "clinicalPresentation": {
      "symptoms": [
        "進行性共濟失調（小腦型）",
        "意向性震顫（intentional tremor，目標導向動作時加重）",
        "過度測量性步態（hypermetria）",
        "廣基站姿（wide-based stance）",
        "頭部搖晃（titubation）",
        "步態不穩頻繁跌倒",
        "眼球震顫",
        "頭部傾斜（部分病例）",
        "行走時步幅誇大且不協調"
      ],
      "physicalExam": [
        "小腦型共濟失調（四肢皆受累）",
        "意向性震顫",
        "過度測量性步態（hypermetria）",
        "姿勢反應延遲但本體感覺正常",
        "威脅反射可能異常（小腦途徑受損）",
        "肌力正常但動作協調障礙"
      ]
    },
    "pathophysiology": "小腦萎縮症的病理機制為小腦皮質浦金野細胞（Purkinje cells）及/或顆粒細胞（granule cells）的進行性變性壞死。這些神經元在胚胎期及新生兒期正常分化與遷移，但出生後因內在代謝缺陷（可能涉及蛋白質折疊、粒線體功能或鈣離子穩態異常）而逐漸凋亡。大多數病例為常染色體隱性遺傳，部分品種已鑑定出致病基因突變。浦金野細胞的喪失導致小腦對運動的精細調控能力進行性衰退。",
    "diagnosis": {
      "primary": [
        "好發品種的進行性小腦共濟失調",
        "MRI 顯示小腦萎縮（小腦溝加深、小腦體積減小）",
        "排除其他小腦疾病（感染、腫瘤、發育不全）",
        "基因檢測（部分品種已有商用檢測）"
      ],
      "differential": [
        "小腦發育不全（cerebellar hypoplasia）— 非進行性",
        "犬瘟熱病毒感染（cerebellar involvement）",
        "腦幹/小腦腫瘤",
        "溶酶體儲積症",
        "小腦炎（感染性或免疫媒介性）",
        "小腦梗塞"
      ],
      "labFindings": [
        "一般血液學及生化正常",
        "腦脊髓液分析通常正常",
        "MRI 可見小腦萎縮（進展期明顯）",
        "組織病理學確認浦金野細胞及顆粒細胞喪失"
      ]
    },
    "treatment": {
      "acute": "無特異性急性治療，以支持療法為主",
      "chronic": "目前無有效治療可阻止或逆轉神經退化；生活品質管理（防滑地墊、輔助進食、限制危險環境）；症狀嚴重影響生活品質時需考慮人道處置",
      "medications": [
        "目前無已證實有效的藥物治療",
        "部分文獻嘗試抗氧化劑（維生素 E 200-400 IU/天）但療效不確定",
        "Omega-3 脂肪酸補充（神經保護支持，療效不確定）",
        "苯二氮平類可暫時緩解嚴重震顫但非長期選項"
      ],
      "surgery": "無手術適應症"
    },
    "prognosis": "預後不良至絕望。小腦萎縮症為進行性退化疾病，無有效治療。進展速度因品種而異：某些品種進展迅速（數週至數月失去行動能力），其他品種進展較慢（可存活數年但功能逐漸衰退）。最終多數因嚴重失能而選擇人道處置。",
    "pearls": [
      "小腦萎縮與小腦發育不全的關鍵鑑別：萎縮症為進行性惡化，發育不全為非進行性（穩定或可能輕微改善）",
      "好發品種幼犬出現進行性共濟失調時應高度懷疑此診斷",
      "基因檢測可用於繁殖管理 — 已知帶原犬不應繁殖",
      "確診通常需要 MRI 及/或組織病理學，但品種 + 進行性小腦症狀的組合高度提示"
    ],
    "diagnosticAlgorithm": {
      "title": "小腦萎縮症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "收集品種和年齡資訊，評估小腦功能障礙症狀",
          "findings": [
            "幼年至青年期發病",
            "品種易感性（澳洲牧羊犬、Kerry Blue Terrier等）",
            "進行性共濟失調",
            "意向性震顫"
          ]
        },
        {
          "step": 2,
          "action": "神經學檢查",
          "details": "進行完整神經學檢查確認小腦病變",
          "findings": [
            "過度測量步態（hypermetria）",
            "寬基步態",
            "頭部震顫",
            "威脅反應缺失但視力正常"
          ]
        },
        {
          "step": 3,
          "action": "進階影像學",
          "details": "進行MRI評估小腦結構",
          "findings": [
            "小腦體積縮小",
            "小腦溝加寬加深",
            "小腦蚓部萎縮",
            "排除其他結構性病變"
          ]
        },
        {
          "step": 4,
          "action": "確診",
          "details": "結合品種、年齡、臨床和影像學進行診斷",
          "findings": [
            "基因檢測（部分品種可用）",
            "排除其他小腦疾病",
            "確定性診斷需死後病理學",
            "組織學見Purkinje細胞退化"
          ]
        }
      ]
    },
    "monitoring": [
      "每 2-4 週評估神經學狀態及共濟失調嚴重程度",
      "記錄功能性能力（自主進食、行走、站立能力）",
      "評估生活品質指標",
      "遺傳諮詢（建議飼主對繁殖犬進行基因檢測）"
    ],
    "reference": "Clinical Veterinary Advisor: Dogs and Cats"
  },
  "peripheral-neuropathy": {
    "zh": "周邊神經病變",
    "en": "Peripheral Neuropathy",
    "definition": "泛指影響周邊神經系統（腦神經、脊神經、自律神經）的各種疾病總稱。可影響運動神經、感覺神經、自律神經或三者的組合。病因多樣，包括免疫媒介性、代謝性、中毒性、感染性、腫瘤相關及遺傳性原因。臨床表現從局部單一神經病變到廣泛性多發性神經病變不等。",
    "synonyms": [
      "末梢神經病變",
      "多發性神經病變",
      "Polyneuropathy",
      "Neuritis"
    ],
    "epidemiology": {
      "species": "犬貓均可發生",
      "breed": "特定遺傳性神經病變好發於某些品種；犬：拳師犬（進行性軸突病變）、拉布拉多（遺傳性多發性神經病變）、大丹犬、Alaskan Malamute（遺傳性多發性神經病變）等",
      "age": "遺傳性型態在幼年發病；免疫媒介性和代謝性型態多見於中老年",
      "sex": "大多數類型無性別差異",
      "prevalence": "整體發生率在小動物神經科疾病中佔有一定比例，確切流行率因病因而異"
    },
    "clinicalPresentation": {
      "symptoms": [
        "進行性四肢無力（通常後肢先受累）",
        "步態異常（短步、跛行、兔跳步態）",
        "肌肉萎縮（神經源性萎縮）",
        "反射減弱或消失（下運動神經元徵象）",
        "感覺異常（觸覺、痛覺減退或異常疼痛感）",
        "聲音改變/吠叫聲異常（喉返神經受累）",
        "吞嚥困難（顱神經受累）",
        "巨食道症（迷走神經受累）",
        "呼吸困難（膈神經受累）",
        "尿失禁（自律神經受累時）"
      ],
      "physicalExam": [
        "下運動神經元徵象（肌張力減低、反射減弱/消失）",
        "神經源性肌肉萎縮",
        "本體感覺缺失",
        "指趾背屈反射延遲或消失",
        "脊髓反射減弱（膝蓋、撓側伸腕反射）",
        "面部肌肉無力或面部神經麻痺（顱神經受累時）"
      ]
    },
    "pathophysiology": "周邊神經病變的病理機制主要分為兩類：(1) 軸突退化（axonopathy）：軸突本身因代謝障礙或毒素作用而退化，通常從遠端開始向近端發展（dying-back pattern）；(2) 脫髓鞘（demyelination）：髓鞘被免疫反應、遺傳缺陷或代謝異常破壞，導致神經傳導速度減慢或傳導阻斷。免疫媒介性多發性神經病變（如急性多發性神經根炎/Coonhound paralysis）類似人類的 Guillain-Barré 症候群，由自身免疫攻擊周邊神經髓鞘或軸突引起。",
    "diagnosis": {
      "primary": [
        "神經學檢查定位為下運動神經元（LMN）病變",
        "肌電圖（EMG）顯示去神經支配電位",
        "神經傳導速度（NCV）檢測（脫髓鞘型減慢）",
        "神經及肌肉切片病理學檢查"
      ],
      "differential": [
        "重症肌無力（myasthenia gravis）",
        "蜱麻痺（tick paralysis）",
        "肉毒桿菌中毒",
        "脊髓疾病",
        "多發性肌炎",
        "內分泌性肌病（甲狀腺功能低下、腎上腺皮質機能亢進）"
      ],
      "labFindings": [
        "EMG 見正銳波（positive sharp waves）及纖維自發電位（fibrillation potentials）",
        "神經傳導速度降低（脫髓鞘型）或複合肌肉動作電位振幅降低（軸突型）",
        "腦脊髓液蛋白質可能升高（蛋白-細胞分離現象，特別是多發性神經根炎）",
        "甲狀腺功能檢測（排除甲狀腺功能低下）",
        "乙醯膽鹼受體抗體（排除重症肌無力）"
      ]
    },
    "treatment": {
      "acute": "免疫媒介性類型：免疫抑制療法（prednisolone 1-2 mg/kg/day）；急性呼吸衰竭需機械通氣支持",
      "chronic": "長期免疫調節治療（免疫媒介性）；物理治療及復健運動維持肌肉量及關節活動度；針對基礎病因治療（如甲狀腺素補充、控制糖尿病）",
      "medications": [
        "Prednisolone 1-2 mg/kg/day PO（免疫媒介性，逐漸減量）",
        "Mycophenolate mofetil 10-20 mg/kg PO BID（免疫媒介性輔助治療）",
        "甲鈷胺（Methylcobalamin/B12）若有 B12 缺乏",
        "Gabapentin 5-10 mg/kg PO TID（神經性疼痛管理）",
        "Levothyroxine 0.02 mg/kg PO BID（甲狀腺功能低下相關病例）"
      ],
      "surgery": "一般無手術適應症；局部壓迫性神經病變可能需手術減壓"
    },
    "prognosis": "取決於病因。免疫媒介性急性多發性神經根炎（Coonhound paralysis）多數在 3-6 週內自行恢復，但恢復可能不完全。遺傳性神經病變通常為進行性，無有效治療。代謝性病因（甲狀腺功能低下、糖尿病）若基礎疾病得到控制，部分可改善。腫瘤相關性神經病變預後不良。",
    "pearls": [
      "犬的急性四肢無力：首先排除蜱麻痺（檢查全身有無蜱蟲），其次考慮免疫媒介性多發性神經根炎",
      "甲狀腺功能低下是犬多發性神經病變的重要可治療病因，應常規篩查",
      "EMG 需在去神經支配後 5-7 天才會出現典型異常放電，太早檢查可能假陰性",
      "呼吸功能監測極為重要 — 膈神經受累可能導致急性呼吸衰竭"
    ],
    "diagnosticAlgorithm": {
      "title": "周邊神經病變 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估下運動神經元症狀和分布模式",
          "findings": [
            "漸進性四肢無力",
            "肌肉萎縮",
            "反射減退或消失",
            "感覺異常或疼痛"
          ]
        },
        {
          "step": 2,
          "action": "實驗室檢查",
          "details": "進行基本血液學和生化排除代謝性和內分泌原因",
          "findings": [
            "甲狀腺功能檢查",
            "血糖評估（糖尿病性神經病變）",
            "感染篩檢",
            "腫瘤標記物"
          ]
        },
        {
          "step": 3,
          "action": "電生理學檢查",
          "details": "進行肌電圖和神經傳導速度檢查",
          "findings": [
            "神經傳導速度下降（脫髓鞘型）",
            "複合肌肉動作電位振幅降低（軸索型）",
            "自發性電位活動",
            "纖維顫動和正尖波"
          ]
        },
        {
          "step": 4,
          "action": "神經活檢",
          "details": "視情況進行周邊神經活檢確認病理類型",
          "findings": [
            "脫髓鞘性vs軸索性病變",
            "炎症性浸潤",
            "Wallerian退化",
            "腫瘤性浸潤"
          ]
        }
      ]
    },
    "monitoring": [
      "每 1-2 週評估肌力及神經學功能恢復進度",
      "監測呼吸功能（呼吸頻率、血氧飽和度）",
      "定期 EMG 追蹤去神經支配及再支配情況",
      "免疫抑制治療期間監測 CBC、肝腎功能"
    ],
    "reference": "Textbook of Veterinary Internal Medicine (Ettinger & Feldman)"
  },
  "lysosomal-storage-disease": {
    "zh": "溶酶體儲積症",
    "en": "Lysosomal Storage Disease",
    "definition": "一群遺傳性代謝疾病的總稱，因溶酶體內特定水解酶的缺乏或功能異常，導致未降解的巨分子基質（如糖脂質、醣蛋白、黏多醣等）在細胞內異常堆積。累積的物質最終損害細胞功能，特別是中樞神經系統神經元，導致進行性神經退化。在犬貓中已辨識出超過 20 種不同的溶酶體儲積症。",
    "synonyms": [
      "溶酶體貯積病",
      "溶體貯積症",
      "LSD",
      "Lysosomal storage disorder"
    ],
    "epidemiology": {
      "species": "犬貓均可發生，已在多個品種中確認",
      "breed": "犬：葡萄牙水犬（GM1 神經節苷脂症）、德國短毛指示犬（GM2）、英國 Springer Spaniel（fucosidosis）等；貓：暹羅貓（GM1）、柯乃爾斯卷毛貓（mannosidosis）等",
      "age": "多數在出生後數週至數月齡發病，少數遲發型可在 1-2 歲後出現",
      "sex": "大多數為常染色體隱性遺傳，無性別差異；少數 X-linked（如 mucopolysaccharidosis II）",
      "prevalence": "個別疾病罕見，但作為一群疾病在繁殖犬貓群中需關注"
    },
    "clinicalPresentation": {
      "symptoms": [
        "進行性神經功能退化（最常見主訴）",
        "共濟失調/步態異常",
        "視力障礙/失明",
        "行為改變（認知功能退化）",
        "癲癇發作",
        "震顫",
        "發育遲緩或生長停滯",
        "骨骼異常/侏儒（黏多醣症）",
        "面部特徵粗糙（黏多醣症）",
        "肝脾腫大",
        "角膜混濁（部分類型）"
      ],
      "physicalExam": [
        "進行性小腦及/或大腦共濟失調",
        "肝脾腫大（部分類型）",
        "骨骼發育異常（黏多醣症：短肢、關節僵硬）",
        "角膜混濁（黏多醣症、gangliosidosis 部分類型）",
        "面部特徵粗糙（黏多醣症）",
        "肌力減退"
      ]
    },
    "pathophysiology": "溶酶體儲積症由編碼溶酶體水解酶的基因突變引起，導致特定酶活性缺乏或嚴重不足。無法被降解的巨分子基質在溶酶體內逐漸堆積，使溶酶體膨脹並佔據大部分細胞質，最終干擾細胞正常功能。神經元因高度依賴溶酶體自噬途徑維持內環境穩定，對儲積物堆積特別敏感。堆積物還會啟動二次病理機制，包括氧化壓力、發炎反應、鈣離子穩態失調及細胞凋亡，加速神經退化。",
    "diagnosis": {
      "primary": [
        "好發品種幼齡動物出現進行性神經退化",
        "特定溶酶體酵素活性檢測（白血球或培養的皮膚纖維母細胞）",
        "基因檢測（已知突變的品種）",
        "尿液代謝物篩檢（如尿液黏多醣分析）"
      ],
      "differential": [
        "小腦萎縮症（cerebellar abiotrophy）",
        "犬瘟熱腦炎",
        "先天性腦積水",
        "肝腦病變",
        "鉛中毒",
        "其他遺傳性神經退化疾病"
      ],
      "labFindings": [
        "特定溶酶體酵素活性顯著降低（確診依據）",
        "周邊血液淋巴球或嗜中性球可見異常顆粒或空泡",
        "尿液黏多醣定量或定性篩檢異常（黏多醣症）",
        "組織病理學見神經元及其他細胞內 PAS 陽性或膜性空泡堆積"
      ]
    },
    "treatment": {
      "acute": "無特異性急性治療；癲癇發作時給予標準抗癲癇藥物",
      "chronic": "目前大多數類型無有效治療；酵素替代療法（ERT）在少數類型有實驗性進展；造血幹細胞移植在某些類型有報導；基因治療為研究方向；支持療法及生活品質管理",
      "medications": [
        "抗癲癇藥物（苯巴比妥、左乙拉西坦）控制癲癇",
        "酵素替代療法（ERT）— 僅在實驗性臨床試驗中（如 MPS I 的 laronidase）",
        "支持性營養補充",
        "止痛藥物（如有骨骼疼痛）"
      ],
      "surgery": "一般無手術適應症；實驗性造血幹細胞移植或基因治療為研究性治療"
    },
    "prognosis": "預後極差至絕望。大多數溶酶體儲積症為進行性致死性疾病。患畜通常在發病後數月至 1-2 年內因嚴重神經退化需人道處置。酵素替代療法及基因治療在實驗階段對部分類型顯示希望，但尚未成為常規治療。",
    "pearls": [
      "幼齡動物出現進行性神經退化 — 需將溶酶體儲積症列入鑑別診斷",
      "周邊血液抹片檢查淋巴球有無空泡是簡便的初步篩查方法",
      "繁殖犬貓的品種特異性基因檢測是預防此類疾病的最有效策略",
      "同窩動物可能也受影響 — 建議對同窩幼犬/幼貓進行篩查"
    ],
    "diagnosticAlgorithm": {
      "title": "溶酶體儲積症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估幼齡動物進行性神經症狀和品種背景",
          "findings": [
            "幼年動物進行性神經退化",
            "品種易感性",
            "生長發育遲緩",
            "視覺障礙或行為異常"
          ]
        },
        {
          "step": 2,
          "action": "血液學與生化檢查",
          "details": "進行血液學和相關酶學檢查",
          "findings": [
            "白血球內異常顆粒或空泡",
            "血漿特定酶活性降低",
            "尿液寡醣或黏多醣排出異常",
            "肝臟酶可能異常"
          ]
        },
        {
          "step": 3,
          "action": "進階影像學",
          "details": "進行MRI評估腦部結構變化",
          "findings": [
            "腦白質異常信號",
            "腦室擴大",
            "腦萎縮",
            "小腦萎縮"
          ]
        },
        {
          "step": 4,
          "action": "酶學與基因診斷",
          "details": "進行特定酶活性測定和基因檢測確診",
          "findings": [
            "白血球或成纖維細胞特定酶活性測定",
            "基因突變檢測（部分疾病可用）",
            "組織活檢見特徵性儲積物",
            "電子顯微鏡見特徵性包涵體"
          ]
        }
      ]
    },
    "monitoring": [
      "每 2-4 週評估神經學功能退化速度",
      "定期評估生活品質（進食能力、行動能力、認知狀態）",
      "癲癇控制情況追蹤",
      "遺傳諮詢及繁殖犬貓的基因篩檢建議"
    ],
    "reference": "A Textbook of the Diseases of Cattle, Horses, Sheep, Pigs, and Goats; Clinical Veterinary Advisor"
  },
  "spinal-arachnoid-diverticulum": {
    "zh": "脊髓蛛網膜憩室",
    "en": "Spinal Arachnoid Diverticulum",
    "definition": "又稱脊髓蛛網膜囊腫（spinal arachnoid cyst），為蛛網膜與軟膜之間的腦脊髓液局部積聚，形成囊袋狀擴張壓迫脊髓。好發於頸胸段或胸腰段脊髓背側。可為先天性或後天性，導致進行性脊髓壓迫症狀。此疾病在犬中較常見，尤其好發於某些中大型品種。",
    "synonyms": [
      "脊髓蛛網膜囊腫",
      "Spinal arachnoid cyst",
      "Subarachnoid cyst",
      "Spinal meningeal cyst"
    ],
    "epidemiology": {
      "species": "犬為主，貓罕見",
      "breed": "犬：法國鬥牛犬、羅威納、Pug、Shih Tzu 等短頭型品種好發；大型品種中 Rottweiler 尤其常見",
      "age": "先天性者多在年輕犬（<3 歲）表現症狀；後天性者可在任何年齡",
      "sex": "雄性可能較雌性略多",
      "prevalence": "相對少見但隨著 MRI 普及而診斷率增加"
    },
    "clinicalPresentation": {
      "symptoms": [
        "進行性後肢無力/癱瘓",
        "步態不穩/共濟失調",
        "後肢僵硬（上運動神經元性）",
        "本體感覺缺失",
        "背部或頸部疼痛（部分病例）",
        "大小便功能障礙（嚴重者）",
        "前肢症狀（頸段病變時）",
        "症狀可能呈波動性（時好時壞）"
      ],
      "physicalExam": [
        "上運動神經元徵象（病變尾側肢體反射亢進）",
        "本體感覺缺失（指趾背屈反射延遲）",
        "步態為上運動神經元型共濟失調",
        "脊髓觸診可能有疼痛反應",
        "膀胱張力增加（上運動神經元性膀胱）"
      ]
    },
    "pathophysiology": "脊髓蛛網膜憩室的形成機制尚不完全清楚。先天性者可能源於蛛網膜發育異常，導致蛛網膜組織局部薄弱或折疊形成單向活瓣效應，腦脊髓液流入但不易流出。後天性者可能繼發於脊髓炎症、創傷或手術後的蛛網膜纖維化與黏連。囊腫逐漸擴大壓迫鄰近脊髓，導致局部缺血、脫髓鞘及軸突變性，引起進行性脊髓功能障礙。腦脊髓液脈動壓力可能在囊腫擴大中扮演角色。",
    "diagnosis": {
      "primary": [
        "MRI 為首選診斷工具（T2 加權像上於脊髓背側見高信號囊性病變，信號同腦脊髓液）",
        "CT 脊髓造影（myelography-CT）可確認囊腫位置及與蛛網膜下腔的溝通",
        "神經學檢查定位脊髓病變節段",
        "排除椎間盤疾病等更常見原因"
      ],
      "differential": [
        "椎間盤疾病（Hansen Type I 或 II）",
        "脊髓腫瘤",
        "纖維軟骨栓塞性脊髓病",
        "退化性脊髓病（degenerative myelopathy）",
        "脊椎不穩定/半脫位",
        "脊髓炎"
      ],
      "labFindings": [
        "一般血液學及生化正常",
        "腦脊髓液分析通常正常或蛋白質輕度升高",
        "MRI 上蛛網膜下腔局部擴張，信號與腦脊髓液一致",
        "CT 脊髓造影見造影劑積聚於憩室內"
      ]
    },
    "treatment": {
      "acute": "症狀輕微者可保守觀察；疼痛管理",
      "chronic": "手術治療為確定性治療 — 椎板切除術（laminectomy）暴露囊腫後行造袋術（marsupialization）或囊腫壁切除（fenestration），恢復腦脊髓液正常流動",
      "medications": [
        "Gabapentin 5-10 mg/kg PO TID（神經性疼痛）",
        "NSAIDs（Meloxicam 0.1 mg/kg PO SID）用於疼痛管理",
        "Prednisolone 短期低劑量 0.5 mg/kg/day（減少脊髓水腫，為手術前橋接治療）"
      ],
      "surgery": "背側椎板切除術（dorsal laminectomy）+ 憩室造袋術或壁切除術為推薦的確定性治療；成功率約 70-80%"
    },
    "prognosis": "手術治療者預後良好，約 70-80% 的病例術後神經功能改善或穩定。保守治療者多數為進行性惡化。術後可能復發（約 10-20%），需長期追蹤 MRI。嚴重且長期脊髓壓迫的病例即使手術，神經功能恢復也可能不完全。",
    "pearls": [
      "MRI 是診斷脊髓蛛網膜憩室的金標準，但需注意與其他脊髓內/外囊性病變鑑別",
      "症狀的波動性（時好時壞）是此病的特徵之一，可能與腦脊髓液壓力變化有關",
      "法國鬥牛犬為近年來報導率增加最快的好發品種",
      "手術時機很重要 — 早期手術（神經功能缺損輕度時）預後優於晚期手術"
    ],
    "diagnosticAlgorithm": {
      "title": "脊髓蛛網膜憩室 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估慢性進行性脊髓壓迫症狀",
          "findings": [
            "漸進性後肢無力和共濟失調",
            "疼痛反應可能正常或減退",
            "好發於中大型犬品種",
            "頸椎或胸腰椎段"
          ]
        },
        {
          "step": 2,
          "action": "神經學定位",
          "details": "進行完整神經學檢查定位病變節段",
          "findings": [
            "上運動神經元徵象",
            "本體感覺缺陷",
            "定位至特定脊髓節段",
            "膀胱功能評估"
          ]
        },
        {
          "step": 3,
          "action": "進階影像學",
          "details": "進行MRI或脊髓造影確認蛛網膜憩室",
          "findings": [
            "MRI見脊髓背側或腹側CSF信號擴張",
            "脊髓受壓和萎縮",
            "脊髓造影顯示造影劑充填缺損",
            "CT脊髓造影精確定位"
          ]
        },
        {
          "step": 4,
          "action": "手術規劃",
          "details": "評估手術指征和術式選擇",
          "findings": [
            "確認憩室位置和範圍",
            "評估脊髓功能殘存",
            "排除其他脊髓壓迫原因",
            "椎板切除減壓術規劃"
          ]
        }
      ]
    },
    "monitoring": [
      "術後每 2-4 週評估神經學恢復進度",
      "術後 3-6 個月 MRI 追蹤（確認囊腫無復發）",
      "長期每 6-12 個月神經學追蹤",
      "注意症狀復發的早期徵象"
    ],
    "reference": "Textbook of Veterinary Diagnostic Radiology (Thrall)"
  },
  "scottie-cramp": {
    "zh": "蘇格蘭㹴痙攣症",
    "en": "Scottie Cramp",
    "definition": "蘇格蘭㹴犬（Scottish Terrier）的遺傳性運動障礙，為常染色體隱性遺傳。此疾病與中樞神經系統血清素代謝異常有關，導致運動時出現特徵性的肌肉過度收縮及步態異常。發作通常由運動、興奮或壓力誘發，休息後可完全恢復正常。此症不會進行性惡化，不影響壽命。",
    "synonyms": [
      "蘇格蘭㹴肌痙攣",
      "Scottish Terrier cramp",
      "Hyperkinetic disorder of Scottish Terriers"
    ],
    "epidemiology": {
      "species": "犬（幾乎僅見於蘇格蘭㹴）",
      "breed": "蘇格蘭㹴（Scottish Terrier）幾乎獨有",
      "age": "通常在數週至數月齡開始出現症狀",
      "sex": "無性別差異（常染色體隱性遺傳）",
      "prevalence": "在蘇格蘭㹴品種中為已知的遺傳性疾病，確切盛行率不明"
    },
    "clinicalPresentation": {
      "symptoms": [
        "運動時出現後肢僵硬/痙攣",
        "背部拱起（弓背姿勢）",
        "步態異常（鵝步樣高抬腿步態）",
        "奔跑時後肢過度屈曲或伸直",
        "嚴重時翻滾或無法行走",
        "面部肌肉痙攣",
        "發作間期完全正常",
        "興奮、壓力或劇烈運動誘發",
        "休息數分鐘至半小時後完全恢復"
      ],
      "physicalExam": [
        "發作間期神經學檢查完全正常",
        "發作時可見步態僵硬及肌張力增高",
        "無疼痛反應",
        "意識完全清醒（非癲癇發作）",
        "肌肉質量及力量正常"
      ]
    },
    "pathophysiology": "Scottie Cramp 的確切病理機制與中樞血清素（5-HT）通路異常有關。研究顯示受影響犬的中樞神經系統血清素代謝或受體功能異常，導致運動調控中樞對血清素信號的處理出現障礙。在運動或情緒激動時，正常的運動調控機制無法正確協調拮抗肌群的收縮與放鬆，導致肌肉同時收縮及特徵性的步態異常。這不是真正的肌肉疾病或癲癇，而是中樞運動調控失常。",
    "diagnosis": {
      "primary": [
        "蘇格蘭㹴品種的特徵性運動誘發性步態異常",
        "發作間期完全正常的神經學檢查",
        "症狀可由運動或興奮誘發",
        "排除其他導致運動障礙的疾病"
      ],
      "differential": [
        "癲癇症",
        "肌強直症（myotonia congenita）",
        "低血糖",
        "運動誘發性虛脫（exercise-induced collapse, EIC）",
        "重症肌無力",
        "脊髓疾病"
      ],
      "labFindings": [
        "一般血液學及生化完全正常",
        "CK 正常（非肌肉損傷）",
        "EMG 正常（非肌原性疾病）",
        "MRI 正常（無結構性神經病變）"
      ]
    },
    "treatment": {
      "acute": "發作時讓犬隻安靜休息即可，通常數分鐘至半小時自行緩解",
      "chronic": "嚴重影響生活品質的病例可嘗試藥物控制；避免過度運動及壓力情境；生活管理為主",
      "medications": [
        "地西泮（Diazepam）0.5-1 mg/kg PO PRN（嚴重發作前後緩解）",
        "Acepromazine 0.1-0.2 mg/kg PO PRN（抑制發作前使用）",
        "維生素 E 補充（抗氧化支持，療效不確定）",
        "大多數病例不需要長期藥物治療"
      ],
      "surgery": "無手術適應症"
    },
    "prognosis": "預後良好。Scottie Cramp 不是進行性疾病，不影響壽命。多數犬在輕度至中度運動下可正常生活。避免誘發因素（過度運動、極度興奮）可減少發作頻率。對日常生活的影響通常輕微至中度。",
    "pearls": [
      "Scottie Cramp 最重要的鑑別是癲癇 — 此症發作時意識完全清醒且無自律神經症狀",
      "飼主常將發作描述為「看起來像機器人在走路」或「後肢好像黏在一起」",
      "繁殖犬應避免帶有此基因的配對",
      "運動前給予小劑量地西泮可預防部分嚴重發作"
    ],
    "diagnosticAlgorithm": {
      "title": "蘇格蘭㹴痙攣症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "確認品種和發作特徵",
          "findings": [
            "蘇格蘭㹴品種",
            "運動或興奮時誘發",
            "四肢僵硬和過度屈曲",
            "休息後症狀緩解"
          ]
        },
        {
          "step": 2,
          "action": "神經學檢查",
          "details": "靜息和運動時的神經學評估",
          "findings": [
            "靜息時神經學檢查正常",
            "運動誘發步態異常",
            "脊柱過度彎曲（弓背）",
            "無意識喪失"
          ]
        },
        {
          "step": 3,
          "action": "排除性診斷",
          "details": "排除其他運動障礙和代謝性疾病",
          "findings": [
            "血液學和生化正常",
            "肌電圖正常",
            "CK正常",
            "基因檢測可能可用"
          ]
        }
      ]
    },
    "monitoring": [
      "記錄發作頻率、持續時間及誘發因素",
      "評估生活品質是否受影響",
      "若有藥物治療，監測藥物副作用",
      "遺傳諮詢（繁殖管理）"
    ],
    "reference": "Saunders Comprehensive Veterinary Dictionary; Clinical Veterinary Advisor"
  },
  "canine-distal-polyneuropathy": {
    "zh": "犬遠端多發性神經病變",
    "en": "Canine Distal Polyneuropathy",
    "definition": "一種主要影響犬遠端周邊神經的退化性神經病變，特徵為遠端肢體感覺及運動功能進行性喪失。病因可為遺傳性、代謝性（如糖尿病、甲狀腺功能低下）、中毒性或特發性。臨床表現為進行性遠端肌肉萎縮、反射消失及感覺缺失，呈典型的「手套-襪子」分布模式。",
    "synonyms": [
      "犬遠端型多發性神經炎",
      "犬末梢神經退化",
      "Distal denervating disease",
      "Distal axonopathy"
    ],
    "epidemiology": {
      "species": "犬",
      "breed": "遺傳性類型：Alaskan Malamute、Leonberger、Greyhound、Rottweiler 等；後天性類型所有品種均可發生",
      "age": "遺傳性者幼年發病（數月齡）；後天性者中老年多見",
      "sex": "無明顯性別差異",
      "prevalence": "整體不常見，但特定品種的遺傳性型態有已知的盛行率"
    },
    "clinicalPresentation": {
      "symptoms": [
        "後肢遠端無力（從趾/掌開始）",
        "進行性肌肉萎縮（遠端為主）",
        "指趾背屈/拖行",
        "指甲過度磨損（拖地行走）",
        "步態異常（短步、跛行）",
        "後肢關節過度伸展（plantigrade stance）",
        "對遠端肢體觸摸或疼痛反應減弱",
        "前肢最終也會受累（疾病進展時）",
        "吠叫聲改變（喉返神經受累時）"
      ],
      "physicalExam": [
        "遠端肌肉萎縮（特別是手部及足部小肌群）",
        "指趾背屈反射延遲或消失",
        "脊髓反射減弱（遠端為主，近端可能保留）",
        "足部觸覺及痛覺減退",
        "跗關節下沉（plantigrade/palmigrade 站姿）",
        "指甲磨損不均（拖行徵象）"
      ]
    },
    "pathophysiology": "犬遠端多發性神經病變的病理特徵為軸突的遠端退化（dying-back axonopathy）。病變從最長的神經纖維遠端開始，逐漸向近端發展。軸突退化可能源於軸突運輸功能障礙（軸突內物質從細胞體到末梢的運輸受損）、粒線體功能異常或細胞骨架蛋白缺陷。在遺傳性病例中，已知部分品種存在特定基因突變影響軸突維護機制。軸突退化後，其所支配的肌肉纖維失去神經支配而萎縮（去神經性萎縮）。",
    "diagnosis": {
      "primary": [
        "神經學檢查定位為遠端周邊神經病變",
        "肌電圖（EMG）顯示遠端肌群去神經支配電位",
        "神經傳導速度檢測（運動及感覺）",
        "神經活體切片（sural nerve biopsy）"
      ],
      "differential": [
        "退化性脊髓病（degenerative myelopathy）",
        "重症肌無力",
        "免疫媒介性多發性神經炎",
        "甲狀腺功能低下性神經病變",
        "糖尿病性神經病變",
        "蜱麻痺"
      ],
      "labFindings": [
        "EMG 見遠端肌群正銳波及纖維自發電位",
        "運動神經傳導速度可能正常或輕度降低（軸突型）",
        "感覺神經動作電位振幅降低",
        "神經活體切片見軸突變性及 Wallerian 退化",
        "甲狀腺功能及血糖檢查排除代謝性病因"
      ]
    },
    "treatment": {
      "acute": "針對可治療的基礎病因治療（甲狀腺素補充、血糖控制等）",
      "chronic": "物理治療及復健運動維持肌肉量與關節活動度；使用足部保護裝具（boots）防止指趾磨損；環境適應（防滑地墊）；基礎病因治療",
      "medications": [
        "Levothyroxine 0.02 mg/kg PO BID（甲狀腺功能低下相關）",
        "B 群維生素補充（B1、B6、B12）— 神經營養支持",
        "Gabapentin 5-10 mg/kg PO TID（神經性疼痛/感覺異常）",
        "Omega-3 脂肪酸（抗發炎及神經保護支持）"
      ],
      "surgery": "一般無手術適應症"
    },
    "prognosis": "取決於病因。代謝性病因（甲狀腺功能低下）若及早治療可部分改善或穩定。遺傳性者多為進行性，最終可能嚴重影響行動能力。特發性者病程難以預測。整體而言，遠端多發性神經病變通常為慢性進行性，多數只能延緩進展而非治癒。",
    "pearls": [
      "犬的「plantigrade stance」（跗關節完全觸地）是遠端神經病變的高度特徵性表現",
      "指甲磨損不均且無明確創傷史 — 應考慮早期遠端神經病變",
      "甲狀腺功能低下是犬最常見的可治療性多發性神經病變病因之一",
      "EMG 及神經傳導速度檢查需在專門的獸醫神經科中心進行"
    ],
    "diagnosticAlgorithm": {
      "title": "犬遠端多發性神經病變 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估遠端為主的對稱性神經病變症狀",
          "findings": [
            "遠端肢體無力",
            "指甲過度磨損",
            "四肢遠端肌肉萎縮",
            "漸進性病程"
          ]
        },
        {
          "step": 2,
          "action": "神經學檢查",
          "details": "進行完整神經學檢查評估分布模式",
          "findings": [
            "遠端反射減退",
            "本體感覺缺陷",
            "肌張力降低",
            "對稱性分布"
          ]
        },
        {
          "step": 3,
          "action": "電生理學與病因篩檢",
          "details": "進行肌電圖、神經傳導速度和代謝篩檢",
          "findings": [
            "遠端神經傳導速度下降",
            "自發性電位活動",
            "甲狀腺和血糖檢查",
            "排除毒物暴露"
          ]
        },
        {
          "step": 4,
          "action": "神經活檢確診",
          "details": "進行周邊神經和肌肉活檢",
          "findings": [
            "遠端軸索退化",
            "脫髓鞘變化",
            "排除炎症性病因",
            "確認退化性vs免疫介導性"
          ]
        }
      ]
    },
    "monitoring": [
      "每 4-8 週評估遠端肌力及感覺功能",
      "記錄功能性能力（行走距離、跌倒頻率）",
      "若有甲狀腺素治療，每 4-6 週監測 T4 濃度",
      "定期檢查足部皮膚完整性（感覺缺失導致無痛性損傷風險）"
    ],
    "reference": "Textbook of Veterinary Internal Medicine (Ettinger & Feldman)"
  },
  "tremor-syndrome": {
    "zh": "特發性全身性震顫症候群",
    "en": "Idiopathic Generalized Tremor Syndrome",
    "definition": "又稱白色犬震顫症候群（white shaker dog syndrome）或響應性全身性震顫症（responsive generalized tremor syndrome），為犬的特發性全身性震顫疾病，病因推測與中樞神經系統的免疫媒介性炎症有關。最初在白色小型犬（Maltese、West Highland White Terrier）中描述，但實際上各毛色及體型犬隻均可發生。臨床特徵為突發的全身性細微震顫，對類固醇治療反應良好。",
    "synonyms": [
      "白色犬震顫症",
      "White shaker dog syndrome",
      "響應性全身性震顫症",
      "Idiopathic cerebellitis",
      "Steroid-responsive tremor syndrome"
    ],
    "epidemiology": {
      "species": "犬（貓極罕見有類似報導）",
      "breed": "最初認為好發於白色小型犬（Maltese、West Highland White Terrier、Bichon Frise、Poodle），但實際上任何品種及毛色均可發生",
      "age": "通常 1-5 歲的年輕成犬發病",
      "sex": "無明顯性別差異",
      "prevalence": "為犬全身性震顫的常見原因之一，小型犬較多報導但大型犬亦有"
    },
    "clinicalPresentation": {
      "symptoms": [
        "突發的全身性細微至中度震顫",
        "震顫在運動及興奮時加重",
        "靜息或睡眠時震顫減輕或消失",
        "頭部震顫（head bobbing）",
        "眼球震顫（部分病例）",
        "輕度共濟失調",
        "意向性震顫",
        "精神狀態通常正常"
      ],
      "physicalExam": [
        "全身性細微到中度震顫",
        "觸診或情緒激動時震顫加重",
        "意識清醒且反應正常",
        "神經學檢查除震顫外多為正常",
        "可能有輕度共濟失調或辨距不良",
        "體溫正常"
      ]
    },
    "pathophysiology": "確切病因尚不完全清楚，但推測為中樞神經系統的免疫媒介性輕度炎症，可能涉及小腦及腦幹。病理學研究在部分病例的中樞神經系統發現輕度非化膿性腦膜腦炎，支持免疫媒介性病理機制。過去認為與酪胺酸代謝異常有關（因好發於白色犬），但此假說已不被廣泛接受，因為各種毛色犬均可發病。對皮質類固醇的良好反應進一步支持免疫媒介性病因。腦脊髓液分析可見輕度單核球性炎症。",
    "diagnosis": {
      "primary": [
        "典型的臨床表現（年輕犬突發全身性震顫，意識正常）",
        "腦脊髓液分析（可見輕度單核球性炎症）",
        "排除中毒及代謝性原因",
        "對皮質類固醇治療反應良好具診斷性意義"
      ],
      "differential": [
        "除蟲菊精中毒",
        "有機磷/氨基甲酸酯中毒",
        "小腦疾病（腫瘤、炎症、萎縮）",
        "低血糖",
        "低鈣血症",
        "肝腦病變"
      ],
      "labFindings": [
        "一般血液學及生化通常正常",
        "腦脊髓液蛋白質輕度升高，單核球增加（輕度炎症）",
        "MRI 通常正常或見輕微非特異性變化",
        "毒物學篩檢陰性"
      ]
    },
    "treatment": {
      "acute": "Prednisolone 1-2 mg/kg/day PO 起始劑量；多數犬在 3-5 天內顯著改善",
      "chronic": "逐漸減量 prednisolone（每 2-4 週減量 25%），持續 3-6 個月後嘗試停藥；部分犬需低劑量長期維持；復發時需重新開始治療",
      "medications": [
        "Prednisolone 1-2 mg/kg/day PO（起始劑量，逐漸減量）",
        "地西泮（Diazepam）0.25-0.5 mg/kg PO TID（嚴重震顫時作為輔助治療）",
        "Levetiracetam 20 mg/kg PO TID（輔助控制震顫）",
        "Mycophenolate mofetil 10-20 mg/kg PO BID（類固醇節約劑，難治性病例）"
      ],
      "surgery": "無手術適應症"
    },
    "prognosis": "預後良好至極佳。大多數犬對皮質類固醇治療反應迅速且顯著（3-7 天內改善）。約 25-30% 的病例在完全停藥後會復發，需重新治療。少數病例需要低劑量長期維持治療。長期預後良好，不影響壽命。",
    "pearls": [
      "雖然名為「白色犬震顫症」，但任何毛色犬均可發病 — 不要因為犬隻不是白色就排除此診斷",
      "對類固醇的快速反應（3-5 天內）本身具有重要的診斷價值",
      "與除蟲菊精中毒的主要鑑別：震顫症候群意識清醒且無跳蚤產品接觸史",
      "初次發作時建議做腦脊髓液分析排除感染性腦炎，復發時通常不需要重複"
    ],
    "diagnosticAlgorithm": {
      "title": "特發性全身性震顫症候群 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估全身性震顫特徵，曾稱白色搖搖犬症候群",
          "findings": [
            "全身性細微至粗大震顫",
            "任何品種和毛色均可發病",
            "通常1-3歲發病",
            "休息時震顫減輕，活動時加重"
          ]
        },
        {
          "step": 2,
          "action": "實驗室檢查",
          "details": "排除代謝性和感染性原因",
          "findings": [
            "全血計數和生化正常",
            "甲狀腺功能正常",
            "感染篩檢陰性",
            "毒物篩檢陰性"
          ]
        },
        {
          "step": 3,
          "action": "進階神經學評估",
          "details": "排除結構性中樞神經系統疾病",
          "findings": [
            "MRI通常正常",
            "CSF可能見輕度單核球增多",
            "排除小腦病變",
            "排除腦炎"
          ]
        },
        {
          "step": 4,
          "action": "治療性確診",
          "details": "免疫抑制治療反應支持診斷",
          "findings": [
            "皮質類固醇治療後快速改善",
            "通常1-3天內震顫明顯減輕",
            "減藥可能復發",
            "排除性診斷確認"
          ]
        }
      ]
    },
    "monitoring": [
      "開始治療後每週評估震顫嚴重程度",
      "類固醇治療期間監測副作用（多飲多尿、體重增加）",
      "減量期間密切觀察震顫是否復發",
      "停藥後追蹤 3-6 個月確認無復發"
    ],
    "reference": "Textbook of Veterinary Internal Medicine (Ettinger & Feldman)"
  },
  "erythema-multiforme": {
    "zh": "多形性紅斑",
    "en": "Erythema Multiforme",
    "definition": "多形性紅斑是一種免疫介導的皮膚疾病，以多形態的紅斑性皮膚病變為特徵，通常由藥物反應、感染或腫瘤引發。病變呈現典型的靶心狀（target lesion）外觀，涉及表皮角質細胞的細胞凋亡。",
    "synonyms": [
      "EM",
      "多形紅斑"
    ],
    "epidemiology": {
      "species": "犬貓均可發生，犬較常見",
      "breed": "無明顯品種好發性",
      "age": "任何年齡均可發生，中老年犬較常見",
      "sex": "無性別好發性",
      "prevalence": "罕見的免疫介導性皮膚病"
    },
    "clinicalPresentation": {
      "symptoms": [
        "多形態皮膚病變（紅斑、丘疹、斑塊）",
        "靶心狀或環狀病變",
        "口腔黏膜潰瘍",
        "皮膚水疱與糜爛",
        "足墊潰瘍或過度角化",
        "皮膚疼痛",
        "食慾下降",
        "精神沉鬱",
        "皮膚紅斑擴展迅速",
        "可能伴有發燒"
      ],
      "physicalExam": [
        "多形態分布的紅斑、丘疹、水疱",
        "黏膜皮膚交界處病變",
        "口腔黏膜糜爛或潰瘍",
        "腹部及腹股溝區域好發",
        "足墊可能有潰瘍",
        "淋巴結可能腫大"
      ]
    },
    "pathophysiology": "多形性紅斑的發病機制涉及細胞介導的免疫反應，T淋巴細胞攻擊表皮角質細胞導致細胞凋亡。藥物代謝產物或感染性抗原與角質細胞結合，被免疫系統識別為異物，引發CD8+ T細胞的細胞毒性反應，造成表皮基底層角質細胞的衛星壞死（satellite cell necrosis）。",
    "diagnosis": {
      "primary": [
        "皮膚組織病理學檢查（顯示界面性皮膚炎與角質細胞凋亡）",
        "詳細藥物使用史調查",
        "排除其他免疫介導性皮膚病",
        "直接免疫螢光檢查"
      ],
      "differential": [
        "中毒性表皮壞死溶解症（TEN）",
        "天疱瘡（Pemphigus）",
        "全身性紅斑狼瘡（SLE）",
        "藥物疹",
        "皮膚淋巴瘤",
        "表淺壞死性皮膚炎"
      ],
      "labFindings": [
        "組織病理：界面性皮膚炎伴角質細胞凋亡",
        "表皮基底層淋巴細胞浸潤",
        "衛星壞死現象",
        "CBC通常正常或輕度白血球增多"
      ]
    },
    "treatment": {
      "acute": "立即停用可疑藥物；免疫抑制治療；支持療法包括液體治療與營養支持",
      "chronic": "找出並消除觸發因素；長期低劑量免疫抑制治療可能需要",
      "medications": [
        "Prednisolone 1-2 mg/kg PO q12h 逐漸減量",
        "Azathioprine 2 mg/kg PO q24h（犬）",
        "Cyclosporine 5 mg/kg PO q12h",
        "Pentoxifylline 10-15 mg/kg PO q8-12h",
        "Mycophenolate mofetil 10-20 mg/kg PO q12h"
      ],
      "surgery": "通常不需要手術治療"
    },
    "prognosis": "預後取決於病因是否可識別和消除。藥物引發的多形性紅斑在停藥後預後良好；特發性病例可能需要長期免疫抑制治療，預後謹慎。嚴重病例可能進展為中毒性表皮壞死溶解症。",
    "pearls": [
      "多形性紅斑與中毒性表皮壞死溶解症（TEN）屬於同一疾病譜，TEN為更嚴重的形式",
      "最常見的藥物觸發因素包括磺胺類藥物、頭孢菌素和NSAIDs",
      "組織病理學是確診的金標準，界面性皮膚炎伴角質細胞凋亡為特徵性表現",
      "貓的多形性紅斑較少見但可能與疱疹病毒感染相關"
    ],
    "diagnosticAlgorithm": {
      "title": "多形性紅斑 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估皮膚黏膜病變特徵和藥物/感染暴露史",
          "findings": [
            "急性發作的多形性皮膚病變",
            "標靶樣環狀病灶",
            "口腔黏膜潰瘍",
            "近期藥物使用或感染病史"
          ]
        },
        {
          "step": 2,
          "action": "實驗室檢查",
          "details": "進行基本實驗室檢查評估全身狀態",
          "findings": [
            "血液學可見白血球增多",
            "藥物相關病史回顧",
            "感染篩檢",
            "自體免疫標記物"
          ]
        },
        {
          "step": 3,
          "action": "組織病理學確診",
          "details": "進行皮膚活檢確認診斷",
          "findings": [
            "基底層淋巴球浸潤",
            "角質細胞個別壞死（凋亡）",
            "界面性皮膚炎",
            "與SLE和TEN鑑別"
          ]
        }
      ]
    },
    "monitoring": [
      "每1-2週複診評估病變消退情況",
      "定期監測CBC和肝腎功能（免疫抑制劑使用時）",
      "記錄並避免已知的觸發藥物",
      "監測是否有繼發感染"
    ],
    "reference": "Blackwell's Five-Minute Veterinary Consult"
  },
  "toxic-epidermal-necrolysis": {
    "zh": "中毒性表皮壞死溶解症",
    "en": "Toxic Epidermal Necrolysis (TEN)",
    "definition": "中毒性表皮壞死溶解症是一種危及生命的嚴重免疫介導性皮膚病，以廣泛的表皮壞死和剝離為特徵。通常由藥物反應引發，造成全層表皮壞死與大面積皮膚剝脫，類似嚴重燒傷。",
    "synonyms": [
      "TEN",
      "毒性表皮壞死鬆解症",
      "Lyell症候群"
    ],
    "epidemiology": {
      "species": "犬貓均可發生",
      "breed": "無明確品種好發性",
      "age": "任何年齡，成年動物較常見",
      "sex": "無性別好發性",
      "prevalence": "極罕見但致死率高的皮膚急症"
    },
    "clinicalPresentation": {
      "symptoms": [
        "突然發生的廣泛皮膚紅斑",
        "大面積表皮剝離（Nikolsky sign陽性）",
        "水疱形成後迅速破裂",
        "口腔黏膜嚴重潰瘍",
        "眼部病變（結膜炎、角膜潰瘍）",
        "足墊脫落",
        "高燒",
        "嚴重疼痛",
        "精神極度沉鬱",
        "食慾廢絕",
        "脫水",
        "可能併發敗血症"
      ],
      "physicalExam": [
        "Nikolsky sign陽性（輕壓皮膚即可導致表皮滑動剝離）",
        "超過30%體表面積的表皮剝離",
        "暴露的真皮層呈紅色濕潤面",
        "黏膜廣泛潰瘍（口腔、鼻腔、眼結膜、肛門）",
        "發燒、心跳過速",
        "疼痛反應明顯"
      ]
    },
    "pathophysiology": "TEN的病理機制涉及藥物代謝產物誘發的免疫反應，Fas-FasL途徑和穿孔素/顆粒酶B介導的角質細胞大量凋亡。CD8+ T細胞和NK細胞釋放的可溶性FasL（sFasL）與角質細胞表面Fas受體結合，觸發caspase級聯反應，導致全層表皮壞死。TNF-α等促炎細胞因子進一步放大組織損傷。",
    "diagnosis": {
      "primary": [
        "皮膚組織病理學（全層表皮壞死）",
        "臨床表現與藥物暴露史",
        "Nikolsky sign測試",
        "排除其他水疱性疾病"
      ],
      "differential": [
        "多形性紅斑（較輕型）",
        "天疱瘡（Pemphigus vulgaris）",
        "大疱性類天疱瘡",
        "全身性紅斑狼瘡",
        "燙傷或化學灼傷",
        "Stevens-Johnson症候群"
      ],
      "labFindings": [
        "組織病理：全層表皮壞死伴真皮表皮分離",
        "角質細胞廣泛凋亡與壞死",
        "CBC可能顯示白血球增多或減少",
        "血液生化可能顯示低白蛋白血症",
        "電解質異常（因大量體液喪失）"
      ]
    },
    "treatment": {
      "acute": "立即停用所有可疑藥物；住院加護治療；積極靜脈輸液治療糾正脫水和電解質失衡；疼痛管理；傷口護理如同大面積燒傷處理",
      "chronic": "存活病例需長期傷口護理至表皮完全再生；避免再次暴露於致病藥物",
      "medications": [
        "靜脈輸液（晶體液和膠體液）維持循環",
        "人類靜脈免疫球蛋白（hIVIG）0.5-1 g/kg IV（阻斷Fas-FasL途徑）",
        "Cyclosporine 5 mg/kg PO q12h",
        "Opioid止痛劑（Buprenorphine 0.01-0.02 mg/kg）",
        "廣譜抗生素預防繼發感染"
      ],
      "surgery": "無特異性手術治療；傷口清創視需要進行"
    },
    "prognosis": "預後不良至極差。死亡率在犬約30-50%，貓可能更高。早期識別和停藥、積極支持療法可改善存活率。存活病例可能有長期併發症包括皮膚瘢痕和眼部後遺症。",
    "pearls": [
      "TEN是皮膚科急症，需如同嚴重燒傷患者般處理",
      "最常見的觸發藥物為磺胺類（特別是trimethoprim-sulfonamide）、頭孢菌素、NSAIDs",
      "hIVIG為目前最有效的特異性治療，可阻斷Fas-FasL介導的角質細胞凋亡",
      "類固醇的使用存在爭議，部分學者認為可能增加感染風險"
    ],
    "diagnosticAlgorithm": {
      "title": "中毒性表皮壞死溶解症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "緊急評估皮膚脫落範圍和全身狀態",
          "findings": [
            "大面積皮膚紅斑和水疱",
            "表皮剝脫（Nikolsky徵陽性）",
            "黏膜受累（口腔、結膜等）",
            "發熱和全身症狀"
          ]
        },
        {
          "step": 2,
          "action": "藥物史回顧",
          "details": "詳細回顧近期所有用藥",
          "findings": [
            "確認可疑致敏藥物",
            "發病前1-3週內新使用的藥物",
            "常見誘因：磺胺類、NSAID、頭孢菌素等",
            "評估藥物時間關係"
          ]
        },
        {
          "step": 3,
          "action": "組織病理學確診",
          "details": "進行皮膚活檢確認全層表皮壞死",
          "findings": [
            "全層表皮壞死",
            "表皮下水疱形成",
            "稀疏淋巴球浸潤",
            "與燙傷和天疱瘡鑑別"
          ]
        },
        {
          "step": 4,
          "action": "支持治療與監測",
          "details": "停用可疑藥物，監測敗血症等併發症",
          "findings": [
            "受累體表面積評估",
            "感染風險監測",
            "電解質和蛋白質流失",
            "血液培養排除敗血症"
          ]
        }
      ]
    },
    "monitoring": [
      "持續監測生命徵象和水合狀態",
      "每日評估表皮剝離面積百分比",
      "監測尿量以評估腎臟灌流",
      "細菌培養監測繼發感染"
    ],
    "reference": "Clinical Veterinary Advisor"
  },
  "color-dilution-alopecia": {
    "zh": "色素稀釋性脫毛症",
    "en": "Color Dilution Alopecia (CDA)",
    "definition": "色素稀釋性脫毛症是一種遺傳性毛囊發育不良，發生於帶有稀釋色基因（d/d）的犬隻。異常的黑色素聚集導致毛幹結構脆弱斷裂，引起進行性脫毛和繼發性毛囊炎。",
    "synonyms": [
      "CDA",
      "藍犬症候群",
      "Blue dog syndrome",
      "稀釋色脫毛症"
    ],
    "epidemiology": {
      "species": "犬（貓極罕見）",
      "breed": "藍色被毛品種好發：藍色杜賓犬、義大利灰獵犬、惠比特犬、大丹犬、標準貴賓犬、約克夏㹴、迷你品犬",
      "age": "通常在6個月至3歲之間開始出現",
      "sex": "無性別好發性",
      "prevalence": "在稀釋色犬種中相對常見，藍色杜賓犬發病率可達93%"
    },
    "clinicalPresentation": {
      "symptoms": [
        "稀釋色被毛區域的進行性脫毛",
        "毛髮乾燥粗糙",
        "反覆發作的細菌性毛囊炎",
        "丘疹和膿疱",
        "皮膚乾燥脫屑",
        "被毛逐漸稀疏",
        "毛髮易斷裂",
        "稀釋色區域皮膚變薄",
        "可能伴輕度搔癢（繼發感染時）"
      ],
      "physicalExam": [
        "稀釋色（藍色、淡褐色）被毛區域選擇性脫毛",
        "深色或正常色被毛區域不受影響",
        "毛囊性丘疹和膿疱",
        "皮膚乾燥、鱗屑",
        "毛髮粗糙、斷裂",
        "軀幹背側較嚴重，頭部和四肢可能保留"
      ]
    },
    "pathophysiology": "色素稀釋性脫毛症的根本原因是MLPH基因（melanophilin）突變，導致黑色素體在毛幹內異常聚集形成大的黑色素塊。這些異常聚集的黑色素塊使毛幹結構變得脆弱，容易在毛囊內或毛囊開口處斷裂。斷裂的毛髮殘留在毛囊中引發異物反應和毛囊炎，最終導致毛囊的永久性損傷和脫毛。",
    "diagnosis": {
      "primary": [
        "毛髮顯微鏡檢查（tricogram）：毛幹內可見大的不規則黑色素塊",
        "皮膚組織病理學檢查",
        "品種和被毛顏色的病史",
        "臨床表現的典型分布"
      ],
      "differential": [
        "甲狀腺功能低下",
        "腎上腺皮質功能亢進",
        "毛囊蟎蟲病",
        "皮黴菌症",
        "細菌性毛囊炎",
        "其他毛囊發育不良"
      ],
      "labFindings": [
        "毛髮鏡檢：毛幹內見巨大不規則黑色素塊聚集",
        "組織病理：毛囊角質化異常、毛球周圍黑色素失禁",
        "毛囊內見破裂的毛幹片段（毛囊炎的原因）",
        "游離黑色素和黑色素巨噬細胞"
      ]
    },
    "treatment": {
      "acute": "繼發性細菌感染的治療：全身性抗生素和抗菌洗浴",
      "chronic": "長期皮膚保濕和營養補充；定期抗菌洗浴預防感染復發；無法治癒基礎疾病",
      "medications": [
        "抗菌洗毛精（Chlorhexidine 2-4%）每週1-2次",
        "必需脂肪酸補充（Omega-3/6）",
        "Vitamin E 400 IU/日作為抗氧化劑",
        "繼發感染時：Cephalexin 22-30 mg/kg PO q12h",
        "局部保濕劑和潤膚劑"
      ],
      "surgery": "不適用"
    },
    "prognosis": "無法治癒的遺傳性疾病。脫毛通常為進行性但不影響整體健康。透過良好的皮膚管理和感染控制，患犬可維持良好的生活品質。不建議患犬進行繁殖。",
    "pearls": [
      "並非所有稀釋色犬隻都會發生CDA，但在某些品種如藍色杜賓犬中發病率極高",
      "毛髮顯微鏡檢查是最快速且低成本的初步診斷方法",
      "治療重點在控制繼發感染和皮膚護理，而非試圖恢復毛髮生長",
      "需與內分泌性脫毛鑑別，CDA僅影響稀釋色區域為重要特徵"
    ],
    "diagnosticAlgorithm": {
      "title": "色素稀釋性脫毛症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估稀釋色被毛區域的脫毛特徵",
          "findings": [
            "藍色或淡黃褐色被毛犬",
            "稀釋色區域漸進性脫毛",
            "通常6個月至3歲發病",
            "非稀釋色區域毛髮正常"
          ]
        },
        {
          "step": 2,
          "action": "毛髮檢查",
          "details": "進行毛髮拔取和顯微鏡檢查",
          "findings": [
            "毛幹內黑色素團塊不規則分布",
            "毛幹扭曲和斷裂",
            "色素團塊呈巨大不規則塊狀",
            "毛囊萎縮"
          ]
        },
        {
          "step": 3,
          "action": "組織病理學確診",
          "details": "進行皮膚活檢確認毛囊病變",
          "findings": [
            "毛囊內黑色素巨大團塊",
            "毛囊角化異常",
            "毛囊周圍輕度炎症",
            "與其他脫毛症鑑別"
          ]
        }
      ]
    },
    "monitoring": [
      "每2-3個月定期皮膚檢查",
      "監測繼發性細菌感染的徵兆",
      "評估脫毛進展程度",
      "營養狀態和被毛品質評估"
    ],
    "reference": "Saunders Comprehensive Veterinary Dictionary"
  },
  "follicular-dysplasia": {
    "zh": "毛囊發育不良",
    "en": "Follicular Dysplasia",
    "definition": "毛囊發育不良是一組遺傳性毛囊結構異常的疾病，以非發炎性脫毛為特徵。毛囊的正常發育週期被破壞，導致異常的毛幹形成和進行性脫毛。包括多種亞型如黑毛毛囊發育不良和週期性毛囊發育不良。",
    "synonyms": [
      "毛囊營養不良",
      "遺傳性毛囊發育異常"
    ],
    "epidemiology": {
      "species": "犬（罕見於貓）",
      "breed": "依亞型不同：黑毛型好發於雙色或三色犬種；週期性側腹脫毛好發於拳師犬、英國鬥牛犬、Airedale㹴",
      "age": "通常在幼犬或青年期（數月至2歲）開始出現",
      "sex": "無明顯性別差異",
      "prevalence": "少見但有品種特異性"
    },
    "clinicalPresentation": {
      "symptoms": [
        "非發炎性進行性脫毛",
        "毛髮質地改變",
        "局部或對稱性脫毛",
        "被毛稀疏或完全缺失",
        "皮膚乾燥",
        "輕度鱗屑",
        "毛髮再生不良",
        "特定顏色區域選擇性脫毛（黑毛型）",
        "季節性側腹脫毛（週期性型）"
      ],
      "physicalExam": [
        "特定模式的非發炎性脫毛",
        "皮膚表面光滑無紅腫",
        "受影響區域毛髮易拔除",
        "可能有輕度色素沉著",
        "無搔癢跡象"
      ]
    },
    "pathophysiology": "毛囊發育不良涉及毛囊幹細胞的遺傳缺陷，導致毛囊週期中的生長期（anagen）異常。毛囊無法正常產生健康的毛幹，毛球部的角質化異常使毛幹結構脆弱或畸形。在黑毛型中，黑色素的異常轉移加劇毛幹結構缺陷。在週期性型中，光照週期變化影響褪黑激素分泌，調控毛囊進入休止期。",
    "diagnosis": {
      "primary": [
        "皮膚組織病理學（顯示毛囊結構異常）",
        "毛髮顯微鏡檢查",
        "臨床表現和品種史",
        "排除內分泌疾病"
      ],
      "differential": [
        "甲狀腺功能低下",
        "腎上腺皮質功能亢進",
        "色素稀釋性脫毛症",
        "生長期脫毛症",
        "皮黴菌症",
        "毛囊蟎蟲病"
      ],
      "labFindings": [
        "組織病理：毛囊結構畸形、角質化異常",
        "毛球周圍黑色素不規則聚集",
        "毛幹鏡檢可見彎曲或畸形毛幹",
        "甲狀腺和腎上腺功能檢查正常（排除內分泌病因）"
      ]
    },
    "treatment": {
      "acute": "繼發感染時給予抗生素治療",
      "chronic": "無特效治療；Melatonin可能對週期性側腹脫毛有效；皮膚保濕護理",
      "medications": [
        "Melatonin 3-6 mg PO q8-12h（週期性側腹脫毛）",
        "必需脂肪酸補充",
        "Vitamin E補充",
        "繼發感染時Cephalexin 22-30 mg/kg PO q12h"
      ],
      "surgery": "不適用"
    },
    "prognosis": "為遺傳性疾病，無法根治。脫毛通常為進行性但不影響全身健康。週期性側腹脫毛的預後最佳，部分犬隻可自發緩解或對褪黑激素治療反應良好。不建議患犬進行繁殖。",
    "pearls": [
      "黑毛毛囊發育不良僅影響黑色被毛區域，是重要的診斷線索",
      "週期性側腹脫毛通常在秋冬發生，春夏可能自然恢復",
      "Melatonin治療週期性側腹脫毛的成功率約為50-60%",
      "需與內分泌性脫毛仔細鑑別，甲狀腺和腎上腺功能檢查為必要"
    ],
    "diagnosticAlgorithm": {
      "title": "毛囊發育不良 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估脫毛模式、品種和發病年齡",
          "findings": [
            "特定品種好發",
            "對稱性或局部脫毛",
            "幼年至青年期發病",
            "皮膚乾燥和鱗屑"
          ]
        },
        {
          "step": 2,
          "action": "皮膚學檢查",
          "details": "進行毛髮拔取檢查和皮膚刮片",
          "findings": [
            "毛幹形態異常",
            "排除蠕形蟎感染",
            "排除皮黴菌感染",
            "甲狀腺功能檢查排除內分泌脫毛"
          ]
        },
        {
          "step": 3,
          "action": "組織病理學確診",
          "details": "進行皮膚活檢確認毛囊結構異常",
          "findings": [
            "毛囊結構發育不良",
            "毛囊角化異常",
            "毛球變形",
            "排除內分泌性脫毛"
          ]
        }
      ]
    },
    "monitoring": [
      "每3-6個月評估脫毛範圍變化",
      "監測繼發感染",
      "如使用Melatonin需評估療效",
      "內分泌功能定期追蹤確認未併發內分泌疾病"
    ],
    "reference": "Clinical Veterinary Advisor"
  },
  "cutaneous-vasculitis": {
    "zh": "皮膚血管炎",
    "en": "Cutaneous Vasculitis",
    "definition": "皮膚血管炎是一種免疫介導的真皮血管炎症性疾病，由免疫複合物沉積於血管壁引起血管損傷、血栓形成和組織缺血壞死。可為原發性（特發性）或繼發於藥物反應、感染、腫瘤或疫苗接種。",
    "synonyms": [
      "皮膚壞死性血管炎",
      "免疫介導性血管炎"
    ],
    "epidemiology": {
      "species": "犬為主，貓少見",
      "breed": "傑克羅素㹴、臘腸犬、洛威拿犬、格雷伊獵犬較常見；疫苗接種後血管炎好發於小型犬如約克夏㹴",
      "age": "任何年齡均可發生",
      "sex": "無明顯性別好發性",
      "prevalence": "少見的免疫介導性皮膚病"
    },
    "clinicalPresentation": {
      "symptoms": [
        "耳翼邊緣壞死和潰瘍",
        "足墊潰瘍和壞死",
        "尾尖壞死",
        "皮膚紫斑（purpura）",
        "皮膚凹陷性潰瘍",
        "網狀青斑（livedo reticularis）",
        "注射部位脫毛（疫苗後）",
        "皮膚疼痛",
        "跛行（足墊受累時）",
        "精神沉鬱",
        "發燒"
      ],
      "physicalExam": [
        "耳翼邊緣、足墊、尾尖等末端部位的壞死性潰瘍",
        "皮膚出血斑點或紫斑",
        "局部組織水腫",
        "凹陷性潰瘍伴壞死中心",
        "受累肢體可能水腫"
      ]
    },
    "pathophysiology": "皮膚血管炎的病理機制主要為III型超敏反應（免疫複合物介導）。抗原-抗體複合物沉積於小血管壁，激活補體級聯反應，招募嗜中性球。嗜中性球釋放蛋白酶和活性氧自由基破壞血管壁完整性，導致血管內皮損傷、血栓形成和缺血性組織壞死。部分病例也涉及II型和IV型超敏反應。",
    "diagnosis": {
      "primary": [
        "皮膚組織病理學（顯示血管壁纖維素樣壞死）",
        "詳細病史（藥物、疫苗、感染史）",
        "直接免疫螢光檢查（血管壁免疫球蛋白沉積）",
        "排除感染性和腫瘤性病因"
      ],
      "differential": [
        "凍傷",
        "播散性血管內凝血（DIC）",
        "冷凝球蛋白血症",
        "全身性紅斑狼瘡",
        "藥物反應",
        "耳翼邊緣皮脂腺症"
      ],
      "labFindings": [
        "組織病理：血管壁纖維素樣壞死、白血球破碎性血管炎",
        "血管周圍嗜中性球浸潤和核塵",
        "直接免疫螢光：血管壁IgG/IgM/C3沉積",
        "CBC可能顯示血小板減少",
        "ANA可能陽性"
      ]
    },
    "treatment": {
      "acute": "免疫抑制治療；停用可疑藥物；傷口護理；疼痛管理",
      "chronic": "長期免疫調節治療；Pentoxifylline改善微循環；避免觸發因素",
      "medications": [
        "Pentoxifylline 10-15 mg/kg PO q8-12h（改善微循環）",
        "Prednisolone 1-2 mg/kg PO q12h 逐漸減量",
        "Doxycycline 5 mg/kg PO q12h 合併 Niacinamide",
        "Niacinamide 250-500 mg PO q8h",
        "嚴重病例：Azathioprine 2 mg/kg PO q24h"
      ],
      "surgery": "壞死組織清創；嚴重肢端壞死可能需截肢"
    },
    "prognosis": "預後依病因而異。藥物或疫苗引發的血管炎在去除觸發因素後預後良好。特發性或與腫瘤相關的血管炎預後謹慎至不良，可能需要長期治療。",
    "pearls": [
      "Pentoxifylline是治療皮膚血管炎的一線藥物，因其可改善微循環和抑制促炎細胞因子",
      "疫苗接種後的血管炎通常在接種後3-6個月出現，好發於注射部位",
      "耳翼邊緣壞死是犬皮膚血管炎最常見的臨床表現",
      "Doxycycline-Niacinamide組合具有免疫調節作用，可作為輕度病例的首選"
    ],
    "diagnosticAlgorithm": {
      "title": "皮膚血管炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估皮膚血管炎典型病變",
          "findings": [
            "紫癜和瘀點瘀斑",
            "耳尖、尾尖和肉墊壞死",
            "皮膚潰瘍",
            "水腫和出血性水疱"
          ]
        },
        {
          "step": 2,
          "action": "實驗室檢查",
          "details": "進行血液學和免疫學篩檢",
          "findings": [
            "全血計數評估血小板",
            "凝血功能檢查",
            "ANA和類風濕因子",
            "感染篩檢（壁蝨媒介疾病等）"
          ]
        },
        {
          "step": 3,
          "action": "組織病理學確診",
          "details": "進行早期病灶的皮膚活檢",
          "findings": [
            "血管壁纖維素樣壞死",
            "白血球碎裂性血管炎",
            "血管周圍嗜中性球或淋巴球浸潤",
            "紅血球外溢"
          ]
        },
        {
          "step": 4,
          "action": "病因學調查",
          "details": "系統性調查可能的觸發因子",
          "findings": [
            "藥物反應",
            "感染相關",
            "疫苗接種史",
            "自體免疫疾病"
          ]
        }
      ]
    },
    "monitoring": [
      "每2-4週評估病變消退和新病變出現",
      "免疫抑制劑使用期間定期監測CBC和生化",
      "記錄可能的觸發因素",
      "疫苗接種策略調整（避免不必要的疫苗）"
    ],
    "reference": "Clinical Veterinary Advisor"
  },
  "superficial-necrolytic-dermatitis": {
    "zh": "表淺壞死性皮膚炎",
    "en": "Superficial Necrolytic Dermatitis (SND)",
    "definition": "表淺壞死性皮膚炎（又稱肝皮症候群、壞死性遊走性紅斑）是一種嚴重的代謝性皮膚病，與肝臟疾病或胰高血糖素瘤相關。以皮膚足墊、皺褶區和黏膜皮膚交界處的紅斑、結痂和潰瘍為特徵。",
    "synonyms": [
      "肝皮症候群",
      "Hepatocutaneous syndrome",
      "壞死性遊走性紅斑",
      "Necrolytic migratory erythema",
      "代謝性表皮壞死"
    ],
    "epidemiology": {
      "species": "犬為主，貓極罕見",
      "breed": "無明確品種好發性，中大型犬較常報告",
      "age": "老年犬為主（通常>8歲）",
      "sex": "雄犬可能略多",
      "prevalence": "罕見但臨床重要的老年犬皮膚病"
    },
    "clinicalPresentation": {
      "symptoms": [
        "足墊嚴重過度角化與裂縫",
        "皮膚皺褶區紅斑與結痂",
        "口腔黏膜潰瘍",
        "眼周紅斑和結痂",
        "會陰區和腹股溝區糜爛",
        "跛行（足墊疼痛）",
        "食慾下降和體重減輕",
        "多飲多尿（伴糖尿病時）",
        "精神沉鬱",
        "嘔吐和腹瀉"
      ],
      "physicalExam": [
        "足墊過度角化、裂縫和疼痛",
        "臉部、耳翼、肘部、踝部的紅斑和結痂",
        "黏膜皮膚交界處潰瘍",
        "可能觸及肝臟腫大",
        "體態消瘦",
        "可能有糖尿病體徵"
      ]
    },
    "pathophysiology": "SND的病因為嚴重的肝臟功能障礙導致氨基酸代謝異常，造成低氨基酸血症。肝臟無法正常合成蛋白質和代謝氨基酸，表皮角質細胞因營養缺乏（特別是氨基酸和鋅）而發生退化和壞死。胰高血糖素瘤導致的SND則是高胰高血糖素血症加速氨基酸分解代謝。組織病理上表現為特徵性的「紅白藍」三層結構。",
    "diagnosis": {
      "primary": [
        "皮膚組織病理學（特徵性「紅白藍」三層結構）",
        "腹部超音波（肝臟蜂窩狀回聲、胰臟腫塊）",
        "血液生化（肝酶升高、低白蛋白）",
        "血漿氨基酸譜分析"
      ],
      "differential": [
        "鋅反應性皮膚病",
        "天疱瘡",
        "全身性紅斑狼瘡",
        "皮黴菌症",
        "藥物反應",
        "泛發性蠕形蟎蟲病"
      ],
      "labFindings": [
        "組織病理：表皮「紅白藍」分層（角質層角化不全、棘層水腫蒼白、基底層增生）",
        "肝酶（ALT、ALP、GGT）顯著升高",
        "低白蛋白血症",
        "超音波：肝臟特徵性蜂窩狀/瑞士起司樣回聲",
        "血漿氨基酸濃度顯著降低"
      ]
    },
    "treatment": {
      "acute": "靜脈氨基酸輸注改善營養缺乏；積極傷口護理；疼痛管理；糾正低白蛋白血症",
      "chronic": "高蛋白飲食；口服氨基酸補充；蛋黃卵磷脂補充；控制併發糖尿病",
      "medications": [
        "靜脈氨基酸溶液輸注（每1-2週一次）",
        "口服氨基酸補充劑",
        "蛋黃（每日3-6個）作為營養補充",
        "鋅補充（Zinc gluconate 5 mg/kg/日）",
        "足墊軟化劑和保護劑"
      ],
      "surgery": "胰高血糖素瘤引起者：腫瘤切除可能治癒；肝臟病變引起者：肝臟移植理論上可行但不實際"
    },
    "prognosis": "肝臟相關SND預後極差，中位存活時間約5-6個月。靜脈氨基酸輸注可暫時改善皮膚病變但無法治癒基礎肝病。胰高血糖素瘤引起的SND在成功切除腫瘤後預後較好。",
    "pearls": [
      "腹部超音波顯示的肝臟蜂窩狀回聲是SND幾乎病理性特徵（pathognomonic）",
      "組織病理的「紅白藍」三層分布是診斷金標準",
      "靜脈氨基酸輸注通常在24-48小時內即可見皮膚改善",
      "約10-20%的SND病例與胰高血糖素瘤相關，腹部超音波檢查胰臟為必要"
    ],
    "diagnosticAlgorithm": {
      "title": "表淺壞死性皮膚炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估特徵性皮膚病變分布",
          "findings": [
            "肉墊過度角化和龜裂",
            "口周、眼周糜爛和結痂",
            "肘部和飛節壓力點病變",
            "外陰和肛周受累"
          ]
        },
        {
          "step": 2,
          "action": "實驗室檢查",
          "details": "進行肝功能和代謝相關檢查",
          "findings": [
            "肝酶升高",
            "低胺基酸血症",
            "血糖可能升高（糖尿病併發）",
            "膽汁酸異常"
          ]
        },
        {
          "step": 3,
          "action": "影像學檢查",
          "details": "進行腹部超音波評估肝臟和胰臟",
          "findings": [
            "肝臟蜂窩狀特徵性超音波表現",
            "胰臟腫塊（升糖素瘤相關）",
            "肝實質異質性回音",
            "腹水"
          ]
        },
        {
          "step": 4,
          "action": "組織病理學確診",
          "details": "進行皮膚活檢確認特徵性組織學模式",
          "findings": [
            "紅白藍三色徵（Red-White-Blue pattern）",
            "表皮上層角化不全",
            "中層水腫和蒼白",
            "深層角化過度"
          ]
        }
      ]
    },
    "monitoring": [
      "每1-2週評估皮膚病變和足墊狀態",
      "定期監測肝功能指數和白蛋白",
      "血糖監測（可能併發或已有糖尿病）",
      "體重和營養狀態追蹤"
    ],
    "reference": "Geriatrics & Gerontology of the Dog and Cat"
  },
  "canine-pattern-alopecia": {
    "zh": "犬模式型脫毛症",
    "en": "Canine Pattern Alopecia",
    "definition": "犬模式型脫毛症是一種常見的非發炎性脫毛症，以特定解剖部位的對稱性毛髮稀疏為特徵。屬於毛囊微小化（follicular miniaturization）所致的漸進性脫毛，不伴隨皮膚發炎或搔癢。",
    "synonyms": [
      "模式性禿",
      "Pattern baldness",
      "犬型禿髮"
    ],
    "epidemiology": {
      "species": "犬",
      "breed": "臘腸犬、吉娃娃、義大利灰獵犬、惠比特犬、波士頓㹴、迷你品犬最常見",
      "age": "通常在6個月至1歲開始出現，隨年齡進展",
      "sex": "雌犬較常見（耳翼型），雄犬也可發生（腹側型）",
      "prevalence": "在好發品種中相當常見"
    },
    "clinicalPresentation": {
      "symptoms": [
        "耳翼腹側面漸進性毛髮稀疏",
        "腹側軀幹和胸部脫毛",
        "頸部腹側脫毛",
        "大腿後側毛髮稀疏",
        "對稱性分布",
        "不伴搔癢",
        "皮膚正常無發炎",
        "脫毛區域皮膚色素沉著"
      ],
      "physicalExam": [
        "特定模式的對稱性脫毛",
        "皮膚光滑無紅腫或丘疹",
        "受影響區域毛髮極細短或完全缺失",
        "耳翼腹側面最常見的脫毛起始部位",
        "可能有輕度色素沉著"
      ]
    },
    "pathophysiology": "犬模式型脫毛症的病理機制為毛囊微小化（follicular miniaturization），類似人類的雄性禿。毛囊逐漸縮小，從終端毛囊退化為絨毛（vellus）毛囊，產生越來越細短的毛髮，最終毛囊停止產生可見的毛幹。確切的遺傳和荷爾蒙機制尚未完全闡明，但與雄激素受體的敏感度可能相關。",
    "diagnosis": {
      "primary": [
        "典型的臨床表現和品種",
        "皮膚組織病理學（毛囊微小化）",
        "排除內分泌疾病",
        "毛髮拔除試驗（trichogram）"
      ],
      "differential": [
        "甲狀腺功能低下",
        "腎上腺皮質功能亢進",
        "性荷爾蒙相關脫毛",
        "色素稀釋性脫毛症",
        "毛囊蟎蟲病",
        "皮黴菌症"
      ],
      "labFindings": [
        "組織病理：毛囊微小化，毛囊數量減少",
        "毛囊周圍無發炎細胞浸潤",
        "甲狀腺功能檢查正常",
        "皮質醇檢查正常"
      ]
    },
    "treatment": {
      "acute": "無需急性治療",
      "chronic": "主要為美容問題，多數病例不需治療；Melatonin可嘗試但效果不一",
      "medications": [
        "Melatonin 3-6 mg PO q8-12h（效果不確定）",
        "局部 Minoxidil 可嘗試但犬的療效有限",
        "必需脂肪酸補充"
      ],
      "surgery": "不適用"
    },
    "prognosis": "良性美容問題，不影響健康和壽命。脫毛為漸進性且通常無法逆轉，但進展緩慢。不需要積極治療。",
    "pearls": [
      "犬模式型脫毛症是純粹的美容問題，不影響動物健康",
      "最重要的是排除甲狀腺功能低下等可治療的內分泌疾病",
      "臘腸犬的耳翼脫毛是最典型的表現形式",
      "向飼主解釋此為良性遺傳性狀態通常比治療更重要"
    ],
    "diagnosticAlgorithm": {
      "title": "犬模式型脫毛症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估脫毛分布模式和品種",
          "findings": [
            "對稱性脫毛（耳廓、腹部、腋窩、大腿內側）",
            "短毛犬品種多見",
            "毛髮漸進性稀疏",
            "皮膚無炎症反應"
          ]
        },
        {
          "step": 2,
          "action": "排除性檢查",
          "details": "排除其他脫毛原因",
          "findings": [
            "甲狀腺功能正常",
            "皮膚刮片排除寄生蟲",
            "真菌培養陰性",
            "無瘙癢"
          ]
        },
        {
          "step": 3,
          "action": "組織病理學確診",
          "details": "進行皮膚活檢確認毛囊微小化",
          "findings": [
            "毛囊微小化",
            "毛囊數量正常但體積縮小",
            "無炎症浸潤",
            "與其他非炎症性脫毛症鑑別"
          ]
        }
      ]
    },
    "monitoring": [
      "年度體檢時評估脫毛進展",
      "定期甲狀腺功能監測排除甲低併發",
      "不需要頻繁追蹤",
      "監測是否有繼發皮膚問題"
    ],
    "reference": "Clinical Veterinary Advisor"
  },
  "acanthosis-nigricans": {
    "zh": "黑色棘皮症",
    "en": "Acanthosis Nigricans",
    "definition": "黑色棘皮症是以皮膚色素沉著加深和棘層增厚（acanthosis）為特徵的皮膚病變。分為原發性（臘腸犬品種特異性）和繼發性（由過敏、摩擦、內分泌疾病等引起）。臨床表現為腋窩和腹股溝區域的黑色增厚皮膚。",
    "synonyms": [
      "黑棘皮症",
      "色素性棘皮增生"
    ],
    "epidemiology": {
      "species": "犬為主",
      "breed": "原發性：幾乎僅見於臘腸犬；繼發性：任何品種均可",
      "age": "原發性：1歲以下發病；繼發性：任何年齡",
      "sex": "無明顯性別差異",
      "prevalence": "原發性罕見（僅臘腸犬）；繼發性相對常見"
    },
    "clinicalPresentation": {
      "symptoms": [
        "腋窩皮膚黑色增厚",
        "腹股溝區域色素沉著",
        "皮膚增厚和苔蘚化",
        "脂漏性皮膚變化",
        "搔癢（繼發性常見）",
        "毛髮脫落",
        "皮膚粗糙",
        "慢性反覆發作",
        "可能擴展至頸部、四肢",
        "異味（繼發感染時）"
      ],
      "physicalExam": [
        "腋窩和腹股溝區域對稱性黑色皮膚增厚",
        "皮膚苔蘚化和角質增生",
        "脂漏性鱗屑",
        "可能有繼發性細菌或酵母菌感染",
        "嚴重病例可擴展至全身",
        "受影響區域毛髮稀疏"
      ]
    },
    "pathophysiology": "原發性黑色棘皮症的確切病因不明，被認為是臘腸犬的遺傳性角質化缺陷。繼發性黑色棘皮症是慢性摩擦和發炎的結果，常見於過敏性皮膚炎、內分泌疾病（甲狀腺功能低下）或肥胖。慢性發炎刺激黑色素細胞增生和表皮棘層增厚，最終形成色素沉著和苔蘚化的外觀。",
    "diagnosis": {
      "primary": [
        "臨床表現和品種（臘腸犬為原發性）",
        "皮膚刮片排除蟎蟲",
        "皮膚細胞學檢查（酵母菌、細菌）",
        "皮膚組織病理學"
      ],
      "differential": [
        "異位性皮膚炎",
        "甲狀腺功能低下",
        "腎上腺皮質功能亢進",
        "馬拉色菌皮膚炎",
        "接觸性皮膚炎",
        "食物過敏"
      ],
      "labFindings": [
        "組織病理：表皮棘層增厚、色素沉著增加",
        "皮膚細胞學可能發現Malassezia酵母菌",
        "可能有繼發性細菌感染",
        "甲狀腺功能檢查排除甲低（繼發性病例）",
        "皮膚刮片排除蟎蟲"
      ]
    },
    "treatment": {
      "acute": "治療繼發感染（細菌和酵母菌）；控制搔癢",
      "chronic": "找出並治療基礎病因（過敏、內分泌疾病）；長期皮膚護理",
      "medications": [
        "抗酵母菌治療：Ketoconazole 5-10 mg/kg PO q24h",
        "局部Miconazole或Chlorhexidine洗浴",
        "Prednisolone 0.5-1 mg/kg PO q24h短期使用（嚴重搔癢）",
        "Vitamin E局部塗抹",
        "Melatonin 3 mg PO q8-12h（原發性病例）"
      ],
      "surgery": "不適用"
    },
    "prognosis": "原發性黑色棘皮症無法治癒但可控制，預後公平。繼發性黑色棘皮症在基礎病因得到控制後預後良好，皮膚外觀可顯著改善。",
    "pearls": [
      "繼發性黑色棘皮症遠比原發性常見，必須積極尋找基礎病因",
      "Malassezia過度增殖常伴隨黑色棘皮症，抗酵母菌治療是重要環節",
      "臘腸犬的原發性黑色棘皮症通常在1歲前出現且逐漸進展",
      "控制肥胖和過敏可顯著改善繼發性病例"
    ],
    "diagnosticAlgorithm": {
      "title": "黑色棘皮症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估皮膚色素沉著和增厚部位",
          "findings": [
            "腋窩和腹股溝對稱性色素沉著",
            "皮膚增厚和苔蘚化",
            "臘腸犬為原發型好發品種",
            "繼發型可見於任何品種"
          ]
        },
        {
          "step": 2,
          "action": "基礎疾病篩檢",
          "details": "排除繼發性黑色棘皮症的基礎病因",
          "findings": [
            "甲狀腺功能低下篩檢",
            "腎上腺皮質功能亢進篩檢",
            "過敏性皮膚炎評估",
            "皮膚感染（細菌、酵母菌）"
          ]
        },
        {
          "step": 3,
          "action": "組織病理學",
          "details": "進行皮膚活檢確認病理變化",
          "findings": [
            "表皮棘層增厚",
            "乳頭狀瘤樣增生",
            "黑色素沉著增加",
            "可能伴有繼發性感染"
          ]
        }
      ]
    },
    "monitoring": [
      "每4-6週追蹤評估治療反應",
      "監測繼發感染（酵母菌和細菌）",
      "定期評估基礎病因的控制狀態",
      "體重管理監測"
    ],
    "reference": "Clinical Veterinary Advisor"
  },
  "intertrigo": {
    "zh": "皮膚皺褶性皮膚炎",
    "en": "Intertrigo (Skin Fold Dermatitis)",
    "definition": "皮膚皺褶性皮膚炎是發生在皮膚皺褶處的表淺性皮膚炎，由皮膚對皮膚的摩擦、潮濕和微生物過度增殖所引起。好發於具有過度皮膚皺褶的短頭犬種和肥胖動物。",
    "synonyms": [
      "摩擦性皮膚炎",
      "皺褶性膿皮症",
      "Skin fold pyoderma"
    ],
    "epidemiology": {
      "species": "犬為主，貓（波斯貓臉部皺褶）",
      "breed": "英國鬥牛犬、法國鬥牛犬、巴哥犬、沙皮犬、北京犬、可卡犬（唇部皺褶）、肥胖犬",
      "age": "任何年齡，幼犬期即可開始",
      "sex": "母犬外陰皺褶型較特殊",
      "prevalence": "在短頭犬種中非常常見"
    },
    "clinicalPresentation": {
      "symptoms": [
        "皺褶區域皮膚紅腫",
        "潮濕發臭的滲出物",
        "皮膚皺褶處毛髮潮濕",
        "臭味（特別是臉部和唇部皺褶）",
        "搔癢和不適",
        "皮膚糜爛",
        "淚痕（臉部皺褶型）",
        "排尿後外陰周圍潮濕（外陰皺褶型）",
        "尾部周圍感染（螺旋尾犬種）"
      ],
      "physicalExam": [
        "皮膚皺褶間紅斑、濕疹和糜爛",
        "臉部皺褶處黏膩的分泌物",
        "唇部皺褶有惡臭分泌物",
        "外陰皺褶區域潮濕和紅斑",
        "尾部根部皺褶發炎",
        "可能觸及淺表淋巴結腫大（嚴重感染時）"
      ]
    },
    "pathophysiology": "皮膚皺褶內的環境溫暖潮濕、通氣不良，加上皮膚間的持續摩擦，破壞正常的皮膚屏障功能。這種環境有利於常在菌群（特別是Staphylococcus和Malassezia）的過度增殖。慢性摩擦引起角質層損傷，微生物侵入導致表淺性感染。淚液、唾液或尿液的浸漬進一步加重皮膚損傷。",
    "diagnosis": {
      "primary": [
        "典型的臨床表現和解剖部位",
        "皮膚細胞學（壓片）檢查微生物",
        "皮膚刮片排除蟎蟲",
        "品種和體型評估"
      ],
      "differential": [
        "蠕形蟎蟲病",
        "皮黴菌症",
        "過敏性皮膚炎",
        "天疱瘡",
        "酵母菌性皮膚炎"
      ],
      "labFindings": [
        "細胞學：大量球菌和/或Malassezia酵母菌",
        "嗜中性球和細胞碎片",
        "細菌培養：多為Staphylococcus pseudintermedius",
        "組織病理（少需要）：表淺性化膿性皮膚炎"
      ]
    },
    "treatment": {
      "acute": "清潔和乾燥皺褶區域；局部抗菌治療；嚴重感染時全身性抗生素",
      "chronic": "定期皺褶清潔護理；保持乾燥；體重管理",
      "medications": [
        "Chlorhexidine 2-4%清潔液每日清潔皺褶",
        "Mupirocin或Fusidic acid局部軟膏",
        "抗酵母菌：Miconazole或Clotrimazole局部",
        "嚴重感染：Cephalexin 22-30 mg/kg PO q12h",
        "乾燥粉劑維持皺褶乾燥"
      ],
      "surgery": "皺褶切除術（cheiloplasty唇部、vulvoplasty外陰部、臉部皺褶切除）是根治性治療"
    },
    "prognosis": "保守治療需要終身護理管理。手術切除多餘皺褶可提供根治性效果，術後預後良好。未治療的病例可能因慢性感染導致深層膿皮症。",
    "pearls": [
      "手術切除多餘皺褶是唯一的根治方法，保守治療僅為控制而非治癒",
      "外陰皺褶性皮膚炎常見於肥胖母犬或幼年絕育後外陰發育不全者",
      "向飼主強調每日清潔皺褶的重要性是管理的關鍵",
      "螺旋尾犬種（英鬥）的尾部皺褶感染可深入至尾椎，嚴重時需截尾"
    ],
    "diagnosticAlgorithm": {
      "title": "皮膚皺褶性皮膚炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "檢查皮膚皺褶區域的炎症和感染",
          "findings": [
            "面部皺褶炎症（短頭犬）",
            "唇褶炎症",
            "尾部皺褶（螺旋尾品種）",
            "外陰皺褶炎症（肥胖母犬）"
          ]
        },
        {
          "step": 2,
          "action": "皮膚學檢查",
          "details": "進行細胞學和微生物學檢查",
          "findings": [
            "皺褶間潮濕和紅腫",
            "異味分泌物",
            "細胞學見細菌和/或酵母菌",
            "表面糜爛或潰瘍"
          ]
        },
        {
          "step": 3,
          "action": "嚴重度評估與治療",
          "details": "評估嚴重程度決定治療方案",
          "findings": [
            "輕度：局部清潔和抗菌治療",
            "中度：全身性抗菌治療",
            "重度/反覆：手術切除皺褶",
            "評估肥胖作為促因"
          ]
        }
      ]
    },
    "monitoring": [
      "每月評估皺褶感染控制狀況",
      "體重管理追蹤（肥胖加重病情）",
      "評估手術適應症",
      "監測深層膿皮症的發展"
    ],
    "reference": "Saunders Comprehensive Veterinary Dictionary"
  },
  "corneal-sequestrum": {
    "zh": "角膜壞死斑",
    "en": "Corneal Sequestrum",
    "definition": "角膜壞死斑是貓特有的角膜病變，以角膜基質內出現棕色至黑色的壞死斑塊為特徵。壞死的角膜基質膠原蛋白變性形成不透明的色素沉著區域，常伴有不同程度的疼痛和角膜血管新生。",
    "synonyms": [
      "角膜黑斑",
      "角膜壞死症",
      "Corneal mummification",
      "Corneal nigrum"
    ],
    "epidemiology": {
      "species": "貓（犬極罕見）",
      "breed": "波斯貓、喜馬拉雅貓、暹羅貓好發",
      "age": "任何年齡均可發生，中年貓最常見",
      "sex": "無性別好發性",
      "prevalence": "貓眼科中相對常見的疾病"
    },
    "clinicalPresentation": {
      "symptoms": [
        "角膜上棕色至黑色斑塊",
        "眼部疼痛（眯眼、流淚）",
        "角膜血管新生",
        "結膜充血",
        "黏液性至黏膿性眼分泌物",
        "畏光",
        "頻繁眨眼或眯眼",
        "可能有角膜水腫",
        "病變可由小點逐漸擴大"
      ],
      "physicalExam": [
        "角膜中央或旁中央的棕黑色不透明斑塊",
        "斑塊周圍可能有角膜血管新生",
        "斑塊深度不等（淺至深基質層）",
        "Schirmer淚液試驗可能偏低",
        "螢光素染色：斑塊本身不著染但周圍可能陽性",
        "眼部不適體徵"
      ]
    },
    "pathophysiology": "角膜壞死斑的確切病因不明，但可能與慢性角膜刺激、疱疹病毒感染（FHV-1）、淚膜異常或角膜上皮缺損有關。持續的角膜刺激導致角膜基質膠原蛋白退化和壞死，壞死組織中的蛋白質氧化和變性產生特徵性的棕黑色外觀。淚膜不穩定和角膜暴露可能為起始因素。短頭品種的眼球突出加重角膜暴露。",
    "diagnosis": {
      "primary": [
        "裂隙燈生物顯微鏡檢查",
        "螢光素角膜染色",
        "Schirmer淚液試驗",
        "眼內壓測量排除青光眼"
      ],
      "differential": [
        "角膜異物",
        "角膜潰瘍伴色素沉著",
        "角膜黑色素瘤",
        "角膜皮樣囊腫",
        "慢性角膜炎",
        "FHV-1角膜炎"
      ],
      "labFindings": [
        "裂隙燈：角膜基質內界定清楚的棕黑色壞死斑",
        "螢光素染色：壞死斑本身陰性，周圍上皮缺損時陽性",
        "Schirmer試驗可能低於正常",
        "FHV-1 PCR可能陽性",
        "組織病理（術後）：角膜基質壞死和退化"
      ]
    },
    "treatment": {
      "acute": "疼痛管理；保護性角膜潤滑；局部抗生素預防繼發感染",
      "chronic": "淺層壞死斑可觀察等待自發脫落；深層或疼痛明顯者需手術",
      "medications": [
        "人工淚液頻繁點眼",
        "局部抗生素（Ofloxacin或Tobramycin）預防感染",
        "Famciclovir 90 mg/kg PO q8h（疑似FHV-1相關時）",
        "局部Atropine 1%控制睫狀肌痙攣引起的疼痛",
        "口服NSAIDs止痛"
      ],
      "surgery": "淺層角膜切除術（superficial keratectomy）為首選手術；深層病變可能需角膜移植（結膜瓣移植或角膜片層移植）"
    },
    "prognosis": "手術治療的預後良好，淺層角膜切除術成功率高。少數病例可能復發（約15-20%）。未治療的病例壞死斑可能自發脫落但可能留下角膜瘢痕或穿孔風險。",
    "pearls": [
      "角膜壞死斑幾乎僅發生於貓，犬出現類似病變時需考慮其他診斷",
      "FHV-1感染與角膜壞死斑的關聯性強，抗病毒治療應納入考慮",
      "淺層角膜切除術是標準治療，術後使用結膜瓣覆蓋可促進癒合",
      "短頭貓品種因眼球突出和淚膜不穩定而好發"
    ],
    "diagnosticAlgorithm": {
      "title": "角膜壞死斑 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估角膜病變特徵，貓特別常見",
          "findings": [
            "角膜上棕色至黑色斑塊",
            "貓（波斯、喜馬拉雅等好發）",
            "流淚和瞇眼",
            "慢性角膜刺激史"
          ]
        },
        {
          "step": 2,
          "action": "眼科檢查",
          "details": "進行完整眼科檢查評估嚴重程度",
          "findings": [
            "裂隙燈檢查評估深度",
            "螢光素染色評估周圍潰瘍",
            "角膜血管新生程度",
            "眼壓測量排除青光眼"
          ]
        },
        {
          "step": 3,
          "action": "病因評估",
          "details": "評估促發因子",
          "findings": [
            "疱疹病毒PCR（貓）",
            "眼瞼異常（內翻、異位睫毛）",
            "乾眼症評估（Schirmer試驗）",
            "慢性角膜暴露"
          ]
        },
        {
          "step": 4,
          "action": "手術評估",
          "details": "評估手術切除指征",
          "findings": [
            "壞死斑深度評估",
            "角膜切除手術規劃",
            "結膜或角膜移植術需求評估",
            "術後追蹤計劃"
          ]
        }
      ]
    },
    "monitoring": [
      "術後每週複診至角膜完全癒合",
      "長期監測復發",
      "Schirmer淚液試驗定期追蹤",
      "監測FHV-1活化跡象"
    ],
    "reference": "Clinical Veterinary Advisor"
  },
  "corneal-dystrophy": {
    "zh": "角膜營養不良",
    "en": "Corneal Dystrophy",
    "definition": "角膜營養不良是一組非發炎性、遺傳性的雙側角膜疾病，以角膜上皮、基質或內皮層的異常物質沉積為特徵。依受累角膜層不同分為上皮性、基質性（最常見，脂質或礦物質沉積）和內皮性營養不良。",
    "synonyms": [
      "角膜失養症",
      "遺傳性角膜混濁"
    ],
    "epidemiology": {
      "species": "犬為主，貓罕見",
      "breed": "基質性：哈士奇、薩摩耶、比格犬、可卡犬、騎士查理王小獵犬；內皮性：波士頓㹴、吉娃娃、臘腸犬",
      "age": "基質性通常在成年初期（1-4歲）出現；內皮性多見於中老年",
      "sex": "某些類型雌犬較好發",
      "prevalence": "在好發品種中相對常見"
    },
    "clinicalPresentation": {
      "symptoms": [
        "角膜出現白色至灰色不透明區域",
        "雙側對稱性病變（但程度可能不同）",
        "通常無疼痛",
        "視力可能受影響（嚴重時）",
        "內皮型：角膜水腫進行性加重",
        "上皮型：可能有反覆角膜糜爛",
        "緩慢進展",
        "通常不伴有結膜充血"
      ],
      "physicalExam": [
        "角膜上界定清楚的白色至灰白色結晶狀或雲霧狀混濁",
        "基質型常位於角膜中央或旁中央",
        "雙側性但不一定完全對稱",
        "內皮型表現為彌漫性角膜水腫",
        "通常無角膜血管新生（除非繼發潰瘍）"
      ]
    },
    "pathophysiology": "角膜營養不良為遺傳性缺陷導致角膜特定層的代謝異常。基質性營養不良：脂質（膽固醇、磷脂）或礦物質（鈣）異常沉積在角膜基質中，與局部脂質代謝異常有關。內皮性營養不良：角膜內皮細胞進行性喪失功能，無法維持角膜的脫水狀態，導致基質水腫和混濁。上皮性營養不良：基底膜異常導致上皮附著力差。",
    "diagnosis": {
      "primary": [
        "裂隙燈生物顯微鏡檢查確定受累層",
        "雙眼對比檢查",
        "螢光素染色排除角膜潰瘍",
        "空腹血脂檢查排除全身性高脂血症"
      ],
      "differential": [
        "脂質性角膜病變（繼發於高脂血症）",
        "角膜退化（degenerative）",
        "慢性淺表性角膜炎（pannus）",
        "角膜鈣化",
        "角膜疤痕"
      ],
      "labFindings": [
        "裂隙燈：角膜特定層的結晶狀或混濁沉積物",
        "空腹血脂：排除全身性高脂血症",
        "螢光素染色通常陰性（除非繼發潰瘍）",
        "組織病理（少需要）：角膜基質脂質或礦物質沉積"
      ]
    },
    "treatment": {
      "acute": "繼發角膜潰瘍時給予局部抗生素和止痛",
      "chronic": "多數基質性營養不良不需治療；內皮性營養不良可能需要手術；控制高脂血症（如有）",
      "medications": [
        "高脂血症相關時：低脂飲食",
        "繼發角膜潰瘍：局部抗生素（Ofloxacin q6-8h）",
        "內皮性角膜水腫：高張生理食鹽水（NaCl 5%）點眼",
        "Atropine 1%（角膜潰瘍疼痛時）"
      ],
      "surgery": "淺層角膜切除術（嚴重脂質沉積時）；內皮性營養不良嚴重者可考慮角膜移植"
    },
    "prognosis": "基質性角膜營養不良通常進展緩慢，多數犬維持功能性視力，預後良好。內皮性營養不良預後較差，可能進展至嚴重角膜水腫和大疱性角膜病變。上皮性營養不良因反覆角膜糜爛可能需要介入治療。",
    "pearls": [
      "角膜營養不良與角膜退化不同——營養不良為遺傳性、雙側性、非發炎性；退化為後天的",
      "基質性營養不良不一定需要治療，除非影響視力或繼發潰瘍",
      "空腹血脂檢查是重要的鑑別步驟，高脂血症導致的脂質沉積可透過飲食控制改善",
      "內皮性營養不良好發於老年小型犬，常伴隨白內障共存"
    ],
    "diagnosticAlgorithm": {
      "title": "角膜營養不良 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估角膜混濁特徵和品種背景",
          "findings": [
            "雙側對稱性角膜混濁",
            "品種易感性（騎士查理王獵犬、哈士奇等）",
            "通常無疼痛症狀",
            "視力可能正常"
          ]
        },
        {
          "step": 2,
          "action": "眼科檢查",
          "details": "進行裂隙燈和其他眼科檢查",
          "findings": [
            "角膜基質結晶狀或白色沉積",
            "病變位置（上皮型、基質型或內皮型）",
            "螢光素染色通常陰性",
            "眼壓正常"
          ]
        },
        {
          "step": 3,
          "action": "分類與鑑別",
          "details": "確定角膜營養不良類型並排除其他角膜疾病",
          "findings": [
            "上皮/前基質型：淺層沉積",
            "基質型：脂質或膽固醇沉積",
            "內皮型：角膜水腫",
            "排除代謝性角膜沉積（高脂血症）"
          ]
        }
      ]
    },
    "monitoring": [
      "每6-12個月眼科檢查追蹤進展",
      "監測角膜潰瘍的發生",
      "內皮型需更頻繁追蹤角膜水腫程度",
      "血脂定期監測（如有高脂血症）"
    ],
    "reference": "Clinical Veterinary Advisor"
  },
  "optic-neuritis": {
    "zh": "視神經炎",
    "en": "Optic Neuritis",
    "definition": "視神經炎是視神經的炎症性疾病，導致急性視力喪失。病因包括感染性疾病、免疫介導性疾病、腫瘤和特發性。可為單側或雙側，對動物的視力功能造成嚴重影響。",
    "synonyms": [
      "視神經發炎",
      "視乳頭炎"
    ],
    "epidemiology": {
      "species": "犬貓均可發生",
      "breed": "無明確品種好發性，但肉芽腫性腦膜腦炎（GME）好發品種可能相關",
      "age": "任何年齡，中年犬較常見",
      "sex": "無性別好發性",
      "prevalence": "不常見但臨床重要的眼科急症"
    },
    "clinicalPresentation": {
      "symptoms": [
        "急性視力喪失（單側或雙側）",
        "瞳孔散大",
        "威脅反射消失",
        "瞳孔對光反射異常",
        "可能伴有其他神經學症狀",
        "突然撞到物體",
        "行為改變（焦慮、不安）",
        "眼球可能外觀正常",
        "雙側受累時完全失明"
      ],
      "physicalExam": [
        "瞳孔散大且對光反射遲鈍或消失",
        "視乳頭水腫（眼底檢查可見）",
        "視乳頭周圍出血",
        "視乳頭模糊隆起",
        "擺動手電筒試驗（swinging flashlight test）顯示傳入性瞳孔缺損（APD）",
        "可能伴有其他顱神經異常"
      ]
    },
    "pathophysiology": "視神經炎的病理機制因病因而異。免疫介導性視神經炎涉及對髓鞘蛋白的自身免疫反應，T細胞和抗體攻擊視神經的髓鞘導致脫髓鞘和軸突損傷。感染性病因（如犬瘟熱、弓蟲症、真菌感染）直接侵入或誘發炎症反應。腫瘤性病因則是腫瘤直接壓迫或浸潤視神經。炎症導致視神經水腫，軸突傳導功能受阻。",
    "diagnosis": {
      "primary": [
        "完整的眼科檢查（直接和間接檢眼鏡）",
        "瞳孔對光反射和威脅反射測試",
        "MRI（首選影像學檢查）",
        "腦脊液（CSF）分析"
      ],
      "differential": [
        "視網膜剝離",
        "突然獲得性視網膜退化症候群（SARDS）",
        "視交叉腫瘤",
        "腦膜腦炎",
        "青光眼",
        "中樞性失明（皮質性）"
      ],
      "labFindings": [
        "眼底檢查：視乳頭水腫、出血、模糊",
        "MRI：視神經增粗、強化",
        "CSF：蛋白升高、細胞數增加",
        "傳染病血清學（犬瘟熱、弓蟲症、真菌）",
        "ERG正常（與SARDS鑑別）"
      ]
    },
    "treatment": {
      "acute": "高劑量免疫抑制性類固醇治療；治療基礎感染（如有）",
      "chronic": "逐漸減量的免疫抑制治療；基礎疾病的長期管理",
      "medications": [
        "Prednisolone 2-4 mg/kg PO q12h起始，逐漸減量",
        "Dexamethasone 0.1-0.2 mg/kg IV（急性期）",
        "Azathioprine 2 mg/kg PO q24h（需長期免疫抑制時）",
        "Cytarabine 50 mg/m2 SC q12h×2天（GME相關時）",
        "針對特定感染的抗微生物藥物"
      ],
      "surgery": "通常不需要手術；腫瘤壓迫性者可能需要減壓或腫瘤切除"
    },
    "prognosis": "預後謹慎至不良。免疫介導性視神經炎在早期積極類固醇治療下可能部分恢復視力。感染性病因在控制感染後預後較好。與GME或CNS腫瘤相關的視神經炎預後不良。延遲治療會導致永久性視神經萎縮和不可逆失明。",
    "pearls": [
      "視神經炎是眼科急症，早期高劑量類固醇治療對挽救視力至關重要",
      "ERG（視網膜電圖）正常可排除SARDS，這是關鍵的鑑別診斷",
      "雙側急性失明的鑑別診斷首要考慮：視神經炎、SARDS和視網膜剝離",
      "視神經炎可能是肉芽腫性腦膜腦炎（GME）的首發表現"
    ],
    "diagnosticAlgorithm": {
      "title": "視神經炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估急性視力喪失和瞳孔反射異常",
          "findings": [
            "急性單側或雙側失明",
            "瞳孔散大且對光反射遲鈍/消失",
            "直接和間接瞳孔反射異常",
            "可能伴有眼後疼痛"
          ]
        },
        {
          "step": 2,
          "action": "眼底檢查",
          "details": "進行直接和間接眼底鏡檢查",
          "findings": [
            "視神經乳頭水腫和充血",
            "視神經乳頭出血",
            "視網膜血管炎",
            "球後視神經炎眼底可能正常"
          ]
        },
        {
          "step": 3,
          "action": "進階影像與實驗室",
          "details": "進行MRI和全面病因學篩檢",
          "findings": [
            "MRI見視神經增粗和增強",
            "CSF分析排除腦膜腦炎",
            "感染篩檢（弓漿蟲、真菌等）",
            "壁蝨媒介疾病篩檢"
          ]
        },
        {
          "step": 4,
          "action": "病因學確認",
          "details": "確定視神經炎的基礎原因",
          "findings": [
            "感染性vs免疫介導性",
            "GME或MUE相關",
            "腫瘤性病因排除",
            "特發性（排除性診斷）"
          ]
        }
      ]
    },
    "monitoring": [
      "治療後每1-2週追蹤視力和瞳孔反射",
      "MRI追蹤視神經變化",
      "免疫抑制劑使用期間監測CBC和生化",
      "長期監測視力功能和復發"
    ],
    "reference": "Clinical Veterinary Advisor"
  },
  "chorioretinitis": {
    "zh": "脈絡膜視網膜炎",
    "en": "Chorioretinitis",
    "definition": "脈絡膜視網膜炎是脈絡膜和視網膜的同時炎症，因兩者共享血供而常同時受累。通常由全身性感染或免疫介導性疾病引起，可導致局部或廣泛的視網膜損傷和視力障礙。",
    "synonyms": [
      "脈絡膜網膜炎",
      "後葡萄膜炎",
      "Posterior uveitis"
    ],
    "epidemiology": {
      "species": "犬貓均可發生",
      "breed": "無明確品種好發性",
      "age": "任何年齡，取決於基礎病因",
      "sex": "無性別好發性",
      "prevalence": "不常見，但在全身性感染疾病中為重要眼部併發症"
    },
    "clinicalPresentation": {
      "symptoms": [
        "視力下降或喪失",
        "瞳孔對光反射可能異常",
        "可能無明顯外觀異常",
        "威脅反射減弱",
        "可能伴隨前葡萄膜炎症狀",
        "雙側或單側視力受損",
        "全身性感染的其他症狀",
        "精神沉鬱（基礎疾病所致）",
        "可能伴有視網膜剝離"
      ],
      "physicalExam": [
        "眼底檢查：視網膜下滲出物（灰白色病灶）",
        "視網膜血管炎（血管套）",
        "視網膜出血",
        "局部或廣泛的視網膜剝離",
        "玻璃體混濁",
        "可能伴有前房反應（flare、細胞）"
      ]
    },
    "pathophysiology": "脈絡膜視網膜炎的病理機制取決於基礎病因。感染性病因（弓蟲症、真菌感染、犬瘟熱、FIP）中，病原體經血行播散到脈絡膜的豐富血管網，引發局部炎症反應。炎症介質破壞血-視網膜屏障，導致滲出液和炎性細胞進入視網膜下腔。免疫介導性病因涉及免疫複合物沉積和補體活化。炎症損傷光受體和視網膜色素上皮（RPE）導致視力喪失。",
    "diagnosis": {
      "primary": [
        "完整眼科檢查含直接和間接檢眼鏡",
        "全身性感染疾病篩查",
        "胸腹部影像學",
        "腦脊液分析（疑似CNS疾病時）"
      ],
      "differential": [
        "視網膜剝離（非炎症性）",
        "視網膜出血（凝血障礙）",
        "視網膜退化",
        "視神經炎",
        "眼內腫瘤",
        "全葡萄膜炎"
      ],
      "labFindings": [
        "眼底檢查：灰白色視網膜下病灶、血管套、出血",
        "感染病原學：弓蟲IgM/IgG、真菌抗原、犬瘟熱PCR",
        "貓：FIV/FeLV、弓蟲、FIP",
        "CBC：可能白血球增多或減少",
        "血液生化：依基礎疾病而異"
      ]
    },
    "treatment": {
      "acute": "治療基礎感染性疾病；全身性和局部抗炎治療",
      "chronic": "免疫介導性病因需長期免疫抑制；感染性病因需完成抗微生物療程",
      "medications": [
        "Prednisolone 1-2 mg/kg PO q12h（免疫介導性或非感染性）",
        "Clindamycin 12.5-25 mg/kg PO q12h（弓蟲症）",
        "Itraconazole 5-10 mg/kg PO q12-24h（真菌感染）",
        "局部Prednisolone acetate 1%點眼q6-8h（伴前葡萄膜炎時）",
        "局部Atropine 1%控制睫狀肌痙攣"
      ],
      "surgery": "通常不需要手術；視網膜剝離嚴重時預後不良"
    },
    "prognosis": "預後取決於病因、受累範圍和治療時機。局部性脈絡膜視網膜炎在控制基礎疾病後可保留部分視力。廣泛性病變伴視網膜剝離預後不良，可能永久失明。感染性病因在有效抗微生物治療後預後較免疫介導性為佳。",
    "pearls": [
      "脈絡膜視網膜炎常為全身性疾病的眼部表現，必須進行全身性感染篩查",
      "貓的脈絡膜視網膜炎需優先排除弓蟲症、FIP和真菌感染",
      "犬瘟熱病毒可引起特徵性的「金牌」樣視網膜病變",
      "感染性病因確認前不應使用免疫抑制劑量的類固醇"
    ],
    "diagnosticAlgorithm": {
      "title": "脈絡膜視網膜炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估視覺障礙和眼底異常",
          "findings": [
            "視力減退",
            "可能無症狀（偶然發現）",
            "單側或雙側受累",
            "可能伴有前葡萄膜炎"
          ]
        },
        {
          "step": 2,
          "action": "眼底檢查",
          "details": "進行詳細眼底檢查評估病變",
          "findings": [
            "視網膜下積液或水腫",
            "灰白色視網膜下浸潤灶",
            "活動性病灶邊界模糊",
            "舊病灶呈色素沉著瘢痕"
          ]
        },
        {
          "step": 3,
          "action": "病因學篩檢",
          "details": "進行全面感染和免疫學篩檢",
          "findings": [
            "弓漿蟲血清學和PCR",
            "壁蝨媒介疾病篩檢",
            "真菌感染篩檢",
            "FeLV/FIV（貓）"
          ]
        },
        {
          "step": 4,
          "action": "確診與分類",
          "details": "確定病因並制定治療計劃",
          "findings": [
            "感染性vs免疫介導性vs腫瘤性",
            "全身性疾病評估",
            "雙側受累提示全身性病因",
            "視網膜電圖評估功能"
          ]
        }
      ]
    },
    "monitoring": [
      "每1-2週眼底檢查追蹤病變消退",
      "監測基礎疾病的治療反應",
      "視力功能評估",
      "感染指標追蹤"
    ],
    "reference": "Textbook of Veterinary Internal Medicine"
  },
  "episcleritis": {
    "zh": "鞏膜外層炎",
    "en": "Episcleritis",
    "definition": "鞏膜外層炎是鞏膜表面結締組織（episclera）的炎症性疾病，在犬常見的形式包括結節性鞏膜外層炎（nodular episcleritis/fibrous histiocytoma）。以單側或雙側的鞏膜表面紅色至粉紅色結節狀增生為特徵，多為免疫介導性。",
    "synonyms": [
      "表層鞏膜炎",
      "結節性筋膜炎",
      "Nodular granulomatous episclerokeratitis",
      "纖維性組織細胞瘤"
    ],
    "epidemiology": {
      "species": "犬為主",
      "breed": "柯利犬、雪達犬、金毛獵犬、拉布拉多犬較常見",
      "age": "中年犬（3-8歲）最常見",
      "sex": "無明顯性別差異",
      "prevalence": "犬眼科中相對常見的免疫介導性眼病"
    },
    "clinicalPresentation": {
      "symptoms": [
        "眼球表面粉紅色至紅色結節狀腫塊",
        "結膜充血",
        "角膜周圍血管新生",
        "可能有角膜脂質沉積",
        "通常不伴明顯疼痛",
        "輕度眼分泌物",
        "可能影響角膜透明度",
        "雙側發生（但程度可不同）",
        "病變緩慢增大"
      ],
      "physicalExam": [
        "鞏膜表面局限性粉紅色至紅色肉芽腫性結節",
        "多位於顳側角膜緣附近",
        "可能延伸至角膜（episcleritis-keratitis）",
        "角膜緣周圍血管新生",
        "角膜可能有脂質或色素沉著",
        "瞳孔反應通常正常"
      ]
    },
    "pathophysiology": "鞏膜外層炎為免疫介導的肉芽腫性炎症反應。組織學上由組織細胞、淋巴細胞、漿細胞和纖維母細胞組成的肉芽腫。T細胞介導的免疫反應導致鞏膜外層結締組織的慢性肉芽腫性炎症。炎症可能擴展至角膜基質引起角膜炎。確切的自身抗原尚未確定，但被認為與結締組織抗原的免疫反應有關。",
    "diagnosis": {
      "primary": [
        "臨床外觀和典型位置",
        "裂隙燈生物顯微鏡檢查",
        "組織切片活檢（排除腫瘤）",
        "眼內壓測量"
      ],
      "differential": [
        "鞏膜外層黑色素瘤",
        "淋巴瘤",
        "肥大細胞瘤",
        "角膜皮樣囊腫",
        "結膜乳突瘤",
        "慢性淺表性角膜炎（pannus）"
      ],
      "labFindings": [
        "組織病理：肉芽腫性炎症（組織細胞、淋巴細胞、漿細胞）",
        "細胞學：混合炎性細胞，無腫瘤細胞",
        "裂隙燈：鞏膜外層增厚和充血",
        "眼內壓通常正常"
      ]
    },
    "treatment": {
      "acute": "局部和全身性免疫抑制治療",
      "chronic": "長期局部免疫抑制維持治療；可能需要終身治療",
      "medications": [
        "局部Prednisolone acetate 1%點眼q6-8h漸減",
        "局部Cyclosporine 0.2-2%眼藥膏q12h（長期維持）",
        "局部Tacrolimus 0.02-0.03%眼藥膏q12h",
        "口服Prednisolone 1-2 mg/kg q12h（嚴重病例）",
        "Azathioprine 2 mg/kg PO q24h（難治病例）"
      ],
      "surgery": "手術切除通常不建議（高復發率）；嚴重影響視力時可考慮減量手術"
    },
    "prognosis": "局部免疫抑制治療通常有效控制病情，但多數需要長期甚至終身維持治療。停藥後復發率高。預後良好，多數犬可維持視力功能。難治型病例可能需要多種免疫抑制劑合併使用。",
    "pearls": [
      "Cyclosporine或Tacrolimus局部眼藥是長期維持治療的首選",
      "手術切除復發率極高，不建議作為單一治療",
      "需與鞏膜外層黑色素瘤鑑別，組織活檢對不典型病例很重要",
      "柯利犬品種同時好發慢性淺表性角膜炎（pannus）和結節性鞏膜外層炎"
    ],
    "diagnosticAlgorithm": {
      "title": "鞏膜外層炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估眼球表面炎症特徵",
          "findings": [
            "結膜和鞏膜外層充血",
            "局部或瀰漫性紅腫",
            "通常不影響視力",
            "可能輕微不適"
          ]
        },
        {
          "step": 2,
          "action": "眼科檢查",
          "details": "進行裂隙燈檢查區分結膜炎和鞏膜炎",
          "findings": [
            "腎上腺素10%點眼後血管不收縮（區別於結膜炎）",
            "鞏膜外層結節或增厚",
            "角膜可能繼發性變化",
            "眼壓通常正常"
          ]
        },
        {
          "step": 3,
          "action": "病因調查與鑑別",
          "details": "排除全身性疾病並確認診斷",
          "findings": [
            "免疫介導性最常見",
            "排除全身性血管炎",
            "與壞死性鞏膜炎鑑別",
            "活檢可見肉芽腫性炎症（嚴重病例）"
          ]
        }
      ]
    },
    "monitoring": [
      "每2-4週追蹤治療反應",
      "評估結節大小和角膜侵犯程度",
      "長期維持治療期間每3-6個月追蹤",
      "監測局部類固醇使用的副作用（眼壓升高）"
    ],
    "reference": "Clinical Veterinary Advisor"
  },
  "endophthalmitis": {
    "zh": "眼內炎",
    "en": "Endophthalmitis",
    "definition": "眼內炎是眼球內部組織的嚴重感染性炎症，涉及玻璃體腔和/或前房。多由穿透性眼外傷、眼內手術後感染或血源性感染引起。為眼科急症，可導致永久失明和眼球喪失。",
    "synonyms": [
      "眼球內炎",
      "化膿性眼內炎"
    ],
    "epidemiology": {
      "species": "犬貓均可發生",
      "breed": "無品種好發性",
      "age": "任何年齡",
      "sex": "無性別好發性",
      "prevalence": "罕見但嚴重的眼科急症；穿透性眼外傷和白內障手術後風險最高"
    },
    "clinicalPresentation": {
      "symptoms": [
        "急性嚴重眼痛",
        "劇烈眼瞼痙攣",
        "大量黏膿性眼分泌物",
        "視力急劇喪失",
        "結膜嚴重充血水腫",
        "角膜水腫混濁",
        "前房積膿",
        "玻璃體混濁",
        "眼球可能腫大",
        "食慾廢絕和精神沉鬱"
      ],
      "physicalExam": [
        "劇烈眼痛表現（眼瞼痙攣、拒觸碰）",
        "角膜彌漫性水腫",
        "前房積膿（hypopyon）",
        "前房flare嚴重",
        "瞳孔可能縮小或不規則（後粘連）",
        "眼內結構無法視覺化（嚴重混濁）"
      ]
    },
    "pathophysiology": "眼內炎的病原體通過三種途徑進入眼內：(1)外源性：穿透性眼外傷或手術後細菌直接侵入；(2)內源性/血源性：全身性感染經血行播散至眼內脈絡膜血管；(3)鄰近組織感染擴散。細菌（常見Staphylococcus、Streptococcus、E. coli）或真菌在玻璃體腔內增殖，引發嚴重的嗜中性球炎症反應。炎症介質和細菌毒素破壞視網膜和玻璃體結構。",
    "diagnosis": {
      "primary": [
        "臨床表現（急性眼痛、前房積膿、視力喪失）",
        "眼超音波檢查（眼內結構無法視覺化時）",
        "前房或玻璃體穿刺液培養",
        "詳細外傷或手術史"
      ],
      "differential": [
        "嚴重前葡萄膜炎（非感染性）",
        "全葡萄膜炎",
        "眼內腫瘤伴繼發炎症",
        "晶體誘發性葡萄膜炎",
        "眶後膿瘍"
      ],
      "labFindings": [
        "前房/玻璃體穿刺液細胞學：大量嗜中性球和細菌",
        "細菌培養和藥敏試驗",
        "眼超音波：玻璃體混濁、可能有視網膜剝離",
        "CBC：白血球增多",
        "血液培養（懷疑血源性時）"
      ]
    },
    "treatment": {
      "acute": "眼科急症處理：玻璃體內抗生素注射；積極全身性和局部抗感染治療；疼痛管理",
      "chronic": "嚴重損傷的眼球可能需要摘除；輕度病例長期追蹤併發症",
      "medications": [
        "玻璃體內注射：Amikacin 0.4 mg + Vancomycin 1 mg",
        "全身性抗生素：Enrofloxacin 5-10 mg/kg PO/IV q24h",
        "局部強化抗生素：Tobramycin + Cefazolin交替頻繁點眼",
        "局部Atropine 1%散瞳預防後粘連",
        "全身性NSAIDs或Prednisolone控制炎症"
      ],
      "surgery": "玻璃體切除術（有經驗的眼科專科醫師）；嚴重無法挽救的眼球需行眼球摘除術"
    },
    "prognosis": "預後不良至極差。即使積極治療，視力保留率低。穿透性外傷後發生的眼內炎預後最差。早期診斷和積極治療可能挽救部分視力功能。許多病例最終需行眼球摘除術以消除疼痛來源。",
    "pearls": [
      "眼內炎是眼科急症中最嚴重的之一，時間是關鍵因素",
      "穿透性眼外傷後的預防性全身抗生素可降低眼內炎風險",
      "白內障手術後眼內炎的發生率犬約為1-2%",
      "懷疑血源性眼內炎時必須同時進行全身性感染源的搜查和治療"
    ],
    "diagnosticAlgorithm": {
      "title": "眼內炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "緊急評估眼內感染的嚴重程度",
          "findings": [
            "嚴重眼痛和視力喪失",
            "結膜充血和水腫",
            "前房積膿",
            "角膜水腫"
          ]
        },
        {
          "step": 2,
          "action": "眼科檢查",
          "details": "進行完整眼科評估",
          "findings": [
            "前房閃輝和纖維素沉積",
            "前房積膿",
            "玻璃體混濁（無法觀察眼底）",
            "眼壓可能升高或降低"
          ]
        },
        {
          "step": 3,
          "action": "病因評估",
          "details": "評估感染來源和病原體",
          "findings": [
            "外源性（穿透性外傷、手術後）",
            "內源性（血行播散感染）",
            "前房穿刺液細胞學和培養",
            "全身感染篩檢"
          ]
        },
        {
          "step": 4,
          "action": "治療與預後評估",
          "details": "評估視力保存可能性",
          "findings": [
            "眼球超音波評估玻璃體",
            "視網膜脫離評估",
            "評估摘除眼球指征",
            "全身性和局部抗菌治療計劃"
          ]
        }
      ]
    },
    "monitoring": [
      "治療初期每日眼科評估",
      "監測眼壓（可能續發青光眼）",
      "眼超音波追蹤玻璃體清澈度和視網膜狀態",
      "疼痛評估決定是否需要眼球摘除"
    ],
    "reference": "Blackwell's Five-Minute Veterinary Consult"
  },
  "anterior-uveitis": {
    "zh": "前葡萄膜炎",
    "en": "Anterior Uveitis",
    "definition": "前葡萄膜炎是虹膜和睫狀體的炎症（又稱虹膜睫狀體炎），是犬貓最常見的眼內炎症。病因多樣，包括感染性、免疫介導性、腫瘤性和外傷性。可導致多種嚴重眼部併發症。",
    "synonyms": [
      "虹膜睫狀體炎",
      "Iridocyclitis",
      "前房炎症"
    ],
    "epidemiology": {
      "species": "犬貓均常見",
      "breed": "金毛獵犬（色素性葡萄膜炎）；貓無品種好發",
      "age": "任何年齡均可發生",
      "sex": "無明顯性別差異",
      "prevalence": "犬貓最常見的眼內疾病之一"
    },
    "clinicalPresentation": {
      "symptoms": [
        "眼痛（眼瞼痙攣、流淚）",
        "結膜和鞏膜充血",
        "畏光",
        "瞳孔縮小（miosis）",
        "角膜水腫",
        "前房混濁（aqueous flare）",
        "前房積血或積膿",
        "視力可能下降",
        "眼內壓降低",
        "虹膜顏色改變",
        "虹膜腫脹"
      ],
      "physicalExam": [
        "瞳孔縮小且可能不規則（後粘連所致）",
        "角膜內皮沉著物（keratic precipitates, KPs）",
        "前房flare（蛋白滲出）和細胞",
        "虹膜充血水腫",
        "低眼壓（<10 mmHg）",
        "結膜和鞏膜外層充血（ciliary flush）"
      ]
    },
    "pathophysiology": "前葡萄膜炎的核心病理為血-房水屏障（blood-aqueous barrier）的破壞。各種病因（感染、免疫複合物、外傷）導致虹膜和睫狀體血管內皮通透性增加，血漿蛋白和炎性細胞進入前房。前列腺素和其他炎症介質導致血管擴張（充血）、睫狀肌痙攣（疼痛）和瞳孔括約肌收縮（縮瞳）。持續炎症導致虹膜後粘連、續發性青光眼和白內障。",
    "diagnosis": {
      "primary": [
        "完整眼科檢查（裂隙燈、眼底檢查）",
        "眼壓測量",
        "全身性疾病篩查",
        "前房穿刺液分析（選擇性）"
      ],
      "differential": [
        "急性青光眼",
        "結膜炎",
        "角膜潰瘍",
        "鞏膜炎",
        "眼內腫瘤",
        "晶體誘發性葡萄膜炎"
      ],
      "labFindings": [
        "低眼壓為重要診斷線索",
        "裂隙燈：前房flare、細胞、KPs",
        "感染篩查：弓蟲、利什曼原蟲、布氏桿菌（犬）",
        "貓：FIV、FeLV、弓蟲、FIP抗體/PCR",
        "CBC和生化排除全身性疾病"
      ]
    },
    "treatment": {
      "acute": "積極抗炎治療；散瞳預防後粘連；治療基礎病因",
      "chronic": "長期低劑量抗炎維持；監測併發症（青光眼、白內障）",
      "medications": [
        "局部Prednisolone acetate 1%點眼q4-6h（急性期）漸減",
        "局部Atropine 1%散瞳q8-12h",
        "全身性NSAIDs：Meloxicam 0.1 mg/kg PO q24h（犬）",
        "全身性Prednisolone 1-2 mg/kg PO q12h（免疫介導性）",
        "針對基礎感染的抗微生物藥物"
      ],
      "surgery": "通常不需要；續發白內障影響視力可考慮晶體乳化術；續發青光眼可能需要手術處理"
    },
    "prognosis": "預後取決於病因和治療時機。急性單次發作且基礎病因可控制者預後良好。慢性反覆發作者可能產生永久性併發症（後粘連、續發性青光眼、白內障）。貓的特發性前葡萄膜炎常為淋巴瘤的前兆，需要長期監測。",
    "pearls": [
      "低眼壓是前葡萄膜炎最具特異性的體徵，與青光眼的高眼壓形成對比",
      "貓的慢性前葡萄膜炎需高度懷疑眼內淋巴瘤的可能",
      "Atropine散瞳不僅止痛還可預防後粘連，是治療不可或缺的一環",
      "前葡萄膜炎的病因診斷比治療炎症本身更重要"
    ],
    "diagnosticAlgorithm": {
      "title": "前葡萄膜炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估眼前段炎症徵象",
          "findings": [
            "眼痛和瞇眼",
            "流淚",
            "畏光",
            "瞳孔縮小"
          ]
        },
        {
          "step": 2,
          "action": "眼科檢查",
          "details": "進行完整裂隙燈和眼底檢查",
          "findings": [
            "前房閃輝（Tyndall效應）",
            "角膜後沉澱物（KP）",
            "虹膜水腫和色素變化",
            "眼壓通常降低"
          ]
        },
        {
          "step": 3,
          "action": "病因學篩檢",
          "details": "進行全面系統性疾病篩檢",
          "findings": [
            "壁蝨媒介疾病篩檢",
            "弓漿蟲和真菌感染",
            "FeLV/FIV（貓）",
            "腫瘤性病因（淋巴瘤）"
          ]
        },
        {
          "step": 4,
          "action": "併發症監測",
          "details": "監測和預防前葡萄膜炎的併發症",
          "findings": [
            "虹膜後黏連",
            "繼發性青光眼",
            "白內障形成",
            "視網膜脫離"
          ]
        }
      ]
    },
    "monitoring": [
      "治療初期每2-3天追蹤",
      "眼壓定期監測（預防續發性青光眼）",
      "裂隙燈追蹤前房炎症程度",
      "長期監測白內障發展和後粘連"
    ],
    "reference": "Handbook of Canine and Feline Emergency Protocols"
  },
  "phthisis-bulbi": {
    "zh": "眼球萎縮",
    "en": "Phthisis Bulbi",
    "definition": "眼球萎縮是嚴重眼內疾病或外傷後的終末期狀態，以眼球體積縮小、結構紊亂和功能完全喪失為特徵。代表眼球已無法挽救的不可逆終末狀態，可續發於慢性葡萄膜炎、青光眼、嚴重外傷或手術後。",
    "synonyms": [
      "眼球癆",
      "萎縮性眼球",
      "End-stage eye"
    ],
    "epidemiology": {
      "species": "犬貓均可發生",
      "breed": "無品種好發性（取決於原發疾病）",
      "age": "任何年齡，老年動物較常見（慢性病程結果）",
      "sex": "無性別好發性",
      "prevalence": "為各種嚴重眼病的共同終末結果"
    },
    "clinicalPresentation": {
      "symptoms": [
        "眼球明顯縮小",
        "完全失明",
        "第三眼瞼突出（因眼球內縮）",
        "眼瞼凹陷",
        "慢性黏液性眼分泌物",
        "眼球外觀畸形",
        "通常無急性疼痛",
        "對側眼可能有原發疾病的徵象"
      ],
      "physicalExam": [
        "眼球明顯小於正常（microphthalmia acquired）",
        "眼球內陷（enophthalmos）",
        "角膜混濁、血管新生和色素沉著",
        "前房消失或極淺",
        "可能觸及眼球硬化或鈣化",
        "低眼壓或無法測量"
      ]
    },
    "pathophysiology": "眼球萎縮是嚴重眼內炎症或組織破壞的最終結果。慢性炎症導致睫狀體破壞，房水分泌減少，眼內壓進行性下降。持續的低眼壓導致眼球壁塌陷。同時，炎症刺激眼內纖維增生和膜形成（cyclitic membrane），進一步收縮牽拉眼內組織。晶體、玻璃體退化，視網膜完全剝離和萎縮。最終眼球骨化（osseous metaplasia）和鈣化。",
    "diagnosis": {
      "primary": [
        "臨床外觀即可診斷",
        "眼超音波評估眼內結構",
        "對側眼的完整檢查",
        "排除眼內腫瘤的可能"
      ],
      "differential": [
        "先天性小眼球症（microphthalmos）",
        "眼球內陷（enophthalmos）其他原因",
        "眼眶脂肪萎縮",
        "Horner症候群"
      ],
      "labFindings": [
        "眼超音波：眼球縮小、眼內結構紊亂、可能有鈣化灶",
        "眼內壓極低或無法測量",
        "組織病理（摘除後）：廣泛纖維化、骨化生、視網膜完全萎縮",
        "評估原發疾病的相關檢查"
      ]
    },
    "treatment": {
      "acute": "通常不需要急性治療（已為終末狀態）",
      "chronic": "維持眼部清潔舒適；眼球摘除術（如有慢性不適或美觀需求）；義眼植入（美觀考量）",
      "medications": [
        "人工淚液維持角膜濕潤",
        "局部抗生素預防繼發感染（如有分泌物）",
        "全身性止痛藥（如有不適跡象）"
      ],
      "surgery": "眼球摘除術（enucleation）為確定性治療；矽膠球義眼植入改善外觀；眼內義眼植入（evisceration with implant）"
    },
    "prognosis": "視力無法恢復。眼球萎縮本身為穩定的終末狀態，多數動物可適應單眼視力。主要關注在確保無持續性疼痛和預防繼發感染。眼球摘除術後預後良好，動物通常迅速適應。",
    "pearls": [
      "眼球萎縮是不可逆的終末狀態，治療重點在於舒適度而非視力恢復",
      "萎縮的眼球內可能隱藏眼內腫瘤，超音波或摘除後病理檢查有助排除",
      "許多飼主對眼球摘除術心理抗拒，需充分解釋動物適應能力良好",
      "對側眼的保護和監測比治療萎縮眼更重要"
    ],
    "diagnosticAlgorithm": {
      "title": "眼球萎縮 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估眼球縮小和功能喪失",
          "findings": [
            "眼球明顯縮小",
            "眼球內陷",
            "視力完全喪失",
            "慢性眼病病史"
          ]
        },
        {
          "step": 2,
          "action": "眼科檢查",
          "details": "評估殘餘眼球結構",
          "findings": [
            "眼球硬度降低",
            "角膜混濁或帶狀角膜病變",
            "前房消失或淺化",
            "晶體鈣化"
          ]
        },
        {
          "step": 3,
          "action": "影像學與評估",
          "details": "進行眼球超音波和評估是否需要摘除",
          "findings": [
            "眼球超音波顯示內部結構紊亂",
            "排除眼內腫瘤",
            "評估義眼植入可行性",
            "對側眼評估"
          ]
        }
      ]
    },
    "monitoring": [
      "定期檢查萎縮眼是否有感染或不適",
      "對側眼的定期眼科檢查",
      "眼球摘除術後的傷口癒合追蹤",
      "評估動物整體適應和生活品質"
    ],
    "reference": "Clinical Veterinary Advisor"
  },
  "eyelid-agenesis": {
    "zh": "眼瞼缺損",
    "en": "Eyelid Agenesis (Eyelid Coloboma)",
    "definition": "眼瞼缺損（眼瞼發育不全）是一種先天性眼瞼發育異常，以上眼瞼外側部分的缺失為特徵。缺損區域缺乏正常的眼瞼邊緣、睫毛和眼板腺，導致角膜長期暴露和繼發性角膜疾病。好發於貓。",
    "synonyms": [
      "眼瞼發育不全",
      "眼瞼缺裂",
      "Eyelid coloboma",
      "先天性眼瞼缺損"
    ],
    "epidemiology": {
      "species": "貓為主（犬極罕見）",
      "breed": "家貓（各品種均可），波斯貓和緬甸貓可能稍多",
      "age": "先天性疾病，出生即存在",
      "sex": "無性別好發性",
      "prevalence": "貓先天性眼瞼異常中最常見"
    },
    "clinicalPresentation": {
      "symptoms": [
        "上眼瞼外側明顯缺損",
        "慢性流淚",
        "眼瞼痙攣",
        "結膜充血",
        "角膜血管新生",
        "角膜色素沉著",
        "角膜潰瘍（反覆發生）",
        "黏膿性眼分泌物",
        "毛髮接觸角膜（缺損邊緣的毛髮）",
        "可能雙側或單側"
      ],
      "physicalExam": [
        "上眼瞼外側三分之一至二分之一缺失",
        "缺損區域眼瞼邊緣不連續",
        "缺損邊緣可能有毛髮直接接觸角膜",
        "角膜對應區域血管新生和色素沉著",
        "可能有角膜潰瘍",
        "結膜充血和腫脹"
      ]
    },
    "pathophysiology": "眼瞼缺損是胚胎發育過程中眼瞼正常融合和分化的失敗。正常胎兒發育中，上下眼瞼從兩側向中央融合再分開，上眼瞼外側是最後融合的區域。發育中斷導致該區域缺失。缺損區域缺乏正常的眼瞼邊緣保護機制（睫毛、眼板腺、結膜），角膜長期暴露於外界環境和缺損邊緣的毛髮刺激，引發慢性角膜炎、血管新生和色素沉著。",
    "diagnosis": {
      "primary": [
        "臨床外觀即可診斷",
        "完整眼科檢查評估角膜狀態",
        "螢光素染色評估角膜潰瘍",
        "Schirmer淚液試驗"
      ],
      "differential": [
        "外傷性眼瞼缺損",
        "眼瞼腫瘤切除後缺損",
        "眼瞼內翻",
        "角膜其他原因的炎症"
      ],
      "labFindings": [
        "臨床診斷為主，通常不需要實驗室檢查",
        "螢光素染色評估角膜潰瘍範圍",
        "Schirmer試驗：淚液分泌通常正常",
        "角膜細胞學（繼發感染時）"
      ]
    },
    "treatment": {
      "acute": "角膜潰瘍的緊急治療；局部抗生素和潤滑劑",
      "chronic": "手術修復為根本治療；術前以人工淚液和抗生素維護角膜",
      "medications": [
        "人工淚液頻繁點眼保護角膜",
        "局部抗生素（Ofloxacin或Tobramycin）預防角膜感染",
        "局部Cyclosporine 0.2%（減少角膜色素沉著和血管新生）",
        "角膜潰瘍時：局部Atropine 1%止痛"
      ],
      "surgery": "眼瞼重建手術為確定性治療：(1)Roberts-Bistner滑行皮瓣技術（最常用）；(2)Mustarde旋轉皮瓣；(3)唇黏膜移植重建眼瞼邊緣；(4)瞼裂縮短術（暫時性措施）"
    },
    "prognosis": "手術重建後預後良好。成功的眼瞼重建可有效保護角膜，減少慢性刺激。術前已有的角膜色素沉著和血管新生可能部分消退。未手術矯正的病例角膜病變將持續進展。",
    "pearls": [
      "眼瞼缺損最常發生在貓的上眼瞼外側三分之一處",
      "早期手術修復比等待角膜病變惡化後再手術效果更好",
      "術後局部Cyclosporine可幫助減少角膜色素沉著",
      "可能合併其他先天性眼部異常如持續性瞳孔膜或虹膜缺損"
    ],
    "diagnosticAlgorithm": {
      "title": "眼瞼缺損 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估先天性眼瞼結構缺損，貓常見",
          "findings": [
            "上眼瞼外側部分缺損（最常見）",
            "角膜暴露和慢性刺激",
            "結膜充血和分泌物",
            "幼齡貓"
          ]
        },
        {
          "step": 2,
          "action": "眼科檢查",
          "details": "評估角膜和結膜續發性變化",
          "findings": [
            "角膜血管新生",
            "角膜色素沉著",
            "角膜潰瘍",
            "乾眼症（Schirmer試驗）"
          ]
        },
        {
          "step": 3,
          "action": "手術規劃",
          "details": "評估重建手術選項",
          "findings": [
            "缺損範圍和程度評估",
            "皮瓣重建選項",
            "Roberts-Bistner或Mustardé旋轉皮瓣",
            "角膜保護評估"
          ]
        }
      ]
    },
    "monitoring": [
      "術後每週追蹤至傷口完全癒合",
      "長期監測角膜色素沉著消退情況",
      "評估重建的眼瞼邊緣功能",
      "監測角膜潰瘍復發"
    ],
    "reference": "Blackwell's Five-Minute Veterinary Consult"
  },
  "mastitis": {
    "zh": "乳腺炎",
    "en": "Mastitis",
    "definition": "乳腺組織的細菌性感染與發炎，常見於哺乳期母犬貓。通常由大腸桿菌（E. coli）、葡萄球菌（Staphylococcus spp.）或鏈球菌（Streptococcus spp.）經乳頭管上行感染引起。嚴重者可進展為膿瘍或壞疽性乳腺炎，危及生命。",
    "synonyms": [
      "乳房炎",
      "哺乳期乳腺感染"
    ],
    "epidemiology": {
      "species": "犬貓，犬較常見",
      "breed": "所有品種均可發生，大型犬略多",
      "age": "繁殖年齡母犬貓，哺乳期最常見",
      "sex": "幾乎僅見於母犬貓，極少數見於假懷孕個體",
      "prevalence": "哺乳期母犬發生率約 5-10%"
    },
    "clinicalPresentation": {
      "symptoms": [
        "乳腺腫脹、發紅、疼痛",
        "乳汁異常（變色、膿性、血性）",
        "發燒（>39.5°C）",
        "食慾下降",
        "精神沉鬱",
        "拒絕哺乳",
        "幼崽體重不增或哭鬧",
        "嘔吐",
        "脫水",
        "患部皮膚變色或壞死（壞疽性）"
      ],
      "physicalExam": [
        "受影響乳腺硬實、腫脹、觸痛明顯",
        "乳汁擠出呈黃綠色或血性",
        "體溫升高（39.5-41°C）",
        "局部淋巴結腫大",
        "壞疽性病例皮膚呈紫黑色"
      ]
    },
    "pathophysiology": "細菌經乳頭管上行進入乳腺組織，引起急性化膿性炎症。乳汁淤積、乳頭創傷或環境衛生不良為誘因。細菌繁殖產生毒素，引起局部組織壞死和全身性炎症反應。嚴重者可導致敗血症和中毒性休克。",
    "diagnosis": {
      "primary": [
        "臨床症狀與理學檢查",
        "乳汁細胞學檢查（大量嗜中性球與細菌）",
        "乳汁細菌培養與藥敏試驗",
        "血液學檢查（白血球增多、左移）"
      ],
      "differential": [
        "乳腺腫瘤（mammary neoplasia）",
        "乳腺增生（mammary hyperplasia）",
        "假懷孕泌乳（pseudopregnancy）",
        "乳腺膿瘍（mammary abscess）",
        "外傷性乳腺損傷"
      ],
      "labFindings": [
        "CBC：嗜中性球增多伴左移",
        "乳汁 pH >7.0（正常 6.0-6.5）",
        "乳汁細胞學：退化性嗜中性球、細胞內細菌",
        "血液生化：低白蛋白血症（嚴重病例）"
      ]
    },
    "treatment": {
      "acute": "廣效抗生素治療（等待培養結果前使用 amoxicillin-clavulanate），溫敷患部促進排乳，靜脈輸液支持（脫水或敗血症病例）",
      "chronic": "根據藥敏結果調整抗生素，療程至少 2-3 週。改善環境衛生，監測幼崽營養狀態",
      "medications": [
        "Amoxicillin-clavulanate 12.5-25 mg/kg PO BID",
        "Cephalexin 22-30 mg/kg PO BID",
        "Enrofloxacin 5 mg/kg PO SID（僅限非哺乳期）",
        "Meloxicam 0.1 mg/kg PO SID（止痛抗炎）",
        "靜脈輸液（乳酸林格氏液）用於敗血症病例"
      ],
      "surgery": "壞疽性乳腺炎需手術清創或乳腺切除術。膿瘍需切開引流。"
    },
    "prognosis": "單純性乳腺炎經適當抗生素治療預後良好。壞疽性乳腺炎預後謹慎至不良，可能危及生命。早期治療是關鍵。",
    "pearls": [
      "壞疽性乳腺炎是急診，需積極靜脈抗生素和手術介入",
      "哺乳期使用抗生素需考慮對幼崽的影響，避免使用 fluoroquinolones",
      "鼓勵持續哺乳或手動擠奶以減少乳汁淤積",
      "幼崽可能需要人工補充餵養"
    ],
    "diagnosticAlgorithm": {
      "title": "乳腺炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估哺乳母犬/母貓的乳腺炎症",
          "findings": [
            "乳腺腫脹、發熱、疼痛",
            "乳汁異常（血性、膿性）",
            "發熱和精神沉鬱",
            "拒絕哺乳幼崽"
          ]
        },
        {
          "step": 2,
          "action": "乳汁檢查",
          "details": "進行乳汁細胞學和培養",
          "findings": [
            "乳汁顏色和性狀異常",
            "細胞學見大量嗜中性球和細菌",
            "乳汁細菌培養和藥敏試驗",
            "常見菌：E. coli、Staphylococcus、Streptococcus"
          ]
        },
        {
          "step": 3,
          "action": "全身評估",
          "details": "評估全身性感染和併發症",
          "findings": [
            "全血計數見白血球增多",
            "生化評估敗血症風險",
            "超音波排除乳腺膿瘍",
            "幼崽健康狀態評估"
          ]
        }
      ]
    },
    "monitoring": [
      "每日監測體溫和乳腺腫脹程度",
      "幼崽每日體重監測",
      "抗生素治療 48-72 小時後評估反應",
      "追蹤乳汁培養確認細菌清除"
    ],
    "reference": "Blackwell's Five-Minute Veterinary Consult"
  },
  "vaginal-prolapse": {
    "zh": "陰道脫垂",
    "en": "Vaginal Prolapse",
    "definition": "陰道壁組織經陰門外翻脫出，可為部分或完全脫垂。常見於懷孕後期或發情期，與雌激素水平升高有關。嚴重者可伴隨膀胱或子宮脫出。",
    "synonyms": [
      "陰道脫出",
      "陰道外翻",
      "vaginal hyperplasia（部分脫垂）"
    ],
    "epidemiology": {
      "species": "犬較常見，貓罕見",
      "breed": "短頭犬種（English Bulldog、Boxer）、Labrador Retriever、Mastiff 品種易發",
      "age": "年輕母犬（1-4 歲），常於第一或第二次發情時發生",
      "sex": "僅見於未絕育母犬",
      "prevalence": "短頭犬種中相對常見"
    },
    "clinicalPresentation": {
      "symptoms": [
        "陰門處可見粉紅色至紅色腫塊突出",
        "頻繁舔舐外陰部",
        "排尿困難或尿液偏向",
        "不適和躁動",
        "組織乾燥、水腫或潰瘍",
        "出血或血性分泌物",
        "排便困難（嚴重病例）",
        "無法正常交配"
      ],
      "physicalExam": [
        "陰門口可見突出的陰道黏膜組織",
        "組織水腫、充血或潰瘍化",
        "尿道口可能被掩蓋",
        "確認有無膀胱嵌頓（觸診或超音波）"
      ]
    },
    "pathophysiology": "雌激素刺激陰道黏膜過度增生和水腫，導致組織鬆弛外翻。發情前期和發情期雌激素濃度升高為主要誘因。結締組織先天性鬆弛（品種傾向）加重脫垂傾向。懷孕後期腹壓增加也可誘發。",
    "diagnosis": {
      "primary": [
        "視診和觸診確認脫垂組織",
        "尿道導管置入確認尿道位置",
        "腹部超音波排除膀胱嵌頓",
        "陰道鏡檢查評估範圍"
      ],
      "differential": [
        "陰道腫瘤（vaginal neoplasia）",
        "陰道息肉（vaginal polyp）",
        "子宮脫垂（uterine prolapse）",
        "尿道脫垂（urethral prolapse）",
        "陰蒂肥大（clitoral hypertrophy）"
      ],
      "labFindings": [
        "陰道細胞學：角化上皮細胞（發情期特徵）",
        "組織病理學：黏膜水腫和增生",
        "血液學通常正常",
        "雌激素水平可能升高"
      ]
    },
    "treatment": {
      "acute": "保持脫出組織濕潤清潔，使用水溶性潤滑劑。輕度脫垂可嘗試手動復位並以荷包縫合維持。嚴重水腫者以高張糖液包裹減少腫脹",
      "chronic": "卵巢子宮切除術（OHE）為根本治療，可預防復發。非繁殖犬建議絕育",
      "medications": [
        "水溶性潤滑劑保護脫出組織",
        "局部抗生素軟膏（潰瘍組織）",
        "Meloxicam 0.1 mg/kg PO SID（止痛）",
        "GnRH agonist 誘導排卵終止發情（暫時性措施）"
      ],
      "surgery": "卵巢子宮切除術為首選根治手術。嚴重壞死組織需切除（陰道切除術 episiotomy approach）。繁殖犬可考慮陰道固定術（vaginopexy）。"
    },
    "prognosis": "絕育後預後良好，復發率極低。未絕育者每次發情均可能復發。組織壞死或膀胱嵌頓者預後需謹慎評估。",
    "pearls": [
      "發情期陰道增生常被誤認為腫瘤，細胞學和組織學可鑑別",
      "必須確認尿道口位置以避免排尿阻塞",
      "OHE 是最有效的預防和治療方法",
      "繁殖犬可考慮在發情結束後自然回縮，但下次發情可能復發"
    ],
    "diagnosticAlgorithm": {
      "title": "陰道脫垂 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估陰道組織脫出的程度和時機",
          "findings": [
            "陰道口可見粉紅色組織突出",
            "通常發生於動情前期/動情期",
            "舔舐會陰部",
            "排尿困難或困難"
          ]
        },
        {
          "step": 2,
          "action": "臨床分級",
          "details": "評估脫垂嚴重程度",
          "findings": [
            "第一型：輕度脫出（黏膜外翻）",
            "第二型：中度脫出",
            "第三型：完全脫垂（甜甜圈狀）",
            "組織活力評估（壞死、水腫）"
          ]
        },
        {
          "step": 3,
          "action": "鑑別與評估",
          "details": "排除其他會陰腫塊原因",
          "findings": [
            "與陰道腫瘤鑑別",
            "與子宮脫垂鑑別",
            "荷爾蒙狀態評估",
            "排除泌尿道阻塞"
          ]
        }
      ]
    },
    "monitoring": [
      "術後監測傷口癒合",
      "監測排尿功能是否正常",
      "未絕育者每次發情期密切觀察",
      "組織壞死病例術後監測感染徵兆"
    ],
    "reference": "Clinical Veterinary Advisor: Dogs and Cats"
  },
  "agalactia": {
    "zh": "無乳症",
    "en": "Agalactia",
    "definition": "產後母犬貓乳腺無法產生足夠乳汁或完全無泌乳的狀態。可為原發性（乳腺發育不全）或繼發性（全身性疾病、壓力、營養不良）。若未及時處理，新生幼崽可能因低血糖和脫水而死亡。",
    "synonyms": [
      "無泌乳症",
      "泌乳不足",
      "dysgalactia（泌乳障礙）"
    ],
    "epidemiology": {
      "species": "犬貓均可發生",
      "breed": "初產母犬、神經質品種較易發生",
      "age": "任何繁殖年齡，初產母犬風險較高",
      "sex": "僅見於產後母犬貓",
      "prevalence": "初產母犬發生率約 10-15%"
    },
    "clinicalPresentation": {
      "symptoms": [
        "幼崽持續哭叫和躁動",
        "幼崽體重不增或下降",
        "乳腺觸診無明顯充盈",
        "擠壓乳頭無乳汁或極少量",
        "幼崽脫水徵象",
        "幼崽低體溫",
        "幼崽低血糖（虛弱、抽搐）",
        "母犬可能精神正常或沉鬱"
      ],
      "physicalExam": [
        "乳腺觸診柔軟、未充盈",
        "擠壓乳頭無乳汁流出",
        "母犬可能有發燒或其他全身性疾病徵兆",
        "幼崽皮膚彈性差、黏膜蒼白"
      ]
    },
    "pathophysiology": "正常泌乳依賴催乳素（prolactin）和催產素（oxytocin）的協調作用。原發性無乳症由乳腺發育不全或荷爾蒙分泌不足引起。繼發性原因包括剖腹產後催產素釋放不足、全身性疾病（子宮蓄膿、乳腺炎）、嚴重壓力抑制催乳素分泌、營養不良或早產。",
    "diagnosis": {
      "primary": [
        "臨床症狀評估（母犬無泌乳 + 幼崽衰弱）",
        "乳腺理學檢查與擠乳試驗",
        "母犬全身性疾病篩查",
        "血液學和生化檢查排除潛在疾病"
      ],
      "differential": [
        "乳腺炎（mastitis）",
        "子宮蓄膿（pyometra）",
        "低鈣血症（eclampsia）",
        "營養不良",
        "假懷孕後泌乳抑制",
        "藥物引起（cabergoline 等）"
      ],
      "labFindings": [
        "CBC/生化：可能正常或反映潛在疾病",
        "血鈣：排除低鈣血症",
        "催乳素水平：可能偏低（不常規檢測）",
        "甲狀腺功能：排除甲狀腺低下"
      ]
    },
    "treatment": {
      "acute": "首先確保幼崽存活：人工哺乳（商業代乳粉）、保溫、低血糖者給予葡萄糖。同時治療母犬潛在疾病",
      "chronic": "促進泌乳的藥物治療，改善母犬營養（高蛋白高熱量飲食），減少環境壓力，鼓勵幼崽吸吮刺激",
      "medications": [
        "Metoclopramide 0.1-0.2 mg/kg PO TID（促進催乳素分泌）",
        "Oxytocin 0.5-2 IU IM/SC（促進排乳反射）",
        "商業犬貓代乳粉（人工哺乳）",
        "Domperidone 2.2 mg/kg PO（促泌乳，部分國家可用）"
      ],
      "surgery": "通常不需要手術。若因子宮蓄膿或其他腹腔疾病導致，需針對原發病手術治療。"
    },
    "prognosis": "繼發性無乳症治療潛在原因後預後較好。原發性乳腺發育不全預後不良，可能需全程人工哺乳。幼崽存活率取決於發現和介入的時間。",
    "pearls": [
      "最重要的是先確保幼崽存活（保溫 + 補充營養），再處理母犬問題",
      "剖腹產後常見暫時性無乳症，通常 24-48 小時內改善",
      "Metoclopramide 同時有止吐和促泌乳作用",
      "幼崽吸吮本身是最強的泌乳刺激"
    ],
    "diagnosticAlgorithm": {
      "title": "無乳症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估產後母體乳汁分泌不足",
          "findings": [
            "幼崽持續哭叫和體重不增",
            "乳腺發育不良或無乳汁",
            "產後母體精神狀態評估",
            "首次生產或早產"
          ]
        },
        {
          "step": 2,
          "action": "母體評估",
          "details": "評估母體健康和荷爾蒙狀態",
          "findings": [
            "全身健康狀態評估",
            "乳腺觸診（發育程度）",
            "排除乳腺炎",
            "排除全身性疾病"
          ]
        },
        {
          "step": 3,
          "action": "病因鑑別",
          "details": "確定無乳症的原因",
          "findings": [
            "原發性：乳腺發育不全",
            "繼發性：全身性疾病、營養不良",
            "藥物相關（某些藥物抑制泌乳）",
            "心理因素（緊迫、排斥幼崽）"
          ]
        }
      ]
    },
    "monitoring": [
      "幼崽每 4-6 小時體重監測",
      "監測幼崽體溫（應 >35°C）",
      "母犬乳腺充盈程度每日評估",
      "母犬食慾和精神狀態監測"
    ],
    "reference": "Management of Pregnant and Neonatal Dogs, Cats, and Exotic Pets"
  },
  "retained-placenta": {
    "zh": "胎盤滯留",
    "en": "Retained Placenta",
    "definition": "分娩後胎盤或胎膜未能在正常時間內完全排出。犬貓正常應在每隻幼崽出生後 15 分鐘內排出對應胎盤。超過 24 小時未排出即視為胎盤滯留，可導致子宮感染和敗血症。",
    "synonyms": [
      "胎衣不下",
      "胎膜滯留",
      "retained fetal membranes"
    ],
    "epidemiology": {
      "species": "犬貓均可發生，犬較常見",
      "breed": "短頭犬種、小型犬（難產風險高者）",
      "age": "任何繁殖年齡",
      "sex": "僅見於產後母犬貓",
      "prevalence": "犬分娩併發症中約佔 5-8%"
    },
    "clinicalPresentation": {
      "symptoms": [
        "產後持續暗綠色或暗紅色惡露",
        "惡露轉為惡臭膿性分泌物",
        "發燒（>39.5°C）",
        "食慾下降",
        "精神沉鬱",
        "嘔吐",
        "腹部疼痛或不適",
        "泌乳量減少",
        "幼崽數量與胎盤數不符"
      ],
      "physicalExam": [
        "陰門處可見暗色惡臭分泌物",
        "腹部觸診子宮增大或疼痛",
        "體溫升高",
        "脫水徵象（嚴重者）",
        "可能從陰門口看到殘留組織"
      ]
    },
    "pathophysiology": "正常分娩中，催產素引起子宮收縮促使胎盤與子宮壁分離並排出。胎盤滯留可能因子宮收縮無力（uterine inertia）、胎盤異常附著、或子宮頸過早閉合所致。滯留的胎盤組織成為細菌繁殖的良好培養基，引起子宮內膜炎進而可能發展為敗血症。",
    "diagnosis": {
      "primary": [
        "分娩記錄比對（幼崽數 vs 胎盤數）",
        "腹部超音波檢查子宮內容物",
        "腹部 X 光排除殘留胎兒",
        "陰道檢查評估子宮頸和殘留組織"
      ],
      "differential": [
        "子宮蓄膿（pyometra）",
        "子宮內膜炎（endometritis）",
        "子宮扭轉（uterine torsion）",
        "殘留死胎",
        "正常產後惡露（前 1-3 週）"
      ],
      "labFindings": [
        "CBC：嗜中性球增多伴左移（感染時）",
        "生化：可能見低白蛋白、高球蛋白",
        "超音波：子宮腔內高回音物質",
        "陰道分泌物細胞學：退化性嗜中性球、細菌"
      ]
    },
    "treatment": {
      "acute": "Oxytocin 促進子宮收縮排出滯留組織，廣效抗生素預防或治療感染，靜脈輸液維持水合狀態",
      "chronic": "若保守治療 24-48 小時無效，需考慮手術。非繁殖犬建議卵巢子宮切除術",
      "medications": [
        "Oxytocin 0.5-2 IU IM/SC q2-4h（促進子宮收縮）",
        "Amoxicillin-clavulanate 12.5-25 mg/kg PO BID",
        "Aglepristone 10 mg/kg SC（抗黃體素，部分國家可用）",
        "靜脈輸液（敗血症病例）",
        "Meloxicam 0.1 mg/kg PO SID（止痛）"
      ],
      "surgery": "保守治療無效時行卵巢子宮切除術（OHE）。嚴重子宮壞死或穿孔為緊急手術指征。"
    },
    "prognosis": "早期發現並治療預後良好。延遲治療導致敗血症者預後謹慎。手術治療後通常恢復良好。",
    "pearls": [
      "分娩時務必計數每隻幼崽對應的胎盤",
      "犬正常可能會吃掉胎盤，導致計數困難",
      "產後暗綠色分泌物（來自 uteroverdin）正常持續 1-3 天，但惡臭或持續超過一週應懷疑滯留",
      "超音波是評估子宮內殘留物的最佳工具"
    ],
    "diagnosticAlgorithm": {
      "title": "胎盤滯留 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估產後胎盤排出情況",
          "findings": [
            "產後持續性陰道分泌物（惡露）",
            "胎盤數量與幼崽數不符",
            "發熱和精神沉鬱",
            "腹部觸診有子宮增大"
          ]
        },
        {
          "step": 2,
          "action": "影像學檢查",
          "details": "進行腹部超音波確認子宮內殘留物",
          "findings": [
            "子宮內殘留高回音物質",
            "子宮壁增厚",
            "子宮內液體積聚",
            "排除殘留胎兒"
          ]
        },
        {
          "step": 3,
          "action": "全身評估",
          "details": "評估感染和代謝併發症",
          "findings": [
            "白血球增多伴左移",
            "發熱",
            "子宮蓄膿風險",
            "敗血症指標監測"
          ]
        }
      ]
    },
    "monitoring": [
      "產後體溫每日監測至少一週",
      "惡露顏色、量和氣味變化",
      "超音波追蹤子宮復舊進度",
      "幼崽健康狀態（母犬感染可影響乳汁品質）"
    ],
    "reference": "Current Therapy in Large Animal Theriogenology"
  },
  "subinvolution-placental-sites": {
    "zh": "胎盤附著部位退化不全",
    "en": "Subinvolution of Placental Sites (SIPS)",
    "definition": "產後子宮胎盤附著部位未能正常退化和修復，導致持續性子宮出血。正常產後子宮復舊應在 4-6 週內完成，SIPS 患犬可持續出血超過 6-12 週。此為犬特有疾病，貓極罕見。",
    "synonyms": [
      "胎盤附著點退化不全",
      "SIPS",
      "產後子宮持續出血"
    ],
    "epidemiology": {
      "species": "犬（貓極罕見）",
      "breed": "無明顯品種傾向",
      "age": "年輕母犬（<3 歲），初產犬最常見",
      "sex": "僅見於產後母犬",
      "prevalence": "年輕初產母犬中並不罕見"
    },
    "clinicalPresentation": {
      "symptoms": [
        "產後持續血性或血漿樣陰道分泌物超過 6 週",
        "分泌物通常為漿液血性而非膿性",
        "母犬通常精神食慾正常",
        "無發燒",
        "無腹部疼痛",
        "慢性出血可導致貧血",
        "偶見嗜睡（嚴重貧血時）",
        "黏膜蒼白（嚴重病例）"
      ],
      "physicalExam": [
        "陰門處持續漿液血性分泌物",
        "母犬整體狀況通常良好",
        "無發燒、無腹痛",
        "嚴重者黏膜蒼白",
        "腹部觸診子宮可能仍略增大"
      ]
    },
    "pathophysiology": "正常產後子宮復舊過程中，胎盤附著部位的滋養層細胞（trophoblast cells）應被逐步清除和取代。SIPS 中，滋養層細胞持續存活並侵入子宮肌層血管壁，阻止正常的血管收縮和血栓形成，導致持續性出血。確切機制不明，可能與局部免疫清除機制缺陷有關。",
    "diagnosis": {
      "primary": [
        "臨床病史（產後 >6 週持續出血）",
        "腹部超音波（子宮復舊不完全、局部增厚）",
        "排除其他出血原因",
        "確診需子宮組織病理學（OHE 後）"
      ],
      "differential": [
        "子宮蓄膿（pyometra）",
        "子宮內膜炎（endometritis）",
        "胎盤滯留（retained placenta）",
        "凝血功能障礙",
        "子宮腫瘤",
        "陰道腫瘤或創傷"
      ],
      "labFindings": [
        "CBC：可能呈再生性貧血（慢性失血）",
        "凝血功能檢查（PT/APTT）：通常正常",
        "陰道細胞學：紅血球為主，少量嗜中性球",
        "超音波：子宮壁局部增厚、胎盤附著處回音異常"
      ]
    },
    "treatment": {
      "acute": "嚴重貧血者需輸血支持。大多數病例可保守觀察，因多數在 3-4 個月內自行停止出血",
      "chronic": "非繁殖犬建議卵巢子宮切除術（OHE），可根治且提供確診的組織學樣本。繁殖犬通常選擇保守等待",
      "medications": [
        "鐵劑補充（慢性貧血者）",
        "輸血（PCV <20% 或臨床顯著貧血時）",
        "Ergometrine 0.2 mg/kg IM（促子宮收縮，效果不一）",
        "Oxytocin（效果有限）"
      ],
      "surgery": "卵巢子宮切除術（OHE）為根治性手術，適用於非繁殖犬或出血嚴重者。術中注意子宮血管可能脆弱。"
    },
    "prognosis": "整體預後良好。多數病例在 3-4 個月內自行緩解。OHE 後預後極佳。嚴重貧血未治療者可能危及生命。下次懷孕可能復發。",
    "pearls": [
      "SIPS 的關鍵特徵：持續出血但母犬整體狀況良好（無發燒、無疼痛）",
      "與子宮蓄膿鑑別：SIPS 分泌物為血性非膿性，且無全身感染徵兆",
      "年輕初產母犬產後持續出血，首先考慮 SIPS",
      "組織病理學可見滋養層細胞侵入子宮肌層為確診依據"
    ],
    "diagnosticAlgorithm": {
      "title": "胎盤附著部位退化不全 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估產後持續性陰道出血",
          "findings": [
            "產後超過4-6週仍有陰道出血",
            "年輕母犬首次生產多見",
            "全身狀態通常良好",
            "出血量通常不大"
          ]
        },
        {
          "step": 2,
          "action": "鑑別診斷",
          "details": "排除其他產後出血原因",
          "findings": [
            "超音波排除子宮蓄膿",
            "排除胎盤滯留",
            "排除凝血功能障礙",
            "排除子宮腫瘤"
          ]
        },
        {
          "step": 3,
          "action": "確診",
          "details": "通常為排除性診斷或組織學確認",
          "findings": [
            "組織學見胎盤附著處滋養層細胞殘存",
            "子宮壁血管正常退化不全",
            "通常自行消退",
            "持續性出血可能需要卵巢子宮切除術"
          ]
        }
      ]
    },
    "monitoring": [
      "每 1-2 週 PCV 監測評估貧血程度",
      "出血量和分泌物性質變化",
      "定期超音波追蹤子宮大小變化",
      "體重和整體狀況評估"
    ],
    "reference": "Clinical Veterinary Advisor: Dogs and Cats"
  },
  "uterine-rupture": {
    "zh": "子宮破裂",
    "en": "Uterine Rupture",
    "definition": "子宮壁全層或部分撕裂，導致子宮內容物（胎兒、胎盤、體液）進入腹腔。為分娩急症，常繼發於難產、過度使用催產素、外傷或子宮壁病變。未及時手術可導致腹膜炎和敗血性休克致死。",
    "synonyms": [
      "子宮穿孔",
      "子宮撕裂"
    ],
    "epidemiology": {
      "species": "犬貓均可發生",
      "breed": "小型犬和短頭犬種（難產風險高者）",
      "age": "任何繁殖年齡，高齡母犬風險略增",
      "sex": "僅見於懷孕或產後母犬貓",
      "prevalence": "罕見但致命，難產併發症中佔比低"
    },
    "clinicalPresentation": {
      "symptoms": [
        "急性腹部劇痛",
        "腹部膨脹",
        "休克徵象（心跳加速、黏膜蒼白、CRT延長）",
        "虛弱至倒臥",
        "陰道出血（可能量少因血液流入腹腔）",
        "嘔吐",
        "分娩過程突然停止",
        "體溫下降（休克）或升高（感染）",
        "呼吸急促"
      ],
      "physicalExam": [
        "腹部觸診嚴重疼痛和防衛反應",
        "腹部波動感（腹腔積液）",
        "先前可觸及的胎兒輪廓消失",
        "休克徵象：黏膜蒼白/發紺、CRT >2秒、脈搏微弱",
        "可能觸及腹腔內游離胎兒"
      ]
    },
    "pathophysiology": "子宮壁在過度擴張、缺血壞死、外傷或醫源性損傷下發生全層撕裂。催產素過量使用可導致子宮過度收縮引起破裂。子宮內容物（胎兒、羊水、血液）流入腹腔引起化學性和感染性腹膜炎。大量內出血和敗血症導致休克。",
    "diagnosis": {
      "primary": [
        "臨床表現（急腹症 + 懷孕/分娩史）",
        "腹部 X 光（腹腔內游離胎兒、腹腔積液）",
        "腹部超音波（腹腔游離液、子宮壁不連續）",
        "腹腔穿刺（血性液體、可能含胎便）"
      ],
      "differential": [
        "子宮扭轉（uterine torsion）",
        "脾臟破裂",
        "腹腔內出血（其他原因）",
        "嚴重子宮蓄膿破裂",
        "胃擴張扭轉（GDV）"
      ],
      "labFindings": [
        "CBC：貧血（急性失血）、嗜中性球增多",
        "生化：乳酸升高、電解質異常",
        "凝血功能：可能出現 DIC 徵兆",
        "腹腔穿刺液：血性、含細菌或胎便"
      ]
    },
    "treatment": {
      "acute": "緊急穩定（靜脈輸液、輸血），抗休克治療，廣效抗生素，止痛。穩定後立即緊急手術探查",
      "chronic": "術後抗生素治療 7-14 天，密集監護支持",
      "medications": [
        "靜脈晶體液（乳酸林格氏液）快速輸注",
        "全血輸血或 packed RBC（嚴重貧血）",
        "Ampicillin 22 mg/kg IV TID + Metronidazole 10 mg/kg IV BID",
        "Fentanyl 2-5 μg/kg/h CRI（止痛）",
        "Norepinephrine CRI（頑固性低血壓）"
      ],
      "surgery": "緊急剖腹探查和卵巢子宮切除術。徹底灌洗腹腔清除污染物。評估並處理腹膜炎。可能需放置腹腔引流管。"
    },
    "prognosis": "預後謹慎至不良，取決於發現時間和併發症嚴重度。早期手術介入存活率約 50-70%。合併 DIC 或嚴重敗血症者預後極差。胎兒存活率低。",
    "pearls": [
      "催產素使用必須謹慎：確認無胎兒-骨盆不相稱（FPD）後才可使用",
      "難產持續時間越長，子宮破裂風險越高",
      "陰道出血量少不能排除子宮破裂（血液流入腹腔）",
      "X 光上腹腔內游離胎兒是高度特異性徵兆"
    ],
    "diagnosticAlgorithm": {
      "title": "子宮破裂 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "緊急評估",
          "details": "評估急性腹部危象和休克徵象",
          "findings": [
            "急性腹痛和腹部膨脹",
            "休克徵象（蒼白黏膜、心搏過速）",
            "分娩困難病史",
            "陰道出血或停止分娩努力"
          ]
        },
        {
          "step": 2,
          "action": "影像學檢查",
          "details": "進行腹部X光和超音波緊急評估",
          "findings": [
            "腹腔游離液體（血性腹水）",
            "胎兒位於子宮外",
            "腹腔內游離氣體",
            "子宮輪廓異常"
          ]
        },
        {
          "step": 3,
          "action": "實驗室與穩定",
          "details": "進行緊急實驗室檢查並穩定患者",
          "findings": [
            "PCV/TP評估出血程度",
            "凝血功能評估",
            "電解質和酸鹼平衡",
            "腹腔穿刺液分析"
          ]
        },
        {
          "step": 4,
          "action": "手術確診與治療",
          "details": "緊急探查性剖腹術確診並修復",
          "findings": [
            "子宮破裂部位確認",
            "胎兒存活評估",
            "腹腔汙染程度",
            "決定修復或切除子宮"
          ]
        }
      ]
    },
    "monitoring": [
      "術後 ICU 密集監護 24-72 小時",
      "連續血壓和心電圖監測",
      "PCV/TS 每 4-6 小時（監測持續出血）",
      "腹腔引流液量和性質監測"
    ],
    "reference": "BSAVA Manual of Canine and Feline Reproduction and Neonatology"
  },
  "prostatitis": {
    "zh": "前列腺炎",
    "en": "Prostatitis",
    "definition": "前列腺的細菌性感染與發炎，可分為急性和慢性。急性前列腺炎為嚴重全身性感染，慢性前列腺炎症狀較隱匿。常見致病菌為大腸桿菌（E. coli），多由泌尿道上行感染引起。僅見於公犬（貓的前列腺疾病極罕見）。",
    "synonyms": [
      "前列腺感染",
      "攝護腺炎"
    ],
    "epidemiology": {
      "species": "犬（貓極罕見）",
      "breed": "無明顯品種傾向，未結紮公犬風險顯著增高",
      "age": "中老年公犬（>5 歲），未結紮者",
      "sex": "僅見於公犬",
      "prevalence": "未結紮中老年公犬中相當常見"
    },
    "clinicalPresentation": {
      "symptoms": [
        "急性：發燒、精神沉鬱、食慾廢絕",
        "排尿困難或疼痛性排尿",
        "血尿或膿尿",
        "尿道膿性或血性分泌物",
        "排便困難或裏急後重",
        "後肢僵硬步態",
        "腰部或會陰部疼痛",
        "慢性：反覆泌尿道感染",
        "慢性：間歇性尿道分泌物"
      ],
      "physicalExam": [
        "直腸觸診前列腺腫大、疼痛（急性）或不對稱（慢性）",
        "急性病例觸診時極度疼痛",
        "發燒（急性：39.5-41°C）",
        "腹後部或會陰壓痛",
        "慢性病例前列腺可能不規則或含囊腫"
      ]
    },
    "pathophysiology": "細菌（主要為 E. coli）經尿道上行至前列腺，在前列腺組織內繁殖引起化膿性炎症。睾酮刺激下的前列腺增生（BPH）為細菌感染提供良好環境。急性感染可形成膿瘍，穿破入腹腔導致腹膜炎。慢性感染中細菌可藏匿於前列腺組織和分泌物中，抗生素難以穿透。",
    "diagnosis": {
      "primary": [
        "直腸觸診前列腺大小、形狀和疼痛度",
        "尿液分析和細菌培養",
        "腹部超音波評估前列腺結構",
        "前列腺液培養（慢性病例需第三段尿液或按摩後收集）"
      ],
      "differential": [
        "良性前列腺增生（BPH）",
        "前列腺囊腫",
        "前列腺膿瘍",
        "前列腺腫瘤（adenocarcinoma）",
        "泌尿道感染（UTI）",
        "膀胱腫瘤"
      ],
      "labFindings": [
        "尿液分析：膿尿、血尿、細菌尿",
        "尿液培養：E. coli 最常見",
        "CBC：急性者嗜中性球增多伴左移",
        "超音波：前列腺腫大、回音不均、可能有膿瘍腔",
        "前列腺液細胞學：大量嗜中性球和細菌"
      ]
    },
    "treatment": {
      "acute": "靜脈廣效抗生素（可穿透前列腺者），靜脈輸液支持，止痛。急性期前列腺血管屏障被破壞，多數抗生素可穿透",
      "chronic": "選擇能穿透前列腺屏障的脂溶性抗生素，療程 4-6 週。結紮可縮小前列腺並改善抗生素穿透",
      "medications": [
        "Enrofloxacin 5-20 mg/kg PO SID（首選，穿透性佳）",
        "Trimethoprim-sulfonamide 15 mg/kg PO BID",
        "Amoxicillin-clavulanate 12.5-25 mg/kg PO BID（急性期）",
        "Meloxicam 0.1 mg/kg PO SID（止痛抗炎）",
        "Finasteride 0.1-0.5 mg/kg PO SID（輔助縮小前列腺）"
      ],
      "surgery": "結紮術（castration）為重要輔助治療。前列腺膿瘍需手術引流或切除。大型膿瘍可行 omentalization 或 Penrose drain 放置。"
    },
    "prognosis": "急性前列腺炎經積極治療預後良好。慢性前列腺炎治療困難，復發率高。結紮可顯著改善預後。前列腺膿瘍手術風險較高但治癒率可接受。",
    "pearls": [
      "急性前列腺炎禁止用力按摩前列腺，可能導致菌血症",
      "結紮是治療和預防前列腺疾病的最佳方法",
      "慢性前列腺炎抗生素必須選擇脂溶性、弱鹼性藥物（如 fluoroquinolones）",
      "前列腺膿瘍破裂是急診，需立即手術"
    ],
    "diagnosticAlgorithm": {
      "title": "前列腺炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估泌尿生殖道和全身症狀",
          "findings": [
            "排尿困難或血尿",
            "排便困難",
            "發熱和精神沉鬱（急性）",
            "會陰疼痛和步態僵硬"
          ]
        },
        {
          "step": 2,
          "action": "前列腺檢查",
          "details": "進行直腸觸診和影像學評估",
          "findings": [
            "直腸觸診前列腺腫大和疼痛",
            "前列腺超音波見實質異常",
            "可能見前列腺膿瘍",
            "前列腺不對稱或結節"
          ]
        },
        {
          "step": 3,
          "action": "實驗室檢查",
          "details": "進行尿液和前列腺液分析",
          "findings": [
            "尿液分析見膿尿和菌尿",
            "前列腺液培養分離細菌",
            "全血計數見白血球增多",
            "C反應蛋白升高"
          ]
        },
        {
          "step": 4,
          "action": "鑑別與治療評估",
          "details": "與其他前列腺疾病鑑別",
          "findings": [
            "與前列腺增生鑑別",
            "與前列腺腫瘤鑑別",
            "去勢狀態評估",
            "超音波引導穿刺排除膿瘍"
          ]
        }
      ]
    },
    "monitoring": [
      "抗生素治療 1 週後複驗尿液培養",
      "完成療程後 1 週再次尿液培養確認清除",
      "超音波追蹤前列腺大小變化",
      "慢性病例每 3 個月追蹤"
    ],
    "reference": "Blackwell's Five-Minute Veterinary Consult"
  },
  "penile-neoplasia": {
    "zh": "陰莖腫瘤",
    "en": "Penile Neoplasia",
    "definition": "發生於公犬陰莖或包皮的腫瘤性病變。最常見類型為傳染性性病腫瘤（TVT, transmissible venereal tumor）、鱗狀上皮細胞癌（SCC）和乳頭狀瘤。TVT 為犬特有的可傳播腫瘤，經由交配或接觸傳播。",
    "synonyms": [
      "陰莖腫瘤",
      "包皮腫瘤",
      "犬傳染性性病腫瘤（TVT）"
    ],
    "epidemiology": {
      "species": "犬（貓極罕見）",
      "breed": "TVT：流浪犬和未結紮犬高發。SCC：淺色皮膚犬種",
      "age": "TVT：年輕至中年性活躍公犬。SCC：老年犬",
      "sex": "公犬為主，TVT 公母犬均可",
      "prevalence": "TVT 在流浪犬族群中常見，SCC 較罕見"
    },
    "clinicalPresentation": {
      "symptoms": [
        "包皮口可見腫塊或組織突出",
        "陰莖或包皮持續出血或血性分泌物",
        "頻繁舔舐包皮區域",
        "排尿困難或尿流偏移",
        "包皮腫脹",
        "膿性分泌物（繼發感染時）",
        "腫塊表面潰瘍或菜花狀",
        "體重下降（晚期或轉移者）"
      ],
      "physicalExam": [
        "翻出包皮可見陰莖或包皮黏膜上腫塊",
        "TVT：粉紅至紅色菜花狀易碎腫塊",
        "SCC：潰瘍性或增生性硬塊",
        "觸診腹股溝淋巴結評估轉移",
        "腫塊觸碰易出血"
      ]
    },
    "pathophysiology": "TVT 是一種自然發生的可傳播腫瘤，活腫瘤細胞經由交配或接觸直接移植到黏膜表面，具有異常染色體核型（57-59 條）。SCC 由陰莖或包皮上皮細胞惡性轉化而來，可能與慢性刺激或 papillomavirus 感染相關。乳頭狀瘤由犬乳頭瘤病毒（CPV）引起，通常為良性且可自行消退。",
    "diagnosis": {
      "primary": [
        "細針穿刺抹片細胞學（TVT 有特徵性圓形細胞）",
        "腫塊活檢組織病理學",
        "胸腔和腹腔 X 光/超音波評估轉移",
        "腹股溝淋巴結細針穿刺（分期）"
      ],
      "differential": [
        "傳染性性病腫瘤（TVT）",
        "鱗狀上皮細胞癌（SCC）",
        "乳頭狀瘤（papilloma）",
        "肥大細胞瘤（mast cell tumor）",
        "包皮炎（balanoposthitis）",
        "纖維肉瘤（fibrosarcoma）"
      ],
      "labFindings": [
        "細胞學：TVT 為圓形細胞，胞漿含特徵性空泡",
        "組織病理學確定腫瘤類型和分級",
        "CBC 通常正常（除非轉移或副腫瘤症候群）",
        "影像學排除肺轉移"
      ]
    },
    "treatment": {
      "acute": "確診後根據腫瘤類型選擇治療方案。TVT 對化療高度敏感。繼發出血可暫時加壓止血",
      "chronic": "TVT 以化療為首選。SCC 以手術為主，可輔以放療。乳頭狀瘤多自行消退，必要時手術切除",
      "medications": [
        "Vincristine 0.5-0.7 mg/m² IV weekly × 4-6 次（TVT 首選）",
        "Doxorubicin 30 mg/m² IV q3weeks（vincristine 抗性 TVT）",
        "Piroxicam 0.3 mg/kg PO SID（SCC 輔助治療）",
        "抗生素（繼發感染時）"
      ],
      "surgery": "SCC：陰莖部分或全切除術（penile amputation）和尿道造口術。乳頭狀瘤：手術切除或冷凍治療。TVT 通常不需要手術（化療反應率 >90%）。"
    },
    "prognosis": "TVT：vincristine 化療治癒率 >90%，預後極佳。SCC：局部控制後預後中等，轉移率依分級而異。乳頭狀瘤：預後極佳，多自行消退。",
    "pearls": [
      "TVT 是少數對 vincristine 單藥化療反應極好的腫瘤（治癒率 >90%）",
      "TVT 細胞學有特徵性表現，可快速確診無需等待組織病理",
      "SCC 早期手術切除是最佳治療，晚期轉移預後不良",
      "年輕犬包皮腫塊首先考慮 TVT（如有交配史）和乳頭狀瘤"
    ],
    "diagnosticAlgorithm": {
      "title": "陰莖腫瘤 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估陰莖和包皮異常腫塊",
          "findings": [
            "陰莖或包皮可見腫塊",
            "血性或膿性分泌物",
            "舔舐生殖器",
            "排尿異常"
          ]
        },
        {
          "step": 2,
          "action": "細胞學檢查",
          "details": "進行腫塊細針抽吸或印片細胞學",
          "findings": [
            "鱗狀細胞癌（最常見）",
            "傳染性性病腫瘤（TVT）",
            "乳頭狀瘤",
            "黑色素瘤"
          ]
        },
        {
          "step": 3,
          "action": "分期檢查",
          "details": "進行區域和遠端轉移評估",
          "findings": [
            "腹股溝淋巴結觸診和FNA",
            "腹部超音波",
            "胸部X光",
            "評估手術切除可行性"
          ]
        },
        {
          "step": 4,
          "action": "組織病理學確診",
          "details": "進行切除或活檢確認腫瘤類型",
          "findings": [
            "組織學確認腫瘤類型和分級",
            "浸潤深度評估",
            "手術邊界評估",
            "TVT免疫組織化學確認"
          ]
        }
      ]
    },
    "monitoring": [
      "TVT 化療每週評估腫塊大小縮小程度",
      "完全緩解後 3 個月和 6 個月追蹤復發",
      "SCC 術後每 2 個月胸腔 X 光篩查轉移",
      "排尿功能評估（陰莖手術後）"
    ],
    "reference": "Textbook of Veterinary Internal Medicine"
  },
  "aplastic-anemia": {
    "zh": "再生不良性貧血",
    "en": "Aplastic Anemia",
    "definition": "骨髓造血功能嚴重衰竭，導致全血球減少（貧血、白血球減少、血小板減少）。可由藥物毒性、感染、免疫介導或特發性原因引起。犬貓均可發生，為嚴重且預後不良的血液疾病。",
    "synonyms": [
      "骨髓造血功能衰竭",
      "全血球減少症",
      "pancytopenia"
    ],
    "epidemiology": {
      "species": "犬貓均可發生",
      "breed": "無明顯品種傾向",
      "age": "任何年齡，中老年犬貓較多",
      "sex": "無性別傾向，未結紮母犬（外源性雌激素暴露風險）",
      "prevalence": "罕見但臨床重要"
    },
    "clinicalPresentation": {
      "symptoms": [
        "進行性虛弱和嗜睡",
        "運動不耐受",
        "黏膜蒼白",
        "自發性出血（瘀斑、瘀點、鼻出血）",
        "牙齦出血",
        "反覆感染和發燒",
        "食慾下降",
        "血尿或黑便",
        "體重下降",
        "呼吸急促"
      ],
      "physicalExam": [
        "黏膜明顯蒼白",
        "皮膚和黏膜瘀斑、瘀點",
        "心跳加速（代償性）",
        "收縮期心雜音（貧血性）",
        "發燒（繼發感染）",
        "脾臟通常不腫大（與白血病鑑別）"
      ]
    },
    "pathophysiology": "骨髓造血幹細胞受損或被抑制，導致紅血球、白血球和血小板生成均減少。常見原因包括：藥物毒性（氯黴素、化療藥、雌激素）、犬 ehrlichiosis、犬 parvovirus、FeLV 感染、免疫介導破壞造血前驅細胞。骨髓中正常造血組織被脂肪組織取代。",
    "diagnosis": {
      "primary": [
        "CBC 顯示全血球減少（三系減少）",
        "網織紅血球計數低（非再生性貧血）",
        "骨髓穿刺和活檢（確診：造血組織減少、脂肪取代）",
        "排除潛在原因的系統性檢查"
      ],
      "differential": [
        "骨髓腫瘤浸潤（白血病、多發性骨髓瘤）",
        "嚴重敗血症",
        "犬 ehrlichiosis 慢性期",
        "FeLV 相關骨髓抑制",
        "骨髓纖維化（myelofibrosis）",
        "免疫介導性全血球減少"
      ],
      "labFindings": [
        "CBC：嚴重非再生性貧血 + 白血球減少 + 血小板減少",
        "網織紅血球計數 <60,000/μL",
        "骨髓活檢：造血組織 <25%，脂肪取代",
        "Ehrlichia/Anaplasma PCR 和抗體檢測",
        "FeLV/FIV 檢測（貓）"
      ]
    },
    "treatment": {
      "acute": "停用所有可能致病藥物。輸血支持（packed RBC + 血小板）。廣效抗生素預防感染。治療可辨認的潛在原因",
      "chronic": "免疫抑制治療（特發性或免疫介導）。造血生長因子。長期支持性輸血",
      "medications": [
        "Cyclosporine 5-10 mg/kg PO BID（免疫介導型）",
        "Mycophenolate mofetil 10 mg/kg PO BID",
        "Darbepoetin alfa 1 μg/kg SC q1week（刺激紅血球生成）",
        "Filgrastim (G-CSF) 5 μg/kg SC SID（刺激白血球生成）",
        "廣效抗生素（嗜中性球減少期間）"
      ],
      "surgery": "通常不適用。骨髓移植在獸醫學中尚不常規。脾臟切除術偶用於免疫介導型。"
    },
    "prognosis": "整體預後謹慎至不良。特發性再生不良性貧血死亡率高（>50%）。藥物引起者停藥後有恢復機會。Ehrlichia 引起者抗感染治療後可能部分恢復。免疫介導型對免疫抑制治療反應不一。",
    "pearls": [
      "氯黴素和雌激素是犬最常見的藥物性骨髓抑制原因",
      "骨髓活檢是確診的金標準，不能僅靠 CBC 診斷",
      "嗜中性球 <500/μL 時感染風險極高，需預防性抗生素",
      "Ehrlichiosis 慢性期可表現為再生不良性貧血，需常規篩查"
    ],
    "diagnosticAlgorithm": {
      "title": "再生不良性貧血 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估非再生性貧血和骨髓衰竭症狀",
          "findings": [
            "蒼白黏膜和虛弱",
            "出血傾向（瘀斑、血尿）",
            "反覆感染",
            "漸進性惡化"
          ]
        },
        {
          "step": 2,
          "action": "血液學檢查",
          "details": "確認全血球減少和非再生性貧血",
          "findings": [
            "嚴重非再生性貧血",
            "網狀紅血球減少或缺如",
            "白血球減少",
            "血小板減少"
          ]
        },
        {
          "step": 3,
          "action": "骨髓穿刺",
          "details": "進行骨髓抽吸和核心活檢確認骨髓衰竭",
          "findings": [
            "骨髓增生不良",
            "脂肪組織取代造血組織",
            "殘餘造血細胞形態正常",
            "排除骨髓增生異常和白血病"
          ]
        },
        {
          "step": 4,
          "action": "病因調查",
          "details": "系統性調查骨髓衰竭的原因",
          "findings": [
            "藥物暴露史（氯黴素、化療藥物、雌激素）",
            "Ehrlichia canis篩檢",
            "FeLV篩檢（貓）",
            "免疫介導性骨髓破壞評估"
          ]
        }
      ]
    },
    "monitoring": [
      "CBC 每 3-7 天監測至穩定",
      "體溫每日監測（嗜中性球減少期間）",
      "出血徵兆每日評估",
      "骨髓活檢每 4-6 週評估治療反應"
    ],
    "reference": "BSAVA Manual of Canine and Feline Haematology and Transfusion Medicine"
  },
  "heinz-body-anemia": {
    "zh": "乃乃氏小體溶血性貧血",
    "en": "Heinz Body Anemia",
    "definition": "因氧化損傷導致血紅素變性沉澱形成 Heinz body（乃乃氏小體），附著於紅血球膜上造成紅血球提前被脾臟清除的溶血性貧血。貓對氧化損傷特別敏感。常見原因包括蔥屬植物（洋蔥、大蒜）攝入、對乙酰氨基酚（acetaminophen）中毒等。",
    "synonyms": [
      "海因茲小體貧血",
      "Heinz body hemolytic anemia",
      "氧化性溶血性貧血"
    ],
    "epidemiology": {
      "species": "犬貓均可發生，貓更敏感",
      "breed": "犬中日本品種（Akita、Shiba Inu）因高 K+ 和低 GSH 紅血球更易受影響",
      "age": "任何年齡",
      "sex": "無性別傾向",
      "prevalence": "取決於氧化劑暴露機會，洋蔥中毒在犬中並不罕見"
    },
    "clinicalPresentation": {
      "symptoms": [
        "虛弱和嗜睡",
        "運動不耐受",
        "黏膜蒼白或黃疸",
        "紅棕色或暗色尿液（血紅素尿）",
        "食慾下降",
        "嘔吐（如因毒物攝入）",
        "腹瀉",
        "呼吸急促",
        "心跳加速",
        "發紺（methemoglobin 形成時）"
      ],
      "physicalExam": [
        "黏膜蒼白或黃疸",
        "心跳加速",
        "收縮期心雜音（貧血性）",
        "脾臟腫大（紅血球清除增加）",
        "暗色尿液",
        "acetaminophen 中毒貓：面部和四肢水腫"
      ]
    },
    "pathophysiology": "氧化劑（如洋蔥中的 n-propyl disulfide、acetaminophen 的代謝物 NAPQI）耗盡紅血球內的還原性谷胱甘肽（GSH），導致血紅素鐵被氧化形成 methemoglobin，進一步變性沉澱為 Heinz body。Heinz body 使紅血球膜僵硬，被脾臟巨噬細胞識別並吞噬（血管外溶血）。貓的血紅素含 8 個反應性巯基（犬僅 2 個），故對氧化損傷更敏感。",
    "diagnosis": {
      "primary": [
        "血液抹片新亞甲藍（NMB）染色見 Heinz body",
        "CBC 確認再生性貧血",
        "病史調查氧化劑暴露",
        "血液 methemoglobin 濃度測定"
      ],
      "differential": [
        "免疫介導性溶血性貧血（IMHA）",
        "急性失血性貧血",
        "鋅中毒",
        "銅中毒",
        "紅血球寄生蟲（Mycoplasma haemofelis）",
        "磷酸激酶缺乏症"
      ],
      "labFindings": [
        "CBC：再生性貧血（網織紅血球增多）",
        "NMB 染色：紅血球表面突出的 Heinz body",
        "血液生化：膽紅素升高（溶血）",
        "尿液：血紅素尿、膽紅素尿",
        "MetHb >10%（正常 <3%）"
      ]
    },
    "treatment": {
      "acute": "移除氧化劑來源，催吐（如攝入 <2 小時）和活性碳。嚴重貧血者輸血。acetaminophen 中毒給予 N-acetylcysteine",
      "chronic": "停止氧化劑暴露後通常可自行恢復。骨髓 5-7 天內開始再生反應",
      "medications": [
        "N-acetylcysteine (NAC) 140 mg/kg IV loading, then 70 mg/kg q6h × 7 doses（acetaminophen 中毒）",
        "S-adenosylmethionine (SAMe) 20 mg/kg PO SID",
        "輸血（PCV <15% 或臨床顯著）",
        "靜脈輸液維持腎灌注（血紅素尿時）",
        "Vitamin C 30 mg/kg PO BID（輔助抗氧化）"
      ],
      "surgery": "通常不需要手術。"
    },
    "prognosis": "移除氧化劑來源後預後通常良好。輕至中度貧血 1-2 週可恢復。大量洋蔥攝入或 acetaminophen 中毒貓若延遲治療預後不良。MetHb >50% 有生命危險。",
    "pearls": [
      "貓對 acetaminophen 極度敏感，一顆 325mg 即可致命",
      "正常貓血液中可見少量 Heinz body（<5%），不一定代表疾病",
      "洋蔥、大蒜、韭菜、蔥均屬蔥屬植物，煮熟後仍有毒性",
      "日本犬種（Akita）紅血球 GSH 含量低，對氧化損傷特別敏感"
    ],
    "diagnosticAlgorithm": {
      "title": "乃乃氏小體溶血性貧血 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估溶血性貧血症狀和氧化劑暴露史",
          "findings": [
            "蒼白或黃疸黏膜",
            "虛弱和運動不耐",
            "暗色尿液",
            "已知接觸氧化性物質（洋蔥、鋅、醋胺酚等）"
          ]
        },
        {
          "step": 2,
          "action": "血液學檢查",
          "details": "進行全血計數和特殊染色血液抹片",
          "findings": [
            "再生性貧血",
            "新亞甲藍染色見Heinz bodies",
            "偏心球形紅血球",
            "網狀紅血球增加"
          ]
        },
        {
          "step": 3,
          "action": "病因鑑定",
          "details": "確定氧化性損傷的來源",
          "findings": [
            "蔥屬植物攝入",
            "鋅中毒（硬幣、螺母攝入）",
            "醋胺酚中毒（貓特別敏感）",
            "糖尿病酮酸中毒相關"
          ]
        },
        {
          "step": 4,
          "action": "併發症監測",
          "details": "監測溶血相關併發症",
          "findings": [
            "連續PCV追蹤",
            "變性血紅素血症評估",
            "腎功能監測",
            "是否需要輸血評估"
          ]
        }
      ]
    },
    "monitoring": [
      "PCV 每 12-24 小時監測至穩定",
      "MetHb 濃度追蹤（acetaminophen 中毒）",
      "腎功能監測（血紅素腎病風險）",
      "網織紅血球計數評估骨髓再生反應"
    ],
    "reference": "Blackwell's Five-Minute Veterinary Consult"
  },
  "methemoglobinemia": {
    "zh": "變性血紅素血症",
    "en": "Methemoglobinemia",
    "definition": "血液中 methemoglobin（MetHb）濃度異常升高的狀態。MetHb 中鐵離子被氧化為 Fe³+ 形式，無法攜帶氧氣。正常 MetHb <3%，>15% 出現臨床症狀，>50% 可致命。常見於 acetaminophen 中毒（貓）和局部麻醉劑（benzocaine）接觸。",
    "synonyms": [
      "高鐵血紅蛋白血症",
      "MetHb 血症"
    ],
    "epidemiology": {
      "species": "犬貓均可發生，貓更敏感",
      "breed": "無明顯品種傾向",
      "age": "任何年齡",
      "sex": "無性別傾向",
      "prevalence": "主要為中毒事件相關"
    },
    "clinicalPresentation": {
      "symptoms": [
        "黏膜發紺（巧克力棕色）",
        "呼吸急促",
        "虛弱和嗜睡",
        "運動不耐受",
        "心跳加速",
        "面部和四肢水腫（acetaminophen 中毒貓）",
        "嘔吐",
        "精神沉鬱至昏迷",
        "深棕色血液（抽血即可見）",
        "死亡（MetHb >70-80%）"
      ],
      "physicalExam": [
        "黏膜呈特徵性巧克力棕色（非典型發紺）",
        "心跳加速",
        "呼吸急促和用力呼吸",
        "脈搏血氧飽和度讀數異常偏低（~85%固定值）",
        "血液顏色暗棕色、暴露空氣中不變紅"
      ]
    },
    "pathophysiology": "正常血紅素含 Fe²+（亞鐵），可逆性結合氧氣。氧化劑將 Fe²+ 氧化為 Fe³+（高鐵），形成 methemoglobin。MetHb 無法攜帶氧氣，且使剩餘正常血紅素的氧親和力增高（左移氧解離曲線），雙重機制導致組織缺氧。正常依賴 NADH-methemoglobin reductase 還原 MetHb，但氧化劑過量或酵素缺陷時系統飽和。",
    "diagnosis": {
      "primary": [
        "臨床表現（巧克力棕色黏膜和血液）",
        "Co-oximetry 測定 MetHb 百分比（金標準）",
        "血液滴在白紙上暴露空氣仍為棕色（簡易測試）",
        "病史調查氧化劑暴露"
      ],
      "differential": [
        "發紺（心肺疾病）",
        "一氧化碳中毒",
        "嚴重貧血",
        "硫血紅素血症（sulfhemoglobinemia）",
        "先天性 MetHb reductase 缺乏症"
      ],
      "labFindings": [
        "Co-oximetry：MetHb >10%（確診）",
        "脈搏血氧：固定在 ~85%（不隨給氧改善）",
        "血液氣體分析：PaO₂ 正常但 SaO₂ 降低",
        "CBC：可能伴隨 Heinz body 形成",
        "肝腎功能檢查（acetaminophen 肝毒性）"
      ]
    },
    "treatment": {
      "acute": "立即給氧支持。Methylene blue 為特效解毒劑（犬），但貓禁用（可加重 Heinz body）。貓以 NAC 和 vitamin C 為主。嚴重者輸血",
      "chronic": "移除氧化劑來源後通常可恢復。監測肝腎功能（acetaminophen 中毒）",
      "medications": [
        "Methylene blue 1.5 mg/kg IV slowly（犬專用，貓禁用）",
        "N-acetylcysteine (NAC) 140 mg/kg IV loading, then 70 mg/kg q6h（貓首選）",
        "Ascorbic acid (Vitamin C) 30 mg/kg IV slowly",
        "氧氣支持（氧氣籠或鼻導管）",
        "輸血（MetHb >50% 或嚴重缺氧）"
      ],
      "surgery": "不適用。"
    },
    "prognosis": "及時治療預後良好。犬給予 methylene blue 後通常 30 分鐘內改善。貓因 acetaminophen 中毒若延遲治療預後不良。MetHb >70% 未治療者可致死。先天性酵素缺乏者需長期管理。",
    "pearls": [
      "Methylene blue 對貓禁用——會加重 Heinz body 溶血",
      "脈搏血氧飽和度固定在 ~85% 不隨給氧改善是 MetHb 的特徵線索",
      "血液滴紙測試：正常血液暴露空氣變鮮紅，MetHb 血液持續棕色",
      "Acetaminophen 是貓最常見的 MetHb 原因，一顆即可致命"
    ],
    "diagnosticAlgorithm": {
      "title": "變性血紅素血症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估組織缺氧症狀和特徵性血液顏色",
          "findings": [
            "黏膜發紺（巧克力棕色）",
            "呼吸困難",
            "虛弱和嗜睡",
            "血液呈巧克力棕色且不因暴露空氣變紅"
          ]
        },
        {
          "step": 2,
          "action": "診斷確認",
          "details": "測定變性血紅素濃度",
          "findings": [
            "共氧計（co-oximetry）測定MetHb百分比",
            "MetHb >15%出現臨床症狀",
            "MetHb >50%可致命",
            "脈搏血氧計讀數異常低（~85%固定）"
          ]
        },
        {
          "step": 3,
          "action": "病因調查",
          "details": "確定氧化性毒物暴露源",
          "findings": [
            "醋胺酚攝入（貓最常見原因）",
            "苯佐卡因或利多卡因局部麻醉劑",
            "洋蔥/大蒜攝入",
            "亞硝酸鹽暴露"
          ]
        },
        {
          "step": 4,
          "action": "治療性確認",
          "details": "亞甲藍治療反應支持診斷",
          "findings": [
            "亞甲藍IV治療後MetHb下降",
            "黏膜顏色改善",
            "Heinz bodies同時存在提示氧化損傷",
            "持續監測至MetHb正常化"
          ]
        }
      ]
    },
    "monitoring": [
      "Co-oximetry 每 1-2 小時追蹤 MetHb 濃度",
      "肝功能每 12-24 小時（acetaminophen 肝毒性）",
      "PCV 監測（伴隨 Heinz body 溶血時）",
      "尿量和腎功能監測"
    ],
    "reference": "Textbook of Veterinary Internal Medicine"
  },
  "microangiopathic-hemolytic-anemia": {
    "zh": "微血管病性溶血性貧血",
    "en": "Microangiopathic Hemolytic Anemia (MAHA)",
    "definition": "紅血球在通過受損或異常微血管時被機械性剪切破壞導致的溶血性貧血。血液抹片可見特徵性裂片紅血球（schistocytes）。常繼發於瀰漫性血管內凝血（DIC）、血管肉瘤（hemangiosarcoma）、血管炎或嚴重心臟疾病。",
    "synonyms": [
      "碎片紅血球溶血性貧血",
      "MAHA",
      "機械性溶血性貧血"
    ],
    "epidemiology": {
      "species": "犬貓均可發生，犬較常見",
      "breed": "German Shepherd、Golden Retriever（血管肉瘤高發品種）",
      "age": "中老年犬（因潛在疾病常見於此年齡層）",
      "sex": "無明顯性別傾向",
      "prevalence": "作為繼發性疾病，取決於原發病的發生率"
    },
    "clinicalPresentation": {
      "symptoms": [
        "進行性虛弱和嗜睡",
        "黏膜蒼白",
        "運動不耐受",
        "呼吸急促",
        "心跳加速",
        "黃疸（溶血產物堆積）",
        "瘀斑或瘀點（DIC 伴隨時）",
        "暗色尿液（血紅素尿）",
        "原發病的症狀（如腹腔積液、腫塊）",
        "突然虛脫（如脾臟血管肉瘤破裂）"
      ],
      "physicalExam": [
        "黏膜蒼白或黃疸",
        "心跳加速和收縮期心雜音",
        "脾臟腫大（血管肉瘤或 DIC 時）",
        "腹部膨脹（腹腔積液）",
        "皮下出血或瘀斑（DIC）"
      ]
    },
    "pathophysiology": "紅血球在通過異常微血管時被纖維蛋白絲（fibrin strands）、受損血管內皮或異常血管結構物理性切割，產生裂片紅血球。DIC 中微血管內廣泛的纖維蛋白沉積是最常見的機制。血管肉瘤中腫瘤內異常血管結構造成機械性溶血。嚴重心瓣膜疾病中湍流也可造成紅血球破壞。",
    "diagnosis": {
      "primary": [
        "血液抹片見裂片紅血球（schistocytes >3/HPF）",
        "CBC 確認再生性貧血",
        "凝血功能檢查排除 DIC",
        "腹部超音波和胸部 X 光尋找原發病"
      ],
      "differential": [
        "免疫介導性溶血性貧血（IMHA）",
        "氧化性溶血（Heinz body anemia）",
        "急性失血性貧血",
        "骨髓疾病",
        "紅血球寄生蟲感染"
      ],
      "labFindings": [
        "CBC：再生性貧血、血小板減少（DIC 時）",
        "血液抹片：schistocytes、keratocytes、acanthocytes",
        "凝血：PT/APTT 延長、D-dimer 升高（DIC）",
        "生化：膽紅素升高、LDH 升高",
        "腹腔穿刺液：血性（血管肉瘤破裂時）"
      ]
    },
    "treatment": {
      "acute": "治療原發病為首要。輸血支持嚴重貧血。DIC 者給予新鮮冷凍血漿。靜脈輸液維持組織灌注",
      "chronic": "長期管理取決於原發病的控制。DIC 治療原發病後通常改善。腫瘤相關者需手術和/或化療",
      "medications": [
        "Packed RBC 輸血（PCV <15-20%）",
        "新鮮冷凍血漿 10-15 mL/kg IV（DIC 補充凝血因子）",
        "Heparin 75-100 IU/kg SC TID（DIC 抗凝）",
        "靜脈晶體液支持",
        "原發病的特異性治療藥物"
      ],
      "surgery": "血管肉瘤需脾臟切除術或腫瘤切除。心臟瓣膜疾病嚴重者可考慮瓣膜修復（限少數中心）。"
    },
    "prognosis": "預後主要取決於原發病。DIC 整體預後謹慎（死亡率 30-50%）。血管肉瘤即使手術後中位存活時間僅 1-3 個月（化療可延長至 6 個月）。可逆性原因（如急性感染引起的 DIC）治療後預後較好。",
    "pearls": [
      "血液抹片上 >3 個 schistocytes/HPF 高度提示微血管病性溶血",
      "中老年大型犬急性貧血 + 腹腔積液 = 直到排除前首先考慮脾臟血管肉瘤",
      "MAHA 幾乎總是繼發性的，必須積極尋找原發病",
      "DIC 是最常見的 MAHA 原因，治療原發病是關鍵"
    ],
    "diagnosticAlgorithm": {
      "title": "微血管病性溶血性貧血 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估溶血性貧血和微血管病變徵象",
          "findings": [
            "蒼白黏膜和虛弱",
            "出血傾向",
            "可能有發熱",
            "可能與嚴重基礎疾病相關"
          ]
        },
        {
          "step": 2,
          "action": "血液學檢查",
          "details": "進行全血計數和血液抹片評估",
          "findings": [
            "再生性溶血性貧血",
            "血液抹片見碎裂紅血球（schistocytes）",
            "血小板減少",
            "網狀紅血球增加"
          ]
        },
        {
          "step": 3,
          "action": "凝血功能評估",
          "details": "評估DIC和血栓性微血管病",
          "findings": [
            "PT/aPTT延長（DIC時）",
            "纖維蛋白原降低",
            "D-dimer升高",
            "抗凝血酶III降低"
          ]
        },
        {
          "step": 4,
          "action": "基礎疾病調查",
          "details": "找出導致微血管損傷的原因",
          "findings": [
            "血管肉瘤篩檢",
            "DIC基礎病因",
            "嚴重感染或敗血症",
            "免疫介導性血管炎"
          ]
        }
      ]
    },
    "monitoring": [
      "PCV/TS 每 6-12 小時（急性期）",
      "凝血功能每 12-24 小時（DIC 監測）",
      "血小板計數追蹤",
      "原發病的特異性監測指標"
    ],
    "reference": "Veterinary Technician's Manual for Small Animal Emergency and Critical Care"
  },
  "erythrocytosis": {
    "zh": "紅血球增多症",
    "en": "Erythrocytosis (Polycythemia)",
    "definition": "血液中紅血球數量、血容比（PCV）和血紅素濃度異常升高。可分為相對性（脫水導致血液濃縮）、適當性絕對性（低氧刺激 EPO 增加）和不適當性絕對性（腫瘤分泌 EPO 或原發性骨髓增殖）。PCV >55%（犬）或 >50%（貓）即視為紅血球增多。",
    "synonyms": [
      "多血症",
      "紅血球過多症",
      "polycythemia"
    ],
    "epidemiology": {
      "species": "犬貓均可發生",
      "breed": "相對性：短頭犬種（慢性低氧）。原發性：無品種傾向",
      "age": "原發性：中老年。繼發性：任何年齡",
      "sex": "無明顯性別傾向",
      "prevalence": "相對性（脫水）常見，絕對性紅血球增多症罕見"
    },
    "clinicalPresentation": {
      "symptoms": [
        "黏膜充血發紅",
        "精神異常或行為改變",
        "癲癇發作",
        "視力障礙或失明",
        "多飲多尿",
        "嗜睡",
        "運動不耐受",
        "打噴嚏或鼻出血",
        "後肢無力",
        "嘔吐"
      ],
      "physicalExam": [
        "黏膜深紅充血（brick red）",
        "脾臟腫大",
        "眼底檢查見血管迂曲擴張",
        "神經學異常（高黏滯症候群）",
        "心雜音（血液黏稠度增加）"
      ]
    },
    "pathophysiology": "相對性：脫水導致血漿容量減少，紅血球濃度相對升高。適當性絕對性：慢性低氧（心肺疾病、高海拔）刺激腎臟分泌 EPO，驅動骨髓增加紅血球生成。不適當性絕對性：腎臟腫瘤等分泌異位 EPO，或原發性真性紅血球增多症（polycythemia vera）為骨髓增殖性腫瘤。血液黏稠度增加導致微循環障礙和血栓形成。",
    "diagnosis": {
      "primary": [
        "CBC 確認 PCV 升高（犬 >55%，貓 >50%）",
        "排除脫水（比較血漿蛋白、補液後複驗 PCV）",
        "血清 EPO 濃度測定",
        "動脈血氣分析（排除低氧性原因）"
      ],
      "differential": [
        "脫水（相對性紅血球增多）",
        "慢性心肺疾病（適當性）",
        "右至左心臟分流（適當性）",
        "腎臟腫瘤（不適當性 EPO）",
        "真性紅血球增多症（原發性）",
        "脾臟收縮（急性興奮、epinephrine）"
      ],
      "labFindings": [
        "CBC：PCV 升高、可能白血球和血小板也升高（PV）",
        "血清 EPO：低或正常（PV）vs 高（繼發性）",
        "動脈血氣：PaO₂ 正常（PV/不適當性）vs 降低（適當性）",
        "腹部超音波：排除腎臟腫塊",
        "骨髓活檢：紅系增生（PV 時三系增生）"
      ]
    },
    "treatment": {
      "acute": "治療性放血（phlebotomy）降低 PCV 至 50-55%。同時靜脈輸液補充容量。治療原發病",
      "chronic": "原發性 PV 以 hydroxyurea 抑制骨髓。繼發性治療原發病。定期放血維持 PCV",
      "medications": [
        "Hydroxyurea 30 mg/kg PO SID 起始，調整至維持 PCV <55%",
        "靜脈輸液（放血後補充容量）",
        "低劑量 Aspirin 0.5 mg/kg PO SID（預防血栓）",
        "原發病特異性治療"
      ],
      "surgery": "腎臟腫瘤引起者行腎切除術。原發心臟分流可考慮手術修補。"
    },
    "prognosis": "相對性紅血球增多：糾正脫水後預後極佳。繼發性：取決於原發病。原發性 PV：以 hydroxyurea 控制，中位存活時間可達數年。腎臟腫瘤切除後若未轉移預後良好。",
    "pearls": [
      "黏膜 brick red 色是紅血球增多症的特徵性表現",
      "EPO 濃度是區分原發性和繼發性紅血球增多的關鍵：PV 時 EPO 低或正常",
      "PCV >65% 時血栓風險顯著增加，需緊急放血",
      "興奮性脾臟收縮可使犬 PCV 暫時升高 5-10%，需冷靜後複驗"
    ],
    "diagnosticAlgorithm": {
      "title": "紅血球增多症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "確認紅血球增多並排除相對性增多",
          "findings": [
            "PCV/Hct升高",
            "紅色黏膜充血",
            "評估脫水狀態",
            "排除脾臟收縮（緊迫相關）"
          ]
        },
        {
          "step": 2,
          "action": "分類鑑別",
          "details": "區分相對性、適當性和不適當性紅血球增多",
          "findings": [
            "補液後PCV仍高排除相對性",
            "血氧飽和度評估",
            "EPO水平測定",
            "排除慢性低氧（心肺疾病）"
          ]
        },
        {
          "step": 3,
          "action": "病因調查",
          "details": "確定紅血球增多的具體原因",
          "findings": [
            "胸部X光和心臟超音波排除心肺疾病",
            "腎臟超音波排除腎臟腫瘤",
            "腹部影像排除其他EPO分泌性腫瘤",
            "骨髓穿刺排除真性紅血球增多症"
          ]
        },
        {
          "step": 4,
          "action": "確診",
          "details": "根據檢查結果確定病因分類",
          "findings": [
            "繼發性適當性：心肺疾病致缺氧",
            "繼發性不適當性：EPO分泌性腫瘤",
            "原發性：真性紅血球增多症",
            "EPO水平為關鍵鑑別指標"
          ]
        }
      ]
    },
    "monitoring": [
      "PCV 每 1-2 週直至穩定",
      "Hydroxyurea 治療者每 2 週 CBC（監測骨髓抑制）",
      "腹部超音波每 3-6 個月（腫瘤篩查）",
      "神經學評估（高黏滯症候群）"
    ],
    "reference": "Clinical Veterinary Advisor: Dogs and Cats"
  },
  "chronic-lymphocytic-leukemia": {
    "zh": "慢性淋巴球性白血病",
    "en": "Chronic Lymphocytic Leukemia (CLL)",
    "definition": "成熟小淋巴球在骨髓中異常增殖並釋放入血液的低度惡性血液腫瘤。進展緩慢，許多病例在常規血檢中偶然發現。犬較貓常見。多數為 T 細胞型，少數為 B 細胞型。",
    "synonyms": [
      "CLL",
      "慢性淋巴細胞白血病"
    ],
    "epidemiology": {
      "species": "犬較常見，貓少見",
      "breed": "Golden Retriever、German Shepherd 可能略高發",
      "age": "中老年犬（>6 歲），平均確診年齡 10-12 歲",
      "sex": "無明顯性別傾向",
      "prevalence": "犬中最常見的慢性白血病類型"
    },
    "clinicalPresentation": {
      "symptoms": [
        "許多病例無臨床症狀（偶然發現）",
        "輕微嗜睡",
        "食慾輕度下降",
        "體重緩慢下降",
        "多飲多尿",
        "間歇性跛行（關節浸潤）",
        "淋巴結輕度腫大",
        "脾臟腫大",
        "反覆感染（免疫功能低下）"
      ],
      "physicalExam": [
        "可能無明顯異常（早期）",
        "輕至中度周邊淋巴結腫大",
        "脾臟腫大（觸診）",
        "肝臟腫大（偶見）",
        "整體狀態通常良好"
      ]
    },
    "pathophysiology": "骨髓中成熟淋巴球發生克隆性增殖，這些細胞功能異常但分裂緩慢，逐漸累積於血液、骨髓、脾臟和淋巴結。T-CLL 較 B-CLL 常見於犬。腫瘤細胞累積可逐步取代正常骨髓造血功能，導致貧血和血小板減少。B-CLL 可產生單克隆免疫球蛋白（monoclonal gammopathy），造成高黏滯症候群。",
    "diagnosis": {
      "primary": [
        "CBC 見持續性淋巴球增多（>20,000/μL、通常 >30,000/μL）",
        "血液抹片見成熟小淋巴球為主",
        "流式細胞術（flow cytometry）確定 T 或 B 細胞型",
        "骨髓穿刺（淋巴球浸潤 >20%）"
      ],
      "differential": [
        "急性淋巴母細胞性白血病（ALL）",
        "Stage V 淋巴瘤（白血病期）",
        "Ehrlichiosis 慢性反應性淋巴球增多",
        "慢性感染反應性淋巴球增多",
        "胸腺瘤"
      ],
      "labFindings": [
        "CBC：淋巴球 >20,000/μL，形態成熟",
        "血液抹片：小型成熟淋巴球，smudge cells 常見",
        "血清蛋白電泳：B-CLL 可見單克隆峰",
        "骨髓：淋巴球浸潤 >20-30%",
        "流式細胞術：CD3+（T-CLL）或 CD21+（B-CLL）"
      ]
    },
    "treatment": {
      "acute": "無症狀者可選擇觀察等待（watch and wait）。出現臨床症狀或血球減少時開始治療",
      "chronic": "口服化療藥物為主，多數犬反應良好。治療目標是控制而非治癒",
      "medications": [
        "Chlorambucil 4-6 mg/m² PO SID 或 20 mg/m² PO q2weeks",
        "Prednisolone 1-2 mg/kg PO SID（初始，後漸減）",
        "Cyclophosphamide 200-250 mg/m² PO q3weeks（替代方案）",
        "Lomustine (CCNU) 70 mg/m² PO q3weeks（refractory 病例）"
      ],
      "surgery": "通常不適用。嚴重脾腫大可考慮脾切除術作為輔助。"
    },
    "prognosis": "犬 CLL 預後相對良好，中位存活時間 1-3 年（甚至更長）。T-CLL 預後通常優於 B-CLL。無症狀者從診斷到需要治療可能長達數月至數年。出現嚴重貧血或血小板減少者預後較差。",
    "pearls": [
      "CLL 是犬中預後最好的白血病類型",
      "與 ALL 鑑別關鍵：CLL 為成熟小淋巴球，ALL 為大型不成熟母細胞",
      "無症狀的 CLL 可先觀察不治療（watch and wait 策略）",
      "B-CLL 伴單克隆球蛋白血症時需注意高黏滯症候群"
    ],
    "diagnosticAlgorithm": {
      "title": "慢性淋巴球性白血病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估漸進性症狀和血液學異常",
          "findings": [
            "多數偶然發現（常規血檢）",
            "漸進性虛弱和體重減輕",
            "脾臟或肝臟腫大",
            "淋巴結可能正常或輕度腫大"
          ]
        },
        {
          "step": 2,
          "action": "血液學檢查",
          "details": "進行全血計數和血液抹片評估",
          "findings": [
            "持續性成熟淋巴球增多（>20,000/μL）",
            "淋巴球形態成熟",
            "可能伴貧血或血小板減少",
            "籃球細胞（basket cells）"
          ]
        },
        {
          "step": 3,
          "action": "免疫分型",
          "details": "進行流式細胞術確認淋巴球類型",
          "findings": [
            "T細胞型或B細胞型分類",
            "表面標記分析",
            "B-CLL CD21+、CD79a+",
            "T-CLL CD3+、CD5+或CD8+"
          ]
        },
        {
          "step": 4,
          "action": "骨髓與分期",
          "details": "進行骨髓穿刺和全身分期",
          "findings": [
            "骨髓淋巴球浸潤（>20%）",
            "腹部超音波評估肝脾",
            "胸部X光",
            "區別於第V期淋巴瘤（白血球性）"
          ]
        }
      ]
    },
    "monitoring": [
      "CBC 每 2-4 週直至穩定，後每 2-3 個月",
      "化療期間每 2 週檢查 CBC 監測骨髓抑制",
      "血清蛋白電泳追蹤 monoclonal peak（B-CLL）",
      "淋巴結和脾臟大小定期評估"
    ],
    "reference": "BSAVA Manual of Canine and Feline Haematology and Transfusion Medicine"
  },
  "acute-lymphoblastic-leukemia": {
    "zh": "急性淋巴母細胞性白血病",
    "en": "Acute Lymphoblastic Leukemia (ALL)",
    "definition": "骨髓中不成熟淋巴母細胞（lymphoblasts）惡性增殖的高度侵襲性血液腫瘤。大量母細胞取代正常骨髓造血組織，導致嚴重貧血、血小板減少和嗜中性球減少。進展快速，未治療者存活時間極短。",
    "synonyms": [
      "ALL",
      "急性淋巴球性白血病",
      "淋巴母細胞性白血病"
    ],
    "epidemiology": {
      "species": "犬貓均可發生",
      "breed": "Golden Retriever、German Shepherd 可能略高發",
      "age": "中年至老年犬（5-11 歲），貓任何年齡（FeLV 陽性者年輕）",
      "sex": "無明顯性別傾向",
      "prevalence": "犬白血病中佔相當比例"
    },
    "clinicalPresentation": {
      "symptoms": [
        "急性發病的虛弱和嗜睡",
        "食慾廢絕",
        "發燒",
        "黏膜蒼白",
        "自發性出血（瘀斑、瘀點、鼻出血）",
        "淋巴結腫大（全身性）",
        "脾臟腫大",
        "骨痛和跛行",
        "體重迅速下降",
        "反覆感染"
      ],
      "physicalExam": [
        "黏膜蒼白",
        "全身性淋巴結腫大",
        "脾臟和肝臟顯著腫大",
        "發燒",
        "皮下瘀斑和黏膜出血點",
        "心跳加速（貧血代償）"
      ]
    },
    "pathophysiology": "骨髓中淋巴系前驅細胞發生惡性轉化，失去正常分化能力而快速增殖。大量淋巴母細胞充填骨髓腔，排擠正常紅血球、白血球和巨核細胞系列的生成空間（骨髓浸潤）。惡性細胞釋入血液循環並浸潤肝臟、脾臟、淋巴結等器官。貓的 ALL 常與 FeLV 感染相關。",
    "diagnosis": {
      "primary": [
        "CBC 見大量循環淋巴母細胞",
        "血液抹片見大型不成熟淋巴母細胞（大核仁、高 N:C 比）",
        "骨髓穿刺（母細胞 >20-30%）",
        "流式細胞術和免疫表型分析"
      ],
      "differential": [
        "慢性淋巴球性白血病（CLL）",
        "Stage V 高分級淋巴瘤",
        "急性骨髓性白血病（AML）",
        "反應性淋巴球增多",
        "多發性骨髓瘤"
      ],
      "labFindings": [
        "CBC：淋巴母細胞增多、貧血、血小板減少",
        "血液抹片：大型母細胞，核仁明顯，N:C 比高",
        "骨髓：母細胞 >20%，正常造血減少",
        "生化：LDH 升高、可能高鈣血症",
        "FeLV/FIV 檢測（貓必做）"
      ]
    },
    "treatment": {
      "acute": "多藥聯合化療方案（CHOP-based）。支持性治療：輸血、抗生素、輸液",
      "chronic": "化療誘導緩解後需維持治療。完全緩解率約 50-70% 但持續時間短",
      "medications": [
        "Vincristine 0.7 mg/m² IV weekly",
        "Prednisolone 2 mg/kg PO SID（誘導期）",
        "Cyclophosphamide 200 mg/m² IV q3weeks",
        "Doxorubicin 30 mg/m² IV q3weeks",
        "L-asparaginase 400 IU/kg IM（誘導期首劑）"
      ],
      "surgery": "不適用於 ALL 的主要治療。脾切除術偶用於嚴重脾腫大或脾破裂。"
    },
    "prognosis": "預後不良。化療可達到短期緩解，但大多數犬在 2-6 個月內復發。中位存活時間約 2-6 個月（化療）。未治療者通常在數天至數週內死亡。貓的 ALL 預後同樣不良。",
    "pearls": [
      "ALL vs CLL 鑑別：ALL 為大型母細胞急性發病，CLL 為小型成熟細胞慢性病程",
      "ALL vs Stage V 淋巴瘤鑑別困難，骨髓母細胞 >20% 傾向診斷 ALL",
      "FeLV 陽性貓發生 ALL 的風險顯著增加",
      "腫瘤溶解症候群（TLS）在化療開始後可能發生，需密切監測電解質"
    ],
    "diagnosticAlgorithm": {
      "title": "急性淋巴母細胞性白血病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估急性發病的全身症狀",
          "findings": [
            "急性虛弱和嗜睡",
            "發熱",
            "出血傾向",
            "食慾廢絕"
          ]
        },
        {
          "step": 2,
          "action": "血液學檢查",
          "details": "進行全血計數和血液抹片評估",
          "findings": [
            "白血球數可高可低",
            "血液抹片見大量淋巴母細胞",
            "貧血和血小板減少",
            "母細胞高核/質比、核仁明顯"
          ]
        },
        {
          "step": 3,
          "action": "骨髓穿刺",
          "details": "進行骨髓抽吸確認母細胞比例",
          "findings": [
            "骨髓母細胞 >20%",
            "正常造血被取代",
            "免疫分型確認細胞來源",
            "排除急性骨髓性白血病"
          ]
        },
        {
          "step": 4,
          "action": "免疫分型與分期",
          "details": "進行流式細胞術和全身分期",
          "findings": [
            "T-ALL或B-ALL分類",
            "免疫組織化學輔助鑑別",
            "影像學評估器官浸潤",
            "與第V期淋巴瘤鑑別"
          ]
        }
      ]
    },
    "monitoring": [
      "CBC 每週（化療誘導期）",
      "電解質和腎功能（TLS 監測）",
      "骨髓穿刺評估緩解程度",
      "體重和整體狀態每次回診評估"
    ],
    "reference": "BSAVA Manual of Canine and Feline Haematology and Transfusion Medicine"
  },
  "septic-arthritis": {
    "zh": "化膿性關節炎",
    "en": "Septic Arthritis",
    "definition": "關節腔的細菌性感染，導致急性嚴重關節發炎和關節軟骨破壞。可經由血行播散、穿刺傷、手術汙染或鄰近組織感染擴散引起。最常見致病菌為 Staphylococcus spp.，未及時治療可導致永久性關節損傷。",
    "synonyms": [
      "感染性關節炎",
      "細菌性關節炎",
      "infectious arthritis"
    ],
    "epidemiology": {
      "species": "犬貓均可發生",
      "breed": "大型犬種較常見（活動量大、外傷風險高）",
      "age": "任何年齡，中大型犬的年輕至中年較多",
      "sex": "公犬可能略高（外傷和打鬥風險）",
      "prevalence": "關節疾病中相對少見但臨床重要"
    },
    "clinicalPresentation": {
      "symptoms": [
        "急性嚴重跛行（通常單側）",
        "受影響關節腫脹",
        "關節觸痛明顯",
        "發燒",
        "食慾下降",
        "精神沉鬱",
        "不願移動",
        "受影響肢體不負重",
        "關節周圍皮膚發紅發熱",
        "可能有穿刺傷口或手術傷口史"
      ],
      "physicalExam": [
        "受影響關節明顯腫脹和波動感（關節積液）",
        "關節觸診極度疼痛",
        "關節活動範圍受限",
        "發燒（39.5-41°C）",
        "可能有穿刺傷或引流竇"
      ]
    },
    "pathophysiology": "細菌進入關節腔後在滑液中快速繁殖，引起急性滑膜炎。細菌產物和宿主免疫反應中的蛋白酶（尤其是基質金屬蛋白酶和嗜中性球彈性酶）破壞關節軟骨的蛋白多醣和膠原纖維。感染持續會導致軟骨下骨侵蝕、關節囊纖維化和永久性關節功能喪失。",
    "diagnosis": {
      "primary": [
        "關節穿刺液分析（混濁、高細胞數、退化性嗜中性球）",
        "關節液細菌培養和藥敏試驗",
        "關節 X 光（軟組織腫脹、骨溶解）",
        "CBC 和血液培養"
      ],
      "differential": [
        "免疫介導性多關節炎（IMPA）",
        "類風濕關節炎",
        "Lyme disease 關節炎",
        "痛風（尿酸鹽結晶關節炎）",
        "外傷性關節炎",
        "退化性關節疾病急性發作"
      ],
      "labFindings": [
        "關節液：高度混濁、WBC >40,000/μL、>90% 退化性嗜中性球",
        "關節液培養：Staphylococcus 最常見",
        "CBC：嗜中性球增多伴左移",
        "X 光：軟組織腫脹、晚期見骨溶解和關節間隙狹窄",
        "血液培養可能陽性（血行性播散）"
      ]
    },
    "treatment": {
      "acute": "關節穿刺引流膿液，關節灌洗。靜脈廣效抗生素（等待培養結果前），止痛",
      "chronic": "根據藥敏結果口服抗生素 4-8 週。物理治療促進關節功能恢復",
      "medications": [
        "Cefazolin 22 mg/kg IV TID（初始經驗性治療）",
        "Amoxicillin-clavulanate 12.5-25 mg/kg PO BID（口服轉換）",
        "Enrofloxacin 5-20 mg/kg PO SID（依培養結果）",
        "Tramadol 2-5 mg/kg PO BID-TID（止痛）",
        "Meloxicam 0.1 mg/kg PO SID（感染控制後）"
      ],
      "surgery": "關節鏡灌洗和清創術。嚴重關節破壞需關節固定術（arthrodesis）。開放性引流用於嚴重膿瘍。"
    },
    "prognosis": "早期診斷和積極治療預後良好至中等。延遲治療 >48 小時關節軟骨損傷通常不可逆。慢性感染可能需要關節固定術。多關節感染（血行性）預後較差。",
    "pearls": [
      "關節液 WBC >40,000/μL 伴退化性嗜中性球高度提示感染",
      "與 IMPA 鑑別：IMPA 通常多關節、非退化性嗜中性球、培養陰性",
      "術後關節感染可在手術後數天到數週才出現",
      "抗生素療程不足是復發的主要原因，至少 4 週"
    ],
    "diagnosticAlgorithm": {
      "title": "化膿性關節炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估急性關節炎症和全身症狀",
          "findings": [
            "急性單關節或多關節腫脹",
            "劇烈疼痛和跛行",
            "發熱和精神沉鬱",
            "穿透傷或手術史"
          ]
        },
        {
          "step": 2,
          "action": "關節液分析",
          "details": "進行關節穿刺和滑液分析",
          "findings": [
            "滑液混濁至膿性",
            "有核細胞顯著增多（>40,000/μL）",
            "嗜中性球 >90%",
            "退化性嗜中性球和細菌"
          ]
        },
        {
          "step": 3,
          "action": "微生物學檢查",
          "details": "進行滑液培養和藥敏試驗",
          "findings": [
            "細菌培養分離病原菌",
            "常見：Staphylococcus、Streptococcus、E. coli",
            "抗生素藥敏指導治療",
            "血液培養排除菌血症"
          ]
        },
        {
          "step": 4,
          "action": "影像學評估",
          "details": "進行X光和進階影像評估關節損傷",
          "findings": [
            "關節腫脹和軟組織增厚",
            "關節間隙改變",
            "骨質侵蝕（晚期）",
            "排除骨髓炎累及"
          ]
        }
      ]
    },
    "monitoring": [
      "關節液分析每 1-2 週追蹤至正常化",
      "X 光每 2-4 週評估骨改變",
      "體溫和跛行程度每日評估（住院期間）",
      "抗生素完成後 2 週複驗關節液"
    ],
    "reference": "Blackwell's Five-Minute Veterinary Consult"
  },
  "osteomyelitis": {
    "zh": "骨髓炎",
    "en": "Osteomyelitis",
    "definition": "骨骼和骨髓的感染性發炎，通常由細菌引起，偶見真菌性。可經由開放性骨折、手術植入物、穿刺傷或血行播散引起。Staphylococcus spp. 為最常見致病菌。慢性骨髓炎治療困難，常需長期抗生素和手術介入。",
    "synonyms": [
      "骨感染",
      "骨骼感染"
    ],
    "epidemiology": {
      "species": "犬貓均可發生，犬較常見",
      "breed": "大型犬和運動犬（外傷和骨折手術風險高）",
      "age": "任何年齡，年輕活躍犬和老年犬較多",
      "sex": "公犬略多（外傷風險高）",
      "prevalence": "開放性骨折後發生率約 5-15%"
    },
    "clinicalPresentation": {
      "symptoms": [
        "跛行（急性或慢性）",
        "患部腫脹",
        "發燒（急性期）",
        "引流竇持續排出膿性分泌物",
        "手術傷口不癒合",
        "食慾下降",
        "精神沉鬱",
        "患部疼痛",
        "骨折術後植入物鬆脫",
        "慢性不明原因跛行"
      ],
      "physicalExam": [
        "患部軟組織腫脹和觸痛",
        "引流竇口持續排膿",
        "患肢肌肉萎縮（慢性）",
        "發燒（急性期較明顯）",
        "觸診骨骼輪廓改變或不穩定"
      ]
    },
    "pathophysiology": "細菌進入骨組織後，在骨髓腔和 Haversian 管系統中繁殖。感染引起骨壞死，壞死骨碎片（sequestrum）無血液供應，成為細菌持續存在的庇護所。周圍活骨形成新骨包殼（involucrum）。Staphylococcus 可形成生物膜（biofilm）附著於骨表面和植入物上，使抗生素難以穿透，這是慢性骨髓炎難以治癒的主要原因。",
    "diagnosis": {
      "primary": [
        "X 光檢查（骨溶解、骨膜反應、sequestrum）",
        "骨培養和藥敏試驗（手術取樣最佳）",
        "CT 掃描（詳細評估骨破壞範圍）",
        "血液學檢查"
      ],
      "differential": [
        "骨腫瘤（osteosarcoma）",
        "真菌性骨髓炎（blastomycosis、coccidioidomycosis）",
        "骨囊腫",
        "肥大性骨病",
        "外傷性骨折不癒合",
        "異物反應"
      ],
      "labFindings": [
        "X 光：骨溶解灶、骨膜增生、sequestrum（硬化骨碎片被溶骨帶圍繞）",
        "骨培養：Staphylococcus spp. 最常見",
        "CBC：嗜中性球增多（急性期）",
        "CRP/SAA 升高（炎症標誌）",
        "組織病理學：化膿性或肉芽腫性炎症"
      ]
    },
    "treatment": {
      "acute": "手術清創移除壞死骨和感染組織，靜脈抗生素（根據培養結果），穩定骨折（若有）",
      "chronic": "長期口服抗生素 6-8 週或更長。反覆手術清創可能必要。移除感染的植入物（骨折癒合後）",
      "medications": [
        "Cephalexin 22-30 mg/kg PO BID-TID",
        "Amoxicillin-clavulanate 12.5-25 mg/kg PO BID",
        "Clindamycin 11 mg/kg PO BID（骨穿透性佳）",
        "Enrofloxacin 5-20 mg/kg PO SID（依培養結果）",
        "局部抗生素珠（antibiotic-impregnated PMMA beads）"
      ],
      "surgery": "手術清創和骨壞死組織移除為治療核心。感染植入物移除。骨缺損可用骨移植填補。嚴重無法控制的感染可能需截肢。"
    },
    "prognosis": "急性骨髓炎早期治療預後良好。慢性骨髓炎預後謹慎，復發率高（30-40%）。植入物相關感染需移除植入物後預後改善。真菌性骨髓炎需數月抗真菌治療。",
    "pearls": [
      "骨培養需從手術取得的深部組織進行，表面拭子培養常受汙染菌干擾",
      "X 光改變通常在感染後 10-14 天才出現，早期可能正常",
      "慢性骨髓炎中的 sequestrum 必須手術移除，單靠抗生素無法治癒",
      "Clindamycin 對骨組織穿透性極佳，是骨髓炎抗生素的良好選擇"
    ],
    "diagnosticAlgorithm": {
      "title": "骨髓炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估骨感染症狀和風險因子",
          "findings": [
            "受累肢體疼痛和腫脹",
            "跛行（可能嚴重不願負重）",
            "發熱",
            "開放性骨折或手術植入物史"
          ]
        },
        {
          "step": 2,
          "action": "影像學檢查",
          "details": "進行X光評估骨骼變化",
          "findings": [
            "骨溶解和不規則骨破壞",
            "骨膜反應",
            "死骨形成",
            "植入物周圍溶解"
          ]
        },
        {
          "step": 3,
          "action": "細菌培養",
          "details": "進行深層組織或骨培養確認病原",
          "findings": [
            "骨活檢組織培養",
            "最常見：Staphylococcus spp.",
            "厭氧菌培養",
            "抗生素藥敏試驗"
          ]
        },
        {
          "step": 4,
          "action": "進階評估",
          "details": "評估骨髓炎範圍和手術需求",
          "findings": [
            "CT評估骨破壞範圍",
            "排除真菌性骨髓炎",
            "評估植入物移除需求",
            "組織病理學排除腫瘤"
          ]
        }
      ]
    },
    "monitoring": [
      "X 光每 4-6 週追蹤骨癒合和感染控制",
      "CRP/SAA 每 1-2 週監測炎症趨勢",
      "引流竇口的分泌物量和性質",
      "抗生素療程結束後 4 週追蹤 X 光和血檢確認"
    ],
    "reference": "Antimicrobial Therapy in Veterinary Medicine"
  },
  "bicipital-tenosynovitis": {
    "zh": "二頭肌腱鞘炎",
    "en": "Bicipital Tenosynovitis",
    "definition": "肱二頭肌肌腱及其腱鞘（位於肱骨結節間溝）的發炎性疾病。為犬前肢跛行的常見原因之一，通常由慢性過度使用、外傷或退化性改變引起。主要影響中大型運動犬。",
    "synonyms": [
      "二頭肌肌腱炎",
      "biceps tendinitis",
      "肱二頭肌腱鞘炎"
    ],
    "epidemiology": {
      "species": "犬（貓極罕見）",
      "breed": "中大型犬和運動犬種（Labrador Retriever、Rottweiler、German Shepherd）",
      "age": "中年至老年犬（4-10 歲）",
      "sex": "無明顯性別傾向",
      "prevalence": "犬前肢跛行的常見原因之一"
    },
    "clinicalPresentation": {
      "symptoms": [
        "前肢間歇性或持續性跛行",
        "休息後起立時跛行加重",
        "運動後跛行惡化",
        "跛行隨活動量增加而加劇",
        "步態短縮（stride shortened）",
        "不願跳躍或上樓梯",
        "患側前肢向外擺動步態",
        "肩部或上臂前方疼痛"
      ],
      "physicalExam": [
        "二頭肌肌腱直接觸壓結節間溝處疼痛（biceps test）",
        "肩關節屈曲同時肘關節伸展時疼痛加劇",
        "肩關節活動範圍可能正常或輕度受限",
        "二頭肌肌肉可能萎縮（慢性）",
        "肩關節無不穩定感"
      ]
    },
    "pathophysiology": "肱二頭肌肌腱穿過肱骨近端的結節間溝，被滑膜腱鞘包裹。反覆運動或急性外傷導致肌腱和腱鞘的微損傷和發炎。慢性炎症導致肌腱退化、腱鞘增厚和關節滑液增多。嚴重者可發展為肌腱部分撕裂、礦化或纖維化。結節間溝的骨贅形成可加重肌腱的機械性刺激。",
    "diagnosis": {
      "primary": [
        "骨科理學檢查（biceps stretch test 陽性）",
        "肩關節 X 光（結節間溝骨贅、肌腱礦化）",
        "超音波檢查（肌腱增粗、腱鞘積液）",
        "MRI（最敏感，可見肌腱退化和積液）"
      ],
      "differential": [
        "肩關節骨關節炎（OA）",
        "岡上肌腱病（supraspinatus tendinopathy）",
        "肩關節不穩定",
        "肩關節 OCD（osteochondritis dissecans）",
        "內側肩關節不穩定（medial shoulder instability）",
        "頸椎疾病引起前肢跛行"
      ],
      "labFindings": [
        "X 光：結節間溝骨贅、肌腱礦化點",
        "超音波：肌腱增粗、回音異常、腱鞘積液",
        "MRI：肌腱訊號改變、關節積液",
        "關節液分析：輕度炎症改變",
        "關節鏡：肌腱充血腫脹、纖維化"
      ]
    },
    "treatment": {
      "acute": "休息限制活動 4-6 週，NSAIDs 止痛抗炎，冷敷。關節內皮質類固醇注射",
      "chronic": "物理治療（超音波治療、被動活動範圍練習）。對保守治療無反應者考慮手術",
      "medications": [
        "Meloxicam 0.1 mg/kg PO SID",
        "Carprofen 2.2 mg/kg PO BID",
        "關節內 methylprednisolone acetate 注射（結節間溝腱鞘內）",
        "Gabapentin 5-10 mg/kg PO BID-TID（慢性疼痛）",
        "關節保健品（glucosamine + chondroitin）"
      ],
      "surgery": "二頭肌肌腱切斷或移位術（biceps tenotomy/tenodesis）。關節鏡下肌腱釋放術。嚴重者可考慮肩關節固定術（罕需）。"
    },
    "prognosis": "保守治療約 50-60% 病例改善。手術治療（tenotomy/tenodesis）預後良好，大多數犬術後功能恢復滿意。早期治療預後優於慢性病例。運動犬可能無法恢復至受傷前的競技水平。",
    "pearls": [
      "Biceps stretch test：肩關節屈曲 + 肘關節伸展產生疼痛是最特異性的臨床測試",
      "結節間溝內局部注射 corticosteroid 可同時作為診斷和治療手段",
      "二頭肌腱病常與其他肩關節疾病（如岡上肌腱病、OA）共存",
      "超音波和 MRI 對軟組織評估優於 X 光"
    ],
    "diagnosticAlgorithm": {
      "title": "二頭肌腱鞘炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估前肢跛行和肩部疼痛",
          "findings": [
            "前肢跛行（運動後加重）",
            "肩部疼痛",
            "二頭肌溝觸診疼痛",
            "肩關節屈曲時疼痛加重"
          ]
        },
        {
          "step": 2,
          "action": "骨科學檢查",
          "details": "進行特異性肩關節和二頭肌腱評估",
          "findings": [
            "二頭肌腱直接觸診疼痛",
            "肩關節屈曲伴前臂旋前誘發疼痛",
            "肩關節活動範圍可能正常",
            "肌肉萎縮（慢性）"
          ]
        },
        {
          "step": 3,
          "action": "影像學檢查",
          "details": "進行肩關節X光和超音波評估",
          "findings": [
            "二頭肌溝骨質增生",
            "結節間溝鈣化",
            "超音波見肌腱增厚和積液",
            "MRI精確評估肌腱病變"
          ]
        },
        {
          "step": 4,
          "action": "關節鏡確診",
          "details": "視情況進行肩關節鏡檢查",
          "findings": [
            "肌腱纖維化和炎症",
            "肌腱部分撕裂",
            "滑膜增生",
            "合併OCD或其他關節病變"
          ]
        }
      ]
    },
    "monitoring": [
      "保守治療 4-6 週後重新評估跛行程度",
      "物理治療進度每 2 週評估",
      "手術後 6-8 週限制活動",
      "術後 3 個月評估功能恢復程度"
    ],
    "reference": "Clinical Veterinary Advisor: Dogs and Cats"
  },
  "fibrotic-myopathy": {
    "zh": "纖維性肌病",
    "en": "Fibrotic Myopathy",
    "definition": "肌肉組織被纖維結締組織取代，導致肌肉攣縮和關節活動受限。犬中最常見於半腱肌（semitendinosus）、半膜肌（semimembranosus）和股薄肌（gracilis），導致特徵性機械性後肢步態異常。通常為慢性進行性。",
    "synonyms": [
      "肌肉纖維化",
      "攣縮性肌病",
      "gracilis/semitendinosus contracture"
    ],
    "epidemiology": {
      "species": "犬（貓罕見）",
      "breed": "German Shepherd Dog 最常見，其他工作犬種",
      "age": "中年犬（3-8 歲），多數為活躍工作犬",
      "sex": "公犬較多",
      "prevalence": "German Shepherd 中相對特有的疾病"
    },
    "clinicalPresentation": {
      "symptoms": [
        "後肢特徵性機械性跛行",
        "步態中腳掌著地前有突然的向後「彈回」動作",
        "患肢步幅縮短",
        "步態異常持續且不因活動量改變",
        "內轉或外轉步態（取決於受影響肌肉）",
        "不隨 NSAIDs 使用改善",
        "患肢肌肉觸感堅硬如索",
        "通常無明顯疼痛（慢性期）"
      ],
      "physicalExam": [
        "受影響肌肉觸診堅硬、呈索狀纖維條",
        "膝關節和跗關節活動範圍受限",
        "肌肉萎縮和纖維帶可觸及",
        "被動伸展時感覺機械性抵抗（非疼痛性）",
        "站立時患肢可能呈異常角度"
      ]
    },
    "pathophysiology": "確切病因不明，可能與反覆肌肉微損傷（運動外傷）、免疫介導性肌炎或區域性循環障礙有關。肌纖維壞死後被纖維結締組織取代而非再生肌肉。纖維組織缺乏彈性，導致肌肉整體縮短和攣縮。German Shepherd 可能有遺傳傾向。受影響肌肉逐漸喪失收縮功能，僅作為纖維帶限制關節活動範圍。",
    "diagnosis": {
      "primary": [
        "臨床表現和特徵性步態分析",
        "理學檢查觸及肌肉纖維帶",
        "肌肉超音波（回音增強、纖維化結構）",
        "肌肉活檢（確診）"
      ],
      "differential": [
        "十字韌帶損傷",
        "髖關節發育不良",
        "腰薦椎疾病",
        "退化性脊髓病（DM）",
        "免疫介導性肌炎",
        "神經性肌萎縮"
      ],
      "labFindings": [
        "CK：可能正常或輕度升高（急性期）",
        "超音波：肌肉回音增強、纖維帶結構",
        "肌肉活檢：肌纖維萎縮被纖維結締組織取代",
        "EMG：可能異常（急性期有自發電位）",
        "X 光：排除骨關節疾病"
      ]
    },
    "treatment": {
      "acute": "急性肌炎階段（若發現）以免疫抑制藥物治療。物理治療維持關節活動範圍",
      "chronic": "手術切除纖維帶或肌腱鬆解術。物理治療和拉伸運動。治療效果常不持久",
      "medications": [
        "Prednisolone 1-2 mg/kg PO SID（急性肌炎期）",
        "Meloxicam 0.1 mg/kg PO SID（有限效果）",
        "Tramadol 2-5 mg/kg PO BID（伴隨疼痛時）",
        "物理治療：拉伸、被動活動範圍、超音波熱療"
      ],
      "surgery": "肌腱切斷術（myotomy/tenotomy）或纖維帶切除術。術後復發率高（50-75%），因為纖維化過程可能繼續。反覆手術可能需要。"
    },
    "prognosis": "功能預後謹慎。手術可暫時改善步態，但復發率高。疾病通常不危及生命但影響生活品質。大多數犬可維持行走能力但步態永久異常。不影響壽命。",
    "pearls": [
      "German Shepherd 的特徵性「彈回」步態幾乎是病理特異性的",
      "步態異常是機械性的（纖維帶限制），而非疼痛性的",
      "NSAIDs 通常對步態改善無效（非炎症性機制）",
      "術後復發率高，飼主應有心理準備"
    ],
    "diagnosticAlgorithm": {
      "title": "纖維性肌病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估機械性步態異常",
          "findings": [
            "特徵性步態（擺動相足部突然向後拉）",
            "受累肌肉堅硬可觸及",
            "股薄肌或半腱肌最常受累",
            "德國牧羊犬好發"
          ]
        },
        {
          "step": 2,
          "action": "觸診與肌肉評估",
          "details": "進行受累肌肉的詳細觸診",
          "findings": [
            "肌肉內可觸及堅硬纖維化帶",
            "關節被動活動範圍受限",
            "肌肉萎縮",
            "無疼痛反應"
          ]
        },
        {
          "step": 3,
          "action": "影像學檢查",
          "details": "進行超音波評估肌肉結構",
          "findings": [
            "超音波見肌肉纖維化和瘢痕組織",
            "肌肉回音性增加",
            "正常肌肉結構喪失",
            "MRI精確評估範圍"
          ]
        },
        {
          "step": 4,
          "action": "組織病理學",
          "details": "必要時進行肌肉活檢確認",
          "findings": [
            "成熟纖維結締組織取代正常肌肉",
            "肌纖維萎縮和退化",
            "排除腫瘤性病變",
            "評估手術治療可行性"
          ]
        }
      ]
    },
    "monitoring": [
      "步態評估每月追蹤",
      "術後物理治療和拉伸練習至少 8-12 週",
      "患肢肌肉量和關節活動範圍定期評估",
      "對側肢體發展纖維化的風險監測"
    ],
    "reference": "Blackwell's Five-Minute Veterinary Consult"
  },
  "hypertrophic-osteopathy": {
    "zh": "肥大性骨病",
    "en": "Hypertrophic Osteopathy (HO)",
    "definition": "四肢長骨骨膜異常增生導致對稱性四肢腫脹和疼痛的副腫瘤症候群。幾乎總是繼發於胸腔或腹腔腫瘤（最常見為肺腫瘤），偶見於慢性感染。移除原發病灶後骨膜增生可消退。",
    "synonyms": [
      "肥大性骨關節病",
      "hypertrophic osteoarthropathy",
      "Marie's disease",
      "肥大性肺性骨關節病"
    ],
    "epidemiology": {
      "species": "犬較常見，貓罕見",
      "breed": "大型犬種",
      "age": "中老年犬（原發腫瘤好發年齡）",
      "sex": "無明顯性別傾向",
      "prevalence": "罕見但具臨床診斷價值"
    },
    "clinicalPresentation": {
      "symptoms": [
        "四肢對稱性腫脹（遠端先開始）",
        "四肢疼痛",
        "跛行或不願移動",
        "步態僵硬",
        "食慾下降",
        "精神沉鬱",
        "呼吸症狀（咳嗽、呼吸困難——原發肺病）",
        "體重下降",
        "肢端皮膚繃緊發亮"
      ],
      "physicalExam": [
        "四肢遠端對稱性硬實腫脹（骨性而非軟組織）",
        "觸診骨表面粗糙不規則且疼痛",
        "掌骨/蹠骨和指/趾骨最先受影響",
        "肺部聽診可能異常",
        "發燒（偶見）"
      ]
    },
    "pathophysiology": "確切機制不完全清楚。目前理論認為胸腔/腹腔腫瘤或慢性感染引起迷走神經傳入纖維刺激，導致四肢末梢血流增加和骨膜血管擴張。增加的血流促進骨膜成骨細胞活化和新骨形成。神經體液因子（如 VEGF、PDGF）也被認為參與。迷走神經切斷可使症狀消退，支持神經機制理論。",
    "diagnosis": {
      "primary": [
        "四肢 X 光（特徵性骨膜增生，柵欄狀或層狀）",
        "胸腔 X 光（尋找肺腫瘤）",
        "腹部超音波（排除腹腔腫瘤）",
        "胸腔 CT（詳細評估肺部病灶）"
      ],
      "differential": [
        "骨髓炎（多骨）",
        "多骨性骨腫瘤",
        "真菌性骨炎",
        "骨膜增生性多關節炎",
        "維生素 A 過多症",
        "氟中毒"
      ],
      "labFindings": [
        "四肢 X 光：沿骨幹的柵欄狀或毛刷狀骨膜新骨生成",
        "胸腔 X 光/CT：肺腫塊、胸腔積液",
        "CBC：可能輕度嗜中性球增多",
        "ALP 可能升高",
        "骨膜新骨生成由遠端向近端進展"
      ]
    },
    "treatment": {
      "acute": "止痛為首要。尋找並處理原發病灶",
      "chronic": "移除原發腫瘤或治療慢性感染後骨膜增生可消退。無法手術者以緩和性止痛為主",
      "medications": [
        "Meloxicam 0.1 mg/kg PO SID",
        "Tramadol 2-5 mg/kg PO BID-TID",
        "Gabapentin 5-10 mg/kg PO BID（神經性疼痛）",
        "Prednisolone 0.5-1 mg/kg PO SID（減少炎症）"
      ],
      "surgery": "原發肺腫瘤的肺葉切除術為首選。肺腫瘤切除後骨膜增生通常在數週至數月內消退。無法手術者可考慮迷走神經切斷術（效果不一）。"
    },
    "prognosis": "取決於原發病。可切除的肺腫瘤（良性或低度惡性）切除後 HO 可完全消退，預後良好。不可切除的惡性肺腫瘤預後不良。慢性感染治療後 HO 通常消退。",
    "pearls": [
      "四肢遠端對稱性骨膜增生的犬必須進行胸腔影像學檢查",
      "原發腫瘤切除後 HO 可完全消退是重要的鑑別點",
      "骨膜增生從遠端向近端進展是特徵性表現",
      "罕見情況下腹腔腫瘤（膀胱、腎臟）也可引起 HO"
    ],
    "diagnosticAlgorithm": {
      "title": "肥大性骨病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估四肢遠端腫脹和潛在胸腔病變",
          "findings": [
            "四肢遠端對稱性腫脹",
            "觸診堅硬且疼痛",
            "跛行和步態僵硬",
            "可能伴有咳嗽或呼吸困難"
          ]
        },
        {
          "step": 2,
          "action": "四肢X光",
          "details": "進行四肢遠端X光確認骨膜增生",
          "findings": [
            "長骨骨幹骨膜新生骨",
            "骨膜增生呈柵欄狀或層狀",
            "掌骨/蹠骨最先受累",
            "軟組織腫脹"
          ]
        },
        {
          "step": 3,
          "action": "胸腹腔篩檢",
          "details": "進行胸部X光和腹部超音波尋找原發病變",
          "findings": [
            "肺部腫塊（最常見原因）",
            "胸腔積液",
            "腹腔腫塊",
            "食道病變"
          ]
        },
        {
          "step": 4,
          "action": "原發病因確認",
          "details": "確認原發病變的性質",
          "findings": [
            "CT精確評估胸腔腫塊",
            "細針抽吸或活檢確認腫瘤類型",
            "原發性肺腫瘤最常見",
            "治療原發病後骨膜變化可消退"
          ]
        }
      ]
    },
    "monitoring": [
      "原發腫瘤治療後四肢 X 光每 4-6 週追蹤骨膜消退",
      "胸腔 X 光每 2-3 個月追蹤腫瘤復發",
      "疼痛評分每日監測",
      "運動能力和生活品質評估"
    ],
    "reference": "Textbook of Veterinary Diagnostic Radiology"
  },
  "luxating-shoulder": {
    "zh": "肩關節脫位",
    "en": "Shoulder Luxation",
    "definition": "肱骨頭與肩胛骨關節窩之間的正常關節關係喪失，可為完全脫位（luxation）或不完全脫位（subluxation）。可由外傷或先天性關節鬆弛引起。內側脫位較外側脫位常見。犬中相對少見的關節脫位。",
    "synonyms": [
      "肩關節脫臼",
      "肩脫位",
      "glenohumeral luxation"
    ],
    "epidemiology": {
      "species": "犬（貓罕見）",
      "breed": "外傷性：任何品種。先天性/發育性：小型和玩具犬種（Toy Poodle、Chihuahua、Pomeranian）",
      "age": "外傷性：任何年齡。先天性：幼犬至年輕犬",
      "sex": "無明顯性別傾向",
      "prevalence": "犬中相對少見"
    },
    "clinicalPresentation": {
      "symptoms": [
        "急性前肢跛行（外傷性）或慢性跛行（先天性）",
        "患肢不負重",
        "肩部輪廓改變",
        "疼痛和抗拒觸碰肩部",
        "肩關節活動受限",
        "先天性：可能雙側受影響",
        "關節不穩定感（subluxation）",
        "患肢向外或向內旋轉（取決於脫位方向）"
      ],
      "physicalExam": [
        "肩關節觸診可感覺肱骨頭位移",
        "內側脫位：肱骨頭可在內側觸及",
        "外側脫位：肩部扁平、肱骨頭在外側突出",
        "關節活動時有彈響感（先天性鬆弛）",
        "關節周圍腫脹和觸痛（急性外傷性）"
      ]
    },
    "pathophysiology": "外傷性脫位由劇烈外力撕裂肩關節囊和支持韌帶（內側和外側盂肱韌帶）造成。先天性/發育性脫位因關節囊鬆弛、關節窩發育淺或支持韌帶先天性缺陷，肱骨頭在正常活動中即可滑出。內側脫位更常見，可能因內側韌帶結構相對薄弱。慢性脫位導致關節面退化和繼發性骨關節炎。",
    "diagnosis": {
      "primary": [
        "骨科理學檢查（觸診肱骨頭位置、drawer test）",
        "肩關節正側位和軸位 X 光",
        "壓力 X 光（評估關節不穩定程度）",
        "CT（評估骨性結構和關節窩深度）"
      ],
      "differential": [
        "肩關節骨折（肩胛骨或肱骨近端）",
        "二頭肌腱鞘炎",
        "肩關節 OCD",
        "內側肩關節不穩定",
        "臂神經叢損傷",
        "肩關節骨關節炎"
      ],
      "labFindings": [
        "X 光：肱骨頭與關節窩不對位",
        "壓力 X 光：關節間隙增寬、肱骨頭位移",
        "CT：關節窩深度評估、骨折碎片辨識",
        "關節液分析：可能有血液（急性外傷）"
      ]
    },
    "treatment": {
      "acute": "鎮靜下閉合復位嘗試，成功後以 Velpeau sling 固定 10-14 天。復位失敗或不穩定者需手術",
      "chronic": "手術穩定為首選。先天性病例多需手術。慢性脫位閉合復位成功率低",
      "medications": [
        "Meloxicam 0.1 mg/kg PO SID",
        "Tramadol 2-5 mg/kg PO BID",
        "Gabapentin 5-10 mg/kg PO BID（慢性疼痛）",
        "關節保健品（長期退化性改變時）"
      ],
      "surgery": "內側脫位：內側盂肱韌帶重建或移位術（biceps transposition）。外側脫位：關節囊緊縮術。嚴重關節破壞：關節固定術（arthrodesis）或關節切除成形術。"
    },
    "prognosis": "閉合復位 + 外固定成功率約 50%。手術穩定後預後良好至中等。先天性雙側脫位預後謹慎但多數犬可維持可接受的活動能力。慢性脫位伴嚴重退化性改變者功能恢復有限。",
    "pearls": [
      "閉合復位後必須立即以 Velpeau sling 固定，否則極易復發",
      "內側脫位：患肢呈外旋姿勢。外側脫位：患肢呈內旋姿勢",
      "小型犬和玩具犬種的肩關節脫位多為先天性/發育性",
      "復發性脫位幾乎都需要手術處理"
    ],
    "diagnosticAlgorithm": {
      "title": "肩關節脫位 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估前肢跛行和肩關節穩定性",
          "findings": [
            "急性或慢性前肢跛行",
            "肩關節外形異常",
            "肩關節活動範圍異常",
            "外傷史或先天性關節鬆弛"
          ]
        },
        {
          "step": 2,
          "action": "骨科學檢查",
          "details": "進行肩關節穩定性測試",
          "findings": [
            "肱骨頭可觸及異常位置",
            "肩關節抽屜試驗異常",
            "內側或外側脫位",
            "關節過度鬆弛"
          ]
        },
        {
          "step": 3,
          "action": "影像學確診",
          "details": "進行肩關節X光確認脫位方向",
          "findings": [
            "肱骨頭與肩胛盂對位異常",
            "排除骨折",
            "退行性關節變化（慢性）",
            "雙側對照"
          ]
        },
        {
          "step": 4,
          "action": "手術規劃",
          "details": "評估復位方式和穩定化手術",
          "findings": [
            "急性vs慢性脫位",
            "先天性vs創傷性",
            "韌帶完整性評估",
            "手術穩定化方案"
          ]
        }
      ]
    },
    "monitoring": [
      "Velpeau sling 每 3-5 天檢查皮膚壓迫性損傷",
      "X 光復位後即刻確認和拆除外固定後複驗",
      "關節穩定性每 2 週評估",
      "術後 8-12 週逐漸恢復正常活動"
    ],
    "reference": "Clinical Veterinary Advisor: Dogs and Cats"
  },
  "ununited-anconeal-process": {
    "zh": "肘突未癒合",
    "en": "Ununited Anconeal Process (UAP)",
    "definition": "尺骨近端肘突（anconeal process）的骨化中心未能在正常時間內與尺骨幹骺端融合，導致游離或部分附著的骨碎片存在於肘關節內。為犬肘關節發育不良（elbow dysplasia）的一種型式。主要影響大型犬種，導致前肢跛行和繼發性骨關節炎。",
    "synonyms": [
      "UAP",
      "肘突骨化不全",
      "肘突分離",
      "肘關節發育不良（部分型式）"
    ],
    "epidemiology": {
      "species": "犬（貓極罕見）",
      "breed": "German Shepherd Dog 最常見，其他大型犬種（Basset Hound、Saint Bernard、Great Dane、Labrador Retriever）",
      "age": "通常 5-12 個月齡開始出現症狀",
      "sex": "公犬略多",
      "prevalence": "大型犬種肘關節疾病中的重要型式，German Shepherd 發生率最高"
    },
    "clinicalPresentation": {
      "symptoms": [
        "前肢跛行（單側或雙側）",
        "運動後跛行加重",
        "肘關節腫脹",
        "前肢步態短縮和僵硬",
        "不願長時間運動",
        "休息後起立時僵硬",
        "可能見前肢外旋姿勢",
        "雙側受影響時步態可能僅表現為僵硬而非明顯跛行"
      ],
      "physicalExam": [
        "肘關節觸診腫脹（關節積液）",
        "肘關節完全伸展時疼痛",
        "肘關節活動範圍減少",
        "過度屈曲肘關節同時旋前可能引起疼痛",
        "前肢肌肉萎縮（慢性病例）",
        "肘關節觸診可能有捻發音"
      ]
    },
    "pathophysiology": "正常犬的肘突骨化中心應在 16-20 週齡與尺骨幹骺端融合（German Shepherd 可延至 5 個月）。UAP 的病因是尺骨和橈骨的不等速生長（radius-ulna length incongruity），導致肱骨滑車對肘突施加異常壓力，阻止或破壞正常的骨融合。游離的肘突造成關節不穩定、軟骨磨損和進行性退化性關節疾病。",
    "diagnosis": {
      "primary": [
        "肘關節屈曲側位 X 光（>5 月齡可見肘突分離線）",
        "CT 掃描（精確評估碎片和關節不合適度）",
        "肘關節正側位 X 光（排除合併其他 elbow dysplasia 型式）",
        "骨科理學檢查"
      ],
      "differential": [
        "內側冠狀突碎裂（FCP/FMCP）",
        "肘關節 OCD",
        "肘關節不合適度（elbow incongruity）",
        "全肘關節炎（panosteitis）",
        "外傷性肘關節骨折",
        "肘關節退化性關節疾病"
      ],
      "labFindings": [
        "屈曲側位 X 光：肘突與尺骨之間可見透亮分離線",
        "正位 X 光：關節積液（fat pad sign）、骨贅形成",
        "CT：精確顯示碎片大小、位置和關節不合適度",
        "關節液分析：輕度炎症改變（非特異性）",
        "X 光分級：完全分離 vs 部分附著"
      ]
    },
    "treatment": {
      "acute": "限制活動，NSAIDs 止痛。早期手術介入預後最佳",
      "chronic": "手術治療為主。藥物控制骨關節炎症狀。體重管理",
      "medications": [
        "Meloxicam 0.1 mg/kg PO SID",
        "Carprofen 2.2 mg/kg PO BID",
        "Glucosamine/Chondroitin 關節保健品",
        "Adequan (PSGAG) 2 mg/kg IM twice weekly × 4 weeks",
        "Omega-3 脂肪酸（抗炎輔助）"
      ],
      "surgery": "年輕犬（<1 歲）首選肘突切除術（anconeal process removal）或尺骨截骨術（ulnar osteotomy）允許肘突自行癒合。螺釘固定術（screw fixation）嘗試保留肘突。嚴重退化性關節疾病可考慮全肘關節置換（limited availability）。"
    },
    "prognosis": "早期手術介入（<1 歲）預後中等至良好。尺骨截骨術在年輕犬（<6 個月）有較高的肘突融合成功率。延遲治療或嚴重骨關節炎者功能改善有限。大多數犬術後仍會發展某程度的退化性關節疾病，需終生管理。",
    "pearls": [
      "German Shepherd >5 個月齡肘關節屈曲側位 X 光仍見肘突分離線即可診斷",
      "UAP 常合併其他肘關節發育不良型式（FCP、OCD），CT 可全面評估",
      "雙側肘關節 X 光是必要的——UAP 雙側發生率約 20-35%",
      "尺骨截骨術（proximal ulnar osteotomy）減壓後肘突可能自行融合，尤其在幼犬"
    ],
    "diagnosticAlgorithm": {
      "title": "肘突未癒合 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估前肢跛行和肘關節症狀",
          "findings": [
            "生長中大型犬前肢跛行",
            "肘關節腫脹",
            "運動後跛行加重",
            "品種易感（德國牧羊犬、巴吉度等）"
          ]
        },
        {
          "step": 2,
          "action": "骨科學檢查",
          "details": "進行肘關節觸診和活動度評估",
          "findings": [
            "肘關節伸展時疼痛",
            "關節積液",
            "關節活動範圍可能減少",
            "肘關節可能有捻發音"
          ]
        },
        {
          "step": 3,
          "action": "影像學確診",
          "details": "進行肘關節X光（屈曲側面位最佳）",
          "findings": [
            "肘突骨化中心與鷹嘴突間透明線",
            "肘突遊離或半附著",
            "繼發性退行性關節病變",
            "CT精確評估遊離碎片"
          ]
        },
        {
          "step": 4,
          "action": "治療規劃",
          "details": "評估手術選項",
          "findings": [
            "年齡和退行性變化程度",
            "碎片移除vs固定",
            "尺骨近端截骨術（動力學矯正）",
            "雙側評估"
          ]
        }
      ]
    },
    "monitoring": [
      "術後 X 光每 4-6 週追蹤骨癒合（截骨術）或肘突融合",
      "肘關節活動範圍和跛行程度每月評估",
      "長期骨關節炎進展每 6-12 個月 X 光追蹤",
      "體重管理和關節保健品終生使用"
    ],
    "reference": "Clinical Veterinary Advisor: Dogs and Cats"
  },
  "arrhythmogenic-rvc": {
    "zh": "致心律不整性右心室心肌病",
    "en": "Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)",
    "definition": "一種以右心室心肌被脂肪或纖維脂肪組織取代為特徵的遺傳性心肌病，導致嚴重的心室心律不整。此病在 Boxer 和 English Bulldog 中有明顯的品種好發性，可導致猝死或進展為充血性心衰竭。",
    "synonyms": [
      "Boxer 心肌病",
      "右心室心肌病",
      "致心律不整性右心室發育不良"
    ],
    "epidemiology": {
      "species": "犬為主，貓罕見",
      "breed": "Boxer 最常見，English Bulldog 亦有報告；其他品種偶見",
      "age": "成年至老年犬（通常 5-10 歲），但年輕犬也可能猝死",
      "sex": "無明顯性別好發性",
      "prevalence": "Boxer 犬中估計發病率約 20-40%，為該品種最常見的心臟疾病之一"
    },
    "clinicalPresentation": {
      "symptoms": [
        "發作性暈厥（syncope）",
        "運動不耐（exercise intolerance）",
        "突然猝死（sudden cardiac death）",
        "呼吸困難（dyspnea）",
        "咳嗽",
        "腹水（ascites）",
        "虛弱無力（weakness）",
        "心律不整相關之昏倒",
        "食慾下降",
        "體重減輕"
      ],
      "physicalExam": [
        "心律不整，常可聽到心室早期收縮（VPCs）",
        "心音減弱或有奔馬律（gallop rhythm）",
        "股動脈脈搏缺損（pulse deficits）",
        "頸靜脈怒張（jugular distension）",
        "腹部波動感（腹水時）",
        "黏膜蒼白或發紺"
      ]
    },
    "pathophysiology": "右心室心肌細胞進行性被脂肪和纖維組織取代，導致右心室壁變薄及功能障礙。此結構異常形成折返迴路（reentrant circuits），產生心室性心律不整（尤其是來自右心室的 VPCs 和心室頻脈 VT）。嚴重病例可進展為雙心室衰竭。遺傳學上與 desmosomal 蛋白基因突變（如 striatin 基因）相關。",
    "diagnosis": {
      "primary": [
        "24 小時 Holter 心電圖監測（>100 VPCs/24hr 高度懷疑，>1000 VPCs 確診性高）",
        "標準心電圖（ECG）：右心室來源的寬 QRS 波 VPCs",
        "心臟超音波（echocardiography）：右心室擴張、壁運動異常",
        "胸腔 X 光：右心擴大、肺部充血徵象"
      ],
      "differential": [
        "擴張型心肌病（dilated cardiomyopathy, DCM）",
        "心包積液（pericardial effusion）",
        "肺動脈瓣狹窄（pulmonic stenosis）",
        "心臟血管瘤（hemangiosarcoma）",
        "心肌炎（myocarditis）",
        "甲狀腺功能低下導致的心臟變化"
      ],
      "labFindings": [
        "心肌肌鈣蛋白 I（cTnI）可能升高",
        "BNP/NT-proBNP 可能升高",
        "一般血液學和生化多正常",
        "基因檢測（striatin 基因突變）可用於 Boxer"
      ]
    },
    "treatment": {
      "acute": "心室頻脈時靜脈給予 Lidocaine（2 mg/kg IV bolus，隨後 CRI 40-80 μg/kg/min）；必要時電除顫；穩定血流動力學",
      "chronic": "口服 Sotalol（1.5-3.5 mg/kg PO BID）或 Mexiletine（5-8 mg/kg PO TID）；充血性心衰竭時加用 Furosemide、Pimobendan、ACE 抑制劑",
      "medications": [
        "Sotalol（1.5-3.5 mg/kg PO BID）",
        "Mexiletine（5-8 mg/kg PO TID）",
        "Lidocaine（急性：2 mg/kg IV bolus + CRI）",
        "Pimobendan（0.25-0.3 mg/kg PO BID，心衰竭時）",
        "Furosemide（1-4 mg/kg PO/IV，心衰竭時）"
      ],
      "surgery": "無常規手術治療；植入式心臟除顫器（ICD）在獸醫領域仍屬實驗性"
    },
    "prognosis": "依嚴重程度不同，預後差異大。無症狀犬（隱匿期）可維持數年正常生活。有暈厥或心衰竭症狀者預後較差，中位存活時間約 12-24 個月。猝死風險始終存在，即使在治療中。",
    "pearls": [
      "Boxer 若出現不明原因暈厥，應首先排除 ARVC，建議進行 Holter 監測",
      "單次 ECG 可能正常，24 小時 Holter 是偵測間歇性心律不整的金標準",
      "ARVC 有三種表型：隱匿型、心律不整型、心肌衰竭型，可依序進展",
      "Sotalol 和 Mexiletine 合用可能比單藥治療更有效控制心室心律不整"
    ],
    "diagnosticAlgorithm": {
      "title": "致心律不整性右心室心肌病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估心律不整症狀，拳師犬為高風險品種",
          "findings": [
            "暈厥或運動不耐",
            "心律不整（可觸及或聽診）",
            "拳師犬或英國鬥牛犬",
            "可能有家族史"
          ]
        },
        {
          "step": 2,
          "action": "心電圖檢查",
          "details": "進行12導程心電圖和24小時Holter監測",
          "findings": [
            "室性早搏（VPCs）",
            "VPCs呈左束支傳導阻滯形態（右心室起源）",
            "Holter >300 VPCs/24h有意義",
            "室性心搏過速"
          ]
        },
        {
          "step": 3,
          "action": "心臟超音波",
          "details": "進行心臟超音波評估心臟結構和功能",
          "findings": [
            "右心室擴大",
            "右心室壁運動異常",
            "部分病例心臟結構正常",
            "排除其他心臟病"
          ]
        },
        {
          "step": 4,
          "action": "基因檢測與分類",
          "details": "進行基因檢測確認突變",
          "findings": [
            "striatin基因突變檢測",
            "依嚴重度分三類：隱匿型、心律不整型、心肌衰竭型",
            "家族篩檢建議",
            "基因陽性不等於臨床發病"
          ]
        }
      ]
    },
    "monitoring": [
      "每 3-6 個月重複 Holter 監測評估 VPC 負荷量",
      "心臟超音波追蹤右心室大小及功能變化",
      "監測臨床症狀（暈厥頻率、運動耐受度）",
      "藥物劑量調整時需重新評估心電圖"
    ],
    "reference": "Manual of Canine and Feline Cardiology, 5th Edition"
  },
  "cardiac-tamponade": {
    "zh": "心包填塞",
    "en": "Cardiac Tamponade",
    "definition": "由於心包腔內液體快速或大量積聚，導致心包內壓力升高並壓迫心室，妨礙心室充盈及心輸出量的危及生命的緊急狀況。在犬貓中最常見的原因包括心臟血管瘤（hemangiosarcoma）、特發性心包積液及心臟基部腫瘤。",
    "synonyms": [
      "心臟壓塞",
      "心包壓塞",
      "Pericardial tamponade"
    ],
    "epidemiology": {
      "species": "犬較常見，貓少見",
      "breed": "大型犬好發，尤其 Golden Retriever、German Shepherd（與心臟血管瘤相關）；中大型犬品種（特發性心包積液）",
      "age": "中老年犬（7 歲以上），腫瘤相關者多見於老年犬",
      "sex": "雄性犬稍有好發傾向",
      "prevalence": "犬心包疾病中最常見的臨床表現；心臟血管瘤佔犬心包積液原因的 40-60%"
    },
    "clinicalPresentation": {
      "symptoms": [
        "急性虛脫或昏厥",
        "運動不耐",
        "呼吸困難或呼吸急促",
        "腹部膨大（腹水）",
        "食慾下降",
        "嗜睡無力",
        "嘔吐",
        "體重減輕",
        "突然倒下"
      ],
      "physicalExam": [
        "心音減弱或消失（muffled heart sounds）",
        "頸靜脈怒張（jugular venous distension）",
        "Beck 三徵：低血壓、心音減弱、頸靜脈怒張",
        "脈搏微弱、奇脈（pulsus paradoxus）",
        "腹部波動感（腹水）",
        "黏膜蒼白，CRT 延長"
      ]
    },
    "pathophysiology": "心包腔內液體（血液、滲出液或漏出液）積聚使心包內壓升高。當心包內壓超過右心房和右心室舒張壓時，心室充盈受限（diastolic collapse），心輸出量下降。代償性交感神經活化導致心跳加速和全身血管收縮，但隨著壓力持續升高，代償機制衰竭，最終導致心因性休克和死亡。急性積液（如血管瘤破裂出血）比慢性積液更快達到致命壓力。",
    "diagnosis": {
      "primary": [
        "心臟超音波（echocardiography）：確認心包積液及右心房/心室舒張期塌陷",
        "胸腔 X 光：典型球形心影（globoid cardiac silhouette）",
        "心電圖（ECG）：低電壓 QRS 波群、電交替現象（electrical alternans）",
        "心包穿刺術（pericardiocentesis）：診斷兼治療，液體送細胞學及培養"
      ],
      "differential": [
        "擴張型心肌病（DCM）",
        "充血性心衰竭（CHF）",
        "胸腔積液",
        "右心衰竭其他原因",
        "腹膜炎導致的腹水",
        "限制性心包炎（constrictive pericarditis）"
      ],
      "labFindings": [
        "心包液細胞學：血性液體最常見；腫瘤細胞（血管瘤除外，因其脫落細胞率低）",
        "PCV 對比：心包液 PCV 通常低於周邊血液 PCV（非急性出血時）",
        "血液學：可能輕度貧血（慢性失血或血管瘤相關）",
        "生化：通常無特異性變化；肝酶可能因鬱血性肝病變升高",
        "cTnI 可能升高"
      ]
    },
    "treatment": {
      "acute": "緊急心包穿刺術（pericardiocentesis）：超音波引導下從右側第 4-6 肋間進入心包腔抽液，通常抽出 50-500 mL 血性液體後症狀迅速改善；同時靜脈輸液支持血壓",
      "chronic": "反覆發作者考慮心包切除術（pericardiectomy）；若為腫瘤引起，針對原發腫瘤治療；特發性心包積液在 2-3 次穿刺後仍復發者建議手術",
      "medications": [
        "靜脈輸液（等張晶體液）穩定血壓",
        "Atropine（若出現心搏過緩）",
        "止痛藥（Butorphanol 0.2-0.4 mg/kg）",
        "Doxorubicin（血管瘤化療方案：30 mg/m² IV q3w）",
        "利尿劑在填塞時禁忌（會進一步降低前負荷）"
      ],
      "surgery": "心包切除術（subtotal pericardiectomy）：經胸骨正中切開或胸腔鏡輔助；心包窗口術（pericardial window）為姑息選項；心臟基部腫瘤或右心耳腫瘤可考慮腫瘤切除"
    },
    "prognosis": "取決於病因。特發性心包積液預後良好（心包切除術後多數長期緩解）。心臟血管瘤預後差（中位存活時間 1-4 個月，化療可延長至 4-6 個月）。心臟基部腫瘤（chemodectoma）進展較慢，預後較血管瘤好。",
    "pearls": [
      "心包穿刺是診斷兼治療的首要步驟，大多數犬在抽液後數分鐘內血壓和臨床狀況明顯改善",
      "利尿劑在心包填塞中是禁忌的，因為會降低已經不足的前負荷",
      "心包液若為血性但不凝固，通常為慢性積液；若迅速凝固則提示急性出血",
      "Golden Retriever 老年犬出現心包積液，應高度懷疑右心房血管瘤"
    ],
    "diagnosticAlgorithm": {
      "title": "心包填塞 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "緊急評估",
          "details": "識別心包填塞的急性徵象",
          "findings": [
            "Beck三聯症：低血壓、頸靜脈怒張、心音減弱",
            "運動不耐或虛脫",
            "腹部膨大（腹水）",
            "心搏過速"
          ]
        },
        {
          "step": 2,
          "action": "心臟超音波",
          "details": "緊急進行心臟超音波確認心包積液",
          "findings": [
            "心包腔大量積液",
            "心臟擺動（搖擺心）",
            "右心房或右心室舒張期塌陷",
            "評估心包積液量"
          ]
        },
        {
          "step": 3,
          "action": "心包穿刺",
          "details": "進行診斷性和治療性心包穿刺引流",
          "findings": [
            "積液分析（出血性vs滲出性vs漏出性）",
            "PCV比較（積液vs外周血）",
            "細胞學評估",
            "引流後血流動力學改善"
          ]
        },
        {
          "step": 4,
          "action": "病因調查",
          "details": "確定心包積液的基礎原因",
          "findings": [
            "血管肉瘤（右心耳常見）",
            "化學感受器瘤",
            "特發性心包積液",
            "間皮瘤"
          ]
        }
      ]
    },
    "monitoring": [
      "穿刺後 12-24 小時內重複超音波確認是否再積液",
      "監測心率、血壓、黏膜顏色及呼吸型態",
      "定期超音波追蹤（每 2-4 週），尤其腫瘤相關者",
      "血液學追蹤（PCV/TS），監測是否持續失血"
    ],
    "reference": "Manual of Canine and Feline Cardiology, 5th Edition"
  },
  "cor-pulmonale": {
    "zh": "肺心症",
    "en": "Cor Pulmonale",
    "definition": "因肺部疾病或肺血管病變導致肺動脈高壓，進而引起右心室肥大、擴張和功能障礙的病理狀態。在犬貓中常繼發於慢性呼吸道疾病、心絲蟲感染、肺血栓栓塞症或原發性肺動脈高壓。",
    "synonyms": [
      "肺源性心臟病",
      "右心衰竭（繼發於肺病）",
      "Pulmonary heart disease"
    ],
    "epidemiology": {
      "species": "犬貓均可發生，犬較多報告",
      "breed": "與基礎肺部疾病相關；West Highland White Terrier（肺纖維化）；心絲蟲流行區域的各品種犬",
      "age": "中老年動物居多，取決於基礎病因",
      "sex": "無明顯性別好發性",
      "prevalence": "確切發病率不明，但隨著心臟超音波使用普及，診斷率逐漸增加；心絲蟲流行區較常見"
    },
    "clinicalPresentation": {
      "symptoms": [
        "呼吸困難（dyspnea）或呼吸急促（tachypnea）",
        "運動不耐",
        "咳嗽（常為慢性）",
        "暈厥（syncope），尤其運動或興奮時",
        "腹水（ascites）",
        "發紺（cyanosis）",
        "嗜睡與虛弱",
        "體重減輕",
        "食慾下降"
      ],
      "physicalExam": [
        "右心雜音（三尖瓣逆流雜音）或肺動脈瓣區雜音",
        "第二心音分裂或增強（S2 splitting）",
        "頸靜脈怒張或搏動",
        "腹部膨大（腹水、肝腫大）",
        "肺部異常聽診音（爆裂音、哮鳴音，取決於基礎肺病）",
        "黏膜發紺"
      ]
    },
    "pathophysiology": "慢性肺部疾病（如纖維化、慢性支氣管炎）或肺血管病變（如心絲蟲、肺血栓）導致肺血管阻力增加和肺動脈壓升高。右心室必須產生更高的壓力來克服增加的後負荷，導致右心室向心性肥大。隨病程進展，右心室失代償、擴張，三尖瓣環擴大導致三尖瓣逆流，最終發展為右心衰竭伴全身靜脈鬱血（腹水、肝鬱血、外周水腫）。低氧血症可進一步加重肺血管收縮，形成惡性循環。",
    "diagnosis": {
      "primary": [
        "心臟超音波（echocardiography）：右心室肥大/擴張、三尖瓣逆流流速增加（>2.8 m/s 提示肺高壓）、心室中隔扁平化",
        "胸腔 X 光：右心擴大、肺動脈主幹擴張、基礎肺部病變",
        "心電圖（ECG）：右軸偏移、P 波增高（P pulmonale）、右心室肥大型態",
        "動脈血氣分析：低氧血症、可能高碳酸血症"
      ],
      "differential": [
        "原發性三尖瓣退行性病變",
        "擴張型心肌病（DCM）",
        "先天性心臟病（如心房中隔缺損、肺動脈瓣狹窄）",
        "限制性心包炎",
        "心臟腫瘤導致的右心衰竭",
        "全身性高血壓"
      ],
      "labFindings": [
        "動脈血氣：PaO2 降低，PaCO2 可能升高",
        "心絲蟲抗原/抗體檢測（排除心絲蟲病）",
        "NT-proBNP 升高",
        "CBC：紅血球增多症（polycythemia，對慢性低氧的代償反應）",
        "肝功能指標可能因鬱血性肝病變而升高"
      ]
    },
    "treatment": {
      "acute": "氧氣治療穩定低氧血症；利尿劑（Furosemide 1-2 mg/kg IV）緩解鬱血；腹水嚴重時考慮治療性腹腔穿刺；積極治療基礎肺部疾病",
      "chronic": "針對基礎病因治療（心絲蟲驅蟲、支氣管擴張劑等）；肺動脈高壓標靶治療（Sildenafil）；右心衰竭管理（利尿劑、ACE 抑制劑）；限制鈉攝入",
      "medications": [
        "Sildenafil（1-2 mg/kg PO BID-TID，肺動脈高壓標靶治療）",
        "Furosemide（1-4 mg/kg PO BID-TID）",
        "Pimobendan（0.25-0.3 mg/kg PO BID）",
        "Theophylline（10 mg/kg PO BID，支氣管擴張）",
        "Enalapril（0.5 mg/kg PO BID）"
      ],
      "surgery": "一般無手術治療選項；嚴重心絲蟲感染可考慮外科取蟲（caval syndrome）"
    },
    "prognosis": "預後取決於基礎病因及肺動脈高壓的嚴重程度。可逆性肺部病變（如心絲蟲治療成功後）預後較好。不可逆性肺纖維化或嚴重肺動脈高壓者預後差，中位存活時間數月至 1-2 年。一旦出現右心衰竭和腹水，預後明顯惡化。",
    "pearls": [
      "慢性咳嗽的犬若出現腹水，應考慮肺心症而非僅治療呼吸道疾病",
      "三尖瓣逆流流速 >2.8 m/s 是超音波估計肺動脈高壓的重要指標",
      "Sildenafil 是目前獸醫領域最常用的肺動脈高壓標靶治療藥物",
      "心絲蟲流行區的犬出現右心衰竭徵象，必須進行心絲蟲篩檢"
    ],
    "diagnosticAlgorithm": {
      "title": "肺心症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估右心衰竭和肺部疾病症狀",
          "findings": [
            "運動不耐和呼吸困難",
            "腹部膨大（腹水）",
            "頸靜脈怒張",
            "慢性肺部疾病病史"
          ]
        },
        {
          "step": 2,
          "action": "心肺影像學",
          "details": "進行胸部X光和心臟超音波",
          "findings": [
            "右心室和右心房擴大",
            "肺動脈增粗",
            "肺部原發病變",
            "胸部X光排除心絲蟲和肺部腫塊"
          ]
        },
        {
          "step": 3,
          "action": "心臟超音波",
          "details": "評估肺高壓和右心功能",
          "findings": [
            "三尖瓣反流速度升高（>2.8 m/s提示肺高壓）",
            "右心室肥大或擴大",
            "室間隔偏位",
            "肺動脈擴張"
          ]
        },
        {
          "step": 4,
          "action": "病因確認",
          "details": "確定導致肺高壓和右心衰竭的原因",
          "findings": [
            "慢性支氣管肺疾病",
            "肺動脈血栓栓塞",
            "心絲蟲病",
            "肺纖維化"
          ]
        }
      ]
    },
    "monitoring": [
      "每 2-3 個月心臟超音波追蹤右心大小及肺動脈壓估計值",
      "呼吸頻率和努力程度的居家監測",
      "定期血氣分析評估氧合狀態",
      "腎功能和電解質監測（使用利尿劑時）"
    ],
    "reference": "Manual of Canine and Feline Cardiology, 5th Edition"
  },
  "endocardiosis": {
    "zh": "心內膜病/退行性瓣膜病",
    "en": "Endocardiosis (Myxomatous Mitral Valve Disease, MMVD)",
    "definition": "犬最常見的後天性心臟病，以二尖瓣（最常見）和/或三尖瓣的黏液樣退行性變為特徵，導致瓣膜增厚、脫垂和逆流。此病佔犬充血性心衰竭病因的 75% 以上，尤其好發於小型犬種。",
    "synonyms": [
      "黏液瘤樣二尖瓣疾病（MMVD）",
      "退行性二尖瓣病",
      "慢性瓣膜病",
      "心內膜症"
    ],
    "epidemiology": {
      "species": "犬極為常見，貓非常罕見",
      "breed": "小型犬種好發：Cavalier King Charles Spaniel（CKCS，發病最早最嚴重）、Dachshund、Poodle、Chihuahua、Maltese、Yorkshire Terrier",
      "age": "中老年犬；CKCS 可早至 1-2 歲出現心雜音，其他小型犬通常 7-10 歲以上；隨年齡增長盛行率急劇上升",
      "sex": "雄性犬好發率為雌性的 1.5 倍",
      "prevalence": "極高，約 30% 的小型犬種在 10 歲以上有此病，CKCS 中幾乎 100% 終身會發展此病"
    },
    "clinicalPresentation": {
      "symptoms": [
        "咳嗽（尤其夜間或運動後，常為左主支氣管壓迫所致）",
        "運動不耐",
        "呼吸困難或呼吸急促",
        "端坐呼吸（orthopnea）",
        "不安、無法平躺",
        "暈厥（嚴重心律不整時）",
        "食慾下降",
        "體重減輕和肌肉消耗",
        "腹部膨大（右心衰竭時的腹水）",
        "舌頭發紺（嚴重肺水腫時）"
      ],
      "physicalExam": [
        "左心尖部收縮期雜音（systolic murmur），強度 I-VI/VI 級",
        "雜音強度與疾病嚴重程度大致相關",
        "心跳加速（tachycardia）",
        "肺部爆裂音（crackles，肺水腫時）",
        "股動脈搏動可能增強（hyperkinetic pulse）或有脈搏缺損",
        "晚期可能聽到奔馬律（S3 gallop）"
      ]
    },
    "pathophysiology": "瓣膜基質中的膠原纖維退化並被糖胺聚醣（glycosaminoglycans）和蛋白聚醣取代（黏液樣退化），導致瓣膜增厚、拉長和脫垂。腱索也可受累而拉長或斷裂。瓣膜無法完全關閉導致二尖瓣逆流（mitral regurgitation, MR），部分心搏量反流回左心房。左心房和左心室容積超負荷導致擴大重塑。代償機制（Frank-Starling 機制、神經體液活化）最終失代償，發展為充血性心衰竭（肺水腫）。RAAS 活化、交感神經活化和利鈉肽系統在疾病進展中扮演重要角色。",
    "diagnosis": {
      "primary": [
        "心臟超音波（echocardiography）：瓣膜增厚/脫垂、MR 嚴重程度評估（彩色都卜勒）、左心房/左心室大小（LA:Ao ratio、LVIDdN）",
        "胸腔 X 光：左心擴大（VHS 增加）、左主支氣管背移、肺靜脈擴張、肺水腫型態",
        "聽診：典型左心尖部收縮期雜音",
        "心電圖：竇性心律或心房顫動（晚期）、P 波增寬（P mitrale）"
      ],
      "differential": [
        "擴張型心肌病（DCM）",
        "感染性心內膜炎",
        "先天性二尖瓣發育不良",
        "心臟腫瘤",
        "貧血導致的功能性雜音",
        "慢性支氣管炎（咳嗽的鑑別）"
      ],
      "labFindings": [
        "NT-proBNP 升高（與疾病嚴重程度相關）",
        "cTnI 可能輕度升高",
        "血液學和生化通常正常；晚期可見腎前性氮血症",
        "胸腔液分析（若有胸腔積液）：改良型漏出液"
      ]
    },
    "treatment": {
      "acute": "肺水腫急性發作：Furosemide（2-4 mg/kg IV，每 1-2 小時重複直至呼吸改善）；氧氣治療；Pimobendan（0.25 mg/kg PO）；嚴重者可加用 Nitroprusside 或 Dobutamine",
      "chronic": "依 ACVIM 共識分期治療：B1 期（無心臟擴大）- 定期監測；B2 期（心臟擴大未心衰）- Pimobendan + ACE 抑制劑；C 期（心衰竭）- Pimobendan + Furosemide + ACE 抑制劑 + Spironolactone；D 期（難治性心衰）- 增加利尿劑劑量、加用 Sildenafil、Digoxin",
      "medications": [
        "Pimobendan（0.25-0.3 mg/kg PO BID）— B2 期以上的基石治療",
        "Furosemide（1-4 mg/kg PO BID-TID，依需要調整）",
        "Enalapril 或 Benazepril（0.5 mg/kg PO BID）",
        "Spironolactone（1-2 mg/kg PO SID-BID）",
        "Digoxin（0.005-0.008 mg/kg PO BID，心房顫動時）"
      ],
      "surgery": "二尖瓣修復術（mitral valve repair, MVR）：在日本和部分歐美中心已有成功經驗，可達到治癒效果但需要專業的心臟外科團隊和體外循環設備"
    },
    "prognosis": "整體來看，從出現心雜音到心衰竭可經過數年。ACVIM B1 期犬可維持多年無症狀。B2 期平均約 1-2 年進展到 C 期。C 期犬以藥物治療的中位存活時間約 9-12 個月（但個體差異大）。EPIC 研究顯示 Pimobendan 可延長 B2 期犬進展至心衰竭的時間約 15 個月。",
    "pearls": [
      "EPIC 試驗證實 Pimobendan 在 B2 期（心臟擴大但無症狀）開始使用可顯著延長心衰竭前的時間",
      "Cavalier King Charles Spaniel 應從 1 歲開始每年進行心臟篩檢",
      "靜息呼吸頻率（sleeping respiratory rate, SRR）>30 次/分 是居家監測心衰竭惡化的敏感指標",
      "腱索斷裂可導致急性惡化，從穩定期突然進入嚴重肺水腫"
    ],
    "diagnosticAlgorithm": {
      "title": "心內膜病/退行性瓣膜病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估心雜音和心衰竭症狀",
          "findings": [
            "左側收縮期心雜音",
            "咳嗽（尤其夜間或運動後）",
            "運動不耐",
            "中老年小型犬"
          ]
        },
        {
          "step": 2,
          "action": "影像學檢查",
          "details": "進行胸部X光評估心臟大小和肺水腫",
          "findings": [
            "左心房和左心室擴大",
            "肺靜脈擴張",
            "肺水腫（失代償期）",
            "主支氣管被擠壓"
          ]
        },
        {
          "step": 3,
          "action": "心臟超音波",
          "details": "進行心臟超音波評估瓣膜病變和心功能",
          "findings": [
            "二尖瓣增厚和脫垂",
            "二尖瓣反流（彩色都卜勒）",
            "LA/Ao比值 >1.6提示顯著擴大",
            "LVIDdN評估左心室擴大"
          ]
        },
        {
          "step": 4,
          "action": "ACVIM分期",
          "details": "按照ACVIM共識分期指導治療",
          "findings": [
            "A期：高風險品種無疾病",
            "B1期：心雜音但無心臟擴大",
            "B2期：心臟擴大但無症狀",
            "C/D期：有/難治性心衰竭症狀"
          ]
        }
      ]
    },
    "monitoring": [
      "居家靜息呼吸頻率監測（正常 <30 次/分）",
      "每 6-12 個月心臟超音波評估進展（B1/B2 期）；心衰竭後每 3-6 個月",
      "腎功能和電解質監測（使用利尿劑和 ACE 抑制劑時）",
      "體重和食慾追蹤"
    ],
    "reference": "BSAVA Manual of Canine and Feline Cardiorespiratory Medicine, 2nd Edition"
  },
  "chronic-enteropathy": {
    "zh": "慢性腸病",
    "en": "Chronic Enteropathy (CE)",
    "definition": "犬貓持續超過 3 週的慢性胃腸道症狀（嘔吐、腹瀉、體重減輕），在排除感染性、寄生蟲性、內分泌性及腫瘤性等已知原因後的統稱。包含食物反應性腸病（FRE）、抗生素反應性腸病（ARE）和免疫抑制劑反應性腸病（IRE/IBD）三個亞型。",
    "synonyms": [
      "慢性腸炎",
      "炎症性腸病（IBD）",
      "蛋白質流失性腸病（嚴重時）"
    ],
    "epidemiology": {
      "species": "犬貓均常見",
      "breed": "German Shepherd（免疫抑制劑反應性腸病）、Basenji（免疫增生性腸病）、Soft-Coated Wheaten Terrier（蛋白質流失性腸病/腎病）、Yorkshire Terrier（蛋白質流失性腸病）、Shar Pei、French Bulldog",
      "age": "中青年至中老年犬（2-8 歲最常見），但任何年齡均可發病",
      "sex": "無明顯性別好發性",
      "prevalence": "犬貓胃腸道疾病中最常見的慢性病因之一；FRE 佔慢性腸病的 50-60%"
    },
    "clinicalPresentation": {
      "symptoms": [
        "慢性間歇性或持續性嘔吐",
        "慢性小腸型或大腸型腹瀉",
        "體重減輕",
        "食慾下降或亢進",
        "腸鳴音增加（borborygmi）",
        "排氣增多（flatulence）",
        "腹痛或腹部不適",
        "嗜睡與精神沉鬱",
        "被毛粗糙、皮膚狀況不佳",
        "水樣或黏液便",
        "血便（hematochezia）或黑便（melena）"
      ],
      "physicalExam": [
        "體態消瘦（body condition score 偏低）",
        "腸道觸診可能增厚或有團塊感",
        "腹部觸診可能有不適反應",
        "嚴重蛋白質流失者可能出現腹水或皮下水腫",
        "脫水徵象（皮膚帳篷試驗延遲、黏膜乾燥）",
        "肛門周圍可能有糞便汙染"
      ]
    },
    "pathophysiology": "慢性腸病的病理機制涉及腸道免疫系統失調、腸道微生物群落異常（dysbiosis）和腸道屏障功能障礙的交互作用。食物反應性腸病可能與食物抗原引起的免疫反應有關。免疫抑制劑反應性腸病涉及腸道黏膜固有層的淋巴細胞-漿細胞浸潤、嗜酸性球浸潤或肉芽腫性炎症，導致絨毛萎縮、隱窩增生和吸收不良。嚴重者蛋白質從腸壁大量流失（protein-losing enteropathy, PLE），導致低白蛋白血症和其併發症。",
    "diagnosis": {
      "primary": [
        "排除性診斷：先排除寄生蟲、感染、內分泌及腫瘤性病因",
        "食物排除試驗（elimination diet trial）：水解蛋白或新型蛋白飲食 2-4 週",
        "腸道內視鏡活檢（endoscopic biopsy）+組織病理學：確診 IRE/IBD 的金標準",
        "CCECAI 或 CIBDAI 臨床活性指數評分"
      ],
      "differential": [
        "腸道淋巴瘤（lymphoma）— 最重要的鑑別診斷",
        "腸道寄生蟲感染（梨形鞭毛蟲 Giardia 等）",
        "胰臟外分泌功能不全（EPI）",
        "慢性胰臟炎",
        "甲狀腺功能亢進（貓）",
        "腸套疊或部分腸道阻塞"
      ],
      "labFindings": [
        "低白蛋白血症（PLE 時）及低球蛋白血症",
        "低膽固醇血症",
        "葉酸降低（近端小腸吸收不良）和/或 Cobalamin（B12）降低（遠端迴腸吸收不良）",
        "糞便檢查排除寄生蟲",
        "胰臟脂肪酶免疫反應性（fPLI/cPLI）排除胰臟炎"
      ]
    },
    "treatment": {
      "acute": "脫水或電解質失衡時靜脈輸液支持；嚴重低白蛋白（<1.5 g/dL）時膠體液或新鮮冷凍血漿輸注；止吐藥（Maropitant 1 mg/kg IV/SC SID）",
      "chronic": "階梯式治療：第一步食物排除試驗（水解蛋白飲食）→ 第二步抗生素試驗（Metronidazole 或 Tylosin）→ 第三步免疫抑制治療（Prednisolone ± Chlorambucil/Azathioprine）；Cobalamin 補充（若缺乏）",
      "medications": [
        "Prednisolone（1-2 mg/kg PO BID 初始，逐步減量）",
        "Chlorambucil（4-6 mg/m² PO q48h，淋巴細胞性 IBD 或 PLE）",
        "Metronidazole（10-15 mg/kg PO BID）",
        "Budesonide（3 mg/m² PO SID，局部作用腸道類固醇）",
        "Cobalamin 注射（犬 250-1000 μg SC q1-2w）"
      ],
      "surgery": "通常不需手術；全厚度腸道活檢（若內視鏡活檢不足）可經腹腔鏡或剖腹探查取得"
    },
    "prognosis": "食物反應性腸病（FRE）預後最好，大多數犬在飲食調整後完全緩解。抗生素反應性腸病（ARE）預後良好但可能復發。免疫抑制劑反應性腸病（IRE）預後較差，需長期藥物控制。蛋白質流失性腸病（PLE）預後最差，尤其白蛋白 <2.0 g/dL 者。Yorkshire Terrier 的 PLE 預後特別差。",
    "pearls": [
      "慢性腸病中約 50-60% 為食物反應性，因此食物排除試驗應始終是第一步",
      "低 Cobalamin（B12）是預後不良的獨立指標，且需補充才能改善治療反應",
      "內視鏡活檢與腸道淋巴瘤的區分有時非常困難，必要時需免疫組織化學（clonality 分析）",
      "CCECAI 評分 >9 分與預後不良和 PLE 風險增加相關"
    ],
    "diagnosticAlgorithm": {
      "title": "慢性腸病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估慢性腸道症狀（>3週）",
          "findings": [
            "慢性嘔吐和/或腹瀉",
            "體重減輕",
            "食慾變化",
            "腸鳴音增加"
          ]
        },
        {
          "step": 2,
          "action": "基本排除",
          "details": "排除常見非炎症性腸病原因",
          "findings": [
            "糞便寄生蟲檢查",
            "基本血液學和生化",
            "胰臟外分泌功能（TLI）",
            "排除甲狀腺功能亢進（貓）"
          ]
        },
        {
          "step": 3,
          "action": "飲食試驗",
          "details": "進行排除性飲食試驗（最少2-4週）",
          "findings": [
            "水解蛋白或新蛋白飲食反應",
            "食物反應性腸病（最常見類型）",
            "抗生素反應性腸病評估",
            "部分反應提示多因子"
          ]
        },
        {
          "step": 4,
          "action": "內視鏡與活檢",
          "details": "飲食和抗生素無反應者進行腸道活檢",
          "findings": [
            "腸黏膜活檢見炎症浸潤",
            "淋巴球-漿細胞性最常見",
            "嗜酸性球性腸炎",
            "排除腸道淋巴瘤"
          ]
        },
        {
          "step": 5,
          "action": "分類與治療",
          "details": "根據反應分類慢性腸病亞型",
          "findings": [
            "食物反應性腸病（FRE）",
            "抗生素反應性腸病（ARE）",
            "免疫抑制劑反應性腸病（IRE/IBD）",
            "蛋白流失性腸病（PLE）"
          ]
        }
      ]
    },
    "monitoring": [
      "體重和 BCS 每 2-4 週追蹤",
      "白蛋白和 Cobalamin 濃度每 4-8 週監測（PLE 患者）",
      "CCECAI/CIBDAI 臨床評分定期評估治療反應",
      "免疫抑制劑使用時監測 CBC（骨髓抑制風險）"
    ],
    "reference": "Blackwell's Five-Minute Veterinary Consult, 6th Edition"
  },
  "bilious-vomiting-syndrome": {
    "zh": "膽汁性嘔吐症候群",
    "en": "Bilious Vomiting Syndrome",
    "definition": "犬（偶見於貓）在空腹時間過長後出現的間歇性膽汁性嘔吐，通常發生在清晨或深夜。嘔吐物為黃色至綠色膽汁液，嘔吐後動物通常表現正常且食慾良好。被認為與十二指腸胃逆流和胃酸刺激空腹胃黏膜有關。",
    "synonyms": [
      "反流性胃炎",
      "空腹嘔吐",
      "膽汁反流性嘔吐"
    ],
    "epidemiology": {
      "species": "犬最常見，貓偶見",
      "breed": "無明顯品種好發性，各品種均可發生",
      "age": "任何年齡，中青年犬較常報告",
      "sex": "無性別好發性",
      "prevalence": "犬常見的嘔吐原因之一，確切盛行率不明，但臨床實踐中非常常見"
    },
    "clinicalPresentation": {
      "symptoms": [
        "清晨或夜間空腹時嘔吐黃色/綠色膽汁",
        "嘔吐物通常不含食物",
        "嘔吐後食慾和精神正常",
        "間歇性發作（非每天）",
        "偶有輕微噁心感（舔嘴唇、流涎）",
        "嘔吐前可能有腹部不適",
        "餵食後症狀消失",
        "整體健康狀況良好"
      ],
      "physicalExam": [
        "體格檢查通常完全正常",
        "體態和體重正常",
        "腹部觸診無異常",
        "脫水徵象缺乏",
        "口腔可能有膽汁染色（剛嘔吐後）"
      ]
    },
    "pathophysiology": "長時間空腹期間，十二指腸內容物（含膽汁和胰液）通過幽門反流至胃部。膽汁酸和胰液中的消化酶刺激胃黏膜，引起噁心和嘔吐反射。胃排空延遲和胃腸蠕動異常可能是促進因素。migrating motor complex (MMC) 的週期性活動在空腹狀態下將十二指腸內容物推向近端，也被認為參與此病理機制。",
    "diagnosis": {
      "primary": [
        "臨床病史特徵（空腹時膽汁性嘔吐、嘔吐後正常）",
        "排除性診斷：排除其他慢性嘔吐的原因",
        "治療性診斷：調整餵食時間後症狀改善確認診斷",
        "腹部超音波和 X 光排除結構性病變"
      ],
      "differential": [
        "慢性胃炎",
        "幽門功能障礙或狹窄",
        "慢性胰臟炎",
        "慢性腸病/IBD",
        "腸道異物（部分阻塞）",
        "Addison 氏病（腎上腺皮質功能低下）"
      ],
      "labFindings": [
        "CBC 和血清生化通常正常",
        "電解質正常（與 Addison 氏病鑑別）",
        "cPLI/fPLI 正常（排除胰臟炎）",
        "糞便檢查正常"
      ]
    },
    "treatment": {
      "acute": "通常不需急性治療；嚴重噁心時可給予 Maropitant（2 mg/kg PO SID）短期使用",
      "chronic": "核心治療為調整餵食策略：在夜間或清晨（嘔吐常發時間前）提供少量食物；增加餵食次數至每日 3-4 餐；睡前提供小零食。藥物治療用於飲食調整效果不佳者",
      "medications": [
        "Omeprazole（1 mg/kg PO SID-BID，減少胃酸分泌）",
        "Famotidine（0.5-1 mg/kg PO BID）",
        "Metoclopramide（0.2-0.4 mg/kg PO TID，促進胃排空）",
        "Maropitant（2 mg/kg PO SID，短期止吐）"
      ],
      "surgery": "不需要手術治療"
    },
    "prognosis": "預後極佳。大多數犬在調整餵食時間表（尤其是睡前加餐）後症狀完全緩解。部分犬需要長期維持少量多餐的餵食策略。藥物治療通常只需短期使用。",
    "pearls": [
      "睡前提供少量零食是最簡單有效的治療方法，常可完全解決問題",
      "本病是排除性診斷——必須先排除其他慢性嘔吐原因",
      "若調整餵食後仍持續嘔吐，應進一步檢查是否有潛在疾病",
      "與飼主溝通時強調這不是嚴重疾病，通常飲食管理即可控制"
    ],
    "diagnosticAlgorithm": {
      "title": "膽汁性嘔吐症候群 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估特徵性嘔吐模式",
          "findings": [
            "清晨空腹時嘔吐膽汁",
            "嘔吐物為黃色至綠色液體",
            "進食後通常正常",
            "全身狀態良好"
          ]
        },
        {
          "step": 2,
          "action": "排除性檢查",
          "details": "排除其他嘔吐原因",
          "findings": [
            "血液學和生化通常正常",
            "排除胰臟炎",
            "排除肝膽疾病",
            "腹部超音波排除結構異常"
          ]
        },
        {
          "step": 3,
          "action": "治療性確診",
          "details": "透過飲食管理的反應確認診斷",
          "findings": [
            "睡前加餐後嘔吐改善",
            "增加餵食頻率有效",
            "制酸劑可能有輔助效果",
            "排除性診斷"
          ]
        }
      ]
    },
    "monitoring": [
      "追蹤嘔吐頻率和嘔吐物性質",
      "確認體重維持穩定",
      "餵食策略調整後 1-2 週評估療效",
      "若使用質子泵抑制劑（PPI），長期使用需注意潛在副作用"
    ],
    "reference": "Clinical Veterinary Advisor: Dogs and Cats, 4th Edition"
  },
  "colorectal-neoplasia": {
    "zh": "結直腸腫瘤",
    "en": "Colorectal Neoplasia",
    "definition": "發生於結腸和直腸的原發性腫瘤，犬中最常見的類型為腺瘤性息肉（adenomatous polyp）和腺癌（adenocarcinoma），貓則以淋巴瘤為主。直腸息肉在犬中相對常見且多為良性，但有惡性轉化的可能；腺癌則具侵襲性且預後較差。",
    "synonyms": [
      "大腸腫瘤",
      "結腸癌",
      "直腸息肉",
      "直腸腺癌"
    ],
    "epidemiology": {
      "species": "犬貓均可發生",
      "breed": "犬：中大型犬稍多見，German Shepherd、Collie 有報告好發；貓：無明顯品種好發性",
      "age": "老年動物為主（犬 8-12 歲，貓 10 歲以上）；直腸息肉可見於中年犬",
      "sex": "雄性犬直腸腺癌稍有好發傾向",
      "prevalence": "佔犬所有消化道腫瘤的 36-60%；犬腸道腫瘤中結直腸腫瘤最為常見"
    },
    "clinicalPresentation": {
      "symptoms": [
        "血便（hematochezia）— 最常見的症狀",
        "排便困難（dyschezia）或裡急後重（tenesmus）",
        "排便頻率增加",
        "糞便形狀改變（變細）",
        "黏液便",
        "直腸脫垂（rectalprolapse）",
        "體重減輕",
        "食慾下降",
        "嘔吐（結腸阻塞時）"
      ],
      "physicalExam": [
        "直腸觸診可觸及腫塊（直腸腫瘤）",
        "腹部觸診可能觸及結腸團塊",
        "肛門周圍可能有血液汙染",
        "體態消瘦（晚期）",
        "腹部疼痛或不適感",
        "觸診腹腔淋巴結可能腫大"
      ]
    },
    "pathophysiology": "結直腸腫瘤的發生涉及腸上皮細胞的基因突變和異常增殖。犬直腸息肉（adenomatous polyps）遵循類似人類的腺瘤-癌序列（adenoma-carcinoma sequence），可由良性息肉進展為惡性腺癌。腺癌具有局部侵襲性，可穿透腸壁並轉移至區域淋巴結和遠處器官（肝、肺）。貓的結直腸淋巴瘤為黏膜相關淋巴組織來源的惡性增殖。腫瘤導致腸壁增厚、管腔狹窄、潰瘍形成和出血。",
    "diagnosis": {
      "primary": [
        "直腸觸診 +/- 直腸鏡（proctoscopy）",
        "結腸鏡檢查（colonoscopy）合併組織活檢",
        "腹部超音波：評估腸壁增厚、淋巴結腫大、遠處轉移",
        "組織病理學確定腫瘤類型和分級"
      ],
      "differential": [
        "慢性結腸炎/IBD",
        "結腸息肉（良性 vs 惡性）",
        "腸套疊",
        "肛門腺腫瘤",
        "會陰疝",
        "直腸狹窄"
      ],
      "labFindings": [
        "CBC：慢性失血導致的缺鐵性貧血",
        "生化：低白蛋白（蛋白質流失時）",
        "糞便潛血試驗陽性",
        "腫瘤分期：胸腔 X 光和腹部超音波評估轉移"
      ]
    },
    "treatment": {
      "acute": "出血控制和支持療法；嚴重貧血時輸血",
      "chronic": "手術切除為主要治療。直腸息肉可經肛門拉出切除（transanal pull-through）或結腸鏡下息肉切除。腺癌需要完整手術切除（結腸切除吻合術）。化療和 NSAIDs 可作為輔助治療",
      "medications": [
        "Piroxicam（0.3 mg/kg PO SID，COX 抑制劑，抗腫瘤作用）",
        "Carboplatin（300 mg/m² IV q3w，腺癌化療）",
        "Doxorubicin（30 mg/m² IV q3w）",
        "Tramadol（2-5 mg/kg PO BID-TID，疼痛管理）"
      ],
      "surgery": "直腸息肉：經肛門切除術（transanal excision）或內視鏡息肉切除術；結腸腺癌：結腸切除及吻合術（colectomy and anastomosis）；直腸腺癌：直腸拉出切除術（rectal pull-through resection）；姑息性結腸造口術（colostomy）"
    },
    "prognosis": "直腸腺瘤性息肉手術切除後預後良好，但可能復發。犬結腸腺癌完整切除後中位存活時間約 22-32 個月；不完整切除者約 1.5-6 個月。犬直腸腺癌預後較差（中位存活時間 6-12 個月）。貓結直腸淋巴瘤對化療反應變異大，低度惡性者預後較好。轉移率約 15-30%。",
    "pearls": [
      "老年犬反覆血便伴排便困難，必須進行直腸觸診——這是診斷直腸腫瘤最簡單且最重要的步驟",
      "犬直腸息肉有惡性轉化的可能，建議積極手術切除",
      "Piroxicam 等 NSAIDs 在結直腸腫瘤中可能具有直接的抗腫瘤效果",
      "結腸鏡活檢對於區分炎症性病變和腫瘤至關重要"
    ],
    "diagnosticAlgorithm": {
      "title": "結直腸腫瘤 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估大腸症狀和直腸腫塊",
          "findings": [
            "便血和裡急後重",
            "排便困難",
            "黏液便",
            "直腸觸診可能觸及腫塊"
          ]
        },
        {
          "step": 2,
          "action": "直腸檢查與影像學",
          "details": "進行直腸觸診和腹部超音波",
          "findings": [
            "直腸觸診腫塊位置和大小",
            "腹部超音波評估結腸壁增厚",
            "區域淋巴結評估",
            "排除腹腔轉移"
          ]
        },
        {
          "step": 3,
          "action": "結腸鏡與活檢",
          "details": "進行結腸鏡檢查和活檢確認腫瘤類型",
          "findings": [
            "息肉狀或潰瘍性腫塊",
            "犬：腺癌或腺瘤性息肉最常見",
            "貓：淋巴瘤最常見",
            "活檢確認組織學類型"
          ]
        },
        {
          "step": 4,
          "action": "分期",
          "details": "進行全身分期評估",
          "findings": [
            "胸部X光排除肺轉移",
            "腹部影像評估淋巴結",
            "CT分期（進階）",
            "評估手術切除可行性"
          ]
        }
      ]
    },
    "monitoring": [
      "手術後每 2-3 個月直腸觸診和/或結腸鏡追蹤（評估復發）",
      "腹部超音波每 3 個月追蹤區域淋巴結和遠處轉移",
      "CBC 追蹤貧血改善情況",
      "使用 NSAIDs 時監測腎功能和 GI 副作用"
    ],
    "reference": "Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition; Geriatrics & Gerontology of the Dog and Cat, 3rd Edition"
  },
  "intestinal-lymphangiectasia": {
    "zh": "腸淋巴管擴張症",
    "en": "Intestinal Lymphangiectasia",
    "definition": "以小腸黏膜及黏膜下層淋巴管異常擴張為特徵的疾病，導致富含蛋白質的淋巴液滲漏至腸腔，引起蛋白質流失性腸病（PLE）。可為原發性（先天性淋巴管發育異常）或繼發性（淋巴引流受阻，如淋巴瘤、慢性炎症、右心衰竭）。",
    "synonyms": [
      "腸淋巴管擴張",
      "淋巴管擴張性腸病",
      "蛋白質流失性腸病（PLE 的一個病因）"
    ],
    "epidemiology": {
      "species": "犬較常見，貓少見",
      "breed": "Yorkshire Terrier（最常見且預後最差）、Soft-Coated Wheaten Terrier、Rottweiler、Norwegian Lundehund、Maltese、Shar Pei",
      "age": "中年犬最常見（4-8 歲），但先天性型可在幼犬出現",
      "sex": "無明顯性別好發性",
      "prevalence": "為犬蛋白質流失性腸病最常見的病因之一"
    },
    "clinicalPresentation": {
      "symptoms": [
        "慢性小腸型腹瀉（水樣或脂肪便）",
        "體重減輕",
        "嘔吐",
        "腹水（低白蛋白血症導致）",
        "皮下水腫（四肢、腹壁）",
        "食慾下降或異常亢進",
        "嗜睡",
        "呼吸困難（胸腔積液時）",
        "肌肉消耗"
      ],
      "physicalExam": [
        "體態消瘦（低 BCS）",
        "腹部波動感（腹水）",
        "皮下凹陷性水腫",
        "腸道觸診可能增厚",
        "脫水徵象",
        "被毛粗糙無光澤"
      ]
    },
    "pathophysiology": "正常情況下，腸道淋巴管負責吸收膳食脂肪（乳糜微粒）和回收間質蛋白質。當淋巴管異常擴張或阻塞時，富含蛋白質和脂肪的淋巴液滲漏至腸腔，導致白蛋白和球蛋白從腸道大量流失。低白蛋白血症引起膠體滲透壓下降，液體從血管內移至第三間隙（腹水、胸腔積液、皮下水腫）。同時淋巴細胞也隨淋巴液流失，造成淋巴球減少症。脂溶性維生素吸收障礙和脂肪吸收不良進一步加重營養不良。",
    "diagnosis": {
      "primary": [
        "小腸內視鏡活檢（endoscopic biopsy）：可見黏膜白色顆粒狀突起（擴張的淋巴管）",
        "組織病理學：黏膜和黏膜下層淋巴管明顯擴張，內含蛋白質性物質",
        "腹部超音波：腸壁增厚、高回音黏膜條紋（mucosal striations）、腹水",
        "排除繼發性原因（淋巴瘤、右心衰竭等）"
      ],
      "differential": [
        "腸道淋巴瘤",
        "慢性腸病/IBD",
        "蛋白質流失性腎病",
        "肝衰竭（低白蛋白）",
        "右心衰竭",
        "腸道寄生蟲感染"
      ],
      "labFindings": [
        "低白蛋白血症和低球蛋白血症（pan-hypoproteinemia）— 高度特異性",
        "低膽固醇血症",
        "淋巴球減少症（lymphopenia）",
        "低鈣血症（結合鈣降低，因白蛋白結合減少）",
        "糞便 alpha-1 蛋白酶抑制劑（α1-PI）升高確認蛋白質流失"
      ]
    },
    "treatment": {
      "acute": "嚴重低白蛋白（<1.5 g/dL）伴臨床症狀時：膠體液輸注（Hetastarch 或新鮮冷凍血漿）；大量腹水時治療性腹腔穿刺；靜脈輸液支持",
      "chronic": "超低脂飲食（<15% ME from fat）為治療基石；中鏈三酸甘油酯（MCT）補充（MCT 不經淋巴系統吸收）；免疫抑制治療（若合併炎症性腸病）；抗血栓預防（低白蛋白患者高凝風險）",
      "medications": [
        "Prednisolone（1-2 mg/kg PO BID，逐漸減量）",
        "Chlorambucil（4-6 mg/m² PO q48h，嚴重 PLE）",
        "Clopidogrel（1-2 mg/kg PO SID，抗血栓預防）",
        "Cobalamin（250-1000 μg SC q1-2w）",
        "Spironolactone（1-2 mg/kg PO BID，腹水管理）"
      ],
      "surgery": "通常不需手術；若為局灶性淋巴管阻塞，腸道切除可能有益；嚴重腹水時重複腹腔穿刺"
    },
    "prognosis": "預後差異大。輕度病例以飲食控制可維持良好生活品質數年。Yorkshire Terrier 的預後最差（中位存活時間數月）。白蛋白 <1.5 g/dL、嚴重腹水、合併凝血異常者預後不良。血栓栓塞是重要的致死併發症。Soft-Coated Wheaten Terrier 可同時發展 PLE 和蛋白質流失性腎病。",
    "pearls": [
      "Pan-hypoproteinemia（白蛋白和球蛋白同時降低）高度提示蛋白質流失性腸病，因肝病和腎病通常不會導致球蛋白同時顯著降低",
      "超低脂飲食是治療的基石——即使需要免疫抑制劑，飲食管理仍不可省略",
      "低白蛋白患者有血栓栓塞的高風險，建議預防性抗血栓治療",
      "腹部超音波見到腸壁高回音條紋是提示淋巴管擴張的特徵性影像"
    ],
    "diagnosticAlgorithm": {
      "title": "腸淋巴管擴張症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估蛋白流失性腸病的臨床徵象",
          "findings": [
            "慢性腹瀉",
            "體重減輕",
            "腹水和外周水腫",
            "Yorkshire Terrier等品種好發"
          ]
        },
        {
          "step": 2,
          "action": "實驗室檢查",
          "details": "進行血液學和生化評估蛋白流失",
          "findings": [
            "低白蛋白血症",
            "低球蛋白血症",
            "低膽固醇血症",
            "淋巴球減少（淋巴液流失）"
          ]
        },
        {
          "step": 3,
          "action": "影像學檢查",
          "details": "進行腹部超音波評估腸道和淋巴系統",
          "findings": [
            "腸黏膜高回音性條紋",
            "腸壁增厚",
            "腹水",
            "腸系膜淋巴結腫大"
          ]
        },
        {
          "step": 4,
          "action": "內視鏡活檢確診",
          "details": "進行腸道活檢確認淋巴管擴張",
          "findings": [
            "絨毛腫脹和乳白色外觀",
            "組織學見擴張的淋巴管",
            "乳糜池擴張",
            "可能合併炎症性浸潤"
          ]
        }
      ]
    },
    "monitoring": [
      "白蛋白每 2-4 週監測直至穩定",
      "體重和 BCS 每 2 週追蹤",
      "腹部超音波每 1-3 個月評估腹水和腸壁變化",
      "CBC 監測（使用 Chlorambucil 時注意骨髓抑制）"
    ],
    "reference": "Clinical Veterinary Advisor: Dogs and Cats, 4th Edition"
  },
  "clostridial-enteritis": {
    "zh": "梭菌性腸炎",
    "en": "Clostridial Enteritis",
    "definition": "由產氣莢膜梭菌（Clostridium perfringens）或困難梭菌（Clostridioides difficile）等產毒素梭菌引起的腸道感染性疾病。這些細菌產生的腸毒素（enterotoxin）損傷腸黏膜，導致急性或慢性腹瀉。在犬貓中，C. perfringens 是最常見的致病種。",
    "synonyms": [
      "梭狀芽孢桿菌腸炎",
      "產氣莢膜梭菌腸炎",
      "Clostridium perfringens 感染"
    ],
    "epidemiology": {
      "species": "犬貓均可感染，犬較多報告",
      "breed": "無明顯品種好發性",
      "age": "任何年齡，幼犬和老年犬較易感；收容所和密飼環境中多見",
      "sex": "無性別好發性",
      "prevalence": "C. perfringens 為犬正常腸道菌群成員，但產毒素菌株可導致臨床疾病；急性腹瀉犬中約 15-30% 可檢出毒素"
    },
    "clinicalPresentation": {
      "symptoms": [
        "急性水樣腹瀉",
        "大腸型腹瀉（黏液便、裡急後重）",
        "血便（hematochezia）",
        "排便頻率增加",
        "腹部痙攣和不適",
        "排氣增多",
        "輕度嘔吐",
        "食慾下降",
        "發熱（嚴重感染時）",
        "嗜睡"
      ],
      "physicalExam": [
        "腹部觸診可能有疼痛反應或腸道脹氣",
        "直腸溫度可能升高",
        "脫水徵象（輕至中度）",
        "腸音增加",
        "直腸觸診可能有黏液或血液"
      ]
    },
    "pathophysiology": "C. perfringens 產生多種毒素，其中腸毒素（CPE, enterotoxin）是導致臨床腹瀉的主要因子。CPE 在芽孢形成過程中釋放，與腸上皮細胞的 claudin 受體結合，形成孔洞複合體，導致細胞滲透壓失衡、鈣離子流入和細胞死亡。這導致腸壁通透性增加、水分和電解質大量分泌至腸腔。NetF 毒素（新近發現）可導致更嚴重的壞死性腸炎。壓力、飲食改變、抗生素使用和免疫抑制是促進致病菌株過度增殖和產毒的重要觸發因素。",
    "diagnosis": {
      "primary": [
        "糞便 C. perfringens 腸毒素（CPE）ELISA 檢測",
        "糞便 PCR 檢測毒素基因（cpe, netF, cpb2）",
        "糞便內孢子計數（>10⁴ spores/g 有意義）",
        "排除其他腸道感染和寄生蟲"
      ],
      "differential": [
        "犬細小病毒腸炎",
        "急性出血性腹瀉症候群（AHDS）",
        "飲食不耐受",
        "寄生蟲感染（鉤蟲、鞭蟲）",
        "其他細菌性腸炎（沙門氏菌、彎曲桿菌）",
        "慢性腸病/IBD"
      ],
      "labFindings": [
        "CBC：嗜中性球增多或左移（嚴重感染時）",
        "生化：通常無特異性變化；嚴重腹瀉可能電解質失衡",
        "糞便鏡檢：大量內孢子",
        "糞便培養：C. perfringens 可分離但需配合毒素檢測才有意義（正常犬也可攜帶）"
      ]
    },
    "treatment": {
      "acute": "輕症可自限性；支持性治療包括靜脈或皮下輸液、電解質矯正；嚴重者給予抗生素治療",
      "chronic": "反覆發作者考慮飲食調整（高纖維飲食）、益生菌補充、長期低劑量 Tylosin；排除潛在的免疫抑制或腸道基礎病變",
      "medications": [
        "Metronidazole（10-15 mg/kg PO BID，7-10 天）",
        "Tylosin（10-20 mg/kg PO BID-TID）",
        "Amoxicillin-Clavulanate（12.5-25 mg/kg PO BID）",
        "益生菌（Saccharomyces boulardii 或多菌株製劑）",
        "Maropitant（2 mg/kg PO SID，止吐）"
      ],
      "surgery": "通常不需手術治療；極罕見的壞死性腸炎（necrotizing enteritis）可能需要腸道切除"
    },
    "prognosis": "大多數犬的急性梭菌性腸炎為自限性或對治療反應良好，預後佳。慢性反覆發作者需要長期管理，但通常可以控制。產 NetF 毒素的菌株引起的壞死性腸炎預後較差，死亡率較高。",
    "pearls": [
      "C. perfringens 是正常腸道菌群成員，單純培養出此菌不等於診斷——必須檢測毒素才有臨床意義",
      "壓力事件（住院、手術、飲食驟變）是常見的觸發因素",
      "Tylosin 反應性腹瀉（TRD）中部分病例可能與梭菌過度增殖有關",
      "糞便中大量內孢子（endospores）的存在支持活躍的毒素產生"
    ],
    "diagnosticAlgorithm": {
      "title": "梭菌性腸炎 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估急性腹瀉症狀和風險因子",
          "findings": [
            "急性水樣或血性腹瀉",
            "腹痛和脹氣",
            "近期飲食變化或抗生素使用",
            "犬舍或住院環境"
          ]
        },
        {
          "step": 2,
          "action": "糞便檢測",
          "details": "進行糞便毒素和培養檢測",
          "findings": [
            "C. perfringens腸毒素ELISA檢測",
            "C. difficile毒素A/B檢測",
            "糞便厭氧菌培養",
            "排除其他腸道病原"
          ]
        },
        {
          "step": 3,
          "action": "支持性診斷",
          "details": "進行實驗室檢查評估全身狀態",
          "findings": [
            "白血球計數變化",
            "電解質和酸鹼評估",
            "低白蛋白血症（嚴重病例）",
            "脫水程度評估"
          ]
        }
      ]
    },
    "monitoring": [
      "症狀改善後追蹤糞便性狀 2-4 週",
      "反覆發作者可重複毒素檢測確認清除",
      "使用 Metronidazole 超過 2 週需注意神經毒性",
      "飲食轉換後監測耐受性和糞便品質"
    ],
    "reference": "Greene's Infectious Diseases of the Dog and Cat, 5th Edition"
  },
  "gastrointestinal-stromal-tumor": {
    "zh": "胃腸道基質瘤",
    "en": "Gastrointestinal Stromal Tumor (GIST)",
    "definition": "起源於胃腸道壁 Cajal 間質細胞（interstitial cells of Cajal, ICC）或其前驅細胞的間葉性腫瘤。GIST 是犬胃腸道間葉性腫瘤中最常見的類型，以 KIT（CD117）蛋白異常表達為特徵，可發生於胃腸道的任何部位，但以大腸和盲腸最為常見。",
    "synonyms": [
      "GIST",
      "胃腸基質腫瘤",
      "Cajal 細胞瘤"
    ],
    "epidemiology": {
      "species": "犬較常見，貓罕見",
      "breed": "大型犬品種好發：German Shepherd、Golden Retriever、Labrador Retriever",
      "age": "老年犬（中位年齡 10-12 歲）",
      "sex": "雄性犬稍有好發傾向",
      "prevalence": "佔犬胃腸道間葉性腫瘤的約 50-70%；整體發病率不高但並非罕見"
    },
    "clinicalPresentation": {
      "symptoms": [
        "嘔吐（間歇性或持續性）",
        "體重減輕",
        "食慾下降",
        "腹部腫塊可觸及",
        "黑便（melena）或血便",
        "腹痛",
        "嗜睡",
        "貧血相關症狀（蒼白、虛弱）",
        "腸道穿孔時急性腹膜炎（罕見）"
      ],
      "physicalExam": [
        "腹部觸診可能觸及中腹部腫塊",
        "黏膜蒼白（慢性失血性貧血）",
        "體態消瘦",
        "腹部壓痛",
        "直腸觸診：直腸/結腸 GIST 可觸及",
        "脫水徵象（嘔吐頻繁時）"
      ]
    },
    "pathophysiology": "GIST 起源於 Cajal 間質細胞或其共同前驅細胞。這些細胞正常功能為胃腸道的起搏器細胞，調控腸道蠕動。KIT（c-kit）原癌基因的功能獲得性突變（gain-of-function mutation）導致 KIT 受體酪胺酸激酶持續活化，促進細胞不受控制地增殖。犬 GIST 多為梭形細胞形態，可表現為壁內（intramural）或腔外（exophytic）生長。腫瘤可導致腸壁潰瘍出血、管腔阻塞或穿孔。轉移率依位置和大小而異，肝臟和腹膜是最常見的轉移部位。",
    "diagnosis": {
      "primary": [
        "腹部超音波：腸壁起源的低至混合回音團塊",
        "組織活檢及組織病理學：梭形細胞或上皮樣細胞排列",
        "免疫組織化學：KIT (CD117) 陽性是確診的關鍵",
        "CT 掃描：評估腫瘤範圍和轉移"
      ],
      "differential": [
        "腸道平滑肌瘤/平滑肌肉瘤（leiomyoma/leiomyosarcoma）",
        "腸道淋巴瘤",
        "腸道腺癌",
        "腸道神經鞘瘤",
        "腹腔內其他腫瘤",
        "肉芽腫性病變"
      ],
      "labFindings": [
        "CBC：再生性或非再生性貧血（慢性失血）",
        "生化：低白蛋白（蛋白質流失時）",
        "免疫組化：CD117 (KIT) 陽性、CD34 可能陽性、desmin 和 SMA 陰性",
        "c-kit 基因突變分析（用於預測酪胺酸激酶抑制劑療效）"
      ]
    },
    "treatment": {
      "acute": "腫瘤出血或穿孔時緊急手術；貧血嚴重時輸血穩定",
      "chronic": "手術完整切除為首選治療。不可切除或轉移性 GIST 可使用酪胺酸激酶抑制劑（TKI）標靶治療",
      "medications": [
        "Toceranib phosphate（Palladia, 2.75 mg/kg PO EOD，KIT 標靶治療）",
        "Imatinib mesylate（Gleevec, 10 mg/kg PO SID，人用藥 off-label）",
        "Masitinib（12.5 mg/kg PO SID，歐洲核准）",
        "Omeprazole（1 mg/kg PO BID，胃 GIST 時保護胃黏膜）"
      ],
      "surgery": "腸道節段切除及端端吻合術為標準治療；需確保足夠的手術邊緣（>2 cm）；術中仔細評估肝臟和腹膜是否有轉移灶"
    },
    "prognosis": "完整手術切除且有絲分裂指數低的 GIST 預後良好（中位存活時間 >2 年）。不完整切除或高有絲分裂指數者預後較差。TKI 標靶治療可為不可切除的 GIST 提供疾病控制。腫瘤大小 >5 cm 和高有絲分裂指數（>5/10 HPF）與預後不良相關。大腸和盲腸 GIST 的整體預後優於小腸和胃 GIST。",
    "pearls": [
      "犬胃腸道間葉性腫瘤中 GIST 最常見，免疫組化（KIT/CD117）是與平滑肌瘤區分的關鍵",
      "Toceranib（Palladia）是目前獸醫領域唯一核准的 KIT 標靶口服藥物",
      "GIST 的生物學行為從良性到高度惡性不等，有絲分裂指數是最重要的預後指標之一",
      "大腸和盲腸是犬 GIST 最好發的部位，與人類（胃為主）不同"
    ],
    "diagnosticAlgorithm": {
      "title": "胃腸道基質瘤 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估腸道腫塊相關症狀",
          "findings": [
            "慢性嘔吐或腹瀉",
            "腹部可觸及腫塊",
            "體重減輕",
            "偶見消化道出血"
          ]
        },
        {
          "step": 2,
          "action": "影像學檢查",
          "details": "進行腹部超音波評估腫塊特徵",
          "findings": [
            "腸壁或胃壁腫塊",
            "腫塊向漿膜面突出為主",
            "腫塊內部可能壞死",
            "區域淋巴結評估"
          ]
        },
        {
          "step": 3,
          "action": "細胞學與活檢",
          "details": "進行細針抽吸或手術活檢",
          "findings": [
            "梭形細胞腫瘤",
            "需與平滑肌瘤/肉瘤鑑別",
            "免疫組織化學c-Kit（CD117）陽性",
            "DOG1標記陽性"
          ]
        },
        {
          "step": 4,
          "action": "分期與手術規劃",
          "details": "進行全身分期評估手術方案",
          "findings": [
            "肝臟和腹膜轉移評估",
            "胸部X光",
            "手術切除為首選治療",
            "有絲分裂指數評估預後"
          ]
        }
      ]
    },
    "monitoring": [
      "術後每 2-3 個月腹部超音波追蹤局部復發和遠處轉移",
      "使用 TKI 時每 2-4 週 CBC 和生化監測（骨髓抑制、肝腎毒性）",
      "體重和食慾追蹤",
      "TKI 治療期間注意 GI 副作用（腹瀉、嘔吐、食慾下降）"
    ],
    "reference": "Clinical Veterinary Advisor: Dogs and Cats, 4th Edition"
  },
  "cecal-inversion": {
    "zh": "盲腸內翻",
    "en": "Cecal Inversion (Cecocolic Intussusception)",
    "definition": "盲腸向結腸內翻套的病理狀態，即盲腸從其正常位置翻轉並套入升結腸腔內。此病在犬中相對罕見，可引起部分或完全腸道阻塞及相關的腸缺血和壞死。可能與盲腸蠕動異常、腸道寄生蟲、飲食改變或先前的腸道疾病有關。",
    "synonyms": [
      "盲腸內套疊",
      "盲腸結腸套疊",
      "Cecocolic intussusception"
    ],
    "epidemiology": {
      "species": "犬為主，貓極罕見",
      "breed": "大型犬品種多見，German Shepherd 有報告好發",
      "age": "年輕至中年犬（1-5 歲較常見）",
      "sex": "無明顯性別好發性",
      "prevalence": "罕見；佔所有犬腸道套疊病例的少數比例"
    },
    "clinicalPresentation": {
      "symptoms": [
        "慢性間歇性腹瀉（大腸型）",
        "血便（hematochezia）或黏液便",
        "裡急後重（tenesmus）",
        "排便困難",
        "間歇性嘔吐",
        "食慾減退",
        "腹部不適或疼痛",
        "體重減輕（慢性病例）"
      ],
      "physicalExam": [
        "腹部觸診右側腹可能觸及管狀團塊",
        "直腸觸診可能感到套疊的盲腸尖端（若延伸至遠端結腸）",
        "腹部壓痛",
        "脫水徵象（嘔吐和腹瀉嚴重時）",
        "直腸觸診可能有血液或黏液"
      ]
    },
    "pathophysiology": "盲腸的正常蠕動波異常增強或不協調，導致盲腸尖端從盲腸結腸連接處翻轉套入結腸腔內。套入的盲腸壁隨著蠕動進一步推進，腸繫膜血管被牽拉和壓迫，導致靜脈回流受阻、腸壁水腫和缺血。若未及時處理，可進展為黏膜壞死、穿孔和腹膜炎。慢性部分套疊可導致間歇性大腸型症狀。",
    "diagnosis": {
      "primary": [
        "腹部超音波：右側腹部可見同心圓或靶環徵（target sign），代表套疊的腸壁層",
        "腹部 X 光：右側腹部軟組織團塊、結腸內氣體分布異常",
        "結腸鏡檢查：可直視套入結腸腔內的盲腸組織",
        "剖腹探查：確診和治療"
      ],
      "differential": [
        "結腸套疊（ileocolic intussusception）",
        "結直腸腫瘤",
        "結腸炎",
        "大腸型慢性腸病/IBD",
        "結腸息肉",
        "結腸異物"
      ],
      "labFindings": [
        "CBC：可能有嗜中性球增多（感染或壞死時）",
        "生化：通常無特異性變化",
        "糞便檢查：排除寄生蟲作為誘因",
        "電解質可能因嘔吐和腹瀉而失衡"
      ]
    },
    "treatment": {
      "acute": "穩定全身狀況（靜脈輸液、電解質矯正）；手術為唯一確定性治療",
      "chronic": "慢性病例仍需手術處理",
      "medications": [
        "靜脈輸液（等張晶體液）穩定",
        "廣效抗生素（Ampicillin 22 mg/kg IV + Enrofloxacin 5 mg/kg IV，術前預防性）",
        "Maropitant（1 mg/kg IV，止吐）",
        "Tramadol（2-5 mg/kg IV/IM，疼痛管理）"
      ],
      "surgery": "剖腹探查後嘗試手動復位（manual reduction）；若復位成功且盲腸組織活力良好，可行盲腸固定術（cecopexy）防止復發；若盲腸已壞死或復位失敗，需行盲腸切除和回結腸吻合術（typhlectomy with ileocolic anastomosis）"
    },
    "prognosis": "手術治療後預後一般良好，尤其在盲腸未壞死且成功復位固定的情況下。若已發展為腸壁壞死或穿孔伴腹膜炎，預後較差。術後復發率不高，特別是在進行盲腸固定術後。",
    "pearls": [
      "犬的慢性大腸型腹瀉伴血便，若常規治療反應不佳，應考慮盲腸內翻的可能",
      "腹部超音波的同心圓/靶環徵是套疊的特徵性影像表現",
      "結腸鏡不僅能診斷還可以直接觀察套入的盲腸組織活力",
      "盲腸固定術（cecopexy）可有效預防復位後的再發"
    ],
    "diagnosticAlgorithm": {
      "title": "盲腸內翻 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估大腸性腹瀉和腹部不適",
          "findings": [
            "慢性或間歇性血便",
            "裡急後重",
            "嘔吐（部分病例）",
            "體重減輕"
          ]
        },
        {
          "step": 2,
          "action": "影像學檢查",
          "details": "進行腹部超音波評估盲腸結腸區域",
          "findings": [
            "超音波見盲腸結腸交界處靶心徵",
            "腸套疊樣表現",
            "局部腸壁增厚",
            "腹部X光可能見局部軟組織密度增加"
          ]
        },
        {
          "step": 3,
          "action": "結腸鏡或手術確診",
          "details": "進行結腸鏡或探查性剖腹術確認",
          "findings": [
            "結腸鏡見盲腸組織突入結腸腔",
            "手術確認盲腸內翻入結腸",
            "評估腸壁活力",
            "盲腸切除術為確定性治療"
          ]
        }
      ]
    },
    "monitoring": [
      "術後 24-72 小時密切監測腹膜炎和敗血症徵象",
      "術後 2 週追蹤傷口癒合和腸道功能恢復",
      "術後 1 個月腹部超音波確認無復發",
      "長期追蹤糞便品質和大腸功能"
    ],
    "reference": "Clinical Veterinary Advisor: Dogs and Cats, 4th Edition"
  },
  "renal-amyloidosis": {
    "zh": "腎澱粉樣變性",
    "en": "Renal Amyloidosis",
    "definition": "異常折疊的蛋白質（澱粉樣蛋白，amyloid）沉積於腎臟組織的系統性或器官限局性疾病。在犬中以 AA 型澱粉樣變性（繼發性/反應性）最常見，沉積於腎絲球導致蛋白質流失性腎病；在貓和 Shar Pei 犬中則常沉積於腎間質和髓質。最終導致慢性腎衰竭。",
    "synonyms": [
      "腎類澱粉沉著症",
      "腎 amyloidosis",
      "系統性澱粉樣變性（腎臟表現）"
    ],
    "epidemiology": {
      "species": "犬貓均可發生",
      "breed": "Shar Pei（家族性澱粉樣變性，與反覆發熱相關）、Beagle、English Foxhound、Abyssinian 貓（家族性）",
      "age": "中年至老年（犬 5-11 歲，Shar Pei 可更年輕 1-6 歲；Abyssinian 貓 1-5 歲）",
      "sex": "無明顯性別好發性",
      "prevalence": "整體不常見，但在特定品種中發病率顯著較高"
    },
    "clinicalPresentation": {
      "symptoms": [
        "多飲多尿（polyuria/polydipsia）",
        "體重減輕和肌肉消耗",
        "食慾下降",
        "嘔吐",
        "嗜睡",
        "皮下水腫和/或腹水（腎病症候群時）",
        "Shar Pei：反覆發熱和關節腫脹（Shar Pei fever）",
        "口腔潰瘍和口臭（尿毒症時）",
        "出血傾向（血栓或 DIC）"
      ],
      "physicalExam": [
        "腎臟觸診可能偏小（慢性期）或正常大小",
        "脫水",
        "黏膜蒼白",
        "口腔潰瘍（尿毒症時）",
        "皮下凹陷性水腫或腹水（嚴重蛋白尿時）",
        "Shar Pei 可能有脛跗關節腫脹"
      ]
    },
    "pathophysiology": "AA 型澱粉樣變性中，慢性炎症或感染導致肝臟持續產生血清澱粉樣 A 蛋白（SAA），SAA 被巨噬細胞部分降解後形成不可溶的 AA 澱粉樣纖維。在犬（除 Shar Pei 外），AA 纖維主要沉積於腎絲球基底膜，導致絲球基底膜增厚、蛋白質濾過增加（蛋白尿）和腎病症候群。在 Shar Pei 和 Abyssinian 貓中，沉積以腎間質和髓質為主，導致腎小管功能障礙和間質纖維化。無論沉積位置如何，最終結果都是進行性腎功能喪失。低白蛋白血症增加血栓風險（抗凝血因子 III 流失）。",
    "diagnosis": {
      "primary": [
        "腎臟活檢（renal biopsy）：剛果紅染色（Congo red stain）在偏光顯微鏡下呈蘋果綠雙折射（apple-green birefringence）— 金標準",
        "尿液分析：顯著蛋白尿（UPC >2.0，常 >3.0）",
        "腹部超音波：腎臟大小和回音性變化",
        "排除其他蛋白尿原因（腎絲球腎炎、腫瘤等）"
      ],
      "differential": [
        "免疫介導性腎絲球腎炎",
        "腎病症候群其他原因",
        "慢性腎衰竭（CKD）其他病因",
        "蛋白質流失性腸病",
        "多發性骨髓瘤（AL 型澱粉樣變性）",
        "腎小管間質性腎炎"
      ],
      "labFindings": [
        "尿蛋白/肌酐比（UPC）顯著升高（通常 >3.5）",
        "低白蛋白血症",
        "氮血症（BUN、Creatinine 升高，晚期）",
        "高膽固醇血症（腎病症候群的一部分）",
        "抗凝血因子 III（AT III）活性降低（尿中流失）"
      ]
    },
    "treatment": {
      "acute": "腎病症候群危象：膠體液輸注、新鮮冷凍血漿（補充 AT III）；血栓栓塞治療；嚴重氮血症進行透析",
      "chronic": "尚無特效治療可逆轉澱粉樣沉積。管理重點為減緩蛋白尿、控制慢性腎病併發症、治療基礎炎症病因（AA 型）。Shar Pei fever 使用 Colchicine 預防澱粉樣物質沉積",
      "medications": [
        "Colchicine（0.01-0.03 mg/kg PO SID-BID，預防性，尤其 Shar Pei）",
        "Enalapril 或 Telmisartan（降低蛋白尿）",
        "Clopidogrel（1-2 mg/kg PO SID，抗血栓預防）",
        "Amlodipine（0.1-0.25 mg/kg PO SID，控制高血壓）",
        "腎臟處方飲食（限磷、適度限蛋白）"
      ],
      "surgery": "無手術治療選項；腎臟移植在理論上可行但實際極少執行"
    },
    "prognosis": "預後差。犬腎絲球型澱粉樣變性確診後中位存活時間約 3-18 個月。Shar Pei 家族性澱粉樣變性預後不良。Abyssinian 貓的中位存活時間約 9-12 個月。血栓栓塞併發症是常見死因。早期使用 Colchicine 可能減緩 Shar Pei 的疾病進展。",
    "pearls": [
      "Shar Pei 反覆不明原因發熱合併脛跗關節腫脹（Shar Pei fever），應警惕後續發展腎澱粉樣變性",
      "顯著蛋白尿（UPC >3.5）合併低白蛋白血症但腎臟大小正常或偏大，應高度懷疑澱粉樣變性",
      "腎臟活檢的剛果紅染色偏光雙折射是確診的金標準",
      "低白蛋白患者需警惕血栓栓塞——AT III 流失是重要的促凝因素"
    ],
    "diagnosticAlgorithm": {
      "title": "腎澱粉樣變性 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估蛋白尿和腎功能障礙症狀",
          "findings": [
            "蛋白尿",
            "外周水腫或腹水",
            "多飲多尿",
            "沙皮犬、阿比西尼亞貓為好發品種"
          ]
        },
        {
          "step": 2,
          "action": "實驗室檢查",
          "details": "進行完整腎臟功能和蛋白定量評估",
          "findings": [
            "尿蛋白/肌酐比值（UPC）升高",
            "低白蛋白血症",
            "氮質血症",
            "高膽固醇血症"
          ]
        },
        {
          "step": 3,
          "action": "影像學檢查",
          "details": "進行腎臟超音波評估",
          "findings": [
            "腎臟大小正常或縮小",
            "腎皮質回音性增加",
            "腎皮質結構改變",
            "排除其他腎臟疾病"
          ]
        },
        {
          "step": 4,
          "action": "腎臟活檢確診",
          "details": "進行腎臟活檢和特殊染色確認澱粉樣物質",
          "findings": [
            "剛果紅染色陽性",
            "偏光顯微鏡下蘋果綠雙折射",
            "腎小球和/或腎髓質沉積",
            "與免疫複合體腎病鑑別"
          ]
        }
      ]
    },
    "monitoring": [
      "UPC 每 4-8 週追蹤蛋白尿變化",
      "腎功能指標（BUN、Creatinine、SDMA）每 4-8 週",
      "白蛋白和 AT III 活性定期監測",
      "血壓監測（每次回診）"
    ],
    "reference": "Pathologic Basis of Veterinary Disease, 7th Edition"
  },
  "ureteral-obstruction": {
    "zh": "輸尿管阻塞",
    "en": "Ureteral Obstruction",
    "definition": "一側或雙側輸尿管因結石、腫瘤、血塊、凝血塊或狹窄導致尿液流通受阻的急性或慢性病態。在貓中以草酸鈣結石（calcium oxalate ureteroliths）為最常見原因，犬亦可發生。雙側或單功能腎的單側阻塞可導致急性腎後性腎衰竭，是泌尿系統急診之一。",
    "synonyms": [
      "輸尿管阻塞性尿路病",
      "輸尿管結石阻塞",
      "Ureteral calculi obstruction"
    ],
    "epidemiology": {
      "species": "貓比犬更常見（尤其草酸鈣結石相關）",
      "breed": "貓：無明顯品種好發性，但有增加趨勢；犬：Miniature Schnauzer、Yorkshire Terrier、Shih Tzu",
      "age": "中老年貓（7 歲以上）；犬視病因而定",
      "sex": "無顯著性別差異",
      "prevalence": "近年來貓輸尿管結石阻塞的發病率顯著增加，可能與飲食和診斷技術改進有關"
    },
    "clinicalPresentation": {
      "symptoms": [
        "突然食慾下降或廢絕",
        "嗜睡與虛弱",
        "嘔吐",
        "腹痛（患側腰部）",
        "尿量減少或無尿（雙側阻塞時）",
        "多飲多尿（單側慢性阻塞代償時）",
        "體重減輕（慢性）",
        "發燒（合併感染時）"
      ],
      "physicalExam": [
        "患側腎臟腫大且可能疼痛（腎盂積水）",
        "脫水",
        "膀胱觸診小（雙側阻塞時）或正常",
        "腰部觸診疼痛",
        "黏膜蒼白或尿毒症表現",
        "體溫可能升高（合併腎盂腎炎時）"
      ]
    },
    "pathophysiology": "輸尿管阻塞導致阻塞近端壓力升高，尿液在腎盂和輸尿管內蓄積（腎盂積水/輸尿管積水）。持續的壓力升高導致腎血流量降低、腎絲球過濾率（GFR）下降和腎小管損傷。急性完全阻塞在 24-48 小時內即可造成顯著的腎功能損害，若超過 7-14 天不解除可導致永久性腎損傷。單側阻塞時對側腎臟代償性增加 GFR，但若對側腎臟已有基礎病變或同時阻塞，則迅速發展為急性腎衰竭。鈣化結石是貓最常見的阻塞原因，通常非常小（1-3 mm）。",
    "diagnosis": {
      "primary": [
        "腹部超音波：腎盂擴張（renal pelvis dilation >5 mm 貓 / >10 mm 犬）、輸尿管擴張、可見結石強回音影",
        "腹部 X 光：鈣化結石可見（草酸鈣為 X 光不透光）",
        "血液學/生化：評估氮血症程度和電解質",
        "CT 掃描：提供最精確的結石定位和大小評估"
      ],
      "differential": [
        "急性腎損傷（其他原因）",
        "慢性腎臟疾病惡化",
        "輸尿管腫瘤",
        "輸尿管狹窄（先前手術或炎症後）",
        "腎盂腎炎",
        "下泌尿道阻塞"
      ],
      "labFindings": [
        "BUN 和 Creatinine 升高（程度取決於是否為雙側或單側）",
        "高血鉀（急性雙側阻塞時危及生命）",
        "代謝性酸中毒",
        "尿液分析：等張尿、可能有血尿或膿尿",
        "尿液培養（排除腎盂腎炎）"
      ]
    },
    "treatment": {
      "acute": "穩定全身狀態：靜脈輸液矯正脫水和電解質失衡（尤其高血鉀）；嚴重氮血症可考慮血液透析暫時穩定；止痛（Buprenorphine 0.01-0.03 mg/kg IV）；盡快解除阻塞",
      "chronic": "預防結石復發：飲食調整（增加水分攝入、泌尿道處方飲食）；定期影像監測；慢性 CKD 的長期管理",
      "medications": [
        "靜脈輸液（0.9% NaCl 或 Lactated Ringer's）",
        "Buprenorphine（0.01-0.03 mg/kg IV/IM，鎮痛）",
        "Calcium gluconate 10%（0.5-1 mL/kg IV slow，高血鉀心臟保護）",
        "Mannitol（0.25-0.5 g/kg IV，利尿劑，術前）",
        "抗生素（若合併感染：Amoxicillin-Clavulanate 或 Marbofloxacin）"
      ],
      "surgery": "輸尿管支架（ureteral stent）置入：透視引導下放置雙 J 支架；皮下輸尿管旁路裝置（SUB, Subcutaneous Ureteral Bypass）：貓中越來越常用，直接繞過阻塞；傳統輸尿管切開取石術（ureterotomy）；輸尿管再植術（neoureterocystostomy）"
    },
    "prognosis": "取決於阻塞持續時間、是否雙側、術前腎功能和腎臟損傷程度。早期介入（<3-5 天）預後較好。貓 SUB 裝置術後中位存活時間約 16-24 個月。輸尿管支架的長期併發症包括支架移位、阻塞和尿道感染。單側阻塞若對側腎臟功能正常，預後較好。",
    "pearls": [
      "貓的輸尿管結石通常非常小（1-3 mm），X 光容易遺漏，超音波看腎盂擴張更為敏感",
      "急性雙側輸尿管阻塞的高血鉀可能在數小時內致命，需優先處理電解質",
      "SUB 裝置在貓中已成為越來越普及的首選治療，避免了直接操作細小輸尿管的困難",
      "阻塞解除後的利尿期（post-obstructive diuresis）需密切監測輸液量和電解質"
    ],
    "diagnosticAlgorithm": {
      "title": "輸尿管阻塞 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估急性或慢性腎後性阻塞症狀",
          "findings": [
            "急性腹痛和嘔吐",
            "少尿或無尿（雙側阻塞）",
            "食慾不振和嗜睡",
            "貓的輸尿管結石為最常見原因"
          ]
        },
        {
          "step": 2,
          "action": "實驗室檢查",
          "details": "進行腎功能和電解質評估",
          "findings": [
            "氮質血症（可能急性惡化）",
            "高血鉀（雙側阻塞時危及生命）",
            "代謝性酸中毒",
            "尿液分析"
          ]
        },
        {
          "step": 3,
          "action": "影像學確診",
          "details": "進行腹部超音波和X光確認阻塞",
          "findings": [
            "腎盂擴張（水腎）",
            "輸尿管擴張至阻塞點",
            "超音波可見輸尿管結石",
            "腹部X光見不透光結石"
          ]
        },
        {
          "step": 4,
          "action": "手術評估",
          "details": "評估手術介入方式",
          "findings": [
            "輸尿管支架或SUB裝置",
            "輸尿管切開取石術",
            "腎盂到膀胱繞道術",
            "對側腎功能評估"
          ]
        }
      ]
    },
    "monitoring": [
      "術後 24-72 小時密切監測尿量、電解質和腎功能",
      "SUB 裝置或支架術後每 1-3 個月超音波和 X 光追蹤",
      "長期每 3-6 個月腎功能和影像追蹤",
      "鼓勵增加水分攝入以預防結石復發"
    ],
    "reference": "Clinical Veterinary Advisor: Dogs and Cats, 4th Edition"
  },
  "renal-infarction": {
    "zh": "腎梗塞",
    "en": "Renal Infarction",
    "definition": "腎動脈或其分支血流突然中斷，導致供應區域腎組織缺血性壞死的急性血管事件。在犬貓中最常繼發於血栓栓塞性疾病，包括感染性心內膜炎、腫瘤（如血管瘤）、免疫介導性溶血性貧血（IMHA）、蛋白質流失性腎病/腸病、和高凝血狀態。",
    "synonyms": [
      "腎栓塞",
      "腎動脈血栓栓塞",
      "Renal thromboembolism"
    ],
    "epidemiology": {
      "species": "犬貓均可發生",
      "breed": "與基礎疾病相關，無特定品種好發；CKCS（心臟病相關）；大型犬（腫瘤相關）",
      "age": "中老年動物居多",
      "sex": "無明顯性別好發性",
      "prevalence": "臨床上可能被低估；屍體解剖研究顯示腎梗塞的發生率高於臨床診斷率"
    },
    "clinicalPresentation": {
      "symptoms": [
        "急性腰部或腹部疼痛（患側）",
        "血尿（hematuria）",
        "嘔吐",
        "食慾下降",
        "發燒",
        "嗜睡",
        "少尿或無尿（雙側大範圍梗塞時）",
        "與基礎疾病相關的症狀"
      ],
      "physicalExam": [
        "患側腎臟區域觸診疼痛",
        "發燒",
        "腹部壓痛",
        "心臟聽診異常（若與心臟疾病相關）",
        "可能觸到腫大的腎臟（急性水腫期）",
        "基礎疾病的相關體格檢查異常"
      ]
    },
    "pathophysiology": "血栓或栓子阻塞腎動脈或其分支，導致該供應區域急性缺血。腎皮質對缺血最為敏感，數小時內即可發生凝固性壞死。壞死區域隨後被纖維化疤痕組織取代，形成楔形的梗塞灶。栓子來源包括：心臟（心內膜炎的菌栓、心臟腫瘤碎片）、動脈粥樣硬化斑塊（犬少見）、全身性高凝狀態（IMHA、腎病症候群導致的 AT III 缺乏、DIC、腫瘤相關高凝）。小範圍梗塞可能無臨床症狀，大範圍或雙側梗塞可導致急性腎損傷。",
    "diagnosis": {
      "primary": [
        "腹部超音波（含都卜勒）：腎臟內楔形低回音灶、腎動脈血流訊號缺失",
        "CT 血管造影（CTA）：增強掃描顯示腎臟灌注缺損區域——最敏感的診斷方法",
        "尿液分析：血尿、蛋白尿",
        "評估基礎病因（心臟超音波、血液培養、凝血功能等）"
      ],
      "differential": [
        "腎盂腎炎",
        "腎臟腫瘤",
        "輸尿管阻塞伴腎盂積水",
        "急性腎損傷（其他原因）",
        "腎臟膿瘍",
        "腹腔內其他器官的急性疾病"
      ],
      "labFindings": [
        "BUN/Creatinine 升高（取決於梗塞範圍和對側腎功能）",
        "尿液：血尿、蛋白尿、可能有白血球",
        "LDH 升高（組織壞死指標）",
        "凝血功能異常（D-dimer 升高、PT/aPTT 延長，若有 DIC）",
        "血液培養（排除感染性心內膜炎）"
      ]
    },
    "treatment": {
      "acute": "支持性治療：靜脈輸液維持腎臟灌注、鎮痛（Buprenorphine 或 Methadone）；若為血栓栓塞：抗凝治療（Heparin 或 Enoxaparin）；積極治療基礎病因",
      "chronic": "長期抗血栓治療（若有持續高凝風險）；CKD 管理（若殘餘腎功能受損）；監測和治療基礎疾病",
      "medications": [
        "Enoxaparin（低分子量肝素，0.8-1 mg/kg SC BID，急性抗凝）",
        "Clopidogrel（1-2 mg/kg PO SID，長期抗血小板）",
        "Buprenorphine（0.01-0.03 mg/kg IV/IM q6-8h，鎮痛）",
        "靜脈輸液維持腎臟灌注",
        "針對基礎病因的藥物（如 IMHA 的免疫抑制劑）"
      ],
      "surgery": "通常不進行手術治療；極罕見情況下可考慮血栓切除術（thrombectomy）或腎切除術（壞死腎臟合併感染時）"
    },
    "prognosis": "取決於梗塞範圍、對側腎功能和基礎病因。小範圍單側梗塞對側腎正常者預後良好。大範圍雙側梗塞或合併嚴重基礎疾病（如晚期腫瘤、重度 IMHA 合併 DIC）者預後差。整體預後主要由基礎疾病決定。",
    "pearls": [
      "犬急性腰痛、血尿和氮血症的三聯徵應高度懷疑腎梗塞",
      "診斷後必須積極尋找基礎病因——腎梗塞幾乎總是全身性疾病的表現",
      "都卜勒超音波可快速評估腎臟血流灌注，但 CT 血管造影是最精確的診斷工具",
      "IMHA 和腎病症候群是犬最常見的高凝狀態，均有顯著的血栓風險"
    ],
    "diagnosticAlgorithm": {
      "title": "腎梗塞 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估急性腎臟疼痛和潛在栓塞來源",
          "findings": [
            "急性腹痛或腰痛",
            "血尿",
            "發熱",
            "心臟疾病（栓塞來源）"
          ]
        },
        {
          "step": 2,
          "action": "實驗室檢查",
          "details": "進行腎功能和凝血評估",
          "findings": [
            "肌酐和BUN可能升高",
            "LDH升高",
            "白血球增多",
            "尿液分析見血尿和蛋白尿"
          ]
        },
        {
          "step": 3,
          "action": "影像學確診",
          "details": "進行腎臟超音波和都卜勒評估",
          "findings": [
            "腎臟楔形低回音區域",
            "都卜勒顯示局部血流缺失",
            "造影CT見楔形灌注缺損",
            "腎臟大小可能不對稱"
          ]
        },
        {
          "step": 4,
          "action": "栓塞來源調查",
          "details": "調查血栓栓塞的來源",
          "findings": [
            "心臟超音波排除心臟內血栓",
            "凝血功能全套評估",
            "抗凝血酶III測定",
            "腫瘤相關高凝狀態篩檢"
          ]
        }
      ]
    },
    "monitoring": [
      "腎功能指標（BUN、Creatinine）每 24-48 小時追蹤（急性期）",
      "凝血功能監測（使用抗凝劑時）",
      "重複腹部超音波評估腎臟大小和血流恢復",
      "基礎疾病的相關監測項目"
    ],
    "reference": "Veterinary Internal Medicine, Ettinger & Feldman, 8th Edition"
  },
  "primary-immune-deficiency": {
    "zh": "原發性免疫缺乏症",
    "en": "Primary Immunodeficiency Disorders",
    "definition": "因免疫系統先天性/遺傳性缺陷導致的免疫功能低下，使動物對感染的抵抗力異常降低。包括體液免疫缺陷（B 細胞/免疫球蛋白缺乏）、細胞免疫缺陷（T 細胞功能障礙）、聯合免疫缺陷（combined immunodeficiency）、吞噬細胞功能缺陷和補體缺陷等多種類型。",
    "synonyms": [
      "先天性免疫缺陷",
      "遺傳性免疫不全症",
      "Primary immunodeficiency disease (PID)"
    ],
    "epidemiology": {
      "species": "犬貓均有報告，犬較多記載",
      "breed": "品種特異性強：Jack Russell Terrier（嚴重聯合免疫缺陷 SCID）、Basset Hound（X-linked SCID）、Weimaraner（IgG 缺乏）、Irish Setter（白血球黏附缺陷 LAD）、Doberman Pinscher（IgM 缺乏）；貓：Birman（補體缺陷）",
      "age": "多在幼年（3-6 月齡）當母源抗體消退後開始出現臨床症狀",
      "sex": "X-linked 型態（如 Basset Hound SCID）只影響雄性",
      "prevalence": "個別疾病罕見，但作為一個群體在品種犬中並不極端罕見"
    },
    "clinicalPresentation": {
      "symptoms": [
        "反覆感染（呼吸道、皮膚、消化道）",
        "抗生素治療反應差或停藥後立即復發",
        "生長遲緩（failure to thrive）",
        "慢性腹瀉",
        "反覆皮膚感染（膿皮症）",
        "慢性呼吸道感染（肺炎、支氣管炎）",
        "淋巴結腫大或異常小（依類型）",
        "發燒（感染相關）",
        "被毛粗糙、發育不良"
      ],
      "physicalExam": [
        "體型偏小、發育不良",
        "淋巴結可能腫大（慢性感染）或缺失（SCID 中淋巴組織發育不全）",
        "皮膚感染灶（膿皮症、膿瘍）",
        "肺部異常呼吸音",
        "發燒",
        "黏膜蒼白（慢性感染或貧血時）"
      ]
    },
    "pathophysiology": "先天性基因突變導致免疫系統某一環節的發育或功能缺陷。SCID 涉及 T 細胞和 B 細胞的共同前驅細胞缺陷或關鍵信號分子（如 DNA-PKcs、IL-2Rγ）突變，導致兩者同時缺乏。選擇性免疫球蛋白缺乏（如 IgA 或 IgG 亞型缺乏）使黏膜和全身的抗體防禦降低。白血球黏附缺陷（LAD）涉及 β2-integrin（CD18）突變，使嗜中性球無法正常從血管遷移至感染部位。補體缺陷影響先天免疫的殺菌和調理功能。無論缺陷類型如何，結果都是反覆或持續性感染，常由條件致病菌引起。",
    "diagnosis": {
      "primary": [
        "免疫球蛋白定量（IgG、IgM、IgA）：排除選擇性或全面性免疫球蛋白缺乏",
        "淋巴細胞亞群分析（流式細胞術）：CD4+、CD8+ T 細胞、B 細胞計數",
        "嗜中性球功能試驗（呼吸爆發試驗、黏附試驗）",
        "基因檢測（已知突變基因的 PCR 檢測）"
      ],
      "differential": [
        "繼發性免疫抑制（藥物、腫瘤、感染如 FIV）",
        "營養不良導致的免疫功能低下",
        "新生兒被動移轉失敗（failure of passive transfer）",
        "骨髓疾病",
        "慢性壓力導致的免疫抑制",
        "先天性中性球減少症（cyclic neutropenia）"
      ],
      "labFindings": [
        "CBC：依類型可見淋巴球減少（SCID）或嗜中性球增多（LAD，因嗜中性球無法遷移而堆積在血管中）",
        "血清免疫球蛋白：一種或多種免疫球蛋白減少或缺乏",
        "補體活性（CH50）降低（補體缺陷時）",
        "骨髓檢查：可能顯示特定細胞系列的成熟停滯"
      ]
    },
    "treatment": {
      "acute": "積極控制感染：廣效殺菌性抗生素（非抑菌性）、抗黴菌藥（若需要）；支持性治療",
      "chronic": "長期預防性抗生素（低劑量）；定期免疫球蛋白替代療法（血漿輸注，每 2-4 週）；避免免疫抑制藥物和活毒疫苗；環境管理減少感染暴露",
      "medications": [
        "Amoxicillin-Clavulanate（12.5-25 mg/kg PO BID，預防性/治療性）",
        "TMP-Sulfa（15 mg/kg PO BID，預防性抗生素）",
        "新鮮冷凍血漿（10-20 mL/kg IV，免疫球蛋白補充）",
        "Itraconazole（5 mg/kg PO SID，抗黴菌）",
        "支持性營養補充"
      ],
      "surgery": "無特定手術治療；骨髓移植在理論上可治癒 SCID 但在獸醫領域極少執行"
    },
    "prognosis": "視免疫缺陷類型和嚴重程度而異。SCID 預後極差，多在 1 歲內死亡。選擇性 IgA 缺乏在良好管理下可存活多年。LAD 預後差，多在幼年死於嚴重感染。Weimaraner 的 IgG 缺乏可能隨年齡部分改善。整體而言，反覆嚴重感染和抗生素耐藥性是影響預後的主要因素。",
    "pearls": [
      "幼犬在 3-6 月齡開始反覆感染且抗生素治療效果不佳，應懷疑原發性免疫缺乏",
      "確診前必須先排除繼發性免疫抑制原因（FIV、腫瘤、藥物等）",
      "SCID 患者絕對禁止接種活毒疫苗——可能引發致命感染",
      "品種背景是重要線索——特定品種的特定免疫缺陷已有明確的基因定位"
    ],
    "diagnosticAlgorithm": {
      "title": "原發性免疫缺乏症 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "評估反覆感染病史和品種背景",
          "findings": [
            "反覆不同部位感染",
            "對常規治療反應不佳",
            "幼年動物發病",
            "品種易感性"
          ]
        },
        {
          "step": 2,
          "action": "基礎免疫學檢查",
          "details": "進行免疫功能基礎評估",
          "findings": [
            "全血計數評估各系白血球",
            "血清免疫球蛋白定量（IgG、IgM、IgA）",
            "淋巴球亞群分析",
            "嗜中性球功能試驗"
          ]
        },
        {
          "step": 3,
          "action": "進階免疫功能評估",
          "details": "進行特異性免疫功能檢測",
          "findings": [
            "淋巴球增生試驗",
            "補體活性測定",
            "嗜中性球殺菌功能",
            "流式細胞術淋巴球分型"
          ]
        },
        {
          "step": 4,
          "action": "基因診斷",
          "details": "進行已知免疫缺陷基因檢測",
          "findings": [
            "X-linked SCID（Basset Hound）",
            "IgA缺乏（多品種）",
            "白血球黏附缺陷（LAD）",
            "特定品種基因突變篩檢"
          ]
        }
      ]
    },
    "monitoring": [
      "感染頻率和嚴重程度的臨床追蹤",
      "定期 CBC 和免疫球蛋白定量（每 2-3 個月）",
      "體重和生長曲線監測（幼犬）",
      "抗生素敏感性試驗（避免耐藥菌發展）"
    ],
    "reference": "Veterinary Immunology: An Introduction, 9th Edition"
  },
  "heat-stroke-exertional": {
    "zh": "運動型熱射病",
    "en": "Exertional Heat Stroke",
    "definition": "因劇烈運動產生過量熱能，超過身體散熱能力，導致核心體溫急劇升高（>41°C / 106°F）並引起全身性炎症反應和多器官功能障礙的危及生命的急症。與環境型（被動型）熱射病不同，運動型熱射病發生在積極活動的動物中，即使環境溫度不高也可能發生。",
    "synonyms": [
      "運動性中暑",
      "活動型熱射病",
      "Exertional hyperthermia"
    ],
    "epidemiology": {
      "species": "犬為主（貓罕見，因活動模式不同）",
      "breed": "短頭犬（brachycephalic breeds）風險最高：English Bulldog、French Bulldog、Pug、Boston Terrier；工作犬和運動犬也常見：Labrador Retriever、Belgian Malinois",
      "age": "年輕至中年犬（高活動量）；老年犬也有風險（散熱功能衰退）",
      "sex": "無明顯性別差異，但未絕育犬可能風險稍高",
      "prevalence": "溫暖季節常見的犬急診之一；短頭品種的發生率顯著高於長頭品種"
    },
    "clinicalPresentation": {
      "symptoms": [
        "劇烈運動後極度喘息（excessive panting）",
        "過度流涎（hypersalivation）",
        "虛脫或無法站立",
        "共濟失調或步態不穩",
        "嘔吐（可能帶血）",
        "血便或黑便",
        "意識狀態改變（定向障礙、嗜睡到昏迷）",
        "抽搐（seizures）",
        "黏膜由磚紅色轉為發紺",
        "少尿或無尿"
      ],
      "physicalExam": [
        "核心體溫 >41°C（106°F），可達 43°C（109°F）",
        "心跳過速（tachycardia）",
        "呼吸急促或呼吸困難",
        "黏膜充血（磚紅色）或發紺",
        "CRT 延長或極短（分布性休克）",
        "瘀點或瘀斑（petechiae/ecchymoses，DIC 徵象）"
      ]
    },
    "pathophysiology": "劇烈肌肉活動產生大量代謝熱。當產熱超過散熱（喘息、皮膚血管擴張、傳導/對流），核心體溫升高。體溫超過 41.5°C 時，細胞蛋白質開始變性，腸道屏障功能破壞導致內毒素（LPS）進入循環。全身性炎症反應症候群（SIRS）被啟動，促炎細胞因子大量釋放。血管內皮損傷啟動凝血級聯反應，導致 DIC。多器官功能障礙依序出現：腸道（黏膜壞死、出血）、肝臟（急性肝細胞壞死）、腎臟（急性腎小管壞死）、心臟（心肌損傷）和腦部（腦水腫）。橫紋肌溶解釋放肌球蛋白，進一步加重腎損傷。",
    "diagnosis": {
      "primary": [
        "病史（劇烈運動後出現症狀）合併核心體溫 >41°C",
        "排除其他高體溫原因（感染、癲癇持續狀態、惡性高熱）",
        "全面的急診血液學和生化評估",
        "凝血功能檢測（PT、aPTT、D-dimer、fibrinogen）"
      ],
      "differential": [
        "環境型（被動型）熱射病",
        "嚴重感染/敗血症",
        "癲癇持續狀態（status epilepticus）",
        "惡性高熱（malignant hyperthermia）",
        "中毒（如殺蟲劑中毒）",
        "甲狀腺風暴"
      ],
      "labFindings": [
        "CBC：血液濃縮（初期）→ 貧血和血小板減少（DIC 時）",
        "生化：肝酶（ALT、AST、ALP）顯著升高（可延遲 24-48 小時達峰值）；BUN/Creatinine 升高；高血糖或低血糖",
        "凝血：PT/aPTT 延長、D-dimer 升高、fibrinogen 降低（DIC）",
        "CK 和乳酸升高（橫紋肌溶解和組織低灌注）",
        "血氣：代謝性酸中毒"
      ]
    },
    "treatment": {
      "acute": "立即主動降溫：用涼水（15-20°C，非冰水）淋濕全身，搭配風扇蒸發散熱；體溫降至 39.5°C 即停止主動降溫（避免過度降溫）；積極靜脈輸液（shock dose crystalloids）；氧氣治療；止吐藥；DIC 時新鮮冷凍血漿",
      "chronic": "無慢性治療需求；重點為器官損傷的恢復期支持治療和併發症處理",
      "medications": [
        "靜脈輸液（等張晶體液 60-90 mL/kg/hr 犬，shock rate）",
        "Maropitant（1 mg/kg IV SID，止吐）",
        "新鮮冷凍血漿（10-15 mL/kg IV，DIC 時補充凝血因子）",
        "Mannitol（0.5-1 g/kg IV over 20 min，腦水腫時）",
        "Ampicillin（22 mg/kg IV q8h，腸道屏障破壞後預防菌血症）"
      ],
      "surgery": "無手術治療適應症"
    },
    "prognosis": "死亡率約 36-50%。預後因素包括：體溫升高的持續時間（從發作到開始降溫的時間是最關鍵的預後因素）、最高核心體溫、DIC 的發展、低血糖、腎衰竭和神經症狀。48 小時內存活的犬預後改善。ALT >200 IU/L 在入院時與預後不良相關。器官功能可能需要數天到數週才能完全恢復。",
    "pearls": [
      "降溫速度是決定預後的最關鍵因素——目標在 30-60 分鐘內將體溫降至 39.5°C",
      "絕對不要用冰水降溫——冰水導致周圍血管收縮反而阻礙散熱",
      "肝酶（ALT）的峰值可能延遲 24-48 小時出現，入院時正常不代表沒有肝損傷",
      "短頭犬即使在不熱的天氣中也可能因輕度運動而發生熱射病——飼主教育至關重要"
    ],
    "diagnosticAlgorithm": {
      "title": "運動型熱射病 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "緊急評估",
          "details": "立即評估體溫和臟器功能",
          "findings": [
            "體溫 >41°C（106°F）",
            "劇烈運動或高溫環境暴露史",
            "喘息和流涎過度",
            "共濟失調或虛脫"
          ]
        },
        {
          "step": 2,
          "action": "器官損傷評估",
          "details": "評估多器官損傷程度",
          "findings": [
            "意識狀態改變",
            "嘔吐和腹瀉（可能血性）",
            "DIC表現（瘀斑、出血）",
            "少尿或無尿"
          ]
        },
        {
          "step": 3,
          "action": "實驗室監測",
          "details": "進行連續實驗室監測",
          "findings": [
            "凝血功能異常（PT/aPTT延長）",
            "肝腎功能指標升高",
            "CK和乳酸升高",
            "血氣分析見代謝性酸中毒"
          ]
        },
        {
          "step": 4,
          "action": "持續監測",
          "details": "入院後48-72小時持續監測",
          "findings": [
            "DIC篩檢每6-12小時",
            "腎功能連續追蹤",
            "肝功能延遲性升高（24-48h後）",
            "神經功能恢復評估"
          ]
        }
      ]
    },
    "monitoring": [
      "核心體溫每 5-15 分鐘監測（降溫過程中）",
      "凝血功能（PT/aPTT/D-dimer）每 6-12 小時（前 48 小時）",
      "肝酶和腎功能每 12-24 小時追蹤至少 72 小時",
      "尿量監測（目標 >1-2 mL/kg/hr）"
    ],
    "reference": "Veterinary Technician's Manual for Small Animal Emergency and Critical Care, 2nd Edition"
  },
  "transfusion-reaction": {
    "zh": "輸血反應",
    "en": "Transfusion Reaction",
    "definition": "動物接受血液或血液製品輸注後發生的不良免疫性或非免疫性反應。免疫介導性反應包括急性溶血反應（最嚴重）、發熱性非溶血反應和過敏反應；非免疫介導性反應包括容量超負荷、細菌污染和枸櫞酸毒性等。輸血反應是獸醫輸血醫學中最重要的併發症。",
    "synonyms": [
      "輸血不良反應",
      "輸血併發症",
      "Adverse transfusion event"
    ],
    "epidemiology": {
      "species": "犬貓均可發生",
      "breed": "無品種好發性，但貓（因 AB 血型系統中 B 型貓對 A 型血有天然抗體）首次輸血即可能發生嚴重溶血反應",
      "age": "任何年齡",
      "sex": "無性別好發性",
      "prevalence": "犬輸血反應發生率約 3-15%（多為發熱性非溶血反應）；貓不相容輸血的急性溶血反應發生率高"
    },
    "clinicalPresentation": {
      "symptoms": [
        "發燒或寒顫（最常見的輕度反應）",
        "嘔吐",
        "蕁麻疹或面部水腫（過敏反應）",
        "呼吸困難或呼吸急促",
        "心跳加速",
        "低血壓或休克",
        "血紅蛋白尿（紅褐色尿液，急性溶血時）",
        "黃疸（延遲性溶血時）",
        "不安躁動",
        "顫抖",
        "DIC 相關出血（嚴重溶血反應）"
      ],
      "physicalExam": [
        "發燒（體溫升高 >1°C）",
        "心跳加速",
        "黏膜發紅或蒼白（取決於反應類型）",
        "呼吸急促或費力",
        "面部或全身水腫（過敏型）",
        "注射部位蕁麻疹"
      ]
    },
    "pathophysiology": "急性溶血反應：受者體內的抗體與供者紅血球表面抗原結合，啟動補體介導的血管內溶血或網狀內皮系統的血管外溶血。游離血紅蛋白導致腎小管損傷和急性腎衰竭；溶血產物啟動凝血級聯反應導致 DIC。發熱性非溶血反應（FNHTR）：受者抗體與供者白血球或血小板反應，釋放促炎細胞因子（IL-1、IL-6、TNF-α）引起發燒。過敏反應：受者 IgE 對供者血漿蛋白的即時型過敏反應，引起肥大細胞脫顆粒和組織胺釋放。容量超負荷（TACO）：過快輸注導致循環容量過多，引起肺水腫。",
    "diagnosis": {
      "primary": [
        "臨床時序關係（輸血開始後出現新症狀）",
        "輸血前後血型比對和交叉配對（crossmatch）回顧",
        "直接抗球蛋白試驗（Coombs test）",
        "輸血前後血漿顏色比較（溶血時呈粉紅至紅色）"
      ],
      "differential": [
        "免疫介導性溶血性貧血（IMHA）惡化",
        "敗血症（與基礎疾病相關）",
        "過敏反應（藥物引起）",
        "心因性肺水腫",
        "基礎疾病的自然進展"
      ],
      "labFindings": [
        "PCV/TS：輸血後 PCV 未升或反降（溶血反應）",
        "血漿顏色：粉紅至紅色（血管內溶血）或黃色（延遲性溶血/膽紅素升高）",
        "尿液：血紅蛋白尿",
        "凝血功能：PT/aPTT 延長、D-dimer 升高（DIC）",
        "Coombs 試驗陽性（免疫介導性溶血確認）"
      ]
    },
    "treatment": {
      "acute": "立即停止輸血；保留靜脈通路；急性溶血反應：積極靜脈輸液（利尿保護腎臟）、地塞米松（0.5-1 mg/kg IV）、Epinephrine（過敏性休克時 0.01 mg/kg IV/IM）；發熱性反應：降低輸注速度或停止，給予 Diphenhydramine",
      "chronic": "記錄反應類型於病歷中；未來輸血需嚴格交叉配對；考慮使用洗滌紅血球（washed RBCs）或白血球減除（leukoreduced）血品",
      "medications": [
        "Diphenhydramine（1-2 mg/kg IM/IV，過敏反應）",
        "Dexamethasone（0.5-1 mg/kg IV，嚴重過敏或溶血反應）",
        "Epinephrine（0.01 mg/kg IV/IM，過敏性休克）",
        "Furosemide（2-4 mg/kg IV，容量超負荷/TACO）",
        "靜脈輸液（利尿保護腎臟，溶血反應時）"
      ],
      "surgery": "無手術治療"
    },
    "prognosis": "發熱性非溶血反應和輕度過敏反應預後良好。急性溶血反應的嚴重程度取決於輸注的不相容血量和溶血程度，可從輕度到致命不等。貓的 B 型血接受 A 型血的急性溶血反應死亡率極高。及早發現和停止輸血是改善預後的關鍵。",
    "pearls": [
      "貓的 B 型血有高力價的天然抗 A 抗體——B 型貓首次接受 A 型血即可發生致命溶血反應，因此貓輸血前必須做血型鑑定",
      "犬首次輸血通常不會有嚴重溶血反應（缺乏預存抗體），但 4 天後抗體產生使第二次輸血風險大增",
      "輸血開始後的前 15 分鐘以低速輸注（1 mL/kg/hr），密切觀察是否有反應",
      "發燒是最常見的輸血反應，但不能僅因發燒就假設無大礙——需排除溶血和敗血症"
    ],
    "diagnosticAlgorithm": {
      "title": "輸血反應 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "急性監測",
          "details": "輸血過程中和輸血後密切監測",
          "findings": [
            "發熱（體溫上升 >1°C）",
            "蕁麻疹或面部水腫",
            "嘔吐和腹瀉",
            "心搏過速和低血壓"
          ]
        },
        {
          "step": 2,
          "action": "反應分類",
          "details": "區分免疫性和非免疫性輸血反應",
          "findings": [
            "急性溶血：血紅素尿、黃疸、休克",
            "遲發性溶血：PCV下降、膽紅素升高",
            "發熱性非溶血反應：僅發熱",
            "過敏性反應：蕁麻疹、血管性水腫"
          ]
        },
        {
          "step": 3,
          "action": "實驗室確認",
          "details": "進行輸血反應相關實驗室檢查",
          "findings": [
            "直接Coombs試驗",
            "血漿和尿液游離血紅素",
            "膽紅素變化",
            "重複交叉配血試驗"
          ]
        }
      ]
    },
    "monitoring": [
      "輸血期間每 15-30 分鐘監測體溫、心率、呼吸頻率",
      "輸血前後 PCV/TS 和血漿顏色比較",
      "尿液顏色和尿量監測",
      "嚴重反應後追蹤凝血功能和腎功能 24-48 小時"
    ],
    "reference": "Clinical Veterinary Advisor: Dogs and Cats, 4th Edition"
  },
  "drug-eruption": {
    "zh": "藥物疹/藥物不良反應",
    "en": "Drug Eruption (Cutaneous Adverse Drug Reaction)",
    "definition": "使用藥物後引起的皮膚和/或黏膜不良反應，可由免疫介導機制（藥物過敏）或非免疫介導機制（藥物不耐受、毒性反應）引起。犬貓中的表現多樣，從輕度蕁麻疹到嚴重的中毒性表皮壞死鬆解症（TEN）均可發生。常見誘發藥物包括抗生素（尤其磺胺類）、NSAIDs 和抗癲癇藥。",
    "synonyms": [
      "藥疹",
      "藥物過敏性皮膚反應",
      "Cutaneous drug reaction",
      "Drug hypersensitivity"
    ],
    "epidemiology": {
      "species": "犬貓均可發生，犬更多報告",
      "breed": "無明顯品種好發性，但 Doberman Pinscher 和 Rottweiler 對磺胺類藥物的反應有報告好發",
      "age": "任何年齡，但先前曾暴露於致敏藥物者風險更高",
      "sex": "無明顯性別好發性",
      "prevalence": "確切發生率不明，估計佔所有藥物不良反應的 10-20%"
    },
    "clinicalPresentation": {
      "symptoms": [
        "皮膚紅斑或丘疹（多對稱分布）",
        "蕁麻疹（urticaria）或血管性水腫",
        "皮膚瘙癢",
        "水泡或大泡（嚴重型）",
        "皮膚潰瘍和糜爛",
        "口腔黏膜潰瘍",
        "眼結膜充血或潰瘍",
        "發燒",
        "Nikolsky 徵陽性（輕觸即脫皮，TEN 時）",
        "食慾下降和嗜睡",
        "關節痛或淋巴結腫大"
      ],
      "physicalExam": [
        "多形態或單一形態的皮膚病變，常對稱分布",
        "黏膜交界處（mucocutaneous junctions）受累：嘴唇、鼻鏡、眼瞼、外陰/包皮、肛門",
        "Nikolsky 徵：輕度側向壓力導致表皮剝離（TEN 特徵）",
        "發燒",
        "淋巴結腫大",
        "眼部檢查可能發現角膜潰瘍或結膜炎"
      ]
    },
    "pathophysiology": "免疫介導型藥物疹涉及藥物或其代謝產物作為半抗原（hapten），與宿主蛋白結合形成完全抗原，誘導特異性免疫反應。Type I 反應（IgE 介導）導致蕁麻疹和血管性水腫。Type III 反應（免疫複合物）導致血管炎。Type IV 反應（T 細胞介導）導致遲發型皮疹和嚴重的全身型反應如 Stevens-Johnson 症候群（SJS）和中毒性表皮壞死鬆解症（TEN）。SJS/TEN 中，細胞毒性 T 細胞和 NK 細胞通過 Fas-FasL 途徑和 granulysin 直接殺死角質細胞，導致大面積表皮壞死和脫落。非免疫介導的反應包括劑量相關毒性和藥理學副作用。",
    "diagnosis": {
      "primary": [
        "詳細藥物史和時間關係評估（給藥後數天至數週出現症狀）",
        "停藥後症狀改善（最重要的診斷依據）",
        "皮膚活檢組織病理學：界面性皮膚炎、角質細胞壞死、淋巴細胞浸潤",
        "排除其他原因的皮膚疾病"
      ],
      "differential": [
        "自身免疫性皮膚病（天疱瘡、狼瘡）",
        "多形性紅斑（erythema multiforme）非藥物性",
        "細菌性或真菌性皮膚感染",
        "接觸性皮膚炎",
        "蕁麻疹其他原因（食物、蟲咬）",
        "淺表性壞死性皮膚炎"
      ],
      "labFindings": [
        "CBC：嗜酸性球增多（部分病例）",
        "生化：肝酶升高（磺胺類引起的 DRESS 反應）",
        "皮膚活檢：表真皮交界處角質細胞凋亡、衛星細胞壞死（satellite cell necrosis）、淋巴細胞界面炎",
        "尿液分析：排除藥物相關腎損傷"
      ]
    },
    "treatment": {
      "acute": "立即停用可疑藥物（最重要的步驟）；輕度反應（蕁麻疹）：抗組織胺和短期類固醇；嚴重反應（SJS/TEN）：住院支持治療，類似燒燙傷照護",
      "chronic": "記錄過敏藥物於病歷中；避免同類藥物再次使用（交叉過敏）；SJS/TEN 恢復後長期追蹤眼部和黏膜併發症",
      "medications": [
        "Diphenhydramine（1-2 mg/kg PO/IM BID-TID，輕度過敏）",
        "Prednisolone（1-2 mg/kg PO BID，中度反應；SJS/TEN 中是否使用仍有爭議）",
        "Cyclosporine（5 mg/kg PO SID，嚴重或頑固型）",
        "人類免疫球蛋白 IVIG（0.5-1 g/kg IV over 6-12h，SJS/TEN）",
        "外用保濕和屏障修復產品"
      ],
      "surgery": "無手術治療；嚴重 TEN 可能需要皮膚傷口清創和類似燒傷的傷口照護"
    },
    "prognosis": "輕度藥物疹（蕁麻疹、丘疹）停藥後 1-3 週內通常完全恢復，預後極佳。SJS 的死亡率約 5-10%，TEN 的死亡率可達 30-50%。影響預後的因素包括：受累體表面積百分比、是否及時停藥、敗血症併發症和基礎健康狀態。",
    "pearls": [
      "停藥是最重要的治療步驟——藥物疹的鑑別診斷中，「最近開始或更換的藥物」是最關鍵的線索",
      "磺胺類抗生素（TMP-sulfa）是犬最常見的引起嚴重藥物疹（SJS/TEN）的藥物",
      "藥物疹可在給藥後數天到數週才出現，停藥後也可能短暫惡化",
      "確診藥物疹後，應在病歷中永久記錄過敏藥物，並告知飼主避免未來再次使用"
    ],
    "diagnosticAlgorithm": {
      "title": "藥物疹/藥物不良反應 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "初步評估",
          "details": "收集完整用藥史和皮膚病變特徵",
          "findings": [
            "用藥後1-3週內出現皮疹",
            "病變形態多樣（斑疹、丘疹、蕁麻疹等）",
            "對稱性分布",
            "可能伴有發熱和精神沉鬱"
          ]
        },
        {
          "step": 2,
          "action": "藥物時間關係評估",
          "details": "建立藥物暴露和症狀發生的時間關係",
          "findings": [
            "確定可疑藥物和開始使用時間",
            "常見致敏藥：磺胺類、頭孢菌素、NSAID",
            "停藥後觀察改善",
            "再暴露可能導致更嚴重反應"
          ]
        },
        {
          "step": 3,
          "action": "組織病理學檢查",
          "details": "進行皮膚活檢排除其他疾病",
          "findings": [
            "界面性皮膚炎",
            "角質細胞凋亡",
            "血管周圍炎症浸潤",
            "排除自體免疫性皮膚病"
          ]
        }
      ]
    },
    "monitoring": [
      "停藥後每 3-7 天評估皮膚和黏膜病變的改善",
      "SJS/TEN 住院患者每日監測體表受累面積、體溫、感染徵象",
      "肝腎功能追蹤（藥物可能已造成多器官損傷）",
      "眼科追蹤（SJS/TEN 可導致角膜瘢痕和乾眼症）"
    ],
    "reference": "Clinical Veterinary Advisor: Dogs and Cats, 4th Edition"
  },
  "anaphylaxis-vaccine": {
    "zh": "疫苗過敏反應",
    "en": "Vaccine-Associated Anaphylaxis",
    "definition": "接種疫苗後發生的急性全身性或局部性過敏反應，由 IgE 介導的 Type I 超敏反應引起。反應可從輕度（蕁麻疹、面部水腫）到危及生命的過敏性休克（anaphylactic shock）。犬的過敏性休克以消化道和肝臟為主要靶器官，貓以呼吸道為主要靶器官。",
    "synonyms": [
      "疫苗過敏性休克",
      "疫苗不良反應",
      "Vaccine adverse event",
      "疫苗誘導性過敏反應"
    ],
    "epidemiology": {
      "species": "犬貓均可發生",
      "breed": "小型犬品種風險較高：Dachshund、Pug、Boston Terrier、Miniature Pinscher、Chihuahua；貓無明顯品種好發",
      "age": "任何年齡；年輕動物首次多劑疫苗接種時風險可能較高",
      "sex": "已絕育的犬風險可能稍高（部分流行病學研究）",
      "prevalence": "整體發生率低（犬約 0.3-0.5%，貓約 0.05%）；但嚴重過敏性休克罕見（約十萬分之一）"
    },
    "clinicalPresentation": {
      "symptoms": [
        "蕁麻疹（urticaria）：面部、耳朵、軀幹的蕁麻疹丘疹",
        "面部水腫（angioedema）：尤其眼周和嘴唇腫脹",
        "嘔吐（犬過敏性休克的早期徵象）",
        "急性腹瀉（可能帶血）",
        "呼吸困難（貓為主，喉頭水腫或支氣管痙攣）",
        "虛脫",
        "低血壓/休克",
        "瘙癢",
        "過度流涎",
        "抽搐（嚴重低氧時）"
      ],
      "physicalExam": [
        "蕁麻疹性丘疹遍布面部和軀幹",
        "面部和眼周水腫",
        "心跳加速",
        "黏膜蒼白或發紺（休克時）",
        "CRT 延長",
        "體溫可低（休克時）或升高（輕度反應）"
      ]
    },
    "pathophysiology": "疫苗中的蛋白質成分（病毒/細菌抗原、殘留培養基蛋白如牛血清白蛋白、明膠穩定劑等）作為過敏原，與先前致敏產生的特異性 IgE 結合在肥大細胞和嗜鹼性球表面。再次暴露時，過敏原交聯 IgE，觸發肥大細胞脫顆粒，大量釋放組織胺、白三烯、前列腺素和血小板活化因子。犬的過敏性休克靶器官為肝靜脈和門靜脈系統（肝靜脈收縮導致門靜脈鬱血、肝腫大和低血壓）以及腸道（黏膜水腫和出血）。貓的靶器官為呼吸道（支氣管痙攣和喉頭水腫）。這些介質導致血管擴張、通透性增加、平滑肌痙攣和分泌增加。",
    "diagnosis": {
      "primary": [
        "臨床診斷：疫苗接種後數分鐘至數小時內出現特徵性症狀",
        "時間關係是最重要的診斷依據（通常在接種後 5-30 分鐘內發生）",
        "排除其他急性過敏原因",
        "病史回顧：先前疫苗反應史"
      ],
      "differential": [
        "蟲咬過敏反應",
        "食物過敏性急性反應",
        "藥物過敏反應",
        "急性蕁麻疹其他原因",
        "血管性水腫其他原因",
        "心因性休克"
      ],
      "labFindings": [
        "通常不需要實驗室檢查即可診斷和治療",
        "嚴重休克時：血液學可見血液濃縮、低蛋白",
        "肝酶可能升高（犬門靜脈鬱血相關）",
        "血氣分析：代謝性酸中毒（休克時）"
      ]
    },
    "treatment": {
      "acute": "輕度（蕁麻疹/面部水腫）：Diphenhydramine（2 mg/kg IM）+ Dexamethasone（0.25-0.5 mg/kg IV/IM）。過敏性休克：Epinephrine（0.01 mg/kg IM/IV，1:1000 稀釋液）是一線急救藥物；同時積極靜脈輸液擴容（shock dose）、氧氣治療",
      "chronic": "未來疫苗接種策略調整：減少同時接種的疫苗數量、延長接種間隔、考慮抗體力價檢測替代常規追加接種、接種前給予抗組織胺預防",
      "medications": [
        "Epinephrine（0.01 mg/kg IM，過敏性休克一線藥物）",
        "Diphenhydramine（2 mg/kg IM/IV，H1 抗組織胺）",
        "Dexamethasone（0.25-1 mg/kg IV/IM）",
        "靜脈輸液（犬 60-90 mL/kg/hr shock rate，貓 40-60 mL/kg/hr）",
        "Aminophylline（5-10 mg/kg IV slowly，支氣管痙攣時）"
      ],
      "surgery": "無手術治療；嚴重喉頭水腫導致氣道完全阻塞時可能需要緊急氣管切開術"
    },
    "prognosis": "輕度反應（蕁麻疹、面部水腫）經治療後預後極佳，通常 12-24 小時內完全消退。過敏性休克若及時使用 Epinephrine 和積極支持治療，多數可以存活。未經治療的嚴重過敏性休克可在數分鐘至數小時內致命。曾有疫苗反應史的動物，未來再次接種同種疫苗的反應風險和嚴重程度均增加。",
    "pearls": [
      "Epinephrine 是過敏性休克的一線救命藥物——每間獸醫診所都必須備有，且所有人員應熟悉使用方法",
      "犬的過敏性休克首先表現為嘔吐和腹瀉（肝臟/腸道為靶器官），與人類的呼吸道症狀不同",
      "小型犬同時接種多種疫苗的反應風險較高——建議將疫苗分次接種，間隔 2-4 週",
      "疫苗接種後建議在醫院觀察 20-30 分鐘——大多數嚴重反應在此時間內出現"
    ],
    "diagnosticAlgorithm": {
      "title": "疫苗過敏反應 診斷流程",
      "steps": [
        {
          "step": 1,
          "action": "緊急評估",
          "details": "疫苗注射後立即或數小時內評估過敏徵象",
          "findings": [
            "面部水腫和蕁麻疹（最常見）",
            "嘔吐和腹瀉",
            "呼吸困難",
            "血壓下降和休克（嚴重過敏性休克）"
          ]
        },
        {
          "step": 2,
          "action": "嚴重度分級",
          "details": "評估過敏反應嚴重程度",
          "findings": [
            "輕度：局部腫脹、蕁麻疹",
            "中度：面部水腫、嘔吐",
            "重度：呼吸困難、心血管塌陷",
            "發作時間越短通常越嚴重"
          ]
        },
        {
          "step": 3,
          "action": "穩定與監測",
          "details": "緊急治療並監測恢復",
          "findings": [
            "腎上腺素為首選急救藥物",
            "抗組織胺和糖皮質激素輔助",
            "IV輸液支持血壓",
            "觀察雙相反應（4-12小時後復發）"
          ]
        },
        {
          "step": 4,
          "action": "記錄與預防",
          "details": "記錄反應並制定未來疫苗接種計劃",
          "findings": [
            "記錄反應的疫苗品牌和成分",
            "未來接種前預處理方案",
            "評估減少抗原數量",
            "考慮抗體效價檢測替代接種"
          ]
        }
      ]
    },
    "monitoring": [
      "疫苗接種後留院觀察 20-30 分鐘",
      "輕度反應治療後觀察 4-6 小時確認無遲發性惡化",
      "過敏性休克治療後住院 12-24 小時（可能發生雙相反應 biphasic reaction）",
      "記錄反應類型和嚴重程度於病歷中，用於未來接種策略規劃"
    ],
    "reference": "Lumb & Jones' Veterinary Anesthesia and Analgesia, 5th Edition; AAHA Canine Vaccination Guidelines"
  }
}